PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Kobayashi, H; Motoyoshi, N; Itagaki, T; Suzuki, M; Inokuchi, N				Kobayashi, Hiroko; Motoyoshi, Naomi; Itagaki, Tadashi; Suzuki, Mamoru; Inokuchi, Norio			Effect of the replacement of aspartic acid/glutamic acid residues with asparagine/glutamine residues in RNase He1 from Hericium erinaceus on inhibition of human leukemia cell line proliferation	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						inhibition of cell proliferation; site-directed mutant; Hericium erinaceus; RNase T1 family RNase	RANA-PIPIENS OOCYTES; PLEUROTUS-OSTREATUS; ASPERGILLUS-SAITOI; RIBONUCLEASE; PURIFICATION; SEQUENCE; HOMOLOGY; PROTEIN; FAMILY	RNase He1 from Hericium erinaceus, a member of the RNase T1 family, has high identity with RNase Po1 from Pleurotus ostreatus with complete conservation of the catalytic sequence. However, the optimal pH for RNase He1 activity is lower than that of RNase Po1, and the enzyme shows little inhibition of human tumor cell proliferation. Hence, to investigate the potential antitumor activity of recombinant RNase He1 and to possibly enhance its optimum pH, we generated RNase He1 mutants by replacing 12 Asn/Gln residues with Asp/Glu residues; the amino acid sequence of RNase Po1 was taken as reference. These mutants were then expressed in Escherichia coli. Using site-directed mutagenesis, we successfully modified the optimal pH for enzyme activity and generated a recombinant RNase He1 that inhibited the proliferation of cells in the human leukemia cell line. These properties are extremely important in the production of anticancer biologics that are based on RNase activity.	[Kobayashi, Hiroko; Motoyoshi, Naomi; Itagaki, Tadashi; Inokuchi, Norio] Nihon Univ, Dept Microbiol, Sch Pharm, Chiba, Japan; [Suzuki, Mamoru] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Kobayashi, H (reprint author), Nihon Univ, Dept Microbiol, Sch Pharm, Chiba, Japan.	kobayashi.hiroko@nihon-u.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was performed under the Cooperative Research Program of Institute for Protein Research, Osaka University.	SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Huang HC, 1998, J BIOL CHEM, V273, P6395, DOI 10.1074/jbc.273.11.6395; Yoshida H, 2001, METHOD ENZYMOL, V341, P28; ABERCROMBIE M, 1962, CANCER RES, V22, P525; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Ardelt W, 2008, CURR PHARM BIOTECHNO, V9, P215, DOI 10.2174/138920108784567245; ARDELT W, 1991, J BIOL CHEM, V266, P245; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ARNI R, 1988, J BIOL CHEM, V263, P15358; IRIE M, 1967, J BIOCHEM-TOKYO, V62, P509; Kobayashi H, 2014, BIOL PHARM BULL, V37, P968, DOI 10.1248/bpb.b13-00929; Kobayashi H, 2013, BIOSCI BIOTECH BIOCH, V77, P1486, DOI 10.1271/bbb.130133; NOMURA H, 1994, J BIOCHEM-TOKYO, V116, P26; OHGI K, 1993, J BIOCHEM-TOKYO, V113, P219; SACCO G, 1983, J BIOL CHEM, V258, P5811; Takahashi K., 1971, J BIOL CHEM, V240, P4117; TITANI K, 1987, BIOCHEMISTRY-US, V26, P2189, DOI 10.1021/bi00382a018; WATANABE H, 1982, J BIOCHEM-TOKYO, V91, P1495	18	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					211	217		10.1080/09168451.2014.972327		7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900007		
J	Yamamoto, K; Nonaka, G; Ozawa, T; Takumi, K; Ishihama, A				Yamamoto, Kaneyoshi; Nonaka, Gen; Ozawa, Takahiro; Takumi, Kazuhiro; Ishihama, Akira			Induction of the Escherichia coli yijE gene expression by cystine	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						cystine resistance; Escherichia coli; yijE; genome expression; cystine	TRANSCRIPTIONAL RESPONSE; CYSTEINE; IDENTIFICATION; SUPERFAMILY; PROMOTERS; TRANSPORT; PROTEIN; EXPORT	Cystine is formed from two molecules of the cysteine under oxidized conditions, but is reversibly converted to cysteine by reduction. Growth of Escherichia coli is retarded in the presence of excess cystine. Transcriptome analysis showed 11 up-regulated and 26 down-regulated genes upon exposure to excess cystine. The reporter assay confirmed regulation by cystine of the expression of one up-regulated membrane gene, yijE, and two down-regulated membrane genes, yhdT and yihN. In order to identify the as yet unidentified gene encoding cystine efflux transporter, the putative cystine efflux candidate, yijE gene, was over-expressed. Expression of the yijE gene suppressed the slow growth of E. coli in the presence of high concentration of extracellular cystine. In good agreement, the knock-out of yijE gene increased the sensibility to cystine. These observations altogether imply that the yijE gene is involved in response to cystine in E. coli.	[Yamamoto, Kaneyoshi; Ozawa, Takahiro; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan; [Yamamoto, Kaneyoshi; Ozawa, Takahiro; Ishihama, Akira] Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo 184, Japan; [Nonaka, Gen; Takumi, Kazuhiro] Ajinomoto Co Inc, Res Inst Biosci Prod & Fine Chem, Kawasaki, Kanagawa, Japan	Yamamoto, K (reprint author), Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan.	kanyamam@hosei.ac.jp			Ajinomoto Co. Ltd of Japan; MEXT [S0801037]	This work was supported by Grant from Ajinomoto Co. Ltd of Japan and MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2008-2012 (S0801037).	Ohtsu I, 2010, J BIOL CHEM, V285, P17479, DOI 10.1074/jbc.M109.081356; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Yamada S, 2006, APPL ENVIRON MICROB, V72, P4735, DOI 10.1128/AEM.02507-05; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Dassler T, 2000, MOL MICROBIOL, V36, P1101, DOI 10.1046/j.1365-2958.2000.01924.x; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Kurata T, 2013, J BACTERIOL, V195, P4496, DOI 10.1128/JB.00304-13; Pittman MS, 2002, J BIOL CHEM, V277, P49841, DOI 10.1074/jbc.M205615200; Yamamoto K, 2005, J BACTERIOL, V187, P6333, DOI 10.1128/JB.187.18.6333-6340.2005; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Jishage M, 1997, J BACTERIOL, V179, P959; BAPTIST EW, 1977, J BACTERIOL, V131, P111; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; ASQUITH RS, 1969, BIOCHIM BIOPHYS ACTA, V184, P345, DOI 10.1016/0304-4165(69)90037-3; Baba T, 2006, MOL SYSTEMS BIOL, V2006: 0008, P1; Desai KK, 2010, P NATL ACAD SCI USA, V107, P17958; Miller J. H., 1972, EXPT MOL GENETICS; Shinohara K, 1934, J BIOL CHEM, V105, P241; VANET A, 1993, J BACTERIOL, V175, P7178; Yamanaka Y, 2012, BIOSCI BIOTECH BIOCH, V76, P1236, DOI 10.1271/bbb.120041	24	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					218	222		10.1080/09168451.2014.972328		5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900008		
J	Kusumoto, T; Aoyagi, M; Sugiyama, T; Sakamoto, J				Kusumoto, Tomoichirou; Aoyagi, Makoto; Sugiyama, Takahiko; Sakamoto, Junshi			Monitoring the enzyme expression in a respiratory chain of Corynebacterium glutamicum in a copper ion-supplemented culture medium	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						EGFP; Corynebacterium glutamicum; respiratory chain; promoter activity; copper ion	CYTOCHROME; PURIFICATION; BACTERIA; FEATURES; GENOME	Corynebacterium glutamicum has a branched respiratory chain: one of the branches is cytochrome bcc complex and cytochrome aa(3)-type cytochrome c oxidase, and the other is cytochrome bd-type menaquinol oxidase. The factors that influence the expression patterns of these respiratory enzymes remain unclear. To investigate the expressional control mechanism of the enzymes, we have previously constructed a promoter assay system utilizing enhanced green fluorescence protein. Here, we monitored respiratory enzymes' expression by using this system during growth in various culture media, with and without Cu2+ ion supplementation. The promoter activities of cytochrome aa(3) oxidase in the early stationary phase in the media supplemented with Cu2+ ion at 40 or 400 mu M were significantly increased 1.49-fold or 1.99-fold, respectively, as compared to the control. Moreover, the H+/O ratio, or the proton-pumping activity of the cells, increased about 1.6 times by the Cu2+ supplementation. These facts indicate that copper ions can switch the branches.	[Kusumoto, Tomoichirou; Aoyagi, Makoto; Sugiyama, Takahiko; Sakamoto, Junshi] Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan	Sakamoto, J (reprint author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan.	sakamoto@bio.kyutech.ac.jp			Japan Society for the Promotion of Science [25440050]	This work was supported in part by Grants-in-Aid for Scientific Research (C) [grant number 25440050 to JS] from the Japan Society for the Promotion of Science.	Sakamoto J, 2001, MICROBIOL-SGM, V147, P2865; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Kim YH, 2006, PROTEOMICS, V6, P1301, DOI 10.1002/pmic.200500329; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Hau mann U, 2009, PROTEOMICS, V9, P3635, DOI [10. 1002/pmic. v9:14, DOI 10.1002/PMIC.V9:14]; Kabashima Y, 2009, J BIOCHEM, V146, P845, DOI 10.1093/jb/mvp140; Kurokawa T, 2005, ARCH MICROBIOL, V183, P317, DOI 10.1007/s00203-005-0775-8; Kusumoto K, 2000, ARCH MICROBIOL, V173, P390, DOI 10.1007/s002030000161; Kusumoto T, 2011, J BIOENERG BIOMEMBR, V43, P257, DOI 10.1007/s10863-011-9355-6; Matsushita K, 2001, FEMS MICROBIOL LETT, V204, P271, DOI 10.1111/j.1574-6968.2001.tb10896.x; MIWA K, 1985, GENE, V39, P281; Sakamoto J, 2004, ADV PHOTO RESPIRAT, V15, P87; Sone N, 2001, BBA-BIOENERGETICS, V1503, P279, DOI 10.1016/S0005-2728(00)00205-X; Sone Nobuhito, 2004, V16, P35; SUGIYAMA Y, 1973, AGR BIOL CHEM TOKYO, V37, P1837	17	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					223	229		10.1080/09168451.2014.968089		7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900009		
J	Bualuang, A; Kageyama, H; Tanaka, Y; Incharoensakdi, A; Takabe, T				Bualuang, Aporn; Kageyama, Hakuto; Tanaka, Yoshito; Incharoensakdi, Aran; Takabe, Teruhiro			Functional characterization of a member of alanine or glycine: cation symporter family in halotolerant cyanobacterium Aphanothece halophytica	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						salt stress; halotolerant cyanobacteria; alanine or glycine:cation symporter; amino acid uptake; nitrogen deficient	ESCHERICHIA-COLI K-12; TRANSPORT-SYSTEM; MARINE BACTERIUM; CARRIER PROTEIN; SALT STRESS; IDENTIFICATION; GENES; SUPERFAMILY; SEQUENCE	Membrane proteins of amino acid-polyamine-organocation (APC) superfamily transport amino acids and amines across membranes and play important roles in the regulation of cellular processes. The alanine or glycine: cation symporter (AGCS) family belongs to APC superfamily and is found in prokaryotes, but its substrate specificity remains to be clarified. In this study, we found that a halotolerant cyanobacterium, Aphanothece halophytica has two putative ApagcS genes. The deduced amino acid sequence of one of genes, ApagcS1, exhibited high homology to Pseudomonas AgcS. The ApagcS1 gene was expressed in Escherichia coli JW4166 which is deficient in glycine uptake. Kinetics studies in JW4166 revealed that ApAgcS1 is a sodium-dependent glycine transporter. Competition experiments showed the significant inhibition by glutamine, asparagine, and glycine. The level of mRNA for ApagcS1 was induced by NaCl and nitrogen-deficient stresses. Uptake of glutamine by ApAgcS1 was also observed. Based on these data, the physiological role of ApAgcS1 was discussed.	[Bualuang, Aporn; Kageyama, Hakuto; Tanaka, Yoshito; Takabe, Teruhiro] Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi, Japan; [Bualuang, Aporn; Incharoensakdi, Aran] Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Takabe, Teruhiro] Meijo Univ, Res Inst, Nagoya, Aichi, Japan	Takabe, T (reprint author), Meijo Univ, Grad Sch Environm & Human Sci, Nagoya, Aichi, Japan.	takabe@meijo-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; International Research Center for Natural Environmental Science of Meijo University; Office of the Higher Education Commission of Thailand; 90th Anniversary of Chulalongkorn University Ratchadaphiseksomphot Endowment Fund	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the International Research Center for Natural Environmental Science of Meijo University (TT). It was also supported by the Office of the Higher Education Commission of Thailand, through a grant in the program "Strategic Scholarships for Frontier Research Network for the Ph.D. Program, Thai Doctoral Degree" and the 90th Anniversary of Chulalongkorn University Ratchadaphiseksomphot Endowment Fund for a Ph.D. Scholarship (to AB).	Akane S, 1999, J BIOCH, V133, P173; Waditee R, 2005, P NATL ACAD SCI USA, V102, P1318, DOI 10.1073/pnas.0409017102; Waditee R, 2003, J BIOL CHEM, V278, P4932, DOI 10.1074/jbc.M210970200; Quintero MJ, 2001, GENOME RES, V11, P2034, DOI 10.1101/gr.196301; Jack DL, 2000, MICROBIOL-SGM, V146, P1797; Satomura T, 2005, J BACTERIOL, V187, P4813, DOI 10.1128/JB.187.4.4813-4821.2005; STANIER RY, 1971, BACTERIOL REV, V35, P171; Boonburapong B, 2012, BIOSCI BIOTECH BIOCH, V76, P1702, DOI 10.1271/bbb.120309; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Flores E, 2014, CELL BIOL CYANOBACTE, P1; GHRIST AC, 1995, MICROBIOL-UK, V141, P133; KAMATA H, 1992, J BIOL CHEM, V267, P21650; Kanamori M, 1999, J BIOCHEM-TOKYO, V125, P454; Laloknam S, 2006, APPL ENVIRON MICROB, V72, P6018, DOI 10.1128/AEM.00733-06; MACLEOD PR, 1992, MOL MICROBIOL, V6, P2673, DOI 10.1111/j.1365-2958.1992.tb01444.x; MACLEOD PR, 1986, J BACTERIOL, V165, P825; Pernil R, 2008, MOL MICROBIOL, V67, P1067, DOI 10.1111/j.1365-2958.2008.06107.x; REIZER J, 1994, BBA-REV BIOMEMBRANES, V1197, P133, DOI 10.1016/0304-4157(94)90003-5; ROBBINS JC, 1973, J BACTERIOL, V116, P12; Waditee-Sirisattha R, 2014, APPL ENVIRON MICROB, V80, P1763, DOI 10.1128/AEM.03729-13	20	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					230	235		10.1080/09168451.2014.968091		6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900010		
J	Mori, S; Kim, H; Rimbara, E; Arakawa, Y; Shibayama, K				Mori, Shigetarou; Kim, Hyun; Rimbara, Emiko; Arakawa, Yoshichika; Shibayama, Keigo			Roles of Ala-149 in the catalytic activity of diadenosine tetraphosphate phosphorylase from Mycobacterium tuberculosis H37Rv	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						kinetics; phosphorylase; mycobacteria; drug target	HISTIDINE TRIAD SUPERFAMILY; FHIT; HYDROLASE; MECHANISM; INSIGHTS; HINT	Diadenosine 5 ',5 '''-P-1,P-4-tetraphosphate (Ap(4)A) phosphorylase from Mycobacterium tuberculosis H37Rv (MtAPA) belongs to the histidine triad motif (HIT) superfamily, but is the only member with an alanine residue at position 149 (Ala-149). Enzymatic analysis revealed that the Ala-149 deletion mutant displayed substrate specificity for diadenosine 5 ',5 '''-P-1,P-5-pentaphosphate and was inactive on Ap(4)A and other substrates that are utilized by the wild-type enzyme.	[Mori, Shigetarou; Kim, Hyun; Rimbara, Emiko; Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Musashimurayama, Japan; [Arakawa, Yoshichika] Nagoya Univ, Dept Bacteriol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Mori, S (reprint author), Natl Inst Infect Dis, Dept Bacteriol 2, Musashimurayama, Japan.	mshige@nih.go.jp	Arakawa, Yoshichika/P-5997-2015		Ministry of Health, Labor, and Welfare of Japan [H25-Shinkou-Ippan-005, H24-Shinkou-Ippan-010]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24780088]	This study was funded by grants from the Ministry of Health, Labor, and Welfare of Japan [H25-Shinkou-Ippan-005 and H24-Shinkou-Ippan-010] to K.S. and a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan [24780088] to S.M.	Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Pace HC, 1998, P NATL ACAD SCI USA, V95, P5484, DOI 10.1073/pnas.95.10.5484; Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; FARR SB, 1989, P NATL ACAD SCI USA, V86, P5010, DOI 10.1073/pnas.86.13.5010; Hou WT, 2013, J MOL BIOL, V425, P2687, DOI 10.1016/j.jmb.2013.04.018; Krakowiak A, 2004, J BIOL CHEM, V279, P18711, DOI 10.1074/jbc.M314271200; McCoy JG, 2006, BIOCHEMISTRY-US, V45, P3154, DOI 10.1021/bi052232m; Mori S, 2011, J MOL BIOL, V410, P93, DOI 10.1016/j.jmb.2011.04.059; Mori S, 2010, PROTEIN EXPRES PURIF, V69, P99, DOI 10.1016/j.pep.2009.09.010; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109	13	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					236	238		10.1080/09168451.2014.973364		3	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900011		
J	Kim, J; Montagne, K; Ushida, T; Furukawa, K				Kim, Jeonghyun; Montagne, Kevin; Ushida, Takashi; Furukawa, Katsuko			Enhanced chondrogenesis with upregulation of PKR using a novel hydrostatic pressure bioreactor	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						ATDC5; chondrogenesis; mechanotransduction; bioreactor; hydrostatic pressure	ARTICULAR CHONDROCYTES	In this study, we developed a novel bioreactor to load hydrostatic pressure to promote chondrogenesis of prechondrogenic ATDC5 cells in as little as 3days. Furthermore, we showed that loading hydrostatic pressure induced the upregulation of PKR, which is known to participate in mechanotransduction in various models.	[Kim, Jeonghyun; Furukawa, Katsuko] Univ Tokyo, Dept Mech Engn, Grad Sch Engn, Tokyo 113, Japan; [Montagne, Kevin; Ushida, Takashi] Univ Tokyo, Sch Med, Ctr Dis Biol & Integrat Med, Div Regenerat Med Engn, Tokyo 113, Japan; [Furukawa, Katsuko] Univ Tokyo, Dept Bioengn, Grad Sch Engn, Tokyo, Japan	Furukawa, K (reprint author), Univ Tokyo, Dept Mech Engn, Grad Sch Engn, 7-3-1 Hongo, Tokyo 113, Japan.	furukawa@mech.u-tokyo.ac.jp					Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Newton PT, 2012, INT J MOL MED, V30, P1187, DOI 10.3892/ijmm.2012.1114; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Elder BD, 2009, TISSUE ENG, V15, P1; Gardinier JD, 2008, CELL MOL BIOENG, V2, P133; Kawanishi M, 2007, TISSUE ENG, V13, P957, DOI 10.1089/ten.2006.0176; Lomas C, 2011, EUR CELLS MATER, V22, P178; Nagatomi J, 2003, ANN BIOMED ENG, V31, P917, DOI 10.1114/1.1553454; WILLIAMS BRG, 1995, SEMIN VIROL, V6, P191, DOI 10.1006/smvy.1995.0024	9	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					239	241		10.1080/09168451.2014.975184		3	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900012		
J	Yamazaki, S; Yamamoto, K; Tokunaga, M; Sakata-Sogawa, K; Harata, M				Yamazaki, Shota; Yamamoto, Koji; Tokunaga, Makio; Sakata-Sogawa, Kumiko; Harata, Masahiko			Nuclear actin activates human transcription factor genes including the OCT4 gene	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						transcription; transcription microarray; nuclear actin; OCT4	VISUALIZATION; FILAMENTS; PROTEINS; CELLS	RNA microarray analyses revealed that nuclear actin activated many human transcription factor genes including OCT4, which is required for gene reprogramming. Oct4 is known to be activated by nuclear actin in Xenopus oocytes. Our findings imply that this process of OCT4 activation is conserved in vertebrates and among cell types and could be used for gene reprogramming of human cells.	[Yamazaki, Shota; Yamamoto, Koji; Harata, Masahiko] Tohoku Univ, Grad Sch Agr Sci, Lab Mol Biol, Sendai, Miyagi 980, Japan; [Tokunaga, Makio; Sakata-Sogawa, Kumiko] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Tokunaga, Makio; Sakata-Sogawa, Kumiko] RIKEN Ctr Integrat Med Sci IMS, Yokohama, Kanagawa, Japan	Harata, M (reprint author), Tohoku Univ, Grad Sch Agr Sci, Lab Mol Biol, Sendai, Miyagi 980, Japan.	mharata@biochem.tohoku.ac.jp			Human Frontier Science Program [RGP0017]	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas to M.T., K.S-S., and M.H., and by the Human Frontier Science Program (RGP0017) to M.H. S.K. was supported by Grant-in-Aid for JSPS Fellows.	Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Herget-Rosenthal S, 2001, AM J PHYSIOL-CELL PH, V281, pC1858; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Kalendova A, 2014, HISTOCHEM CELL BIOL, V142, P139, DOI 10.1007/s00418-014-1243-9; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Belin BJ, 2013, MOL BIOL CELL, V24, P982, DOI 10.1091/mbc.E12-09-0685; Fenn S, 2011, BIOARCHITECTURE, V1, P192; Nishimoto N, 2012, J CELL SCI, V125, P3870, DOI 10.1242/jcs.104349; Oma Y, 2011, NUCLEUS-AUSTIN, V2, P38, DOI 10.4161/nucl.2.1.14510	13	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					242	246		10.1080/09168451.2014.972332		5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900013		
J	Nishiyama, K; Nakamata, K; Ueno, S; Terao, A; Aryantini, NPD; Sujaya, IN; Fukuda, K; Urashima, T; Yamamoto, Y; Mukai, T				Nishiyama, Keita; Nakamata, Koichi; Ueno, Shintaro; Terao, Akari; Aryantini, Ni Putu Desy; Sujaya, I. Nengah; Fukuda, Kenji; Urashima, Tadasu; Yamamoto, Yuji; Mukai, Takao			Adhesion properties of Lactobacillus rhamnosus mucus-binding factor to mucin and extracellular matrix proteins	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						extracellular matrix (ECM) proteins; Lactobacillus rhamnosus; bacterial adhesion; mucus-binding factor	GRAM-POSITIVE BACTERIA; LACTIC-ACID BACTERIA; LISTERIA-MONOCYTOGENES; SURFACE-PROTEINS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; GG; ADHERENCE; STRAINS; FIBRONECTIN	We previously described potential probiotic Lactobacillus rhamnosus strains, isolated from fermented mare milk produced in Sumbawa Island, Indonesia, which showed high adhesion to porcine colonic mucin (PCM) and extracellular matrix (ECM) proteins. Recently, mucus-binding factor (MBF) was found in the GG strain of L. rhamnosus as a mucin-binding protein. In this study, we assessed the ability of recombinant MBF protein from the FSMM22 strain, one of the isolates of L. rhamnosus from fermented Sumbawa mare milk, to adhere to PCM and ECM proteins by overlay dot blot and Biacore assays. MBF bound to PCM, laminin, collagen IV, and fibronectin with submicromolar dissociation constants. Adhesion of the FSMM22 mbf mutant strain to PCM and ECM proteins was significantly less than that of the wild-type strain. Collectively, these results suggested that MBF contribute to L. rhamnosus host colonization via mucin and ECM protein binding.	[Nishiyama, Keita; Nakamata, Koichi; Ueno, Shintaro; Terao, Akari; Yamamoto, Yuji; Mukai, Takao] Kitasato Univ, Sch Vet Med, Dept Anim Sci, Towada, Aomori, Japan; [Aryantini, Ni Putu Desy; Fukuda, Kenji; Urashima, Tadasu] Obihiro Univ Agr & Vet Med, Dept Anim & Food Hyg, Obihiro, Hokkaido 080, Japan; [Sujaya, I. Nengah] Udayana Univ, Integrated Lab Biosci & Biotechnol, Badung, Bali, Indonesia	Mukai, T (reprint author), Kitasato Univ, Sch Vet Med, Dept Anim Sci, Towada, Aomori, Japan.	mukai@vmas.kitasato-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24580397]; Kitasato Research Project for Lactic Acid Bacteria	This work was supported in part by the Japan Society for the Promotion of Science (JSPS) under Grant-in-Aid for Scientific Research C (24580397) and Kitasato Research Project for Lactic Acid Bacteria.	MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Lebeer S, 2010, BENEF MICROBES, V1, P335, DOI 10.3920/BM2010.0032; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; BISWAS I, 1993, J BACTERIOL, V175, P3628; Etzold S, 2014, MOL MICROBIOL, V92, P543, DOI 10.1111/mmi.12574; Servin AL, 2003, BEST PRACT RES CL GA, V17, P741, DOI 10.1016/S1521-6918(03)00052-0; Velez MP, 2010, FEMS IMMUNOL MED MIC, V59, P386, DOI 10.1111/j.1574-695X.2010.00680.x; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; Velez MP, 2007, FEMS MICROBIOL LETT, V276, P140, DOI 10.1111/j.1574-6968.2007.00908.x; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; KOK J, 1984, APPL ENVIRON MICROB, V48, P726; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119; Horie M, 2002, J APPL MICROBIOL, V92, P396, DOI 10.1046/j.1365-2672.2002.01539.x; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Ross CL, 2012, J BIOL CHEM, V287, P34856, DOI 10.1074/jbc.M112.371054; Kang MS, 2013, J BIOL CHEM, V288, P20520, DOI 10.1074/jbc.M113.454462; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Etzold S, 2014, ENVIRON MICROBIOL, V16, P888, DOI 10.1111/1462-2920.12377; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Sabet C, 2005, INFECT IMMUN, V73, P6912, DOI 10.1128/IAI.73.10.6912-6922.2005; Johnson-Henry KC, 2007, CELL MICROBIOL, V9, P356, DOI 10.1111/j.1462-5822.2006.00791.x; Heilmann C, 2005, INFECT IMMUN, V73, P4793, DOI 10.1128/IAI.73..8.4793-4802.2005; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; De Keersmaecker SCJ, 2006, APPL ENVIRON MICROB, V72, P4923, DOI 10.1128/AEM.02605-05; Douillard FP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003683; Linden SK, 2008, ARCH MICROBIOL, V190, P101, DOI 10.1007/s00203-008-0358-6; Lorca G, 2002, FEMS MICROBIOL LETT, V206, P31, DOI 10.1016/S0378-1097(01)00512-2; Nishiyama K, 2014, BIOSCI BIOTECH BIOCH, V78, P1444, DOI 10.1080/09168451.2014.918491; Shi T, 2012, BIOSCI BIOTECH BIOCH, V76, P1897, DOI 10.1271/bbb.120385; Styriak I, 2003, LETT APPL MICROBIOL, V37, P329, DOI 10.1046/j.1472-765X.2003.01402.x; Toba FA, 2013, FEMS MICROBIOL LETT, V338, P24, DOI 10.1111/1574-6968.12018; von Ossowski I, 2011, APPL ENVIRON MICROB, V77, P4465, DOI 10.1128/AEM.02497-10	37	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					271	279		10.1080/09168451.2014.972325		9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900017		
J	Iwasaki, Y; Takahashi, S; Aizawa, K; Mukai, K				Iwasaki, Yuko; Takahashi, Shingo; Aizawa, Koichi; Mukai, Kazuo			Development of singlet oxygen absorption capacity (SOAC) assay method. 4. Measurements of the SOAC values for vegetable and fruit extracts	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						SOAC value; carotenoids; quenching rate; singlet oxygen; food extracts	BIOLOGICAL-SYSTEMS; MOLECULAR-OXYGEN; ANTIOXIDANT CAPACITY; QUENCHING REACTION; CAROTENOIDS; PHOTOOXIDATION; CONSEQUENCES; QUANTITATION; FLAVONOIDS; CHEMISTRY	Measurements of the second-order rate constants and the singlet oxygen absorption capacity (SOAC) values for the reaction of singlet oxygen (O-1(2)) with 23 kinds of food extracts were performed in ethanol/chloroform/D2O (50:50:1, v/v/v) solution at 35 degrees C. It has been clarified that the SOAC method is useful to evaluate the O-1(2)-quenching activity (i.e. the SOAC value) of food extracts having two orders of magnitude different rate constants from 3.18x10(4)Lg(-1)s(-1) for tomato to 1.55x10(2) for green melon. Furthermore, comparison of the observed rate constants for the above food extracts with the calculated ones based on the concentrations of seven kinds of carotenoids included in the food extracts and the rate constants reported for each carotenoids was performed, in order to ascertain the validity of the SOAC assay method developed and to clarify the ratio of the contribution of principal carotenoids to the SOAC value.	[Iwasaki, Yuko; Takahashi, Shingo; Aizawa, Koichi] Kagome Co Ltd, Res & Dev Div, Nasushiobara, Japan; [Mukai, Kazuo] Ehime Univ, Fac Sci, Dept Chem, Matsuyama, Ehime 790, Japan	Iwasaki, Y (reprint author), Kagome Co Ltd, Res & Dev Div, Nasushiobara, Japan.	Yuko_Kino@kagome.co.jp; mukai-k@dpc.ehime-u.ac.jp					DI MASCIO P, 1992, METHOD ENZYMOL, V213, P429; Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; [Anonymous], 1992, ANN NY ACAD SCI, DOI DOI 10.1111/NYAS.1992.669.ISSUE-1; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1; Miyamoto S, 2003, J AM CHEM SOC, V125, P4510, DOI 10.1021/ja029262m; GIROTTI AW, 1990, PHOTOCHEM PHOTOBIOL, V51, P497, DOI 10.1111/j.1751-1097.1990.tb01744.x; MANGELS AR, 1993, J AM DIET ASSOC, V93, P284, DOI 10.1016/0002-8223(93)91553-3; Aizawa K, 2007, FOOD SCI TECHNOL RES, V13, P247, DOI 10.3136/fstr.13.247; Omata Y, 2008, J AGR FOOD CHEM, V56, P3386, DOI 10.1021/jf703771v; YOUNG RH, 1971, J AM CHEM SOC, V93, P5774, DOI 10.1021/ja00751a031; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; MURPHY ME, 1990, METHOD ENZYMOL, V186, P595; Sookwong P, 2007, J AGR FOOD CHEM, V55, P461, DOI 10.1021/jf0621572; DEVASAGAYAM TPA, 1991, BIOCHEMISTRY-US, V30, P6283, DOI 10.1021/bi00239a029; Tuberoso CIG, 2007, FOOD CHEM, V103, P1494, DOI 10.1016/j.foodchem.2006.08.014; PIETTE J, 1991, J PHOTOCH PHOTOBIO B, V11, P241, DOI 10.1016/1011-1344(91)80030-L; THOMAS MJ, 1978, PHOTOCHEM PHOTOBIOL, V27, P683, DOI 10.1111/j.1751-1097.1978.tb07665.x; FOOTE CS, 1968, J AM CHEM SOC, V90, P6233, DOI 10.1021/ja01024a061; Aizawa K, 2011, J AGR FOOD CHEM, V59, P3717, DOI 10.1021/jf104955a; Deli J, 2001, J AGR FOOD CHEM, V49, P1517, DOI 10.1021/jf000958d; CAO GH, 1993, FREE RADICAL BIO MED, V14, P303, DOI 10.1016/0891-5849(93)90027-R; Ouchi A, 2010, J AGR FOOD CHEM, V58, P9967, DOI 10.1021/jf101947a; Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w; Takashima M, 2012, FREE RADICAL BIO MED, V52, P1242, DOI 10.1016/j.freeradbiomed.2012.01.010; Wu XL, 2004, J FOOD COMPOS ANAL, V17, P407, DOI 10.1016/j.jfca.2004.03.001; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Mukai K, 2012, J AGR FOOD CHEM, V60, P7905, DOI 10.1021/jf302021r; Holden Joanne M., 1999, Journal of Food Composition and Analysis, V12, P169, DOI 10.1006/jfca.1999.0827; Hu J.-N, 2009, J FOOD SCI NUTR, V14, P260, DOI DOI 10.3746/JFN.2009.14.3.260; KANOFSKY JR, 1989, CHEM-BIOL INTERACT, V70, P1, DOI 10.1016/0009-2797(89)90059-8; Miyamoto S, 2012, PHOTOCH PHOTOBIO SCI, V11, P1536, DOI 10.1039/c2pp25119a; Nagai S, 2005, J PHYS CHEM B, V109, P4234, DOI 10.1021/jp0451389; TANIELIAN C, 1988, PHOTOCHEM PHOTOBIOL, V48, P277, DOI 10.1111/j.1751-1097.1988.tb02821.x	34	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					280	291		10.1080/09168451.2014.972329		12	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900018		
J	Tsuji, A; Nakamura, T; Shibata, K				Tsuji, Ai; Nakamura, Toshinobu; Shibata, Katsumi			Biotin-deficient diet induces chromosome misalignment and spindle defects in mouse oocytes	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						oocyte quality; biotin; mouse; deficiency	GENE-EXPRESSION; 3-HYDROXYISOVALERIC ACID; PYRUVATE-CARBOXYLASE; URINARY-EXCRETION; MICE; BIOTINYLATION; METABOLISM; MATURATION; TARGETS; HUMANS	Increased abnormal oocytes due to meiotic chromosome misalignment and spindle defects lead to elevated rates of infertility, miscarriage, and trisomic conceptions. Here, we investigated the effect of biotin deficiency on oocyte quality. Three-week-old female ICR mice were fed a biotin-deficient or control diet (0, 0.004g biotin/kg diet) for 21days. On day 22, these mouse oocytes were analyzed by immunofluorescence. Due to biotin, undernutrition increased the frequency of abnormal oocytes (the biotin deficient vs. control: 40 vs. 16%). Next, the remaining mice in the biotin-deficient group were fed a control or biotin-deficient diet from day 22 to 42. Although biotin nutritional status in the recovery group was restored, the frequency of abnormal oocytes in the recovery group was still higher than that in the control group (48 vs. 18%). Our results indicate that steady, sufficient biotin intake is required for the production of high-quality oocytes in mice.	[Tsuji, Ai; Shibata, Katsumi] Univ Shiga Prefecture, Dept Nutr, Sch Human Cultures, Hikone, Japan; [Nakamura, Toshinobu] Nagahama Inst Biosci & Technol, Dept Anim Biosci, Nagahama, Japan	Shibata, K (reprint author), Univ Shiga Prefecture, Dept Nutr, Sch Human Cultures, Hikone, Japan.	kshibata@shc.usp.ac.jp			Japan Society for the Promotion of Science	This investigation was part of the project "Studies on the nutritional evaluation of amino acids and B-group vitamins" (principal investigator, Katsumi Shibata), which was supported by the Research Grant from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science.	Baez-Saldana A, 2009, STEROIDS, V74, P863, DOI 10.1016/j.steroids.2009.06.004; Gallardo ME, 2001, AM J HUM GENET, V68, P334, DOI 10.1086/318202; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Zempleni J, 2005, ANNU REV NUTR, V25, P175, DOI 10.1146/annurev.nutr.25.121304.131724; Baez-Saldana A, 2004, J NUTR, V134, P1970; FUKUI T, 1994, J NUTR SCI VITAMINOL, V40, P491; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Dakshinamurti K, 2005, J NUTR BIOCHEM, V16, P419, DOI 10.1016/j.jnutbio.2005.03.015; Camporeale G, 2004, EUR J BIOCHEM, V271, P2257, DOI 10.1111/j.1432-1033.2004.04167.x; Chew YC, 2006, J NUTR BIOCHEM, V17, P225, DOI 10.1016/j.jnutbio.2005.05.003; Downs SM, 2002, MOL REPROD DEV, V62, P113, DOI 10.1002/mrd.10067; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Ma JY, 2013, CELL CYCLE, V12, P1928, DOI 10.4161/cc.24991; Eng WK, 2013, BRIT J NUTR, V110, P321, DOI 10.1017/S0007114512005065; Kobza K, 2005, FEBS J, V272, P4249, DOI 10.1111/j.1742-4658.2005.04839.x; Combelles CMH, 2001, DEV BIOL, V239, P281, DOI 10.1006/dbio.2001.0444; WASTELL HJ, 1988, ARCH DIS CHILD, V63, P1244; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; Muhlhauser A, 2009, BIOL REPROD, V80, P1066, DOI 10.1095/biolreprod.108.074815; SUCHY SF, 1986, AM J CLIN NUTR, V43, P831; Baez-Saldana A, 2009, EUR J NUTR, V48, P137, DOI 10.1007/s00394-009-0773-8; DAKSHINAMURTI K, 1989, VITAM HORM, V45, P337, DOI 10.1016/S0083-6729(08)60398-2; FREYTAG SO, 1980, P NATL ACAD SCI-BIOL, V77, P1321, DOI 10.1073/pnas.77.3.1321; Harris SE, 2009, MOL REPROD DEV, V76, P231, DOI 10.1002/mrd.20945; Horvath TD, 2011, ANAL BIOANAL CHEM, V401, P2805, DOI 10.1007/s00216-011-5356-x; Jitrapakdee S, 2005, J BIOL CHEM, V280, P27466, DOI 10.1074/jbc.M503836200; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Lu Q, 2002, BIOL REPROD, V66, P29, DOI 10.1095/biolreprod66.1.29; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; McLean A. C., 2012, JOVE-J VIS EXP, V67, pe4389, DOI [10.3791/4389, DOI 10.3791/4389]; Mock DM, 2002, J NUTR, V132, P1945; Mock DM, 2005, J NUTR BIOCHEM, V16, P435, DOI 10.1016/j.jnutbio.2005.03.022; Mock DM, 2003, J NUTR, V133, P2519; Mock NI, 1997, AM J CLIN NUTR, V65, P951; Reeves RG, 1997, J NUTR, V127, p838S; Rodriguez-Fuentes N, 2007, MOL GENET METAB, V92, P222, DOI 10.1016/j.ymgme.2007.06.021; Rodriguez-Melendez R, 2003, J NUTR BIOCHEM, V14, P680, DOI 10.1016/j.jnutbio.2003.07.001; Rodriguez-Melendez R, 1999, MOL GENET METAB, V66, P16, DOI 10.1006/mgme.1998.2777; Smith EM, 2007, J NUTR, V137, P2006; Wang X, 2003, MOL REPROD DEV, V64, P96, DOI 10.1002/mrd.10213; Watanabe T, 2005, J NUTR, V135, P615; Watanabe T, 1996, EXPERIENTIA, V52, P149, DOI 10.1007/BF01923361; WATANABE T, 1990, TERATOLOGY, V42, P295, DOI 10.1002/tera.1420420313; WATANABE T, 1993, J NUTR, V123, P2101; Yamada M, 2012, SCI REP, V2, P1	46	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					292	299		10.1080/09168451.2014.968090		8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900019		
J	Minamida, K; Nishimura, M; Miwa, K; Nishihira, J				Minamida, Kimiko; Nishimura, Mie; Miwa, Kazunori; Nishihira, Jun			Effects of dietary fiber with Bacillus coagulans lilac-01 on bowel movement and fecal properties of healthy volunteers with a tendency for constipation	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						constipation; Bacillus coagulans; human trial; synbiotics; okara		To elucidate the effects of Lilac LAB(Bacillus coagulans lilac-01 and okara [soy pulp] powder) on bowel movements/fecal properties, we conducted a double-blind placebo-controlled randomized trial with healthy Japanese volunteers with a tendency for constipation (n=297). The subjects ingested 2g/d placebo (okara powder) or test food (Lilac LAB, 1x10(8)CFU) once a day for 2weeks. In the test group of functionally constipated subjects, the changes in the average scores of self-reported fecal size, sensation of incomplete evacuation, and defecation frequency were significantly improved compared to the placebo group (p<0.05), and fecal color and odor tended to improve (p=0.07). In the test food group of all subjects and among the non-functionally constipated subjects, the fecal size tended to improve compared to the placebo group (p=0.06, p=0.07, respectively). Lilac LAB was effective in improving bowel movements and fecal properties in functionally constipated persons.	[Minamida, Kimiko; Miwa, Kazunori] Arterio Bio Co Ltd, Sect Res & Dev, Otaru, Hokkaido, Japan; [Nishimura, Mie] Hokkaido Food Ind Promot Org, Sect Res & Dev, Sapporo, Hokkaido, Japan; [Nishimura, Mie; Nishihira, Jun] Hokkaido Informat Univ, Hlth Informat Sci Ctr, Ebetsu, Hokkaido, Japan	Minamida, K (reprint author), Arterio Bio Co Ltd, Sect Res & Dev, Otaru, Hokkaido, Japan.	lilacLAB@live.jp			Japan's Ministry of Economy, Trade and Industry	We are grateful to Ms Akiko Tanaka, Ms Rina Kawamura, Ms Tomoko Mino, and Ms Megumi Shibata for their technical assistance with the data management, and we thank Mr Jungo Hayashi for his management of the clinical trial. This study was supported by Japan's Ministry of Economy, Trade and Industry.	Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; GIBSON GR, 1995, J NUTR, V125, P1401; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Hun L, 2009, POSTGRAD MED, V121, P119, DOI 10.3810/pgm.2009.03.1984; Losada MA, 2002, NUTR RES, V22, P71, DOI 10.1016/S0271-5317(01)00395-5; Koebnick C, 2003, CAN J GASTROENTEROL, V17, P655; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Jurenka JS, 2012, ALTERN MED REV, V17, P76; Endres JR, 2009, FOOD CHEM TOXICOL, V47, P1231, DOI 10.1016/j.fct.2009.02.018; Mateos-Aparicio I, 2010, LWT-FOOD SCI TECHNOL, V43, P1467, DOI 10.1016/j.lwt.2010.05.008; Yang YX, 2008, WORLD J GASTROENTERO, V14, P6237, DOI 10.3748/wjg.14.6237; Ara Katsutoshi, 2002, Microbial Ecology in Health and Disease, V14, P4, DOI 10.1080/089106002760002694; ETHERIDGE RD, 1984, J ANIM SCI, V58, P1403; Food and Agriculture Organization/World Health Organization (FAO/WHO), 2001, REP JOINT FAO WHO EX; Fukushima Y, 2007, BIOSCI MICROFLORA, V23, P139; HERIBAN V, 1993, LETT APPL MICROBIOL, V16, P243, DOI 10.1111/j.1472-765X.1993.tb01409.x; Mashimo K, 1964, J NEW REM CLIN, V13, P977; Matsuzawa T., 1972, Japanese Poultry Science, V9, P153; Nakayama O., 1950, J AGR CHEM SOC JAPAN, V23, P513, DOI DOI 10.1271/NOGEIKAGAKU1924.23.513; Roberfroid M., 2007, J NUTR S2, V137, p830S	20	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					300	306		10.1080/09168451.2014.972331		7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HX	WOS:000349519900020		
J	Sakuragi, H; Morisaka, H; Kuroda, K; Ueda, M				Sakuragi, Hiroshi; Morisaka, Hironobu; Kuroda, Kouichi; Ueda, Mitsuyoshi			Enhanced butanol production by eukaryotic Saccharomyces cerevisiae engineered to contain an improved pathway	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						Saccharomyces cerevisiae; trans-enoyl-CoA reductase; 1-butanol production; Clostridium acetobutylicum; glycerol pathway	ACETOACETYL-COA THIOLASE; ESCHERICHIA-COLI; YEAST; GLYCEROL; BIOFUEL; MANIPULATION; BIOBUTANOL; EXPRESSION; GENES; DNA	Compared with ethanol, butanol has more advantageous physical properties as a fuel, and biobutanol is thus considered a promising biofuel material. Biobutanol has often been produced by Clostridium species; however, because they are strictly anaerobic microorganisms, these species are challenging to work with. We attempted to introduce the butanol production pathway into yeast Saccharomyces cerevisiae, which is a well-known microorganism that is tolerant to organic solvents. 1-Butanol was found to be produced at very low levels when the butanol production pathway of Clostridium acetobutylicum was simply introduced into S. cerevisiae. The elimination of glycerol production pathway in the yeast contributed to the enhancement of 1-butanol production. In addition, by the use of trans-enoyl-CoA reductase in the engineered pathway, 1-butanol production was markedly enhanced to yield 14.1mg/L after 48h of cultivation.	[Sakuragi, Hiroshi; Morisaka, Hironobu; Kuroda, Kouichi; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan; [Morisaka, Hironobu; Ueda, Mitsuyoshi] Kyoto Ind Sci & Technol Innovat Ctr, Kyoto, Japan	Ueda, M (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan.	miueda@kais.kyoto-u.ac.jp			CREST; Science and technology research promotion program for agriculture, forestry, fisheries, and food industry	This research was supported by CREST and Science and technology research promotion program for agriculture, forestry, fisheries, and food industry.	Zheng YN, 2009, J IND MICROBIOL BIOT, V36, P1127, DOI 10.1007/s10295-009-0609-9; Shen CR, 2011, APPL ENVIRON MICROB, V77, P2905, DOI 10.1128/AEM.03034-10; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Antoni D, 2007, APPL MICROBIOL BIOT, V77, P23, DOI 10.1007/s00253-007-1163-x; Miura N, 2012, EUKARYOT CELL, V11, P1075, DOI 10.1128/EC.00075-12; SIKORSKI RS, 1989, GENETICS, V122, P19; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Duerre Peter, 2007, Biotechnology Journal, V2, P1525, DOI 10.1002/biot.200700168; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Costenoble R, 2000, YEAST, V16, P1483, DOI 10.1002/1097-0061(200012)16:16<1483::AID-YEA642>3.3.CO;2-B; Durre P, 2008, ANN NY ACAD SCI, V1125, P353, DOI 10.1196/annals.1419.009; Jain VK, 2012, APPL MICROBIOL BIOT, V93, P131, DOI 10.1007/s00253-011-3431-z; Buijs NA, 2013, CURR OPIN CHEM BIOL, V17, P480, DOI 10.1016/j.cbpa.2013.03.036; Inui M, 2008, APPL MICROBIOL BIOT, V77, P1305, DOI 10.1007/s00253-007-1257-5; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Krivoruchko A, 2013, J IND MICROBIOL BIOT, V40, P1051, DOI 10.1007/s10295-013-1296-0; ITO H, 1983, J BACTERIOL, V153, P163; Chen X, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-21; HISER L, 1994, J BIOL CHEM, V269, P31383; Jain VK, 2011, J IND MICROBIOL BIOT, V38, P1427, DOI 10.1007/s10295-010-0928-x; Kanayama N, 1997, J BIOCHEM, V122, P616; Nishida N, 2013, J BIOTECHNOL, V165, P145, DOI 10.1016/j.jbiotec.2013.03.003; Sakuragi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/416931; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Tucci S, 2007, FEBS LETT, V581, P1561, DOI 10.1016/j.febslet.2007.03.013; Yu KO, 2010, J BIOTECHNOL, V150, P209, DOI 10.1016/j.jbiotec.2010.09.932	26	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					314	320		10.1080/09168451.2014.972330		7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3HZ	WOS:000349520100001		
J	Oda, K; Nagai, T; Ueno, Y; Mori, Y				Oda, Kohei; Nagai, Takeshi; Ueno, Yoshie; Mori, Yoshiharu			Further evidence that a new type of Japanese pickles reduce the blood pressure of spontaneously hypertensive rats	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						gamma-aminobutyric acid (GABA); angiotensin-converting-enzyme (ACE)-inhibitory peptides; antihypertensive effects; spontaneously hypertensive rats; pickles	BIOACTIVE PEPTIDES; FUNCTIONAL FOOD; GABA; MILK; FISH	A new type of pickles (nukazuke) that contain GABA and angiotensin converting enzyme-inhibitory peptides and that reduce blood pressure of rats was studied further. Seven kinds of nukazuke forcefully administrated orally for one day reduced temporarily the blood pressure of spontaneously hypertensive rats. In addition, a fermented shougoin daikon administrated freely for 4weeks did not increase the blood pressure of the rats, but suppressed it throughout the experiment. Taken together with previous data (Oda et al., Biosci. Biotechnol. Biochem., 2014) it was concluded that the nukazuke could reduce the blood pressure of spontaneously hypertensive rats. Thus, the newly developed functional pickles appear to be beneficial for pickles business.	[Oda, Kohei] Kyoto Inst Technol, Kyoto 606, Japan; [Nagai, Takeshi] Japan Food Res Labs, Tokyo, Japan; [Ueno, Yoshie] Kyoto Prefectural Technol Ctr Small & Medium Ente, Kyoto, Japan; [Mori, Yoshiharu] Mori Co Ltd, Kyoto, Japan	Oda, K (reprint author), Kyoto Inst Technol, Kyoto 606, Japan.	bika@kit.ac.jp			monozukuri small and medium size enterprise	This study was supported in part by a grant from 2013 monozukuri small and medium size enterprise in order to develop a product for sales. We thanks to Dr Alexander Wlodawer (NCI at Frederick, USA) and Prof. Ben M. Dunn (University of Florida, USA) for critical reading of the manuscript.	Chiu TH, 2013, J SCI FOOD AGR, V93, P859, DOI 10.1002/jsfa.5809; Rizzello CG, 2008, J AGR FOOD CHEM, V56, P6936, DOI 10.1021/jf800512u; Aoki H, 2003, BIOSCI BIOTECH BIOCH, V67, P1806, DOI 10.1271/bbb.67.1806; Hayakawa K, 2002, EUR J PHARMACOL, V438, P107, DOI 10.1016/S0014-2999(02)01294-3; Minervini F, 2009, FOOD MICROBIOL, V26, P559, DOI 10.1016/j.fm.2009.03.008; De Leo F, 2009, CURR PHARM DESIGN, V15, P3622, DOI 10.2174/138161209789271834; Phelan M, 2011, FOOD FUNCT, V2, P153, DOI 10.1039/c1fo10017c; Hayakawa K, 2004, BRIT J NUTR, V92, P411, DOI 10.1079/BJN20041221; Ryan JT, 2011, NUTRIENTS, V3, P765, DOI 10.3390/nu3090765; Harada A, 2011, J JPN SOC FOOD SCI, V58, P446; Hernandez-Ledesma B, 2011, ADV COLLOID INTERFAC, V165, P23, DOI 10.1016/j.cis.2010.11.001; Hiwatashi K, 2010, J JPN SOC FOOD SCI, V57, P40; Kajimoto O, 2004, JPN PHARMACOL THER, V32, P929; Khakhalin AS, 2011, J NEUROPHYSIOL, V106, P1065, DOI 10.1152/jn.00293.2011; Kim SK, 2012, ADV FOOD NUTR RES, V65, P249, DOI 10.1016/B978-0-12-416003-3.00016-0; Oda K, 2014, BIOSCI BIOTECH BIOCH, V5, P882; Ueno Y., 2007, Seibutsu-kogaku Kaishi, V85, P109	17	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					318	324		10.1080/09168451.2014.973363		7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3IC	WOS:000349520400001		
J	Katayama, T; Ohta, A; Horiuchi, H				Katayama, Takuya; Ohta, Akinori; Horiuchi, Hiroyuki			Protein kinase C regulates the expression of cell wall-related genes in RlmA-dependent and independent manners in Aspergillus nidulans	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						Aspergillus nidulans; RlmA; protein kinase C; cell wall integrity	MOTOR-LIKE DOMAIN; V CHITIN SYNTHASE; INTEGRITY SIGNALING PATHWAY; SACCHAROMYCES-CEREVISIAE; HYPHAL GROWTH; TRANSCRIPTION FACTOR; POLARIZED GROWTH; CLASS-I; CSMA; FUMIGATUS	A protein kinase C of Aspergillus nidulans, PkcA, is required for cell wall integrity (CWI) and is considered a major component of the regulating pathway. To investigate whether PkcA regulates the transcription of cell wall-related genes, we constructed strains expressing pkcA(R429A) that encodes an activated form of PkcA. The mRNA levels of most chitin synthase genes and an alpha-glucan synthase gene, agsB, were increased when pkcA(R429A) expression was induced. These mRNA increases were not observed or were only partially observed, in a deletion mutant of rlmA, an ortholog of RLM1 that encodes a transcription factor in the CWI pathway in Saccharomyces cerevisiae. In addition, in a pkcA temperature-sensitive mutant under heat stress, the mRNA levels of some chitin synthase genes and agsB did not increase. These results suggest that PkcA is involved in CWI maintenance through the transcriptional regulation of cell wall-related genes.	[Katayama, Takuya; Ohta, Akinori; Horiuchi, Hiroyuki] Univ Tokyo, Dept Biotechnol, Tokyo, Japan	Horiuchi, H (reprint author), Univ Tokyo, Dept Biotechnol, Tokyo, Japan.	ahhoriu@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [23380048]	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research [grant number 23380048].	Ronen R, 2007, CURR GENET, V51, P321, DOI 10.1007/s00294-007-0129-y; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NONAKA H, 1995, EMBO J, V14, P5931; Kovacs Z, 2013, FUNGAL GENET BIOL, V54, P1, DOI 10.1016/j.fgb.2013.02.004; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; Borgia PT, 1996, FUNGAL GENET BIOL, V20, P193, DOI 10.1006/fgbi.1996.0035; Herrmann M, 2006, APPL ENVIRON MICROB, V72, P2957, DOI 10.1128/AEM.72.4.2957-2970.2006; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Pinchai N, 2009, EUKARYOT CELL, V8, P511, DOI 10.1128/EC.00336-08; Ichinomiya M, 2002, MICROBIOL-SGM, V148, P1335; WATANABE M, 1994, J BIOL CHEM, V269, P16829; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Ichinomiya M, 2007, BIOSCI BIOTECH BIOCH, V71, P2787, DOI 10.1271/bbb.70409; Fujiwara M, 2000, J BIOCHEM-TOKYO, V127, P359; Fortwendel JR, 2010, ANTIMICROB AGENTS CH, V54, P1555, DOI 10.1128/AAC.00854-09; Chellegatti MASC, 2010, FOLIA MICROBIOL, V55, P228, DOI 10.1007/s12223-010-0033-6; Colabardini AC, 2010, MOL MICROBIOL, V78, P1259, DOI 10.1111/j.1365-2958.2010.07403.x; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; Firon A, 2002, GENETICS, V161, P1077; Fukuda K, 2009, EUKARYOT CELL, V8, P945, DOI 10.1128/EC.00326-08; Futagami T, 2014, BIOSCI BIOTECH BIOCH, V78, P326, DOI 10.1080/09168451.2014.878218; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; Han KH, 2002, MOL MICROBIOL, V43, P1065, DOI 10.1046/j.1365-2958.2002.02774.x; Horiuchi H, 1999, J BACTERIOL, V181, P3721; Horiuchi H, 2009, MED MYCOL, V47, pS47, DOI 10.1080/13693780802213332; Ichinomiya M, 2005, EUKARYOT CELL, V4, P1125, DOI 10.1128/EC.4.6.1125-1136.2005; Katayama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050503; Mellado E, 2003, FUNGAL GENET BIOL, V38, P98, DOI 10.1016/S1087-1845(02)00516-9; OAKLEY CE, 1987, GENE, V53, P293, DOI 10.1016/0378-1119(87)90019-9; ROWLANDS RT, 1973, MOL GEN GENET, V126, P201, DOI 10.1007/BF00267531; Schmitz HP, 2003, CURR GENET, V43, P245, DOI 10.1007/s00294-003-0403-6; Schmitz HP, 2001, J MOL BIOL, V311, P1, DOI 10.1006/jmbi.2001.4848; Takeshita N, 2002, BIOCHEM BIOPH RES CO, V298, P103, DOI 10.1016/S0006-291X(02)02418-X; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2005.05030.x; Takeshita N, 2005, MOL BIOL CELL, V16, P1961, DOI 10.1091/mbc.E04-09-0761; Teepe AG, 2007, FUNGAL GENET BIOL, V44, P554, DOI 10.1016/j.fgb.2006.10.001; Tsuizaki M, 2009, BIOSCI BIOTECH BIOCH, V73, P1163, DOI 10.1271/bbb.90074; Tsuizaki M, 2013, BIOSCI BIOTECH BIOCH, V77, P369, DOI 10.1271/bbb.120822; Yamada E, 2005, BIOSCI BIOTECH BIOCH, V69, P87, DOI 10.1271/bbb.69.87; YANAI K, 1994, BIOSCI BIOTECH BIOCH, V58, P1828; Yoshimi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054893; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	45	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					321	330		10.1080/09168451.2014.973365		10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3II	WOS:000349521000001		
J	Shiraishi, H				Shiraishi, Hideaki			Association of heterotrophic bacteria with aggregated Arthrospira platensis exopolysaccharides: implications in the induction of axenic cultures	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						cyanobacteria; exopolysaccharides; Arthrospira platensis; Alcian blue; axenic cultures	BLUE-GREEN-ALGA; SPIRULINA-PLATENSIS; CALCIUM SPIRULAN; CYANOBACTERIUM ARTHROSPIRA; SULFATED POLYSACCHARIDE; VIRUS	Inducing an axenic culture of the edible cyanobacterium Arthrospira (Spirulina) platensis using differential filtration alone is never successful; thus, it has been thought that, in non-axenic cultures, a portion of contaminating bacteria is strongly associated with Arthrospira cells. However, examination of the behavior of these bacteria during filtration revealed that they were not associated with Arthrospira cells but with aggregates of exopolysaccharides present in the medium away from the Arthrospira cells. Based on this finding, a rapid and reliable method for preparing axenic trichomes of A. platensis was established. After verifying the axenicity of the resulting trichomes on enriched agar plates, they were individually transferred to fresh sterile medium using a handmade tool, a microtrowel, to produce axenic cultures. With this technique, axenic cultures of various A. platensis strains were successfully produced. The technique described in this study is potentially applicable to a wider range of filamentous cyanobacteria.	Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan	Shiraishi, H (reprint author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan.	siraisi@kuchem.kyoto-u.ac.jp			Japan Society for the Promotion of Science [JSPS KAKENHI] [26660063]; Management Expenses Grants for National University Corporations from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science [JSPS KAKENHI grant number 26660063] and the Management Expenses Grants for National University Corporations from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; FRY JC, 1990, METHOD MICROBIOL, V22, P41; Pugh N, 2001, PLANTA MED, V67, P737; Belay A, 2013, HDB MICROALGAL CULTU, VSecond, P339, DOI DOI 10.1002/9781118567166; BOWYER JW, 1968, J GEN MICROBIOL, V54, P299; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, V1, P542; Choi GG, 2008, BIOTECHNOL LETT, V30, P87, DOI 10.1007/s10529-007-9523-2; Grewe CB, 2013, ECOLOGY CYANOBACTERI, P707; Guillard R.R.L., 2005, ALGAL CULTURING TECH, P117, DOI 10.1016/B978-012088426-1/50009-3; HAMANA K, 1983, BIOCHEM BIOPH RES CO, V112, P606, DOI 10.1016/0006-291X(83)91507-3; Hayashi K, 1996, AIDS RES HUM RETROV, V12, P1463, DOI 10.1089/aid.1996.12.1463; Hayashi T, 1996, J NAT PROD, V59, P83, DOI 10.1021/np960017o; HEANEY SI, 1977, BRIT PHYCOL J, V12, P171; Hungate R. E., 1969, METHODS MICROBIOLO B, V3B, P117, DOI 10.1016/S0580-9517(08)70503-8; Jittawuttipoka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055564; Lee JB, 1998, J NAT PROD, V61, P1101, DOI 10.1021/np980143n; Li P, 2001, Biotechnol Genet Eng Rev, V18, P375; Lobner M, 2008, J MED FOOD, V11, P313, DOI 10.1089/jmf.2007.564; Majdoub Hatem, 2009, Biochim Biophys Acta, V1790, P1377, DOI 10.1016/j.bbagen.2009.07.013; Mishima T, 1998, CLIN EXP METASTAS, V16, P541, DOI 10.1023/A:1006594318633; Mori F, 2002, MICROBIOL CULT COLL, V18, P45; Muhling M, 2003, J PHYCOL, V39, P360; OGAWA T, 1970, J FERMENT TECHNOL, V48, P361; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Sambrook J, 2001, MOL CLONING LAB MANU, P74; Scheldeman P, 1999, FEMS MICROBIOL LETT, V172, P213, DOI 10.1111/j.1574-6968.1999.tb13471.x; Sena L, 2011, WORLD J MICROB BIOT, V27, P1045, DOI 10.1007/s11274-010-0549-6; Shiraishi H, 2013, BIOSCI BIOTECH BIOCH, V77, P782, DOI 10.1271/bbb.120919; Sili C, 2013, ECOLOGY CYANOBACTERI, P677; THACKER SP, 1994, BIOTECHNIQUES, V16, P216; Trabelsi L, 2009, BIOTECHNOL BIOPROC E, V14, P27, DOI [10.1007/s12257-008-0102-8, 10.1007/S12257-008-0102-8]; Tragut V, 1995, J APPL PHYCOL, V7, P561, DOI 10.1007/BF00003943; Tseng C-T, 1994, ALG STUD, V75, P303; Vincente-Garcia V., 2004, BIOTECHNOL BIOENG, V85, P306; Watanabe M.M., 1977, B JAP SOC PHYCOL S, V25, P371; Yoshimura H, 2012, J APPL PHYCOL, V24, P237, DOI 10.1007/s10811-011-9672-5; ZIMMERMANN R, 1978, APPL ENVIRON MICROB, V36, P926	40	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB 1	2015	79	2					331	341		10.1080/09168451.2014.972333		11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	CB3II	WOS:000349521000002		
J	Ono, Y; Matsueda, K; Koga, R; Takahashi, Y; Arita, J; Takahashi, M; Inoue, Y; Unno, T; Saiura, A				Ono, Y.; Matsueda, K.; Koga, R.; Takahashi, Y.; Arita, J.; Takahashi, M.; Inoue, Y.; Unno, T.; Saiura, A.			Sinistral portal hypertension after pancreaticoduodenectomy with splenic vein ligation	BRITISH JOURNAL OF SURGERY			English	Article							SEGMENTAL THERMAL ABLATION; RANDOMIZED CLINICAL-TRIAL; ENDOVENOUS LASER-ABLATION; SAPHENOUS VARICOSE-VEINS; FOAM SCLEROTHERAPY; RADIOFREQUENCY ABLATION; VENOUS DISEASE; SURGERY; OBLITERATION	Background: Splenic vein ligation may result in sinistral (left-sided) portal hypertension and gastrointestinal haemorrhage. The aim of this study was to analyse the pathogenesis of sinistral portal hypertension following splenic vein ligation in pancreaticoduodenectomy. Methods: Patients who underwent pancreaticoduodenectomy for pancreatic cancer between January 2005 and December 2012 were included in this retrospective study. The venous flow pattern from the spleen and splenic hypertrophy were examined after surgery. Results: Of 103 patients who underwent pancreaticoduodenectomy with portal vein resection, 43 had splenic vein ligation. There were two predominant venous flow patterns from the spleen. In the varicose route (27 patients), flow from the spleen passed to colonic varices and/or other varicose veins. In the non-varicose route, flow from the spleen passed through a splenocolonic collateral (14 patients) or a spontaneous splenorenal shunt (2 patients). The varicose route was associated with significantly greater splenic hypertrophy than the non-varicose route (median splenic hypertrophy ratio 1.52 versus 0.94; P < 0.001). All patients with the varicose route had colonic varices, and none had a right colic marginal vein at the hepatic flexure. Conclusion: Pancreaticoduodenectomy with splenic vein ligation may lead to sinistral portal hypertension. To avoid the development of varices, it is important to preserve the right colic marginal vein. Reconstruction of the splenic vein should be considered if the right colic marginal vein is divided.	[Ono, Y.; Koga, R.; Takahashi, Y.; Arita, J.; Takahashi, M.; Inoue, Y.; Saiura, A.] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo 1358550, Japan; [Matsueda, K.; Unno, T.] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Diagnost Imaging, Tokyo 1358550, Japan	Saiura, A (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	saiura-tky@umin.ac.jp					Devereux N, 2014, EUR J VASC ENDOVASC, V47, P187, DOI 10.1016/j.ejvs.2013.10.017; Rautio T, 2002, J VASC SURG, V35, P958, DOI 10.1067/mva.2002.123096; Siribumrungwong B, 2012, EUR J VASC ENDOVASC, V44, P214, DOI 10.1016/j.ejvs.2012.05.017; Proebstle TM, 2011, J VASC SURG, V54, P146, DOI 10.1016/j.jvs.2010.12.051; Khilnani NM, 2010, J VASC INTERV RADIOL, V21, P14, DOI 10.1016/j.jvir.2009.01.034; BAKER DM, 1995, EUR J VASC ENDOVASC, V9, P299, DOI 10.1016/S1078-5884(05)80134-0; Almeida JI, 2009, J VASC INTERV RADIOL, V20, P752, DOI 10.1016/j.jvir.2009.03.008; Creton D, 2010, ANN VASC SURG, V24, P360, DOI 10.1016/j.avsg.2009.09.019; Rutherford RB, 2000, J VASC SURG, V31, P1307, DOI 10.1016/S0741-5214(00)90143-5; Myers KA, 2007, EUR J VASC ENDOVASC, V33, P116, DOI 10.1016/j.ejvs.2006.09.005; Pannier F, 2009, PHLEBOLOGY, V24, P26, DOI 10.1258/phleb.2008.008038; Lurie F, 2003, J VASC SURG, V38, P207, DOI 10.1016/S0741-5214(03)00228-3; Proebstle TM, 2008, J VASC SURG, V47, P151, DOI 10.1016/j.jvs.2007.08.056; PORTER JM, 1995, J VASC SURG, V21, P635, DOI 10.1016/S0741-5214(95)70195-8; Biemans AAM, 2013, J VASC SURG, V58, P727, DOI 10.1016/j.jvs.2012.12.074; De Maeseneer M, 2011, EUR J VASC ENDOVASC, V42, P89, DOI 10.1016/j.ejvs.2011.03.013; Shepherd AC, 2010, BRIT J SURG, V97, P810, DOI 10.1002/bjs.7091; Vuylsteke ME, 2010, ANN VASC SURG, V24, P205, DOI 10.1016/j.avsg.2009.06.024; Kistner RL, 1996, MAYO CLIN PROC, V71, P338; Mackay D C, 1995, J R Nav Med Serv, V81, P42; Meissner Mark H, 2005, Semin Intervent Radiol, V22, P147, DOI 10.1055/s-2005-921948; Miller GV, 1996, ANN ROY COLL SURG, V78, P345; Passman MA, 2011, J VASC SURG, V54, p2S, DOI 10.1016/j.jvs.2011.05.117; Rasmussen LH, 2011, BRIT J SURG, V98, P1079, DOI 10.1002/bjs.7555; Shadid N, 2014, PHLEBOLOGY; Tran Nam T, 2002, Semin Vasc Surg, V15, P5, DOI 10.1016/S0895-7967(02)70010-0; vansEekeren RR, 2013, J VASC SURG, V57, P445	27	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	FEB	2015	102	3					219	228		10.1002/bjs.9707		10	Surgery	Surgery	CA6AU	WOS:000348991400009		
J	Omichi, K; Inoue, Y; Hasegawa, K; Sakamoto, Y; Okinaga, H; Aoki, T; Sugawara, Y; Kurahashi, I; Kokudo, N				Omichi, K.; Inoue, Y.; Hasegawa, K.; Sakamoto, Y.; Okinaga, H.; Aoki, T.; Sugawara, Y.; Kurahashi, I.; Kokudo, N.			Differential diagnosis of liver tumours using intraoperative real-time tissue elastography	BRITISH JOURNAL OF SURGERY			English	Article							LYMPH-NODE RATIO; PANCREATIC DUCTAL ADENOCARCINOMA; INTERNATIONAL STUDY-GROUP; PROGNOSTIC RELEVANCE; CURATIVE RESECTION; R1 RESECTIONS; SURGERY ISGPS; MARGIN STATUS; HEAD CANCER; SURVIVAL	Background: Real-time tissue elastography is an innovative tool that informs the surgeon about tissue elasticity by applying the principle of ultrasonography. The aim of this study was to investigate the accuracy of intraoperative real-time tissue elastography (IORTE) for the detection and characterization of liver tumours. Methods: Between October 2010 and November 2011, IORTE was performed for liver lesions after the completion of routine B-mode intraoperative ultrasonography (IOUS). The elasticity images of all tumours, except those of cysts, were classified into six categories according to modified criteria (types 1-6), according to the degree of strain contrast with the surrounding liver. The concordance of IORTE with pathological examination of the tumour, B-mode IOUS and clinical diagnosis after follow-up was assessed. Results: Images were obtained from 92 hepatocellular carcinomas (HCCs), 92 adenocarcinomas, 19 other malignant tumours and 18 benign tumours in 158 patients. Using a minilinear probe, 73 of 88 HCCs were classified as having a 'HCC pattern' (type 3, 4 or 5), resulting in a sensitivity of 83.0 per cent, a specificity of 67.2 per cent and an accuracy of 73.7 per cent. Some 66 of 90 adenocarcinomas were classified as 'adenocarcinoma pattern' (type 6), resulting in a sensitivity of 73.3 per cent, specificity of 95.1 per cent and accuracy of 85.9 per cent. IORTE detected seven new lesions (8 per cent). Conclusion: IORTE is useful for the detection and characterization of liver tumours.	[Omichi, K.; Inoue, Y.; Hasegawa, K.; Sakamoto, Y.; Okinaga, H.; Aoki, T.; Sugawara, Y.; Kokudo, N.] Univ Tokyo, Grad Sch Med, Hepatobiliary Pancreat Surg Div, Dept Surg, Tokyo 1138655, Japan; [Kurahashi, I.] iAnalysis LLC, Tokyo, Japan	Kokudo, N (reprint author), Univ Tokyo, Grad Sch Med, Hepatobiliary Pancreat Surg Div, Dept Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kokudo-2su@h.u-tokyo.ac.jp					ALLEMA JH, 1995, CANCER, V75, P2069, DOI 10.1002/1097-0142(19950415)75:8<2069::AID-CNCR2820750807>3.0.CO;2-7; John BJ, 2013, HPB, V15, P674, DOI 10.1111/hpb.12019; Menon KV, 2009, HPB, V11, P18, DOI 10.1111/j.1477-2574.2008.00013.x; Hartwig W, 2011, ANN SURG, V254, P311, DOI 10.1097/SLA.0b013e31821fd334; Kang MJ, 2014, ANN SURG ONCOL, V21, P1545, DOI 10.1245/s10434-013-3473-9; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Michalski CW, 2007, BRIT J SURG, V94, P265, DOI 10.1002/bjs.5716; Kuhlmann KFCD, 2004, EUR J CANCER, V40, P549, DOI 10.1016/j.ejca.2003.10.026; Wente MN, 2007, SURGERY, V142, P20, DOI 10.1016/j.surg.2007.02.001; Esposito I, 2008, ANN SURG ONCOL, V15, P1651, DOI 10.1245/s10434-008-9839-8; Slidell MB, 2008, ANN SURG ONCOL, V15, P165, DOI 10.1245/s10434-007-9587-1; Berger AC, 2004, AM SURGEON, V70, P235; Wagner M, 2004, BRIT J SURG, V91, P586, DOI 10.1002/bjs.4484; Sugiura T, 2013, SURGERY, V154, P1078, DOI 10.1016/j.surg.2013.04.015; Riediger H, 2009, J GASTROINTEST SURG, V13, P1337, DOI 10.1007/s11605-009-0919-2; Pawlik TM, 2007, SURGERY, V141, P610, DOI 10.1016/j.surg.2006.12.013; Jamieson NB, 2013, J GASTROINTEST SURG, V17, P511, DOI 10.1007/s11605-012-2131-z; House MG, 2007, J GASTROINTEST SURG, V11, P1549, DOI 10.1007/s11605-007-0243-7; Campbell F, 2009, HISTOPATHOLOGY, V55, P277, DOI 10.1111/j.1365-2559.2009.03376.x; Hatzaras I, 2010, ANN SURG ONCOL, V17, P991, DOI 10.1245/s10434-009-0883-9; Lee JH, 2011, AM SURGEON, V77, P322; Falconi M, 2008, ANN SURG ONCOL, V15, P3178, DOI 10.1245/s10434-008-0099-4; Hurtuk MG, 2009, AM J SURG, V197, P348, DOI 10.1016/j.amjsurg.2008.11.010; Hartwig W, 2013, ANN SURG ONCOL, V20, P2188, DOI 10.1245/s10434-012-2809-1; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Verbeke CS, 2006, BRIT J SURG, V93, P1232, DOI 10.1002/bjs.5397; Zhou JG, 2013, CHINESE J CANCER RES, V25, P735, DOI 10.3978/j.issn.1000-9604.2013.12.03; Konstantinidis IT, 2013, ANN SURG, V257, P731, DOI 10.1097/SLA.0b013e318263da2f; van der Gaag NA, 2008, BRIT J SURG, V95, P735, DOI 10.1002/bjs.6076; Winter JM, 2013, J SURG ONCOL, V107, P15, DOI 10.1002/jso.23192; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Bhatti I, 2010, WORLD J SURG, V34, P768, DOI 10.1007/s00268-009-0336-4; Brennan MF, 2004, ANN SURG, V240, P293, DOI 10.1097/01.sla.0000133125.85489.07; Pomianowska E, 2013, ANN SURG ONCOL, V20, P233, DOI 10.1245/s10434-012-2592-z; Beppu T, 2012, J HEPATO-BIL-PAN SCI, V19, P72, DOI 10.1007/s00534-011-0460-z; Chen SC, 2013, HPB, V15, P951, DOI 10.1111/hpb.12071; Connor S, 2004, BRIT J SURG, V91, P1592, DOI 10.1002/bjs.4761; desCastro S, 2004, SURGERY, V136, P994; Distler M, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-12; Hamilton SR, 2000, PATHOLOGY GENETICS T; Janot MS, 2012, LANGENBECK ARCH SURG, V397, P917, DOI 10.1007/s00423-012-0953-5; Kawai M, 2010, AM J SURG, V199, P447, DOI 10.1016/j.amjsurg.2009.01.019; Luo JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076052; Phoa SSKS, 2000, BRIT J RADIOL, V73, P1159; Royal College of Pathologists. Standards and Datasets for Reporting Cancers, 2010, STAND DAT REP CANC D; Sierzega M, 2006, PANCREAS, V33, P240, DOI 10.1097/01.mpa.0000235306.96486.2a; Sobin LH, 2009, TNM CLASSIFICATION M; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; van der Gaag Niels A, 2007, BMC Surg, V7, P3, DOI 10.1186/1471-2482-7-3; Westra W, 2003, SURG PATHOLOGY DISSE, P88	50	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	FEB	2015	102	3					246	253		10.1002/bjs.9728		8	Surgery	Surgery	CA6AU	WOS:000348991400012		
J	Nomi, T; Fuks, D; Govindasamy, M; Mal, F; Nakajima, Y; Gayet, B				Nomi, T.; Fuks, D.; Govindasamy, M.; Mal, F.; Nakajima, Y.; Gayet, B.			Risk factors for complications after laparoscopic major hepatectomy	BRITISH JOURNAL OF SURGERY			English	Article							TIME TISSUE ELASTOGRAPHY; ENHANCED INTRAOPERATIVE ULTRASONOGRAPHY; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; NONINVASIVE ASSESSMENT; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; US ELASTOGRAPHY; VIRAL-HEPATITIS; ULTRASOUND	Background: Although laparoscopic major hepatectomy (MH) is becoming increasingly common in several specialized centres, data regarding outcomes are limited. The aim of this study was to identify the risk factors for postoperative complications of purely laparoscopic MH at a single centre. Methods: All patients who underwent purely laparoscopic MH between January 1998 and March 2014 at the authors' institution were enrolled. Demographic, clinicopathological and perioperative factors were collected prospectively, and data were analysed retrospectively. The dependent variables studied were the occurrence of overall and major complications (Dindo-Clavien grade III or above). Results: A total of 183 patients were enrolled. The types of MH included left-sided hepatectomy in 40 patients (21.9 per cent), right-sided hepatectomy in 135 (73.8 per cent) and central hepatectomy in eight (4.4 per cent). Median duration of surgery was 255 (range 100-540) min, and median blood loss was 280 (10-4500) ml. Complications occurred in 100 patients (54.6 per cent), and the 90-day all-cause mortality rate was 2.7 per cent. Liver-specific and general complications occurred in 62 (33.9 per cent) and 38 (20.8 per cent) patients respectively. Multivariable analysis identified one independent risk factor for global postoperative complications: intraoperative simultaneous radiofrequency ablation (RFA) (odds ratio (OR) 6.93, 95 per cent c.i. 1.49 to 32.14; P = 0.013). There were two independent risk factors for major complications: intraoperative blood transfusion (OR 2.50, 1.01 to 6.23; P = 0.049) and bilobar resection (OR 2.47, 1.00 to 6.06; P = 0.049). Conclusion: Purely laparoscopic MH is feasible and safe. Simultaneous RFA and bilobar resection should probably be avoided.	[Nomi, T.; Fuks, D.; Govindasamy, M.; Mal, F.; Gayet, B.] Univ Paris 05, Inst Mutualiste Montsouris, Dept Digest Dis, F-75014 Paris, France; [Nomi, T.; Nakajima, Y.] Nara Med Univ, Dept Surg, Nara, Japan	Gayet, B (reprint author), Univ Paris 05, Inst Mutualiste Montsouris, Dept Digest Dis, 42 Blvd Jourdan, F-75014 Paris, France.	brice.gayet@imm.fr					Friedrich-Rust M, 2007, AM J ROENTGENOL, V188, P758, DOI 10.2214/AJR.06.0322; Arita J, 2011, ANN SURG, V254, P992, DOI 10.1097/SLA.0b013e31822518be; Davies G, 2011, BRIT J RADIOL, V84, P939, DOI 10.1259/bjr/97637841; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Lyshchik A, 2005, RADIOLOGY, V237, P202, DOI 10.1148/radiol.2363041248; Ferrero A, 2012, J GASTROINTEST SURG, V16, P806, DOI 10.1007/s11605-011-1810-5; Kanamoto M, 2009, J HEPATO-BILIARY-PAN, V16, P463, DOI 10.1007/s00534-009-0075-9; Kato K, 2008, LIVER INT, V28, P1264, DOI 10.1111/j.1478-3231.2008.01701.x; D'Hondt M, 2011, HPB, V13, P665, DOI 10.1111/j.1477-2574.2011.00349.x; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Tsutsumi M, 2007, INT J CLIN ONCOL, V12, P250, DOI 10.1007/s10147-007-0669-7; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Takahashi M, 2012, BRIT J SURG, V99, P1271, DOI 10.1002/bjs.8844; Mazzoni G, 2008, LIVER INT, V28, P88, DOI 10.1111/j.1478-3231.2007.01583.x; Inoue Y, 2010, SURGERY, V148, P1000, DOI 10.1016/j.surg.2010.02.009; Hata S, 2011, WORLD J SURG, V35, P2779, DOI 10.1007/s00268-011-1264-7; Leen E, 2006, ANN SURG, V243, P236, DOI 10.1097/01.sla.0000197708.77063.07; Ellsmere J, 2007, SURG ENDOSC, V21, P1280, DOI 10.1007/s00464-006-9192-6; Koizumi Y, 2011, RADIOLOGY, V258, P610, DOI 10.1148/radiol.10100319; Pesavento A, 2000, PHYS MED BIOL, V45, P1423, DOI 10.1088/0031-9155/45/6/302; Morikawa H, 2011, J GASTROENTEROL, V46, P350, DOI 10.1007/s00535-010-0301-x; MAKUUCHI M, 1987, WORLD J SURG, V11, P615; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Gheorghe L, 2009, J GASTROINTEST LIVER, V18, P439; Makuuchi M, 1983, Ultrasound Med Biol, VSuppl 2, P493; Shiina T, 2002, J MED ULTRASON, V29, P119, DOI 10.1007/BF02481234; Shuang-Ming Tian, 2011, Acad Radiol, V18, P810, DOI 10.1016/j.acra.2011.01.026; Torzilli Guido, 2004, Liver Transpl, V10, pS34, DOI 10.1002/lt.20050; Zhang K, 2007, ARCH SURG-CHICAGO, V142, P1170, DOI 10.1001/archsurg.142.12.1170	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	FEB	2015	102	3					254	260		10.1002/bjs.9726		7	Surgery	Surgery	CA6AU	WOS:000348991400013		
J	Katsumata, K				Katsumata, Kei			A Long-Term Seismic Quiescence before the 2004 Sumatra (M-w 9.1) Earthquake	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							ANDAMAN EARTHQUAKE; DECEMBER 26; RUPTURE PROCESS; JAPAN; SLIP; PRECURSORS; CATALOGS; REGION; MODEL	The 2004 Sumatra (M-w 9.1) earthquake was preceded by a seismic quiescence that began 13 years before the mainshock. An earthquake catalog created by the International Seismological Centre is analyzed in the study area, 80 degrees-110 degrees E, 10 degrees S-20 degrees N, between 1964 and 2004, including 1153 earthquakes shallower than 100 km with body-wavemagnitude of 5.0 <= m(b) <= 6.7. A detailed analysis of the earthquake catalog using a gridding technique (ZMAP) shows the quiescent area is located between 3 degrees and 6 degrees N, which covers the southeastern part of the focal area, including the rupture initiation point of the 2004 Sumatra earthquake. The observed spatial pattern of quiescence can be explained by stress perturbation due to a long-term slow slip located on the deeper edge of the mainshock fault, which is predicted by a numerical simulation based on a laboratory-derived friction law. Although the quiescence is not significant statistically, it may still be considered unlikely that such an anomalous quiescence would occur at almost the same time and location as other long-term anomalies reported in the previous studies, including decreases in b-value and tidal triggering.	Hokkaido Univ, Inst Seismol & Volcanol, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Katsumata, K (reprint author), Hokkaido Univ, Inst Seismol & Volcanol, Kita Ku, North 10 West 8, Sapporo, Hokkaido 0600810, Japan.	kkatsu@mail.sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	I thank S. Wiemer for providing the ZMAP software and H. Aoyama for helping revise the manuscript. The Generic Mapping Tools System (Wessel and Smith, 1991) is used to produce figures. I also thank J. L. Hardebeck and D. D. Fitzenz for valuable comments. This study was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, under its Earthquake and Volcano Hazards Observation and Research Program.	Kamogawa M, 2013, J GEOPHYS RES-SPACE, V118, P1751, DOI 10.1002/jgra.50118; Heki K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047908; Tanioka Y, 2006, EARTH PLANETS SPACE, V58, P203; Bansal AR, 2013, J GEOPHYS RES-SOL EA, V118, P616, DOI 10.1002/jgrb.50068; Tanaka S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041581; Thomas JN, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051022; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; Ammon CJ, 2005, SCIENCE, V308, P1133, DOI 10.1126/science.1112260; Chlieh M, 2007, B SEISMOL SOC AM, V97, pS152, DOI 10.1785/0120050631; Simoes M, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002958; Zhuang J, 2002, J AM STAT ASSOC, V97, P369, DOI 10.1198/016214502760046925; Enescu B, 2001, TECTONOPHYSICS, V338, P297, DOI 10.1016/S0040-1951(01)00085-3; Wyss M, 1999, ANN GEOFIS, V42, P851; Kato N, 2003, EARTH PLANET SC LETT, V216, P17, DOI 10.1016/S0012-821X(03)00483-7; WYSS M, 1988, PURE APPL GEOPHYS, V126, P319, DOI 10.1007/BF00879001; Engdahl ER, 2007, B SEISMOL SOC AM, V97, pS43, DOI 10.1785/0120050614; Wiemer S, 2000, B SEISMOL SOC AM, V90, P859, DOI 10.1785/0119990114; Heki K, 2013, J GEOPHYS RES-SPACE, V118, P6618, DOI 10.1002/jgra.50578; WYSS M, 1981, J GEOPHYS RES, V86, P3881, DOI 10.1029/JB086iB05p03881; OHTAKE M, 1977, PURE APPL GEOPHYS, V115, P375, DOI 10.1007/BF01637115; HABERMANN RE, 1987, B SEISMOL SOC AM, V77, P141; Arvidsson R, 1998, B SEISMOL SOC AM, V88, P1003; DZIEWONSKI AM, 1981, J GEOPHYS RES, V86, P2825, DOI 10.1029/JB086iB04p02825; Gusman AR, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007565; Habermann R. E., 1981, M EWING SERIES, V4, P29; Hardebeck JL, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005410; Imoto M, 2008, EARTH PLANETS SPACE, V60, P693; Kanamori H., 1981, EARTHQUAKE PREDICTIO, V4, P1; Kato N, 1997, PURE APPL GEOPHYS, V150, P249; Katsumata K, 2011, EARTH PLANETS SPACE, V63, P709, DOI 10.5047/eps.2011.06.033; Katsumata K, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007964; Katsumata K, 1999, PURE APPL GEOPHYS, V155, P443, DOI 10.1007/s000240050274; KISSLINGER C, 1988, B SEISMOL SOC AM, V78, P218; MATTHEWS MV, 1988, PURE APPL GEOPHYS, V126, P357, DOI 10.1007/BF00879003; Mignan A, 2006, EARTH PLANET SC LETT, V244, P639, DOI 10.1016/j.epsl.2006.01.058; Mogi K., 1969, B EARTHQ RES I TOKYO, V47, P395; Nanjo KZ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052997; Ohtake M., 1981, M EWING SERIES, V4, P53; Ohtake M, 1980, REPT NATL CENT DISAS, V23, P65; Pesicek JD, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007443; SCHOLZ CH, 1988, PURE APPL GEOPHYS, V126, P701, DOI 10.1007/BF00879016; STUART WD, 1979, J GEOPHYS RES, V84, P1063, DOI 10.1029/JB084iB03p01063; Tanioka Y., 2012, J SEISMOL SOC JAPAN, V64, P265; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI DOI 10.1029/90E000319; WIEMER S, 1994, B SEISMOL SOC AM, V84, P900; Wiemer S., 1996, THESIS U ALASKA FAIR; Wyss M, 1998, GEOPHYS J INT, V134, P329, DOI 10.1046/j.1365-246x.1998.00543.x; WYSS M, 1984, J GEOPHYS RES, V89, P9293, DOI 10.1029/JB089iB11p09293; Wyss M, 1996, GEOPHYS J INT, V127, P735, DOI 10.1111/j.1365-246X.1996.tb04052.x; WYSS M, 1985, EARTHQUAKE PRED RES, V3, P519	50	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	FEB	2015	105	1					167	176		10.1785/0120140116		10	Geochemistry & Geophysics	Geochemistry & Geophysics	CA4TQ	WOS:000348898700010		
J	Pulido, N; Aguilar, Z; Tavera, H; Chlieh, M; Calderon, D; Sekiguchi, T; Nakai, S; Yamazaki, F				Pulido, Nelson; Aguilar, Zenon; Tavera, Hernando; Chlieh, Mohamed; Calderon, Diana; Sekiguchi, Toru; Nakai, Shoichi; Yamazaki, Fumio			Scenario Source Models and Strong Ground Motion for Future Mega-earthquakes: Application to Lima, Central Peru	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							CHILE SUBDUCTION ZONE; 2010 MAULE EARTHQUAKE; CRUSTAL STRUCTURE; RUPTURE; FAULT; SIMULATION; TRENCH; JAPAN; SLIP; MEGATHRUST	The 2011 moment magnitude (M-w) 9.0 Tohoku-Oki Japan earthquake occurred in a region where giant megathrust earthquakes were not expected. This earthquake proved the difficulty in assessing seismic hazard by relying mainly on information from historical and instrumental seismicity. To help improve the seismic-hazard assessment for such rare events, we propose a methodology to estimate the slip distribution of future megathrust earthquakes based on a model of interseismic coupling distribution in subduction margins, as well as information of historical earthquakes, and apply the method to the central Peru region, Lima. The slip model obtained from geodetic data represents the large scale features of asperities within the megathrust, which is appropriate for simulation of long-period waves and tsunami modeling. For the simulation of a broadband strong ground motion, we add small scale heterogeneities to the source slip to be able to simulate high frequencies. To achieve this purpose, we propose broadband source models constructed by adding short-wavelength slip distributions obtained from a Von Karman power spectral density function, to the slip model inferred from interseismic geodetic data. Using these slip models and assuming several hypocenter locations, we calculate a set of strong ground motions for Lima and incorporate site effects obtained from microtremors surveys and geotechnical data. Our simulated average pseudospectral accelerations (period 0.3 s) are above 1.5g for wide areas in Lima, which may be critical in terms of damage of low-to midrise masonry and reinforced concrete buildings, which characterize the majority of buildings in Lima.	[Pulido, Nelson] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan; [Aguilar, Zenon; Calderon, Diana] Univ Nacl Ingn, Lima 31, Peru; [Tavera, Hernando] Inst Geofis Peru, Lima, Peru; [Chlieh, Mohamed] Univ Nice Sophia Geoazur, F-06560 Valbonne, France; [Sekiguchi, Toru; Nakai, Shoichi; Yamazaki, Fumio] Chiba Univ, Inage Ku, Chiba 2638522, Japan	Pulido, N (reprint author), Natl Res Inst Earth Sci & Disaster Prevent, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	nelson@bosai.go.jp			SATREPS project "Enhancement of Earthquake and Tsunami Mitigation Technology in Peru"; National Research Institute for Earth Science and Disaster Prevention project "Development of Monitoring and Forecasting Technology for Crustal Activity"	This study was supported by the SATREPS project "Enhancement of Earthquake and Tsunami Mitigation Technology in Peru" and the National Research Institute for Earth Science and Disaster Prevention project "Development of Monitoring and Forecasting Technology for Crustal Activity." We thank the Associate Editor Ivan G. Wong and two anonymous reviewers for very helpful comments. We also thank Hugo Perfettini for insightful discussions at an early stage of this study.	Aagaard BT, 2010, B SEISMOL SOC AM, V100, P2927, DOI 10.1785/0120090324; Adriano B., 2013, J DISAS RES, V8, P274; Alva Hurtado J. E., 1984, 5 C NAC ING CIV TACN; Perfettini H, 2010, NATURE, V465, P78, DOI 10.1038/nature09062; Causse M, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006747; Mai PM, 2005, B SEISMOL SOC AM, V95, P965, DOI 10.1785/0120040111; Chlieh M, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008166; Kumagai H, 2013, J GEOPHYS RES-SOL EA, V118, P222, DOI 10.1029/2012JB009670; Krabbenhoft A, 2004, GEOPHYS J INT, V159, P749, DOI 10.1111/j.1365-246X.2004.02425.x; [Anonymous], DISTRIBUCION ESPECIA, P89; Rodriguez-Marek A, 2013, B SEISMOL SOC AM, V103, P3149, DOI 10.1785/0120130030; Boore DM, 2003, PURE APPL GEOPHYS, V160, P635, DOI 10.1007/PL00012553; Lay T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043379; Nocquet JM, 2014, NAT GEOSCI, V7, P287, DOI 10.1038/ngeo2099; Chlieh M, 2004, GEOPHYS J INT, V158, P695, DOI 10.1111/j.1365-246X.2004.02326.x; Protti M, 2014, NAT GEOSCI, V7, P117, DOI [10.1038/ngeo2038, 10.1038/NGEO2038]; Gagnon K, 2005, NATURE, V434, P205, DOI 10.1038/nature03412; Graves RW, 2010, B SEISMOL SOC AM, V100, P2095, DOI 10.1785/0120100057; Nakanishi A, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000424; Graves RW, 2011, EARTHQ SPECTRA, V27, P273, DOI 10.1193/1.3570677; Chlieh M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004981; Olsen KB, 2008, J SEISMOL, V12, P145, DOI 10.1007/s10950-007-9082-y; Konca AO, 2008, NATURE, V456, P631, DOI 10.1038/nature07572; Loveless JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048561; Song TRA, 2003, SCIENCE, V301, P630, DOI 10.1126/science.1085557; Yamada N, 2005, EARTH PLANETS SPACE, V57, P197; Sorensen MB, 2007, B SEISMOL SOC AM, V97, pS139, DOI 10.1785/0120050608; Kurahashi S, 2011, EARTH PLANETS SPACE, V63, P571, DOI 10.5047/eps.2011.06.044; Moreno M, 2010, NATURE, V467, P198, DOI 10.1038/nature09349; BOUCHON M, 1981, B SEISMOL SOC AM, V71, P959; Tanaka S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051179; Okal EA, 2006, B SEISMOL SOC AM, V96, P1634, DOI 10.1785/0120050158; Hashimoto C, 2009, NAT GEOSCI, V2, P141, DOI 10.1038/NGEO421; Jones N, 2014, NATURE, V507, P151, DOI 10.1038/507151a; DORBATH L, 1990, B SEISMOL SOC AM, V80, P551; Delouis B, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043899; Kendrick E, 2003, J S AM EARTH SCI, V16, P125, DOI 10.1016/S0895-9811(03)00028-2; Bejar-Pizarro M, 2013, NAT GEOSCI, V6, P462, DOI [10.1038/ngeo1802, 10.1038/NGEO1802]; Lorito S, 2011, NAT GEOSCI, V4, P173, DOI [10.1038/ngeo1073, 10.1038/NGEO1073]; BECK SL, 1990, GEOPHYS RES LETT, V17, P1969, DOI 10.1029/GL017i011p01969; BECK SL, 1989, PHYS EARTH PLANET IN, V57, P199, DOI 10.1016/0031-9201(89)90112-X; Brocher TM, 2008, J SEISMOL, V12, P217, DOI 10.1007/s10950-007-9061-3; Calderon D., 2013, J DISAST RES, V8, P252; Calderon D., 2012, J JAPAN ASS EARTHQ E, V12, P1; Calderon D., 2012, THESIS CHIBA U CHIBA, P113; DORBATH L, 1991, J S AM EARTH SCI, V4, P13, DOI 10.1016/0895-9811(91)90015-D; Frankel A, 2013, TECTONOPHYSICS, V592, P200, DOI 10.1016/j.tecto.2012.11.032; Heuret A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050712; Irikura K., 1994, ANN GEOFIS, VXXXVII, P1721; Irikura K., 1986, 7TH P JAP EARTHQ ENG, P151; Matsuoka M., 2013, J DISAST RES, V8, P328; Nanjo KZ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052997; Okada Y, 2013, J PHYS CONF SER, V433, DOI 10.1088/1742-6596/433/1/012039; Pulido N, 2004, TECTONOPHYSICS, V390, P177, DOI 10.1016/j.tecto.2004.03.032; Pulido N, 2009, B SEISMOL SOC AM, V99, P2305, DOI 10.1785/0120080165; Pulido N, 2011, EARTH PLANETS SPACE, V63, P955, DOI 10.5047/eps.2011.04.008; Pulido N, 2004, TECTONOPHYSICS, V391, P357, DOI 10.1016/j.tecto.2004.07.023; Pulido N., 2013, J DISAST RES, V8, P235; Quispe G., 2013, J DISAST RES, V8, P243; Ripperger J, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020594; Roten D, 2011, B SEISMOL SOC AM, V101, P2045, DOI 10.1785/0120110031; Schnabel P.B., 1972, 7212 EERC U CAL; Sekiguchi T., 2013, Journal of Disaster Research, V8, P259; Silgado E., 1978, I GEOLOGIA MINERIA C; Sorensen MB, 2007, B SEISMOL SOC AM, V97, P881, DOI 10.1785/0120060044; Sufri O, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051316; Wald D. J., 1999, EARTHQ SPECTRA, V15, P557, DOI DOI 10.1193/1.1586058	67	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	FEB	2015	105	1					368	386				19	Geochemistry & Geophysics	Geochemistry & Geophysics	CA4TQ	WOS:000348898700025		
J	Hirai, T; Fukuwa, N				Hirai, Takashi; Fukuwa, Nobuo			Synthesis of Earthquake-Like Sound Using Seismic Ground-Motion Records Notice of Partially Redundant Publication (vol 104, pg 1777, 2014)	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Correction									[Hirai, Takashi] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Fukuwa, Nobuo] Nagoya Univ, Disaster Mitigat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Hirai, T (reprint author), Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	hirai@sharaku.nuac.nagoya-u.ac.jp; fukuwa@sharaku.nuac.nagoya-u.ac.jp					Hirai T, 2014, B SEISMOL SOC AM, V104, P1777, DOI 10.1785/0120130267; Hirai T., 2012, J SEISMOL SOC JAPAN, V63, P153, DOI [10.4294/zisin.63.153, DOI 10.4294/ZISIN.63.153]; Miyakoshi J., 2005, 4 ANN M JAP ASS EART	3	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	FEB	2015	105	1					445	446		10.1785/0120140321		2	Geochemistry & Geophysics	Geochemistry & Geophysics	CA4TQ	WOS:000348898700031		
J	Obana, K; Scherwath, M; Yamamoto, Y; Kodaira, S; Wang, K; Spence, G; Riedel, M; Kao, H				Obana, Koichiro; Scherwath, Martin; Yamamoto, Yojiro; Kodaira, Shuichi; Wang, Kelin; Spence, George; Riedel, Michael; Kao, Honn			Earthquake Activity in Northern Cascadia Subduction Zone Off Vancouver Island Revealed by Ocean-Bottom Seismograph Observations	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							WESTERN CANADA; SEISMIC STRUCTURE; TRANSFORM FAULTS; FORE-ARC; PLATE; DEFORMATION; RUPTURE; SLIP; VELOCITIES; INVERSION	Offshore seismicity at the Cascadia margin is poorly constrained because nearly all previous recordings of earthquakes were made using land-based networks. We conducted earthquake monitoring off Vancouver Island in northern Cascadia using ocean-bottom seismographs. Our results show that most of the offshore seismicity is concentrated along the Nootka fault zone. Otherwise seismicity is extremely low, with no earthquakes located along the shallow, seismogenic part of the megathrust. The lack of interplate seismicity may indicate complete healing and locking of the megathrust over three centuries after the great earthquake of 1700 and a somewhat lower degree of structure heterogeneity, such as subducting seamounts. Events along the Nootka fault zone occur over a 10-15 km depth range. This wide distribution and the previously reported overall moment release rate suggest that a significant part of deformation of this fault zone is aseismic. Several earthquakes beneath the continental shelf may be related to faults dividing tectonic terrains within the overriding plate.	[Obana, Koichiro; Yamamoto, Yojiro; Kodaira, Shuichi] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Earthquake & Tsunami, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Scherwath, Martin] Univ Victoria, Ocean Networks Canada, Victoria, BC V8W 2Y2, Canada; [Wang, Kelin; Riedel, Michael; Kao, Honn] Geol Survey Canada, Pacific Geosci Ctr, Nat Resources Canada, Sidney, BC V8L 4B2, Canada; [Spence, George] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3V6, Canada	Obana, K (reprint author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Earthquake & Tsunami, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	obanak@jamstec.go.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23253005]	We acknowledge helpful discussions with Roy Hyndman and Garry Rogers. We thank the captain and crew of Canadian Coast Guard Research Vessel John P. Tully for their help in our ocean-bottom seismograph deployment and recovery. We also thank Peter Neelands and Greg Middleton of Geological Survey of Canada (GSC) and Ikumasa Terada, Takuya Maekawa, and Kaoru Tsukuda of Nippon Marine Enterprises, LTD for their technical supports. This work was partially supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 23253005, and the paper was written during the first author's stay at GSC as a visiting scientist. This paper is also GSC contribution 20140210. Comments from Anne Trehu and an anonymous reviewer helped to improve the manuscript.	HYNDMAN RD, 1990, CAN J EARTH SCI, V27, P313, DOI 10.1139/e90-030; CASTAGNA JP, 1985, GEOPHYSICS, V50, P571, DOI 10.1190/1.1441933; HYNDMAN RD, 1979, GEOPHYS J ROY ASTR S, V58, P667, DOI 10.1111/j.1365-246X.1979.tb04801.x; Willoughby EC, 2005, GEOPHYS J INT, V160, P855, DOI 10.1111/j.1365-246X.2005.02523.x; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Chaytor JD, 2004, GEOLOGY, V32, P353, DOI 10.1130/G20178.1; McCrory PA, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009407; Kodaira S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016595; Boettcher MS, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003110; Satake K, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002521; Wada I, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002570; Argus DF, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003751; ATWATER BF, 1992, J GEOPHYS RES-SOL EA, V97, P1901, DOI 10.1029/91JB02346; Davis EE, 2006, EARTH PLANET SC LETT, V242, P73, DOI 10.1016/j.epsl.2005.11.054; Goldfinger C, 2003, ANNU REV EARTH PL SC, V31, P555, DOI 10.1146/annurev.earth.31.100901.141246; Hagerty MT, 1996, J GEOPHYS RES-SOL EA, V101, P16043, DOI 10.1029/96JB00528; HIRATA N, 1987, PHYS EARTH PLANET IN, V47, P50, DOI 10.1016/0031-9201(87)90066-5; Hyndman R, 1995, J GEOPHYS RES, V100, P22; HYNDMAN RD, 1981, J GEOPHYS RES, V86, P3867, DOI 10.1029/JB086iB05p03867; IWASAKI T, 1991, GEOPHYS J INT, V105, P693, DOI 10.1111/j.1365-246X.1991.tb00806.x; Kodaira S, 2000, SCIENCE, V289, P104, DOI 10.1126/science.289.5476.104; McCaffrey R, 2013, J GEOPHYS RES-SOL EA, V118, P709, DOI 10.1029/2012JB009473; Obana K, 2009, B SEISMOL SOC AM, V99, P110, DOI 10.1785/0120070236; Obana K, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002370; Obana K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028179; Scherwath M., 2011, EOS T AM GEOPHYS UN, V92, P421; SPENCE GD, 1985, J GEOPHYS RES-SOLID, V90, P6754, DOI 10.1029/JB090iB08p06754; Toomey D. R., 2011, 2011 FALL M AGU SAN; Trehu AM, 2012, GEOLOGY, V40, P103, DOI 10.1130/G32460.1; Wada I, 2010, B SEISMOL SOC AM, V100, P2002, DOI 10.1785/0120090349; Wang K, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001227; Wang K, 2000, TECTONOPHYSICS, V319, P321, DOI 10.1016/S0040-1951(99)00301-7; Wang PL, 2013, J GEOPHYS RES-SOL EA, V118, P2460, DOI 10.1002/jgrb.50101; Watanabe H, 1971, ZISIN, V24, P189	34	2	2	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	FEB	2015	105	1					489	495		10.1785/0120140095		7	Geochemistry & Geophysics	Geochemistry & Geophysics	CA4TQ	WOS:000348898700038		
J	Dionis, SM; Melian, G; Rodriguez, F; Hernandez, PA; Padron, E; Perez, NM; Barrancos, J; Padilla, G; Sumino, H; Fernandes, P; Bandomo, Z; Silva, S; Pereira, JM; Semedo, H				Dionis, Samara M.; Melian, Gladys; Rodriguez, Fatima; Hernandez, Pedro A.; Padron, Eleazar; Perez, Nemesio M.; Barrancos, Jose; Padilla, German; Sumino, Hirochika; Fernandes, Paulo; Bandomo, Zuleyka; Silva, Sonia; Pereira, Jose M.; Semedo, Helio			Diffuse volcanic gas emission and thermal energy release from the summit crater of Pico do Fogo, Cape Verde	BULLETIN OF VOLCANOLOGY			English	Article						Diffuse gas emission; Heat flux; Fogo volcano; Cape Verde	CARBON-DIOXIDE; ISOTOPIC COMPOSITION; GEOTHERMAL AREA; CENTRAL-AMERICA; CANARY-ISLANDS; CO2 EMISSION; HEAT RELEASE; SOIL; HELIUM; HYDROGEN	We report the first detailed study of diffuse emission of carbon dioxide (CO2), hydrogen sulfide (H2S), helium (He), and hydrogen (H-2) from the summit crater of Pico do Fogo volcano, Cape Verde. Diffuse CO2, H2S, He, and H-2 gas fluxes were measured at 57 sampling sites and ranged up to 12,800, 13, 1, and 6 g m(-2) day(-1), respectively. Soil temperature measurements at each sampling site were used to evaluate the heat flux. Most of the summit crater shows relatively high CO2 efflux, with highest values close to the fumarolic area, suggesting a structural control of the degassing process. In contrast, H2S effluxes were negligible or very low at the summit crater, except close to the fumarolic area where anomalously high CO2 efflux and soil temperatures were also measured. We estimate total CO2, H2S, He, and H-2 diffuse gas fluxes of 219 t day(-1), 25, 4, and 33 kg day(-1), respectively. Based on a H2O/CO2 mass ratio of 1.52 measured at the fumaroles, we estimate a diffuse steam flux from the summit crater of approximately 330 t day(-1). The enthalpy of this steam is equivalent to a heat flux of about 10.3 MW. The diffuse gas emission and thermal energy released from the summit crater of Pico do Fogo volcano are comparable to those observed at other volcanoes. Sustained surveillance of Pico do Fogo using these methods will be valuable for monitoring the activity of one of the most active volcanoes in the Atlantic Ocean.	[Dionis, Samara M.; Melian, Gladys; Rodriguez, Fatima; Hernandez, Pedro A.; Padron, Eleazar; Perez, Nemesio M.; Barrancos, Jose; Padilla, German] Antiguo Hotel Taoro, INVOLCAN, Puerto La Cruz 38400, Tenerife, Spain; [Melian, Gladys; Hernandez, Pedro A.; Padron, Eleazar; Perez, Nemesio M.; Barrancos, Jose; Padilla, German] ITER, Div Environm Res, Granadilla De Abona 38611, Tenerife, Spain; [Sumino, Hirochika] Univ Tokyo, Grad Sch Sci, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan; [Fernandes, Paulo; Bandomo, Zuleyka] LEC, Santiago, Cape Verde; [Silva, Sonia; Pereira, Jose M.] UNICV, Santiago, Cape Verde; [Semedo, Helio] SNPC, Santiago, Cape Verde	Dionis, SM (reprint author), Antiguo Hotel Taoro, INVOLCAN, Parque Taoro 22, Puerto La Cruz 38400, Tenerife, Spain.	sdionis@iter.es	Dionis Delgado, Samara M./H-9806-2015; Perez Rodriguez, Nemesio /H-9295-2015; Barrancos, Jose/H-7681-2015; Padilla Hernandez, German Domingo/H-7621-2015; Melian, Gladys/H-7196-2015; Padron, Eleazar/L-5506-2013	Dionis Delgado, Samara M./0000-0002-4555-8484; Perez Rodriguez, Nemesio /0000-0003-1410-7717; Barrancos, Jose/0000-0002-6224-5471; Padilla Hernandez, German Domingo/0000-0002-4524-3829; Melian, Gladys/0000-0002-3707-7170; Sumino, Hirochika/0000-0002-4689-6231; Padron, Eleazar/0000-0003-3907-5766	MAKAVOL of the European Union Transnational Cooperation Programme MAC [MAC/3/C161]; CABOVERDE of the Spanish Agency for International Cooperation & Development, AECID [08-CAP2-1202]; UNICV of the Servicio de Accion Exterior del Cabildo Insular de Tenerife (Canary Island, Spain)	This work has been partially funded by the projects (i) MAKAVOL (MAC/3/C161) of the European Union Transnational Cooperation Programme MAC 2007-2013, (ii) CABOVERDE (08-CAP2-1202) of the Spanish Agency for International Cooperation & Development, AECID, and (iii) UNICV of the Servicio de Accion Exterior del Cabildo Insular de Tenerife (Canary Island, Spain). We are also grateful to Jose Antonio Fernandes "Madjer", Antonio Goncalves, Inocencio Barros, Judite Nascimento and Joao Feliberto Semedo for their logistical support during the field work related to this research, as well as to Takeshi Ohba, Clive Oppenheimer and anonymous reviewer whose useful comments and constructive suggestions greatly improved the manuscript.	Aiuppa A, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008461; Chiodini G, 2001, J GEOPHYS RES-SOL EA, V106, P16213, DOI 10.1029/2001JB000246; Lombardi S, 2010, APPL GEOCHEM, V25, P1206, DOI 10.1016/j.apgeochem.2010.05.006; SANO Y, 1985, J GEOPHYS RES-SOLID, V90, P8729, DOI 10.1029/JB090iB10p08729; Novelli PC, 1999, J GEOPHYS RES-ATMOS, V104, P30427, DOI 10.1029/1999JD900788; Frondini F, 2004, B VOLCANOL, V66, P642, DOI 10.1007/s00445-004-0346-x; Frondini F, 2009, APPL GEOCHEM, V24, P860, DOI 10.1016/j.apgeochem.2009.01.010; Perez NM, 2013, J GEOL SOC LONDON, V170, P585, DOI 10.1144/jgs2012-125; Fridriksson T, 2006, APPL GEOCHEM, V21, P1551, DOI 10.1016/j.apgeochem.2006.04.006; Chiodini G, 2008, EARTH PLANET SC LETT, V274, P372, DOI 10.1016/j.epsl.2008.07.051; GERLACH TM, 1985, NATURE, V313, P273, DOI 10.1038/313273a0; CERLING TE, 1991, GEOCHIM COSMOCHIM AC, V55, P3403, DOI 10.1016/0016-7037(91)90498-T; Etiope G, 2002, PHYS EARTH PLANET IN, V129, P185, DOI 10.1016/S0031-9201(01)00292-8; GIGGENBACH WF, 1980, GEOCHIM COSMOCHIM AC, V44, P2021, DOI 10.1016/0016-7037(80)90200-8; Carapezza ML, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019614; Schaap MG, 2001, J HYDROL, V251, P186, DOI 10.1016/S0022-1694(01)00468-1; Day SJ, 1999, J VOLCANOL GEOTH RES, V94, P191, DOI 10.1016/S0377-0273(99)00103-1; Moussallam Y, 2012, B VOLCANOL, V74, P2109, DOI 10.1007/s00445-012-0649-2; Symonds RB, 2001, J VOLCANOL GEOTH RES, V108, P303, DOI 10.1016/S0377-0273(00)00292-4; CRAIG H, 1976, EARTH PLANET SC LETT, V31, P369, DOI 10.1016/0012-821X(76)90118-7; Hernandez P, 2012, B VOLCANOL, V74, P2435, DOI 10.1007/s00445-012-0673-2; Padron E, 2013, GEOLOGY, V41, P539, DOI 10.1130/G34027.1; Hernandez PA, 2001, CHEM GEOL, V177, P175, DOI 10.1016/S0009-2541(00)00390-9; Matsuda J, 2002, GEOCHEM J, V36, P191; Hernandez PA, 2001, SCIENCE, V292, P83, DOI 10.1126/science.1058450; Melian G, 2012, B VOLCANOL, V74, P1465, DOI 10.1007/s00445-012-0613-1; HILTON DR, 1995, NATURE, V373, P330, DOI 10.1038/373330a0; Granieri D, 2014, J VOLCANOL GEOTH RES, V275, P22, DOI 10.1016/j.jvolgeores.2014.02.011; Arpa MC, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-013-0747-9; Carapezza ML, 2011, J VOLCANOL GEOTH RES, V207, P130, DOI 10.1016/j.jvolgeores.2011.06.010; Cardellini G, 2003, J GEOPHYS RES, V108, P2425, DOI [10.1029/2002JB002165, DOI 10.1029/2002JB002165]; Chiodini G, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003542; COURTNEY RC, 1986, GEOPHYS J INT, V87, P815, DOI 10.1111/j.1365-246X.1986.tb01973.x; Deutsch C. V., 1998, GSLIB GEOSTATISTICAL; Dionis SM, 2012, EL HIERR WORKSH MAKA; Doucelance R, 2003, GEOCHIM COSMOCHIM AC, V67, P733; Doucelance R, 2003, GEOCHIM COSMOCHIM AC, V67, P717; Doucelance R, 2003, GEOCHIM COSMOCHIM AC, V67, P3; Fonseca JFBD, 2003, J VOLCANOL GEOTH RES, V125, P39, DOI 10.1016/S0377-0273(03)00088-X; Giggenbach W., 1989, COLLECTION ANA UNPUB, P81; Granieri D, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026460; Hinkle M, 1979, US GEOL SURV OPEN FI, V79, P1441; Keenan J. H., 1969, STEAM TABLES THERMOD; Mamyrin BA, 1984, HELIUM ISOTOPES NATU, V3, P273; Melian G, 2008, MONITORIZACION GEOQU; Melian G, 2014, J GEOPHYS RES-SOL EA, V119, P6976, DOI 10.1002/2014JB011013; Melian GV, 2007, PURE APPL GEOPHYS, V164, P2465, DOI 10.1007/s00024-007-0282-8; Novelli PC, 1999, J GEOPHYS RES, V104, P30; Padron E, 2012, CHEM GEOL, V312, P138, DOI 10.1016/j.chemgeo.2012.04.018; Padron E, 2012, B VOLCANOL, V74, P1509, DOI 10.1007/s00445-012-0610-4; PARKINSON KJ, 1981, J APPL ECOL, V18, P221, DOI 10.2307/2402491; Perez NM, 2006, PURE APPL GEOPHYS, V163, P883, DOI 10.1007/s00024-006-0050-1; Pogorsky L. A., 1981, UNCONVENTIONAL METHO, P124; REIMER GM, 1981, GEOPHYS RES LETT, V8, P433, DOI 10.1029/GL008i005p00433; Salazar JML, 2001, GEOPHYS RES LETT, V28, P4275, DOI 10.1029/2001GL013709; Sato M, 1981, 1980 ERUPTION MOUNT, P209; Silva S, 2011, CAP VERD TEN WORKSH; Sumino H, 2001, J MASS SPECTROM SOC, V49, P61; THOMAS DM, 1979, SCIENCE, V204, P1195, DOI 10.1126/science.204.4398.1195; Voltaggio M, 2009, J VOLCANOL GEOTH RES, V179, P56, DOI 10.1016/j.jvolgeores.2008.10.009; Weast RC, 1972, HDB CHEM PHYS	61	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0258-8900	1432-0819		B VOLCANOL	Bull. Volcanol.	FEB	2015	77	2							10	10.1007/s00445-014-0897-4		13	Geosciences, Multidisciplinary	Geology	CA6GV	WOS:000349009700004		
J	Setoguchi, S; Watase, D; Matsunaga, K; Matsubara, M; Kubo, Y; Kusuda, M; Nagata-Akaho, N; Enjoji, M; Nakashima, M; Takeshita, M; Karube, Y; Takata, J				Setoguchi, Shuichi; Watase, Daisuke; Matsunaga, Kazuhisa; Matsubara, Misa; Kubo, Yohei; Kusuda, Mariko; Nagata-Akaho, Nami; Enjoji, Munechika; Nakashima, Manabu; Takeshita, Morishige; Karube, Yoshiharu; Takata, Jiro			Enhanced Antitumor Effects of Novel Intracellular Delivery of an Active Form of Menaquinone-4, Menahydroquinone-4, into Hepatocellular Carcinoma	CANCER PREVENTION RESEARCH			English	Article							GAMMA-CARBOXY PROTHROMBIN; VITAMIN-K PRODRUGS; NF-KAPPA-B; ABNORMAL PROTHROMBIN; GENE-EXPRESSION; HEPATOMA-CELLS; GROWTH; MENATETRENONE; OSTEOPOROSIS; TUMOR	Reduced cellular uptake of menaquinone-4 (MK-4), a vitamin K2 homolog, in human hepatocellular carcinoma (HCC) limits its usefulness as a safe long-term antitumor agent for recurrent HCC and produces des-g gamma-carboxy prothrombin (DCP). We hypothesized that effective delivery of menahydroquinone-4 (MKH), the active form of MK-4 for g-glutamyl carboxylation, into HCC cells is critical for regulating HCC growth, and may enable it to be applied as a safe antitumor agent. In this study, we verified this hypothesis using menahydroquinone-4 1,4-bis-N, N-dimethylglycinate hydrochloride (MKH-DMG), a prodrug of MKH, and demonstrated its effectiveness. Intracellular delivery of MKH and subsequent growth inhibition of PLC/PRF/5 and Hep3B (DCPpositive) and SK-Hep-1 (DCP-negative) cells after MKH-DMG administration were determined and compared with MK-4. The activity of MKH-DMG against tumor progression in the liver alongside DCP formation was determined in a spleen-liver metastasis mouse model. MKH-DMG exhibited greater intracellular delivery of MKH in vitro (AUC(0-72) hour of MKH) and increased growth-inhibitory activity against both DCP-positive and DCP-negative HCC cell lines. The phenomena of MKH delivery into cells in parallel with simultaneous growth inhibition suggested that MKH is the active form for growth inhibition of HCCcells. Cell-cycle arrest was determined to be involved in the growth inhibition mechanisms of MKH-DMG. Furthermore, MKH-DMG showed significant inhibition of tumor progression in the liver, and a substantial decrease in plasma DCP levels in the spleen-liver metastasis mouse model. Our results suggest that MKH-DMG is a promising new candidate antitumor agent for safe long-termtreatment of HCC. (C) 2014 AACR.	[Setoguchi, Shuichi; Watase, Daisuke; Matsunaga, Kazuhisa; Matsubara, Misa; Kubo, Yohei; Kusuda, Mariko; Nagata-Akaho, Nami; Enjoji, Munechika; Nakashima, Manabu; Karube, Yoshiharu; Takata, Jiro] Fukuoka Univ, Fac Pharmaceut Sci, Jonan Ku, Fukuoka 8140180, Japan; [Takeshita, Morishige] Fukuoka Univ, Sch Med, Dept Pathol, Jonan Ku, Fukuoka 8140180, Japan	Takata, J (reprint author), Fukuoka Univ, Fac Pharmaceut Sci, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	jtakata@fukuoka-u.ac.jp			Central Research Institute of Fukuoka University [091001]	This work was supported by a grant (no. 091001; to J. Takata) from the Central Research Institute of Fukuoka University.	Murata K, 2009, INT J ONCOL, V35, P1005, DOI 10.3892/ijo_00000415; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Stafford DW, 2005, J THROMB HAEMOST, V3, P1873, DOI 10.1111/j.1538-7836.2005.01419.x; Furie B, 1999, BLOOD, V93, P1798; Shiraki M, 2000, J BONE MINER RES, V15, P515, DOI 10.1359/jbmr.2000.15.3.515; Orimo H, 1998, J BONE MINER METAB, V16, P106, DOI 10.1007/s007740050034; Koike Y, 2001, CANCER, V91, P561, DOI 10.1002/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N; Inagaki Y, 2011, LIVER INT, V31, P22, DOI 10.1111/j.1478-3231.2010.02348.x; BINKLEY NC, 1995, J NUTR, V125, P1812; Suzuki M, 2005, J BIOL CHEM, V280, P6409, DOI 10.1074/jbc.M406714200; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Yoshida H, 2011, HEPATOLOGY, V54, P532, DOI 10.1002/hep.24430; Gao JJ, 2012, BIOSCI TRENDS, V6, P153, DOI 10.5582/bst.2012.v6.4.153; Westhofen P, 2011, J BIOL CHEM, V286, P15085, DOI 10.1074/jbc.M110.210971; OKUDA H, 1987, J HEPATOL, V4, P357, DOI 10.1016/S0168-8278(87)80546-9; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Mizuta T, 2006, CANCER, V106, P867, DOI 10.1002/cncr.21667; Knapen MHJ, 2007, OSTEOPOROSIS INT, V18, P963, DOI 10.1007/s00198-007-0337-9; WEITZ IC, 1993, HEPATOLOGY, V18, P990, DOI 10.1002/hep.1840180434; Inoue T, 2009, J BONE MINER METAB, V27, P66, DOI 10.1007/s00774-008-0008-8; BOUZAHZAH B, 1995, J CELL PHYSIOL, V165, P459, DOI 10.1002/jcp.1041650303; FIDLER IJ, 1986, CANCER METAST REV, V5, P29, DOI 10.1007/BF00049529; FURUKAWA M, 1992, CANCER, V69, P31, DOI 10.1002/1097-0142(19920101)69:1<31::AID-CNCR2820690108>3.0.CO;2-6; Habu D, 2004, JAMA-J AM MED ASSOC, V292, P358, DOI 10.1001/jama.292.3.358; Hallgren KW, 2006, BIOCHEMISTRY-US, V45, P5587, DOI 10.1021/bi051986y; Hitomi M, 2005, INT J ONCOL, V26, P713; HUISSE MG, 1994, CANCER, V74, P1533, DOI 10.1002/1097-0142(19940901)74:5<1533::AID-CNCR2820740507>3.0.CO;2-V; Ishii M, 1995, JPN PHARMACOL THER, V23, P2637; Kaneda M, 2008, CANCER LETT, V263, P53, DOI 10.1016/j.canlet.2007.12.019; Li ZP, 2006, CELL CYCLE, V5, P2440, DOI 10.4161/cc.5.21.3428; Li ZQ, 2002, LIFE SCI, V70, P2085, DOI 10.1016/S0024-3205(01)01525-9; Ma M, 2009, CHEMOTHERAPY, V55, P28, DOI 10.1159/000167022; Matsubara M, 2012, J GASTROEN HEPATOL, V27, P1602, DOI 10.1111/j.1440-1746.2012.07173.x; Otsuka M, 2004, HEPATOLOGY, V40, P243, DOI 10.1002/hep.20260; Ozaki I, 2007, CLIN CANCER RES, V13, P2236, DOI 10.1158/1078-0432.CCR-06-2308; Sano Y, 1995, JPN PHARMACOL THER, V23, P2659; Takata J, 1995, PHARMACEUT RES, V12, P1973, DOI 10.1023/A:1016208409992; TAKATA J, 1995, PHARMACEUT RES, V12, P18, DOI 10.1023/A:1016274201137; WANG ZQ, 1995, HEPATOLOGY, V22, P876, DOI 10.1016/0270-9139(95)90310-0; Yue P, 2011, EUR J CANCER, V47, P1115, DOI 10.1016/j.ejca.2011.01.017	40	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1940-6207	1940-6215		CANCER PREV RES	Cancer Prev. Res.	FEB	2015	8	2					129	138		10.1158/1940-6207.CAPR-14-0292		10	Oncology	Oncology	CA4WM	WOS:000348907800005		
J	Sun, JK; Xu, Q				Sun, Jian-Ke; Xu, Qiang			Metal Nanoparticles Immobilized on Carbon Nanodots as Highly Active Catalysts for Hydrogen Generation from Hydrazine in Aqueous Solution	CHEMCATCHEM			English	Article						hydrogen; nanodots; nanoparticles; nickel; platinum	GRAPHENE QUANTUM DOTS; ROOM-TEMPERATURE; PALLADIUM NANOPARTICLES; METHANOL OXIDATION; ORGANIC FRAMEWORK; STORAGE MATERIALS; ENERGY-STORAGE; DECOMPOSITION; PHOTOLUMINESCENCE; STABILIZATION	Well-dispersed PtNi nanoparticles (NPs) grown on carbon nanodots (CNDs) derived from a metal-organic framework (ZIF-8) are synthesized by a simple reduction of metal precursors in the presence of CNDs, wherein the CNDs prove to be a powerful dispersion agent and distinct support for the PtNi NPs. The resultant PtNi-CND catalyst exerts almost 100% H-2 selectivity and a high activity for the decomposition of hydrous hydrazine at room temperature. This excellent catalytic performance might be a result of the synergistic effect of the CND support and the PtNi NPs. The utilization of CNDs as a support to anchor the active component NPs and thus to facilitate the electron transfer and mass transport kinetics during the catalytic reaction process opens up new avenues to design high-performance catalysts.	[Sun, Jian-Ke; Xu, Qiang] Natl Inst Adv Ind Sci & Technol Inst AIST, Ikeda, Osaka 5638577, Japan	Xu, Q (reprint author), Natl Inst Adv Ind Sci & Technol Inst AIST, Ikeda, Osaka 5638577, Japan.	q.xu@aist.go.jp	Xu, Qiang/H-4997-2011		AIST; JSPS	The authors thank the reviewers for valuable suggestions, Dr. Hiroaki Sakurai for FTIR measurements, Dr. Takeyuki Uchida for TEM measurements, and AIST and JSPS for financial support. J.-K.S. thanks JSPS for a postdoctoral fellowship.	He L, 2012, ANGEW CHEM INT EDIT, V51, P6191, DOI 10.1002/anie.201201737; Zhai YP, 2011, ADV MATER, V23, P4828, DOI 10.1002/adma.201100984; Mathiyarasu J, 2004, J SOLID STATE ELECTR, V8, P968, DOI 10.1007/s10008-004-0526-9; Baker SN, 2010, ANGEW CHEM INT EDIT, V49, P6726, DOI 10.1002/anie.200906623; Zhu SJ, 2013, ANGEW CHEM INT EDIT, V52, P3953, DOI 10.1002/anie.201300519; Yan X, 2010, J AM CHEM SOC, V132, P5944, DOI 10.1021/ja1009376; Liu MM, 2013, NANOSCALE, V5, P12558, DOI 10.1039/c3nr04054b; Chen PC, 2013, CHEM COMMUN, V49, P1639, DOI 10.1039/c3cc38486a; Yan X, 2012, J AM CHEM SOC, V134, P16095, DOI 10.1021/ja303730p; Pukazhselvan D, 2012, NANO ENERGY, V1, P566, DOI 10.1016/j.nanoen.2012.05.004; Schlapbach L, 2001, NATURE, V414, P353, DOI 10.1038/35104634; Su DS, 2013, CHEM REV, V113, P5782, DOI 10.1021/cr300367d; Singh SK, 2009, J AM CHEM SOC, V131, P9894, DOI 10.1021/ja903869y; Cao L, 2013, ACCOUNTS CHEM RES, V46, P171, DOI 10.1021/ar300128j; Simon P, 2013, ACCOUNTS CHEM RES, V46, P1094, DOI 10.1021/ar200306b; Feng XL, 2009, NAT MATER, V8, P421, DOI [10.1038/nmat2427, 10.1038/NMAT2427]; Wei WT, 2012, J POWER SOURCES, V204, P85, DOI 10.1016/j.jpowsour.2012.01.032; Chen XW, 2004, J CATAL, V224, P473, DOI 10.1016/j.jcat.2004.02.003; Tian ZQ, 2006, J PHYS CHEM B, V110, P5343, DOI 10.1021/jp056401o; Eberle U, 2009, ANGEW CHEM INT EDIT, V48, P6608, DOI 10.1002/anie.200806293; Candelaria SL, 2012, NANO ENERGY, V1, P195, DOI 10.1016/j.nanoen.2011.11.006; Chen XM, 2011, J AM CHEM SOC, V133, P3693, DOI 10.1021/ja110313d; Su DS, 2013, J ENERGY CHEM, V22, P151; Guo SJ, 2010, ACS NANO, V4, P547, DOI 10.1021/nn9014483; Huang ZG, 2012, ENERG ENVIRON SCI, V5, P9257, DOI 10.1039/c2ee23039a; Wang HL, 2013, J MATER CHEM A, V1, P14957, DOI 10.1039/c3ta13259e; Enthaler S, 2010, ENERG ENVIRON SCI, V3, P1207, DOI 10.1039/b907569k; Wang J, 2012, ENERG ENVIRON SCI, V5, P6885, DOI 10.1039/c2ee03344e; Singh SK, 2011, J AM CHEM SOC, V133, P19638, DOI 10.1021/ja208475y; Singh SK, 2009, J AM CHEM SOC, V131, P18032, DOI 10.1021/ja908037t; Singh AK, 2013, CHEMCATCHEM, V5, P3000, DOI 10.1002/cctc.201300233; Sun JK, 2014, ENERG ENVIRON SCI, V7, P2071, DOI 10.1039/c4ee00517a; Boddien A, 2012, ENERG ENVIRON SCI, V5, P8907, DOI 10.1039/c2ee22043a; Demirci UB, 2011, ENERG ENVIRON SCI, V4, P3334, DOI 10.1039/c1ee01612a; Shen LM, 2013, LANGMUIR, V29, P16135, DOI [10.1021/la404270w, 10.1021/1a404270w]; Biener J, 2011, ENERG ENVIRON SCI, V4, P656, DOI 10.1039/c0ee00627k; He L, 2013, J CATAL, V298, P1, DOI 10.1016/j.jcat.2012.10.012; Fang YX, 2012, ACS NANO, V6, P400, DOI 10.1021/nn2046373; Hamilton CW, 2009, CHEM SOC REV, V38, P279, DOI 10.1039/b800312m; Yadav M, 2012, ENERG ENVIRON SCI, V5, P9698, DOI 10.1039/c2ee22937d; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; Yang J, 2010, CHEM SOC REV, V39, P656, DOI 10.1039/b802882f; Deivaraj TC, 2003, J MATER CHEM, V13, P2555, DOI 10.1039/b307040a; Liu RH, 2014, ACS CATAL, V4, P328, DOI 10.1021/cs400913h; Tong DG, 2013, J MATER CHEM A, V1, P358, DOI 10.1039/c2ta00015f; Li HT, 2012, J MATER CHEM, V22, P24230, DOI 10.1039/c2jm34690g; Gupta V, 2011, J AM CHEM SOC, V133, P9960, DOI 10.1021/ja2036749; Amali AJ, 2014, CHEM-EUR J, V20, P8279, DOI 10.1002/chem.201402982; Zhang XY, 2013, ACS NANO, V7, P11234, DOI 10.1021/nn405017q; Wu CZ, 2010, J MATER CHEM, V20, P5390, DOI 10.1039/b926880d; Antonietti M, 2010, ADV MATER, V22, P787, DOI 10.1002/adma.200904091; Aranishi K, 2013, CHEMCATCHEM, V5, P2248, DOI 10.1002/cctc.201300143; Baker S. N., 2010, ANGEW CHEM, V122, P6876, DOI 10.1002/ange.200906623; Dey D, 2013, DALTON T, V42, P13821, DOI 10.1039/c3dt51234g; He L., 2012, ANGEW CHEM, V124, P6295; Metz KM, 2007, J PHYS CHEM C, V111, P7260, DOI 10.1021/jp070102c; Schlapbach L., 2009, ANGEW CHEM, V121, P6732; ZHANG JL, 2013, J IRON STEEL RES INT, V20, P1; Zheng MY, 2005, INT J HYDROGEN ENERG, V30, P1081, DOI 10.1016/j.ijhydene.2004.09.014; Zhu S., 2013, ANGEW CHEM, V125, P4045	60	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	FEB	2015	7	3					526	531		10.1002/cctc.201402735		6	Chemistry, Physical	Chemistry	CA8DP	WOS:000349147100022		
J	Hamori, M; Shimizu, Y; Yoshida, K; Fukushima, K; Sugioka, N; Nishimura, A; Naruhashi, K; Shibata, N				Hamori, Mami; Shimizu, Yuki; Yoshida, Kaori; Fukushima, Keizo; Sugioka, Nobuyuki; Nishimura, Asako; Naruhashi, Kazumasa; Shibata, Nobuhito			Preparation of Methacrylic Acid Copolymer S Nano-fibers Using a Solvent-Based Electrospinning Method and Their Application in Pharmaceutical Formulations	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						electrospinning; nano-fiber; methacrylic acid copolymer S; controlled-release	DRUG-DELIVERY SYSTEM; NANOFIBERS	In this study, we applied an electrospinning (ES) method, which is mainly employed in the textile industry, to the field of pharmaceuticals. We developed and modified an ES instrument and then utilized it to produce methacrylic acid copolymer S (MAC) nano-fibers to prepare tablets. By attaching a conductor rod made from stainless steel to the central part of the nano-fiber-collection plate of the ES apparatus, a MAC nano-fiber sheet could be produced effectively. In addition, we studied various operating conditions for this new ES method, including needle gauge, voltage between the electrodes, distance between the needle and nano-fiber-collection plate and the flow rate of MAC polymer solution, but these had no significant effect on the diameter of MAC nano-fibers. On the other hand, the viscosity (concentration) of MAC polymer solution and permittivity of solvent used to dilute MAC were closely related to the mean diameter of the nano-fibers. Tableting of MAC nano-fibers was performed using a tableting machine without lubricants, and addition of Tween 20 to the tablets enabled regulation of the release profile of a water-soluble drug. The modified ES method reported here is a useful technique for the controlled-release of drugs and has wide-ranging potential for pharmaceutical applications.	[Hamori, Mami; Shimizu, Yuki; Yoshida, Kaori; Nishimura, Asako; Naruhashi, Kazumasa; Shibata, Nobuhito] Doshisha Womens Coll Liberal Arts, Dept Biopharmaceut, Fac Pharmaceut Sci, Kyoto 6100395, Japan; [Fukushima, Keizo; Sugioka, Nobuyuki] Kobe Gakuin Univ, Dept Clin Pharmacokinet, Fac Pharmaceut Sci, Hyogo 6508586, Japan	Shibata, N (reprint author), Doshisha Womens Coll Liberal Arts, Dept Biopharmaceut, Fac Pharmaceut Sci, Kyoto 6100395, Japan.	nshibata@dwc.doshisha.ac.jp					ABUIN EB, 1984, J AM CHEM SOC, V106, P6274, DOI 10.1021/ja00333a028; Luo CJ, 2012, CHEM SOC REV, V41, P4708, DOI 10.1039/c2cs35083a; Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004; Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014; Ignatious F, 2010, PHARM RES-DORDR, V27, P576, DOI 10.1007/s11095-010-0061-6; Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481; Okutan N, 2014, FOOD HYDROCOLLOID, V39, P19, DOI 10.1016/j.foodhyd.2013.12.022; DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8; Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024; Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3; Cramariuc B, 2013, J ELECTROSTAT, V71, P189, DOI [10.1016/j.elstat.2012.12.018, 10.1016/j.elstat2012.12.018]; Nagy ZK, 2013, J PHARM SCI-US, V102, P508, DOI 10.1002/jps.23374; Wannatong L, 2004, POLYM INT, V53, P1851, DOI 10.1002/pi.1599; Homayoni H, 2009, CARBOHYD POLYM, V77, P656, DOI 10.1016/j.carbpol.2009.02.008; Hamori M, 2014, INT J PHARMACEUT, V464, P243, DOI 10.1016/j.ijpharm.2013.12.036; Kim W. A., 2006, J BIOMED MATER RES A, V79A, P643; Kodama T., 1989, RIISRR89 RES I IND S, P79; Park Y., 2008, J IND ENG CHEM, V14, P707; Petereit U. H., 1999, EUR J PHARM BIOPHARM, V47, P15; Reneker HD, 1996, NANOTECHNOLOGY, V7, P216; Shenoy L. S., 2005, POLYMER, V46, P3372	21	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	FEB	2015	63	2					81	87				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA1RZ	WOS:000348690500004		
J	Sato, T; Takeuchi, H; Sakurai, T; Tanaka, K; Matsuki, K; Higashi, K; Moribe, K; Yamamoto, K				Sato, Takayuki; Takeuchi, Hiroyuki; Sakurai, Takanobu; Tanaka, Kensuke; Matsuki, Kota; Higashi, Kenjirou; Moribe, Kunikazu; Yamamoto, Keiji			Characterization of a Riboflavin Non-aqueous Nanosuspension Prepared by Bead Milling for Cutaneous Application	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						bead milling; riboflavin; non-aqueous nanosuspension; oleic acid; stabilization; skin permeability	HAIR-FOLLICLES; DRUG-DELIVERY; TRANSDERMAL DELIVERY; OLEIC-ACID; NANOPARTICLES; SKIN; PENETRATION; STABILITY; WATER; PERMEABILITY	The purpose of this study was to characterize the non-aqueous nanosuspension of a hydrophilic drug prepared by bead milling for cutaneous application. Riboflavin was used as the model hydrophilic drug. The non-aqueous nanosuspensions were prepared by grinding riboflavin with zirconia beads using eight nonaqueous bases. The mean particle size of riboflavin in the suspensions ranged from 206 to 469nm, as determined by the dynamic light scattering method. Among the well-dispersed samples, riboflavin nanosuspension prepared in oleic acid was selected for evaluation of the drug permeability through rat skin. The cumulative amount and permeation rate of riboflavin from the nanosuspension were approximately three times higher than those for unprocessed riboflavin in oleic acid. Fluorescence imaging of the riboflavin nanosuspension suggested improved penetration of riboflavin into the stratum corneum. Furthermore, the addition of polysorbate 65 or polyglyceryl-6 polyricinoleate to the nanosuspension prepared in oleic acid markedly improved the riboflavin dispersibility. These results show that the preparation of a nanosuspension in a non-aqueous base by bead milling is one of the simple methods to improve the skin permeability of hydrophilic drugs.	[Sato, Takayuki; Higashi, Kenjirou; Moribe, Kunikazu; Yamamoto, Keiji] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Takeuchi, Hiroyuki; Tanaka, Kensuke; Matsuki, Kota] Taisho Pharmaceut Co Ltd, Res Headquarters, Pharmaceut Pharmaceut Sci Labs, Kita Ku, Saitama 3319530, Japan; [Sakurai, Takanobu] Taisho Pharmaceut Co Ltd, Res Headquarters, Drug Safety & Pharmacokinet Labs, Kita Ku, Saitama 3319530, Japan	Sato, T (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	takayu-satou@so.taisho.co.jp					Cormier M, 2004, J CONTROL RELEASE, V97, P503, DOI 10.1016/j.jconrel.2004.04.003; Rowat AC, 2006, INT J PHARM, V307, P225, DOI 10.1016/j.ijpharm.2005.10.008; Muller RH, 2002, ADV DRUG DELIVER REV, V54, pS131, DOI 10.1016/S0169-409X(02)00118-7; Patzelt A, 2013, EXPERT OPIN DRUG DEL, V10, P787, DOI 10.1517/17425247.2013.776038; Matriano JA, 2002, PHARMACEUT RES, V19, P63, DOI 10.1023/A:1013607400040; Desai P, 2010, MOL MEMBR BIOL, V27, P247, DOI 10.3109/09687688.2010.522203; Takatsuka T, 2009, CHEM PHARM BULL, V57, P1061; HADZIIOANNOU G, 1986, J AM CHEM SOC, V108, P2869, DOI 10.1021/ja00271a014; Filipowicz A, 2011, INT J PHARMACEUT, V408, P152, DOI 10.1016/j.ijpharm.2011.01.033; KONDO N, 1993, CHEM PHARM BULL, V41, P737; Wu NQ, 2004, NANO LETT, V4, P383, DOI 10.1021/nl1035139x; MORIMOTO Y, 1992, J PHARM PHARMACOL, V44, P634; FRANZ TJ, 1975, J INVEST DERMATOL, V64, P190, DOI 10.1111/1523-1747.ep12533356; Lademann J, 2007, EUR J PHARM BIOPHARM, V66, P159, DOI 10.1016/j.ejpb.2006.10.019; Le Roux JP, 2005, SEDIMENT GEOL, V178, P285, DOI 10.1016/j.sedgeo.2005.05.009; Shim J, 2004, J CONTROL RELEASE, V97, P477, DOI 10.1016/j.jconrel.2004.03.028; Mitri K, 2011, INT J PHARMACEUT, V414, P267, DOI 10.1016/j.ijpharm.2011.05.008; Naik A, 1995, J CONTROL RELEASE, V37, P299, DOI 10.1016/0168-3659(95)00088-7; Niwa T, 2011, INT J PHARMACEUT, V405, P218, DOI 10.1016/j.ijpharm.2010.12.013; [Anonymous], 2001, RIBOFLAVIN INT CHEM; Dominguez-Delgado CL, 2011, EUR J PHARM BIOPHARM, V79, P102, DOI 10.1016/j.ejpb.2011.01.017; FLYNN GL, 1988, DRUG DEVELOP RES, V13, P169, DOI 10.1002/ddr.430130209; Gratieri T, 2011, EXPERT OPIN DRUG DEL, V8, P645, DOI 10.1517/17425247.2011.566265; Hasanovic A, 2009, J PHARM PHARMACOL, V61, P1609, DOI 10.1211/jpp/61.12.0004; KITAHARA A, 1979, CHEM LETT, P1127, DOI 10.1246/cl.1979.1127; Kohli A. K., 2004, INT J PHARMACEUT, V275, P13; Liu KC, 2013, INT J PHARMACEUT, V441, P687, DOI 10.1016/j.ijpharm.2012.10.027; PAYNE R, 1972, J PHYS CHEM-US, V76, P2892, DOI 10.1021/j100664a019; Raber AS, 2014, J CONTROL RELEASE, V179, P25, DOI 10.1016/j.jconrel.2014.01.018; Tahara Y, 2008, J CONTROL RELEASE, V131, P14, DOI 10.1016/j.jconrel.2008.07.015; Todo H, 2010, BIOL PHARM BULL, V33, P1394; Tsujimoto H, 2007, BIOORG MED CHEM LETT, V17, P4771, DOI 10.1016/j.bmcl.2007.06.057	32	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	FEB	2015	63	2					88	94				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA1RZ	WOS:000348690500005		
J	Iwao, Y; Kimura, SI; Ishida, M; Mise, R; Yamada, M; Namiki, N; Noguchi, S; Itai, S				Iwao, Yasunori; Kimura, Shin-ichiro; Ishida, Masayuki; Mise, Ryohei; Yamada, Masaki; Namiki, Noriyuki; Noguchi, Shuji; Itai, Shigeru			Preparation and Evaluation of Highly Drug-Loaded Fine Globular Granules Using a Multi-functional Rotor Processor	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						fine globular granule; high drug loading; fluidized-bed rotogranulation	SIZE; SHAPE	The manufacture of highly drug-loaded fine globular granules eventually applied for orally disintegrating tablets has been investigated using a unique multi-functional rotor processor with acetaminophen, which was used as a model drug substance. Experimental design and statistical analysis were used to evaluate potential relationships between three key operating parameters (i.e., the binder flow rate, atomization pressure and rotating speed) and a series of associated micromeritics (i.e., granule mean size, proportion of fine particles (106-212 mu m), flowability, roundness and water content). The results of multiple linear regression analysis revealed several trends, including (1) the binder flow rate and atomization pressure had significant positive and negative effects on the granule mean size value, Carr's flowability index, granular roundness and water content, respectively; (2) the proportion of fine particles was positively affected by the product of interaction between the binder flow rate and atomization pressure; and (3) the granular roundness was negatively and positively affected by the product of interactions between the binder flow rate and the atomization pressure, and the binder flow rate and rotating speed, respectively. The results of this study led to the identification of optimal operating conditions for the preparation of granules, and could therefore be used to provide important information for the development of processes for the manufacture of highly drug-loaded fine globular granules.	[Iwao, Yasunori; Ishida, Masayuki; Mise, Ryohei; Noguchi, Shuji; Itai, Shigeru] Univ Shizuoka, Dept Pharmaceut Engn, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan; [Kimura, Shin-ichiro; Yamada, Masaki] Kissei Pharmaceut Co Ltd, Pharmaceut Res & Dev, Matsumoto, Nagano 3998710, Japan; [Kimura, Shin-ichiro; Namiki, Noriyuki] Univ Shizuoka, Dept Pharm Practice & Sci, Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Itai, S (reprint author), Univ Shizuoka, Dept Pharmaceut Engn, Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	s-itai@u-shizuoka-ken.ac.jp					AlHusban F. A., 2010, RECENT PAT DRUG DELI, V4, P178; Hamashita T, 2007, CHEM PHARM BULL, V55, P1169, DOI 10.1248/cpb.55.1169; Kimura S, 2010, INT J PHARMACEUT, V391, P244, DOI 10.1016/j.ijpharm.2010.03.005; Carr RL, 1965, CHEM ENG, V72, P163; Gonzalez RCB, 2004, INT J PHARM, V279, P27, DOI 10.1016/j.ijpharm.2004.04.010; Kimura S, 2014, CHEM PHARM BULL, V62, P309; Korakianiti E.S., 2000, AAPS PHARMSCITECH, V1, P71, DOI 10.1208/pt010435; Liew CV, 2000, DRUG DEV IND PHARM, V26, P953, DOI 10.1081/DDC-100101322; Myo N., 2003, J JPN SOC PHARM MACH, V12, P189; Rashid HA, 2001, EUR J PHARM BIOPHARM, V51, P227, DOI 10.1016/S0939-6411(01)00129-1; Rashid HA, 1999, DRUG DEV IND PHARM, V25, P605; Tanai I., 2007, J JPN PHARM MACH ENG, V16, P210; WAN LSC, 1993, INT J PHARM, V96, P59, DOI 10.1016/0378-5173(93)90212-X	13	2	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	FEB	2015	63	2					95	101				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA1RZ	WOS:000348690500006		
J	Nohara, T; Fujiwara, Y; Komota, Y; Kondo, Y; Saku, T; Yamaguchi, K; Komohara, Y; Takeya, M				Nohara, Toshihiro; Fujiwara, Yukio; Komota, Yusuke; Kondo, Yoshihiko; Saku, Taiki; Yamaguchi, Koki; Komohara, Yoshihiro; Takeya, Motohiro			Cyclic Sulfoxides-Garlicnins K-1, K-2, and H-1-Extracted from Allium sativum	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Allium sativum; cyclic sulfoxide; garlicnin K; tetrahydrothiophen derivative; M2 activated macrophage; anticancer activity	REGULATING MACROPHAGE ACTIVATION; TUMOR-ASSOCIATED MACROPHAGES; PROGRESSION	Newly identified cyclic sulfoxides-garlicnins K-1 (1), K-2 (2), and H-1 (3)-were isolated from the acetone extracts of the bulbs of garlic, Allium sativum. Garlicnin Hi (3) demonstrated potential to suppress tumor cell proliferation by regulating macrophage activation. The structures of garlicnins K-1 and K-2, 3,4-dimethyl-5-allyl-tetrahydrothiophen-2-one-S-oxides, and the structure of garlicnin H-1, 3-carboxy-3-hydroxy-4-methyl-5-allylsulfoxide-tetrahydrothiophen-2-(ethane-1,2-diol)-S-oxide were characterized by spectroscopic analysis.	[Nohara, Toshihiro; Yamaguchi, Koki] Sojo Univ, Fac Pharmaceut Sci, Ikeda, Kumamoto 8600082, Japan; [Fujiwara, Yukio; Komota, Yusuke; Kondo, Yoshihiko; Saku, Taiki; Komohara, Yoshihiro; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Chuo Ku, Kumamoto 8608556, Japan	Nohara, T (reprint author), Sojo Univ, Fac Pharmaceut Sci, 4-22-1 Nishi Ku, Ikeda, Kumamoto 8600082, Japan.	none@ph.sojo-u.ac.jp					Amagase H., 2006, J NUTR, V136, p716S; El-Aasr M, 2010, J NAT PROD, V73, P1306, DOI 10.1021/np100105u; Hagemann T, 2009, BLOOD, V113, P3139, DOI 10.1182/blood-2008-12-172825; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Mantovani A, 2003, TUMORI, V89, P459; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Rose P, 2005, NAT PROD REP, V22, P351, DOI 10.1039/b417639c; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; El-Aasr M, 2011, CHEM PHARM BULL, V59, P1340, DOI 10.1248/cpb.59.1340; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Block E, 2010, GARLIC AND OTHER ALLIUMS: THE LORE AND THE SCIENCE, P1; Dewick P. M., 2002, MED NATURAL PRODUCTS; JOHNSON CR, 1964, J AM CHEM SOC, V86, P2935, DOI 10.1021/ja01068a035; Joyce J. A., 2009, NAT REV CANCER, V9, P239; JUARISTI E, 1988, TETRAHEDRON, V44, P5653, DOI 10.1016/S0040-4020(01)81426-5; LAMBERT JB, 1966, J ORG CHEM, V31, P3429, DOI 10.1021/jo01348a522; Lewis C. E., 2006, CANCER RES, V66, P605; MARTIN JC, 1964, J AM CHEM SOC, V86, P2936, DOI 10.1021/ja01068a036; Nohara T., 2014, CHEM PHARM BULL, V62, P1142; Nohara T, 2013, CHEM PHARM BULL, V61, P695; Nohara T, 2014, CHEM PHARM BULL, V62, P477, DOI 10.1248/cpb.c14-00003; Nohara T, 2012, CHEM PHARM BULL, V60, P747, DOI 10.1248/cpb.60.747; Ronayne J., 1967, J CHEM SOC B, V1967, P540; Theisen C, 2001, J NATL CANCER I, V93, P1049, DOI 10.1093/jnci/93.14.1049	24	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	FEB	2015	63	2					117	121				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA1RZ	WOS:000348690500008		
J	Tamura, M; Koshibe, Y; Kaji, K; Ueda, JY; Shirataki, Y				Tamura, Masafumi; Koshibe, Yuhei; Kaji, Kiho; Ueda, Jun-ya; Shirataki, Yoshiaki			Attempt to Synthesize 2,3,5,4 '-Tetrahydroxystilbene Derived from 2,3,5,4 '-Tetrahydroxystilbene-2-O-beta-glucoside (THSG)	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Polygonum multiflorum; Mizoroki-Heck reaction; 2-aryl-2,3-dihydrobenzofuran; 2,3,5,4 '-tetrahydroxystilbene-2-O-beta-glucoside (THSG)	POLYGONUM-MULTIFLORUM; RESVERATROL; DERIVATIVES; ANTIOXIDANTS; FLAVONOIDS; INHIBITORS; STILBENES; WITTIG	An attempt to synthesize aglycone 1 derived from 2,3,5,4'-tetrahydroxystilbene-2-O-beta-glucoside (THSG) via the Wittig reaction and Mizoroki-Heck reaction is described. In the Wittig protocol, 2,3,5,4'-tetramethoxystilbene 2 was obtained. Additionally, a palladium-catalyzed Mizoroki- Heck reaction strategy yielded 2-aryl-2,3-dihydrobenzofuran 13 instead of derivative 12 in good yield.	[Tamura, Masafumi; Koshibe, Yuhei; Kaji, Kiho; Shirataki, Yoshiaki] Josai Univ, Fac Pharmaceut Sci, Saitama 3500295, Japan; [Ueda, Jun-ya] Univ Toyama, Frontier Res Core Life Sci, Toyama 9300194, Japan	Tamura, M (reprint author), Josai Univ, Fac Pharmaceut Sci, 1-1 Keyakidai Sakado, Saitama 3500295, Japan.	tamuraty@josai.ac.jp; tshira@josai.ac.jp					ALI MA, 1992, CHEM PHARM BULL, V40, P2842; Alonso F, 2009, EUR J ORG CHEM, P6034, DOI 10.1002/ejoc.200900951; Saleem M, 2005, NAT PROD REP, V22, P696, DOI 10.1039/b514045p; Murias M, 2004, BIOORGAN MED CHEM, V12, P5571, DOI 10.1016/j.bmc.2004.08.008; Ryu G, 2002, ARCH PHARM RES, V25, P636, DOI 10.1007/BF02976935; Regev-Shoshani G, 2004, BIOCHEM BIOPH RES CO, V323, P668, DOI 10.1016/j.bbrc.2004.08.141; Han X, 2012, ATHEROSCLEROSIS, V225, P76, DOI 10.1016/j.atherosclerosis.2012.08.011; Fabris S, 2008, BIOPHYS CHEM, V135, P76, DOI 10.1016/j.bpc.2008.03.005; Albert S, 2011, BIOORGAN MED CHEM, V19, P5155, DOI 10.1016/j.bmc.2011.07.015; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Regev-Shoshani G, 2003, BIOCHEM J, V374, P157, DOI 10.1042/BJ20030141; Hur SJ, 2014, FOOD CHEM, V160, P346, DOI 10.1016/j.foodchem.2014.03.112; Chalal M, 2012, TETRAHEDRON, V68, P3899, DOI 10.1016/j.tet.2012.03.025; Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4; Jiang ZQ, 2009, LIFE SCI, V85, P345, DOI 10.1016/j.lfs.2009.05.022; Rupam Bharti, 2012, Journal of Pharmacy Research, V5, P4278; Caldwell ST, 2012, CAN J CHEM, V90, P23, DOI 10.1139/V11-087; Chang MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050291; Dyer C, 1997, BRIT MED J, V314, P993; Farina A, 2007, NAT PROD RES, V21, P564, DOI 10.1080/14786410701195291; FEUTRILL GI, 1972, AUST J CHEM, V25, P1719, DOI 10.1071/CH9721719; Gangjee A, 2011, BIOORGAN MED CHEM, V19, P4355, DOI 10.1016/j.bmc.2011.05.030; GRECH JN, 1994, J NAT PRODUCTS, V57, P1682, DOI 10.1021/np50114a010; HAN Y N, 1990, Archives of Pharmacal Research (Seoul), V13, P132, DOI 10.1007/BF02857789; Larock RC, 1998, TETRAHEDRON, V54, P7343, DOI 10.1016/S0040-4020(98)00399-8; Ren HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023258; Ren XL, 2011, J PHARMACEUT BIOMED, V55, P211, DOI 10.1016/j.jpba.2010.12.026; RYU S Y, 1988, Archives of Pharmacal Research (Seoul), V11, P230, DOI 10.1007/BF02861314; Schadel U, 2002, HETEROCYCLES, V57, P1049; Su D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054505; Valdameri G., 2000, CHEM BIOL, V7, P322; Wang XM, 2008, EUR J PHARMACOL, V578, P339, DOI 10.1016/j.ejphar.2007.09.013; Zhao Y.-Y., 2012, J LIQ CHROMATOGR, V36, P717	33	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	FEB	2015	63	2					122	125				4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA1RZ	WOS:000348690500009		
J	Suzuki, T; Yasuhara, N; Ueda, T; Inukai, M; Mio, M				Suzuki, Toshinori; Yasuhara, Naoki; Ueda, Takashi; Inukai, Michiyo; Mio, Mitsunobu			Reaction of Acetaldehyde with 5-Aminolevulinic Acid via Dihydropyrazine Derivative	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						acetaldehyde; 5-aminolevulinic acid; 3,6-dihydropyrazine-2,5-dipropanoic acid; 3-ethylpyrazine-2,5-dipropanoic acid	DELTA-AMINOLEVULINIC-ACID; ALCOHOL	When a solution of 5-aminolevulinic acid (ALA) was incubated with acetaldehyde at neutral pH, a product was generated. This product was identified as 3-ethylpyrazine-2,5-dipropanoic acid (ETPY). ETPY was stable at neutral pH. It has been reported that ALA dimerizes at neutral pH generating 3,6-dihydropyrazine-2,5-dipropanoic acid (DHPY), and subsequently resulting in pyrazine-2,5-dipropanoic acid (PY) by autoxidation. In the present reaction, DHPY generated from ALA reacted with acetaldehyde, resulting in ETPY. Preadministration of ALA 3 min prior to acetaldehyde injection supressed the toxicity of acetaldehyde in male mice. These results suggest that ALA may be useful as a scavenger for acetaldehyde.	[Suzuki, Toshinori; Yasuhara, Naoki; Ueda, Takashi; Inukai, Michiyo; Mio, Mitsunobu] Shujitsu Univ, Sch Pharm, Okayama 7038516, Japan	Suzuki, T (reprint author), Shujitsu Univ, Sch Pharm, Okayama 7038516, Japan.	tsuzuki@shujitsu.ac.jp					Guo R, 2010, INT J ENV RES PUB HE, V7, P1285, DOI 10.3390/ijerph7041285; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; Fukuda H, 2005, INT J BIOCHEM CELL B, V37, P272, DOI 10.1016/j.biocel.2004.04.018; BRIEN JF, 1983, CAN J PHYSIOL PHARM, V61, P1; BUTLER AR, 1992, TETRAHEDRON, V48, P7879, DOI 10.1016/S0040-4020(01)80465-8; CHIU EM, 1990, J AGR FOOD CHEM, V38, P58, DOI 10.1021/jf00091a012; GRANICK S, 1958, J BIOL CHEM, V232, P1119; Hiraku Y, 1996, CANCER RES, V56, P1786; Hunter GA, 2005, ARCH BIOCHEM BIOPHYS, V437, P128, DOI 10.1016/j.abb.2005.03.007; Lieber C S, 1975, Adv Exp Med Biol, V59, P185; Novo M, 1996, J PHOTOCH PHOTOBIO B, V34, P143, DOI 10.1016/1011-1344(96)07285-5; Ren Jun, 2008, Ther Adv Cardiovasc Dis, V2, P497, DOI 10.1177/1753944708095137; Truitt E. B., 1971, BIOL ALCOHOL, V1, P161	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	FEB	2015	63	2					126	129				4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA1RZ	WOS:000348690500010		
J	Matsumura, M; Dong, YQ; Kakusawa, N; Yasuike, S				Matsumura, Mio; Dong, Yuqiang; Kakusawa, Naoki; Yasuike, Shuji			Pd-Catalyzed P-Arylation of Triarylantimony Dicarboxylates with Dialkyl H-Phosphites without a Base: Synthesis of Arylphosphonates	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Hirao-type P-arylation; triarylantimony diacetate; arylphosphonate; dialkyl H-phosphite; base-free reaction	CROSS-COUPLING REACTION; CARBON BOND FORMATION; DIETHYL PHOSPHITE; ARYLBORONIC ACIDS; PHOSPHONATE DIESTERS; METHYL ACRYLATE; C-PHENYLATION; PALLADIUM; DIACETATES; ARYL	The reaction of triarylantimony diacetates [Ar3Sb(OAc)(2)] with dialkyl H-phosphites [H-PO(OR)(2)] in the presence of a Pd(PPh3)(4) (5 mol%) catalyst led to the formation of arylphosphonates in moderate to excellent yield under base-free conditions. This reaction is the first example of carbon-phosphorus bond formation by using an organoantimony compound as a pseudo-halide.	[Matsumura, Mio; Yasuike, Shuji] Aichi Gakuin Univ, Sch Pharmaceut Sci, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Dong, Yuqiang; Kakusawa, Naoki] Hokuriku Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201181, Japan	Yasuike, S (reprint author), Aichi Gakuin Univ, Sch Pharmaceut Sci, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	s-yasuik@dpc.agu.ac.jp			Ministry Education, Culture, Sports, Sciences and Technology of Japan; Institute of Pharmaceutical Life Sciences; Aichi Gakuin University; Hokuriku University	This work was supported by a Grant-in-Aid for Scientific Research (C) from the Ministry Education, Culture, Sports, Sciences and Technology of Japan. Financial was support by Institute of Pharmaceutical Life Sciences, Aichi Gakuin University and the Special Research Found from Hokuriku University.	Kohler MC, 2009, TETRAHEDRON LETT, V50, P457, DOI 10.1016/j.tetlet.2008.11.040; Kalek M, 2008, ORGANOMETALLICS, V27, P5876, DOI 10.1021/om800641n; Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517; Van der Jeught S, 2009, CHEM REV, V109, P2672, DOI 10.1021/cr800315j; Demmer CS, 2011, CHEM REV, V111, P7981, DOI 10.1021/cr2002646; Yasuike S, 2007, TETRAHEDRON LETT, V48, P721, DOI 10.1016/j.tetlet.2006.10.163; HIRAO T, 1982, B CHEM SOC JPN, V55, P909, DOI 10.1246/bcsj.55.909; Bloomfield AJ, 2012, ORG LETT, V14, P4370, DOI 10.1021/ol301831k; Berrino R, 2010, ORG BIOMOL CHEM, V8, P4518, DOI 10.1039/c0ob00243g; Kalek M, 2008, ORG LETT, V10, P4637, DOI 10.1021/ol801935r; Kalek M, 2009, ADV SYNTH CATAL, V351, P3207, DOI 10.1002/adsc.200900590; Schwan AL, 2004, CHEM SOC REV, V33, P218, DOI 10.1039/b307538a; Andaloussi M, 2009, CHEM-EUR J, V15, P13069, DOI 10.1002/chem.200901473; Belabassi Y, 2008, J ORGANOMET CHEM, V693, P3171, DOI 10.1016/j.jorganchem.2008.07.020; Kollar L, 2010, CHEM REV, V110, P4257, DOI 10.1021/cr900364c; Kalek M, 2007, ORGANOMETALLICS, V26, P5840, DOI 10.1021/om700797k; Berger O, 2014, CHEM-EUR J, V20, P12385, DOI 10.1002/chem.201404507; Zhuang RQ, 2011, ORG LETT, V13, P2110, DOI 10.1021/ol200465z; Baumgartner T, 2006, CHEM REV, V106, P4681, DOI 10.1021/cr040179m; Zhou T, 2001, SYNTHETIC COMMUN, V31, P3289, DOI 10.1081/SCC-100106038; Wang T, 2014, J ORG CHEM, V79, P608, DOI 10.1021/jo402392t; Queffelec C, 2012, CHEM REV, V112, P3777, DOI 10.1021/cr2004212; Luo Y, 2009, ORGANOMETALLICS, V28, P6823, DOI 10.1021/om900771v; Jablonkai E, 2013, TETRAHEDRON LETT, V54, P4185, DOI 10.1016/j.tetlet.2013.05.111; Bessmertnykh A, 2009, CHEM LETT, V38, P738, DOI 10.1246/cl.2009.738; Bessmertnykh A, 2008, SYNTHESIS-STUTTGART, P1575, DOI 10.1055/s-2008-1072570; Glueck DS, 2010, TOP ORGANOMETAL CHEM, V31, P65, DOI 10.1007/978-3-642-12073-2_4; Goossen LJ, 2005, SYNLETT, P445, DOI 10.1055/s-2005-862372; Gushchin AV, 2001, RUSS CHEM B+, V50, P1291, DOI 10.1023/A:1014079428290; Kang SK, 2000, J ORGANOMET CHEM, V610, P38, DOI 10.1016/S0022-328X(00)00386-7; Kang S.-K., 2001, J CHEM SOC P1, V1, P736; LU XY, 1987, SYNTHESIS-STUTTGART, P726; Moiseev D. V., 2003, J ORGANOMET CHEM, V667, P176, DOI 10.1016/S0022-328X(02)02179-4; Moiseev DV, 2004, J ORGANOMET CHEM, V689, P731, DOI 10.1016/j.jorganchem.2003.11.025; Qin W, 2008, J ORGANOMET CHEM, V693, P109, DOI 10.1016/j.jorganchem.2007.10.030; Tappe FMJ, 2010, SYNTHESIS-STUTTGART, P3037, DOI 10.1055/s-0030-1257960; Wang X, 2009, TETRAHEDRON LETT, V50, P6293, DOI 10.1016/j.tetlet.2009.08.113; Yasuike S, 2014, J ORGANOMET CHEM, V765, P80, DOI 10.1016/j.jorganchem.2014.04.006	38	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	FEB	2015	63	2					130	133				4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA1RZ	WOS:000348690500011		
J	Okamura, M; Masaoka, S				Okamura, Masaya; Masaoka, Shigeyuki			Design of Mononuclear Ruthenium Catalysts for Low-Overpotential Water Oxidation	CHEMISTRY-AN ASIAN JOURNAL			English	Article						oxidation; photosynthesis; ruthenium; transition metals; water chemistry	COUPLED ELECTRON-TRANSFER; ATOM-PROTON TRANSFER; O-O BOND; PHOTOSYSTEM-II; SINGLE-SITE; MOLECULAR CATALYSTS; RU COMPLEXES; ARTIFICIAL PHOTOSYNTHESIS; MONOAQUO COMPLEXES; OXYGEN EVOLUTION	Water oxidation is a key reaction in natural photosynthesis and in many schemes for artificial photosynthesis. Inspired by energy challenges and the emerging understanding of photosystem II, the development of artificial molecular catalysts for water oxidation has become a highly active area of research in recent years. In this Focus Review, we describe recent achievements in the development of single-site ruthenium catalysts for water oxidation with a particular focus on the overpotential of water oxidation. First, we introduce the general scheme to access the high-valent ruthenium-oxo species, the key species of the water-oxidation reaction. Next, the mechanisms of the O-O bond formation from the active ruthenium-oxo species are described. We then discuss strategies to decrease the onset potentials of the water-oxidation reaction. We hope this Focus Review will contribute to the further development of efficient catalysts toward sustainable energy-conversion systems.	[Okamura, Masaya; Masaoka, Shigeyuki] Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi 4448787, Japan	Masaoka, S (reprint author), Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	masaoka@ims.ac.jp			MEXT/JSPS [25708011]	The authors are grateful for MEXT/JSPS Grants-in-Aid for Young Scientists A (no. 25708011), Scientific Research on Innovative Areas "AnApple" (no. 25107526), and JSPS Fellows (no. 254037).	Tommos C, 2000, BBA-BIOENERGETICS, V1458, P199, DOI 10.1016/S0005-2728(00)00069-4; Masaoka S, 2009, CHEM LETT, V38, P182, DOI 10.1246/cl.2009.182; Badiei YM, 2013, INORG CHEM, V52, P8845, DOI 10.1021/ic401023w; GERSTEN SW, 1982, J AM CHEM SOC, V104, P4029, DOI 10.1021/ja00378a053; Concepcion JJ, 2009, ANGEW CHEM INT EDIT, V48, P9473, DOI 10.1002/anie.200901279; Staehle R, 2014, INORG CHEM, V53, P1307, DOI 10.1021/ic401701z; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; Sens C, 2004, J AM CHEM SOC, V126, P7798, DOI 10.1021/ja0486824; Romero I, 2008, INORG CHEM, V47, P1824, DOI 10.1021/ic700911y; Duan L, 2010, CHEM-EUR J, V16, P4659, DOI 10.1002/chem.200902603; Tong LP, 2012, CHEM COMMUN, V48, P10025, DOI 10.1039/c2cc35379b; Polyansky DE, 2011, J AM CHEM SOC, V133, P14649, DOI 10.1021/ja203249e; Hirahara M, 2013, INORG CHEM, V52, P6354, DOI 10.1021/ic400054k; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Li F, 2012, ANGEW CHEM INT EDIT, V51, P2417, DOI 10.1002/anie.201108051; Concepcion JJ, 2008, J AM CHEM SOC, V130, P16462, DOI 10.1021/ja8059649; Chen ZF, 2010, DALTON T, V39, P6950, DOI 10.1039/c0dt00362j; Yagi M, 2001, CHEM REV, V101, P21, DOI 10.1021/cr980108l; Wang L, 2012, J AM CHEM SOC, V134, P18868, DOI 10.1021/ja309805m; Jiang Y, 2013, CHINESE J CATAL, V34, P1489, DOI 10.1016/S1872-2067(12)60600-7; Muckerman JT, 2014, INORG CHEM, V53, P6904, DOI 10.1021/ic500709h; Kiyota J, 2010, CHEM LETT, V39, P1146, DOI 10.1246/cl.2010.1146; Romain S, 2009, J AM CHEM SOC, V131, P2768, DOI 10.1021/ja808166d; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Roeser S, 2011, CHEMSUSCHEM, V4, P197, DOI 10.1002/cssc.201000358; Concepcion JJ, 2013, INORG CHEM, V52, P10744, DOI 10.1021/ic402240t; Nyhlen J, 2010, ANGEW CHEM INT EDIT, V49, P1773, DOI 10.1002/anie.200906439; Cao R, 2012, ENERG ENVIRON SCI, V5, P8134, DOI 10.1039/c2ee21494f; Wada T, 2000, ANGEW CHEM INT EDIT, V39, P1479, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1479::AID-ANIE1479>3.0.CO;2-4; Yoshida M, 2010, CHEM-ASIAN J, V5, P2369, DOI 10.1002/asia.201000323; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Boyer JL, 2011, ANGEW CHEM INT EDIT, V50, P12600, DOI 10.1002/anie.201102648; Li L, 2010, CHEM COMMUN, V46, P7307, DOI 10.1039/c0cc01828g; Klauss A, 2012, P NATL ACAD SCI USA, V109, P16035, DOI 10.1073/pnas.1206266109; Duan LL, 2012, NAT CHEM, V4, P418, DOI [10.1038/nchem.1301, 10.1038/NCHEM.1301]; Vigara L, 2012, CHEM SCI, V3, P2576, DOI 10.1039/c2sc20399e; Muckerman JT, 2008, INORG CHEM, V47, P1787, DOI 10.1021/ic701892v; Kimoto A, 2012, CHEM COMMUN, V48, P239, DOI 10.1039/c1cc15109f; Concepcion JJ, 2010, J AM CHEM SOC, V132, P1545, DOI 10.1021/ja904906v; Karkas MD, 2012, ANGEW CHEM INT EDIT, V51, P11589, DOI 10.1002/anie.201205018; Zong R, 2005, J AM CHEM SOC, V127, P12802, DOI 10.1021/ja054791m; Duan LL, 2011, CHEMSUSCHEM, V4, P238, DOI 10.1002/cssc.201000313; Duan LL, 2013, INORG CHEM, V52, P7844, DOI 10.1021/ic302687d; Xu YH, 2009, INORG CHEM, V48, P2717, DOI 10.1021/ic802052u; Yoshida M, 2009, CHEM LETT, V38, P702, DOI 10.1246/cl.2009.702; Chen ZF, 2010, J AM CHEM SOC, V132, P17670, DOI 10.1021/ja107347n; Tong LP, 2011, ANGEW CHEM INT EDIT, V50, P445, DOI 10.1002/anie.201005141; Wasylenko DJ, 2010, INORG CHEM, V49, P2202, DOI 10.1021/ic902024s; Chen ZF, 2009, J AM CHEM SOC, V131, P15580, DOI 10.1021/ja906391w; Padhi SK, 2012, INORG CHEM, V51, P5386, DOI 10.1021/ic3003542; Concepcion JJ, 2010, INORG CHEM, V49, P1277, DOI 10.1021/ic901437e; Singh A, 2013, COORDIN CHEM REV, V257, P2607, DOI 10.1016/j.ccr.2013.02.027; Tanaka K, 2012, P NATL ACAD SCI USA, V109, P15600, DOI 10.1073/pnas.1120705109; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yamazaki H, 2011, J AM CHEM SOC, V133, P8846, DOI 10.1021/ja2024228; Bernet L, 2011, CHEM COMMUN, V47, P8058, DOI 10.1039/c1cc12615f; Liu X, 2012, COORDIN CHEM REV, V256, P1115, DOI 10.1016/j.ccr.2012.01.015; Wasylenko DJ, 2011, INORG CHEM, V50, P3662, DOI 10.1021/ic2000188; Parent AR, 2013, CHEM SOC REV, V42, P2247, DOI 10.1039/c2cs35225g; Tong LP, 2013, INORG CHEM, V52, P2505, DOI 10.1021/ic302446h; Ashford DL, 2012, INORG CHEM, V51, P6428, DOI 10.1021/ic300061u; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; TAKEUCHI KJ, 1984, INORG CHEM, V23, P1845, DOI 10.1021/ic00181a014; WEAVER TR, 1975, J AM CHEM SOC, V97, P3039, DOI 10.1021/ja00844a020; Chen ZF, 2011, DALTON T, V40, P3789, DOI 10.1039/c0dt01178a; Okamura M, 2012, DALTON T, V41, P13081, DOI 10.1039/c2dt30773a; Lopez I, 2014, ANGEW CHEM INT EDIT, V53, P205, DOI 10.1002/anie.201307509; Duan LL, 2010, INORG CHEM, V49, P209, DOI 10.1021/ic9017486; Tong LP, 2012, INORG CHEM, V51, P3388, DOI 10.1021/ic201348u; Xu YH, 2010, ANGEW CHEM INT EDIT, V49, P8934, DOI 10.1002/anie.201004278; Norris MR, 2013, J AM CHEM SOC, V135, P2080, DOI 10.1021/ja311645d; ROTZINGER FP, 1987, J AM CHEM SOC, V109, P6619, DOI 10.1021/ja00256a010; Nakamura G, 2014, INORG CHEM, V53, P7214, DOI 10.1021/ic5003644; Dau H, 2010, CHEMCATCHEM, V2, P724, DOI 10.1002/cctc.201000126; Wasylenko DJ, 2013, CHEM COMMUN, V49, P218, DOI 10.1039/c2cc35632e; Grabolle M, 2005, BBA-BIOENERGETICS, V1708, P209, DOI 10.1016/j.bbabio.2005.03.007; Wasylenko DJ, 2010, J AM CHEM SOC, V132, P16094, DOI 10.1021/ja106108y; Maji S, 2013, INORG CHEM, V52, P3591, DOI 10.1021/ic3028176; Yagi M, 2009, PHOTOCH PHOTOBIO SCI, V8, P139, DOI 10.1039/b811098k; Lubitz W, 2008, ENERG ENVIRON SCI, V1, P15, DOI 10.1039/b808792j; Yagi M, 2011, DALTON T, V40, P3802, DOI 10.1039/c0dt01826k; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Tseng HW, 2008, INORG CHEM, V47, P11763, DOI 10.1021/ic8014817; Duan LL, 2009, J AM CHEM SOC, V131, P10397, DOI 10.1021/ja9034686; Ruttinger W, 1997, CHEM REV, V97, P1, DOI 10.1021/cr950201z; Duan LL, 2012, P NATL ACAD SCI USA, V109, P15584, DOI 10.1073/pnas.1118347109; Norris MR, 2013, ANGEW CHEM INT EDIT, V52, P13580, DOI 10.1002/anie.201305951; Chen ZF, 2010, P NATL ACAD SCI USA, V107, P7225, DOI 10.1073/pnas.1001132107; Bozoglian F, 2009, J AM CHEM SOC, V131, P15176, DOI 10.1021/ja9036127; RAMARAJ R, 1986, ANGEW CHEM INT EDIT, V25, P1009, DOI 10.1002/anie.198610091; Boyer J. L., 2011, ANGEW CHEM, V123, P12808; BRUDVIG GW, 1989, PROG INORG CHEM, V37, P99, DOI 10.1002/9780470166383.ch2; Concepcion J. J., 2009, ANGEW CHEM, V121, P9637; Karkas M. D., 2013, ANGEW CHEM, V125, P4283; Karkas M. D., 2012, ANGEW CHEM, V124, P11757; Karkas MD, 2013, ANGEW CHEM INT EDIT, V52, P4189, DOI 10.1002/anie.201210226; Kikuchi T, 2014, EUR J INORG CHEM, P607, DOI 10.1002/ejic.201300716; Lewandowska-Andralojc A, 2013, PHYS CHEM CHEM PHYS, V15, P14058, DOI 10.1039/c3cp52038b; Li F., 2012, ANGEW CHEM, V124, P2467; Lopez I., 2014, ANGEW CHEM, V126, P209; MEYER TJ, 1989, ACCOUNTS CHEM RES, V22, P163, DOI 10.1021/ar00161a001; Norris M.R., 2013, ANGEW CHEM, V125, P13825; Nyhlen J., 2010, ANGEW CHEM, V122, P1817; Privalov T, 2011, CHEM-EUR J, V17, P8313, DOI 10.1002/chem.201100901; Ramaraj R., 1986, ANGEW CHEM, V98, P1012, DOI 10.1002/ange.19860981119; Sala X., 2010, ANGEW CHEM, V122, P7911; Sala X, 2010, ANGEW CHEM INT EDIT, V49, P7745, DOI 10.1002/anie.201002398; Tong L., 2011, ANGEW CHEM, V123, P465, DOI 10.1002/ange.201005141; Vennampalli M, 2014, EUR J INORG CHEM, P715, DOI 10.1002/ejic.201301393; Wada T., 2000, ANGEW CHEM, V112, P1539, DOI 10.1002/(SICI)1521-3757(20000417)112:8<1539::AID-ANGE1539>3.0.CO;2-Y; Wasylenko DJ, 2010, EUR J INORG CHEM, P3135, DOI 10.1002/ejic.201000099; Xu Y., 2010, ANGEW CHEM, V122, P9118, DOI 10.1002/ange.201004278; Xu YH, 2011, CHEM-EUR J, V17, P9520, DOI 10.1002/chem.201100274; Yagi M, 1999, LANGMUIR, V15, P7406, DOI 10.1021/la9901985	116	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	FEB	2015	10	2					306	315		10.1002/asia.201402781		10	Chemistry, Multidisciplinary	Chemistry	CA2DQ	WOS:000348719500002		
J	Li, CL; Malgras, V; Aldalbahi, A; Yamauchi, Y				Li, Cuiling; Malgras, Victor; Aldalbahi, Ali; Yamauchi, Yusuke			Dealloying of Mesoporous PtCu Alloy Film for the Synthesis of Mesoporous Pt Films with High Electrocatalytic Activity	CHEMISTRY-AN ASIAN JOURNAL			English	Article						mesoporous materials; mesoporous metals; platinum; dealloying; surfactants	AQUEOUS SURFACTANT SOLUTIONS; HIGH-INDEX FACETS; OXYGEN REDUCTION REACTION; CORE-SHELL NANOPARTICLES; METHANOL ELECTROOXIDATION; PLATINUM NANOCRYSTALS; BIMETALLIC NANODENDRITES; OXIDATION REACTION; FUEL-CELLS; PALLADIUM	Mesoporous Pt film with highly electrocatalytic activity is successfully synthesized by dealloying of mesoporous PtCu alloy film prepared through electrochemical micelle assembly. The resulting mesoporous electrode exhibits high current density and superior stability toward the methanol oxidation reaction.	[Li, Cuiling; Malgras, Victor; Yamauchi, Yusuke] NIMS, Res Ctr Mat Nanoarchitecton MANA, WPI, Tsukuba, Ibaraki 3050044, Japan; [Aldalbahi, Ali] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia	Yamauchi, Y (reprint author), NIMS, Res Ctr Mat Nanoarchitecton MANA, WPI, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	Yamauchi.Yusuke@nims.go.jp	Malgras, Victor/A-8221-2015; Yamauchi, Yusuke/D-2780-2015; Li, Cuiling/E-2014-2015	Malgras, Victor/0000-0002-5667-9118; 	Japanese-Taiwanese Cooperative Program of the Japan Science and Technology Agency (JST); Canon Foundation; Deanship of Scientific Research, College of Science Research Center, King Saud University;  [26708028]	This research is partially supported by the Grants-in-Aid for Young Scientists A (Research Project Number: 26708028), Japanese-Taiwanese Cooperative Program of the Japan Science and Technology Agency (JST), and The Canon Foundation. Ali Aldalbahi acknowledges the financial support by Deanship of Scientific Research, College of Science Research Center, King Saud University.	Qi Y, 2014, CHEM COMMUN, V50, P560, DOI 10.1039/c3cc48061e; Liang HW, 2011, ADV MATER, V23, P1467, DOI 10.1002/adma.201004377; Ataee-Esfahani H, 2013, SMALL, V9, P1047, DOI 10.1002/smll.201202539; Xu JB, 2008, J PHYS CHEM C, V112, P17362, DOI 10.1021/jp8063933; Shui JI, 2011, ADV FUNCT MATER, V21, P3357, DOI 10.1002/adfm.201100723; Tominaka S, 2010, CHEM COMMUN, V46, P8989, DOI 10.1039/c0cc02611e; Yang JH, 2010, ACS APPL MATER INTER, V2, P119, DOI 10.1021/am900623e; Choi KS, 2003, ADV MATER, V15, P2018, DOI 10.1002/adma.200304557; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Li CL, 2013, ANGEW CHEM INT EDIT, V52, P8050, DOI 10.1002/anie.201303035; Zhang K, 2011, J PHYS CHEM C, V115, P379, DOI 10.1021/jp108305v; Chen LY, 2010, ADV FUNCT MATER, V20, P2279, DOI 10.1002/adfm.201000326; Huang XQ, 2013, ANGEW CHEM INT EDIT, V52, P2520, DOI 10.1002/anie.201208901; Wang F, 2012, ANGEW CHEM INT EDIT, V51, P4872, DOI 10.1002/anie.201107376; Abdelsalam ME, 2007, J AM CHEM SOC, V129, P7399, DOI 10.1021/ja071269m; Li CL, 2014, CHEM-EUR J, V20, P729, DOI 10.1002/chem.201302579; Ataee-Esfahani H, 2013, ANGEW CHEM INT EDIT, V52, P13611, DOI 10.1002/anie.201307126; Wang HJ, 2012, CHEM-ASIAN J, V7, P2133, DOI 10.1002/asia.201200316; Teng XW, 2006, SMALL, V2, P249, DOI 10.1002/smll.200500244; Liu XW, 2011, RSC ADV, V1, P1119, DOI 10.1039/c1ra00250c; Biener J, 2009, NAT MATER, V8, P47, DOI [10.1038/nmat2335, 10.1038/NMAT2335]; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Garcia MA, 2007, CHEM MATER, V19, P889, DOI 10.1021/cm061740v; Wang L, 2012, ACS APPL MATER INTER, V4, P2865, DOI 10.1021/am300574e; Zhang S, 2012, J AM CHEM SOC, V134, P5060, DOI 10.1021/ja300708j; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Zhang LG, 2012, J AM CHEM SOC, V134, P11326, DOI 10.1021/ja302959e; Attard GS, 1997, ANGEW CHEM INT EDIT, V36, P1315, DOI 10.1002/anie.199713151; Habas SE, 2007, NAT MATER, V6, P692, DOI 10.1038/nmat1957; Li CL, 2013, CHEM-EUR J, V19, P2242, DOI 10.1002/chem.201203378; Chen JY, 2009, NANO TODAY, V4, P81, DOI 10.1016/j.nantod.2008.09.002; Wang HJ, 2012, CHEM MATER, V24, P1591, DOI 10.1021/cm300054b; Guo SJ, 2011, J AM CHEM SOC, V133, P15354, DOI 10.1021/ja207308b; Sun SH, 2011, ANGEW CHEM INT EDIT, V50, P422, DOI 10.1002/anie.201004631; Wang L, 2011, J AM CHEM SOC, V133, P9674, DOI 10.1021/ja202655j; SOMORJAI GA, 1975, NATURE, V258, P580, DOI 10.1038/258580a0; Sarkar A, 2010, J PHYS CHEM C, V114, P4725, DOI 10.1021/jp908933r; Iyyamperumal R, 2013, J AM CHEM SOC, V135, P5521, DOI 10.1021/ja4010305; Chen LY, 2011, ADV FUNCT MATER, V21, P4364, DOI 10.1002/adfm.201101227; Gong MX, 2014, ACS APPL MATER INTER, V6, P7301, DOI 10.1021/am500656j; Wang HJ, 2012, J AM CHEM SOC, V134, P10819, DOI 10.1021/ja303773z; Huang XQ, 2011, J AM CHEM SOC, V133, P4718, DOI 10.1021/ja1117528; Wakabayashi N, 2005, J PHYS CHEM B, V109, P5836, DOI 10.1021/jp046204+; Taylor E, 2013, CHEMSUSCHEM, V6, P1863, DOI 10.1002/cssc.201300527; Ataee-Esfahani H., 2013, ANGEW CHEM, V125, P13856; Attard G. S., 1997, ANGEW CHEM, V109, P1372, DOI 10.1002/ange.19971091220; Huang X., 2013, ANGEW CHEM, V125, P2580; Lee B, 2001, CHEM COMMUN, P2118, DOI 10.1039/b104516b; Li C., 2013, ANGEW CHEM, V125, P8208; Li CL, 2012, SENSOR ACTUAT B-CHEM, V171, P1192, DOI 10.1016/j.snb.2012.06.073; Liu XW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01404; Nandhakumar I, 2001, CHEM MATER, V13, P3840, DOI 10.1021/cm010484d; Tang JM, 2007, J PHYS CHEM C, V111, P17901, DOI 10.1021/jp071469k; Wang F., 2012, ANGEW CHEM, V124, P4956; Weng YC, 2011, ELECTROCHIM ACTA, V56, P1932, DOI 10.1016/j.electacta.2010.12.029; Xia Y., 2009, ANGEW CHEM, V121, P62, DOI DOI 10.1002/ANGE.200802248	56	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	FEB	2015	10	2					316	320		10.1002/asia.201403181		5	Chemistry, Multidisciplinary	Chemistry	CA2DQ	WOS:000348719500003		
J	Masuda, Y; Ishida, N; Murakami, M				Masuda, Yusuke; Ishida, Naoki; Murakami, Masahiro			Synthesis of Acylphosphonates by a Palladium-Catalyzed Phosphonocarbonylation Reaction of Aryl Iodides with Phosphites	CHEMISTRY-AN ASIAN JOURNAL			English	Article						carbonylation; homogeneous catalysis; palladium; phosphorus; synthetic methods	ACYL PHOSPHONATES; CARBONYLATION REACTIONS; VINYLIC HALIDES; ENANTIOSELECTIVE SYNTHESIS; ALPHA-KETOPHOSPHONATES; ACID; 1-HYDROXYALKYLIDENEDIPHOSPHONATES; HYDROFORMYLATION; REARRANGEMENT; NUCLEOPHILES	Acylphosphonates are conveniently synthesized from aryl iodides by a palladium-catalyzed reaction with dialkyl phosphites under an atmospheric pressure of carbon monoxide. The reaction demonstrates the first example of the use of phosphorus nucleophiles in related metal-catalyzed carbonylation reactions.	[Masuda, Yusuke; Ishida, Naoki; Murakami, Masahiro] Kyoto Univ, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan	Murakami, M (reprint author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan.	murakami@sbchem.kyoto-u.ac.jp			MEXT; ACT-C program of the JST	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Activation Directed toward Straightforward Synthesis", a Grant-in-Aid for Scientific Research (B) from MEXT, and the ACT-C program of the JST.	Birkholz MN, 2009, CHEM SOC REV, V38, P1099, DOI 10.1039/b806211k; Cao H, 2008, J ORG CHEM, V73, P3530, DOI 10.1021/jo800287s; Quesnel JS, 2013, J AM CHEM SOC, V135, P16841, DOI 10.1021/ja4098093; KRANENBURG M, 1995, ORGANOMETALLICS, V14, P3081, DOI 10.1021/om00006a057; Kiss G, 2001, CHEM REV, V101, P3435, DOI 10.1021/cr010328q; Arndtsen BA, 2009, CHEM-EUR J, V15, P302, DOI 10.1002/chem.200800767; BAXTER JE, 1988, POLYMER, V29, P1569, DOI 10.1016/0032-3861(88)90263-7; Grushin VV, 2006, J AM CHEM SOC, V128, P12644, DOI 10.1021/ja064935c; Corbett MT, 2013, J AM CHEM SOC, V135, P594, DOI 10.1021/ja310980q; Yamashita Y, 2011, CHEM-ASIAN J, V6, P2550, DOI 10.1002/asia.201100246; Liu Q, 2011, ANGEW CHEM INT EDIT, V50, P10788, DOI 10.1002/anie.201100763; Jang KP, 2014, J AM CHEM SOC, V136, P76, DOI 10.1021/ja410932t; Ryu I, 1996, ANGEW CHEM INT EDIT, V35, P1050, DOI 10.1002/anie.199610501; HILLEBRAND S, 1995, TETRAHEDRON LETT, V36, P75, DOI 10.1016/0040-4039(94)02206-Q; Evans DA, 1998, J AM CHEM SOC, V120, P4895, DOI 10.1021/ja980423p; Bera AK, 2007, J AM CHEM SOC, V129, P4120, DOI 10.1021/ja068636z; Bloomfield AJ, 2012, ORG LETT, V14, P4370, DOI 10.1021/ol301831k; Hou G, 2013, ADV SYNTH CATAL, V355, P589, DOI 10.1002/adsc.201200810; BHATTACHARYA AK, 1981, CHEM REV, V81, P415, DOI 10.1021/cr00044a004; Fang WW, 2014, SYNTHESIS-STUTTGART, V46, P1689, DOI 10.1055/s-0033-1338635; Wu XF, 2011, CHEM SOC REV, V40, P4986, DOI 10.1039/c1cs15109f; Masuda K, 2011, J AM CHEM SOC, V133, P6918, DOI 10.1021/ja201337x; KARAMAN R, 1989, J CHEM SOC PERK T 1, P765, DOI 10.1039/p19890000765; Frings M, 2014, CHEM-EUR J, V20, P1691, DOI 10.1002/chem.201304331; Miloserdov FM, 2012, ANGEW CHEM INT EDIT, V51, P3668, DOI 10.1002/anie.201200078; Horatscheck A, 2012, ANGEW CHEM INT EDIT, V51, P9441, DOI 10.1002/anie.201201475; Grigg R, 2010, TETRAHEDRON, V66, P5515, DOI 10.1016/j.tet.2010.03.090; Morimoto T, 2004, ANGEW CHEM INT EDIT, V43, P5580, DOI 10.1002/anie.200301736; Liu J, 2008, J AM CHEM SOC, V130, P5654, DOI [10.1021/ja800839w, 10.1021/ja800839W]; Breit B, 2007, TOP ORGANOMETAL CHEM, V24, P145, DOI 10.1007/3418_2007_067; Chatani N, 2010, PURE APPL CHEM, V82, P1443, DOI 10.1351/PAC-CON-09-10-15; FITCH SJ, 1962, J AM CHEM SOC, V84, P1876, DOI 10.1021/ja00869a022; GAJDA T, 1994, TETRAHEDRON-ASYMMETR, V5, P1965, DOI 10.1016/S0957-4166(00)86271-0; Gondi V. B., 2009, ANGEW CHEM, V121, P790; Gondi VB, 2009, ANGEW CHEM INT EDIT, V48, P776, DOI 10.1002/anie.200804244; Goulioukina NS, 2012, ADV SYNTH CATAL, V354, P2727, DOI 10.1002/adsc.201200170; Horatscheck A., 2012, ANGEW CHEM, V124, P9577; Liu Q., 2011, ANGEW CHEM, V123, P10978; MCCONNELL RL, 1956, J AM CHEM SOC, V78, P4450, DOI 10.1021/ja01598a069; MCKENNA CE, 1977, TETRAHEDRON LETT, P155; Miloserdov F. M., 2012, ANGEW CHEM, V124, P3728; Morimoto T., 2004, ANGEW CHEM, V116, P5698, DOI 10.1002/ange.200301736; NAKAZAWA H, 1989, ORGANOMETALLICS, V8, P2272, DOI 10.1021/om00111a029; Negishi E., 2002, HDB ORGANOPALLADIUM, V2, P2309; OJIMA I, 1988, CHEM REV, V88, P1011, DOI 10.1021/cr00089a002; Omae I, 2011, COORDIN CHEM REV, V255, P139, DOI 10.1016/j.ccr.2010.08.001; PRIBAR I, 1989, J ORG CHEM, V54, P36, DOI 10.1021/jo00262a015; Ryu I., 1996, ANGEW CHEM, V108, P1140, DOI 10.1002/ange.19961081005; SCHOENBE.A, 1974, J AM CHEM SOC, V96, P7761, DOI 10.1021/ja00832a024; SCHOENBE.A, 1974, J ORG CHEM, V39, P3318, DOI 10.1021/jo00937a003; SCHOENBE.A, 1974, J ORG CHEM, V39, P3327, DOI 10.1021/jo00937a004; SMYTH MS, 1992, TETRAHEDRON LETT, V33, P4137, DOI 10.1016/S0040-4039(00)74672-7; TANAKA M, 1981, B CHEM SOC JPN, V54, P637, DOI 10.1246/bcsj.54.637; Wu J, 2013, SCI WORLD J, V2013, P1	54	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	FEB	2015	10	2					321	324		10.1002/asia.201403260		4	Chemistry, Multidisciplinary	Chemistry	CA2DQ	WOS:000348719500004		
J	Ishimaru, Y; Shimoyama, N; Fujihara, T; Watanabe, K; Setsune, J				Ishimaru, Yoshihiro; Shimoyama, Naoyuki; Fujihara, Takashi; Watanabe, Keigo; Setsune, Jun-ichiro			Synthesis and Antiaromatic Properties of Highly Planar Dithiaamethyrin	CHEMISTRY-AN ASIAN JOURNAL			English	Article						antiaromaticity; aromaticity; mean plane deviation; planarity; porphyrinoids	MODIFIED EXPANDED PORPHYRINS; NONLINEAR-OPTICAL PROPERTIES; TRANSITION-METAL-COMPLEXES; MESO-ARYL SUBSTITUENTS; ONE-POT SYNTHESIS; STRUCTURAL-CHARACTERIZATION; HEXAPHYRIN(1.0.1.0.0.0); RUBYRIN; AROMATICITY; TERPYRROLE	2,5-Bis(4-propyl-2-pyrrolyl) thiophene was reacted with aryl aldehydes to afford large porphyrinoids; [24]dithiaamethyrin(1.0.0.1.0.0) and [36]trithianonaphyrin(1.0.0.1.0.0.1.0.0). X-ray crystallography of the dithiaamethyrin revealed a highly planar ring structure with mean plane deviation (MPD) value of 0.053 angstrom. A large positive NICS(0) value (+13.9 ppm) calculated for this planar 24 pi system unambiguously indicates an antiaromatic character that is consistent with a remarkably low field H-1 chemical shift of the inner NH proton at 24.0 ppm. The magnitude of the paratropic ring current effect in the 24 pi amethyrin framework in the free base form and the diprotonated form was discussed on the basis of the MPD value and the NICS value. The present dithiaamethyrin is much more strongly antiaromatic than the dodecaalkylamethyrin in their free base forms, but the order inversed in their di-protonated forms.	[Ishimaru, Yoshihiro; Shimoyama, Naoyuki] Saitama Univ, Grad Sch Sci & Engn, Div Mat Sci, Sakura Ku, Saitama 3388570, Japan; [Fujihara, Takashi] Saitama Univ, Comprehens Anal Ctr Sci, Res & Dev Bur, Sakura Ku, Saitama 3388570, Japan; [Watanabe, Keigo; Setsune, Jun-ichiro] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan	Ishimaru, Y (reprint author), Saitama Univ, Grad Sch Sci & Engn, Div Mat Sci, Sakura Ku, 255 Shimo Ohkubo, Saitama 3388570, Japan.	ishimaru@fms.saitama-u.ac.jp			Foundation for Interaction in ScienceTechnology	This work was partially supported by a grant from the Foundation for Interaction in Science&Technology.	Anand VG, 2003, CHEM-EUR J, V9, P2282, DOI 10.1002/chem.200204537; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Shimizu S, 2005, ANGEW CHEM INT EDIT, V44, P2225, DOI 10.1002/anie.200463054; SESSLER JL, 1991, ANGEW CHEM INT EDIT, V30, P977, DOI 10.1002/anie.199109771; Chandrashekar TK, 2003, ACCOUNTS CHEM RES, V36, P676, DOI 10.1021/ar020284n; Cho S, 2010, J PHYS CHEM LETT, V1, P895, DOI 10.1021/jz100039n; Hannah S, 2001, INORG CHIM ACTA, V317, P211, DOI 10.1016/S0020-1693(01)00363-2; Saito S, 2011, ANGEW CHEM INT EDIT, V50, P4342, DOI 10.1002/anie.201003909; Ishida M, 2013, NAT CHEM, V5, P15, DOI [10.1038/nchem.1501, 10.1038/NCHEM.1501]; SESSLER JL, 1992, J AM CHEM SOC, V114, P8306, DOI 10.1021/ja00047a061; Sessler JL, 2007, J PORPHYR PHTHALOCYA, V11, P287; CARRE FH, 1993, ORGANOMETALLICS, V12, P2478, DOI 10.1021/om00031a018; Sessler JL, 2001, TETRAHEDRON, V57, P3743, DOI 10.1016/S0040-4020(01)00243-5; Sessler JL, 2003, ANGEW CHEM INT EDIT, V42, P5134, DOI 10.1002/anie.200200561; Setsune J, 2012, CHEM COMMUN, V48, P4447, DOI 10.1039/c2cc30981e; Sessler JL, 2004, TETRAHEDRON, V60, P11089, DOI 10.1016/j.tet.2004.08.055; Yoon ZS, 2006, J AM CHEM SOC, V128, P14128, DOI 10.1021/ja064773k; Misra R, 2008, ACCOUNTS CHEM RES, V41, P265, DOI 10.1021/ar700091k; Stepien M, 2011, ANGEW CHEM INT EDIT, V50, P4288, DOI 10.1002/anie.201003353; SESSLER JL, 1995, CHEM-EUR J, V1, P56, DOI 10.1002/chem.19950010110; Sankar J, 2008, J AM CHEM SOC, V130, P13568, DOI 10.1021/ja801983d; CORRIU RJP, 1991, J CHEM SOC CHEM COMM, P211, DOI 10.1039/c39910000211; Johnson MR, 1997, J ORG CHEM, V62, P1168, DOI 10.1021/jo961849u; JOHNSON MR, 1992, J ORG CHEM, V57, P4414, DOI 10.1021/jo00042a019; Kee SY, 2011, CHEM COMMUN, V47, P6813, DOI 10.1039/c1cc11733e; Kumar R, 2006, ORG LETT, V8, P4847, DOI 10.1021/ol0619011; Kumar R, 2007, EUR J ORG CHEM, P4552, DOI 10.1002/ejoe.200700466; Lament B, 1999, CHEM-EUR J, V5, P3039, DOI 10.1002/(SICI)1521-3765(19991001)5:10<3039::AID-CHEM3039>3.0.CO;2-3; Melfi PJ, 2008, DALTON T, P1538, DOI 10.1039/b718627d; MILLER DC, 1994, J ORG CHEM, V59, P2877, DOI 10.1021/jo00089a035; Narayanan SJ, 1999, J AM CHEM SOC, V121, P9053, DOI 10.1021/ja991472k; Narayanan SJ, 2000, EUR J ORG CHEM, P2357; Neves MGPMS, 1999, CHEM COMMUN, P385, DOI 10.1039/a808952c; Peterson G. R., 2010, ANGEW CHEM, V122, P4022; Peterson GR, 2010, ANGEW CHEM INT EDIT, V49, P3930, DOI 10.1002/anie.200906580; Saito S., 2011, CHEM COMMUN, V47, P4330; Saito S., 2011, ANGEW CHEM, V50, P4342, DOI DOI 10.1002/ANIE.201003909; Sessler J. L., 2003, ANGEW CHEM, V42, P5134, DOI 10.1002/ange.200200561; Sessler J. L., 1991, ANGEW CHEM, V103, P1018, DOI 10.1002/ange.19911030834; Sessler J. L., 1997, EXPANDED CONTRACTED; Sessler JL, 2000, CHEM COMMUN, P1473, DOI 10.1039/b003777j; Setsune J, 1999, J AM CHEM SOC, V121, P8957, DOI 10.1021/ja991669c; Setsune JI, 2008, J AM CHEM SOC, V130, P2404, DOI 10.1021/ja710424n; Shimizu S., 2005, ANGEW CHEM, V117, P2265, DOI 10.1002/ange.200463054; Stpien M., 2011, ANGEW CHEM, V723, P4376, DOI DOI 10.1002/ANIE.201003353	45	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	FEB	2015	10	2					329	333		10.1002/asia.201403126		5	Chemistry, Multidisciplinary	Chemistry	CA2DQ	WOS:000348719500006		
J	Uraguchi, D; Oyaizu, K; Noguchi, H; Ooi, T				Uraguchi, Daisuke; Oyaizu, Keigo; Noguchi, Haruhiro; Ooi, Takashi			Chiral Ammonium Betaine-Catalyzed Highly Stereoselective Aza-Henry Reaction of alpha-Aryl Nitromethanes with Aromatic N-Boc Imines	CHEMISTRY-AN ASIAN JOURNAL			English	Article						asymmetric synthesis; betaines; aza-Henry reaction; organocatalysis; alpha-aryl nitromethane	IONIC NUCLEOPHILIC CATALYSTS; DIAZA-COPE REARRANGEMENT; MANNICH-TYPE REACTION; DIAMINES; NITROCARBOXYLATES; ORGANOCATALYSIS; ACTIVATION; CARBONATES	A highly stereoselective aza-Henry reaction of alpha-aryl nitromethanes with aromatic N-Boc imines was established by using C-1-symmetric chiral ammonium betaine as a bifunctional organic base catalyst. Various substituted aryl groups for both imines and nitromethanes were tolerated in the reaction, and a series of precursors for the synthesis of unsymmetrical anti-1,2-diaryl ethylenediamines was provided.	[Uraguchi, Daisuke; Oyaizu, Keigo; Noguchi, Haruhiro; Ooi, Takashi] Nagoya Univ, Grad Sch Engn, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648603, Japan; [Uraguchi, Daisuke; Oyaizu, Keigo; Noguchi, Haruhiro; Ooi, Takashi] Nagoya Univ, Grad Sch Engn, Dept Appl Chem, Nagoya, Aichi 4648603, Japan; [Ooi, Takashi] Nagoya Univ, Japan Sci & Technol Agcy JST, CREST, Nagoya, Aichi 4648603, Japan	Ooi, T (reprint author), Nagoya Univ, Grad Sch Engn, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648603, Japan.	tooi@apchem.nagoya-u.ac.jp			NEXT program; CREST-JST; Program for Leading Graduate Schools "Integrative Graduate Education and Research Program in Green Natural Sciences" in Nagoya University; JSPS for Scientific Research	This work was supported by NEXT program, CREST-JST, Program for Leading Graduate Schools "Integrative Graduate Education and Research Program in Green Natural Sciences" in Nagoya University, and Grants of JSPS for Scientific Research.	Surry DS, 2010, CHEM SCI, V1, P13, DOI 10.1039/c0sc00107d; Rueping M, 2008, ORG LETT, V10, P1731, DOI 10.1021/ol8003589; Noble A, 2013, CHEM REV, V113, P2887, DOI 10.1021/cr300272t; Uraguchi D, 2010, ANGEW CHEM INT EDIT, V49, P5567, DOI 10.1002/anie.201002315; Tsutsumi Y, 2010, ORG LETT, V12, P5728, DOI 10.1021/ol102539x; De CK, 2011, J AM CHEM SOC, V133, P14538, DOI 10.1021/ja2060462; Uraguchi D, 2008, J AM CHEM SOC, V130, P10878, DOI 10.1021/ja8041004; Kizirian JC, 2008, CHEM REV, V108, P140, DOI 10.1021/cr040107v; Zhang WQ, 2012, ANGEW CHEM INT EDIT, V51, P4085, DOI 10.1002/anie.201107741; Uraguchi D, 2012, CHEM-EUR J, V18, P8306, DOI 10.1002/chem.201201259; Brak K, 2013, ANGEW CHEM INT EDIT, V52, P534, DOI 10.1002/anie.201205449; Kim H, 2008, ANGEW CHEM INT EDIT, V47, P8678, DOI 10.1002/anie.200801974; Vara BA, 2014, J ORG CHEM, V79, P6913, DOI 10.1021/jo501003r; Novacek J, 2013, EUR J ORG CHEM, P637, DOI 10.1002/ejoc.201201425; Cardona F, 2009, NAT CHEM, V1, P269, DOI [10.1038/nchem.256, 10.1038/NCHEM.256]; Davis TA, 2013, J ORG CHEM, V78, P10605, DOI 10.1021/jo401321a; Davis TA, 2011, CHEM SCI, V2, P1076, DOI 10.1039/c1sc00061f; Kim H, 2008, J AM CHEM SOC, V130, P12184, DOI 10.1021/ja803951u; Min C, 2012, CHEM COMMUN, V48, P10853, DOI 10.1039/c2cc36361e; Nishiwaki N, 2001, ANGEW CHEM INT EDIT, V40, P2992, DOI 10.1002/1521-3773(20010817)40:16<2992::AID-ANIE2992>3.0.CO;2-3; Briere JF, 2012, CHEM SOC REV, V41, P1696, DOI 10.1039/c1cs15200a; Brak K., 2013, ANGEW CHEM, V125, P558; Claraz A, 2013, EUR J ORG CHEM, V2013, P7693; Guillerm B, 2014, CHEM COMMUN, V50, P10098, DOI 10.1039/c4cc03347g; Kim H., 2008, ANGEW CHEM, V120, P8806, DOI 10.1002/ange.200801974; Lucet D., 1998, ANGEW CHEM INT EDIT, V37, P2580, DOI DOI 10.1002/(SICI)1521-3773(19981016)37:19<2580::AID-ANIE2580>3.0.CO;2; Lucet D., 1998, ANGEW CHEM, V110, P2724, DOI 10.1002/(SICI)1521-3757(19981002)110:19<2724::AID-ANGE2724>3.0.CO;2-4; Marques-Lopez E, 2009, EUR J ORG CHEM, P2401, DOI 10.1002/ejoc.200801097; Nishiwaki N., 2001, ANGEW CHEM, V113, P3080, DOI 10.1002/1521-3757(20010817)113:16<3080::AID-ANGE3080>3.0.CO;2-U; Ono N., 2001, NITRO GROUP ORGANIC; Uraguchi D, 2010, CHEM COMMUN, V46, P300, DOI 10.1039/b916627k; Uraguchi D, 2010, TETRAHEDRON-ASYMMETR, V21, P1189, DOI 10.1016/j.tetasy.2010.04.006; Uraguchi D., 2010, ANGEW CHEM, V122, P5699; Uraguchi D, 2012, J AM CHEM SOC, V134, P6972, DOI 10.1021/ja3022939; Zhang W.- Q., 2012, ANGEW CHEM, V124, P4161	35	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	FEB	2015	10	2					334	337		10.1002/asia.201402943		4	Chemistry, Multidisciplinary	Chemistry	CA2DQ	WOS:000348719500007		
J	Kobayashi, T; Nakane, Y; Takeda, T; Hoshino, N; Kawai, H; Akutagawa, T				Kobayashi, Takayuki; Nakane, Yuta; Takeda, Takashi; Hoshino, Norihisa; Kawai, Hidetoshi; Akutagawa, Tomoyuki			Crystal Structures and Redox Responses Coupled with Ion Recognition of p-Benzoquinone- and Hydroquinone-Fused [18]crown-6	CHEMISTRY-AN ASIAN JOURNAL			English	Article						[18]crown-6; hydroquinone; ion recognition; p-benzoquinone; redox property	HOST-GUEST RECOGNITION; DIELS-ALDER REACTION; SUPRAMOLECULAR CHEMISTRY; MACROCYCLE INTERACTION; MOLECULAR CONDUCTORS; QUINOCROWN ETHERS; BUILDING-BLOCKS; PROTON-TRANSFER; KINETIC DATA; ELECTRON	The crystal structures and redox properties of p-benzoquinone (BQ)-fused [18]crown-6 1 and bis-BQ-fused [18] crown-6 2 were examined. The anion radicals of these BQ molecules were stabilized by addition of metal ions, through effective electrostatic interactions between the negatively charged BQ moiety and positively charged ion-capturing [18] crown-6 unit. The electrostatic interactions and solvation energy played important roles in determining the magnitudes of anodic redox shifts in the reduction potentials. Regular pi-stacking of BQ units and regular arrays of [18] crown-6 units were observed in crystal 2, in which one-dimensional pi-electron columns were separated by ionic channels. The hydroquinone-fused [18] crown-6 molecule 3 and a new BQ- and phenol-fused [18] crown-6 derivative 4 were obtained as single crystals. The molecular conformations of [18] crown-6 in crystal 3 and hydrated crystal 3 center dot H2O were different from each other.	[Kobayashi, Takayuki; Nakane, Yuta; Takeda, Takashi; Hoshino, Norihisa; Akutagawa, Tomoyuki] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Kobayashi, Takayuki; Hoshino, Norihisa; Akutagawa, Tomoyuki] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Kawai, Hidetoshi] Tokyo Univ Sci, Grad Sch Sci, Shinjuku Ku, Tokyo 1628601, Japan	Akutagawa, T (reprint author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan.	akuta@tagen.tohoku.ac.jp	Kawai, Hidetoshi/B-1153-2008; Hoshino, Norihisa/B-2168-2015	Hoshino, Norihisa/0000-0002-9841-6375	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Management Expenses Grants for National Universities of Japan	This work was supported by a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by Management Expenses Grants for National Universities of Japan.	AKUTAGAWA T, 1995, B CHEM SOC JPN, V68, P1753, DOI 10.1246/bcsj.68.1753; Akutagawa T, 2001, CHEM-EUR J, V7, P4902, DOI 10.1002/1521-3765(20011119)7:22<4902::AID-CHEM4902>3.0.CO;2-F; Akutagawa T, 2002, P NATL ACAD SCI USA, V99, P5028, DOI 10.1073/pnas.082644299; NAKASUJI K, 1991, J AM CHEM SOC, V113, P1862, DOI 10.1021/ja00005a078; MITANI T, 1988, PHYS REV LETT, V60, P2299, DOI 10.1103/PhysRevLett.60.2299; Tsuda A, 2002, J ORG CHEM, V67, P1282, DOI 10.1021/jo010991e; GLENDENING ED, 1994, J AM CHEM SOC, V116, P10657, DOI 10.1021/ja00102a035; Akutagawa T, 2002, J AM CHEM SOC, V124, P8903, DOI 10.1021/ja02611g; Tsuda A, 2003, J AM CHEM SOC, V125, P5811, DOI 10.1021/ja021444t; Nielsen MB, 2000, CHEM SOC REV, V29, P153, DOI 10.1039/a803992e; Akutagawa T, 2004, LANGMUIR, V20, P4187, DOI 10.1021/la049950e; Barboiu M, 2004, J AM CHEM SOC, V126, P3545, DOI 10.1021/ja039146z; Engelkamp H, 1999, SCIENCE, V284, P785, DOI 10.1126/science.284.5415.785; IZATT RM, 1985, CHEM REV, V85, P271, DOI 10.1021/cr00068a003; [Anonymous], 2004, CRYST STRUCT SINGL C; Akutagawa T, 2005, ANGEW CHEM INT EDIT, V44, P7283, DOI 10.1002/anie.200502336; SIELCKEN OE, 1987, J AM CHEM SOC, V109, P4261, DOI 10.1021/ja00248a021; Meillon JC, 1997, ANGEW CHEM INT EDIT, V36, P967, DOI 10.1002/anie.199709671; BEHR JP, 1982, NATURE, V295, P526, DOI 10.1038/295526a0; Blankenship R. E., 2002, MOL MECH PHOTOSYNTHE; IZATT RM, 1991, CHEM REV, V91, P1721, DOI 10.1021/cr00008a003; Formosinho S, 2012, RSC CATAL SER, pV, DOI 10.1039/9781849733168-FP005; Gokel G. W., 1994, CROWN ETHERS CRYPTAN; Gokel GW, 2007, CHEM SOC REV, V36, P378, DOI 10.1039/b605910b; JORGENSEN T, 1994, CHEM SOC REV, V23, P41, DOI 10.1039/cs9942300041; KRAGTEN UF, 1985, J CHEM SOC CHEM COMM, P1275, DOI 10.1039/c39850001275; Nakamura T, 1998, NATURE, V394, P159, DOI 10.1038/28128; Patai S., 1974, CHEM QUINONOID COM 1; SAKURAI T, 1968, ACTA CRYSTALL B-STRU, VB 24, P403, DOI 10.1107/S0567740868002451; Sheldrick G. M., 1998, SHELX97 PROGRAMS CRY; SHIPLEY GG, 1967, ACTA CRYSTALLOGR, V22, P593, DOI 10.1107/S0365110X67001185; SHIPLEY GG, 1967, ACTA CRYSTALLOGR, V22, P585, DOI 10.1107/S0365110X67001173; Stryer L, 1995, BIOCHEMISTRY; Tsuda A, 1998, ACTA CRYSTALLOGR C, V54, P1362, DOI 10.1107/S010827019800287X; Tsuda A, 1999, J CHEM SOC PERK T 2, P1235, DOI 10.1039/a808752k; vanNostrum CF, 1996, CHEM COMMUN, P2385, DOI 10.1039/cc9960002385; Weber E., 1989, CROWN ETHERS ANALOGS	37	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	FEB	2015	10	2					390	396		10.1002/asia.201403262		7	Chemistry, Multidisciplinary	Chemistry	CA2DQ	WOS:000348719500015		
J	Mitomo, H; Watanabe, Y; Matsuo, Y; Niikura, K; Ijiro, K				Mitomo, Hideyuki; Watanabe, Yukie; Matsuo, Yasutaka; Niikura, Kenichi; Ijiro, Kuniharu			Enzymatic Synthesis of a DNA Triblock Copolymer that is Composed of Natural and Unnatural Nucleotides	CHEMISTRY-AN ASIAN JOURNAL			English	Article						DNA; enzymes; nucleotides; polymerization; template synthesis	SELECTIVE METALLIZATION; LB METHOD; NANOWIRES; FABRICATION; MOLECULES; POLY(DG)-POLY(DC); TRANSISTOR; DEPOSITION; TEMPLATE; FRAGMENT	DNA molecules have come under the spotlight as potential templates for the fabrication of nanoscale products, such as molecular-scale electronic or photonic devices. Herein, we report an enhanced approach for the synthesis of oligoblock copolymer-type DNA by using the Klenow fragment exonuclease minus of E. coli DNA polymerase I (KF-) in a multi-step reaction with natural and unnatural nucleotides. First, we confirmed the applicability of unnatural nucleotides with 7-deaza-nucleosides-which was expected because they were non-metalized nucleotides-on the unique polymerization process known as the "strand-slippage model". Because the length of the DNA sequence could be controlled by tuning the reaction time, analogous to a living polymerization reaction on this process, stepwise polymerization provided DNA block copolymers with natural and unnatural bases. AFM images showed that this DNA block copolymer could be metalized sequence-selectively. This approach could expand the utility of DNA as a template.	[Mitomo, Hideyuki; Matsuo, Yasutaka; Niikura, Kenichi; Ijiro, Kuniharu] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0010021, Japan; [Watanabe, Yukie] Hokkaido Univ, Grad Sch Sci, Sapporo, Hokkaido 0608628, Japan	Ijiro, K (reprint author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0010021, Japan.	ijiro@poly.es.hokudai.ac.jp	Mitomo, Hideyuki/D-6705-2012		JSPS KAKENHI [24750213]; JST-CREST	This work was supported by a JSPS KAKENHI grant ("24750213") and by the JST-CREST. We are grateful for a Hokkaido Innovation through Nano Technology Support (HINTS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Ang WH, 2009, CHEM COMMUN, P5820, DOI 10.1039/b914843d; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; Fletcher TM, 1996, BIOCHEMISTRY-US, V35, P15611, DOI 10.1021/bi961228v; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Berti L, 2005, J AM CHEM SOC, V127, P11216, DOI 10.1021/ja052461w; Dong LQ, 2007, CHEM-EUR J, V13, P822, DOI 10.1002/chem.200601320; Keren K, 2002, SCIENCE, V297, P72, DOI 10.1126/science.1071247; Ford WE, 2001, ADV MATER, V13, P1793, DOI 10.1002/1521-4095(200112)13:23<1793::AID-ADMA1793>3.0.CO;2-V; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; LATIMER LJP, 1991, J BIOL CHEM, V266, P13849; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Park H, 2000, NATURE, V407, P57; Serdio VM, 2012, NANOSCALE, V4, P7161, DOI 10.1039/c2nr32232c; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Green JE, 2007, NATURE, V445, P414, DOI 10.1038/nature05462; Burley GA, 2006, J AM CHEM SOC, V128, P1398, DOI 10.1021/ja055517v; Seeman NC, 1999, TRENDS BIOTECHNOL, V17, P437, DOI 10.1016/S0167-7799(99)01360-8; Taniguchi M, 2006, PHYSICA E, V33, P1, DOI 10.1016/j.physe.2006.01.005; Nishinaka T, 2005, J AM CHEM SOC, V127, P8120, DOI 10.1021/ja050487h; Ma YF, 2004, J AM CHEM SOC, V126, P7097, DOI 10.1021/ja039621t; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Kotlyar AB, 2005, NUCLEIC ACIDS RES, V33, P525, DOI 10.1093/nar/gki178; Deng ZX, 2003, NANO LETT, V3, P1545, DOI 10.1021/nl034720q; Keren K, 2003, SCIENCE, V302, P1380, DOI 10.1126/science.1091022; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Mertig M, 2002, NANO LETT, V2, P841, DOI 10.1021/nl025612r; SEELA F, 1992, NUCLEIC ACIDS RES, V20, P55, DOI 10.1093/nar/20.1.55; Cadet J., 2008, MODIFIED NUCLEOSIDES, P29, DOI 10.1002/9783527623112.ch2; Dong LQ, 2007, ADV MATER, V19, P1748, DOI 10.1002/adma.200602543; Al-Said SAF, 2009, ELECTROCHEM COMMUN, V11, P550, DOI 10.1016/j.elecom.2008.12.031; Ganguly M, 2007, NUCLEIC ACIDS RES, V35, P6181, DOI 10.1093/nar/gkm670; Hashimoto Y, 2005, CHEM LETT, V34, P112, DOI 10.1246/cl.2005.112; Ji JP, 1996, NUCLEIC ACIDS RES, V24, P2835, DOI 10.1093/nar/24.14.2835; Karthikeyan G, 1999, NUCLEIC ACIDS RES, V27, P3851, DOI 10.1093/nar/27.19.3851; Kubicek K, 2010, CHEM-ASIAN J, V5, P244, DOI 10.1002/asia.200900655; Matsuo Y, 2002, INT J NANOSCI SER, V1, P695, DOI 10.1142/S0219581X02000917; Mitomo H, 2013, KOBUNSHI RONBUNSHU, V70, P337; Pivonkova H, 2010, ANAL CHEM, V82, P6807, DOI 10.1021/ac100757v; Reed, 2011, ADV MATER, V23, P1583; Shlotterer C, 1992, NUCLEIC ACIDS RES, V20, P211; Srivatsan SG, 2009, CHEM-ASIAN J, V4, P419, DOI 10.1002/asia.200800370; Tanaka A, 2008, CHEM COMMUN, P4270, DOI 10.1039/b805989f; Tanaka A, 2006, COLLOID SURFACE A, V284, P246, DOI 10.1016/j.colsurfa.2005.11.055; Yang IV, 2002, ANAL CHEM, V74, P347, DOI 10.1021/ac0109063	44	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	FEB	2015	10	2					455	460		10.1002/asia.201403108		6	Chemistry, Multidisciplinary	Chemistry	CA2DQ	WOS:000348719500023		
J	Imahori, H				Imahori, Hiroshi			Across the Board: Hiroshi Imahori	CHEMSUSCHEM			English	Editorial Material						artificial photosynthesis; photoelectrochemical cell; photovoltaics; solar fuels; water oxidation	WATER-OXIDATION	In this series of articles the board members of ChemSusChem discuss recent research articles that they consider of exceptional quality and importance for sustainability. This entry features Prof. Hiroshi Imahori, who discusses a concept in which photosensitizers and binuclear catalysts, both based on ruthenium complexes, can be combined to efficiently oxidize water similar to the PhotosystemII in plants.	[Imahori, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Nishikyo Ku, Kyoto 6158510, Japan; [Imahori, Hiroshi] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan	Imahori, H (reprint author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Nishikyo Ku, Kyoto 6158510, Japan.	imahori@scl.kyoto-u.ac.jp	Imahori, Hiroshi/B-5574-2013	Imahori, Hiroshi/0000-0003-3506-5608			Imahori H, 2007, B CHEM SOC JPN, V80, P621, DOI 10.1246/bcsj.80.621; Zhang LL, 2014, CHEMSUSCHEM, V7, P2801, DOI 10.1002/cssc.201402561; Umeyama T, 2014, J MATER CHEM A, V2, P11545, DOI 10.1039/c3ta15387h; Inoue H, 2011, CHEMSUSCHEM, V4, P173, DOI 10.1002/cssc.201000385; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wada T, 2001, INORG CHEM, V40, P329, DOI 10.1021/ic000552i; Higashino T, 2015, DALTON T, V44, P448, DOI 10.1039/c4dt02756f; Duan LL, 2012, P NATL ACAD SCI USA, V109, P15584, DOI 10.1073/pnas.1118347109	8	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-5631	1864-564X		CHEMSUSCHEM	ChemSusChem	FEB	2015	8	3					426	427		10.1002/cssc.201403326		2	Chemistry, Multidisciplinary	Chemistry	CA8DL	WOS:000349146600001		
J	Ueda, Y; Takeda, H; Yui, T; Koike, K; Goto, Y; Inagaki, S; Ishitani, O				Ueda, Yutaro; Takeda, Hiroyuki; Yui, Tatsuto; Koike, Kazuhide; Goto, Yasutomo; Inagaki, Shinji; Ishitani, Osamu			A Visible-Light Harvesting System for CO2 Reduction Using a Ru-II-Re-I Photocatalyst Adsorbed in Mesoporous Organosilica	CHEMSUSCHEM			English	Article						artificial photosynthesis; co(2) reduction; light harvesting; mesoporous materials; photochemistry	CARBON-DIOXIDE; COMPLEX	A photocatalytic system for CO2 reduction exhibiting visible-light harvesting was developed by preparing a hybrid consisting of a supramolecular metal complex as photocatalyst and periodic mesoporous organosilica (PMO) as light harvester. A (RuReI)-Re-II binuclear complex (RuRe) with methylphosphonic acid anchor groups was adsorbed on acridone or methylacridone embedded in the walls of PMO mesochannels to yield the hybrid structure. The embedded organic groups absorbed visible light, and the excitation energy was funneled to the Ru units. The energy accumulation was followed by electron transfer and catalytic reduction of CO2 to CO on the Re unit. The light harvesting of these hybrids enhanced the photocatalytic CO evolution rate by a factor of up to ten compared with that of RuRe adsorbed on mesoporous silica without a light harvester.	[Ueda, Yutaro; Takeda, Hiroyuki; Ishitani, Osamu] Tokyo Inst Technol, Dept Chem, Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528550, Japan; [Goto, Yasutomo; Inagaki, Shinji] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Yui, Tatsuto] Niigata Univ, Dept Mat Sci & Technol, Fac Engn, Niigata 9502181, Japan; [Koike, Kazuhide] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan	Ueda, Y (reprint author), Tokyo Inst Technol, Dept Chem, Grad Sch Sci & Engn, Meguro Ku, 2-12-1-NE-1 O Okayama, Tokyo 1528550, Japan.	inagaki@mosk.tytlabs.co.jp; ishitani@chem.titech.ac.jp	Ishitani, Osamu/C-4947-2011; Yui, Tatsuto/A-9399-2008	Ishitani, Osamu/0000-0001-9557-7854; Yui, Tatsuto/0000-0002-7526-3521	Japan Society for the Promotion of Science (JSPS) [24107005]; CREST (Japan Science and Technology Agency (JST))	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Artificial photosynthesis (AnApple)' (Japan Society for the Promotion of Science (JSPS), No. 24107005), and CREST (Japan Science and Technology Agency (JST).	Koike K, 2009, J PHOTOCH PHOTOBIO A, V207, P109, DOI 10.1016/j.jphotochem.2008.12.014; Takeda H, 2010, COORDIN CHEM REV, V254, P346, DOI 10.1016/j.ccr.2009.09.030; Miyatake T, 2010, COORDIN CHEM REV, V254, P2593, DOI 10.1016/j.ccr.2009.12.027; Takeda H, 2010, INORG CHEM, V49, P4554, DOI 10.1021/ic1000914; Ishida Y, 2011, J AM CHEM SOC, V133, P14280, DOI 10.1021/ja204425u; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Inoue H, 2011, CHEMSUSCHEM, V4, P173, DOI 10.1002/cssc.201000385; Schulz M, 2012, COORDIN CHEM REV, V256, P1682, DOI 10.1016/j.ccr.2012.02.016; Takeda H, 2014, CHEM-EUR J, V20, P9130, DOI 10.1002/chem.201302815; Kent CA, 2010, J AM CHEM SOC, V132, P12767, DOI 10.1021/ja102804s; Tamaki Y, 2013, J CATAL, V304, P22, DOI 10.1016/j.jcat.2013.04.002; Yui T, 2014, ACS APPL MATER INTER, V6, P1992, DOI 10.1021/am405065a; Balzani V, 2011, NEW J CHEM, V35, P1944, DOI 10.1039/c1nj20142e; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; Takeda H, 2009, CHEM COMMUN, P6032, DOI 10.1039/b910528j; Yokoi T, 2004, J MATER CHEM, V14, P951, DOI 10.1039/b310576h	16	6	7	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-5631	1864-564X		CHEMSUSCHEM	ChemSusChem	FEB	2015	8	3					439	442		10.1002/cssc.201403194		4	Chemistry, Multidisciplinary	Chemistry	CA8DL	WOS:000349146600004		
J	Inagaki, S; Numata, M				Inagaki, Shinsuke; Numata, Masahiko			Fast GC Analysis of Fatty Acid Methyl Esters Using a Highly Polar Ionic Liquid Column and its Application for the Determination of Trans Fatty Acid Contents in Edible Oils	CHROMATOGRAPHIA			English	Article						Fast GC; Ionic liquid; Edible oil; Trans fatty acid; Methyl esterification	GAS-CHROMATOGRAPHY; RESOLUTION; ISOMERS	A simple and rapid methyl esterification technique for edible oils and a high-throughput procedure for the separation and quantification of fatty acid methyl esters including cis/trans isomers by fast GC using a highly polar ionic liquid column have been established. The developed method was successfully applied to the determination of trans fatty acid contents in commercially available edible oils, such as margarine, fat spread, shortening, olive oil, rapeseed oil, salad oil, and sesame oil. Combining the developed methyl esterification and fast GC techniques reduced the time required for the analysis of one edible oil specimen to less than 30 min; thus, the analysis time was shortened substantially to less than one-third that required in the existing official methods such as those of the American Oil Chemists' Society and Japanese Oil Chemists' Society. The contents determined by the developed method agreed with those determined by the existing official methods, thus confirming the reliability of the fast GC method.	[Inagaki, Shinsuke; Numata, Masahiko] Natl Inst Adv Ind Sci & Technol, NMIJ, Organ Stand Sect, Organ Analyt Chem Div, Tsukuba, Ibaraki 3058563, Japan	Inagaki, S (reprint author), Natl Inst Adv Ind Sci & Technol, NMIJ, Organ Stand Sect, Organ Analyt Chem Div, 1-1-1 Umezono, Tsukuba, Ibaraki 3058563, Japan.	inagaki-shin@aist.go.jp			Japan Society for the Promotion of Science (JSPS) [B24780138]	This work was supported by Grants-in-Aid for Young Scientists (B24780138) from the Japan Society for the Promotion of Science (JSPS).	American Oil Chemists' Society, 2009, OFFICIAL METHODS REC; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Cramers CA, 1999, J CHROMATOGR A, V856, P315, DOI 10.1016/S0021-9673(99)00227-7; MACGEE J, 1974, J CHROMATOGR, V100, P35, DOI 10.1016/S0021-9673(00)86037-9; ASCHERIO A, 1994, CIRCULATION, V89, P94; Delmonte P, 2011, J CHROMATOGR A, V1218, P545, DOI 10.1016/j.chroma.2010.11.072; Korytar P, 2002, TRAC-TREND ANAL CHEM, V21, P558, DOI 10.1016/S0165-9936(02)00811-7; AOAC International, 2001, OFFICIAL METHODS ANA; Challinor JM, 1996, J ANAL APPL PYROL, V37, P185, DOI 10.1016/0165-2370(96)00946-1; KOSSA WC, 1979, J CHROMATOGR SCI, V17, P177; Mossoba M. M., 2009, OFFICIAL METHODS DET; Ratnayake WMN, 2002, J AOAC INT, V85, P1112; Rodriguez-Alcala LM, 2013, J CHROMATOGR SCI, V51, P70, DOI 10.1093/chromsci/bms109; Shirasawa Seiichi, 2007, J Oleo Sci, V56, P405; The Japan Oil Chemists' Society, 2013, STAND METH AN FATS O; WOLFF RL, 1995, J AM OIL CHEM SOC, V72, P1197, DOI 10.1007/BF02540988	16	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-5893	1612-1112		CHROMATOGRAPHIA	Chromatographia	FEB	2015	78	3-4					291	295		10.1007/s10337-014-2837-z		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CA5VW	WOS:000348976900017		
J	Kim, Y; Morie, T				Kim, Youngjae; Morie, Takashi			A PWM-Mode Pixel-Parallel Image-Processing Circuit Performing Directional State-Propagation and Its Application to Subjective Contour Generation	CIRCUITS SYSTEMS AND SIGNAL PROCESSING			English	Article						PWM; Pixel-parallel architecture; Focal-plane analog processing; Directional pixel-state propagation; Subjective contour generation; CMOS LSI	PULSE-MODULATION; CMOS; CHIP; COMPRESSION; SILICON; VISION; SYSTEM; ARRAY	As an approach to constructing highly organized and intelligent image recognition systems mimicking the visual architecture in the human brain, we have designed an image processing circuit that performs a directional pixel-state propagation algorithm based on a pixel-parallel architecture using pulse-width modulation (PWM) signals. Directional pixel-state propagation can be used for subjective contour generation, which is a typical function of the visual system in the human brain to fill gaps in natural-image information. A PWM-mode circuit can provide more compact circuit configuration than digital circuits, and can achieve focal-plane analog processing by combining with image sensors without A/D converters. Such circuits are suitable for repetitive algorithms, which require offset-free arithmetic. The proof-of-concept LSI chip has been designed and fabricated using a 0.25 m mixed-signal CMOS process. There are 35 35 processing units included in the chip, the operation cycle time for propagation step is 2.2 s, and the power consumption is 363 mW at a supply voltage of 3.3 V. In experiments using this LSI chip, we have successfully generated subjective contours of Kanizsa figures.	[Kim, Youngjae; Morie, Takashi] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan	Morie, T (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan.	Mr.Youngjae.Kim@ieee.org; morie@brain.kyutech.ac.jp			MEXT, Japan, via a 21st Century COE program [J19]	The authors wish to thank Haichao Liang and Yuichiro Yamaguchi for their assistance in simulation and chip measurement. This work was partly supported by funding from MEXT, Japan, via a 21st Century COE program (center #J19). The LSI chip design was supported by VLSI Design and Education Center (VDEC), the University of Tokyo in collaboration with Cadence Design Systems, Inc.	Oliveira FDVR, 2013, IEEE T CIRCUITS-I, V60, P1331, DOI 10.1109/TCSI.2012.2226505; KANIZSA G, 1976, SCI AM, V234, P48; Posch C, 2011, IEEE J SOLID-ST CIRC, V46, P259, DOI 10.1109/JSSC.2010.2085952; Koyanagi M, 2009, P IEEE, V97, P49, DOI 10.1109/JPROC.2008.2007463; Carmona-Galan R, 2004, IEEE T CIRCUITS-I, V51, P913, DOI 10.1109/TCSI.2004.827641; Cauwenberghs G, 1999, IEEE T CIRCUITS-I, V46, P327, DOI 10.1109/81.747215; DominguezCastro R, 1997, IEEE J SOLID-ST CIRC, V32, P1013, DOI 10.1109/4.597292; Dudek P., 2006, INT WORKSH COMP ARCH, P1; Dudek P, 2005, IEEE T CIRCUITS-I, V52, P13, DOI 10.1109/TCSI.2004.840093; Erkmen B, 2013, CIRC SYST SIGNAL PR, V32, P29, DOI 10.1007/s00034-012-9458-2; Etienne-Cummings R, 2001, IEEE J SOLID-ST CIRC, V36, P64, DOI 10.1109/4.896230; Fernandez-Berni J, 2011, IEEE J SOLID-ST CIRC, V46, P669, DOI 10.1109/JSSC.2010.2102591; Fernandez-Berni J., 2012, IEEE P INT S CIRC SY, P3122; Galan RC, 2003, IEEE T NEURAL NETWOR, V14, P1313, DOI 10.1109/TNN.2003.816377; Hadad BS, 2010, J EXP CHILD PSYCHOL, V106, P163, DOI 10.1016/j.jecp.2010.02.003; Iwata A, 2001, IEICE T FUND ELECTR, VE84A, P486; Joo Y, 1999, IEEE J SEL TOP QUANT, V5, P296, DOI 10.1109/2944.778309; Kim Y, 2005, IEEE INT SYMP CIRC S, P4237; Kim Y., 2006, J SIGNAL PROCESS, V10, P259; Linan G., 2001, EUR C CIRC THEOR DES, pI345; Morie T., 2009, IEEE INT SOL STAT CI, P478; Morie T, 2004, IEICE T ELECTRON, VE87C, P1856; Morie T, 2004, 2004 SYMPOSIUM ON VLSI CIRCUITS, DIGEST OF TECHNICAL PAPERS, P212, DOI 10.1109/VLSIC.2004.1346563; Motoyoshi M, 2009, P IEEE, V97, P43, DOI 10.1109/JPROC.2008.2007462; Poikonen J, 2009, IEEE T CIRCUITS-I, V56, P1541, DOI 10.1109/TCSI.2008.2008273; Poikonen J, 2009, ISCAS: 2009 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-5, P1927; Takahashi N, 2009, IEEE T CIRCUITS-I, V56, P2384, DOI 10.1109/TCSI.2009.2015598	27	0	0	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	0278-081X	1531-5878		CIRC SYST SIGNAL PR	Circuits Syst. Signal Process.	FEB	2015	34	2					605	623		10.1007/s00034-014-9871-9		19	Engineering, Electrical & Electronic	Engineering	CA6CM	WOS:000348996100012		
J	Kou, B; Crawford, SE; Ajami, NJ; Czako, R; Neill, FH; Tanaka, TN; Kitamoto, N; Palzkill, TG; Estes, MK; Atmar, RL				Kou, Baijun; Crawford, Sue E.; Ajami, Nadim J.; Czako, Rita; Neill, Frederick H.; Tanaka, Tomoyuki N.; Kitamoto, Noritoshi; Palzkill, Timothy G.; Estes, Mary K.; Atmar, Robert L.			Characterization of Cross-Reactive Norovirus-Specific Monoclonal Antibodies	CLINICAL AND VACCINE IMMUNOLOGY			English	Article							INFECTIOUS INTESTINAL DISEASE; NORWALK-LIKE VIRUSES; UNITED-STATES; GENOGROUP-II; ENZYME-IMMUNOASSAY; BROAD REACTIVITY; CAPSID ANTIGEN; FECAL SAMPLES; STOOL SAMPLES; GASTROENTERITIS	Noroviruses (NoVs) commonly cause acute gastroenteritis outbreaks. Broadly reactive diagnostic assays are essential for rapid detection of NoV infections. We previously generated a panel of broadly reactive monoclonal antibodies (MAbs). We characterized MAb reactivities by use of virus-like particles (VLPs) from 16 different NoV genotypes (6 from genogroup I [GI], 9 from GII, and 1 from GIV) coating a microtiter plate (direct enzyme-linked immunosorbent assay [ELISA]) and by Western blotting. MAbs were genotype specific or recognized multiple genotypes within a genogroup and between genogroups. We next applied surface plasmon resonance (SPR) analysis to measure MAb dissociation constants (K-d) as a surrogate for binding affinity; a Kd level of < 10 nM was regarded as indicating strong binding. Some MAbs did not interact with the VLPs by SPR analysis. To further assess this lack of MAb-VLP interaction, the MAbs were evaluated for the ability to identify NoV VLPs in a capture ELISA. Those MAbs for which a Kd could not be measured by SPR analysis also failed to capture the NoV VLPs; in contrast, those with a measurable Kd gave a positive signal in the capture ELISA. Thus, some broadly cross-reactive epitopes in the VP1 protruding domain may be partially masked on intact particles. One MAb, NV23, was able to detect genogroup I, II, and IV VLPs from 16 genotypes tested by sandwich ELISA, and it successfully detected NoVs in stool samples positive by real-time reverse transcription-PCR when the threshold cycle (C-T) value was < 31. Biochemical analyses of MAb reactivity, including SPR analysis, identified NV23 as a broadly reactive ligand for application in norovirus diagnostic assays.	[Kou, Baijun; Crawford, Sue E.; Ajami, Nadim J.; Czako, Rita; Neill, Frederick H.; Palzkill, Timothy G.; Estes, Mary K.; Atmar, Robert L.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Palzkill, Timothy G.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Estes, Mary K.; Atmar, Robert L.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Tanaka, Tomoyuki N.] Sakai City Inst Publ Hlth, Sakai, Osaka, Japan; [Kitamoto, Noritoshi] Himeji Coll Hyogo, Dept Food Sci & Nutr, Himeji, Hyogo, Japan	Atmar, RL (reprint author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	ratmar@bcm.edu			Public Health Service [NIH P01 AI057788, NIH P30 DK56338, P30 CA125123]; Agriculture and Food Research Initiative competitive grant from the USDA National Institute of Food and Agriculture [2011-68003-30395]; John S. Dunn Research Foundation	This research was funded by Public Health Service grants NIH P01 AI057788, NIH P30 DK56338, and P30 CA125123; by Agriculture and Food Research Initiative competitive grant 2011-68003-30395, from the USDA National Institute of Food and Agriculture; and by the John S. Dunn Research Foundation.	ALMOUDALLAL Z, 1984, J IMMUNOL METHODS, V68, P35, DOI 10.1016/0022-1759(84)90134-0; GREEN KY, 1993, J CLIN MICROBIOL, V31, P2185; Parker TD, 2005, J VIROL, V79, P7402, DOI 10.1128/JVI.79.12.7402-7409.2005; de Wit MAS, 2001, CLIN INFECT DIS, V33, P280, DOI 10.1086/321875; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hansman GS, 2012, J VIROL, V86, P3635, DOI 10.1128/JVI.06868-11; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Ramani S, 2014, CURR OPIN GASTROEN, V30, P25, DOI 10.1097/MOG.0000000000000022; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Amar CFL, 2007, EUR J CLIN MICROBIOL, V26, P311, DOI 10.1007/s10096-007-0290-8; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Van Regenmortel MHV, 1998, J MOL RECOGNIT, V11, P163; Hardy ME, 1996, VIROLOGY, V217, P252, DOI 10.1006/viro.1996.0112; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Bartsch SM, 2012, VACCINE, V30, P7097, DOI 10.1016/j.vaccine.2012.09.040; Hale AD, 2000, J CLIN MICROBIOL, V38, P1656; Huang WZ, 2014, PROTEIN ENG DES SEL, V27, P339, DOI 10.1093/protein/gzu023; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Katsamba PS, 2006, ANAL BIOCHEM, V352, P208, DOI 10.1016/j.ab.2006.01.034; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Burton-MacLeod JA, 2004, J CLIN MICROBIOL, V42, P2587, DOI 10.1128/JCM.42.6.2587.2595.2004; CANNON MJ, 2005, METHODS STRUCTURAL A, P527; Crawford SE, 2015, CLIN VACCINE IMMUNOL, V22, P168, DOI 10.1128/CVI.00520-14; DUBS MC, 1992, IMMUNOL LETT, V31, P59, DOI 10.1016/0165-2478(92)90011-C; Gray JJ, 2007, CLIN VACCINE IMMUNOL, V14, P1349, DOI 10.1128/CVI.00214-07; Grovit-Ferbas K, 2000, J VIROL, V74, P5802, DOI 10.1128/JVI.74.13.5802-5809.2000; Jiang Xi, 1992, Journal of Virology, V66, P6527; Kitamoto N, 2002, J CLIN MICROBIOL, V40, P2459, DOI 10.1128/JCM.40.7.2459-2456.2002; Koo Hoonmo L, 2013, J Pediatric Infect Dis Soc, V2, P57, DOI 10.1093/jpids/pis070; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Moore C, 2013, J HOSP INFECT, V85, P1, DOI 10.1016/j.jhin.2013.06.005; Parra GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067592; Phillips G, 2009, J CLIN VIROL, V44, P242, DOI 10.1016/j.jcv.2008.12.001; Rogers JD, 2013, J CLIN MICROBIOL, V51, P1803, DOI 10.1128/JCM.00295-13; Sakamaki N, 2012, CLIN VACCINE IMMUNOL, V19, P1949, DOI 10.1128/CVI.00427-12; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; Shiota T, 2007, J VIROL, V81, P12298, DOI 10.1128/JVI.00891-07; Siqueira JAM, 2011, DIAGN MICR INFEC DIS, V71, P391, DOI 10.1016/j.diagmicrobio.2011.08.023; Yoda T, 2003, J CLIN MICROBIOL, V41, P2367, DOI 10.1128/JCM.41.6.2367-2371.2003	41	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	1556-6811	1556-679X		CLIN VACCINE IMMUNOL	Clin. Vaccine Immunol.	FEB	2015	22	2					160	167		10.1128/CVI.00519-14		8	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CA2YN	WOS:000348772200004		
J	Crawford, SE; Ajami, N; Parker, TD; Kitamoto, N; Natori, K; Takeda, N; Tanaka, T; Kou, B; Atmar, RL; Estes, MK				Crawford, Sue E.; Ajami, Nadim; Parker, Tracy Dewese; Kitamoto, Noritoshi; Natori, Katsuro; Takeda, Naokazu; Tanaka, Tomoyuki; Kou, Baijun; Atmar, Robert L.; Estes, Mary K.			Mapping Broadly Reactive Norovirus Genogroup I and II Monoclonal Antibodies	CLINICAL AND VACCINE IMMUNOLOGY			English	Article							NORWALK-LIKE VIRUSES; BLOOD GROUP ANTIGENS; NURSING-HOMES; FOODBORNE OUTBREAK; UNITED-STATES; GASTROENTERITIS; INFECTION; IDENTIFICATION; EPIDEMIOLOGY; RECOGNITION	Noroviruses are responsible for most acute nonbacterial epidemic outbreaks of gastroenteritis worldwide. To develop crossreactive monoclonal antibodies (MAbs) for rapid identification of genogroup I and II (GI and GII) noroviruses (NoVs) in field specimens, mice were immunized with baculovirus-expressed recombinant virus-like particles (VLPs) corresponding to NoVs. Nine MAbs against the capsid protein were identified that detected both GI and GII NoV VLPs. These MAbs were tested in competition enzyme-linked immunosorbent assays (ELISAs) to identify common epitope reactivities to GI and GII VLPs. Patterns of competitive reactivity placed these MAbs into two epitope groups (groups 1 and 2). Epitopes for MAbs NV23 and NS22 (group 1) and MAb F120 (group 2) were mapped to a continuous region in the C-terminal P1 subdomain of the capsid protein. This domain is within regions previously defined to contain cross-reactive epitopes in GI and GII viruses, suggesting that common epitopes are clustered within the P1 domain of the capsid protein. Further characterization in an accompanying paper (B. Kou et al., Clin Vaccine Immunol 22: 160 -167, 2015, http://dx.doi.org/10.1128/CVI.00519-14) revealed that MAb NV23 (epitope group 1) is able to detect GI and GII viruses in stool. Inclusion of the GI and GII cross-reactive MAb NV23 in antigen detection assays may facilitate the identification of GI and GII human noroviruses in stool samples as causative agents of outbreaks and sporadic cases of gastroenteritis worldwide.	[Crawford, Sue E.; Ajami, Nadim; Parker, Tracy Dewese; Kou, Baijun; Atmar, Robert L.; Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Kitamoto, Noritoshi] Univ Hyogo, Sch Human Sci & Environm, Kobe, Hyogo 6500044, Japan; [Natori, Katsuro; Takeda, Naokazu] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan; [Tanaka, Tomoyuki] Sakai City Inst Publ Hlth, Sakai, Osaka, Japan; [Atmar, Robert L.; Estes, Mary K.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Estes, MK (reprint author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	mestes@bcm.edu			Public Health Service [NIH R01 AI38036, P01 AI57788, T32 A107471, P30 CA125123]	This work was supported by Public Health Service grants NIH R01 AI38036 and P01 AI57788, training grant T32 A107471 ( to T.D.P.), and grant P30 CA125123, which funds the Recombinant Protein and Monoclonal Antibody Production Shared Resource at Baylor College of Medicine, from the National Institute of Allergy and Infectious Disease; and by the John S. Dunn Research Foundation ( to R.L.A.).; M.K.E. is named as an inventor on patents related to cloning of the Norwalk virus genome, and M.K.E., T.T., and N.K. receive royalties from commercialization activities through Baylor College of Medicine for NoV monoclonal antibody reagents.	Ajami N, 2010, CLIN INFECT DIS, V51, P123, DOI 10.1086/653530; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Tanaka T, 2006, MICROBIOL IMMUNOL, V50, P883; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.091101p1; GREEN KY, 1993, J CLIN MICROBIOL, V31, P2185; Parker TD, 2005, J VIROL, V79, P7402, DOI 10.1128/JVI.79.12.7402-7409.2005; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Lindesmith LC, 2011, J VIROL, V85, P231, DOI 10.1128/JVI.01364-10; JIANG X, 1993, VIROLOGY, V195, P51, DOI 10.1006/viro.1993.1345; Green KY, 2002, J INFECT DIS, V185, P133, DOI 10.1086/338365; Koo HL, 2010, DISCOV MED, V50, P61; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hansman GS, 2012, J VIROL, V86, P3635, DOI 10.1128/JVI.06868-11; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Smith AJ, 2012, EPIDEMIOL INFECT, V140, P1695, DOI 10.1017/S0950268811002305; Roddie C, 2009, CLIN INFECT DIS, V49, P1061, DOI 10.1086/605557; Swanstrom J, 2014, J VIROL, V88, P829, DOI 10.1128/JVI.02793-13; Atmar RL, 2001, CLIN MICROBIOL REV, V14, P15, DOI 10.1128/CMR.14.1.15-37.2001; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Kirby A, 2010, J CLIN VIROL, V49, P254, DOI 10.1016/j.jcv.2010.08.004; Hardy ME, 1996, VIROLOGY, V217, P252, DOI 10.1006/viro.1996.0112; Yee EL, 2007, CLIN INFECT DIS, V44, P1032, DOI 10.1086/512195; Trivedi TK, 2012, JAMA-J AM MED ASSOC, V308, P1668, DOI 10.1001/jama.2012.14023; da Silva AK, 2011, ENVIRON SCI TECHNOL, V45, P520, DOI 10.1021/es102368d; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; Ambert-Balay K, 2013, J CLIN VIROL, V56, P194, DOI 10.1016/j.jcv.2012.11.001; Hale AD, 2000, J CLIN MICROBIOL, V38, P1656; Wikswo ME, 2011, CLIN INFECT DIS, V52, P1116, DOI 10.1093/cid/cir144; Hansman GS, 2006, J GEN VIROL, V87, P909, DOI 10.1099/vir.0.81532-0; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Calderon-Margalit R, 2005, EPIDEMIOL INFECT, V133, P35, DOI 10.1017/S095026880403115; Daniels NA, 2000, J INFECT DIS, V181, P1467, DOI 10.1086/315365; Debbink K, 2014, J VIROL, V88, P7244, DOI 10.1128/JVI.00203-14; Hale AD, 1999, CLIN DIAGN LAB IMMUN, V6, P142; Hardy ME, 1997, ARCH VIROL, V142, P1469, DOI 10.1007/s007050050173; Higo-Moriguchi K, 2014, J MED VIROL, V86, P558, DOI 10.1002/jmv.23734; HYAMS KC, 1993, J INFECT DIS, V167, P986; Jiang Xi, 1992, Journal of Virology, V66, P6527; Kitamoto N, 2002, J CLIN MICROBIOL, V40, P2459, DOI 10.1128/JCM.40.7.2459-2456.2002; Koo HL, 2010, J CLIN MICROBIOL, V48, P1673, DOI 10.1128/JCM.02072-09; Kou B, 2015, CLIN VACCINE IMMUNOL, V22, P160, DOI 10.1128/CVI.00519-14; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Li XA, 2010, VIRUS RES, V151, P142, DOI 10.1016/j.virusres.2010.04.005; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Morillo SG, 2011, J VIROL METHODS, V173, P13, DOI 10.1016/j.jviromet.2010.12.017; Parra GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067592; Parra GI, 2012, J VIROL, V86, P7414, DOI 10.1128/JVI.06729-11; Rhinehart E, 2012, AM J INFECT CONTROL, V40, P2, DOI 10.1016/j.ajic.2011.10.003; SHARP TW, 1995, J MED VIROL, V45, P61, DOI 10.1002/jmv.1890450112; Shiota T, 2007, J VIROL, V81, P12298, DOI 10.1128/JVI.00891-07; Yoda T, 2003, J CLIN MICROBIOL, V41, P2367, DOI 10.1128/JCM.41.6.2367-2371.2003; Yoda T, 2001, BMC Microbiol, V1, P24, DOI 10.1186/1471-2180-1-24	55	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	1556-6811	1556-679X		CLIN VACCINE IMMUNOL	Clin. Vaccine Immunol.	FEB	2015	22	2					168	177		10.1128/CVI.00520-14		10	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CA2YN	WOS:000348772200005		
J	Akamatsu, T; Inui, N; Kusagaya, H; Nakamura, Y; Suda, T; Chida, K				Akamatsu, Taisuke; Inui, Naoki; Kusagaya, Hideki; Nakamura, Yutaro; Suda, Takafumi; Chida, Kingo			Evaluation of antibody levels over 3 years after 23-valent pneumococcal polysaccharide vaccination in patients with pulmonary diseases receiving steroids and immunosuppressive agents	CLINICAL BIOCHEMISTRY			English	Article						Antibody; Enzyme-linked immunosorbent assay; Immunosuppressive agents; Pneumococcal polysaccharide vaccine; Steroid; Streptococcus pneumoniae	VIRUS-INFECTED SUBJECTS; STREPTOCOCCUS-PNEUMONIAE; CAPSULAR POLYSACCHARIDE; PERSISTENCE; EFFICACY; COPD; RESPONSES; IMMUNITY	Objectives: Pneumococcal capsular polysaccharide vaccine is a mainstay for prevention of Streptococcus pneumoniae infection in adults. There is the possibility that this vaccine is less effective in patients undergoing immunosuppressive therapy. In the present study, we aimed to evaluate the immune response following 23-valent pneumococcal polysaccharide vaccination in pulmonary disease patients receiving steroids and immunosuppressive agents (immunosuppressive group). Design and methods: Antibody levels were measured over 3 years in the immunosuppressive group (median age: 68.5 years) and in aged-match pulmonary disease patients not being treated with immunosuppressive therapy (control group) using enzyme-linked immunosorbent assays. Results: The geometric mean antibody levels were significantly increased after vaccination in both groups (p < 0.05) and remained above baseline for 3 years. The fold increases 1 month after vaccination were 9.4 (95% confidence interval [CI]: 5.7-15.6) and 8.8 (95% CI: 5.8-13.2) in the immunosuppressive and control groups, respectively (p = 0.813). There was no significant difference in the proportion of subjects with a >= two-fold increase of antibody level between the immunosuppressive and control groups at any point. Conclusions: These results suggest that immunization with the 23-valent pneumococcal polysaccharide vaccine was effective, even in patients undergoing immunosuppressive therapy and should be recommended for such patients. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Akamatsu, Taisuke; Inui, Naoki; Kusagaya, Hideki; Nakamura, Yutaro; Suda, Takafumi; Chida, Kingo] Hamamatsu Univ, Sch Med, Dept Internal Med, Div 1, Hamamatsu, Shizuoka 4313192, Japan; [Inui, Naoki] Hamamatsu Univ, Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4313192, Japan	Inui, N (reprint author), Hamamatsu Univ, Sch Med, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	inui@hama-med.ac.jp					SIMBERKOFF MS, 1986, NEW ENGL J MED, V315, P1318, DOI 10.1056/NEJM198611203152104; Alfageme I, 2006, THORAX, V61, P189, DOI 10.1136/thx.2005.043323; Feldman C, 2011, DRUGS, V71, P131, DOI 10.2165/11585310-000000000-00000; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Schauer U, 2003, CLIN DIAGN LAB IMMUN, V10, P202, DOI 10.1128/CDLI.10.2.202-207.2003; de Roux A, 2004, RESP MED, V98, P1187, DOI 10.1016/j.rmed.2004.04.012; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003; LAHOOD N, 1993, ANN ALLERGY, V70, P289; MUSHER DM, 1986, J INFECT DIS, V154, P245; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Schenkein JG, 2008, CHEST, V133, P767, DOI 10.1378/chest.07-0996; BUTLER WT, 1973, J CLIN INVEST, V52, P2629, DOI 10.1172/JCI107455; Chen M, 2007, CLIN VACCINE IMMUNOL, V14, P139, DOI 10.1128/CVI.00336-06; Dransfield MT, 2009, AM J RESP CRIT CARE, V180, P499, DOI 10.1164/rccm.200903-0488OC; Global initiative For Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; HILLEMAN MR, 1981, REV INFECT DIS, V3, pS31; LINNEMANN CC, 1981, ARCH INTERN MED, V141, P1637, DOI 10.1001/archinte.141.12.1637; Mahmoodi M, 2009, EUR CYTOKINE NETW, V20, P69, DOI 10.1684/ecn.2009.0153; Moberley S, 2013, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000422.PUB3.REVIEW; MUFSON MA, 1983, P SOC EXP BIOL MED, V173, P270; RodriguezBarradas MC, 1996, J INFECT DIS, V173, P1347; RODRIGUEZBARRADAS MC, 1992, J INFECT DIS, V165, P553; van Kessel DA, 2005, EUR RESPIR J, V25, P482, DOI 10.1183/09031936.05.00013204	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	FEB	2015	48	3					125	129		10.1016/j.clinbiochem.2014.11.005		5	Medical Laboratory Technology	Medical Laboratory Technology	CA1XX	WOS:000348703300007		
J	Ohyama, K; Baba, M; Tamai, M; Aibara, N; Ichinose, K; Kishikawa, N; Kawakami, A; Kuroda, N				Ohyama, Kaname; Baba, Miyako; Tamai, Mami; Aibara, Nozomi; Ichinose, Kunihiro; Kishikawa, Naoya; Kawakami, Atsushi; Kuroda, Naotaka			Proteomic profiling of antigens in circulating immune complexes associated with each of seven autoimmune diseases	CLINICAL BIOCHEMISTRY			English	Article						Autoimmune disease; Immune complexome analysis; Immune complex; Tandem mass spectrometry	PRIMARY SJOGRENS-SYNDROME; RHEUMATOID-ARTHRITIS; IDENTIFICATION; FODRIN; AUTOANTIGEN; SERUM	Objective: Immune complexes (ICs) trigger humoral immune responses. Therefore, the identification of constituent antigens within ICs would have very different clinical significance than identification of free antigens. Design and methods: Here, we applied immune complexome analysis of serum to the study of seven major autoimmune diseases-anti-neutrophil cytoplasmic antibody-associated vasculitis, Takayasu's arteritis, mixed connective tissue disease, dermatomyositis, Sjogren's syndrome, systemic scleroderma, and systemic lupus erythematosus-and healthy donors to comprehensively identify antigens incorporated into circulating ICs and to find disease-specific antigens. Results: We identified 468 distinct IC-associated antigens using this method. Importantly, 62 of those antigens were disease-specific antigens, and there were at least three disease-specific antigens for each of the seven autoimmune diseases. Of the disease-specific antigens identified, coiled-coil domain-containing protein 158 and spectrin were identified as potential autoantigens important to SSc and SS pathogenesis, respectively; notable titin and spectrin autoantibodies are reportedly found in SSc and SS patients, respectively. Conclusion: Immune complexome analysis may be generally applicable to the study of the relationship between ICs and autoimmune diseases in animals and humans. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Ohyama, Kaname; Baba, Miyako; Aibara, Nozomi; Kishikawa, Naoya; Kuroda, Naotaka] Nagasaki Univ, Grad Sch Biomed Sci, Course Pharmaceut Sci, Nagasaki 8528521, Japan; [Ohyama, Kaname] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis NRGIC, Nagasaki, Japan; [Tamai, Mami; Ichinose, Kunihiro; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, Nagasaki 852, Japan	Kuroda, N (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Course Pharmaceut Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	n-kuro@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Nagasaki University; Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences; Research Foundation for Pharmaceutical Sciences; Kato Memorial Trust For Nambyo Research	This work was supported by a grant-in-aid for Scientific Research (C) and Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant-in-aid for Scientific Research from Nagasaki University, the Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences in 2013, the Research Foundation for Pharmaceutical Sciences and the Kato Memorial Trust For Nambyo Research.	Lubin R, 1995, CLIN CANCER RES, V1, P1463; Bach JF, 1998, IMMUNOL REV, V164, P139, DOI 10.1111/j.1600-065X.1998.tb01216.x; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; Saha K, 2003, ANAL CHEM, V75, P835, DOI 10.1021/ac0204911; Rho JH, 2013, J PROTEOME RES, V12, P2311, DOI 10.1021/pr4001674; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425; Monach PA, 2009, P NATL ACAD SCI USA, V106, P15867, DOI 10.1073/pnas.0908032106; Arason GJ, 2002, ANN RHEUM DIS, V61, P257, DOI 10.1136/ard.61.3.257; BLANGE I, 1994, J AUTOIMMUN, V7, P263, DOI 10.1006/jaut.1994.1020; Kavai M, 2007, AUTOIMMUN REV, V6, P497, DOI 10.1016/j.autrev.2007.01.017; LEVINE J, 1981, J CELL BIOL, V90, P631, DOI 10.1083/jcb.90.3.631; Ohyama K, 2012, ANN RHEUM DIS, V71, P1916, DOI 10.1136/annrheumdis-2012-201305; Ohyama K, 2011, CLIN CHEM, V57, P905, DOI 10.1373/clinchem.2010.157776; Stanilova SA, 2001, J IMMUNOL METHODS, V253, P13, DOI 10.1016/S0022-1759(01)00370-2; THOMSEN BS, 1986, ARTHRITIS RHEUM, V29, P857, DOI 10.1002/art.1780290707	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	FEB	2015	48	3					181	185		10.1016/j.clinbiochem.2014.11.008		5	Medical Laboratory Technology	Medical Laboratory Technology	CA1XX	WOS:000348703300017		
J	Shou, Y; Robinson, DM; Amakye, DD; Rose, KL; Cho, YJ; Ligon, KL; Sharp, T; Haider, AS; Bandaru, R; Ando, Y; Geoerger, B; Doz, F; Ashley, DM; Hargrave, DR; Casanova, M; Tawbi, HA; Rodon, J; Thomas, AL; Mita, AC; MacDonald, TJ; Kieran, MW				Shou, Yaping; Robinson, Douglas M.; Amakye, Dereck D.; Rose, Kristine L.; Cho, Yoon-Jae; Ligon, Keith L.; Sharp, Thad; Haider, Asifa S.; Bandaru, Raj; Ando, Yuichi; Geoerger, Birgit; Doz, Francois; Ashley, David M.; Hargrave, Darren R.; Casanova, Michela; Tawbi, Hussein A.; Rodon, Jordi; Thomas, Anne L.; Mita, Alain C.; MacDonald, Tobey J.; Kieran, Mark W.			A Five-Gene Hedgehog Signature Developed as a Patient Preselection Tool for Hedgehog Inhibitor Therapy in Medulloblastoma	CLINICAL CANCER RESEARCH			English	Article							SOLID TUMORS; EXPRESSION; PATHWAY; ACTIVATION; REGRESSION; SUBGROUPS; CANCER; LASSO	Purpose: Distinct molecular subgroups of medulloblastoma, including hedgehog (Hh) pathway-activated disease, have been reported. We identified and clinically validated a five-gene Hh signature assay that can be used to preselect patients with Hh pathway-activated medulloblastoma. Experimental Design: Gene characteristics of the Hh medulloblastoma subgroup were identified through published bioinformatic analyses. Thirty-two genes shown to be differentially expressed in fresh-frozen and formalin-fixed paraffin-embedded tumor samples and reproducibly analyzed by RT-PCR were measured in matched samples. These data formed the basis for building a multi-gene logistic regression model derived through elastic net methods from which the five-gene Hh signature emerged after multiple iterations. On the basis of signature gene expression levels, the model computed a propensity score to determine Hh activation using a threshold set a priori. The asso-ciation between Hh activation status and tumor response to the Hh pathway inhibitor sonidegib (LDE225) was analyzed. Results: Five differentially expressed genes in medulloblastoma (GLI1, SPHK1, SHROOM2, PDLIM3, and OTX2) were found to associate with Hh pathway activation status. In an independent validation study, Hh activation status of 25 medulloblastoma samples showed 100% concordance between the five-gene signature and Affymetrix profiling. Further, in medulloblastoma samples from 50 patients treated with sonidegib, all 6 patients who responded were found to have Hh-activated tumors. Three patients with Hh-activated tumors had stable or progressive disease. No patients with Hh-nonactivated tumors responded. Conclusions: This five-gene Hh signature can robustly identify Hh-activated medulloblastoma and may be used to preselect patients who might benefit from sonidegib treatment. (C) 2014 AACR.	[Shou, Yaping; Robinson, Douglas M.; Sharp, Thad; Bandaru, Raj] Novartis Inst BioMed Res Inc, Cambridge, MA USA; [Amakye, Dereck D.; Rose, Kristine L.; Haider, Asifa S.] Novartis Pharmaceut, E Hanover, NJ USA; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Ligon, Keith L.; Kieran, Mark W.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Ligon, Keith L.; Kieran, Mark W.] Boston Childrens Hosp, Boston, MA 02115 USA; [Ligon, Keith L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ligon, Keith L.] Brigham & Womens Hosp, Childrens Hosp Boston, Dept Pathol, Boston, MA 02115 USA; [Ligon, Keith L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ligon, Keith L.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Ando, Yuichi] Nagoya Univ Hosp, Nagoya, Aichi, Japan; [Geoerger, Birgit] Univ Paris 11, Inst Gustave Roussy, Villejuif, France; [Doz, Francois] Inst Curie, F-75231 Paris, France; [Doz, Francois] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Ashley, David M.] Deakin Univ, Barwon Hlth, Melbourne, Vic 3217, Australia; [Hargrave, Darren R.] Great Ormond St Hosp Sick Children, London, England; [Casanova, Michela] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Tawbi, Hussein A.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Tawbi, Hussein A.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Rodon, Jordi] Vall Hebron Inst Oncol, Barcelona, Spain; [Rodon, Jordi] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Thomas, Anne L.] Univ Leicester, Leicester, Leics, England; [Mita, Alain C.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [MacDonald, Tobey J.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA	Kieran, MW (reprint author), Dana Farber Canc Inst, 450 Brookline Ave,D 3154, Boston, MA 02215 USA.	mark_kieran@dfci.harvard.edu			Novartis Pharmaceuticals Corporation	This study was supported by Novartis Pharmaceuticals Corporation for clinical studies and medical editorial support.	Rodon J, 2014, CLIN CANCER RES, V20, P1900, DOI 10.1158/1078-0432.CCR-13-1710; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; HOERL AE, 1970, TECHNOMETRICS, V12, P69, DOI 10.2307/1267352; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Castaldi PJ, 2011, BRIEF BIOINFORM, V12, P189, DOI 10.1093/bib/bbq073; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Lee Y, 2003, CANCER RES, V63, P5428; Slade I, 2011, FAM CANCER, V10, P337, DOI 10.1007/s10689-010-9411-0; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Kim K, 2010, J CLIN EPIDEMIOL, V63, P950, DOI 10.1016/j.jclinepi.2010.02.018; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Bonifas JM, 2001, J INVEST DERMATOL, V116, P739, DOI 10.1046/j.1523-1747.2001.01315.x; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; CBTRUS, CBTRUS STAT REP PRIM; ClinicalTrials.gov, DOS FIND SAF OR LDE2; ClinicalTrials.gov, E AS STUD LDE225; ClinicalTrials.gov, DOS FIND SAF STUD OR; Farber MJ, 2011, MOL BIOL CELL, V22, P795, DOI 10.1091/mbc.E10-06-0505; Geoerger B, 2012, J CLIN ONCOL 2012 AS, V30; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Packer R J, 1999, Neuro Oncol, V1, P232, DOI 10.1215/15228517-1-3-232; Packer RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1419, DOI 10.1001/archneur.65.11.1419; Pomies P, 2007, MOL BIOL CELL, V18, P1723, DOI 10.1091/mbc.E06-09-0815	35	6	6	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	FEB 1	2015	21	3					585	593		10.1158/1078-0432.CCR-13-1711		9	Oncology	Oncology	CA4WR	WOS:000348908500013		
J	Yoshida, T; Ishii, G; Goto, K; Neri, S; Hashimoto, H; Yoh, K; Niho, S; Umemura, S; Matsumoto, S; Ohmatsu, H; Iida, S; Niimi, A; Nagai, K; Ohe, Y; Ochiai, A				Yoshida, Tatsuya; Ishii, Genichiro; Goto, Koichi; Neri, Shinya; Hashimoto, Hiroko; Yoh, Kiyotaka; Niho, Seiji; Umemura, Shigeki; Matsumoto, Shingo; Ohmatsu, Hironobu; Iida, Shinsuke; Niimi, Akio; Nagai, Kanji; Ohe, Yuichiro; Ochiai, Atsushi			Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation	CLINICAL CANCER RESEARCH			English	Article							TYROSINE KINASE INHIBITORS; PREDICTS POOR-PROGNOSIS; ACQUIRED-RESISTANCE; 1ST-LINE TREATMENT; OPEN-LABEL; GEFITINIB; GROWTH; CHEMOTHERAPY; STROMA; POLYMORPHISM	Purpose: The biologic characteristics of microenvironmental constituents, especially cancer-associated fibroblasts (CAF), can be key regulators of the cellular sensitivity to molecular-targeted therapy. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) have marked therapeutic effects against non-small cell lung cancer (NSCLC) with EGFR mutations, but some patients have exhibited primary resistance to EGFR-TKIs. We recently reported that podoplanin-positive fibroblasts are associated with a tumor-promoting phenotype of CAFs in lung adenocarcinoma. The aim of this study was to evaluate whether the susceptibility of NSCLC to EGFR-TKIs could be affected by podoplanin-expressing CAFs. Experimental Design: We evaluated the EGFR-TKI sensitivity of EGFR-mutant lung adenocarcinoma cell lines cocultured with podoplanin-expressing CAFs. We also examined the association between the expression of podoplanin in CAFs in surgical specimens and EGFR-TKI response of postoperative recurrent patients with EGFR mutations (N = 106). Results: Lung adenocarcinoma cell lines became more resistant to EGFR-TKI when cocultured with podoplanin-expressing CAFs, compared with control CAFs in vitro. The knockdown of podoplanin expression on CAFs cancelled the resistance to EGFR-TKIs in cancer cells. Compared with control CAFs, the cancer cells that were cocultured with podoplanin-positive CAFs continued to exhibit significantly higher p-ERK levels after treatment with gefitinib. Furthermore, postoperative recurrent patients with podoplanin-positive CAFs had a significantly lower overall response rate to EGFR-TKIs compared with those with podoplanin-negative CAFs (53% vs. 83%; P < 0.01). Conclusions: Podoplanin-positive CAFs play an important role in primary resistance to EGFR-TKIs and may be an ideal therapeutic target for use in combination therapy with EGFR-TKIs. (C) 2014 AACR.	[Yoshida, Tatsuya; Ishii, Genichiro; Neri, Shinya; Hashimoto, Hiroko; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan; [Yoshida, Tatsuya; Goto, Koichi; Yoh, Kiyotaka; Niho, Seiji; Umemura, Shigeki; Matsumoto, Shingo; Ohmatsu, Hironobu; Nagai, Kanji; Ohe, Yuichiro] Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba 2778577, Japan; [Yoshida, Tatsuya; Iida, Shinsuke; Niimi, Akio] Nagoya City Univ, Grad Sch Med Sci, Dept Med Oncol & Immunol, Nagoya, Aichi, Japan	Ishii, G (reprint author), Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	gishii@east.ncc.go.jp			National Cancer Center Research and Development Fund [23-A-12, 23-K-18]; Foundation for the Promotion of Cancer Research; 3rd-Term Comprehensive 10-Year Strategy for Cancer Control; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; JSPS KAKENHI [24659185]	This work was supported by the National Cancer Center Research and Development Fund (23-A-12 and 23-K-18), the Foundation for the Promotion of Cancer Research, 3rd-Term Comprehensive 10-Year Strategy for Cancer Control, the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and JSPS KAKENHI (24659185).	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Neri S, 2012, ANN SURG ONCOL, V19, P3953, DOI 10.1245/s10434-012-2421-4; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Nakagawa T, 2013, CANCER RES, V73, P2428, DOI 10.1158/0008-5472.CAN-12-3479; TEICHER BA, 1990, SCIENCE, V247, P1457, DOI 10.1126/science.2108497; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Nakao M, 2009, CANCER-AM CANCER SOC, V115, P2732, DOI 10.1002/cncr.24303; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Sica G, 2010, AM J SURG PATHOL, V34, P1155, DOI 10.1097/PAS.0b013e3181e4ee32; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Takai Y, 2001, PHYSIOL REV, V81, P153; Mink SR, 2010, MOL CANCER RES, V8, P809, DOI 10.1158/1541-7786.MCR-09-0460; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Ito M, 2012, CHEST, V142, P151, DOI 10.1378/chest.11-2458; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Bremnes RM, 2011, J THORAC ONCOL, V6, P209, DOI 10.1097/JTO.0b013e3181f8a1bd; Yoshida T, 2013, J CANCER RES CLIN, V139, P1691, DOI 10.1007/s00432-013-1495-0; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Ito S, 2012, BIOCHEM BIOPH RES CO, V422, P194, DOI 10.1016/j.bbrc.2012.04.158; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Shekhar MPV, 2007, AM J PATHOL, V170, P1546, DOI 10.2353/ajpath.2007.061004; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Xing F, 2010, FRONT BIOSCI, V15, P166, DOI 10.2741/3613; Cui L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012121; Ishii G, 2010, INT J ONCOL, V37, P317, DOI 10.3892/ijo_00000680; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003	41	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	FEB 1	2015	21	3					642	651		10.1158/1078-0432.CCR-14-0846		10	Oncology	Oncology	CA4WR	WOS:000348908500019		
J	Fukudo, S; Hongo, M; Kaneko, H; Takano, M; Ueno, R				Fukudo, Shin; Hongo, Michio; Kaneko, Hiroshi; Takano, Masahiro; Ueno, Ryuji			Lubiprostone Increases Spontaneous Bowel Movement Frequency and Quality of Life in Patients With Chronic Idiopathic Constipation	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Article						IBS; Rome III Criteria; Functional Disorder; QOL; Intestine; Small-Bowel Transit	CHLORIDE CHANNEL ACTIVATOR; HEALTH SURVEY; DOUBLE-BLIND; DISORDERS; SAFETY; VALIDATION; EFFICACY; TRIAL; SF-36	BACKGROUND & AIMS: Lubiprostone is an activator of the type 2 chloride channel that facilitates spontaneous bowel movement (SBM). We performed phase 3 studies to determine whether lubiprostone increases the frequency of SBM in patients with chronic idiopathic constipation (CIC) in Japan, and whether long-term administration of lubiprostone increases the quality of life of patients with CIC. METHODS: We performed a randomized, double-blind, placebo-controlled, phase 3 trial of lubiprostone. Patients with CIC (n = 124) were assigned randomly to groups given placebo (n = 62) or lubiprostone (48 mu g/day; n = 62) for 4 weeks. The primary efficacy end point was the change from baseline in the weekly average number of SBMs after 1 week of administration. In a longterm study of efficacy and safety, 209 patients with CIC were given lubiprostone (24 mu g twice daily) for 48 weeks. RESULTS: Daily administration of lubiprostone induced a significantly greater change, from baseline, in the weekly average number of SBMs at week 1 (increase of 3.7-2.8), compared with placebo (increase of 1.3-1.8; P < .001). The frequency of SBMs during each week of the study period was significantly higher after subjects began receiving lubiprostone than at baseline (P < .0001 at all weeks). Long-term administration of lubiprostone significantly increased scores from the Short-Form health survey and irritable bowel syndrome quality-of-life questionnaire, compared with baseline. We did not observe any severe adverse reactions to lubiprostone. CONCLUSIONS: In phase 3 studies in Japan, lubiprostone increased the weekly average number of SBMs and increased the quality of life of patients with CIC. Clinical Trial Notification of the Japanese Regulatory Authorities: 20-3296 and 20-3300.	[Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 9808575, Japan; [Hongo, Michio] Kurokawa Hosp, Dept Med, Taiwa, Miyagi, Japan; [Kaneko, Hiroshi] Hoshigaoka Maternal Hosp, Div Psychosomat Med, Nagoya, Aichi, Japan; [Takano, Masahiro] Takano Hosp, Dept Surg, Kumamoto, Japan; [Ueno, Ryuji] Sucampo AG, Zug, Switzerland	Fukudo, S (reprint author), Tohoku Univ, Grad Sch Med, Dept Behav Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	sfukudo@med.tohoku.ac.jp			Sucampo Pharma, Ltd	This trial was funded by Sucampo Pharma, Ltd.	Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Schmulson M, 2011, ALIMENT PHARM THER, V33, P1071, DOI 10.1111/j.1365-2036.2011.04637.x; Chang L, 2006, GASTROENTEROLOGY, V130, P1435, DOI 10.1053/j.gastro.2005.09.071; Creed F, 2003, GASTROENTEROLOGY, V124, P303, DOI 10.1053/gast.2003.50055; Simren M, 2013, GUT, V62, P159, DOI 10.1136/gutjnl-2012-302167; Johanson JF, 2007, ALIMENT PHARM THERAP, V25, P1351, DOI 10.1111/j.1365-2036.2007.03320.x; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Barish CF, 2010, DIGEST DIS SCI, V55, P1090, DOI 10.1007/s10620-009-1068-x; Drossman DA, 2009, ALIMENT PHARM THER, V29, P329, DOI 10.1111/j.1365-2036.2008.03881.x; Okami Y, 2011, J GASTROENTEROL, V46, P1403, DOI 10.1007/s00535-011-0454-2; Shepherd SJ, 2006, J AM DIET ASSOC, V106, P1631, DOI 10.1016/j.jada.2006.07.010; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG647, DOI 10.1152/ajpgi.00183.2006; Patrick DL, 1998, DIGEST DIS SCI, V43, P400, DOI 10.1023/A:1018831127942; Bharucha AE, 2006, GASTROENTEROLOGY, V130, P1510, DOI 10.1053/j.gastro.2005.11.064; Johanson JF, 2008, AM J GASTROENTEROL, V103, P170, DOI 10.1111/j.1572-0241.2007.01524.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Owen RT, 2008, DRUG TODAY, V44, P645, DOI [10.1358/dot.2008.44.9.1269852, 10.1358/dot.2008.44.9.1256003]; Fukudo S, 2011, NEUROGASTROENT MOTIL, V23, P544, DOI 10.1111/j.1365-2982.2011.01668.x; Drossman DA, 2000, AM J GASTROENTEROL, V95, P999; Chey WD, 2012, ALIMENT PHARM THER, V35, P587, DOI 10.1111/j.1365-2036.2011.04983.x; Camilleri M, 2006, AM J PHYSIOL-GASTR L, V290, pG942, DOI 10.1152/ajpgi.00264.2005; Cuppoletti J, 2004, AM J PHYSIOL-CELL PH, V287, pC1173, DOI 10.1152/ajpcell.00528.2003; Food and Drug Administration, 1998, FED REG, V63, P49583; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanazawa Motoyori, 2007, Biopsychosoc Med, V1, P6, DOI 10.1186/1751-0759-1-6; Ueno R, 2004, GASTROENTEROLOGY S2, V126, P298; Watanabe T, 2004, EUR J CANCER, V40, P2109, DOI 10.1016/j.ejca.2004.06.014; Whitehead WE, 2004, ALIMENT PHARM THERAP, V20, P1305, DOI 10.1111/j.1365-2036.2004.02256.x	28	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	FEB	2015	13	2					294	U121		10.1016/j.cgh.2014.08.026		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9BB	WOS:000348505100017		
J	Nikaido, M; Miyamoto, S; Iinuma, S				Nikaido, Mitsuhiro; Miyamoto, Shin'ichi; Iinuma, Shoji			Prevention of Gastric Volvulus-induced Recurrent Acute Pancreatitis by Percutaneous Endoscopic Gastropexy	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Nikaido, Mitsuhiro; Iinuma, Shoji] Rakuwakai Otowa Hosp, Dept Gastroenterol, Yamashina Ku, Kyoto, Japan; [Nikaido, Mitsuhiro; Miyamoto, Shin'ichi] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan	Nikaido, M (reprint author), Rakuwakai Otowa Hosp, Dept Gastroenterol, Yamashina Ku, Kyoto, Japan.						Gorsi U, 2014, SAUDI J GASTROENTERO, V20, P195, DOI 10.4103/1319-3767.133026; Kawai M, 2013, ENDOSCOPY, V45, pE151, DOI 10.1055/s-0032-1326461; Toyota Kazuhiro, 2014, Case Rep Gastroenterol, V8, P32, DOI 10.1159/000358553	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	FEB	2015	13	2					E11	E12		10.1016/j.cgh.2014.09.035		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9BB	WOS:000348505100004		
J	van de Kamp, JM; Errami, A; Howidi, M; Anselm, I; Winter, S; Phalin-Roque, J; Osaka, H; van Dooren, SJM; Mancini, GM; Steinberg, SJ; Salomons, GS				van de Kamp, J. M.; Errami, A.; Howidi, M.; Anselm, I.; Winter, S.; Phalin-Roque, J.; Osaka, H.; van Dooren, S. J. M.; Mancini, G. M.; Steinberg, S. J.; Salomons, G. S.			Genotype-phenotype correlation of contiguous gene deletions of SLC6A8, BCAP31 and ABCD1	CLINICAL GENETICS			English	Article						clinical genetics; creatine transporter deficiency; deletion; intellectual disability; liver disease; metabolic disorders; neurology; X-linked adrenoleukodystrophy	X-LINKED ADRENOLEUKODYSTROPHY; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; BAP31; PROTEIN; MITOCHONDRIAL; INTERACTS; DYSTONIA; DXS1357E; DEAFNESS	The BCAP31 gene is located between SLC6A8, associated with X-linked creatine transporter deficiency, and ABCD1, associated with X-linked adrenoleukodystrophy. Recently, loss-of-function mutations in BCAP31 were reported in association with severe developmental delay, deafness and dystonia. We characterized the break points in eight patients with deletions of SLC6A8, BCAP31 and/or ABCD1 and studied the genotype-phenotype correlations. The phenotype in patients with contiguous gene deletions involving BCAP31 overlaps with the phenotype of isolated BCAP31 deficiency. Only deletions involving both BCAP31 and ABCD1 were associated with hepatic cholestasis and death before 1 year, which might be explained by a synergistic effect. Remarkably, a patient with an isolated deletion at the 3 '-end of SLC6A8 had a similar severe phenotype as seen in BCAP31 deficiency but without deafness. This might be caused by the disturbance of a regulatory element between SLC6A8 and BCAP31.	[van de Kamp, J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1007 MB Amsterdam, Netherlands; [Errami, A.] MRC Holland, Amsterdam, Netherlands; [Howidi, M.] Mafraq Hosp, Dept Pediat, Abu Dhabi, U Arab Emirates; [Anselm, I.] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Winter, S.; Phalin-Roque, J.] Childrens Hosp Cent Calif, Madera, CA USA; [Osaka, H.] Kanagawa Childrens Med Ctr, Clin Res Inst, Yokohama, Kanagawa, Japan; [van Dooren, S. J. M.; Salomons, G. S.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Unit, NL-1007 MB Amsterdam, Netherlands; [Mancini, G. M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Steinberg, S. J.] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MA USA; [Steinberg, S. J.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MA USA	van de Kamp, JM (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, POB 7057, NL-1007 MB Amsterdam, Netherlands.	jm.vandekamp@vumc.nl					Iwasa M, 2013, NEUROPATHOLOGY, V33, P292, DOI 10.1111/j.1440-1789.2012.01348.x; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; van de Kamp JM, 2013, J MED GENET, V50, P463, DOI 10.1136/jmedgenet-2013-101658; Cacciagli P, 2013, AM J HUM GENET, V93, P579, DOI 10.1016/j.ajhg.2013.07.023; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Anselm IM, 2006, J INHERIT METAB DIS, V29, P214, DOI 10.1007/s10545-006-0123-4; Corzo D, 2002, AM J HUM GENET, V70, P1520, DOI 10.1086/340849; Ducret A, 2003, EUR J BIOCHEM, V270, P342, DOI 10.1046/j.1432-1033.2003.03395.x; Gardner HP, 2000, GENOMICS, V63, P279, DOI 10.1006/geno.1999.6091; Hartwig C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-53; Howidi M, 2010, CURR PEDIAT RES, V14, P102; Matsumoto T, 2005, AM J MED GENET A, V138A, P300, DOI 10.1002/ajmg.a.30951; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Osaka H, 2012, MOL GENET METAB, V106, P43, DOI 10.1016/j.ymgme.2012.02.018; Steinberg SJ, 1999, ONLINE GENEREVIEWS; Wang B, 2003, J BIOL CHEM, V278, P14461, DOI 10.1074/jbc.M209684200	18	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9163	1399-0004		CLIN GENET	Clin. Genet.	FEB	2015	87	2					141	147		10.1111/cge.12355		7	Genetics & Heredity	Genetics & Heredity	CA2EB	WOS:000348720600007		
J	Matsuda, I; Nittono, H				Matsuda, Izumi; Nittono, Hiroshi			Motivational significance and cognitive effort elicit different late positive potentials	CLINICAL NEUROPHYSIOLOGY			English	Article						Event-related potential (ERP); Late positive potential (LPP); Affect; Controlled processing; Principal component analysis (PCA); Concealed information test (CIT)	EVENT-RELATED POTENTIALS; CONCEALED INFORMATION TEST; EMOTIONAL PERCEPTION; BRAIN POTENTIALS; FUNCTIONAL MRI; ERP ANALYSIS; SLOW-WAVE; ATTENTION; RESPONSES; PCA	Objective: The interaction between affective and cognitive processes has been examined using the late positive potential (LPP) component of the event-related brain potential. The LPP is elicited not only by affective stimuli but also by nonaffective stimuli that require effortful cognitive processing. However, it is unclear whether these LPPs are equivalent. The present study decomposed the LPP into subcomponents that responded differently to affective content and cognitive demands. Methods: The participants (N = 21) performed four types of revised oddball tasks, in which one affective and five nonaffective pictures were presented. For one of the nonaffective pictures, different cognitive demands were loaded: viewing the display, updating a count, updating two different items, or concealing knowledge of the picture. Results: A temporal-spatial principal component analysis revealed two major subcomponents of the LPP. The central-parietal subcomponent was elicited by affective stimuli, whereas the occipital subcomponent was elicited by nonaffective stimuli with cognitive demands in the two-item updating and concealment conditions. Conclusions: The results suggest that the central-parietal dominant LPP may reflect motivated attentional processing, whereas the occipital dominant LPP may reflect effortful controlled processing. Significance: Dealing with these two LPP subcomponents separately may be useful for examining the interaction between affective and cognitive processing of stimuli. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Matsuda, Izumi] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan; [Nittono, Hiroshi] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima 724, Japan	Matsuda, I (reprint author), Natl Res Inst Police Sci, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	izumi@nrips.go.jp	Nittono, Hiroshi/C-4043-2009	Nittono, Hiroshi/0000-0001-5671-609X	KAKENHI [24730650]	This study was supported by KAKENHI 24730650 to Izumi Matsuda. We thank Tokihiro Ogawa and Michiko Tsuneoka for their helpful comments.	Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Czigler I, 2007, NEUROSCI LETT, V420, P251, DOI 10.1016/j.neulet.2007.05.007; ALLEN JJ, 1992, PSYCHOPHYSIOLOGY, V29, P504, DOI 10.1111/j.1469-8986.1992.tb02024.x; Dien J, 2010, J NEUROSCI METH, V187, P138, DOI 10.1016/j.jneumeth.2009.12.009; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/01.wnr.0000075416.59944.49; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Liu YL, 2012, J NEUROSCI, V32, P14563, DOI 10.1523/JNEUROSCI.3109-12.2012; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Codispoti M, 2006, BRAIN RES, V1068, P213, DOI 10.1016/j.brainres.2005.11.009; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Sabatinelli D, 2013, BIOL PSYCHOL, V92, P513, DOI 10.1016/j.biopsycho.2012.04.005; Matsuda I, 2011, PSYCHOPHYSIOLOGY, V48, P1701, DOI 10.1111/j.1469-8986.2011.01266.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; MacNamara A, 2011, COGN AFFECT BEHAV NE, V11, P321, DOI 10.3758/s13415-011-0036-z; Dunning JP, 2009, PSYCHOPHYSIOLOGY, V46, P28, DOI 10.1111/j.1469-8986.2008.00723.x; Rosler F, 1997, BIOL PSYCHOL, V45, P109, DOI 10.1016/S0301-0511(96)05225-8; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Ferrari V, 2008, J COGNITIVE NEUROSCI, V20, P1753, DOI 10.1162/jocn.2008.20121; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1; Sabatinelli D, 2007, CEREB CORTEX, V17, P1085, DOI 10.1093/cercor/bhl017; Velanova K, 2003, J NEUROSCI, V23, P8460; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Schupp HT, 2008, BRAIN RES, V1230, P168, DOI 10.1016/j.brainres.2008.07.024; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Dien J, 2007, HUM BRAIN MAPP, V28, P742, DOI 10.1002/hbm.20304; Anurova I, 2005, CLIN NEUROPHYSIOL, V116, P1644, DOI 10.1016/j.clinph.2005.02.029; Brown SBRE, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00033; Elbert T., 1987, J PSYCHOPHYSIOL, V4, P317; Gable PA, 2013, PSYCHOPHYSIOLOGY, V50, P1251, DOI 10.1111/psyp.12135; Garcia-Larrea L, 1998, EVOKED POTENTIAL, V108, P260, DOI 10.1016/S0168-5597(97)00085-3; Jung EK, 2013, NEUROIMAGE, V78, P305, DOI 10.1016/j.neuroimage.2013.04.027; Lang PJ, 2005, INT AFFECTIVE PICTUR; Matsuda I, 2009, INT J PSYCHOPHYSIOL, V74, P58, DOI 10.1016/j.ijpsycho.2009.07.004; Matsuda I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00532; Matsuda I, 2013, PSYCHOPHYSIOLOGY, V50, P617, DOI 10.1111/psyp.12046; MCCALLUM WC, 1983, PSYCHOPHYSIOLOGY, V20, P1, DOI 10.1111/j.1469-8986.1983.tb00891.x; Olofsson JK, 2007, BIOL PSYCHOL, V75, P101, DOI 10.1016/j.biopsycho.2006.12.006; Rosenfeld J. P., 2011, MEMORY DETECTION THE, P63, DOI DOI 10.1017/CBO9780511975196.005; RUCHKIN DS, 1982, PSYCHOPHYSIOLOGY, V19, P629, DOI 10.1111/j.1469-8986.1982.tb02514.x; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Verschuere B., 2011, MEMORY DETECTION THE; Weinberg A, 2012, INT J PSYCHOPHYSIOL, V84, P149, DOI 10.1016/j.ijpsycho.2012.01.023; Weinberg A., 2013, HDB COGNITION EMOTIO, P35	51	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	FEB	2015	126	2					304	313		10.1016/j.clinph.2014.05.030		10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AZ9UL	WOS:000348562000012		
J	Hayashi, K; Mukai, N; Sawa, T				Hayashi, Kazuko; Mukai, Nobuhiro; Sawa, Teiji			Poincare analysis of the electroencephalogram during sevoflurane anesthesia	CLINICAL NEUROPHYSIOLOGY			English	Article						Poincare plot; Consciousness; Anesthesia monitoring; State-space representation	HEART-RATE-VARIABILITY; EVOKED POTENTIAL INDEX; BISPECTRAL INDEX; CEREBRAL STATE; TIME-DELAY; INTRAOPERATIVE AWARENESS; NARCOTREND INDEXES; EPILEPTIC SEIZURES; EEG; DYNAMICS	Objective: The Poincare plot is a two-dimensional state-space approach, where a timed signal is plotted against itself after a time delay, enabling determination of the dynamic nature of signals. Quantification of the Poincare plot is a candidate for estimating anesthesia-dependent changes in the electroencephalogram (EEG). Methods: In 20 patients, at four different states of anesthesia (0.5%, 1%, 2% and 3% sevoflurane), frontal EEG signals (10 s) were used to construct Poincare plots. The plot pattern was quantified by the standard deviation of the voltage dispersion along the line of identity (SD2), the standard deviation perpendicular to the line of identity (SD1) and their ratio (SD1/SD2), and compared using spectral EEG features. Results: A significant stepwise decrease in the SD1/SD2 ratio was observed with each stepwise increase in sevoflurane concentration (p < 0.001 for each). From 0.5% to 3% sevoflurane anesthesia, the ratio of relative beta power to delta power (beta/delta) was highly correlated with SD1/SD2 (R = 0.92). Conclusions: The Poincare plot of the frontal EEG can detect the significant changes in the depth of anesthesia induced by different sevoflurane concentrations. Significance: The Poincare plot is a useful technique for detecting the EEG changes induced by anesthesia. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Hayashi, Kazuko; Mukai, Nobuhiro] Nantan Gen Hosp, Dept Anesthesiol, Kyoto, Japan; [Hayashi, Kazuko; Sawa, Teiji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Anesthesiol, Kyoto, Japan	Hayashi, K (reprint author), Nantan Gen Hosp, Dept Anesthesiol, Yagi Cho 25, Kyoto, Japan.	zukko@koto.kpu-m.ac.jp			Japan Society for the Promotion of Science (JSPS), Tokyo, Japan [24592313]	Supported by Grant-in-Aid for Scientific Research (C) No. 24592313 from Japan Society for the Promotion of Science (JSPS), Tokyo, Japan.	Acharya R. U., 2005, COMPUT METH PROG BIO, V80, P37, DOI DOI 10.1016/J.CMPB.2005.06.011; Anier A, 2012, BRIT J ANAESTH, V109, P928, DOI 10.1093/bja/aes312; Jouny CC, 2012, CLIN NEUROPHYSIOL, V123, P658, DOI 10.1016/j.clinph.2011.08.003; Walling PT, 2006, ANESTHESIOLOGY, V105, P927, DOI 10.1097/00000542-200611000-00013; WOO MA, 1992, AM HEART J, V123, P704, DOI 10.1016/0002-8703(92)90510-3; Whitlock EL, 2011, ANESTHESIOLOGY, V115, P1209, DOI 10.1097/ALN.0b013e3182395dcb; Avidan MS, 2011, NEW ENGL J MED, V365, P591, DOI 10.1056/NEJMoa1100403; Litt B, 2002, LANCET NEUROL, V1, P22, DOI 10.1016/S1474-4422(02)00003-0; Hagihira S, 2001, ANESTH ANALG, V93, P966, DOI 10.1097/00000539-200110000-00032; Iasemidis LD, 2004, IEEE T BIO-MED ENG, V51, P493, DOI 10.1109/TBME.2003.821013; Laitio TT, 2000, ANESTHESIOLOGY, V93, P69, DOI 10.1097/00000542-200007000-00015; Otzenberger H, 1998, AM J PHYSIOL-HEART C, V275, pH946; Mantzaridis H, 1997, ANAESTHESIA, V52, P1030, DOI 10.1111/j.1365-2044.1997.185-az0327.x; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244; Pilge S, 2006, ANESTHESIOLOGY, V104, P488, DOI 10.1097/00000542-200603000-00016; Bates D. M., 2014, LME4 LINEAR MIXED EF; Brignol A, 2013, COMPUT METH PROG BIO, V109, P227, DOI 10.1016/j.cmpb.2012.10.002; Choi JM, 1997, J KOREAN PHYS SOC, V30, P328; Cortinez LI, 2007, ANESTH ANALG, V104, P605, DOI 10.1213/01.ane.0000255152.96354.17; Doble M, 2008, INT J BIOL MED SCI, V3, P4; Drongelen W., 2007, INTRO ANAL PHYSL SIG; Fritz BA, 2013, ANESTHESIOLOGY, V118, P1113, DOI 10.1097/ALN.0b013e31828604ab; Goshvarpour A, 2011, J BIOMED SCI ENG, V4, P479; Haenggi M, 2009, ANESTH ANALG, V109, P807, DOI 10.1213/ane.0b013e3181acc85d; Hirose M, 1998, ANESTHESIOLOGY, V89, P666, DOI 10.1097/00000542-199809000-00016; Hsu Che-Hao, 2012, Acta Anaesthesiol Taiwan, V50, P12, DOI 10.1016/j.aat.2012.03.002; Iasemidis LD, 1996, NEUROSCIENTIST, V2, P118, DOI 10.1177/107385849600200213; Karmakar CK, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-17; Kreuzer M, 2012, ANESTH ANALG, V115, P315, DOI [10.1213/ANE.0b013e31825801ea, 10.1213/ANE.0b01301825801ca]; Lee U, 2011, ANESTHESIOLOGY, V114, P872, DOI 10.1097/ALN.0b013e31821102c9; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1218, DOI 10.1097/ALN.0b013e31820fc9b6; Otzenberger H, 1997, NEUROSCI LETT, V229, P173, DOI 10.1016/S0304-3940(97)00448-5; PRITCHARD WS, 1992, PSYCHOPHYSIOLOGY, V29, P182, DOI 10.1111/j.1469-8986.1992.tb01683.x; Raiesdana S, 2008, IEEE ENG MED BIO, P4110, DOI 10.1109/IEMBS.2008.4650113; Rehberg B, 2008, ANESTH ANALG, V107, P117, DOI 10.1213/ane.0b013e31816f1965; Yuan Y, 2008, J PHYSIOL SCI, V58, P239, DOI 10.2170/physiolsci.RP004708; Zanner R, 2009, BRIT J ANAESTH, V103, P394, DOI 10.1093/bja/aep198	37	4	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	FEB	2015	126	2					404	411		10.1016/j.clinph.2014.04.019		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AZ9UL	WOS:000348562000024		
J	Kubota, S; Takigawa, M				Kubota, Satoshi; Takigawa, Masaharu			Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions	CLINICAL SCIENCE			English	Review						CCN family; fibrosis; gene regulation; malignancy; matricellular protein	TISSUE-GROWTH-FACTOR; CCN FAMILY PROTEINS; IDIOPATHIC PULMONARY-FIBROSIS; ACUTE LYMPHOBLASTIC-LEUKEMIA; HUMAN SYNOVIAL FIBROBLASTS; HEPATIC STELLATE CELLS; ANGIOTENSIN-II; FACTOR CTGF/CCN2; FACTOR CTGF; IN-VITRO	CCN family protein 2 (CCN2), also widely known as connective tissue growth factor (CTGF), is one of the founding members of the CCN family of matricellular proteins. Extensive investigation on CCN2 over decades has revealed the novel molecular action and functional properties of this unique signalling modulator. By its interaction with multiple molecular counterparts, CCN2 yields highly diverse and context-dependent biological outcomes in a variety of microenvironments. Nowadays, CCN2 is recognized to conduct the harmonized development of relevant tissues, such as cartilage and bone, in the skeletal system, by manipulating extracellular signalling molecules involved therein by acting as a hub through a web. However, on the other hand, CCN2 occasionally plays profound roles in major human biological disorders, including fibrosis and malignancies in major organs and tissues, by modulating the actions of key molecules involved in these clinical entities. In this review, the physiological and pathological roles of this unique protein are comprehensively summarized from a molecular network-based viewpoint of CCN2 functionalities.	[Kubota, Satoshi; Takigawa, Masaharu] Okayama Univ, Sch Dent, Grad Sch Med Dent & Pharmaceut Sci, ARCOCS,Dept Biochem & Mol Dent,Kita Ku, Okayama 7008525, Japan	Kubota, S (reprint author), Okayama Univ, Sch Dent, Grad Sch Med Dent & Pharmaceut Sci, ARCOCS,Dept Biochem & Mol Dent,Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	kubota1@md.okayama-u.ac.jp			Japan Society for the Promotion of Science [24390415, 25462886]; Wesco Scientific Promotion Foundation	Our own work was supported the programme grants-in-aid for Scientific Research (B) [grant number 24390415 (to M.T.)] and (C) [grant number 25462886 (to S.K.)] sponsored by the Japan Society for the Promotion of Science; and Wesco Scientific Promotion Foundation.	Abd El Kader Tarek, 2014, Bone, V59, P180, DOI 10.1016/j.bone.2013.11.010; Abd El Kader Tarek, 2013, J Cell Commun Signal, V7, P11, DOI 10.1007/s12079-012-0180-4; Andersen S, 2005, KIDNEY INT, V67, P2325, DOI 10.1111/j.1523-1755.2005.00337.x; Branchetti E, 2013, CARDIOVASC RES, V100, P316, DOI 10.1093/cvr/cvt205; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Yan LL, 2013, J CELL COMMUN SIGNAL, V7, P253, DOI 10.1007/s12079-013-0206-6; Mosher DF, 2012, MATRIX BIOL, V31, P155, DOI 10.1016/j.matbio.2012.01.003; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127; Gu J, 2012, EXP CELL RES, V318, P2105, DOI 10.1016/j.yexcr.2012.06.015; Arauz J, 2013, J APPL TOXICOL, V33, P970, DOI 10.1002/jat.2788; Sonnylal S, 2013, J CELL SCI, V126, P2164, DOI 10.1242/jcs.111302; Aoyama E, 2012, FEBS LETT, V586, P4270, DOI 10.1016/j.febslet.2012.10.038; Mundy C, 2014, J CELL PHYSIOL, V229, P672, DOI 10.1002/jcp.24491; Kawata K, 2012, J CELL SCI, V125, P2965, DOI 10.1242/jcs.101956; Koitabashi N, 2008, EUR J HEART FAIL, V10, P373, DOI 10.1016/j.ejheart.2008.02.011; Liu SC, 2013, BBA-MOL CELL RES, V1833, P1114, DOI 10.1016/j.bbamcr.2012.12.014; Lu HB, 2014, ANN HEMATOL, V93, P485, DOI 10.1007/s00277-013-1939-2; Kubota S, 2011, J CELL COMMUN SIGNAL, V5, P209, DOI 10.1007/s12079-011-0123-5; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Nishida T, 2011, ENDOCRINOLOGY, V152, P4232, DOI 10.1210/en.2011-0234; Liang HH, 2014, MOL THER, V22, P1122, DOI 10.1038/mt.2014.42; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lin JP, 2012, J IMMUNOL, V188, P5776, DOI 10.4049/jimmunol.1103201; Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Parada C, 2013, MOL CELL BIOL, V33, P3482, DOI 10.1128/MCB.00615-13; Ohgawara T, 2009, FEBS LETT, V583, P1006, DOI 10.1016/j.febslet.2009.02.025; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Hall-Glenn F, 2011, CELL MOL LIFE SCI, V68, P3209, DOI 10.1007/s00018-011-0782-7; Hall-Glenn F, 2013, J CELL COMMUN SIGNAL, V7, P219, DOI 10.1007/s12079-013-0201-y; Chen L, 2014, HEPATOLOGY, V59, P1118, DOI 10.1002/hep.26768; Mo FE, 2006, CIRC RES, V99, P961, DOI 10.1161/01.RES.0000248426.35019.89; Kikuchi R, 2007, CANCER RES, V67, P7095, DOI 10.1158/0008-5472.CAN-06-4567; Mun JH, 2014, WOUND REPAIR REGEN, V22, P125, DOI 10.1111/wrr.12136; Rooney B, 2011, FEBS LETT, V585, P531, DOI 10.1016/j.febslet.2011.01.004; Morales MG, 2013, CELL TISSUE RES, V353, P173, DOI 10.1007/s00441-013-1642-6; Sumiyoshi K, 2010, J CELL COMMUN SIGNAL, V4, P5, DOI 10.1007/s12079-009-0067-1; Takigawa M, 2013, J CELL COMMUN SIGNAL, V7, P191, DOI 10.1007/s12079-013-0204-8; Neesse A, 2013, P NATL ACAD SCI USA, V110, P12325, DOI 10.1073/pnas.1300415110; Finger EC, 2014, ONCOGENE, V33, P1093, DOI 10.1038/onc.2013.47; Hara ES, 2013, BIOCHIMIE, V95, P374, DOI 10.1016/j.biochi.2012.10.016; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Kawaki H, 2008, J BONE MINER RES, V23, P1751, DOI [10.1359/jbmr.080615, 10.1359/JBMR.080615]; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Junglas B, 2012, AM J PATHOL, V180, P2386, DOI 10.1016/j.ajpath.2012.02.030; Alfaro MP, 2013, LAB INVEST, V93, P81, DOI 10.1038/labinvest.2012.162; Kondo S, 2011, BIOCHEM BIOPH RES CO, V405, P382, DOI 10.1016/j.bbrc.2011.01.034; Cabello-Verrugio C, 2011, BIOCHEM BIOPH RES CO, V410, P665, DOI 10.1016/j.bbrc.2011.06.051; Aoyama E, 2013, J DENT RES, V92, P1329; Batmunkh Rentsenkhand, 2011, J Med Invest, V58, P188; Cabello-Verrugio C, 2012, J CELL MOL MED, V16, P752, DOI 10.1111/j.1582-4934.2011.01354.x; Chan ESL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4229; Charrier A, 2013, CYTOKINE GROWTH F R, V24, P59, DOI 10.1016/j.cytogfr.2012.07.001; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Chen P, 2013, IRRIG DRAIN, V62, P1, DOI 10.1002/ird.1788; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007.; Falke LL, 2014, NEPHROL DIAL TRANSPL, V29, pI30, DOI 10.1093/ndt/gft430; Fox JL, 2013, RNA, V19, P177, DOI 10.1261/rna.036467.112; Fragiadaki M, 2012, DIABETES, V61, P2280, DOI 10.2337/db11-1138; Furumatsu T, 2012, J ORTHOP RES, V30, P1738, DOI 10.1002/jor.22142; Gao S, 2014, CARDIOLOGY, V127, P114, DOI 10.1159/000355429; Garcia P, 2013, INT J EXP PATHOL, V94, P195, DOI 10.1111/iep.12023; Guillon-Munos A, 2011, J BIOL CHEM, V286, P25505, DOI 10.1074/jbc.M110.213231; Heusinger-Ribeiro J, 2004, KIDNEY INT, V66, P187, DOI 10.1111/j.1523-1755.2004.00710.x; Honjo T, 2012, J CELL COMMUN SIGNAL, V6, P225, DOI 10.1007/s12079-012-0177-z; Hoshijima M, 2012, FEBS J, V279, P3584, DOI 10.1111/j.1742-4658.2012.08717.x; Hou CH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4151; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Juric V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031303; Kawaki H, 2011, BONE, V49, P975, DOI 10.1016/j.bone.2011.06.033; Khodosevich K, 2013, NEURON, V79, P1136, DOI 10.1016/j.neuron.2013.07.011; Kubota S., 2012, ENCY SIGNALING MOL, P273; Kubota S, 2012, JPN DENT SCI REV, DOI [10.1016/j.jdsr.2012.02.002, DOI 10.1016/J.JDSR.2012.02.002]; Kubota Satoshi, 2013, Biomol Concepts, V4, P477, DOI 10.1515/bmc-2013-0018; Laug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045430; Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054652; Liu SX, 2013, MOL BIOL CELL, V24, P3939, DOI 10.1091/mbc.E13-08-0472; Liu SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051097; Maeda-Uematsu A, 2014, J CELL BIOCHEM, V115, P854, DOI 10.1002/jcb.24728; Matika CA, 2012, MOL BIOL CELL, V23, P1976, DOI 10.1091/mbc.E11-08-0714; Mochizuki S, 2010, BIOCHEM BIOPH RES CO, V402, P651, DOI 10.1016/j.bbrc.2010.10.077; Mukudai Y, 2008, MOL CELL BIOL, V28, P6134, DOI 10.1128/MCB.00495-08; Muromachi K, 2012, J CELL BIOCHEM, V113, P1348, DOI 10.1002/jcb.24007; Nishida T, 2011, J BONE MINER RES, V26, P351, DOI 10.1002/jbmr.222; Nozawa K, 2013, ARTHRITIS RHEUM-US, V65, P1477, DOI 10.1002/art.37902; Ohshiro Y, 2006, DIABETES, V55, P3112, DOI 10.2337/db06-0895; Pacheco MS, 2008, CELLS TISSUES ORGANS, V187, P199, DOI 10.1159/000112640; Rayego-Mateos S, 2013, J MOL CELL BIOL, V5, P323, DOI 10.1093/jmcb/mjt030; Rodrigues-Diez R, 2013, LAB INVEST, V93, P812, DOI 10.1038/labinvest.2013.67; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Samarin J, 2010, J BIOL CHEM, V285, P4328, DOI 10.1074/jbc.M109.049650; Shimo T, 2006, J BONE MINER RES, V21, P1045, DOI 10.1359/JBMR.060416; Shiraishi R, 2011, J PERIODONTOL, V82, P1498, DOI 10.1902/jop.2011.100627; Takeuchi H, 2010, J DENT RES, V89, P34, DOI 10.1177/0022034509353403; Tran CM, 2013, J BIOL CHEM, V288, P12654, DOI 10.1074/jbc.M112.448860; Tsai HC, 2014, BBA-MOL CELL RES, V1843, P846, DOI 10.1016/j.bbamcr.2014.01.007; Villacorta L, 2003, CIRC RES, V92, P104, DOI 10.1161/01.RES.0000049103.38175.1B; Wallace DM, 2013, INVEST OPHTH VIS SCI, V54, P7836, DOI 10.1167/iovs.13-12494; Wang GM, 2013, J INT MED RES, V41, P1214, DOI 10.1177/0300060513476595; Wang XY, 2009, AM J PHYSIOL-CELL PH, V297, pC1490, DOI 10.1152/ajpcell.00049.2009; Welch MD, 2013, BRIT J HAEMATOL, V162, P537, DOI 10.1111/bjh.12417; Yang WH, 2013, J DENT RES, V92, P629, DOI 10.1177/0022034513488139; Yosimichi G, 2006, BONE, V38, P853, DOI 10.1016/j.bone.2005.11.016	107	7	7	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0143-5221	1470-8736		CLIN SCI	Clin. Sci.	FEB	2015	128	3					181	196		10.1042/CS20140264		16	Medicine, Research & Experimental	Research & Experimental Medicine	CB1CI	WOS:000349363800002		
J	Wu, Y; Wang, KY; Li, Z; Liu, YP; Izumi, H; Yamada, S; Uramoto, H; Nakayama, Y; Ito, K; Kohno, K				Wu, Y.; Wang, K. -Y.; Li, Z.; Liu, Y. -P.; Izumi, H.; Yamada, S.; Uramoto, H.; Nakayama, Y.; Ito, K.; Kohno, K.			Y-box binding protein 1 expression in gastric cancer subtypes and association with cancer neovasculature	CLINICAL & TRANSLATIONAL ONCOLOGY			English	Article						YB-1; Gastric cancer; Cancer vessel; MVD; Pathological classification	YB-1 EXPRESSION; POOR-PROGNOSIS; CELLS; ANGIOGENESIS; GROWTH; PROLIFERATION; SENSITIVITY; PROGRESSION; METASTASIS; AUTOCRINE	Y-box binding protein 1 (YB-1) expression in cancer cells is closely associated with malignant progression and poor prognosis in various cancers. Recently, we demonstrated that YB-1 expression in cancer cells is an immunomarker for patient prognosis and liver metastasis of gastric cancer (GC), and identified YB-1 as an excellent biomarker of angiogenic and proliferating endothelial cells in cancers. We further explored the expression patterns of YB-1 in gastric vasculature and the relationship with the clinical pathologic characteristics, as well as YB-1 phenotype in cancer cells. Immunohistochemical analysis of YB-1 was performed using 163 surgically resected primary GC specimens. YB-1 expression in cancer cells significantly differed with respect to Lauren type, JGCA classification, vascular invasion (VI), and microvessel density (MVD) of cancers (P = 0.018, P = 0.002, P < 0.001, and P < 0.001, respectively). No correlation was found between cancer-cell YB-1 expression and TNM stage or lymphatic invasion. However, YB-1 expression in vascular endothelial cells significantly correlated with N stage, M stage, TNM stage, and MVD of cancers (P < 0.001, P = 0.013, P < 0.001, and P < 0.001, respectively). Notably, cases with YB-1 expression in cancer vasculature also demonstrated YB-1 expression in cancer cells (P = 0.040). YB-1 may promote GC development through its function in both cancer cells and cancer vascular cells, and thus represent a potential biomarker in this disease.	[Wu, Y.] China Med Univ, Hosp 1, Dept Gen Practice, Shenyang 110001, Peoples R China; [Wu, Y.; Kohno, K.] Univ Occupat & Environm Hlth, President Lab, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Wang, K. -Y.] Univ Occupat & Environm Hlth, Shared Use Res Ctr, Kitakyushu, Fukuoka 8078555, Japan; [Li, Z.; Liu, Y. -P.] China Med Univ, Dept Med Oncol, Hosp 1, Shenyang 110001, Peoples R China; [Izumi, H.] Univ Occupat & Environm Hlth, Dept Occupat Pneumol, Inst Ind Ecol Sci, Fukuoka, Japan; [Yamada, S.] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Fukuoka, Japan; [Uramoto, H.; Nakayama, Y.] Univ Occupat & Environm Hlth, Sch Med, Dept Surg, Kitakyushu, Fukuoka 8078555, Japan; [Ito, K.] Shinshu Univ, Dept Surg, Matsumoto, Nagano 390, Japan	Kohno, K (reprint author), Univ Occupat & Environm Hlth, President Lab, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	k-kohno@med.uoeh-u.ac.jp			Ministry for Education, Culture, Sports, Science and Technology of Japan [24501323]; University of Occupational and Environmental Health Grant for Advanced Research; Vehicle Racing Commemorative Foundation; National Natural Science Foundation of China [81201801]	The authors thank Ms. H. Isagai for technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry for Education, Culture, Sports, Science and Technology of Japan (No. 24501323), a University of Occupational and Environmental Health Grant for Advanced Research, and the Vehicle Racing Commemorative Foundation, and a grant from the National Natural Science Foundation of China (No. 81201801).	Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Faury D, 2007, J CLIN ONCOL, V25, P1196, DOI 10.1200/JCO.2006.07.8626; Takahashi M, 2010, CANCER SCI, V101, P1367, DOI 10.1111/j.1349-7006.2010.01534.x; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Moss LAS, 2012, AM J PATHOL, V181, P1895, DOI 10.1016/j.ajpath.2012.08.044; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Fujiwara-Okada Y, 2013, BRIT J CANCER, V108, P836, DOI 10.1038/bjc.2012.579; Wu Y, 2012, J SURG ONCOL, V105, P724, DOI 10.1002/jso.23030; Shibata T, 2013, MOL CANCER THER, V12, P737, DOI 10.1158/1535-7163.MCT-12-1125; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; NOMURA M, 1995, J BIOL CHEM, V270, P28316; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Kosnopfel C, 2014, EUR J CELL BIOL, V93, P61, DOI 10.1016/j.ejcb.2013.11.007; Oda Y, 2003, J PATHOL, V199, P251, DOI 10.1002/path.1282; WEIDNER N, 1992, J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Lasham A, 2013, BIOCHEM J, V449, P11, DOI 10.1042/BJ20121323; Ohga T, 1996, CANCER RES, V56, P4224; Ilson DH, 2014, LANCET, V383, P4, DOI 10.1016/S0140-6736(13)61892-9; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Yasen M, 2005, CLIN CANCER RES, V11, P7354, DOI 10.1158/1078-0432.CCR-05-1027; Hansen S, 2000, BRIT J CANCER, V82, P339; Furuya M, 2008, CURR CANCER DRUG TAR, V8, P253, DOI 10.2174/156800908784533481; Gluz O, 2009, J CLIN ONCOL, V27, P6144, DOI 10.1200/JCO.2008.19.6261; Hämmerling Günter J, 2006, Cell Cycle, V5, P509, DOI 10.4161/cc.5.5.2517; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kitadai Y., 2010, J ONCOL, V2010, DOI DOI 10.1155/2010/468725; Lacal PM, 2005, INT J ONCOL, V27, P1625; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Razzak Mina, 2013, Nat Rev Clin Oncol, V10, P548, DOI 10.1038/nrclinonc.2013.156; Song YH, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.11.003; Suzuki S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-659; Szczuraszek K, 2011, ANTICANCER RES, V31, P2963; Tay WL, 2009, MODERN PATHOL, V22, P282, DOI 10.1038/modpathol.2008.181; Tsofack SP, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-303; Woolley AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020603	38	1	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1699-048X	1699-3055		CLIN TRANSL ONCOL	Clin. Transl. Oncol.	FEB	2015	17	2					152	159		10.1007/s12094-014-1208-4		8	Oncology	Oncology	CB0HY	WOS:000349307800009		
J	Yoshida, E				Yoshida, Eri			PH response behavior of giant vesicles comprised of amphiphilic poly(methacrylic acid)-block-poly(methyl methacrylate-random-mathacrylic acid)	COLLOID AND POLYMER SCIENCE			English	Article						PH response; Giant vesicles; Amphiphilic random block copolymer; Poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid); Spherical vesicles; Film-like morphology; Budding separation; Bilayer-rod transition	RANDOM BLOCK-COPOLYMERS; DEPENDENT FUSION; MEMBRANES; RECEPTOR; SHAPE; TRANSITIONS; ELASTICITY; LIPOSOMES; KINETICS	The pH-dependent transformation of micro-sized giant vesicles comprised of amphiphilic poly(methacrylic acid)-block-poly(methyl methacrylate-random-methacrylic acid) was investigated in order to explore the possibility of using the giant vesicles as artificial models of biomembranes. The vesicles prepared by the photopolymerization-induced self-assembly in an aqueous methanol solution retained their spherical shape and size when placed in water at pH 7.1. The vesicles were disrupted by a pH increase and finally dissociated into micelles at pH 12.8. The vesicles were reconstructed by decreasing the pH to 7.5; however, they had a film-like morphology due to the interaggregation by the salt generated during the neutralization process. The film-like morphology was transformed into spherical vesicles when placed in an aqueous methanol solution. The reconstructed spherical vesicles included budding and hand-shaped vesicles, indicating that spherical vesicles were formed by the budding separation and by way of a bilayer-rod transition.	Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Yoshida, E (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	eyoshida@ens.tut.ac.jp			JSPS [25390003]	The author is thankful for a JSPS Grant-in-Aid for Scientific Research (Grant Number 25390003).	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; Elston T, 1998, NATURE, V391, P510; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Yoshida E, 2015, COLLOID POLYM SCI, V293, P249, DOI 10.1007/s00396-014-3403-9; Sugiura S, 2008, LANGMUIR, V24, P4581, DOI 10.1021/la703509r; CHERNOMORDIK LV, 1993, FEBS LETT, V318, P71, DOI 10.1016/0014-5793(93)81330-3; TOCANNE JF, 1974, CHEM PHYS LIPIDS, V12, P201, DOI 10.1016/0009-3084(74)90075-9; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; KAS J, 1991, BIOPHYS J, V60, P825; ELGSAETER A, 1986, SCIENCE, V234, P1217, DOI 10.1126/science.3775380; KOBAYASHI S, 1990, POLYM J, V22, P759, DOI 10.1295/polymj.22.759; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; KWOK R, 1981, BIOPHYS J, V35, P637; Yoshida E, 2014, COLLOID POLYM SCI, V292, P763, DOI 10.1007/s00396-013-3154-z; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431; HOPE MJ, 1980, BIOCHEM BIOPH RES CO, V92, P846, DOI 10.1016/0006-291X(80)90780-9; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; GUNTHERAUSBORN S, 1995, J BIOL CHEM, V270, P29279; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; Yoshida E, 2014, COLLOID POLYM SCI, V292, P1463, DOI 10.1007/s00396-014-3216-x; Yoshida E, 2013, COLLOID POLYM SCI, V291, P2733, DOI 10.1007/s00396-013-3056-0; HAUSER H, 1990, BIOCHEMISTRY-US, V29, P2321, DOI 10.1021/bi00461a016; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P535, DOI 10.1016/B978-0-12-375182-9.10020-X; Lodish H, 2013, MOL CELL BIOL, P11; OKU N, 1983, BIOCHEMISTRY-US, V22, P855, DOI 10.1021/bi00273a023; SACKMANN E, 1986, FARADAY DISCUSS, V81, P281, DOI 10.1039/dc9868100281; Sadava DE, 1993, CELL BIOL ORGANELLE, P130; STEGMANN T, 1985, BIOCHEMISTRY-US, V24, P3107, DOI 10.1021/bi00334a006; Yoshida E, 2014, COLLOID POLYM SCI, V292, P2555, DOI 10.1007/s00396-014-3297-6; Yoshida E, 2015, SUPRAMOL CHEM, V27, P274, DOI 10.1080/10610278.2014.959014	33	7	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	FEB	2015	293	2					649	653		10.1007/s00396-014-3482-7		5	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	CA3CR	WOS:000348784200032		
J	Narui, K; Ichikawa, Y; Ike, H; Ota, M; Saito, S; Fujii, S; Sasaki, T; Nozawa, A; Shimada, H; Endo, I				Narui, K.; Ichikawa, Y.; Ike, H.; Ota, M.; Saito, S.; Fujii, S.; Sasaki, T.; Nozawa, A.; Shimada, H.; Endo, I.			Optimizing the selection of patients with low rectal cancer for intersphincteric resection by evaluating vertical invasion to the levator and external sphincter	COLORECTAL DISEASE			English	Article						Low rectal cancer; intersphincteric resection; anal preservation; histopathology	LOCAL RECURRENCE; ABDOMINOPERINEAL RESECTION; CIRCUMFERENTIAL MARGIN; COLOANAL ANASTOMOSIS; PRESERVING SURGERY; SURGICAL RESECTION; DISTAL SPREAD; TUMOR SPREAD; ADENOCARCINOMA; THERAPY	AimThe indications for intersphincteric (ISR) anterior resection are not clearly defined. The aim of this study was to evaluate vertical extension of T2 or T3 low rectal cancer treated by rectal amputation to optimize patient selection for ISR. MethodThe abdominoperineal excision specimens of T2 or T3 low rectal cancer from 53 patients treated between 1992 and 2004 were retrospectively reviewed. Vertical invasion was quantified by measuring the shortest distance between the tumour and the striated muscle (T-SM), assuming that this represented the surgical margin that would have be achieved had an ISR been performed. ResultsInvolvement of the dentate line (DL) and intramural distal spread were independent risk factors for T-SM 2mm. The T-SM was less when the inferior border of the tumour was on the distal side of the DL (r=0.572, P<0.001). The probability of involvement of the DL, intramural distal spread or either one of these being associated with T-SM2mm was 43, 46 and 43%, respectively. All patients without both intramural distal spread and involvement of the DL had T-SM>2. ConclusionWe recommend that ISR should only be performed for patients with T2 or T3 low rectal cancer in whom the lowest edge of the tumour is above the DL and there is no intramural distal spread. Such patients are relatively unlikely to have a T-SM 2mm.	[Narui, K.; Ichikawa, Y.; Ota, M.; Saito, S.; Fujii, S.; Shimada, H.; Endo, I.] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 2360004, Japan; [Narui, K.; Ota, M.] Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Yokohama, Kanagawa 2360004, Japan; [Ike, H.] Saiseikai Yokohama City Nanbu Hosp, Dept Surg, Yokohama, Kanagawa, Japan; [Sasaki, T.; Nozawa, A.] Yokohama City Univ, Dept Pathol, Med Ctr, Yokohama, Kanagawa 2360004, Japan	Narui, K (reprint author), Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	nr1@gc5.so-net.ne.jp			Japan Society for the Promotion of Science	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Akasu T, 2008, ANN SURG ONCOL, V15, P2668, DOI 10.1245/s10434-008-0047-3; Ueno H, 2004, ANN SURG, V239, P34, DOI 10.1097/01.sla.0000103070.13030.eb; Schiessel R, 2005, DIS COLON RECTUM, V48, P1858, DOI 10.1007/s10350-005-0134-5; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Kusters M, 2009, ANN SURG, V249, P229, DOI 10.1097/SLA.0b013e318190a664; Nagtegaal ID, 2002, AM J SURG PATHOL, V26, P350, DOI 10.1097/00000478-200203000-00009; Shimada Y, 2011, DIS COLON RECTUM, V54, P1510, DOI 10.1097/DCR.0b013e318233fc4a; Rullier E, 2005, ANN SURG, V241, P465, DOI 10.1097/01.sla.0000154551.06768.e1; Glimelius B, 2010, ANN ONCOL, V21, pv82, DOI 10.1093/annonc/mdq170; Reynolds JV, 1996, BRIT J SURG, V83, P1112, DOI 10.1002/bjs.1800830826; Kulkarni T, 2008, COLORECTAL DIS, V10, P479, DOI 10.1111/j.1463-1318.2007.01451.x; Goldstein NS, 1999, AM J CLIN PATHOL, V111, P349; Dent OF, 2011, COLORECTAL DIS, V13, P974, DOI 10.1111/j.1463-1318.2010.02358.x; Yamada K, 2007, BRIT J SURG, V94, P1272, DOI 10.1002/bjs.5534; QUIRKE P, 1986, LANCET, V2, P996; Hayden DM, 2012, DIS COLON RECTUM, V55, P1206, DOI 10.1097/DCR.0b013e318269fdb3; Parc Y, 2009, DIS COLON RECTUM, V52, P2004, DOI 10.1007/DCR.0b013e3181beb4d8; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Dehni N, 2002, DIS COLON RECTUM, V45, P1635, DOI 10.1097/01.DCR.0000034498.82344.20; GRINNELL RS, 1954, SURG GYNECOL OBSTET, V99, P421; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Portier G, 2007, BRIT J SURG, V94, P341, DOI 10.1002/bjs.5621; Saito N, 2006, DIS COLON RECTUM, V49, pS13, DOI 10.1007/s10350-006-0598-y; Schiessel R, 2005, DIS COLON RECTUM, V48, P65; SHIROUZU K, 1995, CANCER, V76, P388, DOI 10.1002/1097-0142(19950801)76:3<388::AID-CNCR2820760307>3.0.CO;2-Y; Shirouzu K, 2003, Tech Coloproctol, V7, P203, DOI 10.1007/s10151-003-0036-2; Shirouzu K, 2009, DIS COLON RECTUM, V52, P1887, DOI 10.1007/DCR.0b013e3181b1585a; Tilney HS, 2008, ANN SURG, V247, P77, DOI 10.1097/SLA.0b013e31816076c3; Tjandra JJ, 2005, DIS COLON RECTUM, V48, P411, DOI 10.1007/s10350-004-0937-9; Van Cutsem E, 2008, ANN ONCOL S, V19, pvi1, DOI DOI 10.1016/J.RADONC.2009.06.027	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8910	1463-1318		COLORECTAL DIS	Colorectal Dis.	FEB	2015	17	2					133	140		10.1111/codi.12769		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CA2XU	WOS:000348770300010		
J	Hiai, F; Ueda, Y				Hiai, Fumio; Ueda, Yoshimichi			Orbital Free Pressure and Its Legendre Transform	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							FREE PROBABILITY-THEORY; FREE ENTROPY; INFORMATION; ANALOGS	Orbital counterparts of the free pressure and its Legendre transform (or eta- entropy) are introduced and studied in comparison with other entropy quantities in free probability theory and in relation to random multi-matrix models.	[Hiai, Fumio] Tohoku Univ, Abiko, Chiba 2701154, Japan; [Ueda, Yoshimichi] Kyushu Univ, Grad Sch Math, Fukuoka 8190395, Japan	Hiai, F (reprint author), Tohoku Univ, Hakusan 3-8-16-303, Abiko, Chiba 2701154, Japan.	hiai.fumio@gmail.com; ueda@math.kyushu-u.ac.jp			 [24540214]	Y. Ueda is supported in part by Grant-in-Aid for Scientific Research (C) 24540214.	Voiculescu D, 1999, ADV MATH, V146, P101, DOI 10.1006/aima.1998.1819; Ueda Y, 2011, ADV MATH, V228, P2647, DOI 10.1016/j.aim.2011.07.017; Biane P, 2001, GEOM FUNCT ANAL, V11, P1125; Belinschi ST, 2003, PAC J MATH, V211, P35; Biane P, 2013, ADV MATH, V234, P667, DOI 10.1016/j.aim.2012.11.003; Bratteli O., 1981, OPERATOR ALGEBRAS QU; Collins B, 2009, ADV MATH, V222, P172, DOI 10.1016/j.aim.2009.03.019; Dabrowski Y, 2010, J FUNCT ANAL, V258, P3662, DOI 10.1016/j.jfa.2010.02.010; Dabrowski Y., ARXIV12126425; Guionnet A., 2006, ALEA-LAT AM J PROBAB, V1, P241; Guionnet A., 2009, LECT NOTES MATH, V1957; Hiai F, 2006, INFIN DIMENS ANAL QU, V9, P391, DOI 10.1142/S0219025706002457; Hiai F., 2006, ACTA SCI MATH SZEGED, V72, P581; Hiai F, 2005, COMMUN MATH PHYS, V255, P229, DOI 10.1007/s00220-004-1259-4; Hiai F, 2009, INT J MATH, V20, P227; Hiai F., 2000, MATH SURVEYS MONOGRA, V77; Izumi M., ARXIV13065372; Jung K, 2007, MATH ANN, V338, P241, DOI 10.1007/s00208-006-0074-y; Simon B., 1993, PRINCETON SERIES PHY, V1; Ueda Y., 2014, INDIANA U MATH J, V63; VOICULESCU D, 1994, INVENT MATH, V118, P411, DOI 10.1007/BF01231539; Voiculescu D, 2002, B LOND MATH SOC, V34, P257, DOI 10.1112/S0024609301008992; Voiculescu D, 1998, INT MATH RES NOTICES, P41	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-3616	1432-0916		COMMUN MATH PHYS	Commun. Math. Phys.	FEB	2015	334	1					275	300		10.1007/s00220-014-2135-5		26	Physics, Mathematical	Physics	CA5AM	WOS:000348919300007		
J	Benini, F; Eager, R; Hori, K; Tachikawa, Y				Benini, Francesco; Eager, Richard; Hori, Kentaro; Tachikawa, Yuji			Elliptic Genera of 2d=2 Gauge Theories	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							MIRROR SYMMETRY; COMPLETE-INTERSECTIONS; CALABI-YAU; MODELS	We compute the elliptic genera of general two-dimensional and gauge theories. We find that the elliptic genus is given by the sum of Jeffrey-Kirwan residues of a meromorphic form, representing the one-loop determinant of fields, on the moduli space of flat connections on T (2). We give several examples illustrating our formula, with both Abelian and non-Abelian gauge groups, and discuss some dualities for U(k) and SU(k) theories. This paper is a sequel to the authors' previous paper (Benini et al., Lett Math Phys 104:465-493, 2014).	[Benini, Francesco] SUNY Stony Brook, Simons Ctr Geometry & Phys, Stony Brook, NY 11794 USA; [Eager, Richard; Hori, Kentaro] Univ Tokyo, Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Tachikawa, Yuji] Univ Tokyo, Dept Phys, Fac Sci, Bunkyo Ku, Tokyo 1330022, Japan	Benini, F (reprint author), SUNY Stony Brook, Simons Ctr Geometry & Phys, Stony Brook, NY 11794 USA.	fra.benini@gmail.com			NSF [1066293]; DOE [DE-FG02-92ER-40697]; JSPS [21340109, 25870159]; WPI Initiative, MEXT, Japan at IPMU, the University of Tokyo	RE and YT thank the Aspen Center for Physics for hospitality while the manuscript was finalized and were partially supported by the NSF Grant #1066293 during their visit there. FB's work is supported in part by DOE Grant DE-FG02-92ER-40697. KH's work is supported in part by JSPS Grant-in-Aid for Scientific Research No. 21340109. YT's work is supported in part by JSPS Grant-in-Aid for Scientific Research No. 25870159. RE, KH, YT are also supported in part by WPI Initiative, MEXT, Japan at IPMU, the University of Tokyo.	WITTEN E, 1993, NUCL PHYS B, V403, P159, DOI 10.1016/0550-3213(93)90033-L; KAWAI T, 1994, NUCL PHYS B, V414, P191, DOI 10.1016/0550-3213(94)90428-6; EGUCHI T, 1989, NUCL PHYS B, V315, P193, DOI 10.1016/0550-3213(89)90454-9; Benini F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.061601; MORRISON DR, 1995, NUCL PHYS B, V440, P279, DOI 10.1016/0550-3213(95)00061-V; Ma XG, 2005, INT J MATH, V16, P1131, DOI 10.1142/S0129167X05003259; Guo S, 2011, INT J MATH, V22, P695, DOI 10.1142/S0129167X11007008; DISTLER J, 1994, NUCL PHYS B, V413, P213, DOI 10.1016/0550-3213(94)90619-X; Szenes A, 2004, INVENT MATH, V158, P453, DOI 10.1007/s00222-004-0375-2; JEFFREY LC, 1995, TOPOLOGY, V34, P291, DOI 10.1016/0040-9383(94)00028-J; SEIBERG N, 1995, NUCL PHYS B, V435, P129, DOI 10.1016/0550-3213(94)00023-8; CANDELAS P, 1994, NUCL PHYS B, V416, P481, DOI 10.1016/0550-3213(94)90322-0; WITTEN E, 1994, INT J MOD PHYS A, V9, P4783, DOI 10.1142/S0217751X9400193X; KAWAI T, 1994, NUCL PHYS B, V425, P191, DOI 10.1016/0550-3213(94)90178-3; Hori K, 2007, J HIGH ENERGY PHYS; Batyrev VV, 1998, NUCL PHYS B, V514, P640, DOI 10.1016/S0550-3213(98)00020-0; Brion M, 1999, ANN SCI ECOLE NORM S, V32, P715, DOI 10.1016/S0012-9593(01)80005-7; Benini F, 2014, LETT MATH PHYS, V104, P465, DOI 10.1007/s11005-013-0673-y; Benini F., 2011, JHEP, V1110; Benini F., 2013, JHEP, V1306; Benini F., COMMUN MATH PHYS; Doroud N., 2013, J HIGH ENERGY PHYS, V1305; Gadde A., 2014, JHEP, V1403, P080; Gadde A., ARXIV13064320HEPTH; Gadde A., 2014, J HIGH ENERGY PHYS, V1405; Gorbounov V., 2008, J TOPOL, V1, P424; Gorbounov V., 2004, MOSC MATH J, V4, P724; Grassi P.A., ARXIVHEPTH0702044; Hori K, 2013, JHEP, V1310, P121; Jockers H, 2014, COMMUN MATH PHYS, V325, P1139, DOI 10.1007/s00220-013-1874-z; Jockers H., 2012, JHEP, V1211, P166; Orkik P., 1992, GRUNDLEHREN MATH WIS, V300; Rodland EA, 2000, COMPOS MATH, V122, P135, DOI 10.1023/A:1001847914402; Witten E., 1992, Journal of Geometry and Physics, V9, DOI 10.1016/0393-0440(92)90034-X	34	18	18	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-3616	1432-0916		COMMUN MATH PHYS	Commun. Math. Phys.	FEB	2015	333	3					1241	1286		10.1007/s00220-014-2210-y		46	Physics, Mathematical	Physics	AZ6BK	WOS:000348303100005		
J	Yukimoto, Y; Matsuzaki, R; Todoroki, A				Yukimoto, Yoshikazu; Matsuzaki, Ryosuke; Todoroki, Akira			Effects of mixed-mode ratio and step-shaped micro pattern surface on crack-propagation resistance of carbon-fiber-reinforced plastic/adhesive interface	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Adhesion; Fracture toughness; Microstructure; Surface treatments	DELAMINATION FRACTURE-TOUGHNESS; STRUCTURAL ADHESIVE JOINTS; PULTRUDED GFRP JOINTS; FAILURE CRITERIA; COMPOSITE-MATERIALS; ENHANCEMENT; STRENGTH; IMPRINT; ENERGY; EPOXY	This study investigated the effects of the mixed-mode ratio of applied loads (G(II)/G) and aspect ratio A of step-shaped micro patterns on the crack-propagation resistance of a carbon-fiber-reinforced plastic (CFRP)/adhesive interface fabricated by in-mold surface modification. Experiments showed that the fracture behaviors change and that the apparent mixed mode fracture toughness G(c) increases with G(II)/G and A. We used the Benzeggagh-Kenane (B-K) failure criterion for the mixed-mode fracture toughness considering the transition of the failure mode of the step-shaped micro patterns. The B-K criterion agreed well with the improvement of G(c) due to an increase in G(II)/G for various fixed values of A. We clarified the relationship between the aspect ratio A and the parameter eta, which is required to describe the B-K criterion, and therefore, eta can be estimated from A. Consequently, it was verified that G(c) of the CFRP/adhesive interface with step-shaped micro patterns can be predicted for arbitrary G(II)/G and A values by substituting the eta-A relationship in the B-K criterion. (C) 2014 Elsevier Ltd. All rights reserved.	[Yukimoto, Yoshikazu; Matsuzaki, Ryosuke] Tokyo Univ Sci, Dept Mech Engn, Noda, Chiba 2788510, Japan; [Todoroki, Akira] Tokyo Inst Technol, Dept Mech Sci & Engn, Meguro Ku, Tokyo 1528552, Japan	Matsuzaki, R (reprint author), Tokyo Univ Sci, Dept Mech Engn, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	rmatsuza@rs.tus.ac.jp					Camanho PP, 2003, J COMPOS MATER, V37, P1415, DOI 10.1177/002199803034505; Shahverdi M, 2014, COMPOS PART A-APPL S, V59, P45, DOI 10.1016/j.compositesa.2013.12.007; Orifici AC, 2008, COMPOS STRUCT, V86, P194, DOI 10.1016/j.compstruct.2008.03.007; Shahverdi M, 2013, COMPOS PART A-APPL S, V54, P46, DOI 10.1016/j.compositesa.2013.06.017; Kenane M, 2011, COMPOS PART B-ENG, V42, P367, DOI 10.1016/j.compositesb.2010.12.019; Nikbakht M, 2009, J MATER SCI, V44, P3428, DOI 10.1007/s10853-009-3456-1; HASHEMI S, 1990, J COMPOS MATER, V24, P918, DOI 10.1177/002199839002400902; [Anonymous], 2011, K7074 JIS; CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851; Ducept F, 2000, INT J ADHES ADHES, V20, P233, DOI 10.1016/S0143-7496(99)00048-2; Shahsavan H, 2011, LANGMUIR, V27, P7732, DOI 10.1021/la200893n; Molitor P, 2001, INT J ADHES ADHES, V21, P129, DOI 10.1016/S0143-7496(00)00044-0; WILLIAMS JG, 1988, INT J FRACTURE, V36, P101, DOI 10.1007/BF00017790; KINLOCH AJ, 1993, COMPOS SCI TECHNOL, V47, P225, DOI 10.1016/0266-3538(93)90031-B; Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85; [Anonymous], 2011, K7086 JIS; Amada S, 1996, SURF COAT TECH, V78, P50, DOI 10.1016/0257-8972(94)02391-3; Kim BW, 2003, COMPOS SCI TECHNOL, V63, P695, DOI 10.1016/S0266-3538(02)00258-0; Blackman BRK, 2005, ENG FRACT MECH, V72, P877, DOI 10.1016/j.engfracmech.2004.08.007; Kim WS, 2010, INT J ADHES ADHES, V30, P408, DOI 10.1016/j.ijadhadh.2010.05.004; DONALDSON SL, 1985, COMPOSITES, V16, P103, DOI 10.1016/0010-4361(85)90616-0; Balzani C, 2011, INT J ADHES ADHES; Benard Q, 2005, COMPOS PART A-APPL S, V36, P1562, DOI 10.1016/j.compositesa.2005.02.012; Benzeggagh ML, 1996, COMPOS SCI TECHNOL, V56, P439, DOI 10.1016/0266-3538(96)00005-X; Blackman BRK, 1993, COMPOSITES, V25, P332; Blackman BRK, 2003, INT J ADHES ADHES, V23, P293, DOI 10.1016/S0143-7496(03)00047-2; BOATMAN ES, 1988, ENVIRON RES, V45, P242, DOI 10.1016/S0013-9351(88)80050-1; Byskov-Nielsen J, 2010, INT J ADHES ADHES, V30, P485, DOI 10.1016/j.ijadhadh.2010.03.008; Davidson BD, 1996, INT J FRACTURE, V78, P193, DOI 10.1007/BF00034525; Feret V, 2012, APPL COMPOS MATER, V20, P415; Hikosaka Y, 2013, EXPRESS POLYM LETT, V7, P293, DOI 10.3144/expresspolymlett.2013.26; Janarthanan V, 1997, POLYMER, V38, P105, DOI 10.1016/S0032-3861(96)00447-8; Kim WS, 2013, J ADHES SCI TECHNOL, V27, P1625, DOI 10.1080/01694243.2012.747733; Lu YC, 2014, INT J ADHES ADHES, V50, P119, DOI 10.1016/j.ijadhadh.2014.01.021; Mucha P, 2013, APPL PHYS A-MATER, V113, P361, DOI 10.1007/s00339-013-7629-z; Reeder JR, 2012, DAMAGE COMPOS, P5; Suzuki T, 2013, INT J ADHES ADHES, V42, P36, DOI 10.1016/j.ijadhadh.2013.01.008; Whitcomb JD, 1984, TM86301 NASA; Yan XQ, 1991, ENG FRACT MECH, V39, P623, DOI DOI 10.1016/0013-7944(91)90212-J; Yuan H., 2000, STRUCTURAL ENG EARTH, V17, P19; Yukimoto Y, 2014, INT J ADHES ADHES, V50, P191, DOI 10.1016/j.ijadhadh.2014.01.034; YUUKI R, 1994, ENG FRACT MECH, V47, P367	42	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	FEB	2015	69						139	149		10.1016/j.compositesa.2014.11.014		11	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	CA1QB	WOS:000348685700016		
J	Nagai, Y; Ohtake, Y; Suzuki, H				Nagai, Yukie; Ohtake, Yutaka; Suzuki, Hiromasa			Tomographic surface reconstruction from point cloud	COMPUTERS & GRAPHICS-UK			English	Article						Surface reconstruction; Point cloud; Surface mesh; Volume data; Computed tomography	REPRESENTATION	Inspired by computed tomography (Cr), this paper presents a novel surface reconstruction algorithm, tomographic surface reconstruction, to reconstruct a surface mesh from a point cloud equipped with oriented normals. In the process of scanning a real object using an X-ray CT system, it generates a sinogram consisting of projection images that are maps of X-ray transmission lengths, and then, a tomogram (Cr volume) is reconstructed from the sinogram. A hole-free surface mesh is then easily obtained by polygonizing an isosurface. To adopt this CT paradigm to surface reconstruction from a point cloud, only a scheme to generate a sinogram from a point cloud is required. The value of a sinogram for surface reconstruction can be defined as the sum of the distances between the intersecting points of a ray and the underlying surface, which are defined as the maxima of the point density. While ordinary Cr scanning uses projection directions which share a single rotation axis, tomographic surface reconstruction adopts randomly selected projection directions and successfully improved the reconstruction robustness. By applying an iterative CT reconstruction to the sinogram, the algorithm generates a tomogram whose boundary between the foreground and background approximates the surface of the object. The effectiveness for a point cloud with a lack of sampling and outliers is demonstrated from experimental results. (C) 2014 Elsevier Ltd. All rights reserved.	[Nagai, Yukie; Ohtake, Yutaka; Suzuki, Hiromasa] Univ Tokyo, Tokyo 1138654, Japan	Nagai, Y (reprint author), Univ Tokyo, Tokyo 1138654, Japan.	yukie@den.t.u-tokyo.ac.jp					Alexa M., 2001, P IEEE VISUALIZATION, V537, P21; Amenta N, 2001, P 6 ACM S SOL MOD AP, P249, DOI DOI 10.1145/376957.376986]; Amenta N., 1998, P 25 ANN C COMP GRAP, V32, P415; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Bernardini F, 1999, IEEE T VIS COMPUT GR, V5, P349, DOI 10.1109/2945.817351; Carr JC, 2001, COMP GRAPH, P67; BOISSONNAT JD, 1984, ACM T GRAPHIC, V3, P266, DOI 10.1145/357346.357349; Calakli F, 2011, COMPUT GRAPH FORUM, V30, P1993, DOI 10.1111/j.1467-8659.2011.02058.x; HOPPE H, 1992, COMP GRAPH, V26, P71; Ohtake Y, 2003, ACM T GRAPHIC, V22, P463, DOI 10.1145/882262.882293; Ju T, 2002, ACM T GRAPHIC, V21, P339; BERGER M., 2014, EUROGRAPHICS STAR, P165; Berger M, 2013, ACM T GRAPHIC, V32, P1; Curless B., 1996, ACM T GRAPHIC, V30, P303; DEY T. K., 2003, P 8 ACM S SOL MOD AP, P127; Dey T. K., 2006, CURVE SURFACE RECONS; Dey TK, 2006, COMP GEOM-THEOR APPL, V35, P124, DOI 10.1016/j.comgeo.2005.10.006; Fuhrmann S, 2014, ACM T GRAPHIC, V33; Guennebaud G, 2007, ACM T GRAPHIC, V26, DOI [10.1145/1276377.1276406, 10.1145/1239451.1239474]; Hornung A, 2006, SGP 06, P41; Hsieh J., 2003, COMPUTED TOMOGRAPHY; HUANG H, 2009, DYN SURF WAV COAST, P1; Hudson M., 1994, IEEE T MED IMAGING, V13, P601, DOI DOI 10.1109/42.363108; Ihrke I, 2006, GRAPH MODELS, V68, P484, DOI 10.1016/j.gmod.2006.08.001; Kazhdan M, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2487228.2487237; Lorensen W. E., 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422; Manson J, 2008, COMPUT GRAPH FORUM, V27, P1411, DOI 10.1111/j.1467-8659.2008.01281.x; Newcombe R. A., 2011, P 10 IEEE INT S MIX, P127, DOI DOI 10.1109/ISMAR.2011.6092378; Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0097-8493	1873-7684		COMPUT GRAPH-UK	Comput. Graph.-UK	FEB	2015	46				SI		55	63		10.1016/j.cag.2014.09.034		9	Computer Science, Software Engineering	Computer Science	CA2OZ	WOS:000348748700007		
J	Nakamura, T				Nakamura, Takashi			The action of looking at a mobile phone display as nonverbal behavior/communication: A theoretical perspective	COMPUTERS IN HUMAN BEHAVIOR			English	Article						Mobile phone; Smartphone; Nonverbal behavior; Nonverbal communication; Power of sight; Goffman	GRATIFICATIONS; STUDENTS	This study investigates the now-common action of looking at a mobile phone display, thereby offering insight into the present communication situation in an era in which the use of high-performance mobile phones has become ubiquitous. In this study, the action of looking at a mobile phone display is considered nonverbal behavior/communication. This study applies a basic, general model to elucidate the present situation of face-to-face communication in light of the increasing prevalence of social interaction via mobile phone use. The results derived from the model include mobile phone users' increasing social power and an accumulation of potential discontent in relation to different interpretations. This study concludes that in an era of high-performance mobile phones, the social context in face-to-face communication can be influenced by the act of looking at a mobile phone display. (C) 2014 The Author. Published by Elsevier Ltd.	Niigata Univ, Fac Humanities, Nishi Ku, Niigata, Japan	Nakamura, T (reprint author), Niigata Univ, Fac Humanities, Nishi Ku, Ikarashi 2-8050, Niigata, Japan.	takashi-nakamura@human.niigata-u.ac.jp					Acar A, 2014, CULTURE SOCIAL MEDIA, V1st; Nemme HE, 2010, ACCIDENT ANAL PREV, V42, P1257, DOI 10.1016/j.aap.2010.01.019; ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Chen YF, 2009, INT J HUM-COMPUT ST, V67, P179, DOI 10.1016/j.ijhcs.2008.09.002; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; Burke SC, 2011, COMPUT HUM BEHAV, V27, P1162, DOI 10.1016/j.chb.2010.12.010; BRUNSWIK E, 1955, PSYCHOL REV, V62, P193, DOI 10.1037/h0047470; Fujimoto K, 2005, PERSONAL, PORTABLE, PEDESTRIAN: MOBILE PHONES IN JAPANESE LIFE, P77; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; Pierce T, 2009, COMPUT HUM BEHAV, V25, P1367, DOI 10.1016/j.chb.2009.06.003; Baron NS, 2012, LANG SCI, V34, P13, DOI 10.1016/j.langsci.2011.06.018; Caronia L., 2004, CONVERGENCE, V10, P28, DOI 10.1177/135485650401000204; de Souza e Silva A., 2012, MOBILE INTERFACES PU; Farman J., 2012, MOBILE INTERFACE THE; Foucault M., 1995, DISCIPLINE PUNISH BI; Goffman E, 1959, PRESENTATION SELF EV; Goffman E., 1963, BEHAV PUBLIC PLACES; Grellhesl M, 2012, COMPUT HUM BEHAV, V28, P2175, DOI 10.1016/j.chb.2012.06.024; Hall Edward T, 1966, HIDDEN DIMENSION; Ito M, 2005, PERSONAL, PORTABLE, PEDESTRIAN: MOBILE PHONES IN JAPANESE LIFE, P1; Kato F, 2005, PERSONAL, PORTABLE, PEDESTRIAN: MOBILE PHONES IN JAPANESE LIFE, P301; Knapp M.L., 2013, NONVERBAL COMMUNICAT; Leung L, 2000, JOURNALISM MASS COMM, V77, P308; Ling R., 2008, NEW TECH NEW TIES MO; Ling R., 2009, MOBILE COMMUNICATION; Matsuda Misa, 2008, E ASIAN SCI TECHNOLO, V2, P167, DOI 10.1007/s12280-008-9050-9; Nakamura T., 2013, INFOSOCIONOMICS SOC, V7; Nakamura T., 2009, INFOSOCIONOMICS SOC, V4, P27; Nakamura T., 2010, J JAPAN INFORM CULTU, V17, P11; Nakamura T., 2007, J JAPAN INFORM CULTU, V14, P31; Nakamura T., 2008, J JAPAN INFORM CULTU, V15, P12; Okada T, 2005, PERSONAL, PORTABLE, PEDESTRIAN: MOBILE PHONES IN JAPANESE LIFE, P41; Richmond V. P., 2011, NONVERBAL BEHAV INTE; Shellenbarger S., 2013, WALL STREET J; Turkle S., 2011, ALONE TOGETHER WHY W	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0747-5632	1873-7692		COMPUT HUM BEHAV	Comput. Hum. Behav.	FEB	2015	43						68	75		10.1016/j.chb.2014.10.042		8	Psychology, Multidisciplinary; Psychology, Experimental	Psychology	CA4QM	WOS:000348889700008		
J	Zhang, XG; Wang, J; Zhao, YG; Tang, LP; Xing, F				Zhang, Xiaogang; Wang, Jiao; Zhao, Yangang; Tang, Luping; Xing, Feng			Time-dependent probability assessment for chloride induced corrosion of RC structures using the third-moment method	CONSTRUCTION AND BUILDING MATERIALS			English	Article						Chloride-induced corrosion; The TM method; Stochastic model; Time-dependent probability; RC structures	REINFORCED-CONCRETE STRUCTURES; COVER-CRACKING; DIFFUSION-COEFFICIENT; RELIABILITY-ANALYSIS; STEEL REINFORCEMENT; REBAR CORROSION; INITIATION TIME; SERVICE LIFE; PREDICTION; MODEL	This paper presents the time-dependent probability of chloride-induced corrosion of reinforced concrete (RC) structures in marine environments. By using the third-moment (TM) method with improved analytical solutions, the stochastic models of corrosion initiation of reinforcing steel, along with the consequent surface cracking of concrete cover are proposed. The different effects of various influencing factors (including early-age micro crack or initial defect of concrete, etc.) on the time-dependent probability of corrosion initiation and surface cracking are also discussed. It is shown that the TM method developed in the paper is simpler and more efficient than traditional approaches such as Monte Carlo (MC) in analyzing the corrosion-induced probability. It is also shown that the distribution of influencing factors has little or almost no effect on the failure probability, whereas the mean and the coefficient of variation of basic variables affect it to various extents. Based on the detailed analysis, some conclusions with implications for engineering practice are drawn. (C) 2014 Published by Elsevier Ltd.	[Zhang, Xiaogang; Xing, Feng] Shenzhen Univ, Coll Civil Engn, Guangdong Prov Key Lab Durabil Marine Civil Engn, Shenzhen 518060, Peoples R China; [Zhang, Xiaogang; Tang, Luping] Chalmers, Dept Bldg Mat, S-41296 Gothenburg, Sweden; [Wang, Jiao; Zhao, Yangang] Kanagawa Univ, Dept Architecture & Bldg Engn, Yokohama, Kanagawa 2218686, Japan	Wang, J (reprint author), Kanagawa Univ, Dept Architecture & Bldg Engn, Yokohama, Kanagawa 2218686, Japan.	wangjiao19890219@sina.com			National Natural Science Foundation of China [51278304]; National Basic Research Program (973 Program) of China [2011-CB013604]; Technology Research and Development Program (Basic research project) of Shenzhen, China [JCYJ20120613174456685, JCYJ20130329143859418]	This research was supported by the National Natural Science Foundation of China (51278304), the National Basic Research Program (973 Program) of China (2011-CB013604), and the Technology Research and Development Program (Basic research project) of Shenzhen, China (JCYJ20120613174456685, JCYJ20130329143859418). The supports from these institutions are gratefully acknowledged.	Song HW, 2008, CEMENT CONCRETE COMP, V30, P113, DOI [10.1016/j.cemconcomp.2007.09.005, 10.1016/j.cemeoncomp.2007.09.005]; Jang BS, 2010, CEMENT CONCRETE RES, V40, P1441, DOI 10.1016/j.cemconres.2010.03.018; Reale T, 2012, CONSTR BUILD MATER, V36, P475, DOI 10.1016/j.conbuildmat.2012.06.033; Lu ZH, 2011, CEMENT CONCRETE RES, V41, P365, DOI 10.1016/j.cemconres.2010.12.003; Lu CH, 2011, CORROS SCI, V53, P1337, DOI 10.1016/j.corsci.2010.12.026; Apostolopoulos CA, 2013, CONSTR BUILD MATER, V38, P139, DOI 10.1016/j.conbuildmat.2012.07.087; Bhargava K, 2006, ENG STRUCT, V28, P1093, DOI 10.1016/j.engstruct.2005.11.014; Al-Harthy AS, 2011, MAG CONCRETE RES, V63, P655, DOI 10.1680/macr.2011.63.9.655; Pour-Ghaz M, 2009, CORROS SCI, V51, P415, DOI 10.1016/j.corsci.2008.10.034; Xu SL, 2008, ENG FRACT MECH, V75, P4292, DOI 10.1016/j.engfracmech.2008.04.022; Zhong JQ, 2010, J ENG MECH-ASCE, V136, P209, DOI 10.1061/(ASCE)EM.1943-7889.0000074; Zhao YX, 2012, CORROS SCI, V59, P316, DOI 10.1016/j.corsci.2012.03.018; Zhao YG, 2001, STRUCT SAF, V23, P47, DOI 10.1016/S0167-4730(00)00027-8; Jamali A, 2013, CONSTR BUILD MATER, V42, P225, DOI 10.1016/j.conbuildmat.2013.01.019; Kwon SJ, 2009, STRUCT SAF, V31, P75, DOI 10.1016/j.strusafe.2008.03.004; Bitaraf M, 2008, CONSTR BUILD MATER, V22, P546, DOI 10.1016/j.conbuildmat.2006.11.005; Zhao YX, 2011, CORROS SCI, V53, P2803, DOI 10.1016/j.corsci.2011.05.017; Rodriguez OG, 2003, ACI MATER J, V100, P120; Li CQ, 2003, J STRUCT ENG-ASCE, V129, P753, DOI 10.1061/(ASCE)0733-9445(2003)129:6(753); Savija B, 2013, CONSTR BUILD MATER, V44, P626, DOI 10.1016/j.conbuildmat.2013.03.063; Liu YP, 1998, ACI MATER J, V95, P675; Djerbi A, 2008, CEMENT CONCRETE RES, V38, P877, DOI 10.1016/j.cemconres.2007.10.007; Pantazopoulou SJ, 2001, J ENG MECH-ASCE, V127, P342, DOI 10.1061/(ASCE)0733-9399(2001)127:4(342); Zhang XG, 2010, J ASIAN ARCHIT BUILD, V9, P439, DOI 10.3130/jaabe.9.439; Bastidas-Arteaga E, 2011, ENG STRUCT, V33, P720, DOI 10.1016/j.engstruct.2010.11.008; Bentz EC, 2003, ACI MATER J, V100, P391; Boulfiza M, 2003, ACI MATER J, V100, P38; Dimitri VV, 2008, RELIAB ENG SYST SAFE, V93, P364; Duprat F, 2007, CONSTR BUILD MATER, V21, P1605, DOI [10.1016/j.conbuildmat.2006.08.002, 10.1016/j.combuildmat.2006.08.002]; Erdogdu S, 2004, CEMENT CONCRETE RES, V34, P603, DOI 10.1016/j.cemconres.2003.09.024; Guzman S, 2011, CEMENT CONCRETE RES, V41, P893, DOI 10.1016/j.cemconres.2011.04.008; Jonata PT, 2002, ACI MATER J, V99, P27; Kim ATV, 2005, J STRUCT ENG-ASCE, V131, P1681; Li CQ, 2011, J ENG MECH-ASCE, V137, P722, DOI 10.1061/(ASCE)EM.1943-7889.0000289; Li CQ, 2005, ACI STRUCT J, V102, P543; Liang MT, 2003, CEMENT CONCRETE RES, V33, P1917, DOI 10.1016/s0008-8846(03)00081-4; Tang LP, 2007, CEMENT CONCRETE RES, V37, P589, DOI 10.1016/j.cemconres.2007.01.006; Malumbela G, 2011, CONSTR BUILD MATER, V25, P987, DOI 10.1016/j.conbuildmat.2010.06.081; Marita LA, 1995, CEMENT CONCRETE RES, V25, P1179; Matsumura T, 2008, NUCL ENG DES, V238, P1181, DOI 10.1016/j.nucengdes.2007.03.032; Soylev TA, 2005, J MATER CIVIL ENG, V17, P447, DOI 10.1061/(ASCE)0899-1561(2005)17:4(447); Tamer EM, 2007, CEMENT CONCRETE COMP, V29, P168; Tang Luping, 2008, Cement and Concrete Research, V38, DOI 10.1016/j.cemconres.2008.03.008; Tang L, 2009, MATER CORROS, V60, P617, DOI 10.1002/maco.200905282; Torres-Acosta AA, 2003, J MATER CIVIL ENG, V15, P344, DOI 10.1061/(ASCE)0899-1561(2003)15:4(344); Wang XG, 2013, CONSTR BUILD MATER, V38, P846, DOI 10.1016/j.conbuildmat.2012.09.060; Weyers RE, 2003, CONCRETE INT, V25, P61; Yiizer N, 2008, CONSTR BUILD MATER, V22, P1100; Zhao YG, 2012, STRUCT INFRASTRUCT E, V8, P517, DOI 10.1080/15732479.2010.539072; Zhao YG, 2000, J STRUCT ENG-ASCE, V126, P724, DOI 10.1061/(ASCE)0733-9445(2000)126:6(724); Zhao YG, 2007, J STRUCT ENG-ASCE, V133, P916, DOI 10.1061/(ASCE)0733-9445(2007)133:7(916)	51	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0950-0618	1879-0526		CONSTR BUILD MATER	Constr. Build. Mater.	FEB 1	2015	76						232	244		10.1016/j.conbuildmat.2014.10.039		13	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CA4MX	WOS:000348879600023		
J	Horita, N; Miyazawa, N; Kojima, R; Inoue, M; Ishigatsubo, Y; Kaneko, T				Horita, Nobuyuki; Miyazawa, Naoki; Kojima, Ryota; Inoue, Miyo; Ishigatsubo, Yoshiaki; Kaneko, Takeshi			Minimum Clinically Important Difference in Diffusing Capacity of the Lungs for Carbon Monoxide Among Patients with Severe and Very Severe Chronic Obstructive Pulmonary Disease	COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE			English	Article						differential threshold; emphysema; respiratory function tests; surgery	MINIMALLY IMPORTANT DIFFERENCES; 6-MINUTE WALK DISTANCE; HEALTH-STATUS; COPD; VARIABILITY; STANDARDIZATION; QUESTIONNAIRE; SPIROMETRY; EXERCISE; OUTCOMES	Background: The minimum clinically important difference (MCID) for diffusing capacity of the lungs for carbon monoxide (DLCO) has not yet been solidly established. Methods: We used the dataset of surgical cohort of National Emphysema Treatment Trial. Briefly, severe and very severe chronic obstructive pulmonary disease (COPD) patients who were candidate for volume reduction surgery and who could provide sufficient data at 12-month follow-up were included. We used two anchor methods using 6-minute walk distance (6MWD. MCID = 40 m) and forced expiratory volume in 1 sec (FEV1. MCID = 100 ml) as anchors, and two distribution methods. We proposed MCID with a median of estimated values. We estimated MCID for DLCO in raw value and % change from the baseline independently. Results: The surgical cohort included 356 patients, whose average age was 66.6 +/- 5.5 years, and the average % predicted FEV 1 was 27.8 +/- 7.3%. The estimated MCID for DLCO in raw value and % change from the baseline were as follows: anchor method (average, 6MWD) 1.2 ml/min/mmHg, 17%; anchor method (average, FEV1) 0.7 ml/min/mmHg, 11%; anchor method (receiver operating characteristic, 6MWD) 1.1 ml/min/mmHg, 10%; anchor method (receiver operating characteristic, FEV1) 1.2 ml/min/mmHg, 3%; distribution method (0.3 units of standard deviation), 0.9 ml/min/mmHg, 11%; distribution method (standard error of measurement), 1.1 ml/min/mmHg. The median of these values was 1.1 ml/min/mmHg and 11%. Conclusion: We estimated the group-level MCID for DLCO for patients with severe and very severe COPD patients as 1.1 ml/min/mmHg and 11% of baseline DLCO.	[Horita, Nobuyuki; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 2360004, Japan; [Horita, Nobuyuki; Miyazawa, Naoki; Kojima, Ryota; Inoue, Miyo] Saiseikai Yokohamashi Nanbu Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan; [Kaneko, Takeshi] Yokohama City Univ, Med Ctr, Resp Dis Ctr, Yokohama, Kanagawa 232, Japan	Horita, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	nobuyuki_horita@yahoo.co.jp					American Thoracic Society, 1987, AM REV RESPIR DIS, V136, P1299; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Puhan MA, 2008, EUR RESPIR J, V32, P637, DOI 10.1183/09031936.00140507; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Yost KJ, 2005, EVAL HEALTH PROF, V28, P172, DOI 10.1177/0163278705275340; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278; Puhan MA, 2011, EUR RESPIR J, V37, P784, DOI 10.1183/09031936.00063810; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371; Coeytaux RR, 2006, J CLIN EPIDEMIOL, V59, P374, DOI 10.1016/j.jclinepi.2005.05.010; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Donohue James F, 2005, COPD, V2, P111; Drummond MB, 2008, AM J RESP CRIT CARE, V178, P22; Hadeli KO, 2001, CHEST, V120, P88, DOI 10.1378/chest.120.1.88; HATHAWAY EH, 1989, AM REV RESPIR DIS, V140, P1818; Hays Ron D, 2005, COPD, V2, P63; Horita N, 2014, COPD, V11, P26, DOI 10.3109/15412555.2013.808615; Jones Paul W, 2005, COPD, V2, P75; Leidy Nancy Kline, 2005, COPD, V2, P157; Punjabi NM, 2003, CHEST, V123, P1082, DOI 10.1378/chest.123.4.1082; Rationale and design of the National Emphysema Treatment Trial (NETT), 1999, J THORAC CARDIOVASC, V118, P518; Redelmeier DA, 1996, CHEST, V109, P1163, DOI 10.1378/chest.109.5.1163; Robson AG, 2001, THORAX, V56, P358, DOI 10.1136/thorax.56.5.358; Saydain G, 2004, CHEST, V125, P446, DOI 10.1378/chest.125.2.446; Wise Robert A, 2005, COPD, V2, P125	30	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1541-2555	1541-2563		COPD	COPD-J. Chronic Obstr. Pulm. Dis.	FEB	2015	12	1					31	37		10.3109/15412555.2014.898051		7	Respiratory System	Respiratory System	CB1BO	WOS:000349361700006		
J	Sakaguchil, R; Kiyonaka, S; Mori, Y				Sakaguchil, Reiko; Kiyonaka, Shigeki; Mori, Yasuo			Fluorescent sensors reveal subcellular thermal changes	CURRENT OPINION IN BIOTECHNOLOGY			English	Review							SINGLE LIVING CELLS; TEMPERATURE-MEASUREMENT; INTRACELLULAR THERMOMETRY; THERMOGENIC MECHANISMS; HEAT-PRODUCTION; BROWN FAT; PROTEIN; NANOTHERMOMETERS; MITOCHONDRIA; SALMONELLA	In mammals and birds, thermoregulation to conserve body temperature is vital to life. Multiple mechanisms of thermogeneration have been proposed, localized in different subcellular organelles. However, studying thermogenesis directly in intact organelles has been challenging. Visualizing patterns of thermal changes at subcellular resolution would reveal physiologically relevant spatio-temporal information, especially if this could be done in the native cellular configuration of the cell. Here we review and compare the wide variety of intracellular thermosensors currently identified. This review focuses particularly on genetically encoded sensors. It also explores the notable physiological discoveries made using these imaging methods, which are rapidly becoming indispensible to the study of thermal biology.	[Sakaguchil, Reiko; Mori, Yasuo] Kyoto Univ, World Premier Int Res Initiat, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Dept Technol & Ecol, Kyoto 6158510, Japan	Mori, Y (reprint author), Kyoto Univ, World Premier Int Res Initiat, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan.	mori@sbchem.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	TERADA H, 1981, BIOCHIM BIOPHYS ACTA, V639, P225, DOI 10.1016/0304-4173(81)90011-2; Takei Y, 2014, ACS NANO, V8, P198, DOI 10.1021/nn405456e; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Donner JS, 2012, NANO LETT, V12, P2107, DOI 10.1021/nl300389y; Yang JM, 2011, ACS NANO, V5, P5067, DOI 10.1021/nn201142f; Kiyonaka S, 2013, NAT METHODS, V10, P1232, DOI [10.1038/nmeth.2690, 10.1038/NMETH.2690]; Schroder HJ, 1997, EXP PHYSIOL, V82, P403; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Oyama K, 2012, LAB CHIP, V12, P1591, DOI 10.1039/c2lc00014h; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Donner JS, 2013, ACS NANO, V7, P8666, DOI 10.1021/nn403659n; Vetrone F, 2010, ACS NANO, V4, P3254, DOI 10.1021/nn100244a; Maestro LM, 2010, NANO LETT, V10, P5109, DOI 10.1021/nl1036098; Shang L, 2013, ANGEW CHEM INT EDIT, V52, P11154, DOI 10.1002/anie.201306366; Arruda AP, 2008, ENDOCRINOLOGY, V149, P6262, DOI 10.1210/en.2008-0564; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Hilderbrand SA, 2009, CHEM COMMUN, P4188, DOI 10.1039/b905927j; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Zohar O, 1998, BIOPHYS J, V74, P82; Tsuji T, 2013, ANAL CHEM, V85, P9815, DOI 10.1021/ac402128f; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; VanEngelenburg SB, 2008, CURR OPIN CHEM BIOL, V12, P60, DOI 10.1016/j.cbpa.2008.01.020; CHAPMAN CF, 1995, PHOTOCHEM PHOTOBIOL, V62, P416, DOI 10.1111/j.1751-1097.1995.tb02362.x; De Angelis DA, 1998, P NATL ACAD SCI USA, V95, P12312, DOI 10.1073/pnas.95.21.12312; Gota C, 2009, J AM CHEM SOC, V131, P2766, DOI 10.1021/ja807714j; Hurme R, 1996, J BIOL CHEM, V271, P12626; Hurme R, 1997, CELL, V90, P55, DOI 10.1016/S0092-8674(00)80313-X; Inomata N, 2012, APPL PHYS LETT, V100; KOSKI P, 1992, J BIOL CHEM, V267, P12258; McCabe KM, 2011, APPL ENVIRON MICROB, V77, P2863, DOI 10.1128/AEM.01915-10; Meis L, 2005, BIOSCIENCE REP, V25, P181, DOI 10.1007/s10540-005-2884-7; Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714; Paulik MA, 1998, PHARMACEUT RES, V15, P944, DOI 10.1023/A:1011993019385; Suzuki M, 2007, BIOPHYS J, V92, pL46, DOI 10.1529/biophysj.106.098673; Yap SV, 2008, APPL OPTICS, V47, P4895, DOI 10.1364/AO.47.004895; Zeeb V, 2004, J NEUROSCI METH, V139, P69, DOI 10.1016/j.jneumeth.2004.04.010	40	3	3	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0958-1669	1879-0429		CURR OPIN BIOTECH	Curr. Opin. Biotechnol.	FEB	2015	31						57	64		10.1016/j.copbio.2014.07.013		8	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CA5PL	WOS:000348960200009		
J	Uchikawa, S; Yoda, M; Tohmonda, T; Kanaji, A; Matsumoto, M; Toyama, Y; Horiuchi, K				Uchikawa, Shinichi; Yoda, Masaki; Tohmonda, Takahide; Kanaji, Arihiko; Matsumoto, Mono; Toyama, Yoshiaki; Horiuchi, Keisuke			ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface	CYTOKINE			English	Article						ADAM17/TACE; IL-1 receptors; Ectodomain shedding	ALPHA-CONVERTING-ENZYME; NECROSIS-FACTOR-ALPHA; CUTTING EDGE; II RECEPTOR; INTERLEUKIN-1 FAMILY; ACCESSORY PROTEIN; DECOY RECEPTOR; INFLAMMATION; METALLOPROTEINASE; DISINTEGRIN	Interleukin (IL)-1 is one of the most evolutionarily conserved cytokines and plays an essential role in the regulation of innate immunity. IL-1 binds to two different receptors, IL-1R1 and IL-1R2, which share approximately 28% amino acid homology. IL-1R1 contains a cytoplasmic domain and is capable of transducing cellular signals; by contrast, IL-1R2 lacks a functional cytoplasmic domain and serves as a decoy receptor for IL-1. Interestingly, IL-1R2 is proteolytically cleaved and also functions as a soluble receptor that blocks IL-1 activity. In the present study, we examined the shedding properties of IL-1R2 and demonstrate that ADAM17 is de facto the major sheddase for IL-1R2 and that introducing a mutation into the juxta-membrane domain of IL-1R2 significantly desensitizes IL-1R2 to proteolytic cleavage. IL-1R1 was almost insensitive to ADAM17-dependent cleavage; however, the replacement of the juxta-membrane domain of IL-R1 with that of IL-1R2 significantly increased the sensitivity of IL-1R1 to shedding. Furthermore, we demonstrate that ADAM17 indirectly enhances IL-1 signaling in a cell-autonomous manner by selectively cleaving IL-1R2. Taken together, the data collected in the present study indicate that ADAM17 affects sensitivity to IL-1 by changing the balance between IL-1R1 and the decoy receptor IL-1R2. (C) 2014 Elsevier Ltd. All rights reserved.	[Uchikawa, Shinichi; Kanaji, Arihiko; Matsumoto, Mono; Toyama, Yoshiaki; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Yoda, Masaki; Tohmonda, Takahide; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Antiaging Orthoped Res, Shinjuku Ku, Tokyo 1608582, Japan	Horiuchi, K (reprint author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	shine1@yahoo.co.jp; yoda@a2.keio.jp; tohmonda@z7.keio.jp; hikokanaji@gmail.com; morio@a5.keio.jp; toyama@z6.keio.jp; horiuchi@z3.keio.jp			Nakatomi Foundation; Keio University Kanrinmaru Project; MEXT KAKENHI [24390358]; Japanese Ministry of Health, Labor, and Welfare [H23-Nanchi-Ippan-032]	The authors thank Shizue Yamanashi, Kaori Sue, and Mayumi Ito for their excellent technical assistance. This work was supported in part by the Nakatomi Foundation, Keio University Kanrinmaru Project, MEXT KAKENHI (24390358 (to K. Horiuchi)) and by a grant from the Japanese Ministry of Health, Labor, and Welfare (H23-Nanchi-Ippan-032 (to M. Matsumoto)).	Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Lorenzen I, 2012, FEBS LETT, V586, P1093, DOI 10.1016/j.febslet.2012.03.012; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Briso EM, 2008, J IMMUNOL, V180, P7102; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Horiuchi K, 2007, J IMMUNOL, V179, P2686; Rauschmayr T, 1997, P NATL ACAD SCI USA, V94, P5814, DOI 10.1073/pnas.94.11.5814; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Neumann D, 2000, J IMMUNOL, V165, P3350; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Re F, 1996, J EXP MED, V183, P1841, DOI 10.1084/jem.183.4.1841; Cullinan EB, 1998, J IMMUNOL, V161, P5614; RE F, 1994, J EXP MED, V179, P739, DOI 10.1084/jem.179.2.739; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Lang D, 1998, J IMMUNOL, V161, P6871; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Martin P, 2013, J LEUKOCYTE BIOL, V94, P791, DOI 10.1189/jlb.0113035; Yoda M, 2011, BLOOD, V118, P6939, DOI 10.1182/blood-2011-06-357210; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; SYMONS JA, 1995, P NATL ACAD SCI USA, V92, P1714, DOI 10.1073/pnas.92.5.1714; Horiuchi K, 2009, J IMMUNOL, V182, P7408, DOI 10.4049/jimmunol.0801931; Horiuchi Keisuke, 2013, Keio Journal of Medicine, V62, P29, DOI 10.2302/kjm.2012-0003-RE; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Orlando S, 2000, CYTOKINE, V12, P1001, DOI 10.1006/cyto.1999.0601; Orlando S, 1997, J BIOL CHEM, V272, P31764, DOI 10.1074/jbc.272.50.31764; Solomon KA, 1999, J IMMUNOL, V163, P4105; Weber A, 2010, SCI SIGNA, V3, pcm1; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	42	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	FEB	2015	71	2					238	245		10.1016/j.cyto.2014.10.032		8	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CA6YJ	WOS:000349063500016		
J	Fox, JC; Nakayama, T; Tyler, RC; Sander, TL; Yoshie, O; Volkman, BF				Fox, Jamie C.; Nakayama, Takashi; Tyler, Robert C.; Sander, Tara L.; Yoshie, Osamu; Volkman, Brian F.			Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily	CYTOKINE			English	Article						XCL2; XCL1; Lymphotactin; Chemotaxis; Ca2+ flux	NATURAL-KILLER-CELLS; HUMAN LYMPHOTACTIN; DENDRITIC CELLS; T-CELL; MOLECULAR-CLONING; OVARIAN-CARCINOMA; ALIGNMENT EDITOR; CXC-CHEMOKINES; EXPRESSION; PROTEIN	Known for its unusual metamorphic native state structure, XCL1 has been the focus of most efforts to elucidate the structural, functional, and physiological properties of chemokines in the C subfamily. By comparison, its closely related paralog XCL2 remains virtually uncharacterized. Based on the importance of the chemokine N-terminus in receptor activation, it was hypothesized that two amino acid differences in XCL2 would alter its agonist activity relative to XCL1 for their shared receptor XCR1. This present study reveals several properties of XCL2 that were unexamined until now. Structurally, XCL1 and XCL2 are very similar, exchanging between the monomeric chemokine fold and an unrelated dimeric state under physiological NaCl and temperature conditions. Ca2+ flux, chemotaxis, and heparin binding assays showed that the monomer form of XCL2 is responsible for G protein-coupled receptor activation while the dimeric form is important for GAG binding. Despite their high structural similarity, XCL2 displays a slightly higher affinity for heparin than XCL1. Because their in vitro functional profiles are virtually identical, distinct physiological roles for XCL1 and XCL2 are probably encoded at the level of expression. (C) 2014 Elsevier Ltd. All rights reserved.	[Fox, Jamie C.; Tyler, Robert C.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Nakayama, Takashi] Kinki Univ, Fac Pharm, Div Chemotherapy, Higashiosaka, Osaka 5778502, Japan; [Sander, Tara L.] Med Coll Wisconsin, Dept Pediat Pathol, Milwaukee, WI 53226 USA; [Yoshie, Osamu] Kinki Univ, Fac Med, Osaka 589851, Japan	Volkman, BF (reprint author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	bvolkman@mcw.edu			NIH [AI013325, AI058072]	Funding (NIH Grants AI013325 and AI058072); we thank Evgenii Kovrigin for assistance with MATLAB data analysis.	Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Menkin V, 1937, AM J PATHOL, V13, P25; Yoshida T, 1998, J BIOL CHEM, V273, P16551, DOI 10.1074/jbc.273.26.16551; Xu L, 2000, CANCER RES, V60, P4610; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; MULLER S, 1995, EUR J IMMUNOL, V25, P1744, DOI 10.1002/eji.1830250638; Yoshida T, 1996, FEBS LETT, V395, P82, DOI 10.1016/0014-5793(96)01004-6; Huising MO, 2003, TRENDS IMMUNOL, V24, P307, DOI 10.1016/S1471-4906(03)00120-0; Luster AD, 1998, NEW ENGL J MED, V338, P436; Hamel DJ, 2009, METHOD ENZYMOL, V461, P71, DOI 10.1016/S0076-6879(09)05404-4; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; YOSHIDA T, 1995, FEBS LETT, V360, P155, DOI 10.1016/0014-5793(95)00093-O; Dorner B, 1997, J BIOL CHEM, V272, P8817; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Peterson FC, 2004, J BIOL CHEM, V279, P12598, DOI 10.1074/jbc.M311633200; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/008-5472.CAN-06-0983; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Tuinstra RL, 2007, BIOCHEMISTRY-US, V46, P2564, DOI 10.1021/bi602365d; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Kuloglu ES, 2001, BIOCHEMISTRY-US, V40, P12486, DOI 10.1021/bi011106p; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Zimmerman JW, 2012, BRIT J CANCER, V106, P307, DOI 10.1038/bjc.2011.523; Shan LX, 2000, BIOCHEM BIOPH RES CO, V268, P938, DOI 10.1006/bbrc.2000.2235; Baoprasertkul P, 2005, MOL IMMUNOL, V42, P1355, DOI 10.1016/j.molimm.2004.12.012; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Loos T, 2008, BLOOD, V112, P2648, DOI 10.1182/blood-2008-04-149039; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Tyler RC, 2012, BIOCHEMISTRY-US, V51, P9067, DOI 10.1021/bi300842j; Ihrcke NS, 1998, J CELL PHYSIOL, V175, P255, DOI 10.1002/(SICI)1097-4652(199806)175:3<255::AID-JCP3>3.0.CO;2-N; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; Lambeir AM, 2001, FEBS LETT, V507, P327, DOI 10.1016/S0014-5793(01)02982-9; Kuloglu ES, 2002, J BIOL CHEM, V277, P17863, DOI 10.1074/jbc.M200402200; Bartels C., 1995, J BIOMOL NMR, V5, P1; Calabrese EJ, 2001, CRIT REV TOXICOL, V31, P615, DOI 10.1080/20014091111875; Cao W, 2008, CURR MICROBIOL, V57, P189, DOI 10.1007/s00284-008-9172-2; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dong C, 2005, J IMMUNOL METHODS, V302, P136, DOI 10.1016/j.jim.2005.05.008; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Giancarlo B, 1996, EUR J IMMUNOL, V26, P3238, DOI 10.1002/eji.1830261260; Hennemann B, 1999, DNA CELL BIOL, V18, P565, DOI 10.1089/104454999315114; Keller R, 2004, COMPUTER AIDED RESON; KENNEDY J, 1995, J IMMUNOL, V155, P203; Kiaii S, 2013, CANCER IMMUNOL IMMUN, V62, P51, DOI 10.1007/s00262-012-1300-y; Kim M, 2012, MOL CANCER RES, V10, P1419, DOI 10.1158/1541-7786.MCR-12-0361; Lei Y, 2011, MICROBES INFECT; Hughes T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-213; Marcaurelle LA, 2001, CHEM-EUR J, V7, P1129, DOI 10.1002/1521-3765(20010302)7:5<1129::AID-CHEM1129>3.0.CO;2-W; Ogata R, 2011, PERITON DIALYSIS INT, V31, P80, DOI 10.3747/pdi.2009.00159; Shirley B A, 1995, Methods Mol Biol, V40, P177; Wang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-225; Yamazaki C, 2010, BIOCHEM BIOPH RES CO, V397, P756, DOI 10.1016/j.bbrc.2010.06.029; Yoshida T, 1999, J IMMUNOL, V163, P3295	61	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	FEB	2015	71	2					302	311		10.1016/j.cyto.2014.11.010		10	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	CA6YJ	WOS:000349063500026		
J	Tsuneki, H; Tokai, E; Nakamura, Y; Takahashi, K; Fujita, M; Asaoka, T; Kon, K; Anzawa, Y; Wada, T; Takasaki, I; Kimura, K; Inoue, H; Yanagisawa, M; Sakurai, T; Sasaoka, T				Tsuneki, Hiroshi; Tokai, Emi; Nakamura, Yuya; Takahashi, Keisuke; Fujita, Mikio; Asaoka, Takehiro; Kon, Kanta; Anzawa, Yuuki; Wada, Tsutomu; Takasaki, Ichiro; Kimura, Kumi; Inoue, Hiroshi; Yanagisawa, Masashi; Sakurai, Takeshi; Sasaoka, Toshiyasu			Hypothalamic Orexin Prevents Hepatic Insulin Resistance via Daily Bidirectional Regulation of Autonomic Nervous System in Mice	DIABETES			English	Article							ENDOPLASMIC-RETICULUM STRESS; HIGH-FAT DIET; CIRCADIAN-RHYTHMS; GLUCOSE-HOMEOSTASIS; METABOLIC DISEASES; DIABETES-MELLITUS; ENERGY-METABOLISM; KNOCKOUT MICE; MOUSE-LIVER; RAT-BRAIN	Circadian rhythm is crucial for preventing hepatic insulin resistance, although the mechanism remains uncovered. Here we report that the wake-active hypothalamic orexin system plays a key role in this regulation. Wildtype mice showed that a daily rhythm in blood glucose levels peaked at the awake period; however, the glucose rhythm disappeared in orexin knockout mice despite normal feeding rhythm. Central administration of orexin A during nighttime awake period acutely elevated blood glucose levels but subsequently lowered daytime glucose levels in normal and diabetic db/db mice. The glucose-elevating and -lowering effects of orexin A were suppressed by adrenergic antagonists and hepatic para-sympathectomy, respectively. Moreover, the expression levels of hepatic gluconeogenic genes, including Pepck, were increased and decreased by orexin A at nanomolar and femtomolar doses, respectively. These results indicate that orexin can bidirectionally regulate hepatic gluconeogenesis via control of autonomic balance, leading to generation of the daily blood glucose oscillation. Furthermore, during aging, orexin deficiency enhanced endoplasmic reticulum (ER) stress in the liver and caused impairment of hepatic insulin signaling and abnormal gluconeogenic activity in pyruvate tolerance test. Collectively, the daily glucose rhythm under control of orexin 459 appears to be important for maintaining ER homeostasis, thereby preventing insulin resistance in the liver.	[Tsuneki, Hiroshi; Tokai, Emi; Nakamura, Yuya; Takahashi, Keisuke; Fujita, Mikio; Asaoka, Takehiro; Kon, Kanta; Anzawa, Yuuki; Wada, Tsutomu; Sasaoka, Toshiyasu] Toyama Univ, Dept Clin Pharmacol, Toyama 930, Japan; [Takasaki, Ichiro] Toyama Univ, Div Mol Genet Res, Toyama 930, Japan; [Kimura, Kumi; Inoue, Hiroshi] Kanazawa Univ, Frontier Sci Org, Kanazawa, Ishikawa, Japan; [Yanagisawa, Masashi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Sakurai, Takeshi] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa, Japan	Tsuneki, H (reprint author), Toyama Univ, Dept Clin Pharmacol, Toyama 930, Japan.	htsuneki@pha.u-toyama.ac.jp; tsasaoka@pha.u-toyama.ac.jp			Japan Society for the Promotion of Science [24591317, 24390056]; Takeda Science Foundation; Smoking Research Foundation; Research Foundation for Pharmaceutical Sciences; Japan Diabetes Foundation; Foundation for Growth Science; Tamura Science and Technology Foundation	This work was supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) grants 24591317 and 24390056 and grants from the Takeda Science Foundation (H.T.), the Smoking Research Foundation (H.T.), the Research Foundation for Pharmaceutical Sciences (H.T.), the Japan Diabetes Foundation (T.S.), the Foundation for Growth Science (T.S.), and the Tamura Science and Technology Foundation (T.S.).	Yonezawa R, 2012, AM J PHYSIOL-ENDOC M, V303, pE445, DOI 10.1152/ajpendo.00638.2011; Kalsbeek A, 2011, ESSAYS BIOCHEM, V49, P137, DOI 10.1042/BSE0480137; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Zhang SW, 2004, SLEEP, V27, P619; Zeitzer JM, 2003, J NEUROSCI, V23, P3555; Cretenet G, 2010, CELL METAB, V11, P47, DOI 10.1016/j.cmet.2009.11.002; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Mieda M, 2011, J NEUROSCI, V31, P6518, DOI 10.1523/JNEUROSCI.6506-10.2011; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Yi CX, 2009, DIABETES, V58, P1998, DOI 10.2337/db09-0385; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; van den Top M, 2003, J PHYSIOL-LONDON, V549, P809, DOI 10.1113/jphysiol.2002.033290; Hwang LL, 2001, J PHYSIOL-LONDON, V537, P511, DOI 10.1111/j.1469-7793.2001.00511.x; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Chou TC, 2003, J NEUROSCI, V23, P10691; Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449; Tsuneki H, 2012, ENDOCR J, V59, P365, DOI 10.1507/endocrj.EJ12-0030; Goncalves ACD, 2009, HYPERTENSION, V53, P387, DOI 10.1161/HYPERTENSIONAHA.108.124776; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Poli F, 2009, SLEEP, V32, P1491; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Kalsbeek A, 2010, ANN NY ACAD SCI, V1212, P114, DOI 10.1111/j.1749-6632.2010.05800.x; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Coomans CP, 2013, DIABETES, V62, P1102, DOI 10.2337/db12-0507; Boden G, 1996, DIABETES, V45, P1044, DOI 10.2337/diabetes.45.8.1044; Cailotto C, 2008, ENDOCRINOLOGY, V149, P1914, DOI 10.1210/en.2007-0816; Date Y, 2000, NEUROSCI LETT, V288, P87, DOI 10.1016/S0304-3940(00)01195-2; Desarnaud F, 2004, SLEEP, V27, P851; DeVries JH, 2013, DIABETES, V62, P1405, DOI 10.2337/db12-1610; Hiramoto T, 2008, GASTROENTEROLOGY, V134, P2122, DOI 10.1053/j.gastro.2008.03.005; Ikeda O, 2009, J SURG RES, V152, P218, DOI 10.1016/j.jss.2008.02.059; Kalsbeek A, 2010, TRENDS ENDOCRIN MET, V21, P402, DOI 10.1016/j.tem.2010.02.005; Mizuno M, 2008, J PHYSIOL SCI, V58, P381, DOI 10.2170/physiolsci.RP011508; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Takasaki I, 2012, PAIN, V153, P585, DOI 10.1016/j.pain.2011.11.022; Tanida M, 2006, EXP BIOL MED, V231, P1616; Tsuneki H, 2008, DIABETOLOGIA, V51, P657, DOI 10.1007/s00125-008-0929-8; Yamamoto Y, 1999, Brain Res Mol Brain Res, V65, P14	48	2	2	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	FEB	2015	64	2					459	470		10.2337/db14-0695		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CA3ST	WOS:000348827100017		
J	Albers, PH; Pedersen, AJT; Birk, JB; Kristensen, DE; Vind, BF; Baba, O; Nohr, J; Hojlund, K; Wojtaszewski, JFP				Albers, Peter H.; Pedersen, Andreas J. T.; Birk, Jesper B.; Kristensen, Dorte E.; Vind, Birgitte F.; Baba, Otto; Nohr, Jane; Hojlund, Kurt; Wojtaszewski, Jorgen F. P.			Human Muscle Fiber Type-Specific Insulin Signaling: Impact of Obesity and Type 2 Diabetes	DIABETES			English	Article							HUMAN SKELETAL-MUSCLE; OXIDATIVE ENZYME-ACTIVITY; GLYCOGEN-SYNTHASE; GLUCOSE-TRANSPORT; SINGLE FIBERS; MTOR COMPLEX; PHOSPHORYLATION; RESISTANCE; EXERCISE; ACTIVATION	Skeletal muscle is a heterogeneous tissue composed of different fiber types. Studies suggest that insulin-mediated glucose metabolism is different between muscle fiber types. We hypothesized that differences are due to fiber type-specific expression/regulation of insulin signaling elements and/or metabolic enzymes. Pools of type I and II fibers were prepared from biopsies of the vastus lateralis muscles from lean, obese, and type 2 diabetic subjects before and after a hyperinsulinemic-euglycemic clamp. Type I fibers compared with type II fibers have higher protein levels of the insulin receptor, GLUT4, hexokinase II, glycogen synthase (GS), and pyruvate dehydrogenase-El alpha (PDH-E1 alpha) and a lower protein content of Akt2, TBC1 domain family member 4 (TBC1D4), and TBC1D1. In type I fibers compared with type II fibers, the phosphorylation response to insulin was similar (TBC1D4, TBC1D1, and GS) or decreased (Akt and PDH-E1 alpha). Phosphorylation responses to insulin adjusted for protein level were not different between fiber types. Independently of fiber type, insulin signaling was similar (TBC1D1, GS, and PDH-E1 alpha) or decreased (Akt and TBC1D4) in muscle from patients with type 2 diabetes compared with lean and obese subjects. We conclude that human type I muscle fibers compared with type II fibers have a higher glucose-handling capacity but a similar sensitivity for phosphoregulation by insulin.	[Albers, Peter H.; Birk, Jesper B.; Kristensen, Dorte E.; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, August Krogh Ctr, Dept Nutr Exercise & Sports, Sect Mol Physiol, Copenhagen, Denmark; [Albers, Peter H.; Nohr, Jane] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Pedersen, Andreas J. T.; Vind, Birgitte F.; Hojlund, Kurt] Odense Univ Hosp, Diabet Res Ctr, Dept Endocrinol, DK-5000 Odense, Denmark; [Baba, Otto] Ohu Univ, Sch Dent, Dept Oral Funct & Mol Biol, Biol Sect, Koriyama, Fukushima, Japan	Wojtaszewski, JFP (reprint author), Univ Copenhagen, August Krogh Ctr, Dept Nutr Exercise & Sports, Sect Mol Physiol, Copenhagen, Denmark.	jwojtaszewski@nexs.ku.dk	Birk, Jesper/D-3523-2015; Kristensen, Dorte/A-4865-2015	Birk, Jesper/0000-0001-9775-4789; Kristensen, Dorte/0000-0002-8857-8100	University of Copenhagen Excellence Program for Interdisciplinary Research; UNIK project Food, Fitness & Pharma for Health and Disease - Danish Ministry of Science, Technology and Innovation; Danish Council for Independent Research Medical Sciences; Novo Nordisk Foundation; European Foundation for the Study of Diabetes	This work was carried out as a part of the research programs "Physical activity and nutrition for improvement of health" funded by the University of Copenhagen Excellence Program for Interdisciplinary Research and the UNIK project Food, Fitness & Pharma for Health and Disease (see www.foodfitnesspharma.ku.dk) supported by the Danish Ministry of Science, Technology and Innovation. This study was funded by the Danish Council for Independent Research Medical Sciences, the Novo Nordisk Foundation, and a Clinical Research Grant from the European Foundation for the Study of Diabetes.	Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Daugaard JR, 2000, DIABETES, V49, P1092, DOI 10.2337/diabetes.49.7.1092; MARETTE A, 1992, AM J PHYSIOL, V263, pC443; DOHM GL, 1988, J CLIN INVEST, V82, P486, DOI 10.1172/JCI113622; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Pendergrass M, 1998, DIABETES, V47, P387, DOI 10.2337/diabetes.47.3.387; Pilegaard H, 2006, DIABETES, V55, P3020, DOI 10.2337/db06-0152; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Stuart CA, 2013, J CLIN ENDOCR METAB, V98, P2027, DOI 10.1210/jc.2012-3876; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; Wojtaszewski JFP, 2000, DIABETES, V49, P325, DOI 10.2337/diabetes.49.3.325; Gaster M, 2001, DIABETES, V50, P1324, DOI 10.2337/diabetes.50.6.1324; Kiilerich K, 2010, AM J PHYSIOL-REG I, V299, pR1350, DOI 10.1152/ajpregu.00400.2010; Kohn TA, 2006, J PHYSIOL SCI, V56, P355, DOI 10.2170/physiolsci.RP007706; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988; Kristensen JM, 2014, DIABETOLOGIA, V57, P1006, DOI 10.1007/s00125-014-3187-y; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; HotherNielsen O, 1996, METABOLISM, V45, P82, DOI 10.1016/S0026-0495(96)90204-8; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; BONEN A, 1981, DIABETES, V30, P702, DOI 10.2337/diabetes.30.8.702; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Daugaard JR, 2004, PFLUG ARCH EUR J PHY, V447, P452, DOI 10.1007/s00424-003-1195-8; DEFRONZO RA, 1981, DIABETES, V30, P1000; Gallagher P, 2005, ACTA PHYSIOL SCAND, V185, P61, DOI 10.1111/j.1365-201X.2005.01457.x; GRIMBY G, 1976, SCAND J REHABIL MED, V8, P37; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Hojlund K, 2009, J CLIN ENDOCR METAB, V94, P4547, DOI 10.1210/jc.2009-0897; JAMES DE, 1985, AM J PHYSIOL, V248, pE567; Jensen TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031054; Jessen N, 2011, AM J PHYSIOL-ENDOC M, V301, pE164, DOI 10.1152/ajpendo.00042.2011; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; MacKrell JG, 2012, DIABETES, V61, P995, DOI 10.2337/db11-1299; MacKrell JG, 2012, J GERONTOL A-BIOL, V67, P1286, DOI 10.1093/gerona/gls194; Murphy RM, 2011, J APPL PHYSIOL, V110, P820, DOI 10.1152/japplphysiol.01082.2010; Nellemann B, 2014, ACTA PHYSIOL, V210, P392, DOI 10.1111/apha.12183; Ng JM, 2014, J CLIN ENDOCR METAB, V99, pE102, DOI 10.1210/jc.2013-2095; PLOUG T, 1987, AM J PHYSIOL, V253, pE12; Poulsen P, 2005, DIABETES, V54, P1289, DOI 10.2337/diabetes.54.5.1289; Prats C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077774; Song XM, 1999, AM J PHYSIOL-REG I, V277, pR1690; Vendelbo MH, 2012, AM J PHYSIOL-ENDOC M, V302, pE190, DOI 10.1152/ajpendo.00207.2011; Vind BF, 2012, DIABETOLOGIA, V55, P1435, DOI 10.1007/s00125-012-2482-8; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4	49	2	2	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	FEB	2015	64	2					485	497		10.2337/db14-0590		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CA3ST	WOS:000348827100019		
J	Suzuki, H; Kayama, Y; Sakamoto, M; Iuchi, H; Shimizu, I; Yoshino, T; Katoh, D; Nagoshi, T; Tojo, K; Minamino, T; Yoshimura, M; Utsunomiya, K				Suzuki, Hirofumi; Kayama, Yosuke; Sakamoto, Masaya; Iuchi, Hiroyuki; Shimizu, Ippei; Yoshino, Takuya; Katoh, Daisuke; Nagoshi, Tomohisa; Tojo, Katsuyoshi; Minamino, Tohru; Yoshimura, Michihiro; Utsunomiya, Kazunori			Arachidonate 12/15-Lipoxygenase-Induced Inflammation and Oxidative Stress Are Involved in the Development of Diabetic Cardiomyopathy	DIABETES			English	Article							NECROSIS-FACTOR-ALPHA; CELL-DEATH; CARDIAC DYSFUNCTION; ANGIOTENSIN-II; 12-LIPOXYGENASE; EXPRESSION; FIBROSIS; MITOCHONDRIA; METABOLISM; HEART	Diabetes affects cardiac structure and function, and it has been suggested that diabetes leads to cardiomyopathy. Arachidonate 12/15-lipoxygenase (LOX) has been suggested to play an important role in atherogenesis and heart failure. However, the role of 12/15-LOX in diabetic cardiomyopathy has not been examined. In this study, we investigated the effects of cardiac 12/15-LOX on diabetic cardiomyopathy. We created streptozotocin (STZ)-induced diabetic mice and compared them with A/ox/5-deficient mice. Expression of 12/15-LOX and inflammatory cytokines such as tumor necrosis factor (TNF)-alpha and nuclear factor (NF)-kappa B were upregulated in STZ-induced diabetic hearts. Disruption of 12/15-LOX significantly improved STZ-induced cardiac dysfunction and fibrosis. Moreover, deletion of 12/15-LOX inhibited the increases of TNF-alpha and NF-kappa B as well as the production of STZ-induced reactive oxygen species in the heart. Administration of N-acetylcysteine in diabetic mice prevented STZ-induced cardiac fibrosis. Neonatal cultured cardiomyocytes exposed to high glucose conditions induced the expression of 12/15-LOX as well as TNF-alpha, NF-kappa B, and collagen markers. These increases were inhibited by treatment of the 12/15-LOX inhibitor. Our results suggest that cardiac 12/15-LOX-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy and that inhibition of 12/15-LOX could be a novel treatment for this condition.	[Suzuki, Hirofumi; Sakamoto, Masaya; Iuchi, Hiroyuki; Tojo, Katsuyoshi; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Div Diabet Metab & Endocrinol, Dept Internal Med,Minato Ku, Tokyo, Japan; [Kayama, Yosuke; Yoshino, Takuya; Katoh, Daisuke; Nagoshi, Tomohisa; Yoshimura, Michihiro] Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol,Minato Ku, Tokyo, Japan; [Shimizu, Ippei; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Chuo Ku, Niigata, Japan; [Minamino, Tohru] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Kayama, Y (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol,Minato Ku, Tokyo, Japan.	kayama@jikei.ac.jp		Minamino, Tohru/0000-0003-1627-6151	Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from Uehara Memorial Foundation (to Y.K.).	Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Wen YS, 2007, ENDOCRINOLOGY, V148, P1313, DOI 10.1210/en.2006-0665; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Bugger H, 2008, DIABETES, V57, P2924, DOI 10.2337/db08-0079; Westermann D, 2007, BASIC RES CARDIOL, V102, P500, DOI 10.1007/s00395-007-0673-0; Shen E, 2009, DIABETES, V58, P2386, DOI 10.2337/db08-0617; He XY, 2011, CIRC RES, V108, P164, DOI 10.1161/CIRCRESAHA.110.234369; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Lebeau A, 2004, CELL DEATH DIFFER, V11, P875, DOI 10.1038/sj.cdd.4401395; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Yigitkanli K, 2013, ANN NEUROL, V73, P129, DOI 10.1002/ana.23734; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Teshima Y, 2014, CIRC J, V78, P300, DOI 10.1253/circj.CJ-13-1187; Levick SP, 2007, J IMMUNOL, V178, P641; van Leyen K, 2006, STROKE, V37, P3014, DOI 10.1161/01.STR.0000249004.25444.a5; Jin G, 2008, STROKE, V39, P2538, DOI 10.1161/STROKEAHA.108.514927; Nelson DP, 2000, J CLIN INVEST, V105, P1199, DOI 10.1172/JCI8212; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; Dwarakanath RS, 2008, J VASC RES, V45, P132, DOI 10.1159/000109966; Duerrschmid C, 2013, J MOL CELL CARDIOL, V57, P59, DOI 10.1016/j.yjmcc.2013.01.006; Frustaci A, 2000, CIRC RES, V87, P1123; Nakamura K, 1998, CIRCULATION, V98, P794; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; Kang SW, 2003, J AM SOC NEPHROL, V14, P3178, DOI 10.1097/01.ASN.0000099702.16315.DE; Burden KP, 2010, MEDIAT INFLAMM, V2010; Charbeneau RP, 2005, CLIN SCI, V108, P479; Chavali Vishalakshi, 2013, Diabetes Metab Syndr Obes, V6, P151, DOI 10.2147/DMSO.S30968; CHEN XS, 1993, FASEB J, V7, P694; CHEN XS, 1994, J BIOL CHEM, V269, P13979; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Jin HR, 2009, J SEX MED, V6, P3289, DOI 10.1111/j.1743-6109.2009.01464.x; LISCOVITCH M, 1992, TRENDS BIOCHEM SCI, V17, P393, DOI 10.1016/0968-0004(92)90007-V; Mabalirajan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062916; Node K, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-23; Pergola C, 2011, J PHARMACOL EXP THER, V338, P205, DOI 10.1124/jpet.111.180794; Stavniichuk R, 2012, BIOCHEM PHARMACOL, V83, P932, DOI 10.1016/j.bcp.2012.01.015; Wen YS, 2001, CIRC RES, V88, P70; YOKOYAMA C, 1986, J BIOL CHEM, V261, P6714	46	4	4	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	FEB	2015	64	2					618	630		10.2337/db13-1896		13	Endocrinology & Metabolism	Endocrinology & Metabolism	CA3ST	WOS:000348827100029		
J	Kashiwagi, A; Takahashi, H; Ishikawa, H; Yoshida, S; Kazuta, K; Utsuno, A; Ueyama, E				Kashiwagi, A.; Takahashi, H.; Ishikawa, H.; Yoshida, S.; Kazuta, K.; Utsuno, A.; Ueyama, E.			A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long-Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment (LANTERN) study	DIABETES OBESITY & METABOLISM			English	Article						SGLT2 inhibitor	CHRONIC KIDNEY-DISEASE; GLUCOSE-TRANSPORT; INHIBITOR; CANAGLIFLOZIN; DAPAGLIFLOZIN; METFORMIN	AimsTo assess the effects of renal impairment (RI) on the efficacy and safety of ipragliflozin in patients with type 2 diabetes mellitus (T2DM). MethodsA cohort of Japanese patients with T2DM and mild to moderate RI and poor glycaemic control, despite diet/exercise therapy alone or diet/exercise therapy in combination with an oral hypoglycaemic agent (an -glucosidase inhibitor, a sulfonylurea, or pioglitazone), were randomized in a double-blind manner to 50mg ipragliflozin or placebo once daily for 24weeks. The patients continued open-label ipragliflozin for a 28-week extension period (total treatment duration: 52weeks). ResultsIpragliflozin significantly decreased glycated haemoglobin (HbA1c) and fasting plasma glucose (FPG) levels and body weight from baseline to week 24 (last observation carried forward) compared with placebo in all patients with RI. The decreases in HbA1c and FPG levels were statistically significant in patients with mild RI, but not in patients with moderate RI. Ipragliflozin significantly reduced body weight in both RI groups. The improvements in glycaemic control were maintained in the 28-week extension period. Ipragliflozin was associated with no clinically significant safety concerns, and its safety profiles were not influenced by the severity of RI. ConclusionsIpragliflozin significantly improved glycaemic control and body weight in patients with T2DM with mild RI, but did not improve glycaemic control in patients with moderate RI. Ipragliflozin is a valid treatment option for patients with mild RI but not those with moderate RI.	[Kashiwagi, A.] Kusatsu Gen Hosp, Kusatsu, Shiga, Japan; [Takahashi, H.; Ishikawa, H.; Yoshida, S.; Kazuta, K.; Utsuno, A.; Ueyama, E.] Astellas Pharma Inc, Tokyo 1038411, Japan	Takahashi, H (reprint author), Astellas Pharma Inc, Chuo Ku, 2-5-1 Nihonbashi Honch, Tokyo 1038411, Japan.	hideyuki.takahashi@astellas.com			Astellas Pharma Inc.	Ipragliflozin (ASP1941) was developed by Astellas Pharma Inc. and Kotobuki Pharmaceutical Co., Ltd. A. K. is a consultant for and has received consulting fees/honoraria from Astellas Pharma Inc. The remaining authors are employees of Astellas Pharma Inc., Tokyo, Japan.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; Bakris GL, 2009, KIDNEY INT, V75, P1272, DOI 10.1038/ki.2009.87; Krook A, 1997, DIABETES, V46, P2110, DOI 10.2337/diabetes.46.12.2110; Tahara A, 2012, J PHARMACOL SCI, V120, P36, DOI 10.1254/jphs.12089FP; Fonseca VA, 2013, J DIABETES COMPLICAT, V27, P268, DOI 10.1016/j.jdiacomp.2012.11.005; Ferrannini E, 2013, DIABETES CARE, V36, P1260, DOI 10.2337/dc12-1503; Wilding JPH, 2013, DIABETES OBES METAB, V15, P403, DOI 10.1111/dom.12038; Ljunggren O, 2012, DIABETES OBES METAB, V14, P990, DOI 10.1111/j.1463-1326.2012.01630.x; Tahara A, 2012, N-S ARCH PHARMACOL, V385, P423, DOI 10.1007/s00210-011-0713-z; Yale JF, 2013, DIABETES OBES METAB, V15, P463, DOI 10.1111/dom.12090; List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10; Kadokura T, 2014, DIABETES RES CLIN PR, V106, P50, DOI 10.1016/j.diabres.2014.07.020; Kashiwagi A, 2015, DIABETOL INT, V6, P104, DOI 10.1007/s13340-014-0182-y; Kashiwagi A, 2013, J DIABETES INVEST, V5, P382; Kashiwagi A, 2015, DIABETOL INT, V6, P125, DOI 10.1007/s13340-014-0184-9; Kashiwagi A, 2015, DIABETES OBES METAB, V17, P304, DOI 10.1111/dom.12331; Kashiwagi A, 2015, DIABETOL INT, V6, P8, DOI 10.1007/s13340-014-0164-0; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Kohan DE, 2013, KIDNEY INT, V85, P962; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x	22	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	FEB	2015	17	2					152	160		10.1111/dom.12403		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CA4AW	WOS:000348847600008		
J	Hanazaki, K; Munekage, M; Yatabe, T; Kitagawa, H; Yoshihiko, K; Asano, T; Namikawa, T				Hanazaki, K.; Munekage, M.; Yatabe, T.; Kitagawa, H.; Yoshihiko, K.; Asano, T.; Namikawa, T.			COMPARISON BETWEEN A NOVEL AND CONVENTIONAL ARTIFICIAL PANCREAS FOR PERIOPERATIVE GLYCEMIC CONTROL USING A CLOSED-LOOP SYSTEM	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Hanazaki, K.; Munekage, M.; Yatabe, T.; Kitagawa, H.; Yoshihiko, K.; Asano, T.; Namikawa, T.] Kochi Univ, Kochi 780, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		249	A110	A111				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500250		
J	Hiromichi, S				Hiromichi, S.			DRAMATIC CHANGES OVER 30 YEARS IN THE JAPANESE DIABETIC PATIENTS WITH END-STAGE RENAL DISEASE: A SINGLE CENTER RETROSPECTIVE ANALYSIS	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Hiromichi, S.] Saitama Med Univ, Saitama, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		327	A145	A145				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500328		
J	Itoh, M; Hiratsuka, I; Takayanagi, T; Makino, M				Itoh, M.; Hiratsuka, I.; Takayanagi, T.; Makino, M.			DIFFERENT EFFECTS OF GLYCEMIC EXCURSION ON OXIDATIVE STRESS DEPEND ON DURATION OF DIABETES	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Itoh, M.; Hiratsuka, I.; Takayanagi, T.; Makino, M.] Fujita Hlth Univ, Sch Med, Toyoake, Aichi 47011, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		338	A149	A149				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500339		
J	Kato, S; Waki, K; Nakamura, S; Osada, S; Kobayashi, H; Kadowaki, T; Ohe, K; Fujita, H				Kato, S.; Waki, K.; Nakamura, S.; Osada, S.; Kobayashi, H.; Kadowaki, T.; Ohe, K.; Fujita, H.			VALIDATION OF USING PHOTOS TO EVALUATE DIETARY INTAKE - THE METHOD USED BY DIALBETICS, A SMARTPHONE-BASED SELF-MANAGEMENT SYSTEM FOR DIABETES PATIENTS	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Kato, S.; Waki, K.; Fujita, H.] Univ Tokyo, Grad Sch Med, Dept Ubiquitous Hlth Informat, Tokyo, Japan; [Nakamura, S.] Jumonji Univ, Inst Food Nutr & Hlth, Saitama, Japan; [Osada, S.] Kagawa Educ Inst Nutr, Jr Coll Deparment Food & Nutr, Tokyo, Japan; [Kobayashi, H.] NTT DOCOMO Inc, Business Dept, Healthcare Business Smart Life Solut Dept, Tokyo, Japan; [Kadowaki, T.] Tokyo Univ Hosp, Dept Diabet & Metab Dis, Tokyo 113, Japan; [Ohe, K.] Univ Tokyo, Sch Med, Dept Med Informat, Tokyo 113, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		276	A123	A123				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500277		
J	Minakuchi, H; Takei, I; Wakino, S; Hayashi, K; Itoh, H				Minakuchi, H.; Takei, I.; Wakino, S.; Hayashi, K.; Itoh, H.			THE FLUCTUATION IN BLOOD SUGAR AND BLOOD PRESSURE OF INSULIN-DEPENDENT DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Minakuchi, H.; Wakino, S.; Hayashi, K.; Itoh, H.] Keio Univ, Tokyo, Japan; [Takei, I.] Tokyo Dent Coll, Ichikawa Hosp, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		191	A85	A85				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500192		
J	Munekage, M; Yatabe, T; Takezaki, YUKA; Kinoshita, Y; Tsukamoto, Y; Kitagawa, H; Namikawa, T; Hanazaki, K				Munekage, M.; Yatabe, T.; Takezaki, Y. U. K. A.; Kinoshita, Y.; Tsukamoto, Y.; Kitagawa, H.; Namikawa, T.; Hanazaki, K.			INFLUENCE OF GLUCOSE VARIABILITY CAUSED BY AN ARTIFICIAL PANCREAS ON IFLAMMATORY CYTOKINES IN BEAGLES	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Munekage, M.; Yatabe, T.; Takezaki, Y. U. K. A.; Kinoshita, Y.; Tsukamoto, Y.; Kitagawa, H.; Namikawa, T.; Hanazaki, K.] Kochi Med Sch, Nankoku, Kochi, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		250	A111	A112				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500251		
J	Nishimura, A; Harashima, S; Honda, I; Hosoda, K; Inagaki, N				Nishimura, A.; Harashima, S.; Honda, I.; Hosoda, K.; Inagaki, N.			EFFECT OF COLOR DISPLAY ON THE SMBG METER: ANALYSIS OF DATA FROM THE COLOR IMPACT STUDY	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Nishimura, A.; Hosoda, K.] Kyoto Univ, Dept Human Hlth Sci, Grad Sch Med, Kyoto, Japan; [Harashima, S.; Inagaki, N.] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Grad Sch Med, Kyoto, Japan; [Honda, I.] Nagoya Univ, Grad Sch Med, Dept Nursing, Nagoya, Aichi 4648601, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		344	A151	A152				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500345		
J	Ogawa, O; Ogawa, T; Tanimoto, M; Masuzawa, M				Ogawa, O.; Ogawa, T.; Tanimoto, M.; Masuzawa, M.			A CASE OF USING AN ARTIFICIAL ENDOCRINE PANCREAS WITH CLOSED-LOOP GLYCEMIC CONTROL SYSTEM IN CARDIAC SURGERY	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Ogawa, O.; Ogawa, T.; Tanimoto, M.; Masuzawa, M.] Kameda Med Ctr, Dept Endocrinol & Diabet, Kamogawa, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		345	A152	A152				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500346		
J	Sekimoto, S; Shinozaki, K; Murase, Y; Kusaka, Y; Tsugawa, W; Sode, K				Sekimoto, S.; Shinozaki, K.; Murase, Y.; Kusaka, Y.; Tsugawa, W.; Sode, K.			3RD GENERATION CGM SENSOR EMPLOYING DIRECT ELECTRON TRANSFER PRINCIPLE WITH IMPROVED OPERATIONAL CONDITIONS	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Sekimoto, S.; Shinozaki, K.; Murase, Y.; Kusaka, Y.] ARKRAY Inc, Reserch & Dev, Kyoto, Japan; [Tsugawa, W.; Sode, K.] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol, Tokyo, Japan			Sode, Koji/F-6914-2013					0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		202	A90	A90				1	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500203		
J	Shibuta, T; Waki, K; Lee, H; Tomizawa, N; Yamamoto-Mitani, N; Igarashi, A; Ohe, K; Yamauchi, T; Kadowaki, T; Fujita, H				Shibuta, T.; Waki, K.; Lee, H.; Tomizawa, N.; Yamamoto-Mitani, N.; Igarashi, A.; Ohe, K.; Yamauchi, T.; Kadowaki, T.; Fujita, H.			INTENTION OF PATIENTS TO USE ICT-BASED DIABETES SELF-MANAGEMENT SYSTEMS: A CROSS-SECTIONAL INTERVIEW SURVEY	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Shibuta, T.; Yamamoto-Mitani, N.; Igarashi, A.] Univ Tokyo, Grad Sch Med, Dept Adult Nursing Palliat Care Nursing, Tokyo, Japan; [Waki, K.; Lee, H.; Tomizawa, N.; Fujita, H.] Univ Tokyo, Grad Sch Med, Dept Ubiquitous Hlth Informat, Tokyo, Japan; [Ohe, K.] Univ Tokyo, Grad Sch Med, Dept Med Informat & Econ, Tokyo, Japan; [Yamauchi, T.; Kadowaki, T.] Tokyo Univ Hosp, Dept Diabet & Metab Dis, Tokyo 113, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		300	A133	A134				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500301		
J	Waki, K; Aizawa, K; Fujita, H; Kato, S; Lee, H; Kobayashi, H; Ogawa, M; Mouri, K; Kadowaki, T; Ohe, K				Waki, K.; Aizawa, K.; Fujita, H.; Kato, S.; Lee, H.; Kobayashi, H.; Ogawa, M.; Mouri, K.; Kadowaki, T.; Ohe, K.			DIALBETICS WITH A MULTIMEDIA FOOD RECORDING TOOL, FOODLOG: SMARTPHONE-BASED SELF-MANAGEMENT FOR TYPE 2 DIABETES	DIABETES TECHNOLOGY & THERAPEUTICS			English	Meeting Abstract									[Waki, K.; Fujita, H.; Kato, S.; Lee, H.] Univ Tokyo, Dept Ubiquitous Hlth Informat, Tokyo, Japan; [Aizawa, K.] Univ Tokyo, Dept Informat & Commun Engn, Tokyo, Japan; [Kobayashi, H.] NTT DOCOMO Inc, Business Dev Healthcare Business Smart Life Solut, Tokyo, Japan; [Ogawa, M.; Mouri, K.] Foo Log Inc, Dept Informat & Commun Engn, Tokyo, Japan; [Kadowaki, T.] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo, Japan; [Ohe, K.] Univ Tokyo, Dept Med Informat & Econ, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	FEB 1	2015	17			1		307	A137	A138				2	Endocrinology & Metabolism	Endocrinology & Metabolism	CB0LL	WOS:000349317500308		
J	Oda, T; Taneichi, H; Takahashi, K; Togashi, H; Hangai, M; Nakagawa, R; Ono, M; Matsui, M; Sasai, T; Nagasawa, K; Honma, H; Kajiwara, T; Takahashi, Y; Takebe, N; Ishigaki, Y; Satoh, J				Oda, T.; Taneichi, H.; Takahashi, K.; Togashi, H.; Hangai, M.; Nakagawa, R.; Ono, M.; Matsui, M.; Sasai, T.; Nagasawa, K.; Honma, H.; Kajiwara, T.; Takahashi, Y.; Takebe, N.; Ishigaki, Y.; Satoh, J.			Positive association of free triiodothyronine with pancreatic beta-cell function in people with prediabetes	DIABETIC MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; THYROID-HORMONE; FASTING GLUCOSE; SECRETION; PROLIFERATION; HYPERPLASIA; HOMEOSTASIS; ADAPTATION; EXPRESSION	AimTo analyse the effects of thyroid hormones on -cell function and glucose metabolism in people with prediabetes who are euthyroid. MethodsA total of 111 people who were euthyroid underwent 75-g oral glucose tolerance tests, of whom 52 were assigned to the normal glucose tolerance and 59 to the prediabetes groups. Homeostatic model assessment of -cell function, insulinogenic index and areas under the curve for insulin and glucose were evaluated as indices of pancreatic -cell function. ResultsIn both groups, BMI, fasting insulin, homeostasis model assessment ratio and HDL cholesterol correlated significantly with all indices of pancreatic -cell function. Free triiodothyronine correlated positively with all insulin secretion indices in the prediabetes group. Multiple linear regression analysis showed that free triiodothyronine was an independent variable that had a positive correlation with all indices of -cell function in the prediabetes group. By contrast, no such correlation was found in the normal glucose tolerance group. ConclusionsFree triiodothyronine is associated with both basal and glucose-stimulated insulin secretion in people with prediabetes who are euthyroid; therefore, the regulation of insulin secretion by thyroid hormones is a potentially novel therapeutic target for the treatment of diabetes.	[Oda, T.; Taneichi, H.; Takahashi, K.; Togashi, H.; Hangai, M.; Nakagawa, R.; Ono, M.; Matsui, M.; Sasai, T.; Nagasawa, K.; Honma, H.; Kajiwara, T.; Takahashi, Y.; Takebe, N.; Ishigaki, Y.; Satoh, J.] Iwate Med Univ, Dept Internal Med, Div Diabet & Metab, Morioka, Iwate 020, Japan	Ishigaki, Y (reprint author), Iwate Med Univ, Dept Internal Med, Div Diabet & Metab, Morioka, Iwate 020, Japan.	ishigaki@iwate-med.ac.jp					Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Steil GM, 2001, AM J PHYSIOL-ENDOC M, V280, pE788; Kuzuya T, 2002, DIABETES RES CLIN PR, V55, P65, DOI 10.1016/S0168-8227(01)00365-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Rane SG, 1999, NAT GENET, V22, P44; Taneichi H, 2011, TOHOKU J EXP MED, V224, P173, DOI 10.1620/tjem.224.173; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Shepherd PR, 1998, BIOCHEM J, V333, P471; Blanchet E, 2012, FASEB J, V26, P40, DOI 10.1096/fj.11-186841; Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Ledda-Columbano GM, 2005, J ENDOCRINOL, V185, P393, DOI 10.1677/joe.1.06110; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; Furuya F, 2010, J BIOL CHEM, V285, P24477, DOI 10.1074/jbc.M109.100222; Bakker SJL, 1999, J HYPERTENS, V17, P1725, DOI 10.1097/00004872-199917120-00009; Bryzgalova G, 2008, J STEROID BIOCHEM, V111, P262, DOI 10.1016/j.jsbmb.2008.06.010; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Hanefeld M, 2003, DIABETES CARE, V26, P868, DOI 10.2337/diacare.26.3.868; Lin Y, 2011, BRIT J PHARMACOL, V162, P597, DOI 10.1111/j.1476-5381.2010.01056.x; Misiti S, 2005, J CELL PHYSIOL, V204, P286, DOI 10.1002/jcp.20293; MULLER MJ, 1986, J CLIN ENDOCR METAB, V63, P62; Ortega E, 2008, EUR J ENDOCRINOL, V158, P217, DOI 10.1530/EJE-07-0592; SHEN DC, 1985, J CLIN ENDOCR METAB, V60, P1038; SHI YB, 1990, GENE DEV, V4, P1107, DOI 10.1101/gad.4.7.1107; Verga Falzacappa C., 2006, J CELL PHYSIOL, V206, P309, DOI [DOI 10.1002/JCP.20460, 10.1002/jcp.20460]; Verga Falzacappa C, 2007, J MOL ENDOCRINOL, V38, P221, DOI DOI 10.1677/JME.1.02166; World Health Organization, 2006, REP WHO IDF CONS	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3071	1464-5491		DIABETIC MED	Diabetic Med.	FEB	2015	32	2					213	219		10.1111/dme.12589		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AZ9EN	WOS:000348515500011		
J	Tabuchi, T; Fujiwara, T; Nakayama, TO; Miyashiro, I; Tsukuma, H; Ozaki, K; Kondo, N				Tabuchi, Takahiro; Fujiwara, Takeo; Nakayama, Tomio O.; Miyashiro, Isao; Tsukuma, Hideaki; Ozaki, Koken; Kondo, Naoki			Maternal and paternal indoor or outdoor smoking and the risk of asthma in their children: A nationwide prospective birth cohort study	DRUG AND ALCOHOL DEPENDENCE			English	Article						Parental smoking; Outdoor smoking; Asthma; Japan	ENVIRONMENTAL TOBACCO-SMOKE; PARENTAL SMOKING; PASSIVE SMOKING; EXPOSURE; JAPAN; CANCER; LIFE; INTERVENTION; METAANALYSIS; CHILDHOOD	Background: Little is known about the differential impact of combinations of parental smoking behavior (indoor or outdoor smoking, or not smoking) on preventing childhood asthma. Our objective was to examine the association between parental smoking behavior and children's asthma. Methods: A nationally representative population-based birth cohort of 40,580 babies, aged 0.5 years in 2001 (response rate, 87.8%), was studied to estimate adjusted odds ratios of combinations of maternal and paternal indoor or outdoor smoking at home for physician visits and hospitalization for childhood asthma up to 8-years-old, and population attributable fractions. Results: Odds of hospitalization for asthma among children whose father alone smokes indoors at home did not largely increase (up to 20%). However, if the mother also smokes indoors at home, the odds strongly increased. After adjusting for demographic, perinatal and socioeconomic factors, the increase in odds for children whose father and mother both smoke indoors compared to children with non-smoking parents was 54% (95% confidence interval: 21-96%), 43% (8-90%) and 72% (22-143%) for children aged 0.5 < -2.5, 2.5 <-4.5 and 4.5 <-8 years-old, respectively. The odds ratios of smoking outdoors did not largely differ from those of smoking indoors. Our estimation of population attributable fractions revealed that if all parents in Japan quit smoking, hospitalization of children for asthma could be reduced by 8.3% (2.2-14.3%), 9.3% (0.9-17.6%) and 18.2% (7.7-28.8%), respectively. Conclusions: Parental indoor smoking at home increased and exacerbated children's asthma. Smoking at home, whether it is indoors or outdoors, may increase the risks for asthma attacks of their children. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Tabuchi, Takahiro; Nakayama, Tomio O.; Miyashiro, Isao; Tsukuma, Hideaki] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Higashinari Ku, Osaka 5378511, Japan; [Tabuchi, Takahiro; Fujiwara, Takeo; Kondo, Naoki] Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, Tokyo 1578535, Japan; [Ozaki, Koken] Univ Tsukuba, Grad Sch Business Sci, Bunkyo Ku, Tokyo 1120012, Japan; [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Bunkyo Ku, Tokyo 1130033, Japan	Tabuchi, T (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Higashinari Ku, 3-3,Nakamichi 1 Chome, Osaka 5378511, Japan.	tabuchitak@gmail.com					Blizzard L, 2003, AM J PUBLIC HEALTH, V93, P482, DOI 10.2105/AJPH.93.3.482; Leung GM, 2004, ARCH PEDIAT ADOL MED, V158, P687, DOI 10.1001/archpedi.158.7.687; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Halterman JS, 2007, J ASTHMA, V44, P83, DOI 10.1080/02770900601180545; Alati R, 2006, EPIDEMIOLOGY, V17, P138, DOI 10.1097/01.ede.0000198148.02347.33; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Brunekreef B, 2000, EPIDEMIOLOGY, V11, P350, DOI 10.1097/00001648-200005000-00023; Yamakawa M, 2013, JAMA PEDIATR, V167, P919, DOI 10.1001/jamapediatrics.2013.2230; Chaudhuri R, 2003, AM J RESP CRIT CARE, V168, P1308, DOI 10.1164/rccm.200304-503OC; Baena-Cagnani CE, 2009, CURR OPIN ALLERGY CL, V9, P136, DOI 10.1097/ACI.0b013e3283294038; Arshad SH, 2005, CHEST, V127, P502, DOI 10.1378/chest.127.2.502; Fujiwara T, 2013, AM J EPIDEMIOL, V177, P1042, DOI 10.1093/aje/kws355; Kaneita Y, 2006, PREV MED, V42, P210, DOI 10.1016/j.ypmed.2005.11.017; Blackburn C, 2003, BRIT MED J, V327, P257, DOI 10.1136/bmj.327.7409.257; Carlsson N, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-76; Chapman S, 2007, PUBLIC HEALTH ADVOCACY AND TOBACCO CONTROL: MAKING SMOKING HISTORY, P1, DOI 10.1002/9780470692479; Jacobs EA, 2001, PEDIATRICS, V107, P794; Emmons KM, 2001, PREV MED, V32, P321, DOI 10.1006/pmed.2000.0822; Graham J. W., 2012, MISSING DATA ANAL DE; Horner CC, 2007, CURR OPIN PEDIATR, V19, P295, DOI 10.1097/MOP.0b013e32809913a2; Inoue M, 2012, ANN ONCOL, V23, P1362, DOI 10.1093/annonc/mdr437; Johansson A, 2005, ANN EPIDEMIOL, V15, P453, DOI 10.1016/j.annepidem.2004.09.012; Kanoh M, 2012, PREV MED, V54, P94, DOI 10.1016/j.ypmed.2011.10.011; Miller JE, 2001, AM J EPIDEMIOL, V154, P245, DOI 10.1093/aje/154.3.245; Ministry of Health Labour and Welfare, 2013, LONG SURV NEWB 21 CE; Ministry of Internal Affairs and Communications, 2000, CENS; Ohga A, 2005, JPN J MATERN HLTH, V45, P423; Parsons A, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5569; Rothman K, 2008, MODERN EPIDEMIOLOGY; Royal College of Physicians, 2010, REP TOB ADV GROUP RO; Shih SF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-67; Tabuchi T, 2013, ANN ONCOL, V24, P2699, DOI 10.1093/annonc/mdt279; Tamakoshi A, 2009, PREV MED, V48, P486, DOI 10.1016/j.ypmed.2009.02.017; U.S. Department of Health and Human Services Centers for Disease Control Office on Smoking and Health, 2006, HLTH CONS INV SMOK R; Vork KL, 2007, ENVIRON HEALTH PERSP, V115, P1394, DOI 10.1289/ehp.10155	35	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0376-8716	1879-0046		DRUG ALCOHOL DEPEN	Drug Alcohol Depend.	FEB 1	2015	147						103	108		10.1016/j.drugalcdep.2014.12.001		6	Substance Abuse; Psychiatry	Substance Abuse; Psychiatry	CA4RU	WOS:000348893000014		
J	Yoshimasu, K; Mure, K; Hashimoto, M; Takemura, S; Tsuno, K; Hayashida, M; Kinoshita, K; Takeshita, T; Miyashita, K				Yoshimasu, Kouichi; Mure, Kanae; Hashimoto, Marowa; Takemura, Shigeki; Tsuno, Kanami; Hayashida, Mariko; Kinoshita, Kenji; Takeshita, Tatsuya; Miyashita, Kazuhisa			Genetic alcohol sensitivity regulated by ALDH2 and ADH1B polymorphisms is strongly associated with depression and anxiety in Japanese employees	DRUG AND ALCOHOL DEPENDENCE			English	Article						ALDH2; ADH1B; Polymorphisms; Depression; Anxiety; Japanese	INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; RISK-FACTORS; ACETALDEHYDE CONCENTRATIONS; ALDEHYDE DEHYDROGENASE-2; PSYCHOLOGICAL-FACTORS; COMPLETED SUICIDE; DRINKING BEHAVIOR; HEART-DISEASE; DISORDERS; POPULATION	Background: Although alcohol-related disorders (ARD) have been shown to be accompanied by comorbid depressive and anxiety disorders, and alcohol metabolic enzyme genes, ADH1B and ALDH2 polymorphisms, have been associated with an increased risk of ARD, no studies have been conducted to evaluate the associations between these genetic polymorphisms and anxiety or depression. Method: A total of 1944 Japanese workers were interviewed regarding their depressive and anxiety disorders, including suicidality, by a brief psychiatric structured interview (MINI). We investigated the relationship of ADH1B rs1229984 and ALDH2 rs671 polymorphism combinations with mental disorder risks. Logistic regression analysis was used to evaluate the associations between those polymorphisms and anxiety/depressive disorders, adjusting for sex, age, and job rank. The degree of alcohol sensitivity was classified into five groups according to the combination of two enzyme genotypes (Group I-V, in order from the lowest alcohol sensitivity). Results: Those with ALDH2 *1/*1 and ADHIB *1/*1 were likely to be at an increased risk of depressive and anxiety disorders as well as ARD. This tendency was more apparent among non-drinkers (OR 9.20, 95% CI 1.66-50.89). No adverse effects of ALDH2 or ADH1B alone were observed with mental disorder risks. Likewise, analyses conducted combining job rank and genetic alcohol sensitivity showed no material associations with such risks. Conclusions: Genetic alcohol sensitivity, especially that with the genotype combination of ALDH2 *11'1 and ADH1B *10, was significantly associated with an increased risk of depressive and anxiety disorders as well as ARD. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Yoshimasu, Kouichi; Takemura, Shigeki; Tsuno, Kanami; Miyashita, Kazuhisa] Wakayama Med Univ, Sch Med, Dept Hyg, Wakayama 6418509, Japan; [Mure, Kanae; Hashimoto, Marowa; Takeshita, Tatsuya] Wakayama Med Univ, Sch Med, Dept Publ Hlth, Wakayama 6418509, Japan; [Hayashida, Mariko; Kinoshita, Kenji] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Dept Pharm, Nishinomiya, Hyogo 6638179, Japan	Yoshimasu, K (reprint author), Wakayama Med Univ, Sch Med, Dept Hyg, 811-1 Kimiidera, Wakayama 6418509, Japan.	kyoshi@wakayama-med.ac.jp			JSPS KAKENHI [25293153]	This work was supported by JSPS KAKENHI grant number 25293153.	Saraceno L, 2009, ADDICTION, V104, P1100, DOI 10.1111/j.1360-0443.2009.02571.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Yoshimasu Kouichi, 2008, Environmental Health and Preventive Medicine, V13, P243, DOI 10.1007/s12199-008-0037-x; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Abraham HD, 1999, COMPR PSYCHIAT, V40, P44, DOI 10.1016/S0010-440X(99)90076-7; Yao Chung-Tay, 2011, Human Genomics, V5, P569; Takeuchi F, 2011, CIRC J, V75, P911, DOI 10.1253/circj.CJ-10-0774; YOSHIDA A, 1991, PROG NUCLEIC ACID RE, V40, P255, DOI 10.1016/S0079-6603(08)60844-2; Woo JM, 2008, INT J DISABIL HUM DE, V7, P185; JOHNSON CC, 1989, J BEHAV MED, V12, P13, DOI 10.1007/BF00844746; Stautz K, 2013, CLIN PSYCHOL REV, V33, P574, DOI 10.1016/j.cpr.2013.03.003; BOSRON WF, 1986, HEPATOLOGY, V6, P502, DOI 10.1002/hep.1840060330; Rodgers B, 2000, ADDICTION, V95, P1833, DOI 10.1046/j.1360-0443.2000.9512183312.x; Peele S, 2000, DRUG ALCOHOL DEPEN, V60, P221, DOI 10.1016/S0376-8716(00)00112-5; Peng Giia-Sheun, 2009, Human Genomics, V3, P121; Yokoyama A, 2010, ALCOHOL CLIN EXP RES, V34, P1246, DOI 10.1111/j.1530-0277.2010.01202.x; Baker AL, 2012, J AFFECT DISORDERS, V139, P217, DOI 10.1016/j.jad.2011.08.004; Beghi M, 2013, NEUROPSYCH DIS TREAT, V9, P1725, DOI 10.2147/NDT.S40213; Charriau V, 2013, ALCOHOL, V47, P15, DOI 10.1016/j.alcohol.2012.08.008; DeSanto lennaco J., 2010, AM J EPIDEMIOL, V171, P303; Fassino S, 2007, ADV PSYCHOSOM MED, V28, P141, DOI 10.1159/000106802; Hayashida M, 2014, ANAL SCI, V30, P427; Higuchi S, 1996, ALCOHOL CLIN EXP RES, V20, P493, DOI 10.1111/j.1530-0277.1996.tb01080.x; Hishimoto A, 2010, GENES BRAIN BEHAV, V9, P498, DOI 10.1111/j.1601-183X.2010.00577.x; Kent LK, 2009, HARVARD REV PSYCHIAT, V17, P377, DOI 10.3109/10673220903463333; Kim DJ, 2008, HUM MOL GENET, V17, P854, DOI 10.1093/hmg/ddm357; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; Marchand A, 2003, J STUD ALCOHOL, V64, P419; Matsuo K, 2006, CANCER EPIDEM BIOMAR, V15, P1009, DOI 10.1158/1055-9965.EPI-05-0911; Matthews KA, 2005, AM PSYCHOL, V60, P783, DOI 10.1037/0003-066X.60.8.783; Olgiati P, 2007, NEUROPSYCHOBIOLOGY, V56, P111, DOI 10.1159/000112952; Schneider B, 2009, ARCH SUICIDE RES, V13, P303, DOI 10.1080/13811110903263191; Sheehan D. V., 2003, MINIINTERNATIONAL NE; Stuart H, 2008, CURR OPIN PSYCHIATR, V21, P505, DOI 10.1097/YCO.0b013e328305e4c1; Takeshita T, 2012, KOUSHUEISEI, V76, P205; Takeshita T, 1996, HUM GENET, V97, P409, DOI 10.1007/BF02267057; Trigo Miguel, 2005, Rev Port Cardiol, V24, P261; Whitefield JB, 2002, AM J HUM GENET, V81, P842; Yang S.J., 2010, WORLD J GASTROENTERO, V7, P4210; Yoshimasu K, 2015, ALCOHOL ALCOHOLISM, V50, P39, DOI 10.1093/alcalc/agu080	40	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0376-8716	1879-0046		DRUG ALCOHOL DEPEN	Drug Alcohol Depend.	FEB 1	2015	147						130	136		10.1016/j.drugalcdep.2014.11.034		7	Substance Abuse; Psychiatry	Substance Abuse; Psychiatry	CA4RU	WOS:000348893000018		
J	Kobayashi, M; Pelander, A; Ketola, RA; Leinonen, A; Kuuranne, T				Kobayashi, Masaki; Pelander, Anna; Ketola, Raimo A.; Leinonen, Antti; Kuuranne, Tiia			Targeting misuse of 2-amino-N-ethyl-1-phenylbutane in urine samples: in vitro-in vivo correlation of metabolic profiles and development of LC-TOF-MS method	DRUG TESTING AND ANALYSIS			English	Article						designer drugs; LC-TOF-MS; high resolution mass spectrometry; metabolism; doping control; phenethylamine derivatives; 2-amino-N-ethyl-1-phenylbutane	MASS-SPECTROMETRY; DOPING CONTROL; STEREOSELECTIVITY; GLUCURONIDATION	A phenyethylamine derivative, 2-amino-N-ethyl-1-phenylbutane (2-AEPB), has recently been detected in doping control and drugs-of-abuse samples, and identified as a non-labelled ingredient in a dietary supplement. To facilitate efficient control of this substance we have studied the in vitro metabolic behaviour of 2-AEPB with human liver preparation, compared these results with in vivo pathways in human, and finally propose an analytical strategy to target the potential misuse of 2-AEPB for toxicological, forensic and doping control purposes. The major in vitro formed metabolites originated from desethylation (M1) and monohydroxylation (M2). A minor metabolite with hydroxylation/N-oxidation was also observed (M3). In vitro-in vivo correlation was studied in an excretion study with a single, oral dose of 2-AEPB-containing supplement. An unmodified substance was the most abundant target compound and detected until the last point of sample collection (72h), and the detection of M1 (40h) and M2 (27h) demonstrated good correlation to in vitro results. In the study with authentic cases (n=6), 2-AEPB and M1 were mainly found in free urinary fraction, whereas higher inter-individual variability was observed for M2. It was predominantly conjugated and already within this limited number of cases, the ratio between glucuronide- and sulpho-conjugated fractions varied significantly. As a conclusion, hydrolysis is not mandatory in the routine sample preparation, and as the separation can be based on either gas chromatography or liquid chromatography, this study verifies that routine mass spectrometric detection methods targeted to amphetamine derivatives can be easily extended to control the misuse of 2-AEPB. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kobayashi, Masaki; Pelander, Anna; Ketola, Raimo A.] Univ Helsinki, Fac Med, Dept Forens Med, FIN-00014 Helsinki, Finland; [Kobayashi, Masaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Forens Med, Kyoto, Japan; [Kobayashi, Masaki; Leinonen, Antti; Kuuranne, Tiia] United Medix Labs, Doping Control Lab, FI-00380 Helsinki, Finland	Kuuranne, T (reprint author), United Medix Labs, Doping Control Lab, Hoylaamotie 14, FI-00380 Helsinki, Finland.	tiia.kuuranne@medix.fi			Research Foundation of Clinical Chemistry (Kliinisen Kemian Tutkimussaatio)	The Research Foundation of Clinical Chemistry (Kliinisen Kemian Tutkimussaatio) is acknowledged for financial support, World Association of Anti-doping Scientists (WAADS) for providing the reference material for this study, and Dr Ray Kazlauskas for scientific discussions on this topic.	Schwaninger AE, 2011, CLIN CHEM, V57, P1748, DOI 10.1373/clinchem.2011.172254; Shoda T, 2009, CHEM PHARM BULL, V57, P472; Li LH, 2010, BRIT J CLIN PHARMACO, V69, P187, DOI 10.1111/j.1365-2125.2009.03576.x; Schwaninger AE, 2011, DRUG METAB DISPOS, V39, P1998, DOI 10.1124/dmd.111.041129; Schep LJ, 2010, CLIN TOXICOL, V48, P675, DOI 10.3109/15563650.2010.516752; Tyrkko E, 2013, ANAL BIOANAL CHEM, V405, P6697, DOI 10.1007/s00216-013-7137-1; Cohen PA, 2014, DRUG TEST ANAL, V6, P805, DOI 10.1002/dta.1578; Kolmonen M, 2009, DRUG TEST ANAL, V1, P250, DOI 10.1002/dta.50; Kuuranne T, 2003, DRUG METAB DISPOS, V31, P1117, DOI 10.1124/dmd.31.9.1117; Kuuranne T, 2008, DRUG METAB DISPOS, V36, P571, DOI 10.1124/dmd.107.017954; OBERLENDER R, 1990, J PHARMACOL EXP THER, V255, P1098; Schwaninger AE, 2012, TOXICOL LETT, V212, P38, DOI 10.1016/j.toxlet.2012.04.021; Vahermo M, 2009, ARCH PHARM, V342, P201, DOI 10.1002/ardp.200800144; World Anti-Doping Agency, 2013, 2012 ANT TEST FIG RE	14	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-7603	1942-7611		DRUG TEST ANAL	Drug Test. Anal.	FEB	2015	7	2					89	94		10.1002/dta.1642		6	Biochemical Research Methods; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	CA8EW	WOS:000349150800001		
J	Yukutake, Y; Takeda, T; Yoshida, A				Yukutake, Yohei; Takeda, Tetsuya; Yoshida, Akio			The applicability of frictional reactivation theory to active faults in Japan based on slip tendency analysis	EARTH AND PLANETARY SCIENCE LETTERS			English	Article						active fault; stress field; slip tendency; fault reactivation theory; focal mechanism; Japan	EARTHQUAKE FOCAL MECHANISMS; PHILIPPINE SEA PLATE; 1995 KOBE EARTHQUAKE; COMPRESSIONAL INVERSION; SOUTHWEST JAPAN; STRESS TENSOR; GEOMETRY; SEQUENCE; PRESSURE; ROTATION	To investigate the applicability of frictional reactivation theory to active faults, we evaluated the slip tendency of active faults in Japan. Slip tendency is defined as the ratio of shear stress to the frictional resistance acting on a fault plane. To estimate the stress field near active faults, we determined focal mechanisms for numerous shallow earthquakes in the intraplate region of Japan, using data from dense seismic observation networks. The stress fields were estimated by applying the stress inversion method to the focal mechanisms. We found that most active faults are well oriented with respect to the stress field, having slip tendencies of >= 0.6, which indicates that fault reactivation theory is applicable to active faults, and that the present day tectonic stress field has contributed substantially to the development of active faults. Conversely, several steeply dipping active faults in northeast Japan, as well as the source faults of the 1995 Hyogoken-Nanbu earthquake, are mis-oriented, with slip tendencies of <0.6, which may indicate that highly pressurized fluids have contributed to earthquake triggering on these mis-oriented faults. We also discuss the applicability of slip tendency analysis to earthquake hazard assessment; i.e. estimating the probability of a future rupture on active faults. Our results indicate that slip tendency does not correlate with elapsed time since the most recent earthquake event. This observation shows that slip tendency may not be an efficient parameter with which to assess the risk of an earthquake occurring in the near future on a specific fault. (C) 2014 Elsevier B.V. All rights reserved.	[Yukutake, Yohei] Hot Springs Res Inst Kanagawa Prefecture, Odawara, Kanagawa, Japan; [Takeda, Tetsuya] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki, Japan; [Yoshida, Akio] Shizuoka Univ, Shizuoka 4228529, Japan	Yukutake, Y (reprint author), 586 Iriuda, Odawara, Kanagawa 2500031, Japan.	yukutake@onken.odawara.kanagawa.jp			MEXT [23740347]	The authors used waveform data provided by NIED Hi-net, the Japan Meteorological Agency, and the universities of Hokkaido, Hirosaki, Tohoku, Tokyo, Nagoya, Kyoto, Kochi, Kyushu, and Kagoshima. We are thankful to two anonymous reviewers and the Editor, Dr. Peter Shearer, who greatly helped us to improve this manuscript. We thank Dr. Satoshi Ide for providing the program with which to estimate focal mechanisms. We also thank AIST for providing data from the Active Fault Database of Japan. We benefited greatly from discussions with Dr. Ryosuke Doke. This work was supported by a MEXT Grant-in-Aid for Science Research (23740347).	Anderson E.M., 1905, T EDINB GEOL SOC, V8, P387; KAGAN YY, 1991, GEOPHYS J INT, V106, P709, DOI 10.1111/j.1365-246X.1991.tb06343.x; Lisle RJ, 2004, GEOLOGY, V32, P569, DOI 10.1130/G20408.1; Collettini C, 2001, GEOLOGY, V29, P927, DOI 10.1130/0091-7613(2001)029<0927:NFNF>2.0.CO;2; Yukutake Y, 2012, EARTH PLANETS SPACE, V64, P269, DOI 10.5047/eps.2011.09.002; Sibson RH, 1998, B SEISMOL SOC AM, V88, P1014; DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Sibson RH, 2009, TECTONOPHYSICS, V473, P404, DOI 10.1016/j.tecto.2009.03.016; Townend J, 2000, GEOLOGY, V28, P399, DOI 10.1130/0091-7613(2000)28<399:HFKTCS>2.0.CO;2; Hardebeck JL, 2001, J GEOPHYS RES-SOL EA, V106, P21859, DOI 10.1029/2001JB000292; Yukutake Y, 2008, EARTH PLANETS SPACE, V60, P981; Morris A, 1996, GEOLOGY, V24, P275, DOI 10.1130/0091-7613(1996)024<0275:STAAFR>2.3.CO;2; Shiomi K, 2008, GEOPHYS J INT, V173, P1018, DOI 10.1111/j.1365-246X.2008.03786.x; HORIUCHI S, 1995, J GEOPHYS RES-SOL EA, V100, P8327, DOI 10.1029/94JB03284; Frohlich C, 2001, GEOPHYS J INT, V144, P300, DOI 10.1046/j.1365-246x.2001.00341.x; Simpson RW, 1997, J GEOPHYS RES-SOL EA, V102, P17909, DOI 10.1029/97JB01274; Collettini C, 2007, EARTH PLANET SC LETT, V255, P402, DOI 10.1016/j.epsl.2007.01.001; Takayama H, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004690; KAMATA H, 1994, TECTONOPHYSICS, V233, P69, DOI 10.1016/0040-1951(94)90220-8; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; GEPHART JW, 1984, J GEOPHYS RES, V89, P9305, DOI 10.1029/JB089iB11p09305; Tanaka A, 2004, EARTH PLANETS SPACE, V56, P1195; Moeck I, 2009, J STRUCT GEOL, V31, P1174, DOI 10.1016/j.jsg.2009.06.012; Sekiguchi H, 2000, B SEISMOL SOC AM, V90, P117, DOI 10.1785/0119990027; Zhao DP, 1996, SCIENCE, V274, P1891, DOI 10.1126/science.274.5294.1891; Sibson RH, 2007, EARTH PLANET SC LETT, V257, P188, DOI 10.1016/j.epsl.2007.02.031; MICHAEL AJ, 1987, J GEOPHYS RES-SOLID, V92, P7963, DOI 10.1029/JB092iB08p07963; BOATWRIGHT J, 1978, B SEISMOL SOC AM, V68, P1117; Doke R., 2012, ACT FAULT RES, V37, P1; Fukuyama E., 1998, ZISIN, V51, P149; Hardebeck J.L., 2006, J GEOPHYS RES, V111; Ide S., 2003, J GEOPHYS RES, V108; Imanishi K, 2006, EARTH PLANETS SPACE, V58, P831; ISHIDA M, 1992, J GEOPHYS RES-SOL EA, V97, P489, DOI 10.1029/91JB02567; Kawanishi R., 2009, J GEOPHYS RES, V114; Kubo A., 2007, CHIKYU MON S, V57, P77; McCalpin J.P., 1996, INT GEOPHYS, V62, P439; Miyoshi Takaynki, 2008, Quaternary Research (Tokyo), V47, P223; Nakata T., 2002, DIGITAL ACTIVE FAULT; Obara K., 2005, REV SCI INSTRUM, V76; SIBSON RH, 1985, J STRUCT GEOL, V7, P751, DOI 10.1016/0191-8141(85)90150-6; Tada T., 1993, MEM GEOL SOC JPN, V41, P1; Terakawa T, 2013, TECTONOPHYSICS, V608, P138, DOI 10.1016/j.tecto.2013.10.005; Terakawa T, 2010, GEOLOGY, V38, P995, DOI 10.1130/G31457.1; Terakawa T., 2010, TECTONICS, V29; The Research Group for Active Faults of Japan, 1991, ACT FAULTS JAP; Tsukahara H., 1991, J SEISMOL SOC JPN, V44, P221; Tsutsumi H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL054094; Ukawa M., 1984, RES NOTES NATL RES C, V53, P1; Yamashita F, 2004, SCIENCE, V306, P261, DOI 10.1126/science.1101771	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-821X	1385-013X		EARTH PLANET SC LETT	Earth Planet. Sci. Lett.	FEB 1	2015	411						188	198		10.1016/j.epsl.2014.12.005		11	Geochemistry & Geophysics	Geochemistry & Geophysics	CA8UX	WOS:000349197500019		
J	Teranishi, Y				Teranishi, Yuki			SMOOTHED INTEREST RATE SETTING BY CENTRAL BANKS AND STAGGERED LOAN CONTRACTS	ECONOMIC JOURNAL			English	Article							OPTIMAL MONETARY-POLICY; RATE PASS-THROUGH; STICKY PRICE MODELS; REAL EXCHANGE-RATE; MACROECONOMIC STABILITY; COST CHANNEL; TRANSMISSION; COMPETITION; INFLATION; FRAMEWORK	I investigate a new source of economic stickiness: namely, staggered loan interest rate contracts under monopolistic competition. This study introduces this mechanism into a standard new Keynesian model. Simulations show that a response to a financial shock is greatly amplified by the staggered loan contracts, although a response to a productivity, cost-push or monetary policy shock is not much affected. I derive an approximated loss function and analyse optimal monetary policy. Unlike other models, the function includes a quadratic loss of the first-order difference in loan rates. Thus, central banks have an incentive to smooth the policy rate.	[Teranishi, Yuki] Keio Univ, Tokyo 1080073, Japan	Teranishi, Y (reprint author), Keio Univ, Dept Business & Commerce, Minato Ku, 2-14-45 Mita, Tokyo 1080073, Japan.	yukitera@fbc.keio.ac.jp					Chari VV, 2002, REV ECON STUD, V69, P533, DOI 10.1111/1467-937X.00216; Steinsson J, 2008, AM ECON REV, V98, P519, DOI 10.1257/aer.98.1.519; DIXIT AK, 1977, AM ECON REV, V67, P297; Erceg CJ, 2000, J MONETARY ECON, V46, P281, DOI 10.1016/S0304-3932(00)00028-3; Aoki K, 2001, J MONETARY ECON, V48, P55, DOI 10.1016/S0304-3932(01)00069-1; BERGER AN, 1992, J POLIT ECON, V100, P1047, DOI 10.1086/261851; Bernanke BS, 1999, HANDB ECON, V15, P1341; Orphanides A, 2004, J MONEY CREDIT BANK, V36, P151, DOI 10.1353/mcb.2004.0013; Gerali A, 2010, J MONEY CREDIT BANK, V42, P107, DOI 10.1111/j.1538-4616.2010.00331.x; Sander H, 2004, J INT MONEY FINANC, V23, P461, DOI 10.1016/j.jimonfin.2004.02.001; Kobayashi T, 2008, INT J CENT BANK, V4, P77; Gambacorta L, 2008, EUR ECON REV, V52, P792, DOI 10.1016/j.euroecorev.2007.06.022; Ravenna F, 2006, J MONETARY ECON, V53, P199, DOI 10.1016/j.jmoneco.2005.01.004; Rotemberg JJ, 1997, NBER MACROECON ANNU, V12, P297, DOI 10.2307/3585236; Benigno P, 2004, J INT ECON, V63, P293, DOI 10.1016/S0022-1996(03)00055-2; Bank of Japan, 2008, BANK JAP REP RES PAP; Bank of Japan, 2007, BANK JAP REP RES PAP; CALVO GA, 1983, J MONETARY ECON, V12, P383, DOI 10.1016/0304-3932(83)90060-0; Christiano L., 2007, WORKING PAPER SERIES, V214; Christiano L., 2007, SHOCKS STRUCTU UNPUB; Clarida R, 2000, Q J ECON, V115, P147, DOI 10.1162/003355300554692; Fujiwara I, 2011, J INT MONEY FINANC, V30, P1562, DOI 10.1016/j.jimonfin.2011.06.013; Giannoni M., 2000, OPTIMAL INTERE UNPUB; GOODFRIEND M, 1991, CARN ROCH CONF SERIE, V34, P7, DOI 10.1016/0167-2231(91)90002-M; Graham L., 2007, BE J MACROECON, V7, P1; Gropp R., 2007, WORKING PAPER SERIES, V714; Hulsewig O, 2009, ECON MODEL, V26, P1310, DOI 10.1016/j.econmod.2009.06.007; Judd J. P., 1998, ECON REV, V3, P3; Steinsson J, 2003, J MONETARY ECON, V50, P1425, DOI 10.1016/j.jmoneco.2003.08.008; Van Leuvensteijn M., 2008, WORKING PAPER SERIES, V885; Woodford M, 2003, REV ECON STUD, V70, P861, DOI 10.1111/1467-937X.00270; Woodford M, 2003, INTEREST AND PRICES: FOUNDATIONS OF A THEORY OF MONETARY POLICY, P1; Yun T, 1996, J MONETARY ECON, V37, P345, DOI 10.1016/S0304-3932(96)90040-9	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-0133	1468-0297		ECON J	Econ. J.	FEB	2015	125	582					162	183		10.1111/ecoj.12092		22	Economics	Business & Economics	CA4KD	WOS:000348872200007		
J	Sato, H; Inoue, H; Ikeda, H; Sato, C; Onimaru, M; Hayee, B; Phlanusi, C; Santi, EGR; Kobayashi, Y; Kudo, S				Sato, Hiroki; Inoue, Haruhiro; Ikeda, Haruo; Sato, Chiaki; Onimaru, Manabu; Hayee, BuHussain; Phlanusi, Chainarong; Santi, Esperanza Grace R.; Kobayashi, Yasutoshi; Kudo, Shin-ei			Utility of intrapapillary capillary loops seen on magnifying narrow-band imaging in estimating invasive depth of esophageal squamous cell carcinoma	ENDOSCOPY			English	Article							ENDOSCOPIC MUCOSAL RESECTION; MICROVASCULAR ARCHITECTURE; CANCER; FEATURES; LESIONS; SYSTEM	Background and study aims: Intrapapillary capillary loops (IPCLs) have been used to estimate histopathological atypia and the invasion depth of squamous cell carcinoma (SCC). The aim of this study was to evaluate the clinical significance of IPCLs. Patients and methods: A total of 358 consecutive patients with esophageal neoplasia on magnifying narrow-band imaging (M-NBI) were studied. The lesions were categorized according to the IPCL classification of Inoue et al. and were subsequently resected. Resected specimens were histopathologically analyzed to determine the invasion depth. The inter-and intraobserver agreements in the interpretation of IPCL images were also investigated. Results: A total of 446 lesions were diagnosed on M-NBI as IPCL type V lesions, which were further classified as 185 IPCL type V1, 109 type V2, 104 type V3, and 48 type Vn. Sensitivity and specificity of IPCL type V1-2 for invasion confined to the epithelium or lamina propria mucosa (m1-2) were 89.5% (95% confidence interval [CI] 85.4%92.7 %) and 79.6% (95 % CI 72.3%-85.7 %), respectively. Sensitivity and specificity of IPCL type V3 for invasion confined to the muscularis mucosa or slight submucosal invasion (m3-sm1) were 58.7% and 83.8 %, respectively. Sensitivity and specificity of IPCL type Vn for deeper invasion (sm2-3) were 55.8% and 98.6 %, respectively. Interobserver agreement was substantial (kappa=0.609, 0.641, and 0.705), as was intraobserver agreement (kappa=0.705 and kappa=0.819). Conclusion: Changes in the morphology of IPCLs on M-NBI correlated with the depth of SCC invasion, and results were reproducible and reliable among observers. Identification of IPCL type V1-2 proved useful for the intraprocedural identification of m1-2 lesions, which are considered an absolute indication for endoscopic resection.	[Sato, Hiroki; Inoue, Haruhiro; Ikeda, Haruo; Sato, Chiaki; Onimaru, Manabu; Phlanusi, Chainarong; Kudo, Shin-ei] Showa Univ, Ctr Digest Dis, Northern Yokohama Hosp, Yokohama, Kanagawa 2248503, Japan; [Hayee, BuHussain] Kings Coll Hosp NHS Fdn Trust, Dept Gastroenterol, London, England; [Santi, Esperanza Grace R.] De La Salle Univ, Med Ctr, Dept Gastroenterol, Manila 1004, Philippines; [Kobayashi, Yasutoshi] Kobayashi Internal Med Clin, Kobe, Hyogo, Japan	Inoue, H (reprint author), Showa Univ, Ctr Digest Dis, Northern Yokohama Hosp, Tsuzuki Ku, 35-1 Chigasakichuo, Yokohama, Kanagawa 2248503, Japan.	haruinoue777@gmail.com					[Anonymous], 2003, GASTROINTEST ENDOSC, V58, P3; Muto M, 2010, J CLIN ONCOL, V28, P1566, DOI 10.1200/JCO.2009.25.4680; Yoshida T, 2004, GASTROINTEST ENDOSC, V59, P288, DOI 10.1016/S0016-5107(03)02532-X; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Rice TW, 2010, ANN SURG ONCOL, V17, P1721, DOI 10.1245/s10434-010-1024-1; Higuchi K, 2007, ENDOSCOPY, V39, P36, DOI 10.1055/s-2006-945148; Kumagai Y, 2002, LANCET ONCOL, V3, P604, DOI 10.1016/S1470-2045(02)00874-4; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Eguchi T, 2006, MODERN PATHOL, V19, P475, DOI 10.1038/modpathol.3800557; Araki K, 2002, CANCER, V94, P570, DOI 10.1002/cncr.10190; Arima M, 2005, ESOPHAGUS, V2, P191, DOI DOI 10.1007/S10388-005-0060-6; Bosman FT, 2010, WHO CLASSIFICATION T; Chai NL, 2012, WORLD J GASTROENTERO, V18, P1295, DOI 10.3748/wjg.v18.i12.1295; Ide E, 2013, J ONCOL, V2013; Inoue H, 2001, DIGEST ENDOSC, V13, P40; Inoue Haruhiro, 2003, Stomach and Intestine (Tokyo), V38, P1629; Inoue H, 1997, DIGEST ENDOSC, V9/1, P16, DOI 10.1111/j.1443-1661.1997.tb00453.x; Inoue H, 1996, DIGEST ENDOSC, V8, P134, DOI 10.1111/j.1443-1661.1996.tb00429.x; Inoue Haruhiro, 2007, Kyobu Geka, V60, P768; Kaga M, 2011, ONCOL REP, V26, P1063, DOI 10.3892/or.2011.1398; Kumagai Y, 2010, DIGEST ENDOSC, V22, P259, DOI 10.1111/j.1443-1661.2010.01010.x; Kumagai Y, 2002, ENDOSCOPY, V34, P369, DOI 10.1055/s-2002-25285; Minami H, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/529782; Oyama T, 2012, GASTROINTEST ENDOSC, V75, pAB456; Oyama Tsuneo, 2002, Stomach and Intestine (Tokyo), V37, P71; Santi EGR, 2013, ENDOSCOPY, V45, P585, DOI 10.1055/s-0033-1344228; Takemura Y, 2012, GASTROINTEST ENDOSC, V75, P179, DOI 10.1016/j.gie.2011.08.051; The Japan Esophageal Society, 2008, JAP CLASS ES CANC ES; The Japan Society, 2010, GUID CLIN PATH STUD	30	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	FEB	2015	47	2					122	128		10.1055/s-0034-1390858		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CA2YF	WOS:000348771300006		
J	Nonaka, S; Oda, I; Tada, K; Mori, G; Sato, Y; Abe, S; Suzuki, H; Yoshinaga, S; Nakajima, T; Matsuda, T; Taniguchi, H; Saito, Y; Maetani, I				Nonaka, Satoru; Oda, Ichiro; Tada, Kazuhiro; Mori, Genki; Sato, Yoshinori; Abe, Seiichiro; Suzuki, Haruhisa; Yoshinaga, Shigetaka; Nakajima, Takeshi; Matsuda, Takahisa; Taniguchi, Hirokazu; Saito, Yutaka; Maetani, Iruru			Clinical outcome of endoscopic resection for nonampullary duodenal tumors	ENDOSCOPY			English	Article							EARLY GASTRIC-CANCER; SUBMUCOSAL DISSECTION; MUCOSAL RESECTION; SODIUM HYALURONATE; NEOPLASMS; ADENOMAS; CARCINOMA; SESSILE; POLYPS; EMR	Background and study aims: Compared with any other location in the gastrointestinal tract, the duodenum presents the most challenging site for endoscopic resection. The aim of this study was to analyze the clinical outcomes of duodenal endoscopic resection and to assess the feasibility of the technique as a therapeutic procedure. Patients and methods: A total of 113 consecutive patients with 121 nonampullary duodenal tumors underwent endoscopic resection by endoscopic submucosal dissection (ESD), endoscopic mucosal resection (EMR), or polypectomy between January 2000 and September 2013. Longterm outcomes were investigated in patients with more than 1 year follow-up. Results: The median tumor size was 12 mm (range 3-50 mm). Lesions consisted of 63 adenocarcinomas/high-grade intraepithelial neoplasias (53 %) and 57 adenomas/low-grade intraepithelial neoplasias (48 %). Endoscopic resection included 106 EMRs (87 %), 8 ESDs (7 %), and 7 polypectomies (6 %). En bloc resection was achieved in 77 lesions (64 %), and 43 lesions (35 %) underwent piecemeal resection; one procedure was discontinued due to perforation. There were 14 cases of delayed bleeding after EMR (12 %), 1 perforation (1 %) during ESD, and 1 delayed perforation (1 %) after ESD, which required emergency surgery. Of the 76 patients who were followed for more than 1 year, none of the patients died from a primary duodenal neoplasm, and there were no local recurrences during the 51-month median follow-up period (range 12-163 months). Conclusions: Duodenal endoscopic resection was feasible as a therapeutic procedure, but it should only be performed by highly skilled endoscopists because of its technical difficulty. Piecemeal resection by EMR is acceptable for small lesions, based on these excellent long-term outcomes.	[Nonaka, Satoru; Oda, Ichiro; Tada, Kazuhiro; Mori, Genki; Sato, Yoshinori; Abe, Seiichiro; Suzuki, Haruhisa; Yoshinaga, Shigetaka; Nakajima, Takeshi; Matsuda, Takahisa; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo 1040045, Japan; [Taniguchi, Hirokazu] Natl Canc Ctr, Div Pathol, Tokyo 1040045, Japan; [Maetani, Iruru] Toho Univ, Dept Internal Med, Div Gastroenterol, Ohashi Med Ctr, Tokyo, Japan	Nonaka, S (reprint author), Natl Canc Ctr, Endoscopy Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	snonaka@ncc.go.jp					Saito Y, 2007, GASTROINTEST ENDOSC, V66, P966, DOI 10.1016/j.gie.2007.02.053; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Fujishiro M, 2006, GASTROINTEST ENDOSC, V63, P243, DOI 10.1016/j.gie.2005.08.002; Alexander S, 2009, GASTROINTEST ENDOSC, V69, P66, DOI 10.1016/j.gie.2008.04.061; Yamamoto H, 2008, GASTROINTEST ENDOSC, V67, P830, DOI 10.1016/j.gie.2007.07.039; Matsuda T, 2004, GASTROINTEST ENDOSC, V60, P836, DOI 10.1016/S0016-5107(04)02033-4; Fujishiro M, 2009, DIGEST ENDOSC, V21, P109, DOI 10.1111/j.1443-1661.2009.00837.x; Jung JH, 2013, ENDOSCOPY, V45, P133, DOI 10.1055/s-0032-1326178; Nonaka S, 2010, SURG ENDOSC, V24, P1638, DOI 10.1007/s00464-009-0824-5; Fujishiro M, 2004, ENDOSCOPY, V36, P584, DOI 10.1055/s-2004-814524; Maruoka D, 2013, ENDOSCOPY, V45, P138, DOI 10.1055/s-0032-1325799; Oka S, 2003, J CLIN GASTROENTEROL, V37, P381, DOI 10.1097/00004836-200311000-00006; Apel D, 2005, ENDOSCOPY, V37, P444, DOI 10.1055/s-2005-861287; Kedia P, 2010, GASTROINTEST ENDOSC, V72, P1297, DOI 10.1016/j.gie.2010.07.039; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Gotoda T, 1999, GASTROINTEST ENDOSC, V50, P560, DOI 10.1016/S0016-5107(99)70084-2; Abbass R, 2010, GASTROINTEST ENDOSC, V71, P754, DOI 10.1016/j.gie.2009.11.043; Fujishiro M, 2004, ENDOSCOPY, V36, P579, DOI 10.1055/s-2004-814517; JEPSEN JM, 1994, SCAND J GASTROENTERO, V29, P483, DOI 10.3109/00365529409092458; Fanning SB, 2012, GASTROINTEST ENDOSC, V75, P805, DOI 10.1016/j.gie.2011.11.038; Lepilliez V, 2008, ENDOSCOPY, V40, P806, DOI 10.1055/s-2008-1077619; CORTESE AF, 1972, CANCER, V29, P1010, DOI 10.1002/1097-0142(197204)29:4<1010::AID-CNCR2820290448>3.0.CO;2-6; Endo M, 2010, DIGEST ENDOSC, V22, P360, DOI 10.1111/j.1443-1661.2010.01014.x; Honda T, 2009, DIGEST ENDOSC, V21, P270, DOI 10.1111/j.1443-1661.2009.00908.x; Hoteya S, 2013, ENDOSCOPY INT OPEN, V1, pE2; Inoue T, 2014, DIGEST ENDOSC, V26, P220, DOI 10.1111/den.12104; Matsumoto S, 2012, ENDOSCOPY, V45, P136; OBATA S, 1992, ENDOSCOPY, V24, P232, DOI 10.1055/s-2007-1010470; Oda Ichiro, 2006, Gastric Cancer, V9, P262, DOI 10.1007/s10120-006-0389-0; Sakamoto T, 2011, CLIN GASTROENTEROL H, V10, P22; Sohn JW, 2010, SURG ENDOSC, V24, P3195, DOI 10.1007/s00464-010-1114-y; TADA M, 1993, ENDOSCOPY, V25, P445, DOI 10.1055/s-2007-1010365; Yamamoto Y, 2014, DIGEST ENDOSC, V26, P50, DOI 10.1111/den.12273	33	4	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	FEB	2015	47	2					129	135		10.1055/s-0034-1390774		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CA2YF	WOS:000348771300007		
J	Odagiri, H; Matsui, H; Fushimi, K; Kaise, M; Yasunaga, H				Odagiri, Hiroyuki; Matsui, Hiroki; Fushimi, Kiyohide; Kaise, Mitsuru; Yasunaga, Hideo			Factors associated with perforation related to diagnostic balloon-assisted enteroscopy: analysis of a national inpatient database in Japan	ENDOSCOPY			English	Article							ENDOSCOPY; EXPERIENCE; DISEASES	Background and study aims: Balloon-assisted enteroscopy (BAE) is a well-established procedure that is used worldwide for investigation of the small intestine. Previous reports describing the factors associated with perforation related to diagnostic BAE were limited by inclusion of only small numbers of patients who were mostly treated at a few specialized centers. The aim of this study was to clarify the factors associated with perforation by analysis of a large multicenter database. Patients and methods: This study retrospectively analyzed data from the Diagnosis Procedure Combination database in Japan. Patients who underwent diagnostic BAE between July 2007 and March 2013 were included. The primary outcome was the occurrence of perforation requiring open surgery. Logistic regression analysis was used to identify factors associated with perforation. Results: A total of 29 068 patients who underwent diagnostic BAE during the study period were identified. Perforation occurred in 32 patients (0.11 %). Univariable logistic regression analysis showed that patients with inflammatory bowel disease (IBD) on steroids had a significantly higher risk of perforation (odds ratio 8.55; 95% confidence interval 2.87-25.5; P<0.001). Non-IBD patients on steroids had an approximately threefold higher risk of perforation compared with patients who were free from IBD and not taking steroids. Conclusion: Our results suggest that patients with IBD who are using steroids have the highest risk of perforation related to diagnostic BAE.	[Odagiri, Hiroyuki; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan; [Kaise, Mitsuru] Toranomon Gen Hosp, Dept Gastroenterol, Tokyo, Japan	Yasunaga, H (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasunagah-tky@umin.ac.jp		Odagiri, Hiroyuki/0000-0003-1708-4944; Yasunaga, Hideo/0000-0002-6017-469X			Yamamoto H, 2001, GASTROINTEST ENDOSC, V53, P216, DOI 10.1067/mge.2001.112181; Mehdizadeh S, 2007, GASTROINTEST ENDOSC, V65, P633, DOI 10.1016/j.gie.2006.12.038; Mensink PBF, 2007, ENDOSCOPY, V39, P613, DOI 10.1055/s-2007-966444; Mehdizadeh S, 2006, GASTROINTEST ENDOSC, V64, P740, DOI 10.1016/j.gie.2006.05.022; Takano N, 2011, GASTROINTEST ENDOSC, V73, P734, DOI 10.1016/j.gie.2010.10.047; Sunada K, 2009, J GASTROENTEROL, V44, P1, DOI 10.1007/s00535-008-2292-4; Yamamoto H, 2004, CLIN GASTROENTEROL H, V2, P1010, DOI 10.1053/S1542-3565(04)00453-7; Upchurch BR, 2010, GASTROINTEST ENDOSC, V71, P1218, DOI 10.1016/j.gie.2010.01.012; Araki A, 2009, J GASTROEN HEPATOL, V24, P770, DOI 10.1111/j.1440-1746.2009.05787.x; Chen LH, 2010, WORLD J GASTROENTERO, V16, P1655, DOI 10.3748/wjg.v16.i13.1655; Gerson LB, 2009, CLIN GASTROENTEROL H, V7, P1177, DOI 10.1016/j.cgh.2009.07.005; Gurkan OE, 2013, WORLD J GASTROENTERO, V19, P4726, DOI 10.3748/wjg.v19.i29.4726; Maruyama S, 1999, CELL IMMUNOL, V194, P28, DOI 10.1006/cimm.1999.1492; Matsuda S., 2008, Eurohealth, V14, P25; Navaneethan U, 2012, J CROHNS COLITIS, V6, P470, DOI 10.1016/j.crohns.2011.10.005; Pata C, 2010, TURK J GASTROENTEROL, V21, P353, DOI 10.4318/tjg.2010.0120; Rondonotti E, 2012, DIGEST ENDOSC, V24, P209, DOI 10.1111/j.1443-1661.2012.01240.x	17	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0013-726X	1438-8812		ENDOSCOPY	Endoscopy	FEB	2015	47	2					143	146		10.1055/s-0034-1390891		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CA2YF	WOS:000348771300009		
J	Aziz, M				Aziz, Muhammad			Integrated supercritical water gasification and a combined cycle for microalgal utilization	ENERGY CONVERSION AND MANAGEMENT			English	Article						Microalgae; Enhanced process integration; Supercritical water gasification; Combined cycle; Energy efficiency	HYDROTHERMAL BIOMASS GASIFICATION; HYDROGEN-PRODUCTION; FLUIDIZED-BED; COAL; ENERGY; PYROLYSIS; REACTOR; DESIGN; SYNGAS; ALGAE	Integrated energy utilization processes for microalgae based on enhanced process integration are proposed in this study. They consist of supercritical water gasification and combined cycle for power generation. The enhanced process integration is developed based on exergy recovery and process integration technologies. Exergy recovery deals with effective heat circulation throughout a single process which is achieved by exergy elevation and efficient heat coupling. In addition, process integration utilizes the unrecoverable heat from a single process for other processes, thus minimizing the total exergy destruction of the whole integrated processes. Microalga Spirulina sp. is selected as the sample due to its higher gasification and carbon conversion efficiencies than any other microalgae. Process simulation is performed to evaluate the total energy efficiency, specifically the effect of steam flow rate (fluidization velocity), gasification pressure and turbine inlet temperature. Simulation reveals that the proposed integrated processes harvest the energy from microalgae with total energy efficiency exceeding 40%. A temperature-enthalpy diagram shows that the heat involved in the whole processes is recovered effectively. (C) 2014 Elsevier Ltd. All rights reserved.	Tokyo Inst Technol, Solut Res Lab, Meguro Ku, Tokyo 1528550, Japan	Aziz, M (reprint author), Tokyo Inst Technol, Solut Res Lab, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	maziz@ssr.titech.ac.jp	Aziz, Muhammad/B-9248-2015	Aziz, Muhammad/0000-0003-2433-8500			Amin S, 2009, ENERG CONVERS MANAGE, V50, P1834, DOI 10.1016/j.enconman.2009.03.001; Lee JC, 2014, ENERGY, V64, P58, DOI 10.1016/j.energy.2013.11.069; Chakinala AG, 2010, IND ENG CHEM RES, V49, P1113, DOI 10.1021/ie9008293; Kiran B, 2014, ENERG CONVERS MANAGE, V88, P1228, DOI 10.1016/j.enconman.2014.06.022; Chen YA, 2013, INT J HYDROGEN ENERG, V38, P12991, DOI 10.1016/j.ijhydene.2013.03.165; Matsumura Y, 2005, BIOMASS BIOENERG, V29, P269, DOI 10.1016/j.biombioe.2005.04.006; Karayildirim T, 2008, CHEM ENG TECHNOL, V31, P1561, DOI 10.1002/ceat.200800278; Schmieder H, 2000, J SUPERCRIT FLUID, V17, P145, DOI 10.1016/S0896-8446(99)00051-0; Miller A, 2012, BIORESOURCE TECHNOL, V119, P41, DOI 10.1016/j.biortech.2012.05.005; Fiori L, 2012, BIORESOURCE TECHNOL, V121, P139, DOI 10.1016/j.biortech.2012.06.116; Matsumura Y, 2004, INT J HYDROGEN ENERG, V29, P701, DOI 10.1016/j.ijhydene.2003.09.005; Chaiwong K, 2012, MAEJO INT J SCI TECH, V6, P186; Calzavara Y, 2005, ENERG CONVERS MANAGE, V46, P615, DOI 10.1016/j.enconman.2004.04.003; Alghurabie IK, 2013, CHEM ENG RES DES, V91, P1614, DOI 10.1016/j.cherd.2013.04.024; Bilanovic D, 2012, ENERG CONVERS MANAGE, V58, P104, DOI 10.1016/j.enconman.2012.01.007; McGinn PJ, 2011, PHOTOSYNTH RES, V109, P231, DOI 10.1007/s11120-011-9638-0; Sorguven E, 2010, RENEW ENERG, V35, P1956, DOI 10.1016/j.renene.2010.01.024; Liao B, 2013, INT J HYDROGEN ENERG, V38, P13038, DOI 10.1016/j.ijhydene.2013.03.113; Kruse A, 2009, J SUPERCRIT FLUID, V47, P391, DOI 10.1016/j.supflu.2008.10.009; Rosch C, 2012, BIORESOURCE TECHNOL, V107, P191, DOI 10.1016/j.biortech.2011.12.016; Lu YJ, 2013, INT J MULTIPHAS FLOW, V49, P78, DOI 10.1016/j.ijmultiphaseflow.2012.10.005; Lu YJ, 2007, CHEM ENG J, V131, P233, DOI 10.1016/j.cej.2006.11.016; Wei LP, 2013, INT J HYDROGEN ENERG, V38, P13117, DOI 10.1016/j.ijhydene.2013.01.148; Cormos CC, 2011, INT J HYDROGEN ENERG, V36, P5960, DOI 10.1016/j.ijhydene.2011.01.170; Haiduc AG, 2009, J APPL PHYCOL, V21, P529, DOI 10.1007/s10811-009-9403-3; Lu YJ, 2008, INT J HYDROGEN ENERG, V33, P6066, DOI 10.1016/j.ijhydene.2008.07.082; Guan QQ, 2012, J SUPERCRIT FLUID, V61, P139, DOI 10.1016/j.supflu.2011.09.007; Kersten SRA, 2006, IND ENG CHEM RES, V45, P4169, DOI 10.1021/ie0509490; Aziz M, 2014, ENERGY, V70, P307, DOI 10.1016/j.energy.2014.03.126; Aziz M, 2014, DRY TECHNOL, V32, P1621, DOI 10.1080/07373937.2014.915219; Aziz M, 2015, APPL ENERG, V139, P188, DOI 10.1016/j.apenergy.2014.11.038; Aziz M., 2012, APPL ENERG, V109, P163; Craig KR, 1996, TP43021657 NREL; Descamps C, 2012, ENERGY, V33, P874; Grabner M, 2010, ENERG CONVERS MANAGE, V51, P2179, DOI 10.1016/j.enconman.2010.03.011; Guo LJ, 2010, BIOMASS, P165; Hendry D, 2011, BIORESOURCE TECHNOL, V102, P3480, DOI 10.1016/j.biortech.2010.11.003; Hu ZF, 2014, ENERG CONVERS MANAGE, V85, P545, DOI 10.1016/j.enconman.2014.04.096; Kim YS, 2011, ENERG CONVERS MANAGE, V52, P2262, DOI 10.1016/j.enconman.2011.01.009; Kruse A, 2008, BIOFUEL BIOPROD BIOR, V2, P415, DOI 10.1002/bbb.93; Kumar S., 2012, SCI ALGAL FUELS, P467; Kunii D., 1991, FLUIDIZATION ENG; Matsumura Y, 2002, ENERG CONVERS MANAGE, V43, P1301, DOI 10.1016/S0196-8904(02)00016-X; Ventikasamy C, 2011, FUEL, V90, P2662; Vogel F., 2010, HDB GREEN CHEM, V3, P281	45	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0196-8904	1879-2227		ENERG CONVERS MANAGE	Energy Conv. Manag.	FEB	2015	91						140	148		10.1016/j.enconman.2014.12.012		9	Thermodynamics; Energy & Fuels; Mechanics; Physics, Nuclear	Thermodynamics; Energy & Fuels; Mechanics; Physics	CA4PM	WOS:000348887000014		
J	Wan, YJ; Wu, Q; Abualnaja, KO; Asimakopoulos, AG; Covaci, A; Gevao, B; Johnson-Restrepo, B; Kumosani, TA; Malarvannan, G; Moon, HB; Nakata, H; Sinha, RK; Minh, TB; Kannan, K				Wan, Yanjian; Wu, Qian; Abualnaja, Khalid O.; Asimakopoulos, Alexandros G.; Covaci, Adrian; Gevao, Bondi; Johnson-Restrepo, Boris; Kumosani, Taha A.; Malarvannan, Govindan; Moon, Hyo-Bang; Nakata, Haruhiko; Sinha, Ravindra K.; Tu Binh Minh; Kannan, Kurunthachalam			Occurrence of perchlorate in indoor dust from the United States and eleven other countries: Implications for human exposure	ENVIRONMENT INTERNATIONAL			English	Article						Perchlorate; Indoor dust; Human exposure; Global survey	POLYBROMINATED DIPHENYL ETHERS; THYROID-HORMONE LEVELS; DRINKING-WATER; BOTTLED WATER; HUMAN SALIVA; HOUSE-DUST; TAP WATER; CHINA; NITRATE; IODIDE	Perchlorate is a widespread environmental contaminant and potent thyroid hormone disrupting compound. Despite this, very little is known with regard to the occurrence of this compound in indoor dust and the exposure of humans to perchlorate through dust ingestion. In this study, 366 indoor dust samples were collected from 12 countries, the USA, Colombia, Greece, Romania, Japan, Korea, Pakistan, Kuwait, Saudi Arabia, India, Vietnam, and China, during 2010-2014. Dust samples were extracted by 1% (v/v) methylamine in water. Analyte separation was achieved by an ion exchange (AS-21) column and analysis was performed by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The overall concentrations of perchlorate in dust were in the range of 0.02-104 mu g/g (geometric mean: 0.41 mu g/g). The indoor dust samples from China contained the highest concentrations (geometric mean: 5.38 mu g/g). No remarkable differences in perchlorate concentrations in dust were found among various microenvironments (i.e., car, home, office, and laboratory). The estimated median daily intake (EDI) of perchlorate for toddlers through dust ingestion in the USA, Colombia, Greece, Romania, Japan, Korea, Pakistan, Kuwait, Saudi Arabia, India, Vietnam, and China was 1.89, 0.37, 1.71, 0.74, 4.90, 720, 0.60, 0.80, 1.55, 0.70, 2.15, and 21.3 ng/kg body weight (bw)/day, respectively. Although high concentrations of perchlorate were measured in some dust samples, the contribution of dust to total perchlorate intake was <5% of the total perchlorate intake in humans. This is the first multinational survey on the occurrence of perchlorate in indoor dust. (C) 2014 Elsevier Ltd. All rights reserved.	[Wan, Yanjian; Wu, Qian; Asimakopoulos, Alexandros G.; Kannan, Kurunthachalam] SUNY Albany, Sch Publ Hlth, Wadsworth Ctr, New York State Dept Hlth, Albany, NY 12201 USA; [Wan, Yanjian; Wu, Qian; Asimakopoulos, Alexandros G.; Kannan, Kurunthachalam] SUNY Albany, Sch Publ Hlth, Dept Environm Hlth Sci, Albany, NY 12201 USA; [Wan, Yanjian] Gen Hosp Yangtze River Shipping, CDC Changjiang River Adm & Nav Affairs, Wuhan 430019, Peoples R China; [Abualnaja, Khalid O.; Kumosani, Taha A.; Kannan, Kurunthachalam] King Abdulaziz Univ, Fac Sci, King Fand Med Res Ctr, Dept Biochem,Expt Biochem Unit, Jeddah 21589, Saudi Arabia; [Abualnaja, Khalid O.; Kannan, Kurunthachalam] King Abdulaziz Univ, Bioact Nat Prod Res Grp, Jeddah 21589, Saudi Arabia; [Covaci, Adrian; Malarvannan, Govindan] Univ Antwerp, Toxicol Ctr, B-2610 Antwerp, Belgium; [Gevao, Bondi] Kuwait Inst Sci Res, Environm & Life Sci Ctr, Environm Management Program, Safat 13109, Kuwait; [Johnson-Restrepo, Boris] Univ Cartagena, Environm & Chem Grp, Cartagena 130015, Bolivar, Colombia; [Kumosani, Taha A.] King Abdulaziz Univ, Prod Bioprod Ind Applicat Res Grp, Jeddah 21413, Saudi Arabia; [Moon, Hyo-Bang] Hanyang Univ, Coll Sci & Technol, Dept Marine Sci & Convergent Technol, Ansan, South Korea; [Nakata, Haruhiko] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Sinha, Ravindra K.] Univ Patna, Dept Zool, Patna 800005, Bihar, India; [Tu Binh Minh] Vietnam Natl Univ Hanoi, Hanoi Univ Sci, Fac Chem, Hanoi, Vietnam	Kannan, K (reprint author), Wadsworth Ctr, Empire State Plaza,POB 509, Albany, NY 12201 USA.	kkannan@wadsworth.org			Centers for Disease Control and Prevention (CDC, Atlanta, GA) [1U38EH000464-01]	The authors thank Pierina Maza-Anaya, a youth research fellow supported by the Colombian National Science and Technology System, for helping with dust sample collection from Colombia; Dr. Dilip Kumar Kedia helped with collection of dust samples from India. This study was funded by a grant (1U38EH000464-01) from the Centers for Disease Control and Prevention (CDC, Atlanta, GA) to Wadsworth Center, New York State Department of Health, where the study was conceived and performed. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.	Hseu ZY, 2004, BIORESOURCE TECHNOL, V95, P53, DOI 10.1016/j.biortech.2004.02.008; Mendez W, 2012, ENVIRON RES, V118, P137, DOI 10.1016/j.envres.2012.05.010; Wu Q, 2010, ARCH ENVIRON CON TOX, V58, P543, DOI 10.1007/s00244-010-9485-6; Wang ZW, 2009, J AGR FOOD CHEM, V57, P9250, DOI 10.1021/jf901910x; Greer MA, 2002, ENVIRON HEALTH PERSP, V110, P927; Johnson-Restrepo B, 2009, CHEMOSPHERE, V76, P542, DOI 10.1016/j.chemosphere.2009.02.068; Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596; Rao B, 2010, ENVIRON SCI TECHNOL, V44, P2961, DOI 10.1021/es903065f; Blount BC, 2007, J EXPO SCI ENV EPID, V17, P400, DOI 10.1038/sj.jes.7500535; Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; Motzer WE, 2001, ENVIRON FORENSICS, V2, P301, DOI 10.1006/enfo.2001.0059; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3788, DOI 10.1021/es2002106; Dohan O, 2007, P NATL ACAD SCI USA, V104, P20250, DOI 10.1073/pnas.0707207104; Voogt W, 2010, J AGR FOOD CHEM, V58, P12192, DOI 10.1021/jf101227d; Gilbert ME, 2008, ENVIRON HEALTH PERSP, V116, P752, DOI 10.1289/ehp.11089; Zewdie T, 2010, ENVIRON HEALTH PERSP, V118, P42, DOI 10.1289/ehp.0900635; Blount BC, 2010, ENVIRON SCI TECHNOL, V44, P9564, DOI 10.1021/es1025195; Huber DR, 2011, J EXPO SCI ENV EPID, V21, P395, DOI 10.1038/jes.2010.31; Shi YL, 2007, ENVIRON INT, V33, P955, DOI 10.1016/j.envint.2007.05.007; Blount BC, 2009, ENVIRON SCI TECHNOL, V43, P7543, DOI 10.1021/es9008486; Lorber M, 2008, J EXPO SCI ENV EPID, V18, P2, DOI 10.1038/sj.jes.7500572; Zhang T, 2010, ENVIRON SCI TECHNOL, V44, P6947, DOI 10.1021/es101354g; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P9138, DOI 10.1021/es302004w; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282; Geens T, 2009, CHEMOSPHERE, V76, P755, DOI 10.1016/j.chemosphere.2009.05.024; Tonacchera M, 2004, THYROID, V14, P1012, DOI 10.1089/thy.2004.14.1012; Charatcharoenwitthaya N, 2014, J CLIN ENDOCR METAB, V99, P2365, DOI 10.1210/jc.2013-3986; Chen H.X., 2014, ARCH ENV OCCUP HLTH; Eguchi A, 2014, ARCH ENVIRON CON TOX, V67, P29, DOI 10.1007/s00244-014-0021-y; Fisher J, 2000, DRUG CHEM TOXICOL, V23, P243, DOI 10.1081/DCT-100100113; Gan ZW, 2014, SCI TOTAL ENVIRON, V470, P99, DOI 10.1016/j.scitotenv.2013.09.067; Kannan K, 2009, CHEMOSPHERE, V76, P22, DOI 10.1016/j.chemosphere.2009.02.054; Lee JW, 2012, J HAZARD MATER, V243, P52, DOI 10.1016/j.jhazmat.2012.09.037; Oldi JF, 2009, ENVIRON SCI TECHNOL, V43, P142, DOI 10.1021/es802575c; Sanchez CA, 2006, ANAL CHIM ACTA, V567, P33, DOI 10.1016/j.aca.2006.02.013; Urbansky ET, 2001, ENVIRON POLLUT, V112, P299, DOI 10.1016/S0269-7491(00)00132-9; USEPA, 2011, EXP FACT HDB; Valentin-Blasini L, 2011, ENVIRON SCI TECHNOL, V45, P4127, DOI 10.1021/es103160j; Wu FH, 2012, ENVIRON TOXICOL, V27, P445, DOI 10.1002/tox.20655; York RG, 2003, INT J TOXICOL, V22, P453, DOI 10.1080/10915810390256235	40	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-4120	1873-6750		ENVIRON INT	Environ. Int.	FEB	2015	75						166	171		10.1016/j.envint.2014.11.005		6	Environmental Sciences	Environmental Sciences & Ecology	CA2OD	WOS:000348746600017		
J	Chekirbane, A; Tsujimura, M; Kawachi, A; Isoda, H; Tarhouni, J; Benalaya, A				Chekirbane, Anis; Tsujimura, Maki; Kawachi, Atsushi; Isoda, Hiroko; Tarhouni, Jamila; Benalaya, Abdallah			3D simulation of a multi-stressed coastal aquifer, northeast of Tunisia: salt transport processes and remediation scenarios	ENVIRONMENTAL EARTH SCIENCES			English	Article						Salinization; Numerical simulation; SEAWAT; Remediation; Coastal aquifer	SEAWATER INTRUSION; CAP BON; PLAIN; FLOW; SALINIZATION	A salinization of groundwater by oilfield brine and seawater intrusion was detected in the plain of Wadi Al Ayn and Darouda in CapBon, northeast of Tunisia. The objective of this work is to simulate the historical trends of saltwater distribution in the study area and to predict its future dynamics under some proposed countermeasures for remediation. Based on the developed model with SEAWAT, the oilfield brine plume needs at least 5 years to be naturally reduced to less than the half of its actual size, while the seawater-freshwater interface can reach an inland extent of 1.3 km with a TDS of 10 g/L if no countermeasures will be taken until the next three decades. The tested remediation plan by model demonstrated that the artificial recharge with treated wastewater is the best solution to stop seawater intrusion just after 2 years of percolating 1 m/day with TDS of 1.5 g/L of recharge water. The natural remediation of the oilfield brine plume can be enhanced by imposing optimized pumping rates and installation of a restricted pumping perimeter.	[Chekirbane, Anis] Water Res & Technol Ctr CERTE, Soliman 8020, Nabeul, Tunisia; [Tsujimura, Maki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Kawachi, Atsushi; Isoda, Hiroko] Univ Tsukuba, Alliance Res North Africa ARENA, Tsukuba, Ibaraki 3058577, Japan; [Tarhouni, Jamila] Univ Carthage, Natl Agron Inst Tunisia, Tunis 1082, Tunisia; [Benalaya, Abdallah] Univ Carthage, Higher Sch Agr Mograne ESAM, Mograne 1121, Zaghouan, Tunisia	Chekirbane, A (reprint author), Water Res & Technol Ctr CERTE, Borj Cedria Technopk,BP 273, Soliman 8020, Nabeul, Tunisia.	anischkirbene@gmail.com			Science and Technology Research Partnership for Sustainable Development (SATREPS) program - Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA), Japan	This work was supported by the Science and Technology Research Partnership for Sustainable Development (SATREPS) program, funded by the Japan Science and Technology Agency (JST) and the Japan International Cooperation Agency (JICA), Japan. The authors would also like to thank the anonymous reviewers for their constructive comments.	Allen R. G., 1998, IRRIG DRAIN; Al-Maktoumi A, 2007, HYDROGEOL J, V15, P1119, DOI 10.1007/s10040-007-0164-2; Bakker M, 2004, J HYDROL, V287, P270, DOI 10.1016/j.jhydrol.2003.10.007; Narayan KA, 2007, AGR WATER MANAGE, V89, P217, DOI 10.1016/j.agwat.2007.01.008; Kouzana L, 2010, J AFR EARTH SCI, V58, P242, DOI 10.1016/j.jafrearsci.2010.03.005; Mastrocicco M, 2012, WATER AIR SOIL POLL, V223, P4417, DOI 10.1007/s11270-012-1205-6; Simmons CT, 2001, J CONTAM HYDROL, V52, P245, DOI 10.1016/S0169-7722(01)00160-7; Langevin CD, 2003, GROUND WATER, V41, P758, DOI 10.1111/j.1745-6584.2003.tb02417.x; Bauer P, 2006, J HYDROL, V316, P163, DOI 10.1016/j.jhydrol.2005.04.018; Kouzana L, 2009, CR GEOSCI, V341, P21, DOI 10.1016/j.crte.2008.09.008; Qahman K, 2006, HYDROGEOL J, V14, P713, DOI 10.1007/s10040-005-003-2; Ben Hamouda MF, 2011, ENVIRON EARTH SCI, V63, P889, DOI 10.1007/s12665-010-0758-1; Ben Salem H, 1992, THESIS FACULTY SCI T; Chekirbane A, 2013, HYDROLOG SCI J, V58, P1097, DOI 10.1080/02626667.2013.800202; Chekirbane A, 2013, THESIS U TSUKUBA JAP; Chekirbane A, 2012, P 22 SALT WAT INTR M; Chkirbene A, 2008, THESIS NICE U FRANCE; Cobaner M, 2012, J HYDROL, V464, P262, DOI 10.1016/j.jhydrol.2012.07.022; Colleuil B, 1976, THESIS NICE U FRANCE; CRDA of Nabeul, 2004, PROJ RECH NAPP CAPBO; Ennabli M, 1980, THESIS NICE U FRANCE; Guo W, 2002, USERS GUIDE SEAWAT C, P77; Harbaugh AW, 2000, MOD FLOW 2000 US GEO; Hudak FH, 2001, ENVIRON INT, V26, P497; Jemai S, 1996, THESIS INAT TUNISIA; Jin L, 2009, ENVIRON GEOL, V57, P119; Kerrou J, 2008, THESIS NEUCHATEL U S; Khlaifi I, 1998, THESIS U TUNIS EL MA; Langevin C.D., 2003, 03426 US GEOL SURV, P43; Langevin CD, 2008, SEAWAT VERSION 4 COM, V6, P39; Lecca G, 2000, INTERNAL REPORT; Lin HJ, 1997, 3 DIMENSIONAL FINITE; Nazoumou Y, 2002, THESIS ECOLE NATL IN; Paniconi C, 2001, PHYS CHEM EARTH PT B, V26, P345, DOI 10.1016/S1464-1909(01)00017-X; Paniconi C, 2004, TRANSPORT POROUS MED, V43, P3; Rekaya M, 1989, CONTEXTE HYDROGEOLOG; Rouatbi R, 1968, TUDE HYDROGE OLOGIQU; Saidi S, 2013, ENVIRON EARTH SCI, V70, P1551, DOI 10.1007/s12665-013-2241-2; Sanford WE, 1985, 854279 US GEOL SURV, P89; Slama F, 2010, THESIS NEUCHATEL U S; Trabelsi F, 2013, ENVIRON EARTH SCI, V70, P2087, DOI 10.1007/s12665-011-1416-y; Voss CI, 1984, 844369 US GEOL SURV, P409; Zghibi A, 2011, HYDROL PROCESS, V25, P1822, DOI 10.1002/hyp.7948; Zheng C, 2006, MT3DMS V5 2 SUPPLEME, P24; Zheng C., 1999, SERDP991 US ARM CORP	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	FEB	2015	73	4					1427	1442		10.1007/s12665-014-3495-z		16	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	AZ8BF	WOS:000348439000002		
J	Xu, XF; Zheng, GD; Li, S; Takahashi, Y; Shen, G; Dermatas, D				Xu, Xuanfeng; Zheng, Guodong; Li, Shun; Takahashi, Yoshio; Shen, Gang; Dermatas, Dimitris			A quantitative XANES evaluation of the TCLP applicability in phosphate-induced lead stabilization for firing range soils	ENVIRONMENTAL EARTH SCIENCES			English	Article						Immobilization; Leachability; Tumbling; Spectroscopic; Pyromorphite	PRINCIPAL COMPONENT ANALYSIS; ABSORPTION-SPECTROSCOPY; ZINC SPECIATION; SHOOTING RANGES; PB; RELEASE; BULLETS	An acidic (pH 5.2) firing range soil, FDR26 in New Jersey, with Pb content of 6,017 mg kg(-1), was amended by adding 2.5 wt% fish bone grains. The leaching test, toxicity characteristic leaching procedure (TCLP), and spectroscopic technique, non-destructive X-ray absorption near edge structure (LCF-XANES), were employed to determine the leaching behavior and Pb speciation prior to and after the TCLP test. The TCLP-Pb was 209 mg L-1 after the standard 18 h of tumbling and was increased to 288 mg L-1 after an extended tumbling time of 96 h. The XANES of TCLP residue confirmed the existence of extractable Pb species following the 18 h extraction. TCLP-Pb was also reduced to 1.4 mg L-1 after phosphate addition followed by 28 days of curing. LCF-XANES results revealed the transformation of metallic Pb into insoluble pyromorphite precipitates during the leaching test. The acidic extraction solution significantly increased the dissolution of phosphate source and Pb species, and resulted in improved Pb immobilization.	[Xu, Xuanfeng; Zheng, Guodong; Takahashi, Yoshio] Chinese Acad Sci, Inst Geol & Geophys, CAS Key Lab Petr Resource Res, Gansu Prov Key Lab Petr Resources, Lanzhou 730000, Peoples R China; [Xu, Xuanfeng; Zheng, Guodong; Shen, Gang; Dermatas, Dimitris] Stevens Inst Technol, Ctr Environm Syst, WM Keck Geoenvironm Lab, Hoboken, NJ 07030 USA; [Li, Shun] Shenyang Radio & Televis Univ, Coll Informat Engn, Shenyang 110003, Peoples R China; [Takahashi, Yoshio] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Syst Sci, Bunkyo Ku, Tokyo 1138654, Japan	Zheng, GD (reprint author), Stevens Inst Technol, Ctr Environm Syst, WM Keck Geoenvironm Lab, Hoboken, NJ 07030 USA.	gdzhbj@mail.iggcas.ac.cn	Takahashi, Yoshio/F-6733-2011		CAS/SAFEA [KZCX2-YW-T10]; Chinese Academy of Sciences [2012T1Z0035]; US. ARMY DoD TACOM-ARDEC, RANGE SAFE PROGRAM, Picatinny Arsenal; New Jersey Department for Environmental Protection (NJDEP)	This work was partially supported by the CAS/SAFEA International Partnership Program for Creative Research Teams (KZCX2-YW-T10) and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists to YT (Grant No. 2012T1Z0035), and funded in part by US. ARMY DoD TACOM-ARDEC, RANGE SAFE PROGRAM, Picatinny Arsenal and the New Jersey Department for Environmental Protection (NJDEP). The statements and opinions expressed in this paper are those of the authors only; they do not necessarily represent the views of the sponsoring agencies. We also want to thank Dr. Deok Hyun Moon and Dr. Chuanyong Jing for their help with the XANES analysis. The manuscript greatly benefited from constructive comments by Dr. James W. LaMoreaux, and critical reviews from the anonymous reviewers.	STEEFEL CI, 1990, GEOCHIM COSMOCHIM AC, V54, P2657, DOI 10.1016/0016-7037(90)90003-4; Chrysochoou M, 2007, J HAZARD MATER, V144, P1, DOI 10.1016/j.jhazmat.2007.02.008; Dermatas D, 2008, J ENVIRON QUAL, V37, P47, DOI 10.2134/jeq2007.0151; Dermatas D, 2006, J HAZARD MATER, V136, P34, DOI 10.1016/j.jhazmat.2005.11.009; Hartley W, 2004, ENVIRON POLLUT, V131, P495, DOI 10.1016/j.envpol.2004.02.017; Halim CE, 2004, ENVIRON SCI TECHNOL, V38, P3977, DOI 10.1021/es0350740; Beauchemin S, 2002, SOIL SCI SOC AM J, V66, P83; Scheckel KG, 2004, J ENVIRON QUAL, V33, P1288; Ghosh A, 2004, ENVIRON SCI TECHNOL, V38, P4677, DOI 10.1021/es030707w; Toby BH, 2006, POWDER DIFFR, V21, P67, DOI 10.1154/1.2179804; Vantelon D, 2005, ENVIRON SCI TECHNOL, V39, P4808, DOI 10.1021/es0482740; Scheinost AC, 2002, ENVIRON SCI TECHNOL, V36, P5021, DOI 10.1021/es025669f; Roberts DR, 2002, ENVIRON SCI TECHNOL, V36, P1742, DOI 10.1021/es015516c; Cao XD, 2003, J ENVIRON QUAL, V32, P526; Conca JL, 2006, APPL GEOCHEM, V21, P2187, DOI 10.1016/j.apgeochem.2006.08.017; Dermatas D, 2003, ENG GEOL, V2189, P1; Dermatas D, 2006, ENVIRON ENG SCI, V23, P88, DOI 10.1089/ees.2006.23.88; Hetenyi M, 2005, J ANAL APPL PYROL, V74, P45, DOI 10.1016/j.jaap.2004.11.012; Huerta VD, 2005, ANAL CHIM ACTA, V538, P99, DOI 10.1016/j.aca.2005.02.033; JORGENSEN SS, 1987, AMBIO, V16, P11; LaGrega M. D., 1994, HAZARDOUS WASTE MANA; Lin ZX, 1996, ENVIRON GEOL, V27, P370; MDI (Material's Data Inc), 2005, JAD VERS 7 1; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; NRIAGU JO, 1974, GEOCHIM COSMOCHIM AC, V38, P887, DOI 10.1016/0016-7037(74)90062-3; Schwertmann U., 1991, IRON OXIDES LAB PREP; Takahashi Y, 2002, CHEM LETT, P366, DOI 10.1246/cl.2002.366; USEPA, 1996, USEPA540R96018; USEPA, 1992, SW846 USEPA; USEPA, 2005, EPA902B01001; USEPA, 1996, SW846 USEPA; USEPA United States Environmental Protection Agency, 2001, EPA902B01001; Wright J., 2004, P C SUST RANG MAN, pB4; Zheng GD, 2011, ENVIRON EARTH SCI, V64, P2241, DOI 10.1007/s12665-011-1052-6	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	FEB	2015	73	4					1641	1647		10.1007/s12665-014-3515-z		7	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	AZ8BF	WOS:000348439000020		
J	Islam, MS; Ahmed, MK; Habibullah-Al-Mamun, M; Hoque, MF				Islam, Md. Saiful; Ahmed, Md. Kawser; Habibullah-Al-Mamun, Md.; Hoque, Md. Fazlul			Preliminary assessment of heavy metal contamination in surface sediments from a river in Bangladesh	ENVIRONMENTAL EARTH SCIENCES			English	Article						Heavy metals; Sediments; Ecological risk; River; Bangladesh	POTENTIAL ECOLOGICAL RISK; QUALITY GUIDELINES; POLLUTION STATUS; NORTHEAST CHINA; HONG-KONG; WATER; BAY; SPECIATION; ESTUARY; HARBOR	Contamination of heavy metals in sediment is regarded as a major crisis globally, with a large SHARE in developing countries, such as Bangladesh. The objective of this study is to assess the contamination level and seasonal variation of heavy metals and their ecological risk in sediments. Heavy metals (Cr, Ni, Cu, As, Cd, and Pb) in sediments were investigated from eight different sites of Paira River situated at the southern part of Bangladesh and metals were measured by using inductively coupled plasma mass spectrometer. The mean concentration of Cr, Ni, Cu, As, Cd, and Pb in sediments was 45, 34, 30, 12, 0.72 and 25 mg/kg dw, respectively. Metals in sediment during winter were higher than summer season. The concentrations of metals in sediment were compared with both background and toxicological reference values. The comparative results suggested that the selected metals created an adverse effect on the aquatic ecosystems of the studied river. The pollution load index for three sites were higher than baseline values indicating progressive deterioration of sediments by heavy metal. Potential ecological risks of metals in sediment indicated moderate to considerable risk. This study suggested that more attention should be directed to the comprehensive risk assessment of heavy metals of this riverine aquatic environment.	[Islam, Md. Saiful; Hoque, Md. Fazlul] Patuakhali Sci & Technol Univ, Dept Soil Sci, Dumki 8602, Patuakhali, Bangladesh; [Islam, Md. Saiful; Habibullah-Al-Mamun, Md.] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 240, Japan; [Ahmed, Md. Kawser; Habibullah-Al-Mamun, Md.] Univ Dhaka, Dept Fisheries, Dhaka 1000, Bangladesh	Islam, MS (reprint author), Patuakhali Sci & Technol Univ, Dept Soil Sci, Dumki 8602, Patuakhali, Bangladesh.	msaifulpstu@yahoo.com					Agency for Toxic Substances and Diseases Registry ATSDR, 2008, PUBL HLTH STAT CADM; Alam AMS, 2003, DHAKA U J SCI, V51, P201; Al-Khashman OA, 2007, ENVIRON GEOCHEM HLTH, V29, P1, DOI 10.1007/s10653-006-9067-8; Yuan GL, 2011, J HAZARD MATER, V185, P336, DOI 10.1016/j.jhazmat.2010.09.039; Diaz-Somoano M, 2009, ENVIRON SCI TECHNOL, V43, P1078, DOI 10.1021/es801818r; Varol M, 2012, CATENA, V92, P1, DOI 10.1016/j.catena.2011.11.011; Suresh G, 2011, APPL RADIAT ISOTOPES, V69, P1466, DOI 10.1016/j.apradiso.2011.05.020; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; Li FY, 2009, ENVIRON GEOL, V57, P1815, DOI 10.1007/s00254-008-1469-8; Lourino-Cabana B, 2011, J HAZARD MATER, V186, P2129, DOI 10.1016/j.jhazmat.2010.12.124; Liu WX, 2003, ENVIRON POLLUT, V121, P377, DOI 10.1016/S0269-7491(02)00234-8; Hou DK, 2013, ECOTOX ENVIRON SAFE, V93, P135, DOI 10.1016/j.ecoenv.2013.03.012; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Zheng N, 2008, ENVIRON POLLUT, V154, P135, DOI 10.1016/j.envpol.2008.01.001; Suresh G, 2012, ECOTOX ENVIRON SAFE, V84, P117, DOI 10.1016/j.ecoenv.2012.06.027; Zhang R, 2013, MAR POLLUT BULL, V74, P403, DOI [10.1016/j.marpolbul.2013.06.019, 10.1016/j.marpo1bul.2013.06.019]; Datta DK, 1998, ENVIRON GEOL, V36, P93; Bastami KD, 2012, MAR POLLUT BULL, V64, P2877, DOI 10.1016/j.marpolbul.2012.08.015; Baeyens W, 2007, SCI TOTAL ENVIRON, V384, P409, DOI 10.1016/j.scitotenv.2007.05.044; Huang LL, 2013, CHEMOSPHERE, V93, P1957, DOI 10.1016/j.chemosphere.2013.06.080; Jiang X, 2014, MAR POLLUT BULL, V83, P366, DOI 10.1016/j.marpolbul.2014.03.020; McCready S, 2006, ENVIRON INT, V32, P455, DOI 10.1016/j.envint.2005.10.006; Yu GB, 2011, CHEMOSPHERE, V85, P1080, DOI 10.1016/j.chemosphere.2011.07.039; Ahmad MK, 2010, INT J ENVIRON RES, V4, P321; Liu CB, 2009, B ENVIRON CONTAM TOX, V82, P26, DOI 10.1007/s00128-008-9563-x; Zhu YG, 2011, ENVIRON SCI TECHNOL, V45, P5099, DOI 10.1021/es2004254; Yi YJ, 2011, ENVIRON POLLUT, V159, P2575, DOI 10.1016/j.envpol.2011.06.011; Guo WH, 2010, PROCEDIA ENVIRON SCI, V2, P729, DOI 10.1016/j.proenv.2010.10.084; Mohiuddin KM, 2011, INT J ENVIRON SCI TE, V8, P723, DOI 10.1007/BF03326257; El Nemr AM, 2007, ENVIRON MONIT ASSESS, V129, P151, DOI 10.1007/s10661-006-9349-8; Liang Y, 2003, CHEMOSPHERE, V52, P1647, DOI 10.1016/S0045-6535(03)00505-8; Yang ZF, 2009, J HAZARD MATER, V166, P1186, DOI 10.1016/j.jhazmat.2008.12.034; Chen BW, 2012, SCI TOTAL ENVIRON, V439, P141, DOI 10.1016/j.scitotenv.2012.09.025; Pedersen F, 1998, WATER SCI TECHNOL, V37, P233, DOI 10.1016/S0273-1223(98)00203-0; Zhan SF, 2010, B ENVIRON CONTAM TOX, V84, P482, DOI 10.1007/s00128-010-9971-6; CALMANO W, 1993, WATER SCI TECHNOL, V28, P223; Yan CZ, 2010, ENVIRON EARTH SCI, V60, P1469, DOI 10.1007/s12665-009-0282-3; Armitage PD, 2007, RIVER RES APPL, V23, P997, DOI 10.1002/rra.1022; MacDonald DD, 2000, ARCH ENVIRON CON TOX, V39, P20, DOI 10.1007/s002440010075; HILTON J, 1985, CHEM GEOL, V48, P281, DOI 10.1016/0009-2541(85)90053-1; Uluturhan E, 2011, MAR POLLUT BULL, V62, P1989, DOI 10.1016/j.marpolbul.2011.06.019; Saha N, 2013, ENVIRON MONIT ASSESS, V185, P3867, DOI 10.1007/s10661-012-2835-2; Sin SN, 2001, ENVIRON INT, V26, P297, DOI 10.1016/S0160-4120(01)00003-4; Bai JH, 2011, ECOL MODEL, V222, P301, DOI 10.1016/j.ecolmodel.2009.12.002; Singh KP, 2005, J HYDROL, V312, P14, DOI 10.1016/j.jhydrol.2005.01.021; Fu C, 2009, BIOL TRACE ELEM RES, V129, P270, DOI 10.1007/s12011-008-8300-y; Fu J, 2014, J HAZARD MATER, V270, P102, DOI [10.1016/j.jhazmat.2014.01.044, 10.1010/j.jhazmat.2014.01.044]; BBS, 2011, MIN PLANN POP HOUS C; Facetti J, 1998, SCI TOTAL ENVIRON, V209, P79, DOI 10.1016/S0048-9697(97)00299-4; Gupta A, 2009, ENVIRON MONIT ASSESS, V157, P449, DOI 10.1007/s10661-008-0547-4; Hakanson L, 1983, PRINCIPLES LAKE SEDI; Haque MR, 2007, J NOAMI, V23, P97; Islam M. S., 2014, Journal of Water and Environment Technology, V12, P109, DOI 10.2965/jwet.2014.109; [李崇 Li Chong], 2008, [生态环境, Ecology and Environment], V17, P560; Li HB, 2012, SCI TOTAL ENVIRON, V432, P202, DOI 10.1016/j.scitotenv.2012.05.100; Mucha AP, 2003, ENVIRON POLLUT, V121, P169, DOI 10.1016/S0269-7491(02)00229-4; Pravin U.S., 2012, AM J CHEM, V2, P171; Rahman MS, 2013, BANGLADESH ENV EARTH, V71, P2293; Rudnick RL, 2003, TREATISE GEOCHEMISTR, V3, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Ruiz F, 2001, MAR POLLUT B, V42, P481, DOI DOI 10.1016/S0025-326X(00)00192-2; Shikazono N, 2012, ENVIRON GEOCHEM HLTH, V34, P13, DOI 10.1007/s10653-011-9409-z; TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2; US EPA, 1999, SCREEN LEV EC RISKS, V3; US EPA, 2001, EPA823B01002 OFF WAT; Wang SL, 2011, ENVIRON EARTH SCI, V64, P1593, DOI 10.1007/s12665-011-1172-z; Xiao R, 2012, CLEAN-SOIL AIR WATER, V40, P1167, DOI 10.1002/clen.201200016; [徐争启 Xu Zhengqi], 2008, [环境科学与技术, Enuivonmental Science and Technology], V31, P112	68	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	FEB	2015	73	4					1837	1848		10.1007/s12665-014-3538-5		12	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	AZ8BF	WOS:000348439000037		
J	Karube, Z; Tanaka, A; Takeuchi, A; Takazawa, Y; Takagi, M; Kinoshita, A; Seyama, H; Shibata, Y				Karube, Zin-ichi; Tanaka, Atsushi; Takeuchi, Akinori; Takazawa, Yoshikatsu; Takagi, Mai; Kinoshita, Ayako; Seyama, Haruhiko; Shibata, Yasuyuki			Three decades of environmental specimen banking at the National Institute for Environmental Studies, Japan	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Environmental specimen banking; Mussel watch; Coastal environment; QA/QC procedure; Cryo-homogenization; Emergency response	COASTAL WATERS; MUSSEL WATCH; CONTAMINANTS; ACCUMULATION; AUSTRALIA; BIVALVES; CADMIUM; TRENDS; LEAD	After two decades operation of the initial environmental specimen banking, a new program, Environmental Time Capsule Program, started in 2002 as a government-supported long-term program to construct a firm scientific basis for various environmental research studies. The program consists of long-term environmental specimen banking activity and specimen collection of endangered wildlife and is based on cryogenic sample preservation facility called Environmental Time Capsule building, which completed construction in 2004. After 9 years of extensive research, research focuses have been selected and the program was reorganized to the environmental sample collection part and endangered wildlife collection part in 2011. Due to huge environmental disaster caused by the Great East Japan earthquake and the tsunami as well as subsequent nuclear power plant accident at Fukushima, a new sampling and monitoring program started at affected areas in collaboration with the reorganized environmental sample collection and archiving program. Outlines of the quality assurance and quality control (QA/QC) activities in the program and future perspective under related international activities, particularly Stockholm Convention, are reported.	[Karube, Zin-ichi; Tanaka, Atsushi; Takeuchi, Akinori; Takazawa, Yoshikatsu; Takagi, Mai; Kinoshita, Ayako; Seyama, Haruhiko; Shibata, Yasuyuki] Natl Inst Environm Studies, Ctr Environm Measurement & Anal, Tsukuba, Ibaraki 3058506, Japan	Shibata, Y (reprint author), Natl Inst Environm Studies, Ctr Environm Measurement & Anal, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	yshibata@nies.go.jp			Ministry of the Environment; National Institute for Environmental Studies, Japan	The program has been realized and conducted by the valuable support of many researchers and technical/administrative staffs, including Drs. Masatoshi Morita, Makoto Watanabe, Kunimitsu Kaya, Takashi Uehiro, Takashi Kuwana, Toshihiro Horiguchi, Mr. Masao Hirota, Ms. Yuko Kanda, Zhao Quin, Mitsuha Yoshikane, Tomoko Hosoya, Tamiko Fujisaki, Sumiko Komori, Miyako Kobayashi, Miyuki Yanai, Mineko Moto, Emiko Yuhara, Yumiko Goto, and Miho Sekine. Part of the program has been supported by the Ministry of the Environment and the National Institute for Environmental Studies, Japan.	Ambe Y, 1985, RES REP NATL I ENV S, V79, P75; Ambe Y, 1985, STUDIES METHOD LONG; Stern GA, 2005, SCI TOTAL ENVIRON, V342, P223, DOI 10.1016/j.scitotenv.2004.12.046; Mitsuguchi T, 2004, NUCL INSTRUM METH B, V223, P455, DOI 10.1016/j.nimb.2004.04.086; Zheng JA, 2002, ANAL BIOANAL CHEM, V374, P348, DOI 10.1007/s00216-002-1425-5; Tanabe S, 2000, OCEAN COAST MANAGE, V43, P819, DOI 10.1016/S0964-5691(00)00060-0; WARD TJ, 1986, AUST J MAR FRESH RES, V37, P567, DOI 10.1071/MF9860567; Liu FJ, 2012, ENVIRON TOXICOL CHEM, V31, P1292, DOI 10.1002/etc.1823; Doi T, 2013, J ENVIRON RADIOACTIV, V122, P55, DOI 10.1016/j.jenvrad.2013.02.001; Templeton MR, 2009, PHILOS T R SOC A, V367, P3873, DOI 10.1098/rsta.2009.0144; Becker PR, 2006, J ENVIRON MONITOR, V8, P776, DOI 10.1039/b608753c; Day RD, 2014, ENVIRON SCI-PROC IMP, V16, P10, DOI 10.1039/c3em00261f; Edmonds JS, 1997, MAR BIOL, V129, P203, DOI 10.1007/s002270050161; Goldberg SD, 1975, MAR POLLUT B, V6, P111; Morita M, 1997, CHEMOSPHERE, V34, P1907, DOI 10.1016/S0045-6535(97)00052-0; Satake K, 1996, SCI TOTAL ENVIRON, V181, P25, DOI 10.1016/0048-9697(95)04955-X; Schladot JD, 1988, NBS SPEC PUBL, V740, P184; Sericano JL, 1995, MAR POLLUT BULL, V31, P214, DOI 10.1016/0025-326X(95)00197-U; SEYAMA H, 1991, EXPERIENTIA, V47, P1193, DOI 10.1007/BF01918383; Shi DL, 2004, ENVIRON POLLUT, V132, P265, DOI 10.1016/j.envpol.2004.04.023; Shibata Y, 1995, F7795NIES; Shibata Y, 2009, ORGANOHALOGEN COMPD, V71, P3172; Takazawa Y, 2005, B ENVIRON CONTAM TOX, V75, P652; Takazawa Y, 2005, B ENVIRON CONTAM TOX, V75, P561, DOI 10.1007/s00128-005-0788-7; Takeuchi A, 2012, BIOPRESERV BIOBANK, V10, P174, DOI 10.1089/bio.2011.0045; Tanabe S, 2012, MAR POLLUT BULL, V64, P1459, DOI 10.1016/j.marpolbul.2012.05.013; Tanaka A, 2012, ORGANOHALOGEN COMPD, V74, P127; UNEP/POPS/COP.6/INF/31, 2013, UNEPPOPSCOP6INF31; Yoshikane M, 2009, ORGANOHALOGEN COMPD, p[71, 1946]; Yoshikane M, 2009, ORGANOHALOGEN COMPD, V71, P1925; Yoshikane M, 2007, ORGANOHALOGEN COMPD, V69, P1717; YOSHINAGA J, 1993, CLIN CHEM, V39, P1650	32	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	FEB	2015	22	3					1587	1596		10.1007/s11356-014-3039-9		10	Environmental Sciences	Environmental Sciences & Ecology	CA4ZU	WOS:000348917400006		
J	Yustiawati; Kihara, Y; Sazawa, K; Kuramitz, H; Kurasaki, M; Saito, T; Hosokawa, T; Syawal, MS; Wulandari, L; Hendri, I; Tanaka, S				Yustiawati; Kihara, Yusuke; Sazawa, Kazuto; Kuramitz, Hideki; Kurasaki, Masaaki; Saito, Takeshi; Hosokawa, Toshiyuki; Syawal, M. Suhaemi; Wulandari, Linda; Hendri, I; Tanaka, Shunitz			Effects of peat fires on the characteristics of humic acid extracted from peat soil in Central Kalimantan, Indonesia	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Peat fires; Humic acid; Characterization; Elemental analysis; Molecular weight; Thermogravimetry; Pyrolysis-GC/MS	SIZE-EXCLUSION CHROMATOGRAPHY; MATRIX FLUORESCENCE SPECTROSCOPY; ORGANIC-MATTER; THERMAL-ANALYSIS; TG-DTA; FOREST; SUBSTANCES; PERFORMANCE; PARAMETERS; FRACTIONS	When peat forest fires happen, it leads to burn soil and also humic acids as a dominant organic matter contained in peat soil as well as the forest. The structure and properties of humic acids vary depending on their origin and environment, therefore the transformation of humic acid is also diverse. The impacts of the peat fires on peat soil from Central Kalimantan, Indonesia were investigated through the characterization of humic acids, extracted from soil in burnt and unburnt sites. The characterization of humic acids was performed by elemental composition, functional groups, molecular weight by HPSEC, pyrolysate compounds by pyrolysis-GC/MS, fluorescence spectrum by 3DEEM spectrofluorometer, and thermogravimetry. The elemental composition of each humic substance indicated that the value of H/C and O/C of humic acids from burnt sites were lower than that from unburnt sites. The molecular weight of humic acids from burnt sites was also lower than that from unburnt sites. Pyrolysate compounds of humic acids from unburnt sites differed from those of humic acids from burnt soil. The heating experiment showed that burning process caused the significant change in the properties of humic acids such as increasing the aromaticity and decreasing the molecular weight.	[Yustiawati; Kihara, Yusuke; Kurasaki, Masaaki; Tanaka, Shunitz] Hokkaido Univ, Grad Sch Environm Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Sazawa, Kazuto; Kuramitz, Hideki] Toyama Univ, Grad Sch Sci & Engn Res, Dept Environm Biol & Chem, Toyama 9308555, Japan; [Saito, Takeshi] Hokkaido Univ, Grad Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Hosokawa, Toshiyuki] Hokkaido Univ, Inst Adv Higher Educ, Higher Educ Res & Dev Div, Kita Ku, Sapporo, Hokkaido 0600817, Japan; [Yustiawati; Syawal, M. Suhaemi] Indonesian Inst Sci, Limnol Res Ctr, Bogor 16911, Indonesia; [Wulandari, Linda; Hendri, I] Univ Palangka Raya, Fac Agr, Palangka Raya 73112, Indonesia	Yustiawati (reprint author), Hokkaido Univ, Grad Sch Environm Sci, Kita Ku, Kita 10 Nishi 5, Sapporo, Hokkaido 0600810, Japan.	yusti_awati@yahoo.com	Hosokawa, Toshiyuki/A-3851-2012		JST/JICA Science and Technology Research Partnership for Sustainable Development (SATREPS) Project Entitled "Wild Fire and Carbon Management in Peat-forest in Indonesia"	The authors are grateful to Ms. Miwa Kiuchi and Ms. Tomoko Hattori of the Center for Instrumental Analysis of Hokkaido University for their assistance with the elemental analyses, to Dr Masami Fukushima of Division of Sustainable resources Engineering, Graduate School of Engineering, Hokkaido University for his valuable advises in Pyrolysis-GC/MS analysis. This work was supported under the JST/JICA Science and Technology Research Partnership for Sustainable Development (SATREPS) Project Entitled "Wild Fire and Carbon Management in Peat-forest in Indonesia".	ALMENDROS G, 1988, GEODERMA, V42, P115, DOI 10.1016/0016-7061(88)90028-6; Birdwell JE, 2010, ORG GEOCHEM, V41, P270, DOI 10.1016/j.orggeochem.2009.11.002; Richard C, 2004, ENVIRON SCI TECHNOL, V38, P2052, DOI 10.1021/es0300049f; Francioso O, 2005, APPL GEOCHEM, V20, P537, DOI 10.1016/j.apgeochem.2004.10.003; Matthews BJH, 1996, MAR CHEM, V55, P317, DOI 10.1016/S0304-4203(96)00039-4; ALMENDROS G, 1990, SOIL SCI, V149, P158, DOI 10.1097/00010694-199003000-00005; Jaenicke J, 2008, GEODERMA, V147, P151, DOI 10.1016/j.geoderma.2008.08.008; Tanaka F, 2005, CHEMOSPHERE, V58, P1319, DOI 10.1016/j.chemosphere.2004.10.008; Fukushima M, 2009, J ANAL APPL PYROL, V86, P200, DOI 10.1016/j.jaap.2009.06.005; Fernandez I, 1997, SOIL BIOL BIOCHEM, V29, P1, DOI 10.1016/S0038-0717(96)00289-1; YONEBAYASHI K, 1988, SOIL SCI PLANT NUTR, V34, P571; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Pietikainen J, 2000, SOIL BIOL BIOCHEM, V32, P277, DOI 10.1016/S0038-0717(99)00164-9; Gonzalez-Perez JA, 2004, ENVIRON INT, V30, P855, DOI 10.1016/j.envint.2004.02.003; Fukushima M, 2011, J ANAL APPL PYROL, V91, P323, DOI 10.1016/j.jaap.2011.03.008; Vergnoux A, 2011, ENVIRON RES, V111, P205, DOI 10.1016/j.envres.2010.03.005; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Marcos E, 2007, GEODERMA, V138, P237, DOI 10.1016/j.geoderma.2006.11.017; De la Rosa JM, 2008, CATENA, V74, P296, DOI 10.1016/j.catena.2008.03.004; Asakawa D, 2008, ANAL SCI, V24, P607, DOI 10.2116/analsci.24.607; Conte P, 1999, CHEMOSPHERE, V38, P517, DOI 10.1016/S0045-6535(98)00198-2; Fong SS, 2007, ORG GEOCHEM, V38, P967, DOI 10.1016/j.orggeochem.2006.12.010; Francioso O, 2009, GEODERMA, V152, P264, DOI 10.1016/j.geoderma.2009.06.011; Fujitake N, 2009, HUMIC SUBSTANCES RES, V5/6; Gaffney J. S., 1996, HUMIC FULVIC ACIDS I; Gonzales-Vila FJ, 1982, GEODERMA, V31, P3; Gonzales-Perez JA, 2008, ORG GEOCHEM, V39, P940, DOI 10.1016/j.orggeochem.2008.03.014; Lu XQ, 2001, CHEM GEOL, V177, P249, DOI 10.1016/S0009-2541(00)00412-5; Page S., 2010, PAGES (Past Global Changes) News, V18, P25; Picolo A, 2001, SOIL SCI, V166, P810; Prieto-Fernandez A, 2004, GEODERMA, V121, P291, DOI 10.1016/j.geoderma.2003.11.016; Sazawa K, 2013, ANAL METHODS-UK, V5, P2660, DOI 10.1039/c3ay26251k; Sazawa K, 2011, INT J ENV RES PUB HE, V8, P1655, DOI 10.3390/ijerph8051655; Schnitzer M, 1972, HUMIC SUBSTANCES ENV, P323; SCHNITZE.M, 1965, GEOCHIM COSMOCHIM AC, V29, P859, DOI 10.1016/0016-7037(65)90083-9; Siegert F, 2004, INT J REMOTE SENS, V25, P3221, DOI 10.1080/01431160310001642377; Siegert F, 2001, P INT S TROP PEATL 2; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Tan KH, 2003, HUMIC MATTER SOIL EN, P292; Van Krevelen D., 1950, FUEL, V29, P269; Yulianti N., 2012, GLOBAL ENV RES, V16, P105; Zhou QH, 2000, WATER RES, V34, P3505, DOI 10.1016/S0043-1354(00)00115-9	43	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	FEB	2015	22	4					2384	2395		10.1007/s11356-014-2929-1		12	Environmental Sciences	Environmental Sciences & Ecology	CB0MC	WOS:000349319200004		
J	Ariyadasa, BHAKT; Kondo, A; Inoue, Y				Ariyadasa, B. H. A. K. T.; Kondo, Akira; Inoue, Yoshio			Screening for potentially hazardous PRTR chemicals in the Lake Biwa-Yodo River basin of Japan using a one-box multimedia model	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Chemical pollutants; Environmental health risk; Environmental modeling; Lake Biwa-Yodo River basin; One-box multimedia model; PRTR	FUGACITY MODEL; CARBONYLS; DISEASE; FATE	A system is needed to predict the behavior, fate, and occurrence of environmental pollutants for effective environmental monitoring. Available monitoring data and computational modeling were used to develop a one-box multimedia model based on the mass balance of the emitted chemicals. Eight physiochemical phenomena in the atmosphere, soil, water, and sediment were considered in this model. This study was carried out in the Lake Biwa-Yodo River basin which provides multiple land uses and also the natural water resource for nearly 13 million of population in the region. Annual emissions for 214 nonmetallic compounds were calculated using the chemical emission data on Japanese pollutant release and transfer registry and used for executing the model simulations for 1997, 2002, and 2008 as input data. The calculated chemical concentrations by the model for all the environmental media were analyzed to determine trends in concentration over this study span. The majority of the chemicals decreased in concentration over time. Among the 214 nonmetallic chemical pollutants, 36 chemicals did not decrease in concentration and were in the top 10 % for concentration on average. Of these 36 pollutants, 7 occur in all 4 environmental media and pose a potential health risk at humans in the Lake Biwa-Yodo River basin.	[Ariyadasa, B. H. A. K. T.; Kondo, Akira; Inoue, Yoshio] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan	Ariyadasa, BHAKT (reprint author), Osaka Univ, Grad Sch Engn, POB 565-0871,Yamadaoka 2-1, Suita, Osaka, Japan.	tharaka@ea.see.eng.osaka-u.ac.jp; kondo@see.eng.osaka-u.ac.jp; inoue@see.eng.osaka-u.ac.jp					HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885; Bertazzi PA, 2001, AM J EPIDEMIOL, V153, P1031, DOI 10.1093/aje/153.11.1031; Zorrilla LM, 2010, REPROD TOXICOL, V29, P393, DOI 10.1016/j.reprotox.2010.03.010; Sudo M, 2002, WATER RES, V36, P315, DOI 10.1016/S0043-1354(01)00196-8; Inaba T, 2005, TOXICOL LETT, V159, P192, DOI 10.1016/j.toxlet.2005.05.011; Ariyadasa BHAKT, 2014, J ENV ENG EC SCI, V3, P3, DOI [10.7243/2050-1323-3-3, DOI 10.7243/2050-1323-3-3]; Edwards Falicia L, 2005, Int J Environ Res Public Health, V2, P430, DOI 10.3390/ijerph2005030007; Kawamura K, 2013, ATMOS CHEM PHYS, V13, P5369, DOI 10.5194/acp-13-5369-2013; Kawashima M, 2007, J ENVIRON SCI, V20, P119; Kielhorn J, 2004, CONCISE INT CHEM ASS; Kogevinas M, 2001, APMIS, V109, pS223; Kondo A, 2013, CHEMOSPHERE, V92, P497, DOI 10.1016/j.chemosphere.2013.02.013; Liu D, 1999, WATER RES, V33, P2833, DOI 10.1016/S0043-1354(98)00501-6; MACKAY D, 1991, ENVIRON SCI TECHNOL, V25, P427, DOI 10.1021/es00015a008; Ortiz R, 2006, ATMOS RES, V82, P709, DOI 10.1016/j.atmosres.2006.02.025; Seinfeld J. H., 2006, ATMOSPHERIC CHEM PHY; Wania F, 2001, ECOL STU AN, V148, P417	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	FEB	2015	22	4					2757	2764		10.1007/s11356-014-3493-4		8	Environmental Sciences	Environmental Sciences & Ecology	CB0MC	WOS:000349319200039		
J	Ren, WX; Geng, Y; Ma, ZX; Sun, LN; Xue, B; Fujita, T				Ren, Wanxia; Geng, Yong; Ma, Zhixiao; Sun, Lina; Xue, Bing; Fujita, Tsuyoshi			Reconsidering brownfield redevelopment strategy in China's old industrial zone: a health risk assessment of heavy metal contamination	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Health risk assessment; Heavy metal; Land use; Phytoremediation; Brownfield redevelopment sites	URBAN SOILS; TRACE-METALS; CITY; MANAGEMENT; SHENYANG; EXPOSURE; TREES; LAND; SITE; LEAD	Urban environmental quality in brownfield redevelopment sites is of vital importance after most of former industrial areas were replanned or changed into residential and recreational areas. Hence, it is necessary to rethink if those brownfield redevelopment sites have been cleaned up so that there will be no negative health impacts to local residents. Under such a circumstance, this paper aims to evaluate the contamination level of heavy metals within a brownfield redevelopment site in China, namely, the Tiexi old industrial zone in Shenyang. Surface soil and dust samples were collected from local industrial sites, residential/commercial sites, traffic sites, and recreational sites, respectively. Our analysis results revealed that although the soils in the brownfield redevelopment sites had been treated and remediated, heavy metal pollution still exists in certain sites, especially in the current industrial sites that will be planned into residential/commercial or recreational zones, and the current residential sites where the former industrial sites located, showing that past industrial activities did and will continue to influence the soil quality. Further health risk assessment indicates that As and Pb generated from industrial sites and traffic sites has a potential to pose serious health risks to local residents, especially children. The hotspots with more serious health risks to children are mainly concentrated in the areas close to the former Shenyang Smelting Plant. After one decade of redevelopment, the Tiexi old industrial zone has become a new urban area which is not suitable for large-scaled soil remediation efforts. Thus, the phytoremediation by trees or herbs in heavy-metal-contaminated land is more appropriate and should be embedded into urban green land planning. This study provides innovative policy insights on urban brownfield redevelopment to both governmental officials and related stakeholders so that they can make appropriate remediation actions.	[Ren, Wanxia; Geng, Yong; Ma, Zhixiao; Xue, Bing] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China; [Geng, Yong] Shanghai Jiao Tong Univ, Sch Environm Sci & Technol, Shanghai 200240, Peoples R China; [Sun, Lina] Shenyang Univ, Key Lab Ecoremediat Reg Environm, Shenyang 110044, Peoples R China; [Fujita, Tsuyoshi] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan	Geng, Y (reprint author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Peoples R China.	ygeng@sjtu.edu.cn			Natural Science Foundation of China [71303230, 71325006, 41101126, 71033004]; Ministry of Science and Technology [2011BAJ06B01, 2011DFA91810]	This research is sponsored by Natural Science Foundation of China (71303230, 71325006, 41101126, and 71033004), Ministry of Science and Technology (2011BAJ06B01, 2011DFA91810).	Alker S., 2000, J ENVIRON PLANN MAN, V43, P49; Manta DS, 2002, SCI TOTAL ENVIRON, V300, P229, DOI 10.1016/S0048-9697(02)00273-5; Leung AOW, 2008, ENVIRON SCI TECHNOL, V42, P2674, DOI 10.1021/es071873x; Li XY, 2013, GEODERMA, V192, P50, DOI 10.1016/j.geoderma.2012.08.011; Gay JR, 2006, ENVIRON POLLUT, V142, P227, DOI 10.1016/j.envpol.2005.10.035; LEE MM, 1994, INT J EPIDEMIOL, V23, P984, DOI 10.1093/ije/23.5.984; De Kimpe CR, 2000, SOIL SCI, V165, P31, DOI 10.1097/00010694-200001000-00005; Hough RL, 2004, ENVIRON HEALTH PERSP, V112, P215, DOI 10.1289/ehp.5589; Gallagher FJ, 2008, ENVIRON POLLUT, V153, P351, DOI 10.1016/j.envpol.2007.08.011; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; De Sousa CA, 2003, LANDSCAPE URBAN PLAN, V62, P181, DOI 10.1016/S0169-2046(02)00149-4; Li XD, 2004, ENVIRON POLLUT, V129, P113, DOI 10.1016/j.envpol.2003.09.030; Mielke HW, 1998, ENVIRON HEALTH PERSP, V106, P217, DOI 10.2307/3433922; Poggio L, 2009, SCI TOTAL ENVIRON, V407, P5961, DOI 10.1016/j.scitotenv.2009.08.026; Wong CSC, 2006, ENVIRON POLLUT, V142, P1, DOI 10.1016/j.envpol.2005.09.004; Dye C, 2008, SCIENCE, V319, P766, DOI 10.1126/science.1150198; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Aronsson P, 1994, WILLOW VEGETATION FI, V50, P145; Bien J, 2005, ENVIRON MODEL ASSESS, V9, P221, DOI 10.1007/s10666-005-0909-z; Cannell MGR, 1999, FORESTRY, V72, P237, DOI 10.1093/forestry/72.3.237; Hooker PJ, 2006, CHEM GEOL, V226, P340, DOI 10.1016/j.chemgeo.2005.09.028; Linde M., 2001, WATER AIR SOIL POLL, V1, p83 , DOI 10.1023/A:1017599920280; Meuser H, 2010, ENVIRON POLLUT SER, V18, P1, DOI 10.1007/978-90-481-9328-8; Nathanail P, 2005, HUM ECOL RISK ASSESS, V11, P389, DOI 10.1080/10807030590925650; Paulson M., 2003, Land Contamination & Reclamation, V11, P323, DOI 10.2462/09670513.624; Poggio L, 2008, LANDSCAPE URBAN PLAN, V88, P64, DOI 10.1016/j.landurbplan.2008.08.002; Riddell-Black D, 1993, 3467 WRC CO; Ryan JA, 2004, ENV SCI TECHNOL A, V38, p18A; Sun LN, 2013, ECOL ENG, V53, P115, DOI 10.1016/j.ecoleng.2012.12.023; Swickard TJ, 2008, SOIL SEDIMENT CONTAM, V17, P121, DOI 10.1080/15320380701870393; US EPA, 2001, EPA600R09052F; U.S. EPA, 1997, EPA600P95002 OFF RES; US EPA (United States Environmental Protection Agency), 1993, 1A US EPA IRIS; Wong MH, 2002, RESTORATION MANAGEME	34	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	FEB	2015	22	4					2765	2775		10.1007/s11356-014-3548-6		11	Environmental Sciences	Environmental Sciences & Ecology	CB0MC	WOS:000349319200040		
J	Chen, XQ; Fujiwara, T; Fukahori, S; Ishigaki, T				Chen, Xiaoqiang; Fujiwara, Taku; Fukahori, Shuji; Ishigaki, Tomonori			Factors affecting the adsorptive removal of bisphenol A in landfill leachate by high silica Y-type zeolite	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Bisphenol A; High silica Y-type zeolite; Adsorption; Humic acid; Landfill leachate; Affecting factor	ENDOCRINE-DISRUPTING CHEMICALS; COMPOSITE TIO2-ZEOLITE SHEETS; WASTE-WATER TREATMENT; 17-ALPHA-ETHINYL ESTRADIOL; AQUEOUS-SOLUTION; PHOTOCATALYTIC DECOMPOSITION; HYDROPHOBIC ZEOLITE; ORGANIC-COMPONENTS; ACTIVATED CARBON; DISPOSAL SITES	Although bisphenol A (BPA), a representative endocrine-disrupting compound, has been detected frequently in landfill leachate, effective technologies for BPA removal from landfill leachates are limited. We used high silica Y-type zeolite (HSZ-385) for the selective adsorption of BPA from landfill leachate, and factors affecting this adsorption are discussed. Higher removal efficiencies at pH 5.0-9.0 imply that neutral BPA is adsorbed more easily onto HSZ-385 than monomeric or divalent BPA anions. An increase in ionic strength and sodium acetate concentration did not affect BPA adsorption significantly, while the removal efficiency decreased slightly when more than 50 mgC/L of humic acid was added. HSZ-385 was applied to synthetic leachates that simulate the composition of landfill leachate at various degradation stages. In young acidic leachates that contain sodium acetate, the use of HSZ-385 for the adsorptive removal of BPA appears to be more effective than in old alkaline leachates, which contain large amounts of humic acid. In addition, 82 % BPA removal was achieved from young raw leachates using HSZ-385, which demonstrates that selective BPA removal from actual landfill leachate has been achieved.	[Chen, Xiaoqiang; Fujiwara, Taku] Kochi Univ, Agr Unit, Res & Educ Fac, Nanko Ku, Kochi 7838502, Japan; [Fukahori, Shuji] Ehime Univ, Fac Agr, New Paper Ind Program Ctr, Shikokuchuo, Ehime 7990113, Japan; [Ishigaki, Tomonori] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki 3058506, Japan	Chen, XQ (reprint author), Kochi Univ, Agr Unit, Res & Educ Fac, Nanko Ku, 200 Monobe Otsu, Kochi 7838502, Japan.	jm-chen@kochi-u.ac.jp			Ministry of the Environment (Japan) [K113027]	This work was supported financially by the Environment Research and Technology Development Fund (K113027) from the Ministry of the Environment (Japan).	Matos J, 1998, APPL CATAL B-ENVIRON, V18, P281, DOI 10.1016/S0926-3373(98)00051-4; Tsai WT, 2006, J COLLOID INTERF SCI, V299, P513, DOI 10.1016/j.jcis.2006.02.034; Ohko Y, 2001, ENVIRON SCI TECHNOL, V35, P2365, DOI 10.1021/es001757t; Chang HS, 2009, J HAZARD MATER, V172, P1, DOI 10.1016/j.jhazmat.2009.06.135; Eggen T, 2010, SCI TOTAL ENVIRON, V408, P5147, DOI 10.1016/j.scitotenv.2010.07.049; Asada T, 2004, J HEALTH SCI, V50, P588, DOI 10.1248/jhs.50.588; Schwarzbauer J, 2002, WATER RES, V36, P2275, DOI 10.1016/S0043-1354(01)00452-3; Xu J, 2012, LANGMUIR, V28, P8418, DOI 10.1021/la301476p; Pan B, 2010, J SOIL SEDIMENT, V10, P838, DOI 10.1007/s11368-009-0184-8; Yamamoto T, 2001, CHEMOSPHERE, V42, P415, DOI 10.1016/S0045-6535(00)00079-5; Braschi I, 2010, J HAZARD MATER, V178, P218, DOI 10.1016/j.jhazmat.2010.01.066; Asakura H, 2004, WASTE MANAGE, V24, P613, DOI 10.1016/j.wasman.2004.02.004; Fukahori S, 2003, APPL CATAL B-ENVIRON, V46, P453, DOI 10.1016/S0926-3373(03)00270-4; Pan B, 2010, J SOIL SEDIMENT, V10, P845, DOI 10.1007/s11368-009-0185-7; Yasuhara A, 1999, WASTE MANAGE RES, V17, P186, DOI 10.1034/j.1399-3070.1999.00038.x; Ji LL, 2009, ENVIRON SCI TECHNOL, V43, P7870, DOI 10.1021/es901497w; Joseph L, 2011, WATER RES, V45, P4056, DOI 10.1016/j.watres.2011.05.015; Nam SH, 2010, CHEMOSPHERE, V79, P949, DOI 10.1016/j.chemosphere.2010.02.049; Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0; Johnson AC, 2001, ENVIRON SCI TECHNOL, V35, P4697, DOI 10.1021/es010171j; Liu GF, 2009, J HAZARD MATER, V164, P1275, DOI 10.1016/j.jhazmat.2008.09.038; Nakanishi A, 2002, J COLLOID INTERF SCI, V252, P393, DOI 10.1006/jcis.2002.8387; Baun A, 2004, WATER RES, V38, P3845, DOI 10.1016/j.watres.2004.07.006; Dong Y, 2010, J COLLOID INTERF SCI, V348, P585, DOI 10.1016/j.jcis.2010.04.074; Oman CB, 2008, WASTE MANAGE, V28, P1876, DOI 10.1016/j.wasman.2007.06.018; Kjeldsen P, 2002, CRIT REV ENV SCI TEC, V32, P297, DOI 10.1080/10643380290813462; Yap PS, 2012, APPL CATAL A-GEN, V427, P125, DOI 10.1016/j.apcata.2012.03.042; Hohne C, 2008, ENVIRON SCI POLLUT R, V15, P405, DOI 10.1007/s11356-008-0007-2; Racz L, 2010, J ENVIRON MONITOR, V12, P58, DOI 10.1039/b917298j; Foo KY, 2009, J HAZARD MATER, V171, P54, DOI 10.1016/j.jhazmat.2009.06.038; Liu ZH, 2009, SCI TOTAL ENVIRON, V407, P731, DOI 10.1016/j.scitotenv.2008.08.039; Fukahori S, 2003, ENVIRON SCI TECHNOL, V37, P1048, DOI 10.1021/es0260115; Basile T, 2011, IND ENG CHEM RES, V50, P8389, DOI 10.1021/ie101919v; Bautista-Toledo I, 2005, Environ Sci Technol, V39, P6246, DOI 10.1021/es0481169; Chang CY, 2003, J COLLOID INTERF SCI, V260, P273, DOI 10.1016/S0021-9797(02)00174-1; Fukahori S, 2014, J HAZARD MATER, V272, P1, DOI 10.1016/j.jhazmat.2014.02.028; Fukahori S, 2013, WATER SCI TECHNOL, V67, P319, DOI 10.2166/wst.2012.513; Fukahori S, 2011, DESALINATION, V275, P237, DOI 10.1016/j.desal.2011.03.006; Ito M, 2014, ENVIRON SCI POLLUT R, V21, P834, DOI 10.1007/s11356-013-1707-9; Sakamoto H, 2006, J WASTE MANAG, V17, P259; Sakamoto H., 2004, J JPN SOC WASTE MANA, V15, P511; Shu HT, 1997, SEP PURIF TECHNOL, V11, P27, DOI 10.1016/S1383-5866(96)01005-2; Urase T, 2007, J JAPAN SOC WATER EN, V30, P617; Urase T, 2003, J MATER CYCLES WASTE, V5, P77, DOI 10.1007/s101630300012; Wu SuHua, 2010, Desalination, V253, P22; Yap PS, 2012, WATER RES, V46, P3054, DOI 10.1016/j.watres.2012.03.008; Yasuhara A, 1997, J CHROMATOGR A, V774, P321, DOI 10.1016/S0021-9673(97)00078-2	47	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	FEB	2015	22	4					2788	2799		10.1007/s11356-014-3522-3		12	Environmental Sciences	Environmental Sciences & Ecology	CB0MC	WOS:000349319200042		
J	Kataoka, C; Ariyoshi, T; Kawaguchi, H; Nagasaka, S; Kashiwada, S				Kataoka, Chisato; Ariyoshi, Tadashi; Kawaguchi, Hideo; Nagasaka, Seiji; Kashiwada, Shosaku			Salinity increases the toxicity of silver nanocolloids to Japanese medaka embryos	ENVIRONMENTAL SCIENCE-NANO			English	Article							ORYZIAS-LATIPES; ENVIRONMENTAL SALINITY; NANOPARTICLES; EMBRYOGENESIS; WATER	To investigate the effects of salinity on the toxicity of silver nanocolloids (SNCs, 28.4 nm in diameter) in aquatic environments (freshwater, brackish water, and seawater), we exposed 15 medaka eggs in triplicate to SNCs at 10 mg L-1 in different salinities of embryo-rearing medium (ERM) (1x, 5x, 10x, 15x, 20x, and 30x) until hatching (1x ERM and 30x ERM have osmotic pressures equivalent to freshwater and seawater, respectively). With increasing concentration of ERM, SNCs aggregated to 437.3 nm in diameter in 30x ERM solution. Simultaneously, soluble silver chloro complexes (various combinations of [ AgCl](0), [AgCl2](1-), [AgCl3](2-), and [AgCl4](3-)) were calculated to have been formed. The patterns of the absorption spectra of SNCs and AgNO3 (a reference compound) differed markedly in ERM at different salinities, indicating that different soluble silver complexes were present in each solution. With increasing salinity, the chorion resistance decreased, and the salinity in the medaka eggs, as indicated by the osmotic pressure, increased. Simultaneously, uptake of SNCs or other silver complexes into the embryos also increased compared with that of AgNO3 in 20x and 30x ERM. In the presence of SNCs in 20x ERM, embryo hatching rate and full body lengths of post-hatch larvae were significantly lower than those with AgNO3. The toxic effects of SNCs on the hatching rate increased significantly in media of high salinity and were greater than those of AgNO3. SNCs and related silver chloro complexes exhibited higher bioavailability and medaka embryo toxicity in saline conditions than did AgNO3. SNCs pose greater ecological risks to fish embryos in highsalinity aquatic environments than in freshwater environments.	[Kataoka, Chisato; Ariyoshi, Tadashi; Kawaguchi, Hideo; Nagasaka, Seiji; Kashiwada, Shosaku] Toyo Univ, Grad Sch Life Sci, Itakura, Gunma 3740193, Japan; [Kataoka, Chisato; Nagasaka, Seiji; Kashiwada, Shosaku] Toyo Univ, Res Ctr Life & Environm Sci, Itakura, Gunma 3740193, Japan	Kashiwada, S (reprint author), Toyo Univ, Grad Sch Life Sci, 1-1-1 Izumino, Itakura, Gunma 3740193, Japan.	kashiwada@toyo.jp			Special Research Foundation; Bio-Nano Electronics Research Centre of Toyo University; Science Research Promotion Fund of the Promotion and Mutual Aid Corporation for Private Schools of Japan	We are grateful to Ms Kaori Shimizu and Mr Masaki Takasu of the Department of Life Sciences, Toyo University for their technical support. This project was supported by research grants from the Special Research Foundation and Bio-Nano Electronics Research Centre of Toyo University (to SK); by the Science Research Promotion Fund of the Promotion and Mutual Aid Corporation for Private Schools of Japan (to SK); by the New Project Fund for Risk Assessments, from the Ministry of Economy, Trade and Industry (to SK); by a Grant-in-Aid for Challenging Exploratory Research (award 23651028 to SK); by a Grant-in-Aid for Scientific Research (B) (award 23310026-0001 to SK); and by a Grant-in-Aid for Strategic Research Base Project for Private Universities (award S1411016 to SK), from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Inoue K, 2002, ZOOL SCI, V19, P727, DOI 10.2108/zsj.19.727; Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012; Gaiser BK, 2011, J ENVIRON MONITOR, V13, P1227, DOI 10.1039/c1em10060b; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Suwa R, 2014, MAR ENVIRON RES, V99, P198, DOI 10.1016/j.marenvres.2014.06.010; Van Wettere AJ, 2013, TOXICOL PATHOL, V41, P744, DOI 10.1177/0192623312464308; Hayashi Y, 2013, ENVIRON SCI TECHNOL, V47, P14367, DOI 10.1021/es404132w; Griffitt RJ, 2009, TOXICOL SCI, V107, P404, DOI 10.1093/toxsci/kfn256; Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; Yeo MK, 2008, B KOREAN CHEM SOC, V29, P1179; Bianchini A, 2005, AQUAT TOXICOL, V72, P67, DOI 10.1016/j.aquatox.2004.11.012; Kashiwada S, 2006, ENVIRON HEALTH PERSP, V114, P1697, DOI 10.1289/ehp.9209; Kashiwada S, 2012, ENVIRON SCI TECHNOL, V46, P6278, DOI 10.1021/es2045647; Siller L, 2013, ENVIRON POLLUT, V178, P498, DOI 10.1016/j.envpol.2013.03.010; Park K, 2013, ARCH PHARM RES, V36, P125, DOI 10.1007/s12272-013-0005-x; Behra R., 2013, J R SOC INTERFACE, V10; Eisler R., 1996, SILVER HAZARDS FISH; Groh K.J., 2014, NANOTOXICOLOGY, V14, P1; Hirai A., 1993, GYORUIGAKU ZASSHI, V40, P227; Iwamatsu T., 1997, INTEGRATED BOOK BIOL; Kashiwada S, 2008, ENVIRON TOXICOL CHEM, V27, P2397, DOI 10.1897/08-073.1; Machado BE, 2007, J COMP PHYSIOL B, V177, P809, DOI 10.1007/s00360-007-0177-0; MIYAMOTO T, 1986, ZOOL SCI, V3, P859; Newton K. M., 2013, ENVIRON TOXICOL CHEM, V32, P1; Ringbom A., 1963, COMPLEXATION ANAL CH; Sakaizumi M., 1980, J FAC SCI U TOKYO, V4, P369; Sumitani K., 2004, HAIKIBUTSU GAKKAI RO, V15, P472; Villalobos SA, 2000, AQUAT TOXICOL, V48, P309, DOI 10.1016/S0166-445X(99)00032-6; Yue Y., 2014, NANOTOXICOLOGY, V12, P1	33	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2051-8153	2051-8161		ENVIRON-SCI NANO	Environ.-Sci. Nano	FEB	2015	2	1					94	103		10.1039/c4en00175c		10	Chemistry, Multidisciplinary; Environmental Sciences; Nanoscience & Nanotechnology	Chemistry; Environmental Sciences & Ecology; Science & Technology - Other Topics	CA9EC	WOS:000349222200011		
J	Chan, CP; Tsai, YT; Chen, YL; Hsu, YW; Tseng, JT; Chuang, HY; Shiurba, R; Lee, MH; Wang, JY; Chang, WC				Chan, Chien-Pin; Tsai, Yao-Ting; Chen, Yao-Li; Hsu, Yu-Wen; Tseng, Joseph T.; Chuang, Hung-Yi; Shiurba, Robert; Lee, Mei-Hsien; Wang, Jaw-Yuan; Chang, Wei-Chiao			Pb2+ Induces Gastrin Gene Expression by Extracellular Signal-Regulated Kinases 1/2 and Transcription Factor Activator Protein 1 in Human Gastric Carcinoma Cells	ENVIRONMENTAL TOXICOLOGY			English	Article						c-Jun; gastrin; ERK; lead (Pb2+)	BLOOD LEAD LEVELS; EPITHELIAL-CELLS; TRANSGENIC MICE; LUNG-CANCER; GROWTH; SP1; PHOSPHORYLATION; CARCINOGENESIS; PROGASTRIN; INDUCTION	Divalent lead ions (Pb2+) are toxic environmental pollutants known to cause serious health problems in humans and animals. Absorption of Pb2+ from air, water, and food takes place in the respiratory and digestive tracts. The ways in which absorbed Pb2+ affects cell physiology are just beginning to be understood at the molecular level. Here, we used reverse transcription PCR and Western blotting to analyze cultures of human gastric carcinoma cells exposed to 10 M lead nitrate. We found that Pb2+ induces gastrin hormone gene transcription and translation in a time-dependent manner. Promoter deletion analysis revealed that activator protein 1 (AP1) was necessary for gastrin gene transcription in cells exposed to Pb2+. MitogIen-activated protein kinase (MAPK)/ERK kinase inhibitor PD98059 suppressed the Pb2+-induced increase in messenger RNA. Epidermal growth factor receptor (EGFR) inhibitors AG1478 and PD153035 reduced both transcription and phosphorylation by extracellular signal-regulated kinase (ERK1/2). Cells exposed to Pb2+ also increased production of c-Jun protein, a component of AP1, and over-expression of c-Jun enhanced activation of the gastrin promoter. In sum, the findings suggest the EGFR-ERK1/2-AP1 pathway mediates the effects of Pb2+ on gastrin gene activity in cell culture. (c) 2013 Wiley Periodicals, Inc. Environ Toxicol 30: 129-136, 2015.	[Chan, Chien-Pin] Changhua Christian Hosp, Dept Gen Surg, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Tsai, Yao-Ting; Hsu, Yu-Wen; Wang, Jaw-Yuan; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chen, Yao-Li] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Chen, Yao-Li] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Tseng, Joseph T.] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan; [Chuang, Hung-Yi] Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan; [Shiurba, Robert] Waseda Univ, Grad Sch Sci & Engn, Tokyo, Tokyo, Japan; [Lee, Mei-Hsien] Taipei Med Univ, Grad Inst Pharmacognosy, Coll Pharm, Taipei, Taiwan; [Wang, Jaw-Yuan; Chang, Wei-Chiao] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Gastroenterol & Gen Surg, Dept Surg, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Dept Pharm, Wanfang Hosp, Taipei, Taiwan; [Tsai, Yao-Ting; Chang, Wei-Chiao] Taipei Med Univ, Inst Master Program Clin Pharmacogen & Pharmacopr, Sch Pharm, Taipei, Taiwan	Wang, JY (reprint author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	cy614112@ms14.hinet.net; wcc@kmu.edu.tw			Department of Health, Taiwan, Republic of China [DOH102-TD-C-111-002]; Kaohsiung Medical University Research Foundation [100-CCH-KMU-002]; Changhua Christian Hospital; Biosignature in Colorectal Cancers; Academia Sinica, Taiwan	Contract grant sponsor: Department of Health, Taiwan, Republic of China.; Contract grant number: NO. DOH102-TD-C-111-002.; Contract grant sponsor: Kaohsiung Medical University Research Foundation.; Contract grant number: 100-CCH-KMU-002.; Contract grant sponsors: Changhua Christian Hospital, Biosignature in Colorectal Cancers, Academia Sinica, Taiwan.	Piomelli S, 2002, PEDIATR CLIN N AM, V49, P1285, DOI 10.1016/S0031-3955(02)00097-4; GOYER RA, 1993, ENVIRON HEALTH PERSP, V100, P177, DOI 10.2307/3431524; Cordova FM, 2004, BRAIN RES, V998, P65, DOI 10.1016/j.brainres.2003.11.012; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Chang WC, 2011, TOXICOLOGY, V279, P45, DOI 10.1016/j.tox.2010.09.004; Steenland K, 2000, AM J IND MED, V38, P295, DOI 10.1002/1097-0274(200009)38:3<295::AID-AJIM8>3.0.CO;2-L; Jiao JJ, 2011, J SCI FOOD AGR, V91, P485, DOI 10.1002/jsfa.4210; Dockray G, 2005, PFLUG ARCH EUR J PHY, V449, P344, DOI 10.1007/s00424-004-1347-5; Ferrand A, 2006, CANCER LETT, V238, P15, DOI 10.1016/j.canlet.2005.06.025; Cobb S, 2004, CANCER, V100, P1311, DOI 10.1002/cncr.20094; Wang CY, 2009, TOXICOL APPL PHARM, V235, P244, DOI 10.1016/j.taap.2008.12.007; McKinney PE, 2000, J TOXICOL-CLIN TOXIC, V38, P435; Watson SA, 2006, NAT REV CANCER, V6, P936, DOI 10.1038/nrc2014; Garcia-Leston J, 2010, ENVIRON INT, V36, P623, DOI 10.1016/j.envint.2010.04.011; Wagner EF, 2002, ANN RHEUM DIS, V61, P40; Wu YX, 2012, OCCUP ENVIRON MED, V69, P557, DOI 10.1136/oemed-2011-100478; Avazeri N, 2006, BIOCHIMIE, V88, P1823, DOI 10.1016/j.biochi.2006.04.011; Chupreta S, 2000, AM J PHYSIOL-CELL PH, V278, pC697; Cunningham E, 2012, J ACAD NUTR DIET, V112, P1916, DOI 10.1016/j.jand.2012.09.003; Dietary Guidelines for Americans, 1995, NUTR REV, V53, P376; Ford MG, 1997, J CLIN INVEST, V99, P2762, DOI 10.1172/JCI119466; Garcia-Leston J, 2011, MUTAT RES-GEN TOX EN, V721, P81, DOI 10.1016/j.mrgentox.2011.01.001; Gordon RA, 1998, ARCH PEDIAT ADOL MED, V152, P1100; ISHIZUKA J, 1992, ANN SURG, V215, P528, DOI 10.1097/00000658-199205000-00016; Kasuba V, 2010, J APPL TOXICOL, V30, P321, DOI 10.1002/jat.1497; Khan MI, 2010, ENVIRON SCI POLLUT R, V17, P1347, DOI 10.1007/s11356-010-0319-x; Lee PT, 2007, MOL BIOL CELL, V18, P5004, DOI 10.1091/mbc.E07-04-0384; Markowitz M, 2000, Pediatr Rev, V21, P327, DOI 10.1542/pir.21-10-327; Marks P, 1996, AM J PHYSIOL-GASTR L, V271, pG942; Mikler J, 2009, TOXICOL IND HEALTH, V25, P137, DOI 10.1177/0748233709104759; Morbidity and Mortality Weekly Report, 2001, MMWR-MORBID MORTAL W, V50, P457; Nakata H, 1998, GASTROENTEROLOGY, V115, P1144, DOI 10.1016/S0016-5085(98)70085-X; Papanikolaou NC, 2005, MED SCI MONITOR, V11, pRA329; Tsou JH, 2008, NUCLEIC ACIDS RES, V36, P217, DOI 10.1093/nar/gkm1027; Tucker TP, 2010, HELICOBACTER, V15, P438, DOI 10.1111/j.1523-5378.2010.00787.x; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993	37	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-4081	1522-7278		ENVIRON TOXICOL	Environ. Toxicol.	FEB	2015	30	2					129	136		10.1002/tox.21878		8	Environmental Sciences; Toxicology; Water Resources	Environmental Sciences & Ecology; Toxicology; Water Resources	CA1GO	WOS:000348661100001		
J	Thang, ND; Yajima, I; Ohnuma, S; Ohgami, N; Kumasaka, MY; Ichihara, G; Kato, M				Thang, Nguyen D.; Yajima, Ichiro; Ohnuma, Shoko; Ohgami, Nobutaka; Kumasaka, Mayuko Y.; Ichihara, Gaku; Kato, Masashi			Enhanced Constitutive Invasion Activity in Human Nontumorigenic Keratinocytes Exposed to a Low Level of Barium for a Long Time	ENVIRONMENTAL TOXICOLOGY			English	Article						barium; focal adhesion kinase; invasion; keratinocytes; matrix metalloproteinase; well water	INDUCED MALIGNANT-TRANSFORMATION; PROSTATE EPITHELIAL-CELLS; DRINKING-WATER; ARSENIC POLLUTION; EXPRESSION; RET; GROUNDWATER; BANGLADESH; DYSPLASIA; CARCINOMA	We have recently demonstrated that exposure to barium for a short time (4 days) and at a low level (5 mu M = 687 mu g/L) promotes invasion of human nontumorigenic HaCaT cells, which have characteristics similar to those of normal keratinocytes, suggesting that exposure to barium for a short time enhances malignant characteristics. Here we examined the effect of exposure to low level of barium for a long time, a condition mimicking the exposure to barium through well water, on malignant characteristics of HaCaT keratinocytes. Constitutive invasion activity, focal adhesion kinase (FAK) protein expression and activity, and matrix metalloproteinase 14 (MMP14) protein expression in primary cultured normal human epidermal keratinocytes, HaCaT keratinocytes, and HSC5 and A431 human squamous cell carcinoma cells were augmented following an increase in malignancy grade of the cells. Constitutive invasion activity, FAK phosphorylation, and MMP14 expression levels of HaCaT keratinocytes after treatment with 5 mu M barium for 4 months were significantly higher than those of control untreated HaCaT keratinocytes. Taken together, our results suggest that exposure to a low level of barium for a long time enhances constitutive malignant characteristics of HaCaT keratinocytes via regulatory molecules (FAK and MMP14) for invasion. (c) 2013 Wiley Periodicals, Inc. Environ Toxicol 30: 161-167, 2015.	[Thang, Nguyen D.; Yajima, Ichiro; Ohgami, Nobutaka; Kumasaka, Mayuko Y.; Kato, Masashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 4878501, Japan; [Thang, Nguyen D.] Vietnam Natl Univ, Dept Biochem & Plant Biol, Hanoi, Vietnam; [Yajima, Ichiro; Kumasaka, Mayuko Y.; Ichihara, Gaku; Kato, Masashi] Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ohnuma, Shoko; Ohgami, Nobutaka; Kato, Masashi] Voluntary Body Int Hlth Care Chubu Univ, Kasugai, Aichi 4878501, Japan	Kato, M (reprint author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 4878501, Japan.	katomasa@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20406003, 24390157, 24406002, 23650241, 24108001]; MEXT and Chubu University (COE Project [Health Science Hills] for Private Universities) [S0801055]; Japan Society for the Promotion of Science (JSPS [AA Science Platform Program]); Tokyo Biochemical Research Foundation; Naito Foundation Natural Science Scholarship; Uehara Memorial Foundation; AEON Environmental Foundation; Cosmetology Research Foundation	Supported by: Ministry of Education, Culture, Sports, Science and Technology (MEXT) (Grants-in-Aid for Scientific Research [B], Nos. 20406003, 24390157, and 24406002; Grant-in-Aid for Challenging Exploratory Research, No. 23650241; Grant-in-Aid for Scientific Research on Innovative Areas, No. 24108001); MEXT and Chubu University (COE Project [Health Science Hills] for Private Universities, No. S0801055); Supported by: Japan Society for the Promotion of Science (JSPS [AA Science Platform Program]); Tokyo Biochemical Research Foundation; the Naito Foundation Natural Science Scholarship; the Uehara Memorial Foundation; AEON Environmental Foundation; The Cosmetology Research Foundation.	Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Yajima I, 2012, ARCH TOXICOL, V86, P961, DOI 10.1007/s00204-012-0848-9; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Winkel LHE, 2011, P NATL ACAD SCI USA, V108, P1246, DOI 10.1073/pnas.1011915108; Ohgami N, 2012, NEUROTOXICOLOGY, V33, P1276, DOI 10.1016/j.neuro.2012.07.008; Achanzar WE, 2002, J NATL CANCER I, V94, P1888; NISHIOKA H, 1975, MUTAT RES, V31, P185, DOI 10.1016/0165-1161(75)90088-6; Kumasaka MY, 2013, ARCH TOXICOL, V87, P439, DOI 10.1007/s00204-012-0964-6; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Kumasaka MY, 2010, CANCER RES, V70, P24, DOI 10.1158/0008-5472.CAN-09-2838; Calay D, 2010, J INVEST DERMATOL, V130, P1136, DOI 10.1038/jid.2009.415; Tokar EJ, 2010, CRIT REV TOXICOL, V40, P912, DOI 10.3109/10408444.2010.506641; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Zoumpourlis V, 2003, CARCINOGENESIS, V24, P1159, DOI 10.1093/carcin/bgg067; Ahsan H, 2000, J OCCUP ENVIRON MED, V42, P1195, DOI 10.1097/00043764-200012000-00016; AYRE JE, 1966, IND MED SURG, V35, P393; AYRE JE, 1967, ANN NY ACAD SCI, V141, P414, DOI 10.1111/j.1749-6632.1967.tb34905.x; Benbrahim-Tallaa L, 2005, ENVIRON HEALTH PERSP, V113, P1134, DOI 10.1289/ehp.7832; DIETZ DD, 1992, FUND APPL TOXICOL, V19, P527, DOI 10.1016/0272-0590(92)90091-U; Hahne JC, 2005, ONCOGENE, V24, P5384, DOI 10.1038/sj.onc.1208761; Kato M, 2010, J CELL BIOCHEM, V110, P399, DOI 10.1002/jcb.22550; Kato M, 2002, CANCER RES, V62, P2414; Kato M, 1999, ONCOGENE, V18, P837, DOI 10.1038/sj.onc.1202329; Kato M, 2011, TOXICOL IN VITRO, V25, P623, DOI 10.1016/j.tiv.2010.12.012; Kato M, 2011, CANCER EPIDEM BIOMAR, V20, P1622, DOI 10.1158/1055-9965.EPI-11-0228; Kato M, 2008, J TOXICOL ENV HEAL A, V71, P1053, DOI 10.1080/15287390802114998; NTP (National Toxicology Program), 1994, NATL TOXICOL PROGRAM, V432, P1; Ohshima Y, 2010, J DERMATOL SCI, V57, P140, DOI 10.1016/j.jdermsci.2009.11.004; Pimparkar B D, 2010, J Assoc Physicians India, V58, P617; Singh Amrit Pal, 2011, Toxicol Int, V18, P87, DOI 10.4103/0971-6580.84258; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Sun GF, 2006, J HEALTH POPUL NUTR, V24, P176; Thang ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025636; Tsuji T, 2008, P NATL ACAD SCI USA, V105, P16866, DOI 10.1073/pnas.0804277105; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Yajima I, 2012, DERMATOL RES PRACT, V2012, DOI DOI 10.1155/2012/354191	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-4081	1522-7278		ENVIRON TOXICOL	Environ. Toxicol.	FEB	2015	30	2					161	167		10.1002/tox.21881		7	Environmental Sciences; Toxicology; Water Resources	Environmental Sciences & Ecology; Toxicology; Water Resources	CA1GO	WOS:000348661100004		
J	Tanaka, M; Miyajima, M; Hishioka, N; Nishimura, R; Kihara, Y; Hosokawa, T; Kurasaki, M; Tanaka, S; Saito, T				Tanaka, Masato; Miyajima, Miki; Hishioka, Naoko; Nishimura, Ryo; Kihara, Yusuke; Hosokawa, Toshiyuki; Kurasaki, Masaaki; Tanaka, Shunitz; Saito, Takeshi			Humic Acid Induces the Endothelial Nitric Oxide Synthase Phosphorylation at Ser1177 and Thr495 Via Hsp90 alpha and Hsp90 beta Upregulation in Human Umbilical Vein Endothelial Cells	ENVIRONMENTAL TOXICOLOGY			English	Article						humic acid; eNOS; heat shock protein 90; eNOS phosphorylation; Ca2+	BLACKFOOT DISEASE; MECHANISM; APOPTOSIS; TAIWAN; OXYGEN; DAMAGE; DEATH	Humic acid (HA) has been implicated as a contributory factor for blackfoot disease, which is an endemic peripheral vascular disease. We investigated the effect of HA on the regulation of endothelial nitric oxide (NO) synthase (eNOS) in human umbilical vein endothelial cells (HUVECs) to evaluate the involvement of eNOS and related factors in peripheral vascular impairment with HA exposure. Treatment of HUVECs with HA induced upregulation of eNOS. This result coincides with those of previous studies. Furthermore this is the first study to report that HA induces upregulation of heat shock protein (Hsp)90, Hsp90, eNOS phosphorylation at Ser1177, and eNOS phosphorylation at Thr495, as compared to that in the control. In contrast, treatment with BAPTA, an intracellular Ca2+ chelator, inhibited upregulation of these proteins induced by HA. This study demonstrates that HA treatment leads to increases in both Hsp90 and Hsp90 proteins and indicates that Hsp90 leads to eNOS phosphorylation at Ser1177 and that Hsp90 leads to eNOS phosphorylation at Thr495, respectively. Upregulation of eNOS, Hsp90, and Hsp90 in HUVECs is regulated by intracellular Ca2+ accumulation induced by HA. These results suggest that upregulation of eNOS phosphorylation at Ser1177 and eNOS phosphorylation at Thr495 produce NO and superoxide anions, respectively, resulting in generation of peroxynitrite, which causes impairment of vascular endothelial cells. (c) 2013 Wiley Periodicals, Inc. Environ Toxicol 30: 223-231, 2015.	[Tanaka, Masato; Miyajima, Miki; Hishioka, Naoko; Nishimura, Ryo; Saito, Takeshi] Hokkaido Univ, Grad Sch Hlth Sci, Environm Hlth Sci Lab, Sapporo, Hokkaido 0600812, Japan; [Kihara, Yusuke] Hokkaido Univ, Grad Sch Environm Sci, Div Environm Sci Dev, Sapporo, Hokkaido 0600810, Japan; [Hosokawa, Toshiyuki] Hokkaido Univ, Inst Adv Higher Educ, Div Higher Educ Res & Dev, Sapporo, Hokkaido 0600817, Japan; [Kurasaki, Masaaki; Tanaka, Shunitz] Hokkaido Univ, Fac Environm Earth Sci, Grp Environm Adaptat Sci, Sapporo, Hokkaido 0600810, Japan; [Saito, Takeshi] Hokkaido Univ, Environm Hlth Sci Lab, Fac Hlth Sci, Sapporo, Hokkaido 0600812, Japan	Saito, T (reprint author), Hokkaido Univ, Grad Sch Hlth Sci, Environm Hlth Sci Lab, Sapporo, Hokkaido 0600812, Japan.	taksaito@med.hokudai.ac.jp	Hosokawa, Toshiyuki/A-3851-2012		Japan Society for the Promotion of Science [21390185, 22659120]	Contract grant sponsor: Japan Society for the Promotion of Science.; Contract grant numbers: 21390185 and 22659120	Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; Liu CW, 2003, SCI TOTAL ENVIRON, V313, P77, DOI 10.1016/S0048-9697(02)00683-6; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; HARTENSTEIN R, 1981, SCIENCE, V212, P743, DOI 10.1126/science.212.4496.743; TSUTSUKI K, 1978, SOIL SCI PLANT NUTR, V24, P547; Qi S, 2008, ENVIRON TOXICOL PHAR, V26, P96, DOI 10.1016/j.etap.2008.02.007; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Page SE, 2004, J QUATERNARY SCI, V19, P625, DOI 10.1002/jqs.884; Avena MJ, 2002, ENVIRON SCI TECHNOL, V36, P5100, DOI 10.1021/es025582u; Bird IM, 2011, J ENDOCRINOL, V210, P239, DOI 10.1530/JOE-11-0216; CHEN G-S, 1990, Journal of Dermatology (Tokyo), V17, P599; Hseu YC, 2002, FREE RADICAL BIO MED, V32, P619, DOI 10.1016/S0891-5849(02)00752-9; Hseu YC, 2009, ENVIRON TOXICOL, V24, P243, DOI 10.1002/tox.20426; Hseu YC, 2002, TOXICOL APPL PHARM, V182, P34, DOI 10.1006/taap.2002.9429; Iwakiri Y, 2011, NITRIC OXIDE-BIOL CH, V25, P95, DOI 10.1016/j.niox.2011.04.014; Kiang JG, 2000, MOL CELL BIOCHEM, V204, P169, DOI 10.1023/A:1007016822939; Kihara Y, 2014, ENVIRON TOXICOL, V29, P916, DOI 10.1002/tox.21819; Klassen S, 2009, N-S ARCH PHARMACOL, V379, P149, DOI 10.1007/s00210-008-0342-3; Lu FJ, 1986, J FORMOS MED ASSOC, V85, P352; LU FJ, 1994, APPL ORGANOMET CHEM, V8, P223, DOI 10.1002/aoc.590080311; Radjagukguk B., 1992, P INT S TROP PEATL K, P21; Ruef Johannes, 1999, Thrombosis and Haemostasis, V82, P32; Swift R.S., 1996, CHEM METHODS SOIL SC, V5, P1018; TSENG WP, 1989, ANGIOLOGY, V40, P547, DOI 10.1177/000331978904000606; Yang HL, 1996, AM J HEMATOL, V51, P200; Yang ML, 2002, ARCH TOXICOL, V76, P48, DOI 10.1007/s002040-001-0312-8; YU H-S, 1984, Journal of Dermatology (Tokyo), V11, P361	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1520-4081	1522-7278		ENVIRON TOXICOL	Environ. Toxicol.	FEB	2015	30	2					223	231		10.1002/tox.21888		9	Environmental Sciences; Toxicology; Water Resources	Environmental Sciences & Ecology; Toxicology; Water Resources	CA1GO	WOS:000348661100011		
J	Inaida, S; Shobugawa, Y; Matsuno, S; Saito, R; Suzuki, H				Inaida, S.; Shobugawa, Y.; Matsuno, S.; Saito, R.; Suzuki, H.			The spatial diffusion of norovirus epidemics over three seasons in Tokyo	EPIDEMIOLOGY AND INFECTION			English	Article						Geographical information system; household; kriging method; national sentinel surveillance; norovirus; population	NORWALK-LIKE VIRUSES; ENVIRONMENTAL CONTAMINATION; AIRBORNE TRANSMISSION; ACUTE GASTROENTERITIS; UNITED-STATES; OUTBREAK; INFECTION; EVOLUTION; SURVEILLANCE; COMMUNITY	We studied the spatial trend of norovirus (NoV) epidemics using sentinel gastroenteritis surveillance data for patients aged < 15 years (n= 140) in the Tokyo area for the 2006-2007 to 2008-2009 seasons utilizing the kriging method of geographical information system (GIS). This is the first study of the spreading pattern of NoV epidemics using sentinel surveillance data. Correlations of sentinel cases between the seasons and with demographic data were examined to identify the trend and related factors. A similar pattern of diffusion was observed over the seasons, and its mean correlation between seasons was significantly high. A higher number of cases were found in the peripheral area, which surrounds the most populated central area, and showed a correlation with the ratio of the children population (r = 0.321, P < 0.01) and the ratio of residents in larger families (r = 0.263, P < 0.01). While NoV susceptibility remained, the results suggest a transmission route in the local community as a possible epidemic factor. Prevention with focus on the peripheral area is desirable.	[Inaida, S.; Shobugawa, Y.; Saito, R.] Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth Publ Hlth, Niigata 9518510, Japan; [Matsuno, S.] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Suzuki, H.] Niigata Seiryo Univ, Sch Nursing, Niigata, Japan	Inaida, S (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth, Chou Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	inaida@med.niigata-u.ac.jp			national research grant from the Ministry of Health, Labour, and Welfare, Japan	This study was supported by a national research grant from the Ministry of Health, Labour, and Welfare, Japan. The sentinel data were obtained from NESID of NIID in Japan. The authors are grateful to Dr Kiyosu Taniguchi from the National Mie Hospital for his kind advice to this study.	[Anonymous], INF AG SURV REP IASR; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Siebenga JJ, 2008, J INFECT DIS, V198, P994, DOI 10.1086/591627; Wheeler JG, 1999, BRIT MED J, V318, P1046; Arvelo W, 2012, J CLIN VIROL, V55, P8, DOI 10.1016/j.jcv.2012.02.018; Motomura K, 2010, J VIROL, V84, P8085, DOI 10.1128/JVI.02125-09; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Barker J, 2004, J HOSP INFECT, V58, P42, DOI 10.1016/j.jhin.2004.04.021; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; CARRAT F, 1992, AM J EPIDEMIOL, V135, P1293; Mounts AW, 2000, J INFECT DIS, V181, pS284, DOI 10.1086/315586; Huhulescu S, 2009, INFECTION, V37, P103, DOI 10.1007/s15010-008-8106-z; Marks PJ, 2000, EPIDEMIOL INFECT, V124, P481, DOI 10.1017/S0950268899003805; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Evans MR, 2002, EPIDEMIOL INFECT, V129, P355, DOI 10.1017/S0950268802007446; Bernard H, 2013, EPIDEMIOL INFECT, V21, P1, DOI DOI 10.1017/S0950268813000435; Centers for Disease Control and Prevention, 2007, MMWR-MORBID MORTAL W, V56, P842; Centers for Disease Control and Prevention (CDC), 2009, MMWR-MORBID MORTAL W, V58, P694; de Wit MAS, 2001, EMERG INFECT DIS, V7, P82; Dingle KE, 2004, J CLIN MICROBIOL, V42, P3950, DOI 10.1128/JCM.42.9.3950-3957.2004; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Inaida S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071696; Kuusi M, 2002, EPIDEMIOL INFECT, V129, P133, DOI 10.1017/S0950268802007276; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Manish M, 2008, EMERG INFECT DIS, V14, P1224; Marks PJ, 2003, EPIDEMIOL INFECT, V131, P727, DOI 10.1017/S0950268803008689; National Institute of Infectious Diseases (NIID), INF GASTR CAS REP PE; Phillips G, 2011, EPIDEMIOL INFECT, V139, P1676, DOI 10.1017/S0950268810002839; Taniguchi K, 2007, J EPIDEMIOL, V17, pS3, DOI 10.2188/jea.17.S3	31	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	FEB	2015	143	3					522	528		10.1017/S0950268814000697		7	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CA1BC	WOS:000348646700009		
J	Teixeira, MD; Rodrigues, AM; Tsui, CKM; de Almeida, LGP; Van Diepeningen, AD; van den Ende, BG; Fernandes, GF; Kano, R; Hamelin, RC; Lopes-Bezerra, LM; Vasconcelos, ATR; de Hoog, S; de Camargo, ZP; Felipe, MSS				Teixeira, Marcus de Melo; Rodrigues, Anderson Messias; Tsui, Clement K. M.; Paulo de Almeida, Luiz Gonzaga; Van Diepeningen, Anne D.; van den Ende, Bert Gerrits; Fernandes, Geisa Ferreira; Kano, Rui; Hamelin, Richard C.; Lopes-Bezerra, Leila Maria; Ribeiro Vasconcelos, Ana Tereza; de Hoog, Sybren; de Camargo, Zoilo Pires; Soares Felipe, Maria Sueli			Asexual Propagation of a Virulent Clone Complex in a Human and Feline Outbreak of Sporotrichosis	EUKARYOTIC CELL			English	Article							SPOROTHRIX-SCHENCKII COMPLEX; OPHIOSTOMA-NOVO-ULMI; MATING-TYPE; GROSMANNIA-CLAVIGERA; MICROBIAL PATHOGENS; SEXUAL REPRODUCTION; MAXIMUM-LIKELIHOOD; SEQUENCE-ANALYSIS; FUNGAL PATHOGENS; EVOLUTIONARY	Sporotrichosis is one of the most frequent subcutaneous fungal infections in humans and animals caused by members of the plant-associated, dimorphic genus Sporothrix. Three of the four medically important Sporothrix species found in Brazil have been considered asexual as no sexual stage has ever been reported in Sporothrix schenckii, Sporothrix brasiliensis, or Sporothrix globosa. We have identified the mating type (MAT) loci in the S. schenckii (strain 1099-18/ATCC MYA-4821) and S. brasiliensis (strain 5110/ATCC MYA-4823) genomes by using comparative genomic approaches to determine the mating type ratio in these pathogen populations. Our analysis revealed the presence of a MAT1-1 locus in S. schenckii while a MAT1-2 locus was found in S. brasiliensis representing genomic synteny to other Sordariomycetes. Furthermore, the components of the mitogen-activated protein kinase (MAPK)-pheromone pathway, pheromone processing enzymes, and meiotic regulators have also been identified in the two pathogens, suggesting the potential for sexual reproduction. The ratio of MAT1-1 to MAT1-2 was not significantly different from 1:1 for all three Sporothrix species, but the population of S. brasiliensis in the outbreaks originated from a single mating type. We also explored the population genetic structure of these pathogens using sequence data of two loci to improve our knowledge of the pattern of geographic distribution, genetic variation, and virulence phenotypes. Population genetics data showed significant population differentiation and clonality with a low level of haplotype diversity in S. brasiliensis isolates from different regions of sporotrichosis outbreaks in Brazil. In contrast, S. schenckii isolates demonstrated a high degree of genetic variability without significant geographic differentiation, indicating the presence of recombination. This study demonstrated that two species causing the same disease have contrasting reproductive strategies and genetic variability patterns.	[Teixeira, Marcus de Melo; Soares Felipe, Maria Sueli] Univ Brasilia, Inst Ciencias Biol, Brasilia, DF, Brazil; [Rodrigues, Anderson Messias; Fernandes, Geisa Ferreira; de Camargo, Zoilo Pires] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Tsui, Clement K. M.; Hamelin, Richard C.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada; [Paulo de Almeida, Luiz Gonzaga; Ribeiro Vasconcelos, Ana Tereza] Lab Nacl Computacao Cient, Petropolis, RJ, Brazil; [Van Diepeningen, Anne D.; van den Ende, Bert Gerrits; de Hoog, Sybren] Inst Royal Netherlands Acad Arts & Sci, Fungal Biodivers Ctr, Utrecht, Netherlands; [Kano, Rui] Nihon Univ, Dept Pathobiol, Sch Vet Med, Fujisawa, Kanagawa, Japan; [Lopes-Bezerra, Leila Maria] Univ Estado Rio de Janeiro, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio De Janeiro, RJ, Brazil; [Soares Felipe, Maria Sueli] Univ Catolica Brasalia, Brasilia, DF, Brazil	Felipe, MSS (reprint author), Univ Catolica Brasalia, Brasilia, DF, Brazil.	msueliunb@gmail.com	Rodrigues, Anderson M./C-5915-2013; Vasconcelos, Ana Tereza/I-1011-2012	Rodrigues, Anderson M./0000-0003-0891-4563; Vasconcelos, Ana Tereza/0000-0002-4632-2086	FAP-DF; FAPESP; CNPq; Capes; project Pronex [193000569/2009]; project Genoprot [559572/2009-3]; FAPESP [2009/54024-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/07350-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BEX 2325/11-0]; Genome Canada and Genome British Columbia;  [2011/01628-8]	We are grateful to FAP-DF, FAPESP, CNPq, and Capes for the financial support and fellowships of the projects Pronex (grant 193000569/2009), Genoprot (grant 559572/2009-3), and FAPESP (Proc. 2009/54024-2). A.M.R. is a fellow and acknowledges the financial support of the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2011/07350-1) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BEX 2325/11-0). G.F.F. is a fellow of FAPESP (2011/01628-8). C.K.M.T and R.C.H. acknowledge the financial assistance of Genome Canada and Genome British Columbia in support to the Tria I and Tria II Projects.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; Harrington TC, 2001, MYCOLOGIA, V93, P111, DOI 10.2307/3761610; de Meyer EM, 2008, MYCOLOGIA, V100, P647, DOI 10.3852/07-157R; Fernandes GF, 2013, VIRULENCE, V4, P241, DOI 10.4161/viru.23112; Marimon R, 2007, J CLIN MICROBIOL, V45, P3198, DOI 10.1128/JCM.00808-07; de Beer ZW, 2003, MYCOLOGIA, V95, P434, DOI 10.2307/3761885; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Turgeon BG, 1998, ANNU REV PHYTOPATHOL, V36, P115, DOI 10.1146/annurev.phyto.36.1.115; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Martin SH, 2011, MOL BIOL EVOL, V28, P1987, DOI 10.1093/molbev/msr022; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Bowman BH, 1996, MOL PHYLOGENET EVOL, V6, P89, DOI 10.1006/mpev.1996.0061; Theodoro RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037694; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37; Lopes-Bezerra LM, 2006, AN ACAD BRAS CIENC, V78, P293, DOI 10.1590/S0001-37652006000200009; Jacobi V, 2010, CAN J MICROBIOL, V56, P697, DOI [10.1139/w10-053, 10.1139/W10-053]; Rodrigues AM, 2013, MED MYCOL, V51, P405, DOI 10.3109/13693786.2012.719648; Fraser JA, 2004, MOL MICROBIOL, V51, P299, DOI 10.1046/j.1365-2958.2003.03874.x; Solla A, 2008, PLANT PATHOL, V57, P33, DOI 10.1111/j.1365-3059.2007.01692.x; Gioti A, 2012, MOL BIOL EVOL, V29, P3215, DOI 10.1093/molbev/mss132; Li WJ, 2010, EUKARYOT CELL, V9, P46, DOI 10.1128/EC.00259-09; Tibayrenc M, 2012, P NATL ACAD SCI USA, V109, pE3305, DOI 10.1073/pnas.1212452109; BERBEE ML, 1992, EXP MYCOL, V16, P87, DOI 10.1016/0147-5975(92)90044-R; Graser Y, 2006, MED MYCOL, V44, P199, DOI 10.1080/13693780600606810; Paoletti M, 2005, MYCOL RES, V109, P983, DOI 10.1017/S0953756205003308; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Barros MBD, 2011, CLIN MICROBIOL REV, V24, P633, DOI 10.1128/CMR.00007-11; Lopez-Romero E, 2011, FUTURE MICROBIOL, V6, P85, DOI [10.2217/fmb.10.157, 10.2217/FMB.10.157]; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Teixeira MD, 2013, EUKARYOT CELL, V12, P380, DOI 10.1128/EC.05052-11; Ni M, 2011, ANNU REV GENET, V45, P405, DOI 10.1146/annurev-genet-110410-132536; Excoffier L, 2005, EVOL BIOINFORM, V1, P47; Aghayeva DN, 2004, MYCOLOGIA, V96, P866, DOI 10.2307/3762119; Heitman J, 2010, CELL HOST MICROBE, V8, P86, DOI 10.1016/j.chom.2010.06.011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Arrillaga-Moncrieff I, 2009, CLIN MICROBIOL INFEC, V15, P651, DOI 10.1111/j.1469-0691.2009.02824.x; BRASIER CM, 1993, MYCOL RES, V97, P811; Castro RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075656; de Lima Barros Mônica Bastos, 2003, Int J Dermatol, V42, P677, DOI 10.1046/j.1365-4362.2003.01813.x; de Lima Barros MB, 2001, MEM I OSWALDO CRUZ, V96, P777; Debuchy R, 2006, MYCOTA, VI, P293, DOI DOI 10.1007/3-540-28135-5_15; Ene IV, 2014, NAT REV MICROBIOL, V12, P239, DOI 10.1038/nrmicro3236; Fisher MC, 2005, PLOS PATHOG, V1, P159, DOI 10.1371/journal.ppat.0010020; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Haridas S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-373; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; Henk DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002851; HUNT JOHN, 1956, LLOYDIA [CINCINNATI], V19, P1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; MARIAT F, 1968, CR ACAD SCI D NAT, V267, P974; NICOT J, 1973, MYCOPATH MYCOL APPL, V49, P53, DOI 10.1007/BF02057447; Nielsen K, 2007, ADV GENET, V57, P143, DOI 10.1016/S0065-2660(06)57004-X; Paoletti M, 2006, MOL ECOL, V15, P249, DOI 10.1111/j.1365-294X.2005.02728.x; Poggeler S, 2002, CURR GENET, V42, P153, DOI 10.1007/s00294-002-0338-3; Rodrigues AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002281; Sasaki AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086819; Sun S, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-56; Teixeira MM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-943; Tsui CKM, 2013, G3-GENES GENOM GENET, V3, P465, DOI 10.1534/g3.112.004986; Wilken PM, 2012, FUNGAL BIOL-UK, V116, P427, DOI 10.1016/j.funbio.2012.01.002; Wingfield M.J., 1993, CERATOCYSTIS OPHIOST; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116; Zhou X, 2013, FUNGAL DIVERS, V2013, P1, DOI DOI 10.1007/S13225-013-0220-2	70	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	1535-9778	1535-9786		EUKARYOT CELL	Eukaryot. Cell	FEB	2015	14	2					158	169		10.1128/EC.00153-14		12	Microbiology; Mycology	Microbiology; Mycology	CA5CE	WOS:000348924400005		
J	Hashimoto, K				Hashimoto, Kenji			Brain-derived neurotrophic factor (BDNF) and its precursor proBDNF as diagnostic biomarkers for major depressive disorder and bipolar disorder	EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE			English	Letter							SERUM-LEVELS; MOOD DISORDERS		Chiba Univ Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba 2608670, Japan	Hashimoto, K (reprint author), Chiba Univ Ctr Forens Mental Hlth, Div Clin Neurosci, 1-8-1 Inohana, Chiba 2608670, Japan.	hashimoto@faculty.chiba-u.jp					Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Sodersten K, 2014, J AFFECT DISORDERS, V160, P1, DOI 10.1016/j.jad.2014.01.009; Molendijk ML, 2014, MOL PSYCHIATR, V19, P791, DOI 10.1038/mp.2013.105; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Dell'Osso B, 2014, J AFFECT DISORDERS, V166, P330, DOI [10.1016/j.jad.2014.05.020, 10.1010/j.jad.2014.05.020]; Terracciano A, 2013, WORLD J BIOL PSYCHIA, V14, P583, DOI 10.3109/15622975.2011.616533; Tunca Z, 2014, J AFFECT DISORDERS, V166, P193, DOI 10.1016/j.jad.2014.05.012; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Hashimoto K, 2014, JAMA NEUROL, V71, P653, DOI 10.1001/jamaneurol.2013.6414; Hashimoto K, 2014, BRI J PSYCH IN PRESS; Powell TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091076; Yoshida T, 2012, OPEN CLIN CHEM J, V5, P7, DOI DOI 10.2174/1874241601205010007; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676	14	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0940-1334	1433-8491		EUR ARCH PSY CLIN N	Eur. Arch. Psych. Clin. Neurosci.	FEB	2015	265	1					83	84		10.1007/s00406-014-0557-x		2	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CA6HT	WOS:000349012700010		
J	Chandna, AR; Nair, M; Chang, C; Pennington, PR; Yamamoto, Y; Mousseau, DD; Campanucci, VA				Chandna, Andrew R.; Nair, Manoj; Chang, Christine; Pennington, Paul R.; Yamamoto, Yasuhiko; Mousseau, Darrell D.; Campanucci, Veronica A.			RAGE mediates the inactivation of nAChRs in sympathetic neurons under high glucose conditions	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						autonomic neuropathy; diabetes; nicotinic receptors; oxidative stress; RAGE knock-out mice; sympathetic neurons	GLYCATION END-PRODUCTS; NICOTINIC ACETYLCHOLINE-RECEPTOR; CHROMATIN PROTEIN HMGB1; ADULT SENSORY NEURONS; CELL-SURFACE RECEPTOR; OXIDANT STRESS; AUTONOMIC NEUROPATHY; OXIDATIVE STRESS; DIABETIC COMPLICATIONS; SYNAPTIC-TRANSMISSION	Autonomic dysfunction is a serious complication of diabetes and can lead to cardiovascular abnormalities and premature death. It was recently proposed that autonomic dysfunction is triggered by oxidation-mediated inactivation of neuronal nicotinic acetylcholine receptors (nAChRs), impairing synaptic transmission in sympathetic ganglia and resulting in autonomic failure. We investigated whether the receptor for advanced glycation end products (RAGE) and its role in the generation of reactive oxygen species (ROS) could be contributing to the events that initiate sympathetic malfunction under high glucose conditions. Using biochemical, live imaging and electrophysiological tools we demonstrated that exposure of sympathetic neurons to high glucose increases RAGE expression and oxidative markers, and that incubation with RAGE ligands (e.g. AGEs, S100 and HMGB1) mimics both ROS elevation and nAChR inactivation. In contrast, co-treatment with either antioxidants or an anti-RAGE IgG prevented the inactivation of nAChRs. Lastly, a role for RAGE in this context was corroborated by the lack of sensitivity of sympathetic neurons from RAGE knock-out mice to high glucose. These data define a pivotal role for RAGE in initiating the events associated with exposure of sympathetic neurons to high glucose, and strongly support RAGE signaling as a potential therapeutic target in the autonomic complications associated with diabetes.	[Chandna, Andrew R.; Nair, Manoj; Chang, Christine; Campanucci, Veronica A.] Univ Saskatchewan, Dept Physiol, Saskatoon, SK S7N 5E5, Canada; [Pennington, Paul R.; Mousseau, Darrell D.] Univ Saskatchewan, Dept Psychiat, Saskatoon, SK S7N 5E5, Canada; [Yamamoto, Yasuhiko] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa, Japan	Campanucci, VA (reprint author), Univ Saskatchewan, Dept Physiol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	veronica.campanucci@usask.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	This study was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to V.A.C. The authors declare no conflict of interest. We thank Dr Jennifer Nyarko for her assistance with some of the Western blot analyses.	Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Thornalley PJ, 2002, INT REV NEUROBIOL, V50, P37; Krishnaswamy A, 2009, NEURON, V61, P272, DOI 10.1016/j.neuron.2008.11.025; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Vinik AI, 2003, SEMIN NEUROL, V23, P365; Wautier JL, 2004, CIRC RES, V95, P233, DOI 10.1161/01.RES.0000137876.28454.64; Xu DZ, 2003, J BIOL CHEM, V278, P39349, DOI 10.1074/jbc.M302771200; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; DUCHEN LW, 1980, ANN INTERN MED, V92, P301; Campanucci V, 2010, NEURON, V66, P827, DOI 10.1016/j.neuron.2010.06.010; Ding Y, 2007, J LEUKOCYTE BIOL, V81, P520, DOI 10.1189/jlb.0406262; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771; Kosaki A, 2004, J CLIN ENDOCR METAB, V89, P5423, DOI 10.1210/jc.2003-032223; Reiniger N, 2010, DIABETES, V59, P2043, DOI 10.2337/db09-1766; Melendez-Ramirez LY, 2010, ENDOCRIN METAB CLIN, V39, P625, DOI 10.1016/j.ecl.2010.05.009; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; BROWNLEE M, 1992, DIABETES CARE, V15, P1835, DOI 10.2337/diacare.15.12.1835; Zherebitskaya E, 2009, DIABETES, V58, P1356, DOI 10.2337/db09-0034; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685; Rassadi S, 2005, J NEUROSCI, V25, P8555, DOI 10.1523/JNEURSCI.1983-05.2005; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; Marcovecchio ML, 2010, BRIT MED BULL, V94, P145, DOI 10.1093/bmb/ldp053; Schmidt RE, 2008, J NEUROPATH EXP NEUR, V67, P1166, DOI 10.1097/NEN.0b013e318190d6db; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ono Y, 1998, DIABETES RES CLIN PR, V41, P131, DOI 10.1016/S0168-8227(98)00074-6; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; RUDERMAN NB, 1992, FASEB J, V6, P2905; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521; YAN SD, 1994, J BIOL CHEM, V269, P9889; Schmidt AM, 2000, SEMIN THROMB HEMOST, V26, P485, DOI 10.1055/s-2000-13204; Saleh A, 2013, EXP NEUROL, V249, P149, DOI 10.1016/j.expneurol.2013.08.018; Toth C, 2007, CURR MOL MED, V7, P766, DOI 10.2174/156652407783220705; Obrosova IG, 2009, BBA-MOL BASIS DIS, V1792, P931, DOI 10.1016/j.bbadis.2008.11.005; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Kuehl M, 2012, NAT REV ENDOCRINOL, V8, P405, DOI 10.1038/nrendo.2012.21; Campanucci VA, 2008, J NEUROSCI, V28, P1733, DOI 10.1523/JNEUROSCI.5130-07.2008; Taguchi A, 2000, NATURE, V405, P354; Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Campanucci VA, 2006, J NEUROSCI, V26, P9482, DOI 10.1523/JNEUROSCI.1672-06.2006; Donaghue KC, 2005, DIABETIC MED, V22, P1315, DOI 10.1111/j.1464-5491.2005.01631.x; Juranek JK, 2013, BRAIN BEHAV, V3, P701, DOI 10.1002/brb3.176; Saleh A, 2013, EXP NEUROL, V241, P169, DOI 10.1016/j.expneurol.2012.11.009; Schiekofer S, 2003, DIABETES, V52, P621, DOI 10.2337/diabetes.52.3.621; Schmidt RE, 2002, AUTON NEUROSCI-BASIC, V96, P63, DOI 10.1016/S1566-0702(01)00372-1; SCHMIDT RE, 1993, AM J PATHOL, V143, P143; Schmidt RE, 2001, BRAIN RES, V921, P256, DOI 10.1016/S0006-8993(01)03155-9; vansBeijnum J R., 2013, ONCOGENE, V32, P363; Vinik Aaron I, 2013, Handb Clin Neurol, V117, P279, DOI 10.1016/B978-0-444-53491-0.00022-5; Wang NS, 2002, PROG NEUROBIOL, V68, P341, DOI 10.1016/S0301-0082(02)00106-5; Yamamoto Y, 2000, ANN NY ACAD SCI, V902, P163	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	FEB	2015	41	3					341	351		10.1111/ejn.12795		11	Neurosciences	Neurosciences & Neurology	CA8EQ	WOS:000349150000006		
J	Yamada, J; Ohgomori, T; Jinno, S				Yamada, J.; Ohgomori, T.; Jinno, S.			Perineuronal nets affect parvalbumin expression in GABAergic neurons of the mouse hippocampus	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						chondroitinase ABC; neural plasticity; vulnerability; Wisteria floribunda agglutinin	CHONDROITIN SULFATE PROTEOGLYCANS; EXPERIENCE-DEPENDENT PLASTICITY; FAST-SPIKING INTERNEURONS; CALCIUM-BINDING PROTEINS; DEVELOPING VISUAL-CORTEX; RAT CEREBRAL-CORTEX; EXTRACELLULAR-MATRIX; OXIDATIVE STRESS; QUANTITATIVE-ANALYSIS; OPTICAL DISECTOR	Recent studies have suggested that the perineuronal net (PNN), a specialised extracellular matrix structure, and parvalbumin (PV), an EF-hand calcium-binding protein, are involved in the regulation of plasticity of neural circuits. Here, we aimed to quantitatively estimate the relationship between the two plasticity regulators, PV and PNNs, in the hippocampus of young adult mice. Dual fluorescence staining for PV and Wisteria floribunda agglutinin (a broad PNN marker) showed that a substantial population of PV-expressing (PV+) GABAergic neurons lacked PNNs. Optical disector analysis demonstrated that there were fewer PNN+ neurons than PV+ neurons. The ratio of PNN expression in PV+ neurons was generally lower in the dendritic layers than in the principal cell layers, whereas the ratio of PV expression in PNN+ neurons was effectively 100%. The mean PV fluorescence was significantly higher in PNN+/PV+ neurons than in PNN-/PV+ neurons. Cumulative frequencies for single-cell PV fluorescence indicated that intensely stained PV+ neurons tend to be enwrapped by PNNs, whereas weakly stained PV+ neurons are likely to lack PNNs. We digested the PNNs by a unilateral injection of chondroitinase ABC (chABC) into the dorsal CA1 region. Although the densities of PV+ neurons remained unchanged, the PV fluorescence declined 7days after chABC injection. Quantitative real-time polymerase chain reaction analysis demonstrated a reduction in PV mRNA expression following chABC injection. These findings indicate that the presence or absence of PNNs affects the relative PV expression in GABAergic neurons in the hippocampus.	[Yamada, J.; Ohgomori, T.; Jinno, S.] Kyushu Univ, Grad Sch Med Sci, Dept Dev Mol Anat, Higashi Ku, Fukuoka 8128582, Japan	Jinno, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Dev Mol Anat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	sjnno@med.kyushu-u.ac.jp			Uehara Memorial Foundation;  [24110510];  [26110714]	We thank Ms Yoshie Ide for her secretarial assistance. We also appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University. Grant sponsors - this work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Nos. 24110510 and 26110714; S. Jinno) and by the Uehara Memorial Foundation (S. Jinno).	Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; BEST N, 1993, NEUROSCI LETT, V155, P1, DOI 10.1016/0304-3940(93)90660-D; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Morawski M, 2004, EXP NEUROL, V188, P309, DOI 10.1016/j.expneurol.2004.04.017; KOSAKA T, 1989, BRAIN RES, V483, P158, DOI 10.1016/0006-8993(89)90048-6; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Dinocourt C, 2003, J COMP NEUROL, V459, P407, DOI 10.1002/cne.10622; Romberg C, 2013, J NEUROSCI, V33, P7057, DOI 10.1523/JNEUROSCI.6267-11.2013; Schuppel K, 2002, BRAIN RES, V958, P448, DOI 10.1016/S0006-8993(02)03569-2; Jinno S, 2002, J COMP NEUROL, V449, P1, DOI 10.1002/cne.10251; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; Cossart R, 2001, NAT NEUROSCI, V4, P52; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Yamada J, 2013, NEUROSCIENCE, V253, P368, DOI 10.1016/j.neuroscience.2013.08.061; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Orduz D, 2013, J PHYSIOL-LONDON, V591, P3215, DOI 10.1113/jphysiol.2012.250795; Nowicka D, 2009, EUR J NEUROSCI, V30, P2053, DOI 10.1111/j.1460-9568.2009.06996.x; CELIO MR, 1993, HIPPOCAMPUS, V3, P55; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Jinno S, 1998, BRAIN RES, V814, P55, DOI 10.1016/S0006-8993(98)01075-0; Ohira K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-43; Karetko M, 2009, ACTA NEUROBIOL EXP, V69, P564; Beurdeley M, 2012, J NEUROSCI, V32, P9429, DOI 10.1523/JNEUROSCI.0394-12.2012; Giamanco KA, 2012, NEUROSCIENCE, V218, P367, DOI 10.1016/j.neuroscience.2012.05.055; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Chevaleyre Vivien, 2014, Front Cell Neurosci, V8, P93, DOI 10.3389/fncel.2014.00093; DELRIO MR, 1994, J COMP NEUROL, V342, P389, DOI 10.1002/cne.903420307; Franklin G., 1997, MOUSE BRAIN STEREOTA; Guirado R., 2014, INT J NEUROPSYCHOPH, V30, P1, DOI DOI 10.1017/S1461145714000406; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219; Hylin MJ, 2013, LEARN MEMORY, V20, P267, DOI 10.1101/lm.030197.112; Jinno S, 2000, J COMP NEUROL, V428, P377; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; Makara JK, 2007, J NEUROSCI, V27, P10211, DOI 10.1523/JNEUROSCI.2104-07.2007; Mayhew TM, 1996, J ANAT, V188, P1; OKAMOTO M, 1994, NEUROSCI LETT, V172, P51, DOI 10.1016/0304-3940(94)90660-2; Piskorowski RA, 2013, J NEUROSCI, V33, P14567, DOI 10.1523/JNEUROSCI.0649-13.2013; Shah A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.145; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127; STICHEL CC, 1987, J COMP NEUROL, V262, P563, DOI 10.1002/cne.902620409; Suttkus A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.25	46	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	FEB	2015	41	3					368	378		10.1111/ejn.12792		11	Neurosciences	Neurosciences & Neurology	CA8EQ	WOS:000349150000009		
J	Kawamura, T; Kawaguchi, Y; Sugikubo, K; Inagaki, F; Mukai, C				Kawamura, Takamasa; Kawaguchi, Yasuaki; Sugikubo, Katsuya; Inagaki, Fuyuhiko; Mukai, Chisato			Rhodium(I)-Catalyzed Cycloisomerization of Allene-Allenylcyclopropanes	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Allenes; Small ring systems; Rhodium; Cycloisomerization; Cycloaddition	CATALYZED 5+2 CYCLOADDITIONS; ASYMMETRIC TOTAL-SYNTHESIS; FISCHER CARBENE COMPLEXES; 7-MEMBERED RINGS; VINYLCYCLOPROPANES; ALKYNES; 1ST; CYCLOPROPANES; STEREOCHEMISTRY; TRANS	The Rh-I-catalyzed intramolecular [5+2-2]-type cycloisomerization of allene-allenylcyclopropanes was developed. In this reaction, ethylene was liberated from the cyclopropane ring to afford the 1,5,6,7-tetrahydroazulene skeletons.	[Kawamura, Takamasa; Kawaguchi, Yasuaki; Sugikubo, Katsuya; Inagaki, Fuyuhiko; Mukai, Chisato] Kanazawa Univ, Div Pharmaceut Sci, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan	Mukai, C (reprint author), Kanazawa Univ, Div Pharmaceut Sci, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan.	mukai@p.kanazawa-u.ac.jp	INAGAKI, Fuyuhiko/D-8392-2015		Ministry of Education, Culture, Sports, Science, and Technology (Japan)	The authors are grateful for financial support by the Ministry of Education, Culture, Sports, Science, and Technology (Japan) through a Grant-in-Aid for Scientific Research.	Wender PA, 2000, ORG LETT, V2, P2323, DOI 10.1021/ol006085q; Wender PA, 2005, J AM CHEM SOC, V127, P2836, DOI 10.1021/ja042728b; Kulinkovich OG, 2003, CHEM REV, V103, P2597, DOI 10.1021/cr010012i; Yu M, 2005, TETRAHEDRON, V61, P321, DOI 10.1016/j.tet.2004.10.077; Sugikubo K, 2013, ANGEW CHEM INT EDIT, V52, P11369, DOI 10.1002/anie.201305958; Wender PA, 2002, ANGEW CHEM INT EDIT, V41, P4550, DOI 10.1002/1521-3773(20021202)41:23<4550::AID-ANIE4550>3.0.CO;2-D; Wender PA, 2001, ORG LETT, V3, P2105, DOI 10.1021/ol0160699; Wender PA, 2002, J AM CHEM SOC, V124, P2876, DOI 10.1021/ja0176301; Barluenga J, 2004, J AM CHEM SOC, V126, P5974, DOI 10.1021/ja049200r; WENDER PA, 1995, J AM CHEM SOC, V117, P4720, DOI 10.1021/ja00121a036; Carson CA, 2009, CHEM SOC REV, V38, P3051, DOI 10.1039/b901245c; Wender PA, 1998, TETRAHEDRON, V54, P7203, DOI 10.1016/S0040-4020(98)00355-X; Ylijoki KEO, 2013, CHEM REV, V113, P2244, DOI 10.1021/cr300087g; Cid J, 2012, CHEM-EUR J, V18, P1512, DOI 10.1002/chem.201102729; Wang YY, 2007, J AM CHEM SOC, V129, P10060, DOI 10.1021/ja072505w; Shu XZ, 2012, J AM CHEM SOC, V134, P5211, DOI 10.1021/ja2109097; Evans PA, 2008, J AM CHEM SOC, V130, P12838, DOI 10.1021/ja803691p; Shintani R, 2009, CHEM-EUR J, V15, P8692, DOI 10.1002/chem.200901463; Wender PA, 2006, J AM CHEM SOC, V128, P6302, DOI 10.1021/ja058590u; Wender PA, 1999, J AM CHEM SOC, V121, P5348, DOI 10.1021/ja9903072; Wender PA, 1999, ORG LETT, V1, P137, DOI 10.1021/ol990599b; Rubin M, 2007, CHEM REV, V107, P3117, DOI 10.1021/cr050988l; Jiao L, 2008, J AM CHEM SOC, V130, P7178, DOI 10.1021/ja8008715; Shu XZ, 2011, ANGEW CHEM INT EDIT, V50, P8153, DOI 10.1002/anie.201103136; Wender PA, 1998, J AM CHEM SOC, V120, P1940, DOI 10.1021/ja973650k; Barluenga J, 2003, ANGEW CHEM INT EDIT, V42, P231, DOI 10.1002/anie.200390087; Barluenga J., 2003, ANGEW CHEM, V115, P241, DOI 10.1002/ange.200390055; Dang YF, 2013, ORGANOMETALLICS, V32, P2804, DOI 10.1021/om400227u; Hayashi M., 1998, ANGEW CHEM, V110, P877, DOI 10.1002/(SICI)1521-3757(19980316)110:6<877::AID-ANGE877>3.3.CO;2-4; Hayashi M, 1998, ANGEW CHEM INT EDIT, V37, P837, DOI 10.1002/(SICI)1521-3773(19980403)37:6<837::AID-ANIE837>3.0.CO;2-R; Inagaki F., 2010, ANGEW CHEM, V122, P2252; Inagaki F., 2009, ANGEW CHEM, V121, P2041; Inagaki F, 2009, ANGEW CHEM INT EDIT, V48, P2007, DOI 10.1002/anie.200806029; Inagaki F, 2010, ANGEW CHEM INT EDIT, V49, P2206, DOI 10.1002/anie.200906994; JAMES BR, 1979, CAN J CHEM, V57, P180, DOI 10.1139/v79-030; Jiao L, 2010, CHEM COMMUN, V46, P1059, DOI 10.1039/b922417c; Kawamura T, 2010, CHEM-EUR J, V16, P5173, DOI 10.1002/chem.200903568; Kim S. Y., 2008, ANGEW CHEM, V120, P4992, DOI 10.1002/ange.200800432; Kim SY, 2008, ANGEW CHEM INT EDIT, V47, P4914, DOI 10.1002/anie.200800432; KNOWLTON JW, 1949, J RES NAT BUR STAND, V43, P113, DOI 10.6028/jres.043.013; Koga Y, 1999, CHEM LETT, P705; LAMONICA G, 1983, J MOL CATAL, V18, P93, DOI 10.1016/0304-5102(83)80072-8; Lian YQ, 2005, J AM CHEM SOC, V127, P17162, DOI 10.1021/ja0540268; Rubina M, 2004, TETRAHEDRON, V60, P3129, DOI 10.1016/j.tet.2004.01.044; SANGER AR, 1977, J CHEM SOC DALTON, P120, DOI 10.1039/dt9770000120; Shu X.-Z., 2011, ANGEW CHEM, V123, P8303; Sugikubo K., 2013, ANGEW CHEM, V125, P11579; Tamaki T, 2011, ANGEW CHEM INT EDIT, V50, P12067, DOI 10.1002/anie.201106174; Tamaki T., 2011, ANGEW CHEM, V123, P12273; Walczak MAA, 2008, J AM CHEM SOC, V130, P6924, DOI 10.1021/ja802906k; Wender A., 1998, J ORG CHEM, V63, P4164; Wender P. A., 2002, ANGEW CHEM, V114, P4732, DOI 10.1002/1521-3757(20021202)114:23<4732::AID-ANGE4732>3.0.CO;2-B; Wender PA, 1999, ORG LETT, V1, P2089, DOI 10.1021/ol991171f; Wender PA, 1999, J AM CHEM SOC, V121, P10442, DOI 10.1021/ja992580+	54	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	FEB	2015		4					719	722		10.1002/ejoc.201403535		4	Chemistry, Organic	Chemistry	CA3YP	WOS:000348841400005		
J	Nagata, K; Usui, N; Terui, K; Takayasu, H; Goishi, K; Hayakawa, M; Tazuke, Y; Yokoi, A; Okuyama, H; Taguchi, T				Nagata, Kouji; Usui, Noriaki; Terui, Keita; Takayasu, Hajime; Goishi, Keiji; Hayakawa, Masahiro; Tazuke, Yuko; Yokoi, Akiko; Okuyama, Hiroomi; Taguchi, Tomoaki			Risk Factors for the Recurrence of the Congenital Diaphragmatic Hernia-Report from the Long-Term Follow-Up Study of Japanese CDH Study Group	EUROPEAN JOURNAL OF PEDIATRIC SURGERY			English	Article						congenital diaphragmatic hernia; long-term complication; recurrence	PATCH REPAIR; GENTLE VENTILATION; OUTCOMES	Aim of the StudyFew follow-up studies focused on the recurrence regarding the postoperative course of congenital diaphragmatic hernia (CDH) survivors. The aim of this study was to report on risk factor for CDH patients who had the recurrence during the follow-up. Materials and MethodsA multicenter retrospective survey was conducted on neonates diagnosed to have CDH between January 2006 and December 2010. Follow-up survey was conducted between September 2013 and October 2013 (ethical approval: No. 25-222). Nine institutions agreed to participate in this survey. Out of 228, 182 (79.8%) patients were alive and 180 patients were included in this study. Two patients were excluded because the defect had not repaired at the primary operation. The patients were divided into the recurrence group (n=21) and the nonrecurrence group (n=159). Postnatal and postoperative variables were compared between these two groups. Baseline variables which showed significance in univariate analysis were entered into multiple logistic regression analysis for analyzing the recurrence. A value of p<0.05 was considered to be statistically significant by using the JMP software program (version 9; SAS Institute, Inc, Cary, North Carolina, United States). Main ResultsOut of 180, 21 (11.7%) CDH neonates had the recurrence during the course of the follow-up. Five (2.8%) patients had the recurrence before primary discharge and 16 (8.9%) patients had the recurrence after discharge. Univariate analysis showed that liver herniation (crude odds ratio [OR], 7.4; 95% confidence interval [CI], 2.73-23.68), defect size C and D, proposed by the CDH Study Group (crude OR, 7.09; 95% CI, 2.73-19.99) and patch repair (crude OR, 5.00; 95% CI, 1.91-14.70) were risk factors. Multivariate logistic regression analysis showed liver herniation (adjusted OR, 3.96; 95% CI, 1.01-16.92) was the risk factor for the recurrence. ConclusionA wide spectrum of the disease severity and the rarity of the disease mask the risk of the recurrence for CDH patients. This study showed the only factor to predict the recurrence was the liver herniation. These data will be helpful for providing information for the long-term follow-up of the CDH patients.	[Nagata, Kouji; Taguchi, Tomoaki] Kyushu Univ, Dept Pediat Surg, Fukuoka 8128582, Japan; [Usui, Noriaki] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Suita, Osaka, Japan; [Terui, Keita] Chiba Univ, Dept Pediat Surg, Grad Sch Med, Chiba, Japan; [Takayasu, Hajime] Univ Tsukuba, Fac Med, Dept Pediat Surg, Tsukuba, Ibaraki, Japan; [Goishi, Keiji] Natl Ctr Child Hlth & Dev, Div Neonatol, Dept Maternal & Perinatal Med, Tokyo, Japan; [Hayakawa, Masahiro] Nagoya Univ Hosp, Div Neonatol, Ctr Maternal Neonatal Care, Nagoya, Aichi, Japan; [Tazuke, Yuko] Osaka Med Ctr, Dept Pediat Surg, Osaka, Japan; [Tazuke, Yuko] Res Inst Maternal & Child Hlth, Osaka, Japan; [Yokoi, Akiko] Kobe Childrens Hosp, Dept Pediat Surg, Kobe, Hyogo, Japan; [Okuyama, Hiroomi] Hyogo Coll Med, Dept Pediat Surg, Nishinomiya, Hyogo 6638501, Japan	Nagata, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	koujin@pedsurg.med.kyushu-u.ac.jp					Lansdale N, 2010, ANN SURG, V252, P20, DOI 10.1097/SLA.0b013e3181dca0e8; Lally KP, 2013, J PEDIATR SURG, V48, P2408, DOI 10.1016/j.jpedsurg.2013.08.014; Jawaid WB, 2013, BRIT J SURG, V100, P1833, DOI 10.1002/bjs.9306; Gander JW, 2011, J PEDIATR SURG, V46, P1303, DOI 10.1016/j.jpedsurg.2010.11.048; Romao RLP, 2012, J PEDIATR SURG, V47, P1496, DOI 10.1016/j.jpedsurg.2012.01.009; Bagolan Pietro, 2007, Semin Pediatr Surg, V16, P134, DOI 10.1053/j.sempedsurg.2007.01.009; Jancelewicz T, 2013, J PEDIATR SURG, V48, P935, DOI 10.1016/j.jpedsurg.2013.02.005; Lally KP, 2008, PEDIATRICS, V121, P627; Masumoto K, 2006, PEDIATR SURG INT, V25, P487, DOI 10.1007/s00383-009-2370-6; Nagata K, 2013, J PEDIATR SURG, V48, P738, DOI 10.1016/j.jpedsurg.2012.12.017; Tsai J, 2012, J PEDIATR SURG, V47, P637, DOI 10.1016/j.jpedsurg.2011.11.054; Tsao K, 2008, SEMIN PEDIAT SURG, V17, P90, DOI 10.1053/j.sempedsurg.2008.02.004; Usui N, 2014, EUR J PEDIATR SURG, V24, P31, DOI 10.1055/s-0033-1357753	13	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0939-7248	1439-359X		EUR J PEDIATR SURG	Eur. J. Pediatr. Surg.	FEB	2015	25	1					9	14		10.1055/s-0034-1395486		6	Pediatrics; Surgery	Pediatrics; Surgery	AZ9HL	WOS:000348524500005		
J	Shono, T; Izaki, T; Nakahori, R; Yoshimaru, K				Shono, Takeshi; Izaki, Tomoko; Nakahori, Ryouichi; Yoshimaru, Koichirou			Testicular Ascent after Laparoscopic Percutaneous Extraperitoneal Closure for Inguinal Hernias	EUROPEAN JOURNAL OF PEDIATRIC SURGERY			English	Article						LPEC; inguinal hernia; ascending testis; orchiopexy	CRYPTORCHIDISM; CHILDREN; REPAIR; TESTIS	AimLaparoscopic percutaneous extraperitoneal closure (LPEC) has been widely performed for the repair of pediatric inguinal hernias in Japan. This study aimed to evaluate the testicular ascent and orchiopexy after LPEC in males with inguinal hernias. MethodsThe medical records of male patients who underwent LPEC procedures for the repair of an inguinal hernia from January 2010 to December 2013 at our institution were reviewed. The patients who underwent orchiopexy after the LPEC procedure were investigated, the characteristics studied were the birth weight of the patients, the age when they underwent LPEC, the mean time from LPEC to orchiopexy, and the location of the affected testes. The LPEC procedure was performed by extraperitoneal circuit suturing around the internal inguinal ring with a long straight special needle (Lapaherclosure; Hakko Medical Co., Tokyo, Japan). ResultsDuring the 4-year period of this study, 438 LPECs were performed on 367 male patients. Orchiopexy was performed on 14 testes (3.2%) in 10 patients who had previously undergone LPEC. Five of the 10 patients were extremely low-birth-weight infants. The mean time from LPEC to orchiopexy was 13.2 months. In 7 of these 10 patients, both testes were initially identified in the scrotum at 3 months after LPECs, but they later showed ascending or retractile testes. In another three patients, the ipsilateral testes were elevated early after LPECs, and they were thought to be missed congenital undescended testes. At orchiopexy, 10 of the 14 testes were located in the inguinal region, and the other four testes were retractile. During the orchiopexy, the remaining processus vaginalis was found to adhere to the spermatic cord in all of the patients with ascending testes. ConclusionThe postoperative testicular ascent should be carefully examined after the LPEC procedure in patients with pediatric inguinal hernias, especially in extremely low-birth-weight infants.	[Shono, Takeshi; Izaki, Tomoko; Nakahori, Ryouichi] Saga Ken Med Ctr Koseikan, Dept Pediat Surg, Saga 8408571, Japan; [Shono, Takeshi] Kokura Med Ctr, Dept Pediat Surg, Kitakyushu, Fukuoka, Japan; [Yoshimaru, Koichirou] Kyushu Univ, Dept Pediat Surg, Fukuoka 812, Japan	Shono, T (reprint author), Saga Ken Med Ctr Koseikan, Dept Pediat Surg, 400 Nakahara, Saga 8408571, Japan.	shonotak@gmail.com					Takehara H, 2006, J PEDIATR SURG, V41, P1999, DOI 10.1016/j.jpedsurg.2006.08.032; Barthold JS, 2003, J UROLOGY, V170, P2396, DOI 10.1097/01.ju.0000095793.04232.d8; Clarnette TD, 1997, J UROLOGY, V157, P1889, DOI 10.1016/S0022-5347(01)64894-8; Schier F, 2006, J PEDIATR SURG, V41, P1081, DOI 10.1016/j.jpedsurg.2006.02.028; ATWELL JD, 1985, BRIT J UROL, V57, P474, DOI 10.1111/j.1464-410X.1985.tb06315.x; Hutson JM, 1992, DESCENT TESTIS; John Radcliffe Hospital Cryptorchidism Study Group, 1986, BMJ-BRIT MED J, V293, P789; KAPLAN GW, 1976, SURG GYNECOL OBSTET, V142, P671; MISRA D, 1995, BRIT J UROL, V75, P687; Shono T, 1999, BJU INT, V83, P323; Takehara H, 2000, P 7 WORLD C END SURG, P537	11	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0939-7248	1439-359X		EUR J PEDIATR SURG	Eur. J. Pediatr. Surg.	FEB	2015	25	1					105	108		10.1055/s-0034-1387938		4	Pediatrics; Surgery	Pediatrics; Surgery	AZ9HL	WOS:000348524500022		
J	Uehara, S; Oue, T; Nakahata, K; Nara, K; Ueno, T; Owari, M; Usui, N; Miyamura, T; Hashii, Y				Uehara, Shuichiro; Oue, Takaharu; Nakahata, Kengo; Nara, Keigo; Ueno, Takehisa; Owari, Mitsugu; Usui, Noriaki; Miyamura, Takako; Hashii, Yoshiko			Perioperative Management after High-Dose Chemotherapy with Autologous or Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Solid Tumors	EUROPEAN JOURNAL OF PEDIATRIC SURGERY			English	Article						solid tumor; perioperative management; hematopoietic stem cell transplantation; high-dose chemotherapy	REVERSIBLE ENCEPHALOPATHY SYNDROME; TACROLIMUS; RESCUE; MELPHALAN; BUSULFAN; THIOTEPA	IntroductionAn increasing number of children with advanced malignancies have recently received high-dose chemotherapy (HDC) with hematopoietic stem cell transplantation (HSCT), followed by surgery. In this study, we reviewed our experience with surgery after HDC and autologous (auto) or allogeneic (allo) HSCT to elucidate the problems associated with this treatment and establish the optimum surgical management strategy. Patients and MethodsWe retrospectively reviewed the cases of 24 children with advanced malignancy treated with HDC and HSCT before tumor resection at our institution. The tumors included 18 neuroblastomas, 5 soft tissue sarcomas, 2 hepatoblastomas, and 1 Wilms tumor. The source of hematopoietic stem cells was auto-HSCT in 19 patients and allo-HSCT in 5 patients. To be able to undergo surgery, it was necessary that the patient's general condition, including hemostasis, should be fairly good and that the results of hematological examinations should include a white blood cell (WBC) count of>1,000/mu L, hemoglobin level of>10 g/dL and platelet count of>5x10(4)/mu L. ResultsThe mean duration before WBC recovery after HSCT was 14.51.4 days after auto-HSCT and 23.8 +/- 1.2 days after allo-HSCT, respectively (p<0.01). The mean duration before platelet recovery after HSCT was 46.5 +/- 5.2 days for auto-HSCT and 48.6 +/- 5.5 days for allo-HSCT (not significant [n.s.]). The mean interval between allo-HSCT and surgery was significantly longer (92.8 +/- 6.2 days) than that between auto-HSCT and surgery (57.0 +/- 3.9 days) (p<0.01), likely because of the use of steroids and immunosuppressants after HSCT. The tumors were completely resected in all cases without severe complications. All the patients treated with allo-HSCT had an acute graft versus host (aGVH) reaction at 2 to 3 weeks after HSCT, and specifically required the administration of steroids and immunosuppressants to prevent aGVH. The postoperative complications included paralytic ileus in two cases and a tacrolimus-associated encephalopathy in one case involving allo-HSCT. In half of the patients, the WBC count was not elevated after surgery, whereas the postoperative serum C-reactive protein (CRP) level was elevated in all cases. ConclusionsOur data indicate that surgical treatment can be safely performed even after HDC with HSCT if attention is paid to myelosuppression and the adverse effects of both chemotherapeutic agents and immunosuppressants.	[Uehara, Shuichiro; Oue, Takaharu; Nakahata, Kengo; Nara, Keigo; Ueno, Takehisa; Owari, Mitsugu; Usui, Noriaki] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Suita, Osaka 5650871, Japan; [Miyamura, Takako; Hashii, Yoshiko] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan	Uehara, S (reprint author), Osaka Univ, Grad Sch Med, Dept Pediat Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	uehara@pedsurg.med.osaka-u.ac.jp					Hammerstrom AE, 2013, AM J HEMATOL, V88, P301, DOI 10.1002/ajh.23402; Nash RA, 2000, BLOOD, V96, P2062; Wong R, 2003, BRIT J HAEMATOL, V122, P128, DOI 10.1046/j.1365-2141.2003.04447.x; Hawkins D, 2000, MED PEDIATR ONCOL, V34, P328, DOI 10.1002/(SICI)1096-911X(200005)34:5<328::AID-MPO3>3.0.CO;2-4; Stott VL, 2005, INTERN MED J, V35, P83, DOI 10.1111/j.1445-5994.2004.00750.x; Ballen KK, 2012, BIOL BLOOD MARROW TR, V18, P1446, DOI 10.1016/j.bbmt.2012.03.009; Hara J, 1998, BONE MARROW TRANSPL, V22, P7, DOI 10.1038/sj.bmt.1701283; Hashii Y, 2008, PEDIATR HEMAT ONCOL, V25, P439, DOI 10.1080/08880010802104601; Jagasia M, 2012, BLOOD, V119, P296, DOI 10.1182/blood-2011-06-364265; Oue T, 2003, J PEDIATR SURG, V38, P130, DOI 10.1053/jpsu.2003.50026; Perentesis JP, 1999, BONE MARROW TRANSPL, V24, P609, DOI 10.1038/sj.bmt.1701950	11	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0939-7248	1439-359X		EUR J PEDIATR SURG	Eur. J. Pediatr. Surg.	FEB	2015	25	1					118	122		10.1055/s-0034-1386638		5	Pediatrics; Surgery	Pediatrics; Surgery	AZ9HL	WOS:000348524500025		
J	Oue, T; Miyoshi, Y; Hashii, Y; Uehara, S; Ueno, T; Nara, K; Usui, N; Ozono, K				Oue, Takaharu; Miyoshi, Yoko; Hashii, Yoshiko; Uehara, Shuichiro; Ueno, Takehisa; Nara, Keigo; Usui, Noriaki; Ozono, Keiichi			Problems during the Long-Term Follow-Up after Surgery for Pediatric Solid Malignancies	EUROPEAN JOURNAL OF PEDIATRIC SURGERY			English	Article						childhood cancer survivor; late effect; chemotherapy; surgery; radiation therapy	CHILDHOOD-CANCER SURVIVORS; THERAPY	IntroductionWith the recent improvements in the prognosis of pediatric malignancies, the number of patients surviving long-term after surgery has been increasing. Therefore, the late effects of cancer treatments are important issues. In this study, we analyzed the problems associated with the treatment of pediatric patients during the long-term follow-up after surgery. Patients and MethodsA total of 64 patients with pediatric malignancies who underwent surgical treatment and were followed up for more than 5 years and who were older than 13 years of age were included in this study. The average age was 20.8 (13-33) years, and the follow-up ranged from 5 to 31 years (mean, 17.7 years). Twenty-one patients (32.3%) received high-dose chemotherapy (HDC) and nine (14.1%) received radiotherapy. ResultsIn this study, 46 patients (71.9%) developed at least one problem during the follow-up period. With regard to the surgical problems, 14 patients underwent nephrectomy, and 1 of them developed renal failure. One patient received cystectomy with urinary tract reconstruction. One patient received a partial vaginectomy. Two cases with ovarian tumors received oophorectomy, one of whom also received partial hysterectomy. Other complications such as ileus, scoliosis, and leg length discrepancies were seen in some patients. In terms of the medical problems, 15 patients showed growth retardation and 2 were treated with growth hormone therapy. Gonadal dysfunction was observed in 23 patients, and 8 of them were treated with hormone replacement therapy. Six patients developed hypothyroidism, two of whom were treated with thyroid hormone replacement therapy. Other medial issues, such as hearing impairment, low bone mineral density, and hepatitis, were seen in some patients. The rate of growth retardation, gonadal dysfunction, and hypothyroidism were significantly higher in the patients who received HDC (p<0.05). There was one case of second malignancy of the parotid gland. ConclusionVarious treatment-related complications may occur even many years after treatment, especially in patients who receive HDC. Medical problems, especially endocrine disorders, appear to be more serious than surgery-related problems. Lifetime medical surveillance and continuous follow-up by not only pediatric surgeons but also by various specialists, such as pediatric oncologists, pediatric endocrinologists, urologists, and gynecologists, are necessary.	[Oue, Takaharu; Uehara, Shuichiro; Ueno, Takehisa; Nara, Keigo; Usui, Noriaki] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Suita, Osaka 5650871, Japan; [Miyoshi, Yoko; Hashii, Yoshiko; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan	Oue, T (reprint author), Osaka Univ, Grad Sch Med, Dept Pediat Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ooue@pedsurg.med.osaka-u.ac.jp					Bassal M, 2006, J CLIN ONCOL, V24, P476, DOI 10.1200/JCO.2005.02.7235; Mulder RL, 2013, CANCER EPIDEM BIOMAR, V22, P1736, DOI 10.1158/1055-9965.EPI-13-0036; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Dickerman JD, 2007, PEDIATRICS, V119, P554, DOI 10.1542/peds.2006-2826; Sklar CA, 1997, PEDIATR CLIN N AM, V44, P489, DOI 10.1016/S0031-3955(05)70487-9; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Chow EJ, 2007, J PEDIATR-US, V150, P370, DOI 10.1016/j.jpeds.2006.11.036; Elli M, 2013, JPN J CLIN ONCOL, V43, P1004, DOI 10.1093/jjco/hyt105; Meacham Lillian, 2003, Curr Probl Pediatr Adolesc Health Care, V33, P217, DOI 10.1016/S1538-5442(03)00053-1; Miyoshi Y, 2008, ENDOCR J, V55, P1055; Miyoshi Y, 2013, HORM RES PAEDIAT, V79, P17, DOI 10.1159/000346139; Reinmuth S, 2013, J CANCER RES CLIN, V139, P2071, DOI 10.1007/s00432-013-1527-9; Rutter MM, 2007, CURR OPIN PEDIATR, V19, P480, DOI 10.1097/MOP.0b013e3282058b56; Tanaka H, 2005, PEDIAT JAPAN S, V46, P17	14	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0939-7248	1439-359X		EUR J PEDIATR SURG	Eur. J. Pediatr. Surg.	FEB	2015	25	1					123	127		10.1055/s-0034-1386639		5	Pediatrics; Surgery	Pediatrics; Surgery	AZ9HL	WOS:000348524500026		
J	Kinoshita, Y; Tanaka, S; Souzaki, R; Miyoshi, K; Kohashi, K; Oda, Y; Nakatsura, T; Taguchi, T				Kinoshita, Yoshiaki; Tanaka, Sakura; Souzaki, Ryota; Miyoshi, Kina; Kohashi, Kenichi; Oda, Yoshinao; Nakatsura, Tetsuya; Taguchi, Tomoaki			Glypican 3 Expression in Pediatric Malignant Solid Tumors	EUROPEAN JOURNAL OF PEDIATRIC SURGERY			English	Article						glypican 3; tumor marker; immunotherapy	HEPATOCELLULAR-CARCINOMA; MARKER; IDENTIFICATION; HEPATOBLASTOMA	PurposeGlypican 3 (GPC3) is one of the cell surface heparan sulfate proteoglycans that binds to the cell membrane, and it is known as an oncofetal protein in adult malignant tumors. Clinical trials using a GPC3 peptide vaccine have already been started in Japan as a new immunotherapy for hepatocellular carcinoma in adult patients. To investigate the possibility of GPC3 immunotherapy for pediatric malignant tumors, we assessed the expression of GPC3 in pediatric malignant tumors. MethodsImmunohistochemically, the GPC3 expression was examined in 159 pediatric solid tumors, including 35 cases of neuroblastoma, 30 cases of Wilms tumor, 10 cases of hepatoblastoma, 25 cases of germ cell tumors, 56 cases of rhabdomyosarcoma, and 3 cases of other tumors. In addition, to clarify the physiological expression during the fetal to neoinfantile period, autopsy specimens of subjects without any neoplastic diseases were assessed in 9 fetal cases and 21 neoinfantile cases. The serum levels of GPC3 were also analyzed using specimens obtained from 53 subjects by the sandwich enzyme-linked immunosorbent assay method. ResultsHistologically, a high rate of GPC3 expression was noted in 10 (90.9%) of the 11 subjects with yolk sac tumors and 6 (60.0%) of the 10 subjects with hepatoblastoma. In addition, 9 (30.0%) of the 30 subjects with Wilms tumors and 14 (25.0%) of the 56 subjects with rhabdomyosarcoma were positive for the expression of GPC3. Concerning autopsy specimens, most of the 23 subjects younger than 7 months showed positive findings in the liver (94.7%) and kidney (81.8%). Two subjects (100%) with yolk sac tumors and six (75.0%) of the eight subjects with hepatoblastoma serologically demonstrated a high rate of positive expression. Concerning the distribution of the serum GPC3 level according to age, 8 (80.0%) of the 10 subjects younger than 1year showed a positive finding, while only 16 (37.3%) of the 43 subjects older than 1year showed a positive finding. ConclusionMost cases of hepatoblastoma and yolk sac tumor, and some cases of other tumors were found to express GPC3 either histologically or serologically. On the other hand, GPC3 was physiologically expressed during the fetal and neoinfantile period under 1year of age. Although, more preliminary data and experience are required, patients older than 1year that show a positive finding for GPC3 are considered to be appropriate candidates to receive the new immunotherapy using GPC3 peptide vaccination.	[Kinoshita, Yoshiaki; Tanaka, Sakura; Souzaki, Ryota; Taguchi, Tomoaki] Kyushu Univ, Dept Pediat Surg, Fukuoka 8128582, Japan; [Miyoshi, Kina; Kohashi, Kenichi; Oda, Yoshinao] Kyushu Univ, Dept Anat Pathol, Fukuoka 8128582, Japan; [Nakatsura, Tetsuya] Natl Canc Ctr Hosp East, Div Canc Immunotherapy, Kashiwa, Chiba, Japan	Kinoshita, Y (reprint author), Kyushu Univ, Dept Pediat Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kinoppy@pedsurg.med.kyushu-u.ac.jp					Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; Nakatsura T, 2004, CLIN CANCER RES, V10, P6612, DOI 10.1158/1078-0432.CCR-04-0348; Nakatsura T, 2003, BIOCHEM BIOPH RES CO, V306, P16, DOI 10.1016/S0006-291X(03)00908-2; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Lapunzina P, 2005, AM J MED GENET C, V137C, P53, DOI 10.1002/ajmg.c.30064; Hippo Y, 2004, CANCER RES, V64, P2418, DOI 10.1158/0008-5472.CAN-03-2191; Filmus J, 2001, GLYCOBIOLOGY, V11, p19R, DOI 10.1093/glycob/11.3.19R; Gonzalez A D, 1998, J Cell Biol, V141, P1407, DOI 10.1083/jcb.141.6.1407; Maeda D, 2009, MODERN PATHOL, V22, P824, DOI 10.1038/modpathol.2009.40; Nishimura Yasuharu, 2008, Nihon Rinsho Meneki Gakkai Kaishi, V31, P383; Ota S, 2006, VIRCHOWS ARCH, V449, P308, DOI 10.1007/s00428-006-0238-x; Saikali Z, 2000, INT J CANCER, V89, P418; Toretsky JA, 2001, J PEDIAT HEMATOL ONC, V23, P496, DOI 10.1097/00043426-200111000-00006; Zynger DL, 2008, HUM PATHOL, V39, P224, DOI 10.1016/j.humpath.2007.06.006	14	2	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0939-7248	1439-359X		EUR J PEDIATR SURG	Eur. J. Pediatr. Surg.	FEB	2015	25	1					138	143		10.1055/s-0034-1393961		6	Pediatrics; Surgery	Pediatrics; Surgery	AZ9HL	WOS:000348524500029		
J	Hamazaki, K; Nishi, D; Yonemoto, N; Noguchi, H; Kim, Y; Matsuoka, Y				Hamazaki, K.; Nishi, D.; Yonemoto, N.; Noguchi, H.; Kim, Y.; Matsuoka, Y.			The role of high-density lipoprotein cholesterol in risk for posttraumatic stress disorder: Taking a nutritional approach towards universal prevention (vol 29, pg 408, 2014)	EUROPEAN PSYCHIATRY			English	Correction									[Hamazaki, K.; Yonemoto, N.; Noguchi, H.; Matsuoka, Y.] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Clin Epidemiol, Kodaira, Tokyo 1878551, Japan; [Nishi, D.; Yonemoto, N.; Kim, Y.; Matsuoka, Y.] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Kodaira, Tokyo 1878551, Japan; [Nishi, D.; Matsuoka, Y.] Natl Disaster Med Ctr, Dept Psychiat, Tokyo, Japan; [Hamazaki, K.] Toyama Univ, Fac Med, Dept Publ Hlth, Toyama 930, Japan; [Hamazaki, K.; Nishi, D.; Yonemoto, N.; Noguchi, H.; Matsuoka, Y.] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Matsuoka, Y (reprint author), Natl Ctr Neurol & Psychiat, Translat Med Ctr, Dept Clin Epidemiol, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878551, Japan.	yutaka@ncnp.go.jp					Hamazaki K, 2014, EUR PSYCHIAT, V29, P408, DOI 10.1016/j.eurpsy.2014.05.002	1	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0924-9338	1778-3585		EUR PSYCHIAT	Eur. Psychiat.	FEB	2015	30	2								10.1016/j.eurpsy.2014.10.002		1	Psychiatry	Psychiatry	AZ4NG	WOS:000348198100024		
J	Fujii, M; Shimazaki, Y; Muto, Y; Kohno, S; Ohya, S; Nabe, T				Fujii, Masanori; Shimazaki, Yuki; Muto, Yoshiko; Kohno, Shigekatsu; Ohya, Susumu; Nabe, Takeshi			Dietary deficiencies of unsaturated fatty acids and starch cause atopic dermatitis-like pruritus in hairless mice	EXPERIMENTAL DERMATOLOGY			English	Article						atopic dermatitis; cornstarch; dietary deficiency; hairless mice; unsaturated fatty acids	SKIN BARRIER DYSFUNCTION; INTESTINAL MICROBIOTA; T-CELLS; ITCH; INFLAMMATION; DISEASE; OLIGOSACCHARIDES; PATHOPHYSIOLOGY; ACTIVATION; TSLP	Hairless mice fed with a special diet (named HR-AD) show atopic dermatitis (AD)-like pruritic skin inflammation that is almost completely resolved with the supplementation of an unsaturated fatty acid (UFA), the linoleic acid (LA). This suggests that the dietary deficiency of LA is the key cause of this dermatitis. However, because there is no appropriate control diet for HR-AD, the involvement of other dietary ingredients cannot be ruled out. Furthermore, it has not yet been tested whether only UFA deficiency can cause such AD-like pruritus. In this study, using semi-purified custom diets, we attempted to reproduce this syndrome. Four-week-old hairless mice were maintained on a widely used standard diet American Institute of Nutrition-76A (AIN-76A), its modifications, or HR-AD. Several modifications of fat and carbohydrate components revealed that dietary deficiency of both UFAs and cornstarch was required to induce severe skin barrier dysfunction as typically occurred in HR-AD-fed mice. An UFA- and cornstarch-deficient diet caused severe AD-like pruritus comparable to HR-AD, despite weak Th2 immune responses and absence of immunoglobulin E production. On the other hand, a diet lacking UFAs but containing cornstarch significantly alleviated the development of pruritic dermatitis. Furthermore, the supplementation of wheat starch similarly improved skin barrier function. In conclusion, this study showed that a lack of certain starches might also be the cause of diet-induced AD. Our findings could help to reproduce the diet-induced AD itch model and also provide evidence that certain starches can have protective and ameliorative effects on AD-like pruritus.	[Fujii, Masanori; Shimazaki, Yuki; Muto, Yoshiko; Kohno, Shigekatsu; Ohya, Susumu; Nabe, Takeshi] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol, Kyoto 6078414, Japan; [Nabe, Takeshi] Setsunan Univ, Fac Pharmaceut Sci, Toxicol Lab, Osaka, Japan	Fujii, M (reprint author), Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol, Yamashina Ku, 5 Nakauchi, Kyoto 6078414, Japan.	fujii@mb.kyoto-phu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21790096]; Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research [12-05]	This work is partly supported by a Grant-in-Aid for Young Scientist (B) (Grant no. 21790096 to M.F.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research (Grant no. 12-05 to M.F.).	Fujii M, 2006, EUR J PHARMACOL, V530, P152, DOI 10.1016/j.ejphar.2005.11.013; Stremnitzer C, 2014, ALLERGY, V69, P741, DOI 10.1111/all.12399; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; LaMotte RH, 2011, EXP DERMATOL, V20, P778, DOI 10.1111/j.1600-0625.2011.01367.x; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Kawakami T, 2009, CURR OPIN IMMUNOL, V21, P666, DOI 10.1016/j.coi.2009.09.006; Kim HJ, 2012, EXP DERMATOL, V21, P672, DOI 10.1111/j.1600-0625.2012.01539.x; Noti M, 2014, J ALLERGY CLIN IMMUN, V133, P1390, DOI 10.1016/j.jaci.2014.01.021; Wilson SR, 2013, J NEUROSCI, V33, P9283, DOI 10.1523/JNEUROSCI.5318-12.2013; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Stander S, 2002, EXP DERMATOL, V11, P12, DOI 10.1034/j.1600-0625.2002.110102.x; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Gessner A, 2005, J IMMUNOL, V174, P1063; Szegedi K, 2012, EXP DERMATOL, V21, P431, DOI 10.1111/j.1600-0625.2012.01487.x; Kabashima-Kubo R, 2012, J DERMATOL SCI, V67, P37, DOI 10.1016/j.jdermsci.2012.04.004; Fujii M, 2013, EXP DERMATOL, V22, P272, DOI 10.1111/exd.12120; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Buddenkotte J, 2010, ALLERGY, V65, P805, DOI 10.1111/j.1398-9995.2010.01995.x; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2013, J ALLERGY CLIN IMMUN, V132, P601, DOI 10.1016/j.jaci.2013.05.043; Fujii M, 2005, EXP DERMATOL, V14, P460, DOI 10.1111/j.0906-6705.2005.00313.x; Lund Sean, 2013, Current Immunology Reviews, V9, P214; Hansmann B, 2012, EXP DERMATOL, V21, P271, DOI 10.1111/j.1600-0625.2012.01449.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Choi HR, 2012, J COSMET DERMATOL-US, V11, P290, DOI 10.1111/jocd.12009; DesPaepe K, 2002, ACTA DERM-VENEREOL, V82, P184; Fujii M, 2009, EUR J PHARMACOL, V611, P92, DOI 10.1016/j.ejphar.2009.03.051; Morar N, 2006, J ALLERGY CLIN IMMUN, V118, P24, DOI 10.1016/j.jaci.2006.03.037; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Weise C, 2013, PEDIAT ALLERG IMM-UK, V24, P361, DOI 10.1111/pai.12073	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	FEB	2015	24	2					108	113		10.1111/exd.12592		6	Dermatology	Dermatology	CA4XW	WOS:000348911700008		
J	Saigusa, R; Asano, Y; Taniguchi, T; Yamashita, T; Takahashi, T; Ichimura, Y; Toyama, T; Tamaki, Z; Tada, Y; Sugaya, M; Kadono, T; Sato, S				Saigusa, Ryosuke; Asano, Yoshihide; Taniguchi, Takashi; Yamashita, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Tamaki, Zenshiro; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi			A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis	EXPERIMENTAL DERMATOLOGY			English	Article						angiogenesis; CCN1; digital ulcers; systemic sclerosis; vasculogenesis	PRO-ANGIOGENIC ACTIVITIES; TRANSCRIPTION FACTOR FLI1; PROGENITOR CELLS; GROWTH-FACTOR; CYR61 CCN1; T-CELLS; SCLERODERMA; SKIN; REGENERATION; VASCULOPATHY	CCN1 is a pleiotropic molecule involved in angiogenesis and postnatal vasculogenesis, both of which are impaired in systemic sclerosis (SSc). To elucidate the potential role of CCN1 in the development of SSc, we investigated CCN1 expression in the lesional skin of SSc patients and SSc animal models and the clinical correlation of serum CCN1 levels. CCN1 expression was markedly decreased in dermal small blood vessels of SSc patients compared with those of healthy controls, while comparable between normal and SSc dermal fibroblasts. Transcription factor Fli1, whose deficiency due to epigenetic suppression is implicated in the pathogenesis of SSc, occupied the CCN1 promoter and gene silencing of Fli1 resulted in the reduction of CCN1 expression in human dermal microvascular endothelial cells. Consistently, CCN1 expression was suppressed uniformly and remarkably in dermal blood vessels of Fli1(+/-) mice and partially in those of endothelial cell-specific Fli1 knockout mice. Furthermore, serum CCN1 levels were significantly decreased in SSc patients with previous and current history of digital ulcers as compared to those without. Collectively, these results suggest that endothelial CCN1 downregulation at least partially due to Fli1 deficiency may contribute to the development of digital ulcers in SSc patients. This study further supports the idea that epigenetic downregulation of Fli1 is a potential predisposing factor in the pathogenesis of SSc.	[Saigusa, Ryosuke; Asano, Yoshihide; Taniguchi, Takashi; Yamashita, Takashi; Takahashi, Takehiro; Ichimura, Yohei; Toyama, Tetsuo; Tamaki, Zenshiro; Tada, Yayoi; Sugaya, Makoto; Kadono, Takafumi; Sato, Shinichi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp			Ministry of Health, Labour and Welfare of Japan	We thank A. Hatsuta, W. Furuya and T. Kaga for tissue processing and staining, and C. Ohwashi, T. Ikegami and N. Watanabe for technical assistance. This work was supported by a grant for Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan.	Noda S, 2013, ARCH DERMATOL RES, V305, P325, DOI 10.1007/s00403-012-1307-4; LEROY EC, 1988, J RHEUMATOL, V15, P202; Noda S, 2013, RHEUMATOLOGY, V52, P790, DOI 10.1093/rheumatology/kes379; Ichimura Y, 2014, ARCH DERMATOL RES, V306, P331, DOI 10.1007/s00403-013-1431-9; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202; Sgonc R, 2000, ARTHRITIS RHEUM-US, V43, P2550, DOI 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H; Abraham DJ, 2009, RHEUMATOLOGY, V48, P3, DOI 10.1093/rheumatology/ken481; Kahaleh MB, 1999, CLIN IMMUNOL, V91, P188, DOI 10.1006/clim.1999.4694; ROSENBAUM J, 1988, CLIN EXP IMMUNOL, V72, P450; Distler JHW, 2006, RHEUMATOLOGY, V45, P26, DOI 10.1093/rheumatology/kel295; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Asano Y, 2009, MOL CELL BIOL, V29, P425, DOI 10.1128/MCB.01278-08; Kuwana M, 2014, ARTHRITIS RHEUMATOL, V66, P1300, DOI 10.1002/art.38326; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Yamaguchi Y, 2013, HISTOL HISTOPATHOL, V28, P175; Giacomelli R, 1998, ARTHRITIS RHEUM, V41, P327, DOI 10.1002/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S; Spyropoulos DD, 2000, MOL CELL BIOL, V20, P5643, DOI 10.1128/MCB.20.15.5643-5652.2000; Distler O, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar596; Asano Y, 2010, J DERMATOL SCI, V59, P153, DOI 10.1016/j.jdermsci.2010.06.008; Yoshizaki A, 2008, AM J PATHOL, V172, P1650, DOI 10.2353/ajpath.2008.071049; Asano Y, 2007, J BIOL CHEM, V282, P34672, DOI 10.1074/jbc.M703907200; Kuwana M, 2004, LANCET, V364, P603, DOI 10.1016/S0140-6736(04)16853-0; Kubo M, 2003, AM J PATHOL, V163, P571, DOI 10.1016/S0002-9440(10)63685-1; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Rabquer BJ, 2012, CURR RHEUMATOL REP, V14, P56, DOI 10.1007/s11926-011-0219-1; Salojin KV, 1997, AM J MED, V102, P178; Wang YQ, 2006, ARTHRITIS RHEUM, V54, P2271, DOI 10.1002/art.21948; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Hill MB, 1996, CLIN EXP IMMUNOL, V106, P491, DOI 10.1046/j.1365-2249.1996.d01-867.x; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Kuwana M, 2012, ANN RHEUM DIS, V71, P617, DOI 10.1136/annrheumdis-2011-200713; Michalska-Jakubus M, 2011, RHEUMATOLOGY, V50, P746, DOI 10.1093/rheumatology/keq392; Noda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032272; Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Yamaguchi Y, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3180	38	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	FEB	2015	24	2					127	132		10.1111/exd.12602		6	Dermatology	Dermatology	CA4XW	WOS:000348911700011		
J	Tan, X; Takahashi, H; Nishida, J; Aoki, A; Inoue, T; Yanagi, Y				Tan, Xue; Takahashi, Hidenori; Nishida, Junko; Aoki, Aya; Inoue, Tatsuya; Yanagi, Yasuo			Excessive retinol intake exacerbates choroidal neovascularization through upregulated vascular endothelial growth factor in retinal pigment epithelium in mice	EXPERIMENTAL EYE RESEARCH			English	Article						Visual cycle; VEGF; Angiogenesis; Moderator	AGE-RELATED MACULOPATHY; RETINOBLASTOMA Y79 CELLS; VEGF GENE-EXPRESSION; VITAMIN-A; BINDING-PROTEIN; MACULAR DEGENERATION; ACID RECEPTOR; VISUAL CYCLE; ALPHA-TOCOPHEROL; BETA-CAROTENE	As a part of the visual cycle, all-trans-retinol (all-trans-ROL), the major form of vitamin A in circulating blood, is transported to the retinal pigment epithelium (RPE). All-trans-ROL is essential for normal retina function. However, recent researches have shown that excessive retinol intake can cause increase of all-trans-retinal. This can lead to the accumulation of lipofuscin, which is important in the pathogenesis of retina degeneration disease, such as dry type age-related macular degeneration (AMD). Since there are few reports regarding the involvement of all-trans-ROL in exudative AMD, we investigated the effects of all-trans-ROL in vitro and in vivo. We evaluated vascular endothelial growth factor (VEGF) expression in ARPE-19 cells and THP-1 cells after all-trans-ROL treatment using ELISA and real-time RT-PCR. In-vitro tube formation assay was performed with HUVEC cells using the conditioned medium (CM) obtained from ARPE-19 cells treated with all-trans-ROL. Transcriptional activity of retinoic acid receptor (RAR) was evaluated using luciferase assay. In mice, VEGF expressions were investigated in the retina and RPE/choroid after three weeks of excessive oral retinol intake. Laser-induced choroidal neovascularization (CNV) models were evaluated after they were fed with various doses of retinol. VEGF mRNA expression and VEGF production were significantly increased in all-trans-ROL treated ARPE-19 cells, which were inhibited by an RAR antagonist LE540. In contrast, there were no significant changes in VEGF production in THP-1 cells. Transcriptional activity of RAR was upregulated by all-trans-ROL treatment in ARPE-19 cells. The CM, obtained from ARPE-19 cells treated with all-trans-ROL, induced more capillary-like tube formation than cells treated with control vehicles. In vivo, the high retinal diet group has increased VEGF expression in the RPE/choroid and larger lesion size was induced. Our results suggest that all-trans-ROL is a pro-angiogenic factor. Excessive retinoid intake may be a potential risk factor for exudative AMD. (C) 2015 Elsevier Ltd. All rights reserved.	[Tan, Xue; Takahashi, Hidenori; Nishida, Junko; Aoki, Aya; Inoue, Tatsuya; Yanagi, Yasuo] Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138655, Japan	Yanagi, Y (reprint author), Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yanagi-tky@umin.ac.jp					Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Akiyama H, 2002, INVEST OPHTH VIS SCI, V43, P1367; Akiyama H, 2005, AM J PHYSIOL-CELL PH, V288, pC913, DOI 10.1152/ajpcell.00116.2004; Iriyama A, 2008, J BIOL CHEM, V283, P11947, DOI 10.1074/jbc.M708989200; Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Newcomer ME, 2000, BBA-PROTEIN STRUCT M, V1482, P57, DOI 10.1016/S0167-4838(00)00150-3; Takahashi H, 2008, CURR EYE RES, V33, P1002, DOI 10.1080/02713680802492440; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; KEMP CM, 1988, EXP EYE RES, V46, P185, DOI 10.1016/S0014-4835(88)80076-9; Yuda K, 2012, AM J PATHOL, V181, P1464, DOI 10.1016/j.ajpath.2012.06.028; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P1310, DOI 10.1167/iovs.05-1292; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.RI00015-JLR200; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Kubota R, 2012, RETINA-J RET VIT DIS, V32, P183, DOI 10.1097/IAE.0b013e318217369e; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; BERNI R, 1992, FEBS LETT, V308, P43, DOI 10.1016/0014-5793(92)81046-O; Dobri N, 2013, INVEST OPHTH VIS SCI, V54, P85, DOI 10.1167/iovs.12-10050; Kannan R, 2006, MOL VIS, V12, P1649; KURLANDSKY SB, 1994, J BIOL CHEM, V269, P32821; REPA JJ, 1993, P NATL ACAD SCI USA, V90, P7293, DOI 10.1073/pnas.90.15.7293; SCHAFFER EM, 1993, J NUTR, V123, P1497; Schmitz-Valckenberg S, 2006, INVEST OPHTH VIS SCI, V47, P2648, DOI 10.1167/iovs.05.0892; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Shaban H, 2002, EXP EYE RES, V75, P99, DOI 10.1006/exer.2001.1192; Smith W, 1997, AM J OPHTHALMOL, V124, P838; Sreekumar PG, 2008, INVEST OPHTH VIS SCI, V49, P1210, DOI 10.1167/iovs.07-0667; Teikari JM, 1998, ACTA OPHTHALMOL SCAN, V76, P224, DOI 10.1034/j.1600-0420.1998.760220.x; Thurnham DI, 1999, P NUTR SOC, V58, P449, DOI 10.1017/S0029665199000592	38	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	FEB	2015	131						77	83		10.1016/j.exer.2015.01.005		7	Ophthalmology	Ophthalmology	CA5VA	WOS:000348974700009		
J	Doi, T; Makizako, H; Shimada, H; Tsutsumimoto, K; Hotta, R; Nakakubo, S; Park, H; Suzuki, T				Doi, Takehiko; Makizako, Hyuma; Shimada, Hiroyuki; Tsutsumimoto, Kota; Hotta, Ryo; Nakakubo, Sho; Park, Hyuntae; Suzuki, Takao			Objectively measured physical activity, brain atrophy, and white matter lesions in older adults with mild cognitive impairment	EXPERIMENTAL GERONTOLOGY			English	Article						Brain atrophy; Mild cognitive impairment; Physical activity; Accelerometer	VOXEL-BASED MORPHOMETRY; ALZHEIMERS-DISEASE; CONTROLLED-TRIAL; RISK; MRI; METAANALYSIS; POPULATION; PREVALENCE; DISORDER; IMPROVES	Physical activity may help to prevent or delay brain atrophy. Numerous studies have shown associations between physical activity and age-related changes in the brain. However, most of these studies involved self-reported physical activity, not objectively measured physical activity. Therefore, the aim of this study was to examine the association between objectively measured physical activity, as determined using accelerometers, and brain magnetic resonance imaging (MRI) measures in older adults with mild cognitive impairment(MCI). We analyzed 323 older subjects with MCI (mean age 71.4 years) who were recruited from the participants of the Obu Study of Health Promotion for the Elderly. We recorded demographic data and measured physical activity using a tri-axial accelerometer. Physical activity was classified as light-intensity physical activity (LPA) or moderate-to-vigorous physical activity (MVPA). Brain atrophy and the severity of white matter lesions (WML) were determined by MRI. Low levels of LPA and MVPA were associated with severe WML. Subjects with severe WML were older, had lower mobility, and had greater brain atrophy than subjects with mild WML (all P < 0.05). Multivariate analysis revealed that more MVPA was associated with less brain atrophy, even after adjustment for WML (beta = -0.126, P = 0.015), but LPA was not (beta = -0.102, P = 0.136). Our study revealed that objectively measured physical activity, especially MVPA, was associated with brain atrophy in MCI subjects, even after adjusting for WML. These findings support the hypothesis that physical activity plays a crucial role in maintaining brain health. (C) 2014 Elsevier Inc. All rights reserved.	[Doi, Takehiko; Makizako, Hyuma; Shimada, Hiroyuki; Tsutsumimoto, Kota; Hotta, Ryo; Nakakubo, Sho; Park, Hyuntae] Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, Obu, Aichi 4748511, Japan; [Doi, Takehiko] Japan Soc Promot Sci, Tokyo 1020083, Japan; [Doi, Takehiko; Suzuki, Takao] Natl Ctr Geriatr & Gerontol, Res Inst, Obu, Aichi 4748511, Japan	Doi, T (reprint author), Natl Ctr Geriatr & Gerontol, Ctr Gerontol & Social Sci, Dept Functioning Activat, 35 Gengo, Obu, Aichi 4748511, Japan.	take-d@ncgg.go.jp			Comprehensive Research on Aging and Health from Health and Labor Sciences Research Grants; National Center for Geriatrics and Gerontology, Japan [22-16];  [23300205];  [259435]	We wish to thank the Obu office for help with subject recruitment. This work was supported by Grants; Comprehensive Research on Aging and Health from Health and Labor Sciences Research Grants; a Grant-in-Aid for Scientific Research (B) (grant number 23300205); a Grant-in-Aid for JSPS Fellows 259435; and Research Funding for Longevity Sciences (22-16) from the National Center for Geriatrics and Gerontology, Japan.	Brodaty H, 2013, ALZHEIMERS DEMENT, V9, P310, DOI 10.1016/j.jalz.2011.11.010; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Benedict C, 2013, NEUROBIOL AGING, V34, P83, DOI 10.1016/j.neurobiolaging.2012.04.013; Hagstromer M, 2010, J PHYS ACT HEALTH, V7, P541; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Oshima Y, 2010, GAIT POSTURE, V31, P370, DOI 10.1016/j.gaitpost.2010.01.005; Makizako H, 2013, GERIATR GERONTOL INT, V13, P860, DOI 10.1111/ggi.12014; Appelman APA, 2009, CEREBROVASC DIS, V28, P227, DOI 10.1159/000226774; Buchman AS, 2008, AM J GERIAT PSYCHIAT, V16, P697, DOI 10.1097/JGP.0b013e31817945f6; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Lautenschlager NT, 2010, CURR NEUROL NEUROSCI, V10, P352, DOI 10.1007/s11910-010-0121-7; Gow AJ, 2012, NEUROLOGY, V79, P1802, DOI 10.1212/WNL.0b013e3182703fd2; Kooistra M, 2014, ATHEROSCLEROSIS, V234, P47, DOI 10.1016/j.atherosclerosis.2014.02.003; LEYS D, 1991, J NEUROL NEUROSUR PS, V54, P46, DOI 10.1136/jnnp.54.1.46; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Baker LD, 2012, ARCH NEUROL-CHICAGO, V69, P1420, DOI 10.1001/archneurol.2012.1970; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Kerr J, 2013, J AM GERIATR SOC, V61, P1927, DOI 10.1111/jgs.12524; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Rosano C, 2010, NEUROBIOL AGING, V31, P1197, DOI 10.1016/j.neurobiolaging.2008.08.004; Podewils LJ, 2007, NEUROLOGY, V68, P1223, DOI 10.1212/01.wnl.0000259063.50219.3e; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; FAZEKAS F, 1993, NEUROLOGY, V43, P1683; de Laat KF, 2012, NEUROIMAGE, V59, P1478, DOI 10.1016/j.neuroimage.2011.08.005; Hirata Y, 2005, NEUROSCI LETT, V382, P269, DOI 10.1016/j.neulet.2005.03.038; van Uffelen JGZ, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.044735; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; Brown BM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.118; Burzynska AZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107413; Floel A, 2010, NEUROIMAGE, V49, P2756, DOI 10.1016/j.neuroimage.2009.10.043; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gates N, 2013, AM J GERIAT PSYCHIAT, V21, P1086, DOI 10.1016/j.jagp.2013.02.018; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Makizako H., 2014, J GERONTOL A; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; Wirth M., 2014, NEUROBIOL AGING	40	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	FEB	2015	62						1	6		10.1016/j.exger.2014.12.011		6	Geriatrics & Gerontology	Geriatrics & Gerontology	CA3XJ	WOS:000348838100001		
J	Lee, YA; Saito-Nakano, Y; Kim, KA; Min, A; Nozaki, T; Shin, MH				Lee, Young Ah; Saito-Nakano, Yumiko; Kim, Kyeong Ah; Min, Arim; Nozaki, Tomoyoshi; Shin, Myeong Heon			Modulation of endogenous Cysteine Protease Inhibitor (ICP) 1 expression in Entamoeba histolytica affects amoebic adhesion to Extracellular Matrix proteins	EXPERIMENTAL PARASITOLOGY			English	Article						Entamoeba histolytica; Cysteine protease; Adhesion; Extracellular matrix; Endogenous cysteine protease inhibitor (ICP)	PROTOZOAN PARASITE; GAL/GALNAC-LECTIN; CELL-DEATH; ANTISENSE INHIBITION; LIPID RAFTS; LAMININ; HOST; GENE; DEGRADATION; SECRETION	Entamoeba histolytica is an enteric tissue-invading protozoan parasite that causes amoebic colitis and occasionally liver abscess in humans. During tissue invasion, amoebic adhesion to host components is an important event for host cell death leading to successful invasion and infection. Among amoebic virulence factors, Gal/GaINAc lectin is known to be major adhesion factor to host cells. In this study, we investigated the role of amoebic secreted CP (Cysteine Proteases) in amoebic adhesion to extracellular matrix (ECM) protein using CP inhibitor and E. histolytica strains in which the endogenous inhibitor of cysteine protease (ICP) 1 gene was overexpressed (ICP1(+)) or repressed by antisense small RNA-mediated gene silencing (ICP1(-)). We found that pretreatment of wild-type amoebae with CP inhibitor E64, or thiol-group modifiers such as diamide and N-Ethylmaleimide resulted in a significant decrease in adhesion to laminin and collagen ECM proteins. Furthermore, ICP1(+) strain, with a reduction of secreted CP activity, exhibited reduced ability by 40% to adhere to laminin. In contrast, ICP1(-) strain, with a 1.9-fold increase of secreted CP activity, showed a two-fold increase in amoebic adherence to laminin compared to the control strain. In addition, total amount of secreted CP5 was decreased in ICP1(+) amoeba. Conversely, total amount of secreted CP1 and mature-form CP5 were increased in ICP1(-) amoeba. We also found that ICP1 was secreted into extracellular milieu. These results suggest that secreted CP activity by E. histolytica may be an important factor affecting adhesion to host proteins, and regulation of CP secretion by ICP plays a major role in pathogenesis. This study provides insight into the CP-mediated tissue pathogenesis in amoeba-invaded lesions during human amoebiasis. (C) 2014 Elsevier Inc. All rights reserved.	[Lee, Young Ah; Kim, Kyeong Ah; Min, Arim; Shin, Myeong Heon] Yonsei Univ, Coll Med, Dept Environm Med Biol, Inst Trop Med, Seoul 120752, South Korea; [Saito-Nakano, Yumiko; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Shinjuku Ku, Dept Parasitol, Tokyo 1628640, Japan	Shin, MH (reprint author), Yonsei Univ, Coll Med, Dept Environm Med Biol, Inst Trop Med, Seoul 120752, South Korea.	myeong@yuhs.ac			National Research Foundation of Korea (NRF) - Korea Government (MEST) [2012R1A2A2A02015054]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23117001, 23117005, 23390099]	We thank Dr. David Mirelman (Weisman Institute, Israel) for E. histolytica strains (G3, L5, and Rahman) and helpful advice. This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST) (Numbers 2012R1A2A2A02015054) to M.H.S., a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (23117001, 23117005, 23390099) to T.N.	Ankri S, 1999, INFECT IMMUN, V67, P421; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Kim KA, 2007, INT J PARASITOL, V37, P1209, DOI 10.1016/j.ijpara,2007.03.011; Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Nakada-Tsukui K, 2012, CELL MICROBIOL, V14, P1299, DOI 10.1111/j.1462-5822.2012.01800.x; Hou YZ, 2010, J BIOL CHEM, V285, P35497, DOI 10.1074/jbc.M109.066035; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; Raphael P, 2000, MOL BIOCHEM PARASIT, V110, P259, DOI 10.1016/S0166-6851(00)00283-8; LI E, 1995, INFECT IMMUN, V63, P4150; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Lourenssen S, 2010, INFECT IMMUN, V78, P5332, DOI 10.1128/IAI.00699-10; Tillack M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-170; Zhang Z, 2000, MOL MICROBIOL, V37, P542, DOI 10.1046/j.1365-2958.2000.02037.x; KEENE WE, 1990, EXP PARASITOL, V71, P199, DOI 10.1016/0014-4894(90)90022-5; Saito-Nakano Y, 2007, CELL MICROBIOL, V9, P1796, DOI 10.1111/j.1462-5822.2007.00915.x; Sim S, 2005, J IMMUNOL, V174, P4279; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Moncada DM, 2006, GASTROENTEROLOGY, V130, P721, DOI 10.1053/j.gastro.2005.11.012; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Bracha R, 2003, EUKARYOT CELL, V2, P295, DOI 10.1128/EC.2.2.295-305.2003; Rousselle P, 2013, CELL ADHES MIGR, V7, P122, DOI 10.4161/cam.23132; Debnath A, 2007, INT J PARASITOL, V37, P897, DOI 10.1016/j.ijpara.2007.01.016; Huston CD, 2000, CELL MICROBIOL, V2, P617, DOI 10.1046/j.1462-5822.2000.00085.x; Mitra BN, 2007, CELL MICROBIOL, V9, P2112, DOI 10.1111/j.1462-5822.2007.00941.x; Blazquez S, 2008, CELL MICROBIOL, V10, P1676, DOI 10.1111/j.1462-5822.2008.01158.x; Bracha R, 2007, EUKARYOT CELL, V6, P1758, DOI 10.1128/EC.00241-07; Bruchhaus I, 1996, MOL MICROBIOL, V22, P255, DOI 10.1046/j.1365-2958.1996.00111.x; Cheng XJ, 2001, INFECT IMMUN, V69, P5892, DOI 10.1128/IAI.69.9.5892-5898.2001; Davis PH, 2007, MOL BIOCHEM PARASIT, V151, P118, DOI 10.1016/j.molbiopara.2006.10.014; Frederick JR, 2005, GLYCOBIOLOGY, V15, p53R, DOI 10.1093/glycob/cwj007; Goldston AM, 2012, EUKARYOT CELL, V11, P743, DOI 10.1128/EC.00054-12; He C, 2010, J BIOL CHEM, V285, P18516, DOI 10.1074/jbc.M109.086181; Jacobs T, 1998, MOL MICROBIOL, V27, P269, DOI 10.1046/j.1365-2958.1998.00662.x; KEENE WE, 1986, J EXP MED, V163, P536, DOI 10.1084/jem.163.3.536; KELSALL BL, 1993, J INFECT DIS, V168, P1319; Kim KA, 2011, MICROBES INFECT, V13, P1052, DOI 10.1016/j.micinf.2011.06.001; Kozlova NI, 2001, ONCOGENE, V20, P4710, DOI 10.1038/sj.onc.1204619; Kumar S, 2012, MICROB PATHOGENESIS, V52, P69, DOI 10.1016/j.micpath.2011.10.005; Lauwaet T, 2004, INT J PARASITOL, V34, P785, DOI 10.1016/j.ijpara.2004.03.007; Lee YA, 2011, PARASITE IMMUNOL, V33, P349, DOI 10.1111/j.1365-3024.2011.01290.x; LEIPPE M, 1994, MOL MICROBIOL, V14, P895, DOI 10.1111/j.1365-2958.1994.tb01325.x; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; Que XC, 2003, INFECT IMMUN, V71, P1274, DOI 10.1128/IAI.71.3.1274-1280.2003; RAVDIN JI, 1988, INFECT IMMUN, V56, P1505; REED SL, 1989, J CLIN MICROBIOL, V27, P2772; Reed S.L., 1995, J IMMUNOL, V71, P838; Riekenberg S, 2005, FEBS LETT, V579, P1573, DOI 10.1016/j.febslet.2005.01.067; Sasaki T, 2001, FEBS LETT, V509, P181, DOI 10.1016/S0014-5793(01)03167-2; Sato D, 2006, FEBS LETT, V580, P5306, DOI 10.1016/j.febslet.2006.08.081; SCHULTE W, 1989, J PROTOZOOL, V36, P538, DOI 10.1111/j.1550-7408.1989.tb01092.x; Serrano-Luna J., 2013, J TROP MED, V2013; Singh D, 2004, PARASITOLOGY, V129, P127, DOI 10.1017/S0031182004005451; Stanley SL, 2001, AM J PHYSIOL-GASTR L, V280, pG1049; Tran VQ, 1998, J INFECT DIS, V177, P508; Welter BH, 2011, INT J PARASITOL, V41, P1409, DOI 10.1016/j.ijpara.2011.10.003; YAMAGUCHI T, 1994, BBA-BIOMEMBRANES, V1195, P205, DOI 10.1016/0005-2736(94)90257-7	57	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4894	1090-2449		EXP PARASITOL	Exp. Parasitol.	FEB	2015	149						7	15		10.1016/j.exppara.2014.12.001		9	Parasitology	Parasitology	CA8WX	WOS:000349202700002		
J	Ogoh, S				Ogoh, Shigehiko			Cerebral blood flow regulation during hypoxia	EXPERIMENTAL PHYSIOLOGY			English	Editorial Material									Toyo Univ, Dept Biomed Engn, Saitama, Japan	Ogoh, S (reprint author), Toyo Univ, Dept Biomed Engn, Saitama, Japan.	ogoh@toyo.jp					COHEN PJ, 1967, J APPL PHYSIOL, V23, P183; Ogoh S, 2013, EXP PHYSIOL, V98, P692, DOI 10.1113/expphysiol.2012.068015; Ogoh S, 2014, EXP PHYSIOL, V99, P849, DOI 10.1113/expphysiol.2013.076802; Lewis NCS, 2014, J APPL PHYSIOL, V116, P1189, DOI 10.1152/japplphysiol.00114.2014	4	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	FEB 1	2015	100	2					109	110		10.1113/expphysiol.2014.084202		2	Physiology	Physiology	CB0CG	WOS:000349291800001		
J	Makino, A; Abe, M; Murate, M; Inaba, T; Yilmaz, N; Hullin-Matsuda, F; Kishimoto, T; Schieber, NL; Taguchi, T; Arai, H; Anderluh, G; Parton, RG; Kobayashi, T				Makino, Asami; Abe, Mitsuhiro; Murate, Motohide; Inaba, Takehiko; Yilmaz, Neval; Hullin-Matsuda, Francoise; Kishimoto, Takuma; Schieber, Nicole L.; Taguchi, Tomohiko; Arai, Hiroyuki; Anderluh, Gregor; Parton, Robert G.; Kobayashi, Toshihide			Visualization of the heterogeneous membrane distribution of sphingomyelin associated with cytokinesis, cell polarity, and sphingolipidosis	FASEB JOURNAL			English	Article						lipid binding protein; lipid raft; membrane lipids; sphingolipid; toxins	PORE-FORMING TOXIN; ATOMIC-FORCE MICROSCOPY; LIPID PHASE COEXISTENCE; EQUINATOXIN-II; PLASMA-MEMBRANE; EPITHELIAL-CELLS; ACID SPHINGOMYELINASE; ELECTRON-MICROSCOPY; ACTINIA-EQUINA; SEA-ANEMONE	Sphingomyelin (SM) is a major sphingolipid in mammalian cells and is reported to form specific lipid domains together with cholesterol. However, methods to examine the membrane distribution of SM are limited. We demonstrated in model membranes that fluorescent protein conjugates of 2 specific SM-binding toxins, lysenin (Lys) and equinatoxin II (EqtII), recognize different membrane distributions of SM; Lys exclusively binds clustered SM, whereas EqtII preferentially binds dispersed SM. Freeze-fracture immunoelectron microscopy showed that clustered but not dispersed SM formed lipid domains on the cell surface. Glycolipids and the membrane concentration of SM affect the SM distribution pattern on the plasma membrane. Using derivatives of Lys and EqtII as SM distribution-sensitive probes, we revealed the exclusive accumulation ofSM clusters in the midbody at the time of cytokinesis. Interestingly, apical membranes of differentiated epithelial cells exhibited dispersed SM distribution, whereas SM was clustered in basolateral membranes. Clustered but not dispersed SM was absent from the cell surface of acid sphingomyelinase-deficient Niemann-Pick type A cells. These data suggest that both the SM content and membrane distribution are crucial for pathophysiological events bringing therapeutic perspective in the role of SM membrane distribution.	[Makino, Asami; Abe, Mitsuhiro; Murate, Motohide; Inaba, Takehiko; Yilmaz, Neval; Hullin-Matsuda, Francoise; Kishimoto, Takuma; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Hullin-Matsuda, Francoise; Kobayashi, Toshihide] Univ Lyon, INSERM, U1060, Villeurbanne, France; [Schieber, Nicole L.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Taguchi, Tomohiko; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Anderluh, Gregor] Univ Ljubljana, Natl Inst Chem, Ljubljana, Slovenia; [Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia	Kobayashi, T (reprint author), RIKEN, Lipid Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kobayasi@riken.jp	Kobayashi, Toshihide/B-6298-2015	Kobayashi, Toshihide/0000-0002-4811-7270	Lipid Dynamics Program	The authors are grateful to R. Nakazawa for DNA sequence analysis and S. Jones for critical reading. They thank Dr. T. Watanabe and Carl Zeiss Microscopy Co. Ltd., Japan, for structured illumination microscopy images, and also thank the members of T. K.' s laboratory for their support, critical reading, and discussion. This work was supported by Lipid Dynamics Program, Cellular System Program and Integrated Lipidology Programof RIKEN, Grants-in-Aid for Scientific Research 23790115 (to A. M.), 23590251 (to M. M.), 24770135 (to T. Ki.), 23460081 (to F. H.-M.), and 22390018 and 25293015 (to T. Ko.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Naito Foundation. This work was supported by fellowships and a grant from the National Health and Medical Research Council of Australia (to R. G. P., Grants 569542 and 1037320). The authors acknowledge the facilities as well as the scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy and Microanalysis, The University of Queensland. G. A. acknowledges the support of the Slovenian Research Agency.	Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Yachi R, 2012, GENES CELLS, V17, P720, DOI 10.1111/j.1365-2443.2012.01621.x; Akashi K, 1996, BIOPHYS J, V71, P3242; Rojko N, 2014, BIOPHYS J, V106, P1630, DOI 10.1016/j.bpj.2013.11.4507; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Yuan CB, 2002, BIOPHYS J, V82, P2526; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Perry GLW, 2004, ENVIRON MODELL SOFTW, V19, P559, DOI 10.1016/j.envsoft.2003.07.004; De Colibus L, 2012, STRUCTURE, V20, P1498, DOI 10.1016/j.str.2012.06.011; Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Abe M, 2014, BBA-MOL CELL BIOL L, V1841, P720, DOI 10.1016/j.bbalip.2013.07.003; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Maulik PR, 1996, BIOCHEMISTRY-US, V35, P8025, DOI 10.1021/bi9528356; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Lawrence JC, 2003, BIOPHYS J, V84, P1827; Singh B, 2014, ANNU REV PHYSIOL, V76, P275, DOI 10.1146/annurev-physiol-021113-170406; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Schon P, 2008, BIOPHYS J, V95, P691, DOI 10.1529/biophysj.108.129981; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Mizuno H, 2011, CHEM SCI, V2, P1548, DOI 10.1039/c1sc00169h; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Barlic A, 2004, J BIOL CHEM, V279, P34209, DOI 10.1074/jbc.M313817200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Carquin M, 2014, J LIPID RES, V55, P1331, DOI 10.1194/jlr.M048538; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Yilmaz N, 2013, BIOPHYS J, V105, P1397, DOI 10.1016/j.bpj.2013.07.052; Fujimoto K, 1997, HISTOCHEM CELL BIOL, V107, P87, DOI 10.1007/s004180050092; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Bohdanowicz M, 2013, PHYSIOL REV, V93, P69, DOI 10.1152/physrev.00002.2012; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Feigenson GW, 2001, BIOPHYS J, V80, P2775; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Bezombes C, 2001, FASEB J, V15, P297; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; CHALVARD.A, 1970, ANAL BIOCHEM, V36, P225, DOI 10.1016/0003-2697(70)90352-0; Cock J G, 1998, J Biol Chem, V273, P7560, DOI 10.1074/jbc.273.13.7560; De Maria R, 1998, J EXP MED, V187, P897, DOI 10.1084/jem.187.6.897; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Garcia PS, 2012, TOXICON, V60, P724, DOI 10.1016/j.toxicon.2012.05.018; Hubbard A L, 1991, Semin Cell Biol, V2, P365; Hullin-Matsuda F, 2007, J LIPID RES, V48, P1997, DOI 10.1194/jlr.M700154-JLR200; Ikenouchi J, 2013, J CELL SCI, V126, P3585, DOI 10.1242/jcs.122325; Ikenouchi J, 2012, J BIOL CHEM, V287, P9525, DOI 10.1074/jbc.M111.327064; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Kirschnek S, 2000, J BIOL CHEM, V275, P27316; Kiyokawa E, 2004, BIOCHEMISTRY-US, V43, P9766, DOI 10.1021/bi049561j; Levade T, 1999, BBA-MOL CELL BIOL L, V1438, P1, DOI 10.1016/S1388-1981(99)00038-4; Marsh D., 2013, HDB LIPID BILAYERS; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Murate M, 2010, BIOCHEMISTRY-US, V49, P4732, DOI 10.1021/bi100007u; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; SIMONS K, 1992, COLD SPRING HARB SYM, V57, P611; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; VAN MEER G, 1982, EMBO J, V1, P847; Wang T, 2012, BIOCHEMISTRY-US, V51, P74, DOI 10.1021/bi2011652; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamaji-Hasegawa A, 2003, J BIOL CHEM, V278, P22762, DOI 10.1074/jbc.M213209200	78	7	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					477	493		10.1096/fj.13-247585		17	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	WOS:000349370400013		
J	Brun, PJ; Grijalva, A; Rausch, R; Watson, E; Yuen, JJ; Das, BC; Shudo, K; Kagechika, H; Leibel, RL; Blaner, WS				Brun, Pierre-Jacques; Grijalva, Ambar; Rausch, Richard; Watson, Elizabeth; Yuen, Jason J.; Das, Bhaskar C.; Shudo, Koichi; Kagechika, Hiroyuki; Leibel, Rudolph L.; Blaner, William S.			Retinoic acid receptor signaling is required to maintain glucose-stimulated insulin secretion and beta-cell mass	FASEB JOURNAL			English	Article						glucagon; retinoid; dominant-negative RAR; pancreatic islet; Cre recombinase	DOMINANT-NEGATIVE FORM; VITAMIN-A-DEFICIENCY; GENE-EXPRESSION; PANCREATIC-ISLETS; BINDING PROTEINS; THYROID-HORMONE; TRANSGENIC MICE; MESSENGER-RNA; RAT; ALPHA	Retinoic acid signaling is required for maintaining a range of cellular processes, including cell differentiation, proliferation, and apoptosis. We investigated the actions of all-trans-retinoic acid (atRA) signaling in pancreatic beta-cells of adult mice. atRA signaling was ablated in beta-cells by overexpressing a dominant-negative retinoic acid receptor (RAR)-alpha mutant (RARdn) using an inducible Cre-Lox system under the control of the pancreas duodenal homeobox gene promoter. Our studies establish that hypomorphism for RAR in beta-cells leads to an age-dependent decrease in plasma insulin in the fed state and in response to a glucose challenge. Glucose-stimulated insulin secretion was also impaired in islets isolated from mice expressing RARdn. Among genes that are atRA responsive, Glut2 and Gck mRNA levels were decreased in isolated islets from RARdn-expressing mice. Histologic analyses of RARdn-expressing pancreata revealed a decrease in beta-cell mass and insulin per beta-cell 1 mo after induction of the RARdn. Our results indicate that atRA signaling mediated by RARs is required in the adult pancreas for maintaining both beta-cell function and mass, and provide insights into molecular mechanisms underlying these actions.-Brun, P.-J., Grijalva, A., Rausch, R., Watson, E., Yuen, J. J., Das, B. C., Shudo, K., Kagechika, H., Leibel, R. L., Blaner, W. S. Retinoic acid receptor signaling is required to maintain glucose-stimulated insulin secretion and b-cell mass.	[Brun, Pierre-Jacques; Yuen, Jason J.; Blaner, William S.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Rausch, Richard; Watson, Elizabeth; Leibel, Rudolph L.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Grijalva, Ambar] Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; [Das, Bhaskar C.] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA; [Shudo, Koichi] Res Fdn Itsuu Lab, Tokyo, Japan; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan	Blaner, WS (reprint author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.	wsb2@columbia.edu			U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism Grant [RC2-AA019413]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK068437, R01-DK079221, R01-DK052431, P30-DK063608]; Japan Society for Promotion of Science Core-to-Core Program; Russell Berrie Foundation; A. Advanced Research Networks of Japan	These studies were supported by U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism Grant RC2-AA019413 and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK068437, R01-DK079221, R01-DK052431, and P30-DK063608, the Japan Society for Promotion of Science Core-to-Core Program, A. Advanced Research Networks of Japan, and grants from the Russell Berrie Foundation.	Rajaii F, 2008, DEV BIOL, V316, P371, DOI 10.1016/j.ydbio.2008.01.041; REEVES PG, 1993, J NUTR, V123, P1939; Matthews KA, 2004, J NUTR, V134, P1958; Perez RJ, 2013, EXP CELL RES, V319, P2196, DOI 10.1016/j.yexcr.2013.05.032; Blumentrath J, 2001, CELL BIOCHEM FUNCT, V19, P159, DOI 10.1002/cbf.907; Gu GQ, 2002, DEVELOPMENT, V129, P2447; CHERTOW BS, 1987, J CLIN INVEST, V79, P163, DOI 10.1172/JCI112778; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Kane MA, 2010, P NATL ACAD SCI USA, V107, P21884, DOI 10.1073/pnas.1008859107; CLARK AR, 1995, BIOCHEM J, V309, P863; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Hunter CS, 2013, DIABETES, V62, P875, DOI 10.2337/db12-0952; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Chambon P, 1996, FASEB J, V10, P940; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; FERNANDEZMEJIA C, 1992, ENDOCRINOLOGY, V130, P1660, DOI 10.1210/en.130.3.1660; Meier JJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE717, DOI 10.1152/ajpendo.00315.2010; Kappen C, 2009, INT J DEV BIOL, V53, P935, DOI 10.1387/ijdb.082819ck; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.RI00015-JLR200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Cabrera-Valladares G, 1999, ENDOCRINOLOGY, V140, P3091, DOI 10.1210/en.140.7.3091; CHERTOW BS, 1983, DIABETES, V32, P568, DOI 10.2337/diabetes.32.6.568; CHERTOW BS, 1989, RES COMMUN CHEM PATH, V63, P27; CHERTOW BS, 1989, DIABETES, V38, P1544, DOI 10.2337/diabetes.38.12.1544; CHERTOW BS, 1993, DIABETES, V42, P1109, DOI 10.2337/diabetes.42.8.1109; Das BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010004; Dokmanovic-Chouinard M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000137; EIZIRIK DL, 1989, ENDOCRINOLOGY, V125, P752; Gudas J. M., 1994, RETINOIDS, P443; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; KATO M, 1985, P NATL ACAD SCI USA, V82, P2488, DOI 10.1073/pnas.82.8.2488; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Mangelsdorf David J., 1994, P319; Miyazaki S, 2010, DIABETES, V59, P2854, DOI 10.2337/db09-1897; National Research Council, 2011, GUIDE CARE USE LAB A; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Ravnskjaer K, 2005, ENDOCRINOLOGY, V146, P3266, DOI 10.1210/en.2004-1430; Ross A., 2006, MODERN NUTR HLTH DIS, P351; Somenzi G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000836; Tsutusmi A, 2000, BIOCHEM BIOPH RES CO, V278, P229, DOI 10.1006/bbrc.2000.3786; Yanagitani A, 2004, HEPATOLOGY, V40, P366, DOI 10.1002/hep.20335	45	3	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					671	683		10.1096/fj.14-256743		13	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	WOS:000349370400028		
J	Tabassum, S; Sheikh, AM; Yano, S; Ikeue, T; Handa, M; Nagai, A				Tabassum, Shatera; Sheikh, Abdullah M.; Yano, Shozo; Ikeue, Takafumi; Handa, Makoto; Nagai, Atsushi			A carboxylated Zn-phthalocyanine inhibits fibril formation of Alzheimer's amyloid beta peptide	FEBS JOURNAL			English	Article						Alzheimer's disease; amyloid peptide; fibril formation; near infrared; phthalocyanine	PRECURSOR PROTEIN; SINGLET OXYGEN; CNS NEURONS; DISEASE; MECHANISM; CELLS; OLIGOMERIZATION; TETRASULFONATE; THERAPEUTICS; AGGREGATION	Amyloid (A), a 39-42 amino acid peptide derived from amyloid precursor protein, is deposited as fibrils in Alzheimer's disease brains, and is considered to play a major role in the pathogenesis of the disease. We have investigated the effects of a water-soluble Zn-phthalocyanine, ZnPc(COONa)(8), a macrocyclic compound with near-infrared optical properties, on A fibril formation invitro. A thioflavinT fluorescence assay showed that ZnPc(COONa)(8) significantly inhibited A fibril formation, increasing the lag time and dose-dependently decreasing the plateau level of fibril formation. Moreover, it destabilized pre-formed A fibrils, resulting in an increase in low-molecular-weight species. After fibril formation in the presence of ZnPc(COONa)(8), immunoprecipitation of A(1-42) using A-specific antibody followed by near-infrared scanning demonstrated binding of ZnPc(COONa)(8) to A(1-42). A study using the hydrophobic fluorescent probe 8-anilino-1-naphthalenesulfonic acid showed that ZnPc(COONa)(8) decreased the hydrophobicity during A(1-42) fibril formation. CD spectroscopy showed an increase in the helix structure and a decrease in the sheet structure of A(1-40) in fibril-forming buffer containing ZnPc(COONa)(8). SDS/PAGE and a dot-blot immunoassay showed that ZnPc(COONa)(8) delayed the disappearance of low-molecular-weight species and the appearance of higher-molecular-weight oligomeric species of A(1-42). A cell viability assay showed that ZnPc(COONa)(8) was not toxic to a neuronal cell line (A1), but instead protected A1 cells against A(1-42)-induced toxicity. Overall, our results indicate that ZnPc(COONa)(8) binds to A and decreases the hydrophobicity, and this change is unfavorable for A oligomerization and fibril formation.	[Tabassum, Shatera; Sheikh, Abdullah M.; Yano, Shozo; Nagai, Atsushi] Shimane Univ, Dept Lab Med, Sch Med, Izumo, Shimane 6938501, Japan; [Ikeue, Takafumi; Handa, Makoto] Shimane Univ, Interdisciplinary Fac Sci & Engn, Dept Mat Sci, Matsue, Shimane, Japan	Nagai, A (reprint author), Shimane Univ, Dept Lab Med, Sch Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	anagai@med.shimane-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [24310102]	This study was supported by Japan Society for the Promotion of Science KAKENHI grant number 24310102.	AGARWAL R, 1991, CANCER LETT, V56, P125, DOI 10.1016/0304-3835(91)90086-W; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; Esler WP, 1996, J NEUROCHEM, V66, P723; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; Trivedi NS, 2000, PHOTOCHEM PHOTOBIOL, V71, P634, DOI 10.1562/0031-8655(2000)071<0634:QAOPLI>2.0.CO;2; SPIKES JD, 1986, PHOTOCHEM PHOTOBIOL, V43, P691, DOI 10.1111/j.1751-1097.1986.tb05648.x; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Xia WM, 1997, J BIOL CHEM, V272, P7977; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Bancirova M, 2011, LUMINESCENCE, V26, P685, DOI 10.1002/bio.1296; Liu W, 2005, J MED CHEM, V48, P1033, DOI 10.1021/jm049375b; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Malaplate-Armand C, 2006, NEUROBIOL DIS, V23, P178, DOI 10.1016/j.nbd.2006.02.010; El-Agnaf OMA, 2000, BIOCHEM BIOPH RES CO, V273, P1003, DOI 10.1006/bbrc.2000.3051; Petrella JR, 2013, RADIOLOGY, V269, P671, DOI 10.1148/radiol.13122503; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Iqbal K, 2014, BIOCHEM PHARMACOL, V88, P631, DOI 10.1016/j.bcp.2014.01.002; Nagai A, 2005, BRAIN RES, V1066, P120, DOI 10.1016/j.brainres.2005.10.063; COTMAN CW, 1994, ANN NY ACAD SCI, V747, P36; Cruchaga C, 2014, CURR GENET MED REP, V2, P23; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hills RD, 2007, J MOL BIOL, V368, P894, DOI 10.1016/j.jmb.2007.02.043; Ikeue T, 2010, INORG CHEM COMMUN, V13, P1170, DOI 10.1016/j.inoche.2010.06.041; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Leger GC, 2013, EXPERT REV CLIN PHAR, V6, P423, DOI 10.1586/17512433.2013.811237; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Moss MA, 2004, MOL PHARMACOL, V66, P592; Nagai A, 2002, NEUROBIOL DIS, V11, P184, DOI 10.1006/nbdi.2002.0501; Park JW, 2008, CHEMBIOCHEM, V9, P2602, DOI 10.1002/cbic.200800343; RICHARDS SJ, 1991, EMBO J, V10, P297; Rowland LP, 2010, MERRITTS NEUROLOGY, P713; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Sheikh AM, 2011, FEBS J, V278, P634, DOI 10.1111/j.1742-4658.2010.07984.x; Sisodia SS, 1999, AM J HUM GENET, V65, P7, DOI 10.1086/302475; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; VACUS J, 1995, ADV MATER, V7, P797, DOI 10.1002/adma.19950070908; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	FEB	2015	282	3					463	476		10.1111/febs.13151		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA4US	WOS:000348901600004		
J	Odani, W; Urata, K; Okuda, M; Okuma, S; Koyama, H; Pack, CG; Fujiwara, K; Nojima, T; Kinjo, M; Kawai-Noma, S; Taguchi, H				Odani, Wataru; Urata, Kazuhiro; Okuda, Momoko; Okuma, Shunsuke; Koyama, Hiroko; Pack, Chan-Gi; Fujiwara, Kei; Nojima, Tatsuya; Kinjo, Masataka; Kawai-Noma, Shigeko; Taguchi, Hideki			Peptide sequences converting polyglutamine into a prion in yeast	FEBS JOURNAL			English	Article						amyloids; fluorescence correlation spectroscopy; polyglutamine; Sup35; yeast prions	FLUORESCENCE CORRELATION SPECTROSCOPY; CROSS-CORRELATION SPECTROSCOPY; SACCHAROMYCES-CEREVISIAE; NEURODEGENERATIVE DISEASES; CHAPERONE PROTEINS; LIVING CELLS; SUP35; HSP104; PROPAGATION; TRANSMISSION	Amyloids are ordered protein aggregates composed of cross- sheet structures. Amyloids include prions, defined as infectious proteins, which are responsible for mammalian transmissible spongiform encephalopathies, and fungal prions. Although the conventional view is that typical amyloids are associated with nontransmissible mammalian neurodegenerative diseases such as Alzheimer's disease, increasing evidence suggests that the boundary between transmissible and nontransmissible amyloids is ambiguous. To clarify the mechanism underlying the difference in transmissibility, we investigated the dynamics and the properties of polyglutamine (polyQ) amyloids in yeast cells, in which the polyQ aggregates are not transmissible but can be converted into transmissible amyloids. We found that polyQ had an increased tendency to form aggregates compared to the yeast prion Sup35. In addition, we screened dozens of peptides that converted the nontransmissible polyQ to transmissible aggregates when they flanked the polyQ stretch, and also investigated their cellular dynamics aiming to understand the mechanism of transmission.	[Odani, Wataru; Urata, Kazuhiro; Okuda, Momoko; Okuma, Shunsuke; Koyama, Hiroko; Fujiwara, Kei; Kawai-Noma, Shigeko; Taguchi, Hideki] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Okuda, Momoko; Nojima, Tatsuya; Kawai-Noma, Shigeko; Taguchi, Hideki] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Pack, Chan-Gi] Univ Ulsan, Asan Inst Life Sci, Coll Med, Asan Med Ctr, Seoul, South Korea; [Nojima, Tatsuya] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 603, Japan; [Kinjo, Masataka] Hokkaido Univ, Grad Sch Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan	Taguchi, H (reprint author), Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, B-56,4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	taguchi@bio.titech.ac.jp	FUJIWARA, KEI/G-5467-2010		JSPS [19058002, 24657070, 24113705]; MEXT, Japan; Daiichi Sankyo Foundation of Life Science; Mochida Memorial Foundation	We thank Drs Tatsuya Niwa, Hiroshi Kurahashi, Yoshikazu Nakamura and Yoko Kimura for technical advice and helpful discussions. This work was supported by Grants-in-Aid for Scientific Research (19058002, 24657070, 24113705 to H.T.) from JSPS and MEXT, Japan. This work was also supported by grants from the Daiichi Sankyo Foundation of Life Science and the Mochida Memorial Foundation (to H.T.).	TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Sherman F, 2002, METHOD ENZYMOL, V350, P3; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Kawai-Noma S, 2010, J CELL BIOL, V190, P223, DOI 10.1083/jcb.201002149; Kawai-Noma S, 2009, GENES CELLS, V14, P1045, DOI 10.1111/j.1365-2443.2009.01333.x; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Alexandrov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046458; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Kawai-Noma S, 2006, GENES CELLS, V11, P1085, DOI 10.1111/j.1365-2443.2006.01004.x; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Ayano S, 2004, JPN J APPL PHYS 2, V43, pL1429, DOI 10.1143/JJAP.43.L1429; Dulle JE, 2013, J CELL BIOL, V203, P197, DOI 10.1083/jcb.201307040; Nelson ACG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089286; Inou Y, 2004, J BIOL CHEM, V279, P52319, DOI 10.1074/jbc.M408159200; Kimura Y, 2004, GENES CELLS, V9, P685, DOI 10.1111/j.1365-2443.2004.00759.x; Kurahashi H, 2011, GENES CELLS, V16, P576, DOI 10.1111/j.1365-2443.2011.01511.x; Manogaran AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001386; Ohta S, 2013, BIOCHEM BIOPH RES CO, V442, P28, DOI 10.1016/j.bbrc.2013.10.147; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Pack CG, 1999, CYTOMETRY, V36, P247, DOI 10.1002/(SICI)1097-0320(19990701)36:3<247::AID-CYTO15>3.0.CO;2-#; Saito K, 2004, BIOCHEM BIOPH RES CO, V324, P849, DOI 10.1016/j.bbrc.2004.09.126; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Taguchi H, 2010, FEBS J, V277, P1359, DOI 10.1111/j.1742-4658.2010.07569.x; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	FEB	2015	282	3					477	490		10.1111/febs.13152		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA4US	WOS:000348901600005		
J	Ishihara, O; Adamson, GD; Dyer, S; de Mouzon, J; Nygren, KG; Sullivan, EA; Zegers-Hochschild, F; Mansour, R				Ishihara, Osamu; Adamson, G. David; Dyer, Silke; de Mouzon, Jacques; Nygren, Karl G.; Sullivan, Elizabeth A.; Zegers-Hochschild, Fernando; Mansour, Ragaa			International Committee for Monitoring Assisted Reproductive Technologies: World Report on Assisted Reproductive Technologies, 2007	FERTILITY AND STERILITY			English	Article						ART; assisted reproductive technologies; registry; outcomes; multiple births; frozen embryo transfer; single embryo transfer	ICMART; IMPACT; JAPAN; ART	Objective: To analyze information on assisted reproductive technology (ART) performed worldwide, and trends in outcomes over successive years. Design: Cross-sectional survey on access, efficiency, and safety of ART procedures performed in 55 countries during 2007. Setting: Not applicable. Patient(s): Infertile women and men undergoing ART globally. Intervention(s): Collection and analysis of international ART data. Main Outcome Measure(s): Number of cycles performed, by country and region, including pregnancies, single and multiple birth rates, and perinatal mortality. Result(t): Overall, >1,251,881 procedures with ART were reported, and resulted in 229,442 reported babies born. The availability of ART varied by country, from 12 to 4,140 treatments per million population. Of all aspiration cycles, 65.2% (400,617 of 614,540) were intracytoplasmic sperm injection. The overall delivery rate per fresh aspiration was 20.3%, and for frozen-embryo transfer (FET), 18.4%, with a cumulative delivery rate of 25.8%. With wide regional variations, single-embryo transfer represented 23.4% of fresh transfers, and the proportion of deliveries with twins and triplets from fresh transfers was 22.3% and 1.2%, respectively. The perinatal mortality rate was 19.9 per 1,000 births for fresh in vitro fertilization using intracytoplasmic sperm injection, and 9.6 per 1,000 for FET. The proportion of women aged >= 40 years increased to 19.8% from 15.5% in 2006. Conclusion(s): The international trend toward <3 transferred embryos continued, as did the wider uptake of FET. This was achieved without compromising delivery rates. The application of ART for women aged >40 years was a major component of ART services in some regions and countries. (C) 2015 by American Society for Reproductive Medicine.	[Ishihara, Osamu] Saitama Med Univ, Dept Obstet & Gynaecol, Moroyama, Saitama 3500495, Japan; [Adamson, G. David] Palo Alto Med Fdn Fertil Phys North Calif, San Jose, CA USA; [Dyer, Silke] Univ Cape Town, Groote Schuur Hopsital, Dept Obstet & Gynaecol, ZA-7925 Cape Town, South Africa; Univ Cape Town, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [de Mouzon, Jacques] Cochin St Vincent Paul Univ Hosp, Gynecol Obstet & Reprod Med Unit, Natl Inst Hlth & Med Res, Paris, France; [Nygren, Karl G.] Karolinska Inst, Stockholm, Sweden; [Sullivan, Elizabeth A.] Univ Technol Sydney, Fac Hlth, Sydney, NSW 2007, Australia; [Zegers-Hochschild, Fernando] Univ Diego Portales, Clin Condes, Santiago, Chile; [Zegers-Hochschild, Fernando] Univ Diego Portales, Program Eth & Publ Policies Human Reprod, Santiago, Chile; [Mansour, Ragaa] Egyptian In Vitro Fertilizat Embryo Transfer Ctr, Cairo, Egypt	Ishihara, O (reprint author), Saitama Med Univ, Dept Obstet & Gynaecol, Moroyama, Saitama 3500495, Japan.	osamishr@saitama-med.ac.jp		Sullivan, Elizabeth/0000-0002-8718-2753	Merck-Serono; Ferring; Laboratoire Genevrier; Laboratoire Ferring; American Society for Reproductive Medicine (ASRM); European Society for Human Reproduction and Embryology (ESHRE); Fertility Society of Australia (FSA); Japan Society for Reproductive Medicine (JSRM); Japan Society of Fertilization and Implantation (JSFI); Red Latinoamericana de Reproduccion Asistida (REDLARA); Society for Assisted Reproductive Technology (SART); Government of Canada	O.I. has nothing to disclose. G.D.A. is Chairman of the Board of and owns stock in Advanced Reproductive Care; is primary investigator on a research study for Auxogyn, and is a consultant for Bayer and Ziva. S.D. reports sponsorship from Merck-Serono and Ferring for staff to attend conferences. J.d.M. reports personal fees from Laboratoire Genevrier and Laboratoire Ferring for study design and analysis. K.G.N. has nothing to disclose. E.A.S. reports contract funding to the University of New South Wales to manage the Australian and New Zealand Assisted Reproduction Database and annual reporting. F.Z.-H. has nothing to disclose. R.M. has nothing to disclose.; International Committee for Monitoring Assisted Reproductive Technologies (ICMART) receives general financial support from the American Society for Reproductive Medicine (ASRM), European Society for Human Reproduction and Embryology (ESHRE), Fertility Society of Australia (FSA), the Japan Society for Reproductive Medicine (JSRM), Japan Society of Fertilization and Implantation (JSFI), Red Latinoamericana de Reproduccion Asistida (REDLARA) and Society for Assisted Reproductive Technology (SART). Additionally, ICMART has received research grant funding from the Government of Canada.	Adamson GD, 2013, FERTIL STERIL, V100, pS42; Adamson GD, 2006, FERTIL STERIL, V85, P1586, DOI 10.1016/j.fertnstert.2006.01.011; Adamson G David, 2009, Womens Health (Lond Engl), V5, P351, DOI 10.2217/whe.09.28; Sullivan EA, 2013, HUM REPROD, V28, P1375, DOI 10.1093/humrep/det036; Ishihara O, 2014, FERTIL STERIL, V101, P128, DOI 10.1016/j.fertnstert.2013.09.025; Mansour R, 2014, HUM REPROD, V29, P1536, DOI 10.1093/humrep/deu084; Chambers GM, 2014, FERTIL STERIL, V101, P191, DOI 10.1016/j.fertnstert.2013.09.005; Nygren KG, 2011, FERTIL STERIL, V95, P2209, DOI 10.1016/j.fertnstert.2011.03.058; Cohen J, 1991, 8 C VITR ALT ASS REP; de Mouzon J, 1993, 15 INT FED FERT SOC; de Mouzon J, 2009, HUM REPROD, V1, P1; de Mouzon J, 1997, J ASSIST REPROD GEN, V14, P5251; de Mouzon J, 1998, 16 WORLD C FERT STER; Healy DL, 2001, REPROD MED 21 CENTUR, P209; International Federation of Fertility Societies, IFFS SURV 2013; Sazanova A, 2012, HUM REPROD, V27, P1343; Takeshima K, 2014, J ASSIST REPROD GEN, V31, P477, DOI 10.1007/s10815-014-0181-8; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343; Zegers-Hochschild F, 2014, FERTIL STERIL, V101, P366, DOI 10.1016/j.fertnstert.2013.10.005	20	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0015-0282	1556-5653		FERTIL STERIL	Fertil. Steril.	FEB	2015	103	2					402	413		10.1016/j.fertnstert.2014.11.004		12	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CA5RY	WOS:000348966700019		
J	Visetnan, S; Supungul, P; Hirono, I; Tassanakajon, A; Rimphanitchayakit, V				Visetnan, Suwattana; Supungul, Premruethai; Hirono, Ikuo; Tassanakajon, Anchalee; Rimphanitchayakit, Vichien			Activation of Prraelish from Penaeus monodon by yellow head virus	FISH & SHELLFISH IMMUNOLOGY			English	Article						Relish; Imd pathway; Yellow head virus; Penaeus monodon; Antimicrobial proteins	SPOT SYNDROME VIRUS; SHRIMP FENNEROPENAEUS-CHINENSIS; IMMUNE-DEFICIENCY HOMOLOG; B FACTOR RELISH; TOLL RECEPTOR; TIGER SHRIMP; ANTIBACTERIAL DEFENSE; MOLECULAR-CLONING; DROSOPHILA; GENE	Humoral innate immune response against pathogenic infection is partly responsible by the Imd pathway in which a transcription factor Relish relays the infection signals to the nuclei for the expression of antimicrobial proteins. A PmRelish gene which encoded a protein of 1195 amino acids was cloned. The PmRelish was constitutively expressed in all tissues tested and mostly up-regulated upon YHV infection. In hemocytes, the PmRelish expression was up-regulated upon Vibrio harveyi, yellow head virus (YHV) and white spot syndrome virus (WSSV) challenges. Using dsRNA silencing of PmRelish gene, it was shown that the expression of penaeidin5 but not anti-lipopolysaccharide factor ALFPm3, crustinPm1 and penaeidin3 was under the regulation of Imd pathway. Under PmRelish silencing, the shrimp were more susceptible to infection by YHV with the 50% survival rate reduced from about 72 h to 42 h. The PmRelish was detected in the cytoplasm of all the hemocytes from both uninfected and YHV-infected shrimp. The accumulation of activated PmRelish in the nuclei was not clearly observed but the activated PmRelish was detected in the YHV-infected hemocytes by Western blot analysis. Thus, the PmRelish and, hence, the Imd pathway respond to the YHV infection. (C) 2014 Elsevier Ltd. All rights reserved.	[Visetnan, Suwattana; Supungul, Premruethai; Tassanakajon, Anchalee; Rimphanitchayakit, Vichien] Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Bangkok 10330, Thailand; [Supungul, Premruethai] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani 10120, Thailand; [Hirono, Ikuo] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Tokyo 1088477, Japan	Rimphanitchayakit, V (reprint author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Phyathai Rd, Bangkok 10330, Thailand.	kpvr2@yahoo.com	HIRONO, Ikuo/O-1940-2014		NRCT-JSPS ASIAN CORE Program in Fishery Science; Japan International Cooperation Agency (JICA); TRF Senior Research Scholar [RTA5580008]; Thailand Research Fund; Chulalongkorn University	This project was supported by the NRCT-JSPS ASIAN CORE Program in Fishery Science, the Japan International Cooperation Agency (JICA) and the TRF Senior Research Scholar (RTA5580008), Thailand Research Fund. We greatly appreciate Chulalongkorn University for the 60/40 Support for Tuition Fee to Suwattana Visetnan and the support under the Ratchadaphisek Somphot Endowment to the Center of Excellence for Molecular Biology and Genomics of Shrimp.	Pongsomboon S, 2008, BMB REP, V41, P670; Arts JAJ, 2007, FISH SHELLFISH IMMUN, V23, P504, DOI 10.1016/j.fsi.2006.08.018; Huang XD, 2009, FISH SHELLFISH IMMUN, V27, P230, DOI 10.1016/j.fsi.2009.05.003; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Wen R, 2013, FISH SHELLFISH IMMUN, V34, P574, DOI 10.1016/j.fsi.2012.11.034; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Wang DD, 2013, DEV COMP IMMUNOL, V39, P352, DOI 10.1016/j.dci.2012.12.005; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Ponprateep S, 2011, FISH SHELLFISH IMMUN, V31, P1179, DOI 10.1016/j.fsi.2011.10.013; Xie XX, 2005, VIRUS RES, V108, P63, DOI 10.1016/j.virusres.2004.08.002; Li FH, 2009, DEV COMP IMMUNOL, V33, P1093, DOI 10.1016/j.dci.2009.06.001; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; Mekata T, 2008, FISH SHELLFISH IMMUN, V24, P122, DOI 10.1016/j.fsi.2007.10.006; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Jatuyosporn T, 2014, DEV COMP IMMUNOL, V44, P100, DOI 10.1016/j.dci.2013.11.017; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Shi XZ, 2009, FISH SHELLFISH IMMUN, V27, P610, DOI 10.1016/j.fsi.2009.07.005; Yang LS, 2007, MOL IMMUNOL, V44, P1999, DOI 10.1016/j.molimm.2006.09.021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Lan JF, 2013, DEV COMP IMMUNOL, V41, P608, DOI 10.1016/j.dci.2013.07.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Fan ZH, 2008, INFECT IMMUN, V76, P664, DOI 10.1128/IAI.00948-07; Kim CH, 2014, J BIOL CHEM, V289, P20092, DOI 10.1074/jbc.M113.544841; Li F, 2010, INT J IMMUNOGENET, V37, P499, DOI 10.1111/j.1744-313X.2010.00954.x; Li XC, 2013, DEV COMP IMMUNOL, V39, P313, DOI 10.1016/j.dci.2012.11.011; Naitza S, 2004, MOL IMMUNOL, V40, P887, DOI 10.1016/j.molimm.2003.10.008; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	34	3	3	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	FEB	2015	42	2					335	344		10.1016/j.fsi.2014.11.015		10	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CA0QL	WOS:000348621700015		
J	Fukumoto, Y; Mie, Y				Fukumoto, Yasuhide; Mie, Youichi			A Lagrangian approach to the weakly nonlinear interaction of Kelvin waves and a symmetry-breaking bifurcation of a rotating flow	FLUID DYNAMICS RESEARCH			English	Article						Kelvin wave; mean flow; Lagrangian approach; weakly nonlinear instability; secondary instability	STRAIGHT VORTEX FILAMENT; LAMB-OSEEN VORTEX; ELLIPTIC INSTABILITY; FIELD; REDUCTION; STABILITY; BREAKDOWN; CYLINDER; LIE	We develop a general framework of using the Lagrangian variables for calculating the energy of waves on a steady Euler flow and the mean flow induced by their nonlinear interaction. With the mean flow at hand we can determine, without ambiguity, all the coefficients of the amplitude equations to third order in amplitude for a rotating flow subject to a steady perturbation breaking the circular symmetry of the streamlines. Moreover, a resonant triad of waves is identified which brings in the secondary instability of the MooreSaffman- Tsai-Widnall instability, and with the aid of the energetic viewpoint, resonant amplification of the waves without bound is numerically confirmed.	[Fukumoto, Yasuhide] Kyushu Univ, Inst Math Ind, Nishi Ku, Fukuoka 8190395, Japan; [Mie, Youichi] Sumitomo Rubber Ind Ltd, Chuo Ku, Kobe, Hyogo 6510071, Japan	Fukumoto, Y (reprint author), Kyushu Univ, Inst Math Ind, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	yasuhide@imi.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24540407]	We are grateful to Kaoru Fujimura, Yuji Hattori and Makoto Hirota for their invaluable contributions in the previous papers to which the present results are owed. Y Fukumoto was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grant No. 24540407).	Alber MS, 1998, PHYSICA D, V123, P271, DOI 10.1016/S0167-2789(98)00127-4; TSAI CY, 1976, J FLUID MECH, V73, P721, DOI 10.1017/S0022112076001584; Fukumoto Y, 2003, J FLUID MECH, V493, P287, DOI 10.1017/S0022112003006025; Morrison PJ, 1998, REV MOD PHYS, V70, P467, DOI 10.1103/RevModPhys.70.467; Kerswell RR, 1999, J FLUID MECH, V382, P283, DOI 10.1017/S0022112098003954; MOORE DW, 1975, P ROY SOC LOND A MAT, V346, P413, DOI 10.1098/rspa.1975.0183; ARNOLD V, 1966, ANN I FOURIER, V16, P319; Kerswell RR, 2002, ANNU REV FLUID MECH, V34, P83, DOI 10.1146/annurev.fluid.34.081701.171829; Lehner T, 2010, GEOPHYS ASTRO FLUID, V104, P369, DOI 10.1080/03091921003693554; ANDREWS DG, 1978, J FLUID MECH, V89, P609, DOI 10.1017/S0022112078002773; Leweke T, 1998, J FLUID MECH, V360, P85, DOI 10.1017/S0022112097008331; BUHLER O., 2009, WAVES MEAN FLOWS; Eloy C, 2001, PHYS FLUIDS, V13, P660, DOI 10.1063/1.1345716; Eloy C, 2000, PHYS REV LETT, V85, P3400, DOI 10.1103/PhysRevLett.85.3400; Fabre D, 2006, J FLUID MECH, V551, P235, DOI 10.1017/S0022112005008463; Fukumoto Y, 2008, PHYS SCRIPTA, VT132, DOI 10.1088/0031-8949/2008/T132/014041; Fukumoto Y, 2011, GAKUTO INT MSA, V43, P53; Fukumoto Y, 2005, P 3 INT C VORT FLOWS, P149; Fukumoto Y, 2014, P BIRS WORKSH SPECTR, P139; Fukumoto Y, 2010, PHYS SCRIPTA, VT142, DOI 10.1088/0031-8949/2010/T142/014049; Fukumoto Y, 2013, PHYS SCRIPTA, VT155, DOI 10.1088/0031-8949/2013/T155/014042; GUCKENHEIMER J, 1992, PHYS REV LETT, V68, P2257, DOI 10.1103/PhysRevLett.68.2257; Hirota M, 2008, J MATH PHYS, V49, DOI 10.1063/1.2969275; KNOBLOCH E, 1994, PHYSICA D, V73, P49, DOI 10.1016/0167-2789(94)90225-9; MALKUS WVR, 1989, GEOPHYS ASTRO FLUID, V48, P123, DOI 10.1080/03091928908219529; Mason DM, 1999, J FLUID MECH, V396, P73, DOI 10.1017/S0022112099005959; Mie Y, 2010, J MATH IND, V2, P27; Racz JP, 2008, J FLUID MECH, V595, P291, DOI 10.1017/S0022112007009226; Rodrigues SB, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3068188; Schaeffer N, 2010, J FLUID MECH, V646, P471, DOI 10.1017/S002211200999351X; Sipp D, 2000, PHYS FLUIDS, V12, P1715, DOI 10.1063/1.870422; Vladimirov V A, 1983, IZV AS ATMOS OCEAN P, V19, P437; WALEFFE F, 1989, THESIS MIT	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	FEB	2015	47	1							015509	10.1088/0169-5983/47/1/015509		14	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CB1OJ	WOS:000349397000010		
J	Minami, K; Suzuki, K; Inamuro, T				Minami, Keisuke; Suzuki, Kosuke; Inamuro, Takaji			Free flight simulations of a dragonfly-like flapping wing-body model using the immersed boundary-lattice Boltzmann method	FLUID DYNAMICS RESEARCH			English	Article							INSECT FLIGHT; POWER REQUIREMENTS; AERODYNAMICS; FORCES; MOTION; FLOWS	Free flights of the dragonfly-like flapping wing-body model are numerically investigated using the immersed boundary-lattice Boltzmann method. The governing parameters of the problem are the Reynolds number Re, the Froude number Fr, and the non-dimensional mass m, and we set the parameters at Re = 200, Fr = 15, and m = 51. First, we simulate free flights of the model without the pitching rotation for various values of the phase lag angle phi between the forewing and the hindwing motions. We find that the wing-body model goes forward in spite of phi, and the model with phi = 0 degrees and 90 degrees goes upward against gravity. The model with phi = 180 degrees goes almost horizontally, and the model with phi = 270 degrees goes downward. That is, the moving direction of the model depends on the phase lag angle phi. Secondly, we simulate free flights with the pitching rotation for various values of the phase lag angle phi. It is found that in spite of. the wing-body model turns gradually in the nose-up direction and goes back and down as the pitching angle Theta(c) increases. That is, the wing-body model cannot make a stable forward flight without control. Finally, we show a way to control the pitching motion by changing the leadlag angle gamma(t). We propose a simple proportional controller of gamma(t) which makes stable flights within Theta(c) = +/- 5 degrees and works well even for a large disturbance.	[Minami, Keisuke; Suzuki, Kosuke; Inamuro, Takaji] Kyoto Univ, Dept Aeronaut & Astronaut, Grad Sch Engn, Kyoto 6158540, Japan; [Inamuro, Takaji] Kyoto Univ, Adv Res Inst Fluid Sci & Engn, Grad Sch Engn, Kyoto 6158530, Japan	Minami, K (reprint author), Kyoto Univ, Dept Aeronaut & Astronaut, Grad Sch Engn, Kyoto 6158540, Japan.	inamuro@kuaero.kyoto-u.ac.jp		Suzuki, Kosuke/0000-0001-9034-4082	HPCI System Research Project [hp120112]	The authors acknowledge the HPCI System Research Project (Project ID: hp120112) for providing computer time on CRAY XE6 at Academic Center for Computing and Media Studies in Kyoto University.	Cheng B, 2011, J EXP BIOL, V214, P4092, DOI 10.1242/jeb.062760; Luo HX, 2012, COMPUT FLUIDS, V56, P61, DOI 10.1016/j.compfluid.2011.11.015; Wang ZJ, 2007, PHYS REV LETT, V99, DOI [10.1103/PhysRevLett.99.148101, 10.1103/PhysRevLett.99.136804]; Wang ZJ, 2000, PHYS REV LETT, V85, P2216; Sun M, 2004, J EXP BIOL, V207, P1887, DOI 10.1242/jeb.00969; Yin B, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3499739; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Ota K, 2012, FLUID DYN RES, V44, DOI 10.1088/0169-5983/44/4/045504; AZUMA A, 1988, J EXP BIOL, V137, P221; Eldredge JD, 2010, J FLUID MECH, V659, P94, DOI 10.1017/S0022112010002363; Dai H, 2012, J FLUID MECH, V693, P473, DOI 10.1017/jfm.2011.543; Shu C, 2007, J COMPUT PHYS, V226, P1607, DOI 10.1016/j.jcp.2007.06.002; Taira K, 2009, J FLUID MECH, V623, P187, DOI 10.1017/S0022112008005314; Feng ZG, 2005, J COMPUT PHYS, V202, P20, DOI 10.1016/j.jcp.2004.06.020; Eldredge JD, 2007, J COMPUT PHYS, V221, P626, DOI 10.1016/j.jcp.2006.06.038; Ellington CP, 1999, J EXP BIOL, V202, P3439; Inamuro T, 2012, FLUID DYN RES, V44, DOI 10.1088/0169-5983/44/2/024001; Kimura Y, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183113400202; Succi S., 2001, LATTICE BOLTZMANN EQ; Suzuki K, 2011, COMPUT FLUIDS, V49, P173, DOI 10.1016/j.compfluid.2011.05.011; Suzuki K, 2014, J FLUID MECH UNPUB; Wakeling JM, 1997, J EXP BIOL, V200, P583; Wang JK, 2005, J EXP BIOL, V208, P3785, DOI 10.1242/jeb.01852; Yamamoto M, 2005, AIAA J, V43, P2475, DOI 10.2514/1.15899; Yokoyama N, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4790882	27	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	FEB	2015	47	1							015505	10.1088/0169-5983/47/1/015505		17	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CB1OJ	WOS:000349397000006		
J	Suzuki, H; Hasegawa, Y				Suzuki, H.; Hasegawa, Y.			Simplified equations for the rotational speed response to inflow velocity variation in fixed-pitch small wind turbines	FLUID DYNAMICS RESEARCH			English	Article						wind turbine; wind energy; fluid transients; tip-speed ratio; rotational speed; small wind turbines		We propose simplified equations for the rotational speed response to inflow velocity variation in fixed-pitch small wind turbines. The present formulation is derived by introducing a series expansion for the torque coefficient at the constant tip-speed ratio. By focusing on the first-and second-order differential coefficients of the torque coefficient, we simplify the original differential equation. The governing equation based only on the first-order differential coefficient is found to be linear, whereas the second-order differential coefficient introduces nonlinearity. We compare the numerical solutions of the three governing equations for rotational speed in response to sinusoidal and normal-random variations of inflow velocity. The linear equation gives accurate solutions of amplitude and phase lag. Nonlinearity occurs in the mean value of rotational speed variation. We also simulate the rotational speed in response to a step input of inflow velocity using the conditions of two previous studies, and note that the form of this rotational speed response is a system of first-order time lag. We formulate the gain and time constant for this rotational speed response. The magnitude of the gain is approximately three when the wind turbine is operated at optimal tip-speed ratio. We discuss the physical meaning of the derived time constant.	[Suzuki, H.; Hasegawa, Y.] Nagoya Inst Technol, Grad Sch Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Suzuki, H (reprint author), Nagoya Inst Technol, Grad Sch Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	hsuzuki@nitech.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [25420115]	The authors acknowledge Associate Professor T Ushijima (Nagoya Institute of Technology) for his valuable comments on this study. Part of this study is supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology through Grants-in-Aid (No. 25420115).	Datta R, 2003, IEEE T ENERGY CONVER, V18, P163, DOI 10.1109/TEC.2002.808346; Karasudani T, 2008, J JAPAN WIND ENERGY, V32, P128; Karasudani T, 2007, J JAPAN WIND ENERGY, V31, P120; Karasudani T, 2010, J JAPAN WIND ENERGY, V34, P102; Kogaki T, 2009, J ENV ENG, V4, P467; Kogaki T, 2009, J ENV ENG, V4, P479; Manwell J. F., 2010, WIND ENERGY EXPLAINE; Munteanu I, 2008, ADV IND CONTROL, P1; Shimizu Y, 1998, J JAPAN WIND ENERGY, V22, P30; Shimizu Y, 1996, J JAPAN WIND ENERGY, V20, P38; Snel H, 1991, P EUR WIND EUR C AMS; Toshimitsu K, 2012, J FLUID DYN, V2, P215; Wood D, 2011, GREEN ENERGY TECHNOL, P1, DOI 10.1007/978-1-84996-175-2	13	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	FEB	2015	47	1							015510	10.1088/0169-5983/47/1/015510		22	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	CB1OJ	WOS:000349397000011		
J	Chen, LX; Huang, LP; Li, C; Zan, T				Chen, Luxi; Huang, Linpeng; Li, Chen; Zan, Tao			Integrating behavior analysis into architectural modeling	FRONTIERS OF COMPUTER SCIENCE			English	Article						software architecture; component behavior; bidirectional transformation; architecture analysis and design language (AADL); model checking	FORMAL SEMANTICS; TRANSFORMATIONS	Architectural modeling and behavior analysis are two important concerns in the software development. They are often implemented separately, and specified by their own supporting notations. Architectural modeling helps to guarantee the system design to satisfy the requirement, and behavior analysis can ensure the interaction correctness. To improve the trustworthiness, methods trying to combine architectural modeling and behavior analysis notations together have been proposed, e.g., establishing a one-way mapping relation. However, the one-way relation cannot ensure updating one notation specifications in accordance with the other one, which results in inconsistency problems. In this paper, we present an approach to integrating behavior analysis into architectural modeling, which establishes the interoperability between architectural modeling notation and behavior analysis notation by a bidirectional mapping. The architecture is specified by the modeling language, architecture analysis and design language (AADL), and then mapped to behavior analysis notation, Darwin/FSP (finite state process) through the bidirectional transformation. The bidirectional transformation provides traceability, which makes behavior analysis result provided by a model checker can be traced and reflected back to the original AADL specifications. In this way, the behavior analysis is integrated into architectural modeling. The feasibility of our approach is shown by a control system example.	[Chen, Luxi; Huang, Linpeng; Li, Chen] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai 200240, Peoples R China; [Zan, Tao] Grad Univ Adv Studies, Dept Informat, Tokyo 108430, Japan	Huang, LP (reprint author), Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai 200240, Peoples R China.	lphuang@sjtu.edu.cn			National Natural Science Foundation of China [91118004, 61232007]; Innovation Program of Shanghai Municipal Education Commission [13ZZ023]	The authors would like to thank anonymous reviewers for their helpful comments and suggestions. Special thanks to Raymond Cheng, Andrew Liu and Yuan Yao for their careful revisions. This work was supported by the National Natural Science Foundation of China under (Grant Nos. 91118004, 61232007), and the Innovation Program of Shanghai Municipal Education Commission (13ZZ023).	Allen R., 1997, ACM Transactions on Software Engineering and Methodology, V6, DOI 10.1145/258077.258078; Almorsy M, 2013, PROCEEDINGS OF THE 35TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2013), P662; Malavolta I, 2010, IEEE T SOFTWARE ENG, V36, P119, DOI 10.1109/TSE.2009.51; Olveczky PC, 2010, LECT NOTES COMPUT SC, V6117, P47, DOI 10.1007/978-3-642-13464-7_5; Hettel T, 2008, LECT NOTES COMPUT SC, V5063, P31, DOI 10.1007/978-3-540-69927-9_3; Xiong YF, 2009, 7TH JOINT MEETING OF THE EUROPEAN SOFTWARE ENGINEERING CONFERENCE AND THE ACM SIGSOFT SYMPOSIUM ON THE FOUNDATIONS OF SOFTWARE ENGINEERING, P315, DOI 10.1145/1595696.1595757; Kramer J, 2003, LECT NOTES COMPUT SC, V2804, P44; Song H, 2011, J SYST SOFTWARE, V84, P711, DOI 10.1016/j.jss.2010.12.009; Hidaka S, 2009, PROC INT CONF SOFTW, P235, DOI 10.1109/ICSE-COMPANION.2009.5070990; Dashofy E, 2007, PROC INT CONF SOFTW, P67, DOI 10.1109/ICSECOMPANION.2007.21; Dashofy E. M., 2001, Proceedings Working IEEE/IFIP Conference on Software Architecture, DOI 10.1109/WICSA.2001.948416; Dissaux P, 2006, P 2006 DAT SYST AER; Feiler P, 2007, DEPENDABILITY MODELI; Feiler P H, 2006, ARCHITECTURE ANAL DE; Garlan David, 2010, CASCON 1 DECADE HIGH, P159, DOI DOI 10.1145/1925805.1925814; Hidaka S, 2010, ACM SIGPLAN NOTICES, V45, P205, DOI 10.1145/1932681.1863573; Hidaka S, 2008, GROUNDTRAM VERSION 0; Hidaka S, 2011, P 26 IEEE ACM INT C, P480; Johnsen A, 2012, P 14 IEEE INT S HIGH, P130; Johnsen A, 2011, LECT NOTES COMPUT SC, V6903, P105, DOI 10.1007/978-3-642-23798-0_11; Malavolta I, 2009, P 14 IEEE INT C ENG, P341; Wang B, 2013, FRONT COMPUT SCI-CHI, V7, P257, DOI 10.1007/s11704-013-2047-0; Wu W, 2007, THESIS U YORK; Xiong Y., 2007, P 22 IEEE ACM INT C, P164, DOI 10.1145/1321631.1321657; Yang ZB, 2009, DES AUT TEST EUROPE, P1166; Yu YJ, 2012, PROC INT CONF SOFTW, P540; Zhang PC, 2010, J SYST SOFTWARE, V83, P723, DOI 10.1016/j.jss.2009.11.709; Zheng YJ, 2013, SOFTW SYST MODEL, V12, P669, DOI 10.1007/s10270-013-0355-3	28	0	0	HIGHER EDUCATION PRESS	BEIJING	SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA	2095-2228	2095-2236		FRONT COMPUT SCI-CHI	Front.. Comput. Sci.	FEB	2015	9	1					15	33		10.1007/s11704-014-3505-z		19	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CA3HY	WOS:000348798400002		
J	Iida, S; Chen, W; Nakadai, T; Ohkuma, Y; Roeder, RG				Iida, Satoshi; Chen, Wei; Nakadai, Tomoyoshi; Ohkuma, Yoshiaki; Roeder, Robert G.			PRDM16 enhances nuclear receptor-dependent transcription of the brown fat- specific Ucp1 gene through interactions with Mediator subunit MED1	GENES & DEVELOPMENT			English	Article						PRDM16; Mediator/MED1; Ucp1; nuclear receptor; transcriptional regulation; brown/beige adipocytes	UNCOUPLING PROTEIN GENE; PPAR-GAMMA; ADAPTIVE THERMOGENESIS; COACTIVATOR COMPLEX; DIFFERENTIATION; BEIGE; ADIPOGENESIS; PGC-1-ALPHA; ADIPOCYTES; EXPRESSION	PR domain-containing 16 (PRDM16) induces expression of brown fat-specific genes in brown and beige adipocytes, although the underlying transcription-related mechanisms remain largely unknown. Here, in vitro studies show that PRDM16, through its zinc finger domains, directly interacts with the MED1 subunit of the Mediator complex, is recruited to the enhancer of the brown fat-specific uncoupling protein 1 (Ucp1) gene through this interaction, and enhances thyroid hormone receptor (TR)-driven transcription in a biochemically defined system in a Mediator-dependent manner, thus providing a direct link to the general transcription machinery. Complementary cell-based studies show that upon forskolin treatment, PRDM16 induces Ucp1 expression in undifferentiated murine embryonic fibroblasts, that this induction depends on MED1 and TR, and, consistent with a direct effect, that PRDM16 is recruited to the Ucp1 enhancer. Related studies have defined MED1 and PRDM16 interaction domains important for Ucp1 versus Ppargc1a induction by PRDM16. These results reveal novel mechanisms for PRDM16 function through the Mediator complex.	[Iida, Satoshi; Chen, Wei; Nakadai, Tomoyoshi; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [Ohkuma, Yoshiaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, Toyama 9300194, Japan	Roeder, RG (reprint author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA.	roeder@rockefeller.edu			National Institutes of Health [DK071900]	We are grateful to Bruce Spiegelman, Patrick Seale, and Paul Cohen for PRDM16 expression and adenoviral PGC-1 alpha shRNA vectors; Sohail Malik, Miki Jishage, and Neri Minsky for critical reading of the manuscript; and Miho Shimada for technical advice. This work was supported by National Institutes of Health grant DK071900 to R.G.R.	Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Rosen ED, 2001, J BIOL CHEM, V276, P37731; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; KOZAK UC, 1994, MOL CELL BIOL, V14, P59; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Glass CK, 2000, GENE DEV, V14, P121; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Chen W, 2009, MOL CELL, V35, P755, DOI 10.1016/j.molcel.2009.09.015; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Fondell JD, 2013, BBA-GEN SUBJECTS, V1830, P3867, DOI 10.1016/j.bbagen.2012.02.012; Malik S, 2004, MOL CELL BIOL, V24, P8244, DOI 10.1128/MCB.24.18.8244-8254.2004; Malik S, 2003, METHOD ENZYMOL, V364, P257; Mishra A, 2010, J MOL ENDOCRINOL, V44, P247, DOI 10.1677/JME-09-0137; Roeder RG, 2003, NAT MED, V9, P1239, DOI 10.1038/nm938	41	3	3	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	FEB 1	2015	29	3					308	321		10.1101/gad.252809.114		14	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	CA9KZ	WOS:000349243700008		
J	Suzuki, A				Suzuki, Atsushi			MBSJ MCC Young Scientist Award 2012 Liver regeneration: a unique and flexible reaction depending on the type of injury	GENES TO CELLS			English	Review							HEPATIC PROGENITOR CELLS; MOUSE-LIVER; STEM-CELLS; TRANSCRIPTION FACTORS; OVAL CELLS; HEPATOCYTES; PROLIFERATION; FATE; MICE; SNAIL	The liver can be thought of as a mysterious organ, because it has an elegant regenerative capability. This phenomenon has been well known since ancient times and is already applied to medical treatments for severe hepatic disorders by transplanting portions of liver received from living donors. However, it was not until quite recently that the mechanism underlying the principle of liver regeneration was investigated more deeply. Recent advances in the technologies for characterizing cell properties and examining the molecular nature of cells are enabling us to understand what occurs in the regenerating liver. After acute liver damage, hepatocytes actively proliferate in response to external stimulation by humoral factors. However, in the chronically injured liver, hepatocytes cannot proliferate well, but biliary cells appearing after chronic liver damage form primitive ductules around portal veins of the liver. These biliary cells may have a multiple origin, including hepatocytes, and contain progenitor cells giving rise to both hepatocytes and biliary cells, or represent cells that can be directly converted into hepatocytes. Although liver regeneration is more complicated than we had thought, unremitting efforts by researchers will certainly connect the numerous findings obtained in basic research with the development of new therapeutic strategies for liver diseases.	[Suzuki, Atsushi] Kyushu Univ, Med Inst Bioregulat, Div Organogenesis & Regenerat, Higashi Ku, Fukuoka 8128582, Japan; [Suzuki, Atsushi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Suzuki, A (reprint author), Kyushu Univ, Med Inst Bioregulat, Div Organogenesis & Regenerat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	suzukicks@bioreg.kyushu-u.ac.jp			Program for Improvement of the Research Environment for Young Researchers from the Special Coordination Funds for Promoting Science and Technology; Scientific Research from the MEXT of Japan; Health Labour Sciences Research Grant in Japan; Precursory Research for Embryonic Science and Technology Program of the Japan Science and Technology Agency; Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency	This work was generally supported in part by the Program for Improvement of the Research Environment for Young Researchers from the Special Coordination Funds for Promoting Science and Technology commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grants-in-Aid for Scientific Research from the MEXT of Japan, a Health Labour Sciences Research Grant in Japan, the Precursory Research for Embryonic Science and Technology Program of the Japan Science and Technology Agency, and the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency.	Libbrecht L, 2002, SEMIN CELL DEV BIOL, V13, P389, DOI 10.1016/S1084-9521(02)00125-8; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; DESMET V, 1995, PATHOL RES PRACT, V191, P513; FARBER E, 1956, CANCER RES, V16, P142; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Lemaigre FP, 2009, GASTROENTEROLOGY, V137, P62, DOI 10.1053/j.gastro.2009.03.035; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; FACTOR VM, 1993, EXP TOXICOL PATHOL, V45, P239; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Sekiya S, 2011, P NATL ACAD SCI USA, V108, P11175, DOI 10.1073/pnas.1016122108; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; SHINOZUKA H, 1978, CANCER RES, V38, P1092; TATEMATSU M, 1984, AM J PATHOL, V114, P418; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Preisegger KH, 1999, LAB INVEST, V79, P103; CHEN TSN, 1994, J ROY SOC MED, V87, P754; LEMIRE JM, 1991, AM J PATHOL, V139, P535; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Suzuki A, 2013, CURR OPIN GENET DEV, V23, P579, DOI 10.1016/j.gde.2013.04.006	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	FEB	2015	20	2					77	84		10.1111/gtc.12200		8	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CA6LX	WOS:000349026500001		
J	Yoshida, A; Sakai, N; Uekusa, Y; Deguchi, K; Gilmore, JL; Kumeta, M; Ito, S; Takeyasu, K				Yoshida, Aiko; Sakai, Nobuaki; Uekusa, Yoshitsugu; Deguchi, Katashi; Gilmore, Jamie L.; Kumeta, Masahiro; Ito, Shuichi; Takeyasu, Kunio			Probing in vivo dynamics of mitochondria and cortical actin networks using high-speed atomic force/fluorescence microscopy	GENES TO CELLS			English	Article							FORCE MICROSCOPY; F-ACTIN; MEMBRANE-PROTEINS; AXONAL-TRANSPORT; CELLS; MECHANISM; REVEALS; FUSION; OPA1; CYTOSKELETON	The dynamics of the cell membrane and submembrane structures are closely linked, facilitating various cellular activities. Although cell surface research and cortical actin studies have shown independent mechanisms for the cell membrane and the actin network, it has been difficult to obtain a comprehensive understanding of the dynamics of these structures in live cells. Here, we used a combined atomic force/optical microscope system to analyze membrane-based cellular events at nanometer-scale resolution in live cells. Imaging the COS-7 cell surface showed detailed structural properties of membrane invagination events corresponding to endocytosis and exocytosis. In addition, the movement of mitochondria and the spatiotemporal dynamics of the cortical F-actin network were directly visualized in vivo. Cortical actin microdomains with sizes ranging from 1.7x10(4) to 1.4x10(5)nm(2) were dynamically rearranged by newly appearing actin filaments, which sometimes accompanied membrane invaginations, suggesting that these events are integrated with the dynamic regulation of submembrane organizations maintained by actin turnovers. These results provide novel insights into the structural aspects of the entire cell membrane machinery which can be visualized with high temporal and spatial resolution.	[Yoshida, Aiko; Deguchi, Katashi; Gilmore, Jamie L.; Kumeta, Masahiro; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; [Sakai, Nobuaki; Uekusa, Yoshitsugu; Ito, Shuichi] OLYMPUS Co, Corp R&D Ctr, Hachioji, Tokyo 1928512, Japan	Takeyasu, K (reprint author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	takeyasu@lif.kyoto-u.ac.jp			MEXT, Japan [24115003]; JSPS, Japan [26870302]	We thank Mr Akira Yagi, Mr Kiyohiko Tateyama and Ms Yuka Imaoka for helpful assistance throughout the experiments. We are also grateful to Dr Yuki Suzuki for constructive discussion on the manuscript. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Molecular basis of host cell competency in virus infection' (#24115003 To KT) from MEXT, Japan and a Grant-in-Aid for Young Scientists (B) (#26870302 To MK) from JSPS, Japan.	Nightingale TD, 2012, TRENDS CELL BIOL, V22, P329, DOI 10.1016/j.tcb.2012.03.003; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Watanabe H, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4803449; Yamashita H, 2012, J MOL BIOL, V422, P300, DOI 10.1016/j.jmb.2012.05.018; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Fyfe I, 2011, J BIOL CHEM, V286, P34262, DOI 10.1074/jbc.M111.266411; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Casuso I, 2012, NAT NANOTECHNOL, V7, P525, DOI [10.1038/nnano.2012.109, 10.1038/NNANO.2012.109]; Ando T, 2014, CHEM REV, V114, P3120, DOI 10.1021/cr4003837; Schneider SW, 1997, P NATL ACAD SCI USA, V94, P316, DOI 10.1073/pnas.94.1.316; Suzuki Y, 2012, FEBS LETT, V586, P3187, DOI 10.1016/j.febslet.2012.06.033; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Suzuki Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02131; Trifaro JM, 2002, NEUROCHEM RES, V27, P1371, DOI 10.1023/A:1021627800918; Wang C, 2011, EXPERT OPIN THER TAR, V15, P647, DOI 10.1517/14728222.2011.561321; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Suzuki Y, 2014, NUCLEIC ACIDS RES, V42, P7421, DOI 10.1093/nar/gku320; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Pesen D, 2005, BIOPHYS J, V88, P670, DOI 10.1529/biophysj.104.049965; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Smirnova E, 2001, MOL BIOL CELL, V12, P2245; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.02745; Rajendran A, 2014, CHEM REV, V114, P1493, DOI 10.1021/cr300253x; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Correia SC, 2012, ADV EXP MED BIOL, V724, P205, DOI 10.1007/978-1-4614-0653-2_16; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Suzuki Y, 2011, WIRES NANOMED NANOBI, V3, P574, DOI 10.1002/wnan.150; Yokokawa M, 2006, IEE PROC-NANOBIOTECH, V153, P60, DOI 10.1049/ip-nbt:20050018; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Colom A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3155; DesVos K. J., 2008, ANNU REV NEUROSCI, V31, P151; Gilmore L. J., 2009, BIOCHEMISTRY-US, V48, P10492; Lehto T, 2003, FEBS LETT, V551, P25, DOI 10.1016/S0014-5793(03)00867-6; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Pesen D, 2005, FEBS LETT, V579, P473, DOI 10.1016/j.febslet.2004.12.014; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Shevchuk AI, 2012, J CELL BIOL, V197, P499, DOI 10.1083/jcb.201109130; Suzuki Y, 2013, J BIOL CHEM, V288, P778, DOI 10.1074/jbc.M112.422311; Suzuki Y, 2011, NANOSCI TECHNOL, P217, DOI 10.1007/978-3-642-10497-8_8; Yokokawa M, 2011, FEBS J, V278, P3025, DOI 10.1111/j.1742-4658.2011.08222.x; Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326	44	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	FEB	2015	20	2					85	94		10.1111/gtc.12204		10	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CA6LX	WOS:000349026500002		
J	Higa, M; Kita, A; Hagihara, K; Kitai, Y; Doi, A; Nagasoko, R; Satoh, R; Sugiura, R				Higa, Mari; Kita, Ayako; Hagihara, Kanako; Kitai, Yuki; Doi, Akira; Nagasoko, Rie; Satoh, Ryosuke; Sugiura, Reiko			Spatial control of calcineurin in response to heat shock in fission yeast	GENES TO CELLS			English	Article							MAMMALIAN STRESS GRANULES; PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CARDIAC-HYPERTROPHY; ION HOMEOSTASIS; BINDING PROTEIN; CELL INTEGRITY; MESSENGER-RNA; P-BODIES	In fission yeast, Ppb1, the Ca2+/calmodulin-dependent protein phosphatase calcineurin regulates multiple biological processes, such as cytokinesis, Ca2+-homeostasis, membrane trafficking and cell wall integrity. Calcineurin dephosphorylates the Prz1 transcription factor, leading to its nuclear translocation and gene expression under the control of CDRE (calcineurin-dependent response element). Although the calcineurin-mediated spatial control of downstream transcription factors has been intensively studied in many organisms, less is known about the spatial regulation of calcineurin on stresses. Here, we show that heat shock stimulates calcineurin-dependent nuclear translocation of Prz1 and CDRE-dependent gene expression. Notably, calcineurin exhibited a dramatic change in subcellular localization, translocating from diffuse cytoplasmic to dot-like structures on heat shock. The calcineurin dots colocalized with Dcp2 or Pabp, the constituent of P-bodies or stress granules, respectively, thus suggesting that calcineurin is a component of RNA granules under heat shock. Importantly, the calcineurin inhibitor FK506 markedly inhibited the accumulation of calcineurin granules, whereas the constitutively active calcineurin strongly accumulated in the granules on heat shock, suggesting that phosphatase activity is important for calcineurin localization. Notably, the depletion of calcineurin induced a rapid appearance of Nrd1- and Pabp-positive RNA granules. The possible roles of calcineurin in response to heat shock will be discussed.	[Higa, Mari; Kita, Ayako; Hagihara, Kanako; Kitai, Yuki; Doi, Akira; Nagasoko, Rie; Satoh, Ryosuke; Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 5778502, Japan	Sugiura, R (reprint author), Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	sugiurar@phar.kindai.ac.jp					Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Zhao C, 1998, MOL CELL BIOL, V18, P1013; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Takahara T, 2012, CELL CYCLE, V11, P3707, DOI [10.4161/cc.22044, 10.1016/j.molcel.2012.05.019]; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Qin LL, 2006, MOL CANCER RES, V4, P811, DOI 10.1158/1541-7786.MCR-06-0126; YOSHIDA T, 1994, J CELL SCI, V107, P1725; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; COHEN DJ, 1984, ANN INTERN MED, V101, P667; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; THORE A, 1983, J CLIN MICROBIOL, V17, P218; Fujita M, 2002, GENETICS, V161, P971; Toda T, 1996, MOL CELL BIOL, V16, P6752; Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031; Shah KH, 2013, GENETICS, V193, P109, DOI 10.1534/genetics.112.146993; [Anonymous], 1991, METHOD ENZYMOL; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Kozubowski L, 2011, EUKARYOT CELL, V10, P1396, DOI 10.1128/EC.05087-11; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lu YB, 2002, GENES CELLS, V7, P1009, DOI 10.1046/j.1365-2443.2002.00582.x; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Satoh R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029683; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Takada H, 2010, MOL BIOL CELL, V21, P674, DOI 10.1091/mbc.E09-09-0810; Zhou X, 2012, J BIOL CHEM, V287, P23434, DOI 10.1074/jbc.C111.338715	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	FEB	2015	20	2					95	107		10.1111/gtc.12203		13	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CA6LX	WOS:000349026500003		
J	Oshiro, H; Hirabayashi, Y; Furuta, Y; Okabe, S; Gotoh, Y				Oshiro, Hiroaki; Hirabayashi, Yusuke; Furuta, Yasuhide; Okabe, Shigeo; Gotoh, Yukiko			Up-regulation of HP1 gamma expression during neuronal maturation promotes axonal and dendritic development in mouse embryonic neocortex	GENES TO CELLS			English	Article							NEURAL DEVELOPMENT; HISTONE H3; CHROMATIN; HP1; PROTEIN; CORTEX; NEUROGENESIS; PROGENITORS; PLASTICITY; DROSOPHILA	Immature neurons undergo morphological and physiological changes including axonal and dendritic development to establish neuronal networks. As the transcriptional status changes at a large number of genes during neuronal maturation, global changes in chromatin modifiers may take place in this process. We now show that the amount of heterochromatin protein 1 (HP1) increases during neuronal maturation in the mouse neocortex. Knockdown of HP1 suppressed axonal and dendritic development in mouse embryonic neocortical neurons in culture, and either knockdown or knockout of HP1 impaired the projection of callosal axons of superficial layer neurons to the contralateral hemisphere in the developing neocortex. Conversely, forced expression of HP1 facilitated axonal and dendritic development, suggesting that the increase of HP1 is a rate limiting step in neuronal maturation. These results together show an important role for HP1 in promoting axonal and dendritic development in maturing neurons.	[Oshiro, Hiroaki; Hirabayashi, Yusuke; Gotoh, Yukiko] Univ Tokyo, Grad Sch Pharmaceut Sci, Mol Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Oshiro, Hiroaki; Okabe, Shigeo] Univ Tokyo, Grad Sch Med, Dept Cellular Neurobiol, Bunkyo Ku, Tokyo 1130033, Japan; [Furuta, Yasuhide] RIKEN Ctr Dev Biol CDB, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan	Gotoh, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Mol Biol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ygotoh@mol.f.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Innovative Areas 'Neural Diversity and Neocortical Organization' of MEXT; Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency; Japan Society for the Promotion of Science	We thank Y. Itoh (The University of Tokyo) for critical reading of the manuscript; C. L. Cepko (Harvard University), T. Matsuda (Kyoto University), S. Takemoto-Kimura and H. Bito (The University of Tokyo), M. Shimojo and A. Maximov (The Scripps Research Institute) and H. Song (Johns Hopkins University) for plasmids; E. Meijering (The Erasmus University) for NeuronJ plug-in software; H. Shirokawa-Koretsune and members of the Gotoh laboratory for helpful discussion. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, by Innovative Areas 'Neural Diversity and Neocortical Organization' of MEXT, by Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency and by the Japan Society for the Promotion of Science.	Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Mateescu B, 2008, EMBO REP, V9, P267, DOI 10.1038/embor.2008.1; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Feldmeyer D, 2009, J PHYSIOL-LONDON, V587, P1889, DOI 10.1113/jphysiol.2009.169458; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Smallwood A, 2012, GENOME RES, V22, P1426, DOI 10.1101/gr.124818.111; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Tabata H, 2009, CEREB CORTEX, V19, P2092, DOI 10.1093/cercor/bhn227; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Tyssowski K, 2014, NEUROSCIENCE, V264, P4, DOI 10.1016/j.neuroscience.2013.10.008; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Parekh R, 2015, NEUROSCIENTIST, V21, P241, DOI 10.1177/1073858414540216; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Kaur P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103525; Lee DH, 2013, BIOCHEM BIOPH RES CO, V434, P820, DOI 10.1016/j.bbrc.2013.04.020; Sekine K, 2014, NEUROSCI RES, V86, P50, DOI 10.1016/j.neures.2014.06.004; SUNYER T, 1990, P NATL ACAD SCI USA, V87, P278, DOI 10.1073/pnas.87.1.278; Takemoto-Kimura S, 2003, J BIOL CHEM, V278, P18597, DOI 10.1074/jbc.M300578200; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	FEB	2015	20	2					108	120		10.1111/gtc.12205		13	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CA6LX	WOS:000349026500004		
J	Ohsawa, N; Koebis, M; Mitsuhashi, H; Nishino, I; Ishiura, S				Ohsawa, Natsumi; Koebis, Michinori; Mitsuhashi, Hiroaki; Nishino, Ichizo; Ishiura, Shoichi			ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1	GENES TO CELLS			English	Article							MYOTONIC-DYSTROPHY TYPE-1; TRACT BINDING-PROTEIN; 3 UNTRANSLATED REGION; PRE-MESSENGER-RNA; TRINUCLEOTIDE REPEAT; CUGBP1; EXPRESSION; DIFFERENTIATION; TRANSCRIPTS; RECEPTOR	Myotonic dystrophy type 1 (DM1) is an RNA-mediated disorder characterized by muscle weakness, cardiac defects and multiple symptoms and is caused by expanded CTG repeats within the 3 untranslated region of the DMPK gene. In this study, we found abnormal splicing of actin-binding LIM protein 1 (ABLIM1) in skeletal muscles of patients with DM1 and a DM1 mouse model (HSA(LR)). An exon 11 inclusion isoform is expressed in skeletal muscle and heart of non-DM1 individuals, but not in skeletal muscle of patients with DM1 or other adult human tissues. Moreover, we determined that ABLIM1 splicing is regulated by several splice factors, including MBNL family proteins, CELF1, 2 and 6, and PTBP1, using a cellular splicing assay. MBNL proteins promoted the inclusion of ABLIM1 exon 11, but other proteins and expanded CUG repeats repressed exon 11 of ABLIM1. This result is consistent with the hypothesis that MBNL proteins are trapped by expanded CUG repeats and inactivated in DM1 and that CELF1 is activated in DM1. However, activation of PTBP1 has not been reported in DM1. Our results suggest that the exon 11 inclusion isoform of ABLIM1 may have a muscle-specific function, and its abnormal splicing could be related to muscle symptoms of DM1.	[Ohsawa, Natsumi; Koebis, Michinori; Mitsuhashi, Hiroaki; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan	Ishiura, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cishiura@mail.ecc.u-tokyo.ac.jp			NCNP [26-8]; Ministry of Health, Labor and Welfare, Japan; JSPS KAKENHI [249583]	HSA LR mice were kindly provided by Prof. C.A. Thornton and Prof. M. P. Takahashi. This work was supported in part by an intramural research grant (26-8) for Neurological and Psychiatric Disorders of NCNP, Ministry of Health, Labor and Welfare, Japan, and JSPS KAKENHI (grant no. 249583). We would like to thank Dr Noboru Sasagawa, Dr Yoko Oma, Dr Yoshihiro Kino, Miss Zhao Yimeng, Mr Kosuke Oana.	Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Zhang L, 1999, RNA, V5, P117, DOI 10.1017/S1355838299981530; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Southby J, 1999, MOL CELL BIOL, V19, P2699; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Tang ZZ, 2012, HUM MOL GENET, V21, P1312, DOI 10.1093/hmg/ddr568; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Kino Y, 2009, NUCLEIC ACIDS RES, V37, P6477, DOI 10.1093/nar/gkp681; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Ward AJ, 2010, HUM MOL GENET, V19, P3614, DOI 10.1093/hmg/ddq277; Frank D, 2006, J MOL MED-JMM, V84, P446, DOI 10.1007/s00109-005-0033-1; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Jones K, 2012, J CLIN INVEST, V122, P4461, DOI 10.1172/JCI64081; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Bland CS, 2010, NUCLEIC ACIDS RES, V38, P7651, DOI 10.1093/nar/gkq614; Brook J D, 1992, Cell, V69, P385; Chan RCC, 1997, MOL CELL BIOL, V17, P4667; Charlet B. N., 2002, MOL CELL, V9, P649; Charlet BN, 2002, MOL CELL, V10, P45; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; Gooding C, 1998, RNA, V4, P85; Hao MQ, 2008, DEV DYNAM, V237, P403, DOI 10.1002/dvdy.21428; Harper PS, 2001, MYOTONIC DYSTROPHY; Koebis M., 2010, GENES CELLS, V16, P961; Ohsawa N., 2010, BIOCHEM BIOPH RES CO, V409, P64; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Zhang J, 2009, CELL DEATH DIFFER, V16, P1460, DOI 10.1038/cdd.2009.87	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	FEB	2015	20	2					121	134		10.1111/gtc.12201		14	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CA6LX	WOS:000349026500005		
J	Akamatsu, R; Ishida-Kitagawa, N; Aoyama, T; Oka, C; Kawaichi, M				Akamatsu, Rie; Ishida-Kitagawa, Norihiro; Aoyama, Takane; Oka, Chio; Kawaichi, Masashi			BNIP-2 binds phosphatidylserine, localizes to vesicles, and is transported by kinesin-1	GENES TO CELLS			English	Article							TOCOPHEROL-TRANSFER PROTEIN; VITAMIN-E-DEFICIENCY; CAYMAN ATAXIA; HOMOLOGY DOMAIN; VACCINIA VIRUS; ALPHA; CDC42GAP; CAYTAXIN; COMPLEX; CARGO	BNIP-2 shows high homology with the Cayman ataxia protein, caytaxin, which functions as a kinesin-1 adapter bridging cargos and kinesin light chains (KLCs). BNIP-2 is known to induce cell shape changes when over-expressed in culture cells, but its physiological functions are mostly unknown. BNIP-2 interacts with KLC through the conserved WED motif in the N-terminal region of BNIP-2. Interaction with KLC and transportation by kinesin-1 are essential for over-expressed BNIP-2 to elongate cells and induce cellular processes. Endogenous BNIP-2 localizes to the Golgi apparatus, early and recycling endosomes and mitochondria, aligned with microtubules, and moves at a speed compatible with kinesin-1 transportation. The CRAL-TRIO domain of BNIP-2 specifically interacts with phosphatidylserine, and the vesicular localization of BNIP-2 requires interaction with this phospholipid. BNIP-2 mutants which do not bind phosphatidylserine do not induce morphological changes in cells. These data show that similar to caytaxin, BNIP-2 is a kinesin-1 adapter involved in vesicular transportation in the cytoplasm and that association with cargos depends on interaction of the CRAL-TRIO domain with membrane phosphatidylserine.	[Akamatsu, Rie; Aoyama, Takane; Oka, Chio; Kawaichi, Masashi] Nara Inst Sci & Technol, Lab Gene Funct Anim, Nara 6300192, Japan; [Ishida-Kitagawa, Norihiro] Nara Inst Sci & Technol, Mol Oncol Lab, Nara 6300192, Japan	Kawaichi, M (reprint author), Nara Inst Sci & Technol, Lab Gene Funct Anim, 9816-5 Takayama, Nara 6300192, Japan.	mkawaich@bs.naist.jp					Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Bomar JM, 2003, NAT GENET, V35, P264, DOI 10.1038/ng1255; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Zhao RX, 2003, J BIOL CHEM, V278, P22609, DOI 10.1074/jbc.M301560200; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Hayakawa Y, 2007, BRAIN RES, V1129, P100, DOI 10.1016/j.brainres.2006.10.068; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608; Gyoeva FK, 2000, J CELL SCI, V113, P2047; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Dodding MP, 2011, EMBO J, V30, P4523, DOI 10.1038/emboj.2011.326; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Ward BM, 2004, J VIROL, V78, P2486, DOI 10.1128/JVI.78.5.2486-2493.2004; Aoyama T, 2009, J CELL SCI, V122, P4177, DOI 10.1242/jcs.048579; Xiao JF, 2005, MOL BRAIN RES, V141, P181, DOI 10.1016/j.molbrainres.2005.09.009; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; Kono N, 2013, SCIENCE, V340, P1106, DOI 10.1126/science.1233508; Buschdorf JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002686; CHEN C, 1987, MOL CELL BIOL, V7, P2745; GOTODA T, 1995, NEW ENGL J MED, V333, P1313, DOI 10.1056/NEJM199511163332003; Gupta AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033863; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Low BC, 2000, J BIOL CHEM, V275, P37742, DOI 10.1074/jbc.M004897200; Low BC, 1999, J BIOL CHEM, V274, P33123, DOI 10.1074/jbc.274.46.33123; Morgan GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000785; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Schiefermeier N, 2011, CURR OPIN CELL BIOL, V23, P615, DOI 10.1016/j.ceb.2011.04.001; Scott GB, 2010, BIOCHEM J, V431, P423, DOI 10.1042/BJ20091073; Sha BD, 1998, NATURE, V391, P506; Sirokmany G, 2006, J BIOL CHEM, V281, P6096, DOI 10.1074/jbc.M510619200; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; Valencia CA, 2007, BIOCHEM BIOPH RES CO, V364, P495, DOI 10.1016/j.bbrc.2007.10.018; Zhou YT, 2002, J BIOL CHEM, V277, P7483, DOI 10.1074/jbc.M109459200; Zhou Yi Ting, 2005, Experimental Cell Research, V303, P263, DOI 10.1016/j.yexcr.2004.08.044	44	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	FEB	2015	20	2					135	152		10.1111/gtc.12209		18	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	CA6LX	WOS:000349026500006		
J	Izawa, KP; Watanabe, S; Oka, K				Izawa, Kazuhiro P.; Watanabe, Satoshi; Oka, Koichiro			Relationship of thresholds of physical performance to nutritional status in older hospitalized male cardiac patients	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						geriatric nutritional risk index; male; nutritional status; older cardiac inpatients; physical performance	RISK INDEX; HEART-FAILURE; CLINICAL CHARACTERISTICS; SCREENING TOOLS; MORTALITY; ADULTS; REHABILITATION; EXERCISE; OUTCOMES; PEOPLE	AimNutrition is the focus of a new treatment target in older hospitalized cardiac patients. However, little is known about the differences in nutritional status in relation to physical performance in these inpatients. We determined the differences in physical performance based on the Geriatric Nutritional Risk Index (GNRI) and physical performance cut-off values according to the GNRI in older male cardiac inpatients. MethodsWe enrolled 251 Japanese male inpatients aged 65 years (mean age 74.7 years) with cardiac disease in the present cross-sectional study. We divided the patients into two groups according to GNRI: high-GNRI group (92 points; n=178) and low-GNRI group (<92 points; n=73). In-hospital physical performance as measured by handgrip strength (HG), knee extensor muscle strength (KEMS), gait speed (GS), and one-leg standing time (OLST) was assessed and compared between the two groups to determine cut-off values of physical performance. ResultsAfter adjustment for age, HG, KEMS, GS and OLST were significantly lower in the low-GNRI versus high-GNRI group. Cut-off values by receiver operating characteristic curve analysis were 25.75kgf (area under the curve [AUC]=0.740; P<0.001) for HG strength, 46.1% for bodyweight (AUC=0.742; P<0.01) for KEMS, 1.45m/s (AUC=0.782; P<0.01) for GS and 11.32s (AUC=0.705; P<0.01) for OLST. ConclusionThe risk of poor nutrition, as shown by a low GNRI, could be a useful predictor of physical performance. The cut-off values determined in the present study might be expected minimum target values that can be attained by Japanese older male cardiac inpatients. Geriatr Gerontol Int 2015; 15 189-195.	[Izawa, Kazuhiro P.; Watanabe, Satoshi] St Marianna Univ, Dept Rehabil Med, Sch Med Hosp, Kawasaki, Kanagawa 2168511, Japan; [Oka, Koichiro] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Izawa, KP (reprint author), St Marianna Univ, Dept Rehabil Med, Sch Med Hosp, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	izawapk@ga2.so-net.ne.jp			Japanese Association for the Promotion of Rehabilitation (Tokyo, Japan)	The present study was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Association for the Promotion of Rehabilitation (Tokyo, Japan).	Menezes AR, 2012, J GERIATR CARDIOL, V9, P68, DOI 10.3724/SP.J.1263.2012.00068; Jonsson E, 2004, CLIN BIOMECH, V19, P688, DOI 10.1016/j.clinbiomech.2004.04.002; Lomivorotov VV, 2013, NUTRITION, V29, P436, DOI 10.1016/j.nut.2012.08.006; Cereda E, 2006, J AM GERIATR SOC, V54, P1011, DOI 10.1111/j.1532-5415.2006.00754.x; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Muramoto A, 2013, J ORTHOP SCI, V18, P618, DOI 10.1007/s00776-013-0382-5; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777; Kinugasa Y, 2013, CIRC J, V77, P705, DOI 10.1253/circj.CJ-12-1091; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Purser JL, 2005, J REHABIL RES DEV, V42, P535, DOI 10.1682/JRRD.2004.07.0087; Purser JL, 2006, J AM GERIATR SOC, V54, P1674, DOI 10.1111/j.1532-5415.2006.00914.x; Michikawa T, 2009, J ORTHOP SCI, V14, P675, DOI 10.1007/s00776-009-1371-6; Yamada K, 2008, AM J CLIN NUTR, V87, P106; Morey MC, 1998, MED SCI SPORT EXER, V30, P1223, DOI 10.1097/00005768-199808000-00007; Cereda E, 2007, CLIN NUTR, V26, P78, DOI 10.1016/j.clnu.2006.09.007; Chan M, 2012, J RENAL NUTR, V22, P547, DOI 10.1053/j.jrn.2011.11.002; Furuna T, 1998, J Jpn Phys Ther Assoc, V1, P1, DOI 10.1298/jjpta.1.1; Islam MM, 2004, PREV MED, V39, P1148, DOI 10.1016/j.ypmed.2004.04.048; Izawa KP, 2008, J REHABIL MED, V40, P225, DOI 10.2340/16501977-0156; Izawa KP, 2010, AM J PHYS MED REHAB, V89, P24, DOI 10.1097/PHM.0b013e3181c5607d; Kamiya K, 2013, EUR J PREV CARD 0530; Little JP, 2009, APPL PHYSIOL NUTR ME, V34, P817, DOI 10.1139/H09-093; Masuda T, 2009, THEORY TECHNIQUE CAR, P165; Matos AC, 2012, NUTR HOSP, V27, P1981, DOI 10.3305/nh.2012.27.6.5891; Omori Y, 2004, RIGAKU RYOHO GAKU, V31, P106; Takahashi S, 1989, RIGAKU RYOHO GAKU, V16, P261; Tsuchihashi M, 2000, JPN CIRC J, V64, P953, DOI 10.1253/jcj.64.953; Tsuchihashi-Makaya M, 2013, CIRC J, V77, P604, DOI 10.1253/circj.CJ-13-0028	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	FEB	2015	15	2					189	195		10.1111/ggi.12257		7	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CA1JY	WOS:000348670100008		
J	Sung, B; Park, S; Ha, YM; Kim, DH; Park, CH; Jung, KJ; Kim, MS; Kim, YJ; Kim, MK; Moon, JO; Yokozawa, T; Kim, ND; Yu, BP; Chung, HY				Sung, Bokyung; Park, Seongjoon; Ha, Young Mi; Kim, Dae Hyun; Park, Chan Hum; Jung, Kyung Jin; Kim, Min Sun; Kim, You Jung; Kim, Mi Kyung; Moon, Jeon-Ok; Yokozawa, Takako; Kim, Nam Deuk; Yu, Byung Pal; Chung, Hae Young			Salicylideneamino-2-thiophenol modulates nuclear factor-kappa B through redox regulation during the aging process	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						aging; inflammatory mediators; nuclear factor-B; salicylideneamino-2-thiophenol; redox	SODIUM-SALICYLATE; CALORIE RESTRICTION; INFLAMMATION HYPOTHESIS; GLUTAREDOXIN SYSTEMS; ENDOTHELIAL-CELLS; MAPK PATHWAYS; ASPIRIN; ACTIVATION; THIOREDOXIN; INHIBITION	AimMany intracellular components have been implicated in the regulation of redox homeostasis, but homeostasis can be unbalanced by reactive species (RS), which also probably contribute to underlying inflammatory processes. Nuclear factor-B (NF-B) is a well-known redox-sensitive transcription factor that controls the genes responsible for regulating inflammation. MethodsIn the present study, the authors investigated the effect of short-term salicylideneamino-2-thiophenol (SAL-2) administration on the modulation of pro-inflammatory NF-B through redox regulation in aged rats. In addition, we compared the effects of SAL-2 and caloric restriction (CR) on inflammation and redox balance. The subjects were 24-month-old (old) Fischer 344 rats administered SAL-2 (10mg/kg/day) by dietary supplementation or placed on a 30% restricted diet for 10days, and 6-month-old (young) rats fed ad libitum for 10days. ResultsWe found that NF-B activation and the expressions of its related genes (vascular cell adhesion molecule-1, intercellular adhesion molecule-1, cyclooxygenase-2 and inducible nitric oxide synthase) were suppressed by SAL-2 supplementation in old CR rats to the levels observed in young rats. In addition, our molecular studies showed that the inhibitory effect of SAL-2 on the activation of NF-B was mediated by the ability of SAL-2 to block the nuclear translocations of cytosolic thioredoxin and redox factor-1. ConclusionThese findings strongly indicate that SAL-2 stabilizes age-related redox imbalance and modulates the signal transduction pathway involved in the age-associated molecular inflammatory process. Geriatr Gerontol Int 2015; 15: 211-219.	[Sung, Bokyung; Park, Seongjoon; Ha, Young Mi; Kim, Dae Hyun; Park, Chan Hum; Kim, Nam Deuk; Chung, Hae Young] Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan 609735, South Korea; [Moon, Jeon-Ok; Kim, Nam Deuk; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea; [Jung, Kyung Jin] Korea Inst Toxicol, Taejon, South Korea; [Kim, Min Sun] Sunchon Natl Univ, Dept Pharm, Coll Pharm, Sunchon, South Korea; [Kim, You Jung] Busan Womens Coll, Dept Dent Hyg, Pusan, South Korea; [Kim, Mi Kyung; Kim, Nam Deuk; Chung, Hae Young] Pusan Natl Univ, Longev Life Sci & Technol Inst, Pusan 609735, South Korea; [Yokozawa, Takako] Toyama Univ, Toyama 930, Japan; [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	Chung, HY (reprint author), Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent MRCA, Pusan 609735, South Korea.	hyjung@pusan.ac.kr			"Cooperative Research Program for Agriculture Science & Technology Development", Rural Development Administration, Korea [PJ00652213]; Pusan National University; MRC of the Medical Research Center program of the National Research Foundation of Korea [2009-0083538]	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ00652213)" Rural Development Administration, Korea. This study was financially supported by the 2013 Post-Doc. Development Program of Pusan National University. We also acknowledge this was financially supported by the MRC program no. 2009-0083538 of the Medical Research Center program of the National Research Foundation of Korea.	HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; Kim HJ, 2000, FREE RADICAL BIO MED, V28, P683, DOI 10.1016/S0891-5849(99)00274-9; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Ayyadevara S, 2013, ANTIOXID REDOX SIGN, V18, P481, DOI 10.1089/ars.2011.4151; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5; Barnes PJ, 1997, INT J BIOCHEM CELL B, V29, P867, DOI 10.1016/S1357-2725(96)00159-8; Liu TZ, 2001, ANN CLIN LAB SCI, V31, P383; KERR LD, 1995, METHOD ENZYMOL, V254, P619; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Kim HK, 2012, J CELL BIOCHEM, V113, P1833, DOI 10.1002/jcb.24052; FRANTZ B, 1995, SCIENCE, V270, P2017, DOI 10.1126/science.270.5244.2017; Lesniewski LA, 2011, J GERONTOL A-BIOL, V66, P409, DOI 10.1093/gerona/glq233; Yin MJ, 1998, NATURE, V396, P77; Chung J, 2008, BIOTECHNOL LETT, V30, P1553, DOI 10.1007/s10529-008-9744-z; Park S, 2013, ARCH PHARM RES, V36, P880, DOI 10.1007/s12272-013-0116-4; Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Ridker PM, 1998, CIRCULATION, V97, P1671; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Chung HY, 2000, REV CLIN GERONTOL, V10, P207, DOI 10.1017/S0959259800010327; Colantoni A, 1998, FREE RADICAL BIO MED, V25, P87, DOI 10.1016/S0891-5849(98)00033-1; Dong ZG, 1997, J BIOL CHEM, V272, P9962; FLOWER RJ, 1974, PHARMACOL RES COMMUN, V26, P33; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; Jung KJ, 2006, MECH AGEING DEV, V127, P223, DOI 10.1016/j.mad.2005.09.029; Khansari Nemat, 2009, Recent Pat Inflamm Allergy Drug Discov, V3, P73; Masutani H, 2000, ANTIOXIDANT REDOX RE, P297, DOI 10.1016/B978-012636670-9/50015-5; Santa Maria C, 1986, Arch Gerontol Geriatr, V5, P235, DOI 10.1016/0167-4943(86)90025-7; Santa Maria C, 1986, Mech Ageing Dev, V37, P183; Schwenger P, 1998, MOL CELL BIOL, V18, P78; Seo JY, 2002, ANN NY ACAD SCI, V973, P541; SHIMIZU S, 1994, RES COMMUN CHEM PATH, V84, P301; Tauskela JS, 2000, GLIA, V30, P329, DOI 10.1002/(SICI)1098-1136(200006)30:4<329::AID-GLIA20>3.0.CO;2-R; vansJaarsveld H, 1994, RES COMMUN MOL PATH, V86, P287; WINROW VR, 1993, BRIT MED BULL, V49, P506; Wu KK, 2003, THROMB RES, V110, P273, DOI 10.1016/S0049-3848(03)00412-2; YU BP, 2000, AGING METHODS PROTOC, V38, P353, DOI 10.1385/1-59259-070-5:353	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	FEB	2015	15	2					211	219		10.1111/ggi.12255		9	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CA1JY	WOS:000348670100011		
J	Muto, S; Kawano, H; Nakatomi, D; Yamasa, T; Maemura, K				Muto, Shigenori; Kawano, Hiroaki; Nakatomi, Daisuke; Yamasa, Toshihiko; Maemura, Koji			Sinus arrest as a result of rivastigmine in an elderly dementia with Lewy bodies patient	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter									[Muto, Shigenori; Kawano, Hiroaki; Maemura, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, Nagasaki 852, Japan; [Muto, Shigenori; Nakatomi, Daisuke; Yamasa, Toshihiko] Nagasaki Rosai Hosp, Dept Cardiol, Sasebo, Japan	Muto, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, Nagasaki 852, Japan.						Kayrak M, 2008, AM J HEALTH-SYST PH, V65, P1051, DOI 10.2146/ajhp070230; Morganroth J, 2002, J CLIN PHARMACOL, V42, P558, DOI 10.1177/00912700222011490; Knudtzen FC, 2013, J GERIATR CARDIOL, V10, P113, DOI [10.3969/j.issn.1671-5411.2013.01.017, 10.3724/SP.J.1263.2012.05111]; Paulison B, 2010, CARDIOVASC TOXICOL, V10, P306, DOI 10.1007/s12012-010-9088-5; Ballard C, 2006, INT J CLIN PRACT, V60, P639, DOI 10.1111/j.1368-5031.2006.00967.x; Knudtzen FC, 2007, ANN PHARMACOTHER, V41, P1632	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	FEB	2015	15	2					229	230		10.1111/ggi.12311		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CA1JY	WOS:000348670100013		
J	Ishiki, A; Furukawa, K; Une, K; Tomita, N; Okinaga, S; Arai, H				Ishiki, Aiko; Furukawa, Katsutoshi; Une, Kaori; Tomita, Naoki; Okinaga, Shoji; Arai, Hiroyuki			Cognitive examination in older adults living in temporary apartments after the Great East Japan Earthquake	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter							DEMENTIA		[Ishiki, Aiko; Furukawa, Katsutoshi; Une, Kaori; Tomita, Naoki; Okinaga, Shoji; Arai, Hiroyuki] Tohoku Univ, Dept Geriatr & Gerontol, Inst Dev Aging & Canc, Div Brain Sci, Sendai, Miyagi 980, Japan	Ishiki, A (reprint author), Tohoku Univ, Dept Geriatr & Gerontol, Inst Dev Aging & Canc, Div Brain Sci, Sendai, Miyagi 980, Japan.						Furukawa K, 2013, GERIATR GERONTOL INT, V13, P1081, DOI 10.1111/ggi.12085; Furukawa K, 2012, J NEUROL, V259, P1243, DOI 10.1007/s00415-011-6329-x; Ikejima C, 2012, PSYCHOGERIATRICS, V12, P120, DOI 10.1111/j.1479-8301.2012.00415.x; Inoue M, 2009, AM J ALZHEIMERS DIS, V24, P129, DOI 10.1177/1533317508330222; Urakami Katsuya, 2014, Nihon Rinsho, V72, P607; Urakami Katsuya, 2007, Nihon Ronen Igakkai Zasshi, V44, P312, DOI 10.3143/geriatrics.44.312	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	FEB	2015	15	2					232	233		10.1111/ggi.12290		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CA1JY	WOS:000348670100015		
J	Ishii, S; Tanaka, T; Ouchi, Y; Akishita, M; Iijima, K				Ishii, Shinya; Tanaka, Tomoki; Ouchi, Yasuyoshi; Akishita, Masahiro; Iijima, Katsuya			Development of conversion formulae between 4-m, 5-m and 6-m gait speed	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter							SARCOPENIA; CONSENSUS		[Ishii, Shinya; Ouchi, Yasuyoshi; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Tanaka, Tomoki; Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Tokyo, Japan	Ishii, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan.						Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221; Tanimoto Y, 2013, GERIATR GERONTOL INT, V13, P958, DOI 10.1111/ggi.12037; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Arai H, 2014, GERIATR GERONTOL INT, V14, P1, DOI 10.1111/ggi.12236; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	FEB	2015	15	2					233	234		10.1111/ggi.12317		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CA1JY	WOS:000348670100016		
J	Yamauchi, T; Kitamura, K; Tokimitsu, I				Yamauchi, Takeshi; Kitamura, Katsuro; Tokimitsu, Ichiro			Degree of physical activity in elderly disaster victims during the acute phase of the Great East Japan Earthquake	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter									[Yamauchi, Takeshi] Ishinomaki Senshu Univ, Sch Human Studies, Ishinomaki, Miyagi, Japan; [Tokimitsu, Ichiro] Ishinomaki Senshu Univ, Sch Sci & Engn, Ishinomaki, Miyagi, Japan; [Kitamura, Katsuro] Tohoku Univ, Grad Sch Educ Informat, Sendai, Miyagi 980, Japan	Yamauchi, T (reprint author), Ishinomaki Senshu Univ, Sch Human Studies, Ishinomaki, Miyagi, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	FEB	2015	15	2					237	238		10.1111/ggi.12332		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CA1JY	WOS:000348670100018		
J	Ishii, S; Tanaka, T; Akishita, M; Iijima, K				Ishii, Shinya; Tanaka, Tomoki; Akishita, Masahiro; Iijima, Katsuya			Re: Growing research on sarcopenia in Asia	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter							CONSENSUS; ADULTS; SPEED		[Ishii, Shinya; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Tanaka, Tomoki; Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Bunkyo Ku, Tokyo, Japan	Ishii, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan.						Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Capistrant BD, 2014, J AM GERIATR SOC, V62, P329, DOI 10.1111/jgs.12633; Buchner DM, 1996, AGE AGEING, V25, P386, DOI 10.1093/ageing/25.5.386; Yamada M, 2013, J AM MED DIR ASSOC, V14, P911, DOI 10.1016/j.jamda.2013.08.015; Tanimoto Y, 2013, GERIATR GERONTOL INT, V13, P958, DOI 10.1111/ggi.12037; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Yamada Y, 2014, GERIATR GERONTOL INT, V14, P129, DOI 10.1111/ggi.12212; Arai H, 2014, GERIATR GERONTOL INT, V14, P1, DOI 10.1111/ggi.12236; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	FEB	2015	15	2					238	239		10.1111/ggi.12304		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CA1JY	WOS:000348670100019		
J	Fujii, M; Ishizuka, S; Sasaki, H				Fujii, Masahiko; Ishizuka, Satoshi; Sasaki, Hidetada			Small Group Teaching in a psychiatric hospital for dementia patients	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Letter							THERAPY		[Fujii, Masahiko; Ishizuka, Satoshi; Sasaki, Hidetada] Sendai Tomizawa Hosp, Sendai, Miyagi, Japan	Fujii, M (reprint author), Sendai Tomizawa Hosp, Sendai, Miyagi, Japan.						Azumi M, 2011, PSYCHOGERIATRICS, V11, P79, DOI 10.1111/j.1479-8301.2011.00372.x; Butler JP, 2011, GERIATR GERONTOL INT, V11, P1, DOI 10.1111/j.1447-0594.2010.00661.x; Butler JP, 2012, TOHOKU J EXP MED, V227, P203, DOI 10.1620/tjem.227.203; Fujii M, 2014, GERIATR GERONTOL INT, V14, P508, DOI 10.1111/ggi.12127; Iwamoto Y, 2013, EC POLICIES SOCIAL S; Kaneko Y, 2013, GERIATR GERONTOL INT, V13, P808, DOI 10.1111/ggi.12028; Kasaka Y, 2012, GERIATR GERONTOL INT, V12, P319; Matsuda H, 2012, GERIATR GERONTOL INT, V12, P568, DOI 10.1111/j.1447-0594.2011.00802.x; Satoh A, 2012, GERIATR GERONTOL INT, V12, DOI 10.1111/j.1447-0594.2011.00773.x; Satoh A, 2014, GERIATR GERONTOL INT, V14, P233, DOI 10.1111/ggi.12163; Satoh S, 2013, GERIATR GERONTOL INT, V13, P515, DOI 10.1111/ggi.12010; Takahashi M, 2012, GERIATR GERONTOL INT, V12, P570, DOI 10.1111/j.1447-0594.2011.00829.x	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	FEB	2015	15	2					239	240		10.1111/ggi.12370		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CA1JY	WOS:000348670100020		
J	Anderson-Teixeira, KJ; Davies, SJ; Bennett, AC; Gonzalez-Akre, EB; Muller-Landau, HC; Wright, SJ; Abu Salim, K; Zambrano, AMA; Alonso, A; Baltzer, JL; Basset, Y; Bourg, NA; Broadbent, EN; Brockelman, WY; Bunyavejchewin, S; Burslem, DFRP; Butt, N; Cao, M; Cardenas, D; Chuyong, GB; Clay, K; Cordell, S; Dattaraja, HS; Deng, XB; Detto, M; Du, XJ; Duque, A; Erikson, DL; Ewango, CEN; Fischer, GA; Fletcher, C; Foster, RB; Giardina, CP; Gilbert, GS; Gunatilleke, N; Gunatilleke, S; Hao, ZQ; Hargrove, WW; Hart, TB; Hau, BCH; He, FL; Hoffman, FM; Howe, RW; Hubbell, SP; Inman-Narahari, FM; Jansen, PA; Jiang, MX; Johnson, DJ; Kanzaki, M; Kassim, AR; Kenfack, D; Kibet, S; Kinnaird, MF; Korte, L; Kral, K; Kumar, J; Larson, AJ; Li, YD; Li, XK; Liu, SR; Lum, SKY; Lutz, JA; Ma, KP; Maddalena, DM; Makana, JR; Malhi, Y; Marthews, T; Serudin, RM; McMahon, SM; McShea, WJ; Memiaghe, HR; Mi, XC; Mizuno, T; Morecroft, M; Myers, JA; Novotny, V; de Oliveira, AA; Ong, PS; Orwig, DA; Ostertag, R; den Ouden, J; Parker, GG; Phillips, RP; Sack, L; Sainge, MN; Sang, WG; Sri-ngernyuang, K; Sukumar, R; Sun, IF; Sungpalee, W; Suresh, HS; Tan, S; Thomas, SC; Thomas, DW; Thompson, J; Turner, BL; Uriarte, M; Valencia, R; Vallejo, MI; Vicentini, A; Vrska, T; Wang, XH; Wang, XG; Weiblen, G; Wolf, A; Xu, H; Yap, S; Zimmerman, J				Anderson-Teixeira, Kristina J.; Davies, Stuart J.; Bennett, Amy C.; Gonzalez-Akre, Erika B.; Muller-Landau, Helene C.; Wright, S. Joseph; Abu Salim, Kamariah; Zambrano, Angelica M. Almeyda; Alonso, Alfonso; Baltzer, Jennifer L.; Basset, Yves; Bourg, Norman A.; Broadbent, Eben N.; Brockelman, Warren Y.; Bunyavejchewin, Sarayudh; Burslem, David F. R. P.; Butt, Nathalie; Cao, Min; Cardenas, Dairon; Chuyong, George B.; Clay, Keith; Cordell, Susan; Dattaraja, Handanakere S.; Deng, Xiaobao; Detto, Matteo; Du, Xiaojun; Duque, Alvaro; Erikson, David L.; Ewango, Corneille E. N.; Fischer, Gunter A.; Fletcher, Christine; Foster, Robin B.; Giardina, Christian P.; Gilbert, Gregory S.; Gunatilleke, Nimal; Gunatilleke, Savitri; Hao, Zhanqing; Hargrove, William W.; Hart, Terese B.; Hau, Billy C. H.; He, Fangliang; Hoffman, Forrest M.; Howe, Robert W.; Hubbell, Stephen P.; Inman-Narahari, Faith M.; Jansen, Patrick A.; Jiang, Mingxi; Johnson, Daniel J.; Kanzaki, Mamoru; Kassim, Abdul Rahman; Kenfack, David; Kibet, Staline; Kinnaird, Margaret F.; Korte, Lisa; Kral, Kamil; Kumar, Jitendra; Larson, Andrew J.; Li, Yide; Li, Xiankun; Liu, Shirong; Lum, Shawn K. Y.; Lutz, James A.; Ma, Keping; Maddalena, Damian M.; Makana, Jean-Remy; Malhi, Yadvinder; Marthews, Toby; Serudin, Rafizah Mat; McMahon, Sean M.; McShea, William J.; Memiaghe, Herve R.; Mi, Xiangcheng; Mizuno, Takashi; Morecroft, Michael; Myers, Jonathan A.; Novotny, Vojtech; de Oliveira, Alexandre A.; Ong, Perry S.; Orwig, David A.; Ostertag, Rebecca; den Ouden, Jan; Parker, Geoffrey G.; Phillips, Richard P.; Sack, Lawren; Sainge, Moses N.; Sang, Weiguo; Sri-ngernyuang, Kriangsak; Sukumar, Raman; Sun, I-Fang; Sungpalee, Witchaphart; Suresh, Hebbalalu Sathyanarayana; Tan, Sylvester; Thomas, Sean C.; Thomas, Duncan W.; Thompson, Jill; Turner, Benjamin L.; Uriarte, Maria; Valencia, Renato; Vallejo, Marta I.; Vicentini, Alberto; Vrska, Tomas; Wang, Xihua; Wang, Xugao; Weiblen, George; Wolf, Amy; Xu, Han; Yap, Sandra; Zimmerman, Jess			CTFS-ForestGEO: a worldwide network monitoring forests in an era of global change	GLOBAL CHANGE BIOLOGY			English	Review						biodiversity; Center for Tropical Forest Science (CTFS); climate change; demography; forest dynamics plot; Forest Global Earth Observatory (ForestGEO); long-term monitoring; spatial analysis	TROPICAL TREE COMMUNITY; LONG-TERM NITROGEN; RAIN-FOREST; NEOTROPICAL FOREST; FUNCTIONAL TRAITS; SPATIAL-PATTERNS; EL-NINO; PHYLOGENETIC STRUCTURE; SEEDLING RECRUITMENT; DISPERSAL LIMITATION	Global change is impacting forests worldwide, threatening biodiversity and ecosystem services including climate regulation. Understanding how forests respond is critical to forest conservation and climate protection. This review describes an international network of 59 long-term forest dynamics research sites (CTFS-ForestGEO) useful for characterizing forest responses to global change. Within very large plots (median size 25ha), all stems 1cm diameter are identified to species, mapped, and regularly recensused according to standardized protocols. CTFS-ForestGEO spans 25 degrees S-61 degrees N latitude, is generally representative of the range of bioclimatic, edaphic, and topographic conditions experienced by forests worldwide, and is the only forest monitoring network that applies a standardized protocol to each of the world's major forest biomes. Supplementary standardized measurements at subsets of the sites provide additional information on plants, animals, and ecosystem and environmental variables. CTFS-ForestGEO sites are experiencing multifaceted anthropogenic global change pressures including warming (average 0.61 degrees C), changes in precipitation (up to +/- 30% change), atmospheric deposition of nitrogen and sulfur compounds (up to 3.8g Nm(-2)yr(-1) and 3.1g Sm(-2)yr(-1)), and forest fragmentation in the surrounding landscape (up to 88% reduced tree cover within 5km). The broad suite of measurements made at CTFS-ForestGEO sites makes it possible to investigate the complex ways in which global change is impacting forest dynamics. Ongoing research across the CTFS-ForestGEO network is yielding insights into how and why the forests are changing, and continued monitoring will provide vital contributions to understanding worldwide forest diversity and dynamics in an era of global change.	[Anderson-Teixeira, Kristina J.; Davies, Stuart J.; Muller-Landau, Helene C.; Wright, S. Joseph; Basset, Yves; Detto, Matteo; Gilbert, Gregory S.; Hubbell, Stephen P.; Jansen, Patrick A.; Kenfack, David; McMahon, Sean M.; Turner, Benjamin L.] Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Forest Global Earth Observ, Panama City, Panama; [Anderson-Teixeira, Kristina J.; Bennett, Amy C.; Gonzalez-Akre, Erika B.; Zambrano, Angelica M. Almeyda; Bourg, Norman A.; Broadbent, Eben N.; McShea, William J.] Natl Zool Pk, Conservat Ecol Ctr, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Davies, Stuart J.; Erikson, David L.; Kenfack, David] Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Abu Salim, Kamariah] Univ Brunei Darussalam, Fac Sci, BE-1410 Bandar Seri Begawan, Brunei; [Zambrano, Angelica M. Almeyda; Broadbent, Eben N.] Stanford Univ, Stanford Woods Inst Environm, Stanford, CA 94305 USA; [Zambrano, Angelica M. Almeyda; Broadbent, Eben N.] Univ Alabama, Dept Geog, Tuscaloosa, AL USA; [Alonso, Alfonso; Korte, Lisa] Smithsonian Inst, Natl Zool Pk, Ctr Conservat Educ & Sustainabil, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Baltzer, Jennifer L.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada; [Brockelman, Warren Y.] Mahidol Univ, Dept Biol, Bangkok 10700, Thailand; [Bunyavejchewin, Sarayudh] Dept Natl Pk Wildlife & Plant Conservat, Res Off, Bangkok, Thailand; [Burslem, David F. R. P.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Butt, Nathalie] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Butt, Nathalie; Malhi, Yadvinder; Marthews, Toby] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford, England; [Cao, Min; Deng, Xiaobao] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming 650223, Peoples R China; [Cardenas, Dairon] Inst Amazon Invest Cient Sinchi, Bogota, Colombia; [Chuyong, George B.] Univ Buea, Dept Bot & Plant Physiol, Buea, Cameroon; [Clay, Keith; Johnson, Daniel J.; Phillips, Richard P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Cordell, Susan; Giardina, Christian P.] US Forest Serv, Inst Pacific Isl Forestry, USDA, Hilo, HI USA; [Dattaraja, Handanakere S.; Sukumar, Raman; Suresh, Hebbalalu Sathyanarayana] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Du, Xiaojun; Ma, Keping; Mi, Xiangcheng; Sang, Weiguo] Chinese Acad Sci, Inst Bot, Beijing 100093, Peoples R China; [Duque, Alvaro] Univ Nacl Colombia, Dept Ciencias Forestales, Medellin, Colombia; [Ewango, Corneille E. N.] Reserve Faune Okapis, Ctr Format & Rech Conservat Forestiere CEFRECOF E, Ituri Forest, Epulu, DEM REP CONGO; [Fischer, Gunter A.] Kadoorie Farm & Bot Garden, Tai Po, Hong Kong, Peoples R China; [Fletcher, Christine; Kassim, Abdul Rahman] Forest Res Inst Malaysia, Selangor, Malaysia; [Foster, Robin B.] Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; [Gilbert, Gregory S.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Gunatilleke, Nimal; Gunatilleke, Savitri] Univ Peradeniya, Fac Sci, Dept Bot, Peradeniya, Sri Lanka; [Hao, Zhanqing] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110164, Peoples R China; [Hargrove, William W.] US Forest Serv, Eastern Forest Environm Threat Assessment Ctr, USDA, Stn Headquarters, Asheville, NC USA; [Hart, Terese B.; Wang, Xugao] Lukuru Wildlife Res Fdn, Tshuapa Lomami Lualaba Project, Kinshasa, DEM REP CONGO; [Hau, Billy C. H.] Univ Hong Kong, Kadoorie Inst, Pokfulam, Hong Kong, Peoples R China; [Hau, Billy C. H.] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China; [He, Fangliang] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Hoffman, Forrest M.; Kumar, Jitendra; Maddalena, Damian M.] Oak Ridge Natl Lab, Computat Earth Sci Grp, Oak Ridge, TN USA; [Howe, Robert W.] Univ Wisconsin, Dept Nat & Appl Sci, Green Bay, WI 54311 USA; [Hubbell, Stephen P.; Sack, Lawren] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Inman-Narahari, Faith M.] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Honolulu, HI 96822 USA; [Jansen, Patrick A.] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Jiang, Mingxi] Chinese Acad Sci, Wuhan Bot Garden, Wuhan 430074, Peoples R China; [Kanzaki, Mamoru; Mizuno, Takashi] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Kibet, Staline] Natl Museums Kenya, Nairobi, Kenya; [Kibet, Staline] Univ Nairobi, Land Resource Management & Agr Technol Dept, Nairobi, Kenya; [Kinnaird, Margaret F.] Mpala Res Ctr, Nanyuki 10400, Kenya; [Kinnaird, Margaret F.] Wildlife Conservat Soc, Global Conservat Programs, Bronx, NY 10460 USA; [Kral, Kamil; Vrska, Tomas] Silva Tarouca Res Inst, Dept Forest Ecol, Brno, Czech Republic; [Larson, Andrew J.] Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [Li, Yide; Xu, Han] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China; [Li, Xiankun] Chinese Acad Sci, Guangxi Inst Bot, Guilin, Guangxi, Peoples R China; [Liu, Shirong] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Lum, Shawn K. Y.] Nanyang Technol Univ, Natl Inst Educ, Nat Sci & Sci Educ Acad Grp, Singapore 639798, Singapore; [Lutz, James A.] Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA; [Makana, Jean-Remy] Wildlife Conservat Soc, Brazzaville, DEM REP CONGO; [Serudin, Rafizah Mat] Univ Brunei Darussalam, Fac Sci, BE-1410 Bandar Seri Begawan, Brunei; [McMahon, Sean M.; Parker, Geoffrey G.] Smithsonian Environm Res Ctr, Forest Ecol Grp, Edgewater, MD 21037 USA; [Memiaghe, Herve R.] Ctr Natl Rech Sci & Technol, Inst Rech Ecol Tropicale, Libreville, Gabon; [Morecroft, Michael] Nat England, Sheffield, S Yorkshire, England; [Myers, Jonathan A.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Novotny, Vojtech] New Guinea Binatang Res Ctr, Madang, Papua N Guinea; [Novotny, Vojtech] Acad Sci Czech Republic, Ctr Biol, Ceske Budejovice 37005, Czech Republic; [Novotny, Vojtech] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [de Oliveira, Alexandre A.] Univ Sao Paulo, Dept Ecol, Inst Biociencias, Sao Paulo, Brazil; [Ong, Perry S.; Yap, Sandra] Univ Philippines Diliman, Inst Biol, Quezon City, Philippines; [Orwig, David A.] Harvard Univ, Harvard Forest, Petersham, MA USA; [Ostertag, Rebecca] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [den Ouden, Jan] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AP Wageningen, Netherlands; [Sainge, Moses N.] Trop Plant Explorat Grp TroPEG, Mundemba, Southwest Regio, Cameroon; [Sun, I-Fang] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien, Taiwan; [Tan, Sylvester] Sarawak Forest Dept, Kuching, Sarawak, Malaysia; [Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON M5S 3B3, Canada; [Thomas, Duncan W.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA; [Thompson, Jill] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Thompson, Jill; Zimmerman, Jess] Univ Puerto Rico, Inst Trop Ecosyst Studies, Dept Environm Sci, San Juan, PR 00936 USA; [Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Valencia, Renato] Pontifical Catholic Univ Ecuador, Dept Biol Sci, Quito, Ecuador; [Vallejo, Marta I.] Inst Alexander von Humboldt, Bogota, Colombia; [Vicentini, Alberto] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Wang, Xihua] E China Normal Univ, Sch Ecol & Environm Sci, Shanghai 200062, Peoples R China; [Weiblen, George] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Wolf, Amy] UW Green Bay, Dept Biol, Green Bay, WI 54311 USA; [Wolf, Amy] UW Green Bay, Dept Nat & Appl Sci, Green Bay, WI 54311 USA	Anderson-Teixeira, KJ (reprint author), Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Forest Global Earth Observ, Panama City, Panama.	teixeirak@si.edu	Basset, Yves/B-6642-2014; Giardina, Christian/C-3120-2011; Kral, Kamil/E-4415-2014; Turner, Benjamin/E-5940-2011; Jansen, Patrick/G-2545-2015; wang, xugao/B-1111-2015; Novotny, Vojtech/G-9434-2014; Thompson, Jill/K-2200-2012; 	Turner, Benjamin/0000-0002-6585-0722; Jansen, Patrick/0000-0002-4660-0314; Novotny, Vojtech/0000-0001-7918-8023; Thompson, Jill/0000-0002-4370-2593; Almeyda Zambrano, Angelica/0000-0001-5081-9936; Oliveira, Alexandre/0000-0001-5526-8109	Smithsonian Competitive Grants Program for Science; Smithsonian Institution; Smithsonian Tropical Research Institute; Arnold Arboretum of Harvard University; National Science Foundation; Rockefeller Foundation; John Merck Fund; John D. and Catherine T. MacArthur Foundation; Andrew W. Mellon Foundation; Frank Levinson Family Foundation; HSBC Climate Partnership; Bromley Charitable Trust; John Swire Sons Pty Ltd; Celerity; F.H. Levinson Fund; Small World Institute Fund	We thank everyone involved in the collection of the vast quantity of data and information in the CTFS-ForestGEO network; to F. Dentener and W. Laurance for providing data; E. Leigh, Y. Lin, J. McGarvey and A. Miller for helpful comments; E. Aikens, L. Gonzalez and M. Azimi for help with analysis and figures. Study on this manuscript was funded in part by a Smithsonian Competitive Grants Program for Science award to KJAT. The CTFS-ForestGEO network has received major support from the Smithsonian Institution - particularly the Smithsonian Tropical Research Institute, the Arnold Arboretum of Harvard University, the National Science Foundation (multiple grants), the Rockefeller Foundation, the John Merck Fund, the John D. and Catherine T. MacArthur Foundation, the Andrew W. Mellon Foundation, the Frank Levinson Family Foundation, the HSBC Climate Partnership, the Bromley Charitable Trust, John Swire & Sons Pty Ltd, Celerity, F.H. Levinson Fund, Small World Institute Fund and Jennifer and Greg Johnson. Site-specific support is listed in Table S8.	Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; Anderson-Teixeira KJ, 2012, NAT CLIM CHANGE, V2, P177, DOI [10.1038/NCLIMATE1346, 10.1038/nclimate1346]; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Yu GR, 2014, P NATL ACAD SCI USA, V111, P4910, DOI 10.1073/pnas.1317065111; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Li BH, 2012, J VEG SCI, V23, P271, DOI 10.1111/j.1654-1103.2011.01344.x; Usinowicz J, 2012, ECOLOGY, V93, P2073, DOI 10.1890/11-1935.1; Ruger N, 2012, ECOLOGY, V93, P2626, DOI 10.1890/12-0622.1; Baldeck CA, 2013, OECOLOGIA, V173, P1491, DOI 10.1007/s00442-013-2709-5; Thomas D, 2015, ECOLOGY OF LIANAS, P13; Hansen MC, 2013, SCIENCE, V342, P850, DOI 10.1126/science.1244693; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Santiago LS, 2007, FUNCT ECOL, V21, P19, DOI 10.1111/j.1365-2435.2006.01218.x; ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Detto M, 2013, AM NAT, V181, pE68, DOI 10.1086/669678; Wiegand T, 2007, AM NAT, V170, pE77, DOI 10.1086/521240; Bouwman AF, 2002, WATER AIR SOIL POLL, V141, P349, DOI 10.1023/A:1021398008726; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Dong SX, 2012, P ROY SOC B-BIOL SCI, V279, P3923, DOI 10.1098/rspb.2012.1124; Mascaro J, 2011, REMOTE SENS ENVIRON, V115, P3770, DOI 10.1016/j.rse.2011.07.019; Westbrook JW, 2011, AM NAT, V177, P800, DOI 10.1086/659963; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Mayor JR, 2014, J ECOL, V102, P36, DOI 10.1111/1365-2745.12190; Cheng JJ, 2012, OIKOS, V121, P236, DOI 10.1111/j.1600-0706.2011.19428.x; Wright SJ, 2005, ECOLOGY, V86, P848, DOI 10.1890/03-0750; Ngo KM, 2013, FOREST ECOL MANAG, V296, P81, DOI 10.1016/j.foreco.2013.02.004; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Potts MD, 2003, J ECOL, V91, P467, DOI 10.1046/j.1365-2745.2003.00779.x; Katabuchi M, 2012, J ECOL, V100, P643, DOI [10.1111/j.1365-2745.2011.01937.x, 10.1111/J.1365-2745.2011.01937.x]; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Gradowski T, 2006, FOREST ECOL MANAG, V226, P104, DOI 10.1016/j.foreco.2005.12.062; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Baker TR, 2004, PHILOS T ROY SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Kraft NJB, 2010, NEW PHYTOL, V188, P1124, DOI 10.1111/j.1469-8137.2010.03444.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Van Nieuwstadt MGL, 2005, J ECOL, V93, P191, DOI 10.1111/j.1365-2745.2004.00954.x; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Filewod B, 2014, GLOBAL CHANGE BIOL, V20, P360, DOI 10.1111/gcb.12354; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.1890/0012-9658(1999)080[1632:TENOSO]2.0.CO;2; Condit R, 2000, J VEG SCI, V11, P649, DOI 10.2307/3236572; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Dietze MC, 2011, GLOBAL CHANGE BIOL, V17, P3312, DOI 10.1111/j.1365-2486.2011.02477.x; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1046/j.0022-0477.2001.00615.x; CONDIT R, 1992, AM NAT, V140, P261, DOI 10.1086/285412; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Wright SJ, 2007, BIOTROPICA, V39, P363, DOI 10.1111/j.1744-7429.2007.00289.x; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Wright SJ, 2010, ECOLOGY, V91, P3664, DOI 10.1890/09-2335.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.2307/3071933; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Wiegand T, 2007, P NATL ACAD SCI USA, V104, P19029, DOI 10.1073/pnas.0705621104; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Cushman KC, 2014, METHODS ECOL EVOL, V5, P573, DOI 10.1111/2041-210X.12187; Sherwood S, 2014, SCIENCE, V343, P737, DOI 10.1126/science.1247620; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; Dalling JW, 1998, J ECOL, V86, P674, DOI 10.1046/j.1365-2745.1998.00298.x; Gedalof Z, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003699; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; Baltzer JL, 2014, GLOBAL CHANGE BIOL, V20, P824, DOI 10.1111/gcb.12349; Pau S, 2013, NAT CLIM CHANGE, V3, P838, DOI [10.1038/nclimate1934, 10.1038/NCLIMATE1934]; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1023/A:1006152112852; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Banin L, 2014, J ECOL, V102, P1025, DOI 10.1111/1365-2745.12263; Lebrija-Trejos E, 2014, ECOLOGY, V95, P940, DOI 10.1890/13-0623.1; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0548; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Gradowski T, 2008, TREE PHYSIOL, V28, P173; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; Harrison RD, 2013, ECOL LETT, V16, P687, DOI 10.1111/ele.12102; Condit R, 1996, J VEG SCI, V7, P405, DOI 10.2307/3236284; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Hrcek J, 2011, MOL ECOL RESOUR, V11, P786, DOI 10.1111/j.1755-0998.2011.03016.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Lutz JA, 2014, ECOLOGY, V95, P2047; Chisholm RA, 2014, ECOL LETT, V17, P855, DOI 10.1111/ele.12296; McMahon SM, 2010, P NATL ACAD SCI USA, V107, P3611, DOI 10.1073/pnas.0912376107; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Ingwell LL, 2010, J ECOL, V98, P879, DOI 10.1111/j.1365-2745.2010.01676.x; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Laurance WF, 2004, NATURE, V428, P171, DOI 10.1038/nature02383; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Hietz P, 2011, SCIENCE, V334, P664, DOI 10.1126/science.1211979; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Chapin FS, 2008, FRONT ECOL ENVIRON, V6, P313, DOI 10.1890/080005; Chuyong GB, 2011, PLANT ECOL, V212, P1363, DOI 10.1007/s11258-011-9912-4; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Zhou LM, 2014, NATURE, V509, P86, DOI 10.1038/nature13265; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; Zalasiewicz J, 2010, ENVIRON SCI TECHNOL, V44, P2228, DOI 10.1021/es903118j; Baker PJ, 2005, ECOL MONOGR, V75, P317, DOI 10.1890/04-0488; Wang XG, 2011, J ECOL, V99, P1382, DOI 10.1111/j.1365-2745.2011.01857.x; Asner G., 2011, OECOLOGIA, V168, P1147, DOI DOI 10.1007/S00442-011-2165-Z; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2532; Basset Y, 2013, INSECT CONSERV DIVER, V6, P223, DOI 10.1111/j.1752-4598.2012.00205.x; Brown C, 2013, P ROYAL SOC B, V280, P1; Cheesman AW, 2013, NEW PHYTOL, V197, P1185, DOI 10.1111/nph.12098; Chisholm R. A., 2013, Journal of Ecology (Oxford), V101, P1214; CONDIT R, 2005, BIOL SKRIFTER, V55, P565; Condit R, 1995, TRENDS ECOL EVOL, V1, P8; Condit R, 1998, TROPICAL FOREST CENS; Davies SJ, 2003, PASOH: ECOLOGY OF A LOWLAND RAIN FOREST IN SOUTHEAST ASIA, P35; Davies Stuart J., 2001, Harvard Papers in Botany, V6, P371; Davies SJ, 2001, THAI FOREST B, V29, P43; de Oliveira AA, 2014, J PLANT ECOL, V7, P134, DOI 10.1093/jpe/rtt073; DeWalt SJ, 2015, ECOLOGY LIANAS, P133; Dick CW, 2009, BIOSCIENCE, V59, P745, DOI 10.1525/bio.2009.59.9.6; Feeley KJ, 2007, P R SOC B, V274, P2857, DOI 10.1098/rspb.2007.0954; Geddes GA, 2014, AGR FOREST METEOROL, V198, P105; Gereau ER, 2000, ADANSONIA, V22, P39; Goheen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055192; Groombridge B., 2002, WORLD ATLAS BIODIVER; Hargrove WW, 2003, EOS T AM GEOPHYS UN, V84, P529, DOI DOI 10.1029/2003EO480001; Hoffman FM, 2013, LANDSCAPE ECOL, V28, P1567, DOI 10.1007/s10980-013-9902-0; Hubbell S. P., 2001, UNIFIED NEUTRAL THEO; Ickes K, 2001, J TROP ECOL, V17, P191, DOI 10.1017/S0266467401001134; Jansen PA, 2010, SCIENCE, V327, P30, DOI 10.1126/science.327.5961.30-a; Jones FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024506; Kenfack D, 2006, NOVON, V16, P61, DOI 10.3417/1055-3177(2006)16[61:ANSOCR]2.0.CO;2; Kenfack D., 2004, Kew Bulletin, V59, P609, DOI 10.2307/4110920; Kirtman B., 2013, CLIMATE CHANGE 2013, P953, DOI DOI 10.1017/CBO9781107415324.023; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; LaFrankie JV, 2005, FOREST TREES BUKIT T, P178; Lai JS, 2013, OIKOS, V122, P1636, DOI 10.1111/j.1600-0706.2013.00436.x; Susan GWL, 2009, J VEG SCI, V20, P323, DOI 10.1111/j.1654-1103.2009.01044.x; Lee H. S., 2002, Journal of Tropical Forest Science, V14, P379; Leidner AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009534; Leigh EG, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P244; Lin DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048244; Liu XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034767; Losos EC, 2004, TROPICAL FOREST DIVE; Lutz JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082784; Maddalena D, 2014, LANDSCAPE CHARACTERI, DOI 10.15149/1148699; MAGNANI F, 2007, NATURE, V0447; Makana JR, 2011, J TROP ECOL, V27, P447, DOI 10.1017/S0266467411000265; Manokaran N., 1990, RES PAM FOR RES I MA, V104, P1; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; Mayor JR, 2014, BIOGEOCHEMISTRY, V119, P293, DOI 10.1007/s10533-014-9966-1; McGarvey JC, 2013, NORTHEAST NAT, V20, P451, DOI 10.1656/045.020.0301; McMahon SM, 2014, ECOLOGY EVO IN PRESS; Medvigy D, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000812; Melillo JM, 2011, P NATL ACAD SCI USA, V108, P9508, DOI 10.1073/pnas.1018189108; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Muller-Landau H.C., 2014, FORESTS GLOBAL CHANG, P381; Pei NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021273; Rejou-Mechain M, 2014, BIOGEOSCIENCES DISCU, V11, P5711; Ricklefs R. E., 2007, EC NATURE; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; Russo SE, 2013, PLANT ECOL, V214, P1405, DOI 10.1007/s11258-013-0260-4; Schlesinger WH, 2012, BIOGEOCHEMISTRY ANAL; Schmitz OJ, 2013, ECOSYSTEMS, V17, P344; Slot M, 2014, FUNCTIONAL IN PRESS; Soil Survey Staff, 1999, USDA HDB, V436; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Sonke Bonaventure, 2002, Adansonia (Paris), V24, P173; Stocker T.F., 2013, 5 IPCC, P1535; Sukumar R., 2005, P510, DOI 10.1017/CBO9780511541971.022; Suresh HS, 2010, FOREST ECOL MANAG, V259, P762, DOI 10.1016/j.foreco.2009.09.025; Swenson NG, 2011, ECOLOGY, V93, P490; Tan S, 2009, TROPICS, V18, P61; Tans P., 2014, TRENDS ATMOSPHERIC C; Uriarte M, 2005, J ECOL, V93, P291, DOI 10.1111/j.1365-2745.2005.00984.x; US DOE, 2012, DOESC0153; Valencia R, 2009, J TROP ECOL, V25, P473, DOI 10.1017/S0266467409990095; Whittaker R.H., 1975, COMMUNITIES ECOSYSTE; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI 10.1111/j.1749-6632.2010.05455.x; Zalasiewicz J, 2011, PHILOS T R SOC A, V369, P835, DOI 10.1098/rsta.2010.0339; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890; Zomer R. J., 2008, Agriculture, Ecosystems & Environment, V126, P67, DOI 10.1016/j.agee.2008.01.014; Zomer RJ, 2007, TREES WATER SMALLHOL	199	10	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-1013	1365-2486		GLOBAL CHANGE BIOL	Glob. Change Biol.	FEB	2015	21	2					528	549		10.1111/gcb.12712		22	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CA1DE	WOS:000348652400004		
J	Hata, M; Tsujikawa, A; Miyake, M; Yamashiro, K; Ooto, S; Oishi, A; Nakata, I; Takahashi, A; Yoshimura, N				Hata, Masayuki; Tsujikawa, Akitaka; Miyake, Masahiro; Yamashiro, Kenji; Ooto, Sotaro; Oishi, Akio; Nakata, Isao; Takahashi, Ayako; Yoshimura, Nagahisa			Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Polypoidal choroidal vasculopathy; Photodynamic therapy; Ranibizumab; Combined therapy; ARMS2 A69S	ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; JAPANESE PATIENTS; FOLLOW-UP; BEVACIZUMAB; VERTEPORFIN; EFFICACY; ASSOCIATION; VEGF	Purpose To investigate the 2-year outcomes of photodynamic therapy (PDT) combined with intravitreal injections of ranibizumab for polypoidal choroidal vasculopathy (PCV). Methods Ninety-five eyes with subfoveal PCV treated with combined therapy were followed for >= 24 months. The association between visual outcomes and single nucleotide polymorphisms in ARMS2 A69S and CFH I62V genes were examined without adjusting for multiple comparisons. Results Visual acuity (VA) improvement was observed at month 3 (P=0.009). The improvement persisted until month 12 (P=0.003), when VA began the decline back to baseline values at month 24. To investigate the factors associated with VA reduction during the second year, patients were divided into those with and those without a second-year VA reduction. Both patients with and without a second-year VA reduction showed similar VA changes over the first year. The first-year VA improvement was not predictive of the VA decline over the second year. Genetic analyses showed no significant difference in the frequency of the A risk allele of CFH I62V between patients with and without a second-year VA reduction. However, patients with the T risk allele of A69S had a higher rate of recurrence and were more likely to experience a reduction in VA during the second year when compared to patients without (P=0.020 and P=0.048, respectively). Conclusions PDT combined therapy resulted in significant visual recovery in the first year, which was not sustained during the second year. VA reduction in the second year was affected by genetic factors.	[Hata, Masayuki; Tsujikawa, Akitaka; Miyake, Masahiro; Yamashiro, Kenji; Ooto, Sotaro; Oishi, Akio; Nakata, Isao; Takahashi, Ayako; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan	Tsujikawa, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan.	tujikawa@kuhp.kyoto-u.ac.jp		Oishi, Akio/0000-0002-0977-9458	Japan Society for the Promotion of Science (JSPS), Tokyo, Japan [24249082, 24592625]	This research was supported in part by a Grant-in-Aid for Scientific Research (24592625, 24249082) from the Japan Society for the Promotion of Science (JSPS), Tokyo, Japan.	Hirami Y, 2007, RETINA-J RET VIT DIS, V27, P335, DOI 10.1097/01.iae.0000233647.78726.46; Yoshida Y, 2013, JPN J OPHTHALMOL, V57, P283, DOI 10.1007/s10384-013-0234-z; Hikichi T, 2012, AM J OPHTHALMOL, V154, P117, DOI 10.1016/j.ajo.2011.12.019; Ruamviboonsuk P, 2010, BRIT J OPHTHALMOL, V94, P1045, DOI 10.1136/bjo.2009.173120; Oishi A, 2013, AM J OPHTHALMOL, V156, P644, DOI 10.1016/j.ajo.2013.05.024; Hagstrom SA, 2013, OPHTHALMOLOGY, V120, P593, DOI 10.1016/j.ophtha.2012.11.037; Lee YH, 2011, RETINA-J RET VIT DIS, V31, P1287, DOI 10.1097/IAE.0b013e3182003ccd; Saito M, 2012, RETINA-J RET VIT DIS, V32, P1272, DOI 10.1097/IAE.0b013e318236e624; Saito M, 2013, GRAEF ARCH CLIN EXP, V251, P2099, DOI 10.1007/s00417-013-2323-6; Stangos AN, 2010, AM J OPHTHALMOL, V150, P666, DOI 10.1016/j.ajo.2010.05.035; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Kurashige Y, 2008, AM J OPHTHALMOL, V146, P513, DOI 10.1016/j.ajo.2008.05.025; Kokame GT, 2010, BRIT J OPHTHALMOL, V94, P297, DOI 10.1136/bjo.2008.150029; Chen HY, 2012, MOL VIS, V18, P816; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Bessho H, 2011, MOL VIS, V17, P977; Gomi F, 2008, OPHTHALMOLOGY, V115, P141, DOI 10.1016/j.ophtha.2007.02.031; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Schmidt-Erfurth U, 2003, INVEST OPHTH VIS SCI, V44, P4473, DOI 10.1167/iovs.02-1115; Akaza E, 2008, RETINA-J RET VIT DIS, V28, P717, DOI 10.1097/IAE.0b013e31816577cb; Yamashiro K, 2008, JPN J OPHTHALMOL, V52, P457, DOI 10.1007/s10384-008-0582-2; Kim M, 2011, OPHTHALMOLOGICA, V226, P205, DOI 10.1159/000330793; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; Lai TYY, 2011, RETINA-J RET VIT DIS, V31, P1581, DOI 10.1097/IAE.0b013e31820d3f3f; Tomita K, 2012, AM J OPHTHALMOL, V153, P68, DOI 10.1016/j.ajo.2011.07.001; Rouvas AA, 2011, RETINA-J RET VIT DIS, V31, P464, DOI 10.1097/IAE.0b013e3181f274ec; Gomi F, 2010, AM J OPHTHALMOL, V150, P48, DOI 10.1016/j.ajo.2010.02.008; Gotoh N, 2009, AM J OPHTHALMOL, V147, P1037, DOI 10.1016/j.ajo.2008.12.036; Kondo N, 2009, OPHTHALMOLOGY, V116, P304, DOI 10.1016/j.ophtha.2008.11.011; Leal S, 2010, RETINA-J RET VIT DIS, V30, P1197, DOI 10.1097/IAE.0b013e3181d37486; Lee YA, 2012, AM J OPHTHALMOL, V154, P872, DOI 10.1016/j.ajo.2012.03.051; Nakata I, 2013, GRAEF ARCH CLIN EXP, V251, P1073, DOI 10.1007/s00417-012-2137-y; Nemoto Rei, 2012, Clin Ophthalmol, V6, P1633, DOI 10.2147/OPTH.S37252; Ojima Y, 2006, AM J OPHTHALMOL, V141, P958, DOI 10.1016/j.ajo.2005.12.002; Otani A, 2007, AM J OPHTHALMOL, V144, P7, DOI 10.1016/j.ajo.2007.03.014; Romano Mario R, 2010, Clin Ophthalmol, V4, P1237, DOI 10.2147/OPTH.S12577; Saito M, 2008, BRIT J OPHTHALMOL, V92, P1642, DOI 10.1136/bjo.2007.137075; Sakurada Y, 2010, RETINA-J RET VIT DIS, V30, P1616, DOI 10.1097/IAE.0b013e3181e587e3; Sato T, 2010, AM J OPHTHALMOL, V149, P947, DOI 10.1016/j.ajo.2009.12.038; Tano Y, 2008, OPHTHALMOLOGY, V115, P585, DOI 10.1016/j.ophtha.2007.10.018; Tsujikawa A, 2010, JPN J OPHTHALMOL, V54, P310, DOI 10.1007/s10384-010-0813-1; Verteporfin Roundtable Participants, 2005, RETINA, V25, P119; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	FEB	2015	253	2					189	197		10.1007/s00417-014-2675-6		9	Ophthalmology	Ophthalmology	CA6FI	WOS:000349004600005		
J	Hata, M; Tsujikawa, A; Miyake, M; Yamashiro, K; Ooto, S; Oishi, A; Nakanishi, H; Takahashi, A; Yoshimura, N				Hata, Masayuki; Tsujikawa, Akitaka; Miyake, Masahiro; Yamashiro, Kenji; Ooto, Sotaro; Oishi, Akio; Nakanishi, Hideo; Takahashi, Ayako; Yoshimura, Nagahisa			Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Typical neovascular age-related macular degeneration; Polypoidal choroidal vasculopathy; Ranibizumab; ARMS2 A69S; CFH I62V	VERTEPORFIN PHOTODYNAMIC THERAPY; INTRAVITREAL BEVACIZUMAB; SUBGROUP ANALYSIS; LOC387715 A69S; ASSOCIATION; MACULOPATHY; PROGNOSIS; VARIANTS; SUSCEPTIBILITY; POLYMORPHISMS	Purpose To investigate the 2-year outcomes of intravitreal injections of ranibizumab in typical neovascular age-related macular degeneration (tAMD) and polypoidal choroidal vasculopathy (PCV). Factors associated with visual outcomes are examined. Methods We retrospectively reviewed medical records of 128 consecutive eyes with treatment-naive subfoveal AMD treated with ranibizumab and followed for >= 24 months. The association between visual outcomes and single nucleotide polymorphisms (SNPs) in ARMS2 A69S and CFH I62V genes were examined. Results Fifty-eight eyes were diagnosed with tAMD and 70 eyes with PCV. In tAMD eyes, visual acuity (VA) improved at 3 months (P=0.020) but returned to the baseline level at 6 months. Thereafter, VA was maintained until 24 months. In PCV eyes, VA significantly improved at 3 months (P=0.015) and persisted at 12 months (P=0.025), but the VA improvement dissipated by 24 months. With regard to genetic associations with VA and VA change, neither VA nor VA change showed significant associations with these SNPs at all time points in tAMD. In the PCV eyes, there were significant associations between ARMS2 A69S and VA at baseline and 1 year (P=0.017 and P=0.025, respectively). However, VA change showed no significant difference among these genotypes in PCV. Conclusions Intravitreal ranibizumab significantly improved the VA initially, but this improvement did not persist at 2 years post-treatment. In PCV, ARMS2 A69S polymorphism is associated with the baseline and 12-month VA, but is not associated with the visual prognosis at 24 months.	[Hata, Masayuki; Tsujikawa, Akitaka; Miyake, Masahiro; Yamashiro, Kenji; Ooto, Sotaro; Oishi, Akio; Nakanishi, Hideo; Takahashi, Ayako; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan	Tsujikawa, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan.	tujikawa@kuhp.kyoto-u.ac.jp		Oishi, Akio/0000-0002-0977-9458	Japan Society for the Promotion of Science (JSPS, Tokyo, Japan) [21592256]; Japan National Society for the Prevention of Blindness (Tokyo, Japan)	This study was supported, in part, by the Japan Society for the Promotion of Science (JSPS, Tokyo, Japan, Grant-in-Aid for Scientific Research, no. 21592256) and the Japan National Society for the Prevention of Blindness (Tokyo, Japan).	Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Sakurada Y, 2008, AM J OPHTHALMOL, V145, P1058, DOI 10.1016/j.ajo.2008.02.007; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Boyer DS, 2007, OPHTHALMOLOGY, V114, P246, DOI 10.1016/j.ophtha.2006.10.045; Oishi A, 2013, AM J OPHTHALMOL, V156, P644, DOI 10.1016/j.ajo.2013.05.024; Abedi F, 2013, OPHTHALMOLOGY, V120, P1641, DOI 10.1016/j.ophtha.2013.01.014; Hagstrom SA, 2013, OPHTHALMOLOGY, V120, P593, DOI 10.1016/j.ophtha.2012.11.037; Stangos AN, 2010, AM J OPHTHALMOL, V150, P666, DOI 10.1016/j.ajo.2010.05.035; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Chen HY, 2012, MOL VIS, V18, P816; Churchill AJ, 2006, HUM MOL GENET, V15, P2955, DOI 10.1093/hmg/ddl238; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Bessho H, 2011, MOL VIS, V17, P977; Sakurada Y, 2011, OPHTHALMOLOGY, V118, P1402, DOI 10.1016/j.ophtha.2010.12.010; Teper SJ, 2010, MOL VIS, V16, P2598; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Nakata I, 2012, INVEST OPHTH VIS SCI, V53, P794, DOI 10.1167/iovs.11-8468; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Kaiser PK, 2007, AM J OPHTHALMOL, V144, P850, DOI 10.1016/j.ajo.2007.08.012; Cho M, 2009, AM J OPHTHALMOL, V148, P70, DOI 10.1016/j.ajo.2009.02.012; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Ying GS, 2013, OPHTHALMOLOGY, V120, P122, DOI 10.1016/j.ophtha.2012.07.042; Yamashiro K, 2012, AM J OPHTHALMOL, V154, P125, DOI 10.1016/j.ajo.2012.01.010; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Moorthy RS, 1998, OPHTHALMOLOGY, V105, P1380, DOI 10.1016/S0161-6420(98)98016-2; Meyer CH, 2011, EYE, V25, P661, DOI 10.1038/eye.2011.66; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; Tomita K, 2012, AM J OPHTHALMOL, V153, P68, DOI 10.1016/j.ajo.2011.07.001; Fung AE, 2007, AM J OPHTHALMOL, V143, P566, DOI 10.1016/j.ajo.2007.01.028; Hikichi T, 2013, BRIT J OPHTHALMOL, V97, P617, DOI 10.1136/bjophthalmol-2012-302652; Rouvas AA, 2011, RETINA-J RET VIT DIS, V31, P464, DOI 10.1097/IAE.0b013e3181f274ec; Shah AR, 2009, OPHTHALMOLOGY, V116, P1901, DOI 10.1016/j.ophtha.2009.03.055; Despriet DDG, 2009, OPHTHALMOLOGY, V116, P474, DOI 10.1016/j.ophtha.2008.09.055; Gotoh N, 2009, AM J OPHTHALMOL, V147, P1037, DOI 10.1016/j.ajo.2008.12.036; Kang HM, 2013, AM J OPHTHALMOL, V156, P652, DOI 10.1016/j.ajo.2013.05.038; Kondo N, 2009, OPHTHALMOLOGY, V116, P304, DOI 10.1016/j.ophtha.2008.11.011; Park DH, 2012, RETINA-J RET VIT DIS, V32, P299, DOI 10.1097/IAE.0b013e318225290f; Park DH, 2012, JPN J OPHTHALMOL, V56, P60, DOI 10.1007/s10384-011-0089-0; Sakurada Y, 2010, RETINA-J RET VIT DIS, V30, P1616, DOI 10.1097/IAE.0b013e3181e587e3; Takahashi M, 2010, JPN J OPHTHALMOL, V54, P565, DOI 10.1007/s10384-010-0864-3; Tano Y, 2010, ACTA OPHTHALMOL, V88, P309, DOI 10.1111/j.1755-3768.2009.01843.x; Tsujikawa A, 2011, AM J OPHTHALMOL, V151, P961, DOI 10.1016/j.ajo.2011.01.002; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001	45	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	FEB	2015	253	2					221	227		10.1007/s00417-014-2688-1		7	Ophthalmology	Ophthalmology	CA6FI	WOS:000349004600009		
J	Arimura, S; Takamura, Y; Takihara, Y; Matsumura, T; Tomomatsu, T; Inatani, M				Arimura, Shogo; Takamura, Yoshihiro; Takihara, Yuji; Matsumura, Takehiro; Tomomatsu, Takeshi; Inatani, Masaru			Determinants of anterior chamber angle narrowing after mydriasis in the patients with cataract	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Angle analysis; Anterior chamber components; Anterior segment optical coherence tomography; Lens vault; Mydriasis	OPTICAL COHERENCE TOMOGRAPHY; CLOSURE GLAUCOMA; RISK-FACTOR; CHINESE; ASSOCIATION; POPULATION; BIOMETRY; EYES; SINGAPORE; AREA	Purpose To identify the determinants of anterior chamber angle narrowing after mydriasis by quantitative assessment of the anterior chamber components using anterior segment optical coherence tomography (AS-OCT). Methods In this intervention study, anterior chamber angle analysis was performed using AS-OCT in patients with cataract before pharmacological pupillary dilation and 30 min afterwards. Angle narrowing was quantified by the change of angle opening distance 500 after mydriasis (Delta AOD500). Multivariate linear regression and stepwise selection regression were used to identify which parameters in AS-OCT significantly determined Delta AOD500. Results One hundred and two Japanese patients (age, mean+/-standard deviation, 71.9+/-11.2 years) were enrolled. Multivariate analysis indicated that smaller Delta AOD500 were significantly associated with larger lens vault (LV; P<0.001), larger iris area (IA; P=0.003), and posterior corneal arch distance (PCAL; P=0.01). Stepwise linear regression analysis revealed that smaller Delta AOD500 was independently associated with larger LV (partial R-2=0.232, P<0.001), larger IA (partial R-2=0.080, P=0.001), and smaller PCAL (partial R-2=0.066, P=0.002) before mydriasis. These three factors explained 37.7 % of the decrease in Delta AOD500. Conclusion Larger LV, larger IA, and smaller PCAL contribute considerably to anterior chamber angle narrowing after mydriasis in patients with cataract.	[Arimura, Shogo; Takamura, Yoshihiro; Takihara, Yuji; Matsumura, Takehiro; Tomomatsu, Takeshi; Inatani, Masaru] Univ Fukui, Fac Med Sci, Dept Ophthalmol, Fukui 9101193, Japan	Takamura, Y (reprint author), Univ Fukui, Fac Med Sci, Dept Ophthalmol, 23-3 Shimoaizuki, Fukui 9101193, Japan.	ytakamura@hotmail.com					Sihota R, 2000, CLIN EXP OPHTHALMOL, V28, P253, DOI 10.1046/j.1442-9071.2000.00324.x; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Sng CC, 2012, OPHTHALMOLOGY, V119, P1143, DOI 10.1016/j.ophtha.2012.01.011; Seah SKL, 1997, ARCH OPHTHALMOL-CHIC, V115, P1436; Wang BS, 2010, OPHTHALMOLOGY, V117, P11, DOI 10.1016/j.ophtha.2009.06.017; Ozaki M, 2012, GRAEF ARCH CLIN EXP, V250, P1863, DOI 10.1007/s00417-012-2011-y; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; PAVLIN CJ, 1992, AM J OPHTHALMOL, V113, P381; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; Bron AJ, 2000, OPHTHALMOLOGICA, V214, P86, DOI 10.1159/000027475; Congdon NG, 1997, OPHTHALMOLOGY, V104, P1489; Leung CKS, 2005, OPHTHALMOLOGY, V112, P980, DOI 10.1016/j.ophtha.2005.01.022; Yuen LH, 2010, INVEST OPHTH VIS SCI, V51, P3433, DOI 10.1167/iovs.09-4307; Wang BS, 2011, BRIT J OPHTHALMOL, V95, P46, DOI 10.1136/bjo.2009.178129; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; Aptel Florent, 2010, Ophthalmology, V117, P3, DOI 10.1016/j.ophtha.2009.10.030; LOWE RF, 1970, BRIT J OPHTHALMOL, V54, P161, DOI 10.1136/bjo.54.3.161; MAPSTONE R, 1968, BRIT J OPHTHALMOL, V52, P19, DOI 10.1136/bjo.52.1.19; Nongpiur ME, 2010, OPHTHALMOLOGY, V117, P1967, DOI 10.1016/j.ophtha.2010.02.007; Radhakrishnan Sunita, 2005, Ophthalmol Clin North Am, V18, P375, DOI 10.1016/j.ohc.2005.05.007; Wu RY, 2011, ARCH OPHTHALMOL-CHIC, V129, P569, DOI 10.1001/archophthalmol.2011.68	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	FEB	2015	253	2					307	312		10.1007/s00417-014-2817-x		6	Ophthalmology	Ophthalmology	CA6FI	WOS:000349004600018		
J	Shoji, T; Kuroda, H; Suzuki, M; Baba, M; Araie, M; Yoneya, S				Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Baba, Motoyoshi; Araie, Makoto; Yoneya, Shin			Three-dimensional optic nerve head images using optical coherence tomography with a broad bandwidth, femtosecond, and mode-locked laser	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						OCT; Optic nerve head; Lamina cribrosa; Three-dimensional imaging	LAMINA-CRIBROSA THICKNESS; OPEN-ANGLE GLAUCOMA; FOLLOW-UP; DAMAGE; REPRODUCIBILITY; OPHTHALMOSCOPY; PAPILLEDEMA; MORPHOMETRY; RETINA; PORES	Purpose The aim of this study was to demonstrate the fine laminar structure of the optic nerve head (ONH), in vivo, using a broad wavelength, ultra-high resolution, and optically coherent tomography (OCT) system. Methods This high-resolution OCT system, based on a 200 nm bandwidth spectrometer and an 8 femtosecond ultrashort, mode-locked, coherent laser light source, enabled in vivo cross-sectional ONH imaging with 2.0 mu m axial resolution. A total of 300 optic disc B-scans, which consisted of 300x2048 pixels, were obtained in 10 mu m steps. Three-dimensional images were rendered from these images to obtain n face images of the optic disc. Fundus photography, scanning laser ophthalmoscopy (SLO), and standard OCT were also performed for all subjects. Results Thirty-six eyes of normal subjects and ten eyes of glaucoma patients with mean age of 40.0+/-10.0 years were enrolled in this study. Sequential en face images, from the ONH surface to deeper layers, were reconstructed in 2.0 mu m steps. Observation of the images indicated variations in the shape and arrangement of the lamina pores at different depths. Clear lamina pores were identified by this technique in 44 eyes, compared with the fundus camera (identified in six eyes), SLO (identified in 14 eyes), and standard OCT (identified in 24 eyes) (all comparisons, p<0.001). Conclusions The fine structure of the ONH could be resolved in vivo using our OCT, providing improved imaging that can be used in research and clinical applications for a better characterization of the anatomical and pathological features associated with glaucoma.	[Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Araie, Makoto; Yoneya, Shin] Saitama Med Univ, Dept Ophthalmol, Iruma, Saitama 3500495, Japan; [Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Baba, Motoyoshi; Yoneya, Shin] Saitama Med Univ, Dept Ophthalmol, Adv Laser Med Ctr, Iruma, Saitama 3500495, Japan; [Araie, Makoto] Kanto Cent Hosp, Dept Ophthalmol, Tokyo, Japan	Shoji, T (reprint author), Saitama Med Univ, Dept Ophthalmol, 38 Morohongo Moroyama Machi, Iruma, Saitama 3500495, Japan.	shoojii@gmail.com		Shoji, Takuhei/0000-0002-5464-2573	Suda Memorial Fund for Glaucoma Research, Chiyoda, Tokyo, Japan; Takeda Science Foundation, Tokyo, Japan; Japan Society for the Promotion of Science [25870678, 24760048]; Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported in part by the Suda Memorial Fund for Glaucoma Research, Chiyoda, Tokyo, Japan, by the Takeda Science Foundation, Tokyo, Japan, and by a Grant-in-Aid for Young Scientists (numbers 25870678 and 24760048) from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors wish to thank H. Ibuki for clinical input and the volunteers for participating in the study. In addition, the authors would like to thank Edanz (http://www.edanzediting.co.jp) for the English language review.	Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Nassif NA, 2004, OPT EXPRESS, V12, P367, DOI 10.1364/OPEX.12.000367; Rebolleda G, 2009, INVEST OPHTH VIS SCI, V50, P5197, DOI 10.1167/iovs.08-2528; Contreras I, 2007, OPHTHALMOLOGY, V114, P2338, DOI 10.1016/j.ophtha.2007.05.042; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P401; Hausler G, 1998, J BIOMED OPT, V3, P21, DOI 10.1117/1.429899; Ivers KM, 2011, INVEST OPHTH VIS SCI, V52, P5473, DOI 10.1167/iovs.11-7347; Wojtkowski M, 2003, OPT LETT, V28, P1745, DOI 10.1364/OL.28.001745; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Kupersmith MJ, 2011, INVEST OPHTH VIS SCI, V52, P6558, DOI [10.1167/iovs.10-6782, 10.1167/iovs.10.6782]; Schmidt-Erfurth U, 2005, INVEST OPHTH VIS SCI, V46, P3393, DOI 10.1167/iovs.05-0370; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Takayama K, 2013, INVEST OPHTH VIS SCI, V54, P4798, DOI 10.1167/iovs.13-11677; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P5103, DOI 10.1167/iovs.08-2127; Fontana L, 1998, CURR EYE RES, V17, P363, DOI 10.1080/02713689808951216; Akagi T, 2012, INVEST OPHTH VIS SCI, V53, P4111, DOI 10.1167/iovs.11-7536; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Anderson DR, 2000, AM J OPHTHALMOL, V130, P827, DOI 10.1016/S0002-9394(00)00665-6; Kuroda H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824493; Kuroda H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812342; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P7576, DOI 10.1167/iovs.12-10305; Maeda H, 1999, JPN J OPHTHALMOL, V43, P415, DOI 10.1016/S0021-5155(99)00090-8; MILLER KM, 1988, OPHTHALMOLOGY, V95, P135; Park HYL, 2013, OPHTHALMOLOGY, V120, P745, DOI 10.1016/j.ophtha.2012.09.051; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; WILCZEK M, 1947, BRIT J OPHTHALMOL, V31, P551, DOI 10.1136/bjo.31.9.551	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	FEB	2015	253	2					313	321		10.1007/s00417-014-2870-5		9	Ophthalmology	Ophthalmology	CA6FI	WOS:000349004600019		
J	Hidaka, H; Iwakiri, Y				Hidaka, Hisashi; Iwakiri, Yasuko			Hepatic Congestion Leads to Fibrosis: Findings in a Newly Developed Murine Model	HEPATOLOGY			English	Editorial Material							CIRRHOSIS; FIBROGENESIS; DISEASE; MATRIX		[Hidaka, Hisashi] Kitasato Univ, Sch Med, Dept Gastroenterol Internal Med, Sagamihara, Kanagawa 228, Japan; [Iwakiri, Yasuko] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA	Iwakiri, Y (reprint author), Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, 333 Cedar St, New Haven, CT 06520 USA.	yasuko.iwakiri@yale.edu					Lwaleed BA, 2006, J PATHOL, V208, P327, DOI 10.1002/path.1871; Iwakiri Y, 2014, J HEPATOL, V61, P912, DOI 10.1016/j.jhep.2014.05.047; Greiling D, 1997, J CELL SCI, V110, P861; Villa E, 2012, GASTROENTEROLOGY, V143, P1253, DOI 10.1053/j.gastro.2012.07.018; Abe W, 2007, J HEPATOL, V46, P286, DOI 10.1016/j.jhep.2006.08.023; Iwakiri Y, 2012, LIVER INT, V32, P199, DOI 10.1111/j.1478-3231.2011.02579.x; Kendall TJ, 2008, J CLIN PATHOL, V61, P504, DOI 10.1136/jcp.2007.052365; Kader KN, 2000, TISSUE ENG, V6, P241, DOI 10.1089/10763270050044425; Bayraktar UD, 2007, WORLD J GASTROENTERO, V13, P1912; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Anstee QM, 2008, J THROMB HAEMOST, V6, P1336, DOI 10.1111/j.1538-7836.2008.03015.x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Simonetto DA, 2014, HEPATOLOGY, V61, P648; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	FEB	2015	61	2					428	430		10.1002/hep.27550		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9UX	WOS:000348563200006		
J	Esumi, M; Ishibashi, M; Yamaguchi, H; Nakajima, S; Tai, Y; Kikuta, S; Sugitani, M; Takayama, T; Tahara, M; Takeda, M; Wakita, T				Esumi, Mariko; Ishibashi, Mariko; Yamaguchi, Hiromi; Nakajima, Satomi; Tai, Yuhi; Kikuta, Sachiko; Sugitani, Masahiko; Takayama, Tadatoshi; Tahara, Maino; Takeda, Makoto; Wakita, Takaji			Transmembrane Serine Protease TMPRSS2 Activates Hepatitis C Virus Infection	HEPATOLOGY			English	Article							CORONAVIRUS SPIKE PROTEIN; GENE-EXPRESSION; INFLUENZA-VIRUS; PROTEOLYTIC ACTIVATION; CHIMPANZEE LIVER; IN-VITRO; CELLS; REPLICATION; HEMAGGLUTININ; MICROARRAY	The human liver reacts to hepatitis C virus (HCV) with a balanced response consisting of host anti- and proviral activities. To explore these subtle host responses, we used oligonucleotide microarrays to investigate the differential gene expression between two groups of liver samples with high and low HCV loads (>100-fold difference). We identified and validated 26 genes that were up-regulated in livers with high HCV loads, including transmembrane protease serine 2 (TMPRSS2). Trypsin inhibitors inhibited the infection of Huh7-25-CD81 cells with cell-culture-derived HCV (HCVcc) of Japanese fulminant hepatitis 1 isolate at the postbinding and entry step, and trypsin enhanced HCVcc infection at an early stage of infection. Several major transmembrane serine proteases, in particular, furin and hepsin, were detected in Huh7-25-CD81 cells, but TMPRSS2 was not. Huh7-25-CD81 cell clones stably expressing TMPRSS2- WT (wild type) and inactive TMPRSS2-mutant genes showed positive and negative enhancement of their susceptibility to HCVcc infection, respectively. The enhanced susceptibility of TMPRSS2-WT Huh7-25-CD81 cells was confirmed by knockdown of TMPRSS2 using small interfering RNA. The cell-surface protease activity of TMPRSS2-WT cells was markedly active in the cleavage of QAR and QGR, corresponding to amino acid residues at P3 to P1. Conclusion: The cell-surface activity of a trypsin-like serine protease, such as TMPRSS2, activates HCV infection at the postbinding and entry stage. Host transmembrane serine proteases may be involved in the sensitivity, persistence, and pathogenesis of HCV infection and be possible targets for antiviral therapy.	[Esumi, Mariko; Ishibashi, Mariko; Yamaguchi, Hiromi; Nakajima, Satomi; Tai, Yuhi; Kikuta, Sachiko; Sugitani, Masahiko] Nihon Univ, Sch Med, Dept Pathol, Tokyo 1738610, Japan; [Yamaguchi, Hiromi] Nihon Univ, Sch Med, Dept Funct Morphol, Tokyo 1738610, Japan; [Takayama, Tadatoshi] Nihon Univ, Sch Med, Dept Digest Surg, Tokyo 1738610, Japan; [Tahara, Maino; Takeda, Makoto] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Esumi, M (reprint author), Nihon Univ, Sch Med, Dept Pathol, Itabashi Ku, 30-1 Ohyaguchikami Cho, Tokyo 1738610, Japan.	esumi.mariko@nihon-u.ac.jp			"Open Research Center" Project for Private Universities: matching fund from MEXT; Nihon University; MEXT [22590350, 25430142]; "Strategic Research Base Development" Program for Private Universities by MEXT	This work was supported by a grant from the "Open Research Center" Project for Private Universities: matching fund subsidy from MEXT (2005), Nihon University Joint Research Grant for 2006, Nihon University Multidisciplinary Research Grant for 2009, Grants-in-Aid for Scientific Research (C) 22590350 and 25430142 from MEXT (2010), and "Strategic Research Base Development" Program for Private Universities subsidized by MEXT (2010).	Metz P, 2013, J HEPATOL, V59, P1331, DOI 10.1016/j.jhep.2013.07.033; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Shirogane Y, 2010, J BIOL CHEM, V285, P20882, DOI 10.1074/jbc.M110.102590; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j/virol.2004.11.009; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Smith MW, 2003, HEPATOLOGY, V38, P1458, DOI 10.1016/jhep.2003.09.024; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Shirato K, 2011, J VIROL, V85, P7872, DOI 10.1128/JVI.00464-11; Shirogane Y, 2008, J VIROL, V82, P8942, DOI 10.1128/JVI.00676-08; Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Sakai K, 2013, J VIROL, V87, P1105, DOI 10.1128/JVI.02419-12; Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Abe M, 2013, J VIROL, V87, P11930, DOI 10.1128/JVI.01490-13; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.22356210100; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Choi SY, 2009, TRENDS MOL MED, V15, P303, DOI 10.1016/j.molmed.2009.05.003; DesGiorgi V, 2009, J TRANSL MED, V7, P85; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Ishibashi M, 2010, BIOCHEM BIOPH RES CO, V392, P397, DOI 10.1016/j.bbrc.2010.01.034; KATO T, 1992, VIROLOGY, V190, P856, DOI 10.1016/0042-6822(92)90925-F; Sakai K, 2013, J VIROL, V87, P7170, DOI 10.1128/JVI.03479-12; Sakai K, 2014, J VIROL; Tarnow C, 2014, J VIROL; Tikhmyanova N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022102; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	FEB	2015	61	2					437	446		10.1002/hep.27426		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9UX	WOS:000348563200009		
J	Kokudo, N; Hasegawa, K; Akahane, M; Igaki, H; Izumi, N; Ichida, T; Uemoto, S; Kaneko, S; Kawasaki, S; Ku, Y; Kudo, M; Kubo, S; Takayama, T; Tateishi, R; Fukuda, T; Matsui, O; Matsuyama, Y; Murakami, T; Arii, S; Okazaki, M; Makuuchi, M				Kokudo, Norihiro; Hasegawa, Kiyoshi; Akahane, Masaaki; Igaki, Hiroshi; Izumi, Namiki; Ichida, Takafumi; Uemoto, Shinji; Kaneko, Shuichi; Kawasaki, Seiji; Ku, Yonson; Kudo, Masatoshi; Kubo, Shoji; Takayama, Tadatoshi; Tateishi, Ryosuke; Fukuda, Takashi; Matsui, Osamu; Matsuyama, Yutaka; Murakami, Takamichi; Arii, Shigeki; Okazaki, Masatoshi; Makuuchi, Masatoshi			Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)	HEPATOLOGY RESEARCH			English	Article						algorithm for surveillance and diagnosis; algorithm for treatment; clinical practice guidelines; clinical question; evidence-based medicine	SURGICAL RESECTION; NATIONWIDE SURVEY; ABLATION	The 3rd version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine, which was published in October 2013 in Japanese. Here, we briefly describe new or changed recommendations with a special reference to the two algorithms for surveillance, diagnosis, and treatment.	[Kokudo, Norihiro; Hasegawa, Kiyoshi; Akahane, Masaaki; Igaki, Hiroshi; Izumi, Namiki; Ichida, Takafumi; Uemoto, Shinji; Kaneko, Shuichi; Kawasaki, Seiji; Ku, Yonson; Kudo, Masatoshi; Kubo, Shoji; Takayama, Tadatoshi; Tateishi, Ryosuke; Fukuda, Takashi; Matsui, Osamu; Matsuyama, Yutaka; Murakami, Takamichi; Arii, Shigeki; Okazaki, Masatoshi; Makuuchi, Masatoshi] Comm Revis Clin Practice Guidelines Hepatocellula, Tokyo, Japan	Kokudo, N (reprint author), Univ Tokyo, Grad Sch Med, Hepatobiliary Pancreat Surg Div, Dept Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kokudo-2su@h.u-tokyo.ac.jp					Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Hasegawa K, 2013, J HEPATOL, V58, P724, DOI 10.1016/j.jhep.2012.11.009; Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Kokudo N, 2009, J GASTROENTEROL, V44, P119, DOI 10.1007/s00535-008-2244-z; Hasegawa K, 2008, J HEPATOL, V49, P589, DOI 10.1016/j.jhep.2008.05.018; Hasegawa K, 2008, ANN SURG, V247, P557, DOI 10.1097/SLA.0b013e31816617db; Huang GT, 2005, ANN SURG, V242, P36, DOI 10.1097/01.sla.0000167925.90380.fe; Makuuchi M, 2006, WORLD J GASTROENTERO, V12, P828; Makuuchis M, 2010, HEPATOL RES S1, V40, P2	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	FEB	2015	45	2								10.1111/hepr.12464		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA5EE	WOS:000348930300001		
J	Morishita, A; Masaki, T				Morishita, Asahiro; Masaki, Tsutomu			miRNA in hepatocellular carcinoma	HEPATOLOGY RESEARCH			English	Review						diagnostic and prognostic markers; hepatocellular carcinoma; miRNA; therapeutic target	SUPPRESSES CELL-PROLIFERATION; ANTIDIABETIC DRUG METFORMIN; DNA METHYLTRANSFERASE 1; TUMOR-SUPPRESSOR; DOWN-REGULATION; GROWTH-FACTOR; HISTONE DEACETYLASE; HUMAN CANCER; IN-VITRO; MESENCHYMAL TRANSITION	Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. Despite improvements in HCC therapy, the prognosis for HCC patients remains poor due to a high incidence of recurrence. An improved understanding of the pathogenesis of HCC development would facilitate the development of more effective outcomes for the diagnosis and treatment of HCC at earlier stages. miRNA are small, endogenous, non-coding, ssRNA that are 21-30 nucleotides in length and modulate the expression of various target genes at the post-transcriptional and translational levels. Aberrant expression of miRNA is common in various human malignancies and modulates cancer-associated genomic regions or fragile sites. As for the relationship between miRNA and HCC, several studies have demonstrated that the aberrant expression of specific miRNA can be detected in HCC cells and tissues. However, little is known about the mechanisms of miRNA-related cell proliferation and development. In this review, we summarize the central and potential roles of miRNA in the pathogenesis of HCC and elucidate new possibilities that may be useful as diagnostic and prognostic markers, as well as novel therapeutic targets in HCC.	[Morishita, Asahiro; Masaki, Tsutomu] Kagawa Univ, Sch Med, Dept Gastroenterol & Neurol, Miki, Kagawa 7610793, Japan	Masaki, T (reprint author), Kagawa Univ, Sch Med, Dept Gastroenterol & Neurol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	asahiro@med.kagawa-u.ac.jp					Akkiz H, 2011, ASIAN PAC J CANCER P, V12, P3107; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861; El Tayebi HM, 2012, FEBS LETT, V586, P3309, DOI 10.1016/j.febslet.2012.06.054; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Alpini G, 2011, J HEPATOL, V55, P1339, DOI 10.1016/j.jhep.2011.04.015; Choudhury M, 2008, ALCOHOL CLIN EXP RES, V32, P829, DOI 10.1111/j.1530-0277.2008.00630.x; Zhang JF, 2011, HEPATOLOGY, V54, P2137, DOI 10.1002/hep.24595; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Yang X, 2013, HEPATOLOGY, V58, P158, DOI 10.1002/hep.26305; Wang XJ, 2012, BIOCHEM BIOPH RES CO, V428, P525, DOI 10.1016/j.bbrc.2012.10.039; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Gailhouste L, 2013, HEPATOLOGY, V58, P1153, DOI 10.1002/hep.26422; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Scisciani C, 2012, J HEPATOL, V56, P855, DOI 10.1016/j.jhep.2011.11.017; Callegari E, 2012, HEPATOLOGY, V56, P1025, DOI 10.1002/hep.25747; Yang H, 2013, HEPATOLOGY, V58, P205, DOI 10.1002/hep.26315; Maurel M, 2013, HEPATOLOGY, V57, P195, DOI 10.1002/hep.25994; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Diaz G, 2013, INT J CANCER, V133, P816, DOI 10.1002/ijc.28075; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Jiang RQ, 2011, CLIN CANCER RES, V17, P5593, DOI 10.1158/1078-0432.CCR-10-1734; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Zhang S, 2012, ONCOGENE, V31, P3607, DOI 10.1038/onc.2011.523; Jiang XF, 2012, MOL CELLS, V33, P545, DOI 10.1007/s10059-012-2267-4; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Chang Y, 2012, GASTROENTEROLOGY, V143, P177, DOI 10.1053/j.gastro.2012.04.009; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Yuan QG, 2013, HEPATOLOGY, V57, P299, DOI 10.1002/hep.25984; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Chen PJ, 2012, HEPATOLOGY, V56, P632, DOI 10.1002/hep.25695; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Yuan JH, 2011, HEPATOLOGY, V54, P2025, DOI 10.1002/hep.24606; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Huang N, 2012, FEBS LETT, V586, P884, DOI 10.1016/j.febslet.2012.02.017; Vinciguerra M, 2009, HEPATOLOGY, V49, P1176, DOI 10.1002/hep.22737; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhou P, 2012, DIGEST DIS SCI, V57, P1171, DOI 10.1007/s10620-012-2099-2; Wang ZF, 2011, J BIOL CHEM, V286, P39703, DOI 10.1074/jbc.M111.293126; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Zhang LS, 2013, HEPATOLOGY, V57, P1919, DOI 10.1002/hep.26162; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Yamamoto Y, 2009, BIOMARKERS, V14, P529, DOI 10.3109/13547500903150771; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Park JK, 2011, CANCER RES, V71, P7608, DOI 10.1158/0008-5472.CAN-11-1144; Goeppert B, 2010, HEPATOLOGY, V52, P2023, DOI 10.1002/hep.23939; Zhao AH, 2012, J GENET GENOMICS, V39, P29, DOI 10.1016/j.jgg.2011.12.003; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Gramantieri L, 2009, CLIN CANCER RES, V15, P5073, DOI 10.1158/1078-0432.CCR-09-0092; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Shen G, 2013, CARCINOGENESIS, V34, P211, DOI 10.1093/carcin/bgs320; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Michael MZ, 2003, MOL CANCER RES, V1, P882; Wang YL, 2013, J BIOL CHEM, V288, P18484, DOI 10.1074/jbc.M113.458158; Zhang LY, 2013, J BIOL CHEM, V288, P4035, DOI 10.1074/jbc.M112.410506; Banaudha K, 2011, HEPATOLOGY, V53, P53, DOI 10.1002/hep.24016; Buurman R, 2012, GASTROENTEROLOGY, V143, P811, DOI 10.1053/j.gastro.2012.05.033; Shah YA, 2007, MOL CELL BIOL, V27, P4238, DOI 10.1128/MCB.00317-07; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.144406; Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Ying Q, 2011, HEPATOLOGY, V54, P2064, DOI 10.1002/hep.24614; Lang QB, 2012, BIOCHEM BIOPH RES CO, V426, P247, DOI 10.1016/j.bbrc.2012.08.075; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Zhang YL, 2012, HEPATOLOGY, V56, P1631, DOI 10.1002/hep.25849; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Miyoshi H, 2014, INT J ONCOL, V45, P322, DOI 10.3892/ijo.2014.2419; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Wang L, 2014, HEPATOLOGY, V59, P1850, DOI 10.1002/hep.26720; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Takata A, 2013, HEPATOLOGY, V57, P162, DOI 10.1002/hep.26011; Xiang Y, 2012, MOL BIOL REP, V39, P7019, DOI 10.1007/s11033-012-1532-0; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Kobayashi M, 2013, INT J ONCOL, V42, P517, DOI 10.3892/ijo.2012.1722; Tomimaru Y, 2010, BRIT J CANCER, V103, P1617, DOI 10.1038/sj.bjc.6605958; Aus SL, 2012, HEPATOLOGY, V56, P622; Baes HJ, 2014, ONCOGENE, V33, P2557; Baes JS, 2012, DIGEST LIVER DIS, V44, P849; Bis Q, 2012, PLOS ONE, V7; Cais X, 2004, RNA, V10, P1957; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen L, 2012, J INVEST SURG, V25, P156, DOI 10.3109/08941939.2011.618523; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213; Di Fazio P, 2012, EXP CELL RES, V318, P1832, DOI 10.1016/j.yexcr.2012.04.018; Fans DN, 2013, HEPATOLOGY, V57, P637; Fans Q, 2013, CELL BIOCHEM FUNCT, V31, P319; Gaos P, 2011, J HEPATOL, V54, P1177; Griffiths-Jones S., 2010, CURR PROTOC BIOINFOR; Guos J, 2012, PLOS ONE, V7; Hans H, 2013, HEPATOLOGY, V57, P2378; Hans J, 2006, CELL, V125, P887; Hans ZB, 2012, J CANCER RES CLIN, V138, P153; Hes L, 2007, NATURE, V447, P1130; Hes XX, 2012, ONCOGENE, V31, P3357; Hous J, 2011, CANCER CELL, V19, P232; Hous W, 2010, HEPATOLOGY, V51, P1494; Hsus HC, 1993, CANCER RES, V53, P4691; Jias Y, 2012, ONCOL REP, V27, P1865; Jis J, 2010, J HEPATOL, V52, P690; Jis J, 2009, NEW ENGL J MED, V361, P1437; Kims JK, 2013, HEPATOLOGY, V57, P1055; Kims VN, 2009, NAT REV MOL CELL BIO, V10, P126; Kims WH, 2012, GENE, V504, P92; Kims Y, 2012, MOL CELL, V46, P384; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kwak MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041983; Lans FF, 2011, INT J CANCER, V128, P319; Lans SH, 2014, HEPATOLOGY, V59, P505; Laws PT, 2013, J HEPATOL, V58, P1165; Laws PT, 2012, CARCINOGENESIS, V33, P1134; Lees EJ, 2007, INT J CANCER, V120, P1046; Lims L, 2014, HEPATOLOGY, V59, P202; Lins CJ, 2008, BIOCHEM BIOPH RES CO, V375, P315; Lins J, 2011, CARCINOGENESIS, V32, P1641; Lis D, 2012, LIFE SCI, V91, P440; Lis D, 2011, J BIOL CHEM, V286, P36677; Lis LM, 2010, CANCER RES, V70, P9798; Lis N, 2009, CANC LETT, V275, P44; Lis QJ, 2012, TUMOR BIOL, V33, P1455; Lis S, 2009, HEPATOLOGY, V49, P1194; Lis XD, 2010, PATHOLOGY, V42, P669; Lius S, 2012, J HEPATOL, V56, P389; Lius WH, 2011, BIOCHIM BIOPHYS ACTA, V1809, P678; Lius WH, 2009, GASTROENTEROLOGY, V136, P683; Lius WR, 2012, CHIN MED J, V125, P2349; Lius Y, 2012, PLOS ONE, V7; Luedde Tom, 2010, Hepatology, V52, P1164, DOI 10.1002/hep.23854; Mas S, 2010, CELL STEM CELL, V7, P694; Masaki T, 2009, HEPATOL RES, V39, P751, DOI 10.1111/j.1872-034X.2009.00572.x; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Mizuguchi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015304; Petrelli A, 2014, HEPATOLOGY, V59, P228, DOI 10.1002/hep.26616; Petrelli A, 2012, ONCOGENE, V31, P4517, DOI 10.1038/onc.2011.631; Reddi Honey V, 2011, Genes Cancer, V2, P46, DOI 10.1177/1947601911405045; Rubys JG, 2007, NATURE, V448, P83; Shen QL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-227; Suns J, 2013, THESCIENTIFICWORLDJO, V2013; Sus H, 2009, CANCER RES, V69, P1135; Suzuki Hiromu, 2013, Frontiers in Genetics, V4, P258, DOI 10.3389/fgene.2013.00258; Taos ZH, 2013, J EXP MED, V210, P789; Tian Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048958; Tomita K, 2014, HEPATOLOGY, V59, P154, DOI 10.1002/hep.26604; Uras S, 2009, HEPATOLOGY, V49, P1098; Wang CX, 2011, J GASTROEN HEPATOL, V26, P1630, DOI 10.1111/j.1440-1746.2011.06758.x; Wang J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-227; Weis W, 2013, CELL BIOCHEM FUNCT, V31, P82; Weng ZH, 2011, EXP THER MED, V2, P951, DOI 10.3892/etm.2011.288; Wus N, 2011, FEBS J, V278, P2044; Xias H, 2013, HEPATOLOGY, V58, P629; Xias H, 2012, PLOS ONE, V7; Xus J, 2012, LIVER INT, V32, P752; Xus N, 2012, BIOCHEM BIOPH RES CO, V423, P826; Xus T, 2009, HEPATOLOGY, V50, P113; Xus X, 2013, J CLIN INVEST, V123, P630; Xus Y, 2011, INT J CANCER, V128, P412; Yang XY, 2012, PHARMAZIE, V67, P645, DOI 10.1691/ph.2012.1704; Yans XL, 2013, HEPATOLOGY, V57, P2274; Yans Y, 2013, HEPATOLOGY, V57, P667; Yaos J, 2010, HEPATOLOGY, V51, P846; Yins H, 2012, J BIOL CHEM, V287, P9817; Yous X, 2013, CARCINOGENESIS, V34, P1644; Zhang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031450; Zhangs JP, 2013, ONCOGENE; Zheng YX, 2012, FEBS LETT, V586, P2396, DOI 10.1016/j.febslet.2012.05.054; Zhus XC, 2012, INT J MOL MED, V30, P1321; Zhus XM, 2011, J INT MED RES, V39, P2323; Zhus Y, 2012, NUCLEIC ACIDS RES, V40, P4615	203	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	FEB	2015	45	2					128	141		10.1111/hepr.12386		14	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA5EE	WOS:000348930300002		
J	Yoshioka, K; Hashimoto, S; Kawabe, N				Yoshioka, Kentaro; Hashimoto, Senju; Kawabe, Naoto			Measurement of liver stiffness as a non-invasive method for diagnosis of non-alcoholic fatty liver disease	HEPATOLOGY RESEARCH			English	Review						acoustic radiation force impulse; magnetic resonance elastography; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; real-time tissue elastography; transient elastography	FORCE IMPULSE ELASTOGRAPHY; TIME TISSUE ELASTOGRAPHY; CHRONIC VIRAL-HEPATITIS; TRANSIENT ELASTOGRAPHY; XL PROBE; FIBROSIS; STEATOHEPATITIS; BIOPSY; RELIABILITY; PERFORMANCE	Non-alcoholic fatty liver disease (NAFLD) is one of the major causes of liver disease worldwide. To detect early stages of NAFLD and start treatment or to monitor the changes in trials of new drugs, non-invasive diagnostic methods are needed, such as biochemical markers or liver stiffness measurement (LSM). LSM with transient elastography (TE) and acoustic radiation force impulse (ARFI) has been shown to be useful in NAFLD, although the cut-off values have varied among reports. Magnetic resonance elastography and real-time tissue elastography also can be useful for the diagnosis of NAFLD, although the number of studies is limited. Fibrosis is absent in 8-40% of patients with non-alcoholic steatohepatitis (NASH), making it difficult to diagnose NASH by LSM because LSM is usually associated with fibrotic stage. The presence of inflammation or hepatocyte ballooning may affect LSM and aid the diagnosis of NASH without fibrosis. However, obesity significantly increases the failure of LSM and its interference is more conspicuous in TE than in ARFI. The newly implemented XL probe of TE has overcome the difficulty to some degree. Nonetheless, the effects of obesity, hepatocyte ballooning, steatosis and inflammation on LSM values have not yet been adequately investigated, although they are likely to affect LSM values. Further studies are needed to establish the clinical utility of LSM in NAFLD.	[Yoshioka, Kentaro; Hashimoto, Senju; Kawabe, Naoto] Fujita Hlth Univ, Dept Liver Biliary Tract & Pancreas Dis, Toyoake, Aichi 4701192, Japan	Yoshioka, K (reprint author), Fujita Hlth Univ, Dept Liver Biliary Tract & Pancreas Dis, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	kyoshiok@fujita-hu.ac.jp					Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Friedrich-Rust M, 2007, AM J ROENTGENOL, V188, P758, DOI 10.2214/AJR.06.0322; Wong VWS, 2012, AM J GASTROENTEROL, V107, P1862, DOI 10.1038/ajg.2012.331; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Palmeri ML, 2011, J HEPATOL, V55, P666, DOI 10.1016/j.jhep.2010.12.019; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Yoneda M, 2010, RADIOLOGY, V256, P640, DOI 10.1148/radiol.10091662; Nishikawa T, 2014, WORLD J GASTROENTERO, V20, P1289, DOI 10.3748/wjg.v20.i5.1289; Mahadeva S, 2013, J DIGEST DIS, V14, P604, DOI 10.1111/1751-2980.12088; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Nobili V, 2008, HEPATOLOGY, V48, P442, DOI 10.1002/hep.22376; Friedrich-Rust M, 2012, EUR J RADIOL, V81, pE325, DOI 10.1016/j.ejrad.2011.10.029; Guzman-Aroca F, 2012, EUR RADIOL, V22, P2525, DOI 10.1007/s00330-012-2505-3; Myers RP, 2012, HEPATOLOGY, V55, P199, DOI 10.1002/hep.24624; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Gaia S, 2011, J HEPATOL, V54, P64, DOI 10.1016/j.jhep.2010.06.022; Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128; Chen J, 2011, RADIOLOGY, V259, P749, DOI 10.1148/radiol.11101942; Petta S, 2011, ALIMENT PHARM THER, V33, P1350, DOI 10.1111/j.1365-2036.2011.04668.x; Nitta Y, 2009, HEPATOL RES, V39, P675, DOI 10.1111/j.1872-034X.2009.00500.x; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Lupsor M, 2010, J GASTROINTEST LIVER, V19, P53; Ochi H, 2012, HEPATOLOGY, V56, P1271, DOI 10.1002/hep.25756; Foucher J, 2006, EUR J GASTROEN HEPAT, V18, P411, DOI 10.1097/00042737-200604000-00015; Orlacchio A, 2012, ULTRASOUND MED BIOL, V38, P537, DOI 10.1016/j.ultrasmedbio.2011.12.023; Yoneda M, 2008, DIGEST LIVER DIS, V40, P371, DOI 10.1016/j.dld.2007.10.019; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Braticevici CF, 2013, ULTRASOUND MED BIOL, V39, P1942, DOI 10.1016/j.ultrasmedbio.2013.04.019; Bota S, 2014, EUR J RADIOL, V83, P268, DOI 10.1016/j.ejrad.2013.11.019; desLedinghen V, 2010, LIVER INT, V30, P1043; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Kims D, 2013, RADIOLOGY, V268, P411; Kims SU, 2012, PLOS ONE, V7; LEVENSON H, 1991, AM J ROENTGENOL, V156, P307; Nguyen-Khac E, 2008, GUT, V57, P1630; Saitos M, 2008, J MED ULTRASOUND TEC, V33, P659; Tomeno W, 2013, HEPATOL RES, V43, P735, DOI 10.1111/hepr.12023; Yins M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI DOI 10.1016/J.CGH.2007.06.012	40	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	FEB	2015	45	2					142	151		10.1111/hepr.12388		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA5EE	WOS:000348930300003		
J	Hiramatsu, N; Oze, T; Takehara, T				Hiramatsu, Naoki; Oze, Tsugiko; Takehara, Tetsuo			Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy	HEPATOLOGY RESEARCH			English	Review						hepatocellular carcinoma; interferon therapy; sustained virological response	SUSTAINED VIROLOGICAL RESPONSE; VIRUS-RELATED CIRRHOSIS; LONG-TERM; PEGYLATED INTERFERON-ALPHA-2B; RIBAVIRIN THERAPY; ALPHA-FETOPROTEIN; PLUS RIBAVIRIN; RISK-FACTORS; HCV RNA; HEPATOCARCINOGENESIS	The advance of antiviral treatment for chronic hepatitis C has brought a high sustained virological response (SVR) rate. In this review article, the suppressive effect of interferon (IFN)-based therapy on the development of hepatocellular carcinoma (HCC), risk factors for developing HCC and the characteristics of HCC development after SVR among chronic hepatitis C patients given IFN-based therapy were studied. The HCC incidence has been revealed to decrease with IFN-based antiviral therapy, especially in SVR, and the risk factors for developing HCC were older age, advanced liver fibrosis and male sex. -Fetoprotein levels at 24 weeks after the end of IFN-based treatment was associated strongly with HCC incidence irrespective of virological response. In patients with SVR, other risk factors were glucose metabolism disorders, lipid metabolism disorders and alcohol intake. Extra attention to the possibility of HCC incidence should be required for these SVR patients. Antiviral therapy with a combination of HCV-specific direct-acting antivirals (DAA) is expected to be utilized in the future. However, it is not known whether DAA-based treatment can suppress HCC to the level of IFN-based treatment. Further research is required to clarify this.	[Hiramatsu, Naoki; Oze, Tsugiko; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan	Hiramatsu, N (reprint author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	hiramatsu@gh.med.osaka-u.ac.jp					Shiratori Y, 2005, ANN INTERN MED, V142, P105; Hirakawa M, 2008, INTERNAL MED, V47, P1637, DOI 10.2169/internalmedicine.47.1087; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Kurokawa M, 2009, HEPATOL RES, V39, P432, DOI 10.1111/j.1872-034X.2008.00477.x; Hagihara H, 2011, INT J CLIN ONCOL, V16, P210, DOI 10.1007/s10147-010-0150-x; Arase Y, 2013, HEPATOLOGY, V57, P964, DOI 10.1002/hep.26087; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Tokita H, 2005, J GASTROEN HEPATOL, V20, P752, DOI 10.1111/j.1400-1746.2005.03800.x; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Akuta N, 2011, J MED VIROL, V83, P1016, DOI 10.1002/jmv.22094; Shen YC, 2010, J HEPATOL, V52, P889, DOI 10.1016/j.jhep.2009.12.041; Hung CH, 2011, INT J CANCER, V128, P2344, DOI 10.1002/ijc.25585; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Ikeda K, 2000, HEPATOLOGY, V32, P228, DOI 10.1053/jhep.2000.9409; Makiyama A, 2004, CANCER, V101, P1616, DOI 10.1002/cncr.20537; Imai Y, 1998, ANN INTERN MED, V129, P94; Nagaoki Y, 2011, J GASTROENTEROL, V46, P799, DOI 10.1007/s00535-011-0384-z; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Tanaka A, 2007, WORLD J GASTROENTERO, V13, P5180; Kawamura Y, 2010, AM J MED, V123, P951, DOI 10.1016/j.amjmed.2010.05.013; Tateyama M, 2011, J GASTROENTEROL, V46, P92, DOI 10.1007/s00535-010-0293-6; Yoshida H, 1999, ANN INTERN MED, V131, P174; Gramenzi A, 2001, GUT, V48, P843, DOI 10.1136/gut.48.6.843; Hamada H, 2002, CANCER, V95, P331, DOI 10.1002/cncr.10662; Hsus YC, 2013, HEPATOLOGY, V58, P150; Ikeda M, 2006, J GASTROEN HEPATOL, V21, P122, DOI 10.1111/j.1440-1746.2005.04083.x; Miyake Y, 2010, J VIRAL HEPATITIS, V17, P287, DOI 10.1111/j.1365-2893.2009.01181.x; Nishiguchi S, 2001, LANCET, V357, P196, DOI 10.1016/S0140-6736(00)03595-9; Okanoue T, 1999, J HEPATOL, V30, P653, DOI 10.1016/S0168-8278(99)80196-2; Ozes T, 2014, CLIN GASTROENTEROL H, V12, P1186; Sato A, 2013, INTERNAL MED, V52, P2701, DOI 10.2169/internalmedicine.52.1180; Serfaty L, 1998, HEPATOLOGY, V27, P1435, DOI 10.1002/hep.510270535; Tanimoto Y, 2012, ANN SURG ONCOL, V19, P418, DOI 10.1245/s10434-011-1866-1; Toyoda H, 2000, J VIRAL HEPATITIS, V7, P414, DOI 10.1046/j.1365-2893.2000.00241.x; Watanabe S, 2011, HEPATOL RES, V41, P955, DOI 10.1111/j.1872-034X.2011.00847.x	41	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	FEB	2015	45	2					152	161		10.1111/hepr.12393		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA5EE	WOS:000348930300004		
J	Isogawa, M; Tanaka, Y				Isogawa, Masanori; Tanaka, Yasuhito			Immunobiology of hepatitis B virus infection	HEPATOLOGY RESEARCH			English	Review						hepatitis B virus; immune response; immunological priming; immunotherapy; T cells	CD8(+) T-CELLS; TRANSGENIC MOUSE MODEL; REPLICATION IN-VIVO; IMMUNE-RESPONSE; PROTECTIVE IMMUNITY; NUCLEOTIDE-SEQUENCE; VIRAL-HEPATITIS; NATURAL-HISTORY; LIVER-DAMAGE; CORE ANTIGEN	The adaptive immune response, particularly the virus-specific CD8(+) T-cell response, is largely responsible for viral clearance and disease pathogenesis during hepatitis B virus (HBV) infection. The HBV-specific CD8(+) T-cell response is vigorous, polyclonal and multispecific in acutely infected patients who successfully clear the virus and relatively weak and narrowly focused in chronically infected patients. The immunological basis for this dichotomy is unclear. A recent study using HBV transgenic mice and HBV-specific T-cell receptor transgenic mice suggests that intrahepatic antigen presentation by HBV positive hepatocytes suppresses HBV-specific CD8(+) T-cell responses through a co-inhibitory molecule, programmed cell death 1 (PD-1). In contrast, antigen presentation by activated professional antigen-presenting cells induces functional differentiation of HBV-specific CD8(+) T cells. These findings suggest that the outcome of T-cell priming is largely dependent on the nature of antigen-presenting cells. Another study suggests that the timing of HBV-specific CD4(+) T-cell priming regulates the magnitude of the HBV-specific CD8(+) T-cell response. Other factors that could regulate HBV-specific cellular immune responses are high viral loads, mutational epitope inactivation, T-cell receptor antagonism and infection of immunologically privileged tissues. However, these pathways become apparent only in the setting of an ineffective cellular immune response, which is therefore the fundamental underlying cause. Understanding the cellular and molecular mechanisms by which HBV evades host immune responses will eventually help develop new immunotherapeutic strategies designed to terminate chronic HBV infection.	Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi 4678601, Japan; Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi 4678601, Japan	Tanaka, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	ytanaka@med.nagoya-cu.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan	THIS WORK WAS supported in part by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan and the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ALEXANDER GJM, 1986, LANCET, V1, P296; ANDO K, 1994, J IMMUNOL, V153, P482; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; Kusumoto S, 2011, J GASTROENTEROL, V46, P9, DOI 10.1007/s00535-010-0331-4; Boni C, 2001, HEPATOLOGY, V33, P963, DOI 10.1053/jhep.2001.23045; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; CHISARI FV, 1985, SCIENCE, V230, P1157, DOI 10.1126/science.3865369; Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Chen M, 2005, J VIROL, V79, P3016, DOI 10.1128/JVI.79.5.3016-3027.2005; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Reignat S, 2002, J EXP MED, V195, P1089, DOI 10.1084/jem.20011723; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kong XH, 2014, J IMMUNOL, V193, P1645, DOI 10.4049/jimmunol.1303432; FERRARI C, 1991, J CLIN INVEST, V88, P214, DOI 10.1172/JCI115280; ZOULIM F, 1994, J VIROL, V68, P2026; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Wieland SF, 2005, P NATL ACAD SCI USA, V102, P9913, DOI 10.1073/pnas.0504273102; Fisicaro P, 2009, GUT, V58, P974, DOI 10.1136/gut.2008.163600; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006; GUIDOTTI LG, 1995, J VIROL, V69, P6158; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Tjwa ETTL, 2011, J HEPATOL, V54, P209, DOI 10.1016/j.jhep.2010.07.009; Limmer A, 2000, NAT MED, V6, P1348; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Zhang Y, 2011, GASTROENTEROLOGY, V141, P1897, DOI 10.1053/j.gastro.2011.06.051; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Kakimi K, 2002, J VIROL, V76, P8609, DOI 10.1128/JVI.76.17.8609-8620.2002; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Maini MK, 2010, J HEPATOL, V52, P616, DOI 10.1016/j.jhep.2009.12.017; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Dolina JS, 2014, HEPATOLOGY, V59, P1351, DOI 10.1002/hep.26938; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Park TS, 2011, TRENDS BIOTECHNOL, V29, P550, DOI 10.1016/j.tibtech.2011.04.009; Gish R, 2012, LANCET INFECT DIS, V12, P341, DOI 10.1016/S1473-3099(11)70314-0; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.immunol.13.1.29; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Lunemann S, 2014, J INFECT DIS, V209, P1362, DOI 10.1093/infdis/jit561; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Bertolino P, 2001, J IMMUNOL, V166, P5430; Kenna T, 2003, J IMMUNOL, V171, P1775; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Chen S, 2011, CLIN EXP IMMUNOL, V166, P134, DOI 10.1111/j.1365-2249.2011.04445.x; GALIBERT F, 1979, NATURE, V281, P646, DOI 10.1038/281646a0; Michel ML, 2011, J HEPATOL, V54, P1286, DOI [10.1016/j.jhep.2010.12.031, 10.1016/j.jhep.2010.09.040]; Chisaris FV, 2000, AM J PATHOL, V156, P1; Dass A, 2008, J EXP MED, V205, P2111; EHATA T, 1993, J CLIN INVEST, V91, P1206, DOI 10.1172/JCI116281; FERRARI C, 1990, J IMMUNOL, V145, P3442; Guys CS, 2008, J VIROL, V82, P8579; HADLER SC, 1991, J INFECT DIS, V163, P454; Isogawa M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003490; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kohs S, 2013, MOL THERM NUCL ACIDS, V2, pe114; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Nakamoto Y, 1997, J IMMUNOL, V158, P5692; Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648; Rehermann B, 1996, J CLIN INVEST, V97, P1655, DOI 10.1172/JCI118592; Robek MD, 2004, P NATL ACAD SCI USA, V101, P1743, DOI 10.1073/pnas.030834100; Robek MD, 2002, J VIROL, V76, P3570, DOI 10.1128/JVI.76.7.3570-3574.2002; Stefans F, 2005, J VIROL, V79, P9369; Sugiyama M, 2009, GASTROENTEROLOGY, V136, P652, DOI 10.1053/j.gastro.2008.10.048; Suns C, 2012, PLOS PATHOG, V8; Sus A, 2002, P NATL ACAD SCI USA, V99, P15669; TILLMANN H, 1995, GUT, V37, P568, DOI 10.1136/gut.37.4.568; Xus D, 2006, J IMMUNOL, V177, P739; Yoos JY, 1987, J MED VIROL, V23, P273; Zhang ZS, 2001, J CLIN INVEST, V108, P1523, DOI 10.1172/JCI13787; Zhang ZS, 2004, J VIROL, V78, P4566, DOI 10.1128/JVI.78.9.4566-4572.2004; Zhangs J-Y, 2009, HEPATOLOGY, V51, P81; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049135	91	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	FEB	2015	45	2					179	189		10.1111/hepr.12439		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA5EE	WOS:000348930300006		
J	Sato, K; Kawagishi, N; Fujimori, K; Ohuchi, N; Satomi, S				Sato, Kazushige; Kawagishi, Naoki; Fujimori, Keisei; Ohuchi, Noriaki; Satomi, Susumu			Renal function status in liver transplant patients in the first month post-transplant is associated with progressive chronic kidney disease	HEPATOLOGY RESEARCH			English	Article						calcineurin inhibitor; chronic kidney disease; estimated glomerular filtration rate; intraoperative blood loss; liver transplantation	GLOMERULAR-FILTRATION-RATE; MYCOPHENOLATE-MOFETIL; CALCINEURIN INHIBITORS; RISK-FACTORS; FAILURE; DYSFUNCTION; CYCLOSPORINE; ACTIVATION; RECIPIENTS	AimRenal dysfunction is a common complication of liver transplantation (LT), related to hepatorenal syndrome with end-stage liver disease or calcineurin-inhibitor nephrotoxicity. Chronic kidney disease (CKD) is also a common problem in long-term survivors post-LT. This study was done to investigate the association between renal functional status soon after LT and the development of CKD. MethodsWe retrospectively evaluated 63 patients who were aged 18years or older, and underwent LT at Tohoku University Hospital. The estimated glomerular filtration rate (eGFR) was calculated by the Modification of Diet in Renal Disease study equation for Japan. ResultsBefore transplantation, 25 patients (39.7%) were diagnosed with CKD (eGFR, <60mL/min per 1.73m(2)). The incidence of CKD was 22.4% (13/58) at 2years, 23.2% (13/56) at 3years and 22.7% (12/54) at 5years. The patients with CKD at 2years post-transplant were more likely to have a history of glomerulonephritis, and were significantly older at the time of LT, compared to those without CKD. Levels of eGFR of less than 60mL/min per 1.73m(2) in the first month post-transplant and a volume of intraoperative blood loss of more than 300mL/kg were predictive factors for the development of CKD at 2years post-transplant and thereafter. ConclusionWe have shown that there is an improvement of renal function in the majority of patients after LT. Regardless of the presence of pre-existing CKD, both renal function status at the first month post-transplant and a volume of intraoperative blood loss were predictive factors for the development of CKD at 2years post-transplant and thereafter.	[Sato, Kazushige; Kawagishi, Naoki; Fujimori, Keisei; Ohuchi, Noriaki; Satomi, Susumu] Tohoku Univ, Grad Sch Med, Adv Surg Sci & Technol Div, Dept Surg, Sendai, Miyagi 9808574, Japan	Sato, K (reprint author), Tohoku Univ, Grad Sch Med, Adv Surg Sci & Technol Div, Dept Surg,Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	satokazu@med.tohoku.ac.jp					Gonwa T, 2004, LIVER TRANSPLANT, V10, P301, DOI 10.1002/lt.20017; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Paramesh AS, 2004, CLIN TRANSPLANT, V18, P94, DOI 10.1046/j.1399-0012.2003.00132.x; Schlitt HJ, 2001, LANCET, V357, P587, DOI 10.1016/S0140-6736(00)04055-1; LEVEY AS, 1990, KIDNEY INT, V38, P167, DOI 10.1038/ki.1990.182; MCCAULEY J, 1990, NEPHRON, V55, P121; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1002/hep.510230122; Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216; Bilbao I, 1998, CLIN TRANSPLANT, V12, P123; Yuasa T, 2005, TRANSFUSION, V45, P879, DOI 10.1111/j.1537-2995.2005.04330.x; Levey AS, 1999, ANN INTERN MED, V130, P461; Gonwa TA, 2001, TRANSPLANTATION, V72, P1934, DOI 10.1097/00007890-200112270-00012; Thijs A, 2008, CLIN NEPHROL, V70, P325; Gainza FJ, 2002, TRANSPLANT P, V34, P250, DOI 10.1016/S0041-1345(01)02747-6; Kims JY, 2010, TRANSPLANTATION, V89, P215; Mezzano D, 1996, THROMB HAEMOSTASIS, V76, P312; Ojos AO, 2003, NEW ENGL J MED, V349, P931; Pageaux GP, 2006, LIVER TRANSPLANT, V12, P1755, DOI 10.1002/lt.20903; PERSSON H, 1994, TRANSPLANT INT, V7, P172, DOI 10.1111/j.1432-2277.1994.tb01286.x; Reich DJ, 2005, TRANSPLANTATION, V80, P18, DOI 10.1097/01.TP.0000165118.00988.D7; Sato K, 2011, CLIN TRANSPLANT, V25, P61, DOI 10.1111/j.1399-0012.2010.01219.x; VAZIRI ND, 1984, ARCH INTERN MED, V144, P1802, DOI 10.1001/archinte.144.9.1802	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	FEB	2015	45	2					220	227		10.1111/hepr.12339		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA5EE	WOS:000348930300010		
J	Tachi, Y; Hirai, T; Miyata, A; Ohara, K; Iida, T; Ishizu, Y; Honda, T; Kuzuya, T; Hayashi, K; Ishigami, M; Goto, H				Tachi, Yoshihiko; Hirai, Takanori; Miyata, Akihiro; Ohara, Kei; Iida, Tadashi; Ishizu, Youji; Honda, Takashi; Kuzuya, Teiji; Hayashi, Kazuhiko; Ishigami, Masatoshi; Goto, Hidemi			Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response	HEPATOLOGY RESEARCH			English	Article						hepatitis C virus; hepatocellular carcinoma; liver fibrosis; sustained virological response	CHRONIC HEPATITIS-C; INTERFERON THERAPY; TRANSIENT ELASTOGRAPHY; LIVER STIFFNESS; HISTOLOGIC IMPROVEMENT; RANDOMIZED TRIAL; VIRUS-INFECTION; PLUS RIBAVIRIN; FOLLOW-UP; HCV RNA	AimHepatocellular carcinoma develops even in some patients who achieve a sustained virological response following treatment for hepatitis C virus infection. This study investigated the relationship between changes in fibrosis, as assessed by sequential biopsies, and development of hepatocellular carcinoma in patients who achieved a sustained virological response for hepatitis C virus. MethodsWe enrolled 97 patients with sustained virological response who had undergone initial biopsies before therapy and sequential biopsies at an average of 5.81.9 years after the initial biopsy. Factors associated with hepatocellular carcinoma were retrospectively analyzed. ResultsThe liver fibrotic stage regressed in 44 patients (45%), remained stable in 47 patients (48%) and progressed in six patients (6%). The fibrotic stage significantly decreased, from 1.54 +/- 0.86 to 1.16 +/- 1.07 units. Hepatocellular carcinoma was identified in 12 patients (12.4%). The cumulative incidence of hepatocellular carcinoma in patients with progressive fibrosis was significantly higher than that in patients with regressed or stable fibrosis (P<0.001). A Cox proportional hazards regression analysis confirmed that progressive fibrosis in sequential liver biopsies (hazard ratio [HR], 8.30; P=0.001) and low platelet counts before treatment (HR, 8.69; P=0.006) were significant independent factors associated with the development of hepatocellular carcinoma in patients with a sustained virological response. ConclusionProgressive fibrosis, assessed by sequential biopsies, was significantly correlated with development of hepatocellular carcinoma in patients who had achieved a sustained virological response for hepatitis C virus.	[Tachi, Yoshihiko; Hirai, Takanori; Miyata, Akihiro; Ohara, Kei; Iida, Tadashi] Komaki City Hosp, Dept Gastroenterol, Komaki, Aichi 4858520, Japan; [Ishizu, Youji; Honda, Takashi; Kuzuya, Teiji; Hayashi, Kazuhiko; Ishigami, Masatoshi; Goto, Hidemi] Nagoya Univ, Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan	Tachi, Y (reprint author), Komaki City Hosp, Dept Gastroenterol, 1-20 Joubushi, Komaki, Aichi 4858520, Japan.	ytachi@komakihp.gr.jp					ALTER MJ, 1995, SEMIN LIVER DIS, V15, P5, DOI 10.1055/s-2007-1007259; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 1997, ANN INTERN MED, V127, P875; Reichard O, 1999, J HEPATOL, V30, P783, DOI 10.1016/S0168-8278(99)80129-9; Shiratori Y, 2000, ANN INTERN MED, V132, P517; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Yoshioka K, 2008, HEPATOL RES, V38, P1063, DOI 10.1111/j.1872-034X.2008.00386.x; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Butt AA, 2012, CLIN INFECT DIS, V54, P96, DOI 10.1093/cid/cir774; Akuta N, 2011, J MED VIROL, V83, P1016, DOI 10.1002/jmv.22094; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1016/0270-9139(95)90605-3; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506; Nitta Y, 2009, HEPATOL RES, V39, P675, DOI 10.1111/j.1872-034X.2009.00500.x; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Makiyama A, 2004, CANCER, V101, P1616, DOI 10.1002/cncr.20537; Imai Y, 1998, ANN INTERN MED, V129, P94; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Yoshida H, 1999, ANN INTERN MED, V131, P174; Harata M, 2011, HEPATOL RES, V41, P423, DOI 10.1111/j.1872-034X.2011.00797.x; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; TAKANO S, 1995, HEPATOLOGY, V21, P650; Bonis PAL, 1997, HEPATOLOGY, V26, P1035, DOI 10.1002/hep.510260436; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Imazeki F, 2003, HEPATOLOGY, V38, P493, DOI 10.1053/jhep.2003.50329; The French METAVIR Cooperative Study Group, 1994, HEPATOLOGY, V20, P15; Toyoda H, 2003, CANCER DETECT PREV, V27, P498, DOI 10.1016/j.cdp.2003.09.007; Tsubotas A, 2007, J HEPATOL, V27, P49; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Wais CT, 2003, HEPATOLOGY, V38, P518; Ziol M, 1996, J HEPATOL, V25, P833, DOI 10.1016/S0168-8278(96)80286-8	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	FEB	2015	45	2					238	246		10.1111/hepr.12331		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA5EE	WOS:000348930300012		
J	Sarwar, MS; Sarkar, RC; Bhowmick, R; Dewan, SMR; Ahmed, MU; Hasnat, A; Rashid, M; Islam, MS				Sarwar, Md. Shahid; Sarkar, Rakhesh Chandra; Bhowmick, Rumpa; Dewan, Syed Masudur Rahman; Ahmed, Maizbha Uddin; Hasnat, Abul; Rashid, Mamunur; Islam, Mohammad Safiqul			Effect of socio-economic status and estimation of lipid peroxidation and antioxidant in preeclamptic pregnant women: a case-control study	HYPERTENSION IN PREGNANCY			English	Article						Malondialdehyde; Preeclampsia; Pregnant women; Socio-economic status; Vitamin C	OXIDATIVE STRESS; HYPERTENSION	Objective: Increased extent of lipid peroxidation and decreased antioxidant defense has been postulated as a major contributor to the development of preeclampsia. The present study was conducted to determine the serum level of malondialdehyde (MDA) and vitamin C in these patients. Methods: This research was conducted as a case-control study to assess the extent of lipid peroxidation and antioxidant status in 150 preeclampsia patients and 174 healthy pregnant women. Lipid peroxidation was assessed by measuring serum MDA level, and antioxidant defense was evaluated for serum vitamin C by UV spectrophotometric method. Independent sample t test and Pearson's correlation test were used for the statistical analysis with statistical software package SPSS, version 16.0 (SPSS, Inc., Chicago, IL). Results: Our study found significantly higher level of MDA (p<0.05) and significantly lower level of vitamin C (p<0.05) in preeclampsia patients in comparison to the control subjects. Pearson's correlation analysis revealed that there was negative correlation between the serum level of MDA and vitamin C for both patient (r = -0.057, p = 0.669) and control groups (r = -0.128, p = 0.487). Analysis of socio-economic data revealed that preeclampsia was more prevalent among the rural pregnant than the urban pregnant women (OR 1.44, 95% CI 0.665-3.14, p = 0.352). It was also observed that primigravida pregnant were at higher risk for the development of preeclampsia than the multigravida pregnant women (OR 1.87, 95% CI 0.868-4.04, p = 0.108). Conclusions: Elevated serum MDA and depleted serum vitamin C may be associated with the development of preeclampsia.	[Sarwar, Md. Shahid; Rashid, Mamunur] Southeast Univ, Dept Pharm, Dhaka, Bangladesh; [Sarkar, Rakhesh Chandra; Bhowmick, Rumpa; Dewan, Syed Masudur Rahman; Islam, Mohammad Safiqul] Noakhali Sci & Technol Univ, Dept Pharm, Sonapur, Noakhali, Bangladesh; [Ahmed, Maizbha Uddin; Hasnat, Abul] Univ Dhaka, Fac Pharm, Dept Clin Pharm & Pharmacol, Dhaka 1000, Bangladesh; [Islam, Mohammad Safiqul] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane, Japan	Islam, MS (reprint author), Noakhali Sci & Technol Univ, Dept Pharm, Sonapur 3814, Noakhali, Bangladesh.	research_safiq@yahoo.com			University Grant Commission (UGC), Bangladesh	This study was financially supported by University Grant Commission (UGC), Bangladesh.	Adeniji AO, 2013, INT J CLIN MED, V4, P239; Agida ET, 2010, NIGER J CLIN PRACT, V13, P394; Sharma JB, 2006, INT J GYNECOL OBSTET, V94, P23, DOI 10.1016/j.ijgo.2006.03.025; Atamer Y, 2005, EUR J OBSTET GYN R B, V119, P60, DOI 10.1016/j.ejogrb.2004.06.033; WANG YP, 1991, AM J OBSTET GYNECOL, V165, P1695; SATOH K, 1978, CLIN CHIM ACTA, V90, P37; Sarwar MS, 2013, BIOL TRACE ELEM RES, V154, P14, DOI 10.1007/s12011-013-9721-9; Ramsay JE, 2003, HYPERTENSION, V42, P891, DOI 10.1161/01.HYP.0000095981.92542.F6; Kaur G, 2008, MOL CELL BIOCHEM, V313, P37, DOI 10.1007/s11010-008-9739-z; Llurba E, 2004, FREE RADICAL BIO MED, V37, P557, DOI 10.1016/j.freeradbiomed.2004.04.035; ROBERTS JM, 1991, AM J HYPERTENS, V4, P700; Azimi C, 2012, AM J SCI RES, V51, P5; Dhananjay BS, 2009, J PHYSL BIOMED SCI, V22, P2; Direkvand-Moghadam A, 2012, ACTA BIOCHIM POL, V59, P673; Dlamini N J, 1997, Curationis, V20, P16; Fatemeh T, 2010, J PAK MED ASSOC, V60, P707; Gohil J T, 2011, J Obstet Gynaecol India, V61, P638, DOI 10.1007/s13224-011-0094-8; Granger JP, 2001, AM J HYPERTENS, V14, p178S, DOI 10.1016/S0895-7061(01)02086-6; Howlader MZH, 2009, J TROP PEDIATRICS, V55, P363, DOI 10.1093/tropej/fmp025; JONAS O, 1992, AUST NZ J OBSTET GYN, V32, P1, DOI 10.1111/j.1479-828X.1992.tb01885.x; Lowry H, 1945, J BIOL CHEM, V162, P609; Meera KS, 2010, BIOMED RES-INDIA, V21, P393; Nahar Z, 2013, Drug Res (Stuttg), V63, P424, DOI 10.1055/s-0033-1343494; Osungbade OK, 2011, J PREGNANCY, V11, P481; Roberts JM, 2003, J NUTR, V133, P1684; Suhail M, 2011, J CLIN MED RES, V1, P150; Torun M, 1995, TURK J BIOCHEM, V20, P1; Vasiljević N, 1996, Srp Arh Celok Lek, V124, P156; WHO, 2011, REC PREV TREATM PREE	29	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1064-1955	1525-6065		HYPERTENS PREGNANCY	Hypertens. Pregnancy	FEB	2015	34	1					125	135		10.3109/10641955.2014.988349		11	Obstetrics & Gynecology; Physiology; Peripheral Vascular Disease	Obstetrics & Gynecology; Physiology; Cardiovascular System & Cardiology	CA5BX	WOS:000348923600011		
J	Natsui, M; Suzuki, D; Sakimura, N; Nebashi, R; Tsuji, Y; Morioka, A; Sugibayashi, T; Miura, S; Honjo, H; Kinoshita, K; Ikeda, S; Endoh, T; Ohno, H; Hanyu, T				Natsui, Masanori; Suzuki, Daisuke; Sakimura, Noboru; Nebashi, Ryusuke; Tsuji, Yukihide; Morioka, Ayuka; Sugibayashi, Tadahiko; Miura, Sadahiko; Honjo, Hiroaki; Kinoshita, Keizo; Ikeda, Shoji; Endoh, Tetsuo; Ohno, Hideo; Hanyu, Takahiro			Nonvolatile Logic-in-Memory LSI Using Cycle-Based Power Gating and its Application to Motion-Vector Prediction	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Automated design environment; magnetic tunnel junction (MTJ); motion-vector prediction; nonvolatile	MAGNETIC TUNNEL-JUNCTIONS; DEVICES; DESIGN	A magnetic tunnel junction (MTJ)-based logic-in-memory hardware accelerator LSI with cycle-based power gating is fabricated using a 90 nm MTJ/MOS process on a 300 mm wafer fabrication line for practical-scale, fully parallel motion-vector prediction, without wasted power dissipation. The proposed nonvolatile LSI is designed by establishing an automated design environment with MTJ-based logic-circuit IPs and peripheral assistant tools, as well as a precise MTJ device model produced by the fabricated test chips. Through the measurement results of the fabricated LSI, this study shows both the impact of the power-gating technique in a fine temporal granularity utilizing the non-volatility of the MTJ device and the effectiveness of the established automated design environment for designing random logic LSI using nonvolatile logic-in-memory.	[Natsui, Masanori; Hanyu, Takahiro] Tohoku Univ, Lab Brainware Syst, Elect Commun Res Inst, Ctr Spintron Integrated Syst, Sendai, Miyagi 9808577, Japan; [Natsui, Masanori; Suzuki, Daisuke; Hanyu, Takahiro] Tohoku Univ, Ctr Innovat Integrated Elect Syst, Sendai, Miyagi 9808577, Japan; [Suzuki, Daisuke] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 9808577, Japan; [Sakimura, Noboru; Nebashi, Ryusuke; Tsuji, Yukihide; Morioka, Ayuka; Sugibayashi, Tadahiko; Miura, Sadahiko] NEC Corp Ltd, Green Platform Res Labs, Ibaraki 3058501, Japan; [Honjo, Hiroaki] NEC Corp Ltd, Ibaraki 3058501, Japan; [Honjo, Hiroaki; Ikeda, Shoji] Tohoku Univ, Ctr Innovat Integrated Elect Syst, Sendai, Miyagi 9800845, Japan; [Kinoshita, Keizo] Tohoku Univ, Ctr Spintron Integrated Syst, Sendai, Miyagi 9808577, Japan; [Kinoshita, Keizo] SCR, Tsukuba, Ibaraki 3058569, Japan; [Ikeda, Shoji] Tohoku Univ, Ctr Spintron Integrated Syst, Sendai, Miyagi 9800845, Japan; [Endoh, Tetsuo] Tohoku Univ, Ctr Spintron Integrated Syst, Ctr Innovat Integrated Elect Syst, Sendai, Miyagi 9800845, Japan; [Endoh, Tetsuo] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9800845, Japan; [Ohno, Hideo] Tohoku Univ, Ctr Spintron Integrated Syst, Ctr Innovat Integrated Elect Syst, Sendai, Miyagi 9808577, Japan; [Ohno, Hideo] Tohoku Univ, Lab Nanoelect & Spintron, Elect Commun Res Inst, Sendai, Miyagi 9808577, Japan	Natsui, M (reprint author), Tohoku Univ, Lab Brainware Syst, Elect Commun Res Inst, Ctr Spintron Integrated Syst, Sendai, Miyagi 9808577, Japan.				JSPS through FIRST Program; VDEC	This work was supported in part by JSPS through FIRST Program and VDEC.	Suzuki D, 2013, IEICE ELECTRON EXPR, V10, DOI 10.1587/elex.10.20130772; Harms JD, 2010, IEEE T ELECTRON DEV, V57, P1425, DOI 10.1109/TED.2010.2047073; Kim Y, 2012, IEEE INT SYMP CIRC S, P2705; Ikeda S, 2007, IEEE T ELECTRON DEV, V54, P991, DOI 10.1109/TED.2007.894617; Morris D, 2012, DES AUT CON, P486; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/nmat2804, 10.1038/NMAT2804]; Das J, 2012, IEEE T CIRCUITS-I, V59, P2008, DOI 10.1109/TCSI.2012.2185311; Sakimura N, 2012, IEEE INT SYMP CIRC S, P1971, DOI 10.1109/ISCAS.2012.6271663; Sato H, 2013, IEEE T MAGN, V49, P4437, DOI 10.1109/TMAG.2013.2251326; Ohsawa T, 2013, IEEE J SOLID-ST CIRC, V48, P1511, DOI 10.1109/JSSC.2013.2253412; Kostrov A., 2010, MEMSTECH, P20; Liauw Y. Y., 2012, P INT SOL STAT CIRC, P406; Matsunaga S., 2013, S VLSI CIRC, VC9-2, P106; Matsunaga S., 2009, APPL PHYS EXP, V2; Matsunaga S., 2008, APPL PHYS EXP, V1; Matsunaga S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.063004; Natsui M., 2013, P INT SOL STAT CIRC, P194; Natsui M, 2013, IEEE INT SYMP CIRC S, P105, DOI 10.1109/ISCAS.2013.6571793; Natsui M, 2013, J MULT-VALUED LOG S, V21, P597; Ohsawa T., 2013, S VLSI CIRC, pC110; Ohsawa T., 2013, S VLSI CIRC, P110; Ryu K, 2012, IEEE T VLSI SYST, V20, P2044, DOI 10.1109/TVLSI.2011.2172644; Sato H., 2013, P IEEE INT EL DEV M; Suzuki D., 2010, P INT C SOL STAT DEV, P1146; Suzuki D, 2012, J APPL PHYS, V111, DOI 10.1063/1.3672411; Suzuki D, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CM04; Suzuki D, 2012, MIDWEST SYMP CIRCUIT, P334, DOI 10.1109/MWSCAS.2012.6292025; Tsai TH, 2011, IEEE T CIRC SYST VID, V21, P1646, DOI 10.1109/TCSVT.2011.2133230; Tsuji Y., 2012, VLSI TECHN, P63; Windbacher T., 2013, P IEEE ACM INT S NAN, P36; Xiaofeng Yao, 2012, IEEE Transactions on Nanotechnology, V11, DOI 10.1109/TNANO.2011.2158848; Zhao W., 2006, Proceedings of the 2006 IEEE International Behavioral Modeling and Simulation Workshop (IEEE Cat. No. 06TH8895)	32	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	FEB	2015	50	2					476	489		10.1109/JSSC.2014.2362853		14	Engineering, Electrical & Electronic	Engineering	CA9GY	WOS:000349231400007		
J	Malki, B; Yamamoto, T; Verbruggen, B; Wambacq, P; Craninckx, J				Malki, Badr; Yamamoto, Takaya; Verbruggen, Bob; Wambacq, Piet; Craninckx, Jan			A 70 dB DR 10 b 0-to-80 MS/s Current-Integrating SAR ADC With Adaptive Dynamic Range (vol 49, pg 1173, 2014)	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Correction									[Malki, Badr; Verbruggen, Bob; Wambacq, Piet; Craninckx, Jan] IMEC, B-3001 Leuven, Belgium; [Malki, Badr; Wambacq, Piet] Vrije Univ Brussel, ETRO Dept, Brussels, Belgium; [Yamamoto, Takaya] Renesas Elect, Takasaki, Gumma, Japan	Malki, B (reprint author), IMEC, B-3001 Leuven, Belgium.	Jan.Craninckx@imec.be					Ranganathan S, 2003, IEEE J SOLID-ST CIRC, V38, P2087, DOI 10.1109/JSSC.2003.819162; Malki B, 2014, IEEE J SOLID-ST CIRC, V49, P1173, DOI 10.1109/JSSC.2014.2309086; Malki B., 2012, 2012 IEEE International Solid-State Circuits Conference (ISSCC), DOI 10.1109/ISSCC.2012.6177095	3	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	FEB	2015	50	2					619	619		10.1109/JSSC.2014.2388331		1	Engineering, Electrical & Electronic	Engineering	CA9GY	WOS:000349231400018		
J	Liu, T; Katayama, T; Kawaguchi, H				Liu, Tao; Katayama, Takeo; Kawaguchi, Hitoshi			High-Frequency Self-Modulation in Short-External-Cavity VCSEL With Concave Mirror	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Beat note; concave mirror; external-cavity modes; external-cavity VCSEL; polarization-rotated feedback	SURFACE-EMITTING LASERS	We observed high-frequency modulation of optical output from a short-external-cavity vertical-cavity surface-emitting laser with a new configuration. The length L of the external cavity was reduced using a short-radius concave mirror as one end of the cavity and using a thin-film quarter-wave plate in the cavity. With a concave mirror having a radius of 20 mm, a pulse sequence based on the well-known polarization self-modulation and having a repetition rate of similar to 3.5 GHz was generated. When the radius was shortened to 5.08 mm, a sinusoidal modulation with a frequency of similar to 12.6 GHz was generated. With changing drive current, stable modulation sequences with periodic changes in the modulation frequency and polarization direction were observed at discrete current values. We found that two external-cavity modes, which were separated by nearly c/4L, selectively oscillated and the beat of them resulted in modulation of the output.	[Liu, Tao; Katayama, Takeo; Kawaguchi, Hitoshi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300101, Japan	Liu, T (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300101, Japan.	t-liu@ms.naist.jp; tkatayam@ms.naist.jp; khitoshi@ms.naist.jp			Japan Society for the Promotion of Science [24226011, 26420307]	Manuscript received September 12, 2014; revised October 23, 2014; accepted November 3, 2014. Date of publication November 13, 2014; date of current version January 19, 2015. Date of publicaiton November 13, 2014. This work was supported by the Grants-in-Aid for Scientific Research through the Japan Society for the Promotion of Science under Grant 24226011 and Grant 26420307.	Ropars G, 1997, APPL PHYS LETT, V70, P2661, DOI 10.1063/1.118982; Li H, 1998, APPL PHYS LETT, V72, P2355, DOI 10.1063/1.121398; Camargo FA, 2012, IEEE PHOTONIC TECH L, V24, P1218, DOI 10.1109/LPT.2012.2199103; JIANG SJ, 1993, APPL PHYS LETT, V63, P3545, DOI 10.1063/1.110092; Katayama T, 2007, JPN J APPL PHYS 2, V46, pL1231, DOI 10.1143/JJAP.46.L1231	5	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	FEB 1	2015	27	3					280	283		10.1109/LPT.2014.2368582		4	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CA8SH	WOS:000349190700015		
J	Suzuki, T; Motoya, T; Yamaoka, M; Kato, T; Aoki, H; Tanaka, S				Suzuki, Takanori; Motoya, Toru; Yamaoka, Masanao; Kato, Takeshi; Aoki, Hidetaka; Tanaka, Shigehisa			1.3-mu m Silicon Optical Switch Integrated With Germanium Photodiodes for Stable Operation	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						Optical switches; silicon devices; integrated optics		A carrier-injection-type silicon optical switch (OSW) monolithically integrated with germanium photodiodes (Ge-PDs) is proposed and operated at a wavelength of 1310 nm. The Ge-PDs used for monitoring photocurrent achieve stable switching control. A 4 x 4 silicon OSW, ideally a path-independent-loss type, was fabricated on a silicon-on-insulator substrate. Measured loss variations of all 16 paths were similar to 3 dB, and the switching response of the OSW was faster than 10 ns. Feedback control of injection current of the OSW was demonstrated. This result shows that the proposed closed-loop feedback control by monitoring photocurrents of Ge-PDs has the potential for stable operation of matrix OSWs.	[Suzuki, Takanori; Motoya, Toru; Yamaoka, Masanao; Kato, Takeshi; Aoki, Hidetaka; Tanaka, Shigehisa] Hitachi Ltd, Cent Res Lab, Tokyo 1858601, Japan	Suzuki, T (reprint author), Hitachi Ltd, Cent Res Lab, Tokyo 1858601, Japan.	takanori.suzuki.ym@hitachi.com; toru.motoya.uh@hitachi.com; masanao.yamaoka.ns@hitachi.com; takeshi.kato.hk@hitachi.com; hidetaka.aoki.rt@hitachi.com; shigehisa.tanaka.pn@hitachi.com					Porter G, 2013, ACM SIGCOMM COMP COM, V43, P447, DOI 10.1145/2534169.2486007; Suzuki K, 2014, OPT EXPRESS, V22, P3887, DOI 10.1364/OE.22.003887; Campenhout J.V., 2009, OPT EXPRESS, V17, P24020; Lee B. G., 2013, P OPT FIB COMM C MAR, P1; Nakajima H, 1999, IEICE T ELECTRON, VE82C, P297; Nakamura S., 2011, P OPT FIB COMM C, P3; Niwa T., 2013, P OPT FIB COMM C MAR, P3; Suzuki K., 2013, P 39 EUR C EXH OPT C, P1	8	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1041-1135	1941-0174		IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	FEB 1	2015	27	3					304	306		10.1109/LPT.2014.2370061		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CA8SH	WOS:000349190700021		
J	Kokkoniemi, J; Lehtomaki, J; Umebayashi, K; Juntti, M				Kokkoniemi, Joonas; Lehtomaeki, Janne; Umebayashi, Kenta; Juntti, Markku			Frequency and Time Domain Channel Models for Nanonetworks in Terahertz Band	IEEE TRANSACTIONS ON ANTENNAS AND PROPAGATION			English	Article						Continuum absorption; molecular absorption; multiple scattering; nanonetworks; Rayleigh scattering; terahertz radiation	MOLECULAR SPECTROSCOPIC DATABASE; ATMOSPHERIC TRANSMISSION; PULSE-PROPAGATION; ANTENNA; COMMUNICATION; EDITION	Time and frequency domain channel models are proposed for nanonetworks utilizing the terahertz band (0.1-10 THz) for wireless communication. Nanonetworks are formed by tiny nanodevices which consist of nanoscale (molecular scale) components. Channel models capturing the unique peculiarities of the THz band are needed for designing proper physical layer techniques and for accurate performance analysis. Existing channel models have included the free space path loss and the molecular absorption loss, which is significant in the THz band. This paper theoretically analyzes scattering including multiple scattering referring to a sequence of scattering events from small particles, such as aerosols. Both the frequency and the impulse responses are derived. It is shown that the small particle scattering can result into significant additional loss that needs to be taken into account with the loss depending on the density and size distribution of the particles. It is shown that multiple scattering leads to a long tail in the impulse response. As most of the physical layer proposals for nanonetworks are based on the on-off keying, the channel response to pulse waveforms is specifically considered.	[Kokkoniemi, Joonas; Lehtomaeki, Janne; Juntti, Markku] Univ Oulu, Dept Commun Engn, CWC, FI-90014 Oulu, Finland; [Umebayashi, Kenta] Tokyo Univ Agr & Technol, Dept Elect & Elect Engn, Tokyo 1830057, Japan	Kokkoniemi, J (reprint author), Univ Oulu, Dept Commun Engn, CWC, FI-90014 Oulu, Finland.	joonas.kokkoniemi@ee.oulu.fi; janne.lehtomaki@ee.oulu.fi; ume_k@cc.tuat.ac.jp; markku.juntti@ee.oulu.fi	UMEBAYASHI, Kenta/G-1084-2013; 	Kokkoniemi, Joonas/0000-0003-1077-3608	Infotech Oulu doctoral program; Research Council of University of Oulu	This work was supported by Infotech Oulu doctoral program and in part by the Research Council of University of Oulu.	Akyildiz I. F., 2010, NANO COMMUNICATION N, V1, P3; Aleksandropoulou V, 2008, INDOOR BUILT ENVIRON, V17, P237, DOI 10.1177/1420326X08091201; Jacquinet-Husson N, 2011, J QUANT SPECTROSC RA, V112, P2395, DOI 10.1016/j.jqsrt.2011.06.004; Jansen C, 2011, IEEE T THZ SCI TECHN, V1, P462, DOI 10.1109/TTHZ.2011.2153610; Sadowsky JS, 1998, IEEE T VEH TECHNOL, V47, P270, DOI 10.1109/25.661053; Shlivinski A, 1997, IEEE T ANTENN PROPAG, V45, P1140, DOI 10.1109/8.596907; Ghassemzadeh SS, 2004, IEEE T COMMUN, V52, P1786, DOI 10.1109/TCOMM.2003.820755; Alduchov OA, 1996, J APPL METEOROL, V35, P601, DOI 10.1175/1520-0450(1996)035<0601:IMFAOS>2.0.CO;2; Porter JN, 1997, J GEOPHYS RES-ATMOS, V102, P6035, DOI 10.1029/96JD03403; Kandler K, 2007, ATMOS ENVIRON, V41, P8058, DOI 10.1016/j.atmosenv.2007.06.047; Paasschens JCJ, 1997, PHYS REV E, V56, P1135, DOI 10.1103/PhysRevE.56.1135; Franceschetti M, 2004, IEEE T ANTENN PROPAG, V52, P1304, DOI 10.1109/TAP.2004.827540; Jornet JM, 2011, IEEE T WIREL COMMUN, V10, P3211, DOI 10.1109/TWC.2011.081011.100545; Llatser I, 2012, PHOTONIC NANOSTRUCT, V10, P353, DOI 10.1016/j.photonics.2012.05.011; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; Jornet JM, 2013, IEEE J SEL AREA COMM, V31, P685, DOI 10.1109/JSAC.2013.SUP2.1213001; Bodhaine BA, 1999, J ATMOS OCEAN TECH, V16, P1854, DOI 10.1175/1520-0426(1999)016<1854:ORODC>2.0.CO;2; VANEXTER M, 1990, IEEE T MICROW THEORY, V38, P1684, DOI 10.1109/22.60016; Pardo JR, 2001, IEEE T ANTENN PROPAG, V49, P1683, DOI 10.1109/8.982447; Wang P, 2013, AD HOC NETW, V11, P2541, DOI 10.1016/j.adhoc.2013.07.002; Yang YH, 2012, IEEE T THZ SCI TECHN, V2, P406, DOI 10.1109/TTHZ.2012.2203429; Pardo JR, 2001, J QUANT SPECTROSC RA, V68, P419, DOI 10.1016/S0022-4073(00)00034-0; Hussein T, 2004, ATMOS CHEM PHYS, V4, P391; Smolik J, 2005, WATER AIR SOIL POLL, V165, P301, DOI 10.1007/s11270-005-7146-6; Chandrasekhar S., 1960, RAD TRANSFER; Chen G., 2011, NOT AM MATH SOC, V58, P1421; Cid-fuentes R. G., 2012, P IEEE INT C COMM, P4937; Cui H., 2011, J PHYS C SERIES, V276, P1; Fozard J. A., 2005, THESIS U OXFORD OXFO; Franceschetti M, 2004, IEEE T ANTENN PROPAG, V52, P2742, DOI 10.1109/TAP.2004.834376; Goldsmith A., 2005, WIRELESS COMMUNICATI; Halevy I., 2009, J GEOPHYS RES, V114, P1; Haubrich D., 2010, THESIS TEXAS A M U C; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; CALVERT JG, 1990, PURE APPL CHEM, V62, P2167, DOI 10.1351/pac199062112167; Jornet J., 2011, P 8 ANN IEEE COMM SO, P80; Jornet J. M., 2010, P 4 EUR C ANT PROP E, P1; Jornet JM, 2014, IEEE T COMMUN, V62, P1742, DOI 10.1109/TCOMM.2014.033014.130403; Mlawer EJ, 2012, PHILOS T R SOC A, V370, P2520, DOI 10.1098/rsta.2011.0295; Moosmuller H, 2009, J AIR WASTE MANAGE, V59, P1028, DOI 10.3155/1047-3289.59.9.1028; Niu SJ, 2010, ADV ATMOS SCI, V27, P1259, DOI 10.1007/s00376-010-8192-6; Paine S., 2012, 152 SMA, P152; Payne VH, 2011, IEEE T GEOSCI REMOTE, V49, P2194, DOI 10.1109/TGRS.2010.2091416; Pickett H. M., SUBMILLIMETER MILLIM; Pierrehumbert R.T., 2011, PRINCIPLES PLANETARY; Dudzinska MR, 2011, MANAGEMENT OF INDOOR AIR QUALITY, P1; Priebe S, 2013, IEEE T WIREL COMMUN, V12, P4445, DOI 10.1109/TWC.2013.072313.121581; da Costa MR, 2009, MICROELECTRON J, V40, P776, DOI 10.1016/j.mejo.2008.11.016; Rothman LS, 1998, J QUANT SPECTROSC RA, V60, P665, DOI 10.1016/S0022-4073(98)00078-8; Schery SD, 2001, UNDERSTANDING RADIOA; Su K., 2012, THESIS NEW JERSEY I; Weldon J, 2008, PHYS STATUS SOLIDI B, V245, P2323, DOI 10.1002/pssb.200879639; Wendich M., 2012, THEORY ATMOSPHERIC R; Zender C., 2010, PARTICLE SIZE DISTRI; Zheng J, 2011, IEEE COMMUN MAG, V49, P30	55	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-926X	1558-2221		IEEE T ANTENN PROPAG	IEEE Trans. Antennas Propag.	FEB	2015	63	2					678	691		10.1109/TAP.2014.2373371		14	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CA8IQ	WOS:000349162400025		
J	Hatanaka, T; Johguchi, K; Takeuchi, K				Hatanaka, Teruyoshi; Johguchi, Koh; Takeuchi, Ken			Experimental Investigation of Program Voltage (20 V) Generation With Boost Converter for 3-D-Stacked NAND Flash SSD	IEEE TRANSACTIONS ON COMPONENTS PACKAGING AND MANUFACTURING TECHNOLOGY			English	Article						Boost converter; electromagnetic interference (EMI); magnetic field; NAND flash memory; solid-state drive (SSD)	CHIP SPIRAL INDUCTORS; SILICON; PACKAGE; DESIGN; SYSTEM; EMI	This paper experimentally demonstrates program voltage (20 V) generation under emulated condition of a 3-D solid-state drive (3-D-SSD) which vertically integrates boost converter on an flame retardant type 4-interposer and Si-chips. The proposed program voltage generator is a boost converter using a coil on the interposer. A measured peak magnetic field power is approximately -49 dBm above the coil, which satisfies the international regulation. The magnetic field induces the eddy current in a conductor material. The eddy current degrades the boost converter performance due to the lowered effective inductance of the coil. The effects on the performance of the boost converter as a function of the distance from the coil to the conductor are experimentally investigated. A 3-D-SSD requires a >0.84-mm space between the coil and conductor to generate the program voltage. By inserting NAND flash memory chips between the coil and the conductor, a 3-D-SSD can be successfully realized without the output voltage degradation.	[Hatanaka, Teruyoshi; Johguchi, Koh; Takeuchi, Ken] Chuo Univ, Dept Elect Elect & Commun Engn, Tokyo 1920393, Japan; [Hatanaka, Teruyoshi] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138654, Japan	Hatanaka, T (reprint author), Chuo Univ, Dept Elect Elect & Commun Engn, Tokyo 1920393, Japan.	hatanaka@lsi.t.u-tokyo.ac.jp; johguchi@ieee.org; johguchi@takeuchi-lab.org			Japan Science and Technology Agency/Core Research for Evolutionary Science and Technology; VLSI Design and Education Center; University of Tokyo; Synopsys, Inc., Mountain View, CA, USA	This work was supported in part by the Japan Science and Technology Agency/Core Research for Evolutionary Science and Technology, in part by the VLSI Design and Education Center, and in part by the University of Tokyo in collaboration with Synopsys, Inc., Mountain View, CA, USA. Recommended for publication by Associate Editor E.-P. Li upon evaluation of reviewers' comments.	Kuhn WB, 2001, IEEE T MICROW THEORY, V49, P31, DOI 10.1109/22.899959; Niknejad AM, 2001, IEEE T MICROW THEORY, V49, P166, DOI 10.1109/22.900004; Cao Y, 2003, IEEE J SOLID-ST CIRC, V38, P419, DOI 10.1109/JSSC.2002.808285; Kanda K, 2013, IEEE J SOLID-ST CIRC, V48, P159, DOI 10.1109/JSSC.2012.2215094; Li H, 2010, IEEE T ELECTROMAGN C, V52, P1001, DOI 10.1109/TEMC.2010.2071878; Yue CP, 1998, IEEE J SOLID-ST CIRC, V33, P743, DOI 10.1109/4.668989; Yue CP, 2000, IEEE T ELECTRON DEV, V47, P560, DOI 10.1109/16.824729; Sudo T, 2004, IEEE T ADV PACKAGING, V27, P304, DOI 10.1109/TADVP.2004.828817; Craninckx J, 1995, IEEE J SOLID-ST CIRC, V30, P1474, DOI 10.1109/4.482195; [Anonymous], 2006, INF TECHN EQ RAD DIS; Mohan SS, 1999, IEEE J SOLID-ST CIRC, V34, P1419, DOI 10.1109/4.792620; Craninckx J, 1997, IEEE J SOLID-ST CIRC, V32, P736, DOI 10.1109/4.568844; Hamzaoglu F., 2014, IEEE ISSCC, P230; HATANAKA T, 2010, IEEE S VLSI CIRC, P233; Hatanaka T., 2011, IEEE S VLSI CIRC, P200; Hatanaka T., 2012, P IEEE INT 3D SYST I, P1; Ishida K., 2009, IEEE INT SOL STAT CI, P238; Johguchi K, 2011, IEEE T COMP PACK MAN, V1, P268, DOI 10.1109/TCPMT.2010.2101930; Johguchi K., 2011, P INT C SOL STAT DEV, P1057; Li Y., 2012, IEEE INT SOL STAT CI, P436, DOI [DOI 10.1109/ISSCC.2012.6177080, 10.1109/ISSCC.2012.6177080]; Lin H.-N., 2010, P AS PAC S EL COMP A, P727; Oh T.-Y., 2014, IEEE INT SOL STAT CI, P430; Talwalkar NA, 2005, IEEE T ELECTRON DEV, V52, P176, DOI 10.1109/TED.2004.842535; Tamate M., 2010, P IEEE INT POW EL C, P1132	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3950	2156-3985		IEEE T COMP PACK MAN	IEEE Trans. Compon. Pack. Manuf. Technol.	FEB	2015	5	2					188	193		10.1109/TCPMT.2014.2381267		6	Engineering, Manufacturing; Engineering, Electrical & Electronic; Materials Science, Multidisciplinary	Engineering; Materials Science	CA9HI	WOS:000349232500005		
J	Suzuki, Y; Furuya, R; Sundaram, V; Tummala, RR				Suzuki, Yuya; Furuya, Ryuta; Sundaram, Venky; Tummala, Rao R.			Demonstration of 10-mu m Microvias in Thin Dry-Film Polymer Dielectrics for High-Density Interposers	IEEE TRANSACTIONS ON COMPONENTS PACKAGING AND MANUFACTURING TECHNOLOGY			English	Article						Excimer laser; fine pitch via; fine pitch wiring; microvia; thin dielectric film	TECHNOLOGY; LASER	This paper describes the demonstration of 10-mu m diameter interlayer vias with 3.5-mu m wide re-distribution layer copper wiring in a unique dry-film polymer dielectric, ZEONIF ZS100 (ZS100), suitable for panel-based high-density organic and glass interposers. The uniqueness of polymer dielectric includes low dielectric constant, low dielectric loss, low moisture uptake, and low surface roughness. The dry-film polymer dielectric was laminated on thin and low coefficient of thermal expansion organic or glass cores using double-side vacuum lamination processes. The ultrasmall microvias were drilled with 248-nm KrF excimer laser. Metallization by electroless and electrolytic copper plating successfully achieved formation of fully filled vias and copper traces simultaneously without any chemical-mechanical polishing. The processes demonstrated in this paper enable interposers with much finer bump pitch than current organic package technology. In addition, the processes can be scaled to large panels leading to lower cost than the previous work in fine pitch Si interposers fabricated through back-end-of-line wafer processes.	[Suzuki, Yuya; Sundaram, Venky; Tummala, Rao R.] Georgia Inst Technol, Packaging Res Ctr D, Atlanta, GA 30332 USA; [Suzuki, Yuya] Zeon Corp, Res & Develop Ctr, Kawasaki, Kanagawa 2109507, Japan; [Furuya, Ryuta] Ushio Inc, Tokyo 1008150, Japan	Suzuki, Y (reprint author), Georgia Inst Technol, Packaging Res Ctr D, Atlanta, GA 30332 USA.	ysuzuki3@mail.gatech.edu; rfuruya3@mail.gatech.edu; vs24@mail.gatech.edu; rao.tummala@ece.gatech.edu			U.S. Department of Commerce [BS123456]	This work was supported by the U.S. Department of Commerce under Grant BS123456. Recommended for publication by Associate Editor J. J. Liu upon evaluation of reviewers' comments.	Meijer J, 2004, J MATER PROCESS TECH, V149, P2, DOI 10.1016/j.jmatprotec.2004.02.003; Sato Y, 2013, 2013 IEEE 63RD ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE (ECTC), P1656, DOI 10.1109/ECTC.2013.6575795; Atotech GmbH, VIA TECHN COPP TRENC; Blackshear ED, 2005, IBM J RES DEV, V49, P641; Chen Q, 2014, IEEE T COMP PACK MAN, V4, P2035, DOI 10.1109/TCPMT.2014.2364535; Ehrler S., 1996, P 19 IEEE CPMT EL MA, P162; Hondo T, 2013, 2013 IEEE 63RD ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE (ECTC), P136, DOI 10.1109/ECTC.2013.6575563; Huemoeller R., 2008, P 3 INT MICR PACK AS, P110; Ishida M., 2014, P IEEE EL COMP TECHN; Lei W., 2005, P 6 INT C EL PACK TE, P1; Li H, 2011, CONTROL ENG APPL INF, V13, P3; Liu F., 2005, P 6 INT C EL PACK TE, P307; Liu FH, 2001, ELEC COMP C, P1159; Lu H., 2014, P EL COMP TECHN C EC, P1416; Santarinil M., 2011, XCELL J, V74, P9; Shimizu N., 2013, P INT MICR ASS PACK, P414; Souter M. C., 2014, CHIP SCALE REV, V42, P42; Sun YL, 2002, P SOC PHOTO-OPT INS, V4915, P241, DOI 10.1117/12.482893; Suzuki Y., 2014, P IEEE 64 EL COMP TE, P1427; Tanimoto A., 2012, P INT C REN EN RES A, P1; Tzeng PJ, 2013, 2013 IEEE 63RD ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE (ECTC), P86; Yamanaka K, 2010, IEEE T COMPON PACK T, V33, P453, DOI 10.1109/TCAPT.2009.2033666; Zeon Corporation, ZEONIF INS MAT PRINT; Zheng HY, 2001, OPT LASER ENG, V36, P355, DOI 10.1016/S0143-8166(01)00057-4	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3950	2156-3985		IEEE T COMP PACK MAN	IEEE Trans. Compon. Pack. Manuf. Technol.	FEB	2015	5	2					194	200		10.1109/TCPMT.2014.2382339		7	Engineering, Manufacturing; Engineering, Electrical & Electronic; Materials Science, Multidisciplinary	Engineering; Materials Science	CA9HI	WOS:000349232500006		
J	Liu, B; Lu, WL; Chen, TP				Liu, Bo; Lu, Wenlian; Chen, Tianping			Consensus in Continuous-Time Multiagent Systems Under Discontinuous Nonlinear Protocols	IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS			English	Article						Almost sure convergence; consensus; discontinuous; multiagent systems; switching	SWITCHING TOPOLOGIES; NETWORKS; ALGORITHMS; SYNCHRONIZATION; COORDINATION; COOPERATION; STABILITY; DYNAMICS; AGENTS; DELAYS	In this paper, we provide a theoretical analysis for nonlinear discontinuous consensus protocols in networks of multiagents over weighted directed graphs. By integrating the analytic tools from nonsmooth stability analysis and graph theory, we investigate networks with both fixed topology and randomly switching topology. For networks with a fixed topology, we provide a sufficient and necessary condition for asymptotic consensus, and the consensus value can be explicitly calculated. As to networks with switching topologies, we provide a sufficient condition for the network to realize consensus almost surely. In particular, we consider the case that the switching sequence is independent and identically distributed. As applications of the theoretical results, we introduce a generalized blinking model and show that consensus can be realized almost surely under the proposed protocols. Numerical simulations are also provided to illustrate the theoretical results.	[Liu, Bo] Xidian Univ, Minist Educ China, Key Lab Intelligent Percept & Image Understanding, Xian 710071, Peoples R China; [Liu, Bo] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; [Lu, Wenlian] Fudan Univ, Sch Math Sci, Lab Math Nonlinear Sci, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Lu, Wenlian] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Chen, Tianping] Fudan Univ, Sch Comp Sci Math Sci, Shanghai 200433, Peoples R China	Liu, B (reprint author), Xidian Univ, Minist Educ China, Key Lab Intelligent Percept & Image Understanding, Xian 710071, Peoples R China.	liu7bo9@gmail.com; wenlian@fudan.edu.cn; tchen@fuan.edu.cn			National Natural Sciences Foundation of China [61273211, 61273309]; Shanghai Rising-Star Program [11QA1400400]; China Post-Doctoral Science Foundation [2011M500065]; Marie Curie International Incoming Fellowship through the European Commission [FP7-PEOPLE-2011-IIF-302421]	This work was supported in part by the National Natural Sciences Foundation of China under Grant 61273211 and Grant 61273309, in part by the Shanghai Rising-Star Program under Grant 11QA1400400, in part by the China Post-Doctoral Science Foundation under Grant 2011M500065, and in part by the Marie Curie International Incoming Fellowship through the European Commission under Grant FP7-PEOPLE-2011-IIF-302421.	Moreau L, 2004, IEEE DECIS CONTR P, P3998, DOI 10.1109/CDC.2004.1429377; Cortes J, 2005, SIAM J CONTROL OPTIM, V44, P1543, DOI 10.1137/S0363012903428652; Li LL, 2013, IEEE T CIRCUITS-I, V60, P2668, DOI 10.1109/TCSI.2013.2244322; Lu WL, 2004, IEEE T CIRCUITS-I, V51, P2491, DOI 10.1109/TCSI.2004.838308; Liu B, 2008, IEEE T NEURAL NETWOR, V19, P1967, DOI 10.1109/TNN.2008.2004404; Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; Liu B, 2011, SIAM J CONTROL OPTIM, V49, P227, DOI 10.1137/090745945; DeLellis P, 2010, APPL MATH COMPUT, V217, P988, DOI 10.1016/j.amc.2010.01.126; Cortes J, 2008, AUTOMATICA, V44, P726, DOI 10.1016/j.automatica.2007.07.022; Liu XW, 2009, PHYS LETT A, V373, P3122, DOI 10.1016/j.physleta.2009.06.054; Ren W, 2005, P AMER CONTR CONF, P1859; Cortes J, 2006, AUTOMATICA, V42, P1993, DOI 10.1016/j.automatica.2006.06.015; Matei I, 2008, IEEE DECIS CONTR P, P3535; Belykh IV, 2004, PHYSICA D, V195, P188, DOI 10.1016/j.physd.2004.03.013; Hasler M, 2013, SIAM J APPL DYN SYST, V12, P1031, DOI 10.1137/120893410; Olfati-Saber R, 2004, IEEE T AUTOMAT CONTR, V49, P1520, DOI 10.1109/TAC.2004.834113; Olfati-Saber R, 2006, IEEE T AUTOMAT CONTR, V51, P401, DOI 10.1109/TAC.2005.864190; Hasler M, 2013, SIAM J APPL DYN SYST, V12, P1007, DOI 10.1137/120893409; Aubin J. P., 1990, SET VALUED ANAL; Ceragioli F, 2011, AUTOMATICA, V47, P1916, DOI 10.1016/j.automatica.2011.06.020; Clarke F.H., 1983, OPTIMIZATION NONSMOO; DURRETT R., 2005, PROBABILITY THEORY E; Fax A., 2004, IEEE T AUTOMAT CONTR, V49, P1465; Filippov A. F., 1988, DIFFERENTIAL EQUATIO; Hui Q, 2008, P AMER CONTR CONF, P3981; Salehi A., 2007, P 46 IEEE C DEC CONT, P4209	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2162-237X	2162-2388		IEEE T NEUR NET LEAR	IEEE Trans. Neural Netw. Learn. Syst.	FEB	2015	26	2					290	301		10.1109/TNNLS.2014.2314699		12	Computer Science, Artificial Intelligence; Computer Science, Hardware & Architecture; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CA4EE	WOS:000348856200008		
J	Kajiwara, N; Masaki, C; Mukaibo, T; Kondo, Y; Nakamoto, T; Hosokawa, R				Kajiwara, Norihiro; Masaki, Chihiro; Mukaibo, Taro; Kondo, Yusuke; Nakamoto, Tetsuji; Hosokawa, Ryuji			Soft Tissue Biological Response to Zirconia and Metal Implant Abutments Compared With Natural Tooth: Microcirculation Monitoring as a Novel Bioindicator	IMPLANT DENTISTRY			English	Article						blood flow; laser speckle imaging; thermograph; zirconia abutment	GINGIVAL BLOOD-FLOW; LASER-DOPPLER FLOWMETRY; FIXED DENTAL PROSTHESES; PERIODONTAL SURGERY; POSTERIOR REGIONS; IN-VIVO; SPECKLE; TITANIUM; RESTORATIONS; PERFUSION	Introduction: Zirconia is often used for implant abutments for esthetics. The aim of this clinical study was to compare the effects of zirconia and metal abutments on periimplant soft tissue. Materials and Methods: Ten maxillary anterior implant patients, 5 with metal abutments and 5 with zirconia abutments, were enrolled in this trial. The soft tissue around the implant abutments was evaluated by 2-dimensional laser speckle imaging and thermography. The blood flow in soft tissue around natural teeth was also measured to correct for differences among the subjects. Results: Significantly greater blood flow was detected in the zirconia abutment group (95.64 +/- 5.17%) relative to the metal abut-ment group (82.25 +/- 8.92%) in free gingiva (P = 0.0317). Reduced blood flow (by almost 18%) was detected in the tissue surrounding metal abutments compared with the tissue surrounding natural teeth. The surface temperature showed no significant difference for all measurements. Conclusions: These results suggest that blood flow in tissue surrounding zirconia abutments is similar to that in soft tissue around natural teeth. Moreover, zirconia abutments could be advantageous for the maintenance of immune function by improving blood circulation.	[Kajiwara, Norihiro] Kyushu Dent Univ, Dept Oral Reconstruct & Rehabil, Grad Sch, Kitakyushu, Fukuoka 8038580, Japan; [Masaki, Chihiro; Mukaibo, Taro; Kondo, Yusuke; Nakamoto, Tetsuji; Hosokawa, Ryuji] Kyushu Dent Univ, Dept Oral Reconstruct & Rehabil, Kitakyushu, Fukuoka 8038580, Japan	Masaki, C (reprint author), Kyushu Dent Univ, Dept Oral Reconstruct & Rehabil, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	masaki@kyu-dent.ac.jp					Andersson B, 1999, INT J PROSTHODONT, V12, P318; Ketabi M, 1997, J CLIN PERIODONTOL, V24, P888, DOI 10.1111/j.1600-051X.1997.tb01207.x; Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292; Lops D, 2013, INT J ORAL MAX IMPL, V28, P281, DOI 10.11607/jomi.2668; Retzepi M, 2007, J CLIN PERIODONTOL, V34, P903, DOI 10.1111/j.1600-051X.2007.01119.x; Gleissner C, 2006, J PERIODONTOL, V77, P1762, DOI 10.1902/jop.2006.050194; Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6; Kim SS, 2013, CLIN ORAL IMPLAN RES, V24, P517, DOI 10.1111/j.1600-0501.2011.02413.x; Forrester KR, 2004, IEEE T BIO-MED ENG, V51, P2074, DOI 10.1109/TBME.2004.834259; Zembic A, 2013, CLIN ORAL IMPLAN RES, V24, P384, DOI 10.1111/clr.12044; Glauser R, 2004, INT J PROSTHODONT, V17, P285; Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007; NILSSON GE, 1980, IEEE T BIO-MED ENG, V27, P597, DOI 10.1109/TBME.1980.326582; Miyazaki T, 2013, J PROSTHODONT RES, V57, P236, DOI 10.1016/j.jpor.2013.09.001; Abrahamsson I, 1998, J CLIN PERIODONTOL, V25, P721, DOI 10.1111/j.1600-051X.1998.tb02513.x; Tinschert J, 2000, J DENT, V28, P529, DOI 10.1016/S0300-5712(00)00030-0; Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Stewart CJ, 2005, BURNS, V31, P744, DOI 10.1016/j.burns.2005.04.004; Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793; Ekfeldt A, 2011, CLIN ORAL IMPLAN RES, V22, P1308, DOI 10.1111/j.1600-0501.2010.02114.x; Zakharov P, 2009, OPT EXPRESS, V17, P13904, DOI 10.1364/OE.17.013904; Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P119, DOI 10.1111/j.1600-0501.2007.01453.x; Forrester KR, 2002, MED BIOL ENG COMPUT, V40, P687, DOI 10.1007/BF02345307; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195; Beuer F, 2009, DENT MATER, V25, P121, DOI 10.1016/j.dental.2008.04.019; Welander M, 2008, CLIN ORAL IMPLAN RES, V19, P635, DOI 10.1111/j.1600-0501.2008.01543.x; Donos N, 2005, J PERIODONTAL RES, V40, P129, DOI 10.1111/j.1600-0765.2005.00777.x; Gargari M, 2010, Oral Implantol (Rome), V3, P15; Mavropoulos A, 2007, J PERIODONTOL, V78, P1774, DOI 10.1902/jop.2007.060472; Nakamoto T, 2012, IMPLANT DENT, V21, P522, DOI 10.1097/ID.0b013e318272fe81; NILSSON GE, 1984, MED BIOL ENG COMPUT, V22, P343, DOI 10.1007/BF02442104; Pelaez J, 2012, J PROSTHET DENT, V107, P373, DOI 10.1016/S0022-3913(12)60094-8; Takaba M, 2013, J PROSTHODONT, V22, P402, DOI 10.1111/jopr.12001	34	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	FEB	2015	24	1					37	41		10.1097/ID.0000000000000167		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA2AY	WOS:000348712500007		
J	Suzuki, Y; Shimpo, H; Ohkubo, C				Suzuki, Yasunori; Shimpo, Hidemasa; Ohkubo, Chikahiro			Occlusal Contact of Fixed Implant Prostheses Using Functional Bite Impression Technique	IMPLANT DENTISTRY			English	Article						functional bite impression technique; implant impression; maxillomandibular registration; functional generated path	FABRICATION; ACCURACY; SYSTEM; FIT	Objective: Functional bite impression (FBI) has been described as a definitive impression made under occlusal force after functional generated path (FGP) recording. This study compared the accuracy of occlusal contact of implant-fixed prostheses using the FBI technique and the conventional impression technique. Methods: Twelve subjects, each missing a single premolar or molar, were selected for this study. The conditions of the occlusal contacts were identified by the modified transillumination method. The occlusal contact condition was determined by comparing the rate of change in the occlusal contact area of the implant-fixed prostheses and both adjacent teeth before and after occlusal adjustment. Results: The rate of change in the occlusal contact area using the FBI technique was 96%, and the rate using the conventional technique was 54%. The occlusal contact of implant prostheses using the FBI technique revealed better accuracy than that of the conventional technique. Conclusions: Regarding the FBI technique, a precise and functional prosthesis could be produced by completing the maxillomandibular registration, impression, and FGP at the same time.	[Suzuki, Yasunori] Tsurumi Univ, Sch Dent Med, Div Oral & Maxillofacial Implantol, Yokohama, Kanagawa 2308501, Japan; [Shimpo, Hidemasa; Ohkubo, Chikahiro] Tsurumi Univ, Sch Dent Med, Dept Removable Prosthodont, Yokohama, Kanagawa 2308501, Japan	Suzuki, Y (reprint author), Tsurumi Univ, Sch Dent Med, Div Oral & Maxillofacial Implantol, Tsurumi Ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	suzuki-ys@tsurumi-u.ac.jp					DeLong R, 2007, J DENT, V35, P528, DOI 10.1016/j.jdent.2007.02.004; Quirynen M, 1992, Clin Oral Implants Res, V3, P104, DOI 10.1034/j.1600-0501.1992.030302.x; Vigolo P, 2003, J PROSTHET DENT, V89, P186, DOI 10.1067/mpr.2003.15; Kim Y, 2005, CLIN ORAL IMPLAN RES, V16, P26, DOI 10.1111/j.1600-0501.2004.01067.x; Kan JYK, 1999, J PROSTHET DENT, V81, P7, DOI 10.1016/S0022-3913(99)70229-5; NAERT I, 1992, J PROSTHET DENT, V68, P949, DOI 10.1016/0022-3913(92)90557-Q; Chee W, 2006, BRIT DENT J, V201, P429, DOI 10.1038/sj.bdj.4814118; Falk H, 1990, Swed Dent J Suppl, V69, P1; Gross MD, 2008, AUST DENT J S1, V53, P60; HARALDSON T, 1988, SCAND J DENT RES, V96, P243; Liou A D, 1993, Int J Prosthodont, V6, P377; Matsushita K, 1982, J JPN PROSTHODONT SO, V26, P250; Matsushita M, 1985, J JPN PROTHODONT SOC, V29, P1143; Misch C E, 1994, Compendium, V15, P1344; Naert IE, 2001, CLIN ORAL IMPLAN RES, V12, P245, DOI 10.1034/j.1600-0501.2001.012003245.x; Suzuki Y, 2012, J PROSTHODONT RES, V56, P293, DOI 10.1016/j.jpor.2012.02.005; Takahashi T, 2003, J PROSTHET DENT, V89, P256, DOI 10.1067/mpr.2003.40	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	FEB	2015	24	1					42	46		10.1097/ID.0000000000000175		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA2AY	WOS:000348712500008		
J	Jimbo, R; Albrektsson, T				Jimbo, Ryo; Albrektsson, Tomas			Long-term Clinical Success of Minimally and Moderately Rough Oral Implants: A Review of 71 Studies With 5 Years or More of Follow-up	IMPLANT DENTISTRY			English	Article						marginal bone loss; survival; surface roughness; osseointegration	5-YEAR PROSPECTIVE MULTICENTER; CRESTAL/MARGINAL BONE LOSS; SURFACE DENTAL IMPLANTS; RETROSPECTIVE ANALYSIS; EDENTULOUS MAXILLA; PART 1; TREATMENT OUTCOMES; TITANIUM IMPLANTS; FIXED PROSTHESES; CONTROLLED-TRIAL	Purpose: The aim of the review was to compare the long-term clinical success of minimally and moderately rough dental implants in terms of differences in marginal bone loss and survival. Materials and Methods: The pertinent literature was searched by using the PubMed database and requesting major manufacturers to provide reports of their commercially available dental implant systems. Clinical reports meeting the following criteria were reviewed: results of at least 5 years of follow-up, availability of baseline and follow-up radiographs including intraoral radiographs, and availability of marginal bone loss measurements from the baseline to the end of the follow-up period (5 years or more). All the recorded data were analyzed statistically. Results: Seventy-one of 1202 articles met the inclusion criteria. Maxillary moderately rough implants were found to have significantly higher long-term survival rates than maxillary minimally rough implants; no such difference was noticed in the mandible. Significant marginal bone loss occurred around all the implants in the first year but stabilized thereafter, indicating the absence of progressive bone loss. Conclusion: The dental implant systems commercially available today have good long-term clinical success in terms of survival and marginal bone loss.	[Jimbo, Ryo; Albrektsson, Tomas] Malmo Univ, Dept Prosthodont, Fac Odontol, S-20506 Malmo, Sweden; [Jimbo, Ryo] Nagasaki Univ, Grad Sch Biomed Sci, Div Appl Prosthodont, Nagasaki 852, Japan; [Albrektsson, Tomas] Gothenburg Univ, Dept Biomat, Gothenburg, Sweden	Jimbo, R (reprint author), Malmo Univ, Dept Prosthodont, Fac Odontol, S-20506 Malmo, Sweden.	ryo.jimbo@mah.se					Akoglu B, 2011, INT J ORAL MAX IMPL, V26, P188; Albrektsson T, 1993, Int J Prosthodont, V6, P95; Albrektsson T, 2007, CLIN IMPLANT DENT R, V9, P65, DOI 10.1111/j.1708-8208.2007.00054.x; Albrektsson T, 2012, INT J ORAL MAX IMPL, V27, P736; Albrektsson T, 2012, INT J PROSTHODONT, V25, P320; Mertens C, 2011, CLIN ORAL IMPLAN RES, V22, P1354, DOI 10.1111/j.1600-0501.2010.02123.x; Jemt T, 2011, INT J PROSTHODONT, V24, P345; Sennerby L, 2008, CLIN ORAL IMPLAN RES, V19, P219, DOI 10.1111/j.1600-0501.2007.01410.x; Bornstein MM, 2005, CLIN ORAL IMPLAN RES, V16, P631, DOI 10.1111/j.1600-0501.2005.01209.x; Friberg B, 2008, INT J ORAL MAX IMPL, V23, P481; Glauser R, 2013, CLIN IMPLANT DENT R, V15, P322, DOI 10.1111/j.1708-8208.2011.00352.x; Fischer K, 2008, CLIN ORAL IMPLAN RES, V19, P433, DOI 10.1111/j.1600-0501.2007.01510.x; Mura P, 2012, CLIN IMPLANT DENT R, V14, P565, DOI 10.1111/j.1708-8208.2010.00297.x; Albrektsson T, 1998, J ORAL MAXIL SURG, V56, P1312, DOI 10.1016/S0278-2391(98)90616-4; Jemt T, 2006, CLIN IMPLANT DENT R, V8, P61, DOI 10.1111/j.1708-8208.2006.00003.x; Khang W, 2001, J PERIODONTOL, V72, P1384, DOI 10.1902/jop.2001.72.10.1384; Wennstrom JL, 2004, J CLIN PERIODONTOL, V31, P713, DOI 10.1111/j.1600-051X.2004.00568.x; Albrektsson T, 2014, CLIN IMPLANT DENT R, V16, P155, DOI 10.1111/cid.12142; Mertens C, 2011, CLIN ORAL IMPLAN RES, V22, P464, DOI 10.1111/j.1600-0501.2010.02028.x; Schliephake H, 2012, J CLIN PERIODONTOL, V39, P188, DOI 10.1111/j.1600-051X.2011.01816.x; Ma SY, 2010, INT J PROSTHODONT, V23, P321; Jungner M, 2014, CLIN IMPLANT DENT R, V16, P230, DOI 10.1111/j.1708-8208.2012.00473.x; Koldsland OC, 2010, J PERIODONTOL, V81, P231, DOI 10.1902/jop.2009.090269; Vroom MG, 2009, CLIN ORAL IMPLAN RES, V20, P1231, DOI 10.1111/j.1600-0501.2009.01768.x; Albrektsson T, 2008, PERIODONTOL 2000, V47, P15, DOI 10.1111/j.1600-0757.2007.00247.x; Fransson C, 2010, J CLIN PERIODONTOL, V37, P442, DOI 10.1111/j.1600-051X.2010.01537.x; Eliasson A, 2009, CLIN IMPLANT DENT R, V11, P134, DOI 10.1111/j.1708-8208.2008.00099.x; Wennstrom JL, 2005, J CLIN PERIODONTOL, V32, P567, DOI 10.1111/j.1600-051X.2005.00715.x; Hardt CRE, 2002, CLIN ORAL IMPLAN RES, V13, P488, DOI 10.1034/j.1600-0501.2002.130507.x; Albrektsson T, 2012, CLIN IMPLANT DENT R, V14, P783, DOI 10.1111/cid.12013; Finne K, 2007, INT J ORAL MAX IMPL, V22, P226; Rasmusson L, 2005, CLIN IMPLANT DENT R, V7, P36, DOI 10.1111/j.1708-8208.2005.tb00045.x; BRANEMARK PI, 1975, SCAND J PLAST RECONS, V9, P116; Balshe AA, 2008, INT J ORAL MAX IMPL, V23, P1117; Balshe AA, 2009, INT J ORAL MAX IMPL, V24, P1113; Calvo-Guirado JL, 2011, CLIN ORAL IMPLAN RES, V22, P1409, DOI 10.1111/j.1600-0501.2010.02130.x; Glauser R, 2007, J PROSTHET DENT, V97, pS59, DOI 10.1016/S0022-3913(07)60009-2; ALBREKTSSON T, 1988, J PERIODONTOL, V59, P287, DOI 10.1902/jop.1988.59.5.287; Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63; Pinholt EM, 2003, CLIN ORAL IMPLAN RES, V14, P584, DOI 10.1034/j.1600-0501.2003.140508.x; Jemt T, 2002, INT J PROSTHODONT, V15, P544; BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81; Brånemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1; Buddula A, 2011, J PROSTHET DENT, V106, P290, DOI 10.1016/S0022-3913(11)60133-9; Canullo L, 2012, INT J ORAL MAX IMPL, V27, P927; Chang M, 2012, CLIN IMPLANT DENT R, V14, P388, DOI 10.1111/j.1708-8208.2010.00272.x; Eckert S, 2006, INT J PROSTHODONT, V19, P128; Eliasson A, 2000, INT J ORAL MAX IMPL, V15, P505; Engfors Ingela, 2004, Clin Implant Dent Relat Res, V6, P190, DOI 10.1111/j.1708-8208.2004.tb00035.x; Ericsson I, 2000, Clin Implant Dent Relat Res, V2, P70, DOI 10.1111/j.1708-8208.2000.tb00108.x; Friberg B, 2008, CLIN IMPLANT DENT R, V10, P78, DOI 10.1111/j.1708-8208.2007.00064.x; Friberg B, 1997, CLIN ORAL IMPLAN RES, V8, P279, DOI 10.1034/j.1600-0501.1997.080405.x; Geckili O, 2011, J ORAL IMPLANTOL; Gotfredsen K, 2001, J Prosthodont, V10, P2, DOI 10.1111/j.1532-849X.2001.00002.x; Haas R, 1995, Int J Oral Maxillofac Implants, V10, P410; Jacobs R, 2010, J CLIN PERIODONTOL, V37, P1119, DOI 10.1111/j.1600-051X.2010.01626.x; JEMT T, 1994, CLIN ORAL IMPLAN RES, V5, P142, DOI 10.1034/j.1600-0501.1994.050304.x; Friberg Bertil, 2010, Clin Implant Dent Relat Res, V12 Suppl 1, pe95, DOI 10.1111/j.1708-8208.2009.00222.x; Jemt T, 1996, Int J Oral Maxillofac Implants, V11, P291; MALMQVIST J P, 1990, International Journal of Oral and Maxillofacial Implants, V5, P53; Olsson M, 2012, SWED DENT J, V36, P221; Ozkan Y, 2011, INT J ORAL MAX IMPL, V26, P639; Ricci G, 2004, INT J ORAL MAX IMPL, V19, P597; Rocci Antonio, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P57, DOI 10.1111/j.1708-8208.2003.tb00016.x; Roccuzzo M, 2008, CLIN ORAL IMPLAN RES, V19, P148, DOI 10.1111/j.1600-0501.2007.01426.x; Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P283, DOI 10.1111/j.1600-051X.2006.00907.x; Stach Renée M, 2003, Implant Dent, V12, P87; Turkyilmaz Ilser, 2010, Clin Implant Dent Relat Res, V12 Suppl 1, pe39, DOI 10.1111/j.1708-8208.2009.00218.x	68	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	FEB	2015	24	1					62	69		10.1097/ID.0000000000000205		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA2AY	WOS:000348712500011		
J	Pluemsakunthai, W; Le, B; Kasugai, S				Pluemsakunthai, Warunee; Le, Bach; Kasugai, Shohei			Effect of Buccal Gap Distance on Alveolar Ridge Alteration After Immediate Implant Placement: A Microcomputed Tomographic and Morphometric Analysis in Dogs	IMPLANT DENTISTRY			English	Article						buccal gap; bone resorption; bone remodeling; implant position	FRESH EXTRACTION SOCKETS; TISSUE FORMATION ADJACENT; TOOTH EXTRACTION; BONE REGENERATION; AESTHETIC ZONE; SITES; HARD; SOFT; DYNAMICS; MAXILLA	Introduction: The buccal bone resorption and the deformation of soft tissue contour are major problems of immediate implant treatment. This study aims to examine the changes of alveolar bone and soft tissue after immediate implant placement in different buccal gap distances. Materials and Methods: Eight implants were placed randomly in the mandibular premolar sockets of 6 hybrid dogs with 1, 2, and 3 mm buccal gap distances. The dogs were killed after 2 or 4 months for morphometric and microcomputed tomography analyses. Discussion: After 2 months, the 3-mm group had the highest buccal bone volume (BV), buccal bone/soft tissue thickness, and the lowest bone resorption. The wider the buccal gap, the more buccal bone and soft tissue were formed in this experimental setting. After 4 months, the buccal BV had decreased significantly in the 1-mm and the 2-mm groups, whereas the 3-mm group resisted to buccal bone resorption. This difference was more pronounced at the crest. Conclusion: The 3 mm is the optimal gap distance among the groups examined, which drastically influences the healing of bone and soft tissue surrounding the implants.	[Pluemsakunthai, Warunee; Kasugai, Shohei] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Implantol & Regenerat Dent Med, Tokyo, Japan; [Pluemsakunthai, Warunee] Holland Bloorview Kids Rehabil Hosp, Dept Prosthodont, Toronto, ON, Canada; [Le, Bach] Univ So Calif, Herman Ostrow Sch Dent, Dept Oral & Maxillofacial Surg, Los Angeles, CA USA	Pluemsakunthai, W (reprint author), Holland Bloorview Kids Rehabil Hosp, 150 Kilgour Rd,Suite 2E 270, Toronto, ON M4G 1R8, Canada.	waru_waaruu@hotmail.com			BioHorizons IPH, Inc.; Ministry of Education, Cultural, Sports, Science and Technology (MEXT); Tokyo Medical and Dental University	Supported by BioHorizons IPH, Inc., Ministry of Education, Cultural, Sports, Science and Technology (MEXT) Scholarship, Tokyo Medical and Dental University.	Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x; De Santis E, 2011, CLIN ORAL IMPLAN RES, V22, P430, DOI 10.1111/j.1600-0501.2010.02122.x; Chen ST, 2004, INT J ORAL MAX IMPL, V19, P12; Shin SY, 2010, CLIN ORAL IMPLAN RES, V21, P804, DOI 10.1111/j.1600-0501.2010.01917.x; Tomasi C, 2010, CLIN ORAL IMPLAN RES, V21, P30, DOI 10.1111/j.1600-0501.2009.01848.x; Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x; Caneva M, 2010, CLIN ORAL IMPLAN RES, V21, P43, DOI 10.1111/j.1600-0501.2009.01842.x; Kan JYK, 2009, J ORAL MAXIL SURG, V67, P40, DOI 10.1016/j.joms.2009.07.004; Huynh-Ba G, 2010, CLIN ORAL IMPLAN RES, V21, P37, DOI 10.1111/j.1600-0501.2009.01870.x; Vignoletti F, 2012, J CLIN PERIODONTOL, V39, P91, DOI 10.1111/j.1600-051X.2011.01803.x; Sanz M, 2010, CLIN ORAL IMPLAN RES, V21, P13, DOI 10.1111/j.1600-0501.2009.01824.x; Koh RU, 2010, IMPLANT DENT, V19, P98, DOI 10.1097/ID.0b013e3181d47eaf; Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x; Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560; Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x; Oh TJ, 2002, J PERIODONTOL, V73, P322, DOI 10.1902/jop.2002.73.3.322; Lang NP, 2012, CLIN ORAL IMPLAN RES, V23, P39, DOI 10.1111/j.1600-0501.2011.02372.x; Ferrus J, 2010, CLIN ORAL IMPLAN RES, V21, P22, DOI 10.1111/j.1600-0501.2009.01825.x; Caneva M, 2010, CLIN ORAL IMPLAN RES, V21, P885, DOI 10.1111/j.1600-0501.2010.01931.x; Schropp L, 2003, INT J PERIODONT REST, V23, P313; Vignoletti F, 2009, J CLIN PERIODONTOL, V36, P1059, DOI 10.1111/j.1600-051X.2009.01489.x; LINDQUIST LW, 1988, J PROSTHET DENT, V59, P59, DOI 10.1016/0022-3913(88)90109-6; Qahash M, 2008, CLIN ORAL IMPLAN RES, V19, P166, DOI 10.1111/j.1600-0501.2007.01428.x; Kan JYK, 2007, J ORAL MAXIL SURG, V65, P13, DOI 10.1016/j.joms.2007.04.006; Kan JYK, 2003, INT J ORAL MAX IMPL, V18, P31; Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P606, DOI 10.1111/j.1600-0501.2006.01315.x; de Sanctis M, 2009, J CLIN PERIODONTOL, V36, P705, DOI 10.1111/j.1600-051X.2009.01427.x; Chen ST, 2009, J PERIODONTOL, V80, P163, DOI 10.1902/jop.2009.080243 ; Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x; Kan JYK, 2007, J PROSTHET DENT, V97, pS109, DOI 10.1016/S0022-3913(07)60014-6; Covani U, 2007, J PERIODONTOL, V78, P810, DOI 10.1902/jop.2007.060254; De Rouck T, 2008, J CLIN PERIODONTOL, V35, P649, DOI 10.1111/j.1600-051X.2008.01235.x; Botticelli D, 2006, CLIN ORAL IMPLAN RES, V17, P351, DOI 10.1111/j.1600-0501.2006.01270.x; Evans CDJ, 2008, CLIN ORAL IMPLAN RES, V19, P73, DOI 10.1111/j.1600-0501.2007.01413.x; Denissen H W, 1993, Int J Oral Maxillofac Implants, V8, P191; Iorio-Siciliano V, 2014, INT J PERIODONT REST, V34, P541, DOI 10.11607/prd.1678; Jemt T, 1999, Int J Periodontics Restorative Dent, V19, P20; Kasat V, 2012, J Int Soc Prev Community Dent, V2, P38, DOI 10.4103/2231-0762.109358; Novaes AB, 2011, J PERIODONTOL, V82, P872, DOI 10.1902/jop.2010.100244; PENNEL BM, 1967, J PERIODONTOL, V38, P426; Roux W, 1881, BEITRAG VERVOLLSTAND; Spray J R, 2000, Ann Periodontol, V5, P119, DOI 10.1902/annals.2000.5.1.119; Watzek G, 1995, Int J Oral Maxillofac Implants, V10, P561; Werbitt M J, 1992, Int J Periodontics Restorative Dent, V12, P206	44	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	FEB	2015	24	1					70	76		10.1097/ID.0000000000000194		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA2AY	WOS:000348712500012		
J	Perrotti, V; Ravera, L; Ricci, L; Doi, K; Piattelli, A; Shibli, J; Iezzi, G				Perrotti, Vittoria; Ravera, Lorenzo; Ricci, Laura; Doi, Kazuya; Piattelli, Adriano; Shibli, Jamil; Iezzi, Giovanna			Radiographic Comparison of Periimplant Bone Resorption and Assessment of Survival Rates of 2 Implant Systems: A 10-Year Prospective Multicenter Study	IMPLANT DENTISTRY			English	Article						10-year follow-up; radiographic evaluation; periimplant bone resorption; survival rates	DIFFERENT NECK DESIGNS; DENTAL IMPLANTS; TITANIUM IMPLANTS; SUBMERGED IMPLANTS; FIXTURE DESIGN; SURFACE; ADJACENT; DOG; DISEASES; SUCCESS	Purpose: The aim of this multicenter human clinical trial was to radiographically evaluate the marginal bone loss and to assess implant survival rate in patients treated using 2 different implant systems (Bio-Plant and Tuber-Plant) after 10 years of loading. Methods: Ninety-seven patients were selected, and 160 implants were inserted (72 Bio-Plant and 88 Tuber-Plant). Ten years later, 20 patients were lost at follow-up and 77 patients (126 implants; 67 Bio-Plant and 59 Tuber-Plant) were recalled. After 10-year, the periimplant bone resorption was significantly lower (P = 0.0039) for Tuber-Plant (0.74 +/- 0.12 mm) than for Bio-Plant (1.31 +/- 0.09 mm). The cumulative survival rate was 99.11%. Conclusion: Both implant systems demonstrated to be suitable for a long-term successful rehabilitation because of stable marginal bone levels and high survival rates after 10 years of functional loading.	[Perrotti, Vittoria; Piattelli, Adriano; Iezzi, Giovanna] Chieti Pescara Univ, Dept Med Oral & Biotechnol Sci, I-66100 Chieti, Italy; [Doi, Kazuya] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Adv Prosthodont, Hiroshima, Japan; [Shibli, Jamil] Univ Guarulhos, Dent Res Div, Sao Paulo, Brazil	Perrotti, V (reprint author), Chieti Pescara Univ, Dept Med Oral & Biotechnol Sci, Via Vestini 31, I-66100 Chieti, Italy.	v.perrotti@unich.it			Italian Ministry of Education, University and Research (Rome, Italy); Technology, Japan and Brain circulation program to develop new leaders for international dental education course through international collaborative dental research (Tokyo, Japan)	Supported by a grant from the Italian Ministry of Education, University and Research (Rome, Italy) and by a Technology, Japan and Brain circulation program to develop new leaders for international dental education course through international collaborative dental research (Tokyo, Japan).	Albrektsson T, 1986, INT J ORAL MAXILLOF, V1, P11; Andersson B, 1995, Swed Dent J Suppl, V108, P1; Kullman L, 2007, INT J ORAL MAX IMPL, V22, P96; Piao CM, 2009, J ORAL REHABIL, V36, P748, DOI 10.1111/j.1365-2842.2009.01988.x; Kim DM, 2008, CLIN ORAL IMPLAN RES, V19, P254, DOI 10.1111/j.1600-0501.2007.01479.x; Blanes RJ, 2007, CLIN ORAL IMPLAN RES, V18, P699, DOI 10.1111/j.1600-0501.2006.01306.x; Masaki C, 2005, CLIN ORAL IMPLAN RES, V16, P650, DOI 10.1111/j.1600-0501.2005.01170.x; Choquet V, 2001, J PERIODONTOL, V72, P1364, DOI 10.1902/jop.2001.72.10.1364; Karoussis IK, 2004, CLIN ORAL IMPLAN RES, V15, P8, DOI 10.1111/j.1600-0501.2004.00983.x; Bragger U, 2004, CLIN ORAL IMPLAN RES, V15, P158, DOI 10.1111/j.1600-0501.2004.00988.x; Binon PP, 2000, INT J ORAL MAX IMPL, V15, P76; Quirynen M, 1992, Clin Oral Implants Res, V3, P104, DOI 10.1034/j.1600-0501.1992.030302.x; Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P33, DOI 10.1034/j.1600-0501.1990.010105.x; Buser D, 2004, J DENT RES, V83, P529; Klokkevold PR, 2007, INT J ORAL MAX IMPL, V22, P173; Zechner W, 2004, INT J ORAL MAX IMPL, V19, P216; Norton MR, 1998, CLIN ORAL IMPLAN RES, V9, P91, DOI 10.1034/j.1600-0501.1998.090204.x; Hartman GA, 2004, J PERIODONTOL, V75, P572, DOI 10.1902/jop.2004.75.4.572; den Hartog L, 2011, CLIN ORAL IMPLAN RES, V22, P1289, DOI 10.1111/j.1600-0501.2010.02109.x; Hermann JS, 2001, INT J ORAL MAX IMPL, V16, P475; Stanford CM, 1999, J PROSTHET DENT, V81, P553, DOI 10.1016/S0022-3913(99)70209-X; Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x; Mombelli A, 2006, CLIN ORAL IMPLAN RES, V17, P97, DOI 10.1111/j.1600-0501.2006.01354.x; Hermann JS, 2000, J PERIODONTOL, V71, P1412, DOI 10.1902/jop.2000.71.9.1412; Cochran DL, 2009, J PERIODONTOL, V80, P725, DOI 10.1902/jop.2009.080401; Gotfredsen K, 2001, CLIN ORAL IMPLAN RES, V12, P196, DOI 10.1034/j.1600-0501.2001.012003196.x; Shin YK, 2006, INT J ORAL MAX IMPL, V21, P789; Hanggi MP, 2005, J PERIODONTOL, V76, P791, DOI 10.1902/jop.2005.76.5.791; Barboza Eliane P, 2002, Implant Dent, V11, P162, DOI 10.1097/00008505-200204000-00018; BORCHERS L, 1983, J DENT RES, V62, P155, DOI 10.1177/00220345830620021401; Callan D P, 1998, Implant Dent, V7, P258, DOI 10.1097/00008505-199807040-00003; ERICSSON I, 1994, CLIN ORAL IMPLAN RES, V5, P202, DOI 10.1034/j.1600-0501.1994.050402.x; Heitz-Mayfield LJA, 2008, J CLIN PERIODONTOL, V35, P292, DOI 10.1111/j.1600-051X.2008.01275.x	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1056-6163			IMPLANT DENT	Implant Dent.	FEB	2015	24	1					77	82		10.1097/ID.0000000000000195		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CA2AY	WOS:000348712500013		
J	Inada, N; Harada, N; Nakashima, M; Shoji, J				Inada, N.; Harada, N.; Nakashima, M.; Shoji, J.			Severe Staphylococcus lugdunensis keratitis	INFECTION			English	Article						Staphylococcus lugdunensis; Suppurative keratitis; Empiric therapy; Antibiotics	RAPID IDENTIFICATION; SUSCEPTIBILITY	We report a severe case of Staphylococcus lugdunensis (S. lugdunensis) keratitis presenting as suppurative keratitis in a 77-year-old woman. The patient's chief complaint was eye pain and decreased visual acuity in her right eye. Suppurative keratitis with a severe corneal abscess was diagnosed by a slit-lamp ophthalmic examination. The causative organism was identified as S. lugdunensis by bacterial culture, using a corneal abrasion specimen. She was treated with an intravenous drip infusion of ceftazidime and instillation of gentamicin sulfate ophthalmic solution (six times daily) and ofloxacin ophthalmic ointment (once daily before bedtime) as empiric therapy. Her hospital course was complicated by a corneal perforation of her right eye. The antibiotic susceptibility for S. lugdunensis was sensitive, but with a slightly high MIC for antibiotics used in empiric therapy. The therapeutic drug was changed to levofloxacin ophthalmic solution. The corneal abscess left a scar after healing. Representative causative organisms of suppurative keratitis include Pseudomonas aeruginosa and Streptococcus pneumoniae, but care must be taken in cases involving rare causative organisms. Empiric therapy is necessary for rapidly progressing suppurative keratitis, but a detailed examination of the causative organism is important for therapeutic planning before empiric therapy.	[Inada, N.; Harada, N.; Nakashima, M.; Shoji, J.] Nihon Univ, Sch Med, Dept Visual Sci, Div Ophthalmol,Itabashi Ku, Tokyo 1738610, Japan	Inada, N (reprint author), Nihon Univ, Sch Med, Dept Visual Sci, Div Ophthalmol,Itabashi Ku, 30-1 Oyaguchi Kamichou, Tokyo 1738610, Japan.	inada.noriko@nihon-u.ac.jp					Pandita A, 2011, CLIN EXP OPHTHALMOL, V39, P393, DOI 10.1111/j.1442-9071.2010.02480.x; Sueke H, 2010, INVEST OPHTH VIS SCI, V51, P2519, DOI 10.1167/iovs.09-4638; Pinna A, 1999, BRIT J OPHTHALMOL, V83, P771, DOI 10.1136/bjo.83.7.771; Fujita SI, 2005, J CLIN MICROBIOL, V43, P1149, DOI 10.1128/JCM.43.3.1149-1157.2005; Kanemitsu K, 2005, J CLIN MICROBIOL, V43, P5808, DOI 10.1128/JCM.43.11.5808-5810.2005; Lin JF, 2014, J MICROBIOL IMMUNOL, DOI DOI 10.1016/J.JMII.2013.12.010; Papapetropoulos N, 2013, INFECTION, V41, P525, DOI 10.1007/s15010-012-0381-z	7	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-8126	1439-0973		INFECTION	Infection	FEB	2015	43	1					99	101		10.1007/s15010-014-0669-2		3	Infectious Diseases	Infectious Diseases	CA9HO	WOS:000349233200014		
J	Tomohiro, I; Matsubara, W; Shimohira, K; Inenaga, S; Bannai, H; Takeda, M; Narisawa, K; Shinohara, A				Tomohiro, I; Matsubara, Wataru; Shimohira, Kouji; Inenaga, Shunsuke; Bannai, Hideo; Takeda, Masayuki; Narisawa, Kazuyuki; Shinohara, Ayumi			Detecting regularities on grammar-compressed strings	INFORMATION AND COMPUTATION			English	Article						Straight-line programs (SLPs); Runs; Squares; Gapped palindromes; Compressed string processing algorithms	TEST SQUARE-FREENESS; ALGORITHM; ONLINE	We address the problems of detecting and counting various forms of regularities in a string represented as a straight-line program (SLP) which is essentially a context free grammar in the Chomsky normal form. Given an SLP of size n that represents a string s of length N, our algorithm computes all runs and squares in sin O(n(3)h) time and O(n(2)) space, where his the height of the derivation tree of the SLP. We also show an algorithm to compute all gapped-palindromes in O(n(3)h + gnh logN) time and O(n(2)) space, where g is the length of the gap. As one of the main components of the above solution, we propose a new technique called approximate doubling which seems to be a useful tool for a wide range of algorithms on SLPs. Indeed, we show that the technique can be used to compute the periods and covers of the string in O(n(2)h) time and O(nh(n + log(2)N)) time, respectively. (C) 2014 Elsevier Inc. All rights reserved.	[Tomohiro, I; Shimohira, Kouji; Inenaga, Shunsuke; Bannai, Hideo; Takeda, Masayuki] Kyushu Univ, Dept Informat, Nishi Ku, Fukuoka 8190395, Japan; [Tomohiro, I] JSPS, Sendai, Miyagi, Japan; [Matsubara, Wataru; Narisawa, Kazuyuki; Shinohara, Ayumi] Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan	Tomohiro, I (reprint author), Tech Univ Dortmund, Dept Comp Sci, D-44221 Dortmund, Germany.	tomohiro.i@cs.tu-dortmund.ge; tomohiro.i@inf.kyushu-u.ac.jp; inenaga@inf.kyushu-u.ac.jp; bannai@inf.kyushu-u.ac.jp; takeda@inf.kyushu-u.ac.jp; narisawa@ecei.tohoku.ac.jp; ayumi@ecei.tohoku.ac.jp					Bille P, 2011, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P373; MAIN MG, 1989, DISCRETE APPL MATH, V25, P145, DOI 10.1016/0166-218X(89)90051-6; MAIN MG, 1984, J ALGORITHM, V5, P422, DOI 10.1016/0196-6774(84)90021-X; Miyazaki M, 1997, LECT NOTES COMPUT SC, V1264, P1; Bannai H, 2012, INFORM PROCESS LETT, V112, P711, DOI 10.1016/j.ipl.2012.06.017; Lifshits Y, 2007, LECT NOTES COMPUT SC, V4580, P228; Crochemore M, 2009, THEOR COMPUT SCI, V410, P5227, DOI 10.1016/j.tcs.2009.08.024; APOSTOLICO A, 1995, THEOR COMPUT SCI, V141, P163, DOI 10.1016/0304-3975(94)00083-U; Apostolico A, 1996, SIAM J COMPUT, V25, P1318, DOI 10.1137/S0097539793260404; CROCHEMORE M, 1991, INFORM PROCESS LETT, V38, P57, DOI 10.1016/0020-0190(91)90223-5; Crochemore M., 1994, TEXT ALGORITHMS; Jansson J, 2007, INT J FOUND COMPUT S, V18, P401, DOI 10.1142/S0129054107004747; Khvorost L., 2012, P 2 RUSS FINN S DISC, V17, P116; Kolpakov R, 2009, THEOR COMPUT SCI, V410, P5365, DOI 10.1016/j.tcs.2009.09.013; Kolpakov R.M., 1999, P 40 ANN S FDN COMP, P596; MANACHER G, 1975, J ACM, V22, P346, DOI 10.1145/321892.321896; Matsubara W, 2009, THEOR COMPUT SCI, V410, P900, DOI 10.1016/j.tcs.2008.12.016	17	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0890-5401	1090-2651		INFORM COMPUT	Inf. Comput.	FEB	2015	240						74	89		10.1016/j.ic.2014.09.009		16	Computer Science, Theory & Methods; Mathematics, Applied	Computer Science; Mathematics	CA1JB	WOS:000348667800007		
J	Hiyama, A; Watanabe, M; Katoh, H; Sato, M; Nagai, T; Mochida, J				Hiyama, Akihiko; Watanabe, Masahiko; Katoh, Hiroyuki; Sato, Masato; Nagai, Toshihiro; Mochida, Joji			Relationships between posterior ligamentous complex injury and radiographic parameters in patients with thoracolumbar burst fractures	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Thoracolumbar burst fracture; Posterior ligamentous complex; Local kyphosis; Short-tau inversion-recovery weighted MR image; Thoracolumbar injury classification system; Load sharing classification; Computed tomography; Stability	VARIABLE SCREW PLACEMENT; CLASSIFICATION-SYSTEM; DIAGNOSTIC-ACCURACY; SEVERITY SCORE; SPINE; RELIABILITY; INSTRUMENTATION; MANAGEMENT; STABILITY	Introduction: The purpose of this study was to determine whether radiographic findings associated with thoracolumbar burst fractures could also indicate the presence of posterior ligamentous complex (PLC) injuries, which were identified through short-tau inversion-recovery (STIR)-weighted MRI. Patients and method: Sixty-four patients were surgically treated for thoracolumbar burst fractures between April 2007 and February 2014 at our institution. Twenty-four patients were excluded from this study because of the lack of STIR-weighted MRIs, and therefore 40 patients were included in this study. The patients were divided into two groups based upon the integrity of the PLC, which was evaluated using STIR-weighted MRI: a P group with a PLC injury and a C group without such injury. The following radiographic parameters were evaluated: loss of vertebral body height (LOVBH), local kyphosis (LK), vertebral body translation, canal compromise (sagittal transverse ratio, STR), interlaminar distance (ISD), supraspinous distance (SSD) and interspinous distance (ISD). Frankel scale score and total severity score (load sharing and thoracolumbar injury classification systems, respectively) were also evaluated. Results: Preoperative STIR-weighted MRI showed that 25 patients had a PLC injury (P group: 15 men and 10 women), and 15 patients did not have a PLC injury (C group: 8 men and 7 women). More patients in the P group had an LK > 20 degrees: 14 patients in the P group and 1 patient in the C group (p < 0.01). The % SSD differed between the P and C groups (118.8% +/- 53.4% and 88.0% +/- 24.3%, respectively; p < 0.05). Multivariate logistic analysis showed that an LK > 20 degrees was a risk factor for PLC injury in patients with thoracolumbar burst fractures (odds ratio, 55.5 [95% confidence interval, 1.30-2360.1]; p < 0.05). Conclusions: These results demonstrate that while LOVBH, vertebral body translation, and canal compromise do not correlate significantly with the presence of a PLC injury in patients with thoracolumbar fractures, an LK > 20 degrees and increased % SSD are associated with a PLC injury. (C) 2014 Elsevier Ltd. All rights reserved.	[Hiyama, Akihiko; Watanabe, Masahiko; Katoh, Hiroyuki; Sato, Masato; Nagai, Toshihiro; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthopaed Surg, Isehara, Kanagawa 2591193, Japan	Hiyama, A (reprint author), Tokai Univ, Sch Med, Dept Orthopaed Surg, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	a.hiyama@tokai-u.jp; masahiko@is.icc.u-tokai.ac.jp; hero@tokai-u.jp; sato-m@is.icc.u-tokai.ac.jp; zavi127@is.icc.u-tokai.ac.jp; jomo@is.icc.u-tokai.ac.jp					Alvine GF, 2004, J SPINAL DISORD TECH, V17, P251, DOI 10.1097/01.bsd.0000095827.98982.88; Rihn JA, 2010, J NEUROSURG-SPINE, V12, P391, DOI 10.3171/2009.10.SPINE08742; Vaccaro AR, 2009, SPINE, V34, pE841, DOI 10.1097/BRS.0b013e3181bd11be; PETERSILGE CA, 1995, RADIOLOGY, V194, P49; Lee HM, 2000, SPINE, V25, P2079, DOI 10.1097/00007632-200008150-00012; Radcliff K, 2012, SPINE, V37, P1142, DOI 10.1097/BRS.0b013e318240fcd3; Briem D, 2004, ARCH ORTHOP TRAUM SU, V124, P461, DOI 10.1007/s00402-004-0710-5; CANTOR JB, 1993, SPINE, V18, P971, DOI 10.1097/00007632-199306150-00004; NAGEL DA, 1981, J BONE JOINT SURG AM, V63, P62; Rampersaud YR, 2006, J SPINAL DISORD TECH, V19, P477; Patel AA, 2007, SPINE, V32, pE105, DOI 10.1097/01.brs.0000254107.57551.8a; Hitchon PW, 2002, J NEUROSURG, V97, P218, DOI 10.3171/spi.2002.97.2.0218; Chadha M, 1998, INJURY, V29, P737, DOI 10.1016/S0020-1383(98)00173-9; Crosby CG, 2011, SPINE J, V11, P747, DOI 10.1016/j.spinee.2011.07.005; Dai LY, 2009, J TRAUMA, V66, P1610, DOI 10.1097/TA.0b013e3181848206; DENIS F, 1983, SPINE, V8, P817, DOI 10.1097/00007632-198311000-00003; Haba H, 2003, J NEUROSURG, V99, P20, DOI 10.3171/spi.2003.99.1.0020; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; JAMES KS, 1994, SPINE, V19, P1731, DOI 10.1097/00007632-199408000-00013; Lee JY, 2007, SPINE J, V7, P422, DOI 10.1016/j.spinee.2006.07.014; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; MCAFEE PC, 1983, J BONE JOINT SURG AM, V65, P461; Mikles MR, 2004, J AM ACAD ORTHOP SUR, V12, P424; Rechtine G R, 1999, Instr Course Lect, V48, P413; Vaccaro AB, 2006, SPINE, V31, pS62, DOI 10.1097/01.brs.0000218072.25964.a9; Valentini MC, 2006, EUR J RADIOL, V59, P331, DOI 10.1016/j.ejrad.2006.04.025; WEINSTEIN JN, 1988, SPINE, V13, P33, DOI 10.1097/00007632-198801000-00008; WILLEN J, 1990, J SPINAL DISORD, V3, P39	28	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	FEB	2015	46	2					392	398		10.1016/j.injury.2014.10.047		7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CB1FE	WOS:000349371600039		
J	Fukasawa, M; Suzuki, Y; Obara, A; Kim, Y				Fukasawa, Maiko; Suzuki, Yuriko; Obara, Akiko; Kim, Yoshiharu			Relationships Between Mental Health Distress and Work-Related Factors Among Prefectural Public Servants Two Months After the Great East Japan Earthquake	INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE			English	Article						Mental health; Public servants; Disaster-related work; Overwork; Great East Japan Earthquake	POSTTRAUMATIC-STRESS-DISORDER; TRADE-CENTER RESCUE; OF-THE-LITERATURE; RECOVERY WORKERS; PSYCHOLOGICAL DISTRESS; DISASTER; PERFORMANCE; POPULATION; PREVALENCE; ILLNESS	In times of disaster, public servants face multiple burdens as they engage in a demanding and stressful disaster-response work while managing their own needs caused by the disaster. We investigated the effects of work-related factors on the mental health of prefectural public servants working in the area devastated by the Great East Japan Earthquake to identify some ideas for organizational work modifications to protect their mental health. Two months after the earthquake, Miyagi prefecture conducted a self-administered health survey of prefectural public servants and obtained 4,331 (82.8 %) valid responses. We investigated relationships between mental health distress (defined as K6 a parts per thousand yenaEuro parts per thousand 13) and work-related variables (i.e., job type, overwork, and working environment) stratified by level of earthquake damage experienced. The proportion of participants with mental health distress was 3.0 % in the group that experienced less damage and 5.9 % in the group that experienced severe damage. In the group that experienced less damage, working > 100 h of overtime per month (adjusted odds ratio [OR], 2.06; 95 % confidence interval [CI], 1.11-3.82) and poor workplace communication (adjusted OR, 10.96; 95 % CI, 6.63-18.09) increased the risk of mental health distress. In the group that experienced severe damage, handling residents' complaints (adjusted OR, 4.79; 95 % CI, 1.55-14.82) and poor workplace communication (adjusted OR, 9.14; 95 % CI, 3.34-24.97) increased the risk, whereas involvement in disaster-related work (adjusted OR, 0.39; 95 % CI, 0.18-0.86) decreased the risk. Workers who have experienced less disaster-related damage might benefit from working fewer overtime hours, and those who have experienced severe damage might benefit from avoiding contact with residents and engaging in disaster-related work. Facilitating workplace communication appeared important for both groups of workers.	[Fukasawa, Maiko; Suzuki, Yuriko; Kim, Yoshiharu] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Kodaira, Tokyo 1878553, Japan; [Obara, Akiko] Miyagi Mental Hlth & Welf Ctr, Osaki, Miyagi 9896117, Japan; [Kim, Yoshiharu] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Natl Informat Ctr Disaster Mental Hlth, Kodaira, Tokyo 1878553, Japan	Fukasawa, M (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878553, Japan.	s05fukasawa@ncnp.go.jp					Albrecht Sandra S, 2012, Prev Chronic Dis, V9, pE52; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Prochaska JJ, 2012, INT J METH PSYCH RES, V21, P88, DOI 10.1002/mpr.1349; Brackbill Robert M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Perrin MA, 2007, AM J PSYCHIAT, V164, P1385, DOI 10.1176/appi.apj.2007.06101645; Inoue A, 2010, J OCCUP HEALTH, V52, P227, DOI 10.1539/joh.O10002; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Ehring T, 2011, PSYCHIAT RES, V185, P161, DOI 10.1016/j.psychres.2009.10.018; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Kessler RC, 2006, B WORLD HEALTH ORGAN, V84, P930, DOI 10.2471/BLT.06.033019; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Wisnivesky JP, 2011, LANCET, V378, P888, DOI 10.1016/S0140-6736(11)61180-X; Bills CB, 2008, MT SINAI J MED, V75, P115, DOI 10.1002/msj.20026; Neria Y, 2011, AM PSYCHOL, V66, P429, DOI [10.1037/a0024791, 10.1037/0024791]; Inoue A, 2013, INT J BEHAV MED, V20, P265, DOI 10.1007/s12529-012-9224-7; Cukor J, 2011, DEPRESS ANXIETY, V28, P210, DOI 10.1002/da.20776; Eguchi H, 2012, J OCCUP ENVIRON MED, V54, P939, DOI 10.1097/JOM.0b013e31825107bb; Gross R, 2006, ANN NY ACAD SCI, V1071, P495, DOI 10.1196/annals.1364.051; Inoue K, 2012, RINSHO SEISIN IGAKU, V41, P1209; Kato H, 2004, JAPANESE J TRAUMATIC, V2, P51; Kawakami N, 2006, REPORT RES STAT INFO; Miyagi prefecture, 2013, POP NUMB HOUS BAS BA; Mojtabai R, 2011, AM J PUBLIC HEALTH, V101, P2156, DOI 10.2105/AJPH.2011.300258; National Information Center of Disaster Mental Health National Institute of Mental Health National Center of Neurology and Psychiatry, SPEC SUMM REP COMPR; National Police Agency, 2013, DAM POL ACT GREAT E; Norris F. H., 2006, METHODS DISASTER MEN, P20; Reconstruction Agency, 2013, NUMB DEATHS OW EFF G; Sasaki H, 2010, B AKITA U GRADUATE S, V18, P120; Stellman JM, 2008, ENVIRON HEALTH PERSP, V116, P1248, DOI 10.1289/ehp.11164; Suzuki Y, 2010, SEISHIN HOKEN KENKYU, V56, P98; Takeguchi M, 2012, NIHON SHUDAN SAIGAI, V17, P687; Tapp LC, 2005, AM J IND MED, V47, P475, DOI 10.1002/aijm.20177; Virtanen M, 2011, PSYCHOL MED, V18, P1; Virtanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030719	35	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1070-5503	1532-7558		INT J BEHAV MED	Int. J. Behav. Med.	FEB	2015	22	1					1	10		10.1007/s12529-014-9392-8		10	Psychology, Clinical	Psychology	CA6HJ	WOS:000349011500001		
J	Hirokawa, K; Taniguchi, T; Fujii, Y				Hirokawa, Kumi; Taniguchi, Toshiyo; Fujii, Yasuhito			Job Stress and Agentic-Communal Personality Traits Related to Serum Cortisol Levels of Male Workers in a Japanese Medium-Sized Company: A Cross-Sectional Study	INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE			English	Article						Job stress; Agency; Communion; Gender-related personality; Serum cortisol levels; Japanese male workers	MENTAL-HEALTH; CONTROL MODEL; RESPONSES; DEMANDS; STRAIN; AGENCY; ADULTS; SALIVA; BLOOD	Although serum cortisol is a widely accepted index of stress levels, associations between job stress and cortisol levels have been inconsistent. Individual differences in personality traits were discussed as one compelling explanation for this discrepancy. Agentic-communal personality traits have been examined as possible predictive factors for psychological stress. This study investigated correlations among agentic-communal personality traits and serum cortisol levels. It was also investigated whether job stress levels modified correlations between agentic-communal personality and cortisol levels. Participants were 198 male workers (mean age = 52.2 years) employed by a shipbuilding company in Japan. Questionnaire data and blood samples were collected during an annual health checkup. Participants completed a self-report questionnaire that included the Job Content Questionnaire (JCQ) that assesses job control as job stress levels the Communion-Agency scale (CAS) and questions regarding health behaviors. Communion positively correlated with serum cortisol levels and unmitigated agency negatively correlated with serum cortisol levels. Stratified by job control, communion positively correlated with serum cortisol levels and agency negatively correlated with serum cortisol levels in participants with low levels of job control. Unmitigated agency negatively correlated with serum cortisol levels in participants with high levels of job control. Levels of job control may modify correlations of gender-related personality with serum cortisol levels. Especially with exposure to high job stress, male workers with high femininity (i.e., high communion and low agency) were more likely to have a high stress response as measured by serum cortisol levels.	[Hirokawa, Kumi] Baika Womens Univ, Dept Nursing, Ibaraki, Osaka 5678578, Japan; [Taniguchi, Toshiyo; Fujii, Yasuhito] Okayama Prefectural Univ, Dept Welf Syst & Hlth Sci, Soja City, Okayama 7191197, Japan	Hirokawa, K (reprint author), Baika Womens Univ, Dept Nursing, 2-19-5 Shukunosho, Ibaraki, Osaka 5678578, Japan.	k-umi@umin.ac.jp; taniguti@fhw.oka-pu.ac.jp; fujii@fhw.oka-pu.ac.jp					Alderling M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-288; Bibbey A, 2013, INT J PSYCHOPHYSIOL, V90, P28, DOI 10.1016/j.ijpsycho.2012.10.018; THEORELL T, 1990, WORK STRESS, V4, P51, DOI 10.1080/02678379008256964; Montoya ER, 2012, MOTIV EMOTION, V36, P65, DOI 10.1007/s11031-011-9264-3; Wirtz PH, 2007, PSYCHOSOM MED, V69, P249, DOI 10.1097/PSY.0b013e318042589e; Bohnke R, 2010, J NEURAL TRANSM, V117, P629, DOI 10.1007/s00702-010-0391-x; Oswald LM, 2006, NEUROPSYCHOPHARMACOL, V31, P1583, DOI 10.1038/sj.npp.1301012; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Nater UM, 2010, PSYCHONEUROENDOCRINO, V35, P1573, DOI 10.1016/j.psyneuen.2010.02.017; Steptoe A, 2004, PSYCHOSOM MED, V66, P323, DOI 10.1097/01.psy.0000126198.67070.72; McEwen BS, 1998, NEW ENGL J MED, V338, P171; Steptoe A, 1998, ANN BEHAV MED, V20, P84, DOI 10.1007/BF02884453; Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5; Hansen AM, 2003, WORK STRESS, V17, P264, DOI 10.1080/02678370310001628899; HELGESON VS, 1994, PSYCHOL BULL, V116, P412, DOI 10.1037/0033-2909.116.3.412; Steptoe A, 2000, PSYCHOSOM MED, V62, P286; Bakan D., 1966, DUALITY HUMAN EXISTE; Burton RF, 1996, BIOL PSYCHOL, V42, P425, DOI 10.1016/0301-0511(95)05171-6; Dohi I., 2004, JAPANESE J PSYCHOL, V75, P420; Gebauer JE, 2013, J PERS, V81, P261, DOI 10.1111/j.1467-6494.2012.00807.x; Gerritsen L, 2009, AM J GERIAT PSYCHIAT, V17, P1077, DOI 10.1097/JGP.0b013e3181bd1be6; Gianakos I, 2002, SEX ROLES, V46, P149, DOI 10.1023/A:1019675218338; Gianakos I, 2000, SEX ROLES, V42, P1059, DOI 10.1023/A:1007092718727; Hansen AM, 2009, BASIC CLIN PHARMACOL, V105, P73, DOI 10.1111/j.1742-7843.2009.00444.x; Hansen AM, 2008, SCAND J CLIN LAB INV, V1, P1; HARENSTAM A, 1990, BIOL PSYCHOL, V31, P157, DOI 10.1016/0301-0511(90)90015-O; HENRY JP, 1982, SOC SCI MED, V16, P369, DOI 10.1016/0277-9536(82)90047-8; Hirokawa K, 2007, SEX ROLES, V56, P517, DOI 10.1007/s11199-007-9190-8; Hirokawa K, 2009, PERS INDIV DIFFER, V46, P744, DOI 10.1016/j.paid.2009.01.026; Hofstede G., 2001, CULTURES CONSEQUENCE; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kawakami N, 2004, KOSHU EISEI S, V4, P301; KIRSCHBAUM C, 1992, PERS INDIV DIFFER, V13, P1353, DOI 10.1016/0191-8869(92)90181-N; Lemmens SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016826; LESHNER AI, 1979, PHYSIOL BEHAV, V22, P531, DOI 10.1016/0031-9384(79)90021-0; Mori M, 2002, Arch Womens Ment Health, V5, P161, DOI 10.1007/s00737-002-0148-0; Peters ML, 1998, PSYCHONEUROENDOCRINO, V23, P1, DOI 10.1016/S0306-4530(97)00082-6; Theorell T., 1990, HLTH WORK STRESS PRO; van Santen A, 2011, PSYCHONEUROENDOCRINO, V36, P240, DOI 10.1016/j.psyneuen.2010.07.014; Vesely AK, 2013, PERS INDIV DIFFER, V54, P221, DOI 10.1016/j.paid.2012.08.038	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1070-5503	1532-7558		INT J BEHAV MED	Int. J. Behav. Med.	FEB	2015	22	1					11	17		10.1007/s12529-014-9403-9		7	Psychology, Clinical	Psychology	CA6HJ	WOS:000349011500002		
J	Shimazu, A; Schaufeli, WB; Kamiyama, K; Kawakami, N				Shimazu, Akihito; Schaufeli, Wilmar B.; Kamiyama, Kimika; Kawakami, Norito			Workaholism vs. Work Engagement: the Two Different Predictors of Future Well-being and Performance	INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE			English	Article						Hard work investment; Job performance; Physical complaints; Psychological distress; Workaholism; Work engagement	JOB-SATISFACTION; EMPLOYEES; BURNOUT; RESOURCES; DEMANDS; JAPAN; BAD	This study investigated the distinctiveness of two types of heavy work investment (i.e., workaholism and work engagement) by examining their 2-year longitudinal relationships with employee well-being and job performance. Based on a previous cross-sectional study by Shimazu and Schaufeli (Ind Health 47:495-502, 2009) and a shorter term longitudinal study by Shimazu et al. (Ind Health 50:316-21, 2012; measurement interval = 7 months), we predicted that workaholism predicts long-term future unwell-being (i.e., high ill-health and low life satisfaction) and poor job performance, whereas work engagement predicts future well-being (i.e., low ill-health and high life satisfaction) and superior job performance. A two-wave survey was conducted among employees from one Japanese company, and valid data from 1,196 employees was analyzed using structural equation modeling. T1-T2 changes in ill-health, life satisfaction, and job performance were measured as residual scores, which were included in the structural equation model. Workaholism and work engagement were weakly and positively related to each other. In addition, and as expected, workaholism was related to an increase in ill-health and to a decrease in life satisfaction. In contrast, and also as expected, work engagement was related to increases in both life satisfaction and job performance and to a decrease in ill-health. Although workaholism and work engagement are weakly positively related, they constitute two different concepts. More specifically, workaholism has negative consequences across an extended period of 2 years, whereas work engagement has positive consequences in terms of well-being and performance. Hence, workaholism should be prevented and work engagement should be stimulated.	[Shimazu, Akihito; Kawakami, Norito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan; [Schaufeli, Wilmar B.] Univ Utrecht, Dept Social & Org Psychol, Utrecht, Netherlands; [Kamiyama, Kimika] JUKI Corp, Human Resources Dept, Tokyo, Japan	Shimazu, A (reprint author), Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan.	ashimazu@m.u-tokyo.ac.jp					WILLIAMS LJ, 1991, J MANAGE, V17, P601, DOI 10.1177/014920639101700305; Schaufeli WB, 2008, APPL PSYCHOL-INT REV, V57, P173, DOI 10.1111/j.1464-0597.2007.00285.x; Taris TW, 2010, WORK ENGAGEMENT: A HANDBOOK OF ESSENTIAL THEORY AND RESEARCH, P39; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; Shimazu A, 2009, IND HEALTH, V47, P495; Dormann C, 2002, J OCCUP ORGAN PSYCH, V75, P33, DOI 10.1348/096317902167630; George JM, 2002, J APPL PSYCHOL, V87, P687, DOI 10.1037//0021-9010.87.4.687; Smith P, 2008, OCCUP ENVIRON MED, V65, P288, DOI 10.1136/oem.2006.032144; Wanous JP, 1997, J APPL PSYCHOL, V82, P247, DOI 10.1037/0021-9010.82.2.247; Schaufeli WB, 2009, CROSS-CULT RES, V43, P320, DOI 10.1177/1069397109337239; van Beek I, 2012, APPL PSYCHOL-INT REV, V61, P30, DOI 10.1111/j.1464-0597.2011.00454.x; Schaufeli WB, 2009, J ORGAN BEHAV, V30, P893, DOI 10.1002/job.595; van Beek I, 2011, J OCCUP HEALTH PSYCH, V16, P468, DOI 10.1037/a0024392; Snir R, 2012, HUM RESOUR MANAGE R, V22, P232, DOI 10.1016/j.hrmr.2011.11.011; Shimazu A, 2012, IND HEALTH, V50, P316, DOI 10.2486/indhealth.MS1355; Bakker A. B., 2008, LONG WORK HOURS CULT, P203; Bakker A.B., 2011, OXFORD HDB POSITIVE, P178, DOI DOI 10.1093/OXFORDHB/9780199734610.013.0014; Dwyer J. E., 1983, STAT MODELS SOCIAL B; Kanai A., 2007, RES COMPANION WORKIN, P158; Schaufeli WB, 2006, NEW HORIZ MANAG, P193; Schaufeli WB, 2002, J HAPPINESS STUD, V3, P71, DOI DOI 10.1023/A:1015630930326; Shimazu A, 2008, APPL PSYCHOL-INT REV, V57, P510, DOI 10.1111/j.1464-0597.2008.00333.x; Shimomitsu T., 1998, REPORT RES GRANT PRE, P107	23	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1070-5503	1532-7558		INT J BEHAV MED	Int. J. Behav. Med.	FEB	2015	22	1					18	23		10.1007/s12529-014-9410-x		6	Psychology, Clinical	Psychology	CA6HJ	WOS:000349011500003		
J	Shimada, M; Takai, E; Ejima, D; Arakawa, T; Shiraki, K				Shimada, Masato; Takai, Eisuke; Ejima, Daisuke; Arakawa, Tsutomu; Shiraki, Kentaro			Heat-induced formation of myosin oligomer-soluble filament complex in high-salt solution	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						Myosin; Dynamic light scattering; Filament formation; Thermal aggregation; Heat-induced gelation	INDUCED GELATION; MINIFILAMENTS; AGGREGATION; PROTEINS; ARGININE; BINDING; MUSCLE; ACID; PH	Heat-induced aggregation of myosin into an elastic gel plays an important role in the water-holding capacity and texture of meat products. Here, we investigated thermal aggregation of porcine myosin in high-salt solution over a wide temperature range by dynamic light scattering experiments. The myosin samples were readily dissolved in 1.0 M NaCl at 25 degrees C followed by dilution into various salt concentrations. The diluted solutions consistently contained both myosin monomers and soluble filaments. The filament size decreased with increasing salt concentration and temperature. High temperatures above T-m led to at least partial dissociation of soluble filaments and thermal unfolding, resulting in the formation of soluble oligomers and binding to the persistently present soluble filaments. Such a complex formation between the oligomers and filaments has never been observed. Our results provide new insight into the heat-induced myosin gelation in high-salt solution. (C) 2014 Elsevier B.V. All rights reserved.	[Shimada, Masato; Takai, Eisuke; Shiraki, Kentaro] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Ejima, Daisuke] Ajinomoto Inc, AminoSci Labs, Tokyo, Japan; [Arakawa, Tsutomu] Alliance Prot Labs, San Diego, CA 92121 USA	Shiraki, K (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	shiraki@bk.tsukuba.ac.jp					SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Puolanne E, 2010, MEAT SCI, V86, P151, DOI 10.1016/j.meatsci.2010.04.038; Tomita S, 2011, BIOPOLYMERS, V95, P695, DOI 10.1002/bip.21637; Tsunashima Y, 2004, BIOPOLYMERS, V75, P264, DOI 10.1002/bip.20114; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; SINARD JH, 1989, J CELL BIOL, V109, P1537, DOI 10.1083/jcb.109.4.1537; Takai E, 2013, INT J BIOL MACROMOL, V62, P647, DOI 10.1016/j.ijbiomac.2013.09.035; Boyer C, 1996, J FOOD SCI, V61, P1138, DOI 10.1111/j.1365-2621.1996.tb10948.x; EATON BL, 1974, J MOL BIOL, V82, P421, DOI 10.1016/0022-2836(74)90600-7; FUKAZAWA T, 1961, J FOOD SCI, V26, P541, DOI 10.1111/j.1365-2621.1961.tb00403.x; Godfreyt J. E., 1969, BIOCHEMISTRY-US, V580, P886; Godfreyt J. E., 1969, BIOCHEMISTRY-US, V581, P894; ISHIOROSHI M, 1979, J FOOD SCI, V44, P1280, DOI 10.1111/j.1365-2621.1979.tb06419.x; Kamal JKA, 2002, BIOCHEMISTRY-US, V41, P9034, DOI 10.1021/bi025621e; Katsura I., 1971, J BIOCH, V69, P219; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; REISLER E, 1980, J MOL BIOL, V143, P129, DOI 10.1016/0022-2836(80)90127-8; REISLER E, 1982, BIOCHEMISTRY-US, V21, P701, DOI 10.1021/bi00533a018; SAMEJIMA K, 1969, J FOOD SCI, V34, P242, DOI 10.1111/j.1365-2621.1969.tb10331.x; SAMEJIMA K, 1981, J FOOD SCI, V46, P1412, DOI 10.1111/j.1365-2621.1981.tb04187.x; TRYBUS KM, 1987, J CELL BIOL, V105, P3007, DOI 10.1083/jcb.105.6.3007; YAMAMOTO K, 1988, AGR BIOL CHEM TOKYO, V52, P1803; YAMAMOTO K, 1990, J BIOCHEM-TOKYO, V108, P896	23	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	FEB	2015	73						17	22		10.1016/j.ijbiomac.2014.11.005		6	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CA8TR	WOS:000349194300003		
J	Sinthusamran, S; Benjakul, S; Kishimura, H				Sinthusamran, Sittichoke; Benjakul, Soottawat; Kishimura, Hideki			Molecular characteristics and properties of gelatin from skin of seabass with different sizes	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						Seabass; Gelatin; Size; Gel strength; Setting time; Gelling temperature	PERCH LATES-NILOTICUS; RHEOLOGICAL PROPERTIES; UNICORN LEATHERJACKET; FUNCTIONAL-PROPERTIES; EXTRACTION CONDITIONS; CHEMICAL-COMPOSITION; GEL PROPERTIES; COLLAGEN; TEMPERATURES; CALCARIFER	Gelatin was extracted from the skin of seabass (Lutes calcarifer) with different average sizes (2, 4 and 6 kg/fish), termed G2, G4 and G6, respectively and their characteristics and functional properties were determined. Yields of G2, G4 and G6 were 38.22, 40.50 and 43.48% (based on dry weight), respectively. G2 contained cc-chains as dominant component, whilst G4 and G6 comprised alpha-, beta- and gamma-chains with a larger content of high MW cross-links. All gelatins had the similar imino acid (hydroxyproline and proline) content. Net charge of G2, G4 and G6 became zero at pH of 6.73, 6.41 and 7.12, respectively. Amongst all gelatin samples, G6 exhibited the highest gel strength (321.5g) (p < 0.05), but had the lowest turbidity (p < 0.05). Gels of G6 sample had the lower L*-value but higher a*-, b*- and Delta E*-value, compared with others. Gelling and melting temperatures of all gelatins were 17.09-19.01 and 26.92-28.85 degrees C, respectively. Furthermore, all gelatins were able to set at room temperature, regardless of size of seabass used. G6 had the shorter setting time at room temperature than others. Therefore, size of seabass, in which skin was used for gelatin extraction, had the impact on yield, composition and properties of resulting gelatin. (C) 2014 Elsevier B.V. All rights reserved.	[Sinthusamran, Sittichoke; Benjakul, Soottawat] Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai 90112, Songkhla, Thailand; [Kishimura, Hideki] Hokkaido Univ, Res Fac Fisheries Sci, Lab Marine Prod & Food Sci, Hakodate, Hokkaido 0418611, Japan	Benjakul, S (reprint author), Prince Songkla Univ, Fac Agroind, Dept Food Technol, Hat Yai 90112, Songkhla, Thailand.	soottawat.b@psu.ac.th			Graduate School, Prince of Songkla University, Thailand; TRF	The authors would like to express their sincere thanks to Thailand Research Fund under the Royal Golden Jubilee Ph.D. Programme to Sittichoke Sinthusamran (PHD/0053/2553) and the Grant-in-Aid for dissertation from Graduate School, Prince of Songkla University, Thailand for financial support. The TRF Distinguished Research Professor Grant was also acknowledged.	Ahmad M, 2011, FOOD HYDROCOLLOID, V25, P381, DOI 10.1016/j.foodhyd.2010.07.004; Benjakul S, 2009, FOOD CHEM, V116, P445, DOI 10.1016/j.foodchem.2009.02.063; Jellouli K, 2011, LWT-FOOD SCI TECHNOL, V44, P1965, DOI 10.1016/j.lwt.2011.05.005; Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006; BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Shakila RJ, 2012, LWT-FOOD SCI TECHNOL, V48, P30, DOI 10.1016/j.lwt.2012.03.007; Nagarajan M, 2012, FOOD HYDROCOLLOID, V29, P389, DOI 10.1016/j.foodhyd.2012.04.001; Yakimets I, 2005, POLYMER, V46, P12577, DOI 10.1016/j.polymer.2005.10.090; Shyni K, 2014, FOOD HYDROCOLLOID, V39, P68, DOI 10.1016/j.foodhyd.2013.12.008; DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505; Zhang JJ, 2012, FOOD HYDROCOLLOID, V29, P100, DOI 10.1016/j.foodhyd.2012.02.005; Karim AA, 2009, FOOD HYDROCOLLOID, V23, P563, DOI 10.1016/j.foodhyd.2008.07.002; Singh P, 2011, FOOD CHEM, V124, P97, DOI 10.1016/j.foodchem.2010.05.111; Chen LQ, 2014, FOOD HYDROCOLLOID, V36, P316, DOI 10.1016/j.foodhyd.2013.10.012; Sinthusamran S, 2014, FOOD CHEM, V152, P276, DOI 10.1016/j.foodchem.2013.11.109; Sinthusamran S, 2013, FOOD CHEM, V138, P2435, DOI 10.1016/j.foodchem.2012.11.136; Koli JM, 2012, FOOD BIOPROD PROCESS, V90, P555, DOI 10.1016/j.fbp.2011.08.001; Azira TN, 2014, FOOD CHEM, V151, P286, DOI 10.1016/j.foodchem.2013.11.066; Silva RSG, 2014, LWT-FOOD SCI TECHNOL, V57, P580, DOI 10.1016/j.lwt.2014.02.026; Benjakul S, 2012, FOOD BIOCH FOOD PROC, P388; Bonner P. L. R., 2007, PROTEIN PURIFICATION; Ferndandez-Diaz MD, 2003, FOOD HYDROCOLLOID, V17, P281, DOI 10.1016/S0268-005X(02)00078-4; Fernandez-Diaz MD, 2001, FOOD CHEM, V74, P161, DOI 10.1016/S0308-8146(01)00110-8; Foegeding E.A., 1996, FOOD CHEM, V3, P879; Gennadios A, 1996, J FOOD SCI, V61, P585, DOI 10.1111/j.1365-2621.1996.tb13164.x; Gudmundsson M, 2002, J FOOD SCI, V67, P2172, DOI 10.1111/j.1365-2621.2002.tb09522.x; Haugen T. O., 2011, AM FISH SOC S, V76, P1; JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V; Kaewruang P., 2013, FOOD BIOSCIENCE, V2, P1; Kaewruang P, 2013, FOOD CHEM, V138, P1431, DOI 10.1016/j.foodchem.2012.09.114; Kasankala L. M., 2007, BIORESOURCE TECHNOLO, V98, P338; Kittiphattanabawon P, 2010, FOOD HYDROCOLLOID, V24, P164, DOI 10.1016/j.foodhyd.2009.09.001; LAVIALLE F, 1982, BIOCHEMISTRY-US, V21, P2305, DOI 10.1021/bi00539a006; Ledward D. A., 1989, FUNCTIONAL PROPERTIE, P171; Muyonga JH, 2004, FOOD HYDROCOLLOID, V18, P581, DOI 10.1016/j.foodhyd.2003.08.009; Nikoo M., 2014, FOOD BIOSCI, V5, P19; Steel R.G., 1980, PRINCIPLES PROCEDURE; Tabarestani HS, 2010, BIORESOURCE TECHNOL, V101, P6207, DOI 10.1016/j.biortech.2010.02.071; Wangtueai S., 2010, J FOOD SCI, V75, P731; Zeng SK, 2010, INT J FOOD SCI TECH, V45, P1807, DOI 10.1111/j.1365-2621.2010.02332.x	41	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	FEB	2015	73						146	153		10.1016/j.ijbiomac.2014.11.024		8	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	CA8TR	WOS:000349194300021		
J	Usui, Y; Miura, H				Usui, Y.; Miura, H.			Workforce re-entry for Japanese unemployed dental hygienists	INTERNATIONAL JOURNAL OF DENTAL HYGIENE			English	Article						barriers; dental hygiene profession; re-entry; unemployed dental hygienists; work-life balance	ORAL CARE; PERCEPTIONS; PNEUMONIA	ObjectiveThe aim of this study was to define the profile of unemployed dental hygienists who could be enticed to re-enter the workforce and the factors that could facilitate their re-entry into the dental field in Japan. MethodsThe questionnaire was mailed with a postage-paid return envelope to a sample of 3095 licensed dental hygienists. A 50.4% response rate (S=1477) was observed. ResultsThe rate of working dental hygienists was 60.3% (n=891), and of unemployed dental hygienists was 39.7% (n=586). Of the latter, 31.9% (n=187) stated intentions of returning to the workplace. The unemployed dental hygienists seeking employment were more often married and had more children, compared with working dental hygienists currently. This group also had significantly fewer total service years. Moreover, only 11.96% of them belonged to the Japan Dental Hygienists' Association, and 41.3% of those attended training workshops. According to their response, they perceived their top three major barriers to re-entry as lack sufficient dental hygiene skill', child rearing' and poor working atmosphere'. Flexibility in the work schedule' and location' were the most important factors for re-entry from their perspective. ConclusionThere were not many dental hygienists hoping to return to the dental field. The findings suggested that strategies to encourage non-practicing dental hygienists to re-entry should be emphasized in the areas of a flexible working atmosphere, easy access to information on how to return to practice and guidance on how to maintain professionalism during inactivity.	[Usui, Y.; Miura, H.] Natl Inst Publ Hlth, Dept Int Hlth & Collaborat, Wako, Saitama 3510197, Japan; [Usui, Y.] Tokyo Med & Dent Univ, Dept Gerodontol, Tokyo, Japan	Usui, Y (reprint author), Natl Inst Publ Hlth, Dept Int Hlth & Collaborat, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	usui@niph.go.jp			Ministry of Health, Labor and Welfare of Japan	This study was funded by a part of the research project of the Ministry of Health, Labor and Welfare of Japan. A part of this study was presented at the 91st General Session and Exhibition of the International Association for Dental Research on March 22, 2013.	Abbott A, 2005, Int J Dent Hyg, V3, P37, DOI 10.1111/j.1601-5037.2004.00115.x; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; [Anonymous], WALLS PREV WOM CONT, P61; Coomber B, 2007, INT J NURS STUD, V44, P297, DOI 10.1016/j.ijnurstu.2006.02.004; Yoneyama T, 1996, ARCH GERONTOL GERIAT, V22, P11; Tada A, 2012, ARCH GERONTOL GERIAT, V55, P16, DOI 10.1016/j.archger.2011.06.029; Bansal M, 2013, J Med Life, V6, P126; Eaton KA, 2003, BRIT DENT J, V195, P595, DOI 10.1038/sj.bdj.4810736; Forsell M, 2011, INT J DENT HYG, V9, P199, DOI 10.1111/j.1601-5037.2010.00477.x; Horiguchi S., 2011, JMAJ - Japan Medical Association Journal, V54, P31; Johnson PM, 2009, INT DENT J, V59, P63, DOI 10.1922/IDJ_2076Johnson15; Jongbloed-Zoet C, 2012, INT J DENT HYG, V10, P148, DOI 10.1111/j.1601-5037.2012.00573.x; Kanji Z, 2011, INT J DENT HYG, V9, P242, DOI 10.1111/j.1601-5037.2010.00495.x; Luciak-Donsberger C, 2005, INT J DENT HYG, V7, P273; OHara Y, 2012, J DENT HLTH, V62, P282; Saito A, 2009, INT J DENT HYG, V7, P188, DOI 10.1111/j.1601-5037.2009.00388.x; Saito A, 2010, INT J DENT HYG, V8, P134, DOI 10.1111/j.1601-5037.2009.00411.x; Ueda Y, 2011, JAPANESE J DENT PRAC, V45, P286; Widstrom E, 2010, INT DENT J, V4, P312; Yoshida T, 2010, JAPANESE J DENT PRAC, V44, P216	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1601-5029	1601-5037		INT J DENT HYG	Int. J. Dent. Hyg.	FEB	2015	13	1					74	78		10.1111/idh.12101		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AZ9HF	WOS:000348523800009		
J	Shiratori, T; Fukai, K; Yasumizu, M; Taguchi, R; Tsuruta, D; Abe, Y; Hozumi, Y; Suzuki, T				Shiratori, Takahiro; Fukai, Kazuyoshi; Yasumizu, Makiko; Taguchi, Rieko; Tsuruta, Daisuke; Abe, Yuko; Hozumi, Yutaka; Suzuki, Tamio			IL36RN gene analysis of two Japanese patients with generalized pustular psoriasis	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Letter							DEFICIENCY; ANTAGONIST		[Shiratori, Takahiro; Fukai, Kazuyoshi; Yasumizu, Makiko; Taguchi, Rieko; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan; [Abe, Yuko; Hozumi, Yutaka; Suzuki, Tamio] Yamagata Univ, Fac Med, Dept Dermatol, Yamagata 990, Japan	Shiratori, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan.	fukai@msic.med.osaka-cu.ac.jp					Abbas O, 2013, DERMATOLOGY, V226, P28, DOI 10.1159/000346572; Navarini AA, 2013, J INVEST DERMATOL, V133, P1904, DOI 10.1038/jid.2013.44; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Setta-Kaffetzi N, 2013, J INVEST DERMATOL, V133, P1366, DOI 10.1038/jid.2012.490; Sugiura K, 2013, J INVEST DERMATOL, V133, P2514, DOI 10.1038/jid.2013.230; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Faroq M, 2013, HUM MUTAT, V34, P176; Kanazawa N, 2013, J DERMATOL, V40, P749, DOI 10.1111/1346-8138.12227; Tamiya H, 2005, INT J DERMATOL, V44, P791, DOI 10.1111/j.1365-4632.2004.02519.x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	FEB	2015	54	2					E60	E62		10.1111/ijd.12657		3	Dermatology	Dermatology	AZ9DT	WOS:000348512900004		
J	Iwasa, T; Matsuzaki, T; Tungalagsuvd, A; Munkhzaya, M; Kawami, T; Yamasaki, M; Murakami, M; Kato, T; Kuwahara, A; Yasui, T; Irahara, M				Iwasa, Takeshi; Matsuzaki, Toshiya; Tungalagsuvd, Altankhuu; Munkhzaya, Munkhsaikhan; Kawami, Takako; Yamasaki, Mikio; Murakami, Masahiro; Kato, Takeshi; Kuwahara, Akira; Yasui, Toshiyuki; Irahara, Minoru			Developmental changes in hypothalamic toll-like-receptor 4 mRNA expression and the effects of lipopolysaccharide on such changes in female rats	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						TLR4; IL-1 beta; TNF-alpha; IL-6; Hypothalamus	PITUITARY-ADRENAL RESPONSE; SERUM LEPTIN LEVELS; RESPONSIVENESS; ONTOGENY; MICE	Hypothalamic pro-inflammatory cytokine expression exhibits a weaker response to lipopolysaccharides (LPS) during the early neonatal period than during the later developmental period. Although toll-like receptor 4 (TLR4), which recognizes bacterial molecules, activates pro-inflammatory cytokine responses, the developmental changes in hypothalamic TLR4 expression have not been evaluated. In this study, the hypothalamic TLR4 mRNA levels of saline-injected and LPS-injected rats were measured during the neonatal, pre-pubertal, and post-pubertal periods. The rats' hypothalamic TLR4 mRNA levels gradually increased from the neonatal to pubertal period and were altered by the injection of LPS at all examined ages (postnatal day (PND) 5, 15, 25, and 42). LPS injection resulted in decreased hypothalamic TLR4 mRNA expression at PND5, whereas it increased hypothalamic TLR4 mRNA expression at PND15, 25, and 42. After the injection of LPS, the hypothalamic mRNA levels of the pro-inflammatory cytokines interleukin (IL)-1 beta, tumor necrosis factor a, and IL-6 were attenuated during the early developmental period and increased acutely on PND42. The expression profiles of these pro-inflammatory cytokines exhibited similar, but not entirely consistent, changes to those displayed by TLR4 during the developmental period. Hypothalamic TLR4 mRNA expression gradually increased throughout the developmental period, whereas the mRNA expression levels of the pro-inflammatory cytokines increased acutely at PND42. Thus, it is assumed that hypothalamic TLR4 hypoactivity contributes to the low sensitivity of pro-inflammatory cytokines to LPS during the early developmental period. (C) 2014 ISDN. Published by Elsevier Ltd. All rights reserved.	[Iwasa, Takeshi; Matsuzaki, Toshiya; Tungalagsuvd, Altankhuu; Munkhzaya, Munkhsaikhan; Kawami, Takako; Yamasaki, Mikio; Kato, Takeshi; Kuwahara, Akira; Irahara, Minoru] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Obstet & Gynecol, Tokushima 7708503, Japan; [Murakami, Masahiro] Shikoku Med Ctr Children & Adults, Dept Obstet & Gynecol, Zentsuji, Kagawa 7658507, Japan; [Yasui, Toshiyuki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Reprod Technol, Tokushima 7708503, Japan	Iwasa, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Obstet & Gynecol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	iwasa.takeshi@tokushima-u.ac.jp					Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; Matsuguchi T, 2000, J IMMUNOL, V165, P5767; Iwasa T, 2014, INT J DEV NEUROSCI, V34, P76, DOI 10.1016/j.ijdevneu.2014.02.001; Harju K, 2001, PEDIATR RES, V49, P81, DOI 10.1203/00006450-200101000-00018; WALKER CD, 1986, ENDOCRINOLOGY, V118, P1445; Khan MM, 2012, STROKE, V43, P1376, DOI 10.1161/STROKEAHA.111.635516; Iwasa T, 2014, INT J DEV NEUROSCI, V36, P1, DOI 10.1016/j.ijdevneu.2014.03.011; Iwasa T., 2014, INT J DEV NEUROSCI C, V38C, pS0736; Iwasa T, 2014, INT J DEV NEUROSCI, V35, P52, DOI 10.1016/j.ijdevneu.2014.03.007; Iwasa T, 2011, J NEUROIMMUNOL, V236, P10, DOI 10.1016/j.jneuroim.2011.04.004; Rouzic V.L., 2012, J INFLAMM RES, V5, P99; Takeda K, 2001, GENES CELLS, V6, P733, DOI 10.1046/j.1365-2443.2001.00458.x; WIDMAIER EP, 1990, ENDOCRINOLOGY, V126, P3116; WIDMAIER EP, 1989, AM J PHYSIOL, V257, pE757; Wisse BE, 2007, ENDOCRINOLOGY, V148, P5230, DOI 10.1210/en.2007-0394; WITEKJANUSEK L, 1988, AM J PHYSIOL, V255, pE525; Yang QW, 2002, CHINESE MED J-PEKING, V115, P286	17	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748	1873-474X		INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	FEB	2015	40						12	14		10.1016/j.ijdevneu.2014.10.002		3	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CA8TT	WOS:000349194500002		
J	Lafossas, FA; Manetas, C; Mohammadi, A; Kalogirou, M; Koltsakis, G; Samaras, Z; Iida, M; Inoue, M				Lafossas, Francois-Alexandre; Manetas, Christos; Mohammadi, Ali; Kalogirou, Maria; Koltsakis, Grigorios; Samaras, Zissis; Iida, Masahide; Inoue, Mikio			Sulfation and lean/rich desulfation of a NOx storage reduction catalyst: Experimental and simulation study	INTERNATIONAL JOURNAL OF ENGINE RESEARCH			English	Article						Diesel engine; exhaust aftertreatment simulation; NOx storage reduction catalyst; sulfation; sulfur axial distribution; lean; rich desulfation; sulfur speciation; baria; ceria	GLOBAL KINETIC-MODEL; SPATIAL-DISTRIBUTION; SULFUR; TRAP; PT/BAO/AL2O3; DEACTIVATION; REGENERATION; ADSORPTION; CONVERTERS; CO2	A detailed study of the sulfation and desulfation phenomena of a NOx storage reduction catalyst using synthetic gas bench is presented. The experimental observations and results were put together, in order to develop a model, which can simulate the NOx storage reduction catalyst behavior during the sulfation and desulfation conditions. The target is to use the model for simulation of the lean/rich desulfation strategies, in order to comprehend the complicated phenomena and ultimately predict the sulfur speciation at the outlet of the NOx storage reduction catalyst. Sulfation tests in the presence and in the absence of O-2 at different temperatures were conducted, in order to identify the different sulfation sites. Desulfation tests with constantly rich conditions and lean/rich oscillation, using H-2 as the reducing gas, were performed in order to investigate the reaction pathways of the decomposition of the sulfates. Additionally, some preliminary investigation was performed using CO and decane in the reducing gas mixture, in order to evaluate the NOx storage reduction behavior under more realistic gas composition for diesel exhaust gas. The important role of the accurate prediction of sulfur axial distribution at the desulfation onset was identified. It was found that cerium oxides play a critical role in the sulfation process by increasing the sulfur capacity of the NOx storage reduction catalyst. Finally, it was clarified that the oxygen stored on cerium oxides strongly affects the selectivity of the desulfation products by oxidizing H2S and controlling H-2 availability.	[Lafossas, Francois-Alexandre; Mohammadi, Ali] Toyota Motor Europe NV SA, Powertrain Engn Div, B-1930 Zaventem, Belgium; [Manetas, Christos; Kalogirou, Maria] Exothermia SA, Thessaloniki, Greece; [Koltsakis, Grigorios; Samaras, Zissis] Aristotle Univ Thessaloniki, Lab Appl Thermodynam, GR-54006 Thessaloniki, Greece; [Iida, Masahide; Inoue, Mikio] Toyota Motor Co Ltd, Toyota, Japan	Lafossas, FA (reprint author), Toyota Motor Europe NV SA, Powertrain Engn Div, Hoge Wei 33 B, B-1930 Zaventem, Belgium.	Francois-A.Lafossas@toyota-europe.com					Olsson L, 2005, IND ENG CHEM RES, V44, P3021, DOI 10.1021/ie0494059; Elbouazzaoui S, 2005, APPL CATAL B-ENVIRON, V61, P236, DOI 10.1016/j.apcatb.2005.05.012; Matsumoto S, 2000, APPL CATAL B-ENVIRON, V25, P115, DOI 10.1016/S0926-3373(99)00124-1; Luo T, 2002, J CATAL, V210, P397, DOI 10.1006/jcat.2002.3689; Scholz CML, 2007, J CATAL, V245, P215, DOI 10.1016/j.jcat.2006.10.011; Koltsakis GC, 1997, APPL CATAL B-ENVIRON, V12, P161, DOI 10.1016/S0926-3373(96)00073-2; Bhatia D, 2009, CATAL TODAY, V147, pS250, DOI 10.1016/j.cattod.2009.07.024; Bisaiji Y, 2011, 2011012089 SAE; Breen JP, 2002, CATAL LETT, V80, P123, DOI 10.1023/A:1015404324617; Choi JS, 2010, CATAL TODAY, V151, P354, DOI 10.1016/j.cattod.2010.01.016; Choi JS, 2008, CATAL TODAY, V136, P173, DOI 10.1016/j.cattod.2008.01.008; Dawody J, 2007, APPL CATAL B-ENVIRON, V70, P179, DOI 10.1016/j.apcatb.2005.11.021; Di-Penta D, 2011, 2011011300 SAE; Easterling V, 2010, CATAL TODAY, V151, P338, DOI 10.1016/j.cattod.2009.12.007; Hachisuka I, 2000, 2000011196 SAE; Kim JY, 2006, 2006010470 SAE; Koci P, 2009, CATAL TODAY, V147, pS257, DOI 10.1016/j.cattod.2009.07.036; Koltsakis G, 2006, 2006010471 SAE; Lafossas F, 2011, 2011011244 SAE; Larson RS, 2012, CHEM ENG J, V189, P134, DOI 10.1016/j.cej.2012.02.042; Laurent F, 2003, CHEM ENG SCI, V58, P1793, DOI 10.1016/S0009-2509(03)00014-9; Limousy L, 2003, APPL CATAL B-ENVIRON, V42, P237, DOI 10.1016/S0926-3373(02)00235-7; Luo JY, 2011, APPL CATAL B-ENVIRON, V106, P664, DOI 10.1016/j.apcatb.2011.06.033; Margaritis NK, 2007, TOP CATAL, V42-43, P65, DOI 10.1007/s11244-007-0153-7; Nakatani K, 2002, 2002010957 SAE; Olsson L, 2011, APPL CATAL, V100, P31; Partridge B, 2010, DEER 2010 C DETR MIC; Rohr F, 2007, APPL CATAL B-ENVIRON, V70, P189, DOI 10.1016/j.apcatb.2005.12.033; Shakya BM, 2012, CATAL TODAY, V184, P27, DOI 10.1016/j.cattod.2012.01.037; Toops TJ, 2008, CATAL TODAY, V136, P164, DOI 10.1016/j.cattod.2008.02.007; Tsinoglou DN, 2002, IND ENG CHEM RES, V41, P1152, DOI 10.1021/ie010576c; Wei XY, 2005, APPL CATAL B-ENVIRON, V58, P41, DOI 10.1016/j.apcatb.2004.04.021	32	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1468-0874	2041-3149		INT J ENGINE RES	Int. J. Engine Res.	FEB	2015	16	2					197	212		10.1177/1468087414526188		16	Thermodynamics; Engineering, Mechanical; Transportation Science & Technology	Thermodynamics; Engineering; Transportation	CA9EZ	WOS:000349225300006		
J	Endo, M				Endo, M.			Study on an alternative deformation concept for the Timoshenko beam and Mindlin plate models	INTERNATIONAL JOURNAL OF ENGINEERING SCIENCE			English	Article						Alternative deformation concept; First-order shear deformation theory; Timoshenko beam model; Mindlin plate model	COUPLE STRESS THEORY; SOUTHWELL-DUNKERLEY METHODS; COMPOSITE PLATES; SYNTHESIZING FREQUENCIES; TRANSVERSE VIBRATIONS; LAMINATED COMPOSITE; SHEAR; FORMULATION; EXTENSION; NANOBEAMS	An overall historical survey on the bending and shearing deformation concepts in first-order shear deformation theories is carried out in relation to the corrected classical models from the viewpoint of distinguishability of both the deflections in beams and plates, including the alternative deformation concept for the Timoshenko beam and Mindlin plate models proposed by the author and his co-worker. The survey shows that in the corrected classical models, the bending and shearing deflections are recognized as distinguishable physical entities, and which has gained widespread acceptance in the various fields of continuum and structure mechanics, though both deflections cannot be obtained concurrently using a deductive approach. With regard to the conventional first-order shear deformation theory, both deflections are not to be recognized as distinguishable physical entities, and it is shown that these two deflections cannot be uniquely determined for a beam and cannot be specifically defined for a plate. In contrast to this, the alternative deformation concept is shown to be effective in resolving all the above inconsistencies. To demonstrate its effectiveness and practical advantages, both static and dynamic analyses are carried out. The static analysis involves a simply supported beam subjected to a uniform or concentrated static load, for which both the bending and shearing deflections are obtained concurrently and uniquely in addition to the total deflection using a deductive approach, and a thought experiment that distinguishes both deflections as physical entities is also presented. The dynamic analysis involves the application of an extension of the Southwell-Dunkerley methods for synthesizing frequencies. Based on a series-type synthetic-frequency method established by the author and his co-worker, a frequency analysis with two deflections coupled in series is carried out for isotropic plates and carbon fiber reinforced plastic laminated composite beams. It is also shown that the alternative deformation concept is a model that can contribute to the development of a practical finite element formulation that is free from shear locking. (C) 2014 Elsevier Ltd. All rights reserved.	[Endo, M.] Tokyo Inst Technol, Dept Mech Sci & Engn, Tokyo 1528550, Japan	Endo, M (reprint author), 2-5-15 Hongodai,Sakae Ku, Yokohama, Kanagawa 2470008, Japan.	mendo2nd@lake.ocn.ne.jp					ABADI MM, 2014, INT J ENG SCI, V74, P1; Allen H.G., 1969, ANAL DESIGN STRUCTUR; ANDERSON RA, 1953, J APPL MECH-T ASME, V20, P504; ANDERSON RA, 1953, THESIS CALIFORNIA I; Thai HT, 2010, INT J MECH SCI, V52, P626, DOI 10.1016/j.ijmecsci.2010.01.002; REISSNER E, 1947, Q APPL MATH, V5, P55; Shimpi RP, 2006, J SOUND VIB, V296, P979, DOI 10.1016/j.jsv.2006.03.030; Timoshenko SP, 1921, PHILOS MAG, V41, P744; Carrera E, 2010, AIAA J, V48, P2852, DOI 10.2514/1.J050316; Abadi MM, 2014, INT J ENG SCI, V75, P40, DOI 10.1016/j.ijengsci.2013.11.009; Tessler A, 2010, J MECH MATER STRUCT, V5, P341, DOI 10.2140/jomms.2010.5.341; Simsek M, 2013, INT J ENG SCI, V64, P37, DOI 10.1016/j.ijengsci.2012.12.002; Rahmani O, 2014, INT J ENG SCI, V77, P55, DOI 10.1016/j.ijengsci.2013.12.003; Thai HT, 2013, COMPOS STRUCT, V101, P332, DOI 10.1016/j.compstruct.2013.02.019; Ma HM, 2008, J MECH PHYS SOLIDS, V56, P3379, DOI 10.1016/j.jmps.2008.09.007; Timoshenko SP, 1922, PHILOS MAG, V43, P125; Ma HM, 2011, ACTA MECH, V220, P217, DOI 10.1007/s00707-011-0480-4; Shimpi RP, 2007, J APPL MECH-T ASME, V74, P523, DOI 10.1115/1.2423036; Szekrenyes A, 2014, EUR J MECH A-SOLID, V43, P9, DOI 10.1016/j.euromechsol.2013.08.004; Roque CMC, 2011, INT J ENG SCI, V49, P976, DOI 10.1016/j.ijengsci.2011.05.010; Shimpi RP, 2002, AIAA J, V40, P137, DOI 10.2514/2.1622; Endo M, 2007, J SOUND VIB, V301, P355, DOI 10.1016/j.jsv.2006.10.005; Carrera E, 2011, BEAM STRUCTURES: CLASSICAL AND ADVANCED THEORIES, P1, DOI 10.1002/9781119978565; CARRERA E, 2011, J APPL MECH-T ASME, V78; Challamel N, 2011, MECH RES COMMUN, V38, P388, DOI 10.1016/j.mechrescom.2011.05.004; DAVIDSON T, 1946, P SESA, V4, P88; Donnell L. H, 1976, BEAMS PLATES SHELLS; DONNELL LH, 1946, J APPL MECH-T ASME, V68, pA249; ENDO M, 2000, T JSME C, V66, P2143; ENDO M, 1976, J SOUND VIB, V49, P517, DOI 10.1016/0022-460X(76)90832-4; ENDO M, 1976, J SOUND VIB, V49, P501, DOI 10.1016/0022-460X(76)90831-2; Jacobsen L., 1958, ENG VIBRATIONS APPL; KATORI H, 2003, T JSME A, V69, P1374; Kolakowski Z, 2014, THIN WALL STRUCT, V74, P261, DOI 10.1016/j.tws.2013.09.009; KONDO K, 1993, VIBRATION THEORY; Love A E H, 1944, TREATISE MATH THEORY; MINDLIN RD, 1951, J APPL MECH-T ASME, V18, P31; NAKAHARA I, 1965, STRENGTH MAT 1; NARITA Y, 1995, T JSME C, V61, P738; Noor AK, 1989, APPL MECH REV, V42, P1, DOI DOI 10.1115/1.3152418; Pai PF, 2013, THIN WALL STRUCT, V65, P7, DOI 10.1016/j.tws.2013.01.001; Plantema F.J., 1966, SANDWICH CONSTRUCTIO; Rayleigh JWS, 1945, THEORY SOUND, V1; REDDY JN, 1989, INT J NUMER METH ENG, V27, P361, DOI 10.1002/nme.1620270210; REISSNER E, 1945, J APPL MECH-T ASME, V12, pA69; Senjanovic I, 2013, J SOUND VIB, V332, P1868, DOI 10.1016/j.jsv.2012.11.022; Thai HT, 2013, INT J MECH SCI, V73, P40, DOI 10.1016/j.ijmecsci.2013.03.017; Thai HT, 2013, COMPOS STRUCT, V106, P754, DOI 10.1016/j.compstruct.2013.06.013; Timoshenko S., 1974, VIBRATION PROBLEMS E; Timoshenko S., 1955, VIBRATION PROBLEMS E; Timoshenko S P, 1953, HIST STRENGTH MAT; Timoshenko SP, 1940, STRENGTH MAT 1; Xiang Y, 2003, J SOUND VIB, V263, P285, DOI 10.1016/S0022-460X(02)01124-0; Zenkert D., 1995, INTRO SANDWICH CONST	54	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7225	1879-2197		INT J ENG SCI	Int. J. Eng. Sci.	FEB	2015	87						32	46		10.1016/j.ijengsci.2014.11.001		15	Engineering, Multidisciplinary	Engineering	CA2NZ	WOS:000348746200004		
J	Nakamura, K; Sawada, K; Sugiyama, M; Mabuchi, S; Hisamatsu, T; Nishio, Y; Ito, K; Kimura, T; Kamiura, S; Morishige, K				Nakamura, Koji; Sawada, Kenjiro; Sugiyama, Michiyo; Mabuchi, Seiji; Hisamatsu, Takeshi; Nishio, Yukihiro; Ito, Kimihiko; Kimura, Tadashi; Kamiura, Shoji; Morishige, Ken-ichirou			Efficacy of Raloxifene Hydrochloride for the Prevention of Health Care Problems in Patients Who Undergo Surgery for Endometrial Cancer A Multicenter Randomized Clinical Trial	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Endometrial cancer; Raloxifene; Osteoporosis; LDL-cholesterol; Postoperative health care	GYNECOLOGIC-ONCOLOGY-GROUP; POSTMENOPAUSAL WOMEN; CARDIOVASCULAR EVENTS; SURGICAL MENOPAUSE; FRACTURE RISK; OSTEOPOROSIS; BONE; OOPHORECTOMY; HYSTERECTOMY; OUTCOMES	Objective: Removal of the ovaries is common during surgery for endometrial cancer. However, because loss of the ovaries can cause several health problems in patients, strategies for the prevention of such problems need to be established. Hence, we decided to conduct a multicenter randomized clinical trial to assess the effect of raloxifene on bone mineral density (BMD), bone metabolism, and the lipid profile of patients who had undergone surgery for patients with endometrial cancer. Materials and Methods: Patients with endometrial cancer were enrolled after treatment. The participants were randomized into 2 groups: group 1 included 39 women who received alfacalcidol (1 Kg/d) alone and group 2 included 37 women who received alfacalcidol and the test drug, raloxifene hydrochloride, at a dose of 60 mg/d. The BMD of lumbar spine and femoral neck, serum bone markers, as well as lipid profile parameters were evaluated at enrollment as well as 6, 12, and 24 months after the enrollment. The primary efficacy end point was the percentage change from baseline to 24 months in lumbar spine (L2-L4) and femoral neck BMD. Results: Sixty-four women completed the 24-month study. At 24 months, the lumbar and femoral neck BMDs were significantly increased in group 2 compared with group 1 (3.5% vs -0.8% and 2.3% vs -2.8%, respectively). In group 2, low-density lipoprotein-cholesterol levels were significantly reduced by 13.6% and serum N-terminal telopeptide of type I collagen as well as bone-specific alkaline phosphatase values were significantly reduced by 16.7% and 25.7%, respectively. The patients who received adjuvant therapy for endometrial cancer showed a significantly higher response to raloxifene (5.8% vs 1.9%). Recurrence was detected in 2 (2.6%) patients in group 1. No severe adverse events were noted in any patient during the study period. Conclusions: Raloxifene exerts positive effects on BMD, bone metabolism, and lipid profile parameters and could provide an improved therapeutic option for patients with endometrial cancer.	[Nakamura, Koji; Sawada, Kenjiro; Mabuchi, Seiji; Hisamatsu, Takeshi; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan; [Sugiyama, Michiyo; Morishige, Ken-ichirou] Gifu Univ, Grad Sch Med, Dept Obstet & Gynecol, Gifu, Japan; [Nishio, Yukihiro] Osaka Police Hosp, Dept Obstet & Gynecol, Osaka, Japan; [Ito, Kimihiko] Kansai Rosai Hosp, Dept Obstet & Gynecol, Amagasaki, Hyogo, Japan; [Kamiura, Shoji] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gynecol, Osaka, Japan	Sawada, K (reprint author), Osaka Univ, Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 565, Japan.	daasawada@gyne.med.osaka-u.ac.jp			Japan Osteoporosis Foundation; Lily Scientific Research Fund	Supported partly by the Japan Osteoporosis Foundation and the Lily Scientific Research Fund (to K.S.).	Parker WH, 2009, OBSTET GYNECOL, V113, P1027, DOI 10.1097/AOG.0b013e3181a11c64; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; [Anonymous], 2014, SEER CANC STAT FACTS; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Tashjian AH, 2006, J BONE MINER RES, V21, P354, DOI 10.1359/JBMR.051023; van Leeuwen BL, 2000, CANCER TREAT REV, V26, P363, DOI 10.1053/ctrv.2000.0180; Melton LJ, 2003, J BONE MINER RES, V18, P900, DOI 10.1359/jbmr.2003.18.5.900; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Cranney A, 2002, ENDOCR REV, V23, P524, DOI 10.1210/er.2001-4002; Yoshida T, 2011, CLIMACTERIC, V14, P445, DOI 10.3109/13697137.2011.562994; Lobo RA, 2007, MENOPAUSE, V14, P562, DOI 10.1097/gme.0b013e318038d333; DeMichele A, 2008, J CLIN ONCOL, V26, P4151, DOI 10.1200/JCO.2007.14.0921; HOWLAND WJ, 1975, RADIOLOGY, V117, P677; Das S, 2013, DRUG DES DEV THER, V7, P435, DOI 10.2147/DDDT.S31504; Gallagher JC, 2007, MENOPAUSE, V14, P567, DOI 10.1097/gme.0b013e31804c793d; Barakat RR, 2006, J CLIN ONCOL, V24, P587, DOI 10.1200/JCO.2005.02.8464; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; Douchi T, 1997, OBSTET GYNECOL, V90, P12, DOI 10.1016/S0029-7844(97)00124-5; HOWE HL, 1984, AM J PUBLIC HEALTH, V74, P560, DOI 10.2105/AJPH.74.6.560; IKEDA T, 1991, J CLIN LAB ANAL, V5, P90, DOI 10.1002/jcla.1860050204; Lynnet TS, 2010, MENOPAUSAL MED, V4, pS1; National Osteoporosis Foundation, 1998, PHYS GUID PREV TREAT; Nishio Keina, 2013, Endocr Connect, V2, P11, DOI 10.1530/EC-12-0043; Wakatsuki A, 2001, J AM COLL CARDIOL, V37, P425, DOI 10.1016/S0735-1097(00)01153-0	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	FEB	2015	25	2					288	295		10.1097/IGC.0000000000000333		8	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CA3TZ	WOS:000348831000016		
J	Nomura, H; Matoda, M; Okamoto, S; Omatsu, K; Kondo, E; Kato, K; Umayahara, K; Takeshima, N				Nomura, Hidetaka; Matoda, Maki; Okamoto, Sanshiro; Omatsu, Kohei; Kondo, Eiji; Kato, Kazuyoshi; Umayahara, Kenji; Takeshima, Nobuhiro			Clinical Characteristics of Non-Squamous Cell Carcinoma of the Vagina	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Vaginal carcinoma; Adenocarcinoma; Chemotherapy; Treatment outcome; Non-squamous cell carcinoma	PROGNOSTIC-FACTORS; CANCER; ADENOCARCINOMA; RADIOTHERAPY; THERAPY; SERIES; AGE	Objective: The prognosis and vaginal disease control rate after treatment with radiotherapy or concurrent chemoradiotherapy (CCRT) are reported to be worse for primary non-squamous cell carcinoma (non-SCC) of the vagina than for squamous cell carcinoma (SCC) of the vagina. Our objective was to examine the clinicopathological characteristics of primary non-SCC of the vagina and suggest an appropriate treatment strategy. Materials and Methods: In a retrospective chart review, we identified patients with primary vaginal cancer who were treated in our hospital between 1990 and 2013. Twelve patients with histologically diagnosed non-SCC were identified. None of these cases was associated with in utero diethylstilbestrol exposure. Clinical data, including patient characteristics, stage, treatment outcome, and the site of recurrence, were recorded. Results: The 12 identified cases included 5 of clear cell carcinoma, 3 of adenocarcinoma, 2 of adenosquamous carcinoma, 1 of carcinosarcoma, and 1 of mucinous adenocarcinoma. The most common location of the tumor was the upper one third of the vagina (56%). Initial treatment involved surgery in 8 patients. Among them, 4 received adjuvant chemotherapy, 3 received adjuvant radiotherapy, and 1 received neither. The initial treatment among the remaining 4 patients was CCRT in 1, neoadjuvant chemotherapy in 2 (followed by CCRT or surgery), and best supportive care in 1. The last 3 patients had lung metastasis. Six patients experienced recurrence, including vaginal recurrence in 2 patients and lymphatic spread in 4 patients. Five of these 6 patients experienced hematogenous metastasis. Conclusions: Despite the absence of in utero diethylstilbestrol exposure in our cases, clear cell adenocarcinoma accounted for 41.7% (5/12) cases. A favorable local control rate was achieved in all 12 cases, but the incidence of distant metastasis, especially to the lung, was high. Prevention of distant metastasis may be the key to treating patients with non-SCC of the vagina.	[Nomura, Hidetaka; Matoda, Maki; Okamoto, Sanshiro; Omatsu, Kohei; Kondo, Eiji; Kato, Kazuyoshi; Umayahara, Kenji; Takeshima, Nobuhiro] Canc Inst Hosp, Dept Gynecol, Tokyo, Japan	Nomura, H (reprint author), Canc Inst Hosp, Dept Gynecol, Koto Ku, Ariake 3-8-31, Tokyo 1358550, Japan.	hidetaka.nomura@jfcr.or.jp					Creasman WT, 1998, CANCER, V83, P1033, DOI 10.1002/(SICI)1097-0142(19980901)83:5<1033::AID-CNCR30>3.0.CO;2-6; Hellman K, 2006, INT J GYNECOL CANCER, V16, P1201, DOI 10.1111/j.1525-1438.2006.00520.x; Hiniker SM, 2013, GYNECOL ONCOL, V131, P380, DOI 10.1016/j.ygyno.2013.08.012; Beriwal S, 2012, BRACHYTHERAPY, V11, P68, DOI 10.1016/j.brachy.2011.06.008; Gunderson CC, 2013, J LOW GENIT TRACT DI, V17, P409, DOI 10.1097/LGT.0b013e3182800ee2; Hellman K, 2004, INT J GYNECOL CANCER, V14, P491, DOI 10.1111/j.1048-891x.2004.014310.x; Chyle V, 1996, INT J RADIAT ONCOL, V35, P891, DOI 10.1016/0360-3016(95)02394-1; Blecharz P, 2013, EUR J GYNAECOL ONCOL, V34, P436; Blecharz P, 2012, GINEKOL POL, V83, P904; Greenwalt JC, 2015, AM J CLIN ONCOL-CANC, V38, P583, DOI 10.1097/COC.0000000000000002; Hacker NF, 2000, PRACTICAL GYNECOLOGI, P597; Miyamoto DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065048; Murakami N, 2013, J RADIAT RES, V54, P931, DOI 10.1093/jrr/rrt028; Nashiro T, 2008, INT J CLIN ONCOL, V13, P335, DOI 10.1007/s10147-007-0758-7; SENEKJIAN EK, 1988, GYNECOL ONCOL, V31, P56, DOI 10.1016/0090-8258(88)90269-7; SENEKJIAN EK, 1987, CANCER, V60, P1319, DOI 10.1002/1097-0142(19870915)60:6<1319::AID-CNCR2820600626>3.0.CO;2-H; Siegel R, 2012, CA-CANCER J CLIN, V2012, P10, DOI DOI 10.3322/CAAC.20138; Tabata T, 2002, GYNECOL ONCOL, V84, P309, DOI 10.1006/gyno.2001.6520; Tjalma WAA, 2006, INT J GYNECOL CANCER, V16, P1461, DOI 10.1111/j.1525-1438.2006.00575.x; Wu XC, 2008, CANCER, V113, P2873, DOI 10.1002/cncr.23757	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	FEB	2015	25	2					320	324		10.1097/IGC.0000000000000351		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CA3TZ	WOS:000348831000021		
J	Hiramatsu, K; Kobayashi, E; Ueda, Y; Egawa-Takata, T; Matsuzaki, S; Kimura, T; Sawada, K; Yoshino, K; Fujita, M; Kimura, T				Hiramatsu, Kosuke; Kobayashi, Eiji; Ueda, Yutaka; Egawa-Takata, Tomomi; Matsuzaki, Shinya; Kimura, Toshihiro; Sawada, Kenjiro; Yoshino, Kiyoshi; Fujita, Masami; Kimura, Tadashi			Optimal Timing for Drainage of Infected Lymphocysts After Lymphadenectomy for Gynecologic Cancer	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Lymphocyst; Lymphadenectomy; Drainage; Infection; Gynecologic cancer; Antibiotics	HUMAN COAGULATION-FACTORS; RETROPERITONEAL LYMPHADENECTOMY; PELVIC LYMPHADENECTOMY; RADICAL HYSTERECTOMY; PREVENTION; COMPLICATION; SURGERY; OVARIAN	Background: A lymphocyst (lymphocele) is a common complication of lymphadenectomy, which is a widely used surgical method for gynecologic cancers. In cases of infected lymphocysts, therapeutic strategies, including the timing and duration of antibiotics administration and cyst drainage, may vary depending on the physician. The aim of this study was to determine the optimal timing for drainage of lymphocysts infected with bacteria resistant to antibiotic treatment. Materials and Methods: Clinical data for 1175 patients who underwent a lymphadenectomy as part of surgery for a gynecologic malignancy between April 2000 and August 2012 at Osaka University Hospital, Osaka, Japan, were analyzed. Results: Of the 282 patients who developed a lymphocyst (24%), 35 with infected lymphocysts (12%) were analyzed. Lymphocyst infection was not associated with tumor origin, type of hysterectomy, or region of lymphadenectomy (P = 0.81, P = 0.59, and P = 0.86, respectively). The total treatment period of cases treated only with antibiotics tended to be shorter than that of cases treated with combined antibiotics and drainage, but the difference was not significant (P = 0.061). However, for severe cases which needed drainage, initiating the drainage by day 5 significantly shortened the total treatment period compared with cases started on or after day 6 (P = 0.042). Conclusions: The appropriate time point for initiating lymphocyst drainage has been difficult to determine. The present study implies that for severe lymphocyst infections, where drainage is required in addition to antibiotics, the earlier the drainage is performed, the shorter the treatment period is. Further studies may be required to decide other optimal treatment strategies for infected lymphocysts.	[Hiramatsu, Kosuke; Kobayashi, Eiji; Ueda, Yutaka; Egawa-Takata, Tomomi; Matsuzaki, Shinya; Kimura, Toshihiro; Sawada, Kenjiro; Yoshino, Kiyoshi; Fujita, Masami; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan	Kobayashi, E (reprint author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ekobayashi@gyne.med.osaka-u.ac.jp					Kim JK, 1999, RADIOLOGY, V212, P390; Tinelli A, 2013, INT J GYNECOL CANCER, V23, P956, DOI 10.1097/IGC.0b013e31828eeea4; Kondo E, 2013, ARCH GYNECOL OBSTET, V288, P587, DOI 10.1007/s00404-013-2769-0; Ghezzi F, 2012, ANN SURG ONCOL, V19, P259, DOI 10.1245/s10434-011-1854-5; Franchi M, 2007, EUR J CANCER, V43, P1265, DOI 10.1016/j.ejca.2007.03.011; GRAY MJ, 1958, AM J OBSTET GYNECOL, V75, P1059; ILANCHERAN A, 1988, GYNECOL ONCOL, V29, P333, DOI 10.1016/0090-8258(88)90232-6; Kim Hee Yeon, 2004, Cancer Res Treat, V36, P377, DOI 10.4143/crt.2004.36.6.377; METCALF KS, 1993, ANN ROY COLL SURG, V75, P387; MORI N, 1955, J Jpn Obstet Gynecol Soc, V2, P178; PETRU E, 1989, AM J OBSTET GYNECOL, V161, P937; RUTLEDGE F, 1959, AM J OBSTET GYNECOL, V77, P1165; Srisomboon J, 2002, J OBSTET GYNAECOL RE, V28, P149, DOI 10.1046/j.1341-8076.2002.00027.x; Suzuki M, 1998, J SURG ONCOL, V68, P149, DOI 10.1002/(SICI)1096-9098(199807)68:3<149::AID-JSO3>3.0.CO;2-5; Tinelli A, 2012, J SURG ONCOL, V105, P835, DOI 10.1002/jso.22110; Yamamoto R, 2000, JPN J CLIN ONCOL, V30, P397, DOI 10.1093/jjco/hyd107	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	FEB	2015	25	2					337	341		10.1097/IGC.0000000000000353		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CA3TZ	WOS:000348831000025		
J	Shibata, N				Shibata, Nobuyuki			Effect of phase difference on biodynamic response of seated body to dual-axis vibration	INTERNATIONAL JOURNAL OF INDUSTRIAL ERGONOMICS			English	Article						Phase angle; Whole-body vibration; Seated posture; Apparent mass; Seat-to-head transmissibility	FORK-LIFT TRUCK; PLUS-Z-AXES; VERTICAL VIBRATION; APPARENT MASS; BACK DISORDERS; SINGLE-AXIS; HORIZONTAL VIBRATION; INTENSITY JUDGMENTS; OCCUPANTS; HEAD	The apparent mass (APMS) and seat-to-head transmissibility (STHT) responses were investigated to elucidate the effect of phase angles between translational vibration components along two arbitrary orthogonal axes on biodynamic responses of the seated human body. This study considered correlated dual-axis vibration that consists of three combinations of two sinusoidal vibrations conducted along orthogonal two arbitrary basicentric axes: fore-aft and lateral, lateral and vertical, and fore-aft and vertical. Data acquisition was performed for twelve subjects exposed to correlated dual-axis vibration with eight conditions (0-315 degrees) of phase difference between two basicentric axis components at six frequencies (1-20 Hz). The magnitude of sinusoidal vibration applied to each axis was 0.6 m/s(2) r.m.s. (unweighted). Consequently the phase angle difference between two vibrating axes intensively affected the vertical APMS and STHT: particularly at 1-4 Hz in APMS and at 1-8 Hz in STHT. Also the effect of cross-axis vibration and phase difference sensitively appeared to a combination of dual-axis fore-aft and vertical vibration. Biodynamic responses of the seated human body in the lateral direction were less affected by cross-axis vibration or by phase difference. The results suggest that phase angle between arbitrary two vibration components is of importance for better understanding of biodynamic responses of the seated body to multi-axis whole-body vibration. Relevance to industry: This study reports the effect of phase angles in dual-axis vibration on biodynamic responses of the seated human body to whole-body vibration. The results obtained in this study can help better understanding of the biodynamic response of the seated body to multi-axial whole-body vibration. (C) 2014 Elsevier B.V. All rights reserved.	[Shibata, Nobuyuki] Natl Inst Occupat Safety & Hlth, Human Engn & Risk Management Res Grp, Kawasaki, Kanagawa 2148585, Japan	Shibata, N (reprint author), Natl Inst Occupat Safety & Hlth, Tama Ku, 6-21-1 Nagao, Kawasaki, Kanagawa 2148585, Japan.	shibata@h.jniosh.go.jp					GRIFFIN MJ, 1977, J SOUND VIB, V54, P107, DOI 10.1016/0022-460X(77)90409-6; BOSHUIZEN HC, 1990, INT ARCH OCC ENV HEA, V62, P117, DOI 10.1007/BF00383587; PADDAN GS, 1988, J BIOMECH, V21, P191, DOI 10.1016/0021-9290(88)90169-8; BOSHUIZEN HC, 1992, SPINE, V17, P59, DOI 10.1097/00007632-199201000-00010; Hinz B, 2010, IND HEALTH, V48, P565, DOI 10.2486/indhealth.MSWBVI-03; Wang W, 2006, INT J IND ERGONOM, V36, P171, DOI 10.1016/j.ergon.2005.09.006; BOVENZI M, 1992, SPINE, V17, P1048, DOI 10.1097/00007632-199209000-00007; BONGERS PM, 1988, INT ARCH OCC ENV HEA, V61, P59, DOI 10.1007/BF00381608; BONGERS PM, 1988, INT ARCH OCC ENV HEA, V60, P129, DOI 10.1007/BF00381494; BRENDSTRUP T, 1987, SCAND J WORK ENV HEA, V13, P445; FAIRLEY TE, 1989, J BIOMECH, V22, P81, DOI 10.1016/0021-9290(89)90031-6; International Organisation for Standardization, 263111997 ISO; Kitazaki S, 1997, J SOUND VIB, V200, P83, DOI 10.1006/jsvi.1996.0674; Mandapuram S, 2011, J SOUND VIB, V330, P4064, DOI 10.1016/j.jsv.2011.04.003; Mandapuram S, 2012, INT J IND ERGONOM, V42, P268, DOI 10.1016/j.ergon.2012.02.002; Mandapuram S, 2010, IND HEALTH, V48, P698, DOI 10.2486/indhealth.MSWBVI-15; Mandapuram SC, 2005, IND HEALTH, V43, P421, DOI 10.2486/indhealth.43.421; Mansfield NJ, 2006, J SOUND VIB, V298, P841, DOI 10.1016/j.jsv.2006.06.017; Matsumoto Y, 2006, J SOUND VIB, V298, P773, DOI 10.1016/j.jsv.2006.06.006; Nawayseh N, 2005, J SOUND VIB, V281, P921, DOI 10.1016/j.jsv.2004.02.047; PADDAN GS, 1988, J BIOMECH, V21, P199, DOI 10.1016/0021-9290(88)90170-4; Qiu Y, 2010, IND HEALTH, V48, P615; Rakheja S, 2002, J SOUND VIB, V253, P57, DOI 10.1006/jsvi.2001.4249; Shibata N, 2010, MED ENG PHYS, V32, P577, DOI 10.1016/j.medengphy.2010.02.007; SHOENBERGER RW, 1988, AVIAT SPACE ENVIR MD, V59, P749; SHOENBERGER RW, 1987, AVIAT SPACE ENVIR MD, V58, P783; Wang W, 2004, INT J IND ERGONOM, V34, P289, DOI 10.1016/j.ergon.2004.04.009; Winter D., 1990, BIOMECHANICS MOTOR C	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-8141	1872-8219		INT J IND ERGONOM	Int. J. Ind. Ergon.	FEB	2015	45						55	63		10.1016/j.ergon.2014.11.005		9	Engineering, Industrial; Ergonomics	Engineering	CA4OF	WOS:000348883500006		
J	Mori, K; Maeno, T; Yamada, H; Matsumoto, H				Mori, Ken-ichiro; Maeno, Tomoyoshi; Yamada, Hiroaki; Matsumoto, Hayato			1-Shot hot stamping of ultra-high strength steel parts consisting of resistance heating, forming, shearing and die quenching	INTERNATIONAL JOURNAL OF MACHINE TOOLS & MANUFACTURE			English	Article						Hot stamping; One shot; Ultra-high strength steel; Resistance heating; Die quenching	LOAD PULSATION; SERVO PRESS; SHEET-METAL; PLATE; FLOW; TUBE	A 1-shot hot stamping process consisting of resistance heating, forming, shearing and die quenching was developed to produce small- and medium-size ultra-high strength steel parts. A rectangular sheet was resistance-heated to obtain a uniform distribution of temperature, and just after the end of heating, a sequence of forming, shearing and die quenching was performed by one shot to prevent the drop in temperature. An ultra-high strength steel spur gear having a hardness of 540 HV2 was produced by 1-shot hot stamping composed of heating, blanking and die quenching. The rollover was improved by partial compression of the blanked gear. An ultra-high strength stainless steel part having a hardness of 580 HV2 was produced by 1-shot hot stamping consisting of the heating, bending, shearing and die quenching, and no springback and quenching distortion of the produced part were observed by holding at the bottom dead centre of the press. An operation for thickening the edge of the punched hole was included in 1-shot hot stamping to improve the strength of a product. (C) 2014 Elsevier Ltd. All rights reserved.	[Mori, Ken-ichiro; Maeno, Tomoyoshi; Yamada, Hiroaki; Matsumoto, Hayato] Toyohashi Univ Technol, Dept Mech Engn, Toyohashi, Aichi 4418580, Japan	Mori, K (reprint author), Toyohashi Univ Technol, Dept Mech Engn, Toyohashi, Aichi 4418580, Japan.	mori@plast.me.tut.ac.jp	Maeno, Tomoyoshi/N-4333-2014; Mori, Ken-ichiro/N-4378-2014	Maeno, Tomoyoshi/0000-0003-1685-7255; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology [21360360]	This work was supported in part by the Japanese Ministry of Education, Culture, Sports, Science, and Technology with Grant-in-Aid for Scientific Research (B) (No. 21360360).	Neugebauer R, 2006, CIRP ANN-MANUF TECHN, V55, P793, DOI 10.1016/j.cirp.2006.10.008; Merklein M, 2011, CIRP ANN-MANUF TECHN, V60, P283, DOI 10.1016/j.cirp.2011.03.146; Maeno T, 2014, J MATER PROCESS TECH, V214, P97, DOI 10.1016/j.jmatprotec.2013.08.004; Merklein M, 2012, CIRP ANN-MANUF TECHN, V61, P725, DOI 10.1016/j.cirp.2012.05.007; Mori K, 2012, CIRP ANN-MANUF TECHN, V61, P255, DOI 10.1016/j.cirp.2012.03.124; Karbasian H, 2010, J MATER PROCESS TECH, V210, P2103, DOI 10.1016/j.jmatprotec.2010.07.019; Mori K, 2005, CIRP ANN-MANUF TECHN, V54, P209, DOI 10.1016/S0007-8506(07)60085-7; Maeno T, 2011, KEY ENG MATER, V473, P69, DOI 10.4028/www.scientific.net/KEM.473.69; Cai J, 2004, J MATER PROCESS TECH, V150, P48, DOI 10.1016/j.jmatprotec.2004.01.019; Kolleck R., 2009, CIRP ANN-MANUF TECHN, V58, P275; Maeno T, 2011, INT J MACH TOOL MANU, V51, P612, DOI 10.1016/j.ijmachtools.2011.03.007; Maeno T, 2014, J MATER PROCESS TECH, V214, P1379, DOI 10.1016/j.jmatprotec.2014.01.018; Merklein M, 2006, CIRP ANN-MANUF TECHN, V55, P229, DOI 10.1016/S0007-8506(07)60404-1; Mori K, 2013, J MATER PROCESS TECH, V213, P508, DOI 10.1016/j.jmatprotec.2012.10.005; Mori K, 2011, CIRP ANN-MANUF TECHN, V60, P299, DOI 10.1016/j.cirp.2011.03.144; Mori K, 2012, T NONFERR METAL SOC, V22, pS496, DOI [10.1016/S1003-6326(12)61752-x, 10.1016/S1003-6326(12)61752-X]; Osakada K, 2011, CIRP ANN-MANUF TECHN, V60, P651, DOI 10.1016/j.cirp.2011.05.007; Ozturk F, 2013, MAT SCI ENG A-STRUCT, V578, P207, DOI 10.1016/j.msea.2013.04.079; Salfeld V., 2011, PROCEDIA CIRP, V3, P32; Wieland M., 2011, P 3 INT C HOT SHEET, P361; Yoon J, 2013, MATER DESIGN, V49, P449, DOI 10.1016/j.matdes.2013.02.048	21	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0890-6955	1879-2170		INT J MACH TOOL MANU	Int. J. Mach. Tools Manuf.	FEB	2015	89						124	131		10.1016/j.ijmachtools.2014.10.008		8	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CA0SX	WOS:000348627800012		
J	Grossi, N; Scippa, A; Sallese, L; Sato, R; Campatelli, G				Grossi, N.; Scippa, A.; Sallese, L.; Sato, R.; Campatelli, G.			Spindle speed ramp-up test: A novel experimental approach for chatter stability detection	INTERNATIONAL JOURNAL OF MACHINE TOOLS & MANUFACTURE			English	Article						Chatter; Milling; Dynamics; Order analysis	AUDIO SIGNAL; PREDICTION; STRATEGY; IDENTIFICATION; COMPENSATION; INDICATOR; SELECTION; LOBES; TOOL	Chatter is one of the most limiting factors in improving machining performances. Stability Lobe Diagram (SLD) is the most used tool to select optimal stable cutting parameters in order to avoid chatter occurrence. Its prediction is affected by reliability of input data such as machine tool dynamics or cutting coefficients that are difficult to be evaluated accurately, especially at high speed. This paper presents a novel approach to experimentally evaluate SLD without requiring specific knowledge of the process; this approach is called here Spindle Speed Ramp-up (SSR) test. During this test spindle speed is ramped up, and chatter occurrence is detected by the Order Analysis technique. As result one single test ensures optimal spindle speed identification at one cutting condition, while if few tests are performed the entire SLD could be obtained. Results of the method applied to slotting operation on aluminum are provided and a comparison between different measurements devices is presented. This quick, easy-to-use and efficient test is suitable for industrial application: no knowledge of the process is required, different sensors can be used such as accelerometer, dynamometer or microphone. (C) 2014 Elsevier Ltd. All rights reserved.	[Grossi, N.; Scippa, A.; Sallese, L.; Campatelli, G.] Univ Florence, Dept Ind Engn, I-50139 Florence, Italy; [Sato, R.] Kobe Univ, Nada Ku, Kobe, Hyogo 6578501, Japan	Grossi, N (reprint author), Univ Florence, Dept Ind Engn, Via Santa Marta 3, I-50139 Florence, Italy.	niccolo.grossi@unifi.it		Campatelli, Gianni/0000-0002-9699-1368; Grossi, Niccolo/0000-0003-3634-9995	Fabio Marzo of LMS Italiana Sri	The authors would like to thank the DMG Mori Seiki Co. and the Machine Tool Technology Research Foundation (MTTRF) for the loaned machine tool (Mori Seiki NMV1500DCG 5-axes vertical-type machining centre). The support of Fabio Marzo of LMS Italiana Sri, is also gratefully acknowledged.	Al-Khazali H., 2012, INT J SCI ENG RES, V3, P1; Altintas Y, 2012, MANUFACTURING AUTOMATION: METAL CUTTING MECHANICS, MACHINE TOOL VIBRATIONS, AND CNC DESIGN, 2ND EDITION, P1; Altintas Y., 1995, ANN CIRP, V44, P357; Quintana G, 2011, INT J MACH TOOL MANU, V51, P363, DOI 10.1016/j.ijmachtools.2011.01.001; Ratchev S, 2006, INT J MACH TOOL MANU, V46, P542, DOI 10.1016/j.ijmachtools.2005.06.003; Bucher I, 2001, PHILOS T ROY SOC A, V359, P61; Quintana G, 2008, INT J MACH TOOL MANU, V48, P1637, DOI 10.1016/j.ijmachtools.2008.07.006; Gagnol V, 2007, INT J MACH TOOL MANU, V47, P1176, DOI 10.1016/j.ijmachtools.2006.09.002; Dombovari Z, 2010, INT J MACH TOOL MANU, V50, P511, DOI 10.1016/j.ijmachtools.2010.03.006; Faassen RPH, 2003, INT J MACH TOOL MANU, V43, P1437, DOI 10.1016/S0890-6955(03)00171-8; Grossi N, 2014, PROC CIRP, V14, P170, DOI 10.1016/j.procir.2014.03.019; Bediaga I, 2009, INT J MACH TOOL MANU, V49, P384, DOI 10.1016/j.ijmachtools.2008.12.003; DELIO T, 1992, J ENG IND-T ASME, V114, P146; Ismail F, 1997, INT J MACH TOOL MANU, V37, P763, DOI 10.1016/S0890-6955(96)00032-6; ISMAIL F, 1995, INT J ADV MANUF TECH, V10, P299, DOI 10.1007/BF01178983; Kolluru K, 2013, J MATER PROCESS TECH, V213, P1565, DOI 10.1016/j.jmatprotec.2013.03.018; Kuljanic E, 2009, MECH SYST SIGNAL PR, V23, P1704, DOI 10.1016/j.ymssp.2009.01.003; Liao YS, 1996, INT J MACH TOOL MANU, V36, P651, DOI 10.1016/0890-6955(95)00076-3; Rantalo M., 2006, THESIS; Schmitz TL, 2003, J SOUND VIB, V262, P721, DOI 10.1016/S0022-460X(03)00119-6; Schmitz T.L., 2000, ANN CIRP, V49, P303; Schmitz TL, 2002, MACH SCI TECHNOL, V6, P215, DOI 10.1081/MST.120005957; Scippa A, 2013, PROC CIRP, V8, P450, DOI 10.1016/j.procir.2013.06.132; Scippa A, 2015, MECH SYST SIGNAL PR, V54-55, P314, DOI 10.1016/j.ymssp.2014.08.019; Scippa A, 2014, PROC CIRP, V14, P287, DOI 10.1016/j.procir.2014.03.023; Sporna D., 2011, P 8 INT C STRUCT DYN; Tuysuz O, 2013, INT J MACH TOOL MANU, V66, P66, DOI 10.1016/j.ijmachtools.2012.12.002; Wang X, 2010, WOODHEAD PUBL MECH E, P1, DOI 10.1533/9781845698041	28	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0890-6955	1879-2170		INT J MACH TOOL MANU	Int. J. Mach. Tools Manuf.	FEB	2015	89						221	230		10.1016/j.ijmachtools.2014.11.013		10	Engineering, Manufacturing; Engineering, Mechanical	Engineering	CA0SX	WOS:000348627800022		
J	Ohmori, S; Sugaya, A; Toida, N; Suzuki, E; Izutsu, M; Tsutsui, T; Kataoka, Y; Maeda, Y; Fukushima, K; Nishizaki, K				Ohmori, Shuhei; Sugaya, Akiko; Toida, Naomi; Suzuki, Etsuji; Izutsu, Masato; Tsutsui, Tomoko; Kataoka, Yuko; Maeda, Yukihide; Fukushima, Kunihiro; Nishizaki, Kazunori			Does the introduction of newborn hearing screening improve vocabulary development in hearing-impaired children? A population-based study in Japan	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Newborn hearing screening; Vocabulary; Language development; Hearing impairment	INTERVENTION PROGRAMS; EARLY IDENTIFICATION; POSITION STATEMENT; LANGUAGE; PRINCIPLES; GUIDELINES	Objective: Permanent hearing impairment has a life-long impact on children and its early identification is important for language development. A newborn hearing screening (NHS) program has started in Okayama Prefecture, Japan, in 1999 to detect hearing impairment immediately after birth. We aim to examine the effect of this screening program on vocabulary development in pre-school children in a before and after comparative study design. Methods: A total of 107 5-year-old children who graduated from Okayama Kanariya Gakuen (an auditory center for hearing-impaired children) between 1998 and 2011 were enrolled in this study. The pre-NHS group (n = 40) was defined as those who graduated between 1998 and 2003, while the post-NHS group (n = 67) was defined as those who graduated between 2004 and 2011. The primary outcome was receptive vocabulary, which was assessed by the Picture Vocabulary Test [score <18 (low) vs. score >18 (high)]. The secondary outcome was productive vocabulary, or the number of productive words, which was assessed by an original checklist [<1773 words (low) vs. >1773 (high)]. We calculated odds ratios and 95% confidence intervals for vocabulary development and compared both groups. Results: The adjusted Picture Vocabulary Test score and number of productive words were significantly higher (p < 0.01) in the post-NHS group than the pre-NHS group. Odds ratios were 2.63 (95% confidence interval: 1.17-5.89) for receptive vocabulary and 4.17 (95% confidence interval: 1.69-10.29) for productive vocabulary. Conclusions: The introduction of NHS in Okayama Prefecture significantly improved both receptive and productive vocabulary development in hearing-impaired children. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ohmori, Shuhei; Sugaya, Akiko; Kataoka, Yuko; Maeda, Yukihide; Fukushima, Kunihiro; Nishizaki, Kazunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, Kita Ku, Okayama 7008558, Japan; [Suzuki, Etsuji; Izutsu, Masato] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Kita Ku, Okayama 7008558, Japan; [Ohmori, Shuhei; Toida, Naomi; Tsutsui, Tomoko] Auditory Ctr Hearing Impaired Children, Kita Ku, Okayama Kanariya Gakuen, Okayama 7000927, Japan; [Izutsu, Masato] Minist Hlth Labour & Welf, Hlth Policy Bur, Chiyoda Ku, Tokyo 1008916, Japan; [Fukushima, Kunihiro] Shinkurasiki Ear Nose & Throat Clin, Kurashiki, Okayama 7100253, Japan	Sugaya, A (reprint author), 2-5-1,Shikata Cho,Rita Ku, Okayama 7008558, Japan.	sugaya-a@cc.okayama-u.ac.jp			JSPS KAKENHI (Ministry of Education, Culture, Sports, Science and Technology of Japan) [25462641]	We thank all of the members of Okayama Kanariya Gakuen for facilitating the intervention, particularly former Chief Director Dr. Yu Masuda, for his enthusiastic support. Furthermore, we appreciate the co-operation of the parents and school children who participated in the study. This work was partly supported by a grant from JSPS KAKENHI (Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan: Grant number 25462641).	Doyle KJ, 1998, INT J PEDIATR OTORHI, V43, P207, DOI 10.1016/S0165-5876(98)00007-X; Mason JA, 1998, PEDIATRICS, V101, P221, DOI 10.1542/peds.101.2.221; Pimperton H, 2012, ARCH DIS CHILD, V97, P648, DOI 10.1136/archdischild-2011-301501; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Mehl AL, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e4; Bubbico L, 2007, Minerva Pediatr, V59, P307; Calderon R., 2000, J DEAF STUD DEAF EDU, V5, P140, DOI DOI 10.1093/DEAFED/5.2.140; DOWNS MP, 1995, INT J PEDIATR OTORHI, V32, P257, DOI 10.1016/0165-5876(95)01183-C; Fukushima K, 2008, ANN OTO RHINOL LARYN, V117, P166; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Finitzo T, 2000, PEDIATRICS, V106, P798; Kosaka K., 2000, ANN RES EARLY CHILD, V22, P19; Matsubara K., 2004, HEARING IMPAIRMENT I, P121; McPhillips HA, 2010, J PEDIATR-US, V157, P170, DOI 10.1016/j.jpeds.2010.05.008; Mishina J., 2000, RES EFFECTIVENESS NE, P147; Profant M., 2008, ACTA OTO-LARYNGOL, V128, P368; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	17	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	FEB	2015	79	2					196	201		10.1016/j.ijporl.2014.12.006		6	Otorhinolaryngology; Pediatrics	Otorhinolaryngology; Pediatrics	CA4QC	WOS:000348888700023		
J	Hayami, H; Nakamura, M; Nakamura, AO				Hayami, Hitoshi; Nakamura, Masao; Nakamura, Alice O.			Economic performance and supply chains: The impact of upstream firms' waste output on downstream firms' performance in Japan	INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS			English	Article						Green procurement; Firm performance; Sustainability; Supply chain waste management; Input-output analysis; Japan	RESOURCE-BASED VIEW; ENVIRONMENTAL-MANAGEMENT; PRODUCT DEVELOPMENT; COMPETITIVE ADVANTAGE; MANUFACTURING PERFORMANCE; EMPIRICAL-EVIDENCE; GREEN INNOVATION; INVENTORY MODEL; INTEGRATION; COMPLEXITY	A novel application of input-output analysis is used to statistically map out average levels of generation of unwanted solid and liquid waste materials and also greenhouse gases along manufacturing supply chains for the final demand products of manufacturing industries in Japan. One key finding is that assembler dominated manufacturing supply chains have different within-chain waste generation patterns than manufacturing supply chains that are not assembler dominated. A second key finding is that assemblers with suppliers that produce less waste tend also to have better economic performance. This suggests that for manufacturing supply chains in Japan at least, the adoption by a downstream assembler of green procurement policies can improve both environmental and economic performance. This in turn suggests that both the private sector and public policies aimed at reducing manufacturing waste should take account of the incentives for achieving waste reduction all along a supply chain of a downstream assembler or other focal firm in a position to coordinate product/service flows, knowledge flows, information flows and flows of funds within a supply chain. (C) 2014 Elsevier B.V. All rights reserved.	[Hayami, Hitoshi] Keio Univ, Fac Business & Commerce, Tokyo, Japan; [Hayami, Hitoshi] Keio Univ, Keio Econ Observ, Tokyo, Japan; [Nakamura, Masao] Univ British Columbia, Sauder Sch Business, Vancouver, BC V6T 1Z2, Canada; [Nakamura, Alice O.] Univ Alberta, Alberta Sch Business, Edmonton, AB T6G 2R6, Canada	Nakamura, M (reprint author), Univ British Columbia, Sauder Sch Business, Vancouver, BC V6T 1Z2, Canada.	masao.nakamura@sauder.ubc.ca			Social Sciences and Humanities Research Council of Canada	The authors thank participants at the Sao Paulo Conference, the Editor and two Referees of this journal for comments on earlier drafts that allowed us to greatly improve the paper. This research is in part supported by the Social Sciences and Humanities Research Council of Canada.	Russo MV, 1997, ACAD MANAGE J, V40, P534, DOI 10.2307/257052; Chiou TY, 2011, TRANSPORT RES E-LOG, V47, P822, DOI 10.1016/j.tre.2011.05.016; Vachon S, 2007, INT J PROD RES, V45, P4357, DOI 10.1080/00207540701440303; Bozdogan K, 1998, R&D MANAGE, V28, P163, DOI 10.1111/1467-9310.00093; Takeishi A, 2001, STRATEGIC MANAGE J, V22, P403, DOI 10.1002/smj.164; Dyer JH, 1996, STRATEGIC MANAGE J, V17, P271, DOI 10.1002/(SICI)1097-0266(199604)17:4<271::AID-SMJ807>3.0.CO;2-Y; Lau AKW, 2010, J PROD INNOVAT MANAG, V27, P761; Narasimhan R, 2012, INT J PROD RES, V50, P1185, DOI 10.1080/00207543.2011.555785; Vachon S, 2002, IEEE T ENG MANAGE, V49, P218, DOI 10.1109/TEM.2002.803387; Rosenzweig ED, 2003, J OPER MANAG, V21, P437, DOI 10.1016/S0272-6963(03)00037-8; Kumar S, 2012, INT J PROD RES, V50, P1278, DOI 10.1080/00207543.2011.571924; Zhu QH, 2004, J OPER MANAG, V22, P265, DOI 10.1016/j.jom.2004.01.005; Vachon S, 2008, INT J PROD ECON, V111, P299, DOI 10.1016/j.ijpe.2006.11.030; LEONTIEF W, 1970, REV ECON STAT, V52, P262, DOI 10.2307/1926294; Genovese A, 2013, INT J PROD RES, V51, P2868, DOI 10.1080/00207543.2012.748224; Ragatz GL, 2002, J BUS RES, V55, P389, DOI 10.1016/S0148-2963(00)00158-2; Liker JK, 2000, SLOAN MANAGE REV, V42, P81; Judge WQ, 1998, J MANAGE STUD, V35, P241, DOI 10.1111/1467-6486.00092; Seuring S, 2008, J CLEAN PROD, V16, P1699, DOI 10.1016/j.jclepro.2008.04.020; Halldorsson A, 2007, SUPPLY CHAIN MANAG, V12, P284, DOI 10.1108/13598540710759808; Zhu Q, 2007, INT J PROD RES, V45, P4333, DOI 10.1080/00207540701440345; Flynn BB, 2005, INT J PROD RES, V43, P3421, DOI 10.1080/00207540500118071; Frohlich MT, 2001, J OPER MANAG, V19, P185, DOI 10.1016/S0272-6963(00)00055-3; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Hadjiyiannis C, 2009, SOUTH ECON J, V75, P703; HART SL, 1995, ACAD MANAGE REV, V20, P986, DOI 10.2307/258963; Schroeder RG, 2002, STRATEGIC MANAGE J, V23, P105, DOI 10.1002/smj.213; Johnsen TE, 2009, J PURCH SUPPLY MANAG, V15, P187, DOI 10.1016/j.pursup.2009.03.008; Hult GTM, 2006, J OPER MANAG, V24, P458, DOI 10.1016/j.jom.2005.11.009; Banerjee A, 1995, INT J OPER PROD MAN, V15, P237, DOI 10.1108/01443579510099760; Dyer JH, 1998, ACAD MANAGE REV, V23, P660, DOI 10.2307/259056; Seuring S, 2008, J CLEAN PROD, V16, P1545, DOI 10.1016/j.jclepro.2008.02.002; Chen YS, 2006, J BUS ETHICS, V67, P331, DOI 10.1007/s10551-006-9025-5; Kelle P, 2005, INT J PROD ECON, V93-4, P41, DOI 10.1016/j.ijpe.2004.06.004; Akyuz GA, 2010, INT J PROD RES, V48, P5137, DOI 10.1080/00207540903089536; Geffen CA, 2000, INT J OPER PROD MAN, V20, P166, DOI 10.1108/01443570010304242; Nakamura AO, 2011, J ECONOMETRICS, V161, P47, DOI 10.1016/j.jeconom.2010.09.005; Mishra N, 2012, INT J PROD RES, V50, P2396, DOI 10.1080/00207543.2011.581003; Freeman RB, 2011, CAN J ECON, V44, P486, DOI 10.1111/j.1540-5982.2011.01641.x; Vachon S, 2006, INT J OPER PROD MAN, V26, P795, DOI 10.1108/01443570610672248; Nakamura M, 2001, J ENVIRON ECON MANAG, V42, P23, DOI 10.1006/jeem.2000.1148; PORTER ME, 1995, J ECON PERSPECT, V9, P97; Rao P, 2005, INT J OPER PROD MAN, V25, P898, DOI 10.1108/01443570510613956; Wong CWY, 2012, INT J PROD ECON, V140, P283, DOI 10.1016/j.ijpe.2011.08.031; Gonzalez-Benito J, 2008, INT J PROD RES, V46, P7017, DOI 10.1080/00207540701474021; BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108; Vachon S, 2007, INT J PROD RES, V45, P401, DOI 10.1080/00207540600597781; Kovacs G, 2008, J CLEAN PROD, V16, P1571, DOI 10.1016/j.jclepro.2008.04.013; Ate M. A., 2012, INT J PROD RES, V50, P1079; Bhateja A.K., 2011, INT J COMPUT ENG MAN, V13, P84; Blinder A.S., 1991, BUSINESSWEEK; Blome C, 2014, INT J PROD RES, V52, P32, DOI 10.1080/00207543.2013.825748; Boin R.A., 2010, INT J PROD ECON, V126, P1; BONACCORSI A, 1994, J PROD INNOVAT MANAG, V11, P134; Bowen FE., 2001, GREENER MANAGEMENT I, V35, P41; Cairncross F, 1992, COSTING THE EARTH; Carter J., 2011, SUPPLY CHAIN MANAG R, V15, P18; Caterpillar, 2008, 2008 SUST REP; Cetinkaya B, 2011, SUSTAINABLE SUPPLY CHAIN MANAGEMENT: PRACTICAL IDEAS FOR MOVING TOWARDS BEST PRACTICE, P1, DOI 10.1007/978-3-642-12023-7; Chen IJ, 2004, J OPER MANAG, V22, P505, DOI 10.1016/j.jom.2004.06.002; Cisco, 2010, CISC GREEN SUPPL CHA; Clark K.B., 1991, PRODUCT DEV PERFORMA; DYER JH, 1993, SLOAN MANAGE REV, V35, P51; Ernst & Young, 2010, CLIM CHANG SUST 5 AR; European Commission, 2001, EMPL EFF WAST MAN PO; Fazel F, 1997, INT J PHYS DISTRIB, V27, P496, DOI 10.1108/09600039710182680; Feng TW, 2014, INT J PROD RES, V52, P2901, DOI 10.1080/00207543.2013.857055; Flynn M., 1996, 21 CENTURY SUPPLY CH; Ganeshan R, 2001, INT J PROD ECON, V71, P111, DOI 10.1016/S0925-5273(00)00109-2; Geffen C., 1997, THESIS MIT CAMBRIDGE; General Motors Corporation, 1997, GEN MOT ENV; Brousseau E, 2008, NEW INSTITUTIONAL ECONOMICS: A GUIDEBOOK, P1, DOI 10.1017/CBO9780511754043; GOLHAR DY, 1992, INT J PROD RES, V30, P961, DOI 10.1080/00207549208942936; Green K, 1998, SUPPLY CHAIN MANAG, V3, P89, DOI DOI 10.1108/13598549810215405; Hall J, 2012, INT J PROD RES, V50, P1332, DOI 10.1080/00207543.2011.571930; Hall J, 2000, J CLEAN PROD, V8, P455, DOI DOI 10.1016/S0959-6526(00)00013-5; Hamner B., 2006, GREENING SUPPLY CHAI, P25, DOI 10.1007/1-84628-299-3_2; Hayami H., 1997, MANAGERIAL DECISION, V18, P195, DOI 10.1002/(SICI)1099-1468(199703)18:2<195::AID-MDE819>3.0.CO;2-5; Hayami H., 2013, EC PERFORMANCE SUPPL; Hayami H, 2007, J ENVIRON MANAGE, V85, P371, DOI 10.1016/j.jenvman.2006.10.002; HUANG GH, 1994, J ENVIRON MANAGE, V42, P63, DOI 10.1006/jema.1994.1061; Hunt SD, 2012, J SUPPLY CHAIN MANAG, V48, P14, DOI 10.1111/j.1745-493X.2012.03266.x; Jayaram J, 2010, INT J PROD RES, V48, P6837, DOI 10.1080/00207540903358329; Kawamoto K., 2008, SCI TECHNOL TRENDS, V27, P38; KELLE P, 1992, INT J PROD ECON, V26, P319, DOI 10.1016/0925-5273(92)90082-I; Kelle P., 1999, P DSI C NEW ORLEANS, P564; Koh SCL, 2013, INT J PROD RES, V51, P2092, DOI 10.1080/00207543.2012.705042; Krishnan H., 2011, INF OPER MANAG, V5, P147; Lamming R., 1996, BRIT J MANAGE, V7, pS45, DOI 10.1111/j.1467-8551.1996.tb00147.x; Lavassani K.M., 2008, P 19 ANN C PROD OP M; Leontief W., 1986, INPUT OUTPUT EC; Li Y, 2005, INT J PROD RES, V43, P2577, DOI 10.1080/00207540500045634; Linnanen L, 1995, BUSINESS STRATEGY EN, V4, P117, DOI 10.1002/bse.3280040303; Lloyd M., 1994, PURCH SUPPLY MAN OCT, P36; Maclean HL, 2003, ENVIRON SCI TECHNOL, V37, P5445, DOI 10.1021/es034574q; Makower J., 1994, THE E FACTOR; Memon MA, 2010, J MATER CYCLES WASTE, V12, P30, DOI 10.1007/s10163-009-0274-0; Milgrom P., 1992, EC ORG MANAGEMENT; Miller P. A., 1998, INT J PURCHASING MAT, V34, P25; Ministry of Economy Trade and Industry (METI), 2006, WAST BY PROD SURV JA; Ministry of Internal Affairs and Communications (MIAC) Statistics Bureau, INP OUTP TABL JAP; Ministry of Internal Affairs and Communications (MIAC) Statistics Bureau, 2005, JAP STAND IND CLASS; Mollenkopf D, 2010, INT J PHYS DISTR LOG, V40, P14, DOI 10.1108/09600031011018028; Myers MB, 2000, J RETAILING, V76, P455, DOI 10.1016/S0022-4359(00)00036-1; Nakamura A.O., 2009, LABOR MARKET INTERME, P27; National Institue for Environmental Studies (NIES), 2010, EMB EN EM INT DAT JA; NEC Corporation, 2004, GREEN PROC GUID SUPP; Pagell M, 2007, INT J PROD RES, V45, P2005, DOI 10.1080/00207540600634931; Piplani R., 2008, INT J PROD EC, V111, P193; Rajagopal S., 1993, INT J PURCHASING MAT, V29, P13; Rao P, 2002, INT J OPER PROD MAN, V22, P632, DOI 10.1108/01443570210427668; Rothenberg S., 1999, THESIS MIT CAMBRIDGE; Schmidheiny S., 1992, CHANGING COURSE GLOB; Shrivastava P., 1995, STRATEG MANAG J, V16, pS183; Silva ECD, 2009, J ENVIRON ECON MANAG, V58, P169, DOI 10.1016/j.jeem.2009.04.001; Silva E.C.D., 2011, WP2011003 SCH EC GEO; Solow R, 1952, ECONOMETRICA, V20, P29, DOI 10.2307/1907805; Sony, 2010, SUPPL GREEN PROC; Toshiba Corporation, 2006, GREEN PROC GUID; Toyota Motors, 2013, COLL BUS PARTN; Tsurumi Y., 1991, MANAGERIAL DECISION, V12, P123, DOI 10.1002/mde.4090120206; Tukker A., 2001, J SUSTAINABLE PRODUC, V1, P171; United Nations, 1999, STUDIES METHOD HDB F, V74; Vermulen W. J. V., 2002, GREENING SOC PARADIG, P67; Viswanathan S, 2001, EUR J OPER RES, V129, P277, DOI 10.1016/S0377-2217(00)00225-3; Wada Y, 2008, J MATER CYCLES WASTE, V10, P173, DOI 10.1007/s10163-008-0209-1; Weber MM, 2000, IND MARKET MANAG, V29, P57, DOI 10.1016/S0019-8501(99)00112-1; Wiebe J., 2014, GLOBE MAIL, pG3; WILLIAMSON O.E., 1985, EC I CAPITALISM FIRM; Wolters T, 1997, BUSINESS STRATEGY EN, V6, P121, DOI 10.1002/(SICI)1099-0836(199707)6:3<121::AID-BSE107>3.0.CO;2-C	130	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-5273	1873-7579		INT J PROD ECON	Int. J. Prod. Econ.	FEB	2015	160						47	65		10.1016/j.ijpe.2014.09.012		19	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Engineering; Operations Research & Management Science	CA4SA	WOS:000348893500005		
J	Teo, AR; Fetters, MD; Stufflebam, K; Tateno, M; Balhara, Y; Choi, TY; Kanba, S; Mathews, CA; Kato, TA				Teo, Alan R.; Fetters, Michael D.; Stufflebam, Kyle; Tateno, Masaru; Balhara, Yatan; Choi, Tae Young; Kanba, Shigenobu; Mathews, Carol A.; Kato, Takahiro A.			Identification of the hikikomori syndrome of social withdrawal: Psychosocial features and treatment preferences in four countries	INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY			English	Article						Social isolation; cross-national; culture	CULTURE-BOUND SYNDROME; COMMUNITY POPULATION; PRIMARY-CARE; MECHANISMS; DISORDERS; VERSION; SCALE; JAPAN; RISK	Background: Hikikomori, a form of social withdrawal first reported in Japan, may exist globally but cross-national studies of cases of hikikomori are lacking. Aims: To identify individuals with hikikomori in multiple countries and describe features of the condition. Method: Participants were recruited from sites in India, Japan, Korea and the United States. Hikikomori was defined as a 6-month or longer period of spending almost all time at home and avoiding social situations and social relationships, associated with significant distress/impairment. Additional measures included the University of California, Los Angeles (UCLA) Loneliness Scale, Lubben Social Network Scale (LSNS-6), Sheehan Disability Scale (SDS) and modified Cornell Treatment Preferences Index. Results: A total of 36 participants with hikikomori were identified, with cases detected in all four countries. These individuals had high levels of loneliness (UCLA Loneliness Scale M = 55.4, SD = 10.5), limited social networks (LSNS-6 M = 9.7, SD = 5.5) and moderate functional impairment (SDS M = 16.5, SD = 7.9). Of them 28 (78%) desired treatment for their social withdrawal, with a significantly higher preference for psychotherapy over pharmacotherapy, in-person over telepsychiatry treatment and mental health specialists over primary care providers. Across countries, participants with hikikomori had similar generally treatment preferences and psychosocial features. Conclusion: Hikikomori exists cross-nationally and can be assessed with a standardized assessment tool. Individuals with hikikomori have substantial psychosocial impairment and disability, and some may desire treatment.	[Teo, Alan R.] Portland VA Med Ctr, Portland, OR 97239 USA; [Fetters, Michael D.] Univ Michigan, Dept Family Med, Japanese Family Hlth Program, Ann Arbor, MI 48109 USA; [Stufflebam, Kyle] Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, Ann Arbor, MI 48109 USA; [Tateno, Masaru] Sapporo Med Univ, Dept Neuropsychiat, Sapporo Hana Dev Psychiat Clin, Sapporo, Hokkaido, Japan; [Balhara, Yatan] All India Inst Med Sci, Natl Drug Dependence Treatment Ctr, New Delhi, India; [Choi, Tae Young] Catholic Univ Daegu, Sch Med, Dept Psychiat, Taegu, South Korea; [Kanba, Shigenobu; Kato, Takahiro A.] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan; [Mathews, Carol A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Kato, Takahiro A.] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan	Teo, AR (reprint author), Portland VA Med Ctr, 3710 SW US Vet Hosp Rd R&D 66, Portland, OR 97239 USA.	teoa@ohsu.edu; takahiro@npsych.med.kyushu-u.ac.jp					Lubben J, 2006, GERONTOLOGIST, V46, P503; Teo AR, 2010, J NERV MENT DIS, V198, P444, DOI 10.1097/NMD.0b013e3181e086b1; Olfson M, 1997, AM J PSYCHIAT, V154, P1734; Nagata T, 2013, INT J SOC PSYCHIATR, V59, P73, DOI 10.1177/0020764011423184; Grov C, 2010, AIDS CARE, V22, P630, DOI 10.1080/09540120903280901; Pfeiffer PN, 2011, GEN HOSP PSYCHIAT, V33, P29, DOI 10.1016/j.genhosppsych.2010.10.002; Schwarz N, 2007, APPL COGNITIVE PSYCH, V21, P277, DOI 10.1002/acp.1340; Koyama A, 2010, PSYCHIAT RES, V176, P69, DOI 10.1016/j.psychres.2008.10.019; Raue PJ, 2009, PSYCHIAT SERV, V60, P337, DOI 10.1176/appi.ps.60.3.337; Lee YS, 2013, PSYCHIAT CLIN NEUROS, V67, P193, DOI 10.1111/pcn.12043; Kato TA, 2012, SOC PSYCH PSYCH EPID, V47, P1061, DOI 10.1007/s00127-011-0411-7; Meyer-Lindenberg A, 2012, NAT NEUROSCI, V15, P663, DOI 10.1038/nn.3083; De Michele F, 2013, RIV PSICHIATR, V48, P354, DOI 10.1708/1319.14633; Dickens AP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-647; Furuhashi T., 2011, NAGOYA J HLTH PHYS F, V34, P29; Furuhashi T., 2012, PSYCHIAT NEUROLOGIA, V114, P1173; Garcia-Campayo J, 2007, MED CLIN-BARCELONA, V129, P318, DOI 10.1157/13109125; Hong M, 2011, CLIN GERONTOLOGIST, V34, P319, DOI 10.1080/07317115.2011.572534; Jayashankar, 2013, LECT COND IND I TECH; Kim O. S., 1997, J KOREAN ACAD NURS, V27, P871; Krieg A, 2013, INT J SOC PSYCHIATR, V59, P61, DOI 10.1177/0020764011423182; Kudou R., 1983, EXPT SOCIAL PSYCHOL, V22, P99; Kurimoto A., 2011, JAPANESE J GERIATRIC, V48, P149; Lee Jungyoon, 2004, [The Korea Journal of Youth Counseling, 청소년상담연구], V12, P145; Lee YS, 1991, KOREAN J CLIN PSYCHO, V10, P98; Proudfoot JG, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-196; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Saito K., 2010, HIKIKOMORI NO HYOUKA; Sakamoto N, 2005, INT J PSYCHIAT MED, V35, P191, DOI 10.2190/7WEQ-216D-TVNH-PQJ1; Sheehan D. V., 1983, SHEEHAN DISABILITY S; Tateno M, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-169; Teo AR, 2013, INT J SOC PSYCHIATR, V59, P339, DOI 10.1177/0020764012437128; Umeda M, 2012, PSYCHIAT CLIN NEUROS, V66, P121, DOI 10.1111/j.1440-1819.2011.02292.x; Watts J, 2002, LANCET, V359, P1131, DOI 10.1016/S0140-6736(02)08186-2; Yoshida T., 2004, RINSYO SEISHIN YAKUR, V7, P1645	35	3	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0020-7640	1741-2854		INT J SOC PSYCHIATR	Int. J. Soc. Psychiatr.	FEB	2015	61	1					64	72		10.1177/0020764014535758		9	Psychiatry	Psychiatry	CA8CD	WOS:000349143200009		
J	Teo, AR; Kato, TA				Teo, Alan R.; Kato, Takahiro A.			The prevalence and correlates of severe social withdrawal in Hong Kong	INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY			English	Letter									[Teo, Alan R.] Portland VA Med Ctr, Portland, OR 97239 USA; [Teo, Alan R.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Kato, Takahiro A.] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan; [Kato, Takahiro A.] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan	Teo, AR (reprint author), Portland VA Med Ctr, 3710 SW US Vet Hosp Rd R&D 66, Portland, OR 97239 USA.	teoa@ohsu.edu					Teo AR, 2010, J NERV MENT DIS, V198, P444, DOI 10.1097/NMD.0b013e3181e086b1; Teo AR, 2015, INT J SOC PSYCHIATR, V61, P64, DOI 10.1177/0020764014535758; Wong P. W., 2014, INT J SOC PSYCHIAT, DOI [10.1177/0020764014543711, DOI 10.1177/0020764014543711]	3	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0020-7640	1741-2854		INT J SOC PSYCHIATR	Int. J. Soc. Psychiatr.	FEB	2015	61	1					102	102		10.1177/0020764014554923		1	Psychiatry	Psychiatry	CA8CD	WOS:000349143200013		
J	Maeo, S; Yamamoto, M; Kanehisa, H				Maeo, S.; Yamamoto, M.; Kanehisa, H.			Muscular Adaptations to Short-term Low-frequency Downhill Walking Training	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						lengthening contraction; muscle damage; repeated-bout effect	INDUCED MUSCLE DAMAGE; ECCENTRIC EXERCISE; NEUROMUSCULAR ADAPTATIONS; STRIDE LENGTH; REPEATED BOUT; STRENGTH; ADULTS; SIZE; CONTRACTION; ACTIVATION	This study examined muscular adaptations of knee extensors following short-term low-frequency downhill walking training. 22 young males (training group: TG, n = 12; control group: CG, n = 10) participated. TG conducted 40-min downhill treadmill walking (load: 10 % of body mass, gradient: 28 %, velocity: 5 km/h) 1 session/week for 4 weeks. Before and after the intervention, muscle thickness of knee extensors and maximal knee extension torques in eccentric (-120, -60, -30 degrees/s), isometric (0 degrees/s), and concentric (30, 60, 120, 240 degrees/s) conditions were measured. For TG, muscle damage markers were also measured before and up to 72 h following each session. After the intervention, CG did not show any changes in all variables. TG had significant increases in maximal knee extension torques at all angular velocities, with higher relative gains in eccentric torques (+ 24 % on average) than isometric (+ 13 %) and concentric (+ 12 % on average) torques. No changes were found in the muscle thickness. Although considerable muscle damage was observed after the first training session in TG, the magnitudes of changes in all markers following the second to fourth sessions were minimal. These results indicate that even with relatively short-term and low-frequency, downhill walking training can increase the strength capacity of knee extensors, especially in eccentric strength.	[Maeo, S.; Yamamoto, M.; Kanehisa, H.] Natl Inst Fitness & Sports Kanoya, Kagoshima, Japan; [Maeo, S.] Japan Soc Promot Sci, Tokyo, Japan; [Maeo, S.] Edith Cowan Univ, Joondalup, Australia	Maeo, S (reprint author), Natl Inst Fitness & Sports Kanoya, 1 Shiromizu, Kanoya 8912311, Japan.	smaeo1985@gmail.com					Aagaard P., 2011, STRENGTH COND, P105; Andersen LL, 2005, EUR J APPL PHYSIOL, V93, P511, DOI 10.1007/s00421-004-1297-9; ABE T, 1994, AM J HUM BIOL, V6, P161, DOI 10.1002/ajhb.1310060204; Yang YR, 2010, AM J PHYS MED REHAB, V89, P706, DOI 10.1097/PHM.0b013e3181e721c5; Aagaard P, 2000, J APPL PHYSIOL, V89, P2249; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Eston RG, 2000, SCAND J MED SCI SPOR, V10, P199, DOI 10.1034/j.1600-0838.2000.010004199.x; Duclay J, 2008, MED SCI SPORT EXER, V40, P722, DOI 10.1249/MSS.0b013e31816184dc; Aagaard P, 1996, ACTA PHYSIOL SCAND, V156, P123, DOI 10.1046/j.1365-201X.1996.438162000.x; Holm L, 2008, J APPL PHYSIOL, V105, P1454, DOI 10.1152/japplphysiol.90538.2008; Norrbrand L, 2008, EUR J APPL PHYSIOL, V102, P271, DOI 10.1007/s00421-007-0583-8; KAWAKAMI Y, 1993, J APPL PHYSIOL, V74, P2740; Ahmadi S, 2008, CLIN PHYSIOL FUNCT I, V28, P55, DOI 10.1111/j.1475-097X.2007.00777.x; Guilhem G., 2010, Annals of Physical and Rehabilitation Medicine, V53, P319, DOI 10.1016/j.rehab.2010.04.003; Fleck SJ, 1999, J STRENGTH COND RES, V13, P82; Higbie EJ, 1996, J APPL PHYSIOL, V81, P2173; Roig M, 2009, BRIT J SPORT MED, V43, P556, DOI 10.1136/bjsm.2008.051417; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Paulsen G, 2012, EXERC IMMUNOL REV, V18, P42; Chen TC, 2009, EUR J APPL PHYSIOL, V106, P267, DOI 10.1007/s00421-009-1016-7; Del Balso C, 2007, J APPL PHYSIOL, V103, P402, DOI 10.1152/japplphysiol.00477.2006; Seger JY, 1998, EUR J APPL PHYSIOL O, V79, P49, DOI 10.1007/s004210050472; Paschalis V, 2011, MED SCI SPORT EXER, V43, P64, DOI 10.1249/MSS.0b013e3181e91d90; Rich C, 2000, MED SCI SPORT EXER, V32, P190; Isner-Horobeti ME, 2013, SPORTS MED, V43, P483, DOI 10.1007/s40279-013-0052-y; Farr T, 2002, J SCI MED SPORT, V5, P297, DOI 10.1016/S1440-2440(02)80018-4; Hortobagyi T, 1996, J APPL PHYSIOL, V81, P1677; Gabriel DA, 2006, SPORTS MED, V36, P133, DOI 10.2165/00007256-200636020-00004; Baroni BM, 2013, INT J SPORTS MED, V34, P904, DOI 10.1055/s-0032-1333263; DUNCAN P W, 1989, Journal of Orthopaedic and Sports Physical Therapy, V11, P70; Gault ML, 2013, BIOGERONTOLOGY, V14, P197, DOI 10.1007/s10522-013-9423-x; Gross M, 2010, INT J SPORTS MED, V31, P572, DOI 10.1055/s-0030-1254082; Guilhem G, 2013, MED SCI SPORT EXER, V45, P326, DOI 10.1249/MSS.0b013e31826e7066; Howatson G, 2011, MED SCI SPORT EXER, V43, P140, DOI 10.1249/MSS.0b013e3181e4b649; LaStayo PC, 1999, AM J PHYSIOL-REG I, V276, pR611; LaStayo PC, 2000, AM J PHYSIOL-REG I, V278, pR1282; Maeo S, 2012, JPN J MOUNTAIN MED, V32, P103; Maffiuletti NA, 2001, MED SCI SPORT EXER, V33, P1220; Pensini M, 2002, INT J SPORTS MED, V23, P567, DOI 10.1055/s-2002-35558; Rowlands AV, 2001, J SPORT SCI, V19, P333, DOI 10.1080/02640410152006108; Theodorou Anastasios A, 2013, BMC Res Notes, V6, P87, DOI 10.1186/1756-0500-6-87; TOMBERLIN J P, 1991, Journal of Orthopaedic and Sports Physical Therapy, V14, P31; Zeppetzauer M, 2013, EUR J PREV CARDIOL, V20, P577, DOI 10.1177/2047487312444236	43	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	FEB	2015	36	2					150	156		10.1055/s-0034-1385885		7	Sport Sciences	Sport Sciences	CA3II	WOS:000348799400009		
J	Ono, T; Higashihara, A; Shinohara, J; Hirose, N; Fukubayashi, T				Ono, T.; Higashihara, A.; Shinohara, J.; Hirose, N.; Fukubayashi, T.			Estimation of Tensile Force in the Hamstring Muscles during Overground Sprinting	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						muscle strain; voluntary contraction; musculotendon length; ground reaction force; early stance phase	KNEE FLEXOR MUSCLES; KINETIC-ANALYSIS; STRAIN INJURIES; ARCHITECTURE; MECHANICS; FOOTBALL; FLEXION; PHASE; RISK; HIP	The purpose of this study was to identify the period of the gait cycle during which the hamstring muscles were likely injured by estimating the magnitude of tensile force in each muscle during overground sprinting. We conducted three-dimensional motion analysis of 12 male athletes performing overground sprinting at their maximal speed and calculated the hamstring muscle-tendon length and joint angles of the right limb throughout a gait cycle during which the ground reaction force was measured. Electromyographic activity during sprinting was recorded for the biceps femoris long head, semitendinosus, and semimembranosus muscles of ipsilateral limb. We estimated the magnitude of tensile force in each muscle by using the length change occurred in the musculotendon and normalized electromyographic activity value. The study found a quick increase of estimated tensile force in the biceps femoris long head during the early stance phase of the gait cycle during which the increased hip flexion angle and ground reaction force occurred at the same time. This study provides quantitative data of tensile force in the hamstring muscles suggesting that the biceps femoris long head muscle is susceptible to a strain injury during the early stance phase of the sprinting gait cycle.	[Ono, T.] Waseda Univ, Fac Sports Sci, Tokorozawa, Saitama 3591192, Japan; [Higashihara, A.] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Japan; [Shinohara, J.] Kyusyu Kyoritsu Univ, Fac Sports Sci, Fukuoka, Japan; [Hirose, N.] Waseda Univ, Dept Sports Sci, Tokyo, Japan; [Fukubayashi, T.] Waseda Univ, Fac Sport Sci, Saitama, Japan	Ono, T (reprint author), Waseda Univ, Fac Sports Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan.	ono-t@aoni.waseda.jp					Brooks JHM, 2006, AM J SPORT MED, V34, P1297, DOI 10.1177/0363546505286022; Kumazaki T, 2012, INT J SPORTS MED, V33, P950, DOI 10.1055/s-0032-1311593; Hoskins W, 2005, MANUAL THER, V10, P96, DOI 10.1016/j.math.2005.03.006; Woods C, 2004, BRIT J SPORT MED, V38, P36, DOI 10.1136/bjsm.2002.002352; Harriss DJ, 2013, INT J SPORTS MED, V34, P1025, DOI 10.1055/s-0033-1358756; Woodley SJ, 2005, CELLS TISSUES ORGANS, V179, P125, DOI 10.1159/000085004; MANN R, 1980, RES Q EXERCISE SPORT, V51, P334; Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714; Ono T, 2011, RES SPORTS MED, V19, P42, DOI 10.1080/15438627.2011.535769; Schache AG, 2012, MED SCI SPORT EXER, V44, P647, DOI 10.1249/MSS.0b013e318236a3d2; Heiderscheit BC, 2005, CLIN BIOMECH, V20, P1072, DOI 10.1016/j.clinbiomech.2005.07.005; Kuitunen S, 2002, MED SCI SPORT EXER, V34, P166, DOI 10.1097/00005768-200201000-00025; Verrall GM, 2001, BRIT J SPORT MED, V35, P435, DOI 10.1136/bjsm.35.6.435; Makihara Y, 2006, KNEE SURG SPORT TR A, V14, P310, DOI 10.1007/s00167-005-0701-2; Thelen DG, 2005, MED SCI SPORT EXER, V37, P108, DOI 10.1249/01.MSS.0000150078.79120.C8; Onishi H, 2002, J ELECTROMYOGR KINES, V12, P399, DOI 10.1016/S1050-6411(02)00033-0; Chumanov ES, 2007, J BIOMECH, V40, P3555, DOI 10.1016/j.jbiomech.2007.05.026; Ono T, 2010, RES SPORTS MED, V18, P188, DOI 10.1080/15438627.2010.490185; Arnason A., 2004, AM J SPORTS MED, V32, P5, DOI DOI 10.1177/0363546503258912; FRIEDERICH JA, 1990, J BIOMECH, V23, P91, DOI 10.1016/0021-9290(90)90373-B; Garrett WE, 1996, AM J SPORT MED, V24, pS2; MANN RV, 1981, MED SCI SPORT EXER, V13, P325; MONTGOMERY WH, 1994, AM J SPORT MED, V22, P272, DOI 10.1177/036354659402200220; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Ono T, 2013, JPN J PHYS FIT SPORT, V62, P87; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard JW, 2012, BRIT J SPORT MED, V46, P88, DOI 10.1136/bjsports-2011-090127; TIDBALL JG, 1993, J APPL PHYSIOL, V74, P1280; Wood G, 1987, MED SPORT SCI, V25, P58	29	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	FEB	2015	36	2					163	168		10.1055/s-0034-1385865		6	Sport Sciences	Sport Sciences	CA3II	WOS:000348799400011		
J	Kono, Y; Kawajiri, H; Kamisaka, K; Kamiya, K; Akao, K; Asai, C; Inuzuka, K; Yamada, S				Kono, Yuji; Kawajiri, Hiroyuki; Kamisaka, Kenta; Kamiya, Kuniyasu; Akao, Keigo; Asai, Chikako; Inuzuka, Kana; Yamada, Sumio			Predictive impact of daily physical activity on new vascular events in patients with mild ischemic stroke	INTERNATIONAL JOURNAL OF STROKE			English	Article						atherothrombotic; mild stroke; physical activity; predictors of outcome; prevention; vascular events	BLOOD-PRESSURE; MEASURING STEPS; PREVENTION; GUIDELINES; EXERCISE; DISEASE; ATTACK; RISK; METAANALYSIS; HYPERTENSION	BackgroundDaily physical inactivity is associated with a substantially increased risk of cardiovascular events. However, the target level of daily physical activity remains unclear. AimWe aimed to evaluate the impact of physical activity on long-term vascular events in patients with mild ischemic stroke. MethodsWe designed a single hospital-based prospective observational study and studied 166 ischemic stroke patients (mean age: 63992) who had a modified Rankin Scale 0-1. We measured the daily step count as a variable of the daily physical activity after three-months from the stroke onset. Other clinical characteristics including age, body mass index, blood pressure, blood laboratory tests, vascular function and medications were also assessed. The primary outcomes were hospitalization due to stroke recurrence, myocardial infarction, angina pectoris and peripheral artery disease. Survival curves were calculated by a Kaplan-Meier survival analysis, and the hazard ratios for recurrences were determined by univariate and multivariate Cox proportional hazards regression models. ResultsAfter a median follow-up periods of 1332 days, 34 vascular events (23 stroke recurrences, 11 coronary artery disease) and 7 drop-outs occurred, and the remaining patients were divided into two groups: the without recurrence group (n=125) and the with recurrence group (n=34). The daily step count was lower in the nonsurvivor group than in the survivor group. Univariate and multivariate Cox proportional hazards analyses revealed that the daily step counts was independent predictors of new vascular events. A daily step count cutoff value of 6025 steps per day was determined by analyzing the receiver-operating characteristics that showed a sensitivity of 694% and a specificity of 794%. The Kaplan-Meier survival curves after a log-rank test showed a significantly lower event rate in the more than 6025 steps per day group compared with the less than 6025 steps per day group (P=00002). The positive and negative predictive values of less than 6025 steps were 380% and 916%, respectively. ConclusionOur data indicate that daily physical activity evaluated by step counts may be useful for forecasting the prognosis in patients with mild ischemic stroke. Daily step counts of approximately 6000 steps per day may be an initial target level for reducing new vascular events.	[Kono, Yuji; Yamada, Sumio] Nagoya Univ, Grad Sch Med, Dept Rehabil Sci, Nagoya, Aichi 4648601, Japan; [Kawajiri, Hiroyuki; Kamisaka, Kenta; Kamiya, Kuniyasu; Akao, Keigo; Asai, Chikako; Inuzuka, Kana] Nagoya Univ, Grad Sch Med, Program Phys & Occupat Therapy, Nagoya, Aichi 4648601, Japan	Yamada, S (reprint author), Nagoya Univ, Grad Sch Med, Higashi Ku, 1-1-20 Daiko Minami, Nagoya, Aichi 4648601, Japan.	yamadas@met.nagoya-u.ac.jp			Japan Society for the Promotion of Science [21650135]	This work was partly supported by the Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science (grant no. 21650135; Clinical Principal Investigator: Sumio Yamada).	Schneider PL, 2003, MED SCI SPORT EXER, V35, P1779, DOI 10.1249/01.MSS.0000089342.96098.C4; Brook RD, 2013, HYPERTENSION, V61, P1360, DOI 10.1161/HYP.0b013e318293645f; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS31, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.004; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Vickrey BG, 2002, STROKE, V33, P901, DOI 10.1161/hs0402.105246; Imai Y, 2012, HYPERTENS RES, V35, P777, DOI 10.1038/hr.2012.56; Wendel-Vos GCW, 2004, INT J EPIDEMIOL, V33, P787, DOI 10.1093/ije/dyh168; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; Kim JS, 2012, STROKE, V43, P3313, DOI 10.1161/STROKEAHA.112.658500; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Japan Ministry of Health Labour and Welfare, 2012, SUMM STAT REP JAP PO; KIYONAGA A, 1985, HYPERTENSION, V7, P125; Kono Y, 2013, CEREBROVASC DIS, V36, P88, DOI 10.1159/000352052; Kono Y, 2011, CEREBROVASC DIS, V31, P365, DOI 10.1159/000323233; Portney LG, 2000, FDN CLIN RES APPL PR, P92; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; URATA H, 1987, HYPERTENSION, V9, P245; vansWijk I, 2005, LANCET, V365, P2098; Yamasue K, 2006, J HUM HYPERTENS, V20, P593, DOI 10.1038/sj.jhh.1002049	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	FEB	2015	10	2					219	223		10.1111/ijs.12392		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CA2BH	WOS:000348713500023		
J	Parmar, P; Krishnamurthi, R; Ikram, MA; Hofman, A; Mirza, SS; Varakin, Y; Kravchenko, M; Piradov, M; Thrift, AG; Norrving, B; Wang, W; Mandal, DK; Barker-Collo, S; Sahathevan, R; Davis, S; Saposnik, G; Kivipelto, M; Sindi, S; Bornstein, NM; Giroud, M; Bejot, Y; Brainin, M; Poulton, R; Narayan, KMV; Correia, M; Freire, A; Kokubo, Y; Wiebers, D; Mensah, G; BinDhim, NF; Barber, PA; Pandian, JD; Hankey, GJ; Mehndiratta, MM; Azhagammal, S; Ibrahim, NM; Abbott, M; Rush, E; Hume, P; Hussein, T; Bhattacharjee, R; Purohit, M; Feigin, VL				Parmar, Priya; Krishnamurthi, Rita; Ikram, M. Arfan; Hofman, Albert; Mirza, Saira S.; Varakin, Yury; Kravchenko, Michael; Piradov, Michael; Thrift, Amanda G.; Norrving, Bo; Wang, Wenzhi; Mandal, Dipes Kumar; Barker-Collo, Suzanne; Sahathevan, Ramesh; Davis, Stephen; Saposnik, Gustavo; Kivipelto, Miia; Sindi, Shireen; Bornstein, Natan M.; Giroud, Maurice; Bejot, Yannick; Brainin, Michael; Poulton, Richie; Narayan, K. M. Venkat; Correia, Manuel; Freire, Antonio; Kokubo, Yoshihiro; Wiebers, David; Mensah, George; BinDhim, Nasser F.; Barber, P. Alan; Pandian, Jeyaraj Durai; Hankey, Graeme J.; Mehndiratta, Man Mohan; Azhagammal, Shobhana; Ibrahim, Norlinah Mohd; Abbott, Max; Rush, Elaine; Hume, Patria; Hussein, Tasleem; Bhattacharjee, Rohit; Purohit, Mitali; Feigin, Valery L.		Stroke Riskometer Collaboration	The Stroke Riskometer (TM) App: Validation of a data collection tool and stroke risk predictor	INTERNATIONAL JOURNAL OF STROKE			English	Article						prevention; stroke prediction; Stroke Riskometer(TM) App; validation	CARDIOVASCULAR-DISEASE RISK; PROSPECTIVE OPEN COHORT; EXTERNAL VALIDATION; ALCOHOL-CONSUMPTION; SYSTEMATIC ANALYSIS; PRIMARY PREVENTION; ELDERLY-PEOPLE; GLOBAL BURDEN; PRIMARY-CARE; FOLLOW-UP	BackgroundThe greatest potential to reduce the burden of stroke is by primary prevention of first-ever stroke, which constitutes three quarters of all stroke. In addition to population-wide prevention strategies (the mass' approach), the high risk' approach aims to identify individuals at risk of stroke and to modify their risk factors, and risk, accordingly. Current methods of assessing and modifying stroke risk are difficult to access and implement by the general population, amongst whom most future strokes will arise. To help reduce the burden of stroke on individuals and the population a new app, the Stroke Riskometer(TM), has been developed. We aim to explore the validity of the app for predicting the risk of stroke compared with current best methods. Methods752 stroke outcomes from a sample of 9501 individuals across three countries (New Zealand, Russia and the Netherlands) were utilized to investigate the performance of a novel stroke risk prediction tool algorithm (Stroke Riskometer(TM)) compared with two established stroke risk score prediction algorithms (Framingham Stroke Risk Score [FSRS] and QStroke). We calculated the receiver operating characteristics (ROC) curves and area under the ROC curve (AUROC) with 95% confidence intervals, Harrels C-statistic and D-statistics for measure of discrimination, R-2 statistics to indicate level of variability accounted for by each prediction algorithm, the Hosmer-Lemeshow statistic for calibration, and the sensitivity and specificity of each algorithm. ResultsThe Stroke Riskometer(TM) performed well against the FSRS five-year AUROC for both males (FSRS=750% (95% CI 723%-776%), Stroke Riskometer(TM)=740(95% CI 713%-767%) and females [FSRS=703% (95% CI 679%-728%, Stroke Riskometer(TM)=715% (95% CI 690%-739%)], and better than QStroke [males - 597% (95% CI 573%-620%) and comparable to females=711% (95% CI 690%-731%)]. Discriminative ability of all algorithms was low (C-statistic ranging from 051-056, D-statistic ranging from 001-012). Hosmer-Lemeshow illustrated that all of the predicted risk scores were not well calibrated with the observed event data (P<0006). ConclusionsThe Stroke Riskometer(TM) is comparable in performance for stroke prediction with FSRS and QStroke. All three algorithms performed equally poorly in predicting stroke events. The Stroke Riskometer(TM) will be continually developed and validated to address the need to improve the current stroke risk scoring systems to more accurately predict stroke, particularly by identifying robust ethnic/race ethnicity group and country specific risk factors.	[Parmar, Priya; Krishnamurthi, Rita; Abbott, Max; Rush, Elaine; Hume, Patria; Hussein, Tasleem; Bhattacharjee, Rohit; Purohit, Mitali; Feigin, Valery L.] AUT Univ, Auckland 1142, New Zealand; [Ikram, M. Arfan; Hofman, Albert; Mirza, Saira S.] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Varakin, Yury; Kravchenko, Michael; Piradov, Michael] RAMS, Res Ctr Neurol, Moscow, Russia; [Thrift, Amanda G.] Monash Univ, Sch Clin Sci, Dept Med, Clayton, Vic 3800, Australia; [Norrving, Bo] Lund Univ, S-22100 Lund, Sweden; [Wang, Wenzhi] Beijing Neurosurg Inst, Beijing, Peoples R China; [Mandal, Dipes Kumar; Azhagammal, Shobhana] Stroke Fdn Bengal, Kolkata, India; [Barker-Collo, Suzanne; Barber, P. Alan] Univ Auckland, Auckland 1, New Zealand; [Sahathevan, Ramesh; Ibrahim, Norlinah Mohd] Univ Kebangsaan Malaysia, Med Ctr, Kl, Malaysia; [Davis, Stephen] Univ Melbourne, Melbourne, Vic 3010, Australia; [Saposnik, Gustavo] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Kivipelto, Miia; Sindi, Shireen] Karolinska Inst, S-10401 Stockholm, Sweden; [Bornstein, Natan M.] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Giroud, Maurice] Ctr Hosp Univ, Dijon, France; [Bejot, Yannick] Univ Burgundy, Dijon, France; [Brainin, Michael] Danube Univ, Krems An Der Donau, Austria; [Poulton, Richie] Univ Otago, Dunedin, New Zealand; [Narayan, K. M. Venkat] Emory Univ, Atlanta, GA 30322 USA; [Correia, Manuel] Hosp Santo Antonio, Oporto, Portugal; [Freire, Antonio] Univ Hosp Coimbra, Coimbra, Portugal; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Wiebers, David] Mayo Clin, Rochester, MN USA; [Mensah, George] NHLBI, NIH, Bethesda, MD USA; [BinDhim, Nasser F.] Univ Sydney, Sydney, NSW 2006, Australia; [Pandian, Jeyaraj Durai] Christian Med Coll & Hosp, Ludhiana, Punjab, India; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Mehndiratta, Man Mohan] Janakpuri Super Special Hosp, Dept Neurol, New Delhi, India	Parmar, P (reprint author), AUT Univ, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, AUT North Shore Campus,AA254,90 Akoranga Dr, Auckland 1142, New Zealand.	pparmar@aut.ac.nz	Kravchenko, Mikhail/B-2596-2012; Hankey, Graeme /H-4968-2014	Hankey, Graeme /0000-0002-6044-7328	Faculty of Health and Environmental Studies, AUT University, Auckland, NZ	Faculty of Health and Environmental Studies, AUT University, Private Bag 92006, Auckland, NZ.	HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; ROSE G, 1981, BRIT MED J, V282, P1847; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Dalton ARH, 2013, EUR J PREV CARDIOL, V20, P142, DOI 10.1177/1741826711428797; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Chang MH, 2001, J CLIN EPIDEMIOL, V54, P634, DOI 10.1016/S0895-4356(00)00343-7; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; WOLF PA, 1991, STROKE, V22, P312; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Fagerlin A, 2011, J NATL CANCER I, V103, P1436, DOI 10.1093/jnci/djr318; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Cooney MT, 2009, EUR J CARDIOV PREV R, V16, P541, DOI 10.1097/HJR.0b013e32832b38a1; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Brindle P, 2003, BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Eckel RH, 2014, J AM COLL CARDIOL, V63, P2960, DOI 10.1016/j.jacc.2013.11.003; Jones SP, 2010, AGE AGEING, V39, P11, DOI 10.1093/ageing/afp196; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Bazzano LA, 2007, ANN NEUROL, V62, P569, DOI 10.1002/ana.21194; Majed B, 2013, PREV MED, V57, P49, DOI 10.1016/j.ypmed.2013.04.003; Arab F, 2013, LECT NOTES COMPUT SC, V8120, P547; Arts EE, 2014, ANN RHEUM DIS, V0, P1; Asplund K, 2009, STROKE, V40, P2319, DOI 10.1161/STROKEAHA.109.547869; Bineau S, 2009, STROKE, V40, P1564, DOI 10.1161/STROKEAHA.108.532325; Bos MJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001634; Brouillette RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065925; Collins GS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2442; Cook NR, 2012, CIRCULATION, V125, pS1741; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; Feigin VL, 2014, INT J STROKE, V9, P624, DOI 10.1111/ijs.12300; Ferrucci L, 1996, J AM GERIATR SOC, V44, P237; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hickey Anne, 2009, BMC Geriatr, V9, P35, DOI 10.1186/1471-2318-9-35; Hill S, 2010, COMPET-BASE CRIT CAR, P1, DOI 10.1007/978-1-84996-146-2_1; Hippisley-Cox J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2573; Kayabai K, 2008, HYPERTENS RES, V31, P1489, DOI 10.1291/hypres.31.1489; Krishnamurthi R, 2014, INT J STROKE, V9, P140, DOI 10.1111/ijs.12108; Leung R, 2012, ACM T ACCESS COMPUT, V4, P1; Liao DP, 1997, STROKE, V28, P1908; McClure LA, 2014, STROKE, V45, P1716, DOI 10.1161/STROKEAHA.114.004915; Mvundura M, 2010, PUBLIC HEALTH GENOMI, V13, P13, DOI 10.1159/000209879; Pendlebury Sarah T, 2009, Cerebrovasc Dis, V27 Suppl 3, P1, DOI 10.1159/000209260; Pennells L, 2014, AM J EPIDEMIOL, V179, P621, DOI 10.1093/aje/kwt298; R Development Core Team, 2013, R LANG ENV STAT COMP; SHINTON R, 1993, J NEUROL NEUROSUR PS, V56, P458, DOI 10.1136/jnnp.56.5.458; vansAsch CJJ, 2010, LANCET NEUROL, V9, P167; World Health Organisation, 2013, GLOB ACT PLAN PREV C; World Health Organization (WHO), 2007, PREV CARD DIS POCK G; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	56	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	FEB	2015	10	2					231	244		10.1111/ijs.12411		14	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CA2BH	WOS:000348713500025		
J	Toyoda, K; Uchiyama, S; Hoshino, H; Kimura, K; Origasa, H; Naritomi, H; Minematsu, K; Yamaguchi, T				Toyoda, Kazunori; Uchiyama, Shinichiro; Hoshino, Haruhiko; Kimura, Kazumi; Origasa, Hideki; Naritomi, Hiroaki; Minematsu, Kazuo; Yamaguchi, Takenori		CSPS Com Study Investigators	Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial	INTERNATIONAL JOURNAL OF STROKE			English	Article						aspirin; clopidogrel; cilostazol; cerebral infarction; clinical trial; dual antiplatelet therapy; ischemic stroke; stroke prevention	INTRACRANIAL ARTERIAL-STENOSIS; TRANSIENT ISCHEMIC ATTACK; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; SECONDARY PREVENTION; CEREBRAL-ISCHEMIA; CLINICAL-TRIALS; ASPIRIN; CLOPIDOGREL; RISK	Rationale and aimsMonotherapy with antiplatelet agents is only modestly effective in secondary prevention of ischemic stroke (IS), particularly in patients with multiple risk factors such as cervicocephalic arterial stenosis, diabetes, and hypertension. While dual antiplatelet therapy (DAPT) with aspirin and clopidogrel reduced IS recurrence, particularly in the early stages after IS, it increased the risk of bleeding. Compared with aspirin, cilostazol prevented IS recurrence without increasing the incidence of serious bleeds. In patients with intracranial arterial stenosis, no significant increase in bleeding events was observed for DAPT with cilostazol and aspirin, compared to that for aspirin monotherapy. DAPT involving cilostazol may therefore be safer than conventional DAPT. These findings prompted us to conduct the Cilostazol Stroke Prevention Study for Antiplatelet Combination (; identifier: NCT01995370) to evaluate the safety and efficacy of DAPT involving cilostazol for secondary IS prevention, in comparison with that of antiplatelet monotherapy. DesignThe is a multicenter, randomized, open-label, parallel-group trial. A total of 4000 high-risk patients with noncardioembolic IS will be randomized 8-180 days after onset to receive aspirin or clopidogrel monotherapy, or DAPT with cilostazol and aspirin or clopidogrel for at least one-year. Study outcomesThe primary outcome is IS recurrence. Secondary outcomes are composite occurrences of any stroke, death from any cause, myocardial infarction, vascular death, and other vascular events. DiscussionThe is expected to provide evidence indicating whether secondary IS prevention in high-risk patients can be improved by using DAPT involving cilostazol.	[Toyoda, Kazunori; Minematsu, Kazuo; Yamaguchi, Takenori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Uchiyama, Shinichiro] Int Univ Hlth & Welf, Ctr Brain & Cerebral Vessels, Clin Res Ctr Med, Sanno Hosp,Minato Ku, Tokyo 1070052, Japan; [Uchiyama, Shinichiro] Sanno Med Ctr, Minato Ku, Tokyo 1070052, Japan; [Hoshino, Haruhiko] Tokyo Saiseikai Cent Hosp, Dept Neurol, Minato Ku, Tokyo 1080073, Japan; [Kimura, Kazumi] Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Binkyou ku, Tokyo 113, Japan; [Origasa, Hideki] Toyama Univ, Div Biostat & Clin Epidemiol, Toyama 9300194, Japan; [Naritomi, Hiroaki] Senri Chuo Hosp, Dept Neurol, Toyonaka, Osaka 5600082, Japan	Toyoda, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	toyoda@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845	Otsuka Pharmaceutical Co., Ltd.; Japan Cardiovascular Research Foundation; Otsuka Pharmaceutical Co, Ltd (Tokyo, Japan)	The CSPS.com will be conducted under a trial contract between the consignee, Japan Cardiovascular Research Foundation, and the consignor, Otsuka Pharmaceutical Co., Ltd. Japan Cardiovascular Research Foundation will receive funding for trial implementation and management from Otsuka Pharmaceutical Co., Ltd. Participating members, including the authors and each committee member, will receive scientific consultancy fees for trial design and management, depending on their roles.; List of individuals who will play a critical role in this trial: Sponsor - Japan Cardiovascular Research Foundation. Funding organization - Otsuka Pharmaceutical Co, Ltd (Tokyo, Japan). Principal investigator - Takenori Yamaguchi. Steering committee - Shinichirou Uchiyama (Chair), Yasushi Okada, Kazumi Kimura, Nobuyuki Sakai, Kortaro Tanaka, Kazunori Toyoda, Haruhiko Hoshino. Protocol committee - Kazunori Toyoda (Chair), Kazumi Kimura, Haruhiko Hoshino. Independent data monitoring committee - Hiroaki Naritomi (Chair), Tatsuya Isomura, Shinya Goto. Event review committee - Kazuo Minematsu (Chair), Yasuo Terayama, Teiji Tominaga, Hidekazu Tomimoto, Kiyohiro Houkin, Masayasu Matsumoto, Satoshi Yasuda. Statistical analysis committee - Hideki Origasa (Chair), Naoko Kumagai.	TOPOL E, 1993, NEW ENGL J MED, V329, P673; LAKATOS E, 1992, STAT MED, V11, P179, DOI 10.1002/sim.4780110205; Kwon SU, 2005, STROKE, V36, P782, DOI 10.1161/01.STR.0000157667.06542.b7; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Kasahara Y, 2012, STROKE, V43, P499, DOI 10.1161/STROKEAHA.111.635417; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Halkes PHA, 2006, LANCET, V367, P1665; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Sakurai R, 2013, INT J CARDIOL, V167, P2250, DOI 10.1016/j.ijcard.2012.06.010; Kwon SU, 2011, STROKE, V42, P2883, DOI 10.1161/STROKEAHA.110.609370; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Diener HC, 2004, LANCET, V364, P331; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Baigent C, 2002, BRIT MED J, V324, P71; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Uchiyama S, 2011, CEREBROVASC DIS, V31, P601, DOI 10.1159/000327035; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Hase Y, 2012, EXP NEUROL, V233, P523, DOI 10.1016/j.expneurol.2011.11.038; Diener HC, 2005, EXPERT OPIN PHARMACO, V6, P755, DOI 10.1517/14656566.6.5.755; Gotoh F, 2000, J Stroke Cerebrovasc Dis, V9, P147, DOI 10.1053/jscd.2000.7216; HAYBITTL.JL, 1971, BRIT J RADIOL, V44, P793; Hiatt WR, 2008, J VASC SURG, V47, P330, DOI 10.1016/j.jvs.2007.10.009; Ishiguro M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015178; Kamouchi M, 2012, CEREBROVASC DIS, V34, P351, DOI 10.1159/000343503; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Nicolaides AN, 2010, J VASC SURG, V52, P1486, DOI 10.1016/j.jvs.2010.07.021; Suzuki N, 2012, J STROKE CEREBROVASC, V21, P245, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.010; The CATHARSIS Study Group, 2013, STROKE, V44, pAWP423; vansAsch CJJ, 2010, LANCET NEUROL, V9, P167; Wilhite DB, 2003, J VASC SURG, V38, P710, DOI 10.1016/S0741-5214(03)01029-2	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	FEB	2015	10	2					253	258		10.1111/ijs.12420		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CA2BH	WOS:000348713500028		
J	Mitarai, S				Mitarai, Satoshi		TB Res Comm RYOKEN	Nationwide survey of anti-tuberculosis drug resistance in Japan	INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE			English	Article						tuberculosis; MDR-TB; drug susceptibility testing	MYCOBACTERIUM-TUBERCULOSIS; STRAINS	OBJECTIVE: To determine the prevalence of anti-tuberculosis drug resistance in Japan. DESIGN: A nationwide drug resistance survey was conducted by convenience sampling based on a voluntary hospital consortium. Mycobacterium tuberculosis isolates (n = 2292) were collected from August 2007 to July 2008. Drug susceptibilities were analysed according to the patients' treatment history, age, sex, comorbidities and residential area. We determined susceptibility to the following drugs: isoniazid (INH), rifampicin (RMP), streptomycin (SM), ethambutol (EMB) and levofloxacin (LVX). RESULTS: The frequencies of drug-resistant isolates from new cases were as follows: INH, 3.1%; RMP, 0.7%; SM, 5.6%; EMB, 1.3%; and 8.5% to any drug. The frequencies of drug-resistant isolates from previously treated patients were as follows: INH, 12.3%; RMP, 6.7%; SM, 12.3%; and EMB, 2.6%. The frequencies of LVX-resistant isolates from new and previously treated patients were respectively 3.2% and 6.1% (n = 852). The frequencies of multidrug-resistant isolates from new and previously treated patients were respectively 0.4% and 4.1%, with only one extensively drug-resistant case. CONCLUSION: In general, the prevalence of drug-resistant TB in Japan during this period was low. However, LVX resistance among new patients was relatively high. Japan should establish a nationwide surveillance system.	[Mitarai, Satoshi] Japan AntiTB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Tokyo 2048533, Japan	Mitarai, S (reprint author), Japan AntiTB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, 3-1-24 Matsuyama, Tokyo 2048533, Japan.	mitarai@jata.or.jp			Health Science Research Grant from the Ministry of Health, Labour and Welfare, Tokyo, Japan [H18-Shinko-Ippan-012, H21-Shinko-Ippan-016]	The authors extend their sincere appreciation to all the participants of this study. This study was supported by a Health Science Research Grant from the Ministry of Health, Labour and Welfare (H18-Shinko-Ippan-012 and H21-Shinko-Ippan-016), Tokyo, Japan.	Abe C, 2001, INT J TUBERC LUNG D, V5, P46; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; Springer B, 1996, J CLIN MICROBIOL, V34, P296; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Fisher-Hoch SP, 2008, SCAND J INFECT DIS, V40, P888, DOI 10.1080/00365540802342372; Japan Anti-Tuberculosis Association, 2008, STAT TB 2007; Japan Anti-Tuberculosis Association, 2011, STAT TB 2010; KOPANOFF DE, 1978, AM REV RESPIR DIS, V118, P835; Ministry of Health Labour and Welfare, 2011, STAT TUB JAP; Sugawara T., 2012, JPN J INFECT PREV CO, V27, P195; Tuberculosis Research Committee (RYOKEN), 2007, INT J TUBERC LUNG D, V11, P1129; World Health Organization, 2008, WHOHTMTB2008394; World Health Organization, 2010, MULT EXT DRUG RES TB; World Health Organization, 2006, XDR TB EXT DRUG RES; World Health Organization, 2008, WHOHTMTB2008392; World Health Orgnization, 2009, WHOHTMTB2009422; Yokota S, 2012, CHEMOTHERAPY, V58, P52, DOI 10.1159/000336129; Yokota SI, 2008, J CLIN MICROBIOL, V46, P361, DOI 10.1128/JCM.01561-07	21	1	1	INT UNION AGAINST TUBERCULOSIS LUNG DISEASE (I U A T L D)	PARIS	68 BOULEVARD SAINT-MICHEL,, 75006 PARIS, FRANCE	1027-3719	1815-7920		INT J TUBERC LUNG D	Int. J. Tuberc. Lung Dis.	FEB	2015	19	2					157	162		10.5588/ijtld.13.0905		6	Infectious Diseases; Respiratory System	Infectious Diseases; Respiratory System	CA1UM	WOS:000348696900008		
J	Saito, T; Uchida, K; Ishida, H; Tanabe, K; Nitta, K				Saito, Takako; Uchida, Keiko; Ishida, Hideki; Tanabe, Kazunari; Nitta, Kosaku			Changes in glomerular filtration rate after donation in living kidney donors: A single-center cohort study	INTERNATIONAL UROLOGY AND NEPHROLOGY			English	Article						Living kidney donor; Nephrectomy; Arteriosclerosis; GFR; Kidney transplantation	RENAL-FUNCTION; FOLLOW-UP; RISK-FACTORS; NEPHRECTOMY; BIOPSY	A number of studies have reported on decline in glomerular filtration rate (GFR) after donation in Japanese living kidney donors. The purpose of the present study was to examine the clinicopathological factors associated with changes in GFR after donation in living kidney donors. We reviewed the charts of living kidney donors (n = 294) and monitored estimated GFR (eGFR) values from the time of 0-h kidney biopsy until 3 years after donation. We assessed donor age, gender, body mass index, blood pressure, urinalysis, and several other clinical parameters including the severity of glomerulosclerosis and arteriosclerosis. The grade of arteriosclerosis in 0-h biopsy specimens was higher in the older donor group (57-76 years) than in the younger donor group (30-56 years). Mean donor eGFR at the time of the donation was 80.1 +/- A 13.6 ml/min/1.73 m(2). Most of the living kidney donors in this study developed stage 3 chronic kidney disease (CKD). The mean changes in eGFR at 1-3 years after donation showed a steady state that was distinct from the generally accepted notion that GFR declines with age. Multivariate regression analyses showed that the changes in eGFR were negatively associated with age (r = -0.21, P < 0.001) and preoperative eGFR (r = -0.18, P < 0.001), but not associated with the grade of glomerulosclerosis and arteriosclerosis. Donor age and pre-GFR at the time of nephrectomy were associated with decline in kidney function in living kidney donors after donation. Most of the donors developed stage 3 CKD within 3 years after donation but without subsequent progression, at least for several years.	[Saito, Takako; Uchida, Keiko; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo 1628666, Japan; [Ishida, Hideki; Tanabe, Kazunari] Tokyo Womens Med Univ, Dept Urol, Tokyo 1628666, Japan	Nitta, K (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, Tokyo 1628666, Japan.	knitta@kc.twmu.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mandelbrot DA, 2007, AM J TRANSPLANT, V7, P2333, DOI 10.1111/j.1600-6143.2007.01932.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007; Epstein M, 1996, J AM SOC NEPHROL, V7, P1106; Gossmann J, 2005, AM J TRANSPLANT, V5, P2417, DOI 10.1111/j.1600-6143.2005.01037.x; Kubo M, 2003, KIDNEY INT, V63, P1508, DOI 10.1046/j.1523-1755.2003.00886.x; Okamoto M, 2009, TRANSPLANTATION, V87, P419, DOI 10.1097/TP.0b013e318192dc95; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Norris KC, 2005, KIDNEY INT, V68, P914, DOI 10.1111/j.1523-1755.2005.00485.x; Blake GM, 2013, INT UROL NEPHROL, V45, P1445, DOI 10.1007/s11255-013-0408-0; Kasiske BL, 2013, AM J KIDNEY DIS, V62, P577, DOI 10.1053/j.ajkd.2013.01.027; Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319; Boudville N, 2006, ANN INTERN MED, V145, P185; Choi KH, 2014, TRANSPL P, V46, P359, DOI 10.1016/j.transproceed.2013.11.087; Gibney EM, 2007, TRANSPLANTATION, V84, P647, DOI 10.1097/01.tp.0000277288.78771.c2; Goldfarb DA, 2001, J UROLOGY, V166, P2043, DOI 10.1016/S0022-5347(05)65502-4; Horio M, 2012, CLIN EXP NEPHROL, V16, P415, DOI 10.1007/s10157-012-0586-6; Kido R, 2010, CLIN EXP NEPHROL, V14, P356, DOI 10.1007/s10157-010-0279-y; Matas Aj, 2012, ADV CHRONIC KIDNEY D, V19, P269; Nozaki T, 2010, TRANSPL P, V42, P1476, DOI 10.1016/j.transproceed.2009.11.054; Saran R, 1997, NEPHROL DIAL TRANSPL, V12, P1615, DOI 10.1093/ndt/12.8.1615; Steiner RW, 2010, AM J TRANSPLANT, V10, P737, DOI 10.1111/j.1600-6143.2010.03023.x; Textor SC, 2004, TRANSPLANTATION, V78, P276, DOI 10.1097/01.TP.0000128168.97735.B3; Wazna E, 2009, TRANSPL P, V41, P2975, DOI 10.1016/j.transproceed.2009.08.022	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-1623	1573-2584		INT UROL NEPHROL	Int. Urol. Nephrol.	FEB	2015	47	2					397	403		10.1007/s11255-014-0861-4		7	Urology & Nephrology	Urology & Nephrology	CA6CH	WOS:000348995500028		
J	Yusuf, S; Okuwa, M; Shigeta, Y; Dai, M; Iuchi, T; Rahman, S; Usman, A; Kasim, S; Sugama, J; Nakatani, T; Sanada, H				Yusuf, Saldy; Okuwa, Mayumi; Shigeta, Yoshie; Dai, Misako; Iuchi, Terumi; Rahman, Sulaiman; Usman, Awaluddin; Kasim, Sukmawati; Sugama, Junko; Nakatani, Toshio; Sanada, Hiromi			Microclimate and development of pressure ulcers and superficial skin changes	INTERNATIONAL WOUND JOURNAL			English	Article						microclimate; pressure ulcer; superficial skin changes; skin temperature; skin moisture	SUBEPIDERMAL MOISTURE; DIABETIC FOOT; TEMPERATURE; RISK; PREVALENCE; ULCERATION; RESIDENTS; TEXTILES; DAMAGE; MODEL	This study aims to evaluate the microclimate and development of pressure ulcers and superficial skin changes. A prospective cohort study was conducted in an acute care ward in Indonesia. Risk factors for pressure ulcers and superficial skin changes were identified based on the Bergstrom Braden conceptual model. Microclimate data were collected every 3 days for 15 days while the development of pressure ulcers and superficial skin changes was observed every day. Pressure ulcers and superficial skin changes were developed in 20 of the 71 participants. Total mean difference in skin temperature was higher for patients with pressure ulcers and superficial skin changes (09 +/- 06 degrees C) compared with controls (06 +/- 08 degrees C) (P = 0071). Binary logistic regression predictor values for pressure ulcers and superficial skin changes were 0111 for type of sheet and 0347 for Braden Scale results. In conclusion, difference in skin temperature seems to be a predictor for pressure ulcer development and superficial skin changes, while synthetic fibre sheets are able to maintain a beneficial microclimate.	[Yusuf, Saldy; Okuwa, Mayumi; Shigeta, Yoshie; Dai, Misako; Iuchi, Terumi; Sugama, Junko; Nakatani, Toshio] Kanazawa Univ, Clin Nursing Dept, Kanazawa, Ishikawa 9200942, Japan; [Rahman, Sulaiman; Usman, Awaluddin] ETN Ctr, Wound Care Clin, Makassar, Indonesia; [Yusuf, Saldy; Kasim, Sukmawati] Griya Afiat, Wound Care Clin, Makassar, Indonesia; [Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan	Sugama, J (reprint author), Kanazawa Univ, Clin Nursing Dept, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	junkosgm@mhs.mp.kanazawa-u.ac.jp	Shigeta, Yasuteru/D-4714-2015; OKUWA, Mayumi/L-3687-2015; 中谷, 壽男/C-3220-2015	中谷, 壽男/0000-0003-4949-5123			Bates-Jensen BM, 2009, J WOUND OSTOMY CONT, V36, P277, DOI 10.1097/WON.0b013e3181a19e53; Reger SI, 2007, OSTOMY WOUND MANAG, V53, P50; VanGilder C, 2009, OSTOMY WOUND MANAG, V55, P39; Clarys P, 2012, SKIN RES TECHNOL, V18, P316, DOI 10.1111/j.1600-0846.2011.00573.x; Gerhardt LC, 2008, J R SOC INTERFACE, V5, P1317, DOI 10.1098/rsif.2008.0034; Gerhardt LC, 2008, SKIN RES TECHNOL, V14, P77, DOI 10.1111/j.1600-0846.2007.00264.x; Beeckman D, 2007, J ADV NURS, V60, P682, DOI 10.1111/j.1365-2648.2007.04474.x; Lavery LA, 2004, DIABETES CARE, V27, P2642, DOI 10.2337/diacare.27.11.2642; Zhong W, 2006, CUTAN OCUL TOXICOL, V25, P23, DOI 10.1080/15569520500536600; KOKATE JY, 1995, ARCH PHYS MED REHAB, V76, P666, DOI 10.1016/S0003-9993(95)80637-7; Kwong EWY, 2009, J ADV NURS, V65, P2608, DOI 10.1111/j.1365-2648.2009.05117.x; Armstrong DG, 2007, AM J MED, V120, P1042, DOI 10.1016/j.amjmed.2007.06.028; Vanderwee K, 2007, J EVAL CLIN PRACT, V13, P227, DOI 10.1111/j.1365-2753.2006.00684.x; Gefen A, 2011, J TISSUE VIABILITY, V20, P81, DOI 10.1016/j.jtv.2010.10.002; Armstrong DG, 1997, PHYS THER, V77, P169; Sibbald RG, 2011, ADV SKIN WOUND CARE, V24, P571, DOI 10.1097/01.ASW.0000408467.26999.6d; Baldwin K M, 2001, Adv Skin Wound Care, V14, P26, DOI 10.1097/00129334-200101000-00014; BERGSTROM N, 1987, NURS RES, V36, P205; Bouten CVC, 2001, ANN BIOMED ENG, V29, P153, DOI 10.1114/1.1349698; Clark M, 2011, WOUNDS INT, V2, P1; Derler S, 2011, TRIBOL INT, V46, P208; Doughty D, 2012, OSTOMY WOUND MANAG, V58, P20; Guihan M, 2012, J SPINAL CORD MED, V35, P46, DOI 10.1179/204577211X13209212104141; HERSHLER C, 1992, J MED ENG TECHNOL, V16, P117, DOI 10.3109/03091909209021973; Jonsson A, 2005, MED BIOL ENG COMPUT, V43, P541, DOI 10.1007/BF02351025; Kelechi Teresa J, 2003, J Wound Ostomy Continence Nurs, V30, P17, DOI 10.1067/mjw.2003.10; Kelechi TJ, 2007, BIOL RES NURS, V9, P70, DOI 10.1177/1099800407299424; Knox D M, 1999, Adv Wound Care, V12, P246; Kottner J, 2010, J CLIN NURS, V19, P716, DOI 10.1111/j.1365-2702.2009.03109.x; Mahoney M, 2011, J WOUND OSTOMY CONT, V38, P635, DOI 10.1097/WON.0b013e31822fc3e5; Min K, 2007, INT J HEAT MASS TRAN, V50, P5292, DOI 10.1016/j.ijheatmasstransfer.2007.06.016; National Pressure Ulcer Advisory Panel and European Pressure Ulcer Advisory Panel, 2009, PREV TREATM PRESS UL; Newman DK, 2007, CHRONIC WOUND CARE C, V4th, P609; Nicholson GP, 1999, MED ENG PHYS, V21, P701, DOI 10.1016/S1350-4533(00)00003-5; Okamoto Kazue, 1998, Applied Human Science, V17, P115, DOI 10.2114/jpa.17.115; Patel S, 1999, J REHABIL RES DEV, V36, P189; Pell MF, 2009, J REHABIL RES DEV, V46, P945; Pryczynska E, 2003, FIBRES TEXT EAST EUR, V11, P50; Rapp MP, 2009, ADV SKIN WOUND CARE, V22, P506, DOI 10.1097/01.ASW.0000305496.15768.82; Sae-Sia W, 2005, APPL NURS RES, V18, P29, DOI 10.1016/j.apnr.2004.03.005; Sanada H, 2008, WOUNDS, V20, P176; Sayre Elizabeth K, 2007, J Vasc Nurs, V25, P46, DOI 10.1016/j.jvn.2007.06.002; Sprigle S, 2001, Adv Skin Wound Care, V14, P133, DOI 10.1097/00129334-200105000-00010; Suriadi, 2008, Nurs Crit Care, V13, P34, DOI 10.1111/j.1478-5153.2007.00250.x; Suriadi Sanada H, 2006, J TISSUE VIABILITY, V16, P21; Wong VK, 2011, ADV SKIN WOUND CARE, V24, P562, DOI 10.1097/01.ASW.0000408466.88880.f8; Wounds International, 2010, INT REV PRESS ULC PR; Zhong W, 2008, CUTAN OCUL TOXICOL, V27, P21, DOI 10.1080/15569520701856765; Zulkowski K, 2012, ADV SKIN WOUND CARE, V25, P231, DOI 10.1097/01.ASW.0000414707.33267.92	49	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-4801	1742-481X		INT WOUND J	Int. Wound J.	FEB	2015	12	1					40	46		10.1111/iwj.12048		7	Dermatology; Surgery	Dermatology; Surgery	CA4CK	WOS:000348851700008		
J	Imaizumi, M; Ohishi, W; Nakashima, E; Sera, N; Neriishi, K; Yamada, M; Tatsukawa, Y; Takahashi, I; Fujiwara, S; Sugino, K; Ando, T; Usa, T; Kawakami, A; Akahoshi, M; Hida, A				Imaizumi, Misa; Ohishi, Waka; Nakashima, Eiji; Sera, Nobuko; Neriishi, Kazuo; Yamada, Michiko; Tatsukawa, Yoshimi; Takahashi, Ikuno; Fujiwara, Saeko; Sugino, Keizo; Ando, Takao; Usa, Toshiro; Kawakami, Atsushi; Akahoshi, Masazumi; Hida, Ayumi			Association of Radiation Dose With Prevalence of Thyroid Nodules Among Atomic Bomb Survivors Exposed in Childhood (2007-2011)	JAMA INTERNAL MEDICINE			English	Article							RESPONSE RELATIONSHIPS; CHERNOBYL ACCIDENT; CANCER INCIDENCE; DEGREE RELATIVES; POOLED ANALYSIS; IN-UTERO; DISEASES; RISK; NAGASAKI; FALLOUT	IMPORTANCE Few studies have evaluated the association of radiation dose with thyroid nodules among adults exposed to radiation in childhood. OBJECTIVE To evaluate radiation dose responses on the prevalence of thyroid nodules in atomic bomb survivors exposed in childhood. DESIGN, SETTING, AND PARTICIPANTS This survey study investigated 3087 Hiroshima and Nagasaki atomic bomb survivors who were younger than 10 years at exposure and participated in the thyroid study of the Adult Health Study at the Radiation Effects Research Foundation. Thyroid examinations including thyroid ultrasonography were conducted between October 2007 and October 2011, and solid nodules underwent fine-needle aspiration biopsy. Data from 2668 participants (86.4% of the total participants; mean age, 68.2 years; 1213 men; and 1455 women) with known atomic bomb thyroid radiation doses (mean dose, 0.182 Gy; median dose, 0.018 Gy; dose range, 0-4.040 Gy) were analyzed. MAIN OUTCOMES AND MEASURES The prevalence of all thyroid nodules having a diameter of 10mmor more (consisting of solid nodules [malignant and benign] and cysts), prevalence of small thyroid nodules that were less than 10 mm in diameter detected by ultrasonography, and atomic bomb radiation dose-responses. RESULTS Thyroid nodules with a diameter of 10mmor more were identified in 470 participants (17.6%): solid nodules (427 cases [16.0%]), malignant tumors (47 cases [1.8%]), benign nodules (186 cases [7.0%]), and cysts (49 cases [1.8%]), and all were significantly associated with thyroid radiation dose. Excess odds ratios per gray unit were 1.65 (95% CI, 0.89-2.64) for all nodules, 1.72 (95% CI, 0.93-2.75) for solid nodules, 4.40 (95% CI, 1.75-9.97) for malignant tumors, 2.07 (95% CI, 1.16-3.39) for benign nodules, and 1.11 (95% CI, 0.15-3.12) for cysts. The interaction between age at exposure and the dose was significant for the prevalence of all nodules (P=.003) and solid nodules (P<.001), indicating that dose effects were significantly higher with earlier childhood exposure. No interactions were seen for sex, family history of thyroid disease, antithyroid antibodies, or seaweed intake. No dose-response relationships were observed for small (<10-mm diameter) thyroid nodules. CONCLUSIONS AND RELEVANCE Radiation effects on thyroid nodules exist in atomic bomb survivors 62 to 66 years after their exposure in childhood. However, radiation exposure is not associated with small thyroid nodules.	[Imaizumi, Misa; Ohishi, Waka; Sera, Nobuko; Yamada, Michiko; Tatsukawa, Yoshimi; Takahashi, Ikuno; Akahoshi, Masazumi; Hida, Ayumi] Radiat Effects Res Fdn, Dept Clin Studies, Nagasaki 8500013, Japan; [Imaizumi, Misa; Ando, Takao; Usa, Toshiro; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biochem Sci, Dept Internal Med 1, Nagasaki 852, Japan; [Nakashima, Eiji] Radiat Effects Res Fdn, Dept Stat, Nagasaki 8500013, Japan; [Sera, Nobuko] Nagasaki Univ Hosp, Dept Metab Diabet & Clin Nutr, Nagasaki, Japan; [Neriishi, Kazuo] Yachiyo Hosp, Dept Internal Med, Akitakata, Japan; [Fujiwara, Saeko] Hiroshima Atom Bomb Casualty Council, Hiroshima, Japan; [Sugino, Keizo] Nakajima Tsuchiya Clin, Dept Thyroid Surg, Hiroshima, Japan; [Usa, Toshiro] Nagasaki Univ Hosp, Int Hibakusha Med Ctr, Nagasaki, Japan	Imaizumi, M (reprint author), Radiat Effects Res Fdn, Dept Clin Studies, 1-8-6 Nakagawa, Nagasaki 8500013, Japan.	misaima@rerf.or.jp			Radiation Effects Research Foundation [2-99, 3-07]; Japanese Ministry of Health, Labour, and Welfare; US Department of Energy	This study was supported by the Radiation Effects Research Foundation research protocols 2-99 and 3-07. The Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan, is a public interest foundation funded by the Japanese Ministry of Health, Labour, and Welfare and the US Department of Energy.	Akahoshi M, 2007, RAD EFFECTS RES FDN, V3-07, P1; Akaike H., 1973, P 2 INT S INF THEOR, P267; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; SCHNEIDER AB, 1993, J CLIN ENDOCR METAB, V77, P362, DOI 10.1210/jc.77.2.362; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Furukawa K, 2013, INT J CANCER, V132, P1222, DOI 10.1002/ijc.27749; Hemminki K, 2000, INT J CANCER, V85, P201, DOI 10.1002/(SICI)1097-0215(20000115)85:2<201::AID-IJC9>3.0.CO;2-L; METTLER FA, 1992, JAMA-J AM MED ASSOC, V268, P616, DOI 10.1001/jama.268.5.616; Rago T, 2001, J ENDOCRINOL INVEST, V24, P763; Tronko MD, 2006, J NATL CANCER I, V98, P897, DOI 10.1093/jnci/djj244; RON E, 1987, J NATL CANCER I, V79, P1; Zablotska LB, 2011, BRIT J CANCER, V104, P181, DOI 10.1038/sj.bjc.6605967; Hamatani K, 2008, CANCER RES, V68, P7176, DOI 10.1158/0008-5472.CAN-08-0293; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Preston DL, 2004, RADIAT RES, V162, P377, DOI 10.1667/RR3232; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Tan GH, 1997, ANN INTERN MED, V126, P226; Cardis E, 2005, J NATL CANCER I, V97, P724; Hamatani K, 2012, THYROID, V22, P1153, DOI 10.1089/thy.2011.0511; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Feldt-Rasmussen U, 2001, THYROID, V11, P483, DOI 10.1089/105072501300176435; PIERCE DA, 1990, RADIAT RES, V123, P275, DOI 10.2307/3577733; Pal T, 2001, J CLIN ENDOCR METAB, V86, P5307, DOI 10.1210/jc.86.11.5307; Bosetti C, 2001, CANCER CAUSE CONTROL, V12, P375, DOI 10.1023/A:1011267123398; Inskip PD, 1997, RADIAT RES, V147, P225, DOI 10.2307/3579424; Cologne JB, 2000, LANCET, V356, P303, DOI 10.1016/S0140-6736(00)02506-X; Davis S, 2004, JAMA-J AM MED ASSOC, V292, P2600, DOI 10.1001/jama.292.21.2600; Atomic Bomb Casualty Commission, 1962, 1162 ABCC ATOM BOM C, P1; Belsley David A., 1980, REGRESSION DIAGNOSTI; Frich L, 2001, CANCER EPIDEM BIOMAR, V10, P113; Graf H, 2013, WERNER INBARS THYROI, V10th, P635; Grosche B, 2002, RADIAT ENVIRON BIOPH, V41, P75, DOI 10.1007/s00411-001-0136-1; Hatch M, 2009, J CLIN ENDOCR METAB, V94, P899, DOI 10.1210/jc.2008-2049; Hayashi Y, 2010, CANCER-AM CANCER SOC, V116, P1646, DOI 10.1002/cncr.24872; Hayashida N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083220; Hegedus L, 2013, WERNER INGBARS THYRO, P310; Imaizumi M, 2006, JAMA-J AM MED ASSOC, V295, P1011, DOI 10.1001/jama.295.9.1011; Imaizumi M, 2008, J CLIN ENDOCR METAB, V93, P1641, DOI 10.1210/jc.2008-0042; Knobel M, 2007, ARQ BRAS ENDOCRINOL, V51, P701, DOI 10.1590/S0004-27302007000500007; Land CE, 2008, RADIAT RES, V169, P373, DOI 10.1667/RR1063.1; MABUCHI K, 1994, RADIAT RES, V137, pS1, DOI 10.2307/3578891; Mushkacheva G, 2006, RADIAT RES, V166, P715, DOI 10.1667/RR0410.1; NAGATAKI S, 1967, J CLIN ENDOCR METAB, V27, P638; NAGATAKI S, 1994, JAMA-J AM MED ASSOC, V272, P364, DOI 10.1001/jama.272.5.364; O'Kane P, 2010, THYROID, V20, P959, DOI 10.1089/thy.2010.0032; PERKEL VS, 1988, J CLIN ENDOCR METAB, V66, P1316; Preston DL, 1993, EPICURE USERS GUIDE; Radiation Effects Research Foundation, 2013, BRIEF DESCR RAD EFF; Soda M, 2003, CANC INCIDENCE 5 CON, V8, P390; Taniguchi N, 2013, J MED ULTRASON, V40, P219, DOI 10.1007/s10396-013-0456-1; Young RW, 2005, REASSESSMENT ATOMIC	52	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6106	2168-6114		JAMA INTERN MED	JAMA Intern. Med.	FEB	2015	175	2					228	236		10.1001/jamainternmed.2014.6692		9	Medicine, General & Internal	General & Internal Medicine	CA7TL	WOS:000349120100021		
J	Irwin, M; Kondo, Y; Moteki, N				Irwin, M.; Kondo, Y.; Moteki, N.			An empirical correction factor for filter-based photo-absorption black carbon measurements	JOURNAL OF AEROSOL SCIENCE			English	Article						Filter measurements; Photometer; Continuous soot monitoring system (COSMOS); Black carbon; Absorption coefficient	AEROSOL LIGHT-ABSORPTION; HEATED-INLET; CALIBRATION; PARTICLES; INSTRUMENT; PHOTOMETRY; COSMOS; PSAP	Filter-based BC measurement techniques such as the Continuous Soot Monitoring System (COSMOS) are particularly well suited to long-term observations of black carbon (BC) due to their relative robustness and reliability. However, caution is required when determining the threshold transmittance, Tr-thresh (roughly proportional to the time interval between filter changes), in order to ensure that acceptable measurement accuracy is maintained throughout the sampling period. We present a new, empirically derived transmittance-dependent correction factor used to interpret the response characteristics of filter-based aerosol absorption measurements performed by COSMOS. Simultaneous measurements of ambient BC aerosol mass (M-BC) were conducted in Tokyo, Japan, using two identical COSMOS instruments operated with different threshold transmittance, Tr-thresh, values, of 0.95 and 0.6. The derived values for M-BC were consistently underestimated by the COSMOS operating at lower Tr-thresh, as a function of decreasing filter transmittance. The 1-hour averaged values of M-BC were underestimated by around 10%, incorporating measurements across the entire range of filter transmittance (1-0.6), with a maximum underestimation at around 17% immediately preceding filter advancement (i.e. Tr=similar to 0.6). An empirical correction factor was derived from these ambient measurements, and was applied to M-BC as a function of filter transmittance, resolving the instruments to within 2%. Further to the transmittance-based correction, the operational performance of COSMOS was tested for two types of quartz fibre filter (PALLFLEX and HEPA). Agreement in derived values of M-BC for two COSMOS using the same type of filter was around 2%; however, a comparison of the PALLFLEX and HEPA filters demonstrated a systematic overestimation of M-BC derived when using HEPA filters, of around 6-8%. A sensitivity study of a radiative transfer model indicated that this enhanced absorption was primarily a result of the increased thickness of the HEPA filter. (C) 2014 Elsevier Ltd. All rights reserved.	[Irwin, M.; Kondo, Y.; Moteki, N.] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 113, Japan	Irwin, M (reprint author), Cambustion Ltd, Cambridge CB1 8DH, England.	mirwin@cambustion.com			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan; GRENE Arctic Climate Change Research Project; strategic international cooperative programme of the Japan Science and Technology Agency (JST); global environment research fund of the Japanese Ministry of the Environment [A-1101, 2-1403]	This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) in Japan, the GRENE Arctic Climate Change Research Project, the strategic international cooperative programme of the Japan Science and Technology Agency (JST), and the global environment research fund of the Japanese Ministry of the Environment (A-1101 and 2-1403).	Moosmuller H, 2009, J QUANT SPECTROSC RA, V110, P844, DOI 10.1016/j.jqsrt.2009.02.035; Petzold A, 2005, AEROSOL SCI TECH, V39, P40, DOI 10.1080/027868290901945; HANSEN ADA, 1984, SCI TOTAL ENVIRON, V36, P191, DOI 10.1016/0048-9697(84)90265-1; Virkkula A, 2005, AEROSOL SCI TECH, V39, P68, DOI 10.1080/027868290901963; Nakayama T, 2010, J AEROSOL SCI, V41, P333, DOI 10.1016/j.jaerosci.2010.01.004; Moteki N, 2010, J AEROSOL SCI, V41, P401, DOI 10.1016/j.jaerosci.2010.02.002; Bond TC, 1999, AEROSOL SCI TECH, V30, P582, DOI 10.1080/027868299304435; Weingartner E, 2003, J AEROSOL SCI, V34, P1445, DOI 10.1016/S0021-8502(03)00359-8; Hinds WC, 1999, AEROSOL TECHNOLOGY; Irwin M, 2013, AEROSOL SCI TECH, V47, P895, DOI 10.1080/02786826.2013.800187; Kanaya Y, 2013, AEROSOL SCI TECH, V47, P1, DOI 10.1080/02786826.2012.716551; Kondo Y, 2009, AEROSOL SCI TECH, V43, P741, DOI 10.1080/02786820902889879; Kondo Y., 2011, AEROSOL SCI TECHNOL, V45, P295, DOI DOI 10.1080/02786826.2010.533215; Miyazaki Y, 2008, J ENVIRON MONITOR, V10, P1195, DOI 10.1039/b806957c; Ogren JA, 2010, AEROSOL SCI TECH, V44, P589, DOI 10.1080/02786826.2010.482111; Sheridan PJ, 2005, AEROSOL SCI TECH, V39, P1, DOI 10.1080/027868290901891; Virkkula A, 2010, AEROSOL SCI TECH, V44, P706, DOI 10.1080/02786826.2010.482110	17	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-8502	1879-1964		J AEROSOL SCI	J. Aerosol. Sci.	FEB	2015	80						86	97		10.1016/j.jaerosci.2014.11.001		12	Engineering, Chemical; Engineering, Mechanical; Environmental Sciences; Meteorology & Atmospheric Sciences	Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CA8TD	WOS:000349192900007		
J	Konnecke, M; Akeroyd, FA; Bernstein, HJ; Brewster, AS; Campbell, SI; Clausen, B; Cottrell, S; Hoffmann, JU; Jemian, PR; Mannicke, D; Osborn, R; Peterson, PF; Richter, T; Suzuki, J; Watts, B; Wintersberger, E; Wuttke, J				Koennecke, Mark; Akeroyd, Frederick A.; Bernstein, Herbert J.; Brewster, Aaron S.; Campbell, Stuart I.; Clausen, Bjoern; Cottrell, Stephen; Hoffmann, Jens Uwe; Jemian, Pete R.; Maennicke, David; Osborn, Raymond; Peterson, Peter F.; Richter, Tobias; Suzuki, Jiro; Watts, Benjamin; Wintersberger, Eugen; Wuttke, Joachim			The NeXus data format	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						NeXus data format; data exchange; data archiving; platform-independent; HDF5		NeXus is an effort by an international group of scientists to define a common data exchange and archival format for neutron, X-ray and muon experiments. NeXus is built on top of the scientific data format HDF5 and adds domain-specific rules for organizing data within HDF5 files, in addition to a dictionary of well defined domain-specific field names. The NeXus data format has two purposes. First, it defines a format that can serve as a container for all relevant data associated with a beamline. This is a very important use case. Second, it defines standards in the form of application definitions for the exchange of data between applications. NeXus provides structures for raw experimental data as well as for processed data.	[Koennecke, Mark] Paul Scherrer Inst, Lab Dev & Methods, CH-5232 Villigen, Switzerland; [Akeroyd, Frederick A.; Cottrell, Stephen] Rutherford Appleton Lab, ISIS Facil, STFC, Didcot OX11 0QX, Oxon, England; [Bernstein, Herbert J.] Dowling Coll, ImgCIF, Shirley, NY 11769 USA; [Brewster, Aaron S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Campbell, Stuart I.; Peterson, Peter F.] Oak Ridge Natl Lab, Spallat Neutron Source, Oak Ridge, TN 37831 USA; [Clausen, Bjoern] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Hoffmann, Jens Uwe] Helmholtz Zentrum Berlin Mat & Energie Gmb, D-14109 Berlin, Germany; [Jemian, Pete R.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Maennicke, David] Australian Nucl Sci & Technol Org, Menai, NSW 2234, Australia; [Osborn, Raymond] Argonne Natl Lab, Argonne, IL 60439 USA; [Richter, Tobias] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Suzuki, Jiro] KEK, Tsukuba, Ibaraki 3050801, Japan; [Watts, Benjamin] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Wintersberger, Eugen] Deutsch Elektronen Synchrotron DESY, D-22607 Hamburg, Germany; [Wuttke, Joachim] Forschungszentrum Julich, JCNS, MLZ, D-85747 Garching, Germany	Konnecke, M (reprint author), Paul Scherrer Inst, Lab Dev & Methods, CH-5232 Villigen, Switzerland.	mark.koennecke@psi.ch		Wuttke, Joachim/0000-0002-4028-1447; Campbell, Stuart/0000-0001-7079-0878	DOE; NIH; NSF in the USA; Scientific User Facilities Division; Materials Science and Engineering Division, Basic Energy Sciences, Office of Science, US Department of Energy; European Commission	The NIAC acknowledges the support of all the institutions contributing to NeXus and their respective funding agencies, most notably the DOE, NIH and NSF in the USA. Work at DOE National Laboratories was supported by the Scientific User Facilities Division and the Materials Science and Engineering Division, Basic Energy Sciences, Office of Science, US Department of Energy. The development of the mu SR NeXus data format was partly funded by the European Commission within the sixth Framework Programme.	Konnecke M, 2006, PHYSICA B, V385-86, P1343, DOI 10.1016/j.physb.2006.06.106; Willendrup P, 2004, PHYSICA B, V350, pE735, DOI 10.1016/j.physb.2004.03.193; Bernstein H. J., 2005, INT TABLES CRYSTALLO, P544; canSAS, 2014, DESCR CANSAS2012 DAT; Cottrell S, 2012, PHYSCS PROC, V30, P20, DOI 10.1016/j.phpro.2012.04.031; Flannery D, 2003, PHYSICA B, V326, P238, DOI 10.1016/S0921-4526(02)01613-7; Hall S., 2005, INT TABLES CRYSTALLO; HDF Group, 2014, HDFVIEW; HDF Group, 2014, HDF 5; NIAC, 2014, NXVALIDATE JAV GUI T; NIAC, 2014, NEXUS MAN; NIAC, 2014, NEXUS COMM DAT FORM; Rivers M., 2014, AREADETECTOR EPICS S	13	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8898	1600-5767		J APPL CRYSTALLOGR	J. Appl. Crystallogr.	FEB	2015	48		1				301	305		10.1107/S1600576714027575		5	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CA8ZU	WOS:000349210700039		
J	Fukamachi, T; Jongsukswat, S; Ju, DY; Negishi, R; Hirano, K; Kawamura, T				Fukamachi, Tomoe; Jongsukswat, Sukswat; Ju, Dongying; Negishi, Riichirou; Hirano, Keiichi; Kawamura, Takaaki			An X-ray diffractometer using mirage diffraction (vol 47, pg 1267, 2014)	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Correction						mirage diffraction; mirage fringes; interference fringes; X-ray difractometers; monochromators; dynamical theory of X-ray diffraction		Errors in the article by Fukamachi, Jongsukswat, Ju, Negishi, Hirano & Kawamura [] are corrected.	[Fukamachi, Tomoe; Jongsukswat, Sukswat; Ju, Dongying; Negishi, Riichirou] Saitama Inst Technol, Fukaya, Saitama 3690293, Japan; [Hirano, Keiichi] High Energy Accelerator Res Org, Inst Mat Struct Sci, KEK PF, Tsukuba, Ibaraki 3050801, Japan; [Kawamura, Takaaki] Univ Yamanashi, Kofu, Yamanashi 4008510, Japan	Fukamachi, T (reprint author), Saitama Inst Technol, Fukaya, Saitama 3690293, Japan.	tomoe-f@wonder.ocn.ne.jp					Fukamachi T, 2014, J APPL CRYSTALLOGR, V47, P1267, DOI 10.1107/S1600576714012114	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8898	1600-5767		J APPL CRYSTALLOGR	J. Appl. Crystallogr.	FEB	2015	48		1				312	312		10.1107/S1600576714026028		1	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CA8ZU	WOS:000349210700043		
J	Takahashi, M; Kita, Y; Kusaka, K; Mizuno, A; Goto-Yamamoto, N				Takahashi, M.; Kita, Y.; Kusaka, K.; Mizuno, A.; Goto-Yamamoto, N.			Evaluation of microbial diversity in the pilot-scale beer brewing process by culture-dependent and culture-independent method	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						beer; culture-dependent method; fermentation; flow cytometry; microbiota; next-generation sequencing; quantitative PCR	LACTIC-ACID BACTERIA; IDENTIFICATION; HYBRIDIZATION; COMMUNITIES; DATABASE; RNA	AimsIn the brewing industry, microbial management is very important for stabilizing the quality of the product. We investigated the detailed microbial community of beer during fermentation and maturation, to manage beer microbiology in more detail. Methods and ResultsWe brewed a beer (all-malt) and two beerlike beverages (half- and low-malt) in pilot-scale fermentation and investigated the microbial community of them using a next-generation sequencer (454 GS FLX titanium), quantitative PCR, flow cytometry and a culture-dependent method. From 28 to 88 genera of bacteria and from 9 to 38 genera of eukaryotic micro-organisms were detected in each sample. Almost all micro-organisms died out during the boiling process. However, bacteria belonging to the genera Acidovorax, Bacillus, Brevundimonas, Caulobacter, Chryseobacterium, Methylobacterium, Paenibacillus, Polaromonas, Pseudomonas, Ralstonia, Sphingomonas, Stenotrophomonas, Tepidimonas and Tissierella were detected at the early and middle stage of fermentation, even though their cell densities were low (below approx. 10(3)cellsml(-1)) and they were not almost detected at the end of fermentation. ConclusionsWe revealed that the microbial community of beer during fermentation and maturation is very diverse and several bacteria possibly survive during fermentation. Significance and Impact of the StudyIn this study, we revealed the detailed microbial communities of beer using next-generation sequencing. Some of the micro-organisms detected in this study were found in beer brewing process for the first time. Additionally, the possibility of growth of several bacteria at the early and middle stage of fermentation was suggested.	[Takahashi, M.; Kita, Y.; Kusaka, K.; Mizuno, A.; Goto-Yamamoto, N.] Natl Res Inst Brewing, Higashihiroshima 7390046, Japan	Takahashi, M (reprint author), Natl Res Inst Brewing, 3-7-1 Kagamiyama, Higashihiroshima 7390046, Japan.	m.takahashi@nrib.go.jp					Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Bokulich NA, 2013, MICROBIOL MOL BIOL R, V77, P157, DOI 10.1128/MMBR.00060-12; Koyanagi T, 2011, LETT APPL MICROBIOL, V53, P635, DOI 10.1111/j.1472-765X.2011.03155.x; Loy A, 2005, APPL ENVIRON MICROB, V71, P3624, DOI 10.1128/AEM.71.7.3624-3632.2005; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Millet V, 2000, LETT APPL MICROBIOL, V30, P136, DOI 10.1046/j.1472-765X.2000.00684.x; Jespersen L, 1996, INT J FOOD MICROBIOL, V33, P139, DOI 10.1016/0168-1605(96)01154-3; Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Suzuki K, 2008, J I BREWING, V114, P209; Cleusix V, 2010, J APPL MICROBIOL, V108, P181, DOI 10.1111/j.1365-2672.2009.04408.x; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357; Bokulich NA, 2012, FOOD MICROBIOL, V31, P126, DOI 10.1016/j.fm.2012.02.007; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035507; Boulton C., 2006, BREWING YEAST FERMEN, P510; Brewery Convention of Japan, 2004, BEER AN METH; Campbell I., 2003, BREWING MICROBIOLOGY, P247; Core Team R., 2011, R LANG ENV STAT COMP; Desfosses-Foucault E, 2012, FRONT MICROBIOL, V3, P1; Haakensen M, 2008, CAN J MICROBIOL, V54, P321, DOI [10.1139/w08-007, 10.1139/W08-007]; Herzog P, 2008, INT J SYST EVOL MICR, V58, P26, DOI 10.1099/ijs.0.65362-0; Juste A, 2014, FOOD MICROBIOL, V39, P39, DOI 10.1016/j.fm.2013.10.010; Kumar PA, 2011, CURR MICROBIOL, V63, P193, DOI 10.1007/s00284-011-9966-5; Lan YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032491; Liu CM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-255; Oevelen D. van, 1977, Journal of the Institute of Brewing, V83, P356; Ploner A, 2012, HEATPLUS HEATMAPS RO; Priest F.G., 2003, BREWING MICROBIOLOGY, P181; Rainbow C., 1981, BREW SCI, V2, P491; Rigottier-Gois L, 2003, FEMS MICROBIOL ECOL, V43, P237, DOI 10.1111/j.1574-6941.2003.tb01063.x; Spitaels F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095384; VansVuuren H. J. J., 2003, BREWING MICROBIOLOGY, P219	33	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	FEB	2015	118	2					454	469		10.1111/jam.12712		16	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CA4DM	WOS:000348854500018		
J	Sasaki, E; Suzuki, S; Fukui, Y; Yajima, N				Sasaki, E.; Suzuki, S.; Fukui, Y.; Yajima, N.			Cell-bound exopolysaccharides of Lactobacillus brevis KB290 enhance cytotoxic activity of mouse splenocytes	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						cell-bound exopolysaccharides; cell-mediated cytotoxicity; heat-killed KB290; Lactobacillus brevis KB290; Lactobacillus brevis KB392	INFLUENZA-VIRUS INFECTION; RESPIRATORY IMMUNE-RESPONSES; DENDRITIC CELLS; FERMENTED MILK; PROTECTS MICE; GASSERI; PROBIOTICS; STRAIN; GUT	AimsThis study aimed to identify the main active component of Lactobacillus brevis KB290 (KB290) that is responsible for enhanced cell-mediated cytotoxic activity of mouse splenocytes Live KB290, a probiotic strain derived from a Japanese traditional pickle, was previously reported to modulate innate immune responses as affecting on cell-mediated cytotoxic activity of mouse splenocytes. Methods and ResultsWe used live KB290, heat-killed KB290, a derivative strain (Lact.brevis KB392) with different amounts of cell-bound exopolysaccharide (EPS-b), and a crude extract of EPS-b from KB290 cell surface. Female BALB/c mice were fed a diet containing 10(10)CFU live KB290, 10(10)CFU live KB392, 15mg heat-killed KB290 or 600g crude extract of EPS-b for 1day. Live KB290 (P<001), heat-killed KB290 (P<005) and crude EPS-b at 600g (P<005) per mouse significantly enhanced cytotoxic activity; however, live KB392 had no effect. ConclusionsBoth live and heat-killed KB290 and crude EPS-b significantly enhanced cytotoxic activity of mouse splenocytes. Significance and Impact of the StudyWe demonstrated that EPS-b produced by KB290 has a critical role in enhancing cell-mediated cytotoxic activity in mouse spleen.	[Sasaki, E.; Suzuki, S.; Fukui, Y.; Yajima, N.] Kagome Co Ltd, Nat & Wellness Res Dept, Res Inst, Nasushiobara, Tochigi 3292762, Japan	Sasaki, E (reprint author), Kagome Co Ltd, Nat & Wellness Res Dept, Res Inst, 17 Nishitomiyama, Nasushiobara, Tochigi 3292762, Japan.	Erika_sasaki@kagome.co.jp			Kagome Co. Ltd.	This research received no specific grant from any funding agency, commercial or not-for-profit sectors but was supported by the Kagome Co. Ltd.	Akhmatova N. K., 2014, FRONT IMMUNOL, V5, P1; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI 10.1111/j.1574-6976.2010.00208.x; LeBlanc J, 2004, CLIN DIAGN LAB IMMUN, V11, P1171, DOI 10.1128/CDLI.11.6.1171-1181.2004; Namba K, 2010, BIOSCI BIOTECH BIOCH, V74, P939, DOI 10.1271/bbb.90749; Harata G, 2010, LETT APPL MICROBIOL, V50, P597, DOI 10.1111/j.1472-765X.2010.02844.x; Makino S, 2006, J DAIRY SCI, V89, P2873; Kishi A, 1996, J AM COLL NUTR, V15, P408; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Backer R, 2010, P NATL ACAD SCI USA, V107, P216, DOI 10.1073/pnas.0909541107; Reddy VS, 2013, NUTRIENTS, V5, P679, DOI 10.3390/nu5030679; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Scaldaferri F, 2013, BIOMED RES INT, DOI 10.1155/2013/435268; Kato-Mori Y, 2010, J MED FOOD, V13, P1460, DOI 10.1089/jmf.2010.1137; Kawase M, 2012, FEMS IMMUNOL MED MIC, V64, P280, DOI 10.1111/j.1574-695X.2011.00903.x; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Suzuki S, 2013, CAN J MICROBIOL, V59, P549, DOI 10.1139/cjm-2013-0115; Waki N, 2014, LETT APPL MICROBIOL, V58, P87, DOI 10.1111/lam.12160; Sarowska J, 2013, ADV CLIN EXP MED, V22, P759; Fukao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060521; Fukui Y., 2013, BR J NUTR, V2, P1; Fukui Y., 2014, BR J NUTR, V110, P1617; Horn N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059957; Joint Food and Agriculture Organization of the United Nations-World Health Organization Working Group, 2002, GUID EV PROB FOODS R; Kikuchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086416; Kiso M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01563; Kuhara T, 2006, J INTERF CYTOK RES, V26, P489, DOI 10.1089/jir.2006.26.489; Murakami Katsumi, 2012, Biopsychosoc Med, V6, P16, DOI 10.1186/1751-0759-6-16; Nakayama Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04638; Nobuta Y., 2009, International Journal of Probiotics and Prebiotics, V4, P263; Park MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075368; Qin HL, 2005, WORLD J GASTROENTERO, V11, P2591; Suzuki S, 2014, CAN J MICROBIOL, V60, P139, DOI 10.1139/cjm-2013-0774; Takeda K, 2007, J NUTR, V137, p791S; Toh ZQ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00171; Yakabe T, 2009, FOOD CHEM TOXICOL, V47, P2450, DOI 10.1016/j.fct.2009.07.001	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	FEB	2015	118	2					506	514		10.1111/jam.12686		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CA4DM	WOS:000348854500022		
J	Zhao, DP				Zhao, Dapeng			The 2011 Tohoku earthquake (Mw 9.0) sequence and subduction dynamics in Western Pacific and East Asia	JOURNAL OF ASIAN EARTH SCIENCES			English	Review						Tohoku earthquakes; Subduction dynamics; Western Pacific; East Asia; Megathrust zone; Pacific plate; Philippine Sea plate; Intraplate volcanism; Deep earthquakes	PHILIPPINE SEA PLATE; NORTHEAST JAPAN ARC; WAVE ANISOTROPIC TOMOGRAPHY; TROUGH SEISMOGENIC ZONE; MANTLE TRANSITION ZONE; SP DEPTH-PHASE; CHANGBAI INTRAPLATE VOLCANISM; SMALL EPICENTRAL DISTANCES; LOW-FREQUENCY EARTHQUAKES; SEISMIC STRUCTURE BENEATH	We review recent findings on the causal mechanism of the great 2011 Tohoku earthquake (Mw 9.0) sequence and related issues on seismic structure and subduction dynamics in Western Pacific and East Asia. High-resolution tomography revealed significant lateral heterogeneities in the interplate megathrust zone beneath the Tohoku, South Kuril and Southwest Japan forearc regions. Large megathrust earthquakes since 1900 generally occurred in or around high-velocity (high-V) patches in the megathrust zone, which may reflect asperities resulting from subducted seamounts, oceanic ridges and other topographic highs on the Pacific seafloor. In contrast, low-velocity (low-V) patches in the megathrust zone may contain more sediments and fluids, where the subducting oceanic plate and the overlying continental plate are less coupled or even decoupled. The nucleation of large crustal earthquakes in the Japan Islands, including the 11 April 2011 Iwaki earthquake (M 7.0) in SE Tohoku, is affected by arc magma and fluids resulting from slab dehydration. The Philippine Sea plate has subducted aseismically down to 430-460 km depth under East China Sea, Tsushima Strait and Japan Sea. A window in the aseismic Philippine Sea slab is detected, which may be caused by splitting of weak parts of the slab at the subducted ridges (e.g., Kyushu-Paula ridge) and hot upwelling in the mantle wedge above the Pacific slab. The intraplate volcanism in Northeast Asia is caused by hot and wet upwelling flows in the big mantle wedge above the stagnant Pacific slab in the mantle transition zone. Frequent generation of large deep earthquakes (>500 km depth) in the Pacific slab may supply additional fluids preserved in the slab to the mantle wedge under the Changbai volcano, making Changbai the largest and most active intraplate volcano in Northeast Asia. Fluids may be involved in nucleation and rupture processes of all types of earthquakes. (C) 2014 The Authors. Published by Elsevier Ltd.	Tohoku Univ, Dept Geophys, Sendai, Miyagi 9808578, Japan	Zhao, DP (reprint author), Tohoku Univ, Dept Geophys, Sendai, Miyagi 9808578, Japan.	zhao@aob.gp.tohoku.ac.jp		Zhao, Dapeng/0000-0003-2096-5195	Japan Society for the Promotion of Science [Kiban-A 17204037, Kiban-S 11050123]; Global-COE program of Earth and Planetary Sciences, Tohoku University	This work was partially supported by Grant-in-aid for Scientific Research (Kiban-A 17204037, Kiban-S 11050123) from Japan Society for the Promotion of Science as well as the Global-COE program of Earth and Planetary Sciences, Tohoku University. The author is grateful to the effective collaborations and helpful discussions with many colleagues and coworkers, including Zhouchuan Huang, Xin Liu, Jian Wang, You Tian, Wei Wei, Ping Tong, Dayong Yu, A. Hasegawa, H. Kanamori, N. Umino, Y. Yamamoto, T. Yanada, G. Toyokuni, and H. Kitagawa. Prof. Bor-ming Jahn (the Editor) and two anonymous referees provided thoughtful review comments which have improved this paper.	Abdelwahed MF, 2014, J ASIAN EARTH SCI, V89, P66, DOI 10.1016/j.jseaes.2014.03.017; Abdelwahed MF, 2007, PHYS EARTH PLANET IN, V162, P32, DOI 10.1016/j.pepi.2007.03.001; Abdelwahed MF, 2005, EARTH PLANETS SPACE, V57, P1039; Wang J, 2014, GEOCHEM GEOPHY GEOSY, V15, P2195, DOI 10.1002/2014GC005279; Sdrolias M, 2004, TECTONOPHYSICS, V394, P69, DOI 10.1016/j.tecto.2004.07.061; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Julian BR, 1998, REV GEOPHYS, V36, P525, DOI 10.1029/98RG00716; Xu JD, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052600; Duan YH, 2009, TECTONOPHYSICS, V470, P257, DOI 10.1016/j.tecto.2009.01.004; Zhao DP, 2010, ISL ARC, V19, P4, DOI 10.1111/j.1440-1738.2009.00694.x; Huang ZC, 2013, J ASIAN EARTH SCI, V75, P82, DOI 10.1016/j.jseaes.2013.07.002; Gorczyk W, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001075; PACHECO JF, 1993, J GEOPHYS RES-SOL EA, V98, P14133, DOI 10.1029/93JB00349; Fukao Y, 2001, REV GEOPHYS, V39, P291, DOI 10.1029/1999RG000068; Liu X, 2013, GEOPHYS J INT, V194, P1069, DOI 10.1093/gji/ggt150; SIBSON RH, 1992, TECTONOPHYSICS, V211, P283, DOI 10.1016/0040-1951(92)90065-E; Huang ZC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046804; Chen CX, 2014, PHYS EARTH PLANET IN, V230, P1, DOI 10.1016/j.pepi.2014.01.016; Gerya T, 2011, J GEODYN, V52, P344, DOI 10.1016/j.jog.2011.06.005; KIMURA G, 1986, GEOLOGY, V14, P404, DOI 10.1130/0091-7613(1986)14<404:OSACFT>2.0.CO;2; Bird P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000252; Wang JA, 2010, J ASIAN EARTH SCI, V39, P396, DOI 10.1016/j.jseaes.2010.04.009; Yamanaka Y, 2003, EARTH PLANETS SPACE, V55, pE21; Hall R, 1995, TECTONOPHYSICS, V251, P229, DOI 10.1016/0040-1951(95)00038-0; Faccenda M, 2009, NAT GEOSCI, V2, P790, DOI 10.1038/NGEO656; Kodaira S, 2002, GEOPHYS J INT, V149, P815, DOI 10.1046/j.1365-246X.2002.01691.x; Ishise M, 2008, PHYS EARTH PLANET IN, V166, P83, DOI 10.1016/j.pepi.2007.11.003; Zou HB, 2008, CHEM GEOL, V255, P134, DOI 10.1016/j.chemgeo.2008.06.022; Zhao DP, 2012, GLOBAL PLANET CHANGE, V90-91, P29, DOI 10.1016/j.gloplacha.2012.01.004; Koper KD, 2011, EARTH PLANETS SPACE, V63, P599, DOI 10.5047/eps.2011.05.026; Koketsu K, 2011, EARTH PLANET SC LETT, V310, P480, DOI 10.1016/j.epsl.2011.09.009; Hall PS, 2001, SCIENCE, V292, P2472, DOI 10.1126/science.1060488; Hyndman RD, 2003, EARTH PLANET SC LETT, V212, P417, DOI 10.1016/S0012-821X(03)00263-2; Kuritani T, 2009, LITHOS, V112, P247, DOI 10.1016/j.lithos.2009.02.007; Tsuru T, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001664; Zhao DP, 2007, B SEISMOL SOC AM, V97, P1121, DOI 10.1785/0120050256; Scholz CH, 1997, GEOLOGY, V25, P487, DOI 10.1130/0091-7613(1997)025<0487:TEOSSO>2.3.CO;2; Qi C, 2006, CHINESE J GEOPHYS-CH, V49, P805; Tajima F, 2009, PHYS EARTH PLANET IN, V172, P183, DOI 10.1016/j.pepi.2008.09.013; Zhao DP, 2004, CHINESE SCI BULL, V49, P1401, DOI 10.1360/04wd0125; Kuritani T, 2011, NAT GEOSCI, V4, P713, DOI [10.1038/ngeo1250, 10.1038/NGEO1250]; Wiens DA, 2008, ANNU REV EARTH PL SC, V36, P421, DOI 10.1146/annurev.earth.33.092203.122633; Bostock MG, 2002, NATURE, V417, P536, DOI 10.1038/417536a; Tajima F, 2013, TECTONOPHYSICS, V586, P15, DOI 10.1016/j.tecto.2012.09.014; Huang JL, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000137; Faccenda M, 2014, TECTONOPHYSICS, V614, P1, DOI 10.1016/j.tecto.2013.12.020; Nanayama F, 2003, NATURE, V424, P660, DOI 10.1038/nature01864; Zhao DP, 2005, EARTH PLANET SC LETT, V235, P623, DOI 10.1016/j.epsl.2005.04.039; Seno T, 1996, J GEOPHYS RES-SOL EA, V101, P11305, DOI 10.1029/96JB00532; Satake K, 2008, EARTH PLANETS SPACE, V60, P925; PEACOCK SM, 1990, SCIENCE, V248, P329, DOI 10.1126/science.248.4953.329; Wang J, 2013, TECTONOPHYSICS, V582, P177, DOI 10.1016/j.tecto.2012.10.004; Zhao DP, 2009, PHYS EARTH PLANET IN, V173, P197, DOI 10.1016/j.pepi.2008.11.009; Wei HQ, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-013-0706-5; Ranero CR, 2004, GEOLOGY, V32, P549, DOI 10.1139/G20379.1; Mishra OP, 2003, EARTH PLANET SC LETT, V212, P393, DOI 10.1016/S0012-821X(03)00285-1; Fujie G, 2013, EARTH PLANETS SPACE, V65, P75, DOI 10.5047/eps.2012.06.003; Zhao DP, 2008, CHINESE SCI BULL, V53, P3897, DOI 10.1007/s11434-008-0484-1; Zhao D, 2001, EARTH PLANET SC LETT, V192, P251, DOI 10.1016/S0012-821X(01)00465-4; Lay T, 2011, EARTH PLANETS SPACE, V63, P713, DOI 10.5047/eps.2011.05.006; Wang Z, 2005, PHYS EARTH PLANET IN, V152, P144, DOI 10.1016/j.pepi.2005.06.010; Huang ZC, 2011, GEOPHYS J INT, V184, P1428, DOI 10.1111/j.1365-246X.2011.04934.x; Fujie G, 2013, GEOPHYS RES LETT, V40, P88, DOI 10.1029/2012GL054340; Wei W, 2012, J ASIAN EARTH SCI, V60, P88, DOI 10.1016/j.jseaes.2012.08.001; Faccenda M, 2008, NATURE, V455, P1097, DOI 10.1038/nature07376; Zhao DP, 2002, PHYS EARTH PLANET IN, V132, P249, DOI 10.1016/S0031-9201(02)00082-1; Cheng B, 2014, J ASIAN EARTH SCI, V87, P141, DOI 10.1016/j.jseaes.2014.01.006; Miller AD, 1998, REV GEOPHYS, V36, P551, DOI 10.1029/98RG00717; TATSUMI Y, 1989, J GEOPHYS RES-SOLID, V94, P4697, DOI 10.1029/JB094iB04p04697; SENO T, 1993, J GEOPHYS RES-SOL EA, V98, P17941, DOI 10.1029/93JB00782; Kikuchi M, 2003, EARTH PLANETS SPACE, V55, P159; Ye LL, 2011, GEOPHYS J INT, V186, P706, DOI 10.1111/j.1365-246X.2011.05063.x; Zhao DP, 2013, GONDWANA RES, V23, P595, DOI 10.1016/j.gr.2012.08.004; Li J, 2013, EARTH PLANET SC LETT, V367, P71, DOI 10.1016/j.epsl.2013.02.026; Liu X, 2013, PHYS EARTH PLANET IN, V216, P59, DOI 10.1016/j.pepi.2013.01.003; Huang JL, 2009, PHYS EARTH PLANET IN, V173, P330, DOI 10.1016/j.pepi.2009.01.015; Kodaira S, 2000, J GEOPHYS RES-SOL EA, V105, P5887, DOI 10.1029/1999JB900394; Ranero CR, 2003, NATURE, V425, P367, DOI 10.1038/nature01961; SILVER PG, 1995, SCIENCE, V268, P69, DOI 10.1126/science.268.5207.69; Lei JS, 2005, TECTONOPHYSICS, V397, P281, DOI 10.1016/j.tecto.2004.12.009; Zhao DP, 2009, TECTONOPHYSICS, V467, P89, DOI 10.1016/j.tecto.2008.12.017; Ohtani E, 2009, RUSS GEOL GEOPHYS+, V50, P1073, DOI 10.1016/j.rgg.2009.11.006; CLOOS M, 1992, GEOLOGY, V20, P601, DOI 10.1130/0091-7613(1992)020<0601:TTSZEA>2.3.CO;2; Zhao DP, 2007, GONDWANA RES, V11, P120, DOI 10.1016/j.gr.2006.06.006; Zhao DP, 2013, GEOPHYS J INT, V195, P706, DOI 10.1093/gji/ggt289; Gerya TV, 2006, PHYS EARTH PLANET IN, V156, P59, DOI 10.1016/j.pepi.2006.02.005; Obana K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050399; Stern RJ, 2002, REV GEOPHYS, V40, DOI 10.1029/2001RG000108; Zhao DP, 2004, PHYS EARTH PLANET IN, V146, P3, DOI 10.1016/j.pepi.2003.07.032; Gerya TV, 2003, EARTH PLANET SC LETT, V212, P47, DOI 10.1016/S0012-821X(03)00265-6; Asano Y, 2011, EARTH PLANETS SPACE, V63, P669, DOI 10.5047/eps.2011.06.016; Tian Y, 2013, GEOPHYS J INT, V195, P1796, DOI 10.1093/gji/ggt333; Wei W, 2013, PHYS EARTH PLANET IN, V222, P47, DOI 10.1016/j.pepi.2013.07.002; He LJ, 2014, J GEOPHYS RES-SOL EA, V119, P3662, DOI 10.1002/2013JB010657; Peacock SM, 2001, GEOLOGY, V29, P299, DOI 10.1130/0091-7613(2001)029<0299:ATLPOD>2.0.CO;2; Zhao DP, 1996, SCIENCE, V274, P1891, DOI 10.1126/science.274.5294.1891; Nakajima J, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006101; Sagiya T, 1999, J GEOPHYS RES-SOL EA, V104, P1111, DOI 10.1029/98JB02644; HILDE TWC, 1984, TECTONOPHYSICS, V102, P85, DOI 10.1016/0040-1951(84)90009-X; Hasegawa A, 2005, TECTONOPHYSICS, V403, P59, DOI 10.1016/j.tecto.2005.03.018; Hasegawa A, 2009, GONDWANA RES, V16, P370, DOI 10.1016/j.gr.2009.03.007; Zhao DP, 2012, GEOPHYS J INT, V190, P816, DOI 10.1111/j.1365-246X.2012.05550.x; Scambelluri M, 2001, LITHOS, V55, P213, DOI 10.1016/S0024-4937(00)00046-3; Long MD, 2013, REV GEOPHYS, V51, P76, DOI 10.1002/rog.20008; Ozawa S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009120; Deschamps A, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001706; Huang JL, 2004, TECTONOPHYSICS, V385, P159, DOI 10.1016/j.tecto.2004.04.024; Bangs NLB, 2009, EARTH PLANET SC LETT, V284, P44, DOI 10.1016/j.epsl.2009.04.026; Ohta Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052430; Gamage SSN, 2009, GEOPHYS J INT, V178, P195, DOI 10.1111/j.1365-246X.2009.04048.x; Kato A, 2013, GEOPHYS RES LETT, V40, P273, DOI [10.1002/GRL.50104, 10.1002/grl.50104]; Tamura Y, 2002, EARTH PLANET SC LETT, V197, P105, DOI 10.1016/S0012-821X(02)00465-X; Kawasaki I, 2001, TECTONOPHYSICS, V330, P267, DOI 10.1016/S0040-1951(00)00245-6; Kuritani T, 2013, LITHOS, V156, P1, DOI 10.1016/j.lithos.2012.10.010; Arita K, 1998, TECTONOPHYSICS, V290, P197, DOI 10.1016/S0040-1951(98)00018-3; Azuma R, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004135; Baba T, 2001, GEOPHYS RES LETT, V28, P1827, DOI 10.1029/2000GL012266; Bowman DD, 2001, GEOPHYS RES LETT, V28, P4039, DOI 10.1029/2001GL013022; Cheng B, 2011, PHYS EARTH PLANET IN, V184, P172, DOI 10.1016/j.pepi.2010.11.006; ENGDAHL ER, 1986, B SEISMOL SOC AM, V76, P77; Yener Eyuboglu, 2013, [Geoscience Frontiers, 地学前缘], V4, P349; FORSYTH DW, 1982, PHYS EARTH PLANET IN, V28, P141, DOI 10.1016/0031-9201(82)90079-6; Frohlich C., 2006, DEEP EARTHQUAKES, P573; FROHLICH C, 1994, SCIENCE, V264, P804, DOI 10.1126/science.264.5160.804; Fujie G., 2002, GEOPHYS RES LETT, V29; Gupta S, 2009, J ASIAN EARTH SCI, V35, P377, DOI 10.1016/j.jseaes.2009.01.004; Hasegawa A., 1994, MAGMATIC SYSTEMS, P179; Heki K., 1997, NATURE, V386, P592; Helmberger DV, 2001, J GEOPHYS RES-SOL EA, V106, P609, DOI 10.1029/2000JB900231; HERRMANN RB, 1976, B SEISMOL SOC AM, V66, P1221; HICKMAN S, 1995, J GEOPHYS RES-SOL EA, V100, P12831, DOI 10.1029/95JB01121; Hino R, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002415; HIRAHARA K, 1981, TECTONOPHYSICS, V79, P1, DOI 10.1016/0040-1951(81)90231-6; Honda S, 2003, EARTH PLANET SC LETT, V216, P703, DOI 10.1016/S0012-821X(03)00537-5; Huang JL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004066; Huang ZC, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003343; Huang ZC, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003626; Huang ZC, 2013, J ASIAN EARTH SCI, V70-71, P160, DOI 10.1016/j.jseaes.2013.03.010; Huang ZC, 2013, TECTONOPHYSICS, V586, P35, DOI 10.1016/j.tecto.2012.10.019; Iinuma T., 2012, J GEOPHYS RES, V117, DOI 10.1029/2012JB009186; Itoh Y, 2005, TECTONOPHYSICS, V395, P81, DOI 10.1016/j.tecto.2004.09.003; Iwamori H, 2000, GEOPHYS RES LETT, V27, P425, DOI 10.1029/1999GL010917; Iwasaki T, 2004, TECTONOPHYSICS, V388, P59, DOI 10.1016/j.tecto.2004.03.025; Jiang GM, 2011, J ASIAN EARTH SCI, V42, P1411, DOI 10.1016/j.jseaes.2011.08.005; Jiang GM, 2008, EARTH PLANET SC LETT, V270, P300, DOI 10.1016/j.epsl.2008.03.037; Kameyama M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051678; Kanamori H, 2004, P JPN ACAD B-PHYS, V80, P297, DOI 10.2183/pjab.80.297; KANAMORI H, 1971, TECTONOPHYSICS, V12, P187, DOI 10.1016/0040-1951(71)90003-5; Kato N, 1997, PHYS EARTH PLANET IN, V102, P51, DOI 10.1016/S0031-9201(96)03264-5; Katsumata K., 2006, GEOPHYS B HOKKAIDO U, V69, P23; Katsumata K, 2006, EARTH PLANETS SPACE, V58, pE37; Kayal J.R., 2002, GEOPHYS RES LETT, V29; Kimura G., 1996, ISL ARC, V5, P262, DOI DOI 10.1111/J.1440-1738.1996.TB00031.X; Kita S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009356; Kobayashi K., 1995, BACKARC BASINS TECTO, P381; Kubo H, 2013, GEOPHYS RES LETT, V40, P3003, DOI 10.1002/grl.50558; Lay T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009133; Lei JS, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002590; Lei JS, 2006, EARTH PLANET SC LETT, V241, P438, DOI 10.1016/j.epsl.2005.11.038; Liu J.Q., 1999, VOLCANOES IN CHINA; Liu X, 2014, J GEOPHYS RES-SOL EA, V119, P1094, DOI 10.1002/2013JB010591; Machida Y, 2009, TECTONOPHYSICS, V465, P164, DOI 10.1016/j.tecto.2008.11.009; Miller MS, 2006, PHYS EARTH PLANET IN, V156, P1, DOI 10.1016/j.pepi.2006.01.007; Mishra OP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019489; Mishra O.P., 2003, GEOPHYS RES LETT, V30; Miura S, 2003, TECTONOPHYSICS, V363, P79, DOI 10.1016/S0040-1951(02)00655-8; UYEDA S, 1974, GEOL SOC AM BULL, V85, P1159, DOI 10.1130/0016-7606(1974)85<1159:PTATJI>2.0.CO;2; Mukhopadhyay S, 2006, TECTONOPHYSICS, V415, P1, DOI 10.1016/j.tecto.2005.10.041; Munekane H, 2012, EARTH PLANETS SPACE, V64, P1077, DOI 10.5047/eps.2012.07.009; Murai Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016459; Nagai R., 2001, ZISIN, V54, P267; Nakajima J., 2011, GEOPHYS RES LETT, V38; Nakamichi H, 2003, GEOPHYS J INT, V154, P811, DOI 10.1046/j.1365-246X.2003.01991.x; Nakanishi A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002574; Nakanishi A, 2002, EARTH PLANET SC LETT, V203, P255, DOI 10.1016/S0012-821X(02)00866-X; Nishizawa A, 2009, EARTH PLANETS SPACE, V61, pE37; Okada T, 2011, EARTH PLANETS SPACE, V63, P749, DOI 10.5047/eps.2011.06.027; Okada Y., 2004, EARTH PLANETS SPACE, V56, pxv; Okino K, 1999, GEOPHYS RES LETT, V26, P2287, DOI 10.1029/1999GL900537; Padhy S, 2011, TECTONOPHYSICS, V509, P55, DOI 10.1016/j.tecto.2011.06.002; Park JO, 2004, EARTH PLANET SC LETT, V217, P77, DOI 10.1016/S0012-821X(03)00553-3; Romano F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05631; Sakuyama T, 2014, J PETROL, V55, P499, DOI 10.1093/petrology/egt074; Salah MK, 2005, TECTONOPHYSICS, V395, P1, DOI 10.1016/j.tecto.2004.08.005; Salah MK, 2003, TECTONOPHYSICS, V364, P191, DOI 10.1016/S0040-1951(03)00059-3; Shao GF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049164; Xia SH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030026; Sun A, 2008, GONDWANA RES, V14, P535, DOI 10.1016/j.gr.2008.04.004; Tahara M, 2008, PHYS EARTH PLANET IN, V167, P19, DOI 10.1016/j.pepi.2008.02.001; Tian Y, 2012, GEOPHYS J INT, V190, P629, DOI 10.1111/j.1365-246X.2012.05512.x; Tian Y, 2007, CHINESE J GEOPHYS-CH, V50, P1488; Tong P, 2012, SOLID EARTH, V3, P43, DOI 10.5194/se-3-43-2012; Tong P, 2011, GEOPHYS J INT, V187, P278, DOI 10.1111/j.1365-246X.2011.05139.x; Tsuboi C., 1956, J PHYS EARTH, V4, P63, DOI DOI 10.4294/JPE1952.4.63; Uehira K., 2013, PROGR SEISM SOC JAP, pD11; Umino N., 1990, Tohoku Geophysical Journal, Science Reports of the Tohoku University, Fifth Series, V33; UMINO N, 1994, J PHYS EARTH, V42, P321; UMINO N, 1995, GEOPHYS J INT, V120, P356, DOI 10.1111/j.1365-246X.1995.tb01824.x; Usami T., 2003, MAT COMPREHENSIVE LI; van Keken PE, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007922; van Keken PE, 2003, EARTH PLANET SC LETT, V215, P323, DOI 10.1016/S0012-821X(03)00460-6; Wada I, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047705; Wang J, 2009, TECTONOPHYSICS, V469, P137, DOI 10.1016/j.tecto.2009.02.005; Wang J, 2008, PHYS EARTH PLANET IN, V170, P115, DOI 10.1016/j.pepi.2008.07.042; Wang J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004081; Wang J, 2013, GEOPHYS J INT, V193, P1166, DOI 10.1093/gji/ggt086; Wang Z, 2006, PHYS EARTH PLANET IN, V155, P313, DOI 10.1016/j.pepi.2006.01.006; Wang Z, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007797; Wang Z, 2006, EARTH PLANET SC LETT, V244, P16, DOI 10.1016/j.epsl.2006.02.015; WEI W, 2013, DIXUE QIANYUAN, V20, P155; Xia SH, 2008, TECTONOPHYSICS, V449, P85, DOI 10.1016/j.tecto.2007.12.007; Xis S., 2014, J ASIAN EARTH SCI, V96, P46; Xis S., 2008, PHYS EARTH PLANET IN, V166, P153; Yagi Y, 1999, GEOPHYS RES LETT, V26, P3161, DOI 10.1029/1999GL005340; Yagi Y., 1998, ZISIN, V51, P139; Yamanaka Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002683; Yamanaka Y., 2006, EARTH MONTHLY, V28, P427; Yamashita Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051476; Ye LL, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008847; Yoshida K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049729; ZHAO DP, 1992, J GEOPHYS RES-SOL EA, V97, P19909, DOI 10.1029/92JB00603; Zhao DP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048408; Zhao D., 2012, MONOGR ENV EARTH PLA, V1, P1, DOI [10.5047/meep.2012.00101.0001, DOI 10.5047/MEEP.2012.00101.0001]; Zhao DP, 2015, GEOPHYS J INT, V200, P149, DOI 10.1093/gji/ggu381; Zhao DP, 2011, PHYS EARTH PLANET IN, V188, P82, DOI 10.1016/j.pepi.2011.06.013; Zhao DP, 2011, J ASIAN EARTH SCI, V42, P1381, DOI 10.1016/j.jseaes.2011.08.003; Zhao DP, 1997, GEOPHYS RES LETT, V24, P519, DOI 10.1029/97GL00258	227	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	FEB	2015	98						26	49		10.1016/j.jseaes.2014.10.022		24	Geosciences, Multidisciplinary	Geology	CA5NT	WOS:000348955800003		
J	Amiot, R; Wang, X; Zhou, ZH; Wang, XL; Lecuyer, C; Buffetaut, E; Fluteau, F; Ding, ZL; Kusuhashi, N; Mo, JY; Philippe, M; Suteethorn, V; Wang, YQ; Xu, X				Amiot, Romain; Wang, Xu; Zhou, Zhonghe; Wang, Xiaolin; Lecuyer, Christophe; Buffetaut, Eric; Fluteau, Frederic; Ding, Zhongli; Kusuhashi, Nao; Mo, Jinyou; Philippe, Marc; Suteethorn, Varavudh; Wang, Yuanqing; Xu, Xing			Environment and ecology of East Asian dinosaurs during the Early Cretaceous inferred from stable oxygen and carbon isotopes in apatite	JOURNAL OF ASIAN EARTH SCIENCES			English	Article						Dinosaurs; Reptiles; Early Cretaceous; East Asia; Stable isotopes; Climate; Ecology	MESOZOIC WOOD GENUS; BONE PHOSPHATE; TOOTH ENAMEL; JEHOL-BIOTA; TERRESTRIAL PALEOCLIMATES; PALEOMAGNETIC CONSTRAINTS; DELTA-O-18 RECORD; BIOGENIC APATITES; MARINE-SEDIMENTS; OSTRICH EGGSHELL	During the cold Late Barremian-Early Albian interval, terrestrial environments in East Asia were populated by rich and diverse vertebrate faunas characterized by a strong provincialism. The latitudinal gradient of temperature and the existence of geographic barriers likely accounted for some aspects of this heterogeneous distribution of faunas. Other factors, however, such as local environmental conditions and interactions within vertebrate communities, which could have influenced their distribution, have not yet been fully identified and understood. Therefore, new and published oxygen and carbon isotope compositions of apatite from Chinese and Thai reptiles (dinosaurs, crocodilians and turtles) have been analyzed and interpreted in terms of ecology, local air temperature and precipitation amounts. Differences in carbon and oxygen isotope compositions between various groups of sympatric plant-eating dinosaurs (sauropods, ornithopods and ceratopsians) indicate food resources partitioning among them most likely to avoid competition. Mid-latitude environments, where the Jehol Biota flourished, were submitted to cool temperate climatic conditions with Mean Air Temperature (MAT) of 10 +/- 4 degrees C and Mean Annual Precipitations (MAP) of about 600 mm/yr compatible with the existence of forest environments. By contrast, sub-tropical regions, characterized by MAT of about 20-25 degrees C were either submitted to high amounts of seasonal precipitations (of about 1200 mm/yr in Thailand) or to significant aridity (MAP of about 400 mm/yr in South China). This difference in precipitation regime between Thailand and South China may be attributed to the occurrence of the Coastal Cordillera extending along the East margin of the South China block. These mountain ranges likely prevented humid air masses from the Pacific to penetrate some parts of South China, thus generating a "rain shadow effect". Mosaic environments characterizing East Asia during the Late Early Cretaceous may have acted as a cradle for the origination of advanced dinosaur taxa that subsequently radiated over Eurasia and North America during the Late Cretaceous. (C) 2014 Elsevier Ltd. All rights reserved.	[Amiot, Romain; Zhou, Zhonghe; Wang, Xiaolin; Wang, Yuanqing; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Amiot, Romain; Lecuyer, Christophe; Philippe, Marc] Univ Lyon 1, CNRS, UMR 5276, F-69622 Villeurbanne, France; [Amiot, Romain; Lecuyer, Christophe; Philippe, Marc] Ecole Normale Super Lyon, F-69622 Villeurbanne, France; [Wang, Xu; Ding, Zhongli] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing 100029, Peoples R China; [Buffetaut, Eric] Ecole Normale Super, Geol Lab, CNRS, UMR 8538, F-75231 Paris 05, France; [Fluteau, Frederic] Inst Phys Globe Paris, F-75005 Paris, France; [Kusuhashi, Nao] Ehime Univ, Grad Sch Sci & Engn, Dept Earths Evolut & Environm, Matsuyama, Ehime 7908577, Japan; [Mo, Jinyou] Nat Hist Museum Guangxi, Nanning 530012, Peoples R China; [Suteethorn, Varavudh] Mahasarakham Univ, Palaeontol Res & Educ Ctr, Maha Sarakham, Thailand	Amiot, R (reprint author), Univ Lyon 1, CNRS, UMR 5276, 2 Rue Raphael Dubois, F-69622 Villeurbanne, France.	romain.amiot@univ-lyon1.fr			National Basic Research Program of China Grant [2012CB821900]; CNRS PICS program "DINASIA"; special INSU grant	The authors would like to thank the two anonymous reviewers for their constructive comments that greatly helped to improve the first draft of this manuscript. This manuscript also benefited from fruitful discussions that have taken place during the second IGCP608 meeting in September 2014 (Waseda University, Japan). This work was supported by the National Basic Research Program of China Grant 2012CB821900, by the CNRS PICS program "DINASIA" and a special INSU grant to Eric Buffetaut.	Amiot R, 2007, PALAEOGEOGR PALAEOCL, V243, P412, DOI 10.1016/j.palaeo.2006.08.013; Amiot R, 2009, GEOL SOC SPEC PUBL, V315, P271, DOI 10.1144/SP315.19; Angst D, 2014, NATURWISSENSCHAFTEN, V101, P313, DOI 10.1007/s00114-014-1158-2; Besse J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000050; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Suarez CA, 2012, PALAEOGEOGR PALAEOCL, V313, P78, DOI 10.1016/j.palaeo.2011.10.011; EHLERINGER JR, 1993, ANNU REV ECOL SYST, V24, P411, DOI 10.1146/annurev.es.24.110193.002211; Puceat E, 2004, CHEM GEOL, V205, P83, DOI 10.1016/j.chemgeo.2003.12.014; Kusuhashi N, 2009, J VERTEBR PALEONTOL, V29, P1264; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Lecuyer C, 1998, GEOCHIM COSMOCHIM AC, V62, P2429, DOI 10.1016/S0016-7037(98)00170-7; Amiot R, 2004, EARTH PLANET SC LETT, V226, P255, DOI 10.1016/j.epsl.2004.07.015; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Metcalfe I, 2013, J ASIAN EARTH SCI, V66, P1, DOI 10.1016/j.jseaes.2012.12.020; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3; Rey K, 2013, PALAEOGEOGR PALAEOCL, V388, P48, DOI 10.1016/j.palaeo.2013.07.021; Li XH, 2000, J ASIAN EARTH SCI, V18, P293, DOI 10.1016/S1367-9120(99)00060-7; Kolodny Y, 1996, PALAEOGEOGR PALAEOCL, V126, P161, DOI 10.1016/S0031-0182(96)00112-5; DANSGAARD W, 1964, TELLUS, V16, P436; Fricke HC, 2008, PALAEOGEOGR PALAEOCL, V266, P13, DOI 10.1016/j.palaeo.2008.03.030; Blake RE, 1997, GEOCHIM COSMOCHIM AC, V61, P4411, DOI 10.1016/S0016-7037(97)00272-X; Lecuyer C, 2003, PALAEOGEOGR PALAEOCL, V193, P457, DOI 10.1016/S0031-0182(03)00261-X; ENKIN RJ, 1992, J GEOPHYS RES-SOL EA, V97, P13953, DOI 10.1029/92JB00648; Boutton TW, 1998, GEODERMA, V82, P5, DOI 10.1016/S0016-7061(97)00095-5; Johnson BJ, 1998, GEOCHIM COSMOCHIM AC, V62, P2451, DOI 10.1016/S0016-7037(98)00175-6; Suarez MB, 2013, GEOL SOC SPEC PUBL, V382, P143, DOI 10.1144/SP382.1; LECUYER C, 1993, PALAEOGEOGR PALAEOCL, V105, P235, DOI 10.1016/0031-0182(93)90085-W; Xu X, 2002, NATURE, V416, P314, DOI 10.1038/416314a; BALESDENT J, 1993, ECOLOGY, V74, P1713, DOI 10.2307/1939930; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Philippe M, 2009, LETHAIA, V42, P393, DOI 10.1111/j.1502-3931.2009.00160.x; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Huang CM, 2012, CRETACEOUS RES, V33, P42, DOI 10.1016/j.cretres.2011.08.001; CROWSON RA, 1991, ANAL CHEM, V63, P2397, DOI 10.1021/ac00020a038; Fluteau F, 2007, PALAEOGEOGR PALAEOCL, V247, P357, DOI 10.1016/j.palaeo.2006.11.016; Fricke HC, 2008, PALEOBIOLOGY, V34, P534, DOI 10.1666/08020.1; Barrick RE, 1999, PALAIOS, V14, P186, DOI 10.2307/3515374; Amiot R, 2011, P NATL ACAD SCI USA, V108, P5179, DOI 10.1073/pnas.1011369108; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; KOLODNY Y, 1983, EARTH PLANET SC LETT, V64, P398, DOI 10.1016/0012-821X(83)90100-0; Fricke HC, 1998, EARTH PLANET SC LETT, V160, P193, DOI 10.1016/S0012-821X(98)00088-0; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Philippe M, 1996, REV PALAEOBOT PALYNO, V91, P353, DOI 10.1016/0034-6667(95)00067-4; Manabe M, 2000, NATURE, V404, P953; VONSCHIRNDING Y, 1982, ARCHAEOMETRY, V24, P3, DOI 10.1111/j.1475-4754.1982.tb00643.x; Zhou D, 2008, ISL ARC, V17, P186, DOI 10.1111/j.1440-1738.2008.00611.x; Tang F, 2001, CRETACEOUS RES, V22, P115, DOI 10.1006/cres.2000.0242; Vennemann TW, 2001, GEOCHIM COSMOCHIM AC, V65, P1583, DOI 10.1016/S0016-7037(00)00629-3; Hong SK, 2012, EARTH PLANET SC LETT, V327, P23, DOI 10.1016/j.epsl.2012.01.014; Brudevold F, 1967, STRUCTURE CHEM ORG T, P247; Bryant D.J., 1996, GEOCHIM COSMOCHIM AC, V60, P5145; Buffetaut E, 2011, ANN PALEONTOL, V97, P51, DOI 10.1016/j.annpal.2011.08.001; Buffetaut E., 2006, 2005 HEYUAN INT DIN, P19; Chenery CA, 2012, RAPID COMMUN MASS SP, V26, P309, DOI 10.1002/rcm.5331; Christiansen Per, 2000, Historical Biology, V14, P137; CORMIE AB, 1994, GEOCHIM COSMOCHIM AC, V58, P3439, DOI 10.1016/0016-7037(94)90097-3; DANGELA D, 1990, CHEM GEOL, V86, P75, DOI 10.1016/0168-9622(90)90007-Y; Domingo L, 2013, PALAIOS, V28, P195, DOI 10.2110/palo.2012.p12-097r; EHLERINGER JR, 1987, OECOLOGIA, V72, P109, DOI 10.1007/BF00385053; Erickson GM, 1996, J MORPHOL, V228, P189, DOI 10.1002/(SICI)1097-4687(199605)228:2<189::AID-JMOR7>3.0.CO;2-0; Fernandez V, 2009, GEOL SOC SPEC PUBL, V315, P285, DOI 10.1144/SP315.20; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; Fricke HC, 1999, EARTH PLANET SC LETT, V170, P181, DOI 10.1016/S0012-821X(99)00105-3; Grafenstein UV, 1996, GEOCHIMICA COSMOCHIM, V60, P4025; Holdridge L.R., 1967, LIFE ZONE ECOLOGY; Iacumin P., 1996, EARTH PLANET SC LETT, V142, P1, DOI DOI 10.1016/0012-821X(96)00093-3; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P3889, DOI 10.1016/0016-7037(96)00248-7; Lecuyer C, 2010, GEOCHIM COSMOCHIM AC, V74, P2072, DOI 10.1016/j.gca.2009.12.024; Li Chuan-Kui, 2005, Vertebrata Palasiatica, V43, P245; Lin W, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002169; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Luo ZX, 1999, NATURE, V400, P23, DOI 10.1038/21790; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Meesook A, 2011, GEOLOGY OF THAILAND, P169; O'Neil James R., 1994, ISR J EARTH SCI, V43, P203; Ohta T, 2011, J GEOL, V119, P81, DOI 10.1086/657341; Philippe M, 2014, REV PALAEOBOT PALYNO, V204, P18, DOI 10.1016/j.revpalbo.2014.02.002; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P69, DOI 10.1144/SP315.6; RINK WJ, 1995, J ARCHAEOL SCI, V22, P251, DOI 10.1006/jasc.1995.0026; Shen ZY, 2005, SCI CHINA SER D, V48, P406, DOI 10.1360/03yd0378; Spoetl C., 2003, RAPID COMMUN MASS SP, V17, P1004; Straight WH, 2004, PALAEOGEOGR PALAEOCL, V206, P239, DOI 10.1016/j.palaeo.2004.01.006; Trueman C, 2003, J GEOL SOC LONDON, V160, P895, DOI 10.1144/0016-764903-019; Tutken T., 2011, BIOL SAUROPOD DINOSA, P57; Tutken T., 2008, PALAEOGEOGR PALAEOCL, V266, P254; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Wang X.-L., 2003, JEHOL BIOTA, P19; Yang W.-B., 2013, SCI REPORTS; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P2245, DOI 10.1016/j.gca.2003.11.009; Zhang S.-X., 2009, GEOLOGICAL FORMATION; Zhao Q., 2007, PALAEONTOLOGY, V50, P1023; Zhou ZG, 2006, GEOL J, V41, P377, DOI 10.1002/gj.1045	94	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	FEB	2015	98						358	370		10.1016/j.jseaes.2014,11.032		13	Geosciences, Multidisciplinary	Geology	CA5NT	WOS:000348955800028		
J	Yokomizo, T				Yokomizo, Takehiko			JB Special Review-Recent Progress in Lipid Mediators Two distinct leukotriene B-4 receptors, BLT1 and BLT2	JOURNAL OF BIOCHEMISTRY			English	Review						aspirin; eicosanoids; immune response; inflammation; wound healing	INDUCED AIRWAY HYPERRESPONSIVENESS; COLLAGEN-INDUCED ARTHRITIS; T-CELL RECRUITMENT; IN-VIVO; 12-HYDROXYHEPTADECATRIENOIC ACID; POLYMORPHONUCLEAR LEUKOCYTES; EOSINOPHIL ACCUMULATION; NEUTROPHIL RECRUITMENT; ARACHIDONIC-ACID; CDNA CLONING	Leukotriene B-4 (LTB4) is a potent inflammatory mediator derived from arachidonic acid. Two G protein-coupled receptors for LTB4 have been identified: a high-affinity receptor, BLT1, and a low-affinity receptor, BLT2. Both receptors mainly couple to pertussis toxin-sensitive Gi-like G proteins and induce cell migration. 12(S)-hydroxy-5Z,8E,10E-heptadecatrienoic acid (12-HHT) was identified to bind BLT2 with higher affinity than LTB4. Expression of BLT1 was confirmed in type 1 helper T cells, type 2 helper T cells, type 17 helper T cells, effector CD8(+) T cells, dendritic cells and osteoclasts in addition to granulocytes, eosinophils and macrophages, and BLT1-deficient mice showed greatly reduced phenotypes in models of various inflammatory diseases, such as peritonitis, bronchial asthma, rheumatoid arthritis, atherosclerosis and osteoporosis. In mice, BLT2 expression is restricted to intestinal epithelial cells and epidermal keratinocytes. BLT2-deficient mice showed enhanced colitis after administration of dextran sulfate, possibly due to reduced intestinal barrier function. An aspirin-dependent reduction in 12-HHT production was responsible for delayed skin wound healing, showing that the 12-HHT/BLT2 axis also plays an important role in skin biology. BLT1 and BLT2 are therefore potential targets for the development of novel drugs.	Juntendo Univ, Grad Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan	Yokomizo, T (reprint author), Juntendo Univ, Grad Sch Med, Dept Biochem, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	yokomizo-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22116001, 22116002]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Nos. 22116001, and 22116002), the Naito Foundation, Ono Medical Research Foundation, and the Uehara Memorial Foundation.	Andoh T, 2011, EXP DERMATOL, V20, P894, DOI 10.1111/j.1600-0625.2011.01346.x; Yokomizo T, 2011, ADV ENZYME REGUL, V51, P59, DOI 10.1016/j.advenzreg.2010.08.002; Sumida H, 2014, J IMMUNOL, V192, P4361, DOI 10.4049/jimmunol.1302959; Miyahara N, 2005, AM J RESP CRIT CARE, V172, P161, DOI 10.1164/rccm.200502-205OC; MURPHY RC, 1979, P NATL ACAD SCI USA, V76, P4275, DOI 10.1073/pnas.76.9.4275; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Wada K, 2006, FASEB J, V20, P1785, DOI 10.1096/fj.06-5809com; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Sun R, 2009, MOL CELLS, V27, P403, DOI 10.1007/s10059-009-0053-8; Terawaki K, 2005, J IMMUNOL, V175, P4217; Liu M, 2014, J EXP MED, V211, P1063, DOI 10.1084/jem.20132063; SUMIMOTO H, 1984, BIOCHIM BIOPHYS ACTA, V803, P271, DOI 10.1016/0167-4889(84)90117-4; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; PALMER RMJ, 1980, PROSTAGLANDINS, V20, P411, DOI 10.1016/S0090-6980(80)80058-X; Mathis S, 2007, AUTOIMMUN REV, V7, P12, DOI 10.1016/j.autrev.2007.03.005; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Lee JW, 2013, J BIOL CHEM, V288, P30054, DOI 10.1074/jbc.M113.481283; HAHN RA, 1990, J PHARMACOL EXP THER, V253, P58; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Islam SA, 2006, BLOOD, V107, P444, DOI 10.1182/blood-2005-06-2362; Oyoshi MK, 2012, IMMUNITY, V37, P747, DOI 10.1016/j.immuni.2012.06.018; Back M, 2014, BRIT J PHARMACOL, V171, P3551, DOI 10.1111/bph.12665; Kuraishi Y, 2013, BIOL PHARM BULL, V36, P1228; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Johansson AS, 2011, PROSTAG LEUKOTR ESS, V84, P109, DOI 10.1016/j.plefa.2010.11.003; Kim H, 2014, J BIOL CHEM, V289, P22151, DOI 10.1074/jbc.M114.556126; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Kamohara M, 2000, J BIOL CHEM, V275, P27000; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; Qiu H, 2006, P NATL ACAD SCI USA, V103, P6913, DOI 10.1073/pnas.0602208103; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Miyahara N, 2008, J IMMUNOL, V181, P1170; Kato K, 2000, J EXP MED, V192, P413, DOI 10.1084/jem.192.3.413; Matsunobu T, 2013, J LIPID RES, V54, P2979, DOI 10.1194/jlr.M037754; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Clish CB, 2000, J BIOL CHEM, V275, P25372, DOI 10.1074/jbc.M002863200; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; DRAZEN JM, 1980, P NATL ACAD SCI-BIOL, V77, P4354, DOI 10.1073/pnas.77.7.4354; Ensor CM, 1998, BIOCHEM J, V330, P103; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Hikiji H, 2009, P NATL ACAD SCI USA, V106, P21294, DOI 10.1073/pnas.0905209106; Kikuta Y, 1998, ARCH BIOCHEM BIOPHYS, V355, P201, DOI 10.1006/abbi.1998.0724; Kuwabara K, 2000, EUR J PHARMACOL, V402, P275, DOI 10.1016/S0014-2999(00)00518-5; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Matsunaga Y, 2013, FASEB J, V27, P3306, DOI 10.1096/fj.12-217000; Morato CI, 2014, MICROBES INFECT, V16, P945, DOI 10.1016/j.micinf.2014.08.015; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Patnode ML, 2014, J EXP MED, V211, P1281, DOI 10.1084/jem.20132336; Peters-Golden M, 1999, CLIN REV ALLERG IMMU, V17, P261, DOI 10.1007/BF02737609; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Toda A, 2010, BIOCHIMIE, V92, P682, DOI 10.1016/j.biochi.2009.12.002; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 1996, J BIOL CHEM, V271, P2844; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200	63	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	FEB	2015	157	2					65	71		10.1093/jb/mvu078		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA9WH	WOS:000349275000001		
J	Sugimoto, Y; Inazumi, T; Tsuchiya, S				Sugimoto, Yukihiko; Inazumi, Tomoaki; Tsuchiya, Soken			JB Special Review-Recent Progress in Lipid Mediators Roles of prostaglandin receptors in female reproduction	JOURNAL OF BIOCHEMISTRY			English	Review						cumulus cell; fertilization; luteolysis; parturition; prostanoid receptor	PROSTANOID RECEPTORS; DEFICIENT MICE; F RECEPTOR; EXTRACELLULAR-MATRIX; INTERNATIONAL UNION; OXYTOCIN RECEPTOR; CUMULUS-OOPHORUS; IN-VIVO; PARTURITION; OVULATION	Prostaglandins (PGs) have long been known to play roles in various processes of female reproduction; however, the molecular mechanisms therein remained unsolved until recently. This review summarizes the recent progress towards understanding the molecular mechanisms underlying PG actions in fertilization and parturition. A series of studies using EP2-deficient mice demonstrated that after ovulation chemokine signalling in the cumulus cells stimulates integrin activation and cumulus extracellular matrix (ECM) assembly through the RhoA/ROCK/actomyosin pathway, although excessive chemokine signalling disturbs sperm penetration. PGE(2)-EP2 signalling suppresses such a chemokine signalling and stimulates cumulus ECM disassembly, which contributes to successful fertilization. A series of studies using FP-deficient mice revealed that PGF(2 alpha)-FP signalling induces parturition at least by terminating progesterone production; however, some other EP signals are likely to be involved in parturition by inducing myometrial contraction. Therefore, it should be clarified as to which EP and/or FP receptor signals are physiologically essential for myometrial contraction and successful parturition.	[Sugimoto, Yukihiko; Inazumi, Tomoaki; Tsuchiya, Soken] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Biochem, Kumamoto 8620973, Japan; [Sugimoto, Yukihiko; Tsuchiya, Soken] Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan	Sugimoto, Y (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Biochem, Chuo Ku, Oe Honmachi, Kumamoto 8620973, Japan.	ysugi@kumamoto-u.ac.jp			Japan science and technology (JST) agency; Japanese Ministry of Education, Science, Sports, Culture and Technology (MEXT)	This work was supported in part by grants from the Japan science and technology (JST) agency and the Japanese Ministry of Education, Science, Sports, Culture and Technology (MEXT); grant-in-aid for scientific research on innovative areas 'machineries of bioactive lipids in homeostasis and diseases' and grant-in-aid for scientific research (B).	Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; LEWIS RB, 1973, LANCET, V2, P1159; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Talbot P, 2003, BIOL REPROD, V68, P1, DOI 10.1095/biolreprod.102.007856; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; SUGIMOTO Y, 1994, J BIOL CHEM, V269, P1356; SIROIS J, 1992, J BIOL CHEM, V267, P11586; Hasumoto K, 1997, J REPROD FERTIL, V109, P45; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Peluffo MC, 2014, HUM REPROD, V29, P1400, DOI 10.1093/humrep/deu083; Helliwell RJA, 2004, PROSTAG LEUKOTR ESS, V70, P101, DOI 10.1016/j.plefa.2003.04.002; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Isobe T, 2002, HUM REPROD, V17, P1441, DOI 10.1093/humrep/17.6.1441; Gross GA, 1998, P NATL ACAD SCI USA, V95, P11875, DOI 10.1073/pnas.95.20.11875; Richards JS, 1998, MOL CELL ENDOCRINOL, V145, P47, DOI 10.1016/S0303-7207(98)00168-3; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200; Narumiya S, 1999, PHYSIOL REV, V79, P1193; Uozumi N, 1997, NATURE, V390, P618; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Tamba S, 2008, P NATL ACAD SCI USA, V105, P14539, DOI 10.1073/pnas.0805699105; BROWN CG, 1984, J REPROD FERTIL, V72, P407; CHAN WY, 1991, CAN J PHYSIOL PHARM, V69, P1262; Coleman R.A., 1990, COMPREHENSIVE MED CH, V3, P643; GOLDBERG VJ, 1975, PHYSIOL REV, V55, P325; HORTON EW, 1976, PHYSIOL REV, V56, P595; HUSSLEIN P, 1981, AM J OBSTET GYNECOL, V141, P688; McCracken J. A., 1988, PROSTAGLANDINS BIOL, P425; MURDOCH WJ, 1993, PROSTAGLANDINS, V46, P85, DOI 10.1016/0090-6980(93)90037-8; OJEDA SR, 1982, ENDOCRINOLOGY, V111, P1031; SKINNER KA, 1985, AM J OBSTET GYNECOL, V151, P519; Smith W. L., 2002, BIOCH LIPIDS LIPOPRO, P341; Tamba S, 2010, BIOCHIMIE, V92, P665, DOI 10.1016/j.biochi.2010.04.006; Trafriri A., 1996, REPROD ENDOCRINOLOGY, P235; Tsuboi K, 2003, BIOL REPROD, V69, P195, DOI 10.1095/biolreprod.102.013870; Tsuboi T., 2000, ENDOCRINOLOGY, V141, P315; Wassarman P. M., 1994, THE PHYSIOLOGY OF RE, P79; Yao CC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2684; Yodoi R, 2009, ENDOCRINOLOGY, V150, P3345, DOI 10.1210/en.2008-1449	49	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	FEB	2015	157	2					73	80		10.1093/jb/mvu081		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA9WH	WOS:000349275000002		
J	Aikawa, S; Hashimoto, T; Kano, K; Aoki, J				Aikawa, Shizu; Hashimoto, Takafumi; Kano, Kuniyuki; Aoki, Junken			JB Special Review-Recent Progress in Lipid Mediators Lysophosphatidic acid as a lipid mediator with multiple biological actions	JOURNAL OF BIOCHEMISTRY			English	Review						autotaxin; G protein-coupled receptor; lipid mediator; lysophosphatidic acid; PA-PLA(1)	PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHOLIPASE-D ACTIVITY; LPA-PRODUCING ENZYME; HUMAN HAIR-GROWTH; BIOCHEMICAL-CHARACTERIZATION; NEUROPATHIC PAIN; MOUSE UTERUS; LUNG INJURY; EDG-FAMILY; IN-VITRO	Lysophosphatidic acid (LPA) is one of the simplest glycerophospholipids with one fatty acid chain and a phosphate group as a polar head. Although LPA had been viewed just as a metabolic intermediate in de novo lipid synthetic pathways, it has recently been paid much attention as a lipid mediator. LPA exerts many kinds of cellular processes, such as cell proliferation and smooth muscle contraction, through cognate G protein-coupled receptors. Because lipids are not coded by the genome directly, it is difficult to know their patho- and physiological roles. However, recent studies have identified several key factors mediating the biological roles of LPA, such as receptors and producing enzymes. In addition, studies of transgenic and gene knockout animals for these LPA-related genes, have revealed the biological significance of LPA. In this review we will summarize recent advances in the studies of LPA production and its roles in both physiological and pathological conditions.	[Aikawa, Shizu; Hashimoto, Takafumi; Kano, Kuniyuki; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Aoki, Junken] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Aoki, J (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	jaoki@m.tohoku.ac.jp			CREST (Japan Science and technology Corporation); Science, Sports, and Culture of Japan	The researched based on this review was supported by grants from CREST (Japan Science and technology Corporation to J.A.), Science, Sports, and Culture of Japan to J.A.	Giganti A, 2008, J BIOL CHEM, V283, P7776, DOI 10.1074/jbc.M708705200; Funke M, 2012, AM J RESP CELL MOL, V46, P355, DOI 10.1165/rcmb.2010-0155OC; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Yukiura H, 2011, J BIOL CHEM, V286, P43972, DOI 10.1074/jbc.M111.301093; GERRARD JM, 1989, BIOCHIM BIOPHYS ACTA, V1001, P282, DOI 10.1016/0005-2760(89)90112-4; Hashimoto T, 2012, J BIOCHEM, V151, P89, DOI 10.1093/jb/mvr126; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Hiramatsu T, 2003, J BIOL CHEM, V278, P49438, DOI 10.1074/jbc.M213018200; Tokumura A, 1999, BIOL REPROD, V61, P195, DOI 10.1095/biolreprod61.1.195; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Pradere JP, 2007, J AM SOC NEPHROL, V18, P3110, DOI 10.1681/ASN.2007020196; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Pyne S, 2004, SEMIN CELL DEV BIOL, V15, P491, DOI 10.1016/j.semcdb.2004.05.007; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Inoue M, 2008, NEUROSCIENCE, V152, P296, DOI 10.1016/j.neuroscience.2007.12.041; Ye XQ, 2008, BIOL REPROD, V79, P328, DOI 10.1095/biolreprod.108.068783; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Tanaka M, 2004, FEBS LETT, V571, P197, DOI 10.1016/j.febslet.2004.06.083; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Zhang GX, 1999, CHINESE MED J-PEKING, V112, P330; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tigyi G, 2003, PROG LIPID RES, V42, P498, DOI 10.1016/S0163-7827(03)00035-3; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Foell JL, 2008, PEDIATR BLOOD CANCER, V51, P228, DOI 10.1002/pbc.21602; Yoshida K, 2003, CIRCULATION, V108, P1746, DOI 10.1161/01.CIR.0000089374.35455.F3; Baumforth KRN, 2005, BLOOD, V106, P2138, DOI 10.1182/blood-2005-02-0471; TOKUMURA A, 1995, PROG LIPID RES, V34, P151, DOI 10.1016/0163-7827(95)00001-G; Jasinska R, 1999, BIOCHEM J, V340, P677, DOI 10.1042/0264-6021:3400677; Yue JM, 2004, CELL SIGNAL, V16, P385, DOI 10.1016/j.cellsig.2003.08.012; Hama K, 2007, BIOL REPROD, V77, P954, DOI 10.1095/biolreprod.107.060293; Hama K, 2006, LIFE SCI, V79, P1736, DOI 10.1016/j.lfs.2006.06.002; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Baker DL, 2000, ANN NY ACAD SCI, V905, P267; Cimpean A, 2004, BIOCHEM J, V381, P71, DOI 10.1042/BJ20040465; Diao HL, 2011, BIOL REPROD, V84, P255, DOI 10.1095/biolreprod.110.086942; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Hinokio K, 2002, LIFE SCI, V70, P759, DOI 10.1016/S0024-3205(01)01448-5; JALINK K, 1995, BIOCHEM J, V307, P609; Kunikata K, 1999, LIFE SCI, V65, P833, DOI 10.1016/S0024-3205(99)00310-0; Lee SJ, 2008, FASEB J, V22, P3706, DOI 10.1096/fj.08-106088; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; SCHUMACHER KA, 1979, THROMB HAEMOSTASIS, V42, P631; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Stassar MJJG, 2001, BRIT J CANCER, V85, P1372, DOI 10.1054/bjoc.2001.2074; Sugiura T, 2002, J LIPID RES, V43, P2049, DOI 10.1194/jlr.M200242-JLR200; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; TAKAYAMA K, 1990, BIOCHEM BIOPH RES CO, V167, P1309, DOI 10.1016/0006-291X(90)90666-B; Tokumura A, 2007, LIFE SCI, V80, P1641, DOI 10.1016/j.lfs.2006.12.041; TOKUMURA A, 1978, LIPIDS, V13, P572, DOI 10.1007/BF02533598; Tokumura A, 2002, BIOL REPROD, V67, P1386, DOI 10.1095/biolreprod.102.004051; TOKUMURA A, 1986, BIOCHIM BIOPHYS ACTA, V875, P31; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196	67	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	FEB	2015	157	2					81	89		10.1093/jb/mvu077		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA9WH	WOS:000349275000003		
J	Nishida, T; Kubota, S; Aoyama, E; Janune, D; Lyons, KM; Takigawa, M				Nishida, Takashi; Kubota, Satoshi; Aoyama, Eriko; Janune, Danilo; Lyons, Karen M.; Takigawa, Masaharu			CCN family protein 2 (CCN2) promotes the early differentiation, but inhibits the terminal differentiation of skeletal myoblasts	JOURNAL OF BIOCHEMISTRY			English	Article						CCN2; CTGF; C2C12 cells; myoblasts; skeletal myogenesis; TNF alpha	TISSUE-GROWTH-FACTOR; CHONDROCYTIC CELL-LINE; FACTOR CTGF/CCN2; MUSCLE-CELLS; PROLIFERATION; EXPRESSION; FIBROSIS; INTEGRIN; DISTINCT; PROGENITORS	Many studies have reported that CCN family protein 2 (also known as connective tissue growth factor) induces fibrotic response in skeletal muscle, thus emphasizing the pathological role of CCN2 in muscle tissues. However, the physiological role of CCN2 in myogenesis is still unknown. This study clarified the CCN2 functions during myogenesis. Recombinant CCN2 (rCCN2) promoted proliferation and MyoD production in C2C12 cells and primary myoblasts, but inhibited myogenin production. In accordance with these findings, the gene expression levels of myosin heavy chain, which is a marker of terminally differentiated myoblasts and desmin, which is the main intermediate filament protein of muscle cells, were decreased by rCCN2 treatment. In vivo analyses with Ccn2-deficient skeletal muscle revealed decreased proliferating cell nuclear antigen (PCNA)/MyoD double positive cells and muscle hypoplasia. Consistent with this finding, myogenic marker genes and myotube formation were repressed in Ccn2-deficient myoblasts. The protein production of CCN2 was increased in C2C12 myoblasts treated with tumor necrosis factor-alpha, which is a pro-inflammatory cytokine, suggesting its role in muscle regeneration after inflammation. These findings indicate that CCN2 promotes proliferation and early differentiation but inhibits the terminal differentiation of myoblasts, thus suggesting that CCN2 plays a physiological role in myogenesis.	[Nishida, Takashi; Kubota, Satoshi; Takigawa, Masaharu] Okayama Univ, Dept Biochem & Mol Dent, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan; [Aoyama, Eriko; Janune, Danilo; Takigawa, Masaharu] Okayama Univ, Adv Res Ctr Oral & Craniofacial Sci, Sch Dent, Okayama 7008525, Japan; [Lyons, Karen M.] Univ Calif Los Angeles, Dept Orthopaed Surg, David Geffen Sch Med, Los Angeles, CA 90095 USA	Nishida, T (reprint author), Okayama Univ, Dept Biochem & Mol Dent, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	tnishida@md.okayama-u.ac.jp; takigawa@md.okayama-u.ac.jp			Japan Society for the Promotion of Sciences, Japan [23592732, 26462810, 25462886, 24390415]; Japan Society for the Promotion of Science	This work was supported in part by grants from the programs Grants-in-Aid for Scientific Research (C) to T.N. (Nos. 23592732, 26462810) and to S.K. (No. 25462886), and (B) to M.T. (No. 24390415) from Japan Society for the Promotion of Sciences, Japan. D.J. is a recipient of a Postdoctoral Fellowship from Japan Society for the Promotion of Science. They thank Drs Takako Hattori and Mitsuhiro Hoshijima for helpful suggestions and Miss Yoshiko Miyake for secretarial assistance.	Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Huang GC, 2012, FRONT BIOSCI-LANDMRK, V17, P2495, DOI 10.2741/4067; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jpc.10277; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Nishida T, 2011, ENDOCRINOLOGY, V152, P4232, DOI 10.1210/en.2011-0234; Leblanc E, 2011, J BONE MINER RES, V26, P1166, DOI 10.1002/jbmr.311; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; Williams NG, 2011, ENDOCRINOLOGY, V152, P172, DOI 10.1210/en.2010-0488; Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Kubota S, 2007, INT REV CYTOL, V257, P1, DOI 10.1016/S0074-7696(07)57001-4; Karalaki M, 2009, IN VIVO, V23, P779; Nishida T, 2009, BONE, V44, P24, DOI 10.1016/j.bone.2008.08.125; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Rodgers BD, 2014, ENDOCRINOLOGY, V155, P670, DOI 10.1210/en.2013-2107; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; Cabello-Verrugio C, 2012, J CELL MOL MED, V16, P752, DOI 10.1111/j.1582-4934.2011.01354.x; Calhabeua F, 2006, EXP CELL RES, V312, P1876, DOI 10.1016/j.yexcr.2006.02.027; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Du J, 2014, AM J PHYSIOL-CELL PH, V306, pC28, DOI 10.1152/ajpcell.00066.2013; ENOMOTO MI, 1993, DEV BIOL, V155, P180, DOI 10.1006/dbio.1993.1017; Francetic T, 2011, TRANSCRIPTION, V2, P109, DOI DOI 10.4161/TRNS.2.3.15829); Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Kubota S, 2000, FEBS LETT, V474, P58, DOI 10.1016/S0014-5793(00)01573-8; Nishida T, 1998, BIOCHEM BIOPH RES CO, V247, P905, DOI 10.1006/bbrc.1998.8895; Nishida T, 2007, J CELL COMMUN SIGNAL, V1, P45, DOI 10.1007/s12079-007-0005-z; Nishida T, 2011, J BONE MINER RES, V26, P351, DOI 10.1002/jbmr.222; Nishida T, 2013, OSTEOARTHR CARTILAGE, V21, P700, DOI 10.1016/j.joca.2013.01.013; Perbal B, 2005, CCN PROTEINS: A NEW FAMILY OF CELL GROWTH AND DIFFERENTIATION REGULATORS, P1, DOI 10.1142/9781860946899_0001; Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169; Yoshida S, 1996, J CELL BIOL, V132, P181, DOI 10.1083/jcb.132.1.181; Zimowska M, 2008, INT J DEV BIOL, V52, P307, DOI 10.1387/ijdb.072331mz	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	FEB	2015	157	2					91	100		10.1093/jb/mvu056		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA9WH	WOS:000349275000004		
J	Kumari, P; Kamiseki, M; Biyani, M; Suzuki, M; Nemoto, N; Aita, T; Nishigaki, K				Kumari, Parmila; Kamiseki, Meiko; Biyani, Manish; Suzuki, Miho; Nemoto, Naoto; Aita, Takuyo; Nishigaki, Koichi			Detection of ultra-low levels of DNA changes by drinking water: epidemiologically important finding	JOURNAL OF BIOCHEMISTRY			English	Article						drinking water; GPMA; high sensitivity; mutagens; mutation assay	GRADIENT GEL-ELECTROPHORESIS; IDENTIFICATION; GUIDELINES; PRODUCTS; CANCER; ASSAY	The safety of drinking water is essential to our health. In this context, the mutagenicity of water needs to be checked strictly. However, from the methodological limit, the lower concentration (less than parts per million) of mutagenicity could not be detected, though there have been of interest in the effect of less concentration mutagens. Here, we describe a highly sensitive mutation assay that detects mutagens at the ppb level, termed genome profiling-based mutation assay (GPMA). This consists of two steps; (i) Escherichia coli culture in the medium with/without mutagens and (ii) Genome profiling (GP) method (an integrated method of random PCR, temperature gradient gel electrophoresis and computer-aided normalization). Owing to high sensitivity of this method, very low concentration of mutagens in tap water could be directly detected without introducing burdensome concentration processes, enabling rapid measurement of low concentration samples. Less expectedly, all of the tap waters tested (22 samples) were shown to be significantly mutagenic while mineral waters were not. Resultantly, this article informs two facts that the GPMA method is competent to measure the mutagenicity of waters directly and the experimental results supported the former reports that the city tap waters contain very low level of mutagenicity reagent trihalomethanes.	[Kumari, Parmila; Kamiseki, Meiko; Suzuki, Miho; Nemoto, Naoto; Aita, Takuyo; Nishigaki, Koichi] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Biyani, Manish] Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan	Nishigaki, K (reprint author), Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	koichi@fms.saitama-u.ac.jp			Saitama University	This work was supported by Research Grant-in-aid of Saitama University. We thank Mita for his technical assistance in the GC-MS experiments.	Blanchoud H, 2007, SCI TOTAL ENVIRON, V375, P168, DOI 10.1016/j.scitotenv.2006.12.009; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Richardson SD, 2008, ENVIRON SCI TECHNOL, V42, P8330, DOI 10.1021/es801169k; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; BUTRUM RR, 1988, AM J CLIN NUTR, V48, P888; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Chandra S, 2005, SCI TOTAL ENVIRON, V347, P46, DOI 10.1016/j.scitotenv.2005.01.002; AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; Richardson SD, 2010, ANAL CHEM, V82, P4742, DOI 10.1021/ac101102d; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525; Biyani M, 2001, ELECTROPHORESIS, V22, P23; Carlton B. C., 1981, MANUAL METHODS GENER, P222; Carpi M., 2003, LCGC ASIA PAC, V6, P36; Futakami M, 2007, J BIOCHEM, V141, P675, DOI 10.1093/jb/mvm074; Futakami M, 2007, CHEM LETT, V36, P358, DOI 10.1246/cl.2007.358; Hilary N., 2007, TRANSPORT RES D-TR E, V12, P564; Koivusalo Meri, 1997, Reviews on Environmental Health, V12, P81; Lucia B., 2009, J INT ENV APPL SCI, V4, P357; Naimuddin M, 2000, GENE, V261, P243, DOI 10.1016/S0378-1119(00)00502-3; Nishigaki K, 2000, J BIOCHEM-TOKYO, V128, P107; Paul A. W., 1998, MUTAT RES, V410, P223; SAKUMA Y, 1994, J BIOCHEM-TOKYO, V116, P736	24	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	FEB	2015	157	2					113	119		10.1093/jb/mvu072		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA9WH	WOS:000349275000006		
J	Minami, T; Uranaka, Y; Tanaka, M; Negishi, K; Uchida, K; Masuda, M				Minami, Tomoyuki; Uranaka, Yasuko; Tanaka, Makoto; Negishi, Koji; Uchida, Keiji; Masuda, Munetaka			Coronary Subclavian Steal Syndrome Detected During Coronary Bypass Surgery in a Hemodialysis Patient	JOURNAL OF CARDIAC SURGERY			English	Article							INTERNAL THORACIC ARTERY; FISTULA	Coronary subclavian steal syndrome associated with upper extremity arteriovenous fistula is an uncommon but potentially life-threatening condition. We present a case of a 65-year-old male on hemodialysis with a left upper extremity arteriovenous fistula who underwent coronary revascularization involving bypass with the left internal thoracic artery to the left anterior descending artery. Intraoperative transit-time graft flow measurements and fluorescence imaging showed a reversed flow in the left internal thoracic artery, and the left internal thoracic artery was successfully converted as a free graft from the ascending aorta to the left anterior descending artery. doi: 10.1111/jocs.12444 (J Card Surg 2015;30:154-156)	[Minami, Tomoyuki; Uranaka, Yasuko; Tanaka, Makoto; Negishi, Koji] Yokohama Municipal Citizens Hosp, Cardiovasc Ctr, Hodogaya Ku, Yokohama, Kanagawa 2408555, Japan; [Uchida, Keiji] Yokohama City Univ, Cardiovasc Ctr, Med Ctr, Minami Ku, Yokohama, Kanagawa 232, Japan; [Masuda, Munetaka] Yokohama City Univ, Dept Surg, Kanazawa Ku, Yokohama, Kanagawa 232, Japan	Minami, T (reprint author), Yokohama Municipal Citizens Hosp, Hodogaya Ku, Okazawa Cho 56, Yokohama, Kanagawa 2408555, Japan.	tomo373@yokohama-cu.ac.jp					Gaudino M, 2003, CIRCULATION, V107, P2653, DOI 10.1161/01.CIR.0000074777.87467.73; Crowley SD, 2002, AM J KIDNEY DIS, V40, P852, DOI 10.1053/ajkd.2002.35701; Carrascal Y, 2010, ANN THORAC SURG, V90, P1004, DOI 10.1016/j.athoracsur.2010.02.097; Kato H, 2003, ANN THORAC SURG, V75, P270, DOI 10.1016/S0003-4975(02)04306-0; Nanda S, 2009, EUR J CARDIO-THORAC, V35, P740, DOI 10.1016/j.ejcts.2009.01.008; Rahbar R, 2006, ANN THORAC SURG, V81, P145, DOI 10.1016/j.athoracsur.2005.06.018; Ura M, 2001, ANN THORAC SURG, V71, P148, DOI 10.1016/S0003-4975(00)01700-8	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	FEB	2015	30	2					154	156		10.1111/jocs.12444		3	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CA4UO	WOS:000348901200006		
J	Minami, T; Imoto, K; Uchida, K; Karube, N; Yasuda, S; Choh, T; Suzuki, S; Masuda, M				Minami, Tomoyuki; Imoto, Kiyotaka; Uchida, Keiji; Karube, Norihisa; Yasuda, Shota; Choh, Tomoki; Suzuki, Shinichi; Masuda, Munetaka			Thoracic Endovascular Aortic Repair for Ruptured Descending Thoracic Aortic Aneurysm	JOURNAL OF CARDIAC SURGERY			English	Article							STENT-GRAFT PLACEMENT; SURGERY; OUTCOMES; INTERVENTIONS; DISSECTION; SECONDARY; NECROSIS; SOCIETY; ERA	BackgroundWe evaluated clinical outcomes of thoracic endovascular aortic repair (TEVAR) for ruptured descending thoracic aortic aneurysm (rDTAA). MethodsTwenty-three patients with rDTAA (mean age, 76.88.8 years) underwent TEVAR at our center between January 2008 and April 2013. ResultsIn twenty-three patients, five patients (21.7%) were in shock before surgery. Technical success was achieved in 21 patients. After TEVAR, retrograde Type A aortic dissection occurred in one patient, Type I endoleak in one patient, and Type II endoleak in three patients. The 30-day mortality rate was 4.3% (n=1), and there were five in-hospital deaths (21.7%). Six patients (26.1%) developed cerebral complications and two patients suffered from paraplegia. In the late phase, four patients died because of the following aortic events: re-rupture in one patient, rupture of another untreated aneurysm in two patients, and esophageal perforation in one patient. ConclusionsTEVAR is associated with relatively low early morbidity and mortality and can be performed in older and high-risk patients. However, because aortic events during follow-up after TEVAR are not rare, we recommend close follow-up and application of early and aggressive reintervention. doi: 10.1111/jocs.12499(J Card Surg 2015;30:163-169)	[Minami, Tomoyuki; Imoto, Kiyotaka; Uchida, Keiji; Karube, Norihisa; Yasuda, Shota; Choh, Tomoki] Yokohama City Univ, Med Ctr, Cardiovasc Ctr, Yokohama, Kanagawa 232, Japan; [Minami, Tomoyuki] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa 2408555, Japan; [Suzuki, Shinichi; Masuda, Munetaka] Yokohama City Univ Med, Dept Surg, Yokohama, Kanagawa, Japan	Minami, T (reprint author), Yokohama Municipal Citizens Hosp, Hodogaya Ku, Okazawa Cho 56, Yokohama, Kanagawa 2408555, Japan.	tomo373@yokohama-cu.ac.jp					Achneck HE, 2007, ANN THORAC SURG, V84, P1180, DOI 10.1016/j.athoracsur.2007.05.038; Cambria RP, 2002, ANN SURG, V236, P471, DOI 10.1097/01.SLA.0000031240.26001.E2; Jonker FHW, 2010, CIRCULATION, V121, P2718, DOI 10.1161/CIRCULATIONAHA.109.908871; Grabenwoger M, 2012, EUR HEART J, V33, P1558, DOI 10.1093/eurheartj/ehs074; Eggebrecht H, 2005, CATHETER CARDIO INTE, V66, P474, DOI 10.1002/ccd.20536; CRAWFORD ES, 1991, ANN SURG, V213, P417, DOI 10.1097/00000658-199105000-00006; Barbato JE, 2007, J VASC SURG, V45, P667, DOI 10.1016/j.jvs.2006.12.049; Amabile P, 2006, ANN VASC SURG, V20, P723, DOI 10.1007/s10016-006-9096-x; Matsumura JS, 2009, J VASC SURG, V50, P1155, DOI 10.1016/j.jvs.2009.08.090; Girardi LN, 2002, ANN THORAC SURG, V74, P1066, DOI 10.1016/S0003-4975(02)03849-3; JOHANSSON G, 1995, J VASC SURG, V21, P985, DOI 10.1016/S0741-5214(95)70227-X; Mitchell ME, 2011, J VASC SURG, V54, P1298, DOI 10.1016/j.jvs.2011.05.010; Patel HJ, 2009, J VASC SURG, V50, P1265, DOI 10.1016/j.jvs.2009.07.091; Doss M, 2005, J THORAC CARDIOV SUR, V129, P645, DOI 10.1016/j.jtcvs.2004.09.034; Estrera AL, 2001, ANN THORAC SURG, V72, P481, DOI 10.1016/S0003-4975(01)02679-0; Kaya A, 2006, ANN THORAC SURG, V82, P560, DOI 10.1016/j.athoracsur.2006.03.053; Lacombe M, 1971, Ann Thorac Surg, V11, P171; LEE KR, 1977, JAMA-J AM MED ASSOC, V237, P1233, DOI 10.1001/jama.237.12.1233; Minami T, 2013, EUR J CARDIO-THORAC, V44, P360, DOI 10.1093/ejcts/ezs703; Minatoya K, 2008, J THORAC CARDIOV SUR, V136, P431, DOI 10.1016/j.jtcvs.2008.03.034; Minatoya K, 2000, ANN THORAC SURG, V69, P1584, DOI 10.1016/S0003-4975(00)01183-8; Morishita K, 2004, ANN THORAC SURG, V78, P1630, DOI 10.1016/j.athoracsur.2004.05.014; Park NH, 2004, ANN THORAC SURG, V78, P2175, DOI 10.1016/j.athoracsur.2003.07.003; Scheinert D, 2004, EUR HEART J, V25, P694, DOI 10.1016/j.ehj.2004.02.022; Schermerhorn ML, 2008, J VASC SURG, V48, P821, DOI 10.1016/j.jvs.2008.05.022; Sugiura T, 2011, ANN THORAC SURG, V92, P568, DOI 10.1016/j.athoracsur.2011.04.031	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	FEB	2015	30	2					163	169		10.1111/jocs.12499		7	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CA4UO	WOS:000348901200008		
J	Hokimoto, S; Tabata, N; Akasaka, T; Arima, Y; Kaikita, K; Morita, K; Kumagae, N; Oniki, K; Nakagawa, K; Ogawa, H				Hokimoto, Seiji; Tabata, Noriaki; Akasaka, Tomonori; Arima, Yuichiro; Kaikita, Koichi; Morita, Kazunori; Kumagae, Naoki; Oniki, Kentaro; Nakagawa, Kazuko; Ogawa, Hisao			Gender Differences in Impact of CYP2C19 Polymorphism on Development of Coronary Artery Disease	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						gender; CYP2C19 polymorphism; coronary artery disease	ASSOCIATION TASK-FORCE; ACCF/AHA FOCUSED UPDATE; MYOCARDIAL-INFARCTION; PRACTICE GUIDELINES; SEX-DIFFERENCES; CLOPIDOGREL; RISK; MANAGEMENT; JAPANESE; METABOLISM	The aim was to clarify whether CYP2C19 polymorphism is associated with the development of coronary artery disease (CAD). This study enrolled 723 patients with CAD (men 71%, 70 years) and healthy subjects undergoing a medical checkup (n = 453) as controls (men 69%, 53 years). We analyzed the incidence of CYP2C19 polymorphism and its association with the development of CAD in the absence of diabetes, dyslipidemia, and chronic kidney disease to minimize the influence of conventional coronary risk factors. In the analysis without risk factors, there was no difference in the incidence of the CYP2C19 genotype between CAD (n = 115) and control (n = 194) groups [extensive metabolizer, intermediate metabolizer, poor metabolizer (PM) in non-risk CAD: 33%, 46%, 21%, respectively; in non-risk control: 31%, 52%, 17%, respectively]. Analysis between CAD and control groups by the chi(2) test showed that there was significant difference in distribution of CYP2C19 genotype in women alone (P = 0.025) but not in total subjects (P = 0.471) or men (P = 0.678), respectively. CYP2C19 PM was an independent predictor of CAD risk in women alone (odds ratio, 10.717; 95% confidence interval, 1.753-65.505; P = 0.010) but not in men. CYP2C19 PM status might be associated with the development of CAD as a disease susceptibility gene, especially in women.	[Hokimoto, Seiji; Tabata, Noriaki; Akasaka, Tomonori; Arima, Yuichiro; Kaikita, Koichi; Morita, Kazunori; Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Morita, Kazunori; Kumagae, Naoki; Oniki, Kentaro; Nakagawa, Kazuko] Kumamoto Univ, Div Pharmacol & Therapeut, Grad Sch Med & Pharmaceut Sci, Kumamoto 8608556, Japan	Hokimoto, S (reprint author), Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	shokimot@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Wright RS, 2011, J AM COLL CARDIOL, V57, P1920, DOI 10.1016/j.jacc.2011.02.009; Spiecker M, 2004, CIRCULATION, V110, P2132, DOI 10.1161/01.CIR.0000143832.91812.60; Kubota T, 1996, CLIN PHARMACOL THER, V60, P661, DOI 10.1016/S0009-9236(96)90214-3; Zhang R, 2012, AM J PHYSIOL-HEART C, V303, pH1183, DOI 10.1152/ajpheart.00327.2012; Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132; Kajiwara A, 2013, PHARMACOGENET GENOM, V23, P717, DOI 10.1097/FPC.0000000000000009; Elbekai RH, 2006, PHARMACOL THERAPEUT, V112, P564, DOI 10.1016/j.pharmthera.2005.05.011; Hokimoto S, 2014, THROMB RES, V133, P599, DOI 10.1016/j.thromres.2014.01.003; Bylund J, 1998, ANAL BIOCHEM, V265, P55, DOI 10.1006/abio.1998.2897; Ercan B, 2008, CELL BIOCHEM FUNCT, V26, P309, DOI 10.1002/cbf.1437; Yamamoto K, 2011, J CARDIOL, V57, P194, DOI 10.1016/j.jjcc.2010.10.007; Fer M, 2008, J LIPID RES, V49, P2379, DOI 10.1194/jlr.M800199-JLR200; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015; Mizobe M, 2014, THROMB RES, V134, P72, DOI 10.1016/j.thromres.2014.04.020; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Bertrand-Thiebault C, 2008, ANN HUM GENET, V72, P178, DOI 10.1111/j.1469-1809.2007.00417.x; Borgel J, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-41; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Shahabi P, 2014, PHARMACOL THERAPEUT, V164, P134; Tabata N, 2014, THROMB RES IN PRESS; Villar IC, 2008, J ENDOCRINOL, V197, P447, DOI 10.1677/JOE-08-0070; Visser LE, 2007, PHARMACOGENET GENOM, V17, P473; Zordoky BNM, 2010, PHARMACOL THERAPEUT, V125, P446, DOI 10.1016/j.pharmthera.2009.12.002	26	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0160-2446	1533-4023		J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	FEB	2015	65	2					148	152				5	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CB0KE	WOS:000349313800008		
J	Tawa, M; Shimosato, T; Iwasaki, H; Imamura, T; Okamura, T				Tawa, Masashi; Shimosato, Takashi; Iwasaki, Hirotaka; Imamura, Takeshi; Okamura, Tomio			Different Influences of Extracellular and Intracellular Superoxide on Relaxation Through the NO/sGC/cGMP Pathway in Isolated Rat Iliac Arteries	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						cGMP; nitric oxide; soluble guanylate cyclase; superoxide; vasorelaxation	SOLUBLE GUANYLATE-CYCLASE; SMOOTH-MUSCLE RELAXATION; NITRIC-OXIDE; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; VASCULAR-DISEASE; CORONARY-ARTERY; HEME; NO; INVOLVEMENT	Superoxide production is increased in diseased blood vessels, which is considered to lead to impairment of the nitric oxide (NO)/soluble guanylate cyclase (sGC)/cGMP pathway. To investigate the respective influence of extracellular and intracellular superoxide on vascular function through the NO/sGC/cGMP pathway, mechanical responses of rat external iliac arteries without endothelium were studied under exposure to a superoxide-generating agent, pyrogallol, or menadione. Exposure to pyrogallol impaired the relaxation induced by acidified NaNO2 (exogenous NO) but not that by nitroglycerin (organic nitrate), BAY 41-2272 (sGC stimulator), BAY 60-2770 (sGC activator), or 8-Br-cGMP (cGMP analog). Superoxide dismutase (SOD) and tempol restored the impaired relaxation by acidified NaNO2. Superoxide production in the bathing solution, but not in artery segments, was significantly increased by exposure to pyrogallol, which was abolished in the presence of SOD or tempol. However, exposure to menadione impaired the relaxant response to acidified NaNO2, nitroglycerin, or BAY 41-2272, whereas it augmented that to BAY 60-2770. Also, this exposure had no effect on the 8-Br-cGMP-induced vasorelxation. Superoxide production in artery segments was dramatically enhanced by exposure to menadione, whereas that in the bathing solution was not affected. This increase in vascular superoxide production was normalized by tempol but not by SOD. These findings suggest that extracellular superoxide reacts with NO only outside the cell, whereas intracellular superoxide not only scavenges NO inside the cell but also shifts the sGC redox equilibrium.	[Tawa, Masashi; Shimosato, Takashi; Iwasaki, Hirotaka; Imamura, Takeshi; Okamura, Tomio] Shiga Univ Med Sci, Dept Pharmacol, Otsu, Shiga 5202192, Japan	Tawa, M (reprint author), Shiga Univ Med Sci, Dept Pharmacol, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	tawa@belle.shiga-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23390055]	Supported in part by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (grant number 23390055).	LYNCH RE, 1978, J BIOL CHEM, V253, P4697; Rabinowitz JD, 1998, J AM CHEM SOC, V120, P2464, DOI 10.1021/ja973560f; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; MAO GD, 1992, FEBS LETT, V305, P233, DOI 10.1016/0014-5793(92)80675-7; Schmidt Harald H. H. W., 2009, V191, P309; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; RAPOPORT RM, 1983, NATURE, V306, P174, DOI 10.1038/306174a0; Wunder F, 2005, ANAL BIOCHEM, V339, P104, DOI 10.1016/j.ab.2004.12.025; Wang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL570, DOI 10.1152/ajplung.00262.2005; Schrammel A, 1996, MOL PHARMACOL, V50, P1; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Tawa M, 2011, J PHARMACOL SCI, V116, P188, DOI 10.1254/jphs.11031FP; Roy B, 2008, BRIT J PHARMACOL, V153, P1495, DOI 10.1038/sj.bjp.0707687; Stasch Johannes-Peter, 2009, V191, P277; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P29, DOI 10.1161/01.ATV.0000150649.39934.13; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Krishna MC, 1996, J BIOL CHEM, V271, P26018; Virdis A, 2013, HYPERTENSION, V62, P337, DOI 10.1161/HYPERTENSIONAHA.111.00995; Leopold JA, 2005, ARTERIOSCL THROM VAS, V25, P1332, DOI 10.1161/01.ATV.0000163846.51473.09; Weitz JI, 1996, CIRCULATION, V94, P3026; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Chester M, 2011, AM J PHYSIOL-LUNG C, V301, pL755, DOI 10.1152/ajplung.00138.2010; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; GOLDSTEIN S, 1995, FREE RADICAL BIO MED, V19, P505, DOI 10.1016/0891-5849(95)00034-U; Haj-Yehia AI, 1999, ANTIOXID REDOX SIGN, V1, P221, DOI 10.1089/ars.1999.1.2-221; Hanspal IS, 2002, NITRIC OXIDE-BIOL CH, V6, P263, DOI 10.1006/niox.2001.0412; THOR H, 1982, J BIOL CHEM, V257, P2419; IGNARRO LJ, 1988, J PHARMACOL EXP THER, V244, P181; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; Kaw S, 1999, N-S ARCH PHARMACOL, V359, P133, DOI 10.1007/PL00005332; Kwak CJ, 2009, J HYPERTENS, V27, P92, DOI 10.1097/HJH.0b013e3283186994; Lee JY, 2001, CHEM-BIOL INTERACT, V137, P169, DOI 10.1016/S0009-2797(01)00235-6; Li CG, 1996, BRIT J PHARMACOL, V118, P57; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; Minoves N, 2002, CLIN SCI, V103, P239; Samuni AM, 2001, BBA-GEN SUBJECTS, V1525, P70, DOI 10.1016/S0304-4165(00)00172-0; Schmidt P, 2003, PROTEIN EXPRES PURIF, V31, P42, DOI 10.1016/S1046-5928(03)00142-6; Tawa M, 2014, J PHARMACOL SCI, V125, P169, DOI 10.1254/jphs.14046FP; TODA N, 1992, HYPERTENSION, V19, P161; Zhou ZM, 2008, AM J PHYSIOL-HEART C, V295, pH1763, DOI 10.1152/ajpheart.51.2008	43	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0160-2446	1533-4023		J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	FEB	2015	65	2					160	167				8	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	CB0KE	WOS:000349313800010		
J	Yumimoto, K; Akiyoshi, S; Ueo, H; Sagara, Y; Onoyama, I; Ueo, H; Ohno, S; Mori, M; Mimori, K; Nakayama, KI				Yumimoto, Kanae; Akiyoshi, Sayuri; Ueo, Hiroki; Sagara, Yasuaki; Onoyama, Ichiro; Ueo, Hiroaki; Ohno, Shinji; Mori, Masaki; Mimori, Koshi; Nakayama, Keiichi I.			F-box protein FBXW7 inhibits-cancer metastasis in a non-cell-autonomous manner	JOURNAL OF CLINICAL INVESTIGATION			English	Article							NOTCH INTRACELLULAR DOMAIN; SCFFBW7 UBIQUITIN LIGASE; HUMAN ENDOTHELIAL-CELLS; MESENCHYMAL STEM-CELLS; TUMOR-SUPPRESSOR; CYCLIN-E; C-MYC; MICE; FBW7; DEGRADATION	The gene encoding F-box protein FBXW7 is frequently mutated in many human cancers. Although most previous studies have focused on the tumor-suppressive capacity of FBXW7 in tumor cells themselves, we determined that FBXW7 in the host microenvironment also suppresses cancer metastasis. Deletion of Fbxw7 in murine BM-derived stromal cells induced accumulation of NOTCH and consequent transcriptional activation of Ccl2. FBXW7-deficient mice exhibited increased serum levels of the chemokine CCL2, which resulted in the recruitment of both monocytic myeloid-derived suppressor cells and macrophages, thereby promoting metastatic tumor growth. Administration of a CCL2 receptor antagonist blocked the enhancement of metastasis in FBXW7-deficient mice. Furthermore, in human breast cancer patients, FBXW7 expression in peripheral blood was associated with serum CCL2 concentration and disease prognosis. Together, these results suggest that FBXW7 antagonizes cancer development in not only a cell-autonomous manner, but also a non-cell-autonomous manner, and that modulation of the FBXW7/NOTCH/CCL2 axis may provide a potential approach to suppression of cancer metastasis.	[Yumimoto, Kanae; Onoyama, Ichiro; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Akiyoshi, Sayuri; Ueo, Hiroki; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita, Japan; [Sagara, Yasuaki] Sagara Hosp, Kagoshima, Japan; [Ueo, Hiroaki] Ueo Breast Surg Hosp, Oita, Japan; [Ohno, Shinji] Natl Hosp Org, Kyushu Canc Ctr, Clin Res Inst, Fukuoka, Japan; [Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan	Nakayama, KI (reprint author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp			Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)	We thank T. Honjo for RbpJk<SUP>fl/fl</SUP> mice; I.M. de Alboran for c-Myc<SUP>fl/fl</SUP> mice; K. Rajewsky for Mx1-Cre transgenic mice; M. Okabe for CAG-EGFP transgenic mice; S. Okano for B16F1 melanoma cells; T. Kitamura for pMX-puro; Sanwa Kagaku Kenkyusho Co. for propagermanium; A. Kataoka for collection of BM and peripheral blood from breast cancer patients; S. Tokunaga for comments on statistical analysis; Y. Tateishi, S. Yamamura, K. Watanabe, N. Nishimura, K. Tsunematsu, A. Niihara, M. Tanaka, K. Motomura, and N. Kinoshita for technical assistance; members of our laboratories for comments on the manuscript; and A. Ohta for help with manuscript preparation. This work was supported in part by a grant from the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT).	Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Babaei-Jadidi R, 2011, J EXP MED, V208, P295, DOI 10.1084/jem.20100830; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; Lu Y, 2007, INT J CANCER, V121, P724, DOI 10.1002/ijc.22704; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Allers C, 2004, TRANSPLANTATION, V78, P503, DOI 10.1097/01.TP.0000128334.93343.B3; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Ross DA, 2001, MOL CELL BIOL, V21, P7537, DOI 10.1128/MCB.21.22.7537-7544.2001; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Youn JI, 2008, J IMMUNOL, V181, P5791; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Van Coillie E, 1999, CYTOKINE GROWTH F R, V10, P61, DOI 10.1016/S1359-6101(99)00005-2; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Salcedo R, 2000, BLOOD, V96, P34; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; STANDIFORD TJ, 1991, J BIOL CHEM, V266, P9912; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Khaled YS, 2013, IMMUNOL CELL BIOL, V91, P493, DOI 10.1038/icb.2013.29; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LING PD, 1993, P NATL ACAD SCI USA, V90, P9237, DOI 10.1073/pnas.90.20.9237; Molloy AP, 2009, INT J CANCER, V124, P326, DOI 10.1002/ijc.23939; Mukaida N, 2011, EXP CELL RES, V318, P95; Nagahara H, 2005, CLIN CANCER RES, V11, P6800, DOI 10.1158/1078-0432.CCR-05-0943; Silzle T, 2003, EUR J IMMUNOL, V33, P1311, DOI 10.1002/eji.200323057; Zhu XM, 2011, J NEURO-ONCOL, V104, P83, DOI 10.1007/s11060-010-0473-5	70	7	7	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	FEB	2015	125	2					621	635		10.1172/JCI78782		15	Medicine, Research & Experimental	Research & Experimental Medicine	CA5QK	WOS:000348962700020		
J	Okabayashi, T; Sasaki, T; Masrinoul, P; Chantawat, N; Yoksan, S; Nitatpattana, N; Chusri, S; Vargas, REM; Grandadam, M; Brey, PT; Soegijanto, S; Mulyantno, KC; Churrotin, S; Kotaki, T; Faye, O; Faye, O; Sow, A; Sall, AA; Puiprom, O; Chaichana, P; Kurosu, T; Kato, S; Kosaka, M; Ramasoota, P; Ikuta, K				Okabayashi, Tamaki; Sasaki, Tadahiro; Masrinoul, Promsin; Chantawat, Nantarat; Yoksan, Sutee; Nitatpattana, Narong; Chusri, Sarunyou; Vargas, Ronald E. Morales; Grandadam, Marc; Brey, Paul T.; Soegijanto, Soegeng; Mulyantno, Kris Cahyo; Churrotin, Siti; Kotaki, Tomohiro; Faye, Oumar; Faye, Ousmane; Sow, Abdourahmane; Sall, Amadou Alpha; Puiprom, Orapim; Chaichana, Panjaporn; Kurosu, Takeshi; Kato, Seiji; Kosaka, Mieko; Ramasoota, Pongrama; Ikuta, Kazuyoshi			Detection of Chikungunya Virus Antigen by a Novel Rapid Immunochromatographic Test	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							DIAGNOSIS; INFECTION; DENGUE; FEVER; TRAVELERS; ACCURACY; DISEASE; PROTEIN; ASSAY	Chikungunya fever is a mosquito-borne disease of key public health importance in tropical and subtropical countries. Although severe joint pain is the most distinguishing feature of chikungunya fever, diagnosis remains difficult because the symptoms of chikungunya fever are shared by many pathogens, including dengue fever. The present study aimed to develop a new immunochromatographic diagnosis test for the detection of chikungunya virus antigen in serum. Mice were immunized with isolates from patients with Thai chikungunya fever, East/Central/South African genotype, to produce mouse monoclonal antibodies against chikungunya virus. Using these monoclonal antibodies, a new diagnostic test was developed and evaluated for the detection of chikungunya virus. The newly developed diagnostic test reacted with not only the East/Central/South African genotype but also with the Asian and West African genotypes of chikungunya virus. Testing of sera from patients suspected to have chikungunya fever in Thailand (n = 50), Laos (n = 54), Indonesia (n = 2), and Senegal (n = 6) revealed sensitivity, specificity, and real-time PCR (RT-PCR) agreement values of 89.4%, 94.4%, and 91.1%, respectively. In our study using serial samples, a new diagnostic test showed high agreement with the RT-PCR within the first 5 days after onset. A rapid diagnostic test was developed using mouse monoclonal antibodies that react with chikungunya virus envelope proteins. The diagnostic accuracy of our test is clinically acceptable for chikungunya fever in the acute phase.	[Okabayashi, Tamaki; Masrinoul, Promsin; Chantawat, Nantarat; Puiprom, Orapim; Chaichana, Panjaporn] Mahidol Univ, Fac Trop Med, Mahidol Osaka Ctr Infect Dis, Bangkok, Thailand; [Vargas, Ronald E. Morales] Mahidol Univ, Fac Trop Med, Dept Med Entomol, Bangkok, Thailand; [Ramasoota, Pongrama] Mahidol Univ, Fac Trop Med, Ctr Excellence Antibody Res, Bangkok, Thailand; [Masrinoul, Promsin; Yoksan, Sutee; Nitatpattana, Narong] Mahidol Univ, Ctr Vaccine Dev, Nakhon Pathom, Thailand; [Chusri, Sarunyou] Prince Songkla Univ, Fac Med, Dept Internal Med, Div Infect Dis, Hat Yai, Thailand; [Okabayashi, Tamaki; Sasaki, Tadahiro; Kurosu, Takeshi; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Osaka, Japan; [Grandadam, Marc; Brey, Paul T.] Inst Pasteur Laos, Viangchan, Laos; [Soegijanto, Soegeng; Mulyantno, Kris Cahyo; Churrotin, Siti; Kotaki, Tomohiro] Airlangga Univ, Inst Trop Dis, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Surabaya, Indonesia; [Kotaki, Tomohiro] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo, Japan; [Faye, Oumar; Faye, Ousmane; Sow, Abdourahmane; Sall, Amadou Alpha] Inst Pasteur, Arboviruses & Viral Hemorrhag Fever Unit, Dakar, Senegal; [Kato, Seiji; Kosaka, Mieko] Alfresa Pharma Corp, Osaka, Japan; [Kosaka, Mieko] Arkray Inc, Kyoto, Japan	Okabayashi, T (reprint author), Mahidol Univ, Fac Trop Med, Mahidol Osaka Ctr Infect Dis, Bangkok, Thailand.	tamaoka@biken.osaka-u.ac.jp			Japan Initiative for Global Research Network on Infectious Diseases; Alfresa Pharma Corporation	This work was supported by a program of the Japan Initiative for Global Research Network on Infectious Diseases, directed by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by Alfresa Pharma Corporation.	Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Powers AM, 2000, J GEN VIROL, V81, P471; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11; Masrinoul P, 2014, VIROLOGY, V464, P111, DOI 10.1016/j.virol.2014.05.038; Lim CK, 2009, AM J TROP MED HYG, V81, P865, DOI 10.4269/ajtmh.2009.09-0009; Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16; Grivard P, 2007, PATHOL BIOL, V55, P490, DOI 10.1016/j.patbio.2007.07.002; Chopra A, 2008, ARTHRITIS RHEUM, V58, P2921, DOI 10.1002/art.23753; Mourya DT, 2006, LANCET, V368, P186, DOI 10.1016/S0140-6736(06)69017-X; Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P1773, DOI 10.1128/CVI.05288-11; Kanai Y, 2010, VIRUS RES, V153, P218, DOI 10.1016/j.virusres.2010.08.005; Kang BK, 2007, J VET DIAGN INVEST, V19, P78; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Mulyatno KC, 2012, JPN J INFECT DIS, V65, P92; Nishizono A, 2008, MICROBIOL IMMUNOL, V52, P243, DOI 10.1111/j.1348-0421.2008.00031.x; Puiprom O, 2013, INFECT GENET EVOL, V17, P210, DOI 10.1016/j.meegid.2013.04.005; Rianthavorn P, 2010, SE ASIAN J TROP MED, V41, P92; Sasayama M, 2014, 2010 VIRUS GENES, V49, P485; STRAUSS JH, 1995, TRENDS MICROBIOL, V3, P346, DOI 10.1016/S0966-842X(00)88973-8; Takanashi S, 2008, J VIROL METHODS, V148, P1, DOI 10.1016/j.jviromet.2007.10.010; Watthanaworawit W, 2011, T ROY SOC TROP MED H, V105, P32, DOI 10.1016/j.trstmh.2010.09.007	26	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	FEB	2015	53	2					382	388		10.1128/JCM.02033-14		7	Microbiology	Microbiology	AZ9XU	WOS:000348568500004		
J	German, AC; Iturriza-Gomara, M; Dove, W; Sandrasegaram, M; Nakagomi, T; Nakagomi, O; Cunliffe, N; Radford, AD; Morgan, KL				German, A. C.; Iturriza-Gomara, M.; Dove, W.; Sandrasegaram, M.; Nakagomi, T.; Nakagomi, O.; Cunliffe, N.; Radford, A. D.; Morgan, K. L.			Molecular Epidemiology of Rotavirus in Cats in the United Kingdom	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							GROUP-A ROTAVIRUSES; RNA-RNA HYBRIDIZATION; VIRUS-LIKE PARTICLES; CANINE ROTAVIRUS; ACUTE GASTROENTERITIS; SEQUENCE-ANALYSIS; GENETIC-CHARACTERIZATION; PORCINE ROTAVIRUS; SEROTYPE G6; INTERSPECIES TRANSMISSION	Rotaviruses are leading causes of gastroenteritis in the young of many species. Molecular epidemiological studies in children suggest that interspecies transmission contributes to rotavirus strain diversity in people. However, population-based studies of rotaviruses in animals are few. We investigated the prevalence, risk factors for infection, and genetic diversity of rotavirus A in a cross-sectional survey of cats housed within 25 rescue catteries across the United Kingdom. Morning litter tray fecal samples were collected during the winter and summer in 2012 from all pens containing kittens and a random sample of those housing adult cats. Group A rotavirus RNA was detected by real-time reverse transcription-PCR, and positive samples were G and P genotyped using nested VP4 and VP7 PCR assays. A total of 1,727 fecal samples were collected from 1,105 pens. Overall, the prevalence of rotavirus was 3.0% (95% confidence interval [CI], 1.2 to 4.9%). Thirteen out of 25 (52%; 95% CI, 31.3 to 72.2%) centers housed at least one rotavirus-positive cat. The prevalence of rotavirus was associated with season (odds ratio, 14.8 [95% CI, 1.1 to 200.4]; P = 0.04) but not age or diarrhea. It was higher during the summer (4.7%; 95% CI, 1.2 to 8.3%) than in winter (0.8%; 95% CI, 0.2 to 1.5%). Asymptomatic epidemics of infection were detected in two centers. G genotypes were characterized for 19 (33.3%) of the 57 rotavirus-positive samples and P genotypes for 36 (59.7%). Two rotavirus genotypes were identified, G3P[9] and G6P[9]. This is the first population-based study of rotavirus in cats and the first report of feline G6P[9], which questions the previous belief that G6P[9] in people is of bovine origin.	[German, A. C.; Iturriza-Gomara, M.; Dove, W.; Sandrasegaram, M.; Cunliffe, N.; Radford, A. D.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [German, A. C.; Radford, A. D.; Morgan, K. L.] Univ Liverpool, Sch Vet Sci, Wirral L64 7TE, Merseyside, England; [Nakagomi, T.; Nakagomi, O.] Nagasaki Univ, Nagasaki 852, Japan; [Morgan, K. L.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England	German, AC (reprint author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.	allison.german@liv.ac.uk			RCVS Charitable Trust Blue Sky [BSR11 1428]; Institute of Infection and Global Health, University of Liverpool	This work was supported by an RCVS Charitable Trust Blue Sky award in virology (BSR11 1428) and internal funding from the Institute of Infection and Global Health, University of Liverpool.	ABOUDY Y, 1988, J MED VIROL, V25, P351, DOI 10.1002/jmv.1890250312; Doan YH, 2013, J CLIN MICROBIOL, V51, P182, DOI 10.1128/JCM.02062-12; GERNA G, 1992, J CLIN MICROBIOL, V30, P9; NAKAGOMI O, 1985, J MED VIROL, V17, P29, DOI 10.1002/jmv.1890170105; Ghosh S, 2010, J GEN VIROL, V91, P2367, DOI 10.1099/vir.0.022244-0; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; De Grazia S, 2011, INFECT GENET EVOL, V11, P1449, DOI 10.1016/j.meegid.2011.05.015; Banyai K, 2003, J MED VIROL, V71, P124, DOI 10.1002/jmv.10462; Cho YI, 2013, VET MICROBIOL, V166, P375, DOI 10.1016/j.vetmic.2013.07.001; Banyai K, 2009, J MED VIROL, V81, P362, DOI 10.1002/jmv.21375; Iturriza-Gomara M, 2009, J INFECT DIS, V200, pS215, DOI 10.1086/605049; Atchison CJ, 2010, P R SOC B, V277, P933, DOI 10.1098/rspb.2009.1755; He B, 2013, J VIROL, V87, P12357, DOI 10.1128/JVI.02013-13; Griffin DD, 2002, VIROLOGY, V294, P256, DOI 10.1006/viro.2001.1333; FU ZF, 1987, RES VET SCI, V43, P297; Miyazaki A, 2013, VET MICROBIOL, V163, P162, DOI 10.1016/j.vetmic.2012.11.044; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Afrad MH, 2013, INFECT GENET EVOL, V19, P120, DOI 10.1016/j.meegid.2013.06.030; Steyer A, 2013, INFECT GENET EVOL, V13, P89, DOI 10.1016/j.meegid.2012.09.004; Pratelli A, 1999, MICROBIOLOGICA, V22, P105; Dhama K, 2009, VET RES COMMUN, V33, P1, DOI 10.1007/s11259-008-9070-x; NAKAGOMI T, 1989, J VIROL, V63, P1431; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Diwakarla S, 2002, MICROBIOL IMMUNOL, V46, P499; Palombo EA, 2002, VIRUS GENES, V24, P11, DOI 10.1023/A:1014073618253; Mino S, 2013, VET MICROBIOL, V161, P239, DOI 10.1016/j.vetmic.2012.07.033; Mukhopadhya I, 2013, J MED VIROL, V85, P1661, DOI 10.1002/jmv.23641; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Gazal S, 2012, VET J, V193, P299, DOI 10.1016/j.tvjl.2011.11.018; Santos N, 2001, J CLIN MICROBIOL, V39, P1157, DOI 10.1128/JCM.39.3.1157-1160.2001; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Abe M, 2011, J GEN VIROL, V92, P952, DOI 10.1099/vir.0.028175-0; Martella V, 2011, J GEN VIROL, V92, P1214, DOI 10.1099/vir.0.027425-0; Matthijnssens J, 2008, J GEN VIROL, V89, P2630, DOI 10.1099/vir.0.2008/003780-0; Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004; Netherwood T, 1996, EPIDEMIOL INFECT, V117, P375; Khamrin P, 2006, J MED VIROL, V78, P986, DOI 10.1002/jmv.20651; Monini M, 2011, VET MICROBIOL, V149, P248, DOI 10.1016/j.vetmic.2010.11.007; FITZGERALD TA, 1995, ARCH VIROL, V140, P1541, DOI 10.1007/BF01322528; Coyne KP, 2007, J CLIN MICROBIOL, V45, P3239, DOI 10.1128/JCM.01226-07; GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1338; Parra GI, 2008, VET MICROBIOL, V126, P243, DOI 10.1016/j.vetmic.2007.06.06; Ergler CR, 2013, SOC SCI MED, V91, P178, DOI 10.1016/j.socscimed.2012.11.034; Pitzer VE, 2011, J R SOC INTERFACE, V8, P1584, DOI 10.1098/rsif.2011.0062; Patel MM, 2013, PEDIATR INFECT DIS J, V32, pE134, DOI 10.1097/INF.0b013e31827d3b68; Cooney MA, 2001, J MED MICROBIOL, V50, P462; ARCHAMBAULT D, 1990, J VET MED B, V37, P73; Banerjee I, 2007, J MED VIROL, V79, P1768, DOI 10.1002/jmv.20988; BIRCH CJ, 1985, J GEN VIROL, V66, P2731, DOI 10.1099/0022-1317-66-12-2731; BOHL EH, 1979, J AM VET MED ASSOC, V174, P613; BRIDGER JC, 1987, J GEN VIROL, V68, P2311, DOI 10.1099/0022-1317-68-9-2311; Chang KO, 2000, ARCH VIROL, V145, P725, DOI 10.1007/s007050050666; Civardi E, 2013, AM J INFECT CONTROL, V41, P854, DOI 10.1016/j.ajic.2013.01.026; Collins PJ, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-13; DEBOUCK P, 1983, ANN RECH VET, V14, P447; De Grazia S, 2007, EMERG INFECT DIS, V13, P1091, DOI 10.3201/eid1307.070239; Estes M, 2007, FIELDS VIROLOGY, V2, P1917; Eurorota: Rotavirus Surveillance Network, 2009, APP 2 ROT DET TYP ME; Fredj MB, 2013, EMERG INFECT DIS, V19, P630, DOI 10.3201/eid1904.121383; FULTON RW, 1981, AM J VET RES, V42, P841; Gaskell RM, 2010, TXB VET INTERNAL MED, V1, P946; GELBERG HB, 1991, VET MICROBIOL, V28, P213, DOI 10.1016/0378-1135(91)90077-S; Ghosh S, 2007, ARCH VIROL, V152, P1935, DOI 10.1007/s00705-007-1009-y; GOUVEA V, 1993, J CLIN MICROBIOL, V31, P917; De Grazia S, 2008, J CLIN MICROBIOL, V46, P357, DOI 10.1128/JCM.01593-07; HOSHINO Y, 1983, INFECT IMMUN, V41, P169; HOSHINO Y, 1981, J GEN VIROL, V54, P313, DOI 10.1099/0022-1317-54-2-313; HOSHINO Y, 1982, ARCH VIROL, V72, P113, DOI 10.1007/BF01314456; Iturriza-Gomara M, 2013, P 5 EUR ROT BIOL M 6; JOCHLE W, 1993, J REP FER S, P419; Kang BK, 2007, J VET DIAGN INVEST, V19, P78; Khamrin P, 2007, J MED VIROL, V79, P843, DOI 10.1002/jmv.20840; Lee JB, 2003, ARCH VIROL, V148, P643, DOI 10.1007/s00705-002-0963-7; LI BG, 1993, VIROLOGY, V196, P825, DOI 10.1006/viro.1993.1540; MALHERBE HH, 1967, ARCH GES VIRUSFORSCH, V22, P235, DOI 10.1007/BF01240518; MARSHALL JA, 1987, AUST VET J, V64, P100, DOI 10.1111/j.1751-0813.1987.tb09638.x; MARSHALL JA, 1984, AUST VET J, V61, P33, DOI 10.1111/j.1751-0813.1984.tb07186.x; Martella V, 2001, J VIROL METHODS, V96, P43, DOI 10.1016/S0166-0934(01)00312-3; MCNULTY MS, 1978, VET REC, V102, P534; MOCHIZUKI M, 1984, JPN J VET SCI, V46, P905; MOCHIZUKI M, 1992, ARCH VIROL, V122, P373, DOI 10.1007/BF01317199; Mochizuki M, 1997, J CLIN MICROBIOL, V35, P1272; MOCHIZUKI M, 1987, JPN J VET SCI, V49, P159; MUNOZ M, 1995, VET MICROBIOL, V45, P351, DOI 10.1016/0378-1135(95)00002-R; NAKAGOMI O, 1990, J CLIN MICROBIOL, V28, P1198; Nakagomi T, 2000, ARCH VIROL, V145, P2403, DOI 10.1007/s007050070029; Novikova N A, 2008, Vopr Virusol, V53, P35; Oka T, 2001, MICROBIOL IMMUNOL, V45, P173; Okada N, 2002, VET MICROBIOL, V84, P297, DOI 10.1016/S0378-1135(01)00445-X; Pisanelli G, 2005, VET MICROBIOL, V110, P1, DOI 10.1016/j.vetmic.2005.06.013; Ruiz VLA, 2009, ARQ BRAS MED VET ZOO, V61, P996, DOI 10.1590/S0102-09352009000400031; Santos N, 1998, MOL CELL PROBE, V12, P379, DOI 10.1006/mcpr.1998.0198; Schoondermark-van de Ven E, 2013, VET MICROBIOL, V166, P154, DOI 10.1016/j.vetmic.2013.05.028; El Sherif M, 2011, INFECT GENET EVOL, V11, P1436, DOI 10.1016/j.meegid.2011.05.012; SILBERSTEIN I, 1995, J CLIN MICROBIOL, V33, P1421; SNODGRASS DR, 1979, VET REC, V104, P222; Wastlhuber J., 1991, Feline husbandry: diseases and management in the multiple-cat environment., P1; Westerman LE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-40; World Health Organisation, 2013, WKLY EPIDEMIOL REC, V88, P49; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P220; Yamaguchi N, 1996, EPIDEMIOL INFECT, V116, P217; Yamamoto D, 2011, VIRUS GENES, V43, P215, DOI 10.1007/s11262-011-0624-6	102	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	FEB	2015	53	2					455	464		10.1128/JCM.02266-14		10	Microbiology	Microbiology	AZ9XU	WOS:000348568500013		
J	Kuramitsu, M; Okuma, K; Yamagishi, M; Yamochi, T; Firouzi, S; Momose, H; Mizukami, T; Takizawa, K; Araki, K; Sugamura, K; Yamaguchi, K; Watanabe, T; Hamaguchi, I				Kuramitsu, Madoka; Okuma, Kazu; Yamagishi, Makoto; Yamochi, Tadanori; Firouzi, Sanaz; Momose, Haruka; Mizukami, Takuo; Takizawa, Kazuya; Araki, Kumiko; Sugamura, Kazuo; Yamaguchi, Kazunari; Watanabe, Toshiki; Hamaguchi, Isao			Identification of TL-Om1, an Adult T-Cell Leukemia (ATL) Cell Line, as Reference Material for Quantitative PCR for Human T-Lymphotropic Virus 1	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							POLYMERASE-CHAIN-REACTION; HTLV-1 PROVIRAL LOAD; BLOOD-DONORS; TYPE-1; INTEGRATION; INFECTION; CARRIERS; DISEASE; DNA; QUANTIFICATION	Quantitative PCR (qPCR) for human T-lymphotropic virus 1 (HTLV-1) is useful for measuring the amount of integrated HTLV-1 proviral DNA in peripheral blood mononuclear cells. Many laboratories in Japan have developed different HTLV-1 qPCR methods. However, when six independent laboratories analyzed the proviral load of the same samples, there was a 5-fold difference in their results. To standardize HTLV-1 qPCR, preparation of a well-defined reference material is needed. We analyzed the integrated HTLV-1 genome and the internal control (IC) genes of TL-Om1, a cell line derived from adult T-cell leukemia, to confirm its suitability as a reference material for HTLV-1 qPCR. Fluorescent in situ hybridization (FISH) showed that HTLV-1 provirus was monoclonally integrated in chromosome 1 at the site of 1p13 in the TL-Om1 genome. HTLV-1 proviral genome was not transferred from TL-Om1 to an uninfected T-cell line, suggesting that the HTLV-1 proviral copy number in TLOm1 cells is stable. To determine the copy number of HTLV-1 provirus and IC genes in TL-Om1 cells, we used FISH, digital PCR, and qPCR. HTLV-1 copy numbers obtained by these three methods were similar, suggesting that their results were accurate. Also, the ratio of the copy number of HTLV-1 provirus to one of the IC genes, RNase P, was consistent for all three methods. These findings indicate that TL-Om1 cells are an appropriate reference material for HTLV-1 qPCR.	[Kuramitsu, Madoka; Okuma, Kazu; Momose, Haruka; Mizukami, Takuo; Takizawa, Kazuya; Araki, Kumiko; Yamaguchi, Kazunari; Hamaguchi, Isao] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan; [Yamagishi, Makoto; Yamochi, Tadanori; Firouzi, Sanaz; Watanabe, Toshiki] Univ Tokyo, Grad Sch Frontier Sci, Tumor Cell Biol Lab, Dept Med Genome Sci, Tokyo, Japan; [Sugamura, Kazuo] Miyagi Canc Ctr, Res Inst, Div Mol & Cellular Oncol, Natori, Miyagi 9811293, Japan	Hamaguchi, I (reprint author), Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan.	130hama@niid.go.jp			Ministry of Health, Labor and Welfare of Japan [H23-shinkou-ippan-016]	This work was supported by grants-in-aid for scientific research and by Health and Labor Sciences research grant H23-shinkou-ippan-016 from the Ministry of Health, Labor and Welfare of Japan.	White HE, 2010, BLOOD, V116, pE111, DOI 10.1182/blood-2010-06-291641; SUGAMURA K, 1984, INT J CANCER, V34, P221, DOI 10.1002/ijc.2910340213; Tanaka G, 2005, J INFECT DIS, V191, P1140, DOI 10.1086/428625; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Watanabe T, 2011, INT J HEMATOL, V94, P430, DOI 10.1007/s12185-011-0934-4; Takenouchi N, 2003, J NEUROVIROL, V9, P29, DOI 10.1080/13550280390173418; Watanabe M, 2005, BLOOD, V106, P2462, DOI 10.1182/blood-2004-09-3646; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534; Satake M, 2012, J MED VIROL, V84, P327, DOI 10.1002/jmv.23181; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Kamihira S, 2000, INT J HEMATOL, V72, P79; Iwanaga M, 2010, BLOOD, V116, P1211, DOI 10.1182/blood-2009-12-257410; Nagai M, 2001, ANN NEUROL, V50, P807, DOI 10.1002/ana.10065; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Watanabe T, 1997, INT J HEMATOL, V66, P257; Costa JMP, 2009, J CLIN VIROL, V44, P185, DOI 10.1016/j.jcv.2008.12.015; Kamihira S, 2010, CANCER SCI, V101, P2361, DOI 10.1111/j.1349-7006.2010.01720.x; Firouzi S, 2014, GENOME MED, V6, DOI 10.1186/gm568; Fryer JF, 2011, WHOBS20112170 COLL S; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Ishida T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-69; Koiwa T, 2002, J VIROL, V76, P9389, DOI 10.1128/JVI.76.18.9389-9397.2002; Ueno S, 2012, INT J CANCER, V130, P2318, DOI 10.1002/ijc.26289; World Health Organization, 2011, WHOBS20112178; YAMAGUCHI K, 1984, BLOOD, V63, P1235; Zanjani DS, 2011, AIDS RES HUM RETROV, V27, P131, DOI 10.1089/aid.2010.0017	27	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	FEB	2015	53	2					587	596		10.1128/JCM.02254-14		10	Microbiology	Microbiology	AZ9XU	WOS:000348568500030		
J	Umene, YD; Wong, LK; Satoh, T; Yamane, K; Matsui, M; Riley, LW; Arakawa, Y; Suzuki, S				Umene, Yasuyo D.; Wong, Lisa K.; Satoh, Tomoya; Yamane, Kunikazu; Matsui, Mari; Riley, Lee W.; Arakawa, Yoshichika; Suzuki, Satowa			Molecular Epidemiological Characterization of Uropathogenic Escherichia coli from an Outpatient Urology Clinic in Rural Japan	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INFECTION; DIAGNOSIS; ADULTS	In the remote Japanese community of Saku, a rural town in the Nagano Prefecture, a large proportion of outpatient urinary tract infections was caused by well-recognized globally dispersed clonal lineages of uropathogenic Escherichia coli (UPEC). However, most of these strains were drug susceptible, suggesting that factors other than selection pressure account for the clonal spread of drug-susceptible UPEC.	[Umene, Yasuyo D.] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth & Med Sci, UC Berkeley UC San Francisco Joint Med Program, Berkeley, CA 94720 USA; [Wong, Lisa K.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA; [Satoh, Tomoya] Satoh Continence Clin, Saku, Nagano, Japan; [Yamane, Kunikazu; Matsui, Mari; Arakawa, Yoshichika; Suzuki, Satowa] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Yamane, Kunikazu] Kawasaki Med Univ, Dept Publ Hlth, Kurashiki, Okayama, Japan; [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Arakawa, Yoshichika] Nagoya Univ, Grad Sch Med, Dept Bacteriol, Nagoya, Aichi, Japan	Umene, YD (reprint author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth & Med Sci, UC Berkeley UC San Francisco Joint Med Program, Berkeley, CA 94720 USA.	umene@ohsu.edu	Arakawa, Yoshichika/P-5997-2015		Korea University RD grant	This study was supported by a Korea University R&D grant in 2013.	van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; Casiano-Colon AE, 2003, J CLIN VIROL, V28, P169, DOI 10.1016/S1386-6532(03)00002-7; Papenburg J, 2013, J PEDIATR-US, V163, P911, DOI 10.1016/j.jpeds.2013.03.067; Popow-Kraupp Therese, 2011, Open Microbiol J, V5, P128, DOI 10.2174/1874285801105010128; Rabon-Stith KM, 2013, J CLIN VIROL, V58, P575, DOI 10.1016/j.jcv.2013.09.012	5	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	FEB	2015	53	2					681	686		10.1128/JCM.03068-14		6	Microbiology	Microbiology	AZ9XU	WOS:000348568500045		
J	Nakamura, I; Omori, N; Umeda, A; Ohkusu, K; Matsumoto, T				Nakamura, Itaru; Omori, Nami; Umeda, Ayaka; Ohkusu, Kiyofumi; Matsumoto, Tetsuya			First Case Report of Fatal Sepsis Due to Campylobacter upsaliensis	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							INFECTION; DIARRHEA	We encountered a rare case of severe fatal infection in a 70-year-old woman due to Campylobacter upsaliensis, identified by PCR amplification and sequencing analysis of the 16S rRNA gene using DNA extracted from the isolates. To our knowledge, fatal sepsis due to this organism has never been described to date.	[Nakamura, Itaru] Tokyo Med Univ Hosp, Dept Infect Control & Prevent, Tokyo, Japan; [Omori, Nami; Umeda, Ayaka] Tokyo Med Univ Hosp, Dept Microbiol, Tokyo, Japan; [Ohkusu, Kiyofumi; Matsumoto, Tetsuya] Tokyo Med Univ, Dept Microbiol, Tokyo 1608402, Japan	Ohkusu, K (reprint author), Tokyo Med Univ, Dept Microbiol, Tokyo 1608402, Japan.	ohkusu@tokyo-med.ac.jp					Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Vandenberg O, 2006, J ANTIMICROB CHEMOTH, V57, P908, DOI 10.1093/jac/dkl080; GOOSSENS H, 1991, LANCET, V337, P1486, DOI 10.1016/0140-6736(91)93182-9; Bourke B, 1998, CLIN MICROBIOL REV, V11, P440; Carter JE, 1996, NEPHRON, V74, P489; Clinical and Laboratory Standards Institute (CLSI), 2010, M45A2 CLSI; Couturier BA, 2012, J CLIN MICROBIOL, V50, P3792, DOI 10.1128/JCM.01807-12; Damborg P, 2008, J CLIN MICROBIOL, V46, P1504, DOI 10.1128/JCM.00079-08; Funato M, 2011, J CLIN MICROBIOL, V49, P3432, DOI 10.1128/JCM.00478-11; GAUDREAU C, 1992, J CLIN MICROBIOL, V30, P1354; Goddard EA, 1997, ARCH DIS CHILD, V76, P526; GOOSSENS H, 1995, J INFECT DIS, V172, P1298; GOOSSENS H, 1990, J CLIN MICROBIOL, V28, P1039; GURGAN T, 1994, J CLIN MICROBIOL, V32, P3093; Ho TW, 1997, NEUROLOGY, V48, P717; Issartel B, 2002, EUR J CLIN MICROBIOL, V21, P234, DOI 10.1007/s10096-001-0693-x; Jenkin GA, 1998, CLIN INFECT DIS, V27, P816, DOI 10.1086/514957; LASTOVICA AJ, 1989, J CLIN MICROBIOL, V27, P657; PATTON CM, 1989, J CLIN MICROBIOL, V27, P66	19	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	FEB	2015	53	2					713	715		10.1128/JCM.02349-14		3	Microbiology	Microbiology	AZ9XU	WOS:000348568500053		
J	Tsutsui, S; Iwasaki, H; Yamada, H; Hashizume, H; Minamide, A; Nakagawa, Y; Nishi, H; Yoshida, M				Tsutsui, Shunji; Iwasaki, Hiroshi; Yamada, Hiroshi; Hashizume, Hiroshi; Minamide, Akihito; Nakagawa, Yukihiro; Nishi, Hideto; Yoshida, Munehito			Augmentation of motor evoked potentials using multi-train transcranial electrical stimulation in intraoperative neurophysiologic monitoring during spinal surgery	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Intraoperative neurophysiologic monitoring; Motor evoked potential; Multi-train transcranial electrical stimulation; Spinal surgery	GENERAL-ANESTHESIA; PROPOFOL ANESTHESIA; RESPONSES; AMPLITUDE; NERVE; CORD; MUSCLE	Transcranial motor evoked potentials (TcMEPs) are widely used to monitor motor function during spinal surgery. Improvements in transcranial stimulation techniques and general anesthesia have made it possible to record reliable and reproducible potentials. However, TcMEPs are much smaller in amplitude compared with compound muscle action potentials (CMAPs) evoked by maximal peripheral nerve stimulation. In this study, multi-train transcranial electrical stimulation (mt-TES) was introduced to enhance TcMEPs, and the optimal setting of mt-TES was investigated. In 30 patients undergoing surgical correction of spinal deformities (4 males and 26 females with normal motor status; age range 11-75 years), TcMEPs from the abductor hallucis (AH) and quadriceps femoris (QF) were analyzed. A multipulse (train) stimulus with an individual pulse width of 0.5 ms and an inter-pulse interval of 2 ms was delivered repeatedly (2-7 times) at different rates (2, 5, and 10 Hz). TcMEP amplitudes increased with the number of train stimuli for AH, with the strongest facilitation observed at 5 Hz. The response amplitude increased 6.1 times on average compared with single-train transcranial electrical stimulation (st-TES). This trend was also observed in the QF. No adverse events (e.g., seizures, cardiac arrhythmias, scalp burns, accidental injury resulting from patient movement) were observed in any patients. Although several facilitative techniques using central or peripheral stimuli, preceding transcranial electrical stimulation, have been recently employed to augment TcMEPs during surgery, responses are still much smaller than CMAPs. Changing from conventional st-TES to mt-TES has potential to greatly enhance TcMEP responses.	[Tsutsui, Shunji; Iwasaki, Hiroshi; Yamada, Hiroshi; Hashizume, Hiroshi; Minamide, Akihito; Nakagawa, Yukihiro; Nishi, Hideto; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama 6418510, Japan	Tsutsui, S (reprint author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418510, Japan.	stsutsui1116@gmail.com					Woodforth IJ, 1996, ANESTH ANALG, V82, P744, DOI 10.1097/00000539-199604000-00012; MacDonald DB, 2003, SPINE, V28, P194, DOI 10.1097/00007632-200301150-00018; Andersson G, 1999, CLIN NEUROPHYSIOL, V110, P720, DOI 10.1016/S1388-2457(98)00049-2; MacDonald DB, 2013, CLIN NEUROPHYSIOL, V124, P2291, DOI 10.1016/j.clinph.2013.07.025; Langeloo DD, 2003, SPINE, V28, P1043, DOI 10.1097/00007632-200305150-00017; Frei FJ, 2007, SPINE, V32, P911, DOI 10.1097/01.brs.0000259836.84151.75; Journee HL, 2004, MED BIOL ENG COMPUT, V42, P110, DOI 10.1007/BF02351019; Journee HL, 2007, NEUROPHYSIOL CLIN, V37, P423, DOI 10.1016/j.neucli.2007.10.002; Kombos T, 2001, J NEUROSURG, V95, P608, DOI 10.3171/jns.2001.95.4.0608; TAYLOR BA, 1993, J NEUROL NEUROSUR PS, V56, P104, DOI 10.1136/jnnp.56.1.104; Calancie B, 2008, SPINE, V33, P406, DOI 10.1097/BRS.0b013e3181642a2f; Cioni B, 1999, ARCH ITAL BIOL, V137, P115; Deletis V, 2002, NEUROPHYSIOLOGY NEUR, P25, DOI 10.1016/B978-012209036-3/50004-4; Deletis V, 2008, HDB CLIN NEUROPHYSIO, V8, P235; Hayashi H, 2008, SPINE, V33, pE994, DOI 10.1097/BRS.0b013e318188adfc; Hemmer LB, 2014, WORLD NEUROSURG, V81, P99, DOI 10.1016/j.wneu.2012.05.034; Hilibrand AS, 2004, J BONE JOINT SURG AM, V86A, P1248; Iwasaki Hiroshi, 2003, J Orthop Sci, V8, P635, DOI 10.1007/s00776-003-0693-z; JELLINEK D, 1991, NEUROSURGERY, V29, P551; Jones SJ, 1996, EVOKED POTENTIAL, V100, P375; Kakimoto M, 2005, ANESTHESIOLOGY, V102, P733, DOI 10.1097/00000542-200504000-00007; KELLER BP, 1992, NEUROSURGERY, V30, P557; Kothbauer K, 1997, PEDIATR NEUROSURG, V26, P247, DOI 10.1159/000121199; Macdonald DB, 2007, EUR SPINE J S, V16, P171, DOI 10.1007/s00586-007-0426-7; MacDonald DB, 2012, J CLIN NEUROPHYSIOL, V29, P118, DOI 10.1097/WNP.0b013e31824ceeaf; Matsuda H, 1989, NEUROMONITORING SURG, P175; Meylaerts SA, 1999, ANN SURG, V230, P742, DOI 10.1097/00000658-199912000-00002; Muramoto A, 2013, SPINE, V38, pE21, DOI 10.1097/BRS.0b013e3182796b15; Pechstein U, 1996, NEUROSURGERY, V39, P335, DOI 10.1097/00006123-199608000-00020; Penfield W, 1937, BRAIN, V60, P339; Sakaki K, 2012, SPINE, V37, pE913, DOI 10.1097/BRS.0b013e31824caab6; Tsutsui S, 2013, J CLIN MONIT COMPUT, V27, P633, DOI 10.1007/s10877-013-9480-3; Tsutsui S, 2003, CLIN NEUROPHYSIOL, V114, P1431, DOI 10.1016/S1388-2457(03)00090-7	33	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	FEB	2015	29	1					35	39		10.1007/s10877-014-9565-7		5	Anesthesiology	Anesthesiology	CA5ID	WOS:000348941200008		
J	Yamada, H; Saeki, M; Ito, J; Kawada, K; Higurashi, A; Funakoshi, H; Takeda, K				Yamada, Hiroshi; Saeki, Minako; Ito, Junko; Kawada, Kazuhiro; Higurashi, Aya; Funakoshi, Hiromi; Takeda, Kohji			The relative trending accuracy of noninvasive continuous hemoglobin monitoring during hemodialysis in critically ill patients	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						SpHb; Pulse CO-oximetry; Noninvasive continuous hemoglobin monitoring; Polar plot analysis; Relative trending accuracy; Hemodialysis	BLOOD-VOLUME; CARDIAC-OUTPUT; FLUID BALANCE; ABILITY; ULTRAFILTRATION; HEMATOCRIT	The pulse CO-Oximeter (Radical-7; Masimo Corp., Irvine, CA) is a multi-wavelength spectrophotometric method for noninvasive continuous monitoring of hemoglobin (SpHb). Because evaluating the relative change in blood volume (Delta BV) is crucial to avoid hypovolemia and hypotension during hemodialysis, it would be of great clinical benefit if Delta BV could be estimated by measurement of SpHb during hemodialysis. The capability of the pulse CO-Oximeter to monitor Delta BV depends on the relative trending accuracy of SpHb. The purpose of the current study was to evaluate the relative trending accuracy of SpHb by the pulse CO-Oximeter using Crit-Line as a reference device. In 12 patients who received hemodialysis (total 22 sessions) in the intensive care unit, Delta BV was determined from SpHb. Relative changes in blood volume determined from SpHb were calculated according to the equation: Delta BV(SpHb) = [starting SpHb]/[current SpHb] - 1. The absolute values of SpHb and hematocrit measured by Crit-Line (CL-Hct) showed poor correlation. On the contrary, linear regression analysis showed good correlation between Delta BV(SpHb) and the relative change in blood volume measured by Crit-Line [Delta BV(CL-Hct)] (r = 0.83; P a parts per thousand currency sign 0.001). Bland-Altman analysis also revealed good agreement between Delta BV(SpHb) and Delta BV(CL-Hct) (bias, -0.77 %; precision, 3.41 %). Polar plot analysis revealed good relative trending accuracy of SpHb with an angular bias of 4.1A degrees and radial limits of agreement of 24.4A degrees (upper) and -16.2A degrees (lower). The results of the current study indicate that SpHb measurement with the pulse CO-Oximeter has good relative trending accuracy.	[Yamada, Hiroshi] Fujisawa City Hosp, Crit Care Div, Fujisawa, Kanagawa 2518550, Japan; [Saeki, Minako; Ito, Junko; Kawada, Kazuhiro; Higurashi, Aya; Funakoshi, Hiromi; Takeda, Kohji] Fujisawa City Hosp, Dept Anesthesiol & Crit Care Med, Fujisawa, Kanagawa 2518550, Japan	Yamada, H (reprint author), Fujisawa City Hosp, Crit Care Div, 2-6-1 Fujisawa, Fujisawa, Kanagawa 2518550, Japan.	hiroymd52@gmail.com					Lamhaut L, 2011, ANESTHESIOLOGY, V115, P548, DOI 10.1097/ALN.0b013e3182270c22; Shamir MY, 2012, ANESTH ANALG, V114, P972, DOI 10.1213/ANE.0b013e318233041a; Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; Miller RD, 2011, ANESTH ANALG, V112, P858, DOI 10.1213/ANE.0b013e31820eecd1; Booth J, 2011, NEPHRON CLIN PRACT, V117, pC179, DOI 10.1159/000320196; Colquhoun DA, 2012, J CLIN MONIT COMPUT, V26, P69, DOI 10.1007/s10877-012-9335-3; Frasca D, 2011, CRIT CARE MED, V39, P2277, DOI 10.1097/CCM.0b013e3182227e2d; Macknet MR, 2010, ANESTH ANALG, V111, P1424, DOI 10.1213/ANE.0b013e3181fc74b9; Critchley LA, 2011, J CARDIOTHOR VASC AN, V25, P536, DOI 10.1053/j.jvca.2011.01.003; Bagshaw SM, 2008, CRIT CARE, V12, DOI 10.1186/cc6948; Dasselaar Judith J, 2007, Hemodial Int, V11, P448, DOI 10.1111/j.1542-4758.2007.00216.x; Garzoni D, 2007, INT J ARTIF ORGANS, V30, P16; Giraud B, 2013, BRIT J ANAESTH, V111, P946, DOI 10.1093/bja/aet252; Locatelli F, 2005, NEPHROL DIAL TRANSPL, V20, P22, DOI 10.1093/ndt/gfh555; Mitra S, 2004, J AM SOC NEPHROL, V15, P463, DOI 10.1097/01.ASN.0000108970.48370.33; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; STEUER RR, 1993, DIALYSIS TRANSPLANT, V22, P260	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	FEB	2015	29	1					107	112		10.1007/s10877-014-9574-6		6	Anesthesiology	Anesthesiology	CA5ID	WOS:000348941200016		
J	Adachi, YU; Numaguchi, A; Matsuda, N				Adachi, Yushi U.; Numaguchi, Atsushi; Matsuda, Naoyuki			Ultrasonography-guided radial artery catheterization and further optimal sequences	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Letter							TIME ULTRASOUND GUIDANCE; TRIAL; CANNULATION; PUNCTURE; ACCESS		[Adachi, Yushi U.; Numaguchi, Atsushi; Matsuda, Naoyuki] Nagoya Univ Hosp, Dept Emergency Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Adachi, YU (reprint author), Nagoya Univ Hosp, Dept Emergency Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	adachi.yushi@i.nagoya-u.jp					Adachi YU, 2013, J CLIN MONIT COMPUT, V27, P703, DOI 10.1007/s10877-013-9482-1; Shiver S, 2006, ACAD EMERG MED, V13, P1275, DOI 10.1197/j.aem.2006.07.015; SLOGOFF S, 1983, ANESTHESIOLOGY, V59, P42, DOI 10.1097/00000542-198307000-00008; Hansen MA, 2014, ACTA ANAESTH SCAND, V58, P446, DOI 10.1111/aas.12299; Weiner MM, 2013, J CARDIOTHOR VASC AN, V27, P345, DOI 10.1053/j.jvca.2012.07.007; Bobbia X, 2013, AM J EMERG MED, V31, P810, DOI 10.1016/j.ajem.2013.01.029; Levin PD, 2003, CRIT CARE MED, V31, P481, DOI 10.1097/01.CCM.0000050452.17304.2F; Dudeck O, 2004, INT J CARDIOVAS IMAG, V20, P363, DOI 10.1023/B:CAIM.0000041949.59255.3f; Seto AH, 2010, JACC-CARDIOVASC INTE, V3, P751, DOI 10.1016/j.jcin.2010.04.015; Bloc S, 2010, ACTA ANAESTH SCAND, V54, P421, DOI 10.1111/j.1399-6576.2009.02195.x; Kucuk A, 2014, J CLIN MONIT COMPUT, V28, P567, DOI 10.1007/s10877-014-9552-z; Kumar Ajay, 2009, Best Pract Res Clin Anaesthesiol, V23, P299; Mizukoshi K, 2009, CAN J ANAESTH, V56, P427, DOI 10.1007/s12630-009-9093-y; Scheer Bernd, 2002, Crit Care, V6, P199, DOI 10.1186/cc1489; Shioya U, 2014, J CLIN ANESTH JPN, V38	15	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	FEB	2015	29	1					201	202		10.1007/s10877-014-9608-0		2	Anesthesiology	Anesthesiology	CA5ID	WOS:000348941200029		
J	Takeda, T; Shindo, Y; Wei, ZJ; Kuronuma, Y; Narita, F				Takeda, Tomo; Shindo, Yasuhide; Wei, Zhijuan; Kuronuma, Yu; Narita, Fumio			Fatigue failure and electrical resistance behaviors of carbon nanotube-based polymer composites under uniaxial tension-tension loading in a cryogenic environment	JOURNAL OF COMPOSITE MATERIALS			English	Article						Cryomechanics; mechanical testing; carbon nanotubes; polymer-matrix composites; fatigue; self-sensing	ELASTIC PROPERTIES; POLYCARBONATE; NANOCOMPOSITES; CONDUCTIVITY; SENSORS; DAMAGE	This paper investigates the fatigue failure and electrical resistance behaviors of carbon nanotube-based polymer composites at cryogenic temperatures. Tension-tension fatigue tests were performed on carbon nanotube /polycarbonate composites at room temperature and liquid nitrogen temperature (77K), and the electrical resistance of the specimens was monitored during the tests. Based on the obtained results, the dependence of the mechanical and electrical responses of the nanocomposites on the temperature and the nanotube content was studied. Microscopic examinations were also carried out on the specimen fracture surfaces, and the failure mechanisms of the nanocomposites were discussed.	[Takeda, Tomo; Shindo, Yasuhide; Wei, Zhijuan; Kuronuma, Yu; Narita, Fumio] Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Sendai, Miyagi 9808579, Japan	Shindo, Y (reprint author), Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Aoba Yama 6-6-02, Sendai, Miyagi 9808579, Japan.	shindo@material.tohoku.ac.jp					Han F, 2014, COMP MATER SCI, V81, P652, DOI 10.1016/j.commatsci.2013.07.008; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Kang IP, 2006, SMART MATER STRUCT, V15, P737, DOI 10.1088/0964-1726/15/3/009; Zhang W, 2006, J NANOSCI NANOTECHNO, V6, P960, DOI 10.1166/jnn.2006.171; Kuronuma Y, 2012, COMPOS SCI TECHNOL, V72, P1678, DOI 10.1016/j.compscitech.2012.07.001; Yao SH, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2870104; Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038; Paradise M, 2007, MATER DESIGN, V28, P1477, DOI 10.1016/j.matdes.2006.03.008; Chou TW, 2010, COMPOS SCI TECHNOL, V70, P1, DOI 10.1016/j.compscitech.2009.10.004; Wernik JM, 2010, APPL MECH REV, V63, DOI 10.1115/1.4003503; Seidel GD, 2006, MECH MATER, V38, P884, DOI 10.1016/j.mechmat.2005.06.029; Li CY, 2008, COMPOS SCI TECHNOL, V68, P3373, DOI 10.1016/j.compscitech.2008.09.025; Zhou J, 2013, ACS APPL MATER INTER, V5, P6189, DOI 10.1021/am4011622; [Anonymous], 2003, D63803 ASTM; Ding W, 2003, NANO LETT, V3, P1593, DOI 10.1021/nl0345973; Li C, 2008, COMPOS SCI TECHNOL, V68, P1227, DOI 10.1016/j.compscitech.2008.01.006; Takeda T, 2011, POLYMER, V52, P3852, DOI 10.1016/j.polymer.2011.06.046; Thostenson ET, 2005, COMPOS SCI TECHNOL, V65, P491, DOI 10.1016/j.compscitech.2004.11.003; Han F, 2014, COMP MATER SCI, V81, P641, DOI 10.1016/j.commatsci.2013.07.036; Ventura IA, 2013, COMPOS SCI TECHNOL, V84, P23, DOI 10.1016/j.compscitech.2013.05.002; Qian H, 2010, J MATER CHEM, V20, P4751, DOI 10.1039/c000041h; Lubineau G, 2012, CARBON, V50, P2377, DOI 10.1016/j.carbon.2012.01.059; Kuronuma Y, 2011, ENG FRACT MECH, V78, P3102, DOI 10.1016/j.engfracmech.2011.09.006; Lau KT, 2006, COMPOS PART B-ENG, V37, P425, DOI 10.1016/j.compositesb.2006.02.020; Njuguna J., 2003, Advanced Engineering Materials, V5, DOI 10.1002/adem.200310101; Oliver A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/50/505702; Shindo Y, 2008, ADV THEOR APPL MECH, V1, P361; Takeda T, 2009, MATER TRANS, V50, P436, DOI 10.2320/matertrans.MBW200817; Takeda T., 2013, International Journal of Materials and Structural Integrity, V7; Wang B, 2003, THEOR APPL FRACT MEC, V39, P163, DOI 10.1016/S0167-8442(02)00156-8	30	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	FEB	2015	49	4					457	463		10.1177/0021998314521059		7	Materials Science, Composites	Materials Science	CA4CW	WOS:000348852800006		
J	Budiman, BA; Takahashi, K; Inaba, K; Kishimoto, K				Budiman, Bentang Arief; Takahashi, Kosuke; Inaba, Kazuaki; Kishimoto, Kikuo			A new method of evaluating interfacial properties of a fiber/matrix composite	JOURNAL OF COMPOSITE MATERIALS			English	Article						Stress contour; interfacial properties; single-fiber fragmentation	SINGLE-FIBER COMPOSITES; FRAGMENTATION TEST; RESIDUAL-STRESS; ENERGY-BALANCE; MATRIX; TOUGHNESS; FRICTION; ZONE	Interfacial debonding frequently initiates composite failure in a fiber/matrix composite. A single-fiber fragmentation test and its modifications can be used to evaluate interfacial properties. However, they still have accuracy problems due to fiber impurities and friction work. This paper presents a new method of evaluating interfacial properties using a stress contour of composite matrix. A single-fiber fragmentation test model was developed to simulate the stress contour. The interface was modeled as a cohesive zone model. Four characteristic lengths on the stress contour were found after conducting simulations with many interfacial properties values. The stress contour was then captured from the single-fiber fragmentation test employing a photo-elasticity technique and the four characteristic lengths were measured. Iteration in simulation involved changing interfacial properties until corresponding characteristic lengths from experiment and simulation were obtained. The results were compared with those obtained with existing methods and found to be reasonable.	[Budiman, Bentang Arief; Takahashi, Kosuke; Inaba, Kazuaki; Kishimoto, Kikuo] Tokyo Inst Technol, Dept Mech Sci & Engn, Tokyo 152, Japan; [Budiman, Bentang Arief] Bandung Inst Technol, Dept Mech Engn, Bandung, Indonesia	Budiman, BA (reprint author), Tokyo Inst Technol, Kishimoto Inaba Lab, Meguro Ku, 2nd Floor 16 Bldg,2-12-1 Ookayama, Tokyo 152, Japan.	budiman.b.aa@m.titech.ac.jp			Mizuho Foundation for the Promotion of Sciences	Financial support for this study was provided by a grant from Mizuho Foundation for the Promotion of Sciences.	MOBASHER B, 1995, COMPOS ENG, V5, P1349, DOI 10.1016/0961-9526(95)00056-S; Shet C, 2002, J ENG MATER-T ASME, V124, P440, DOI 10.1115/1.1494093; vandenHeuvel PWJ, 1997, COMPOS PART A-APPL S, V28, P237, DOI 10.1016/S1359-835X(96)00114-5; FEILLARD P, 1994, COMPOS SCI TECHNOL, V50, P265, DOI 10.1016/0266-3538(94)90148-1; Segurado J, 2005, ACTA MATER, V53, P4931, DOI 10.1016/j.actamat.2005.07.013; Geubelle PH, 1998, COMPOS PART B-ENG, V29, P589, DOI 10.1016/S1359-8368(98)00013-4; ZHOU LM, 1993, COMPOS SCI TECHNOL, V48, P227, DOI 10.1016/0266-3538(93)90140-C; BELTZER AI, 1992, MECH MATER, V13, P285, DOI 10.1016/0167-6636(92)90021-5; Broutman L. J., 1974, Rheologica Acta, V13, DOI 10.1007/BF01521765; COX HL, 1952, BRIT J APPL PHYS, V3, P72, DOI 10.1088/0508-3443/3/3/302; Dibenedetto AT, 1998, J MATER SCI, V33, P4239, DOI 10.1023/A:1004486026347; Kim BW, 2002, J MATER SCI, V37, P3965, DOI 10.1023/A:1019684312272; Kim J.-K., 1991, J MATER SCI, V27, P3143; Kimura S, 2006, JSME INT J A-SOLID M, V49, P451, DOI 10.1299/jsmea.49.451; LIANG C, 1993, MECH MATER, V14, P207, DOI 10.1016/0167-6636(93)90067-2; Mei H, 2010, P 12 IEEE INT C THER, P1, DOI DOI 10.1109/ITHERM.2010.5501290; QIU YP, 1993, COMPOS SCI TECHNOL, V48, P5, DOI 10.1016/0266-3538(93)90114-V; Ramirez FA, 2009, COMPOS PART A-APPL S, V40, P679, DOI 10.1016/j.compositesa.2009.04.011; Rich JM, 2002, POOR MANS PLIGHT UNC, P1; SCHUSTER DM, 1964, T METALL SOC AIME, V230, P1635; Smith D. G., 1972, Engineering Fracture Mechanics, V4, DOI 10.1016/0013-7944(72)90050-1; Suh JG, 2003, KSME INT J, V17, P1674; Yallee RB, 1998, COMPOS SCI TECHNOL, V58, P1907, DOI 10.1016/S0266-3538(98)00008-6	23	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	FEB	2015	49	4					465	475		10.1177/0021998314521061		11	Materials Science, Composites	Materials Science	CA4CW	WOS:000348852800007		
J	Park, H; Niida, A; Miyano, S; Imoto, S				Park, Heewon; Niida, Atushi; Miyano, Satoru; Imoto, Seiya			Sparse Overlapping Group Lasso for Integrative Multi-Omics Analysis	JOURNAL OF COMPUTATIONAL BIOLOGY			English	Article						gene networks; multi-omics analysis; group sparse regularization; uncovering driver genes; graph	CELL LUNG-CANCER; GENE-EXPRESSION; OVARIAN-CANCER; DRIVER GENES; IDENTIFICATION; PATHWAYS	Gene networks and graphs are crucial tools for understanding a heterogeneous system of cancer, since cancer is a disease that does not involve individual genes but combinations of genes associated with oncogenic process. A goal of genomic data analysis via gene networks is to identify both gene networks and individual genes within the selected networks. Existing methods, however, perform only network selection, and thus all genes in selected networks are included in models. This leads to overfitting when uncovering driver genes, and the results are not biologically interpretable. To accomplish both "groupwise sparsity" and "within group sparsity" for identifying driver genes based on biological knowledge (i.e., predefined overlapping groups of features), we propose a sparse overlapping group lasso via duplicated predictors in extended space. The proposed method effectively identifies driver genes and their interactions using known biological pathway information. Monte Carlo simulations and The Cancer Genome Atlas (TCGA) project data analysis indicate that the proposed method is effective for fitting a regression model (i.e., feature selection and prediction accuracy) constructed with duplicated predictors in overlapping groups. In the TCGA data analysis, we uncover potential cancer driver genes via expression modules and gene networks constructed by multi-omics data and identify that the uncovered genes have strong evidences as a cancer driver gene. The proposed method is a useful tool for identifying cancer driver genes and for integrative multi-omics analysis.	[Park, Heewon; Niida, Atushi; Miyano, Satoru; Imoto, Seiya] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo 1088639, Japan	Park, H (reprint author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	hwpark@ims.u-tokyo.ac.jp			RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp140230]	This research used computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID: hp140230) and the Super Computer System, Human Genome Center, Institute of Medical Science, University of Tokyo.	Zhang X, 2005, INT J GYNECOL CANCER, V15, P50, DOI 10.1111/j.1048-891X.2005.15007.x; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Yuan M, 2006, J ROY STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Liu HY, 2006, PLOS MED, V3, P1090, DOI 10.1371/journal.pmed.0030232; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Hua X, 2013, AM J HUM GENET, V93, P439, DOI 10.1016/j.ajhg.2013.07.003; Adam JK, 2003, PHARMACOL THERAPEUT, V99, P113, DOI 10.1016/S0163-7258(03)00056-1; Muscarella LA, 2011, EPIGENETICS-US, V6, P710, DOI 10.4161/epi.6.6.15773; Annunziata CM, 2010, CANCER-AM CANCER SOC, V116, P3276, DOI 10.1002/cncr.25190; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Percival D, 2012, ELECTRON J STAT, V6, P269, DOI 10.1214/12-EJS672; Denner LA, 2012, J NEUROSCI, V32, P16725, DOI 10.1523/JNEUROSCI.2153-12.2012; Klammer M, 2012, MOL CELL PROTEOMICS, V11, P651, DOI 10.1074/mcp.M111.016410; Bonato V., 2010, THESIS U TEXAS AUSTI; Chan K.-S., 2012, CELL DEATH DIS, V3; Chandrasekhar T., 2011, INT J COMP APP, V32, P25; DeWan AT, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-95; Gonzalez A, 2006, HUM REPROD, V21, P943, DOI 10.1093/humrep/dei443; Hanisch D, 2002, BIOINFORMATICS, V18, P145; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Huttenhower C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-250; Jacob L., 2009, P 26 ANN INT C MACH, P433; Jaramillo M. C., 2014, GENE DEV, V27, P2179; Kawaguchi A, 2012, CLIN CANCER RES, V18, P5672, DOI 10.1158/1078-0432.CCR-12-0596; Kim D., 2014, J AM MED INFORM ASSN, DOI [10.1136/amiajnl-2013.002481, DOI 10.1136/AMIAJNL2013.002481]; Nancy J. N., 2013, JNCI-J NATL CANCER I, V105, P1766; Niida A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-71; Obozinski G., 2011, CORR; Pan Y., 2010, THESIS E TENNESSEE S; Simon N., 2012, J COMPUT GRAPH STAT, V22, P231; Stany MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021121; Strand AD, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030059; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Tibshirani R, 1996, J R STAT SOC B, V73, P273; Yan T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-524	36	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1066-5277	1557-8666		J COMPUT BIOL	J. Comput. Biol.	FEB 1	2015	22	2					73	84		10.1089/cmb.2014.0197		12	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CB0NK	WOS:000349322900001		
J	Lu, W; Tamura, T; Song, JN; Akutsu, T				Lu, Wei; Tamura, Takeyuki; Song, Jiangning; Akutsu, Tatsuya			Computing Smallest Intervention Strategies for Multiple Metabolic Networks in a Boolean Model	JOURNAL OF COMPUTATIONAL BIOLOGY			English	Article						metabolic network; Boolean model; NP-complete; elementary mode; integer linear programming; algorithm	MINIMAL CUT SETS; FLUX BALANCE ANALYSIS; KNOCKOUT STRATEGIES; CONSTRUCTION; DEFINITION; ROBUSTNESS; ALGORITHMS; EVOLUTION; PATHWAYS; FAILURE	This article considers the problem whereby, given two metabolic networks N-1 and N-2, a set of source compounds, and a set of target compounds, we must find the minimum set of reactions whose removal (knockout) ensures that the target compounds are not producible in N-1 but are producible in N-2. Similar studies exist for the problem of finding the minimum knockout with the smallest side effect for a single network. However, if technologies of external perturbations are advanced in the near future, it may be important to develop methods of computing the minimum knockout for multiple networks (MKMN). Flux balance analysis (FBA) is efficient if a well-polished model is available. However, that is not always the case. Therefore, in this article, we study MKMN in Boolean models and an elementary mode (EM)-based model. Integer linear programming (ILP)-based methods are developed for these models, since MKMN is NP-complete for both the Boolean model and the EM-based model. Computer experiments are conducted with metabolic networks of clostridium perfringens SM101 and bifidobacterium longum DJO10A, respectively known as bad bacteria and good bacteria for the human intestine. The results show that larger networks are more likely to have MKMN solutions. However, solving for these larger networks takes a very long time, and often the computation cannot be completed. This is reasonable, because small networks do not have many alternative pathways, making it difficult to satisfy the MKMN condition, whereas in large networks the number of candidate solutions explodes. Our developed software minFvskO is available online.	[Lu, Wei; Tamura, Takeyuki; Akutsu, Tatsuya] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto 6110011, Japan; [Song, Jiangning] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Song, Jiangning] Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China	Tamura, T (reprint author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto 6110011, Japan.	tamura@kuicr.kyoto-u.ac.jp			JSPS, Japan [25730005, 25250028, 22240009]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, China	T.T. was partially supported by JSPS, Japan [Grant-in-Aid for Young Scientists (B) 25730005 and Grant-in-Aid for Scientific Research (A) 25250028]. J.S. is an Australian National Health and Medical Research Council (NHMRC) Peter Doherty fellow and a recipient of the Hundred Talents Program of the Chinese Academy of Sciences (CAS). T.A. was partly supported by the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, China, and Grant-in-Aid #22240009 from JSPS, Japan.	Klamt S, 2004, BIOINFORMATICS, V20, P226, DOI 10.1093/bioinformatics/btg395; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Handorf T, 2005, J MOL EVOL, V61, P498, DOI 10.1007/s00239-005-0027-1; Schuster S, 2008, J THEOR BIOL, V252, P497, DOI 10.1016/j.jtbi.2007.12.008; Goncalves E, 2013, MOL BIOSYST, V9, P1576, DOI 10.1039/c3mb25489e; Klamt S, 2006, BIOSYSTEMS, V83, P233, DOI 10.1016/j.biosystems.2005.04.009; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; [Anonymous], 2015, MINFVSKO; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Ballerstein K, 2012, BIOINFORMATICS, V28, P381, DOI 10.1093/bioinformatics/btr674; Trinh CT, 2006, METAB ENG, V8, P628, DOI 10.1016/j.ymben.2006.07.006; Smart AG, 2008, P NATL ACAD SCI USA, V105, P13223, DOI 10.1073/pnas.0803571105; Acuna V, 2009, BIOSYSTEMS, V95, P51, DOI 10.1016/j.biosystems.2008.06.015; Unrean P, 2010, METAB ENG, V12, P112, DOI 10.1016/j.ymben.2009.11.002; Akutsu T, 2012, IEICE T INF SYST, VE95D, P2960, DOI 10.1587/transinf.E95.D.2960; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; [Anonymous], 2010, IBM ILOG CPLEX OPT; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Hadicke O, 2011, METAB ENG, V13, P204, DOI 10.1016/j.ymben.2010.12.004; AUSIELLO G., 1999, COMPLEXITY APPROXIMA; Flottmann M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-58; Jiang D, 2009, BIOTECHNOL BIOENG, V103, P361, DOI 10.1002/bit.22237; Jin GX, 2011, BIOINFORMATICS, V27, pI310, DOI 10.1093/bioinformatics/btr202; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; Lemke N, 2004, BIOINFORMATICS, V20, P115, DOI 10.1093/bioinformatics/btg386; Li Z, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156; Lu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092637; Samaga R, 2010, J COMPUT BIOL, V17, P39, DOI 10.1089/cmb.2009.0121; Schrijver A., 1998, THEORY LINEAR INTEGE; Schuster S., 1994, J BIOL SYST, V2, P165, DOI 10.1142/S0218339094000131; Shlomi T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.22; Sridhar P., 2008, PAC S BIOCOMPUT, V13, P291; Tamura Takeyuki, 2010, International Journal of Knowledge Discovery in Bioinformatics, V1, DOI 10.4018/jkdb.2010100202; Tamura T, 2011, IEICE T INF SYST, VE94D, P2393, DOI 10.1587/transinf.E94.D.2393; Tamura T, 2010, IEICE T FUND ELECTR, VE93A, P1497, DOI 10.1587/transfun.E93.A.1497; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Wunderlich Z, 2006, BIOPHYS J, V91, P2304, DOI 10.1529/biophysj.105.080572; Zhao Y, 2013, BIOINFORMATICS, V29, P2178, DOI 10.1093/bioinformatics/btt364	42	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1066-5277	1557-8666		J COMPUT BIOL	J. Comput. Biol.	FEB 1	2015	22	2					85	110		10.1089/cmb.2014.0274		26	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CB0NK	WOS:000349322900002		
J	Nakajima, K; Itoh, F; Nakamura, M; Kawamura, A; Yamazaki, T; Kozakai, T; Takusari, N; Ishisaki, A				Nakajima, K.; Itoh, F.; Nakamura, M.; Kawamura, A.; Yamazaki, T.; Kozakai, T.; Takusari, N.; Ishisaki, A.			Short communication: Opposing effects of lactoferrin on the proliferation of fibroblasts and epithelial cells from bovine mammary gland	JOURNAL OF DAIRY SCIENCE			English	Article						cell proliferation; lactoferrin; mammary epithelial cell; mammary stromal fibroblast	RECEPTOR-RELATED PROTEIN; GROWTH-FACTOR-BETA; DRY PERIOD; GENE-EXPRESSION; MILK; INVOLUTION; LACTATION; BINDING; TISSUE; INHIBITION	Lactoferrin is present in several physiologic fluids, including milk and colostrum. Recently, evidence has accumulated that lactoferrin acts as a regulator of cell proliferation. Lactoferrin mRNA and protein levels in bovine mammary glands are known to markedly increase after cessation of milking. To clarify the role of bovine lactoferrin (bLF) in mammary involution and remodeling during dry periods, we investigated whether bLF affects the proliferation of cultured cells derived from bovine mammary gland and examined the mechanism underlying the proliferative response to bLF. Addition of bLF to the culture medium increased the proliferation of bovine mammary stromal fibroblasts (bMSF), but decreased that of bovine mammary epithelial cells (bMEC). Proliferation was significantly increased in the bMSF treated with bLF (100 mu g/mL or greater) as compared with unstimulated cells. The maximal proliferative effect of bLF on bMSF occurred at 1,000 mu g/mL, such that the proliferation of the bLF-stimulated bMSF was approximately 2.5 times that of unstimulated cells. The bLF increased the production of proliferating cell nuclear antigen and rapid phosphorylation of the p44/ p42 mitogen-activated protein kinase in bMSF, but not in bMEC. The bLF-induced proliferation and production of proliferating cell nuclear antigen in bMSF was suppressed by U0126, a specific inhibitor of mitogen-activated protein kinase. Furthermore, treatment with bLF for 24 h decreased the mRNA levels of the 3 isoforms of transforming growth factor beta in bMSF (16-66%) but upregulated those in bMEC (122-157%). These opposite effects of bLF on the proliferation of epithelial and fibroblast cells and their expression of transforming growth factor beta may play a crucial role in bovine mammary involution and remodeling.	[Nakajima, K.; Itoh, F.; Nakamura, M.; Kawamura, A.; Yamazaki, T.; Kozakai, T.; Takusari, N.] NARO Hokkaido Agr Res Ctr, Sapporo, Hokkaido 0628555, Japan; [Ishisaki, A.] Iwate Med Univ, Dept Biochem, Sch Dent, Yahaba, Iwate 0283694, Japan	Nakajima, K (reprint author), NARO Hokkaido Agr Res Ctr, Hitsujigaoka 1, Sapporo, Hokkaido 0628555, Japan.	k1nakaji@affrc.go.jp			Akiyama Life Science Foundation (Sapporo, Japan)	This work was supported in part by the Akiyama Life Science Foundation (Sapporo, Japan). We are grateful to the staff of the Research Support Center at NARO Hokkaido Agricultural Research Center for their help with animal management.	JI ZS, 1994, ARTERIOSCLER THROMB, V14, P2025; Duarte DC, 2011, J DAIRY SCI, V94, P66, DOI 10.3168/jds.2010-3629; DERYNCK R, 1988, EMBO J, V7, P3737; Cheng JB, 2008, J DAIRY SCI, V91, P970, DOI 10.3168/jds.2007-0689; Steijns JM, 2000, BRIT J NUTR, V84, pS11; Sorensen MT, 2006, J DAIRY SCI, V89, P4632; ANDERSON BF, 1989, J MOL BIOL, V209, P711, DOI 10.1016/0022-2836(89)90602-5; Cornish J, 2004, ENDOCRINOLOGY, V145, P4366, DOI 10.1210/en.2003-1307; ROBERTS AB, 1990, ANN NY ACAD SCI, V580, P225, DOI 10.1111/j.1749-6632.1990.tb17931.x; Wilde CJ, 1997, EXP PHYSIOL, V82, P943; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Cunha GR, 1996, J MAMMARY GLAND BIOL, V1, P21, DOI 10.1007/BF02096300; Capuco AV, 1997, J DAIRY SCI, V80, P477; Xu XX, 2010, J DAIRY SCI, V93, P2344, DOI 10.3168/jds.2009-2926; Ward PP, 2005, CELL MOL LIFE SCI, V62, P2540, DOI 10.1007/s00018-005-5369-8; Okubo N, 2010, J VASC RES, V47, P369, DOI 10.1159/000277724; SCHANBACHER FL, 1993, J DAIRY SCI, V76, P3812, DOI 10.3168/jds.S0022-0302(93)77725-5; Grey A, 2004, MOL ENDOCRINOL, V18, P2268, DOI 10.1210/me.2003-0456; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; HURLEY WL, 1993, CELL BIOL INT, V17, P283, DOI 10.1006/cbir.1993.1064; BYATT JC, 1990, BIOCHEM BIOPH RES CO, V173, P548, DOI 10.1016/S0006-291X(05)80069-5; Caccavo D, 2002, J ENDOTOXIN RES, V8, P403, DOI 10.1179/096805102125001000; Delabarre S, 1997, TISSUE CELL, V29, P99, DOI 10.1016/S0040-8166(97)80076-6; De Vries LD, 2010, J DAIRY SCI, V93, P2433, DOI 10.3168/jds.2009-2764; HASEGAWA K, 1994, JPN J MED SCI BIOL, V47, P73; HURLEY WL, 1994, LIFE SCI, V55, P1955, DOI 10.1016/0024-3205(94)00528-1; Kolek O, 2003, COMP BIOCHEM PHYS C, V134, P417, DOI 10.1016/S1532-0456(02)00249-1; MAIER R, 1991, MOL CELL ENDOCRINOL, V82, P191, DOI 10.1016/0303-7207(91)90031-M; Musters S, 2004, J DAIRY SCI, V87, P896; Nadolska B, 2010, PHARMACOL REP, V62, P1139; Nakajima K, 2008, BIOSCI BIOTECH BIOCH, V72, P1103, DOI 10.1271/bbb.70713; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; PLAUT K, 1993, J DAIRY SCI, V76, P1526, DOI 10.3168/jds.S0022-0302(93)77485-8; RAINARD P, 1982, ANN RECH VET, V13, P321; REJMAN JJ, 1989, J DAIRY SCI, V72, P555, DOI 10.3168/jds.S0022-0302(89)79141-4; Riley LG, 2008, J DAIRY RES, V75, P135, DOI 10.1017/S0022029907002920; Rozen S, 2000, Methods Mol Biol, V132, P365; Sasaki M, 1999, ENDOCR J, V46, P359, DOI 10.1507/endocrj.46.359; Tang L, 2010, WOUND REPAIR REGEN, V18, P123, DOI 10.1111/j.1524-475X.2009.00563.x; Vash B, 1998, BLOOD, V92, P3277; WELTY FK, 1976, J DAIRY SCI, V59, P224; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; WOODWARD TL, 1995, J CELL PHYSIOL, V165, P339, DOI 10.1002/jcp.1041650215	44	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	FEB	2015	98	2					1069	1077		10.3168/jds.2014-8430		9	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	AZ2BK	WOS:000348039300034		
J	Nishigori, C; Aoyama, Y; Ito, A; Suzuki, K; Suzuki, T; Tanemura, A; Ito, M; Katayama, I; Oiso, N; Kagohashi, Y; Sugiura, S; Fukai, K; Funasaka, Y; Yamashita, T; Matsunaga, K				Nishigori, Chikako; Aoyama, Yumi; Ito, Akiko; Suzuki, Kayoko; Suzuki, Tamio; Tanemura, Atsushi; Ito, Masaaki; Katayama, Ichiro; Oiso, Naoki; Kagohashi, Yuji; Sugiura, Shinichi; Fukai, Kazuyoshi; Funasaka, Yoko; Yamashita, Toshiharu; Matsunaga, Kayoko			Guide for medical professionals (i.e. dermatologists) for the management of Rhododenol-induced leukoderma	JOURNAL OF DERMATOLOGY			English	Editorial Material						cosmetics; leukoderma; Rhododenol; skin-lightening agent; ultraviolet light irradiation		Because some users develop depigmentation after the use of melanogenesis-inhibiting products containing the quasi-drug ingredient Rhododenol, Japanese Dermatological Association (JDA) established a Special Committee on the Safety of Cosmetics Containing Rhododenol on July 17, 2013 and management guide for dermatologists has been updated on the website in order to delineate the diagnostic criteria for Rhododenol-induced leukoderma and provides a broad guide for standard treatment based on current knowledge. This guide is produced on the basis of the guide (version 7) updated on June 20, 2014 in the website. Rhododenol-induced leukoderma refers to depigmentation of varying severity that develops after the use of cosmetics containing Rhododenol, mainly at the site of use. In most cases, repigmentation of part or all the affected area is evident after discontinuation. Histopathologically cellular infiltration around the hair follicles and melanophages are present in most cases. The number of melanocytes in the lesion is declined but not totally absent in most cases. Rhododenol itself is a good substrate for tyrosinase, resulting in the formation of Rhododenol metabolites (e.g., Rhododenol quinone). Melanocytes are damaged by Rhododenol metabolites during the subsequent metabolic process. The continued use of cosmetics containing Rhododenol thus induces tyrosinase activity-dependent cytotoxicity in melanocytes in the epidermis at application sites, resulting in decreasing the amount of melanin produced by melanocytes; the addition of some other factor to this process is believed to subsequently cause the decrease or disappearance of melanocytes themselves from the epidermis.	[Nishigori, Chikako] Kobe Univ, Div Dermatol, Grad Sch Med, Dept Internal Related, Kobe, Hyogo 6500017, Japan; [Aoyama, Yumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Ito, Akiko] Niigata Univ, Med & Dent Hosp, Dept Dermatol, Niigata, Japan; [Suzuki, Kayoko] Kariya Toyota Gen Hosp, Dept Dermatol, Kariya, Aichi, Japan; [Suzuki, Tamio] Yamagata Univ, Fac Med, Dept Dermatol, Yamagata 990, Japan; [Tanemura, Atsushi; Katayama, Ichiro] Osaka Univ, Dept Dermatol, Course Integrated Med, Grad Sch Med, Osaka, Japan; [Ito, Masaaki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Niigata, Japan; [Oiso, Naoki] Kinki Univ, Fac Med, Dept Dermatol, Osaka, Japan; [Kagohashi, Yuji] Japanese Soc Dermatoallergol & Contact Dermatitis, Tokyo, Japan; [Sugiura, Shinichi] Nagoya Univ, Dept Healthcare Adm, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Fukai, Kazuyoshi] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan; [Funasaka, Yoko] Nippon Med Sch, Dept Dermatol, Tokyo 113, Japan; [Yamashita, Toshiharu] Sapporo Med Univ, Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan; [Matsunaga, Kayoko] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi 47011, Japan	Nishigori, C (reprint author), Kobe Univ, Dept Dermatol, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	chikako@med.kobe-u.ac.jp						0	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					113	128		10.1111/1346-8138.12744		16	Dermatology	Dermatology	CA4KJ	WOS:000348872800001		
J	Murata, Y; Song, M; Kikuchi, H; Hisamichi, K; Xu, XL; Greenspan, A; Kato, M; Chiou, CF; Kato, T; Guzzo, C; Thurmond, RL; Ohtsuki, M; Furue, M				Murata, Yoko; Song, Michael; Kikuchi, Hisayuki; Hisamichi, Katsuya; Xu, Xie L.; Greenspan, Andrew; Kato, Mai; Chiou, Chiun-Fang; Kato, Takeshi; Guzzo, Cynthia; Thurmond, Robin L.; Ohtsuki, Mamitaro; Furue, Masutaka			Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis	JOURNAL OF DERMATOLOGY			English	Article						atopic dermatitis; H-4 receptor; itch; Japan	HISTAMINE H-4 RECEPTOR; ALLERGIC CONTACT-DERMATITIS; INDUCED AGRANULOCYTOSIS; EXPERIMENTAL PRURITUS; EXPERIMENTAL-MODEL; SKIN INFLAMMATION; H4 RECEPTOR; MAST-CELLS; T-CELLS; ANTAGONIST	This trial was conducted to evaluate the safety and efficacy of the H4R-antagonist JNJ-39758979 in adult Japanese patients with moderate atopic dermatitis (AD). Eligible patients were randomly assigned to JNJ-39758979 300mg, 100mg or placebo once daily for 6weeks in this phase 2a, double-blind, multicenter, placebo-controlled study. Primary efficacy was assessed via week-6 Eczema Area and Severity Index (EASI) scores. Secondary efficacy assessments included Investigator's Global Assessment (IGA) and patient-reported outcome (PRO) pruritus assessments (Pruritus Categorical Response Scale [PCRS], Pruritus Numeric Rating Scales [PNRS], Pruritus Interference Numeric Rating Scale [PINRS] and Subject's Global Impressions of Change in Pruritus [SGICP]). Eighty-eight of 105 planned patients were randomized before the study was stopped and unblinded for safety reasons. The study did not meet the primary end-point. However, numerical improvements (i.e. decreases) in median EASI were observed with JNJ-39758979 100mg (-3.7) and 300mg (-3.0) versus placebo (-1.3) at week 6. Nominally significant improvements across PRO PCRS, PNRS and SGICP assessments were consistently observed, particularly with JNJ-39758979 300mg. Safety, including adverse events (AE), was comparable between JNJ-39758979 and placebo with the exception of two patients (both receiving JNJ-39758979 300mg) with serious AE of neutropenia, leading to premature study discontinuation. No deaths were reported. Except for neutropenia, no clinically relevant changes in laboratory values were observed. Although not conclusive, findings suggest H4R-antagonism may be beneficial for AD, particularly in controlling pruritus. JNJ-39758979 appears to be associated with drug-induced agranulocytosis, likely an off-target effect.	[Murata, Yoko; Kikuchi, Hisayuki; Hisamichi, Katsuya; Kato, Mai; Kato, Takeshi] Janssen Pharmaceut KK, Res & Dev, Tokyo, Japan; [Ohtsuki, Mamitaro] Jichi Med Univ, Dept Dermatol, Shimotsuke, Tochigi, Japan; [Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 812, Japan; [Song, Michael] Janssen Res & Dev LLC, Immunol, Spring House, PA USA; [Greenspan, Andrew; Guzzo, Cynthia] Janssen Sci Affairs LLC, Med Affairs, Horsham, PA USA; [Xu, Xie L.; Thurmond, Robin L.] Janssen Res & Dev LLC, Immunol, San Diego, CA USA; [Chiou, Chiun-Fang] Janssen Global Serv LLC, Patient Reported Outcomes, Raritan, NJ USA	Murata, Y (reprint author), Janssen Pharmaceut, Chiyoda Ku, 5-2 Nishi Kanda 3 Chome, Tokyo 1010065, Japan.	ymurata5@its.jnj.com					Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Kollmeier A, 2014, J PHARMACOL EXP THER, V350, P181, DOI 10.1124/jpet.114.215749; Sher LG, 2012, ACTA DERM-VENEREOL, V92, P455, DOI 10.2340/00015555-1360; Dunford PJ, 2006, J IMMUNOL, V176, P7062; Norman GR, 2001, MED CARE, V39, P1039, DOI 10.1097/00005650-200110000-00002; Rajka G, 1989, Acta Derm Venereol Suppl (Stockh), V144, P13; Shin N, 2012, EUR J PHARMACOL, V675, P47, DOI 10.1016/j.ejphar.2011.11.027; HORSMANHEIMO L, 1994, BRIT J DERMATOL, V131, P348, DOI 10.1111/j.1365-2133.1994.tb08522.x; Glatzer F, 2013, J ALLERGY CLIN IMMUN, V132, P1358, DOI 10.1016/j.jaci.2013.06.023; Walter M, 2011, EUR J PHARMACOL, V668, P1, DOI 10.1016/j.ejphar.2011.06.029; Tamai H, 1996, ANN INTERN MED, V124, P490; Eichenfield LF, 2002, J AM ACAD DERMATOL, V46, P495, DOI 10.1067/mjd.2002.122187; Massari NA, 2013, J DERMATOL SCI, V72, P252, DOI 10.1016/j.jdermsci.2013.07.012; Dunford PJ, 2007, J ALLERGY CLIN IMMUN, V119, P176, DOI 10.1016/j.jaci.2006.08.034; Jarvikallio A, 1997, BRIT J DERMATOL, V136, P871, DOI 10.1046/j.1365-2133.1997.01831.x; Gutzmer R, 2009, J ALLERGY CLIN IMMUN, V123, P619, DOI 10.1016/j.jaci.2008.12.1110; Liu ZC, 1995, J PHARMACOL EXP THER, V275, P1476; Seike M, 2010, ALLERGY, V65, P319, DOI 10.1111/j.1398-9995.2009.02240.x; Cowden JM, 2010, J INVEST DERMATOL, V130, P1023, DOI 10.1038/jid.2009.358; Thurmond RL, 2014, J PHARMACOL EXP THER, V349, P176, DOI 10.1124/jpet.113.211714; Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x; Raap U, 2008, J ALLERGY CLIN IMMUN, V122, P421, DOI 10.1016/j.jaci.2008.05.047; Cowden JM, 2014, ANN RHEUM DIS, V73, P600, DOI 10.1136/annrheumdis-2013-203832; Schram ME, 2012, ALLERGY, V67, P99, DOI 10.1111/j.1398-9995.2011.02719.x; Andersohn F, 2007, ANN INTERN MED, V146, P657; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; CORZO D, 1995, BLOOD, V86, P3835; Furue Masutaka, 2011, Asia Pac Allergy, V1, P64, DOI 10.5415/apallergy.2011.1.2.64; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; JOHNSON HH, 1960, J INVEST DERMATOL, V34, P237; JUHLIN L, 1967, ACTA DERM-VENEREOL, V47, P383; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Lundberg K, 2011, EUR J PHARMACOL, V651, P197, DOI 10.1016/j.ejphar.2010.10.065; Matsushita A, 2012, EXP DERMATOL, V21, P714, DOI 10.1111/j.1600-0625.2012.01559.x; Muto T, 2003, BRIT J DERMATOL, V148, P117, DOI 10.1046/j.1365-2133.2003.05092.x; Ohsawa Y, 2012, ALLERGY, V67, P1014, DOI 10.1111/j.1398-9995.2012.02854.x; Rossbach K, 2009, EXP DERMATOL, V18, P57, DOI 10.1111/j.1600-0625.2008.00762.x; Saeki H, 2009, J DERMATOL, V36, P563, DOI 10.1111/j.1346-8138.2009.00706.x; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Suwa E, 2011, EUR J PHARMACOL, V667, P383, DOI 10.1016/j.ejphar.2011.05.037; Thurmond RL, 2014, FRONT NEUROSCI, P143; Yamaura K, 2009, J TOXICOL SCI, V34, P427; Yunis J J, 1992, Drug Saf, V7 Suppl 1, P7	44	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					129	139		10.1111/1346-8138.12726		11	Dermatology	Dermatology	CA4KJ	WOS:000348872800002		
J	Takemoto, A; Cho, O; Morohoshi, Y; Sugita, T; Muto, M				Takemoto, Akemi; Cho, Otomi; Morohoshi, Yuka; Sugita, Takashi; Muto, Masahiko			Molecular characterization of the skin fungal microbiome in patients with psoriasis	JOURNAL OF DERMATOLOGY			English	Article						fungal microbiome; Malassezia; psoriasis; pyrosequencing	ATOPIC-DERMATITIS; HEALTHY-SUBJECTS; MALASSEZIA MICROFLORA; DISEASE; LESIONS; DEFENSE	The skin surface is colonized by a wide variety of fungi and bacteria. While many of these organisms, including Malassezia, Candida, Streptococcus and Staphylococcus species, are associated with provocation and/or exacerbation of psoriasis, a detailed analysis of the cutaneous fungal microbiome in psoriatic patients has yet to be performed. To identify the disease-specific fungal microbiota on psoriatic scale samples, fungal rRNA gene sequences from 12 psoriatic patients and 12 healthy controls were analyzed by pyrosequencing. A total of 317806 high-quality sequences were obtained, representing 142 genera. Malassezia species were the most abundant sequences in both populations (46.9 +/- 14.0% in psoriasis vs 76.0 +/- 14.6% for healthy controls). Principal coordinate analysis revealed that the fungal microbiomes were independent. Although an association between the cutaneous fungal microbiome and psoriasis has yet to be established, our data indicate that the microbiome in patients with psoriasis is independent of that in healthy controls.	[Takemoto, Akemi; Muto, Masahiko] Yamaguchi Univ, Dept Dermatol, Yamaguchi, Japan; [Cho, Otomi; Morohoshi, Yuka; Sugita, Takashi] Meiji Pharmaceut Univ, Dept Microbiol, Tokyo 2048588, Japan	Sugita, T (reprint author), Meiji Pharmaceut Univ, Dept Microbiol, 2-522-1 Noshio, Tokyo 2048588, Japan.	sugita@my-pharm.ac.jp					Paulino LC, 2008, FEMS YEAST RES, V8, P460, DOI 10.1111/j.1567-1364.2008.00359.x; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI [10.1128/​CMR.00021-11, 10.1128/CMR.00021-11]; Fry L, 2007, CLIN DERMATOL, V25, P606, DOI 10.1016/j.clindermatol.2007.08.015; Zhang ES, 2011, MICROBIOL IMMUNOL, V55, P625, DOI 10.1111/j.1348-0421.2011.00364.x; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Fahlen A, 2012, ARCH DERMATOL RES, V304, P15, DOI 10.1007/s00403-011-1189-x; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Munz OH, 2010, ARCH DERMATOL RES, V302, P495, DOI 10.1007/s00403-010-1065-0; Baroni A, 2004, J CUTAN PATHOL, V31, P35, DOI 10.1046/j.0303-6987.2004.0135.x; Bhate K, 2012, BRIT J DERMATOL, V68, P474; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Hay RJ, 2011, BR J DERMATOL S2, V165, P2; Park HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032847; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Sugita T, 2001, J CLIN MICROBIOL, V39, P3486, DOI 10.1128/JCM.39.10.3486-3490.2001; Tajima M, 2008, J INVEST DERMATOL, V128, P345, DOI 10.1038/sj.jid.5701017; Takahata Y, 2007, BRIT J DERMATOL, V157, P670, DOI 10.1111/j.1365-2133.2007.08090.x	26	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					166	170		10.1111/1346-8138.12739		5	Dermatology	Dermatology	CA4KJ	WOS:000348872800007		
J	Takei, K; Mitoma, C; Hashimoto-Hachiya, A; Uchi, H; Takahara, M; Tsuji, G; Kido-Nakahara, M; Nakahara, T; Furue, M				Takei, Kenjiro; Mitoma, Chikage; Hashimoto-Hachiya, Akiko; Uchi, Hiroshi; Takahara, Masakazu; Tsuji, Gaku; Kido-Nakahara, Makiko; Nakahara, Takeshi; Furue, Masutaka			Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor	JOURNAL OF DERMATOLOGY			English	Article						aryl hydrocarbon receptor; filaggrin; Glyteer; nuclear factor-erythroid 2-related factor-2; reactive oxygen species; soybean tar	IMPROVE SKIN BARRIER; HUMAN KERATINOCYTES; ENDOTHELIAL-CELLS; ATOPIC-DERMATITIS; OXIDATIVE STRESS; DIOXIN RECEPTOR; DIFFERENTIATION; AHR; ACTIVATION; INDUCTION	Soybean tar Glyteer (Gly) has been widely used for the treatment of various inflammatory skin diseases in Japan since 1924 as an alternative to coal tar remedy. Recently, coal tar has been shown to induce barrier repair in atopic dermatitis via aryl hydrocarbon receptor (AhR). In this study, we demonstrated that Gly activated AhR by inducing its cytoplasmic to nuclear translocation in keratinocytes. The AhR ligation by Gly was biologically active, with significant and dose-dependent upregulation of CYP1A1 expression, which is a specific marker for AhR activation. Gly upregulated the expression of filaggrin in an AhR-dependent manner because its enhancing effect was completely abrogated in AhR-knockdown keratinocytes. T-helper (Th)2 cytokines inhibited the expression of filaggrin; however, Gly completely restored the Th2-mediated inhibition of filaggrin expression. Furthermore, Gly coordinately upregulated a series of epidermal differentiation complex genes, including involucrin, loricrin and hornerin. In addition, Gly exhibited potent antioxidant activity through the activation of nuclear factor-erythroid 2-related factor-2 (Nrf2) and downstream antioxidant enzymes such as NAD(P)H:quinone oxidoreductase 1 (Nqo1), which actually inhibited the generation of reactive oxygen species in keratinocytes treated with tumor necrosis factor- or benzo[]pyrene. In conclusion, antioxidant Gly rescues the downregulated expression of filaggrin (and plausibly other barrier proteins) in a Th2-skewed milieu via AhR activation, which may partly explain its empirical anti-inflammatory therapeutic effects.	[Takei, Kenjiro; Mitoma, Chikage; Hashimoto-Hachiya, Akiko; Uchi, Hiroshi; Takahara, Masakazu; Tsuji, Gaku; Kido-Nakahara, Makiko; Nakahara, Takeshi; Furue, Masutaka] Kyushu Univ, Dept Dermatol, Fukuoka 8128582, Japan; [Mitoma, Chikage; Uchi, Hiroshi; Furue, Masutaka] Kyushu Univ, Res & Clin Ctr Yusho & Dioxin, Fukuoka 8128582, Japan; [Nakahara, Takeshi; Furue, Masutaka] Kyushu Univ, Div Skin Surface Sensing, Fukuoka 8128582, Japan	Furue, M (reprint author), Kyushu Univ, Dept Dermatol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	furue@dermatol.med.kyushu-u.ac.jp					Yin YQ, 2013, TOXICOL APPL PHARM, V269, P89, DOI 10.1016/j.taap.2013.03.015; Ramyaa P, 2014, BBA-GEN SUBJECTS, V1840, P681, DOI 10.1016/j.bbagen.2013.10.024; Ray SS, 2003, TOXICOL APPL PHARM, V192, P131, DOI 10.1016/S0041-008X(03)00277-1; McLean WHI, 2013, J CLIN INVEST, V123, P551, DOI 10.1172/JCI67438; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; van Drongelen V, 2013, EXP DERMATOL, V22, P807, DOI 10.1111/exd.12271; Han SG, 2012, TOXICOL APPL PHARM, V261, P181, DOI 10.1016/j.taap.2012.03.024; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Kennedy LH, 2013, TOXICOL SCI, V132, P235, DOI 10.1093/toxsci/kfs325; Kim B, 2014, PHYTOTHER RES, V28, P1359, DOI 10.1002/ptr.5138; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Roelofzen JHJ, 2010, J INVEST DERMATOL, V130, P953, DOI 10.1038/jid.2009.389; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Tsuji G, 2011, J DERMATOL SCI, V62, P42, DOI 10.1016/j.jdermsci.2010.10.017; Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109; Costa C, 2010, TOXICOLOGY, V271, P83, DOI 10.1016/j.tox.2010.02.014; Magiatis P, 2013, J INVEST DERMATOL, V133, P2023, DOI 10.1038/jid.2013.92; Kohda F, 2013, J DERMATOL SCI, V72, P75, DOI 10.1016/j.jdermsci.2013.05.008; Ikuta T, 2009, BIOCHEM PHARMACOL, V77, P588, DOI 10.1016/j.bcp.2008.10.003; Ma Q, 2004, BIOCHEM J, V377, P205, DOI 10.1042/BJ20031123; van den Bogaard EH, 2013, J CLIN INVEST, V123, P917, DOI 10.1172/JCI65642; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Loertscher JA, 2001, TOXICOL APPL PHARM, V175, P121, DOI 10.1006/taap.2001.9202; Loertscher JA, 2002, TOXICOL SCI, V68, P465, DOI 10.1093/toxsci/68.2.465; Asahi K, 1924, CHUGAI IJI SHINPOU, V1052, P199; Dohi K, 1924, JIKKEN IHOU, V10, P787; Furue M, 2014, ARCH DERMATOL RES, V306, P769, DOI 10.1007/s00403-014-1481-7; Haarmann-Stemmann T, 2012, J INVEST DERMATOL, V132, P7, DOI 10.1038/jid.2011.359; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Mohammadi-Bardbori A, 2012, CHEM RES TOXICOL, V17, P1878; National Toxicology Program, 2011, REP CARCINOG, V12, P111; TAKEUCHI K, 1990, FOLIA PHARMACOL JPN, V95, P149, DOI 10.1254/fpj.95.4_149; Tsuji G, 2012, J INVEST DERMATOL, V132, P59, DOI 10.1038/jid.2011.194; Yang JH, 2010, CHEMOSPHERE, V79, P278, DOI 10.1016/j.chemosphere.2010.01.040	36	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					171	180		10.1111/1346-8138.12717		10	Dermatology	Dermatology	CA4KJ	WOS:000348872800008		
J	Isoda, K; Seki, T; Inoue, Y; Umeda, K; Nishizaka, T; Tanabe, H; Takagi, Y; Ishida, K; Mizutani, H				Isoda, Kenichi; Seki, Tsuyoshi; Inoue, Yosuke; Umeda, Koji; Nishizaka, Takahiro; Tanabe, Hisateru; Takagi, Yutaka; Ishida, Koichi; Mizutani, Hitoshi			Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin	JOURNAL OF DERMATOLOGY			English	Article						acne; barrier function; ceramide; dry skin; sensitive skin	HUMAN STRATUM-CORNEUM; ATOPIC-DERMATITIS; OILY SKIN; VULGARIS; JAPANESE; SULFATE; BARRIER	Acne is a common skin disease that involves the seborrheic area of the face and results from the obstruction of hair follicles followed by inflammation. Careful face washing helps to improve and prevent acne; however, intensive washing has a risk of inducing skin barrier impairment and dry skin, especially in sensitive skin. We hypothesized that skin care combining mild skin cleansing and intensive moisturizing (combination skin care) may be effective in the care of acne in subjects with dry skin and/or sensitive skin. We developed a combination skin care with a weakly acidic foaming facial skin cleanser based on a mild detergent, an aqueous lotion with eucalyptus extract and a moisturizing gel containing pseudo-ceramide and eucalyptus extract. To optimize an ideal facial skin care system for mild acne on sensitive skin, we performed a 4-week clinical trial with 29 post-adolescent Japanese women with mild acne with dry and sensitive skin. The acne significantly decreased after this trial accompanied by the improvement of dry skin, a significantly increased endogenous ceramide level in the stratum corneum and an elongated alkyl chain length of the non-hydroxy acyl sphingosine type ceramide. No adverse events due to the test samples were observed. Based on diagnosis by a dermatologist, 97% of the subjects found the combination skin care to be useful or slightly useful. Based on these findings, the combined use of a facial skin cleanser and moisturizers is safe and effective for the care of acne in post-adolescent Japanese women with sensitive skin.	[Isoda, Kenichi; Umeda, Koji; Mizutani, Hitoshi] Mie Univ, Dept Dermatol, Tsu, Mie 5148507, Japan; [Umeda, Koji] KSK Lab Inc, Tsu, Mie, Japan; [Seki, Tsuyoshi; Nishizaka, Takahiro; Tanabe, Hisateru; Takagi, Yutaka; Ishida, Koichi] Kao Corp, Skin Care Prod Res Lab, Tokyo, Tochigi, Japan; [Inoue, Yosuke] Kao Corp, Analyt Sci Res Lab, Tokyo, Tochigi, Japan	Mizutani, H (reprint author), Mie Univ, Grad Sch Med, Dept Dermatol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	h-mizuta@clin.medic.mie-u.ac.jp					IMOKAWA G, 1991, J INVEST DERMATOL, V96, P523, DOI 10.1111/1523-1747.ep12470233; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Masukawa Y, 2009, J LIPID RES, V50, P1708, DOI 10.1194/jlr.D800055-JLR200; Abad-Casintahan F, 2011, J DERMATOL, V38, P1041, DOI 10.1111/j.1346-8138.2011.01266.x; IMOKAWA G, 1989, J SOC COSMET CHEM, V40, P273; Hayashi N, 2008, J DERMATOL, V35, P255, DOI 10.1111/j.1346-8138.2008.00462.x; Masukawa Y, 2008, J LIPID RES, V49, P1466, DOI 10.1194/jlr.M800014-JLR200; YAMAMOTO A, 1995, ARCH DERMATOL RES, V287, P214, DOI 10.1007/BF01262335; Choi JM, 2006, PEDIATR DERMATOL, V23, P421, DOI 10.1111/j.1525-1470.2006.00276.x; Sakuma TH, 2012, SKIN PHARMACOL PHYS, V25, P227, DOI 10.1159/000338978; Santner SJ, 1998, J CLIN ENDOCR METAB, V83, P2104, DOI 10.1210/jc.83.6.2104; Hayashi N, 2014, J DERMATOL, V41, P592, DOI 10.1111/1346-8138.12520; Ishikawa J, 2010, J INVEST DERMATOL, V130, P2511, DOI 10.1038/jid.2010.161; Choi YS, 2010, J DERMATOL TREAT, V21, P201, DOI 10.3109/09546630903401454; Aramaki J, 2002, BRIT J DERMATOL, V146, P1052, DOI 10.1046/j.1365-2133.2002.04509.x; Berson DS., 2013, AM AC DERM SUMM AC M; Chularojanamontri Leena, 2014, J Clin Aesthet Dermatol, V7, P36; Davis Erica C, 2010, J Clin Aesthet Dermatol, V3, P24; DEJONG FH, 1991, CANCER RES, V51, P3445; Del Rosso James Q, 2013, J Clin Aesthet Dermatol, V6, P19; Del Rosso James Q, 2013, J Clin Aesthet Dermatol, V6, P28; Draelos ZD, 2006, CUTIS, V78, P34; Eto T., 2005, J JPN COSMET SCI SOC, V29, P125; Ishikawa J, 2012, INT J COSMETIC SCI, V34, P17, DOI 10.1111/j.1468-2494.2011.00675.x; Isoda K, 2011, J DERMATOL, V38, P685, DOI 10.1111/j.1346-8138.2010.01084.x; Isoda K, 2014, SKIN RES TE IN PRESS, DOI [10.1111/srt.12183, DOI 10.1111/SRT.12183]; Jo HY, 2007, SKIN RES TECHNOL, V13, P162, DOI 10.1111/j.1600-0846.2007.00176.x; Kawasaki Y., 1999, SKIN RES TECHNOL, V5, P96, DOI 10.1111/j.1600-0846.1999.tb00122.x; LEE CH, 1994, CONTACT DERMATITIS, V30, P205, DOI 10.1111/j.1600-0536.1994.tb00644.x; Matsuki H, 2004, EXOG DERMATOL, V3, P293, DOI 10.1159/000091910; Matsuki H, 2004, EXOG DERMATOL, V3, P282, DOI 10.1159/000091909; Mukhopadhyay Partha, 2011, Indian J Dermatol, V56, P2, DOI 10.4103/0019-5154.77542; Takagi Y, 2014, INT J COSMETIC SCI, V36, P305, DOI 10.1111/ics.12127; Taylor SC, 2002, J AM ACAD DERMATOL, V46, pS98, DOI 10.1067/mjd.2002.120791	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					181	188		10.1111/1346-8138.12720		8	Dermatology	Dermatology	CA4KJ	WOS:000348872800009		
J	Motegi, S; Toki, S; Yamada, K; Uchiyama, A; Ishikawa, O				Motegi, Sei-ichiro; Toki, Sayaka; Yamada, Kazuya; Uchiyama, Akihiko; Ishikawa, Osamu			Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies	JOURNAL OF DERMATOLOGY			English	Article						anti-RNA polymerase III antibody; autoantibody; malignancy; renal crisis; systemic sclerosis	LINKED-IMMUNOSORBENT-ASSAY; JAPANESE PATIENTS; SCLERODERMA; ASSOCIATION; CANCER	Anti-RNA polymerase III antibody (RNAP) is primarily detected in diffuse cutaneous type systemic sclerosis (dcSSc) patients and strongly associated with renal crisis. Additionally, there has been increasing evidence that cancer in SSc patients is associated with RNAP. The aim of this study was to examine the demographic and clinical features of SSc patients with RNAP. Among 246 SSc patients, 5.7% were positive for RNAP, 20.7% were positive for anti-topoisomerase I antibody (Topo I) alone and 39.4% were positive for anticentromere antibody (ACA) alone. The modified Rodnan total skin score (mRTSS) in SSc patients with RNAP (19.1 +/- 2.6) was significantly higher than those in SSc patients with Topo I (11.5 +/- 1.1) and patients with ACA (4.4 +/- 0.4). Furthermore, among SSc patients with RNAP, the levels of RNAP were positively correlated with mRTSS. Renal crisis is also significantly more prevalent in SSc patients with RNAP than patients without RNAP. Male sex, dcSSc subtype, digital vasculopathy, including digital ulcers and acro-osteolysis, interstitial lung disease and rheumatoid arthritis complications were prevalent in SSc patients with RNAP and patients with Topo-I. Primary biliary cirrhosis and Sjogren's syndrome were more in SSc patients with RNAP and patients with ACA compared with patients with Topo 1. No significant difference in the frequency of complications, including Raynaud's phenomenon, pulmonary artery hypertension and malignancy was observed between the three groups. Thus, measurement of RNAP in SSc patients is useful for the diagnosis and risk stratification of severe manifestation, such as renal crisis and severe skin sclerosis.	[Motegi, Sei-ichiro; Toki, Sayaka; Yamada, Kazuya; Uchiyama, Akihiko; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gunma 3718511, Japan	Motegi, S (reprint author), Gunma Univ, Grad Sch Med, Dept Dermatol, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	smotegi@gunma-u.ac.jp					LEROY EC, 1988, J RHEUMATOL, V15, P202; Johnstone EM, 2012, RHEUMATOLOGY, V51, P2234, DOI 10.1093/rheumatology/kes214; Kuwana M, 2005, ARTHRITIS RHEUM, V52, P2425, DOI 10.1002/art.21232; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Kuwana M, 2002, ARTHRITIS RHEUM, V46, P2742, DOI 10.1002/art.10521; Shah AA, 2010, ARTHRITIS RHEUM-US, V62, P2787, DOI 10.1002/art.27549; Santiago M, 2007, J RHEUMATOL, V34, P1528; Meyer O, 2010, J RHEUMATOL, V37, P125, DOI 10.3899/jrheum.090677; Airo' P, 2011, J RHEUMATOL, V38, P1329, DOI 10.3899/jrheum.101144; Hamaguchi Y, 2008, BRIT J DERMATOL, V158, P487, DOI 10.1111/j.1365-2133.2007.08392.x; Moinzadeh P, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4486; Motegi S, 2014, J DERMATOL, V41, P604, DOI 10.1111/1346-8138.12532; Nikpour M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3544; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Satoh T, 2009, RHEUMATOLOGY, V48, P1570, DOI 10.1093/rheumatology/kep290; Tanahashi K, 2014, J EUR ACAD DERMATOL, DOI [10.1111/jdv.12512, DOI 10.1111/JDV.12512]	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					189	192		10.1111/1346-8138.12722		4	Dermatology	Dermatology	CA4KJ	WOS:000348872800010		
J	Inada, T; Fukushima, S; Murai, M; Jinnin, M; Miyashita, A; Nakahara, S; Yamashita, J; Aoi, J; Masuguchi, S; Ihn, H				Inada, Taisuke; Fukushima, Satoshi; Murai, Masayuki; Jinnin, Masatoshi; Miyashita, Azusa; Nakahara, Satoshi; Yamashita, Junji; Aoi, Jun; Masuguchi, Shinichi; Ihn, Hironobu			Hair shaft miRNA-221 levels as a new tumor marker of malignant melanoma	JOURNAL OF DERMATOLOGY			English	Article						hair shaft; malignant melanoma; miRNA-221; miR-221; tumor marker	DERMAL FIBROBLASTS; MICRORNAS; SCLERODERMA; SERUM; BIOMARKERS; EXPRESSION; MICROVESICLES; DIAGNOSIS; PSORIASIS; CANCER	miRNA-221 (miR-221) is known to be abnormally expressed in many human cancers. The serum levels of miR-221 have been reported as a tumor marker for malignant melanoma (MM). We hypothesized that the hair shaft miR-221 levels may be increased in patients with MM. We therefore assessed the possibility that hair shaft miR-221 levels could be a marker for MM. The hair shaft miR-221 levels were significantly higher in patients with MM than controls. The rates of increased hair shaft miR-221 levels above the cut-off value were comparable to those of serum 5-S-CD, which is a tumor marker commonly used for MM. Measurements of the hair shaft miR-221 levels could have potential clinical value in the detection of MM. This is the first report investigating the hair shaft levels of an miRNA in patients with MM. Our investigations offer new insight into the relationship between miR-221 and MM, and may provide a new, non-invasive way to screen for melanoma.	[Inada, Taisuke; Fukushima, Satoshi; Murai, Masayuki; Jinnin, Masatoshi; Miyashita, Azusa; Nakahara, Satoshi; Yamashita, Junji; Aoi, Jun; Masuguchi, Shinichi; Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto 8608556, Japan	Fukushima, S (reprint author), Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	satoshi.fukushima.tb@gmail.com					Wang ZZ, 2013, J DERMATOL SCI, V72, P134, DOI 10.1016/j.jdermsci.2013.06.018; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kanemaru H, 2011, J DERMATOL SCI, V61, P187, DOI 10.1016/j.jdermsci.2010.12.010; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Takemoto R, 2013, EXP DERMATOL, V22, P832, DOI 10.1111/exd.12245; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Igoucheva O, 2009, BIOCHEM BIOPH RES CO, V379, P790, DOI 10.1016/j.bbrc.2008.12.152; Shiiyama R, 2013, MELANOMA RES, V23, P366, DOI 10.1097/CMR.0b013e328363e485; Honda N, 2013, AM J PATHOL, V182, P206, DOI 10.1016/j.ajpath.2012.09.023; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Sing T, 2012, RHEUMATOLOGY, V51, P1550, DOI 10.1093/rheumatology/kes120; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Errico MC, 2013, INT J CANCER, V133, P879, DOI 10.1002/ijc.28097; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hirao H, 2013, EUR J DERMATOL, V23, P807, DOI 10.1684/ejd.2013.2190; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ichihara A, 2012, EUR J DERMATOL, V22, P68, DOI 10.1684/ejd.2011.1600; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					198	201		10.1111/1346-8138.12730		4	Dermatology	Dermatology	CA4KJ	WOS:000348872800012		
J	Ansai, S; Noro, S; Ogita, A; Fukumoto, H; Katano, H; Kawana, S				Ansai, Shin-ichi; Noro, Sachiko; Ogita, Azusa; Fukumoto, Hitomi; Katano, Harutaka; Kawana, Seiji			Case of Merkel cell carcinoma with squamous cell carcinoma possibly arising in chronic radiodermatitis of the hand	JOURNAL OF DERMATOLOGY			English	Article						chronic radiodermatitis; fingers; ionizing radiation; Merkel cell carcinoma; Merkel cell polyoma virus; squamous cell carcinoma	POLYOMAVIRUS	We report a case of Merkel cell carcinoma (MCC) on the dorsal aspect of the right middle finger associated with multiple squamous cell carcinomas (SCC) possibly arising in chronic radiation dermatitis of the hand of an 80-year-old surgeon. In spite of resection of the primary lesion and right axillary lymph nodes, he died of the tumor 5months after the first visit. Cutaneous and lymph node lesions of MCC were negative for Merkel cell polyoma virus (MCPyV) by immunostaining using monoclonal antibody (CM2B4) and anti-large T antigen of MCPyV polyclonal antibody, and real-time polymerase chain reaction. Several differences in clinicopathological findings have been found between MCPyV-positive cases and negative ones. Several authors have reported that MCPyV-negative cases have a worse prognosis than MCPyV-positive ones. Furthermore, in cases of MCC associated with SCC, most tumors have been reported to be MCPyV-negative. We should pay more attention to the relationship between the carcinogenesis of MCC and ionizing irradiation.	[Ansai, Shin-ichi; Ogita, Azusa] Musashi Kosugi Hosp, Nippon Med Sch, Div Dermatol, Kawasaki, Kanagawa 2118533, Japan; [Noro, Sachiko; Fukumoto, Hitomi; Kawana, Seiji] Musashi Kosugi Hosp, Nippon Med Sch, Dept Dermatol, Kawasaki, Kanagawa 2118533, Japan; [Katano, Harutaka] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan	Ansai, S (reprint author), Musashi Kosugi Hosp, Nippon Med Sch, Div Dermatol, Nakahara Ku, 1-396 Kosugi Cho, Kawasaki, Kanagawa 2118533, Japan.	shin8113@nms.ac.jp					Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Bhatia K, 2010, INT J CANCER, V127, P1493, DOI 10.1002/ijc.25136; Kuwamoto S, 2011, HUM PATHOL, V42, P1063, DOI 10.1016/j.humpath.2011.01.020; Sihto H, 2009, J NATL CANCER I, V101, P938, DOI 10.1093/jnci/djp139; Bertrand M, 2013, ANN DERMATOL VENER, V140, P41, DOI 10.1016/j.annder.2012.10.598; Lardy F, 1996, ANN DERMATOL VENER, V123, P464; Laude HC, 2010, PLOS PATHOG, V6	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					207	209		10.1111/1346-8138.12737		3	Dermatology	Dermatology	CA4KJ	WOS:000348872800014		
J	Yamaguchi, S; Okubo, Y; Katano, A; Sano, A; Uezato, H; Takahashi, K				Yamaguchi, Sayaka; Okubo, Yuko; Katano, Azusa; Sano, Ayako; Uezato, Hiroshi; Takahashi, Kenzo			Primary cutaneous mucormycosis caused by Mucor irregularis in an elderly person	JOURNAL OF DERMATOLOGY			English	Article						Mucor irregularis; primary cutaneous mucormycosis; zygomycetes	RHIZOMUCOR-VARIABILIS; ZYGOMYCOSIS; INFECTION	Primary cutaneous mucormycosis is a rare but often lethal severe fungal infection, which usually occurs in immunocompromised patients. We report a case of primary cutaneous mucormycosis caused by Mucor irregularis in an elderly patient. Seven months after the surgical dissection of the involved skin, cutaneous mucormycosis recurred at the peripheral edge of the skin graft. Shortly subsequent to the administration of liposomal amphotericin B, the remaining skin lesion was excised again. M.irregularis is rarely but increasingly reported as a cause of mucormycosis in immunocompetent individuals, especially in Asian farmers. M.irregularis may be largely disseminated in the soils of Asia and thus the trivial trauma at the time of farm work may be a trigger for the onset. These cases tend to leave severe cosmetic damage even in healthy individuals, although the vital prognosis is not affected.	[Yamaguchi, Sayaka; Okubo, Yuko; Katano, Azusa; Uezato, Hiroshi; Takahashi, Kenzo] Univ Ryukyus, Grad Sch Med, Dept Dermatol, Nishihara, Okinawa 9030125, Japan; [Sano, Ayako] Univ Ryukyus, Fac Agr, Dept Anim Sci, Nishihara, Okinawa 9030125, Japan	Takahashi, K (reprint author), Univ Ryukyus, Grad Sch Med, Dept Dermatol, 207 Uehara, Nishihara, Okinawa 9030125, Japan.	kenzot@med.u-ryukyu.ac.jp					Hemashettar BM, 2011, J CLIN MICROBIOL, V49, P2372, DOI 10.1128/JCM.02326-10; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Xia ZK, 2013, CLIN INFECT DIS, V56, P993, DOI 10.1093/cid/cis1045; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Zhao Y, 2009, MYCOPATHOLOGIA, V168, P243, DOI 10.1007/s11046-009-9219-3; Li DM, 2012, MYCOPATHOLOGIA, V174, P429, DOI 10.1007/s11046-012-9559-2; Alvarez E, 2011, MED MYCOL, V49, P62, DOI 10.3109/13693786.2010.499521; Kang DX, 2014, MYCOPATHOLOGIA, V178, P129, DOI 10.1007/s11046-014-9770-4; Lu XL, 2009, CLIN INFECT DIS, V49, pE39, DOI 10.1086/600817; Patil AB, 2013, INDIAN J MED MICROBI, V31, P302, DOI 10.4103/0255-0857.115662; Schell WA, 2011, MED MYCOL, V49, P714, DOI 10.3109/13693786.2011.568975; Tomita H, 2010, CLIN EXPT DERMATOL, V36, P305	12	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					210	214		10.1111/1346-8138.12736		5	Dermatology	Dermatology	CA4KJ	WOS:000348872800015		
J	Kuriyama, S; Kasuya, A; Fujiyama, T; Tatsuno, K; Sakabe, J; Yamaguchi, H; Ito, T; Tokura, Y				Kuriyama, Sachiko; Kasuya, Akira; Fujiyama, Toshiharu; Tatsuno, Kazuki; Sakabe, Jun-ichi; Yamaguchi, Hayato; Ito, Taisuke; Tokura, Yoshiki			Leukoderma in patients with atopic dermatitis	JOURNAL OF DERMATOLOGY			English	Article						atopic dermatitis; filaggrin; leukoderma; thymus and activation regulated chemokine; vitiligo	VITILIGO; SKIN	Atopic dermatitis (AD) is occasionally associated with vitiligo, however, the incidence and conditions of vitiligo or leukoderma, and the characteristics of concurrent AD, remain unclear. We conducted a prospective observational study to investigate the leukoderma-related clinical manifestations and bioparameters of AD. Because vitiligo in AD lesions is occasionally associated with inflammation, we used leukoderma in this study. Enrolled were all AD patients who had been followed up in our AD outpatient clinic and visited within the previous 4months. During this period, we carefully inspected whether the patients had leukoderma. Eight of 52 patients had leukoderma (15.4%) and were designated as the leukoderma group, and the remaining 44 patients comprised the non-leukoderma group. While the ages were statistically not different between the two groups, female preponderance was significantly observed in the leukoderma group. The leukoderma patients tended to have higher values of SCORAD, CCL17/thymus and activation regulated chemokine and lactate dehydrogenase than the non-leukoderma patients. The leukoderma group was also characterized by a lower frequency of allergic rhinitis and a higher frequency of prurigo lesions. Thus, despite the possession of high AD severity, the leukoderma patients may possibly retain a relatively T-helper 1-skewing state in relation to the development of leukoderma and less association with rhinitis.	[Kuriyama, Sachiko; Kasuya, Akira; Fujiyama, Toshiharu; Tatsuno, Kazuki; Sakabe, Jun-ichi; Yamaguchi, Hayato; Ito, Taisuke; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Tokura, Y (reprint author), Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	tokura@hama-med.ac.jp					Sandoval-Cruz M, 2011, AUTOIMMUN REV, V10, P762, DOI 10.1016/j.autrev.2011.02.004; Silverberg JI, 2013, JAMA DERMATOL, V149, P983, DOI 10.1001/jamadermatol.2013.4228; Nemoto-Hasebe I, 2009, BRIT J DERMATOL, V161, P1387, DOI [10.1111/j.1365-2133.2009.09406.x, 10.1111/j.1365-2133.2009.09406]; Vrijman C, 2012, BRIT J DERMATOL, V167, P1224, DOI 10.1111/j.1365-2133.2012.11198.x; Yamaguchi H, 2013, J DERMATOL SCI, V72, P240, DOI 10.1016/j.jdermsci.2013.07.009; Ezzedine K, 2012, BRIT J DERMATOL, V167, P490, DOI 10.1111/j.1365-2133.2012.11002.x; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Kabashima-Kubo R, 2012, J DERMATOL SCI, V67, P37, DOI 10.1016/j.jdermsci.2012.04.004; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Ito T, 2013, J DERMATOL SCI, V72, P327, DOI 10.1016/j.jdermsci.2013.07.014; MACMILLAN A, 1971, British Journal of Dermatology, V85, P491; Park K, 2011, EUR J DERMATOL, V21, P135, DOI 10.1684/ejd.2010.1196; Sugita K, 2006, CLIN EXP DERMATOL, V31, P80, DOI 10.1111/j.1365-2230.2005.01987.x; Tanemura A, 2012, EUR J DERMATOL, V22, P279, DOI 10.1684/ejd.2012.1656; Tanemura A, 2012, J DERMATOL SCI, V67, P207, DOI 10.1016/j.jdermsci.2012.06.010	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					215	218		10.1111/1346-8138.12746		4	Dermatology	Dermatology	CA4KJ	WOS:000348872800016		
J	Tsunemi, Y; Takehara, K; Oe, M; Sanada, H; Kawashima, M				Tsunemi, Yuichiro; Takehara, Kimie; Oe, Makoto; Sanada, Hiromi; Kawashima, Makoto			Diagnostic accuracy of tinea unguium based on clinical observation	JOURNAL OF DERMATOLOGY			English	Letter							TOENAIL ONYCHOMYCOSIS		[Tsunemi, Yuichiro; Kawashima, Makoto] Tokyo Womens Med Univ, Dept Dermatol, Tokyo 1628666, Japan; [Takehara, Kimie] Univ Tokyo, Grad Sch Med, Dept Nursing Adm, Tokyo, Japan; [Oe, Makoto] Univ Tokyo, Grad Sch Med, Dept Adv Nursing Technol, Tokyo, Japan; [Kawashima, Makoto] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing & Wound Care Management, Tokyo, Japan	Tsunemi, Y (reprint author), Tokyo Womens Med Univ, Dept Dermatol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ytsun-tky@umin.ac.jp					Watanabe S, 2010, J DERMATOL, V37, P397, DOI 10.1111/j.1346-8138.2009.00741.x; Karimzadegan-Nia M, 2007, AUSTRALAS J DERMATOL, V48, P18, DOI 10.1111/j.1440-0960.2007.00320.x; Thomas J, 2010, J CLIN PHARM THER, V35, P497, DOI 10.1111/j.1365-2710.2009.01107.x; Lilly KK, 2006, J AM ACAD DERMATOL, V55, P620, DOI 10.1016/j.jaad.2006.03.033; Sei Yoshihiro, 2012, Med Mycol J, V53, P185, DOI 10.3314/mmj.53.185	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					221	222		10.1111/1346-8138.12750		2	Dermatology	Dermatology	CA4KJ	WOS:000348872800019		
J	Minami-Hori, M; Komatsu, S; Komura, K; Iizuka, H; Ishida-Yamamoto, A				Minami-Hori, Masako; Komatsu, Shigetsuna; Komura, Keiji; Iizuka, Hajime; Ishida-Yamamoto, Akemi			Periorbital lupus profundus successfully treated with oral tacrolimus plus low-dose prednisolone	JOURNAL OF DERMATOLOGY			English	Letter							ERYTHEMATOSUS; EDEMA		[Minami-Hori, Masako; Komatsu, Shigetsuna; Iizuka, Hajime; Ishida-Yamamoto, Akemi] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; [Komura, Keiji] Asahikawa Med Univ, Dept Internal Med, Div Metab & Biosyst Sci, Asahikawa, Hokkaido 0788510, Japan	Minami-Hori, M (reprint author), Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	masakoh@asahikawa-med.ac.jp					CYRAN S, 1992, J AM ACAD DERMATOL, V26, P334, DOI 10.1016/0190-9622(92)70049-L; Serarslan G, 2011, J DERMATOL, V38, P486, DOI 10.1111/j.1346-8138.2010.01096.x; SHEEHANDARE RA, 1988, CLIN EXP DERMATOL, V13, P406, DOI 10.1111/j.1365-2230.1988.tb00739.x; TUFFANELLI DL, 1964, ARCH DERMATOL, V90, P377	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					222	223		10.1111/1346-8138.12742		2	Dermatology	Dermatology	CA4KJ	WOS:000348872800020		
J	Adachi, A; Komine, M; Murata, S; Ohtsuki, M				Adachi, Akimasa; Komine, Mayumi; Murata, Satoru; Ohtsuki, Mamitaro			Japanese case of metastatic cutaneous Crohn's disease of the groin	JOURNAL OF DERMATOLOGY			English	Letter							VASCULITIS		[Adachi, Akimasa; Komine, Mayumi; Murata, Satoru; Ohtsuki, Mamitaro] Jichi Med Univ, Dept Dermatol, Shimotsuke, Tochigi 3290498, Japan	Komine, M (reprint author), Jichi Med Univ, Dept Dermatol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	mkomine12@jichi.ac.jp					Chiba M, 1997, J GASTROENTEROL, V32, P817, DOI 10.1007/BF02936961; Ishida M, 2013, INT J CLIN EXP PATHO, V6, P2263; Misago N, 2012, AM J DERMATOPATH, V34, P325, DOI 10.1097/DAD.0b013e3182318db9; Saha M, 2008, CLIN EXP DERMATOL, V34, P88; Susan K, 2009, PEDIAT DERMATOL, V26, P604	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					224	225		10.1111/1346-8138.12723		2	Dermatology	Dermatology	CA4KJ	WOS:000348872800021		
J	Kitamura, S; Iwata, H; Imafuku, K; Hata, H; Natsuga, K; Aoyagi, S; Shimizu, H				Kitamura, Shinya; Iwata, Hiroaki; Imafuku, Keisuke; Hata, Hiroo; Natsuga, Ken; Aoyagi, Satoru; Shimizu, Hiroshi			Bowen's disease on the palm presents refractory skin erosion without erythematous plaque	JOURNAL OF DERMATOLOGY			English	Letter									[Kitamura, Shinya; Iwata, Hiroaki; Imafuku, Keisuke; Hata, Hiroo; Natsuga, Ken; Aoyagi, Satoru; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan	Iwata, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	hiroaki.iwata@med.hokudai.ac.jp		Natsuga, Ken/0000-0003-3865-6366			Col M, 1999, ENVIRON HEALTH PERSP, V107, P687, DOI 10.2307/3434463; Cavicchini S, 2010, J AM ACAD DERMATOL, V62, P356, DOI 10.1016/j.jaad.2009.01.035; Harnalikar Manoj, 2011, Indian J Dermatol, V56, P353, DOI 10.4103/0019-5154.82497; KOSSARD S, 1992, J AM ACAD DERMATOL, V27, P406, DOI 10.1016/0190-9622(92)70208-W; Murao K, 2013, CLIN EXP DERMATOL, V38, P489, DOI 10.1111/j.1365-2230.2012.04382.x	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					225	226		10.1111/1346-8138.12745		2	Dermatology	Dermatology	CA4KJ	WOS:000348872800022		
J	Kamiya, K; Niwa, H; Niwa, M; Kamiya, Y; Saito, A; Natsume, T; Tokura, Y				Kamiya, Koji; Niwa, Haruo; Niwa, Miwako; Kamiya, Yasunari; Saito, Akitoshi; Natsume, Tadashi; Tokura, Yoshiki			Immunoglobulin A vasculitis in the oldest old	JOURNAL OF DERMATOLOGY			English	Letter							HENOCH-SCHONLEIN PURPURA		[Kamiya, Koji; Niwa, Haruo; Niwa, Miwako; Saito, Akitoshi; Natsume, Tadashi] Toei Hosp, Dept Gen Med, Toei Chou, Aichi 4490293, Japan; [Kamiya, Yasunari] Toei Hosp, Dept Orthoped Surg, Toei Chou, Aichi 4490293, Japan; [Kamiya, Koji; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Kamiya, K (reprint author), Toei Hosp, 5 Miwakamikuri, Toei Chou, Aichi 4490293, Japan.	m01023kk@jichi.ac.jp					Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; MILLS JA, 1990, ARTHRITIS RHEUM, V33, P1114; Diehl MP, 2008, J AM GERIATR SOC, V56, P2157, DOI 10.1111/j.1532-5415.2008.01983.x; Weiss PF, 2007, PEDIATRICS, V120, P1079, DOI 10.1542/peds.2007-0667; Chen MJ, 2005, WORLD J GASTROENTERO, V11, P2354	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					226	227		10.1111/1346-8138.12747		2	Dermatology	Dermatology	CA4KJ	WOS:000348872800023		
J	Jinno, N; Yamana, Y; Kawashima, M; Tsunemi, Y				Jinno, Naoko; Yamana, Yayoi; Kawashima, Makoto; Tsunemi, Yuichiro			Mycosis fungoides with psoriasiform lesions	JOURNAL OF DERMATOLOGY			English	Letter									[Jinno, Naoko; Yamana, Yayoi; Kawashima, Makoto; Tsunemi, Yuichiro] Tokyo Womens Med Univ, Dept Dermatol, Tokyo 1628666, Japan	Jinno, N (reprint author), Tokyo Womens Med Univ, Dept Dermatol, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.	mdmqt476@yahoo.co.jp					Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Zackheim HS, 2002, J AM ACAD DERMATOL, V47, P155, DOI 10.1067/mjd.2002.120571; BARR RJ, 1985, J CUTAN PATHOL, V12, P412, DOI 10.1111/j.1600-0560.1985.tb00439.x; Parmentier L, 2010, ARCH DERMATOL, V146, P1287, DOI 10.1001/archdermatol.2010.325; Suga H, 2014, ACTA DERM-VENEREOL, V94, P233, DOI 10.2340/00015555-1675	5	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					227	229		10.1111/1346-8138.12749		3	Dermatology	Dermatology	CA4KJ	WOS:000348872800024		
J	Ohtsuka, T				Ohtsuka, Tsutomu			Reply from Dr. Ohtsuka to Interferon-alpha for the treatment of severe entero- and neuro-Behcet's disease	JOURNAL OF DERMATOLOGY			English	Letter									Int Univ Hlth & Welf Hosp, Dept Dermatol, Tokyo, Tochigi, Japan	Ohtsuka, T (reprint author), Int Univ Hlth & Welf Hosp, Dept Dermatol, Tokyo, Tochigi, Japan.	tohtsuka@iuhw.ac.jp					Levy-Clarke G, 2014, OPHTHALMOLOGY, V121, P785, DOI 10.1016/j.ophtha.2013.09.048; Arida A, 2011, SEMIN ARTHRITIS RHEU, V41, P61, DOI 10.1016/j.semarthrit.2010.09.002; Monastirli A, 2010, QJM-INT J MED, V103, P787, DOI 10.1093/qjmed/hcq125; Chroni E, 2008, SEIZURE-EUR J EPILEP, V17, P744, DOI 10.1016/j.seizure.2008.05.008; Saleh Zeinab, 2014, Ther Adv Chronic Dis, V5, P112, DOI 10.1177/2040622314523062	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	FEB	2015	42	2					230	230		10.1111/1346-8138.12716		1	Dermatology	Dermatology	CA4KJ	WOS:000348872800026		
J	Badano, A; Revie, C; Casertano, A; Cheng, WC; Green, P; Kimpe, T; Krupinski, E; Sisson, C; Skrovseth, S; Treanor, D; Boynton, P; Clunie, D; Flynn, MJ; Heki, T; Hewitt, S; Homma, H; Masia, A; Matsui, T; Nagy, B; Nishibori, M; Penczek, J; Schopf, T; Yagi, Y; Yokoi, H				Badano, Aldo; Revie, Craig; Casertano, Andrew; Cheng, Wei-Chung; Green, Phil; Kimpe, Tom; Krupinski, Elizabeth; Sisson, Christye; Skrovseth, Stein; Treanor, Darren; Boynton, Paul; Clunie, David; Flynn, Michael J.; Heki, Tatsuo; Hewitt, Stephen; Homma, Hiroyuki; Masia, Andy; Matsui, Takashi; Nagy, Balazs; Nishibori, Masahiro; Penczek, John; Schopf, Thomas; Yagi, Yukako; Yokoi, Hideto			Consistency and Standardization of Color in Medical Imaging: a Consensus Report	JOURNAL OF DIGITAL IMAGING			English	Article						Color imaging; Medical imaging; Color calibration; Color management	PERFORMANCE; LESIONS; IMAGES; CAMERA	This article summarizes the consensus reached at the Summit on Color in Medical Imaging held at the Food and Drug Administration (FDA) on May 8-9, 2013, co-sponsored by the FDA and ICC (International Color Consortium). The purpose of the meeting was to gather information on how color is currently handled by medical imaging systems to identify areas where there is a need for improvement, to define objective requirements, and to facilitate consensus development of best practices. Participants were asked to identify areas of concern and unmet needs. This summary documents the topics that were discussed at the meeting and recommendations that were made by the participants. Key areas identified where improvements in color would provide immediate tangible benefits were those of digital microscopy, telemedicine, medical photography (particularly ophthalmic and dental photography), and display calibration. Work in these and other related areas has been started within several professional groups, including the creation of the ICC Medical Imaging Working Group.	[Badano, Aldo; Cheng, Wei-Chung] US FDA, Div Imaging & Appl Math, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Revie, Craig] FFEI Ltd, London, England; [Revie, Craig] Int Color Consortium, London, England; [Casertano, Andrew] SAN Business Consultants LLP, New York, NY USA; [Green, Phil] Gjovik Univ Coll, Tromso, Norway; [Kimpe, Tom] Barco NV, Healthcare Div, Brussels, Belgium; [Krupinski, Elizabeth] Univ Arizona, Dept Med Imaging, Tucson, AZ USA; [Krupinski, Elizabeth] Univ Arizona, Arizona Telemed Program, Tucson, AZ USA; [Sisson, Christye] Rochester Inst Technol, Sch Photog Arts & Sci, Rochester, NY 14623 USA; [Skrovseth, Stein] Univ Hosp North Norway, Norwegian Ctr Integrated Care & Telemed, Tromso, Norway; [Treanor, Darren] Leeds Teaching Hosp NHS Trust, London, England; [Treanor, Darren] Univ Leeds, London, England; [Boynton, Paul] NIST, Gaithersburg, MD 20899 USA; [Clunie, David] PixelMed Publishing, Philadelphia, PA USA; [Flynn, Michael J.] Henry Ford Hlth Syst, New York, NY USA; [Heki, Tatsuo] Fujifilm Corp, Healthcare Business Dev Off, Tokyo, Japan; [Hewitt, Stephen] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Homma, Hiroyuki] Olympus Med Syst Corp, Tokyo, Japan; [Masia, Andy] X Rite, Boston, MA USA; [Matsui, Takashi] Eizo Corp, Tokyo, Japan; [Nagy, Balazs] Inst Psychol, Dept Expt Psychol, Sao Paulo, Brazil; [Nishibori, Masahiro] Int Univ Hlth & Welf, Dept Social Serv & Healthcare Management, Tokyo, Japan; [Penczek, John] NIST, Boulder, CO USA; [Penczek, John] Univ Colorado, Boulder, CO 80309 USA; [Schopf, Thomas] Univ Hosp North Norway, Norwegian Ctr Integrated Care & Telemed, Tromso, Norway; [Yokoi, Hideto] Kagawa Univ Hosp, Dept Med Informat, Tokyo, Japan; [Yagi, Yukako] Harvard Univ, Sch Med, Boston, MA USA; [Yagi, Yukako] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Nagy, Balazs] Budapest Univ Technol & Econ, Ctr Neurosci & Behav, Budapest, Hungary; [Nagy, Balazs] Budapest Univ Technol & Econ, Dept Mechatron Opt & Engn Informat, Budapest, Hungary	Badano, A (reprint author), US FDA, Div Imaging & Appl Math, Ctr Devices & Radiol Hlth, 10993 New Hampshire Ave, Silver Spring, MD 20993 USA.	aldo.badano@fda.hhs.gov	NAGY, Balazs Vince/K-6546-2015; Clunie, David/Q-2777-2015; 	NAGY, Balazs Vince/0000-0002-8489-7200; Clunie, David/0000-0002-2406-1145; Skrovseth, Stein Olav/0000-0003-3568-867X; Hewitt, Stephen/0000-0001-8283-1788	Research Council of Norway [174,934]	SS and TS were funded by the Research Council of Norway grant no. 174,934, Tromso Telemedicine Laboratory. The mention of commercial products, their sources, or their use in connection with material reported herein is not to be construed as either an actual or implied endorsement of such products by the Department of Health and Human Services.	ACR/NEMA, 2011, TECHNICAL REPORT; Ahmad I, 2009, BRIT DENT J, V207, P13, DOI 10.1038/sj.bdj.2009.558; [Anonymous], 2010, 150761 ISO; Samei E, 2005, MED PHYS, V32, P1205, DOI 10.1118/1.1861159; Bergmo TS, 2009, ACTA PAEDIATR, V98, P316, DOI 10.1111/j.1651-2227.2008.01033.x; Glatz J, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101302; Morovic J, 2001, J IMAGING SCI TECHN, V45, P283; Korotkov K, 2012, ARTIF INTELL MED, V56, P69, DOI 10.1016/j.artmed.2012.08.002; Narasimha-Iyer H, 2006, IEEE T BIO-MED ENG, V53, P1084, DOI 10.1109/TBME.2005.863971; Sluzker A, 2011, AM J DENT, V24, P300; Krupinski EA, 2012, J DIGIT IMAGING, V25, P738, DOI 10.1007/s10278-012-9479-1; Bengel Wolfgang M, 2003, J Esthet Restor Dent, V15 Suppl 1, pS21, DOI 10.1111/j.1708-8240.2003.tb00315.x; Bengel WM, 2003, J ESTHET RESTOR D S1, V15, pS32; Bentley C, 1999, J AM DENT ASSOC, V130, P809; Cheng WC, 2013, SPIE MED IMAGING; Curtin RE, 2007, J OPHTHALMIC PHOTOGR, V29, P143; Hu Erzhong, 2013, Conf Proc IEEE Eng Med Biol Soc, V2013, P5477, DOI 10.1109/EMBC.2013.6610789; Hubbard LD, 2007, J OPHTHALMIC PHOTOGR, V29, P145; Lasserre JF, 2011, J DENT, V39, pE29, DOI 10.1016/j.jdent.2011.11.002; Madjarov B, 2002, J OPHTHALMIC PHOTOGR, V29, P31; McLaren EA, 2011, COMPEND CONTIN ED DE, V32, P32; Michalec GS, 2006, J OPHTHALMIC PHOTOGR, V28, P93; Moncada G, 2013, OPER DENT; Nishibori M, 2004, J IMAGING SCI TECHN, V48, P125; Penczek J, 2014, J DIGIT IMAGING, V27, P182, DOI 10.1007/s10278-013-9644-1; Schalenbourg A, 2013, EYE, V27, P224, DOI 10.1038/eye.2012.267; Torlakovic L, 2012, AM J ORTHOD DENTOFAC, V142, P191, DOI 10.1016/j.ajodo.2012.03.025; Yagi Y, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S15; Yamaguchi M, 2011, ADV TELEMEDICINE TEC; Yamaguchi M, 2009, P 3 INT UN COMM S AC, P150, DOI 10.1145/1667780.1667810	30	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0897-1889	1618-727X		J DIGIT IMAGING	J. Digit. Imaging	FEB	2015	28	1					41	52		10.1007/s10278-014-9721-0		12	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ7KO	WOS:000348398200007		
J	Uchiyama, Y; Abe, A; Muramatsu, C; Hara, T; Shiraishi, J; Fujita, H				Uchiyama, Yoshikazu; Abe, Akiko; Muramatsu, Chisako; Hara, Takeshi; Shiraishi, Junji; Fujita, Hiroshi			Eigenspace Template Matching for Detection of Lacunar Infarcts on MR Images	JOURNAL OF DIGITAL IMAGING			English	Article						Lacunar infarcts; Computer-aided diagnosis; Template matching; Eigenspace	SILENT BRAIN INFARCTS; MUTUAL INFORMATION; CHEST RADIOGRAPHS; SCHEME; RISK; MASSES; STROKE	Detection of lacunar infarcts is important because their presence indicates an increased risk of severe cerebral infarction. However, accurate identification is often hindered by the difficulty in distinguishing between lacunar infarcts and enlarged Virchow-Robin spaces. Therefore, we developed a computer-aided detection (CAD) scheme for the detection of lacunar infarcts. Although our previous CAD method indicated a sensitivity of 96.8 % with 0.71 false positives (FPs) per slice, further reduction of FPs remained an issue for the clinical application. Thus, the purpose of this study is to improve our CAD scheme by using template matching in the eigenspace. Conventional template matching is useful for the reduction of FPs, but it has the following two pitfalls: (1) It needs to maintain a large number of templates to improve the detection performance, and (2) calculation of the cross-correlation coefficient with these templates is time consuming. To solve these problems, we used template matching in the lower dimension space made by a principal component analysis. Our database comprised 1,143 T-1- and T-2-weighted images obtained from 132 patients. The proposed method was evaluated by using twofold cross-validation. By using this method, 34.1 % of FPs was eliminated compared with our previous method. The final performance indicated that the sensitivity of the detection of lacunar infarcts was 96.8 % with 0.47 FPs per slice. Therefore, the modified CAD scheme could improve FP rate without a significant reduction in the true positive rate.	[Uchiyama, Yoshikazu; Shiraishi, Junji] Kumamoto Univ, Dept Med Phys, Fac Life Sci, Kumamoto 8620976, Japan; [Abe, Akiko; Muramatsu, Chisako; Hara, Takeshi; Fujita, Hiroshi] Gifu Univ, Grad Sch Med, Dept Intelligent Image Informat, Gifu 5011194, Japan	Uchiyama, Y (reprint author), Kumamoto Univ, Dept Med Phys, Fac Life Sci, 4-24-1 Kuhonji, Kumamoto 8620976, Japan.	y_uchi@kumamoto-u.ac.jp			JSPS KAKENHI [24591815]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [21103001]	This work was partly supported by JSPS KAKENHI Grant Number 24591815, and a Grant-in-Aid for Scientific Research on Innovative Areas 21103001 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Uchiyama Y, 2007, ACAD RADIOL, V14, P1554, DOI 10.1016/j.acra.2007.09.012; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Kobayashi S, 1997, STROKE, V28, P1932; Tourassi GD, 2003, MED PHYS, V30, P2123, DOI 10.1118/1.1589494; Lee Y, 2001, IEEE T MED IMAGING, V20, P595; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Mazurowski MA, 2011, J BIOMED INFORM, V44, P815, DOI 10.1016/j.jbi.2011.04.008; Bokura Hirokazu, 2006, J Stroke Cerebrovasc Dis, V15, P57, DOI 10.1016/j.jstrokecerebrovasdis.2005.11.001; Jolliffe I., 2002, PRINCIPAL COMPONENT; Kilic N, 2009, J MED SYST, V33, P9, DOI 10.1007/s10916-008-9159-3; Li Q, 2001, MED PHYS, V28, P2070, DOI 10.1118/1.1406517; Morishita J, 2004, ACAD RADIOL, V11, P309, DOI 10.1016/S1076-6332(03)00655-X; Murase H, 1994, PROCEEDINGS OF THE I; Shintani S, 1998, J NEUROL SCI, V160, P82, DOI 10.1016/S0022-510X(98)00182-8; Theodoridis S., 1999, PATTERN RECOGNITION; Uchiyama Y, 2012, J DIGIT IMAGING, V25, P497, DOI 10.1007/s10278-011-9444-4; Yokoyama R, 2007, IEICE T INF SYST, VE90D, P943, DOI 10.1093/ietisy/e90-d.6.943	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0897-1889	1618-727X		J DIGIT IMAGING	J. Digit. Imaging	FEB	2015	28	1					116	122		10.1007/s10278-014-9711-2		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ7KO	WOS:000348398200014		
J	Herbst, MK; Camargo, CA; Perez, A; Moore, CL				Herbst, Meghan Kelly; Camargo, Carlos A., Jr.; Perez, Alberto; Moore, Christopher L.			USE OF POINT-OF-CARE ULTRASOUND IN CONNECTICUT EMERGENCY DEPARTMENTS	JOURNAL OF EMERGENCY MEDICINE			English	Article						ultrasound; survey; emergency department	PHYSICIANS; ULTRASONOGRAPHY; ACCESS	Background: Point-of-care ultrasound (PoC US) is now taught and used in nearly all academic emergency departments (EDs), but prior surveys have shown that adoption in the community ED setting is much lower. Objective: Our aim was to characterize the current practice of emergency physician (EP)-performed PoC US in Connecticut. Methods: We conducted a 20-question online survey of all ED directors in Connecticut to determine how PoC US is utilized. The questions addressed ED demo-graphics, ownership of ultrasound (US) equipment, frequency of PoC US performance in general and by examination type, credentialing patterns, quality assurance methods, and billing patterns. Results: The response rate was 83% (25 of 30). Almost all (96%) respondent EDs owned at least one US machine, and 24% used US regularly for diverse applications according to 2008 American College of Emergency Physicians (ACEP) guidelines. PoC US was most commonly used for Focused Assessment with Sonography in Trauma examinations, procedural guidance, and assessing the aorta for an abdominal aortic aneurysm. Although 64% reported hospital ultrasonography privileges, 40% did not keep any record of PoC US performed in the ED. More than half (56%) required an over-read by radiology, and 36% required an over-read by another EP (e. g., ED Ultrasound Director). Only 8% of EDs billed for PoC US. Conclusions: Most Connecticut EDs own an US machine and have hospital privileges for PoC US. However, a minority use or bill for PoC US regularly for diffuse applications, and most do not have a quality assurance program as described by ACEP guidelines. (C) 2015 Elsevier Inc.	[Herbst, Meghan Kelly] Univ Connecticut, Sch Med, Hartford Hosp, Dept Emergency Med, Hartford, CT 06112 USA; [Camargo, Carlos A., Jr.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA USA; [Perez, Alberto] Univ Connecticut, Sch Med, Dept Emergency Med, John Dempsey Hosp, Farmington, CT USA; [Moore, Christopher L.] Yale Univ, Yale New Haven Hosp, Dept Emergency Med, New Haven, CT USA	Herbst, MK (reprint author), Hartford Hosp, 80 Seymour St, Ishikari, Hokkaido 06102, Japan.						Agency for Health Care Research and Quality (AHRQ), 2007, EV REP TECHN ASS NUM; American College of Emergency Physicians, 2009, ANN EMERG MED, V53, P550; American College of Emergency Physicians, 2001, ANN EMERG MED, V38, P470; American Medical Association, POL SUNS REP 2000 AM; JEHLE D, 1989, AM J EMERG MED, V7, P605, DOI 10.1016/0735-6757(89)90283-0; Durston W, 1999, AM J EMERG MED, V17, P642, DOI 10.1016/S0735-6757(99)90150-X; Labovitz AJ, 2010, J AM SOC ECHOCARDIOG, V23, P1225, DOI 10.1016/j.echo.2010.10.005; Leung J, 2006, ANN EMERG MED, V48, P540, DOI 10.1016/j.annemergmed.2006.01.011; Plummer D, 2000, ACAD EMERG MED, V7, P186, DOI 10.1111/j.1553-2712.2000.tb00525.x; Moore CL, 2006, ANN EMERG MED, V47, P147, DOI 10.1016/j.annemergmed.2005.08.023; Sullivan AF, 2006, ANN EMERG MED, V48, P694, DOI 10.1016/j.annemergmed.2006.08.020; Cardenas E, 1998, WESTERN J MED, V168, P188; Counselman FL, 2003, ACAD EMERG MED, V10, P37, DOI 10.1111/j.1553-2712.2003.tb01974.x; Eurle B, 2004, CRITICAL DECISIONS E, V18, P1; Moak J, SAEM ENDORSES 2008 A; Muelleman RL, 2010, ACAD EMERG MED, V17, P1390, DOI 10.1111/j.1553-2712.2010.00924.x; National Institute of Clinical Excellence, 2002, FIN APPR DET ULTR LO; Ollerton JE, 2006, J TRAUMA, V60, P785, DOI 10.1097/01.ta.0000214583.21492.e8; Pitts SR, 2008, NATL HLTH STAT REPOR, V7; SCHLAGER D, 1994, AM J EMERG MED, V12, P185, DOI 10.1016/0735-6757(94)90244-5; Stein JC, 2009, J ULTRAS MED, V28, P757; Talley Brad E, 2011, West J Emerg Med, V12, P96	22	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	FEB	2015	48	2					191	U194		10.1016/j.jemermed.2014.09.017		8	Emergency Medicine	Emergency Medicine	AZ9AO	WOS:000348503900018		
J	Komasawa, N; Fujiwara, S; Miyazaki, S; Ohchi, F; Minami, T				Komasawa, Nobuyasu; Fujiwara, Shunsuke; Miyazaki, Shinichiro; Ohchi, Fumihiro; Minami, Toshiaki			SHIFTS IN ENDOTRACHEAL TUBE POSITION DUE TO CHEST COMPRESSIONS: A SIMULATION COMPARISON BY FIXATION METHOD	JOURNAL OF EMERGENCY MEDICINE			English	Article						endotracheal tube; position shift; chest compression; tape fixation; tube fixation; simulation	INTENSIVE-CARE-UNIT; RESUSCITATION COUNCIL GUIDELINES; UNPLANNED EXTUBATION; FORCE; TAPE	Background: Endotracheal tube placement during resuscitation is important for definite tracheal protection. Accidental extubation due to endotracheal tube displacement is a rare event that can result in severe complications. Objective: This study evaluated how endotracheal tube displacement is affected by tape vs. tube holder fixation using a manikin and auto-chest compression machine simulation. Methods: The endotracheal tube was placed in either a shallow or a deep position, with the tube cuff at the center of the glottis or 26 cm from the incisors in an advanced life-saving simulator. Trials were performed five times in each setting with: no fixation; Durapore (R) tape fixation; Multipore (R) tape fixation; and Thomas tube holder (R) fixation. After 10 min of automated chest compressions, endotracheal tube shift was measured. Statistical analysis was performed with one-way repeated analysis of variance or c 2 test, with p < 0.05 considered significant. Results: In the shallow setting, endotracheal tube extubation occurred in all trials with no fixation, Durapore, and Multipore. In contrast, no extubation occurred in the Tube holder trials (p < 0.05). In the deep setting, no extubation was confirmed in any trial. Relative to no fixation (0.56 +/- 0.11 cm), endotracheal tube shift was significantly less in the Durapore tape, Multipore tape, and Tube holder groups (p < 0.05). Of the three fixation methods, Tube holder (0.04 +/- 0.05 cm) showed significantly less shift (p < 0.05) relative to Durapore (0.28 +/- 0.04 cm) and Multipore (0.32 +/- 0.08 cm). Conclusion: Endotracheal tube displacement occurs less with Tube holder fixation than with Durapore tape or Multipore tape during simulation of continuous chest compressions. (C) 2015 Elsevier Inc.	[Komasawa, Nobuyasu; Fujiwara, Shunsuke; Miyazaki, Shinichiro; Ohchi, Fumihiro; Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan	Komasawa, N (reprint author), Osaka Med Coll, Dept Anesthesiol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.						Achauer BM, 1997, ANN PLAS SURG, V38, P280, DOI 10.1097/00000637-199703000-00016; Kupas DF, 2010, PREHOSP EMERG CARE, V14, P26, DOI 10.3109/10903120903144932; Bouza C, 2007, HEART LUNG, V36, P270, DOI 10.1016/j.hrtlng.2006.10.002; Christie JM, 1996, J CLIN ANESTH, V8, P289, DOI 10.1016/0952-8180(96)00037-2; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; Kapadia FN, 2000, CRIT CARE MED, V28, P659, DOI 10.1097/00003246-200003000-00010; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Komasawa N, 2010, J ANESTH, V24, P582, DOI 10.1007/s00540-010-0950-1; Carlson J, 2007, ANN EMERG MED, V50, P686, DOI 10.1016/j.annemergmed.2007.05.013; Carrion MI, 2000, CRIT CARE MED, V28, P63, DOI 10.1097/00003246-200001000-00010; Chiang AA, 1996, INTENS CARE MED, V22, P1269; Gardner A, 2005, AUST CRIT CARE, V18, P158, DOI 10.1016/S1036-7314(05)80029-3; Grove P, 2000, Aust Crit Care, V13, P6, DOI 10.1016/S1036-7314(00)70609-6; Matera P., 1998, J EMERG MED SERV, V23, P34; Owen R, 2009, RESUSCITATION, V80, P1296, DOI 10.1016/j.resuscitation.2009.08.007; Shimizu T, 2011, RESP CARE, V56, P1825, DOI 10.4187/respcare.00954	16	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	FEB	2015	48	2					241	246		10.1016/j.jemermed.2014.06.064		6	Emergency Medicine	Emergency Medicine	AZ9AO	WOS:000348503900033		
J	Sawamoto, K; Hase, M; Uemura, S; Kasai, T; Narimatsu, E				Sawamoto, Keigo; Hase, Mamoru; Uemura, Shuji; Kasai, Takehiko; Narimatsu, Eichi			TAKOTSUBO CARDIOMYOPATHY INDUCED BY SUICIDAL NECK HANGING	JOURNAL OF EMERGENCY MEDICINE			English	Article						takotsubo cardiomyopathy; apical balloon syndrome; neck hanging; suicide	MYOCARDIAL-INFARCTION	Background: Takotsubo cardiomyopathy (TC) is an uncommon immune-endocrinologic cause of acute reversible heart failure, generally caused by some form of stress. Case Report: We report a case of TC after hanging for attempted suicide. Upon admission, the patient demonstrated an almost entirely normal electrocardiogram (ECG) and mild hypotension. However, on the third day after hanging, she developed chest and back pain with inverted T waves and QTc prolongation on ECG. Her coronary arteries were normal on angiogram, but the left ventricle showed apical ballooning, consistent with TC. She was treated with an intra-aortic balloon pump and fully recovered. We observed that the QTc interval seemed to be a good guide for clinical course in this case. Why Should an Emergency Physician Be Aware of This?: TC should be considered in any acute stressful presentation, and to assist in the diagnosis as TC, we suggest following the QTc on ECG. TC should be taken into consideration in patients after suicide attempt with low blood pressure or an abnormal ECG, including ST segment elevation, Twave inversion, and QTc prolongation. (C) 2015 Elsevier Inc.	[Sawamoto, Keigo; Hase, Mamoru; Uemura, Shuji; Kasai, Takehiko; Narimatsu, Eichi] Sapporo Med Univ, Dept Emergency Med, Sapporo, Hokkaido 0608543, Japan	Sawamoto, K (reprint author), Sapporo Med Univ, Dept Emergency Med, Chuo Ku, S1W16, Sapporo, Hokkaido 0608543, Japan.						Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032; Bybee KA, 2004, ANN INTERN MED, V141, P858; Gnanavelu G, 2008, J Assoc Physicians India, V56, P545; Nakata H, 2005, J JPN ASS ACUTE MED, V16, P587; Sato H, 1990, CLIN ASPECT MYOCARDI, P56	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	FEB	2015	48	2					E35	E38		10.1016/j.jemermed.2014.10.003		4	Emergency Medicine	Emergency Medicine	AZ9AO	WOS:000348503900002		
J	Fujimura, S; Muramatsu, Y; Ohno, T; Saitou, M; Suzuki, Y; Kobayashi, T; Yoshioka, K; Ueda, Y				Fujimura, Shigeto; Muramatsu, Yasuyuki; Ohno, Takeshi; Saitou, Masaaki; Suzuki, Yasukazu; Kobayashi, Tomoyuki; Yoshioka, Kunio; Ueda, Yoshikatsu			Accumulation of Cs-137 by rice grown in four types of soil contaminated by the Fukushima Dai-ichi Nuclear Power Plant accident in 2011 and 2012	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Aging effect; Brown rice; Cesium uptake; Exchangeable radiocesium; Inedible rice parts; Transfer factor	ORGANIC SOILS; PADDY-FIELD; LONG-TERM; RADIOCESIUM; RADIOSTRONTIUM; SR-90; CROPS	The ability to predict radiocesium transfer from soil to agricultural products is necessary for assessing management options in a radiocesium contaminated area. In this study, we evaluated the differences in transfer factors among soil samples and the differences in transfer factors between the first and the second years of contamination in rice. We employed pot experiments using four types of soils that are representative of the agricultural soils present in the Fukushima Prefecture contaminated by Cs-137 released from the Fukushima Dal-ichi Nuclear Power Plant after the March 2011 accident. The experiments were conducted during the 2011 and 2012 growing seasons. The geometric mean of transfer factors for brown rice and inedible rice part was 0.011 and 0.031, respectively, in 2011 and 0.0061 and 0.020, respectively, in 2012. The average decreasing rate of the transfer factor was 40% and 30% in brown rice and inedible rice part, respectively, from 2011 to 2012, presumably owing to the irreversible sorption of Cs-137 to clay minerals. (C) 2014 Elsevier Ltd. All rights reserved.	[Fujimura, Shigeto; Saitou, Masaaki; Suzuki, Yasukazu; Kobayashi, Tomoyuki; Yoshioka, Kunio] Fukushima Agr Technol Ctr, Koriyama, Fukushima 9630531, Japan; [Muramatsu, Yasuyuki; Ohno, Takeshi] Gakushuin Univ, Toshima Ku, Tokyo 1718588, Japan; [Ueda, Yoshikatsu] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan	Fujimura, S (reprint author), NARO Tohoku Agr Res Ctr, 50 Harajukuminami, Fukushima 9602156, Japan.	fujimu@affrc.go.jp; yasuyuki.muramatsu@gakushuin.ac.jp; takeshi.ohno@gakushuin.ac.jp; saitou_masaaki_03@pref.fukushima.lg.jp; suzuki_yasukazu_01@pref.fukushima.lg.jp; kobayashi_tomoyuki_01@pref.fukushima.lg.jp; yoshioka_kunio_01@pref.fukushima.lg.jp; ueda.yoshikatsu.4e@kyoto-u.ac.jp			Kyoto University; Research Institute for Sustainable Humanosphere, Kyoto University	This work was financially supported by the Kyoto University and Research Institute for Sustainable Humanosphere, Kyoto University. We thank M. Sato, M. Sato, T. Yamauchi, Y. Suzuki, S. Fujita, Y. Sakuma and Y. Ono (Fukushima Agricultural Technology Centre) and T. Ota and Y. Abe (NARO Tohoku Agricultural Research Center) for data collection and discussion. The authors thanks Dr. Jean Moran (Department of Earth & Environmental Science, California State University) for her useful comments.	Absalom JP, 1999, ENVIRON SCI TECHNOL, V33, P1218, DOI 10.1021/es9808853; Absalom JP, 2001, J ENVIRON RADIOACTIV, V52, P31, DOI 10.1016/S0265-931X(00)00098-9; Ehlken S, 2002, J ENVIRON RADIOACTIV, V58, P97, DOI 10.1016/S0265-931X(01)00060-1; Rigol A, 1999, ENVIRON SCI TECHNOL, V33, P887, DOI 10.1021/es980720u; Qi Z, 2008, J EXP BOT, V59, P595, DOI 10.1093/jxb/erm330; Zhu YG, 2000, J EXP BOT, V51, P1635, DOI 10.1093/jexbot/51.351.1635; Ohmori Y, 2014, J PLANT RES, V127, P57, DOI 10.1007/s10265-013-0616-9; Endo S, 2013, J ENVIRON RADIOACTIV, V116, P59, DOI 10.1016/j.jenvrad.2012.08.018; BILO M, 1993, J ENVIRON RADIOACTIV, V19, P25, DOI 10.1016/0265-931X(93)90056-D; Fujimura S., 2014, J RADIOANAL NUCL CHE; Hyojun Dojou, 2003, DOJOU HYOJUN BUNSEKI; Komamura M., 2006, B NATL I AGROENVIRON, V24, P1; Krouglov SV, 1997, J ENVIRON RADIOACTIV, V34, P267, DOI 10.1016/0265-931X(96)00043-4; NISBET AF, 1993, SCI TOTAL ENVIRON, V137, P99, DOI 10.1016/0048-9697(93)90380-O; NISBET AF, 1994, J ENVIRON RADIOACTIV, V23, P1, DOI 10.1016/0265-931X(94)90502-9; NOORDIJK H, 1992, J ENVIRON RADIOACTIV, V15, P277, DOI 10.1016/0265-931X(92)90063-Y; SQUIRE HM, 1966, RADIAT BOT, V6, P413, DOI 10.1016/S0033-7560(66)80074-1; Tsukada H, 2002, J ENVIRON RADIOACTIV, V59, P351, DOI 10.1016/S0265-931X(01)00083-2; Tsukada H, 2002, ENVIRON POLLUT, V117, P403, DOI 10.1016/S0269-7491(01)00199-3; Tsumura A, 1984, B NATL I AGR SCI B, V36, P57	20	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	FEB	2015	140						59	64		10.1016/j.jenvrad.2014.10.018		6	Environmental Sciences	Environmental Sciences & Ecology	CA2OG	WOS:000348746900008		
J	Parajuli, D; Takahashi, A; Tanaka, H; Sato, M; Fukuda, S; Kamimura, R; Kawamoto, T				Parajuli, Durga; Takahashi, Akira; Tanaka, Hisashi; Sato, Mutsuto; Fukuda, Shigeharu; Kamimura, Ryuichi; Kawamoto, Tohru			Variation in available cesium concentration with parameters during temperature induced extraction of cesium from soil	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Cs in soil; Extraction; Decontamination; Canonical equation	ORGANIC-MATTER; ADSORPTION; RADIOCESIUM; CS-137; CHERNOBYL; ACCIDENT; SORPTION; DESORPTION; SEDIMENT; MINERALS	Cesium extraction behavior of brown forest type soil collected from paddy fields in Fukushima nuclear accident affected areas was studied. In nitric acid or sulfuric acid solutions at elevated temperature, the concentration of Cs in soil available for extraction, m(0), has been estimated on the basis of modified canonical equation and the equations derived from assumed equilibria. With the variation in temperature, mixing time, and soil to solvent ratio, the observed m(0) values in 0.5 M acid solution ranged between 1.5 and 2.9 mg cesium per kilogram of soil. By increasing the acid concentration to 3 M, the value of m(0) could be sharply increased to 5.1 mg/kg even at 95 degrees C. This variation in the extractable concentration of cesium with the parameters signifies the existence of different binding sites in the soil matrix. The results observed for uncontaminated sample could be reproduced with the radioactive cesium contaminated sample belonging to the same soil group. (C) 2014 Elsevier Ltd. All rights reserved.	[Parajuli, Durga; Takahashi, Akira; Tanaka, Hisashi; Kawamoto, Tohru] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058565, Japan; [Sato, Mutsuto] Fukushima Agr Technol Ctr, Koriyama, Fukushima 9630531, Japan; [Fukuda, Shigeharu; Kamimura, Ryuichi] Tokyo Power Technol Ltd, Koto Ku, Tokyo 1350061, Japan	Parajuli, D (reprint author), Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	parajuli.durga@aist.go.jp; tohru.kawamoto@aist.go.jp	Kawamoto, Tohru/B-7145-2008; Parajuli, Durga/I-7953-2015	Kawamoto, Tohru/0000-0002-3984-2980; Parajuli, Durga/0000-0001-6930-924X	Strategic Funds for the Promotion of Science and Technology, Japan	This work was partially supported by Strategic Funds for the Promotion of Science and Technology, Japan.	Altman SJ, 2005, ENVIRON SCI TECHNOL, V39, P2679, DOI 10.1021/es049103y; Bostick BC, 2002, ENVIRON SCI TECHNOL, V36, P2670, DOI 10.1021/es0156892; Hendricks SB, 1940, J AM CHEM SOC, V62, P1457, DOI 10.1021/ja01863a037; Liu Y, 2008, LANGMUIR, V24, P11625, DOI 10.1021/la801839b; Dushenkov S, 1999, ENVIRON SCI TECHNOL, V33, P469, DOI 10.1021/es980788+; FRANCIS CW, 1976, NATURE, V260, P511, DOI 10.1038/260511a0; Liu CX, 2003, ENVIRON SCI TECHNOL, V37, P2640, DOI 10.1021/es02622fh; Qin HB, 2012, GEOCHEM J, V46, P297; Dumat C, 2000, ENVIRON SCI TECHNOL, V34, P2985, DOI 10.1021/es990657o; Steinhauser G, 2014, SCI TOTAL ENVIRON, V470, P800, DOI 10.1016/j.scitotenv.2013.10.029; Tsukada H, 2008, J ENVIRON RADIOACTIV, V99, P875, DOI 10.1016/j.jenvrad.2007.11.014; [Anonymous], 2006, IAEA RAD ASS REP SER; Parajuli D, 2013, ENVIRON SCI TECHNOL, V47, P3800, DOI 10.1021/es303467n; BLANCHARD G, 1984, WATER RES, V18, P1501, DOI 10.1016/0043-1354(84)90124-6; CREMERS A, 1988, NATURE, V335, P247, DOI 10.1038/335247a0; Koarashi J, 2012, SCI TOTAL ENVIRON, V431, P392, DOI 10.1016/j.scitotenv.2012.05.041; [Anonymous], 2012, IAEA FUK DAIICH STAT; ANSPAUGH LR, 1988, SCIENCE, V242, P1513, DOI 10.1126/science.3201240; Burk P, 2009, J PHYS CHEM A, V113, P10734, DOI 10.1021/jp9046243; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Comans R.N.J., 1999, ACS S SERIES; LINDBLOM G, 1969, TELLUS, V21, P127; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Nakamaru Y, 2007, COLLOID SURFACE A, V306, P111, DOI 10.1016/j.colsurfa.2007.01.014; Parajuli D., 2013, WM2013 WAST MAN C, P13275; Stone R, 2011, SCIENCE, V331, P1507, DOI 10.1126/science.331.6024.1507; US Department of Health and Human Services, 2004, TOX PROF CES; Vandebroek L, 2012, J ENVIRON RADIOACTIV, V104, P87, DOI 10.1016/j.jenvrad.2011.09.002; Wendling LA, 2004, CLAY CLAY MINER, V52, P375, DOI 10.1346/CCMN.2004.0520312; Wendling LA, 2005, ENVIRON SCI TECHNOL, V39, P4505, DOI 10.1021/eso048809p	30	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	FEB	2015	140						78	83		10.1016/j.jenvrad.2014.11.005		6	Environmental Sciences	Environmental Sciences & Ecology	CA2OG	WOS:000348746900011		
J	Kumamoto, Y; Aoyama, M; Hamajima, Y; Murata, A; Kawano, T				Kumamoto, Yuichiro; Aoyama, Michio; Hamajima, Yasunori; Murata, Akihiko; Kawano, Takeshi			Impact of Fukushima-derived radiocesium in the western North Pacific Ocean about ten months after the Fukushima Dai-ichi nuclear power plant accident	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Fukushima Dai-ichi nuclear power plant accident; Radiocesium; Seawater; Western North Pacific Ocean; Nuclear weapons testing	SUBTROPICAL MODE WATER; NORTHEASTERN JAPAN; SURFACE-WATER; SOURCE-TERM; CS-137; SEAWATER; RADIONUCLIDES; DISPERSION; SANRIKU; FALLOUT	We measured vertical distributions of radiocesium (Cs-134 and Cs-137) at stations along the 149 degrees E meridian in the western North Pacific during winter 2012, about ten months after the Fukushima Dai-ichi Nuclear Power Plant (FNPP1) accident. The Fukushima-derived Cs-134 activity concentration and water-column inventory were largest in the transition region between 35 and 40 degrees N approximately due to the directed discharge of the contaminated water from the FNPP1. The bomb-derived Cs-137 activity concentration just before the FNPP1 accident was derived from the excess Cs-137 activity concentration relative to the Cs-134 activity concentration. The water-column inventory of the bomb-derived Cs-137 was largest in the subtropical region south of 35 degrees N, which implies that the Fukushima-derived Cs-134 will also be transported from the transition region to the subtropical region in the coming decades. Mean values of the water-column inventories decay-corrected for the Fukushima-derived Cs-134 and the bomb-derived Cs-137 were estimated to be 1020 +/- 80 and 820 +/- 120 Bq m(-2), respectively, suggesting that in winter 2012 the impact of the FNPP1 accident in the western North Pacific Ocean was nearly the same as that of nuclear weapons testing. Relationship between the water-column inventory and the activity concentration in surface water for the radiocesium is essential information for future evaluation of the total amount of Fukushima-derived radiocesium released into the North Pacific Ocean. (C) 2014 The Authors. Published by Elsevier Ltd.	[Kumamoto, Yuichiro; Murata, Akihiko; Kawano, Takeshi] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, Yokosuka, Kanagawa 2370061, Japan; [Aoyama, Michio] Fukushima Univ, Inst Environm Radioact, Fukushima 9601296, Japan; [Hamajima, Yasunori] Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan	Kumamoto, Y (reprint author), Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, 2-15 Natushima Cho, Yokosuka, Kanagawa 2370061, Japan.	kumamoto@jamstec.go.jb	HAMAJIMA, Yasunori/L-3802-2015	HAMAJIMA, Yasunori/0000-0002-8485-4606	Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI), Interdisciplinary Study on Environmental Transfer of Radionuclides from the Fukushima Dai-ichi NPP Accident [24110005]	We thank the crew of the R/V Mirai and the staff of Marine Works Japan, Ltd. for their help during onboard sample collection. This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI), Interdisciplinary Study on Environmental Transfer of Radionuclides from the Fukushima Dai-ichi NPP Accident (#24110005).	Povinec PP, 2013, BIOGEOSCIENCES, V10, P5481, DOI 10.5194/bg-10-5481-2013; Kofuji H, 2013, J ENVIRON RADIOACTIV, V124, P239, DOI 10.1016/j.jenvrad.2013.06.003; MASUZAWA J, 1969, DEEP-SEA RES, V16, P463, DOI 10.1016/0011-7471(69)90034-5; Kamenik J, 2013, BIOGEOSCIENCES, V10, P6045, DOI 10.5194/bg-10-6045-2013; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Inomata Y, 2009, J ENVIRON MONITOR, V11, P116, DOI 10.1039/b811421h; Miyazawa Y, 2013, BIOGEOSCIENCES, V10, P2349, DOI 10.5194/bg-10-2349-2013; Aoyama M, 2012, GEOCHEM J, V46, P321; Morino Y, 2013, ENVIRON SCI TECHNOL, V47, P2314, DOI 10.1021/es304620x; Rypina II, 2013, BIOGEOSCIENCES, V10, P4973, DOI 10.5194/bg-10-4973-2013; du Bois PB, 2012, J ENVIRON RADIOACTIV, V114, P2, DOI 10.1016/j.jenvrad.2011.11.015; Morino Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048689; Charette MA, 2013, BIOGEOSCIENCES, V10, P2159, DOI 10.5194/bg-10-2159-2013; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Kaeriyama H, 2014, ENVIRON SCI TECHNOL, V48, P3120, DOI 10.1021/es403686v; Stohl A, 2012, ATMOS CHEM PHYS, V12, P2313, DOI 10.5194/acp-12-2313-2012; Aoyama M, 2006, J ENVIRON MONITOR, V8, P431, DOI 10.1039/b512601k; Aoyama M, 2013, J RADIOANAL NUCL CH, V296, P535, DOI 10.1007/s10967-012-2033-2; Aoyama M, 2013, BIOGEOSCIENCES, V10, P3067, DOI 10.5194/bg-10-3067-2013; Povinec PP, 2005, J ENVIRON RADIOACTIV, V81, P63, DOI 10.1016/j.jenvrad.2004.12.003; [Anonymous], 2011, MON INF ENV RAD LEV; Suga T, 1997, J PHYS OCEANOGR, V27, P140, DOI 10.1175/1520-0485(1997)027<0140:TDITNP>2.0.CO;2; Kaeriyama H, 2013, BIOGEOSCIENCES, V10, P4287, DOI 10.5194/bg-10-4287-2013; Oikawa S, 2013, BIOGEOSCIENCES, V10, P5031, DOI 10.5194/bg-10-5031-2013; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493; Kobayashi T, 2013, J NUCL SCI TECHNOL, V50, P255, DOI 10.1080/00223131.2013.772449; Aoyama M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031964; Aoyama M, 2008, RADIOACTIV ENVIRONM, V11, P137, DOI 10.1016/S1569-4860(07)11004-4; Broecker W. S., 1982, TRACERS SEA; Estournel C, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007933; Hamajima Y, 2004, APPL RADIAT ISOTOPES, V61, P179, DOI 10.1016/j.apradiso.2004.03.041; Hirose K, 2003, DEEP-SEA RES PT II, V50, P2675, DOI 10.1016/S0967-0645(03)00141-3; Honda C.M., 2012, GEOCHEM J, V46, pe1; Inoue M, 2012, J ENVIRON RADIOACTIV, V111, P116, DOI 10.1016/j.jenvrad.2011.09.012; International Atomic Energy Agency, 2011, IAEA ANAL QUAL NUCL, V21, P19; Karasev E. V., 2012, P 2 INT M AM OKH CON, P75; Kawamura H, 2011, J NUCL SCI TECHNOL, V48, P1349, DOI 10.3327/jnst.48.1349; Kumamoto Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04276; Kumamoto Y, 2013, RADIOCARBON, V55, P1641; Nair RN, 2014, ENVIRON EARTH SCI, V71, P1007, DOI 10.1007/s12665-013-2501-1; Nishiharai Kenji, 2012, Transactions of the Atomic Energy Society of Japan, V11, DOI 10.3327/taesj.J11.040; Nuclear Regulation Authority, 2012, EST BAS TAK MEAS ENV; Pham MK, 2011, J RADIOANAL NUCL CH, V288, P603, DOI 10.1007/s10967-010-0976-8; Povinec PP, 2003, DEEP-SEA RES PT II, V50, P2607, DOI 10.1016/S0967-0645(03)00138-3; Prime Minister of Japan and His Cabinet, 2011, JAP GOV IAEA MIN C N; Ramzaev V, 2014, J ENVIRON RADIOACTIV, V135, P13, DOI 10.1016/j.jenvrad.2014.03.016; Schlitzer R., 2014, OCEAN DATA VIEW	47	2	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	FEB	2015	140						114	122		10.1016/j.jenvrad.2014.11.010		9	Environmental Sciences	Environmental Sciences & Ecology	CA2OG	WOS:000348746900015		
J	Aung, HP; Djedidi, S; Yokoyama, T; Suzuki, S; Bellingrath-Kimura, SD				Aung, Han Phyo; Djedidi, Salem; Yokoyama, Tadashi; Suzuki, Sohzoh; Bellingrath-Kimura, Sonoko Dorothea			Transfer of radiocesium to four cruciferous vegetables as influenced by organic amendment under different field conditions in Fukushima Prefecture	JOURNAL OF ENVIRONMENTAL RADIOACTIVITY			English	Article						Radiocesium; Plant growth; Cruciferous vegetables; Compost; Transfer factor	TO-PLANT TRANSFER; RADIOACTIVE CESIUM; CONTAMINATED SOIL; PADDY FIELD; CS-137; MATTER; CS; RADIONUCLIDES; ADSORPTION; SR-90	Soil-to-plant transfer of radiocesium (Cs-137) in four cruciferous vegetables as influenced by cattle manure-based compost amendment was investigated. Komatsuna, mustard, radish and turnip were cultivated in three different Cs-137-contaminated fields at Nihonmatsu City in Fukushima Prefecture from June to August 2012. Results revealed that organic compost amendments stimulated plant biomass production and tended to induce higher Cs-137 concentration in the cruciferous vegetables in most cases. Among the studied sites, Takanishi soil possessing low exchangeable potassium (0.10 cmol(c) kg(-1)) was associated with an increased concentration of Cs-137 in plants. Radiocesium transfer factor (TF) values of the vegetables ranged from 0.025 to 0.119. The increase in Cs-137 TFs was dependent on larger plant biomass production, high organic matter content, and high sand content in the studied soils. Average Cs-137 TF values for all study sites and compost treatments were higher in Komatsuna (0.072) and radish (0.059), which exhibited a higher biomass production compared to mustard and turnip. The transferability of Cs-137 to vegetables from soils was in the order Komatsuna > radish > mustard > turnip. The highest Cs-137 TF value (0.071) of all vegetables was recorded for a field where the soil had high organic matter content and a high clay proportion of 470 g kg(-1) consisting of Al-vermiculite clay mineral. (C) 2014 Elsevier Ltd. All rights reserved.	[Aung, Han Phyo] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Tokyo 1838509, Japan; [Djedidi, Salem; Yokoyama, Tadashi; Suzuki, Sohzoh; Bellingrath-Kimura, Sonoko Dorothea] Tokyo Univ Agr & Technol, Inst Agr, Tokyo 1838509, Japan	Bellingrath-Kimura, SD (reprint author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Int Environm & Agr Sci, Saiwaicho 3-5-8, Tokyo 1838509, Japan.	skimura@cc.tuat.ac.jp	yokoyama, tadashi/G-1095-2013; Djedidi, Salem/K-2178-2015	Djedidi, Salem/0000-0002-1520-946X	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS) [24380176]	This work received financial support from the Special Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, titled "Research and development of security and safe crop production to reconstruct agricultural lands in Fukushima prefecture based on novel techniques to remove radioactive compounds using advanced bio-fertilizer and plant protection strategies." This work was also supported by a Grant-in-Aid for Scientific Research (B): 24380176 from the Japan Society for the Promotion of Science (JSPS). The authors also thank growers who assisted with the implementation of the research experiments in their farmlands.	Dumat C, 1999, J ENVIRON RADIOACTIV, V46, P187, DOI 10.1016/S0265-931X(98)00125-8; Rigol A, 2002, J ENVIRON RADIOACTIV, V58, P191, DOI 10.1016/S0265-931X(01)00066-2; KIRK GJD, 1989, J SOIL SCI, V40, P71; Smolders E, 1997, ENVIRON SCI TECHNOL, V31, P3432, DOI 10.1021/es970113r; Waegeneers N, 2001, PLANT SOIL, V235, P11, DOI 10.1023/A:1011882621798; Zhu YG, 2000, J EXP BOT, V51, P1635, DOI 10.1093/jexbot/51.351.1635; Entry JA, 1998, WATER AIR SOIL POLL, V104, P339, DOI 10.1023/A:1004994123880; EPSTEIN E, 1976, J ENVIRON QUAL, V5, P422; Frissel MJ, 2002, J ENVIRON RADIOACTIV, V58, P113, DOI 10.1016/S0265-931X(01)00061-3; Ban-Nai T, 1999, J RADIOANAL NUCL CH, V241, P529, DOI 10.1007/BF02347208; Tamponnet C, 2008, J ENVIRON RADIOACTIV, V99, P820, DOI 10.1016/j.jenvrad.2007.10.011; ENTRY JA, 1994, ENVIRON POLLUT, V86, P201, DOI 10.1016/0269-7491(94)90191-0; CREMERS A, 1988, NATURE, V335, P247, DOI 10.1038/335247a0; BANNAI T, 1995, J RADIAT RES, V36, P143, DOI 10.1269/jrr.36.143; BARBER DA, 1964, NATURE, V204, P1326, DOI 10.1038/2041326a0; Broadley M.R., 1997, ENVIRON POLLUT, V95, P311; CORNELL RM, 1993, J RADIOAN NUCL CH AR, V171, P483, DOI 10.1007/BF02219872; D'souza T., 1980, 538 BLG; ALVAREZ MAD, 1995, APPL ENVIRON MICROB, V61, P194; Delvaux B, 2001, TRACE ELEMENTS IN THE RHIZOSPHERE, P61; Entry JA, 2001, WATER AIR SOIL POLL, V126, P385, DOI 10.1023/A:1005201220596; Evans C.H., 1983, GEOCHIM COSMOCHIM AC, V47, P1041; FAO/IAEA/IUR, 1998, PROT EXP STUD UPT RA; Fuhrmann M, 2003, J ENVIRON QUAL, V32, P2272; Fujimura S, 2013, PLANT PROD SCI, V16, P166; Gee G. W., 1986, METHODS SOIL ANAL, V1, P383; Gomez K.A., 1984, STAT PROCEDURES AGR; IAEA (International Atomic Energy Agency), 2006, P CHAN CRET, P22; Massas I, 2002, J ENVIRON RADIOACTIV, V59, P245, DOI 10.1016/S0265-931X(01)00077-7; Moore R., 1998, BOTANY; Nakano M, 2013, ENG GEOL, V155, P87, DOI 10.1016/j.enggeo.2012.12.010; Nakao A., 2012, SANSAI ENV J GLOB CO, V6, P17; NERH (Nuclear Emergency Response Headquarters) Government of Japan, 2011, JAP GOV IAEA MIN C N; Nisbet A.F., 2000, HEALTH PHYS, V78, P278; Ohmori Y, 2014, J PLANT RES, V127, P67, DOI 10.1007/s10265-013-0618-7; Pequerul A., 1993, Optimization of plant nutrition: refereed papers from the Eighth International Colloquium for the Optimization of Plant Nutrition, 31 August-8 September 1992, Lisbon, Portugal., P3; RIISE G, 1990, J RADIOAN NUCL CH AR, V142, P531, DOI 10.1007/BF02040324; Roca MC, 1997, J ENVIRON QUAL, V26, P1354; Sanchez AL, 1999, ENVIRON SCI TECHNOL, V33, P2752, DOI 10.1021/es990058h; SCHOLLENBERGER CJ, 1945, SOIL SCI, V59, P13, DOI 10.1097/00010694-194501000-00004; Schumacher A.B., 2002, ECOLOGICAL RISK ASSE, P6; Stautnton S, 2002, J ENVIRON RADIOACTIV, V58, P163, DOI 10.1016/S0265-931X(01)00064-9; Sunovska A., 2012, NOVA BIOTECHNOL CHIM, V11, P153; Takahashi T., 2002, GLOBAL ENV RES, V6, P83; Tsukada H, 2002, J ENVIRON RADIOACTIV, V59, P351, DOI 10.1016/S0265-931X(01)00083-2; VANBERGEIJK KE, 1992, J ENVIRON RADIOACTIV, V15, P265, DOI 10.1016/0265-931X(92)90062-X; Wasserman M.A., 2006, CLASSIFICATION SOIL, P22; Wasserman MA, 2008, J ENVIRON RADIOACTIV, V99, P554, DOI 10.1016/j.jenvrad.2007.08.012; Whittig L. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P331	49	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0265-931X	1879-1700		J ENVIRON RADIOACTIV	J. Environ. Radioact.	FEB	2015	140						148	155		10.1016/j.jenvrad.2014.11.015		8	Environmental Sciences	Environmental Sciences & Ecology	CA2OG	WOS:000348746900019		
J	Matsumoto, Y; Matsukawa, H; Seno, H; Ono, S				Matsumoto, Y.; Matsukawa, H.; Seno, H.; Ono, S.			Gastrointestinal: Breast cancer metastasis to the esophagus diagnosed using endoscopic ultrasound-guided fine-needle aspiration	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Matsumoto, Y.; Matsukawa, H.; Ono, S.] Ako City Hosp, Div Gastroenterol, Kobe, Hyogo, Japan; [Matsumoto, Y.; Seno, H.] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan	Matsumoto, Y (reprint author), Ako City Hosp, Div Gastroenterol, Kobe, Hyogo, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	FEB	2015	30	2					233	233		10.1111/jgh.12819		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9KU	WOS:000348533600004		
J	Fujita, K; Fujimoto, M; Terajima, H; Yazumi, S				Fujita, K.; Fujimoto, M.; Terajima, H.; Yazumi, S.			Hepatology: Pancreatic lymphoepithelial cyst mimicking mucinous cystic neoplasm	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Fujita, K.] Yodogawa Christians Hosp, Div Gastroenterol & Hepatol, Osaka, Japan; [Terajima, H.] Tazuke Kofukai Med Res Inst, Kitano Hosp, Div Gastroenterol Surg & Oncol, Ctr Digest Dis, Osaka, Japan; [Yazumi, S.] Tazuke Kofukai Med Res Inst, Kitano Hosp, Div Gastroenterol & Hepatol, Ctr Digest Dis, Osaka, Japan; [Fujimoto, M.] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan	Fujita, K (reprint author), Yodogawa Christians Hosp, Div Gastroenterol & Hepatol, Osaka, Japan.							0	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	FEB	2015	30	2					235	235		10.1111/jgh.12829		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9KU	WOS:000348533600006		
J	Nagata, N; Niikura, R; Sekine, K; Sakurai, T; Shimbo, T; Kishida, Y; Tanaka, S; Aoki, T; Okubo, H; Watanabe, K; Yokoi, C; Akiyama, J; Yanase, M; Mizokami, M; Uemura, N				Nagata, Naoyoshi; Niikura, Ryota; Sekine, Katsunori; Sakurai, Toshiyuki; Shimbo, Takuro; Kishida, Yoshihiro; Tanaka, Shohei; Aoki, Tomonori; Okubo, Hidetaka; Watanabe, Kazuhiro; Yokoi, Chizu; Akiyama, Junichi; Yanase, Mikio; Mizokami, Masashi; Uemura, Naomi			Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: A case-control study	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						acetylsalicylic acid; bleeding ulcer; helicobacter pylori; interaction; non-variceal upper gastrointestinal bleeding	UPPER GASTROINTESTINAL ULCER; CALCIUM-CHANNEL BLOCKERS; ANTIPLATELET AGENTS; JAPANESE PATIENTS; HEMORRHAGE; PREVENTION; INHIBITORS; THERAPY; DISEASE; ATTACK	Background and AimThe associations between antithrombotic or antihypertensive drugs and peptic ulcer bleeding (PUB) remain unknown, particularly in Asia, where Helicobacter pylori infection is prevalent. This study aims to evaluate the risks of PUB from antithrombotic drugs, angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, calcium channel blockers, -blockers, and -blockers. MethodsThis prospective hospital-based case-control study included 230 patients with endoscopically verified PUB and 920 age and sex-matched controls (1:4) without bleeding on screening endoscopy. Adjusted odds ratios (AOR) for the risk of PUB were determined by conditional logistic regression analysis. ResultsIn multivariate analysis, alcohol consumption (AOR, 2.2; P<0.001), history of peptic ulcer (AOR, 4.8; P<0.001), H.pylori infection (AOR, 2.1; P<0.001), comorbidity index (AOR, 1.1; P=0.089), nonsteroidal anti-inflammatory drugs (NSAIDs) (AOR, 2.0; P=0.025), and low-dose aspirin (AOR, 2.8; P=0.003) increased the risk of PUB, whereas H.pylori eradication (AOR, 0.03; P<0.001), proton pump inhibitors (PPIs) (AOR, 0.1; P<0.001), and histamine 2-receptor antagonists (H2RA) (AOR, 0.1; P<0.001) reduced it. No significant interactions were observed between H.pylori infection and NSAIDs use for PUB (P=0.913). ARBs (P=0.564), ACE inhibitors (P=0.213), calcium channel blockers (P=0.215), -blockers (P=0.810), and -blockers (P=0.864) were not associated with PUB. ConclusionWe found that alcohol consumption, history of peptic ulcer, H.pylori infection, NSAIDs use, and low-dose aspirin use were independent risk factors for PUB, whereas H.pylori-eradication, PPIs use, and H2RA use reduced its risk. Interactions between H.pylori and NSAIDs use in PUB were not observed. No antihypertensive drug was associated with PUB.	[Nagata, Naoyoshi; Niikura, Ryota; Sekine, Katsunori; Sakurai, Toshiyuki; Kishida, Yoshihiro; Tanaka, Shohei; Aoki, Tomonori; Okubo, Hidetaka; Watanabe, Kazuhiro; Yokoi, Chizu; Akiyama, Junichi; Yanase, Mikio] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Res Inst, Int Clin Res Ctr, Tokyo, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Res Inst, Int Clin Res Ctr, Tokyo, Japan; [Mizokami, Masashi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	Nagata, N (reprint author), Natl Ctr Global Hlth & Med NCGM, Dept Gastroenterol & Hepatol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [26A-201]	The authors declare no conflicts of interest. This study was supported in part by a grant from the National Center for Global Health and Medicine (26A-201). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Anglin R, 2014, AM J GASTROENTEROL, V109, P810, DOI 10.1038/ajg.2014.82; Verhamme KMC, 2006, BRIT MED J, V333, P330, DOI 10.1136/bmj.38883.479549.2F; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Rothwell PM, 2011, LANCET, V377, P1681, DOI 10.1016/S0140-6736(11)60516-3; Gisbert JP, 2012, AM J GASTROENTEROL, V107, P1197, DOI 10.1038/ajg.2012.132; Hallas J, 2006, BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Shiotani A, 2009, J GASTROENTEROL, V44, P126, DOI 10.1007/s00535-008-2290-6; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Uemura N, 2014, J GASTROENTEROL, V49, P814, DOI 10.1007/s00535-013-0839-5; Chan FKL, 2013, GASTROENTEROLOGY, V144, P528, DOI 10.1053/j.gastro.2012.12.038; Sakamoto C, 2006, EUR J CLIN PHARMACOL, V62, P765, DOI 10.1007/s00228-006-0171-6; Papatheodoridis GV, 2006, CLIN GASTROENTEROL H, V4, P130, DOI 10.1053/S1542-3565(05)01042-6; Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115; Shiotani A, 2011, DIGEST DIS SCI, V56, P465, DOI 10.1007/s10620-010-1382-3; Fock KM, 2010, J GASTROEN HEPATOL, V25, P479, DOI 10.1111/j.1440-1746.2009.06188.x; Delaney JA, 2007, CAN MED ASSOC J, V177, P347, DOI 10.1053/cmaj.070186; Crooks CJ, 2013, GASTROENTEROLOGY, V144, P1384, DOI 10.1053/j.gastro.2013.02.040; Lanas A, 2000, NEW ENGL J MED, V343, P834, DOI 10.1056/NEJM200009213431202; Nadatani Y, 2013, SCAND J GASTROENTERO, V48, P320, DOI 10.3109/00365521.2012.758771; Lanas A, 2006, GUT, V55, P1731, DOI 10.1136/gut.2005.080754; Nagata N, 2014, GASTROINTEST ENDOSC, V80, P1124, DOI 10.1016/j.gie.2014.06.039; Lanas A, 2002, ALIMENT PHARM THERAP, V16, P779, DOI 10.1046/j.1365-2036.2002.01230.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colin R, 2000, GASTROEN CLIN BIOL, V24, P31; Crooks CJ, 2013, GASTROENTEROLOGY, V144, P1393; Crooks CJ, 2013, GASTROENTEROLOGY, V144, pe18; Crooks CJ, 2013, GASTROENTEROLOGY, V144, pe1; desGroot NL, 2014, J GASTROENTEROL, V49, P245; Kang JM, 2011, SCAND J GASTROENTERO, V46, P1295, DOI 10.3109/00365521.2011.605468; Kaplan RC, 2000, ARCH INTERN MED, V160, P1849, DOI 10.1001/archinte.160.12.1849; Kelly JP, 1999, LANCET, V353, P559, DOI 10.1016/S0140-6736(98)05202-7; Nagata N, 2014, J GASTROEN HEPATOL, V29, P1786, DOI 10.1111/jgh.12595; Pahor M, 1996, LANCET, V347, P1061, DOI 10.1016/S0140-6736(96)90276-7; Smalley WE, 1998, AM J EPIDEMIOL, V148, P350; Stürmer T, 2000, J Epidemiol Biostat, V5, P125; Tu TC, 1999, GASTROINTEST ENDOSC, V49, P302, DOI 10.1016/S0016-5107(99)70005-2; Wu CY, 1999, SCAND J GASTROENTERO, V34, P234	38	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	FEB	2015	30	2					292	298		10.1111/jgh.12805		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9KU	WOS:000348533600014		
J	Kashihara, H; Shimada, M; Kurita, N; Sato, H; Yoshikawa, K; Higashijima, J; Chikakiyo, M; Nishi, M; Takasu, C				Kashihara, Hideya; Shimada, Mitsuo; Kurita, Nobuhiro; Sato, Hirohiko; Yoshikawa, Kozo; Higashijima, Jun; Chikakiyo, Motoya; Nishi, Masaaki; Takasu, Chie			Duodenal-jejunal bypass improves diabetes and liver steatosis via enhanced glucagon-like peptide-1 elicited by bile acids	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						bariatric surgery; gastrointestinal hormone; incretin; liraglutide	LOWERS BODY-WEIGHT; Y GASTRIC BYPASS; GLYCEMIC CONTROL; BARIATRIC SURGERY; HEPATIC STEATOSIS; GLP-1 ANALOG; RAT MODEL; TYPE-2; GLUCOSE; LIRAGLUTIDE	Background and AimBariatric surgery not only elicits weight loss but also rapidly resolves diabetes. However, the mechanisms remain unclear. The present study investigates how diabetes and liver steatosis are improved after duodenal-jejunal bypass (DJB) compared with a glucagon-like peptide-1 (GLP-1) analog and correlations between bile acids and GLP-1 secretion. MethodsWe initially determined the effects of bile acids on GLP-1 in vitro and then assigned 12 male 16-week-old Otsuka Long-Evans Tokushima Fatty rats to groups that underwent DJB, a sham operation, or were treated with the GLP-1 receptor agonist, liraglutide (n=4 each). Blood glucose, insulin, GLP-1, serum bile acids, liver steatosis, and the number of GLP-1 positive cells (L cells) in the small intestine and colon were investigated in the three groups at eight weeks postoperatively. ResultsLevels of GLP-1mRNA were upregulated and GLP-1 secretion increased in cells incubated with bile acids in vitro. Weight gain was suppressed more in the DJB than in the sham group in vivo. Diabetes was more improved and GLP-1 levels were significantly higher in the DJB than in the sham group. Serum bile acids were significantly increased, the number of L cells in the ileum was upregulated compared with the sham group, and liver steatosis was significantly improved in the DJB compared with the other two groups. ConclusionsDuodenal-jejunal bypass might improve diabetes and liver steatosis by enhancing GLP-1 secretion through increasing serum bile acids and the proliferation of L cells in the ileum, compared with liraglutide.	[Kashihara, Hideya; Shimada, Mitsuo; Kurita, Nobuhiro; Sato, Hirohiko; Yoshikawa, Kozo; Higashijima, Jun; Chikakiyo, Motoya; Nishi, Masaaki; Takasu, Chie] Univ Tokushima, Inst Hlth Biosci, Dept Surg, Tokushima 7708503, Japan	Kashihara, H (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Surg, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	kashihara@clin.med.tokushima-u.ac.jp					Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; Vilsboll T, 2007, DIABETES CARE, V30, P1608, DOI 10.2337/dc06-2593; Kohli R, 2013, ENDOCRINOLOGY, V154, P2341, DOI 10.1210/en.2012-2069; Cummings DE, 2004, J CLIN ENDOCR METAB, V89, P2608, DOI 10.1210/jc.2004-0433; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Scopinaro N, 1996, SURGERY, V119, P261, DOI 10.1016/S0039-6060(96)80111-5; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Patriti A, 2005, OBES SURG, V15, P1258, DOI 10.1381/096089205774512573; NAUCK MA, 1993, J CLIN ENDOCR METAB, V76, P912, DOI 10.1210/jc.76.4.912; Nauck MA, 2006, EXP CLIN ENDOCR DIAB, V114, P417, DOI 10.1055/s-2006-924230; Rubino FA, 2004, ANN SURG, V239, P1, DOI 10.1097/01.sla.0000102989.54824.fc; Pacheco D, 2007, AM J SURG, V194, P221, DOI 10.1016/j.amjsurg.2006.11.015; Drucker DJ, 2003, DIABETES CARE, V26, P2929, DOI 10.2337/diacare.26.10.2929; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Salehi M, 2008, ENDOCR REV, V29, P367, DOI 10.1210/er.2007-0031; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Sato M, 2010, SURGERY, V148, P1012, DOI 10.1016/j.surg.2010.03.007; Patriti A, 2004, OBES SURG, V14, P840, DOI 10.1381/0960892041590818; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Suzuki S, 2005, SURGERY, V138, P283, DOI 10.1016/j.surg.2005.05.013; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.0139; Kashihara H, 2013, HEPATOGASTR IN PRESS; Madsbad S, 2004, DIABETES CARE, V27, P1335, DOI 10.2337/diacare.27.6.1335; Mells JE, 2012, AM J PHYSIOL-GASTR L, V302, pG225, DOI 10.1152/ajpgi.00274.2011; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Rohit Kohli MK, 2010, AM J PHYSIOL-GASTR L, V299, pG652; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sidhu SS, 2000, J PHYSIOL-LONDON, V528, P165, DOI 10.1111/j.1469-7793.2000.00165.x; Van Citters Gregg W, 2006, Curr Gastroenterol Rep, V8, P367, DOI 10.1007/s11894-006-0021-9	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	FEB	2015	30	2					308	315		10.1111/jgh.12690		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9KU	WOS:000348533600016		
J	Honda, T; Ishigami, M; Masuda, H; Ishizu, Y; Kuzuya, T; Hayashi, K; Itoh, A; Hirooka, Y; Nakano, I; Ishikawa, T; Urano, F; Yoshioka, K; Toyoda, H; Kumada, T; Katano, Y; Goto, H				Honda, Takashi; Ishigami, Masatoshi; Masuda, Hiroko; Ishizu, Yoji; Kuzuya, Teiji; Hayashi, Kazuhiko; Itoh, Akihiro; Hirooka, Yoshiki; Nakano, Isao; Ishikawa, Tetsuya; Urano, Fumihiro; Yoshioka, Kentaro; Toyoda, Hidenori; Kumada, Takashi; Katano, Yoshiaki; Goto, Hidemi			Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						hepatitis C virus; hepatocellular carcinoma; older patients; peginterferon	INTERFERON-ALPHA-2B PLUS RIBAVIRIN; SUSTAINED VIROLOGICAL RESPONSE; HCV-RELATED CIRRHOSIS; ELDERLY-PATIENTS; VIRUS-INFECTION; PEGYLATED INTERFERON-ALPHA-2B; HISTOLOGIC IMPROVEMENT; INITIAL TREATMENT; ADVANCED FIBROSIS; RANDOMIZED-TRIAL	Background and AimsThe population of patients chronically infected with hepatitis C virus (HCV) is aging, and the number of older patients with HCV-related hepatocellular carcinoma (HCC) is increasing. The purpose of this study was to elucidate the effects of peginterferon and ribavirin combination therapy on prevention of HCC in older patients with chronic hepatitis C (CH-C). MethodsWe compared the sustained virological response (SVR) and treatment discontinuation rates between older (65 years) and younger patients (<65 years) among 1280 CH-C patients treated with peginterferon alfa-2b and ribavirin. Cumulative incidence of HCC was determined by Kaplan-Meier analysis, and factors associated with liver carcinogenesis were analyzed by Cox proportional hazards regression. ResultsOlder patients had a significantly lower SVR rate and a significantly higher discontinuation rate of treatment than younger patients. Fifty patients developed HCC during median follow-up period of 47 months. Cox proportional hazards regression analysis indicated that the following were independent risk factors associated with the development of HCC: older age, male, advanced fibrosis, non-SVR in all patients: higher gamma-glutamyltranspeptidase, and non-SVR in older patients. Older patients who achieved SVR had a significantly reduced rate of HCC compared with those who did not achieve SVR, especially those who had gamma-glutamyltranspeptidase over 44IU/L. ConclusionsThe SVR rate was lower and the combination therapy discontinuation rate was higher in older CH-C patients than in younger patients. However, older patients who achieved SVR had a markedly lower rate of HCC development compared with older patients who did not achieve SVR.	[Honda, Takashi; Ishigami, Masatoshi; Masuda, Hiroko; Ishizu, Yoji; Kuzuya, Teiji; Hayashi, Kazuhiko; Itoh, Akihiro; Hirooka, Yoshiki; Nakano, Isao; Ishikawa, Tetsuya; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4668550, Japan; [Katano, Yoshiaki] Fujita Hlth Univ, Sch Med, Banbuntane Hotokukai Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Urano, Fumihiro] Toyohashi Municipal Hosp, Dept Gastroenterol, Toyohashi, Aichi, Japan; [Yoshioka, Kentaro] Fujita Hlth Univ, Dept Internal Med, Div Liver & Biliary Dis, Toyoake, Aichi, Japan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan	Ishigami, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	masaishi@med.nagoya-u.ac.jp			AstraZeneca; Astellas Pharma; Ajinomoto Pharmaceutical Co.; Bristol-Myers Squibb; Chugai Pharmaceutical Co.; Daiichi Sankyo Dainippon Sumitomo Pharma; Eisai; Mitsubishi Tanabe Pharma; MSD; Otsuka Pharmaceutical Co.; Takeda Pharmaceutical Co.	Dr Goto received research grants from AstraZeneca, Astellas Pharma, Ajinomoto Pharmaceutical Co., Bristol-Myers Squibb, Chugai Pharmaceutical Co., Daiichi Sankyo Dainippon Sumitomo Pharma, Eisai, Mitsubishi Tanabe Pharma, MSD, Otsuka Pharmaceutical Co., and Takeda Pharmaceutical Co. Dr Hayashi received research grants from AstraZeneca, Eisai, and MSD.	Shiratori Y, 2005, ANN INTERN MED, V142, P105; Villela-Nogueira CA, 2005, J CLIN GASTROENTEROL, V39, P728, DOI 10.1097/01.mcg.0000174025.19214.32; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Kurokawa M, 2009, HEPATOL RES, V39, P432, DOI 10.1111/j.1872-034X.2008.00477.x; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 1997, ANN INTERN MED, V127, P875; Huang CF, 2010, J INFECT DIS, V201, P751, DOI 10.1086/650470; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Shiratori Y, 2000, ANN INTERN MED, V132, P517; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Imai Y, 2010, J VIRAL HEPATITIS, V17, P185, DOI 10.1111/j.1365-2893.2009.01163.x; Lai MY, 1996, GASTROENTEROLOGY, V111, P1307, DOI 10.1053/gast.1996.v111.pm8898645; Oze T, 2011, J HEPATOL, V54, P604, DOI 10.1016/j.jhep.2010.07.043; Veldt BJ, 2007, ANN INTERN MED, V147, P677; Osaki Y, 2012, J GASTROENTEROL, V47, P444, DOI 10.1007/s00535-011-0505-8; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Pittaluga F, 2008, J MED VIROL, V80, P254, DOI 10.1002/jmv.21073; Suzuki F, 2011, HEPATOLOGY, V53, P415, DOI 10.1002/hep.24058; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Imai Y, 1998, ANN INTERN MED, V129, P94; Honda T, 2010, LIVER INT, V30, P527, DOI 10.1111/j.1478-3231.2009.02064.x; Colucci G, 2007, J CLIN MICROBIOL, V45, P3595, DOI 10.1128/JCM.01320-07; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Yoshida H, 1999, ANN INTERN MED, V131, P174; Arase Y, 2007, INTERVIROLOGY, V50, P16, DOI 10.1159/000096308; BRESCI G, 1993, J AM GERIATR SOC, V41, P857; Fernandez-Rodriguez CM, 2010, AM J GASTROENTEROL, V105, P2164, DOI 10.1038/ajg.2010.294; Hiramatsu N, 2006, HEPATOL RES, V35, P185, DOI 10.1016/j.hepres.2006.03.008; Hirashima N, 1996, J GASTROEN HEPATOL, V11, P955; Honda T, 2013, J MED VIROL, V85, P228, DOI 10.1002/jmv.23444; HORIIKE N, 1995, J GASTROEN HEPATOL, V10, P246, DOI 10.1111/j.1440-1746.1995.tb01088.x; Ikeda K, 2009, AM J MED, V122, P479, DOI 10.1016/j.amjmed.2008.09.045; Ikeda Y, 2005, METHOD ENZYMOL, V401, P408, DOI 10.1016/S0076-6879(05)01025-6; Ohno O, 1997, J Clin Microbiol, V35, P201; Sizmann D, 2007, J CLIN VIROL, V38, P326, DOI 10.1016/j.jcv.2006.12.021; Taliani G, 2006, GASTROENTEROLOGY, V130, P1098, DOI 10.1053/j.gastro.2006.02.016; Taliani G, 2002, CLIN IMMUNOL, V105, P279, DOI 10.1006/clim.2002.5288; Tamori A, 1996, HEPATO-GASTROENTEROL, V43, P1079; Toyoda H, 2000, J VIRAL HEPATITIS, V7, P414, DOI 10.1046/j.1365-2893.2000.00241.x; Weich V, 2011, J GASTROENTEROL, V46, P1427, DOI 10.1007/s00535-011-0458-y; Yoshizawa H, 2002, ONCOLOGY-BASEL, V62, P8, DOI 10.1159/000048270	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	FEB	2015	30	2					321	328		10.1111/jgh.12703		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9KU	WOS:000348533600017		
J	Yokoyama, S; Kawakami, Y; Imamura, M; Hayes, CN; Kohno, H; Kohno, H; Tsuji, K; Aisaka, Y; Kira, S; Yamashina, K; Nonaka, M; Takahashi, S; Moriya, T; Kitamoto, M; Aimitsu, S; Nakanishi, T; Kawakami, H; Chayama, K				Yokoyama, Satoe; Kawakami, Yoshiiku; Imamura, Michio; Hayes, C. Nelson; Kohno, Hiroshi; Kohno, Hirotaka; Tsuji, Keiji; Aisaka, Yasuyuki; Kira, Shinsuke; Yamashina, Keitarou; Nonaka, Michihiro; Takahashi, Shoichi; Moriya, Takashi; Kitamoto, Mikiya; Aimitsu, Shiomi; Nakanishi, Toshio; Kawakami, Hiroiku; Chayama, Kazuaki			Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: Propensity score-matched analysis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						genotype 2a; genotype 2b; hepatitis C; pegylated interferon plus ribavirin therapy; prolonged therapy	HEPATITIS-C VIRUS; ALPHA-2B PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2B; HCV GENOTYPE-2; COMBINATION THERAPY; VIRAL RESPONSE; INFECTION; RNA; 1B	Background and AimChronic hepatitis C genotype 2 patients show high susceptibility to pegylated interferon plus ribavirin therapy (PEG/RBV). However, the differences in response to therapy between genotypes 2a and 2b, and the efficacy of prolonged therapy for refractory patients have not been evaluated. We investigated the differences in response to PEG/RBV between each genotype and examined the efficacy of prolonged therapy. MethodsA total of 343 chronic hepatitis patients infected with hepatitis C virus (HCV) genotype 2 (2a: n=195; 2b: n=148) were enrolled in this study. All patients received PEG/RBV for 24 (24 week group, n=242) or more weeks (prolonged group, n=101). We analyzed the differences in virological response between genotypes 2a and 2b. Clinical and virological factors of patients in the 24-week group and the prolonged treatment group were matched using propensity score analysis, and the efficacy of prolonged therapy established by comparing time of serum HCV disappearance for each genotype. ResultsVirological response tended to be higher for genotype 2a compared with genotype 2b; however, there was no significant difference in sustained virological response rates between genotypes (2a: 78.3%; 2b: 70.2%; P=0.19). After propensity score matching, the adjusted P-value for sustained virological response rate was significantly different for genotype 2b patients with undetectable HCV-RNA between weeks 5 and 8, and for genotype 2a patients with detectable HCV-RNA at week 8. ConclusionProlonged therapy with PEG/RBV may be effective when serum HCV-RNA is detectable at week 4 and week 8 for genotype 2b and 2a patients, respectively.	[Yokoyama, Satoe; Kawakami, Yoshiiku; Imamura, Michio; Hayes, C. Nelson; Takahashi, Shoichi; Chayama, Kazuaki] Hiroshima Univ, Dept Gastroenterol & Metab, Inst Biomed & Hlth Sci, Hiroshima 7348551, Japan; [Kawakami, Yoshiiku; Hayes, C. Nelson; Takahashi, Shoichi; Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima 7348551, Japan; [Tsuji, Keiji] Hiroshima City Asa Hosp, Dept Gastroenterol, Hiroshima, Japan; [Aisaka, Yasuyuki; Kira, Shinsuke] Hiroshima Red Cross Hosp, Dept Gastroenterol, Hiroshima, Japan; [Yamashina, Keitarou; Aimitsu, Shiomi] West Japan Railway Co, Hiroshima Gen Hosp, Dept Gastroenterol, Hiroshima, Japan; [Nonaka, Michihiro; Nakanishi, Toshio] Miyoshi Cent Hosp, Dept Gastroenterol, Hiroshima, Japan; [Moriya, Takashi] Chugoku Rousai Hosp, Dept Gastroenterol, Hiroshima, Japan; [Kitamoto, Mikiya] Hiroshima Prefectural Hosp, Dept Gastroenterol, Hiroshima, Japan; [Kawakami, Hiroiku] Kawakami Clin, Dept Gastroenterol, Hiroshima, Japan; [Kohno, Hiroshi; Kohno, Hirotaka] Kure Med Ctr, Dept Gastroenterol, Kure, Japan	Kawakami, Y (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Div Frontier Med Sci,Programs Biomed Res,Minami K, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	kamy4419@hiroshima-u.ac.jp					Alberti A, 2004, J HEPATOL, V40, P1032, DOI 10.1016/j.jhep.2004.04.008; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Everson GT, 2006, HEPATOLOGY, V44, P1675, DOI 10.1002/hep.21440; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI 10.1016/j.jhep.2004.02.007; ENOMOTO N, 1990, BIOCHEM BIOPH RES CO, V170, P1021, DOI 10.1016/0006-291X(90)90494-8; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Sezaki H, 2009, INTERVIROLOGY, V52, P43, DOI 10.1159/000213504; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Kawaoka T, 2011, J HEPATOL, V54, P408, DOI 10.1016/j.jhep.2010.07.032; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Nimer A, 2012, WORLD J GASTROENTERO, V18, P800, DOI 10.3748/wjg.v18.i8.800; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346; Arase Y, 2004, INTERVIROLOGY, V47, P19, DOI 10.1159/000076638; El-Shamy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030513; Kim Yeon Joo, 2012, Chonnam Med J, V48, P21, DOI 10.4068/cmj.2012.48.1.21; Nagoshi S, 2012, INTERNAL MED, V51, P9, DOI 10.2169/internalmedicine.51.6237; Numata M, 2010, HEPAT RES TREAT, V2010; Porter CJH, 2000, J PHARM SCI, V89, P297, DOI 10.1002/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P; Rembeck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029370; Sakamoto N, 2011, J MED VIROL, V83, P871, DOI 10.1002/jmv.22038; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Suda G, 2010, VIROLOGY, V407, P80, DOI 10.1016/j.virol.2010.07.041; Wong JB, 2003, AM J GASTROENTEROL, V98, P2354, DOI 10.1016/j.amjgastroenterol.2003.08.027	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	FEB	2015	30	2					337	344		10.1111/jgh.12706		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9KU	WOS:000348533600019		
J	Nakagawa, H; Fujiwara, N; Tateishi, R; Arano, T; Nakagomi, R; Kondo, M; Minami, T; Sato, M; Uchino, K; Enooku, K; Asaoka, Y; Kondo, Y; Shiina, S; Yoshida, H; Koike, K				Nakagawa, Hayato; Fujiwara, Naoto; Tateishi, Ryosuke; Arano, Toru; Nakagomi, Ryo; Kondo, Mayuko; Minami, Tatsuya; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Asaoka, Yoshinari; Kondo, Yuji; Shiina, Shuichiro; Yoshida, Haruhiko; Koike, Kazuhiko			Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						adipokine; hepatitis C; inflammatory cytokine; mortality	HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; VIRUS-INFECTION; NONALCOHOLIC STEATOHEPATITIS; CARDIOVASCULAR-DISEASE; REACTIVE PROTEIN; RISK; CANCER; INFLAMMATION; MICE	Background and AimVarious inflammatory cytokines and adipokines have been implicated in hepatitis C virus (HCV)-mediated liver disease, and interleukin-6 (IL-6) and adiponectin may play key roles. In addition, these factors may be associated with chronic hepatitis C (CHC)-induced extrahepatic manifestations. However, little data are available on the role of these factors on future outcomes of CHC patients. This study aims to evaluate the impact of serum levels of IL-6 and adiponectin on all-cause mortality, liver-related mortality, and liver-unrelated mortality. MethodsA long-term follow-up study was conducted, consisting of 325 CHC patients, for which we previously reported positive associations between these factors (Serum levels of IL-6 and adiponectin) and hepatocellular carcinoma (HCC) development. ResultsDuring the follow-up period (mean, 13.0 year), there were 92 events consisting of 91 deaths (liver related, 72; liver unrelated, 19) and 1 liver transplantation due to liver failure. High IL-6 and adiponectin levels, defined as being higher than each median value at baseline, were associated with significantly higher incidences of not only HCC development but also all-cause mortality. Interestingly, high IL-6 was strongly associated with only liver-related mortality, whereas high-serum adiponectin was associated with not only liver-related, but also liver-unrelated mortality. Multivariate analysis identified high IL-6 as an independent risk factor for liver-related mortality and high adiponectin as an independent risk factor for liver-unrelated mortality. ConclusionHigh serum levels of IL-6 and adiponectin were associated with higher all-cause and liver-related mortality in CHC patients. In addition, high adiponectin was associated with liver-unrelated mortality. The measurement of these factors may provide information useful for predicting future outcomes in CHC patients.	[Nakagawa, Hayato; Fujiwara, Naoto; Tateishi, Ryosuke; Arano, Toru; Nakagomi, Ryo; Kondo, Mayuko; Minami, Tatsuya; Sato, Masaya; Uchino, Koji; Enooku, Kenichiro; Asaoka, Yoshinari; Kondo, Yuji; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Tokyo 1138655, Japan; [Shiina, Shuichiro] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan	Nakagawa, H (reprint author), Univ Tokyo, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hayaton0120@gmail.com	Nakagawa, Hayato/I-2837-2012		Astellas Foundation for Research on Metabolic Disorders;  [25893042]	This work was supported by a Grant-in-Aid for Scientific Research (#25893042) and Astellas Foundation for Research on Metabolic Disorders.	Wu ZJ, 2014, METABOLISM, V63, P1157, DOI 10.1016/j.metabol.2014.05.001; Loria P, 2014, ATHEROSCLEROSIS, V232, P99, DOI 10.1016/j.atherosclerosis.2013.10.030; Nakagawa H, 2009, INT J CANCER, V125, P2264, DOI 10.1002/ijc.24720; CHOI I, 1994, CLIN EXP IMMUNOL, V95, P530; Jang JW, 2012, CYTOKINE, V60, P686, DOI 10.1016/j.cyto.2012.07.017; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Kizer JR, 2014, METABOLISM, V63, P1079, DOI 10.1016/j.metabol.2014.06.011; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Arano T, 2011, INT J CANCER, V129, P2226, DOI 10.1002/ijc.25861; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Duggan C, 2011, J CLIN ONCOL, V29, P32, DOI 10.1200/JCO.2009.26.4473; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/S0016-5085(03)01509-9; Chen MJ, 2012, J SURG ONCOL, V106, P181, DOI 10.1002/jso.23059; Ohishi W, 2014, INT J CANCER, V134, P154, DOI 10.1002/ijc.28337; Peake PW, 2008, BIOCHEM BIOPH RES CO, V367, P560, DOI 10.1016/j.bbrc.2007.12.161; Aleksandrova K, 2014, HEPATOLOGY, V60, P858, DOI 10.1002/hep.27016; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Nieto N, 2006, HEPATOLOGY, V44, P1487, DOI 10.1002/hep.21427; Ezure T, 2000, AM J PATHOL, V156, P1627, DOI 10.1016/S0002-9440(10)65034-1; Huang BQ, 2014, ONCOTARGET, V5, P4732; Guiltinan AM, 2008, AM J EPIDEMIOL, V167, P743, DOI 10.1093/aje/kwm370; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Menon V, 2006, J AM SOC NEPHROL, V17, P2599, DOI 10.1681/ASN.2006040331; van der Poorten D, 2013, HEPATOLOGY, V57, P2180, DOI 10.1002/hep.26072; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071; Balmer ML, 2010, CLIN SCI, V119, P431, DOI 10.1042/CS20100008; Chen CL, 2014, CANCER EPIDEM BIOMAR, V23, P1659, DOI 10.1158/1055-9965.EPI-14-0161; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fujiwara N, 2014, HEPATOL RES, DOI [10.1111/hepr.12398, DOI 10.1111/HEPR.12398]; Hartridge-Lambert SK, 2012, HEPATOLOGY, V55, P634, DOI 10.1002/hep.25499; Koike K, 1997, P NATL ACAD SCI USA, V94, P233, DOI 10.1073/pnas.94.1.233; Matsumoto M, 2008, METABOLISM, V57, P811, DOI 10.1016/j.metabol.2008.01.024; Michikawa T, 2013, CANCER EPIDEM BIOMAR, V22, P2250, DOI 10.1158/1055-9965.EPI-13-0363; Ohki T, 2008, CLIN GASTROENTEROL H, V6, P459, DOI [10.1016/j.cgh.2008.02.012, 10.1016/j.cgh.2008.02.0.12]; Shiota G, 2009, HEPATOL RES, V39, P951, DOI 10.1111/j.1872-034X.2009.00596.x; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Singer JR, 2012, DIABETES CARE, V35, P1858, DOI 10.2337/dc11-2215	48	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	FEB	2015	30	2					379	388		10.1111/jgh.12719		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9KU	WOS:000348533600025		
J	Ogasawara, S; Akiba, J; Nakayama, M; Nakashima, O; Torimura, T; Yano, H				Ogasawara, Sachiko; Akiba, Jun; Nakayama, Masamichi; Nakashima, Osamu; Torimura, Takuji; Yano, Hirohisa			Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						combined hepatocellular-cholangiocarcinoma; epithelial cell adhesion molecule; hepatic stem; progenitor cell	CANCER STEM-CELLS; LIVER-CANCER; INTRAHEPATIC CHOLANGIOCARCINOMA; STEM/PROGENITOR CELLS; PROGENITOR CELLS; CARCINOMA CELLS; MOUSE-LIVER; EPCAM; FEATURES; MARKER	Background and AimHuman combined hepatocellular-cholangiocarcinoma (CHC) expresses several hepatic stem/progenitor cell (HSPC) markers, suggesting this neoplasm originates from HSPCs. We examined the significance of HSPC marker in CHC using a human CHC cell line. MethodsWe used a human CHC cell line (KMCH-1) previously established in our laboratory. The original tumor was classified as CHC, showing areas of typical hepatocellular carcinoma (HCC) and cholangiocarcinoma (ChC). We examined the expression of HSPC markers and hepatocyte markers in KMCH-1 by flow cytometry (FCM) and quantitative real-time polymerase chain reaction. EpCAM(+) and EpCAM(-) KMCH-1 cells were isolated. Subsequently, their morphological features, HSPC marker expression, and biological characteristics were examined in vitro and in vivo. ResultsFCM showed expression of EpCAM, K7, K19, and ABCG2 in KMCH-1, with various degrees. EpCAM(+) cells expressed K19 mRNA, but did not express -fetoprotein (AFP). In contrast, EpCAM(-) cells expressed AFP mRNA, but did not express K19. EpCAM(+) cells produced both EpCAM(+) and EpCAM(-) cells, but EpCAM(-) cells produced only EpCAM(-) cells in vitro. EpCAM(+) cells showed higher tumorigenicity and formed larger tumors than EpCAM(-) cells. Inoculation of EpCAM(+) and EpCAM(-) cells produced both ChC and HCC-like component and HCC-like component only, respectively. ConclusionIt is speculated that some CHCs may originate from EpCAM(+) neoplastic cells, and that these cells may affect malignant behavior and progression in such CHCs.	[Ogasawara, Sachiko; Akiba, Jun; Nakayama, Masamichi; Yano, Hirohisa] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan; [Nakashima, Osamu] Kurume Univ Hosp, Dept Clin Lab Med, Kurume, Fukuoka, Japan; [Torimura, Takuji] Kurume Univ, Dept Med, Div Gastroenterol, Kurume, Fukuoka 8300011, Japan	Ogasawara, S (reprint author), Kurume Univ, Sch Med, Dept Pathol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	sachiko@med.kurume-u.ac.jp					Theise ND, 2003, HISTOPATHOLOGY, V43, P263, DOI 10.1046/j.1365-2559.2003.01707.x; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gasrtro.2007.06.016; Gires O, 2010, J CLIN ONCOL, V28, pE239, DOI 10.1200/JCO.2009.26.8540; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Kurtz JE, 2010, EXPERT OPIN BIOL TH, V10, P951, DOI 10.1517/14712598.2010.482098; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Jarnagin WR, 2002, CANCER, V94, P2040, DOI 10.1002/cncr.10392; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Kowalski M, 2012, J UROLOGY, V188, P1712, DOI 10.1016/j.juro.2012.07.020; Koh KC, 2005, AM J SURG, V189, P120, DOI 10.1016/j.amjsurg.2004.03.018; Holczbauer A, 2013, GASTROENTEROLOGY, V145, P221, DOI 10.1053/j.gastro.2013.03.013; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614; Fujii T, 2008, HUM PATHOL, V39, P1185, DOI 10.1016/j.humpath.2007.12.010; Lee CC, 2002, HEPATO-GASTROENTEROL, V49, P1487; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Akiba J, 2013, AM J SURG PATHOL, V37, P496, DOI 10.1097/PAS.0b013e31827332b0; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Nakayama M, 2014, J GASTROEN HEPATOL, V29, P1092, DOI 10.1111/jgh.12484; Marquardt JU, 2010, J HEPATOL, V53, P568, DOI 10.1016/j.jhep.2010.05.003; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yano Y, 2003, JPN J CLIN ONCOL, V33, P283, DOI 10.1093/jjco/hyg056; desBoer CJ, 1999, J PATHOL, V188, P201; Fong D, 2014, HISTOPATHOLOGY, V64, P683, DOI 10.1111/his.12307; Gires O, 2010, J CLIN ONCOL, V28, pe41; Kim H, 2004, J HEPATOL, V40, P298, DOI 10.1016/j.jhep.2003.10.023; Kozaka K, 2007, HISTOPATHOLOGY, V51, P390, DOI 10.1111/j.1365-2559.2007.02735.x; MacDonald Glen C, 2009, Drug Des Devel Ther, V2, P105; Nakanuma Y, 2008, HEPATOL RES, V38, P325, DOI 10.1111/j.1872-034X.2007.00312.x; Ng IOL, 1998, J GASTROEN HEPATOL, V13, P34, DOI 10.1111/j.1440-1746.1998.tb00542.x; Ogasawara S, 1996, HEPATOLOGY, V24, P198, DOI 10.1002/hep.510240132; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; SELL S, 1993, INT J DEV BIOL, V37, P189; Theise ND, 2010, WHO CLASSIFICATION T, P225; Ueda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075463; Wittekind C, 2000, WHO CLASSIFICATION T, P181; Yano H, 1999, HEPATOLOGY, V29, P1708, DOI 10.1002/hep.510290624	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	FEB	2015	30	2					413	420		10.1111/jgh.12692		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AZ9KU	WOS:000348533600029		
J	Shikino, K; Ikusaka, M; Takada, T				Shikino, Kiyoshi; Ikusaka, Masatomi; Takada, Toshihiko			Cervicofacial Actinomycosis	JOURNAL OF GENERAL INTERNAL MEDICINE			English	Editorial Material						Actinomyces; facial abscess; formation of fistulae			[Shikino, Kiyoshi; Ikusaka, Masatomi; Takada, Toshihiko] Chiba Univ Hosp, Dept Gen Med, Chiba, Japan	Shikino, K (reprint author), Chiba Univ Hosp, Dept Gen Med, Chuo Ku, 1-8-1 Inohana, Chiba, Japan.	kshikino@gmail.com					Miller M, 1998, ORAL SURG ORAL MED O, V85, P496, DOI 10.1016/S1079-2104(98)90280-3	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0884-8734	1525-1497		J GEN INTERN MED	J. Gen. Intern. Med.	FEB	2015	30	2					263	263		10.1007/s11606-014-3001-z		1	Health Care Sciences & Services; Medicine, General & Internal	Health Care Sciences & Services; General & Internal Medicine	CA9HX	WOS:000349234300028		
J	Kuno, T; Ishihama, T				Kuno, Takahito; Ishihama, Tomohiro			A convergent conical algorithm with omega-bisection for concave minimization	JOURNAL OF GLOBAL OPTIMIZATION			English	Article						Global optimization; Concave minimization; Conical algorithm; Bisection; omega-subdivision	SUBDIVISIONS; POLYTOPES	The conical algorithm is a global optimization algorithm proposed by Tuy in 1964 to solve concave minimization problems. Introducing the concept of pseudo-nonsingularity, we give an alternative proof of convergence of the algorithm with the -subdivision rule. We also develop a new convergent subdivision rule, named -bisection, and report numerical results of comparing it with the usual omega-subdivision.	[Kuno, Takahito; Ishihama, Tomohiro] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan	Kuno, T (reprint author), Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan.	takahito@cs.tsukuba.ac.jp			Japan Society for the Promotion of Science [C 25330022]	Takahito Kuno was partially supported by a Grant-in-Aid for Scientific Research (C 25330022) from Japan Society for the Promotion of Science.	Bali S., 1973, THESIS U CALIFORNIA; HAMAMI M, 1988, MATH OPER RES, V13, P479, DOI 10.1287/moor.13.3.479; Horst R., 1993, GLOBAL OPTIMIZATION; Jaumard B, 1998, J GLOBAL OPTIM, V13, P407, DOI 10.1023/A:1008325507949; Jaumard B, 2001, J OPTIMIZ THEORY APP, V110, P119, DOI 10.1023/A:1017595513275; Locatelli M, 1999, MATH PROGRAM, V85, P593, DOI 10.1007/s101070050073; Rockafellar R T, 1970, CONVEX ANAL; Sahni S., 1974, SIAM Journal on Computing, V3, DOI 10.1137/0203021; Thoai N. V., 1980, MATH OPER RES, V5, P556; TUY H, 1991, MATH PROGRAM, V51, P229, DOI 10.1007/BF01586935; Tuy H., 1998, CONVEX ANAL GLOBAL O; Tuy H, 1991, J GLOBAL OPTIM, V1, P23, DOI DOI 10.1007/BF00120663; Tuy H, 1964, SOV MATH, V5, p[32, 1437]; ZWART PB, 1973, OPER RES, V21, P1260, DOI 10.1287/opre.21.6.1260; ZWART PB, 1974, OPER RES, V22, P602, DOI 10.1287/opre.22.3.602	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-5001	1573-2916		J GLOBAL OPTIM	J. Glob. Optim.	FEB	2015	61	2					203	220		10.1007/s10898-014-0197-8		18	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	CA9MJ	WOS:000349247800001		
J	Hamada, Y; Hibino, N; Kobayashi, A				Hamada, Y.; Hibino, N.; Kobayashi, A.			Surgical rehabilitation for correction of severe flexion contracture of the proximal interphalangeal joint by modified Ilizarov method	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Letter									[Hamada, Y.] Tokushima Prefectural Cent Hosp, Dept Orthoped, Tokushima, Japan; [Hibino, N.] Tokushima Naruto Hosp, Hand Ctr, Tokushima, Japan; [Kobayashi, A.] Tokushima Prefectural Cent Hosp, Ctr Clin Educ, Tokushima, Japan	Hamada, Y (reprint author), Tokushima Prefectural Cent Hosp, Dept Orthoped, Tokushima, Japan.	handhamada@hotmail.co.jp					ABBIATI G, 1995, J HAND SURG-BRIT EUR, V20B, P385, DOI 10.1016/S0266-7681(05)80099-3; Ghidella SD, 2002, J HAND SURG-AM, V27A, P799, DOI 10.1053/jhsu.2002.35303; Hogan Christopher J, 2006, J Am Acad Orthop Surg, V14, P524; Houshian S, 2007, J HAND SURG-AM, V32A, P651, DOI 10.1016/j.jhsa.2007.02.015	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	FEB	2015	40	2					208	210		10.1177/1753193413516243		3	Orthopedics; Surgery	Orthopedics; Surgery	AZ9JL	WOS:000348529500018		
J	Morohashi, A; Shingyouchi, Y; Hattori, H				Morohashi, A.; Shingyouchi, Y.; Hattori, H.			Multiple subungual glomus tumours associated with neurofibromatosis type 1	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Letter							DIAGNOSIS; HAND		[Morohashi, A.] Jinwakai Gen Hosp, Dept Orthoped Surg, Tokyo, Japan; [Shingyouchi, Y.] Tokorozawa Cent Hosp, Dept Orthoped Surg, Tokorozawa, Saitama, Japan; [Hattori, H.] Tokyo Med Univ, Dept Orthoped Surg, Tokyo 1608402, Japan	Hattori, H (reprint author), Tokyo Med Univ, Dept Orthoped Surg, Tokyo 1608402, Japan.	hiroyuki.hattori@jcom.home.ne.jp					Brems H, 2009, CANCER RES, V69, P7393, DOI 10.1158/0008-5472.CAN-09-1752; Al-Qattan MM, 2005, J HAND SURG-BRIT EUR, V30B, P535, DOI 10.1016/j.jhsb.2005.06.009; Stewart DR, 2010, J MED GENET, V47, P525, DOI 10.1136/jmg.2009.073965; VanGeertruyden J, 1996, J HAND SURG-BRIT EUR, V21B, P257, DOI 10.1016/S0266-7681(96)80110-0	4	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	FEB	2015	40	2					212	213		10.1177/1753193413495352		2	Orthopedics; Surgery	Orthopedics; Surgery	AZ9JL	WOS:000348529500020		
J	Kowada, A; Takasaki, J; Kobayashi, N				Kowada, A.; Takasaki, J.; Kobayashi, N.			Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries	JOURNAL OF HOSPITAL INFECTION			English	Article						Interferon-gamma release assay; Healthcare worker; Tuberculosis control; Cost-effectiveness	CHEST-X-RAY; LATENT TUBERCULOSIS; SKIN-TEST; UNITED-STATES; TB INFECTION; RISK; HEPATOTOXICITY; DIAGNOSIS	Background: Tuberculosis (TB) is one of the important occupationally acquired infectious diseases in low-incidence countries. Delays in TB diagnosis and treatment among health-care workers (HCWs) result in costly large-scale TB contact screening among patients and other HCWs. Aim: To assess the cost-effectiveness of TB screening for HCWs using interferon-gamma release assays (IGRAs) compared with tuberculin skin test (TST) and chest x ray (CXR). Methods: Markov models were constructed using a hospital payer perspective. The target populations were a hypothetical cohort of 30-year-old HCWs at the time of employment, and a hypothetical cohort of HCWs working on a high-risk ward until 60 years of age. Six strategies were modelled: TST, QuantiFERON-TB Gold In-Tube (QFT), T-SPOT. TB (T-SPOT), TST followed by QFT, TST followed by T-SPOT, and CXR. The main outcome measure of effectiveness was quality-adjusted life-years (QALYs). Costs and QALYs gained per person screened were calculated. Findings: QFT was the most cost-effective strategy at the 'willingness to pay' level of US$ 50,000/QALYs gained (at the time of employment: US$ 334.91, 21.071 QALYs; on a high-risk ward: US$ 1050.32, 20.968 QALYs; values for 2012). Cost-effectiveness was sensitive to latent TB infection (LTBI) rate and bacillus Calmette-Guerin vaccination rate. TST followed by QFT was more cost-effective than QFT when the LTBI rate was <0.026 at the time of employment and <0.08 on a high-risk ward. Conclusion: Systematic TB screening using QFT is cost-effective for screening HCWs, and is recommended in low-incidence countries. (C) 2014 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.	[Kowada, A.] Dept Gen Affairs, Ota, Tokyo, Japan; [Takasaki, J.] Natl Ctr Global Hlth & Med, Div Pulm Med, Tokyo, Japan; [Kobayashi, N.] Tokyo Natl Hosp, Natl Hosp Org, Tokyo, Japan	Kowada, A (reprint author), Dept Gen Affairs, Ota, Tokyo, Japan.	kowadaa@gmail.com			National Centre for Global Health and Medicine, Tokyo, Japan [23A-108]	This research was supported by a grant from the National Centre for Global Health and Medicine, Tokyo, Japan (23A-108).	Chee CBE, 2010, EUR RESPIR J, V36, P355, DOI 10.1183/09031936.00151309; Fong KS, 2012, CHEST, V142, P55, DOI 10.1378/chest.11-0992; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Pai M, 2008, ANN INTERN MED, V149, P177; de Perio MA, 2009, ARCH INTERN MED, V169, P179, DOI 10.1001/archinternmed.2008.524; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Kunst H, 2010, INT J TUBERC LUNG D, V14, P1374; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Costa JT, 2009, EUR RESPIR J, V34, P1423, DOI 10.1183/09031936.00053809; Eralp MN, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000630; Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116; Gran G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-353; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Igakutsushin-sya, 2013, MED INS REIMB TABL J; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kowada A, 2013, NEPHROL DIAL TRANSPL, V28, P682, DOI 10.1093/ndt/gfs479; Kowada A, 2011, J HOSP INFECT, V78, P152, DOI 10.1016/j.jhin.2011.01.026; Kowada A, 2011, AM J INFECT CONTROL, V39, pE67, DOI 10.1016/j.ajic.2011.04.329; Kowada A, 2010, MOL DIAGN THER, V14, P367, DOI 10.2165/11586190-000000000-00000; Kowada A, 2014, J INFECTION, V68, P32, DOI 10.1016/j.jinf.2013.08.009; Kowada A, 2013, EPIDEMIOL INFECT, V141, P2224, DOI 10.1017/S0950268812002907; Nienhaus A, 2013, EXPERT REV ANTI-INFE, V11, P37, DOI [10.1586/eri.12.150, 10.1586/ERI.12.150]; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; Schablon A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-107; Swindells JE, 2009, J HOSP INFECT, V73, P101, DOI 10.1016/j.jhin.2009.05.005; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; Tuberculosis Research Committee, 2009, KEKKAKU, V84, P617	30	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	FEB	2015	89	2					99	108		10.1016/j.jhin.2014.10.002		10	Infectious Diseases	Infectious Diseases	AZ9BT	WOS:000348507000004		
J	Chou, FNF; Wu, CW				Chou, Frederick N. -F.; Wu, Chia-Wen			Stage-wise optimizing operating rules for flood control in a multi-purpose reservoir	JOURNAL OF HYDROLOGY			English	Article						Multi-purpose reservoir; Flood control operation; Optimal release rules; BOBYQA	DISTRIBUTED HYDROLOGICAL MODEL; DECISION-SUPPORT-SYSTEM; MULTIRESERVOIR SYSTEM; GENETIC ALGORITHM; MANAGEMENT; METHODOLOGY; RIVER	This paper presents a generic framework of release rules for reservoir flood control operation during three stages. In the stage prior to flood arrival, the rules indicate the timing and release discharge of pre-releasing reservoir storage to the initial level of flood control operation. In the stage preceding the flood peak, the rules prescribe the portion of inflow to be detained to mitigate downstream flooding, without allowing the water surface level of reservoir to exceed the acceptable safety level of surcharge. After the flood peak, the rules suggest the timing for stepwise reduction of the release flows and closing the gates of spillways and other outlets to achieve the normal level of conservation use. A simulation model is developed and linked with BOBYQA, an efficient optimization algorithm, to determine the optimal rule parameters in a stage-wise manner. The release rules of Shihmen Reservoir of Taiwan are established using inflow records of 59 historical typhoons and the probable maximum flood. The deviations from target levels at the end of different stages of all calibration events are minimized by the proposed method to improve the reliability of flood control operation. The optimized rules satisfy operational objectives including dam safety, flood mitigation, achieving sufficient end-of-operation storage for conservation purposes and smooth operation. (C) 2014 Elsevier B.V. All rights reserved.	[Chou, Frederick N. -F.; Wu, Chia-Wen] Natl Cheng Kung Univ, Dept Hydraul & Ocean Engn, Taiwa, Miyagi, Japan	Wu, CW (reprint author), Natl Cheng Kung Univ, Dept Hydraul & Ocean Engn, 1 Univ Rd, Taiwa, Miyagi, Japan.	hyd4691@mail.ncku.edu.tw; chiawenwu1977@gmail.com			National Science Council, Taiwan, R.O.C. [NSC 100-2221-E-006-201]	This work was supported by the National Science Council (Grant No. NSC 100-2221-E-006-201), Taiwan, R.O.C.	Ahmad S, 2006, WATER RESOUR MANAG, V20, P391, DOI 10.1007/s11269-006-0326-3; Wei CC, 2009, J HYDROL, V365, P213, DOI 10.1016/j.jhydrol.2008.11.038; WASIMI SA, 1983, WATER RESOUR RES, V19, P1511, DOI 10.1029/WR019i006p01511; Braga B, 2001, J AM WATER RESOUR AS, V37, P837, DOI 10.1111/j.1752-1688.2001.tb05516.x; Chang LC, 2008, J HYDROL, V354, P65, DOI 10.1016/j.jhydrol.2008.02.021; Shim KC, 2002, J WATER RES PLAN MAN, V128, P190, DOI 10.1061/(ASCE)0733-9496; Needham JT, 2000, J WATER RES PL-ASCE, V126, P118, DOI 10.1061/(ASCE)0733-9496(2000)126:3(118); Hsu NS, 2007, J HYDROL, V336, P282, DOI 10.1016/j.jhydrol.2007.01.001; Bagis A, 2004, HYDROL PROCESS, V18, P2485, DOI 10.1002/hyp.1477; CAN EK, 1984, J WATER RES PL-ASCE, V110, P297; Chang FJ, 1998, WATER RESOUR MANAG, V12, P185, DOI 10.1023/A:1007900110595; Cheng CT, 2001, J AM WATER RESOUR AS, V37, P1381, DOI 10.1111/j.1752-1688.2001.tb03646.x; Chou FNF, 2013, J HYDROL, V497, P1, DOI 10.1016/j.jhydrol.2013.05.039; Chou FNF, 2010, ADV WATER RESOUR, V33, P146, DOI 10.1016/j.advwatres.2009.10.011; Chou F.N.F., 2010, 14TH CROSS STRAIT HY; Chou F.N.F., 2011, 4TH ASCE EWRI INTERN; Delgoda D.K., 2012, WATER RESOUR MANAG, V27, P765; Faber B., 2001, PROC USING PRECIPITA; FIACCO AV, 1967, OPER RES, V15, P820, DOI 10.1287/opre.15.5.820; Government of India Central Water Commission, 2005, REAL TIME INTEGRATED; Huang WC, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008422; Karbowski A, 2005, DECIS SUPPORT SYST, V38, P599, DOI 10.1016/j.dss.2003.10.001; Kearney M., 2011, 2011 AUSTRALIAN CONT; KOJIRI T, 1989, STOCH HYDROL HYDRAUL, V3, P31, DOI 10.1007/BF01543426; Li XA, 2010, J HYDROL, V391, P126, DOI 10.1016/j.jhydrol.2010.07.011; Li YH, 2010, J WATER RES PL-ASCE, V136, P217, DOI 10.1061/(ASCE)WR.1943-5452.0000027; Mediero L, 2007, HYDROLOG SCI J, V52, P523, DOI 10.1623/hysj.52.3.523; Niewiadomska-Szynkiewicz E, 1996, WATER RESOUR RES, V32, P2885, DOI 10.1029/96WR01443; Pitman M.V., 1980, HYDROLOGICAL FORECAS; Powell M., 2009, TECH REP; Qin H, 2010, WATER RESOUR MANAG, V24, P2611, DOI 10.1007/s11269-009-9570-7; SEQwater, 2011, MANUAL OF OPERATIONA; Sinotech Engineering Consultants Inc, 1979, TECH REP; Unver O., 1990, WATER RESOUR MANAG, V4, P21, DOI 10.1007/BF00429923; U.S. Army Corps of Engineers, 1987, MANAGEMENT OF WATER; Valdes J.B., 1995, U S ITALY RESEARCH W; Valeriano OCS, 2010, J HYDROL ENG, V15, P580, DOI 10.1061/(ASCE)HE.1943-5584.0000212; WINDSOR JS, 1973, WATER RESOUR RES, V9, P1219, DOI 10.1029/WR009i005p01219; Yang DW, 2004, HYDROL PROCESS, V18, P3119, DOI 10.1002/hyp.5752	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-1694	1879-2707		J HYDROL	J. Hydrol.	FEB	2015	521						245	260		10.1016/j.jhydrol.2014.11.073		16	Engineering, Civil; Geosciences, Multidisciplinary; Water Resources	Engineering; Geology; Water Resources	CA4MZ	WOS:000348879900020		
J	Inoue, Y; Watanabe, S; Suzuki, R; Murata, I; Kanamoto, I				Inoue, Yutaka; Watanabe, Shota; Suzuki, Rina; Murata, Isamu; Kanamoto, Ikuo			Evaluation of actarit/gamma-cyclodextrin complex prepared by different methods	JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY			English	Article						Molecular interaction; Ground mixture; Freeze dried; gamma-Cyclodextrin; Actarit	BETA-CYCLODEXTRIN; DISSOLUTION RATE; SOLID-STATE; GAMMA-CYCLODEXTRIN; INCLUSION COMPLEX; SOLUBILITY; IMPROVEMENT; DRUG; NANOPARTICLES; FORMULATIONS	This study used actarit (ACT), an antirheumatic drug, to examine the molecular interaction of ACT and gamma-CD in a solid state as a result of cogrinding or freeze-drying and it assessed the dissolution of ACT. Differential scanning calorimetry revealed that coground ACT and gamma-CD at molar ratios of 1:2 and 1:3 and freeze-dried ACT and gamma-CD at molar ratios of 1:1 and 1:2 lacked an endothermic peak due to melting of ACT crystals. Thus, coground ACT and gamma-CD at a molar ratio of 1:2 had molecular interaction, as did freeze-dried ACT and gamma-CD at a molar ratio of 1:1. Powder x-ray diffraction revealed that coground and humidified ACT and gamma-CD at a molar ratio of 1:2 produced a characteristic diffraction peak at 2 theta = 15.2 degrees and 16.5 degrees due to the cage structure of gamma-CD. In addition, freeze-dried ACT and gamma-CD at a molar ratio of 1:1 that had been humidified produced a diffraction peak at 2 theta = 6.0 degrees and 15.9 degrees characteristic of a hexagonal structure with head-to-head channels due to gamma-CD. Assessment of dissolution revealed that ground mixtures (GMs) and freeze-dried mixtures had improved dissolution of ACT compared to ACT, ground ACT alone, and physical mixtures. The mechanism for this is presumably the result of molecular interaction in a solid state or molecular interaction in an aqueous solution. H-1-H-1 NOESY NMR spectra suggested that in a GM of ACT and gamma-CD the benzene ring and methyl group of ACT partially enter the CD cavity. In addition, spectra for freeze-dried ACT and gamma-CD suggested that protons of the methylene group of ACT and the benzene ring of ACT partially enter the CD cavity. These findings indicate that ACT and gamma-CD inclusion complexes feature different forms of inclusion depending on how they are prepared, e.g., cogrinding or freeze-drying. Findings also indicated that selection of a method of preparation may play a major role in drug development.	[Inoue, Yutaka; Watanabe, Shota; Suzuki, Rina; Murata, Isamu; Kanamoto, Ikuo] Josai Univ, Lab Drug Safety Management, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan	Inoue, Y (reprint author), Josai Univ, Lab Drug Safety Management, Fac Pharmaceut Sci, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.	yinoue@josai.ac.jp					Al Omari AA, 2011, J PHARMACEUT BIOMED, V54, P503, DOI 10.1016/j.jpba.2010.09.027; Cabral-Marques H, 2009, EUR J PHARM BIOPHARM, V73, P121, DOI 10.1016/j.ejpb.2009.05.002; Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012; Ogawa N, 2010, J PHARM SCI-US, V99, P5019, DOI 10.1002/jps.22193; Hirayama F, 1999, ADV DRUG DELIVER REV, V36, P125, DOI 10.1016/S0169-409X(98)00058-1; Nagase Y, 2001, INT J PHARM, V229, P163, DOI 10.1016/S0378-5173(01)00851-1; Ye J, 2008, INT J PHARM, V352, P273, DOI 10.1016/j.ijpharm.2007.10.014; MIKI K, 1988, J AM CHEM SOC, V110, P6594, DOI 10.1021/ja00227a067; Xiao CF, 2014, CARBOHYD POLYM, V102, P297, DOI 10.1016/j.carbpol.2013.11.049; Prabhu S, 2005, INT J PHARM, V301, P209, DOI 10.1016/j.ijpharm.2005.05.032; Mangolim CS, 2014, FOOD CHEM, V153, P361, DOI 10.1016/j.foodchem.2013.12.067; Dollo G, 1999, J PHARM SCI, V88, P889, DOI 10.1021/js990067o; Tao T, 2009, INT J PHARMACEUT, V367, P109, DOI 10.1016/j.ijpharm.2008.09.034; Toropainen T, 2007, PHARM RES, V24, P1058, DOI 10.1007/s11095-006-9227-7; Anzai K, 2007, CHEM PHARM BULL, V55, P1466, DOI 10.1248/cpb.55.1466; Chung JW, 2011, NANOSCALE, V3, P1766, DOI 10.1039/c0nr00894j; Higashi K, 2010, CHEM PHARM BULL, V58, P769; Hu JH, 2004, INT J PHARM, V271, P145, DOI 10.1016/j.ijpharm.2003.11.003; Inoue Y, 2011, CHEM PHARM BULL, V59, P1299; Inoue Y, 2014, J INCL PHENOM MACRO, V78, P457, DOI 10.1007/s10847-013-0317-y; Iwata M, 2009, PHARMAZIE, V64, P390, DOI 10.1691/ph.2009.9045; Pankajkumar S.Y., 2013, SAUDI PHARM J, V22, P77; Torikai Eiji, 2006, Mod Rheumatol, V16, P350, DOI 10.1007/s10165-006-0517-z; UEKAMA K, 1977, J PHARM SCI, V66, P706, DOI 10.1002/jps.2600660525; Wongmekiat A, 2007, CHEM PHARM BULL, V55, P359, DOI 10.1248/cpb.55.359; Yeo L, 1997, ACTA CRYSTALLOGR B, V53, P822, DOI 10.1107/S0108768197005417	26	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-0750	1573-1111		J INCL PHENOM MACRO	J. Incl. Phenom. Macrocycl. Chem.	FEB	2015	81	1-2					161	168		10.1007/s10847-014-0445-z		8	Chemistry, Multidisciplinary	Chemistry	AZ7RN	WOS:000348415700014		
J	Kimuro, T; Yamada, M; Hamada, F				Kimuro, Takashi; Yamada, Manabu; Hamada, Fumio			One-pot synthesis of p-tert-butylthiacalix[6/8]arenes	JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY			English	Article						Thiacalix[n]arenes; Cyclization; Macrocyclic compounds; Synthetic method	METAL COORDINATION; TERT-BUTYLPHENOL; CALIXARENES; COMPLEX; SENSOR; THIACALIXARENES; ASSEMBLIES; EXTRACTION; ACID	Since Miyano and co-workers' facile synthesis of p-tert-butylthiacalix[4]arene (1), many studies related to 1 have been published. In contrast, because of their extremely low yields, investigation of the larger macrocycles p-tert-butylthiacalix[6]arene (2) and p-tert-butylthiacalix[8]arene (3) has been limited. An improved synthetic method for 1-3 by the heating of p-tert-butylphenol, sulfur, and catalytic NaOH in a one-pot, two-stage procedure is described. The first step (oligomer formation) proceeds optimally at 180 degrees C for 24 h with 2 mol % NaOH. The second step (cyclization) is conducted at 230 degrees C with 50 mol % NaOH. Investigations by H-1 NMR spectroscopy and matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS) revealed that 2 and 3 transform into 1 and oligomers at the high temperature required for the cyclization step. Moreover, even 1 transforms into oligomers at high temperature for 48 h. Heating times of 5 and 24 h were optimal for the preparation of 2 (18.1 %) and 3 (4.6 %), respectively. A comparison of the thermal stability of the p-tert-butylthiacalix[n]arenes determined their stability in the order 1, 2, and 3.	[Kimuro, Takashi; Hamada, Fumio] Akita Univ, Dept Appl Chem Environm, Grad Sch Engn & Resource Sci, Akita 0108502, Japan; [Yamada, Manabu] Akita Univ, Res Ctr Engn Sci, Grad Sch Engn & Resource Sci, Akita 0108502, Japan	Hamada, F (reprint author), Akita Univ, Dept Appl Chem Environm, Grad Sch Engn & Resource Sci, 1-1 Tegatagakuen Machi, Akita 0108502, Japan.	myamada@gipc.akita-u.ac.jp; hamada@gipc.akita-u.ac.jp					Iki N, 2000, TETRAHEDRON, V56, P1437, DOI 10.1016/S0040-4020(00)00030-2; Morohashi N, 2006, CHEM REV, V106, P5291, DOI 10.1021/cr050565j; GUTSCHE CD, 1981, J AM CHEM SOC, V103, P3782, DOI 10.1021/ja00403a028; Kim JS, 2007, CHEM REV, V107, P3780, DOI 10.1021/cr068046j; Grady T, 1997, ANALYST, V122, P803, DOI 10.1039/a701343d; Evtugyn GA, 2011, ELECTROANAL, V23, P2281, DOI 10.1002/elan.201100197; AOKI I, 1992, J CHEM SOC CHEM COMM, P730, DOI 10.1039/c39920000730; Asfari Z., 2001, CALIXARENES 2001; Ben A.M., 2000, MAT SCI ENG C, V7, P83; Endo K, 2003, TETRAHEDRON LETT, V44, P1355, DOI 10.1016/S0040-4039(02)02873-3; Gutsche C. D., 1989, CALIXARENES; Gutsche C. D., 1998, CALIXARENES REVISITE; Gutsche CD, 1999, J ORG CHEM, V64, P3747, DOI 10.1021/jo982387i; Iki N, 2003, B CHEM SOC JPN, V76, P1763, DOI 10.1246/bcsj.76.1763; Iki N, 2001, J INCL PHENOM MACRO, V41, P99, DOI 10.1023/A:1014406709512; Itoh S., 2010, INT J SOC MAT ENG RE, V17, P211; JIN T, 1992, J CHEM SOC CHEM COMM, P499, DOI 10.1039/c39920000499; Kajiwara T, 2002, J AM CHEM SOC, V124, P11274, DOI 10.1021/ja0273391; Katagiri H, 2002, CHEM COMMUN, P2080, DOI 10.1039/b205303a; Kon N, 2002, TETRAHEDRON LETT, V43, P2231, DOI 10.1016/S0040-4039(02)00214-9; Kondo Y, 2005, CHEM COMMUN, P711, DOI 10.1039/b413373k; Kondo Y, 2005, J INCL PHENOM MACRO, V52, P45, DOI 10.1007/s10847-004-2384-6; Kondo Y, 2007, J INCL PHENOM MACRO, V58, P123, DOI 10.1007/s10847-006-9133-y; Mandolini L., 2000, CALIXARENES ACTION; Stoikov II, 2008, TETRAHEDRON, V64, P7112, DOI 10.1016/j.tet.2008.05.057; Torgov VG, 2012, RUSS J INORG CHEM+, V57, P1621, DOI 10.1134/S0036023612120212; Yamada M, 2008, TETRAHEDRON LETT, V49, P3906, DOI 10.1016/j.tetlet.2008.04.057; Yamada M., 2008, INT J SOC MAT ENG RE, V15, P50; Yamada M, 2008, TETRAHEDRON LETT, V49, P1790, DOI 10.1016/j.tetlet.2008.01.049; Yamada Manabu, 2007, International Journal of the Society of Materials Engineering for Resources, V15; Yamada M, 2011, TETRAHEDRON, V67, P7392, DOI 10.1016/j.tet2011.07.027; Yamada M, 2013, CRYSTENGCOMM, V15, P5703, DOI 10.1039/c3ce40431e	32	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-0750	1573-1111		J INCL PHENOM MACRO	J. Incl. Phenom. Macrocycl. Chem.	FEB	2015	81	1-2					245	249		10.1007/s10847-014-0435-1		5	Chemistry, Multidisciplinary	Chemistry	AZ7RN	WOS:000348415700022		
J	Kawamoto, A				Kawamoto, Atsushi			Inverse problems for linear degenerate parabolic equations by "time-like" Carleman estimate	JOURNAL OF INVERSE AND ILL-POSED PROBLEMS			English	Article						Carleman estimate; inverse source problem; conditional stability; uniqueness; linear degenerate parabolic equation	CLIMATE MODEL; POPULATION-GENETICS; OPERATORS	In this paper, we study inverse problems for multi-dimensional linear degenerate parabolic equations and strongly coupled systems. In particular we discuss the Lipschitz type stability results for the inverse source problems which determine a source term by boundary data on an appropriate sub-boundary and the data on any fixed time. Our arguments are based on the Carleman estimate. Here we prove and use the Carleman estimate with the x-independent weight function for linear degenerate parabolic equations and systems.	Univ Tokyo, Dept Math Sci, Meguro Ku, Tokyo 153, Japan	Kawamoto, A (reprint author), Univ Tokyo, Dept Math Sci, Meguro Ku, Tokyo 153, Japan.	kawamo@ms.u-tokyo.ac.jp					Ames K., 1997, NONSTANDARD IMPROPER; ETHIER SN, 1993, SIAM J CONTROL OPTIM, V31, P345, DOI 10.1137/0331019; KLIBANOV MV, 1992, INVERSE PROBL, V8, P575, DOI 10.1088/0266-5611/8/4/009; Yin JX, 2007, J DIFFER EQUATIONS, V237, P421, DOI 10.1016/j.jde.2007.03.012; Deng ZC, 2011, J COMPUT APPL MATH, V235, P4404, DOI 10.1016/j.cam.2011.04.006; Imanuvilov OY, 1998, INVERSE PROBL, V14, P1229, DOI 10.1088/0266-5611/14/5/009; Hetzer G, 2001, NONLINEAR ANAL-REAL, V2, P259, DOI 10.1016/S0362-546X(00)00103-6; Cannarsa P, 2008, CONTROL CYBERN, V37, P831; Yamamoto M, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123013; Diaz JI, 2006, NONLINEAR ANAL-THEOR, V64, P2053, DOI 10.1016/j.na.2005.07.038; BUKHGEIM AL, 1981, DOKL AKAD NAUK SSSR+, V260, P269; Klibanov MV, 2013, J INVERSE ILL-POSE P, V21, P477, DOI 10.1515/jip-2012-0072; Cannarsa P, 2008, SIAM J CONTROL OPTIM, V47, P1, DOI 10.1137/04062062X; Beilina L., 2012, APPROXIMATE GLOBAL C; Buchot JM, 2006, J MATH FLUID MECH, V8, P510, DOI 10.1007/s00021-005-0186-2; Cannarsa P, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/10/105003; Cannarsa P, 2009, CR MATH, V347, P147, DOI 10.1016/j.crma.2008.12.011; Diaz J. I., 1997, NATO ASI SER I, V48, P217; ETHIER SN, 1976, COMMUN PUR APPL MATH, V29, P483, DOI 10.1002/cpa.3160290503; Isakov V., 1998, INVERSE PROBLEMS PAR; Klibanov M., 2004, CARLEMAN ESTIMATES C; Kumano-go H., 1978, PARTIAL DIFFERENTIAL; Lavrent'ev MM, 1986, ILL POSED PROBLEMS M; LEES M, 1961, DUKE MATH J, V28, P369, DOI 10.1215/S0012-7094-61-02833-2; Martinez P, 2006, J EVOL EQU, V6, P325, DOI 10.1007/s00028-006-0214-6; Oleinik O.A., 1999, APPL MATH MATH COMPU, V15; Payne L. E., 1975, IMPROPERLY POSED PRO; Tort J, 2010, CR MATH, V348, P1287, DOI 10.1016/j.crma.2010.10.031; Tort J, 2012, ANN I H POINCARE-AN, V29, P683, DOI 10.1016/j.anihpc.2012.03.003; Vancostenoble J., 2011, DISCRETE CONTIN DY S, V4, P761; Wang C., 2010, J EVOL EQU, V10, P161	31	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0928-0219	1569-3945		J INVERSE ILL-POSE P	J. Inverse Ill-Posed Probl.	FEB	2015	23	1					1	21		10.1515/jiip-2013-0027		21	Mathematics, Applied; Mathematics	Mathematics	CA7JT	WOS:000349094300001		
J	Mochizuki, K; Trooshin, I				Mochizuki, Kiyoshi; Trooshin, Igor			Spectral problems and scattering on noncompact star-shaped graphs containing finite rays	JOURNAL OF INVERSE AND ILL-POSED PROBLEMS			English	Article						Star graph; Schrodinger operator; scattering	INVERSE PROBLEM	We consider Schrodinger operators on noncompact star-shaped graphs. The following topics will be treated under suitable decay conditions on the potential: characterization of the set of eigenvalues and expression of each eigen-projection; low-energy behavior of the resolvent, spectral representations of the operator restricted on infinite rays; determination of the Marchenko equations and the inverse scattering problems.	[Mochizuki, Kiyoshi] Chuo Univ, Dept Math, Bunkyo Ku, Kasuga, Tokyo 1128551, Japan; [Mochizuki, Kiyoshi] Tokyo Metropolitan Univ, Tokyo, Japan; [Trooshin, Igor] Tohoku Univ, Inst Int Educ, Sendai, Miyagi 9808576, Japan	Mochizuki, K (reprint author), Chuo Univ, Dept Math, Bunkyo Ku, Kasuga, Tokyo 1128551, Japan.	mochizuk@math.chuo-u.ac.jp; trushin@m.tohoku.ac.jp			Japan Society for Promotion of Science [22540204, 23540181]	The first author was partly supported by Grant-in Aid for Scientific Research (C) (No. 22540204 and No. 23540181), Japan Society for Promotion of Science. The second author was partly supported by Grand-in-Aid for Scientifc Research (C) (No. 23540181), Japan Society for Promotion of Science.	Agranovich Z. S., 1963, INVERSE PROBLEM SCAT; GERASIMENKO NI, 1988, THEOR MATH PHYS+, V75, P460, DOI 10.1007/BF01017484; Belishev MI, 2004, INVERSE PROBL, V20, P647, DOI 10.1088/0266-5611/20/3/002; Kurasov P, 2002, J PHYS A-MATH GEN, V35, P101, DOI 10.1088/0305-4470/35/1/309; Yurko V, 2005, INVERSE PROBL, V21, P1075, DOI [10.1088/0266-5611/21/3/017, 10.1088/0266-5611/215/3/017]; Exner P., 1989, Reports on Mathematical Physics, V28, DOI 10.1016/0034-4877(89)90023-2; FADDEYEV LD, 1963, J MATH PHYS, V4, P72, DOI 10.1063/1.1703891; Faddeev LD, 1974, J SOVIET MATH, V5, P334, DOI DOI 10.1007/BF01083780; Freiling G, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/9/095003; Gerasimenko N. I., 1988, TEOR MAT FIZ, V74, p[345, 230]; Kuchment P, 2002, WAVE RANDOM MEDIA, V12, pR1, DOI 10.1088/0959-7174/12/4/201; Latushkin Y, 2008, INTEGR EQUAT OPER TH, V61, P365, DOI 10.1007/s00020-008-1597-2; Marchenko V., 2008, ANAL METHODS ANAL DI, P237; Marchenko V. A., 1986, OPER THEORY ADV APPL, V22; Mochizuki K., 2012, PROGR MATH, V301, P227; Pivovarchik V., 2001, OPER THEORY ADV APPL, V124, P527; Yafaev D. R., 2010, MATH SURVEYS MONOGR, V158	17	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0928-0219	1569-3945		J INVERSE ILL-POSE P	J. Inverse Ill-Posed Probl.	FEB	2015	23	1					23	40		10.1515/jiip-2013-0049		18	Mathematics, Applied; Mathematics	Mathematics	CA7JT	WOS:000349094300002		
J	Miyano, G; Fukuzawa, H; Morita, K; Kaneshiro, M; Miyake, H; Nouso, H; Yamoto, M; Fukumoto, K; Urushihara, N				Miyano, Go; Fukuzawa, Hiroaki; Morita, Keiichi; Kaneshiro, Masakatsu; Miyake, Hiromu; Nouso, Hiroshi; Yamoto, Masaya; Fukumoto, Koji; Urushihara, Naoto			Laparoscopic Repair of Malrotation: What Are the Indications in Neonates and Children?	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							INTESTINAL MALROTATION; SURGICAL-MANAGEMENT; LADD PROCEDURE; VOLVULUS; INFANTS; MIDGUT	Aim: To define the role of laparoscopy for treating malrotation in children. Materials and Methods: The Ladd procedure (9 laparoscopic [lap-Ladd], 17 open [open-Ladd]; n=26) was performed in children up to and including 30 days of age (neonatal [Group N]) and older (Group C). These groups were compared retrospectively. Results: Group N (n=14) comprised 3 lap-Ladd and 11 open-Ladd patients. Group C (n=12) comprised 6 lap-Ladd and 6 open-Ladd patients. No case had ischemic bowel preoperatively. Intestinal volvulus was confirmed in 3 of 3 lap-Ladd and 9 of 11 open-Ladd patients in Group N, compared with 5 of 6 lap-Ladd and 6 of 6 open-Ladd patients in Group C (P=not significant). Mean operating times were significantly longer for lap-Ladd patients (130.7 minutes versus 81.1 minutes in Group N and 119.2 minutes versus 74.2 minutes in Group C). Conversion to an open-Ladd procedure was necessary in 1 of 3 patients in Group N and 1 of 6 patients in Group C (P=not significant). Complications arose in open-Ladd patients, bowel obstruction in Group N (1 of 11), and mesenteric chylorrhea in Group C (1 of 6). There was recurrence in 1 of 3 lap-Ladd patients in Group N. Mean time to recommence feeding was earlier for lap-Ladd patients (P=not significant). Length of hospitalization was similar in Group N but was shorter for lap-Ladd patients in Group C (P=not significant). Conclusions: Although lap-Ladd appears to be a safe procedure, it cannot be recommended for the treatment of malrotation in neonates.	[Miyano, Go; Fukuzawa, Hiroaki; Morita, Keiichi; Kaneshiro, Masakatsu; Miyake, Hiromu; Nouso, Hiroshi; Yamoto, Masaya; Fukumoto, Koji; Urushihara, Naoto] Shizuoka Childrens Hosp, Dept Pediat Surg, Shizuoka 4208660, Japan	Miyano, G (reprint author), Shizuoka Childrens Hosp, Dept Pediat Surg, Aoi Ku, 860 Urushiyama, Shizuoka 4208660, Japan.	go1993@hotmail.co.jp					Long FR, 1996, RADIOLOGY, V198, P775; Stanfill AB, 2010, J LAPAROENDOSC ADV S, V20, P369, DOI 10.1089/lap.2009.0118; Gross E, 1996, SURG ENDOSC-ULTRAS, V10, P936, DOI 10.1007/BF00188488; Bass KD, 1998, J PEDIATR SURG, V33, P279, DOI 10.1016/S0022-3468(98)90447-X; VANDERZEE DC, 1995, SURG ENDOSC-ULTRAS, V9, P1123; Fraser JD, 2009, J SURG RES, V156, P80, DOI 10.1016/j.jss.2009.03.063; Hagendoorn J, 2011, SURG ENDOSC, V25, P217, DOI 10.1007/s00464-010-1162-3; Dilley AV, 2000, PEDIATR SURG INT, V16, P45, DOI 10.1007/s003830050012; Draus JM, 2007, AM SURGEON, V73, P693; FORD EG, 1992, ANN SURG, V215, P172, DOI 10.1097/00000658-199202000-00013; Kalfa N, 2004, SURG ENDOSC, V18, P1815, DOI 10.1007/s00464-004-9029-0; Ladd WE, 1936, NEW ENGL J MED, V215, P705, DOI 10.1056/NEJM193610152151604; Matzke GM, 2005, SURG ENDOSC, V19, P1416, DOI 10.1007/s00464-004-8249-7; MAXSON RT, 1995, AM SURGEON, V61, P135; Mazziotti MV, 1997, J AM COLL SURGEONS, V185, P172, DOI 10.1016/S1072-7515(01)00900-0; Waldhausen JHT, 1996, J LAPAROENDOSC SURG, V6, pS103	16	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	FEB 1	2015	25	2					155	158		10.1089/lap.2014.0236		4	Surgery	Surgery	CB0NU	WOS:000349324100014		
J	Takahashi, H; Goto, T; Yamazaki, Y; Kamakari, K; Hirata, M; Suzuki, H; Shibata, D; Nakata, R; Inoue, H; Takahashi, N; Kawada, T				Takahashi, Haruya; Goto, Tsuyoshi; Yamazaki, Yota; Kamakari, Kosuke; Hirata, Mariko; Suzuki, Hideyuki; Shibata, Daisuke; Nakata, Rieko; Inoue, Hiroyasu; Takahashi, Nobuyuki; Kawada, Teruo			Metabolomics reveal 1-palmitoyl lysophosphatidylcholine production by peroxisome proliferator-activated receptor alpha	JOURNAL OF LIPID RESEARCH			English	Article						lysoglycerophospholipid; mass spectrometry; liver; phospholipases; A2; omics	CORONARY-ARTERY-DISEASE; NECROSIS-FACTOR-ALPHA; INDUCED INFLAMMATORY CHANGES; INSULIN-RESISTANCE; PPAR-ALPHA; LIPID-METABOLISM; GENE-EXPRESSION; ADIPOSE-TISSUE; 3T3-L1 ADIPOCYTES; HEPG2 HEPATOCYTES	PPAR is well known as a master regulator of lipid metabolism. PPAR activation enhances fatty acid oxidation and decreases the levels of circulating and cellular lipids in obese diabetic patients. Although PPAR target genes are widely known, little is known about the alteration of plasma and liver metabolites during PPAR activation. Here, we report that metabolome analysis-implicated upregulation of many plasma lysoGP species during bezafibrate (PPAR agonist) treatment. In particular, 1-palmitoyl lysophosphatidylcholine [LPC(16:0)] is increased by bezafibrate treatment in both plasma and liver. In mouse primary hepatocytes, the secretion of LPC(16:0) increased on PPAR activation, and this effect was attenuated by PPAR antagonist treatment. We demonstrated that Pla(2)g7 gene expression levels in the murine hepatocytes were increased by PPAR activation, and the secretion of LPC(16:0) was suppressed by Pla(2)g7 siRNA treatment. Interestingly, LPC(16:0) activates PPAR and induces the expression of PPAR target genes in hepatocytes. Furthermore, we showed that LPC(16:0) has the ability to recover glucose uptake in adipocytes induced insulin resistance. These results reveal that LPC(16:0) is induced by PPAR activation in hepatocytes; LPC(16:0) contributes to the upregulation of PPAR target genes in hepatocytes and the recovery of glucose uptake in insulin-resistant adipocytes.	[Takahashi, Haruya; Goto, Tsuyoshi; Yamazaki, Yota; Kamakari, Kosuke; Hirata, Mariko; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto 6110011, Japan; [Goto, Tsuyoshi; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Res Unit Physiol Chem, Kyoto 6068501, Japan; [Suzuki, Hideyuki; Shibata, Daisuke] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan; [Nakata, Rieko; Inoue, Hiroyasu] Nara Womens Univ, Nara 6308506, Japan	Kawada, T (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto 6110011, Japan.	fat@kais.kyoto-u.ac.jp			Research and Development Projects for Application in Promoting New Policies Agriculture, Forestry, and Fisheries of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22228001, 24688015]; Japan Society for the Promotion of Science for Young Scientists [24521]	This work was supported in part by Research and Development Projects for Application in Promoting New Policies Agriculture, Forestry, and Fisheries of Japan; by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (22228001 and 24688015); and by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (24521).	Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Duval C, 2002, TRENDS MOL MED, V8, P422, DOI 10.1016/S1471-4914(02)02385-7; Srivastava RAK, 2009, EUR J PHARMACOL, V607, P258, DOI 10.1016/j.ejphar.2009.02.024; Goto T, 2005, BIOCHEM BIOPH RES CO, V337, P440, DOI 10.1016/j.bbrc.2005.09.077; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; TUGWOOD JD, 1992, EMBO J, V11, P433; Ericsson CG, 1996, LANCET, V347, P849, DOI 10.1016/S0140-6736(96)91343-4; Huang F, 2005, AM J PHYSIOL-LUNG C, V289, pL176, DOI 10.1152/ajplung.00003.2005; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Takahashi N, 2002, FEBS LETT, V514, P315, DOI 10.1016/S0014-5793(02)02390-6; Roepstorff C, 2005, AM J PHYSIOL-ENDOC M, V288, pE133, DOI 10.1152/ajpendo.00379.2004; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Permana PA, 2006, BIOCHEM BIOPH RES CO, V341, P507, DOI 10.1016/j.bbrc.2006.01.012; Kim YI, 2011, MOL NUTR FOOD RES, V55, P585, DOI 10.1002/mnfr.201000264; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Birgbauer E, 2006, CELL MOL LIFE SCI, V63, P2695, DOI 10.1007/s00018-006-6155-y; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Goto T, 2011, BIOCHEM J, V438, P111, DOI 10.1042/BJ20101939; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Iijima Y, 2008, PLANT J, V54, P949, DOI 10.1111/j.1365-313X.2008.03434.x; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI200320514; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Yea K, 2009, J BIOL CHEM, V284, P33833, DOI 10.1074/jbc.M109.024869; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Parks BW, 2005, J LIPID RES, V46, P1405, DOI 10.1194/jlr.M500085-JLR200; Takahashi N, 2003, FEBS LETT, V550, P190, DOI 10.1016/S0014-5793(03)00859-7; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Tenenbaum A, 2004, CIRCULATION, V109, P2197, DOI 10.1161/01.CIR.0000126824.12785.B6; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; XU Y, 1995, BIOCHEM J, V309, P933; Tenenbaum A, 2005, ARCH INTERN MED, V165, P1154, DOI 10.1001/archinte.165.10.1154; Balogun KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082399; Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Goldenberg Ilan, 2008, Vasc Health Risk Manag, V4, P131, DOI 10.2147/vhrm.2008.04.01.131; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Hespel P, 1996, DIABETES, V45, pS99; Hu CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013318; Rosenblat M, 2006, BIOCHEM BIOPH RES CO, V344, P1271, DOI 10.1016/j.bbrc.2006.04.038; Takahashi H, 2013, BIOSCI BIOTECH BIOCH, V77, P2288, DOI 10.1271/bbb.130572; Tenenbaum A, 2006, ARCH INTERN MED, V166, P737, DOI 10.1001/archinte.166.7.737; Yamamoto M, 2002, ATHEROSCLEROSIS, V163, P223, DOI 10.1016/S0021-9150(02)00007-2	56	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	FEB	2015	56	2					254	265		10.1194/jlr.M052464		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA4VR	WOS:000348905000006		
J	Ancel, D; Bernard, A; Subramaniam, S; Hirasawa, A; Tsujimoto, G; Hashimoto, T; Passilly-Degrace, P; Khan, NA; Besnard, P				Ancel, Deborah; Bernard, Arnaud; Subramaniam, Selvakumar; Hirasawa, Akira; Tsujimoto, Gozoh; Hashimoto, Toshihiro; Passilly-Degrace, Patricia; Khan, Naim-Akhtar; Besnard, Philippe			The oral lipid sensor GPR120 is not indispensable for the orosensory detection of dietary lipids in mice	JOURNAL OF LIPID RESEARCH			English	Article						lipids; diet and dietary lipids; nutrition; receptors; G-protein; fat taste; feeding behavior; mouse	CHAIN FATTY-ACIDS; CIRCUMVALLATE PAPILLAE; TASTE SENSITIVITY; LINOLEIC-ACID; CD36 GENE; PREFERENCE; MOUSE; PERCEPTION; OBESITY; GPR40	Implication of the long-chain fatty acid (LCFA) receptor GPR120, also termed free fatty acid receptor 4, in the taste-guided preference for lipids is a matter of debate. To further unravel the role of GPR120 in the taste of fat, the present study was conducted on GPR120-null mice and their wild-type littermates. Using a combination of morphological [i.e., immunohistochemical staining of circumvallate papillae (CVP)], behavioral (i.e., two-bottle preference tests, licking tests and conditioned taste aversion) and functional studies [i.e., calcium imaging in freshly isolated taste bud cells (TBCs)], we show that absence of GPR120 in the oral cavity was not associated with changes in i) gross anatomy of CVP, ii) LCFA-mediated increases in intracellular calcium levels ([Ca2+](i)), iii) preference for oily and LCFA solutions and iv) conditioned avoidance of LCFA solutions. In contrast, the rise in [Ca2+](i) triggered by grifolic acid, a specific GPR120 agonist, was dramatically curtailed when the GPR120 gene was lacking. Taken together, these data demonstrate that activation of lingual GPR120 and preference for fat are not connected, suggesting that GPR120 expressed in TBCs is not absolutely required for oral fat detection in mice	[Ancel, Deborah; Bernard, Arnaud; Subramaniam, Selvakumar; Passilly-Degrace, Patricia; Khan, Naim-Akhtar; Besnard, Philippe] Univ Bourgogne, NUTox, UMR INSERM U866, AgroSup Dijon, F-21000 Dijon, France; [Hirasawa, Akira; Tsujimoto, Gozoh] Kyoto Univ, Dept Pharmacogen, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Hashimoto, Toshihiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima 770, Japan	Besnard, P (reprint author), Univ Bourgogne, NUTox, UMR INSERM U866, AgroSup Dijon, F-21000 Dijon, France.	pbesnard@u-bourgogne.fr			French National Research Agency [ANR-12-BSV1-0027-01]	This work was supported by a grant from the French National Research Agency (ANR-12-BSV1-0027-01, SensoFAT-2 project to P.B.).	Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Chevrot M, 2013, J LIPID RES, V54, P2485, DOI 10.1194/jlr.M039446; Yu T, 2012, PFLUG ARCH EUR J PHY, V464, P227, DOI 10.1007/s00424-012-1116-9; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Dramane G, 2012, J CLIN INVEST, V122, P2267, DOI 10.1172/JCI59953; Sclafani A, 2013, AM J PHYSIOL-REG I, V305, pR1490, DOI 10.1152/ajpregu.00440.2013; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Kawai T, 2003, AM J PHYSIOL-REG I, V285, pR447, DOI 10.1152/ajpregu.00729.2002; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1823, DOI 10.1152/ajpregu.00211.2007; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Keller KL, 2012, OBESITY, V20, P1066, DOI 10.1038/oby.2011.374; Voigt N, 2014, J LIPID RES, V55, P870, DOI 10.1194/jlr.M046029; Love-Gregory L, 2011, HUM MOL GENET, V20, P193, DOI 10.1093/hmg/ddq449; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Simons PJ, 2011, ACTA HISTOCHEM, V113, P839, DOI 10.1016/j.acthis.2010.08.006; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Galindo MM, 2012, CHEM SENSES, V37, P123, DOI 10.1093/chemse/bjr069; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Chen CSY, 2013, AM J PHYSIOL-REG I, V305, pR1346, DOI 10.1152/ajpregu.00582.2012; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Faurion A, 2006, PHYSIOL BEHAV, V89, P44, DOI 10.1016/j.physbeh.2006.05.008; Gilbertson T. A., 2010, FAT DETECTION TASTE; Godinot N, 2013, NEUROSCIENCE, V250, P20, DOI 10.1016/j.neuroscience.2013.06.043; Martin C, 2012, J LIPID RES, V53, P2256, DOI 10.1194/jlr.M025874; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Matsumura S, 2007, BIOMED RES-TOKYO, V28, P49, DOI 10.2220/biomedres.28.49; Montmayeur JP, 2011, FLAVOUR FRAG J, V26, P223, DOI 10.1002/ffj.2043; Osada K, 1997, CHEM SENSES, V22, P249, DOI 10.1093/chemse/22.3.249; Ozdener M. H., 2014, GASTROENTEROLOGY; Shin AC, 2011, AM J PHYSIOL-REG I, V301, pR1267, DOI 10.1152/ajpregu.00314.2011	35	4	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	FEB	2015	56	2					369	378		10.1194/jlr.M055202		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA4VR	WOS:000348905000016		
J	Nagao, A; Maoka, T; Ono, H; Kotake-Nara, E; Kobayashi, M; Tomita, M				Nagao, Akihiko; Maoka, Takashi; Ono, Hiroshi; Kotake-Nara, Eiichi; Kobayashi, Miyuki; Tomita, Mie			A 3-hydroxy beta-end group in xanthophylls is preferentially oxidized to a 3-oxo epsilon-end group in mammals	JOURNAL OF LIPID RESEARCH			English	Article						-cryptoxanthin; keto-carotenoid; liver; lutein; mouse; oxidation; metabolism; zeaxanthin	SINGLE NUCLEOTIDE POLYMORPHISMS; NATURAL CAROTENOIDS; DIETARY CAROTENOIDS; PLASMA KINETICS; ADIPOSE-TISSUE; HEPG2 CELLS; EGG-YOLK; ZEAXANTHIN; LUTEIN; IDENTIFICATION	We previously found that mice fed lutein accumulated its oxidative metabolites (3-hydroxy-epsilon,epsilon-caroten-3-one and epsilon,epsilon-carotene-3,3-dione) as major carotenoids, suggesting that mammals can convert xanthophylls to keto-carotenoids by the oxidation of hydroxyl groups. Here we elucidated the metabolic activities of mouse liver for several xanthophylls. When lutein was incubated with liver postmitochondrial fraction in the presence of NAD(+), (3R,6R)-3-hydroxy-,epsilon-caroten-3-one and (6RS,3R,6R)-3-hydroxy-epsilon,epsilon-caroten-3-one were produced as major oxidation products. The former accumulated only at the early stage and was assumed to be an intermediate, followed by isomerization to the latter. The configuration at the C3 and C6 of the epsilon-end group in lutein was retained in the two oxidation products. These results indicate that the 3-hydroxy -end group in lutein was preferentially oxidized to a 3-oxo epsilon-end group via a 3-oxo -end group. Other xanthophylls such as -cryptoxanthin and zeaxanthin, which have a 3-hydroxy -end group, were also oxidized in the same manner as lutein. These keto-carotenoids, derived from dietary xanthophylls, were confirmed to be present in plasma of normal human subjects, and ,epsilon-caroten-3-one was significantly increased by the ingestion of -cryptoxanthin. Thus, humans as well as mice have oxidative activity to convert the 3-hydroxy -end group of xanthophylls to a 3-oxo epsilon-end group.	[Nagao, Akihiko; Ono, Hiroshi; Kotake-Nara, Eiichi; Kobayashi, Miyuki; Tomita, Mie] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Maoka, Takashi] Res Inst Prod & Dev, Sakyo Ku, Kyoto 6060805, Japan	Nagao, A (reprint author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan.	nagao@affrc.go.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [23580189]; Kieikai Research Foundation	This work was supported by a grant for scientific research (number 23580189) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and by a grant from Kieikai Research Foundation.	Albert GI, 2008, COMP BIOCHEM PHYS B, V151, P70, DOI 10.1016/j.cbpb.2008.05.014; MATSUNO T, 1986, COMP BIOCHEM PHYS B, V84, P477, DOI 10.1016/0305-0491(86)90110-0; Yonekura L, 2010, J NUTR, V140, P1824, DOI 10.3945/jn.110.126466; Yonekura L, 2007, MOL NUTR FOOD RES, V51, P107, DOI 10.1002/mnfr.200600145; Landrum JT, 1999, METHOD ENZYMOL, V299, P457; KHACHIK F, 1992, ANAL CHEM, V64, P2111, DOI 10.1021/ac00042a016; Murakami A, 2002, CARCINOGENESIS, V23, P795, DOI 10.1093/carcin/23.5.795; Kiefer C, 2001, J BIOL CHEM, V276, P14110; BURTON GW, 1984, SCIENCE, V224, P569, DOI 10.1126/science.6710156; Stahl W, 2005, BBA-MOL BASIS DIS, V1740, P101, DOI 10.1016/j.bbadis.2004.12.006; Nagao A, 2011, BIOFACTORS, V37, P83, DOI 10.1002/biof.151; BONE RA, 1992, METHOD ENZYMOL, V213, P360; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; LoPachin RM, 2008, TOXICOL SCI, V104, P235, DOI 10.1093/toxsci/kfm301; Kotake-Nara E, 2012, BIOSCI BIOTECH BIOCH, V76, P875, DOI 10.1271/bbb.110777; FOOTE CS, 1968, J AM CHEM SOC, V90, P6233, DOI 10.1021/ja01024a061; Elliott R, 2005, BBA-MOL BASIS DIS, V1740, P147, DOI 10.1016/j.bbadis.2004.12.009; Asai A, 2004, DRUG METAB DISPOS, V32, P205, DOI 10.1124/dmd.32.2.205; Matsuno T, 2001, FISHERIES SCI, V67, P771, DOI 10.1046/j.1444-2906.2001.00323.x; Borel P, 2012, MOL NUTR FOOD RES, V56, P228, DOI 10.1002/mnfr.201100322; Nishino H, 2002, CANCER METAST REV, V21, P257, DOI 10.1023/A:1021206826750; Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002; Barua AB, 2001, J NUTR, V131, P3212; Borel P, 2014, AM J CLIN NUTR, V100, P168, DOI 10.3945/ajcn.114.085720; Britton G., 1995, CAROTENOIDS, V1B, P13; BUCHECKER R, 1979, HELV CHIM ACTA, V62, P2817, DOI 10.1002/hlca.19790620831; Chew B. P., 2004, J NUTR, V134, p257S; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; El-Subbagh HI, 2000, J MED CHEM, V43, P2915, DOI 10.1021/jm000038m; Englert G, 1995, CAROTENOIDS, V1, P147; Gerhauser C, 2009, MOL NUTR FOOD RES, V53, P1237, DOI 10.1002/mnfr.200800492; Hartmann D, 2004, AM J CLIN NUTR, V79, P410; Hendrickson SJ, 2012, AM J CLIN NUTR, V96, P1379, DOI 10.3945/ajcn.112.034934; HUDON J, 1994, BIOTECHNOL ADV, V12, P49, DOI 10.1016/0734-9750(94)90290-9; Jaswir I, 2012, FOOD CHEM, V132, P865, DOI 10.1016/j.foodchem.2011.11.053; Liaaen-Jensen S., 1966, ACTA CHEM SCAND, V20, P1703; Lietz G, 2012, J NUTR, V142, p161S, DOI 10.3945/jn.111.140756; MAYER H, 1980, HELV CHIM ACTA, V63, P1451, DOI 10.1002/hlca.19800630614; McGraw KJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P843, DOI 10.1086/323797; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Richard B., 1995, CAROTENOIDS SPECTR B, V1B, P63; Thurmann PA, 2005, AM J CLIN NUTR, V82, P88; Tian R, 2010, ANIM GENET, V41, P253, DOI 10.1111/j.1365-2052.2009.01990.x; Vage DI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-10	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	FEB	2015	56	2					449	462		10.1194/jlr.P055459		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CA4VR	WOS:000348905000024		
J	Onuki, Y; Hara, K; Utsunomiya, H; Szpunar, JA				Onuki, Yusuke; Hara, Kenichiro; Utsunomiya, Hiroshi; Szpunar, Jerzy A.			High-Speed Rolling of AZ31 Magnesium Alloy Having Different Initial Textures	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						dynamic plastic deformation; high-speed rolling; magnesium alloy; shear band; texture evolution; twinning	TEMPERATURE UNIAXIAL COMPRESSION; MICROSTRUCTURE EVOLUTION; DEFORMATION MECHANISMS; TENSILE DEFORMATION; PLASTIC-DEFORMATION; ZIRCONIUM ALLOYS; MG; DUCTILITY; SHEETS; TWINS	It is known that magnesium alloys can be rolled up to a large thickness reduction and develop a unique texture when the rolling speed is high (> 1000 m/min). In order to understand the texture formation mechanism during high-strain-rate deformation, high-speed rolling of AZ31 magnesium alloy samples having different initial textures was conducted. The main components of the textures after the rolling were the RD-split basal, which consisted of 10A degrees-20A degrees inclining basal poles from the normal direction toward the rolling direction of the sheet, regardless of the different initial textures. With preheating at 473 K, all the samples were rolled without cracking while all were cracked when preheating was not applied. The optical micrographs and EBSD measurements showed a significant amount of twins and the cracks that developed along the shear bands consisted with laminated twins. Based on the texture simulation using the visco-plastic self-consistent model, it is concluded that the rapid development of the RD-split basal component from the initial basal alignment along the transverse direction was attributable to the tension twinning, The effect of the initial texture on the crack formation can be explained by the activation of the twinning system.	[Onuki, Yusuke] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Hara, Kenichiro] Kobe Steel Ltd, Tech Dev Grp, Mat Res Lab, Nishi Ku, Kobe, Hyogo 6512271, Japan; [Utsunomiya, Hiroshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Szpunar, Jerzy A.] Univ Saskatchewan, Dept Mech Engn, Saskatoon, SK S7N 5A9, Canada	Onuki, Y (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 1-1 Katahira,2 Chome, Sendai, Miyagi 9808577, Japan.	onuki@tagen.tohoku.ac.jp		Onuki, Yusuke/0000-0001-9763-0970	Auto21, Canadian Network of Centers of Excellence	The authors would like to acknowledge Mr. Miyamoto, Osaka University, for helping with the high-speed rolling experiment. We thank Mr. Asgari and Mr. Ouellet for valuable discussion and providing language help. We also thank Professor Tome for providing the code of VPSC-7. The project was supported by Auto21, Canadian Network of Centers of Excellence.	Al-Samman T, 2009, ACTA MATER, V57, P2229, DOI 10.1016/j.actamat.2009.01.031; Marya M, 2006, MAT SCI ENG A-STRUCT, V418, P341, DOI 10.1016/j.msea.2005.12.003; Agnew SR, 2005, INT J PLASTICITY, V21, P1161, DOI 10.1016/j.ijplas.2004.05.018; Hutchinson WB, 2010, SCRIPTA MATER, V63, P737, DOI 10.1016/j.scriptamat.2010.05.047; Takuda H, 1998, J MATER PROCESS TECH, V80-1, P513, DOI 10.1016/S0924-0136(98)00154-X; Helming K, 2003, POWDER DIFFR, V18, P99, DOI 10.1154/1.1577353; Mordike BL, 2001, MAT SCI ENG A-STRUCT, V302, P37, DOI 10.1016/S0921-5093(00)01351-4; Barnett MR, 2004, MAT SCI ENG A-STRUCT, V386, P205, DOI 10.1016/j.msea.2004.07.030; LEBENSOHN RA, 1993, ACTA METALL MATER, V41, P2611, DOI 10.1016/0956-7151(93)90130-K; Koike J, 2008, MATER TRANS, V49, P2792, DOI 10.2320/matertrans.MRA2008283; Styczynski A, 2004, SCRIPTA MATER, V50, P943, DOI 10.1016/j.scriptamat.2004.01.010; Al-Samman T, 2008, MAT SCI ENG A-STRUCT, V488, P406, DOI 10.1016/j.msea.2007.11.056; Li HL, 2008, J MATER SCI, V43, P7148, DOI 10.1007/s10853-008-3021-3; Gehrmann R, 2005, MAT SCI ENG A-STRUCT, V395, P338, DOI 10.1016/j.msea.2005.01.002; TOME CN, 1991, ACTA METALL MATER, V39, P2667, DOI 10.1016/0956-7151(91)90083-D; Sandlobes S, 2011, ACTA MATER, V59, P429, DOI 10.1016/j.actamat.2010.08.031; Asgari H., 2013, P 16 WERKST K CHEMN; Barnett MR, 2007, MAT SCI ENG A-STRUCT, V464, P8, DOI 10.1016/j.msea.2007.02.109; Barnett MR, 2007, MAT SCI ENG A-STRUCT, V464, P1, DOI 10.1016/j.msea.2006.12.037; Helis L, 2006, MAT SCI ENG A-STRUCT, V430, P98, DOI 10.1016/j.msea.2006.04.125; Koh H, 2007, MATER TRANS, V48, P2023, DOI 10.2320/matertrans.L-MRA2007875; Kim J, 2013, MATER SCI FORUM, V753, P493, DOI 10.4028/www.scientific.net/MSF.753.493; PAWLIK K, 1991, TEXTURE MICROSTRUCT, V14, P25, DOI 10.1155/TSM.14-18.25; Sanjari M., 2012, MG2012 9 INT C MAGN, P375	24	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	FEB	2015	24	2					972	985		10.1007/s11665-014-1318-8		14	Materials Science, Multidisciplinary	Materials Science	CA6GS	WOS:000349009400046		
J	Sabri, MFM; Ono, T; Said, SM; Kawai, Y; Esashi, M				Sabri, Mohd Faizul Mohd; Ono, Takahito; Said, Suhana Mohd; Kawai, Yusuke; Esashi, Masayoshi			Fabrication and Characterization of Microstacked PZT Actuator for MEMS Applications	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						Piezoelectric actuator; silicon stage; micropositioning; amplification mechanism; microelectromechanical systems (MEMS)	MICRO-XY-STAGE; PROBE; NANOPOSITIONER; SWITCH	A microstacked PZT actuator of dimensions 8 mmx 0.8 mm x 0.4 mm and capable of 2.3-mu m actuation under a voltage of 100 V was fabricated and characterized. This actuator was then integrated into a silicon microstage with dimensions of 20 mm x 20 mm x 0.4 mm requiring actuation by a miniaturized actuator. The microstage was designed containing a Moonie amplification mechanism in order to further amplify the actuation of the stacked PZT actuator. Experimental characterization of the microstage performance indicated that the combination of a stacked PZT actuator with the Moonie amplification mechanism was successful in enabling high amplification of the microstage to similar to 15 times the original displacement of the PZT actuator. A displacement of 16.5 mu m at an applied voltage of 60 V and a resonant frequency of 456 Hz in the lateral vibration mode was observed. The relationship between the actuator parameters and the microstage design and performance was also discussed in order to show that the customized fabrication of a miniature actuator was imperative for the successful design of a high area-efficiency microstage. Analytical derivation of the displacement of the stacked PZT actuator was also carried out in order to evaluate the effectiveness of the fabricated actuator compared with the ideal stacked PZT structure. [2013-0231]	[Sabri, Mohd Faizul Mohd] Univ Malaya, Dept Mech Engn, Fac Engn, Kuala Lumpur 50603, Malaysia; [Ono, Takahito; Kawai, Yusuke] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Said, Suhana Mohd] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur 50603, Malaysia; [Esashi, Masayoshi] Micro Syst Integrat Ctr, Sendai, Miyagi 9800845, Japan	Sabri, MFM (reprint author), Univ Malaya, Dept Mech Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.	faizul@um.edu.my; ono@nme.mech.tohoku.ac.jp; ono@nme.mech.tohoku.ac.jp; kawai@nme.mech.tohoku.ac.jp; esashi@mems.mech.tohoku.ac.jp	MOHD SABRI, MOHD FAIZUL/B-9084-2010; Engineering, Faculty /I-7935-2015; MOHD SAID, SUHANA/B-9852-2010	MOHD SABRI, MOHD FAIZUL/0000-0001-8096-2709; Engineering, Faculty /0000-0002-4848-7052; MOHD SAID, SUHANA/0000-0001-5258-9070	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science through the Program for World-Leading Innovative Research and Development on Science and Technology; High Impact Research Fund Project [UM.C/625/1/HIR/M/OHE/ENG/29]; Universiti Malaya [RP003A-13AET]; Hitachi Scholarship Foundation	This work was supported in part by the Cabinet Office, Government of Japan; in part by the Japan Society for the Promotion of Science through the Program for World-Leading Innovative Research and Development on Science and Technology; in part by the High Impact Research Fund Project under Grant UM.C/625/1/HIR/M/OHE/ENG/29; and in part by the Universiti Malaya Research Grant under Grant RP003A-13AET. The work M. F. M. Sabri was supported by the Hitachi Scholarship Foundation. Subject Editor S. M. Spearing.	Ma HW, 2006, SENSOR ACTUAT A-PHYS, V132, P730, DOI 10.1016/j.sna.2005.12.028; [Anonymous], 2013, PHYS INSTRUMENTE PI; Hubbard NB, 2005, J MICROMECH MICROENG, V15, P1482, DOI 10.1088/0960-1317/15/8/015; Lantz MA, 2007, J MICROELECTROMECH S, V16, P130, DOI 10.1109/JMEMS.2006.886032; Eleftheriou E, 2003, IEEE T MAGN, V39, P938, DOI 10.1109/TMAG.2003.808953; [Anonymous], 2006, MULT PIEZ ACT PROT C; Arscott S, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/2/025023; Ataman C, 2006, P SOC PHOTO-OPT INS, V6186, P18603, DOI 10.1117/12.664777; Choi JJ, 2001, P SOC PHOTO-OPT INS, V4334, P363, DOI 10.1117/12.436622; Golda D. S., 2008, P SOL STAT SENS ACT, P60; Huang W. H., 2000, P IEEE INT C ROB AUT, V3, P2153, DOI 10.1109/ROBOT.2000.846347; Kageshima M., 2006, REV SCI INSTRUM, V77; Kim CH, 2002, J MICROMECH MICROENG, V12, P103, DOI 10.1088/0960-1317/12/2/301; Lee K. I., 2007, P NAN, V3, P221; Rothuizen H, 2002, PROC IEEE MICR ELECT, P582; Sabri M. F. M., 2009, P TRANSD INT SOL STA, P2405; Sabri M. F. M., 2009, IEEJ T SM, V129, P471; Sabri MFM, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/9/095004; Sasaki M, 2008, JPN J APPL PHYS, V47, P3226, DOI 10.1143/JJAP.47.3226; Severi S., 2009, P TRANSD 2009 DENV U, P2409; Shen SC, 2002, J MAGN MAGN MATER, V239, P610, DOI 10.1016/S0304-8853(01)00682-5; Takahashi K, 2006, IEICE ELECTRON EXPR, V3, P197, DOI 10.1587/elex.3.197; Liu X, 2007, J MICROMECH MICROENG, V17, P1796, DOI 10.1088/0960-1317/17/9/007; Xu HG, 2006, MICROSYST TECHNOL, V12, P883, DOI 10.1007/s00542-006-0206-z; Xu HG, 2006, J MICROMECH MICROENG, V16, P2747, DOI 10.1088/0960-1317/16/12/031; Zhang DY, 2005, SENSOR ACTUAT A-PHYS, V122, P301, DOI 10.1016/j.sna.2005.03.076	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7157	1941-0158		J MICROELECTROMECH S	J. Microelectromech. Syst.	FEB	2015	24	1					80	90		10.1109/JMEMS.2014.2317495		11	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	CA8JG	WOS:000349164300011		
J	Kitamura, N; Chim, J; Miki, N				Kitamura, N.; Chim, J.; Miki, N.			Electrotactile display using microfabricated micro-needle array	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						electrotactile display; micro-needle; electrochemical etching; microelectromechanical systems; information communication technology	TACTILE; ELECTRODES; SKIN	This paper describes an electrotactile display with micro-needle electrodes. The electrotactile display can produce tactile sensations by stimulating tactile receptors using an electric current. Micro-needle electrodes can drastically decrease the threshold voltage required to stimulate tactile receptors by penetrating the stratum corneum, which has a higher impedance than the dermis. In addition, the optimized length of the needle allows us to stimulate tactile receptors painlessly. In the present study, we developed a process for fabricating a micro-needle array in which the length and tip radius can be controlled using electrochemical etching. A micro-needle array was successfully fabricated to form an electrotactile display. In addition, we experimentally determined the suitable shape of the micro-needle electrodes for electrotactile display applications. When the tip radius of the needle is too small, the impedance between the finger and micro-needles becomes large due to the small contact area. On the other hand, when the tip radius is too large, the needle cannot penetrate the skin surface and the impedance is not sufficiently small. The experiments verified the superiority of needle electrode devices to flat electrode devices with respect to the threshold voltage at each frequency.	[Kitamura, N.; Chim, J.; Miki, N.] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 223, Japan; [Miki, N.] JST PRESTO, Chiyoda Ku, Tokyo 102, Japan	Kitamura, N (reprint author), Keio Univ, Dept Mech Engn, 3-14-1 Hiyoshi, Yokohama, Kanagawa 223, Japan.	norihide.kitamura@z2.keio.jp	Miki, Norihisa/F-7659-2014		JST PRESTO	This work was supported in part by JST PRESTO (Information Environment and Humans).	Kwon HJ, 2009, SENSOR ACTUAT A-PHYS, V154, P238, DOI 10.1016/j.sna.2008.10.002; Ju BF, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3529880; Kajimoto H, 2012, IEEE T HAPTICS, V5, P184, DOI [10.1109/TOH.2011.39, 10.1109/ToH.2011.39]; Ninomiya T, 2011, SENSOR ACTUAT A-PHYS, V166, P277, DOI 10.1016/j.sna.2009.07.002; Biet M, 2007, IEEE T ULTRASON FERR, V54, P2678, DOI 10.1109/TUFFC.2007.596; JOHANSSON RS, 1983, TRENDS NEUROSCI, V6, P27, DOI 10.1016/0166-2236(83)90011-5; Ami Y, 2011, J MICRO-NANOLITH MEM, V10, DOI 10.1117/1.3553393; WHITTON JT, 1973, BRIT J DERMATOL, V89, P467, DOI 10.1111/j.1365-2133.1973.tb03007.x; Park JH, 2007, IEEE T BIO-MED ENG, V54, P903, DOI 10.1109/TBME.2006.889173; Bach-y-Rita P, 1998, J REHABIL RES DEV, V35, P427; Kajimoto H, 2004, IEEE COMPUT GRAPH, V24, P36, DOI 10.1109/MCG.2004.1255807; Griss P, 2001, J MICROELECTROMECH S, V10, P10, DOI 10.1109/84.911086; Arouette X, 2010, SENSORS-BASEL, V10, P2946, DOI 10.3390/s100402946; Deguchi T., 2010, J SURF FINISH SOC JA, V61, P305, DOI 10.4139/sfj.61.305; Hirayama H, 1961, J MED ASS NIPPON MED, V28, P81; HORCH K, 1992, J HAND SURG-AM, V17A, P829, DOI 10.1016/0363-5023(92)90452-U; Huang CA, 2011, CORROS SCI, V53, P2566, DOI 10.1016/j.corsci.2011.04.014; Ikei Y, 2002, HAPT INT VIRT ENV TE, P327; Ishii T., 2002, Sixth International Conference on Motion and Vibration Control. Proceedings; Jungmann M, 2002, EUROHAPTICS 2002, P12; Kajimoto H, 2001, P IEEE VIRT REAL ANN, P289, DOI 10.1109/VR.2001.913801; Kitamura N, 2014, MEMS 14, P1183; Kitamura N, 2013, TRANSDUCERS 13, P106; Kosemura Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JM11; Levesque V, 2007, World Haptics 2007: Second Joint EuroHaptics Conference and Symposium on Haptic Interfaces for Virtual Environment and Teleoperator Systems, Proceedings, P115; Montagna W., 1964, THE EPIDERMIS; Moy G., 2000, ICRA 00 P IEEE C ROB, V4, P3409; Nakagawa H, 2010, J SURF FINISH SOC JA, V61, P58; Ohka M, 2007, ROBOTICA, V25, P451, DOI 10.1017/S0263574706003274; Sato K., 2010, P IEEE HAPT S WALTH, P121; Wagner C. R., 2002, HAPTICS 2002 P 10 S, P354; Watanabe J, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FL11; Watanabe T, 1995, IEEE INT C ROB AUT N, P1134	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	FEB	2015	25	2							025016	10.1088/0960-1317/25/2/025016		8	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CA7OL	WOS:000349106800017		
J	Muto, Y; Guindon, S; Umemura, T; Kohidai, L; Ueda, H				Muto, Yoshinori; Guindon, Stephane; Umemura, Toshiaki; Kohidai, Laszlo; Ueda, Hiroshi			Adaptive Evolution of Formyl Peptide Receptors in Mammals	JOURNAL OF MOLECULAR EVOLUTION			English	Article						Molecular evolution; Formyl peptide receptor; Positive selection; Mammal	PROTEIN-COUPLED RECEPTORS; AMINO-ACID SITES; CODON-SUBSTITUTION MODELS; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; LIGAND; PRIMATES; BINDING; IDENTIFICATION; PHYLOGENIES	The formyl peptide receptors (FPRs) are a family of chemoattractant receptors with important roles in host defense and the regulation of inflammatory reactions. In humans, three FPR paralogs have been identified (FPR1, FPR2, and FPR3) and may have functionally diversified by gene duplication and adaptive evolution. However, the evolutionary mechanisms operating in the diversification of FPR family genes and the changes in selection pressures have not been characterized to date. Here, we have made a comprehensive evolutionary analysis of FPR genes from mammalian species. Phylogenetic analysis showed that an early duplication was responsible for FPR1 and FPR2/FPR3 splitting, and FPR3 originated from the latest duplication event near the origin of primates. Codon-based tests of positive selection reveal interesting patterns in FPR1 and FPR2 versus FPR3, with the first two genes showing clear evidence of positive selection at some sites while the majority of them evolve under strong negative selection. In contrast, our results suggest that the selective pressure may be relaxed in the FPR3 lineage. Of the six amino acid sites inferred to evolve under positive selection in FPR1 and FPR2, four sites were located in extracellular loops of the protein. The electrostatic potential of the extracellular surface of FPR might be affected more frequently with amino acid substitutions in positively selected sites. Thus, positive selection of FPRs among mammals may reflect a link between changes in the sequence and surface structure of the proteins and is likely to be important in the host's defense against invading pathogens.	[Muto, Yoshinori; Ueda, Hiroshi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011193, Japan; [Muto, Yoshinori] Gifu Univ, Sch Med, Dept Funct Biosci, Gifu 5011193, Japan; [Guindon, Stephane] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Umemura, Toshiaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Kohidai, Laszlo] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1089 Budapest, Hungary; [Ueda, Hiroshi] Gifu Univ, Dept Biomol Sci, Fac Engn, Gifu 5011193, Japan	Muto, Y (reprint author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, 1-1 Yanagido, Gifu 5011193, Japan.	ymuto@gifu-u.ac.jp		Kohidai, Laszlo/0000-0002-9002-0296			Alvarez V, 1996, IMMUNOGENETICS, V44, P446, DOI 10.1007/BF02602806; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Guindon S, 2004, P NATL ACAD SCI USA, V101, P12957, DOI 10.1073/pnas.0402177101; Cui YH, 2002, J LEUKOCYTE BIOL, V72, P628; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Nielsen R, 1998, GENETICS, V148, P929; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Southgate EL, 2008, J IMMUNOL, V181, P1429; Tsuruki T, 2007, BIOSCI BIOTECH BIOCH, V71, P1198, DOI 10.1271/bbb.60656; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Wooding S, 2011, J MOL EVOL, V73, P257, DOI 10.1007/s00239-011-9481-0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Rompler H, 2007, MOL INTERV, V7, P17, DOI 10.1124/mi.7.1.5; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Graham GJ, 2006, TRENDS IMMUNOL, V27, P381, DOI 10.1016/j.it.2006.06.006; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Rabiet MJ, 2011, J BIOL CHEM, V286, P26718, DOI 10.1074/jbc.M111.244590; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2002, MOL BIOL EVOL, V19, P49; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Gavins FNE, 2010, TRENDS PHARMACOL SCI, V31, P266, DOI 10.1016/j.tips.2010.04.001; de Paulis A, 2004, J IMMUNOL, V173, P5739; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Edwards BS, 2005, MOL PHARMACOL, V68, P1301, DOI 10.1124/mol.105.014068; Endo T, 1996, MOL BIOL EVOL, V13, P685; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fredriksson R, 2005, ANN NY ACAD SCI, V1040, P89, DOI 10.1196/annals.1327.011; Fujita H, 2011, ARCH BIOCHEM BIOPHYS, V516, P121, DOI 10.1016/j.abb.2011.09.017; Furlong RF, 2008, J MOL EVOL, V66, P384, DOI 10.1007/s00239-008-9092-6; Ha HS, 2011, MAMM GENOME, V22, P621, DOI 10.1007/s00335-011-9341-7; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Khlebnikov AI, 2012, J MOL MODEL, V18, P2831, DOI 10.1007/s00894-011-1307-x; Lu A, 2014, MOL BIOL EVOL, V31, P484, DOI 10.1093/molbev/mst198; Migeotte I, 2005, J EXP MED, V201, P83, DOI 10.1084/jem.20041277; Mills JS, 2000, J BIOL CHEM, V275, P39012, DOI 10.1074/jbc.M003081200; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SCHIFFMANN E, 1975, J IMMUNOL, V114, P1831; Stabenau A, 2004, GENOME RES, V14, P929, DOI 10.1101/gr.1857204; Yang H, 2010, J GENET GENOMICS, V37, P771, DOI 10.1016/S1673-8527(09)60094-1; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZD, 2008, J MOL EVOL, V66, P446, DOI 10.1007/s00239-008-9097-1; Zhou HY, 2009, J NEUROSCI METH, V181, P1, DOI 10.1016/j.jneumeth.2009.04.002	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2844	1432-1432		J MOL EVOL	J. Mol. Evol.	FEB	2015	80	2					130	141		10.1007/s00239-015-9666-z		12	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	CA9MM	WOS:000349248200007		
J	Gallego-Jutgla, E; Sole-Casals, J; Vialatte, FB; Elgendi, M; Cichocki, A; Dauwels, J				Gallego-Jutgla, Esteve; Sole-Casals, Jordi; Vialatte, Francois-Benoit; Elgendi, Mohamed; Cichocki, Andrzej; Dauwels, Justin			A hybrid feature selection approach for the early diagnosis of Alzheimer's disease	JOURNAL OF NEURAL ENGINEERING			English	Article						Alzheimer's disease; mild cognitive impairment; electroencephalography; synchrony; relative power; Granger causality; Gram-Schmidt orthogonal forward regression	MILD COGNITIVE IMPAIRMENT; SPONTANEOUS EEG; COMPLEXITY; BRAIN; SIGNALS; RECORDINGS; RHYTHMS	Objective. Recently, significant advances have been made in the early diagnosis of Alzheimer's disease (AD) from electroencephalography (EEG). However, choosing suitable measures is a challenging task. Among other measures, frequency relative power (RP) and loss of complexity have been used with promising results. In the present study we investigate the early diagnosis of AD using synchrony measures and frequency RP on EEG signals, examining the changes found in different frequency ranges. Approach. We first explore the use of a single feature for computing the classification rate (CR), looking for the best frequency range. Then, we present a multiple feature classification system that outperforms all previous results using a feature selection strategy. These two approaches are tested in two different databases, one containing mild cognitive impairment (MCI) and healthy subjects (patients age: 71.9 +/- 10.2, healthy subjects age: 71.7 +/- 8.3), and the other containing Mild AD and healthy subjects (patients age: 77.6 +/- 10.0; healthy subjects age: 69.4 +/- 11.5). Main results. Using a single feature to compute CRs we achieve a performance of 78.33% for the MCI data set and of 97.56% for Mild AD. Results are clearly improved using the multiple feature classification, where a CR of 95% is found for the MCI data set using 11 features, and 100% for the Mild AD data set using four features. Significance. The new features selection method described in this work may be a reliable tool that could help to design a realistic system that does not require prior knowledge of a patient's status. With that aim, we explore the standardization of features for MCI and Mild AD data sets with promising results.	[Gallego-Jutgla, Esteve; Sole-Casals, Jordi] Univ Vic, Cent Univ Catalonia, Data & Signal Proc Grp, Vic 08500, Catalonia, Spain; [Vialatte, Francois-Benoit] PSL Res Univ, ESPCI ParisTech, Lab SIGMA, F-75231 Paris 05, France; [Elgendi, Mohamed] Univ Alberta, Edmonton, AB T6G 2E8, Canada; [Elgendi, Mohamed; Dauwels, Justin] Nanyang Technol Univ, Singapore 639798, Singapore; [Cichocki, Andrzej] BSI RIKEN ABSP Lab, Wako, Saitama 3510198, Japan; [Cichocki, Andrzej] Polish Acad Sci, Syst Res Inst, PL-01447 Warsaw, Poland	Sole-Casals, J (reprint author), Univ Vic, Cent Univ Catalonia, Data & Signal Proc Grp, Vic 08500, Catalonia, Spain.	esteve.gallego@uvic.cat; jordi.sole@uvic.cat; vialatte@espci.fr; moe.elgendi@gmail.com; cia@brain.riken.jp; jdauwels@ntu.edu.sg	Sole-Casals, Jordi/B-7754-2008	Sole-Casals, Jordi/0000-0002-6534-1979	University of Vic-Central University of Catalonia (UVic-UCC) [2011MOB005, 2013_1MOB/003]	Esteve Gallego-Jutgla wishes to thank the University of Vic-Central University of Catalonia (UVic-UCC) for partially supporting this project under a PhD grant ('Amb el suport de l'ajut predoctoral de la Universitat de Vic') and under the mobility grants 2011MOB005 and 2013_1MOB/003. The authors would like to thank Drs Sarah Umbrene Khan and Srinivasan Kannan for their valuable suggestions regarding the manuscript.	Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Korzeniewska A, 2003, J NEUROSCI METH, V125, P195, DOI 10.1016/S0165-0270(03)00052-9; Wackermann J, 1999, INT J PSYCHOPHYSIOL, V34, P65, DOI 10.1016/S0167-8760(99)00038-0; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; COOLEY JW, 1965, MATH COMPUT, V19, P297, DOI 10.2307/2003354; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Czigler B, 2008, INT J PSYCHOPHYSIOL, V68, P75, DOI 10.1016/j.ijpsycho.2007.11.002; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; [Anonymous], 1998, ACOUST SPEECH SIG PR; Dauwels J, 2010, CURR ALZHEIMER RES, V7, P487; Bamidis PD, 2014, NEUROSCI BIOBEHAV R, V44, P206, DOI 10.1016/j.neubiorev.2014.03.019; Woon WL, 2007, PHYSIOL MEAS, V28, P335, DOI 10.1088/0967-3334/28/4/001; Babiloni C, 2011, J ALZHEIMERS DIS, V26, P201, DOI 10.3233/JAD-2011-0051; Vialatte FB, 2009, LECT NOTES COMPUT SC, V5507, P979, DOI 10.1007/978-3-642-03040-6_119; Cichocki A, 2005, CLIN NEUROPHYSIOL, V116, P729, DOI 10.1016/j.clinph.2004.09.017; Bhattacharya J, 2000, ACTA NEUROBIOL EXP, V60, P495; Elgendi M, 2011, IEEE ENG MED BIO, P6087, DOI 10.1109/IEMBS.2011.6091504; Latchoumane CFV, 2012, J NEUROSCI METH, V207, P41, DOI 10.1016/j.jneumeth.2012.03.005; CHEN S, 1989, INT J CONTROL, V50, P1873, DOI 10.1080/00207178908953472; Babiloni C, 2006, BRAIN RES BULL, V69, P63, DOI 10.1016/j.brainresbull.2005.10.013; Chambers J. A., 2007, EEG SIGNAL PROCESSIN; Dauweis J., 2011, INT J ALZHEIMERS DIS, V2011, DOI [10.4061/2011/539621, DOI 10.4061/2011/539621]; Dauwels J, 2009, IEEE ENG MED BIO, P2224, DOI 10.1109/IEMBS.2009.5334862; de Waal H, 2012, NEUROBIOL AGING, V33; Dreyfus G, 2008, APPRENTISSAGE STAT R; Duda R. O., 2001, PATTERN CLASSIFICATI; Gallego-Jutgla E, 2012, IEEE ENG MED BIO, P4266, DOI 10.1109/EMBC.2012.6346909; Kaminski Maciej, 2005, Critical Reviews in Biomedical Engineering, V33, P347, DOI 10.1615/CritRevBiomedEng.v33.i4.20; Kropotov JD, 2009, QUANTITATIVE EEG, EVENT-RELATED POTENTIALS AND NEUROTHERAPY, P1; Nunez PL, 2006, ELECT FIELDS BRAIN N; Oppenheim A. V., 1975, DIGITAL SIGNAL PROCE; Pascual-Marqui RD, 2007, ARXIV07111455; Saito N, 1998, BIOL PSYCHIAT, V43, P794, DOI 10.1016/S0006-3223(97)00547-7; Scinto L F M, 2000, EARLY DIAGNOSIS ALZH; Stoppiglia H., 2003, Journal of Machine Learning Research, V3, DOI 10.1162/153244303322753733; Vecchio F., 2013, CLIN NEUROPHYSIOL, V62, P223, DOI [10.1016/B978-0-7020-5307-8.00015-6, DOI 10.1016/B978-0-7020-5307-8.00015-6]; Vialatte F, 2005, 2005 IEEE Workshop on Machine Learning for Signal Processing (MLSP), P27, DOI 10.1109/MLSP.2005.1532869; Vialatte FB, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-46; Vialatte FB, 2009, LECT NOTES COMPUT SC, V5506, P224, DOI 10.1007/978-3-642-02490-0_28; Wackermann J, 1996, ACTA NEUROBIOL EXP, V56, P197; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI 10.1016/j.jalz.2011.09.172	43	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	FEB	2015	12	1							016018	10.1088/1741-2560/12/1/016018		16	Engineering, Biomedical; Neurosciences	Engineering; Neurosciences & Neurology	CA2UE	WOS:000348762500020		
J	Pinegger, A; Faller, J; Halder, S; Wriessnegger, SC; Muller-Putz, GR				Pinegger, Andreas; Faller, Josef; Halder, Sebastian; Wriessnegger, Selina C.; Mueller-Putz, Gernot R.			Control or non-control state: that is the question! An asynchronous visual P300-based BCI approach	JOURNAL OF NEURAL ENGINEERING			English	Article						brain-computer interface; BCI; P300; asynchronous; control state	BRAIN-COMPUTER-INTERFACE; MENTAL PROSTHESIS; P300; CLASSIFICATION; EEG	Objective. Brain-computer interfaces (BCI) based on event-related potentials (ERP) were proven to be a reliable synchronous communication method. For everyday life situations, however, this synchronous mode is impractical because the system will deliver a selection even if the user is not paying attention to the stimulation. So far, research into attention-aware visual ERP-BCIs (i.e., asynchronous ERP-BCIs) has led to variable success. In this study, we investigate new approaches for detection of user engagement. Approach. Classifier output and frequency-domain features of electroencephalogram signals as well as the hybridization of them were used to detect the user' s state. We tested their capabilities for state detection in different control scenarios on offline data from 21 healthy volunteers. Main results. The hybridization of classifier output and frequency-domain features outperformed the results of the single methods, and allowed building an asynchronous P300-based BCI with an average correct state detection accuracy of more than 95%. Significance. Our results show that all introduced approaches for state detection in an asynchronous P300-based BCI can effectively avoid involuntary selections, and that the hybrid method is the most effective approach.	[Pinegger, Andreas; Faller, Josef; Wriessnegger, Selina C.; Mueller-Putz, Gernot R.] Graz Univ Technol, BioMedTech Graz, Inst Knowledge Discovery, A-8010 Graz, Austria; [Halder, Sebastian] Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany; [Halder, Sebastian] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Brain Funct, Syst Neurosci Sect, Tokorozawa, Saitama, Japan	Pinegger, A (reprint author), Graz Univ Technol, BioMedTech Graz, Inst Knowledge Discovery, A-8010 Graz, Austria.	gernot.mueller@tugraz.at			FP7 research project Back-Home [288566]	This work is supported by the FP7 research project Back-Home (No. 288566). The authors want to thank Marcello Turconi for his help with the measurements. This paper only reflects the authors views and funding agencies are not liable for any use that may be made of the information contained herein.	Aloise F, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025025; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Mota AR, 2013, SENSOR ACTUAT A-PHYS, V199, P310, DOI 10.1016/j.sna.2013.06.013; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Zickler C, 2013, ARTIF INTELL MED, V59, P99, DOI 10.1016/j.artmed.2013.08.003; Panicker RC, 2011, IEEE T BIO-MED ENG, V58, P1781, DOI 10.1109/TBME.2011.2116018; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Muller-Putz GR, 2010, MED BIOL ENG COMPUT, V48, P229, DOI 10.1007/s11517-009-0572-7; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Zhang HH, 2008, IEEE T BIO-MED ENG, V55, P1754, DOI 10.1109/TBME.2008.919128; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; Billinger M, 2013, PRACTICAL BRAIN COMP, P333; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Guger C, 2012, FRONTIERS NEUROSCI, V6; Jin J, 2010, BIOMED TECH, V55, P203, DOI 10.1515/BMT.2010.029; Lenhardt A, 2010, LECT NOTES COMPUT SC, V6444, P58, DOI 10.1007/978-3-642-17534-3_8; Liu YC, 2012, IEEE ENG MED BIO, P3850; LIU YC, 2013, 6 INT IEEE EMBS C NE, P1066; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037//0033-2909.89.3.506; Riechmann H, 2011, I IEEE EMBS C NEUR E, P412	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	FEB	2015	12	1							014001	10.1088/1741-2560/12/1/014001		8	Engineering, Biomedical; Neurosciences	Engineering; Neurosciences & Neurology	CA2UE	WOS:000348762500002		
J	Yoshikawa, A; Kamide, T; Hashida, K; Ta, HM; Inahata, Y; Takarada-Iemata, M; Hattori, T; Mori, K; Takahashi, R; Matsuyama, T; Hayashi, Y; Kitao, Y; Hori, O				Yoshikawa, Akifumi; Kamide, Tomoya; Hashida, Koji; Hieu Minh Ta; Inahata, Yuki; Takarada-Iemata, Mika; Hattori, Tsuyoshi; Mori, Kazutoshi; Takahashi, Ryosuke; Matsuyama, Tomohiro; Hayashi, Yutaka; Kitao, Yasuko; Hori, Osamu			Deletion of Atf6 alpha impairs astroglial activation and enhances neuronal death following brain ischemia in mice	JOURNAL OF NEUROCHEMISTRY			English	Article						astrogliosis; brain ischemia; ER stress; neuronal death	PROTEIN-TYROSINE-PHOSPHATASE; ENDOPLASMIC-RETICULUM STRESS; FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; REACTIVE ASTROCYTES; STROKE; ORP150; STAT3; PATHOPHYSIOLOGY; GLUCONEOGENESIS	To dissect the role of endoplasmic reticulum (ER) stress and unfolded protein response in brain ischemia, we investigated the relevance of activating transcription factor 6 (ATF6), a master transcriptional factor in the unfolded protein response, after permanent middle cerebral artery occlusion (MCAO) in mice. Enhanced expression of glucose-regulated protein78, a downstream molecular chaperone of ATF6, was observed in both neurons and glia in the peri-infarct region of wild-type mice after MCAO. Analysis using wild-type and Atf6(-/-) mice revealed a larger infarct volume and increased cell death in the peri-ischemic region of Atf6(-/-) mice 5days after MCAO. These phenotypes in Atf6(-/-) mice were associated with reduced levels of astroglial activation/glial scar formation, and a spread of tissue damage into the non-infarct area. Further analysis in mice and cultured astrocytes revealed that signal transducer and activator of transcription 3 (STAT3)-glial fibrillary acidic protein signaling were diminished in Atf6(-/-) astrocytes. A chemical chaperone, 4-phenylbutyrate, restored STAT3-glial fibrillary acidic protein signaling, while ER stressors, such as tunicamycin and thapsigargin, almost completely abolished signaling in cultured astrocytes. Furthermore, ER stress-induced deactivation of STAT3 was mediated, at least in part, by the ER stress-responsive tyrosine phosphatase, TC-PTP/PTPN2. These results suggest that ER stress plays critical roles in determining the level of astroglial activation and neuronal survival after brain ischemia	[Yoshikawa, Akifumi; Kamide, Tomoya; Hayashi, Yutaka] Kanazawa Univ, Grad Sch Med Sci, Dept Neurosurg, Kanazawa, Ishikawa, Japan; [Hashida, Koji; Hieu Minh Ta; Inahata, Yuki; Takarada-Iemata, Mika; Hattori, Tsuyoshi; Kitao, Yasuko; Hori, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Neuroanat, Kanazawa, Ishikawa, Japan; [Hashida, Koji; Takarada-Iemata, Mika; Mori, Kazutoshi; Takahashi, Ryosuke; Kitao, Yasuko; Hori, Osamu] JST Japan Sci & Technol Agcy, CREST Core Res Evolutionary Sci & Technol, Tokyo, Japan; [Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan; [Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Matsuyama, Tomohiro] Hyogo Coll Med, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan	Hori, O (reprint author), Kanazawa Univ Grad Sch Med Sci, Dept Neuroanat, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	osamuh3@staff.kanazawa-u.ac.jp			Ministry of Education, Science, Technology, Sports and Culture of Japan [24500419]	We thank Mr Takashi Tamatani for technical assistance. We are also grateful to Dr Hideaki Hara (Gifu Pharmaceutical University) for valuable comments regarding MCAO. This work was supported by a Grant-in Aid for Scientific Research (24500419) from the Ministry of Education, Science, Technology, Sports and Culture of Japan. The authors have no conflicts of interest to declare.	Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Koumura A, 2009, BRAIN RES, V1292, P148, DOI 10.1016/j.brainres.2009.07.050; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Fukushima A, 2010, DIABETES, V59, P1906, DOI 10.2337/db09-1365; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Huang J, 2013, STROKE, V44, P190, DOI 10.1161/STROKEAHA.112.670299; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; Beamer CA, 2006, J NEUROSCI RES, V83, P1220, DOI 10.1002/jnr.20825; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Yeo S, 2013, GLIA, V61, P1488, DOI 10.1002/glia.22536; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Kitao Y, 2001, J CLIN INVEST, V108, P1439, DOI 10.1172/JCI12978; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Morimoto N, 2007, NEUROSCIENCE, V147, P957, DOI 10.1016/j.neuroscience.2007.04.017; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; FAURE R, 1993, GLIA, V9, P311, DOI 10.1002/glia.440090409; Hashida K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047950; HORI O, 1994, J NEUROCHEM, V62, P1489; Horvat A, 2001, J NEUROSCI, V21, P865; Kuwabara K, 1996, J BIOL CHEM, V271, P5025; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Muppirala M, 2013, BBA-MOL CELL RES, V1833, P1125, DOI 10.1016/j.bbamcr.2013.01.004; Navis AC, 2010, ACTA NEUROPATHOL, V119, P157, DOI 10.1007/s00401-009-0614-0; Servidei T, 1998, NEUROSCIENCE, V82, P529; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	36	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	FEB	2015	132	3					342	353		10.1111/jnc.12981		12	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CA2AU	WOS:000348712200008		
J	Kawai, T; Yoshimura, A; Oka, Y				Kawai, Takafumi; Yoshimura, Atsushi; Oka, Yoshitaka			Neurones in the Preoptic Area of the Male Goldfish are Activated by a Sex Pheromone 17 alpha,20 beta-Dihydroxy-4-Pregnen-3-One	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						sex pheromone; c-fos; goldfish; preoptic area; androgen	GONADOTROPIN-RELEASING-HORMONE; CARASSIUS-AURATUS; FEMALE GOLDFISH; OLFACTORY-BULB; SYNAPTIC-TRANSMISSION; KISSPEPTIN NEURONS; VOMERONASAL SYSTEM; SPAWNING BEHAVIOR; TERMINAL NERVE; BRAIN	Pheromones are interesting molecules given their ability to evoke changes in the endocrine state and behaviours of animals. In goldfish, a sex pheromone, 17,20-dihydroxy-4-pregnen-3-one (17,20-P), which is released by preovulatory females, is known to trigger the elevation of luteinising hormone (LH) levels, as well as reproductive behaviour in males. Interestingly, when 11-ketotestosterone (11-KT) is implanted into adult female fish, LH levels increase in response to the pheromone at any time of the day, which is normally a male-specific response. However, the neural mechanisms underlying the male-specific information processing of 17,20-P and its androgen dependence are yet unknown. In the present study, we focused on the preoptic area (POA), which plays important roles in the regulation of reproduction and reproductive behaviours. We mapped activity in the POA evoked by 17,20-P exposure using the immediate-early gene c-fos. We found that a population of ventral POA neurones close to kisspeptin2 (kiss2) neurones that appear to have important roles in reproduction was activated by 17,20-P exposure, suggesting that these activated neurones are important for the 17,20-P response. Next, we investigated the distribution of androgen receptor (ar) in the POA and its relationship with 17,20-P-responsive and kiss2 neurones. We found that ar is widely expressed in the ventral POA, whereas it is only expressed in approximately 10% of 17,20-P-activated neurones. On the other hand, it is expressed in almost 90% of the kiss2 neurones. Taken together, it is possible that ar expressing neurones in the ventral POA, most of which were not labelled by c-fos in the present study, may at least partly account for androgen effects on responses to primer pheromones; the ar-positive kiss2 neurones in the ventral POA may be a candidate. These results offer a novel insight into the mechanisms underlying male-specific information processing of 17,20-P in goldfish.	[Kawai, Takafumi; Yoshimura, Atsushi; Oka, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kawai, Takafumi] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan	Oka, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	okay@biol.s.u-tokyo.ac.jp	OKA, YOSHITAKA/G-4952-2014; Oka, Yoshitaka/C-9670-2010	OKA, YOSHITAKA/0000-0002-3482-3051; Oka, Yoshitaka/0000-0002-3482-3051	JSPS [22-8084, 20247005]; PRO-BRAIN of Japan	We thank Drs Park Min-Kyn, Hideki Abe and Shinji Kanda and Mr Buntaro Zempo for helpful advice and discussion, as well as Ms Miho Kyokuwa for animal care. We also thank Dr Shinji Kanda and Ms Kiyoko Kataoka for providing the RNA probes and Dr Heather Eisthen for critically reading the manuscript. This work was supported by a Grant-in-Aid from the JSPS (22-8084) to T.K., as well as funding from JSPS (20247005) and PRO-BRAIN of Japan to Y.O. The authors declare that there are no conflicts of interest.	Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; YU KL, 1990, NEUROENDOCRINOLOGY, V52, P276; DULKA JG, 1987, NATURE, V325, P251, DOI 10.1038/325251a0; Chung-Davidson YW, 2008, J NEUROSCI, V28, P14492, DOI 10.1523/JNEUROSCI.3589-08.2008; Kanda S, 2012, J NEUROENDOCRINOL, V24, P897, DOI 10.1111/j.1365-2826.2012.02296.x; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; SORENSEN PW, 1995, GEN COMP ENDOCR, V100, P128, DOI 10.1006/gcen.1995.1141; Swaney WT, 2009, BEHAV BRAIN RES, V200, P239, DOI 10.1016/j.bbr.2008.09.039; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; SORENSEN PW, 1994, ACTA PHYSIOL SCAND, V152, P191, DOI 10.1111/j.1748-1716.1994.tb09799.x; Stacey N, 2003, CAN J PHYSIOL PHARM, V81, P329, DOI 10.1139/Y03-024; PETER RE, 1975, J COMP NEUROL, V159, P69, DOI 10.1002/cne.901590106; Stacey N, 1996, HORM BEHAV, V30, P434, DOI 10.1006/hbeh.1996.0048; Popesku JT, 2008, MOL CELL ENDOCRINOL, V293, P43, DOI 10.1016/j.mce.2008.06.017; Kobayashi M, 2002, FISH PHYSIOL BIOCHEM, V26, P71, DOI 10.1023/A:1023375931734; Inoue N, 2011, P NATL ACAD SCI USA, V108, P17527, DOI 10.1073/pnas.1113035108; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; SORENSEN PW, 1988, BIOL REPROD, V39, P1039, DOI 10.1095/biolreprod39.5.1039; Oka Y, 2009, J NEUROENDOCRINOL, V21, P334, DOI 10.1111/j.1365-2826.2009.01850.x; Caraty A, 2010, J NEUROENDOCRINOL, V22, P710, DOI 10.1111/j.1365-2826.2010.02022.x; Chaudhuri A, 1997, NEUROREPORT, V8, pR5; DEFRAIPONT M, 1993, ANIM BEHAV, V46, P245, DOI 10.1006/anbe.1993.1186; DULKA JG, 1992, GEN COMP ENDOCR, V86, P496, DOI 10.1016/0016-6480(92)90074-T; Eisthen HL, 2006, CURR BIOL, V16, pR73, DOI 10.1016/j.cub.2006.01.038; Fraser EJ, 2002, J EXP ZOOL, V293, P511, DOI 10.1002/jez.10120; Hanson LR, 1998, ANN NY ACAD SCI, V855, P521, DOI 10.1111/j.1749-6632.1998.tb10619.x; Ishizaki M, 2001, NEUROSCI LETT, V299, P121, DOI 10.1016/S0304-3940(01)01492-6; Kawai T, 2013, J PHYSIOL-LONDON, V591, P5509, DOI 10.1113/jphysiol.2013.258343; Kawai T, 2010, J NEUROPHYSIOL, V104, P3540, DOI 10.1152/jn.00639.2010; Kawai T, 2012, J NEUROPHYSIOL, V107, P1313, DOI 10.1152/jn.00536.2011; Kawai T, 2009, BBA-GEN SUBJECTS, V1790, P1681, DOI 10.1016/j.bbagen.2009.09.009; Kawai T, 2009, ZOOL SCI, V26, P669, DOI 10.2108/zsj.26.669; Kobayashi M, 1997, GEN COMP ENDOCR, V108, P434, DOI 10.1006/gcen.1997.6993; KOBAYASHI M, 1986, GEN COMP ENDOCR, V63, P451, DOI 10.1016/0016-6480(86)90145-0; MURTHY CK, 1994, GEN COMP ENDOCR, V96, P427, DOI 10.1006/gcen.1994.1199; NAGAHAMA Y, 1983, GEN COMP ENDOCR, V51, P15, DOI 10.1016/0016-6480(83)90092-8; Poling KR, 2001, COMP BIOCHEM PHYS B, V129, P645, DOI 10.1016/S1096-4959(01)00361-X; SATOU M, 1984, PHYSIOL BEHAV, V33, P441, DOI 10.1016/0031-9384(84)90167-7; SORENSEN PW, 1989, HORM BEHAV, V23, P317, DOI 10.1016/0018-506X(89)90046-9; Sorensen PW, 2005, CHEM SENSES, V30, pI315, DOI 10.1093/chemse/bjh241; Sorensen PW, 1996, CHEM SENSES, V21, P245, DOI 10.1093/chemse/21.2.245; Sorensen PW, 2005, GEN COMP ENDOCR, V140, P164, DOI 10.1016/j.ygcen.2004.11.006; SORENSEN PW, 1991, BRAIN RES, V558, P343, DOI 10.1016/0006-8993(91)90790-3; STACEY NE, 1989, GEN COMP ENDOCR, V75, P62, DOI 10.1016/0016-6480(89)90008-7; WILSON EO, 1963, RECENT PROG HORM RES, V19, P673; Zheng WB, 1997, J EXP BIOL, V200, P2833; Zheng WB, 1997, GEN COMP ENDOCR, V105, P228, DOI 10.1006/gcen.1996.6825; Zippel HP, 2000, CHEM SENSES, V25, P339, DOI 10.1093/chemse/25.3.339	48	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	FEB	2015	27	2					123	130		10.1111/jne.12243		8	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	CA1ND	WOS:000348678300005		
J	Sato, D; Yamashiro, K; Onishi, H; Yasuhiro, B; Shimoyama, Y; Maruyama, A				Sato, Daisuke; Yamashiro, Koya; Onishi, Hideaki; Yasuhiro, Baba; Shimoyama, Yoshimitsu; Maruyama, Atsuo			Whole-hand water flow stimulation increases motor cortical excitability: a study of transcranial magnetic stimulation and movement-related cortical potentials	JOURNAL OF NEUROPHYSIOLOGY			English	Article						whole-hand water flow stimulation; primary motor cortex; corticospinal excitability; intracortical circuit; movement-related cortical potentials	SOMATOSENSORY-EVOKED POTENTIALS; POSITRON-EMISSION-TOMOGRAPHY; FRAIL ELDERLY-PEOPLE; DAY-SERVICE FACILITY; HIGH-RESOLUTION EEG; QUALITY-OF-LIFE; ELECTRICAL-STIMULATION; CORTEX EXCITABILITY; MUSCLE VIBRATION; CORTICOCORTICAL INHIBITION	Previous studies examining the influence of afferent stimulation on corticospinal excitability have demonstrated that the intensity of afferent stimulation and the nature of the afferents targeted (cutaneous/proprioceptive) determine the effects. In this study, we assessed the effects of whole-hand water immersion (WI) and water flow stimulation (WF) on corticospinal excitability and intracortical circuits by measuring motor evoked potential (MEP) recruitment curves and conditioned MEP amplitudes. We further investigated whether whole-hand WF modulated movement-related cortical activity. Ten healthy subjects participated in three experiments, comprising the immersion of participants' right hands with (whole-hand WF) or without (whole-hand WI) water flow, and no immersion (control). We evaluated MEP recruitment curves produced by a single transcranial magnetic stimulation (TMS) pulse at increasing stimulus intensities, short-interval intracortical inhibition (SICI), and intracortical facilitation (ICF) using the paired TMS technique before and after 15 min of intervention. Movement-related cortical potentials (MRCPs) were evaluated to examine primary motor cortex, supplementary motor area, and somatosensory cortex excitability upon movement before and after whole-hand WF. After whole-hand WF, the slope of the MEP recruitment curve significantly increased, whereas SICI decreased and ICF increased in the contralateral motor cortex. The amplitude of the Bereitschaftspotential, negative slope, and motor potential of MRCPs significantly increased after whole-hand WF. We demonstrated that whole-hand WF increased corticospinal excitability, decreased SICI, and increased ICF, although whole-hand WI did not change corticospinal excitability and intracortical circuits. Whole-hand WF modulated movement-related cortical activity, increasing motor cortex activation for the planning and execution of voluntary movements.	[Sato, Daisuke; Yamashiro, Koya; Onishi, Hideaki; Maruyama, Atsuo] Niigata Univ Hlth & Welfare, Inst Human Movement & Med Sci, Niigata 9503198, Japan; [Sato, Daisuke; Yamashiro, Koya; Yasuhiro, Baba; Shimoyama, Yoshimitsu; Maruyama, Atsuo] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata 9503198, Japan; [Onishi, Hideaki] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata 9503198, Japan	Sato, D (reprint author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Kita Ku, Shimami Cho 1398, Niigata 9503198, Japan.	daisuke@nuhw.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Niigata University of Health and Welfare	This study was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. It was also supported by a Grant-in-Aid for Advanced Research from the Niigata University of Health and Welfare.	Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873; Rosenkranz K, 2003, EXP BRAIN RES, V149, P9, DOI 10.1007/s00221-002-1330-3; HESS G, 1994, J NEUROPHYSIOL, V71, P2543; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; Radovanovic S, 2002, EXP BRAIN RES, V143, P276, DOI 10.1007/s00221-001-0994-4; KAKIGI R, 1994, J NEUROL SCI, V125, P198, DOI 10.1016/0022-510X(94)90036-1; Christova M, 2011, EUR J APPL PHYSIOL, V111, P3051, DOI 10.1007/s00421-011-1933-0; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Chen R, 1999, EXP BRAIN RES, V129, P77, DOI 10.1007/s002210050938; Moller C, 2009, CLIN NEUROPHYSIOL, V120, P1003, DOI 10.1016/j.clinph.2009.03.001; Rosenkranz K, 2003, J PHYSIOL-LONDON, V551, P649, DOI 10.1113/jphysiol.2003.043752; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501; RIDDING MC, 1995, J PHYSIOL-LONDON, V487, P541; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; Weiller C, 1996, NEUROIMAGE, V4, P105, DOI 10.1006/nimg.1996.0034; EVARTS EV, 1977, NEUROSCI LETT, V5, P267, DOI 10.1016/0304-3940(77)90077-5; Golaszewski SM, 2012, CLIN NEUROPHYSIOL, V123, P193, DOI 10.1016/j.clinph.2011.06.010; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Kossev A, 1999, MUSCLE NERVE, V22, P946, DOI 10.1002/(SICI)1097-4598(199907)22:7<946::AID-MUS22>3.0.CO;2-O; Chipchase LS, 2011, CLIN NEUROPHYSIOL, V122, P456, DOI 10.1016/j.clinph.2010.07.025; NESHIGE R, 1988, BRAIN, V111, P719; Naito E, 1999, J NEUROSCI, V19, P6134; Ziemann U, 1996, EXP BRAIN RES, V109, P127; DEUSCHL G, 1991, EXP BRAIN RES, V83, P403; Sato D, 2012, BRAIN TOPOGR, V25, P220, DOI 10.1007/s10548-011-0204-z; Cui RQ, 1999, NEUROIMAGE, V9, P124, DOI 10.1006/nimg.1998.0388; Urbano A, 1996, NEUROREPORT, V8, P203, DOI 10.1097/00001756-199612200-00041; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; Arezzo J, 1980, Prog Brain Res, V54, P77, DOI 10.1016/S0079-6123(08)61610-6; Bertolasi L, 1998, J PHYSIOL-LONDON, V511, P947, DOI 10.1111/j.1469-7793.1998.947bg.x; Christova M, 2013, HUM BRAIN MAPP, V34, P2767, DOI 10.1002/hbm.22102; CLAUS D, 1988, ELECTROEN CLIN NEURO, V69, P431, DOI 10.1016/0013-4694(88)90065-X; CLAUS D, 1988, EXP BRAIN RES, V71, P273; Fernandez-del-Olmo M, 2008, CLIN NEUROPHYSIOL, V119, P1834, DOI 10.1016/j.clinph.2008.04.002; Fothergill DM, 1998, UNDERSEA HYPERBAR M, V25, P1; Golaszewski SM, 2010, CLIN NEUROPHYSIOL, V121, P248, DOI 10.1016/j.clinph.2009.09.024; HAGBARTH KE, 1968, J NEUROL NEUROSUR PS, V31, P207, DOI 10.1136/jnnp.31.3.207; Hallett M, 1999, EEG CL N SU, V50, P85; HEATH CJ, 1976, J PHYSIOL-LONDON, V257, P199; Holler I, 2006, NEUROSCI LETT, V392, P221, DOI 10.1016/j.neulet.2005.09.018; HORE J, 1976, J NEUROPHYSIOL, V39, P484; IKEDA A, 1992, J CLIN NEUROPHYSIOL, V9, P509, DOI 10.1097/00004691-199210000-00005; Jones E G, 1980, Brain Res, V203, P1; KAAS JH, 1993, ANN ANAT, V175, P509; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; KRISTEVAFEIGE R, 1994, EUR J NEUROSCI, V6, P632, DOI 10.1111/j.1460-9568.1994.tb00308.x; DENOORDHOUT AM, 1992, J PHYSIOL-LONDON, V447, P535; MAERTENS M, 1992, J RHEUMATOL, V19, P1978; MARSDEN C D, 1969, Brain Behavior and Evolution, V92, P829, DOI 10.1093/brain/92.4.829; Mima T, 2004, NEUROSCI LETT, V355, P85, DOI 10.1016/j.neulet.2003.10.045; Misiaszek JE, 2001, CLIN NEUROPHYSIOL, V112, P324, DOI 10.1016/S1388-2457(00)00520-4; Murakami T, 2010, CLIN NEUROPHYSIOL, V121, P939, DOI 10.1016/j.clinph.2010.01.011; NEAFSEY EJ, 1978, ELECTROEN CLIN NEURO, V44, P706, DOI 10.1016/0013-4694(78)90205-5; Ridding MC, 2001, J PHYSIOL-LONDON, V537, P623, DOI 10.1111/j.1469-7793.2001.00623.x; Rocco MM, 2007, J NEUROSCI METH, V162, P139, DOI 10.1016/j.jneumeth.2007.01.002; Rossi S, 2000, CEREB CORTEX, V10, P802, DOI 10.1093/cercor/10.8.802; Rossini PM, 1996, MUSCLE NERVE, V19, P1302; Sato D, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-13; Sato D, 2013, CLIN NEUROPHYSIOL; Sato D, 2009, DISABIL REHABIL, V31, P84, DOI 10.1080/09638280701817552; Sato D, 2007, QUAL LIFE RES, V16, P1577, DOI 10.1007/s11136-007-9269-2; Schabrun SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051298; Shibasaki H, 1996, ADV NEUROL, V70, P117; Thompson AK, 2011, EXP BRAIN RES, V210, P143, DOI 10.1007/s00221-011-2607-1	69	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	FEB 1	2015	113	3					822	833		10.1152/jn.00161.2014		12	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CA9PD	WOS:000349256300015		
J	Kawaguchi, N; Sakamoto, K; Saito, N; Furusawa, Y; Tanji, J; Aoki, M; Mushiake, H				Kawaguchi, Norihiko; Sakamoto, Kazuhiro; Saito, Naohiro; Furusawa, Yoshito; Tanji, Jun; Aoki, Masashi; Mushiake, Hajime			Surprise signals in the supplementary eye field: rectified prediction errors drive exploration-exploitation transitions	JOURNAL OF NEUROPHYSIOLOGY			English	Article						exploration-exploitation transition; monkey; oculomotor search; supplementary eye field; surprise signal	ANTERIOR CINGULATE CORTEX; LATERAL PREFRONTAL CORTEX; MEDIAL FRONTAL-CORTEX; NEURONAL-ACTIVITY; REPETITION SUPPRESSION; EXECUTIVE CONTROL; DECISION-MAKING; MOTOR AREA; REWARD; PERFORMANCE	Visual search is coordinated adaptively by monitoring and predicting the environment. The supplementary eye field (SEF) plays a role in oculomotor control and outcome evaluation. However, it is not clear whether the SEF is involved in adjusting behavioral modes based on preceding feedback. We hypothesized that the SEF drives exploration-exploitation transitions by generating "surprise signals" or rectified prediction errors, which reflect differences between predicted and actual outcomes. To test this hypothesis, we introduced an oculomotor two-target search task in which monkeys were required to find two valid targets among four identical stimuli. After they detected the valid targets, they exploited their knowledge of target locations to obtain a reward by choosing the two valid targets alternately. Behavioral analysis revealed two distinct types of oculomotor search patterns: exploration and exploitation. We found that two types of SEF neurons represented the surprise signals. The error-surprise neurons showed enhanced activity when the monkey received the first error feedback after the target pair change, and this activity was followed by an exploratory oculomotor search pattern. The correct-surprise neurons showed enhanced activity when the monkey received the first correct feedback after an error trial, and this increased activity was followed by an exploitative, fixed-type search pattern. Our findings suggest that error-surprise neurons are involved in the transition from exploitation to exploration and that correct-surprise neurons are involved in the transition from exploration to exploitation.	[Kawaguchi, Norihiko; Saito, Naohiro; Furusawa, Yoshito; Tanji, Jun; Mushiake, Hajime] Tohoku Univ, Sch Med, Dept Physiol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kawaguchi, Norihiko; Aoki, Masashi] Tohoku Univ, Sch Med, Dept Neurol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Sakamoto, Kazuhiro] Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Mushiake, Hajime] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan	Mushiake, H (reprint author), Tohoku Univ, Sch Med, Dept Physiol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	hmushiak@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22500283, 26350991]; MEXT [4103, 22120504, 24120703, 4303, 26120703]; Japan Science and Technology Agency (Exploratory Research for Advanced Technology and Core Research for Evolutional Science and Technology); Japanese Ministry of Health, Labor and Welfare	This research was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (No. 22500283, No. 26350991); a Grant-in-Aid for Scientific Research on Innovative Areas "The study on the neural dynamics for understanding communication in terms of complex hetero systems (No. 4103)" (No. 22120504, No. 24120703) and "Elucidation of the neural computation for prediction and decision making (No. 4303)" (No. 26120703) of MEXT; the Japan Science and Technology Agency (Exploratory Research for Advanced Technology and Core Research for Evolutional Science and Technology); and Research Grants for Nervous and Mental Disorders and Measures Against Intractable Diseases from the Japanese Ministry of Health, Labor and Welfare.	Amiez C, 2012, NEUROIMAGE, V63, P1078, DOI 10.1016/j.neuroimage.2012.06.023; Berdyyeva TK, 2010, J NEUROPHYSIOL, V104, P141, DOI 10.1152/jn.00639.2009; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Wessel JR, 2012, J NEUROSCI, V32, P7528, DOI 10.1523/JNEUROSCI.6352-11.2012; Middlebrooks PG, 2012, NEURON, V75, P517, DOI 10.1016/j.neuron.2012.05.028; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Cohen JD, 2007, PHILOS T R SOC B, V362, P933, DOI 10.1098/rstb.2007.2098; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; KREBS JR, 1978, NATURE, V275, P27, DOI 10.1038/275027a0; Isoda M, 2003, J NEUROPHYSIOL, V90, P3054, DOI 10.1152/jn.00367.2003; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; GEMBA H, 1986, NEUROSCI LETT, V70, P223, DOI 10.1016/0304-3940(86)90467-2; Asaad WF, 2011, J NEUROSCI, V31, P17772, DOI 10.1523/JNEUROSCI.3793-11.2011; Lu XF, 2002, NEURON, V34, P317, DOI 10.1016/S0896-6273(02)00657-8; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Mushiake H, 2006, NEURON, V50, P631, DOI 10.1016/j.neuron.2006.03.045; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Britten KH, 1996, VISUAL NEUROSCI, V13, P87; Amador N, 2000, J NEUROPHYSIOL, V84, P2166; GITTINS JC, 1979, J ROY STAT SOC B MET, V41, P148; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037//0033-295X.87.6.532; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101; Todorovic A, 2012, J NEUROSCI, V32, P13389, DOI 10.1523/JNEUROSCI.2227-12.2012; Husain M, 2003, NAT NEUROSCI, V6, P117, DOI 10.1038/nn1005; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Stuphorn V, 2000, NATURE, V408, P857; Fujii N, 2002, J NEUROPHYSIOL, V87, P2158, DOI 10.1152/jn.00867.2001; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Mirpour K, 2012, P NATL ACAD SCI USA, V109, P10083, DOI 10.1073/pnas.1120763109; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Donahue CH, 2013, NEURON, V80, P223, DOI 10.1016/j.neuron.2013.07.040; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037//0033-295X.109.4.679; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; So NY, 2012, J NEUROSCI, V32, P2950, DOI 10.1523/JNEUROSCI.4419-11.2012; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; ARNSTEN AFT, 1984, BRAIN RES, V106, P9; Campos M, 2010, J NEUROPHYSIOL, V104, P2831, DOI 10.1152/jn.01124.2009; Emeric EE, 2008, J NEUROPHYSIOL, V99, P759, DOI 10.1152/jn.00896.2006; Heinen SJ, 1997, VISUAL NEUROSCI, V14, P853; HUERTA MF, 1990, J COMP NEUROL, V293, P299, DOI 10.1002/cne.902930211; Kamigaki T, 2012, J COGNITIVE NEUROSCI, V24, P2171; Konishi S, 2010, NEUROSCI LETT, V484, P182, DOI 10.1016/j.neulet.2010.08.047; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90; Moorman DE, 2007, J NEUROPHYSIOL, V97, P2159, DOI 10.1152/jn.00848.2006; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Schall JD, 2007, COGN AFFECT BEHAV NE, V7, P396, DOI 10.3758/CABN.7.4.396; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179; SHOOK BL, 1990, J COMP NEUROL, V301, P618, DOI 10.1002/cne.903010410; Stuphorn V, 2002, MUSCLE NERVE, V26, P326, DOI 10.1002/mus.10158; Sutton R., 1998, REINFORCEMENT LEARNI; Uchida Y, 2007, J NEUROSCI, V27, P13750, DOI 10.1523/JNEUROSCI.2693-07.2007; Wang Y, 2005, NEUROSCI RES, V53, P1, DOI 10.1016/j.neures.2005.05.005; Yang SN, 2014, J NEUROPHYSIOL, V111, P2644, DOI 10.1152/jn.00543.2013	80	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	FEB 1	2015	113	3					1001	1014		10.1152/jn.00128.2014		14	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CA9PD	WOS:000349256300030		
J	Nath, SKD				Nath, S. K. Deb			Formation, microstructure and mechanical properties of ternary ZrxCu90 - Al-x(10) metallic glasses	JOURNAL OF NON-CRYSTALLINE SOLIDS			English	Article						Metallic glasses; Glass forming ability; Stiffness of ternary ZrxCu90 _ Al-x(10) metallic glasses; Strength of ternary ZrxCu90 _ Al-x(10) metallic glasses	MOLECULAR-DYNAMICS SIMULATIONS; MEDIUM-RANGE ORDER; AMORPHOUS-ALLOYS; FORMING ABILITY; STRUCTURAL-PROPERTIES; TRANSITION; MODEL; BEHAVIOR; PACKING; CLUSTER	Using the same embedded atom method (EAM) potential for Zr-Cu-Al system, binary Zr35Cu65 and ternary ZrxCu90 _ Al-x(10) systems are simulated to form metallic glasses. Firstly to validate the present model, the total radial distribution function of formed solid Zr35Cu65 is compared with that of the published experimental results. The total radial distribution functions of Zr35Cu65 and Zr30Cu60Al10 are compared to understand the effect of the addition of Al on the total concentration sensitivity of their elements. Besides, the partial radial distribution functions of Zr-Zr, Cu-Cu and Zr-Cu as a function of the radial distance for the case of metallic glasses Zr35Cu65 and Zr30Cu60Al10 are studied to understand the effects of addition of Al on the concentration sensitivity in Zr30Cu60Al10. In the ternary system, Zr(20)Cu70Al10, Zr30Cu(60)Al(10), Zr40Cu50Al10, Zr50Cu40Al10, Zr60Cu30Al10, and Zr70Cu20Al10 are formed and found out which one shows the best metallic glass that has the best glass forming ability. The best glass forming ability of metallic glasses in ternary systems is obtained from the cluster density in the solid metallic glasses and rate of volume changes with temperature during cooling. To understand the effect of heating and cooling during the simulation of Zr(60)Cu(30)A(110), the total radial distribution function of Zr60Cu30Al10, the partial radial distribution functions of Zr-Zr, Cu-Cu, Al-Al, Zr-Cu, Cu-Al and Al-Al at different temperatures are studied as a comparative manner. Effects of concentration of Zr on the stiffness and strength of ternary metallic glasses, Zr20Cu70Al10, Zr30Cu60Al10, Zr40Cu50Al10, Zr50Cu40Al10, Zr30Cu60Al10, and Zr70Cu20Al10 under tension are studied. (C) 2014 Elsevier B.V. All rights reserved.	[Nath, S. K. Deb] Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Osaka 5608531, Japan; [Nath, S. K. Deb] Tohoku Univ, Inst Mat Res, Computat Mat Res Initiat, Sendai, Miyagi 9808577, Japan	Nath, SKD (reprint author), Kongju Natl Univ, Div Mech & Automot Engn, Gongju Si, Chungcheongnam, South Korea.	sankar_20005@yahoo.com					Almyras GA, 2010, SCRIPTA MATER, V62, P33, DOI 10.1016/j.scriptamat.2009.09.019; Antonowicz J, 2011, J ALLOY COMPD, V509, pS34, DOI 10.1016/j.jallcom.2010.10.105; Miracle DB, 2003, J NON-CRYST SOLIDS, V319, P174, DOI 10.1016/S0022-3093(02)01917-8; Miracle DB, 2006, ACTA MATER, V54, P4317, DOI 10.1016/j.actamat.2006.06.002; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; Egami T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024203; Saida J, 2001, APPL PHYS LETT, V79, P412, DOI 10.1063/1.1385802; Cheng YQ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.245501; Wang D, 2004, APPL PHYS LETT, V84, P4029, DOI 10.1063/1.1751219; Miracle DB, 2004, NAT MATER, V3, P697, DOI 10.1038/nmat1219; Ma D, 2009, NAT MATER, V8, P30, DOI [10.1038/nmat2340, 10.1038/NMAT2340]; CLERI F, 1993, PHYS REV B, V48, P22, DOI 10.1103/PhysRevB.48.22; JONSSON H, 1988, PHYS REV LETT, V60, P2295, DOI 10.1103/PhysRevLett.60.2295; Li Y, 2008, SCIENCE, V322, P1816, DOI 10.1126/science.1163062; Xu DH, 2004, ACTA MATER, V52, P2621, DOI 10.1016/j.actamat.2004.02.009; Inoue A, 2002, MATER TRANS, V43, P1892, DOI 10.2320/matertrans.43.1892; Wang CC, 2012, J ALLOY COMPD, V510, P107, DOI 10.1016/j.jallcom.2011.07.110; Cui YY, 2011, PHYS CHEM CHEM PHYS, V13, P4103, DOI 10.1039/c0cp01722a; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; Mattern N, 2008, J NON-CRYST SOLIDS, V354, P1054, DOI 10.1016/j.jnoncrysol.2007.08.035; DAW MS, 1984, PHYS REV B, V29, P6443, DOI 10.1103/PhysRevB.29.6443; Yu P, 2005, J NON-CRYST SOLIDS, V351, P1328, DOI 10.1016/j.jnoncrysol.2005.03.012; Duan G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.224208; Li Y, 2007, MRS BULL, V32, P624, DOI 10.1557/mrs2007.123; BUSCHOW KHJ, 1984, J PHYS F MET PHYS, V14, P593, DOI 10.1088/0305-4608/14/3/005; Chen H.S., 1979, PHYS STATUS SOLIDI, V51, P51; Cheng YQ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014207; Nath SKD, 2012, J APPL PHYS, V112, DOI 10.1063/1.4770356; DebNath S.K., 2014, ISRN CONDENS MATTER, V2014, P1; den Beukel A.V., 1990, ACTA METALL MATER, V38, P383; Gaskell PH, 2005, J NON-CRYST SOLIDS, V351, P1003, DOI 10.1016/j.jnoncrysol.2005.01.011; Haile J. M., 1992, MOL DYNAMICS SIMULAT; Ichitsubo T, 2005, MATER TRANS, V46, P2282, DOI 10.2320/matertrans.46.2282; Ishii A., 2008, MAT T, V40, P1975; Johnson W.L, 1999, MAT RES B, V24, P426; Kob W., 1999, PHYS CONDENS MATTER, V11, pR85; Li H.X., 2009, APPL PHYS LETT, V95; LI M, 1993, PHYS REV LETT, V70, P1120, DOI 10.1103/PhysRevLett.70.1120; Nath SKD, 2013, J NON-CRYST SOLIDS, V376, P50, DOI 10.1016/j.jnoncrysol.2013.04.057; Inoue A, 2007, MRS BULL, V32, P651, DOI 10.1557/mrs2007.128; Schenk T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.075507; Sha Z., 2009, J APPL PHYS, V105; Sha Z.D., 2010, APPL PHYS LETT, V96; Shao G, 2003, INTERMETALLICS, V11, P313, DOI 10.1016/S0966-9795(02)00248-0; Wang WH, 2005, J MATER RES, V20, P2307, DOI 10.1557/JMR.2005.0302; Wang X.D., 2008, J APPL PHYS, V104; Yano T, 2005, MATER TRANS, V46, P2886, DOI 10.2320/matertrans.46.2886	47	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3093	1873-4812		J NON-CRYST SOLIDS	J. Non-Cryst. Solids	FEB 1	2015	409						95	105		10.1016/j.jnoncrysol.2014.11.004		11	Materials Science, Ceramics; Materials Science, Multidisciplinary	Materials Science	CA4PU	WOS:000348888000014		
J	Shao, DD; Li, JX; Tan, XL; Yang, ZS; Okuno, K; Oya, Y				Shao, Dadong; Li, Jiaxing; Tan, Xiaoli; Yang, Zhongshi; Okuno, Kenji; Oya, Yasuhisa			XPS investigation of impurities containing boron films affected by energetic deuterium implantation and thermal desorption	JOURNAL OF NUCLEAR MATERIALS			English	Article							THIN-FILMS; CHEMICAL BEHAVIOR; 1ST WALL; RETENTION BEHAVIOR; HYDROGEN ISOTOPES; BORONIZATION; TOKAMAK; TRITIUM; LHD; JT-60U	Effect of impurities on existing states of boron, carbon and oxygen in boron films were investigated by XPS technique. Carbon mainly exists as B-C-B bond and B-C bond in 70% B boron films, and BAC bond and C-C bond in 50% B boron films. The existing state of oxygen depends on impurities composition in 70% B and 50% B boron films. D+ implantation and thermal desorption result in the reconstruction of boron films, which mainly includes the elimination of B2O3, increasing of B-O bond and decreasing of B-B bond. Implanted D+ into boron films can be trapped by carbon and oxygen, and remits as D2O and CDx in TDS process. Comparing to carbon, oxygen can be trapped easily by B-B bond and difficult to remit from boron films. (C) 2014 Elsevier B.V. All rights reserved.	[Shao, Dadong; Li, Jiaxing; Tan, Xiaoli; Yang, Zhongshi] Chinese Acad Sci, Inst Plasma Phys, Hefei 230031, Peoples R China; [Okuno, Kenji; Oya, Yasuhisa] Shizuoka Univ, Fac Sci, Radiosci Res Lab, Suruga Ku, Shizuoka 4228529, Japan	Shao, DD (reprint author), Chinese Acad Sci, Inst Plasma Phys, POB 1126, Hefei 230031, Peoples R China.	shaodadong@126.com; lijx@ipp.ac.cn; srkokun@ipc.shizuoka.ac.jp; syoya@ipc.shizuoka.ac.jp	li, jiaxing/H-9805-2012	li, jiaxing/0000-0002-7683-2482	National Magnetic Confinement Fusion Science Program [2013GB1100005, 2013GB110004, 2013GB105002]; NIFS collaboration program [NIFS07KOBA020, NIFS10KUHR008]; Science Foundation of Institute of Plasma Physics, Chinese Academy of Sciences [DSJJ-13-YY01]; Center of Instrumental Analysis at Shizuoka University	Financial support from National Magnetic Confinement Fusion Science Program (2013GB1100005, 2013GB110004, 2013GB105002), NIFS collaboration program (NIFS07KOBA020, NIFS10KUHR008), Science Foundation of Institute of Plasma Physics, Chinese Academy of Sciences (DSJJ-13-YY01), and Center of Instrumental Analysis at Shizuoka University.	Abadli S, 2009, THIN SOLID FILMS, V517, P1961, DOI 10.1016/j.tsf.2008.10.048; Ennaceur MM, 2000, J NUCL MATER, V280, P33, DOI 10.1016/S0022-3115(00)00037-4; Noda N, 1999, J NUCL MATER, V266, P234, DOI 10.1016/S0022-3115(98)00527-3; WINTER J, 1989, J NUCL MATER, V162, P713, DOI 10.1016/0022-3115(89)90352-8; Lyu SC, 2011, CARBON, V49, P1532, DOI 10.1016/j.carbon.2010.12.012; Buzhinskij OI, 1999, FUSION ENG DES, V45, P343, DOI 10.1016/S0920-3796(99)00007-1; Ronning C, 2002, SURF COAT TECH, V158, P382, DOI 10.1016/S0257-8972(02)00248-7; Ashikawa N, 2007, J NUCL MATER, V363, P1352, DOI 10.1016/j.jnucmat.2007.01.271; DYLLA HF, 1990, J NUCL MATER, V176, P337, DOI 10.1016/0022-3115(90)90069-Y; Jacobsohn LG, 2004, SURF SCI, V572, P418, DOI 10.1016/j.susc.2004.09.020; Kikuchi Y, 2009, J NUCL MATER, V386-88, P371, DOI 10.1016/j.jnucmat.2008.12.125; Kodama H, 2004, J NUCL MATER, V329, P889, DOI 10.1016/j.jnucmat.2004.04.277; Kodama H, 2003, J NUCL MATER, V313, P153, DOI 10.1016/S0022-3115(02)01404-6; Kulikovsky V, 2011, SURF COAT TECH, V205, P4052, DOI 10.1016/j.surfcoat.2011.02.052; Kumar A, 1998, FUSION ENG DES, V42, P329, DOI 10.1016/S0920-3796(98)00133-1; Miyauchi H, 2007, J NUCL MATER, V363, P925, DOI 10.1016/j.jnucmat.2007.01.116; Nakagawa S, 2004, J NUCL MATER, V329, P904, DOI 10.1016/j.jnucmat.2004.04.274; Nakano T, 2003, J NUCL MATER, V313, P149, DOI 10.1016/S0022-3115(02)01402-2; Okuno K, 2010, FUSION ENG DES, V85, P2328, DOI 10.1016/j.fusengdes.2010.09.021; Oya Y, 2004, J NUCL MATER, V329, P870, DOI 10.1016/j.jnucmat.2004.04.279; SCHNEIDER U, 1990, J NUCL MATER, V176, P350; Shang ZK, 2000, SURF COAT TECH, V131, P109; Song ZF, 2011, APPL RADIAT ISOTOPES, V69, P443, DOI 10.1016/j.apradiso.2010.09.017; Suzuki M, 2011, J NUCL MATER, V415, pS728, DOI 10.1016/j.jnucmat.2010.12.312; Suzuki S, 2009, J NUCL MATER, V390-91, P200, DOI 10.1016/j.jnucmat.2009.01.167; Traeger F, 2004, J PHYS CHEM B, V108, P14710, DOI 10.1021/jp049430s; Vortler K, 2010, J PHYS CHEM C, V114, P5382, DOI 10.1021/jp9054473; Wang MX, 2007, J NUCL MATER, V367, P1503, DOI 10.1016/j.jnucmat.2007.04.011; WINTER J, 1990, J NUCL MATER, V176, P14, DOI 10.1016/0022-3115(90)90025-I; Yang ZS, 2011, J NUCL MATER, V417, P520, DOI 10.1016/j.jnucmat.2010.12.110; Yoshikawa A, 2009, J NUCL MATER, V386-88, P367, DOI 10.1016/j.jnucmat.2008.12.126	31	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	FEB	2015	457						118	123		10.1016/j.jnucmat.2014.10.097		6	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CA8KO	WOS:000349169100015		
J	Miura, T; Fujii, K; Fukuya, K				Miura, Terumitsu; Fujii, Katsuhiko; Fukuya, Koji			Micro-mechanical investigation for effects of helium on grain boundary fracture of austenitic stainless steel	JOURNAL OF NUCLEAR MATERIALS			English	Article							HIGH-TEMPERATURE EMBRITTLEMENT; TENSILE PROPERTIES; PWR; STRENGTH; STRESS; MICRO	Effects of helium (He) on grain boundary (GB) fracture of austenitic stainless steel were investigated by micro-tensile tests. Micro-bicrystal tensile specimens were fabricated for non-coincidence site lattice boundaries of He ion-irradiated 316 stainless steel by focused ion beam (FIB) micro-processing. Micro-tensile tests were conducted in a vacuum at room temperature in the FIB system. Specimens containing more than 2 at.% He fractured at GBs. The criteria for brittle fracture occurrence on GBs were: (1) He concentrations higher than 2 at.%; (2) formation of He bubbles on the GBs with less than a 5 nm spacing; and (3) matrix hardening to more than 4.6 GPa (nano-indentation hardness). The fracture stress of GB brittle fracture was lower for a specimen with higher He concentration while the size and areal density of the GB He bubbles were the same. The specimens that contained 10 at.% He and had been annealed at 923 K after irradiation fractured at the GB nominally in a brittle manner; however the inter-bubble matrix at the GB experienced ductile fracture. The annealing caused He bubbles to grow but decreased the areal density so that the spacing of the GB He bubbles widened and the hardness decreased, therefore the fracture mode changed from brittle to ductile. The findings revealed that He promotes GB fracture by weakening the GB strength and hardening the matrix due to the formation of He bubbles both on GBs and in the matrix. In addition, the findings suggested that GB segregated He atoms may have a role in GB fracture. (C) 2014 Elsevier B.V. All rights reserved.	[Miura, Terumitsu; Fujii, Katsuhiko; Fukuya, Koji] Inst Nucl Safety Syst Inc, Mihama, Fukui 9191205, Japan	Miura, T (reprint author), Inst Nucl Safety Syst Inc, 64 Sata, Mihama, Fukui 9191205, Japan.	miura@inss.co.jp; fujiik@inss.co.jp; fukuya@inss.co.jp					Fukuya K, 2004, J NUCL SCI TECHNOL, V41, P673, DOI 10.3327/jnst.41.673; Fukuya K, 2013, J NUCL SCI TECHNOL, V50, P213, DOI 10.1080/00223131.2013.772448; Fukuya K, 2006, J NUCL SCI TECHNOL, V43, P159, DOI 10.3327/jnst.43.159; Edwards DJ, 2009, J NUCL MATER, V384, P249, DOI 10.1016/j.jnucmat.2008.11.025; Gibson J, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014056; Gianola DS, 2009, JOM-US, V61, P24, DOI 10.1007/s11837-009-0037-3; Yamaguchi M, 2004, J PHYS-CONDENS MAT, V16, P3933, DOI 10.1088/0953-8984/16/23/013; TRINKAUS H, 1994, J NUCL MATER, V212, P303, DOI 10.1016/0022-3115(94)90076-0; ULLMAIER H, 1985, J NUCL MATER, V133, P100, DOI 10.1016/0022-3115(85)90118-7; SHINNO H, 1981, J NUCL MATER, V97, P291, DOI 10.1016/0022-3115(81)90477-3; Bennetch J.I., 1981, J NUCL MATER, V103, P809; Fujii K, 2011, MATER TRANS, V52, P20, DOI 10.2320/matertrans.M2010320; Fujimoto K., 2005, 12 INT S ENV DEGR MA, P299; Fukuya K, 2008, J NUCL MATER, V378, P211, DOI 10.1016/j.jnucmat.2008.06.028; Gerke R.D., 1985, ASTM STP, P605; Hasegawa A., 2002, 10 INT C ENV DEGR MA; Hashishin T, 1997, J CERAM SOC JPN, V105, P1042, DOI 10.2109/jcersj.105.1042; Kuroda T, 2000, VACUUM, V59, P301, DOI 10.1016/S0042-207X(00)00283-9; MANSUR LK, 1988, J NUCL MATER, V155, P130, DOI 10.1016/0022-3115(88)90235-8; MATSUMOTO K, 1977, J NUCL MATER, V67, P97; Miura T, 2011, J NUCL MATER, V417, P984, DOI 10.1016/j.jnucmat.2010.12.197; Sharon J, 2014, MAT RES LETT, V2, P57; Shiraishi H, 1996, J NUCL MATER, V233, P985, DOI 10.1016/S0022-3115(96)00270-X; Taki E., 2007, J SOLID MECH MAT ENG, V1, P779, DOI 10.1299/jmmp.1.779; Ullmaier H, 2003, J NUCL MATER, V318, P228, DOI 10.1016/S0022-3115(03)00024-2; Wang CA, 1996, J NUCL MATER, V239, P85, DOI 10.1016/S0022-3115(96)00490-4; Was GS, 2012, CURR OPIN SOLID ST M, V16, P134, DOI 10.1016/j.cossms.2012.03.003; Ziegler J. F., 1985, STOPPING RANGE IONS	28	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	FEB	2015	457						279	290		10.1016/j.jnucmat.2014.11.062		12	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CA8KO	WOS:000349169100038		
J	Oishi, K; Yamamoto, S; Itoh, N; Nakao, R; Yasumoto, Y; Tanaka, K; Kikuchi, Y; Fukudome, S; Okita, K; Takano-Ishikawa, Y				Oishi, Katsutaka; Yamamoto, Saori; Itoh, Nanako; Nakao, Reiko; Yasumoto, Yuki; Tanaka, Keiko; Kikuchi, Yosuke; Fukudome, Shin-ichi; Okita, Kimiko; Takano-Ishikawa, Yuko			Wheat Alkylresorcinols Suppress High-Fat, High-Sucrose Diet-Induced Obesity and Glucose Intolerance by Increasing Insulin Sensitivity and Cholesterol Excretion in Male Mice	JOURNAL OF NUTRITION			English	Article						alkylresorcinol; metabolic disorder; obesity; glucose intolerance; insulin sensitivity; cholesterol absorption; microbiota; circadian rhythm	WIDE EXPRESSION ANALYSIS; WHOLE-GRAIN INTAKE; GUT MICROBIOTA; CEREAL ALKYLRESORCINOLS; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; MOUSE-LIVER; FOOD-INTAKE; ALL-CAUSE; IN-VITRO	Background: Epidemiologic studies have shown that the consumption of whole grains can reduce the risk of type 2 diabetes mellitus, cardiovascular disease, and all-cause, mortality. However, the underlying mechanisms remain a matter of debate. Objective: We aimed to determine the effects of wheat bran derived alkylresorcinols on diet-induced metabolic disorders in mice. Methods: We fed C57BL/6J mice a normal refined diet or a high-fat, high-sucrose diet [29.1% fat, 20.7% protein, 34.0% carbohydrates containing 20.0% sucrose (w/w)] alone (FS) or containing 0.4% (wt:wt) alkylresorcinols (FS-AR) for 10 wk. Results: The alkylresorcinols suppressed FS-induced increases in body weight by 31.0% as well as FS-induced hepatic triglyceride accumulation (means +/- SEMs: 29.6 +/- 3.18 and 19.8 +/- 2.42 mg/g tissue in the FS and FS-AR groups, respectively), without affecting energy intake. We measured circadian changes in blood metabolic hormones and found that FS-induced hyperinsulinemia 15.1 and 2.1 mu g/L at night in the FS and FS-AR groups, respectively) and hyperleptinemia (21.6 and 10.8 mu g/L at night in the FS and FS-AR groups, respectively) were suppressed by alkylresorcinols. Glucose and insulin tolerance tests showed that alkylresorcinols significantly reduced fasting blood glucose concentrations (190 +/- 3.62 and 160 +/- 8.98 mg/dL in the FS and FS-AR groups, respectively) and suppressed glucose intolerance as well as insulin resistance induced by the FS diet. Furthermore, alkylresorcinols significantly increased insulin-stimulated hepatic serinefthreonine protein kinase B phosphorylation compared to the FS diet (+81.3% and +57.4% for Ser473 and Thr308, respectively). On the other hand, pyruvate and starch tolerance tests suggested that alkylresorcinols did not affect gluconeogenesis and carbohydrate digestion, respectively. Alkylresorcinols significantly increased fecal cholesterol excretion by 39.6% and reduced blood cholesterol concentrations by 30.4%, while upregulating the expression of hepatic cholesterol synthetic genes such as sterol regulatory element binding protein 2 (Srebf2) and 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (Hmgcs1). Conclusions: These findings suggest that wheat alkylresorcinols increase glucose tolerance and insulin sensitivity by suppressing hepatic lipid accumulation and intestinal cholesterol absorption, which subsequently suppresses diet-induced obesity in mice.	[Oishi, Katsutaka; Yamamoto, Saori; Itoh, Nanako; Nakao, Reiko; Yasumoto, Yuki] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Tsukuba, Ibaraki, Japan; [Oishi, Katsutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba, Japan; [Oishi, Katsutaka; Yasumoto, Yuki] Tokyo Univ Sci, Grad Sch Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Tanaka, Keiko; Kikuchi, Yosuke; Fukudome, Shin-ichi] Nisshin Seifun Grp Inc, Res Ctr Basic Sci Res & Dev, Qual Assurance Div, Fujimino, Saitama, Japan; [Okita, Kimiko] Oriental Yeast Co Ltd, Yeast Funct Dev Unit, Itabashi Ku, Tokyo, Japan; [Takano-Ishikawa, Yuko] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan	Oishi, K (reprint author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Tsukuba, Ibaraki, Japan.	k-ooishi@aist.go.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25350179]	Supported in part by Grant-in-Aid for Scientific Research KAKENHI (25350179 to K Oishi) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan.	Andersson U, 2011, MOL NUTR FOOD RES, V55, pS290, DOI 10.1002/mnfr.201100231; Ross AB, 2004, J NUTR, V134, P506; Zeyda M, 2009, GERONTOLOGY, V55, P379, DOI 10.1159/000212758; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Etxeberria U, 2013, J AGR FOOD CHEM, V61, P9517, DOI 10.1021/jf402506c; Bray GA, 2000, P NUTR SOC, V59, P373, DOI 10.1017/S0029665100000422; Rosen LAH, 2011, J AGR FOOD CHEM, V59, P12149, DOI 10.1021/jf2019837; Lee DE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1210, DOI 10.1152/ajpendo.00015.2009; Ross AB, 2004, NUTR REV, V62, P81, DOI 10.1301/nr.2004.mar.81-95; He MA, 2010, CIRCULATION, V121, P2162, DOI 10.1161/CIRCULATIONAHA.109.907360; Kamal-Eldin A, 2001, J SCI FOOD AGR, V81, P353, DOI 10.1002/1097-0010(200102)81:3<353::AID-JSFA826>3.0.CO;2-X; Fung TT, 2002, AM J CLIN NUTR, V76, P535; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Ross AB, 2012, AM J CLIN NUTR, V95, P204, DOI 10.3945/ajcn.110.008508; WOLEVER TMS, 1991, AM J CLIN NUTR, V54, P846; Qiao Y, 2014, FOOD FUNCT, V5, P1241, DOI 10.1039/c3fo60630a; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Bartlomiej S, 2012, FOOD SCI TECHNOL INT, V18, P559, DOI 10.1177/1082013211433079; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Langkamp-Henken B, 2012, J NUTR, V142, P2025, DOI 10.3945/jn.112.164996; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; Cox LM, 2013, CELL METAB, V17, P883, DOI 10.1016/j.cmet.2013.05.004; Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325; Costabile A, 2008, BRIT J NUTR, V99, P110, DOI 10.1017/S0007114507793923; Ross AB, 2003, J NUTR, V133, P2222; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; FOLCH J, 1957, J BIOL CHEM, V226, P497; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Jacobs DR, 2000, J AM COLL NUTR, V19, p326S; Kovatcheva-Datchary P, 2013, BEST PRACT RES CL GA, V27, P59, DOI 10.1016/j.bpg.2013.03.017; Landberg R, 2006, J NUTR, V136, P2760; McKeown NM, 2013, J NUTR, V143, p744S; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Rejman J, 1997, CELL MOL BIOL LETT, V2, P411; Rejman J, 2004, J AGR FOOD CHEM, V52, P246, DOI 10.1021/jf034745a; Ross AB, 2003, BRIT J NUTR, V90, P787, DOI 10.1079/BJN2003965; Ross A.B., 2012, J NUTR METAB, V2012; Ross AB, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/585876; Ross AB, 2009, BRIT J NUTR, V102, P1547, DOI 10.1017/S0007114509990845; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228; Tu J, 2013, PHARMACOGN MAG, V9, P309, DOI 10.4103/0973-1296.117826	47	1	2	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3166	1541-6100		J NUTR	J. Nutr.	FEB	2015	145	2					199	206		10.3945/jn.114.202754		8	Nutrition & Dietetics	Nutrition & Dietetics	CA6WT	WOS:000349057200003		
J	Yamagami, W; Aoki, D				Yamagami, Wataru; Aoki, Daisuke			Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						annual report; cervical cancer; endometrial cancer; ovarian cancer; gynecologic cancer; Japan		The Japan Society of Obstetrics and Gynecology collects and analyzes annual data on gynecologic cancers from member institutions. Here we present the Patient Annual Report for 2012 and the Treatment Annual Report for 2006. Data on 7028 patients with cervical cancer, 8217 with endometrial cancer, 5140 with ovarian cancer and 1725 with ovarian borderline tumor for whom treatment was initiated in 2012 were summarized in the Patient Annual Report. Data on the prognosis of 2699 patients with cervical cancer, 3243 with endometrial cancer and 1898 with ovarian cancer for whom treatment was initiated in 2006 were analyzed in the Treatment Annual Report. In the Patient Annual Report for 2012, stage I accounted for 55.4%, stage II for 23.0%, stage III for 11.0% and stage IV for 10.6% of all patients with cervical cancer. Stage I accounted for 72.2%, stage II for 7.0%, stage III for 13.4% and stage IV for 7.3% of all patients with endometrial cancer. Stage I accounted for 43.1%, stage II for 9.2%, stage III for 29.7% and stage IV for 7.2% of all patients with ovarian cancer. In the Treatment Annual Report for 2006, the 5-year overall survival rates for patients with cervical cancer were 92.9% for stage I, 74.6% for stage II, 55.3% for stage III and 24.3% for stage IV. The equivalent rates for patients with endometrial cancer were 96.3%, 92.7%, 80.6% and 35.8%, respectively; and those for patients with ovarian surface epithelial-stromal tumors were 90.6%, 82.9%, 48.7% and 40.9%, respectively.	[Yamagami, Wataru; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1608582, Japan	Aoki, D (reprint author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	aoki@z7.keio.jp					Aoki D, 2014, J OBSTET GYNAECOL RE, V40, P338, DOI 10.1111/jog.12360; Aoki D, 2014, ACTA OBSTET GYNAECOL, V66, P1039; Aoki Daisuke, 2014, ACTA OBSTET GYNAECOL, V66, P995	3	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	FEB	2015	41	2					167	177		10.1111/jog.12596		11	Obstetrics & Gynecology	Obstetrics & Gynecology	CA1KW	WOS:000348672400001		
J	Tokuhisa, T; Ibara, S; Minakami, H; Maede, Y; Ishihara, C; Matsui, T				Tokuhisa, Takuya; Ibara, Satoshi; Minakami, Hisanori; Maede, Yoshinobu; Ishihara, Chie; Matsui, Takako			Outcome of infants with hypoxic ischemic encephalopathy treated with brain hypothermia	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						brain hypothermia; cerebral palsy; neonatal encephalopathy; hypoxemia; hypoxic ischemic encephalopathy	WHOLE-BODY HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; CEREBRAL-PALSY; TERM INFANTS; THERAPEUTIC HYPOTHERMIA; SYSTEMIC HYPOTHERMIA; PROGNOSTIC VALUE; METABOLISM; ARREST; LABOR	AimThe aim of this study was to determine perinatal factors associated with cerebral palsy (CP) in infants treated with brain hypothermia (BHT). Material and MethodsWe carried out a retrospective review of 23 infants with hypoxic ischemic encephalopathy in whom BHT was applied within 6h after birth. Outcome regarding the presence or absence of CP was assessed at the age of 18 months. Oxygen extraction fraction (OEF) was measured before, during and after BHT at the jugular sinus. ResultsThree infants died and 12 developed CP (poor outcome group). The remaining eight infants did not have CP at 18 months old (favorable outcome group). There were no differences in gestational age, birthweight, pH, base deficit, or lactate level between infants with favorable and poor outcomes. Infants with flat trace on electroencephalography on admission were less likely to have favorable outcome (0.0% [0/8] vs 53% [8/15], respectively, P=0.02), while those with Apgar score at 10min 5 (57% [8/14] vs 0.0% [0/9], P=0.007) or 6 (70% [7/10] vs 7.7% [1/13], P=0.002), OEF13.3% during BHT (64% [7/11] vs 8.3% [1/12], P=0.009), and OEF18.5% after BHT (73% [8/11] vs 0.0% [0/12], P=0.002) were more likely to have favorable outcome compared with those with counterpart characteristics. ConclusionInfants with an Apgar score at 10min 5, activity on electroencephalography on admission, and higher OEF during and after BHT were likely to have a favorable outcome.	[Tokuhisa, Takuya; Ibara, Satoshi; Maede, Yoshinobu; Ishihara, Chie; Matsui, Takako] Kagoshima City Hosp, Perinatal Med Ctr, Dept Neonatol, Kagoshima, Japan; [Minakami, Hisanori] Hokkaido Univ, Dept Obstet, Grad Sch Med, Sapporo, Hokkaido, Japan	Tokuhisa, T (reprint author), Kagoshima City Hosp, Perinatal Med Ctr, Dept Neonatol, 20-17 Kajiya Chou, Kagoshima, Japan.	tokutaku0305@nifty.com					Yamada T, 2012, EARLY HUM DEV, V88, P861, DOI 10.1016/j.earlhumdev.2012.06.008; Spitzmiller RE, 2007, J CHILD NEUROL, V22, P1069, DOI 10.1177/088307307306258; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 2008, J PEDIATR-US, V152, P55, DOI 10.1016/j.jpeds.2007.06.003; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Hallberg B, 2010, ACTA PAEDIATR, V99, P531, DOI 10.1111/j.1651-2227.2009.01653.x; Thoresen M, 2010, PEDIATRICS, V126, pE131, DOI 10.1542/peds.2009-2938; Laptook AR, 2009, PEDIATRICS, V124, P1619, DOI 10.1542/peds.2009-0934; HALLENBECK JM, 1990, ARCH NEUROL-CHICAGO, V47, P1245; Badawi N, 1998, BRIT MED J, V317, P1554; WATANABE K, 1980, ELECTROEN CLIN NEURO, V49, P618, DOI 10.1016/0013-4694(80)90402-2; Shankaran S, 2002, PEDIATRICS, V110, P377, DOI 10.1542/peds.110.2.377; Shankaran S, 2008, PEDIATRICS, V122, pE791, DOI 10.1542/peds.2008-0456; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Takenouchi T, 2012, BRAIN DEV-JPN, V34, P165, DOI 10.1016/j.braindev.2011.06.009; Hoffman WE, 1996, NEUROL RES, V18, P185; KARIBE H, 1995, J NEUROSURG, V83, P93, DOI 10.3171/jns.1995.83.1.0093; Kato T, 2014, BRAIN DEV, V35, P372; Minima T, 1973, J NEUROSURG, V39, P442; Nakamura T, 2008, ACT NEUR S, V102, P203, DOI 10.1007/978-3-211-85578-2_40; NOVITZKY D, 1988, TRANSPLANTATION, V45, P32; Parer JT, 2000, AM J OBSTET GYNECOL, V182, P982, DOI 10.1016/S0002-9378(00)70358-9; Phelan JP, 2000, SEMIN PERINATOL, V24, P221, DOI 10.1053/sper.2000.7079; STANLEY FJ, 1994, ACTA OBSTET GYN SCAN, V73, P5, DOI 10.3109/00016349409013384; TAKASU A, 1995, RESUSCITATION, V29, P189, DOI 10.1016/0300-9572(94)00853-8; Thoresen M, 2010, SEMIN FETAL NEONAT M, V15, P247, DOI 10.1016/j.siny.2010.05.008; Yamada T, 2013, J OBSTET GYNAECOL RE, V39, P1159, DOI 10.1111/jog.12036; Yoneda S, 2005, J OBSTET GYNAECOL RE, V31, P57, DOI 10.1111/j.1447-0756.2005.00241.x	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	FEB	2015	41	2					229	237		10.1111/jog.12520		9	Obstetrics & Gynecology	Obstetrics & Gynecology	CA1KW	WOS:000348672400009		
J	Jimbo, T; Fujita, Y; Yumoto, Y; Fukushima, K; Kato, K				Jimbo, Tomoka; Fujita, Yasuyuki; Yumoto, Yasuo; Fukushima, Kotaro; Kato, Kiyoko			Rare fetal complications associated with placental mesenchymal dysplasia: A report of two cases	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						fetal complication; mesenchymal hamartoma; molar pregnancy; placental mesenchymal dysplasia; neonatal disseminated intravascular coagulation	OF-THE-LITERATURE; HAMARTOMA; DEMISE; TUMOR; LIVER	Placental mesenchymal dysplasia (PMD) is a rare disease that may be difficult to distinguish from molar pregnancy. The disease is associated with major fetal complications, including Beckwith-Wiedemann syndrome, fetal growth restriction and intrauterine fetal death. Rarely, fetal hematological disorders and liver tumors also may occur. Two patients were referred to our hospital during their second trimesters because of suspected molar pregnancies. Fetal karyotyping and maternal serum human chorionic gonadotropin level determinations led to the PMD diagnoses. In one case, the maternal clinical course was normal, but the neonate suffered from disseminated intravascular coagulation and needed a platelet transfusion. In the second case, the PMD decreased during pregnancy, but a gradually increasing fetal liver tumor appeared. The tumor was diagnosed as mesenchymal hamartoma, based on ultrasound and magnetic resonance imaging studies. The neonate was delivered without cardiovascular compromise. Due to the difficulty of immediate surgical treatment, expectant management, with close follow-up, was chosen.	[Jimbo, Tomoka; Fujita, Yasuyuki; Yumoto, Yasuo; Fukushima, Kotaro; Kato, Kiyoko] Kyushu Univ Hosp, Dept Obstet & Gynecol, Fukuoka 8128582, Japan	Fujita, Y (reprint author), Kyushu Univ Hosp, Dept Obstet & Gynecol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yfujita@med.kyushu-u.ac.jp					Cohen MC, 2005, PRENATAL DIAG, V25, P187, DOI 10.1002/pd.1103; Kitano Y, 2000, FETAL DIAGN THER, V15, P134, DOI 10.1159/000020992; Nayeri UA, 2013, ULTRASOUND OBST GYN, V41, P366, DOI 10.1002/uog.12359; Laberge JM, 2005, FETAL DIAGN THER, V20, P141, DOI 10.1159/000082439; SANDER CM, 1993, PEDIATR PATHOL, V13, P621; Tortoledo M, 2010, FETAL PEDIATR PATHOL, V29, P261, DOI 10.3109/15513811003782474; Pham T, 2006, AM J CLIN PATHOL, V126, P67, DOI 10.1309/RV45HRD53YQ2YFTP; Cornette J, 2009, FETAL DIAGN THER, V25, P196, DOI 10.1159/000212057; Kamata S, 2003, J PEDIATR SURG, V38, P639, DOI 10.1053/jpsu.2003.50142; Tovbin J, 1997, ULTRASOUND OBST GYN, V10, P63, DOI 10.1046/j.1469-0705.1997.10010063.x	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	FEB	2015	41	2					304	308		10.1111/jog.12518		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CA1KW	WOS:000348672400019		
J	Yamamoto, N; Koga, K; Akahane, M; Wada-Hiraike, O; Fujii, T; Osuga, Y				Yamamoto, Naoko; Koga, Kaori; Akahane, Masaaki; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Osuga, Yutaka			Temporary balloon occlusion of the uterine arteries to control hemorrhage during hysterectomy in a case of uterine arteriovenous fistula	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						balloon occlusion; Elastica van Gieson stain; histology; hysterectomy; uterine arteriovenous fistula	INTERNAL ILIAC ARTERIES; PLACENTA-ACCRETA; CERVICAL MYOMA; MANAGEMENT; EMBOLIZATION	Arteriovenous fistula is any abnormal connection between an artery and a vein that bypasses the normal capillary bed and shunts arterial blood directly to the venous circulation. Uterine arteriovenous fistula (UAVF) is a potentially life-threatening condition by causing massive bleeding. This report describes a case of UAVF with massive hemorrhage. Prior to surgery, endovascular catheters for balloon occlusion were placed within bilateral uterine arteries. During surgery, the surgeon requested temporary balloon inflation for navigating and identifying inflow arteries. The balloon was kept inflated during the ligation of the vessels. Once ligation was completed, the balloon was deflated to confirm hemostasis. A total hysterectomy with removal of the UAVF was successfully achieved without significant blood loss. The fistula, in the resected specimen, was confirmed histologically with Elastica van Gieson staining. The preoperative placement of endovascular balloon-occlusion catheters should be considered when hysterectomy is planned where UAVF is located at the cardinal ligament.	[Yamamoto, Naoko; Koga, Kaori; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Osuga, Yutaka] Univ Tokyo, Dept Obstet & Gynecol, Sch Med, Tokyo 1138655, Japan; [Akahane, Masaaki] Univ Tokyo, Dept Radiol, Tokyo 1138655, Japan	Koga, K (reprint author), Univ Tokyo, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kawotan-tky@umin.ac.jp					Ghai S, 2003, J VASC INTERV RADIOL, V14, P1401, DOI 10.1097/01.RVI.0000096761.74047.7D; Sadashivaiah J, 2011, INT J OBSTET ANESTH, V20, P282, DOI 10.1016/j.ijoa.2011.06.006; Weeks SM, 2000, J VASC INTERV RADIOL, V11, P622, DOI 10.1016/S1051-0443(07)61615-7; Yang JJ, 2005, INT J GYNECOL OBSTET, V89, P114, DOI 10.1016/j.ijgo.2004.11.037; Tan CH, 2007, AM J ROENTGENOL, V189, P1158, DOI 10.2214/AJR.07.2417; Kidney DD, 2001, AM J ROENTGENOL, V176, P1521; Hasegawa A, 2012, J MINIM INVAS GYN, V19, P780, DOI 10.1016/j.jmig.2012.07.004; Hoffman M K, 1997, Obstet Gynecol Surv, V52, P736, DOI 10.1097/00006254-199712000-00004; Hudon L, 1998, Obstet Gynecol Surv, V53, P509, DOI 10.1097/00006254-199808000-00024; Moulder Janelle K, 2013, Case Rep Oncol, V6, P303, DOI 10.1159/000351609; Salazar Gloria M M, 2009, Tech Vasc Interv Radiol, V12, P139, DOI 10.1053/j.tvir.2009.08.007; Sexton Jennifer A, 2011, Adv Surg, V45, P83; Soeda S, 2012, TOHOKU J EXP MED, V228, P181, DOI 10.1620/tjem.228.181; Takeda A, 2011, EUR J OBSTET GYN R B, V158, P319, DOI 10.1016/j.ejogrb.2011.05.015	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	FEB	2015	41	2					314	318		10.1111/jog.12515		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CA1KW	WOS:000348672400021		
J	Mori, M; Furusawa, A; Kino, N; Uno, M; Ozaki, Y; Yasugi, T				Mori, Mayuyo; Furusawa, Akiko; Kino, Nao; Uno, Masaya; Ozaki, Yoshikazu; Yasugi, Toshiharu			Rare case of endometrioid adenocarcinoma arising from cystic adenomyosis	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						cystic adenomyosis; endometrioid adenocarcinoma; magnetic resonance imaging; malignant transformation	OVARIAN-CANCER; PELVIS	Few reports on malignant transformation of adenomyosis are available, and endometrioid adenocarcinoma arising from cystic adenomyosis is further rarely reported. We report a case of a 67-year-old asymptomatic woman who was referred to our hospital for evaluation of a cystic lesion in the pelvis, which had been diagnosed as cystic degeneration of leiomyoma for 3 years. Magnetic resonance imaging revealed a cystic mass measuring 11cm in diameter, which was contiguous with uterine myometrium. The lesion contained solid areas enhanced on gadolinium-enhanced T-1-weighted imaging. Transabdominal simple total hysterectomy with bilateral salpingo-oophorectomy was performed. Pathological examination revealed endometrioid adenocarcinoma arising from cystic adenomyosis. The patient underwent six courses of adjuvant combination chemotherapy with paclitaxel and carboplatin. No metastasis or recurrence has been demonstrated for 16 months following surgery. Our case demonstrates that cystic adenomyoma possesses the risk of malignant transformation, indicating the importance of long-term follow-up with imaging examination.	[Mori, Mayuyo; Furusawa, Akiko; Kino, Nao; Uno, Masaya; Ozaki, Yoshikazu; Yasugi, Toshiharu] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Gynecol, Tokyo 1138677, Japan	Mori, M (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Gynecol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138677, Japan.	mayumori-tky@umin.ac.jp					Moyle PL, 2010, RADIOGRAPHICS, V30, P921, DOI 10.1148/rg.304095706; Kunz G, 2005, HUM REPROD, V20, P2309, DOI 10.1093/humrep/dei021; Verit FF, 2013, ASIAN PAC J CANCER P, V14, P5589, DOI 10.7314/APJCP.2013.14.10.5589; Levy G, 2013, J RADIOL DIAGN INTER, V94, P3; Campo S, 2012, REPROD BIOMED ONLINE, V24, P35, DOI 10.1016/j.rbmo.2011.10.003; Van Gorp T, 2004, BEST PRACT RES CL OB, V18, P349, DOI 10.1016/j.bpobgyn.2003.03.001; Aris A, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-2; Heo SH, 2011, BRIT J RADIOL, V84, pE210, DOI 10.1259/bjr/24318075; Irvin W, 1998, GYNECOL ONCOL, V71, P313, DOI 10.1006/gyno.1998.5142; Kobayashi H, 2009, INT J CLIN ONCOL, V14, P378, DOI 10.1007/s10147-009-0931-2; Koike N, 2013, ONCOL REP, V29, P861, DOI 10.3892/or.2012.2184; Koshiyama M, 2002, INT J GYNECOL PATHOL, V21, P239, DOI 10.1097/00004347-200207000-00006; Kumar S, 2011, AM J OBSTET GYNECOL, V204, p63e1; Ohta Y, 2008, PATHOL RES PRACT, V204, P677, DOI 10.1016/j.prp.2008.02.005	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	FEB	2015	41	2					324	328		10.1111/jog.12513		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CA1KW	WOS:000348672400023		
J	Tanaka, T; Yasuda, I; Onishi, H; Ueno, H; Masujima, M				Tanaka, T.; Yasuda, I.; Onishi, H.; Ueno, H.; Masujima, M.			Observations of current and mixing around the shelf break in Pribilof Canyon in the Bering Sea	JOURNAL OF OCEANOGRAPHY			English	Article						Vertical turbulent mixing; Microstructure observation; Tidal current; Pribilof Canyon	NEW-ENGLAND SHELF; INTERNAL WAVES; BUSSOL STRAIT; WATER MASSES; CHUKCHI SEAS; MIXED-LAYER; GREEN BELT; OCEAN; DISSIPATION; VARIABILITY	Tide-induced vertical mixing along the shelf break in the eastern Bering Sea is considered one of the main physical processes that sustain local summertime high biological production. However, observations based on microstructure measurements that show enhanced tidal mixing are scarce. In this study, repeated casts of current and turbulence in the vicinity of the shelf break within Pribilof Canyon were conducted over a day in June 2012, enabling us to evaluate the representativeness of the vertical mixing intensity during one day and to detect the relationship between turbulence and tidal current. The cross-sectional distributions of the one-day averaged vertical diffusivity and the turbulent energy dissipation rate showed that strong vertical mixing occurred at the subsurface within about 15 km of the shelf break and near the seabed of the outer shelf. This result agrees with prior observations that were made by us and based on a single profile at each station, which indicated that the observed spatial pattern of turbulence is robust. Diurnal and semidiurnal tidal currents dominated the flow variations off the shelf break, and a statistically significant positive correlation was detected between the vertical shear of the horizontal tidal currents and the turbulent energy dissipation rate. This result suggests that the high turbulent energy dissipation and the enhanced vertical mixing off the shelf break were induced by the strong vertical shear of tidal currents.	[Tanaka, T.; Yasuda, I.] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Onishi, H.; Ueno, H.] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Masujima, M.] Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Yokohama, Kanagawa 2368648, Japan	Tanaka, T (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	tanaka-t@aori.u-tokyo.ac.jp			JSPS (KAKENHI) [20221002, 25257206, 25121503]	This paper forms a part of Ph.D. thesis (Tanaka 2014; Graduate School of Science, The University of Tokyo). We appreciate helpful comments from Profs. T. Hibiya, Y. Masumoto, K. Iga, M. Uematsu, and Y. Tanaka, and two anonymous reviewers. We are grateful to Prof. K. Kuma for kindly providing data on iron concentration. We are also grateful to the officers and crew of the T/S Oshoro-maru and to all of the scientists onboard it for their assistance in conducting observations and their thoughtful arrangement of the field observations. This work was supported by a JSPS Research Fellowship and Grant-in-Aid for Scientific Research (KAKENHI, 20221002/25257206/25121503). We thank Dr. R. Saito for his help obtaining AVISO data.	Aguilar-Islas AM, 2007, PROG OCEANOGR, V73, P99, DOI 10.1016/j.pocean.2006.12.002; Stabeno PJ, 1999, UASGCP REP, V99, P1; Hurst MP, 2010, CONT SHELF RES, V30, P467, DOI 10.1016/j.csr.2010.01.001; Carter GS, 2005, CONT SHELF RES, V25, P1499, DOI 10.1016/j.csr.2005.04.011; OAKEY NS, 1982, J PHYS OCEANOGR, V12, P256, DOI 10.1175/1520-0485(1982)012<0256:DOTROD>2.0.CO;2; FISCHER J, 1993, J ATMOS OCEAN TECH, V10, P764, DOI 10.1175/1520-0426(1993)010<0764:DVPWSC>2.0.CO;2; Springer AM, 1996, FISH OCEANOGR, V5, P205, DOI 10.1111/j.1365-2419.1996.tb00118.x; COACHMAN LK, 1986, CONT SHELF RES, V5, P23, DOI 10.1016/0278-4343(86)90011-7; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; MacKinnon JA, 2005, J PHYS OCEANOGR, V35, P2425, DOI 10.1175/JPO2821.1; WALSH JJ, 1989, PROG OCEANOGR, V22, P277, DOI 10.1016/0079-6611(89)90006-2; MacKinnon JA, 2003, J PHYS OCEANOGR, V33, P1476, DOI 10.1175/1520-0485(2003)033<1476:MOTLNE>2.0.CO;2; Whitney FA, 2011, J OCEANOGR, V67, P481, DOI 10.1007/s10872-011-0051-2; Asahara Y, 2012, DEEP-SEA RES PT II, V61-64, P155, DOI 10.1016/j.dsr2.2011.12.004; Egbert GD, 2002, J ATMOS OCEAN TECH, V19, P183, DOI 10.1175/1520-0426(2002)019<0183:EIMOBO>2.0.CO;2; Stabeno PJ, 2001, FISH OCEANOGR, V10, P81, DOI 10.1046/j.1365-2419.2001.00157.x; COACHMAN LK, 1981, DEEP-SEA RES, V28, P819; Efron B, 1983, AM STAT, V37, P36, DOI DOI 10.2307/2685844; Foreman MGG, 2006, J MAR RES, V64, P797, DOI 10.1357/002224006779698341; Gill AE, 1982, ATMOSPHERE OCEAN DYN; Hunt GL, 2008, DEEP-SEA RES PT II, V55, P1919, DOI 10.1016/j.dsr2.2008.04.032; Katsumata K, 2001, GEOPHYS RES LETT, V28, P319, DOI 10.1029/2000GL011489; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; Miura T, 2002, J OCEANOGR, V58, P815, DOI 10.1023/A:1022871112946; Mizobata K, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003335; Osafune S, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005110; Palmer MR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004531; SCHUMACHER JD, 1992, J GEOPHYS RES-OCEANS, V97, P9423, DOI 10.1029/92JC00512; Simpson J.H., 2012, INTRO PHYS BIOL OCEA; St Laurent L. C, 2003, DEEP-SEA RES, VI, p[50, 987], DOI DOI 10.1016/S0967-0637(03)00096-7; Tanaka T, 2013, J GEOPHYS RES-OCEANS, V118, P6525, DOI 10.1002/2013JC009113; Tanaka T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051164; Tanaka Y, 2014, PROG OCEANOGR, V126, P98, DOI 10.1016/j.pocean.2014.04.009; Vlasenko V., 2005, BAROCLINIC TIDES THE, P351; Wang T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049993; Yagi M, 2014, PROG OCEANOGR, V126, P121, DOI 10.1016/j.pocean.2014.04.023; Yagi M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050349	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					1	17		10.1007/s10872-014-0256-2		17	Oceanography	Oceanography	CB0ND	WOS:000349322200001		
J	Ishizu, M; Sukigara, C; Suga, T; Richards, KJ				Ishizu, Miho; Sukigara, Chiho; Suga, Toshio; Richards, Kelvin J.			Estimating the nitrate concentration from the dissolved oxygen concentration and seawater temperature in the Kuroshio extension, Oyashio, and mixed water regions	JOURNAL OF OCEANOGRAPHY			English	Article						Oxygen; Nitrate; Mixed water region between Kuroshio and Oyashio	PACIFIC INTERMEDIATE WATER; SUB-ARCTIC PACIFIC; REDFIELD RATIOS; NEUTRAL DENSITY; OCEAN; VARIABILITY; SOLUBILITY	For the purpose of estimating nitrate concentration using the dissolved oxygen concentration and seawater temperature recorded in an instrument such as a profiling float with an oxygen sensor, we examined the relationship between oxygen and nitrate concentrations in the Kuroshio Extension, Oyashio, and mixed water regions (34-43A(0)N, 140-150A(0)E) using vertical profile data, which includes temperature, salinity, oxygen, and nitrate, from the World Ocean Database 2005. Examining the NO3/O-2 ratio along isotherms, we found a clear linear regression between the oxygen and nitrate concentrations in each potential temperature range, irrespective of water mass and seasonal variation. The slopes represented by the NO3/O-2 ratio in each temperature range varied from -0.07 to -0.12. The benefit of analyzing data on constant potential temperature surfaces arises because of the strong dependence of the oxygen saturation of surface waters on temperature. This sets the end point of subducted waters and helps distinguish waters that may have similar preformed nitrate values. Our results suggest that subsequent reminearlization in the subducted water retained the Redfield ratio between N and O-2. The estimate of nitrate concentration, by using the oxygen-nitrate relationship discovered in the present study, showed good accuracy with in general a mean error of less than 2.0 mu mol/kg. The present method has been demonstrated to be a useful tool for estimating the nitrate concentration from temperature and oxygen.	[Ishizu, Miho] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Sukigara, Chiho] Nagoya Univ, Hydrospher Atmospher Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Suga, Toshio] Tohoku Univ, Grad Sch Sci, Dept Geophys, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Richards, Kelvin J.] Univ Hawaii Manoa, Int Pacific Res Ctr, Dept Oceanog, Honolulu, HI 96822 USA	Ishizu, M (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778564, Japan.	mishizu@aori.u-tokyo.ac.jp; suki@hyrc.nagoya-u.ac.jp; suga@pol.gp.tohoku.ac.jp; rkelvin@hawaii.edu			Agriculture, Forestry and Fisheries Research Council (AFFRC), Japan; Japanese Agency for Marine Earth Science and Technology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22106007]	The authors thank the members of the Oceanography Group at Tohoku University and at University of Hawaii at Manoa for their helpful discussions throughout this study. Thanks also to Dr. B. Qiu and M. Izumi who carefully read this paper and made suggestions. We would also like to thank anonymous reviewers whose comments have greatly improved the manuscript. This work was supported by "Studies on Prediction and Application of Fish Species Alteration (SUPRFISH)" sponsored by the Agriculture, Forestry and Fisheries Research Council (AFFRC), Japan and the Japanese Agency for Marine Earth Science and Technology. TS was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant-in-Aid for Scientific Research on Innovative Areas (22106007).	TALLEY LD, 1993, J PHYS OCEANOGR, V23, P517, DOI 10.1175/1520-0485(1993)023<0517:DAFONP>2.0.CO;2; Yasuda I, 1996, J PHYS OCEANOGR, V26, P448, DOI 10.1175/1520-0485(1996)026<0448:DAMONP>2.0.CO;2; Jackett DR, 1997, J PHYS OCEANOGR, V27, P237, DOI 10.1175/1520-0485(1997)027<0237:ANDVFT>2.0.CO;2; ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; McDougall TJ, 2005, J MAR RES, V63, P159, DOI 10.1357/0022240053693734; Shimizu Y, 2001, J PHYS OCEANOGR, V31, P1561, DOI 10.1175/1520-0485(2001)031<1561:DACOTC>2.0.CO;2; Kasai H, 1997, FISH OCEANOGR, V6, P118, DOI 10.1046/j.1365-2419.1997.00034.x; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307; Riser SC, 2008, NATURE, V451, P323, DOI 10.1038/nature06441; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; BOULAHDID M, 1989, MAR CHEM, V26, P133, DOI 10.1016/0304-4203(89)90057-1; BROECKER WS, 1985, J GEOPHYS RES-OCEANS, V90, P6925, DOI 10.1029/JC090iC04p06925; BROECKER WS, 1974, EARTH PLANET SC LETT, V23, P100, DOI 10.1016/0012-821X(74)90036-3; Ishizu M, 2013, J GEOPHYS RES-OCEANS, V118, P3586, DOI 10.1002/jgrc.20249; Kortzinger A, 2001, LIMNOL OCEANOGR, V46, P964; Limsakul A, 2002, DEEP-SEA RES PT II, V49, P5487, DOI 10.1016/S0967-0645(02)00208-4; Noto N, 1999, CAN J FISH AQUAT SCI, V56, P973; Noto N, 2003, FISH OCEANOGR, V12, P1; Redfield A. C., 1963, SEA, V2, P26; Saito Hiroaki, 1998, Bulletin of the Hokkaido National Fisheries Research Institute, V62, P1; Sarmiento J. L, 2006, OCEAN BIOGEOCHEMICAL; Shiomoto Akihiro, 1994, Journal of Oceanography, V50, P515, DOI 10.1007/BF02235421; Yasuda I, 1996, FISH OCEANOGR, V5, P63, DOI 10.1111/j.1365-2419.1996.tb00018.x; Yasuda Ichiro, 1994, Fisheries Oceanography, V3, P172, DOI 10.1111/j.1365-2419.1994.tb00094.x; Yasuda I, 1999, FISH OCEANOGR, V8, P18, DOI 10.1046/j.1365-2419.1999.00089.x	26	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					19	26		10.1007/s10872-014-0257-1		8	Oceanography	Oceanography	CB0ND	WOS:000349322200002		
J	Nishibe, Y; Takahashi, K; Shiozaki, T; Kakehi, S; Saito, H; Furuya, K				Nishibe, Yuta; Takahashi, Kazutaka; Shiozaki, Takuhei; Kakehi, Shigeho; Saito, Hiroaki; Furuya, Ken			Size-fractionated primary production in the Kuroshio Extension and adjacent regions in spring	JOURNAL OF OCEANOGRAPHY			English	Article						Primary production; Kuroshio Extension; Spring bloom; Size fractionation; Nutrients; Kuroshio; Oyashio	SARDINE SARDINOPS-MELANOSTICTUS; JAPANESE SARDINE; PHYTOPLANKTON BLOOMS; POPULATION DECLINE; NORTH PACIFIC; VARIABILITY; TEMPERATURE; RECRUITMENT; PICOPLANKTON; NUTRIENT	Size-fractionated primary production was investigated in the Kuroshio Extension (KE) and adjacent regions from winter to spring in order to understand dynamics of spring phytoplankton bloom. Primary production in both the Kuroshio and KE regions was low in winter and ranged from 61 to 185 mg C m(-2) day(-1), and was composed mostly of small phytoplankton (< 10 A mu m). While large phytoplankton (> 10 A mu m) became major producers in spring with high production of 443-871 mg C m(-2) day(-1) in the Kuroshio region, the main primary producers remained small in the KE region, and primary production was not elevated as observed in the Kuroshio, ranging from 82 to 492 mg C m(-2) day(-1). Low production in the KE region in spring was associated with a lack of primary production by large phytoplankton, and this was primarily due to the low availability of nitrate and silicic acid in early spring. Within the KE region, primary production tended to be high in the northern edge and around the axis of the first ridge of the KE meandering compared with other regions of KE. The shoaling of the surface mixed layer produced by intrusion of the southern warmer water was responsible for the high primary productivity.	[Nishibe, Yuta; Takahashi, Kazutaka; Shiozaki, Takuhei; Furuya, Ken] Univ Tokyo, Dept Aquat Biosci, Tokyo, Japan; [Shiozaki, Takuhei; Saito, Hiroaki] Univ Tokyo, Atomosphere & Ocean Res Inst, Chiba, Japan; [Kakehi, Shigeho; Saito, Hiroaki] Fisheries Res Agcy, Tohoku Natl Fisheries Res Inst, Shiogama, Miyagi, Japan	Furuya, K (reprint author), Univ Tokyo, Dept Aquat Biosci, Tokyo, Japan.	furuya@fs.a.u-tokyo.ac.jp			Research Development of Agriculture Forestry and Fisheries Research Council; MEXT [24121005]	We thank the captains, crew members and scientists on board the cruises of R/V Wakataka-Maru, Soyo-Maru, Hakuho-Maru, and Tansei-Maru for the cooperation at the sea. We also thank M. Nakamachi and T. Ikeya for chlorophyll a and nutrients data, and K. Hayashizaki for his cooperation in mass spectrometry. This study was financially supported by the grant 'Studies on Prediction and Application of Fish Species Alternation' (SUPRFISH) from the Research Development of Agriculture Forestry and Fisheries Research Council, and a MEXT grant (24121005).	EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; TOWNSEND DW, 1992, NATURE, V360, P59, DOI 10.1038/360059a0; Yasuda I, 2003, J OCEANOGR, V59, P389, DOI 10.1023/A:1025580313836; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; WATANABE Y, 1995, CAN J FISH AQUAT SCI, V52, P1609, DOI 10.1139/f95-154; Maranon E, 2012, LIMNOL OCEANOGR, V57, P1266, DOI 10.4319/lo.2012.57.5.1266; Agawin NSR, 2000, LIMNOL OCEANOGR, V45, P591; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Qiu B, 2006, J PHYS OCEANOGR, V36, P457, DOI 10.1175/JPO2849.1; Shiozaki T, 2014, J GEOPHYS RES-OCEANS, V119, P253, DOI 10.1002/2013JC009187; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Barton AD, 2013, ECOL LETT, V16, P522, DOI 10.1111/ele.12063; Kimura S, 2000, ICES J MAR SCI, V57, P133, DOI 10.1006/jmsc.1999.0564; Nishikawa H, 2011, FISH OCEANOGR, V20, P570, DOI 10.1111/j.1365-2419.2011.00603.x; Yasuda I, 2007, FISH OCEANOGR, V16, P482, DOI 10.1111/j.1365-2419.2007.00457.x; Aruga Y, 1968, J OCEANOGR, V24, P275; BOWER AS, 1991, J PHYS OCEANOGR, V21, P173, DOI 10.1175/1520-0485(1991)021<0173:ASKMFM>2.0.CO;2; FALKOWSKI P G, 1981, Journal of Plankton Research, V3, P203, DOI 10.1093/plankt/3.2.203; Hansen HP, 1999, METHODS SEAWATER ANA, P159, DOI DOI 10.1002/9783527613984.CH10; Hashimoto S, 2002, J PLANKTON RES, V24, P83, DOI 10.1093/plankt/24.1.83; Ito S, 2000, B TOHOKU NATL FISH R, V63, P125; Kawai H, 1972, KUROSHIO ITS PHYSICA, P235; Kondo Y, 2013, J OCEANOGR, V69, P97, DOI 10.1007/s10872-012-0160-6; Levitus S, 1982, 13 NOAA; Nakata K, 1988, B TOKAI REG FISH RES, V126, P11; Nakata Kaoru, 1995, Bulletin of the National Research Institute of Fisheries Science, V7, P265; Noto M, 1999, CAN J FISH AQUAT SCI, V56, P973, DOI 10.1139/cjfas-56-6-973; RUNGE JA, 1980, LIMNOL OCEANOGR, V25, P134; Saijo Y, 1960, J OCEANOGR SOC JPN, V16, P139; Shiomoto A, 1997, J PLANKTON RES, V19, P907, DOI 10.1093/plankt/19.7.907; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; Takasugi S, 1993, J FISH OCEANOGR SOC, V57, P333; Watanabe Y, 2007, J SEA RES, V58, P46, DOI 10.1016/j.seares.2007.02.002; Yamamoto T, 1998, J PLANKTON RES, V10, P1113; Yokouchi K, 2007, GLOBAL CLIMATE CHANG, P65	36	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					27	40		10.1007/s10872-014-0258-0		14	Oceanography	Oceanography	CB0ND	WOS:000349322200003		
J	Igeta, Y; Yamazaki, K; Watanabe, T				Igeta, Yosuke; Yamazaki, Keiichi; Watanabe, Tatsuro			Amplification of coastal-trapped waves resonantly generated by wind around Sado Island, Japan	JOURNAL OF OCEANOGRAPHY			English	Article						Wind-induced coastal-trapped wave; Resonance; Sado island; Mooring observation; Numerical experiment	BERMUDA	Current observations were made from 4 July 2009 to 6 March 2011 with an acoustic Doppler current profiler mounted on the seafloor near the northern tip of Sado Island, Japan, and an electromagnetic current meter off the western coast of the island to investigate wind-induced coastal-trapped waves (CTW). Oscillating alongshore flows with a period of about 2 days occurred intermittently in association with atmospheric disturbances throughout the observation period. The period of the current fluctuation changed from 48 to 60 h in both summer and winter, and the fluctuations were coherent with northward wind velocity fluctuations with a period of about 2 days around the island, even though northward wind fluctuations with periods of about 3, 4, and 6 days were predominant. Thus, the 2-day-period current fluctuations were selectively enhanced by the wind. Because the wavelength of internal Kelvin waves with a 2-day period was comparable to the distance around Sado Island (210 km), we inferred that the wind-induced CTWs around the island were resonant with the 2-day-period northward wind fluctuations. This inference was supported by the results of a numerical experiment performed with a two-layer model using realistic topography, which showed that resonance effectively occurred along the western coast of the island, where the water is deep and the continental shelf is narrow, and the resonance period was controlled by the ocean stratification strength and the shape of the island.	[Igeta, Yosuke; Yamazaki, Keiichi; Watanabe, Tatsuro] Fisheries Res Agcy, Japan Sea Natl Fisheries Res Inst, Chuo Ku, Niigata 9518121, Japan; [Yamazaki, Keiichi] Tokyo Univ Marine Sci & Technol, Grad Sch, Minato Ku, Tokyo 1088477, Japan	Igeta, Y (reprint author), Fisheries Res Agcy, Japan Sea Natl Fisheries Res Inst, Chuo Ku, 1-5939-22 Suido Cho, Niigata 9518121, Japan.	igeta@affrc.go.jp			Research Project for Utilizing Advanced Technologies in Agriculture, Forestry, and Fisheries in Japan	We thank Dr. Y. Kitade, Dr. T. Senjyu, Dr. H. Nakamura, and Dr. N. Hirose for useful discussions. This research was supported by the Research Project for Utilizing Advanced Technologies in Agriculture, Forestry, and Fisheries in Japan. GPV-MSM data were provided by the Japan Meteorological Agency. The figures were produced by the GFD-DENNOU software library.	Aiki T, 2007, OCEANOGR JAPAN, V16, P291; GILL AE, 1974, J PHYS OCEANOGR, V4, P83, DOI 10.1175/1520-0485(1974)004<0083:TGOLSW>2.0.CO;2; Brink KH, 1999, DYNAM ATMOS OCEANS, V29, P93, DOI 10.1016/S0377-0265(99)00003-2; HOGG NG, 1980, J PHYS OCEANOGR, V10, P1353, DOI 10.1175/1520-0485(1980)010<1353:OOIKWT>2.0.CO;2; Igeta Y, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005305; Kajiura K, 1974, J OCEANOGR SOC JAPAN, V30, P271, DOI 10.1007/BF02109670; Kitade Y, 2011, J OCEANOGR, V67, P613, DOI 10.1007/s10872-011-0061-0; Kitade Y, 2000, J OCEANOGR, V56, P727, DOI 10.1023/A:1011186018956; LONGUETH.MS, 1969, J FLUID MECH, V37, P773, DOI 10.1017/S0022112069000875; Merrifield MA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001134; Orlic M, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006955; Watanabe T, 2006, J OCEANOGR, V62, P527, DOI 10.1007/s10872-006-0073-3; Yoshida K., 1955, REC OCEANOGR WORKS J, V2, P1	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					41	51		10.1007/s10872-014-0259-z		11	Oceanography	Oceanography	CB0ND	WOS:000349322200004		
J	Abe, K; Tsujino, M; Nakagawa, N; Abo, K				Abe, Kazuo; Tsujino, Mutsumi; Nakagawa, Norihisa; Abo, Katsuyuki			Characteristic of Si:P:N ratio in bottom water in central Suo-Nada, western Seto Inland Sea	JOURNAL OF OCEANOGRAPHY			English	Article						Nutrient; Regeneration; Bottom water; Si:P:N ratio; Suo-Nada; Seto Inland Sea		The nutrient composition in seawater is considered to determine the regional phytoplankton species, its composition, and its productivity. In order to examine the nutrient composition ratio in Suo-Nada, western Seto Inland Sea, where the oligotrophication process is progressing, the relationship among silicic acid [Si(OH)(4)], phosphate (PO4),and total dissolved inorganic nitrogen (DIN; NO3 + NO2 + NH4) in bottom water was investigated. From April through July, as stratification progressed, a stagnant water mass appeared in the bottom layer of the central part of Suo-Nada. Nutrient and apparent oxygen utilization (AOU) concentrations in this bottom water increased in this period. A plot of nutrients against AOU concentrations showed good linearity for Si(OH)(4), PO4, and DIN, which suggests that increase in nutrients was accompanied by dissolved oxygen consumption due to the degradation of organic matter. The Si:P:N ratio calculated based on the increased nutrient-AOU relationship in bottom water from April through October was determined to be 25:1:9. Meanwhile, the average Si:P:N ratio existing in bottom water during the same period was 28:1:8. The two ratios obtained showed good agreement in general, although the difference between them is probably attributed to the existence of preformed fractions of each nutrient. This finding suggests that the nutrient composition ratio in bottom water generally could be regulated by the biological uptake-regeneration process from April through October in this study area, and the obtained ratio (28:1:8) is a regional characteristic with large deviation from the Redfield-Brzezinski nutrient ratio of 15:1:16.	[Abe, Kazuo; Tsujino, Mutsumi; Nakagawa, Norihisa; Abo, Katsuyuki] Natl Res Inst Fisheries & Environm Inland Sea, Hatsukaichi 7390452, Japan	Abe, K (reprint author), Natl Res Inst Fisheries & Environm Inland Sea, 2-17-5 Maruishi, Hatsukaichi 7390452, Japan.	abek@fra.affrc.go.jp					Abe K, 2014, J OCEANOGR, V70, P267, DOI 10.1007/s10872-014-0229-5; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Yamamoto T, 2003, MAR POLLUT BULL, V47, P37, DOI 10.1016/S0025-326X(02)00416-2; Takeoka H, 2002, J OCEANOGR, V58, P93, DOI 10.1023/A:1015828818202; Sanudo-Wilhelmy SA, 2004, NATURE, V432, P897, DOI 10.1038/nature03125; Fujiwara T, 1989, B COAST OCEANOGR, V27-1, P38; Iwao T, 2001, B OITA INS MAR FISH, V3, P19; JOH H, 1984, B JPN SOC SCI FISH, V50, P1693; Katayama S, 2002, B FUKUOKA FISH MAR T, V12, P67; Kobayashi S, 2006, OCEANOGR JPN, V15, P207; Kobayashi S, 2006, UMI TO SORA, V82, P1; La Roche J, 2002, EUR J PHYCOL, V37, P1; Montani S, 2002, B COAST OCEANOGR, V39, P171; Nakajima S, 2010, P COAST ENG JSCE, V66, P951; Nielsen MV, 1996, MAR ECOL PROG SER, V136, P205, DOI 10.3354/meps136205; Wanishi A, 2007, B YAMAGUCHI PREF FIS, V5, P1; Yamamoto Tamiji, 2000, Journal of Oceanography, V56, P131, DOI 10.1023/A:1011126911262; Yanagi T, 2004, OCEANOGRAPHY JAPAN, V13, P197	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					53	63		10.1007/s10872-014-0262-4		11	Oceanography	Oceanography	CB0ND	WOS:000349322200005		
J	Kodama, T; Ichikawa, T; Hidaka, K; Furuya, K				Kodama, Taketoshi; Ichikawa, Tadafumi; Hidaka, Kiyotaka; Furuya, Ken			A highly sensitive and large concentration range colorimetric continuous flow analysis for ammonium concentration	JOURNAL OF OCEANOGRAPHY			English	Article						Ammonia; Ammonium ion; Nanomolar level; Liquid waveguide capillary cell; Salt effect; Highly sensitive; Nitrogen dynamics; Autoanalyzer	GUIDE CAPILLARY CELL; SOUTH-PACIFIC OCEAN; NANOMOLAR CONCENTRATIONS; SPECTROPHOTOMETRIC DETECTION; NITRIFICATION RATES; INJECTION ANALYSIS; ORGANIC-MATTER; TRACE AMMONIUM; NORTH PACIFIC; SEAWATER	A continuous flow method for the determination of ammonium concentration in seawater from a nanomolar to a micromolar level is described. To prevent spurious peaks derived from salinity difference, a gas-permeable hydrophobic membrane filter was used to separate the manifold into an outgassing section and an indophenol blue reaction section. The indophenol blue reaction section was adopted for colorimetric analysis and is equipped with a 1-m path length liquid capillary cell and a fiber-optic spectrometer, which is able to record the absorbance at multiple wavelengths. The minimum detection limit at wavelength 630 nm is 5.5 +/- A 1.8 nM, and the calibration curves are linear to at least 2,000 nM. In addition, the minimum detection limit at wavelength 530 nm was 13 +/- A 5.3 nM, and linear calibration curves were observed until at least 10,000 nM. The slopes of the calibration curves were similar for standards prepared using filtered seawater and ultrapure water. The ammonium concentration of the ultrapure water was similar to those of ion-exchanged water and unfiltered low-nutrient seawater, but was significantly lower than those of filtered seawater and solutions that contained sodium hydroxide. Therefore, ultrapure water is optimal for both blank and standard preparations because of its stable quality and availability. Given its large concentration range and the use of readily available blanks, this method is suitable for the determination of ammonium concentration and helps our understanding of ammonium dynamics in the ocean.	[Kodama, Taketoshi; Ichikawa, Tadafumi; Hidaka, Kiyotaka] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan; [Furuya, Ken] Univ Tokyo, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan	Kodama, T (reprint author), Fisheries Res Agcy, Japan Sea Natl Fisheries Res Inst, Chuo Ku, 1-5939-22 Suido Cho, Niigata 9518121, Japan.	takekodama@affrc.go.jp		Kodama, Taketoshi/0000-0001-8031-7881	Ministry of Agriculture, Forestry and Fisheries, Japan; MEXT [24121005]	We thank the officers and crewmembers of the R/V Soyo-maru Koda cruise for their cooperation at sea. We are grateful to Mr. H. Kikuchi of BL-TEC for his technical assistance and advice. This work was financially supported by the Ministry of Agriculture, Forestry and Fisheries, Japan through a research project entitled "Development of technologies for mitigation and adaptation to climate change in Agriculture, Forestry and Fisheries" and by a MEXT grant (24121005) to K. F.	Almeida M, 2014, CHEM TRENDS ANAL, DOI [10.1016/j.trac.2014.03.012, DOI 10.1016/J.TRAC.2014.03.012]; Amornthammarong N, 2008, ANAL CHEM, V80, P1019, DOI 10.1021/ac701942f; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Raimbault P, 2008, BIOGEOSCIENCES, V5, P323; WHEELER PA, 1986, LIMNOL OCEANOGR, V31, P998; DORTCH Q, 1990, MAR ECOL PROG SER, V61, P183, DOI 10.3354/meps061183; Harrison WG, 1996, LIMNOL OCEANOGR, V41, P16; Kodama T, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006814; Ma J, 2014, TRAC-TREND ANAL CHEM, V60, P1, DOI 10.1016/j.trac.2014.04.013; Raimbault P, 2008, BIOGEOSCIENCES, V5, P281; Steinberg DK, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1135, DOI 10.1016/B978-0-12-372522-6.00026-8; Kerouel R, 1997, MAR CHEM, V57, P265, DOI 10.1016/S0304-4203(97)00040-6; Hashihama F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036866; Li QP, 2008, ANAL CHIM ACTA, V611, P68, DOI 10.1016/j.aca.2008.01.074; GARSIDE C, 1982, MAR CHEM, V11, P159, DOI 10.1016/0304-4203(82)90039-1; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Coverly S, 2012, ANAL CHIM ACTA, V712, P94, DOI 10.1016/j.aca.2011.11.008; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Plant JN, 2009, LIMNOL OCEANOGR-METH, V7, P144; Bronk D. A., 2002, BIOGEOCHEMISTRY MARI, P153, DOI DOI 10.1016/B978-012323841-2/50007-5; BRZEZINSKI MA, 1988, LIMNOL OCEANOGR, V33, P1176; BRZEZINSKI MA, 1987, MAR CHEM, V20, P277, DOI 10.1016/0304-4203(87)90078-8; Chen GH, 2011, ANAL LETT, V44, P310, DOI 10.1080/00032719.2010.500775; Clark DR, 2007, MAR CHEM, V103, P84, DOI 10.1016/j.marchem.2006.06.005; Dean J A, 1998, LANGES HDB CHEM; Gordon LI, 1993, 911 WHPO; Hashihama F., 2010, LA MER, V47, P119; Hashihama F, 2010, DEEP-SEA RES PT I, V57, P338, DOI 10.1016/j.dsr.2009.12.005; Hashihama F, 2014, DEEP-SEA RES PT I, V90, P115, DOI 10.1016/j.dsr.2014.05.004; Hydes D, 2010, ICPC PUBLICATION SER, V14; Ikeda T, 2001, MAR BIOL, V139, P587; JONES RD, 1991, LIMNOL OCEANOGR, V36, P814; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105; Karl DM, 1992, TRICHODESMIUM BLOOMS, P219; KIRCHMAN DL, 1990, LIMNOL OCEANOGR, V35, P1258; Li QP, 2005, MAR CHEM, V96, P73, DOI 10.1016/j.marchem.2004.12.001; Lipschultz F, 2001, DEEP-SEA RES PT II, V48, P1897, DOI 10.1016/S0967-0645(00)00168-5; Matsumoto K, 2004, DEEP-SEA RES PT I, V51, P1851, DOI 10.1016/j.dsr.2004.07.015; McCarthy M. D., 2008, NITROGEN MARINE ENV, P1220, DOI DOI 10.1016/B978-0-12-372522-6.00028-1; Miller J. C., 1988, STAT ANAL CHEM; Nishino S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047885; Oliveira SM, 2009, J ENVIRON MONITOR, V11, P228, DOI 10.1039/b812624k; Parsons T.R, 1984, MANUAL CHEM BIOL MET; Rees AP, 2006, DEEP-SEA RES PT II, V53, P1649, DOI 10.1016/j.dsr2.2006.05.008; SAINO T, 1983, DEEP-SEA RES, V30, P1157, DOI 10.1016/0198-0149(83)90094-8; SCHULZE G, 1988, ANAL CHIM ACTA, V214, P121, DOI 10.1016/S0003-2670(00)80435-3; VANSON M, 1983, ANAL CHIM ACTA, V153, P271, DOI 10.1016/S0003-2670(00)85513-0; Ward BB, 2011, METHOD ENZYMOL, V486, P307, DOI [10.1016/B978-0-12-381294-0.00013-4, 10.1016/S0076-6879(11)86013-1]; Zhu Y, 2014, MAR CHEM, V162, P114, DOI 10.1016/j.marchem.2014.03.011	49	2	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					65	75		10.1007/s10872-014-0260-6		11	Oceanography	Oceanography	CB0ND	WOS:000349322200006		
J	Wirasatriya, A; Kawamura, H; Shimada, T; Hosoda, K				Wirasatriya, Anindya; Kawamura, Hiroshi; Shimada, Teruhisa; Hosoda, Kohtaro			Climatology of hot events in the western equatorial Pacific	JOURNAL OF OCEANOGRAPHY			English	Article						High SST; Hot event; Merged SST; Western Pacific warm pool	SEA-SURFACE TEMPERATURE; WARM-POOL; TROPICAL PACIFIC; IN-SITU; OCEANS; CLOUDS; FLUXES	We investigated the climatology of hot events (HEs) in the western equatorial Pacific. HEs are characterized by well-organized high sea surface temperatures (SSTs). We proposed a method for identifying HEs using a space-time-dependent threshold with a minimum areal size of 2 x 10(6) km(2), and with a duration (period) of > 6 days. We thus identified 71 HEs from the optimally interpolated SST dataset during 2003-2011. Their mean duration, areal size, and amplitude were 18.14 days, 6.30 x 10(6) km(2), and 0.33 A degrees C, respectively. On average, the HEs developed more slowly than they decayed. They were distributed within the equatorial band to the subtropical Pacific (20A degrees S-30A degrees N), with an eastward extension to 150A degrees W. In particular, the HEs occurred most frequently along the northern coasts of New Guinea and the Solomon Islands to 180A degrees E. Seasonal variation in the HE distribution was observed: a northward shift during boreal summer and a southward shift during boreal winter. The distribution of HE occurrences corresponded to the climatological SST of the western Pacific warm pool. HEs occurred under conditions of low wind speeds (similar to 2.56 m/s) and high levels of solar radiation (similar to 225 W/m(2)). However, since the high levels of solar radiation occurred over the entire area of the western equatorial Pacific during HE periods, the low wind speed distribution became a key factor in the occurrence of HEs in the western equatorial Pacific. Seasonal shifts in wind speed and solar radiation were found to influence the seasonal shift in HE distribution.	[Wirasatriya, Anindya; Kawamura, Hiroshi; Shimada, Teruhisa; Hosoda, Kohtaro] Tohoku Univ, Ctr Atmospher & Ocean Studies, Grad Sch Sci, Sendai, Miyagi 980, Japan	Kawamura, H (reprint author), Tohoku Univ, Ctr Atmospher & Ocean Studies, Grad Sch Sci, Sendai, Miyagi 980, Japan.	kamu@ocean.caos.tohoku.ac.jp	Shimada, Teruhisa/L-5974-2013				RAMANATHAN V, 1991, NATURE, V351, P27, DOI 10.1038/351027a0; Webster PJ, 1996, J CLIMATE, V9, P1712, DOI 10.1175/1520-0442(1996)009<1712:CRATDC>2.0.CO;2; WALLACE JM, 1992, NATURE, V357, P230, DOI 10.1038/357230a0; Clement AC, 2005, J CLIMATE, V18, P5294, DOI 10.1175/JCLI3582.1; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Yu LS, 2007, B AM METEOROL SOC, V88, P527, DOI 10.1175/BAMS-88-4-527; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Shinoda T, 1998, J CLIMATE, V11, P1685, DOI 10.1175/1520-0442(1998)011<1685:IVOSFA>2.0.CO;2; ARKING A, 1994, J CLIMATE, V7, P988, DOI 10.1175/1520-0442(1994)007<0988:RBCASS>2.0.CO;2; Chongyin L, 1999, ADV ATMOS SCI, V16, P378, DOI 10.1007/s00376-999-0017-0; Clement A, 1999, J CLIMATE, V12, P3383, DOI 10.1175/1520-0442(1999)012<3383:CATTO>2.0.CO;2; Harweijer C, 2005, TELLUS A, V57A, P662; Hosoda K, 2013, J OCEANOGR, V69, P631, DOI 10.1007/s10872-013-0194-4; Kawai Y, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003313; Kawamura H, 2008, J OCEANOGR, V64, P847, DOI 10.1007/s10872-008-0070-9; KIM ST, 2012, GEOPHYS RES LETT, V39, P1602, DOI DOI 10.1029/201; Kurihara Y., 2006, WEATHER B, V73, ps1; Lin CY, 2011, GLOBAL PLANET CHANGE, V77, P26, DOI 10.1016/j.gloplacha.2011.02.006; Pierrehumbert RT, 2000, P NATL ACAD SCI USA, V97, P1355, DOI 10.1073/pnas.97.4.1355; Qin H, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003969; Qin HL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004640; Qin HL, 2009, ADV SPACE RES, V44, P395, DOI 10.1016/j.asr.2009.03.003; Qin HL, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041685; Thoron TG, 2005, NATURE, V433, P294; WALISER DE, 1993, J GEOPHYS RES-ATMOS, V98, P12881, DOI 10.1029/93JD00872; Waliser DE, 1996, J CLIMATE, V9, P161, DOI 10.1175/1520-0442(1996)009<0161:FALMFV>2.0.CO;2; Wilks D.S., 2006, STAT METHODS ATMOSPH, P260; Wyrtki K, 1989, P W PAC INT M WORKSH, P99; YAN XH, 1992, SCIENCE, V258, P1643, DOI 10.1126/science.258.5088.1643; Zhang YS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003779	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					77	90		10.1007/s10872-014-0263-3		14	Oceanography	Oceanography	CB0ND	WOS:000349322200007		
J	Tuyet, DTA; Tanaka, T; Sohrin, R; Hao, DM; Nagaosa, K; Kato, K				Dao Thi Anh Tuyet; Tanaka, Toshinari; Sohrin, Rumi; Do Manh Hao; Nagaosa, Kazuyo; Kato, Kenji			Effects of warming on microbial communities in the coastal waters of temperate and subtropical zones in the Northern Hemisphere, with a focus on Gammaproteobacteria	JOURNAL OF OCEANOGRAPHY			English	Article						Warming; Temperate and subtropical zones; Coastal water; Bottom-up; Top-down; Gammaproteobacteria	GROWTH-RATE; OLIGODEOXYNUCLEOTIDE PROBES; OLIGONUCLEOTIDE PROBES; ENVIRONMENTAL-CHANGES; SEASONAL-VARIATIONS; CHESAPEAKE BAY; BACTERIAL; MARINE; PHYTOPLANKTON; OCEAN	We examined the effect of warming on microbes in coastal waters in temperate and subtropical zones, Suruga Bay in Japan and Ha Long Bay in Viet Nam, respectively. Incubation of intact communities (500 mL each) at temperatures three or five degrees higher than the in-situ temperatures enhanced both the abundance and growth rate of prokaryotes. We also conducted size fractionation and dilution experiments to elucidate whether this behavior was the result of an increased rate of reproduction ("bottom-up" effect) or reduced mortality ("top-down" effect). For two of the five cases analyzed, enhancement of the growth rate could be ascribed to the bottom-up effect of the warming. For two other cases it could be ascribed to the top-down effect, irrespective of whether or not warming enhanced the bottom-up effect. The effect of warming was not clearly apparent for prokaryotes of subtropical coastal waters, where the in-situ temperature was nearly 30 A degrees C. Among the prokaryotes, Gammaproteobacteria tended to predominate as a result of warming. These results suggest that warming may affect microbial growth even in subtropical coastal waters in some seasons and that the response of Gammaproteobacteria to warming of temperate and subtropical coastal waters is among the most rapid.	[Dao Thi Anh Tuyet; Kato, Kenji] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka 4228529, Japan; [Dao Thi Anh Tuyet; Do Manh Hao] Vietnamese Acad Sci & Technol, Inst Marine Environm & Resources, Hai Phong, Vietnam; [Tanaka, Toshinari; Sohrin, Rumi; Nagaosa, Kazuyo; Kato, Kenji] Shizuoka Univ, Grad Sch Sci, Shziuoka 4228529, Japan	Kato, K (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, 836 Oya, Shizuoka 4228529, Japan.	skkato@ipc.shizuoka.ac.jp			Graduate School of Science and Technology, Shizuoka University; Special Research Fund for Future Program of Shizuoka University, Japan;  [VAST03.06/13-14]	We thank editors and two anonymous reviewers for their careful reading the manuscript. This study was supported by the Graduate School of Science and Technology, Shizuoka University; Special Research Fund for Future Program of Shizuoka University, Japan; and project VAST03.06/13-14, Viet Nam. We thank all laboratory members for their assistance in sampling and in conducting the experiments.	Vezzulli L, 2013, MICROB ECOL, V65, P817, DOI 10.1007/s00248-012-0163-2; SHIAH FK, 1994, MAR ECOL PROG SER, V103, P297; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P720; Jiang ZB, 2014, WATER RES, V54, P1, DOI 10.1016/j.watres.2014.01.032; SOGIN ML, 1987, ANN NY ACAD SCI, V503, P125, DOI 10.1111/j.1749-6632.1987.tb40603.x; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593; Sarmento H, 2010, PHILOS T R SOC B, V365, P2137, DOI 10.1098/rstb.2010.0045; Lomas MW, 2002, GLOBAL CHANGE BIOL, V8, P51, DOI 10.1046/j.1365-2486.2002.00454.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Sjostedt J, 2012, AQUAT MICROB ECOL, V66, P237, DOI 10.3354/ame01579; Tsai AY, 2013, BIOGEOSCIENCES, V10, P3055, DOI 10.5194/bg-10-3055-2013; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; SOLIC M, 1994, MAR ECOL PROG SER, V114, P219, DOI 10.3354/meps114219; Solic M, 2009, AQUAT MICROB ECOL, V58, P15, DOI 10.3354/ame01342; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Tsai AY, 2008, AQUAT MICROB ECOL, V51, P263, DOI 10.3354/ame01196; Lara E, 2013, AQUAT MICROB ECOL, V70, P17, DOI 10.3354/ame01636; Bouvy M, 2011, ENVIRON MICROBIOL, V13, P1842, DOI 10.1111/j.1462-2920.2011.02498.x; WHITE PA, 1991, MICROBIAL ECOL, V21, P99, DOI 10.1007/BF02539147; Vezzulli L, 2012, ISME J, V6, P21, DOI 10.1038/ismej.2011.89; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Yokokawa T, 2005, APPL ENVIRON MICROB, V71, P6799, DOI 10.1128/AEM.71.11.6799-6807.2005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Brown JR, 2004, BIOESSAYS, V26, P463, DOI 10.1002/bies.20030; Hao DM, 2010, MICROBES ENVIRON, V25, P126; KATO K, 1984, ARCH HYDROBIOL, V102, P177; KOGURE K, 1980, B JPN SOC SCI FISH, V46, P323; Lane JD, 1991, NUCL ACID TECHNIQUES, P115; LIM EL, 1993, APPL ENVIRON MICROB, V59, P1647; Lim EL, 1996, APPL ENVIRON MICROB, V62, P1416; Madigan MT, 2000, BIOL MICROORGANISMS, P455; Oliver J. D., 2013, Food microbiology: fundamentals and frontiers, P401; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548; Stocker T. F., 2013, CLIMATE CHANGE 2013; Takenaka T, 2007, MICROBES ENVIRONMENT, V22, P257, DOI 10.1264/jsme2.22.257; von Scheibner M., 2013, ENVIRON MICROBIOL, V16, P718; WRIGHT RT, 1983, MAR ECOL PROG SER, V11, P205, DOI 10.3354/meps011205; Yokokawa T, 2004, LIMNOL OCEANOGR, V49, P1620	44	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					91	103		10.1007/s10872-014-0264-2		13	Oceanography	Oceanography	CB0ND	WOS:000349322200008		
J	Tozuka, T; Qu, TD; Yamagata, T				Tozuka, Tomoki; Qu, Tangdong; Yamagata, Toshio			Impacts of South China Sea throughflow on the mean state and El Nino/Southern Oscillation as revealed by a coupled GCM	JOURNAL OF OCEANOGRAPHY			English	Article						South China Sea; ENSO; Coupled general circulation model; Walker circulation; South China Sea throughflow; Indonesian throughflow	INDIAN-OCEAN DIPOLE; INDONESIAN THROUGHFLOW; CIRCULATION; ENSO; CONVECTION; TRANSPORT; STRAIT; MODEL; TEMPERATURE; VARIABILITY	The South China Sea (SCS) throughflow (SCSTF) enters the SCS from the Luzon Strait and exits it through the straits to the south. Using a coupled general circulation model (CGCM), this study reveals impacts of the SCSTF on the mean state and El Nio/Southern Oscillation (ENSO). It is found that the model's sea surface temperature becomes cooler in the eastern and far western equatorial Pacific and south of Japan, but significantly warmer in the SCS, when the SCSTF is blocked. The warming in the SCS is likely a result of accumulated surface heat flux which otherwise would be transported out of the SCS by the SCSTF. Furthermore, the dominant period of ENSO is 4 years when the SCSTF is allowed, but it becomes 5 years when the SCSTF is blocked. This is because the meridional extent of zonal wind anomalies becomes broader and the Walker Circulation in the Indian Ocean becomes stronger in the no-SCSTF case. On the other hand, changes in the zonal location of zonal wind anomalies, the phase speed of baroclinic Kelvin waves, the occurrence of westerly wind bursts, and strength of atmospheric feedbacks do not contribute to the difference between the two experiments even though they are known to influence the ENSO period. The climatic importance of the SCSTF has been so far overlooked because of its small volume transport compared with other major currents in the global ocean, but the present work shows for the first time its possible impacts on ENSO.	[Tozuka, Tomoki] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Qu, Tangdong] Univ Hawaii Manoa, SOEST, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Yamagata, Toshio] JAMSTEC, Applicat Lab, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan	Tozuka, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tozuka@eps.s.u-tokyo.ac.jp	Tozuka, Tomoki/A-1805-2009; Yamagata, Toshio/A-1807-2009		Japan Society for Promotion of Science [21740341, 20340125]; NSF [OCE10-29704]	This manuscript benefitted from constructive comments from three anonymous reviewers and discussions with Drs. J. McCreary, S.P. Xie, and S. Kida. We thank the INSTANT project team for kindly providing the mooring data in the Makassar Strait (http://www.marine.csiro.au/similar to cow074/instantdata.htm). The CGCM was run on HITACHI SR11000/J1 of Information Technology Center, the University of Tokyo under the cooperative research with Atmosphere Ocean Research Institute, the University of Tokyo. Wavelet software was provided by C. Torrence and G. Compo, and is available online (http://paos.colorado.edu/research/wavelets/). T.T. and T.Y. were supported by Japan Society for Promotion of Science through Grant-in-Aid for Young Scientists (B) 21740341 and Grant-in-Aid for Scientific Research (B) 20340125, respectively. T.Q. was supported by NSF through grant OCE10-29704. School of Ocean and Earth Science and Technology contribution number 9242 and IPRC contribution number IPRC-1094.	Fang GH, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006225; Luo JJ, 2010, J CLIMATE, V23, P726, DOI 10.1175/2009JCLI3104.1; Qu TD, 2004, J CLIMATE, V17, P3644, DOI 10.1175/1520-0442(2004)017<3644:CLSTPA>2.0.CO;2; NORTH GR, 1982, MON WEATHER REV, V110, P699, DOI 10.1175/1520-0493(1982)110<0699:SEITEO>2.0.CO;2; An SI, 2000, J CLIMATE, V13, P2044, DOI 10.1175/1520-0442(2000)013<2044:ICOTSO>2.0.CO;2; Qu TD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024698; Yaremchuk M, 2009, J PHYS OCEANOGR, V39, P753, DOI 10.1175/2008JPO3955.1; Li L, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003164; Tozuka T, 2014, CLIM DYNAM, V43, P2197, DOI 10.1007/s00382-013-2044-x; Tian JW, 2009, J PHYS OCEANOGR, V39, P3191, DOI 10.1175/2009JPO3899.1; Qu TD, 2000, J PHYS OCEANOGR, V30, P1450, DOI 10.1175/1520-0485(2000)030<1450:ULCITS>2.0.CO;2; Gordon AL, 2003, NATURE, V425, P824, DOI 10.1038/nature02038; Tozuka T, 2007, J CLIMATE, V20, P2881, DOI 10.1175/JCLI4168.1; Du Y, 2010, DYNAM ATMOS OCEANS, V50, P233, DOI 10.1016/j.dynatmoce.2010.04.001; Koch-Larrouy A, 2010, CLIM DYNAM, V34, P891, DOI 10.1007/s00382-009-0642-4; Takaya K, 2001, J ATMOS SCI, V58, P608, DOI 10.1175/1520-0469(2001)058<0608:AFOAPI>2.0.CO;2; Qu TD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028350; GRAHAM NE, 1987, SCIENCE, V238, P657, DOI 10.1126/science.238.4827.657; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; BJERKNES J, 1966, TELLUS, V18, P820; Feng M, 2003, DEEP-SEA RES PT II, V50, P2263, DOI 10.1016/S0967-0645(03)00056-0; Seiki A, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015039; Sprintall J, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005257; Burgers G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024155; Wang YH, 2003, ESTUAR COAST SHELF S, V57, P193, DOI 10.1016/S0272-7714(02)00344-X; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Behera SK, 2006, J CLIMATE, V19, P1688, DOI 10.1175/JCLI3797.1; PALMER TN, 1986, Q J ROY METEOR SOC, V112, P1001, DOI 10.1002/qj.49711247406; Cai W, 2014, NATURE CLIM IN PRESS; Doi T, 2010, DYNAM ATMOS OCEANS, V50, P415, DOI 10.1016/j.dynatmoce.2010.03.001; Doi T, 2010, J CLIMATE, V23, P455, DOI 10.1175/2009JCLI3198.1; Dommenget D, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025871; EMANUEL KA, 1991, J ATMOS SCI, V48, P2313, DOI 10.1175/1520-0469(1991)048<2313:ASFRCC>2.0.CO;2; Gordon AL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036372; Guan Z, 2000, FTR1; Hautala SL, 1996, J GEOPHYS RES-OCEANS, V101, P12375, DOI 10.1029/96JC00037; Hibiya T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025218; Kida S, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008162; Levitus S., 1994, WORLD OCEAN ATLAS; Levitus S, 1994, WORLD OCEAN ATLAS, V3; Lukas R, 1996, J GEOPHYS RES-OCEANS, V101, P12209, DOI 10.1029/96JC01204; Metzger EJ, 2010, DYNAM ATMOS OCEANS, V50, P275, DOI 10.1016/j.dynatmoce.2010.04.002; Pacanowski RC, 1999, MOM 3 0 MANUAL; Sakamoto TT, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023384; SLINGO A, 1991, J GEOPHYS RES-ATMOS, V96, P15341, DOI 10.1029/91JD00930; Song Q, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020360; Susanto RD, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002425; Tozuka T, 2006, OCEAN ATMOS RES REP, V7, P44; Tozuka T, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030420; Tozuka T, 2009, DYNAM ATMOS OCEANS, V47, P73, DOI 10.1016/j.dynatmoce.2008.09.001; Tozuka T, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006717; Tozuka T, 2014, CLIM DYNAM, V42, P433, DOI 10.1007/s00382-013-1738-4; Viterbo P, 1995, 75 RES DEP; YAMAGATA T, 1989, PHILOS T R SOC A, V329, P225, DOI 10.1098/rsta.1989.0072; Yang JL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028571; Yuan CX, 2012, CLIM DYNAM, V39, P1643, DOI 10.1007/s00382-011-1204-0; ZEBIAK SE, 1987, MON WEATHER REV, V115, P2262, DOI 10.1175/1520-0493(1987)115<2262:AMENO>2.0.CO;2; Zhuang W, 2013, J GEOPHYS RES-OCEANS, V118, P6759, DOI 10.1002/2013JC009376	58	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					105	114		10.1007/s10872-014-0265-1		10	Oceanography	Oceanography	CB0ND	WOS:000349322200009		
J	Grossmann, MM; Gallager, SM; Mitarai, S				Grossmann, Mary M.; Gallager, Scott M.; Mitarai, Satoshi			Continuous monitoring of near-bottom mesoplankton communities in the East China Sea during a series of typhoons	JOURNAL OF OCEANOGRAPHY			English	Article						Typhoon; OCTOPUS cabled observatory; Trichodesmium; Benthic resuspension; Mesozooplankton	PARTICULATE ORGANIC-CARBON; CHLOROPHYLL-A; OCEAN INTERACTION; JAPAN; PACIFIC; MORAKOT; BIOMASS; WATERS; FLUX	Typhoons are a common feature of summer and autumn months in the East China Sea. These events often promote phytoplankton growth in surface waters as a result of upwelling and transport of nutrients, but their effects on sub-surface waters and ecosystems are little known. Furthermore, biological studies tend to focus on phytoplankton (using chlorophyll a assays), rather than on heterotrophic zooplankton. Indeed, using standard shipboard sampling techniques, measurements of biological and physicochemical changes induced by the storms are difficult to perform and risky. Using a camera mounted on an underwater, cabled observatory system in shallow coastal waters of Okinawa, Japan, we collected the first continuous, in situ observations of the near-bottom mesoplankton community during a series of typhoons. An increase in diatoms and radiolarians was found during all typhoons, whereas the response of larger zooplankton groups was variable between typhoons. A bloom of Trichodesmium cyanobacteria and diatoms was seen after a series of typhoons, while the total chlorophyll a concentration remained nearly unchanged at the sampling location. These findings shed new light on short-term responses of sub-surface ecosystems during typhoons.	[Grossmann, Mary M.; Mitarai, Satoshi] Okinawa Inst Sci & Technol, Marine Biophys Unit, Onna, Okinawa 9040495, Japan; [Gallager, Scott M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Grossmann, MM (reprint author), Okinawa Inst Sci & Technol, Marine Biophys Unit, 1919-1 Tancha, Onna, Okinawa 9040495, Japan.	grossmann.mary@gmail.com	Grossmann, Mary/G-3445-2013	Grossmann, Mary/0000-0002-6800-6092	Special Framework budget, Okinawa Promotion for Education and Research Project	We are grateful to the editor and two anonymous reviewers for critical and constructive comments on the manuscript. We also thank the captain and crew of the Kuroshio-maru, Amber York, and the rest of the WHOI OceanCube engineering team, Shohei Nakada and Yukiko Murayabashi, Koichi Toda, Takeshi Sannomiya, Yuko Hasegawa, and the rest of the Marine Science Resources Section, OIST, for the installation and maintenance of the OCTOPUS observatory. We also thank Steven D. Aird, for English editing of the manuscript. MMG also thanks Dr. Dhugal Lindsay, Naoto Jimi, Michitaka Shimomura, and Dr. Russell Hopcroft for help with taxonomic identification of the CPICS ROIs. This work was funded by the Special Framework budget, Okinawa Promotion for Education and Research Project awarded to OIST for the 2012 fiscal year.	Guo XY, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007292; Chen YLL, 2009, MAR ECOL PROG SER, V385, P111, DOI 10.3354/meps08053; Chung CC, 2012, MAR ECOL PROG SER, V448, P39, DOI 10.3354/meps09490; IRIARTE A, 1994, MAR ECOL PROG SER, V115, P283, DOI 10.3354/meps115283; Hung CC, 2013, J MAR RES, V71, P133; Hung CC, 2011, OCEANOGRAPHY, V24, P42; Zheng GM, 2007, MAR ECOL PROG SER, V333, P61, DOI 10.3354/meps333061; Davis CS, 2006, SCIENCE, V312, P1517, DOI 10.1126/science.1123570; Hung CC, 2010, BIOGEOSCIENCES, V7, P3007, DOI 10.5194/bg-7-3007-2010; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; D'Asaro E, 2011, OCEANOGRAPHY, V24, P24; Ye HJ, 2013, J MARINE SYST, V128, P138, DOI 10.1016/j.jmarsys.2013.04.010; Gallager SM, 1996, DEEP-SEA RES PT II, V43, P1627, DOI 10.1016/S0967-0645(96)00058-6; Hashihama F, 2013, J OCEANOGR, V69, P357, DOI 10.1007/s10872-013-0178-4; Hung CC, 2013, BIOGEOSCIENCES, V10, P6469, DOI 10.5194/bg-10-6469-2013; Japan Meteorological Agency, 2014, REG SPEC MET CTR TRO; Koh CH, 2006, MAR ECOL PROG SER, V312, P85, DOI 10.3354/meps312085; Liu HX, 2013, CONT SHELF RES, V68, P123, DOI 10.1016/j.csr.2013.08.009; MAITA Y, 1988, Journal of the Oceanographical Society of Japan, V44, P268, DOI 10.1007/BF02302569; Oksanen J., 2013, COMMUNITY ECOLOGY PA; Pun I, 2011, OCEANOGRAPHY, V24, P32; Shih YY, 2013, TERR ATMOS OCEAN SCI, V24, P899, DOI 10.3319/TAO.2013.05.23.01(Oc); Suga N, 2012, INTERDISCIPLINARY ST, P353; Tada K, 1999, LA MER, V36, P139; Tada K, 2003, J PLANKTON RES, V25, P991, DOI 10.1093/plankt/25.8.991; Tsuchiya Kenji, 2013, Plankton & Benthos Research, V8, P74; Tsuchiya K, 2014, J PLANKTON RES, V36, P424, DOI 10.1093/plankt/fbt127; Wu J, 2003, GLOBAL BIOGEOCHEMICA, V17, P1	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					115	124		10.1007/s10872-014-0268-y		10	Oceanography	Oceanography	CB0ND	WOS:000349322200010		
J	Kida, S; Yamashiki, YA				Kida, Shinichiro; Yamashiki, Yosuke A.			A layered model approach for simulating high river discharge events from land to the ocean	JOURNAL OF OCEANOGRAPHY			English	Article						Hydrological-ocean coupled model; Freshwater plume; River discharge events; Surface runoff	PLUME; SCHEMES	This study presents a new approach for simulating surface runoff, river flow, and oceanic flow. Hydrological-ocean coupled models often stitch the two models at the river mouth because they typically differ in formulation, dynamically and dimensionally. An isopycnal-layered model is shown to naturally couple hydrological and oceanic processes seamlessly with the use of a single dynamical core. Numerical experiments show the high discharge event of the Abukuma River in Japan during Typhoon Roke with realistic river flows and freshwater plumes in the ocean. The time series of the river discharge rates also match well with observations from upstream to downstream.	[Kida, Shinichiro] Japan Agcy Marine Earth Sci & Technol, Applicat Lab, Yokohama, Kanagawa 2360001, Japan; [Yamashiki, Yosuke A.] Kyoto Univ, Grad Sch Adv Integrated Studies Human Survivabil, Kyoto, Japan	Kida, S (reprint author), Japan Agcy Marine Earth Sci & Technol, Applicat Lab, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	kidas@jamstec.go.jp	Kida, Shinichiro/E-9137-2014	Kida, Shinichiro/0000-0002-9471-4316	KAKENHI [22106002, 24110006]; MEXT HPCI-SPIRE [3]	The authors thank the anonymous reviewers for many useful comments. S. Kida was supported by KAKENHI (22106002). Y. Yamashiki was supported by MEXT HPCI-SPIRE (Field 3) and KAKENHI (24110006).	Griffies SM, 2000, MON WEATHER REV, V128, P2935, DOI 10.1175/1520-0493(2000)128<2935:BFWASL>2.0.CO;2; Hallberg R, 1996, J PHYS OCEANOGR, V26, P913, DOI 10.1175/1520-0485(1996)026<0913:BDCIAO>2.0.CO;2; Hallberg R, 2006, J PHYS OCEANOGR, V36, P2232, DOI 10.1175/JPO2980.1; Paiva RCD, 2013, HYDROL PROCESS, V27, P333, DOI 10.1002/hyp.8425; Beven K, 2001, HYDROL PROCESS, V15, P1993, DOI 10.1002/hyp.252; PRICE JF, 1994, PROG OCEANOGR, V33, P161, DOI 10.1016/0079-6611(94)90027-2; MacCready P, 1999, J PHYS OCEANOGR, V29, P708, DOI 10.1175/1520-0485(1999)029<0708:EATCIR>2.0.CO;2; Nash JD, 2005, NATURE, V437, P400, DOI 10.1038/nature03936; Simpson JH, 1997, J MARINE SYST, V12, P3, DOI 10.1016/S0924-7963(96)00085-1; Cheng P, 2013, J GEOPHYS RES-OCEANS, V118, P856, DOI 10.1002/jgrc.20070; Chua VP, 2011, OCEAN MODEL, V39, P332, DOI 10.1016/j.ocemod.2011.05.007; Hallberg R, 1997, J COMPUT PHYS, V135, P54, DOI 10.1006/jcph.1997.5734; Jan S, 2013, J MAR RES, V71, P19; Isobe A, 2005, J PHYS OCEANOGR, V35, P2337, DOI 10.1175/JPO2837.1; Kato H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052928; Hetland RD, 2005, J PHYS OCEANOGR, V35, P1667, DOI 10.1175/JPO2774.1; Sugiyama M, 2010, P NATL ACAD SCI USA, V107, P571, DOI 10.1073/pnas.0903186107; Chen C., 2004, 040601 SMASTUMASSD, P183; Jin M, 1997, J HYDRAUL ENG-ASCE, V123, P166, DOI 10.1061/(ASCE)0733-9429(1997)123:3(166); Kojima T, 2003, IAHS-AISH P, P234; Nakada S., 2012, HYDROL RES LETT, V6, P47, DOI DOI 10.3178/HRL.6.47; Simpson J. E., 1999, GRAVITY CURRENTS ENV; Turner JS, 1986, J FLUID MECH, V173, P71; Wooding R. A., 1965, J HYDROL, V3, P254, DOI [10.1016/0022-1694(65)90084-3, DOI 10.1016/0022-1694(65)90085-5]; Yamashiki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03714	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					125	132		10.1007/s10872-014-0254-4		8	Oceanography	Oceanography	CB0ND	WOS:000349322200011		
J	Sakata, M; Miwa, A; Mitsunobu, S; Senga, Y				Sakata, Masahiro; Miwa, Ai; Mitsunobu, Satoshi; Senga, Yasuhiro			Relationships between trace element concentrations and the stable nitrogen isotope ratio in biota from Suruga Bay, Japan	JOURNAL OF OCEANOGRAPHY			English	Article						Coastal seawater; Food web; Trace elements; Biomagnification; Biodilution	MARINE FOOD-WEB; TROPHIC RELATIONSHIPS; MERCURY BIOMAGNIFICATION; NORTHWATER POLYNYA; WATER ORGANISMS; DELTA-N-15; SEA; BIOACCUMULATION; DELTA-C-13; FISH	Relationships between the concentrations of 13 trace elements and delta N-15 were identified to investigate the trophic-level-dependent accumulation of elements in biota from Suruga Bay, Japan. The results showed biomagnification for Hg, As and Se (very weak for As and Se), biodilution for Cd, Cu, Mn, Ni, Pb, Sb and Zn, and nontrophic relationships for Co, Cs and Mo. It is likely that the biomagnification of Hg does not differ significantly with the location, whereas some trace elements, such as As, Se and Zn, show a characteristic trophic transfer in each location, depending on the food web structure and environmental factors.	[Sakata, Masahiro; Miwa, Ai; Mitsunobu, Satoshi; Senga, Yasuhiro] Univ Shizuoka, Grad Program Environm Hlth Sci, Shizuoka 4228526, Japan; [Senga, Yasuhiro] Tokai Univ, Sch Marine Sci & Technol, Shizuoka 4248610, Japan	Sakata, M (reprint author), Univ Shizuoka, Grad Program Environm Hlth Sci, 52-1 Yada, Shizuoka 4228526, Japan.	sakatam@u-shizuoka-ken.ac.jp					Baeyens W, 2003, ARCH ENVIRON CON TOX, V45, P498, DOI 10.1007/s00244-003-2136-4; Loseto LL, 2008, J MARINE SYST, V74, P1012, DOI 10.1016/j.jmarsys.2007.10.004; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; Nfon E, 2009, SCI TOTAL ENVIRON, V407, P6267, DOI 10.1016/j.scitotenv.2009.08.032; KIDD KA, 1995, WATER AIR SOIL POLL, V80, P1011, DOI 10.1007/BF01189756; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Lavoie RA, 2010, SCI TOTAL ENVIRON, V408, P5529, DOI 10.1016/j.scitotenv.2010.07.053; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Atwell L, 1998, CAN J FISH AQUAT SCI, V55, P1114, DOI 10.1139/cjfas-55-5-1114; Bisi TL, 2012, ECOL INDIC, V18, P291, DOI 10.1016/j.ecolind.2011.11.015; Jarman WM, 1996, ENVIRON SCI TECHNOL, V30, P654, DOI 10.1021/es950392n; Rahman MA, 2012, ENVIRON RES, V116, P118, DOI 10.1016/j.envres.2012.03.014; Fisk AT, 2001, ENVIRON SCI TECHNOL, V35, P732, DOI 10.1021/es001459w; Jaeger I, 2009, SCI TOTAL ENVIRON, V407, P4744, DOI 10.1016/j.scitotenv.2009.04.004; Wagemann R, 1998, SCI TOTAL ENVIRON, V218, P19, DOI 10.1016/S0048-9697(98)00192-2; Al-Reasi HA, 2007, ENVIRON TOXICOL CHEM, V26, P1572, DOI 10.1897/06-359R.1; Di Beneditto APM, 2012, ARCH ENVIRON CON TOX, V62, P264, DOI 10.1007/s00244-011-9701-z; Asante KA, 2008, ENVIRON POLLUT, V156, P862, DOI 10.1016/j.envpol.2008.05.020; Asante KA, 2010, MAR POLLUT BULL, V60, P1560, DOI 10.1016/j.marpolbul.2010.04.011; Borga K, 2011, INTEGR ENVIRON ASSES, DOI [10.1002/ieam.244, DOI 10.1002/IEAM.244]; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Dehn LA, 2006, SCI TOTAL ENVIRON, V362, P103, DOI 10.1016/j.scitotenv.2005.11.012; FRANCESCONI KA, 1992, MAR ENVIRON RES, V33, P189, DOI 10.1016/0141-1136(92)90148-F; Friberg L, 1979, HDB METAL TOXICOLOGY; Fry B., 1984, MAR SCI, V27, P13; Gantner N, 2010, ENVIRON TOXICOL CHEM, V29, P621, DOI 10.1002/etc.95; Ikemoto T, 2008, ARCH ENV CONTAM TOXI, V62, P264; Ruangsomboon S, 2006, AQUAT TOXICOL, V78, P15, DOI 10.1016/j.aquatox.2006.01.015; Sohrin Y, 2002, B COAST OCEANOGR, V40, P21; Stewart BC, 2004, ENVIRON SCI TECHNOL, V38, P4519; Watanabe I, 2002, CHIKYUKAGAKU, V36, P179	33	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					141	149		10.1007/s10872-014-0261-5		9	Oceanography	Oceanography	CB0ND	WOS:000349322200013		
J	Sato-Takabe, Y; Suzuki, S; Shishikura, R; Hamasaki, K; Tada, Y; Kataoka, T; Yokokawa, T; Yoshie, N; Suzuki, S				Sato-Takabe, Yuki; Suzuki, Shotaro; Shishikura, Ryuki; Hamasaki, Koji; Tada, Yuya; Kataoka, Takafumi; Yokokawa, Taichi; Yoshie, Naoki; Suzuki, Satoru			Spatial distribution and cell size of aerobic anoxygenic phototrophic bacteria in the Uwa Sea, Japan	JOURNAL OF OCEANOGRAPHY			English	Article						Aerobic anoxygenic phototrophic bacteria; Photoheterotrophy; Bacterial cell size; Bacterial biovolume; The Uwa Sea	GRAZING MORTALITY-RATES; SETO INLAND SEA; BOTTOM INTRUSION; GROWTH-RATES; PHOTOHETEROTROPHIC BACTERIA; SEASONAL-CHANGES; PACIFIC-OCEAN; BUNGO CHANNEL; UCHIUMI BAY; COASTAL SEA	Aerobic anoxygenic phototrophic bacteria (AAnPB) are bacteriochlorophyll a-containing photoheterotrophic organisms that rely on phototrophy and heterotrophy processes for energy acquisition. Here, we demonstrate the ubiquitous distribution of AAnPB in the Uwa Sea and their relatively larger cell size among members of the bacteria community. The contribution of AAnPB in terms of cell number to the total bacterial abundance ranged from 3.5 % to 7.9 %. The mean cell volume for AAnPB was 2.78 +/- A 0.72 times larger than the mean cell volume of the total bacteria. The ratio of the contribution of their biovolume to the total bacteria was estimated to be 9.7-22 %.	[Sato-Takabe, Yuki; Kataoka, Takafumi; Yokokawa, Taichi; Yoshie, Naoki; Suzuki, Satoru] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908577, Japan; [Suzuki, Shotaro; Shishikura, Ryuki; Hamasaki, Koji; Tada, Yuya] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Sato-Takabe, Y (reprint author), Ehime Univ, Ctr Marine Environm Studies, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	takabe.yuki.mf@ehime-u.ac.jp			Special Research Grant in Ehime University	We thank Prof. Shin-ichi Uye for his arranging the Toyoshio-maru cruise (Hiroshima University), the captain and crews of the ship, and many other colleagues on board for their assistance in collecting samples during the cruises. We also thank Prof. Koji Suzuki and Dr. Eisuke Tsutsumi for their helpful support. This study was funded in part by a Special Research Grant in Ehime University.	ANDERSSON A, 1986, MAR ECOL PROG SER, V33, P51, DOI 10.3354/meps033051; Koblizek M, 2007, ENVIRON MICROBIOL, V9, P2401, DOI 10.1111/j.1462-2920.2007.01354.x; Cottrell MT, 2006, APPL ENVIRON MICROB, V72, P557, DOI 10.1128/AEM.72.1.557-564.2006; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583; Lamy D, 2011, BIOGEOSCIENCES, V8, P973, DOI 10.5194/bg-8-973-2011; Ferrera I, 2011, APPL ENVIRON MICROB, V77, P7451, DOI 10.1128/AEM.00208-11; Masin M, 2006, AQUAT MICROB ECOL, V45, P247, DOI 10.3354/ame045247; Zhang Y, 2007, FEMS MICROBIOL ECOL, V61, P459, DOI 10.1111/j.1574-6941.2007.00355.x; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Takeoka H, 2002, J OCEANOGR, V58, P93, DOI 10.1023/A:1015828818202; Kolber ZS, 2000, NATURE, V407, P177; Pernthaler J, 1996, AQUAT MICROB ECOL, V10, P255, DOI 10.3354/ame010255; Cottrell MT, 2009, APPL ENVIRON MICROB, V75, P4958, DOI 10.1128/AEM.00117-09; Lami R, 2007, APPL ENVIRON MICROB, V73, P4198, DOI 10.1128/AEM.02652-06; Hirose M, 2008, J PLANKTON RES, V30, P241, DOI 10.1093/plankt/fbm101; Zeder M, 2011, MICROSC MICROANAL, V17, P799, DOI 10.1017/S1431927611012104; Chen Y, 2011, HYDROBIOLOGIA, V661, P435, DOI 10.1007/s10750-010-0553-8; Sieracki ME, 2006, LIMNOL OCEANOGR, V51, P38; Lamy D, 2011, AQUAT MICROB ECOL, V62, P153, DOI 10.3354/ame01467; Yokokawa T, 2005, APPL ENVIRON MICROB, V71, P6799, DOI 10.1128/AEM.71.11.6799-6807.2005; Gasol JM, 1995, MAR ECOL PROG SER, V128, P91, DOI 10.3354/meps128091; Hamaoka H, 2014, AQUAT ECOL, V48, P63, DOI 10.1007/s10452-013-9466-8; Hirose M, 2008, ESTUAR COAST SHELF S, V76, P293, DOI 10.1016/j.ecss.2007.07.030; Ichinotsuka D, 2010, AQUAT BIOL, V9, P123, DOI 10.3354/ab00240; Ichinotsuka D, 2006, AQUAT MICROB ECOL, V42, P139, DOI 10.3354/ame042139; Kaneda A, 2002, J OCEANOGR, V58, P547, DOI 10.1023/A:1021262609923; Katano T, 2005, MAR ECOL PROG SER, V298, P59, DOI 10.3354/meps298059; Katano T, 2007, AQUAT MICROB ECOL, V46, P191, DOI 10.3354/ame046191; Lebaron P, 1999, AQUAT MICROB ECOL, V19, P255, DOI 10.3354/ame019255; Nakano S, 2004, AQUAT ECOL, V38, P485, DOI 10.1007/s10452-004-0441-2	31	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	FEB	2015	71	1					151	159		10.1007/s10872-014-0267-z		9	Oceanography	Oceanography	CB0ND	WOS:000349322200014		
J	Koyama, S; Sairenchi, T; Shimura, N; Arisaka, O				Koyama, Satomi; Sairenchi, Toshimi; Shimura, Naoto; Arisaka, Osamu			Association between Timing of Adiposity Rebound and Body Weight Gain during Infancy	JOURNAL OF PEDIATRICS			English	Article							CORONARY-HEART-DISEASE; CATCH-UP GROWTH; MASS INDEX; PREDICTING OBESITY; INSULIN-RESISTANCE; YOUNG ADULTHOOD; CHILDHOOD; RISK; COHORT; CHILDREN	Objective To investigate whether increments of weight gain in early infancy are related to the timing of adiposity rebound (AR). Study design A total of 271 children (147 boys and 124 girls) in 1 community were enrolled in the study. Serial measurements of body mass index were carried out at the ages of 4, 8, and 12 months and 1.5, 2, 3, 4, 5, 6, 7, 8, 9, and 10 years, based on which the age of AR was determined. We also calculated body weight increments in 3 separate periods: birth to 4 months, 4-8 months, and 8-12 months. Results There was no significant relationship between weight gain in any period of infancy and the age of AR. Weight gain between birth and 4 months was positively correlated only with body mass index at 7 years of age. Conclusions We could not find an association between body weight gain during infancy and the timing of AR. This suggests that infantile weight gain is not related to childhood obesity through AR.	[Koyama, Satomi; Shimura, Naoto; Arisaka, Osamu] Dokkyo Med Univ, Dept Pediat, Mibu, Tochigi 3210293, Japan; [Sairenchi, Toshimi] Dokkyo Med Univ, Dept Publ Hlth, Mibu, Tochigi 3210293, Japan	Koyama, S (reprint author), Dokkyo Med Univ, Dept Pediat, Mibu, Tochigi 3210293, Japan.	s-koyama@dokkyomed.ac.jp			Ministry of Health, Labor, and Welfare of Japan	Supported by the Ministry of Health, Labor, and Welfare of Japan. The authors declare no conflicts of interest.	Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Levy-Marchal C, 2010, J CLIN ENDOCR METAB, V95, P5189, DOI 10.1210/jc.2010-1047; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Eriksson JG, 1999, BRIT MED J, V318, P427; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Ong KK, 2004, DIABETOLOGIA, V47, P1064, DOI 10.1007/s00125-004-1405-8; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Reilly JJ, 2005, BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Baird J, 2005, BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Lundgren EM, 2001, J HYPERTENS, V19, P1533, DOI 10.1097/00004872-200109000-00003; Chivers P, 2010, INT J OBESITY, V34, P1169, DOI 10.1038/ijo.2010.61; Williams SM, 2009, OBESITY, V17, P335, DOI 10.1038/oby.2008.547; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Freedman DS, 2001, INT J OBESITY, V25, P543, DOI 10.1038/sj.ijo.0801581; Koyama S, 2014, PEDIATRICS, V133, pE114, DOI 10.1542/peds.2013-0966; Kroke A, 2006, INT J OBESITY, V30, P261, DOI 10.1038/sj.ijo.0803143; MELLBIN T, 1976, BRIT J PREV SOC MED, V30, P233; ROLLANDCACHERA MF, 1987, ANN HUM BIOL, V14, P219, DOI 10.1080/03014468700008991; Rolland-Cachera MF, 1995, OBES REV, V19, P573; Rolland-Cachera MF, 2013, WORLD REV NUTR DIET, V106, P127, DOI 10.1159/000342564; Schroeder DG, 1999, AM J EPIDEMIOL, V149, P177; Sugiura R, 2011, PEDIATR INT, V53, P643, DOI 10.1111/j.1442-200X.2011.03322.x; Wadsworth M, 2005, DIABETOLOGIA, V48, P2505, DOI 10.1007/s00125-005-0007-4	31	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2015	166	2					309	312		10.1016/j.jpeds.2014.10.003		4	Pediatrics	Pediatrics	AZ8XY	WOS:000348496200026		
J	Takenouchi, T; Yamaguchi, Y; Tanikawa, A; Kosaki, R; Okano, H; Kosaki, K				Takenouchi, Toshiki; Yamaguchi, Yu; Tanikawa, Akiko; Kosaki, Rika; Okano, Hideyuki; Kosaki, Kenjiro			Novel Overgrowth Syndrome Phenotype Due to Recurrent De Novo PDGFRB Mutation	JOURNAL OF PEDIATRICS			English	Article							BASAL GANGLIA CALCIFICATION; FACTOR-RECEPTOR-BETA; BLOOD-BRAIN-BARRIER; INFANTILE MYOFIBROMATOSIS; TYROSINE KINASES; AUTOINHIBITION; PERICYTES; DISEASE	Using exome analysis, we identified a novel overgrowth syndrome arising from a mutation in PDGFRB, which plays a critical role in growth and differentiation. This entity is characterized by somatic overgrowth, distinctive facial features, hyperelastic and fragile skin, white matter lesions, and neurologic deterioration.	[Takenouchi, Toshiki; Yamaguchi, Yu] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Tanikawa, Akiko] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan; [Kosaki, Rika] Natl Ctr Child Hlth & Dev, Div Med Genet, Tokyo, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo 1608582, Japan	Kosaki, K (reprint author), Keio Univ, Sch Med, Ctr Med Genet, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kkosaki@z3.keio.jp	Okano, Hideyuki/J-5973-2013		Research on Applying Health Technology from the Ministry of Health, Labour and Welfare [H23-013]; Leading Project for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	Supported by Research on Applying Health Technology (H23-013) from the Ministry of Health, Labour and Welfare, and the Leading Project for Realization of Regenerative Medicine, Support for the Core Institutes for iPS cell research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. H.O. is a scientific consultant to San Bio, Co Ltd., and Daiichi Sankyo Co, Ltd. The other authors declare no conflicts of interest.	Apperley JF, 2002, NEW ENGL J MED, V347, P481, DOI 10.1056/NEJMoa020150; Martignetti JA, 2013, AM J HUM GENET, V92, P1001, DOI 10.1016/j.ajhg.2013.04.024; Oliveira JRM, 2004, NEUROLOGY, V63, P2165; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Neylon OM, 2012, CURR OPIN PEDIATR, V24, P505, DOI 10.1097/MOP.0b013e3283558995; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MORI S, 1993, EMBO J, V12, P2257; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Cheung YH, 2013, AM J HUM GENET, V92, P996, DOI 10.1016/j.ajhg.2013.04.026; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Lemos RR, 2013, INT REV NEUROBIOL, V110, P349, DOI 10.1016/B978-0-12-410502-7.00015-6; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; Watanabe K, 2011, J PEDIATR ORTHOPED, V31, P186, DOI 10.1097/BPO.0b013e3182093da5	19	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2015	166	2					483	486		10.1016/j.jpeds.2014.10.015		4	Pediatrics	Pediatrics	AZ8XY	WOS:000348496200056		
J	Abe, MF; Sai, S; Kosugiyama, K				Abe, Michiko F.; Sai, Shuji; Kosugiyama, Kiyotaka			Neonatal Airway Infection Due to Herpes Simplex Virus	JOURNAL OF PEDIATRICS			English	Editorial Material									[Abe, Michiko F.; Sai, Shuji; Kosugiyama, Kiyotaka] Teine Keijinkai Hosp, Dept Pediat, Sapporo, Hokkaido, Japan	Abe, MF (reprint author), Teine Keijinkai Hosp, Dept Pediat, Sapporo, Hokkaido, Japan.						Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; NADEL S, 1992, J PEDIATR-US, V120, P127, DOI 10.1016/S0022-3476(05)80616-X	2	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2015	166	2					493	+		10.1016/j.jpeds.2014.10.035		2	Pediatrics	Pediatrics	AZ8XY	WOS:000348496200061		
J	Hara, T; Huang, Y; Ito, A; Kawakami, T; Hojo, H; Murata, M				Hara, Toshiaki; Huang, Yue; Ito, Akihiro; Kawakami, Toru; Hojo, Hironobu; Murata, Michio			Trifluoroethanol-containing RP-HPLC mobile phases for the separation of transmembrane peptides human glycophorin-A, integrin alpha-1, and p24: analysis and prevention of potential side reactions due to formic acid	JOURNAL OF PEPTIDE SCIENCE			English	Article						transmembrane peptide; HPLC analysis; peptide purification; 2,2,2-trifluoroethanol-containing mobile phase; formylation; deformylation	PERFORMANCE LIQUID-CHROMATOGRAPHY; MELANOCYTE-STIMULATING HORMONE; HYDROPHOBIC PEPTIDES; MASS-SPECTROMETRY; MEMBRANE-PROTEIN; PURIFICATION; DOMAIN; FORMYLATION; SOLVENTS; VACCINE	Reversed-phase high-pressure liquid chromatography analysis and purification of three hydrophobic, aggregation-prone peptides, composed mainly of the transmembrane (TM) sequence, were performed using elution systems containing 2,2,2-trifluoroethanol (TFE). The addition of 10-16% TFE to a common mobile phase, such as a water/acetonitrile/propanol (PrOH) or a water/PrOH/formic acid system, markedly improved the chromatographic separation of these peptides. The superior performance of TFE-containing systems in separating peptides over water/PrOH/formic acid systems [Bollhagen R. et al., J. Chromatogr. A, 1995; 711: 181-186.] clearly demonstrated that adding TFE to the mobile phase is one of best methods for TM-peptide purification. Characterization of the potential side reactions using MALDI and ESI-LIT/Orbitrap mass spectrometry indicated that prolonged incubation of peptides in a mixture of TFE-formic acid possibly induces O-formylation of the Ser residue and N-formylation of the N-terminus of peptides. The conditions for selective removal of the formyl groups from TM peptides were also screened. We believe that these results will expand our ability to analyze and prepare hydrophobic, aggregation-prone TM peptides and proteins. Copyright (c) 2014 European Peptide Society and John Wiley & Sons, Ltd.	[Hara, Toshiaki; Huang, Yue; Ito, Akihiro; Murata, Michio] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Hara, Toshiaki; Murata, Michio] Osaka Univ, Lipid Act Struct Project, JST ERATO, Toyonaka, Osaka 5600043, Japan; [Hara, Toshiaki; Murata, Michio] Osaka Univ, Project Res Ctr Fundamental Sci, Toyonaka, Osaka 5600043, Japan; [Kawakami, Toru; Hojo, Hironobu] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Hara, T (reprint author), Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan.	harat11@chem.sci.osaka-u.ac.jp					Mengerink Y, 2000, J CHROMATOGR A, V871, P259, DOI 10.1016/S0021-9673(99)01072-9; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Subiros-Funosas R, 2009, CHEM-EUR J, V15, P9394, DOI 10.1002/chem.200900614; Kondejewski LH, 1996, J BIOL CHEM, V271, P25261; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; Kawakami T, 2013, B CHEM SOC JPN, V86, P690, DOI 10.1246/bcsj.20130026; Valiyaveetil FI, 2002, J AM CHEM SOC, V124, P9113, DOI 10.1021/ja0266722; Maurya IK, 2013, J BIOL CHEM, V288, P16775, DOI 10.1074/jbc.M113.467159; Clive KS, 2012, J SURG ONCOL, V105, P452, DOI 10.1002/jso.21723; BOLLHAGEN R, 1995, J CHROMATOGR A, V711, P181, DOI 10.1016/0021-9673(95)00056-S; Carmichael MG, 2010, CANCER, V116, P292, DOI 10.1002/cncr.24756; Dais J, 2005, RAPID COMMUN MASS SP, V19, P1130; DEMPSEY CE, 1982, J CHEM SOC PERK T 1, P2625, DOI 10.1039/p19820002625; Dittmann M, 2014, J PEPT SCI, V20, P137, DOI 10.1002/psc.2605; Duewell HS, 1998, J PROTEIN CHEM, V17, P337, DOI 10.1023/A:1022555232364; Fisher LE, 2001, ANAL BIOCHEM, V293, P102, DOI 10.1006/abio.2001.5122; Glover KJ, 1999, ANAL BIOCHEM, V272, P270, DOI 10.1006/abio.1999.4182; GOODLETT DR, 1990, ANAL BIOCHEM, V186, P116, DOI 10.1016/0003-2697(90)90583-U; HEUKESHOVEN J, 1982, J CHROMATOGR, V252, P241, DOI 10.1016/S0021-9673(01)88415-6; Kassim SY, 1998, J CHROMATOGR A, V816, P11, DOI 10.1016/S0021-9673(98)00250-7; KIENHUIS H, 1959, NATURE, V184, P2015, DOI 10.1038/1842015a0; Lis A, 2001, ANAL CHEM, V73, P5395; Lis Y, 2010, MASS SPECTROM, V45, P587; Loos RR, 2007, ANAL CHEM, V79, P1115; MARRIQ C, 1985, J CHROMATOGR, V323, P395, DOI 10.1016/S0021-9673(01)90401-7; Mas C, 2002, PROTEIN SCI, V11, P546; NARITA K, 1959, J AM CHEM SOC, V81, P1751, DOI 10.1021/ja01516a057; Oliveira E, 1997, J PEPT RES, V49, P300; Sato T, 2002, J PEPT SCI, V8, P172, DOI 10.1002/psc.381; SHEUMACK DD, 1988, ANAL BIOCHEM, V174, P548, DOI 10.1016/0003-2697(88)90054-1; WELINDER BS, 1991, J CHROMATOGR, V537, P181, DOI 10.1016/S0021-9673(01)88894-4; Wutss PGM, 2006, GREENES PROTECTIVE G, P222; YAJIMA H, 1968, J AM CHEM SOC, V90, P527, DOI 10.1021/ja01004a078; YAJIMA H, 1968, CHEM PHARM BULL, V16, P919	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1075-2617	1099-1387		J PEPT SCI	J. Pept. Sci.	FEB	2015	21	2					61	70		10.1002/psc.2717		10	Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CA4VF	WOS:000348903300001		
J	Mitani, A; Niedbala, W; Fujimura, T; Mogi, M; Miyamae, S; Higuchi, N; Abe, A; Hishikawa, T; Mizutani, M; Ishihara, Y; Nakamura, H; Kurita, K; Ohno, N; Tanaka, Y; Hattori, M; Noguchi, T				Mitani, Akio; Niedbala, Wanda; Fujimura, Takeki; Mogi, Makio; Miyamae, Shin; Higuchi, Naoya; Abe, Atsushi; Hishikawa, Toshimitsu; Mizutani, Makoto; Ishihara, Yuichi; Nakamura, Hiroshi; Kurita, Kenichi; Ohno, Norikazu; Tanaka, Yoshinobu; Hattori, Masami; Noguchi, Toshihide			Increased Expression of Interleukin (IL)-35 and IL-17, But Not IL-27, in Gingival Tissues With Chronic Periodontitis	JOURNAL OF PERIODONTOLOGY			English	Article						Gingival crevicular fluid; interleukin-17; interleukin-27; interleukin-35; human; periodontal diseases	COLLAGEN-INDUCED ARTHRITIS; REGULATORY T-CELLS; KAPPA-B LIGAND; CREVICULAR FLUID; CARTILAGE DESTRUCTION; RHEUMATOID-ARTHRITIS; RECEPTOR ANTAGONIST; ADULT PERIODONTITIS; BONE DESTRUCTION; FAMILY-MEMBERS	Background: Interleukin (IL)-35 plays an important role in immune regulation through the suppression of effector T-cell populations, including T-helper 17 (Th17) cells. Although Th17 cells and IL-17 are involved in the pathogenesis of periodontitis, the level of IL-35 in inflamed periodontal tissues is unclear. Here, IL-35, IL-17, and IL-27 production/expression in gingival crevicular fluid (GCF) and human gingival tissue were investigated. Methods: GCF samples were collected from buccal (mesial, center, and distal) sites of teeth from patients with chronic periodontitis (CP) and healthy controls and were analyzed by enzyme-linked immuno-sorbent assay for IL-35 (periodontitis, n = 36; healthy, n = 30) and IL-17 (periodontitis, n = 16; healthy, n = 13). Gingival tissue, including sulcus/pocket epithelium and underlying connective tissue, was collected from an additional 10 healthy participants and 10 patients with CP and were analyzed by quantitative polymerase chain reaction (qPCR) for Epstein Barr virus-induced gene 3 (EBI3), IL12A, and IL17A. IL27p28 was also tested by qPCR. Results: IL-35 and IL-17 were significantly higher in GCF from patients with periodontitis than healthy participants (P < 0.01, P < 0.05, respectively). In both healthy participants and those with periodontitis, positive correlations were found among IL-35 and probing depth and clinical attachment level (CAL) as well as between IL-17 and CAL. EBI3, IL12A (components of IL-35), and IL17A messenger RNA expression levels were significantly higher in inflamed gingival tissue than in healthy control tissues (P < 0.05). IL27p28 was not detected in any sample, suggesting that IL-27 is not produced in large quantities in periodontal tissue. Conclusion: IL-35 and IL-17, but not IL-27, may play important roles in the pathogenesis of periodontitis.	[Mitani, Akio; Fujimura, Takeki; Hishikawa, Toshimitsu; Ishihara, Yuichi; Noguchi, Toshihide] Aichi Gakuin Univ, Sch Dent, Dept Periodont, Nagoya, Aichi 4648651, Japan; [Mitani, Akio; Niedbala, Wanda] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow, Lanark, Scotland; [Mitani, Akio; Niedbala, Wanda] Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland; [Mogi, Makio] Aichi Gakuin Univ, Sch Pharm, Dept Med Biochem, Nagoya, Aichi 4648651, Japan; [Miyamae, Shin; Hattori, Masami] Aichi Gakuin Univ, Sch Dent, Dept Gerontol, Nagoya, Aichi 4648651, Japan; [Higuchi, Naoya; Nakamura, Hiroshi] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi 4648651, Japan; [Abe, Atsushi; Kurita, Kenichi] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Surg 1, Nagoya, Aichi 4648651, Japan; [Mizutani, Makoto; Ohno, Norikazu] Aichi Gakuin Univ, Sch Dent, Dept Oral Anat, Nagoya, Aichi 4648651, Japan; [Tanaka, Yoshinobu] Aichi Gakuin Univ, Sch Dent, Dept Removable Prosthodont, Nagoya, Aichi 4648651, Japan	Mitani, A (reprint author), Aichi Gakuin Univ, Sch Dent, Dept Periodont, Chikusa Ku, 2-11 Suemori Dori, Nagoya, Aichi 4648651, Japan.	minita@dpc.agu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [21792134];  [24593134]	The authors thank Prof. Eddy FY Liew from the University of Glasgow for his helpful advice. This study was supported by Ministry of Education, Culture, Sports, Science, and Technology Grant-in-Aid for Young Scientists (B) 21792134 and Grant-in-Aid for Scientific Research (C) 24593134. The authors report no conflicts of interest related to this study.	Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.2007378101; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116; Gaffen SL, 2008, J DENT RES, V87, P817; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Ishihara Y, 1997, J PERIODONTAL RES, V32, P524, DOI 10.1111/j.1600-0765.1997.tb00568.x; Chapple ILC, 1999, J PERIODONTAL RES, V34, P79, DOI 10.1111/j.1600-0765.1999.tb02226.x; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; REINHARDT RA, 1993, J CLIN PERIODONTOL, V20, P225, DOI 10.1111/j.1600-051X.1993.tb00348.x; Beklen A, 2007, J DENT RES, V86, P347; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Gilowski L, 2014, ARCH ORAL BIOL, V59, P729, DOI 10.1016/j.archoralbio.2014.04.007; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Sandros J, 2000, J DENT RES, V79, P1808; Takahashi S, 2014, J PERIODONTAL RES, V49, P390, DOI 10.1111/jre.12118; Neurath MF, 2008, MUCOSAL IMMUNOL, V1, pS28, DOI 10.1038/mi.2008.45; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Kochetkova I, 2010, J IMMUNOL, V184, P7144, DOI 10.4049/jimmunol.0902739; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Koenders MI, 2005, ARTHRITIS RHEUM, V52, P3239, DOI 10.1002/art.21342; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Abe T, 2012, J IMMUNOL, V189, P5442, DOI 10.4049/jimmunol.1202339; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Engebretson SP, 1999, J PERIODONTOL, V70, P567, DOI 10.1902/jop.1999.70.6.567; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Mogi M, 2004, J DENT RES, V83, P166; Lubberts E, 2004, ARTHRITIS RHEUM, V50, P650, DOI 10.1002/art.2001; Vernal R, 2005, J CLIN PERIODONTOL, V32, P383, DOI 10.1111/j.1600-051X.2005.00684.x; Kotake S, 2001, ARTHRITIS RHEUM, V44, P1003, DOI 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#; Dutzan N, 2009, J CLIN PERIODONTOL, V36, P396, DOI 10.1111/j.1600-051X.2009.01390.x; GENCO RJ, 1992, J PERIODONTOL, V63, P338, DOI 10.1902/jop.1992.63.4s.338; GRBIC JT, 1991, J PERIODONTOL, V62, P322; Gumus P, 2013, J PERIODONTOL, V84, P1627, DOI 10.1902/jop.2013.120595; Ju JH, 2008, IMMUNOL LETT, V117, P16, DOI 10.1016/j.imlet.2007.09.011; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; LUNDQVIST C, 1994, J IMMUNOL, V153, P2302; Niedbala W, 2011, P NATL ACAD SCI USA, V108, P9220, DOI 10.1073/pnas.1100667108; Roberts FA, 1997, J DENT RES, V76, P1833; Takahashi K, 2005, J CLIN PERIODONTOL, V32, P369, DOI 10.1111/j.1600-051X.2005.00676.x; Zhao L, 2011, J CLIN PERIODONTOL, V38, P509, DOI 10.1111/j.1600-051X.2011.01712.x	46	1	1	AMER ACAD PERIODONTOLOGY	CHICAGO	737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA	0022-3492	1943-3670		J PERIODONTOL	J. Periodont.	FEB	2015	86	2					301	309		10.1902/jop.2014.140293		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CB1IK	WOS:000349380500016		
J	Volkin, DB; Hershenson, S; Ho, RJY; Uchiyama, S; Winter, G; Carpenter, JF				Volkin, David B.; Hershenson, Susan; Ho, Rodney J. Y.; Uchiyama, Susumu; Winter, Gerhard; Carpenter, John F.			Two Decades of Publishing Excellence in Pharmaceutical Biotechnology	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Editorial Material							FDA DRUG APPROVALS; THERAPEUTICS; PARTICLES; QUALITY; TRENDS		[Volkin, David B.] Univ Kansas, Dept Pharmaceut Chem, Macromol & Vaccine Stabilizat Ctr, Lawrence, KS 66047 USA; [Hershenson, Susan] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA; [Ho, Rodney J. Y.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Ho, Rodney J. Y.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Winter, Gerhard] Univ Munich, Dept Pharm Pharmaceut Technol & Biopharmaceut, D-81377 Munich, Germany; [Carpenter, John F.] Univ Colorado, Dept Pharmaceut Sci, Ctr Pharmaceut Biotechnol, Aurora, CO 80045 USA	Carpenter, JF (reprint author), Univ Colorado, Dept Pharmaceut Sci, Ctr Pharmaceut Biotechnol, Anschutz Med Campus, Aurora, CO 80045 USA.	volkin@ku.edu; John.Carpenter@ucdenver.edu					Singh SK, 2010, J PHARM SCI-US, V99, P3302, DOI 10.1002/jps.22097; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Mach H, 2006, J PHARM SCI-US, V95, P2195, DOI 10.1002/jps.20696; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Mullard A, 2014, NAT REV DRUG DISCOV, V13, P85, DOI 10.1038/nrd4239; Shealy D, 2010, MABS-AUSTIN, V2, P428; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P87, DOI 10.1038/nrd3946; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Clark HF, 2003, PEDIATR INFECT DIS J, V22, P914, DOI 10.1097/01.inf.0000091887.48999.77; Carpenter JF, 2010, J PHARM SCI-US, V99, P2200, DOI 10.1002/jps.21989; Ho RJY, 2012, J PHARM SCI-US, V101, P2668, DOI 10.1002/jps.23154; Ho RJY, 2003, BIOTECHNOLOGY BIOPHA, P3; Ho RJY., 2013, BIOTECHNOLOGY BIOPHA, P427; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P91, DOI 10.1038/nrd3657; US Food and Drug Administration Website, BIOL APPR YEAR	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	FEB	2015	104	2			SI		290	300		10.1002/jps.24285		11	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA7HX	WOS:000349089500003		
J	Krayukhina, E; Tsumoto, K; Uchiyama, S; Fukui, K				Krayukhina, Elena; Tsumoto, Kouhei; Uchiyama, Susumu; Fukui, Kiichi			Effects of Syringe Material and Silicone Oil Lubrication on the Stability of Pharmaceutical Proteins	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						protein aggregation; prefilled syringe; physical stability; silicone oil; biopharmaceuticals characterization; subvisible particles; HPLC (high-performance; pressure liquid chromatography); analytical ultracentrifugation; UV; Vis spectroscopy; imaging methods	SIZE-EXCLUSION CHROMATOGRAPHY; FIELD-FLOW FRACTIONATION; ANALYTICAL ULTRACENTRIFUGATION; SEDIMENTATION-VELOCITY; SUBVISIBLE PARTICLES; MONOCLONAL-ANTIBODY; AGGREGATION; QUANTITATION; QUALITY; IMMUNOGENICITY	Currently, polymer-based prefillable syringes are being promoted to the pharmaceutical market because they provide an increased break resistance relative to traditionally used glass syringes. Despite this significant advantage, the possibility that barrel material can affect the oligomeric state of the protein drug exists. The present study was designed to compare the effect of different syringe materials and silicone oil lubrication on the protein aggregation. The stability of a recombinant fusion protein, abatacept (Orencia), and a fully human recombinant immunoglobulin G1, adalimumab (Humira), was assessed in silicone oil-free (SOF) and silicone oil-lubricated 1-mL glass syringes and polymer-based syringes in accelerated stress study. Samples were subjected to agitation stress, and soluble aggregate levels were evaluated by size-exclusion chromatography and verified with analytical ultracentrifugation. In accordance with current regulatory expectations, the amounts of subvisible particles resulting from agitation stress were estimated using resonant mass measurement and dynamic flow-imaging analyses. The amount of aggregated protein and particle counts were similar between unlubricated polymer-based and glass syringes. The most significant protein loss was observed for lubricated glass syringes. These results suggest that newly developed SOF polymer-based syringes are capable of providing biopharmaceuticals with enhanced physical stability upon shipping and handling. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:527-535, 2015	[Krayukhina, Elena; Uchiyama, Susumu; Fukui, Kiichi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Krayukhina, Elena] U Med Inc, Suita, Osaka 5650871, Japan; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	Uchiyama, S (reprint author), Osaka Univ, Grad Sch Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	suchi@bio.eng.osaka-u.ac.jp; kfukui@bio.eng.osaka-u.ac.jp					Singh SK, 2010, J PHARM SCI-US, V99, P3302, DOI 10.1002/jps.22097; Maa YF, 1997, BIOTECHNOL BIOENG, V54, P503, DOI 10.1002/(SICI)1097-0290(19970620)54:6<503::AID-BIT1>3.0.CO;2-N; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Liu J, 2006, AAPS J, V8, pE580, DOI 10.1208/aapsj080367; Majumdar S, 2011, J PHARM SCI-US, V100, P2563, DOI 10.1002/jps.22515; Krayukhina E, 2013, J BIOSCI BIOENG, V115, P104, DOI 10.1016/j.jbiosc.2012.07.021; Rudiuk S, 2012, SOFT MATTER, V8, P2651, DOI 10.1039/c2sm07017k; Liu L, 2013, J PHARM SCI-US, V102, P2460, DOI 10.1002/jps.23622; Patel AR, 2012, ANAL CHEM, V84, P6833, DOI 10.1021/ac300976g; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P359; Fradkin AH, 2011, J PHARM SCI-US, V100, P4953, DOI 10.1002/jps.22683; Schuck P, 2000, BIOPHYS J, V78, P1606; Berkowitz SA, 2006, AAPS J, V8, pE590, DOI 10.1208/aapsj080368; Barnard JG, 2013, J PHARM SCI-US, V102, P915, DOI 10.1002/jps.23415; Gabrielson JP, 2007, J PHARM SCI-US, V96, P268, DOI 10.1002/jps.20760; Thirumangalathu R, 2009, J PHARM SCI-US, V98, P3167, DOI 10.1002/jps.21719; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Basu P, 2013, J PHARM SCI-US, V102, P852, DOI 10.1002/jps.23434; Bristol-MyersSquibb Canada, 2013, ORENCIA ABATACEPT PR; Carpenter JF, 2010, J PHARM SCI-US, V99, P2200, DOI 10.1002/jps.21989; Corporation Zeon, 2010, CYCLO OLEFIN POLYMER; Kirshner S, 2012, REGULATORY EXPECTATI; Makwana Sagar, 2011, Int J Pharm Investig, V1, P200, DOI 10.4103/2230-973X.93004; Rosenberg Amy S, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Yoshino K, 2014, J PHARM SCI-US, V103, P1520, DOI 10.1002/jps.23945; Yumioka R, J PHARM SCI, V99, P618	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	FEB	2015	104	2			SI		527	535		10.1002/jps.24184		9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA7HX	WOS:000349089500025		
J	Kurinomaru, T; Shiraki, K				Kurinomaru, Takaaki; Shiraki, Kentaro			Noncovalent PEGylation of L-Asparaginase Using PEGylated Polyelectrolyte	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						complexation; pegylation; polyelectrolytes; protein aggregation; protein formulation; stabilization	PROTEIN PEGYLATION; SALMON-CALCITONIN; AGGREGATION; THERAPEUTICS; DERIVATIVES; FORMULATION; TRYPTOPHAN; STABILITY; LYSOZYME; PEPTIDE	Noncovalent PEGylation has great potential for stabilization of therapeutic proteins. Here, we demonstrated that the noncovalent PEGylation with a PEGylated polyelectrolyte stabilized a therapeutic protein, l-asparaginase (ASNase). Anionic ASNase and cationic poly(ethylene glycol)-block-poly(N,N-dimethylaminoethyl methacrylate) (PEG-b-PAMA) formed a water-soluble protein-polyelectrolyte complex (PPC) without loss of secondary structure and enzyme activity. PPC with PEG-b-PAMA successfully inhibited the shaking-induced inactivation and aggregation of ASNase as well as protease digestion, corresponding to the behaviors of covalently PEGylated ASNase. Thus, noncovalent PEGylation by PEGylated polyelectrolytes is a new candidate for handling of therapeutic proteins. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:587-592, 2015	[Kurinomaru, Takaaki; Shiraki, Kentaro] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Shiraki, K (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	shiraki@bk.tsukuba.ac.jp			University of Tsukuba; Terumo Corporation	We thank Prof. Yukio Nagasaki for analysis of the light-scattering spectrometer data. This study was supported financially by University of Tsukuba and Terumo Corporation.	Alconcel SNS, 2011, POLYM CHEM-UK, V2, P1442, DOI 10.1039/c1py00034a; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; PACE CN, 1995, PROTEIN SCI, V4, P2411; Tomita S, 2011, J POLYM SCI POL CHEM, V49, P3835, DOI 10.1002/pola.24822; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Mueller C, 2011, J PHARM SCI-US, V100, P1648, DOI 10.1002/jps.22401; Kurinomaru T, 2012, LANGMUIR, V28, P4334, DOI 10.1021/la2043312; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Lee H, 2003, J PHARM SCI, V92, P97, DOI 10.1002/jps.10270; Ganguli S, 2009, J AM CHEM SOC, V131, P6549, DOI 10.1021/ja900786z; Pasut G, 2008, ADV DRUG DELIVER REV, V60, P69, DOI 10.1016/j.addr.2007.04.018; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Tomita S, 2010, SOFT MATTER, V6, P5320, DOI 10.1039/c000930j; Soares AL, 2002, INT J PHARMACEUT, V237, P163, DOI 10.1016/S0378-5173(02)00046-7; Nguyen TH, 2013, NAT CHEM, V5, P221, DOI [10.1038/nchem.1573, 10.1038/NCHEM.1573]; Mero A, 2011, PHARM RES-DORDR, V28, P2412, DOI 10.1007/s11095-011-0468-8; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Mueller C, 2011, EUR J PHARM BIOPHARM, V79, P646, DOI 10.1016/j.ejpb.2011.06.003; Kayitmazer AB, 2013, SOFT MATTER, V9, P2553, DOI 10.1039/c2sm27002a; Kurinomaru T, 2014, LANGMUIR, V30, P3826, DOI 10.1021/la500575c; Hinds K, 2000, BIOCONJUGATE CHEM, V11, P195, DOI 10.1021/bc9901189; Khondee S, 2011, BIOMACROMOLECULES, V12, P3880, DOI 10.1021/bm2007967; KODERA Y, 1994, BIOCONJUGATE CHEM, V5, P283, DOI 10.1021/bc00028a001; Kurinomaru T, 2014, J PHARM SCI-US, V103, P2248, DOI 10.1002/jps.24025; Mueller C, 2012, J PHARM SCI-US, V101, P1995, DOI 10.1002/jps.23110; Pfister D, 2014, J CONTROL RELEASE, V180, P134, DOI 10.1016/j.jconrel.2014.02.002; Stecher A L, 1999, Pharm Acta Helv, V74, P1, DOI 10.1016/S0031-6865(99)00009-6; Tamura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02252; Tomita S, 2013, CHEM COMMUN, V49, P10430, DOI 10.1039/c3cc45640d; Wang W, 2005, INT J PHARM, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014	32	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	FEB	2015	104	2			SI		587	592		10.1002/jps.24217		6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA7HX	WOS:000349089500031		
J	Totoki, S; Yamamoto, G; Tsumoto, K; Uchiyama, S; Fukui, K				Totoki, Shinichiro; Yamamoto, Gaku; Tsumoto, Kouhei; Uchiyama, Susumu; Fukui, Kiichi			Quantitative Laser Diffraction Method for the Assessment of Protein Subvisible Particles	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						laser diffraction method; proteins; protein aggregation; biopharmaceutical characterization; subvisible particles; imaging methods; particle size	SIZE-EXCLUSION CHROMATOGRAPHY; FIELD-FLOW FRACTIONATION; ANALYTICAL ULTRACENTRIFUGATION; SEDIMENTATION-VELOCITY; ANTIBODY; THERAPEUTICS; FORMULATIONS; AGGREGATION; MICROSCOPY; QUALITY	Laser diffraction (LD) has been recognized as a method for estimating particle size distribution. Here, a recently developed quantitative LD (qLD) system, which is an LD method with extensive deconvolution analysis, was employed for the quantitative assessment of protein particles sizes, especially aimed at the quantification of 0.2-10 m diameter subvisible particles (SVPs). The qLD accurately estimated concentration distributions for silica beads with diameters ranging from 0.2 to 10 m that have refractive indices similar to that of protein particles. The linearity of concentration for micrometer-diameter silica beads was confirmed in the presence of a fixed concentration of submicrometer diameter beads. Similarly, submicrometer-diameter silica beads could be quantified in the presence of micrometer-diameter beads. Subsequently, stir- and heat-stressed intravenous immunoglobulins were evaluated by using the qLD, in which the refractive index of protein particles that was determined experimentally was used in the deconvolution analysis. The results showed that the concentration distributions of protein particles in SVP size range differ for the two stresses. The number concentration of the protein particles estimated using the qLD agreed well with that obtained using flow microscopy. This work demonstrates that qLD can be used for quantitative estimation of protein aggregates in SVP size range. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:618-626, 2015	[Totoki, Shinichiro] Shimadzu Co Ltd, Kyoto 6048511, Japan; [Yamamoto, Gaku; Uchiyama, Susumu; Fukui, Kiichi] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Tsumoto, Kouhei] Univ Tokyo, Dept Chem & Biotechnol, Minato Ku, Tokyo 1088639, Japan; [Uchiyama, Susumu] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	Uchiyama, S (reprint author), Osaka Univ, Grad Sch Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	suchi@bio.eng.osaka-u.ac.jp			MEXT [25440071]; Manufacturing Technology Research of Biologics from METI	We would like to thank Dr. Haruo Shimaoka (Shimadzu corp.) for insightful comments during the research. This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (25440071) from MEXT and Manufacturing Technology Research of Biologics from METI to S. U.	Singh SK, 2010, J PHARM SCI-US, V99, P3302, DOI 10.1002/jps.22097; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Sharma DK, 2010, AAPS J, V12, P455, DOI 10.1208/s12248-010-9205-1; Zolls S, 2013, J PHARM SCI-US, V102, P1434, DOI 10.1002/jps.23479; Liu J, 2006, AAPS J, V8, pE580, DOI 10.1208/aapsj080367; Demeule B, 2010, AAPS J, V12, P708, DOI 10.1208/s12248-010-9233-x; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Krayukhina E, 2013, J BIOSCI BIOENG, V115, P104, DOI 10.1016/j.jbiosc.2012.07.021; Rudiuk S, 2012, SOFT MATTER, V8, P2651, DOI 10.1039/c2sm07017k; Patel AR, 2012, ANAL CHEM, V84, P6833, DOI 10.1021/ac300976g; Weinbuch D, 2013, J PHARM SCI-US, V102, P2152, DOI 10.1002/jps.23552; Zolls S, 2013, AAPS J, V15, P1200, DOI 10.1208/s12248-013-9522-2; Filipe V, 2012, MABS-AUSTIN, V4, P740, DOI 10.4161/mabs.22066; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Hawe A, 2009, EUR J PHARM SCI, V38, P79, DOI 10.1016/j.ejps.2009.06.001; Filipe V, 2012, PHARM RES-DORDR, V29, P2202, DOI 10.1007/s11095-012-0749-x; Ishikawa T, 2010, BIOL PHARM BULL, V33, P1043; Gabrielson JP, 2007, J PHARM SCI-US, V96, P268, DOI 10.1002/jps.20760; Barnard JG, 2012, J PHARM SCI, V102, P915; Carpenter JF, 2010, J PHARM SCI-US, V99, P2200, DOI 10.1002/jps.21989; Cordes AA, 2012, J PHARM SCI-US, V101, P2307, DOI 10.1002/jps.23150; FDA draft guidance, 2013, IMM ASS THE IN PRESS; Rhyner MN, 2011, AAPS J, V13, P54, DOI 10.1208/s12248-010-9245-6; Uchiyama S, 2014, BBA-PROTEINS PROTEOM, V1844, P2041, DOI 10.1016/j.bbapap.2014.07.016	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	FEB	2015	104	2			SI		618	626		10.1002/jps.24288		9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA7HX	WOS:000349089500035		
J	Morishita, M; Takahashi, Y; Nishikawa, M; Sano, K; Kato, K; Yamashita, T; Imai, T; Saji, H; Takakura, Y				Morishita, Masaki; Takahashi, Yuki; Nishikawa, Makiya; Sano, Kohei; Kato, Kana; Yamashita, Takuma; Imai, Takafumi; Saji, Hideo; Takakura, Yoshinobu			Quantitative Analysis of Tissue Distribution of the B16BL6-Derived Exosomes Using a Streptavidin-Lactadherin Fusion Protein and Iodine-125-Labeled Biotin Derivative After Intravenous Injection in Mice	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						exosome; streptavidin; lactadherin; radioisotope; quantitative analysis; pharmacokinetics; biomaterials; nanoparticles; phospholipids; clearance	EXTRACELLULAR VESICLES; ENDOTHELIAL-CELLS; BIODISTRIBUTION; LIPOSOMES; NANOPARTICLES; MATURATION	We previously succeeded in the visualization of tissue distribution of B16BL6 cells-derived exosomes by labeling with Gaussia luciferase (gLuc)-LA, a fusion protein of gLuc (a reporter protein) and lactadherin (LA; an exosome-tropic protein). However, total amount of B16BL6-derived exosomes delivered to each organ could not be evaluated because of the reduction of luminescent signal from gLuc-LA. The aim of the present study was to quantitatively evaluate the tissue distribution of B16BL6-derived exosomes. To this end, we labeled B16BL6-derived exosomes with iodine-125 (I-125) based on streptavidin (SAV)-biotin system. A plasmid vector encoding fusion protein, SAV-LA, was constructed, and B16BL6 cells were transfected with the plasmid to obtain SAV-LA-coupled exosomes. SAV-LA-coupled exosomes were incubated with (3-I-125-iodobenzoyl) norbiotinamide (I-125-IBB) to obtain I-125-labeled B16BL6 exosomes. After intravenous injection of I-125-labeled B16BL6 exosomes into mice, radioactivity quickly disappeared from the blood circulation. At 4 h, 28%, 1.6%, and 7% of the injected radioactivity/organ was detected in the liver, spleen, and lung, respectively. These results indicate that I-125-labeling of exosomes using SAV-biotin system is a useful method to quantitatively evaluate the amount of exogenously administered exosomes delivered to each organ and that the liver is the major organ in the clearance of exogenously administered B16BL6-derived exosomes. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:705-713, 2015	[Morishita, Masaki; Takahashi, Yuki; Nishikawa, Makiya; Kato, Kana; Yamashita, Takuma; Imai, Takafumi; Takakura, Yoshinobu] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut & Drug Metab, Sakyo Ku, Kyoto 6068501, Japan; [Sano, Kohei; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, Kyoto 6068501, Japan	Takakura, Y (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut & Drug Metab, Sakyo Ku, Kyoto 6068501, Japan.	takakura@pharm.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	This work was partly supported by a Grant-in-Aid for Scientific Research (B) and a Grant-in-Aid for Exploratory Research from the Japan Society for the Promotion of Science (JSPS).	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P31; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P547, DOI 10.1007/BF01062109; Delcayre A, 2005, BLOOD CELL MOL DIS, V35, P158, DOI 10.1016/j.bcmd.2005.07.003; Sun DM, 2013, ADV DRUG DELIVER REV, V65, P342, DOI 10.1016/j.addr.2012.07.002; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Grange C, 2014, INT J MOL MED, V33, P1055, DOI 10.3892/ijmm.2014.1663; Balthasar S, 2005, BIOMATERIALS, V26, P2723, DOI 10.1016/j.biomaterials.2004.07.047; Choi CHJ, 2011, P NATL ACAD SCI USA, V108, P6656, DOI 10.1073/pnas.1103573108; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Takahashi Y, 2013, J BIOTECHNOL, V165, P77, DOI 10.1016/j.jbiotec.2013.03.013; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; Sano K, 2010, BIOL PHARM BULL, V33, P1589; Soininen SK, 2012, EUR J PHARM SCI, V47, P848, DOI 10.1016/j.ejps.2012.09.001; CHONN A, 1991, J IMMUNOL, V146, P4234; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; JOHNSTONE RM, 1992, BIOCHEM CELL BIOL, V70, P179; BENNETT CM, 1976, J CLIN INVEST, V57, P1287, DOI 10.1172/JCI108396; Fomina AF, 2003, EXP CELL RES, V291, P150, DOI 10.1016/S0014-4827(03)00372-0; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Hsu CK, 2010, J MOL GRAPH MODEL, V29, P295, DOI 10.1016/j.jmgm.2010.09.009; Ishiwata H, 2000, J CONTROL RELEASE, V69, P139, DOI 10.1016/S0168-3659(00)00293-5; Kudo T, 2009, J NUCL MED, V50, P942, DOI 10.2967/jnumed.108.061119; ORR L, 1987, BIOCHEM CELL BIOL, V65, P1080; Patel H. M., 1998, ADV DRUG DELIV REV, V32, P45; Rothkopf C, 2005, BBA-BIOMEMBRANES, V1668, P10, DOI 10.1016/j.bbamem.2004.10.013; Sedlik C., 2014, J EXTRACELL VESICLES, V3; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	30	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	FEB	2015	104	2			SI		705	713		10.1002/jps.24251		9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA7HX	WOS:000349089500043		
J	Lu, Y; Nakanishi, T; Hosomi, A; Komori, H; Tamai, I				Lu, Yang; Nakanishi, Takeo; Hosomi, Atsushi; Komori, Hisakazu; Tamai, Ikumi			In-vitro evidence of enhanced breast cancer resistance protein-mediated intestinal urate secretion by uremic toxins in Caco-2 cells	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						breast cancer resistance protein; chronic kidney disease; indoxyl sulfate; urate; uremic toxins	ARYL-HYDROCARBON RECEPTOR; CHRONIC KIDNEY-DISEASE; INDOXYL SULFATE; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; FUNCTIONAL COOPERATION; RENAL REABSORPTION; RETENTION SOLUTES; GENE-EXPRESSION; P-CRESOL	ObjectivesIt has been reported that intestinal urate excretion is increased at chronic kidney disease (CKD) state. In this report, whether uremic toxins are involved in the upregulation of intestinal breast cancer resistance protein (BCRP), an intestinal urate exporter, was examined. MethodsUremic toxins that were increased at least 15-fold at CKD state were selected for investigation. Caco-2 cells were exposed to these uremic toxins at clinically relevant concentrations. mRNA was quantified by real-time PCR, and flow cytometry was utilized to measure BCRP protein and function in Caco-2 cells. Transcellular secretory transport of [C-14]urate was determined utilizing Transwell studies after uremic toxin exposure. Key findingsIndoxyl sulfate (IS) treatment alone resulted in approximate to 3-fold increase in BCRP mRNA in Caco-2 cells. Membrane protein expression of BCRP in Caco-2 cells also was increased by 1.8-fold after treatment with IS. Intracellular accumulation of pheophorbide A, a selective BCRP substrate, was decreased by 22% after IS treatment for 3 days. Consistent with these findings, transcellular secretory transport of urate across Caco-2 cell monolayers was increased by 22%. ConclusionIntestinal urate secretion may be increased at CKD state partially by upregulation of intestinal BCRP by uremic toxins such as IS.	[Lu, Yang; Nakanishi, Takeo; Hosomi, Atsushi; Komori, Hisakazu; Tamai, Ikumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa 9201192, Japan	Tamai, I (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tamai@p.kanazawa-u.ac.jp	TAMAI, Ikumi/D-8412-2015; Nakanishi, Takeo/C-3891-2015	Nakanishi, Takeo/0000-0002-6561-7138	Ministry of Education, Culture, Sports, Science and Technology, Japan [21390044]	This study was supported in part by a grant-in-aid for the Scientific Research (21390044 to I.T.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Adachi Tatsuhiko, 2007, J Exp Ther Oncol, V6, P335; Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Vanholder R, 2008, BLOOD PURIFICAT, V26, P77, DOI 10.1159/000110570; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Jourde-Chiche N, 2009, SEMIN DIALYSIS, V22, P334, DOI 10.1111/j.1525-139X.2009.00576.x; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Nakanishi T, 2012, CHIN J CANCER, V31, P73, DOI 10.5732/cjc.011.10320; Schwabedissen HEMZ, 2006, DRUG METAB DISPOS, V34, P524, DOI 10.1124/dmd.105.007591; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610; VAZIRI ND, 1995, J AM SOC NEPHROL, V6, P1313; NIWA T, 1994, J LAB CLIN MED, V124, P96; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Eloot S, 2008, KIDNEY INT, V73, P765, DOI 10.1038/sj.ki.5002750; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Robey RW, 2004, CANCER RES, V64, P1242, DOI 10.1158/0008-5472.CAN-03-3298; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; Tumur Z, 2009, AM J NEPHROL, V29, P551, DOI 10.1159/000191468; Tan KP, 2010, MOL PHARMACOL, V78, P175, DOI 10.1124/mol.110.065078; Hosomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030456; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Lekawanvijit S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083687; Lu Y, 2013, DRUG METAB PHARMACOK, V28, P153, DOI 10.2133/dmpk.DMPK-12-RG-070; Lu Y, 2014, PHYTOTHER RES, V28, P788, DOI 10.1002/ptr.5063; Mutsaers HAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018438; Nakanishi T, 2013, NEPHROL DIAL TRANSPL, V28, P603, DOI 10.1093/ndt/gfs574; Ruilope L M, 2001, Curr Hypertens Rep, V3, P197, DOI 10.1007/s11906-001-0038-2; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Yano H, 2014, CLIN EXP NEPHROL, V18, P50, DOI 10.1007/s10157-013-0806-8	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	FEB	2015	67	2					170	177		10.1111/jphp.12328		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ9BU	WOS:000348507100003		
J	Taguchi, K; Chuang, VTG; Yamasaki, K; Urata, Y; Tanaka, R; Anraku, M; Seo, H; Kawai, K; Maruyama, T; Komatsu, T; Otagiri, M				Taguchi, Kazuaki; Chuang, Victor Tuan Giam; Yamasaki, Keishi; Urata, Yukino; Tanaka, Ryota; Anraku, Makoto; Seo, Hakaru; Kawai, Keiichi; Maruyama, Toru; Komatsu, Teruyuki; Otagiri, Masaki			Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						albumin; diabetes; fatty acid; glucagon like peptide-1 receptor agonist; insulin analogue	OXYGEN CARRIER; BINDING SITES; DIABETIC-RATS; PERMEABILITY; INSULIN; RETENTION; PROTEINS; WARFARIN; DELIVERY; IMPACT	ObjectivesThe half-life of fatty acid-conjugated antidiabetic drugs are prolonged through binding to albumin, but this may not occur in diabetic patients with nephropathy complicated with hypoalbuminemia. We previously showed that human serum albumin (HSA) dimerized at the protein's Cys34 by 1,6-bis(maleimido)hexane has longer half-life than the monomer under high permeability conditions. The aim of this study was to investigate the superior ability of this HSA dimer as a plasma-retaining agent for fatty acid conjugated antidiabetic drugs. MethodsThe diabetic nephropathy rat model was prepared by administering a single injection of streptozotocin (STZ) intravenously, and the pharmacokinetic properties of HSA monomer and dimer were evaluated. Site-specific fluorescent probe displacement experiments were performed using warfarin and dansylsarcosine as site I and site II specific fluorescent probes, respectively. Key findingsThe half-life of the HSA dimer in STZ-induced diabetic nephropathy model rats was 1.5 times longer than the HSA monomer. The fluorescent probe displacement experiment results for HSA monomer and dimer were similar, where fatty acid-conjugated antidiabetic drugs displaced dansylsarcosine but not warfarin in a concentration-dependent manner. ConclusionsThe HSA dimer shows potential for use as a plasma-retaining agent for antidiabetic drugs due to its favourable pharmacokinetic properties.	[Taguchi, Kazuaki; Yamasaki, Keishi; Anraku, Makoto; Seo, Hakaru; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Kumamoto, Japan; [Yamasaki, Keishi; Seo, Hakaru; Otagiri, Masaki] Sojo Univ, DDS Res Inst, Kumamoto, Japan; [Urata, Yukino; Tanaka, Ryota; Maruyama, Toru; Otagiri, Masaki] Kumamoto Univ, Dept Biopharmaceut, Kumamoto, Japan; [Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Ctr Clin Pharmaceut Sci, Kumamoto, Japan; [Kawai, Keiichi] Kanazawa Univ, Fac Med, Sch Hlth Sci, Kanazawa, Ishikawa, Japan; [Komatsu, Teruyuki] Chuo Univ, Bunkyo Ku, Fac Sci & Engn, Dept Appl Chem, Tokyo, Japan; [Chuang, Victor Tuan Giam] Curtin Univ, Fac Hlth Sci, Sch Pharm, Perth, WA 6845, Australia	Otagiri, M (reprint author), Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8620082, Japan.	otagirim@ph.sojo-u.ac.jp			JSPS [20350058]; MEXT Japan [2107]; MHLW Japan	This research was partially supported by Grant-in-Aid for Scientific Research (no. 20350058) from JSPS, and Grant-in-Aid for Scientific Research for Priority Area (area 2107) from MEXT Japan, and Health Science Research Grants (Regulatory Science) from MHLW Japan.	Ahren B, 2012, DIABETES OBES METAB, V14, P121, DOI 10.1111/j.1463-1326.2011.01482.x; Taguchi K, 2010, DRUG METAB DISPOS, V38, P2124, DOI 10.1124/dmd.109.031989; Kratz F, 2012, J CONTROL RELEASE, V161, P429, DOI 10.1016/j.jconrel.2011.11.028; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; YAMAJI T, 1993, CIRC RES, V72, P947; Ishima Y, 2012, BIOCONJUGATE CHEM, V23, P264, DOI 10.1021/bc2005363; Kratz F, 2014, J CONTROL RELEASE, V190, P331, DOI 10.1016/j.jconrel.2014.03.013; Simard JR, 2006, J MOL BIOL, V361, P336, DOI 10.1016/j.jmb.2006.06.028; Gough SCL, 2013, DIABETES OBES METAB, V15, P301, DOI 10.1111/dom.12052; Matsushita S, 2006, PHARM RES, V23, P882, DOI 10.1007/s11095-006-9933-1; Elsadek B, 2012, J CONTROL RELEASE, V157, P4, DOI 10.1016/j.jconrel.2011.09.069; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; PANJEHSHAHIN MR, 1991, BIOCHEM PHARMACOL, V41, P1227, DOI 10.1016/0006-2952(91)90662-O; Fujiwara S, 2011, CHEM PHARM BULL, V59, P860; Fujiwara S, 2013, BBA-GEN SUBJECTS, V1830, P5427, DOI 10.1016/j.bbagen.2013.03.032; Satoh M, 2010, MICROCIRCULATION, V17, P103, DOI 10.1111/j.1549-8719.2009.00010.x; Taguchi K, 2012, J PHARM SCI-US, V101, P3033, DOI 10.1002/jps.23181; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; MacIsaac RJ, 2011, CURR OPIN NEPHROL HY, V20, P246, DOI 10.1097/MNH.0b013e3283456546; Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102; ELIAS D, 1994, DIABETES, V43, P992, DOI 10.2337/diabetes.43.8.992; BEALS CC, 1993, MICROVASC RES, V45, P11, DOI 10.1006/mvre.1993.1002; Komatsu T, 1999, MACROMOLECULES, V32, P8388, DOI 10.1021/ma990826p; Komatsu T, 2005, BIOMACROMOLECULES, V6, P3397, DOI 10.1021/bm050454u; Komatsu T, 2004, BBA-GEN SUBJECTS, V1675, P21, DOI 10.1016/j.bbagen.2004.08.010; Kragh-Hansen U, 2006, J MOL BIOL, V363, P702, DOI 10.1016/j.jmb.2006.08.056; Rennen HJJM, 2001, NUCL MED BIOL, V28, P401, DOI 10.1016/S0969-8051(01)00208-6; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; Yuan SY, 2007, MICROCIRCULATION, V14, P363, DOI 10.1080/10739680701283091; Zhao T, 2012, BIOL PHARM BULL, V35, P280	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	FEB	2015	67	2					255	263		10.1111/jphp.12338		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AZ9BU	WOS:000348507100011		
J	Fuku-En, S; Furukawa, K; Sasamori, T; Tokitoh, N; Abe, M; Yamamoto, Y				Fuku-en, Shin-ichi; Furukawa, Ko; Sasamori, Takahiro; Tokitoh, Norihiro; Abe, Manabu; Yamamoto, Yohsuke			Oxidation of an allene compound bearing 1,8-dichloroacridene moieties and photolysis of the halogenated allene compound for the generation of triplet carbenes	JOURNAL OF PHYSICAL ORGANIC CHEMISTRY			English	Article						triplet carbene; allene; oxidation	HIGHLY HINDERED DIARYLCARBENES; PARA-SUBSTITUENTS; ROOM-TEMPERATURE; VINYL CATION; STABLE CARBENES; KINETICS; DIPHENYLCARBENES; HALIDES; PHOTOCHEMISTRY; STABILIZATION	New allene compounds, 5c and 5d, bearing 1,8-dichloroacridene moieties were synthesized, and the oxidation of 5c and 5d was performed to generate thermally stable triplet carbenes. Since the oxidation resulted in the formation of decomposition products, the photolysis of brominated allene compound 18 was performed. UV-vis measurement at low temperatures indicated the generation of intermediates with decreasing starting material 18, although the efficiency of photolysis was quite low. ESR and electron spin transient nutation (ESTN) spectra suggested that the multiplicity of intermediates is triplet, probably the target triplet carbene 6d is generated. In terms of |D| values of the intermediates, ESR showed that unpaired electrons are more effectively delocalized in 6d by the introduction of nitrogen atoms in the skeleton (biradical character in Scheme1). The observed triplet species 6d was not stable enough to isolate. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Fuku-en, Shin-ichi; Abe, Manabu; Yamamoto, Yohsuke] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan; [Furukawa, Ko] Niigata Univ, Inst Res Promot, Ctr Instrumental Anal, Niigata 9502181, Japan; [Sasamori, Takahiro; Tokitoh, Norihiro] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Yamamoto, Y (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Chem, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan.	yyama@sci.hiroshima-u.ac.jp	Abe, Manabu/A-9221-2008; Sasamori, Takahiro/C-4963-2009	Sasamori, Takahiro/0000-0001-5410-8488	Ministry of Education, Culture, Sports, Science and Technology, Japan [24109002]	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (No. 24109002, Stimuli-responsive Chemical Species) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank Prof. Konrad Seppelt for oxidation of 5c and helpful discussions.	Martin D, 2011, CHEM SCI, V2, P389, DOI 10.1039/c0sc00388c; Woodcock HL, 2007, J AM CHEM SOC, V129, P3763, DOI 10.1021/ja068899t; Yamaguchi T, 2008, J AM CHEM SOC, V130, P6894, DOI 10.1021/ja710423d; Kamada K, 2013, J AM CHEM SOC, V135, P232, DOI 10.1021/ja308396a; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; NISHI H, 1981, B CHEM SOC JPN, V54, P1897, DOI 10.1246/bcsj.54.1897; Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Vignolle J, 2009, CHEM REV, V109, P3333, DOI 10.1021/cr800549j; Hirai K, 1999, J AM CHEM SOC, V121, P10213, DOI 10.1021/ja991387c; Hirai K, 2009, CHEM REV, V109, P3275, DOI 10.1021/cr800518t; Arduengo AJ, 1999, ACCOUNTS CHEM RES, V32, P913, DOI 10.1021/ar980126p; Bertrand G., 2004, REACTIVE INTERMEDIAT, P329, DOI 10.1002/0471721492.ch8; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; des Fremont P., 2009, COORDIN CHEM REV, V253, P862; Fuku-en S, 2011, J PHYS ORG CHEM, V24, P1009, DOI 10.1002/poc.1870; Glorius F, 2007, TOP ORGANOMETAL CHEM, V21, P1, DOI 10.1007/3418_2006_059; Gronheid R, 2003, J ORG CHEM, V68, P3205, DOI 10.1021/jo0264877; Hirai K., 2000, J AM CHEM SOC, V122, P398; HIRAI K, 1994, CHEM LETT, P503, DOI 10.1246/cl.1994.503; Itoh T, 2007, B CHEM SOC JPN, V80, P138, DOI 10.1246/bcsj.80.138; Hu YM, 2000, CHEM LETT, P94; Hu YM, 2001, B CHEM SOC JPN, V74, P2207, DOI 10.1246/bcsj.74.2207; Hu YM, 1999, J PHYS CHEM A, V103, P9280, DOI 10.1021/jp991576h; Iikubo T, 2002, ORG LETT, V4, P2261, DOI 10.1021/ol026119p; Itakura H, 2000, J ORG CHEM, V65, P8797, DOI 10.1021/jo001418i; Itoh T, 2006, J AM CHEM SOC, V128, P957, DOI 10.1021/ja056575j; Iwamoto E, 2003, J AM CHEM SOC, V125, P14664, DOI 10.1021/ja038423z; Kawano M, 2007, J AM CHEM SOC, V129, P2383, DOI 10.1021/ja067306b; KITAMURA T, 1982, J ORG CHEM, V47, P2323, DOI 10.1021/jo00133a018; KROPP PJ, 1983, J AM CHEM SOC, V105, P6907, DOI 10.1021/ja00361a028; Makarov BP, 2004, ORG BIOMOL CHEM, V2, P1834, DOI 10.1039/b404061a; Nemirowski A, 2007, J ORG CHEM, V72, P9533, DOI 10.1021/jo701615x; Nolan S. P., 2006, N HETEROCYCLIC CARBE; Sato K, 1997, J AM CHEM SOC, V119, P6607, DOI 10.1021/ja963372+; Sheldrick G. M., 1997, SHELX 97 PROGRAM REF; Suzuki T., 1981, J ORG CHEM, V46, P2275; Tomioka H., 1997, J CHEM SOC CHEM COMM, P2261; Tomioka H, 1997, ACCOUNTS CHEM RES, V30, P315, DOI 10.1021/ar9602157; Tomioka H., 2004, REACTIVE INTERMEDIAT, P375, DOI 10.1002/0471721492.ch9; TOMIOKA H, 1993, J AM CHEM SOC, V115, P1285, DOI 10.1021/ja00057a010; Tomioka H, 2001, NATURE, V412, P626, DOI 10.1038/35088038; TOMIOKA H, 1995, J AM CHEM SOC, V117, P6376, DOI 10.1021/ja00128a035; TOMIOKA H, 1992, ACTA CHEM SCAND, V46, P680, DOI 10.3891/acta.chem.scand.46-0680; Tomioka H, 1996, J AM CHEM SOC, V118, P8723, DOI 10.1021/ja9616488; Tomioka H, 1997, J AM CHEM SOC, V119, P1582, DOI 10.1021/ja9635903; VERBEEK JM, 1994, J PHYS CHEM-US, V98, P9526, DOI 10.1021/j100089a027; Winter AH, 2010, J AM CHEM SOC, V132, P215, DOI 10.1021/ja906139m; Yamaguchi T, 2010, AUST J CHEM, V63, P1638, DOI 10.1071/CH10297	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-3230	1099-1395		J PHYS ORG CHEM	J. Phys. Org. Chem.	FEB	2015	28	2			SI		79	87		10.1002/poc.3398		9	Chemistry, Organic; Chemistry, Physical	Chemistry	CA7EE	WOS:000349079600004		
J	Agou, T; Wasano, T; Sasamori, T; Tokitoh, N				Agou, Tomohiro; Wasano, Tatsuya; Sasamori, Takahiro; Tokitoh, Norihiro			Syntheses and structures of a stable gallole free of Lewis base coordination and its dianion	JOURNAL OF PHYSICAL ORGANIC CHEMISTRY			English	Article						heteroles of heavier group 13 elements; gallole; gallole dianions; X-ray crystallographic analysis	MOLECULAR-STRUCTURE; RING-SYSTEMS; AROMATICITY; GALLIUM; DERIVATIVES; REACTIVITY; (PENTAPHENYL)ALUMINACYCLOPENTADIENE; ANTIAROMATICITY; CYCLOPENTADIENE; HETEROCYCLES	A stable Lewis base-free gallole bearing a bulky Mes* group (=2,4,6-(t-Bu)(3)C6H2) was synthesized by the treatment of Mes*GaCl2 with a 3,6-dilithio-3,5-octadiene derivative. Reduction of the gallole with lithium metal afforded the corresponding gallole dianion species as a lithium salt. Structures of the gallole and the lithium salt of the gallole dianion have been elucidated by using X-ray crystallographic analysis, NMR spectroscopies, and density functional theory calculations. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Agou, Tomohiro; Wasano, Tatsuya; Sasamori, Takahiro; Tokitoh, Norihiro] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Tokitoh, N (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	tokitoh@boc.kuicr.kyoto-u.ac.jp	Sasamori, Takahiro/C-4963-2009	Sasamori, Takahiro/0000-0001-5410-8488	JSPS KAKENHI [24550048, 24109013, 26620028]; MEXT Project of Integrated Research on Chemical Synthesis from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; RIKEN Advanced Science Institute; Ube Industries Award in Synthetic Organic Chemistry, Japan; Kyoto Technoscience Center; Research Institute for Production Development	This work was supported by JSPS KAKENHI (Nos., 24550048, 24109013, and 26620028), MEXT Project of Integrated Research on Chemical Synthesis from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, the "Molecular Systems Research" project of RIKEN Advanced Science Institute, and the Ube Industries Award in Synthetic Organic Chemistry, Japan. T.A. thanks the Kyoto Technoscience Center and the Research Institute for Production Development for the financial supports.	Xi ZF, 2000, ANGEW CHEM INT EDIT, V39, P2950, DOI 10.1002/1521-3773(20000818)39:16<2950::AID-ANIE2950>3.0.CO;2-Y; Braunschweig H, 2011, CHEM COMMUN, V47, P10903, DOI 10.1039/c1cc13071d; Liu LT, 2010, ORGANOMETALLICS, V29, P278, DOI 10.1021/om00872u; EISCH JJ, 1966, J AM CHEM SOC, V88, P2976, DOI 10.1021/ja00965a018; Agou T, 2013, ANGEW CHEM INT EDIT, V52, P10031, DOI 10.1002/anie.201304143; Braunschweig H, 2013, ADV ORGANOMET CHEM, V61, P1, DOI 10.1016/B978-0-12-407692-1.00001-1; Matsumoto T, 2013, J AM CHEM SOC, V135, P4211, DOI 10.1021/ja400287y; Clyburne JAC, 1996, INORG CHEM, V35, P6651, DOI 10.1021/ic960647d; Chen ZF, 2005, CHEM REV, V105, P3613, DOI 10.1021/cr0300892; Cyranski MK, 2002, J ORG CHEM, V67, P1333, DOI 10.1021/jo016255s; Wasano T, 2014, CHEM COMMUN, V50, P8148, DOI 10.1039/c4cc03470h; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; DECKEN A, 1995, INORG CHEM, V34, P3853, DOI 10.1021/ic00119a002; SCHLEYER PV, 1995, ANGEW CHEM INT EDIT, V34, P337; Poater J, 2003, CHEM-EUR J, V9, P400, DOI 10.1002/chem.200390041; BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726; FAGAN PJ, 1994, J AM CHEM SOC, V116, P1880, DOI 10.1021/ja00084a031; KRUGER C, 1977, J ORGANOMET CHEM, V141, P141, DOI 10.1016/S0022-328X(00)92267-8; Schleyer PV, 1996, J AM CHEM SOC, V118, P6317, DOI 10.1021/ja960582d; Chesnut DB, 2000, CHEM PHYS, V257, P175, DOI 10.1016/S0301-0104(00)00119-1; BEACHLEY OT, 1986, ORGANOMETALLICS, V5, P1814, DOI 10.1021/om00140a010; Cowley AH, 1996, CHEM COMMUN, P2425, DOI 10.1039/cc9960002425; COWLEY AH, 1994, ANGEW CHEM INT EDIT, V33, P1370, DOI 10.1002/anie.199413701; D'yakonov VA, 2011, RUSS CHEM B+, V60, P1633, DOI 10.1007/s11172-011-0244-2; Fallah-Bagher-Shaidaei H, 2006, ORG LETT, V8, P863, DOI 10.1021/ol0529546; Frisch M. J., 2010, GAUSSIAN 09; HOBERG H, 1977, J ORGANOMET CHEM, V127, pC29, DOI 10.1016/S0022-328X(00)89718-1; HOBERG H, 1977, ANGEW CHEM INT EDIT, V16, P183, DOI 10.1002/anie.197701832; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pangborn A. B., 1996, ORGANOMETALLICS, V15, P151; PETRIE MA, 1993, ORGANOMETALLICS, V12, P1086, DOI 10.1021/om00028a025; Saito M, 2013, CHEM-EUR J, V19, P16946, DOI 10.1002/chem.201303672; SCHULZ S, 1993, INORG CHEM, V32, P3343, DOI 10.1021/ic00067a026; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Su JR, 1998, J AM CHEM SOC, V120, P12994, DOI 10.1021/ja983547a; Wei PR, 1999, CHEM COMMUN, P1287, DOI 10.1039/a903166i	36	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-3230	1099-1395		J PHYS ORG CHEM	J. Phys. Org. Chem.	FEB	2015	28	2			SI		104	107		10.1002/poc.3344		4	Chemistry, Organic; Chemistry, Physical	Chemistry	CA7EE	WOS:000349079600007		
J	Omokawa, Y; Hatano, S; Abe, M				Omokawa, Yasuyuki; Hatano, Sayaka; Abe, Manabu			Electron-spin resonance (ESR) characterization of quintet spin-state bis-nitroxide-bearing cyclopentane-1,3-diyl diradicals	JOURNAL OF PHYSICAL ORGANIC CHEMISTRY			English	Article						high-spin molecules; quintet spin state; electron spin resonance; cyclopentane-1; 3-diyl diradicals; nitroxide	AB-INITIO CALCULATIONS; TRIPLET GROUND-STATE; FERROMAGNETIC COUPLER; ORGANIC-MOLECULES; 1,3-CYCLOPENTANEDIYL BIRADICALS; PHOTOELECTRON-SPECTROSCOPY; PHOTOCHEMICAL GENERATION; EPR CHARACTERIZATION; SINGLET DIRADICALS; HYDROCARBON	High-spin organic molecules have attracted much attention as spin sources for magnetic materials. In this paper, a novel high-spin organic molecule was designed according to a logical strategy. A 2,2-dimethylcyclopentane-1,3-diyl diradical unit was utilized as a spin source and a spin-bridged fragment. In addition, nitroxides were introduced as spin sources. Quintet electron-spin resonance (ESR) signals, which were attributed to the 1,3-di(3-nitoroxyphenyl)-2,2-dimethylcyclopentane-1,3-diyl tetraradical (TR), were observed in a 2-methyltetrahydrofuran glassy matrix at 80K after the photodenitrogenation of a newly synthesized azoalkanes AZ. A simulation of the signal provided the zero-field splitting parameters D (|D|/hc=0.0127cm(-1)) and E (|E|/hc=0.0014cm(-1)) for the quintet state of the tetraradical TR. The parameter D of the quintet state of TR was found similar to those of the previously reported quintet spin states of tetraradical TR1 with two cyclobutane-1,3-diyl units (0.0190cm(-1)) and TR2 with two 2,2-dimethylcyclopentane-1,3-diyl diradicals (0.0116cm(-1)). Copyright (c) 2014 John Wiley & Sons, Ltd.	[Omokawa, Yasuyuki; Hatano, Sayaka; Abe, Manabu] Hiroshima Univ HIRODAI, Grad Sch Sci, Dept Chem, Hiroshima 7398526, Japan; [Abe, Manabu] Inst Mol Sci, Okazaki, Aichi 4448787, Japan	Abe, M (reprint author), Hiroshima Univ HIRODAI, Grad Sch Sci, Dept Chem, 1-3-1 Kagamiyama, Hiroshima 7398526, Japan.	mabe@hiroshima-u.ac.jp	Abe, Manabu/A-9221-2008		Ministry of Education, Culture, Sports, Science, and Technology, Japan [24109008]	NMR and MS measurements were performed at N-BARD, Hiroshima University. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Stimuli-responsive Chemical Species" (No. 24109008) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Adam W, 2000, J AM CHEM SOC, V122, P6735, DOI 10.1021/ja0003369; Adam W, 1998, ADV PHOTOCH, V24, P205; ADAM W, 1995, SYNTHESIS-STUTTGART, P1163; Adam W, 2000, J ORG CHEM, V65, P7650, DOI 10.1021/jo0012795; ADAM W, 1993, ANGEW CHEM INT EDIT, V32, P1339, DOI 10.1002/anie.199313391; Adam W, 1996, J AM CHEM SOC, V118, P3974, DOI 10.1021/ja953494m; BUCHWALTER SL, 1975, J AM CHEM SOC, V97, P3857, DOI 10.1021/ja00846a073; Wenthold PG, 1999, J AM SOC MASS SPECTR, V10, P800, DOI 10.1016/S1044-0305(99)00043-4; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; ITOH K, 1978, PURE APPL CHEM, V50, P1251, DOI 10.1351/pac197850111251; FUJITA I, 1990, J AM CHEM SOC, V112, P4074, DOI 10.1021/ja00166a074; EADE RHA, 1981, CHEM PHYS LETT, V83, P362, DOI 10.1016/0009-2614(81)85480-2; ISHIDA T, 1991, J AM CHEM SOC, V113, P4238, DOI 10.1021/ja00011a028; ADAM W, 1994, J ORG CHEM, V59, P3786, DOI 10.1021/jo00093a010; Okazawa A, 2008, INORG CHEM, V47, P8859, DOI 10.1021/ic800937n; YOSHIZAWA K, 1995, J AM CHEM SOC, V117, P6921, DOI 10.1021/ja00131a014; BECK K, 1987, CHEM BER-RECL, V120, P477, DOI 10.1002/cber.19871200406; Abe M, 2013, CHEM REV, V113, P7011, DOI 10.1021/cr400056a; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Abe M, 2012, CHEM SOC REV, V41, P3808, DOI 10.1039/c2cs00005a; Abe M, 1998, J AM CHEM SOC, V120, P11304, DOI 10.1021/ja9822761; YAMAGUCHI K, 1988, CHEM PHYS LETT, V149, P537, DOI 10.1016/0009-2614(88)80378-6; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Huang LH, 2011, J ORG CHEM, V76, P5732, DOI 10.1021/jo200840y; CALDER A, 1969, J AM CHEM SOC, V91, P3724, DOI 10.1021/ja01042a006; DOUGHERTY DA, 1991, ACCOUNTS CHEM RES, V24, P88, DOI 10.1021/ar00003a005; Dubrovina NV, 2003, TETRAHEDRON-ASYMMETR, V14, P2739, DOI 10.1016/S0957-4166(03)00595-0; DVOLAITZKY M, 1992, ANGEW CHEM INT EDIT, V31, P180, DOI 10.1002/anie.199201801; FANG S, 1995, J AM CHEM SOC, V117, P6727, DOI 10.1021/ja00130a012; FORT RC, 1992, J AM CHEM SOC, V114, P7549, DOI 10.1021/ja00045a031; Frisch M.J., 2009, GAUSSIAN 09; Fu H. -H., 2008, J CHEM PHYS, V129; GETTY SJ, 1994, J AM CHEM SOC, V116, P1521, DOI 10.1021/ja00083a041; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Hu AG, 2005, ORG LETT, V7, P455, DOI 10.1021/ol0474812; Itoh K, 2004, P JPN ACAD B-PHYS, V80, P29, DOI 10.2183/pjab.80.29; Itoh K, 1967, CHEM PHYS LETT, V1, P235, DOI 10.1016/0009-2614(67)85061-9; JACOBS SJ, 1993, J AM CHEM SOC, V115, P1744, DOI 10.1021/ja00058a020; JACOBS SJ, 1994, ANGEW CHEM INT EDIT, V33, P1104, DOI 10.1002/anie.199411041; Korhe G., 1970, ANGEW CHEM INT EDIT, V9, P906; Lafuente P, 1999, THEOR CHEM ACC, V102, P309, DOI 10.1007/s002140050503; Misochko E. Y., 2012, J CHEM PHYS, V137; MUKAI K, 1975, B CHEM SOC JPN, V48, P2381, DOI 10.1246/bcsj.48.2381; NAKAMURA T, 1995, J AM CHEM SOC, V117, P11292, DOI 10.1021/ja00150a029; NOVAK JA, 1989, J AM CHEM SOC, V111, P7618, DOI 10.1021/ja00201a055; Ohshita J, 2002, ORG LETT, V4, P403, DOI 10.1021/ol017093p; PRANATA J, 1989, J AM CHEM SOC, V111, P2026, DOI 10.1021/ja00188a012; PRANATA J, 1987, J AM CHEM SOC, V109, P1621, DOI 10.1021/ja00240a003; RAJCA A, 1990, J AM CHEM SOC, V112, P5890, DOI 10.1021/ja00171a045; RAJCA A, 1993, J AM CHEM SOC, V115, P10688, DOI 10.1021/ja00076a029; RAJCA A, 1993, J AM CHEM SOC, V115, P2396, DOI 10.1021/ja00059a039; Rajca A, 2011, J AM CHEM SOC, V133, P4750, DOI 10.1021/ja200708b; RASSAT A, 1972, ANGEW CHEM INT EDIT, V11, P303, DOI 10.1002/anie.197203031; RULE M, 1979, J AM CHEM SOC, V101, P5098, DOI 10.1021/ja00511a066; SILVERMAN SK, 1993, J PHYS CHEM-US, V97, P13273, DOI 10.1021/j100152a035; Wenthold PG, 1997, J AM CHEM SOC, V119, P1354, DOI 10.1021/ja9623830; WRIGHT BB, 1983, J AM CHEM SOC, V105, P628, DOI 10.1021/ja00341a057; XU JD, 1994, J AM CHEM SOC, V116, P5425, DOI 10.1021/ja00091a054; Zhang DY, 2003, J AM CHEM SOC, V125, P12823, DOI 10.1021/ja0355067	59	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-3230	1099-1395		J PHYS ORG CHEM	J. Phys. Org. Chem.	FEB	2015	28	2			SI		116	120		10.1002/poc.3381		5	Chemistry, Organic; Chemistry, Physical	Chemistry	CA7EE	WOS:000349079600009		
J	Ranaweera, RAAU; Weragoda, GK; Bain, J; Watanabe, S; Abe, M; Gudmundsdottir, AD				Ranaweera, Ranaweera A. A. Upul; Weragoda, Geethika K.; Bain, John; Watanabe, Shinji; Abe, Manabu; Gudmundsdottir, Anna D.			Photolysis of acetophenone derivatives with alpha-cyclopropyl substituents	JOURNAL OF PHYSICAL ORGANIC CHEMISTRY			English	Article						laser flash photolysis; DFT calculations	INTERSYSTEM CROSSING RATES; DENSITY-FUNCTIONAL THEORY; TRIPLET ALKYL NITRENES; BETA-PHENYL RINGS; EXCITED-STATES; CARBONYL TRIPLETS; SOLVATION MODELS; BOND-CLEAVAGE; RADICALS; DEACTIVATION	Laser flash photolysis of cyclopropyl(phenyl)methanone 6 in argon-saturated methanol yields the triplet ketone (T-1K) of 6 that is formed with a rate constant of similar to 1.7x10(7)s(-1) ((max)=360nm) and has a lifetime of similar to 1.4 mu s. T-1K of 6 decays to form ketyl radical 7 ((max) similar to 300nm), which dimerizes to form photoproducts, pinacol derivatives 8 and 9. In comparison, photolysis of trans-phenyl(2-phenylcyclopropyl)methanone 1 in argon-saturated chloroform-d results in cis-phenyl(2-phenylcyclopropyl)methanone 2 and a smaller amount of 3, presumably through 1,3-biradical 11. Nanosecond laser flash photolysis of 1 does not reveal significant transient absorption, although the T-1K of 1 is detected with phosphorescence at 77K. Density functional theory calculations were used to elucidate the triplet reactivity of 1, 2 and 6 by comparing the feasibility of H atom abstraction, cyclopropyl cleavage and -quenching of their triplet ketones. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ranaweera, Ranaweera A. A. Upul; Weragoda, Geethika K.; Bain, John; Gudmundsdottir, Anna D.] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA; [Watanabe, Shinji; Abe, Manabu] Hiroshima Univ, Grad Sch Sci, Dept Chem, Hiroshima 7398526, Japan	Gudmundsdottir, AD (reprint author), Univ Cincinnati, Dept Chem, POB 210172, Cincinnati, OH 45221 USA.	Anna.Gudmundsdottir@uc.edu	Abe, Manabu/A-9221-2008		National Science Foundation; Ohio Supercomputer Center; University of Cincinnati Research Council; NSF-REU	This work was supported by the National Science Foundation and the Ohio Supercomputer Center. R. A. A. U. R. acknowledges the University of Cincinnati Research Council for a URC Fellowship and J. B. NSF-REU for a summer Fellowship. A. D. G. is grateful for the opportunity to spend a sabbatical in the laboratory of Professor Abe as a Fulbright Scholar.	GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; Stratmann RE, 1998, J CHEM PHYS, V109, P8218, DOI 10.1063/1.477483; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Zard SZ, 2008, CHEM SOC REV, V37, P1603, DOI 10.1039/b613443m; Bauernschmitt R, 1996, CHEM PHYS LETT, V256, P454, DOI 10.1016/0009-2614(96)00440-X; Kutateladze AG, 2001, J AM CHEM SOC, V123, P9279, DOI 10.1021/ja016092p; MCGARRY PF, 1994, J PHOTOCH PHOTOBIO A, V77, P109, DOI 10.1016/1010-6030(94)80033-2; Cramer CJ, 1999, CHEM REV, V99, P2161, DOI 10.1021/cr960149m; Ranaweera RAAU, 2011, J ORG CHEM, V76, P8177, DOI 10.1021/jo201304c; Muthukrishnan S, 2009, ORG LETT, V11, P2345, DOI 10.1021/ol900754a; Cances E, 2001, J CHEM PHYS, V114, P4744, DOI 10.1063/1.1349091; Anamimoghadam O, 2013, ORG LETT, V15, P2970, DOI 10.1021/ol401117g; Muthukrishnan S, 2007, J ORG CHEM, V72, P2757, DOI 10.1021/jo062160k; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Moorthy JN, 1999, J AM CHEM SOC, V121, P3093, DOI 10.1021/ja9818708; Gamage DW, 2013, J ORG CHEM, V78, P11349, DOI 10.1021/jo401819g; CALDWELL RA, 1984, PURE APPL CHEM, V56, P1167, DOI 10.1351/pac198456091167; Griesbeck AG, 2004, ACCOUNTS CHEM RES, V37, P919, DOI 10.1021/ar040081u; TOMASI J, 1994, CHEM REV, V94, P2027, DOI 10.1021/cr00031a013; BOWRY VW, 1991, J AM CHEM SOC, V113, P5687, DOI 10.1021/ja00015a024; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; FORESMAN JB, 1992, J PHYS CHEM-US, V96, P135, DOI 10.1021/j100180a030; BOCH R, 1991, CAN J CHEM, V69, P2053, DOI 10.1139/v91-297; Bucher G, 2014, PHYS CHEM CHEM PHYS, V16, P18813, DOI 10.1039/c4cp02783c; Bucher G, 2008, J PHYS CHEM A, V112, P5411, DOI 10.1021/jp711266z; Bunau G. V., 1970, BER BUNSEN PHYS CHEM, V74, P1294; Mennucci B, 1997, J PHYS CHEM B, V101, P10506, DOI 10.1021/jp971959k; GONZALEZ C, 1990, J PHYS CHEM-US, V94, P5523, DOI 10.1021/j100377a021; Griesbeck A., 2012, CRC HDB ORGANIC PHOT, V1; Griesbeck A. G., 2005, MOL SUPRAMOL PHOTOCH, V12; Halgren TA, 2000, J AM CHEM SOC, V122, P2988, DOI 10.1021/ja991114h; Ichinose N, 1998, J ORG CHEM, V63, P3176, DOI 10.1021/jo971111s; KITA F, 1995, J AM CHEM SOC, V117, P8670, DOI 10.1021/ja00138a025; Klima RF, 2007, J ORG CHEM, V72, P6372, DOI 10.1021/jo070558q; LEIGH WJ, 1993, J CHEM SOC CHEM COMM, P988, DOI 10.1039/c39930000988; Moorthy JN, 1997, J AM CHEM SOC, V119, P11094, DOI 10.1021/ja971296k; NETTOFERREIRA JC, 1985, J AM CHEM SOC, V107, P2617, DOI 10.1021/ja00295a009; Newcomb M, 1996, J AM CHEM SOC, V118, P8505, DOI 10.1021/ja961615s; Ng D, 2001, TETRAHEDRON LETT, V42, P9113, DOI 10.1016/S0040-4039(01)01922-0; Parr R. G., 1989, DENSITY FUNCTIONAL T; Rajam S, 2011, J ORG CHEM, V76, P9934, DOI 10.1021/jo200877k; Ranaweera RAAU, 2014, J PHYS CHEM A, V118, P10433, DOI 10.1021/jp504174t; Samanta S, 2006, J ORG CHEM, V71, P4453, DOI 10.1021/jo060200e; SCAIANO JC, 1983, J PHOTOCHEM, V21, P137, DOI 10.1016/0047-2670(83)80016-1; Singh PND, 2003, J ORG CHEM, V68, P7951, DOI 10.1021/jo034674e; Singh PND, 2007, J AM CHEM SOC, V129, P16263, DOI 10.1021/ja077523s; Srivastava S, 1998, J AM CHEM SOC, V120, P6173, DOI 10.1021/ja981093b; Wagner P. J., 1970, MOL PHOTOCHEM, V2, P81; WISMONTSKIKNITTEL T, 1984, J PHYS CHEM-US, V88, P110, DOI 10.1021/j150645a028; Zhang X., 2013, J ORG CHEM, V79, P653; ZIMMERMAN HE, 1985, TETRAHEDRON LETT, V26, P5859, DOI 10.1016/S0040-4039(00)98246-7	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-3230	1099-1395		J PHYS ORG CHEM	J. Phys. Org. Chem.	FEB	2015	28	2			SI		137	146		10.1002/poc.3389		10	Chemistry, Organic; Chemistry, Physical	Chemistry	CA7EE	WOS:000349079600011		
J	Akiba, Y; Inoue, T; Kaji, I; Higashiyama, M; Narimatsu, K; Iwamoto, K; Watanabe, M; Guth, PH; Engel, E; Kuwahara, A; Kaunitz, JD				Akiba, Yasutada; Inoue, Takuya; Kaji, Izumi; Higashiyama, Masaaki; Narimatsu, Kazuyuki; Iwamoto, Ken-ichi; Watanabe, Masahiko; Guth, Paul H.; Engel, Eli; Kuwahara, Atsukazu; Kaunitz, Jonathan D.			Short-chain fatty acid sensing in rat duodenum	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							GLUCAGON-LIKE PEPTIDE-2; ENTEROENDOCRINE CELLS; FUNCTIONAL DYSPEPSIA; BICARBONATE SECRETION; HEALTHY-SUBJECTS; GASTROINTESTINAL-TRACT; BACTERIAL OVERGROWTH; MOUSE INTESTINE; ENTERIC NEURONS; RECEPTOR GPR40	Key points Luminal lipid in the duodenum modulates gastroduodenal functions via the release of gut hormones and mediators such as cholecystokinin and 5-HT. The effects of luminal short-chain fatty acids (SCFAs) in the foregut are unknown. Free fatty acid receptors (FFARs) for long-chain fatty acids (LCFAs) and SCFAs are expressed in enteroendocrine cells. SCFA receptors, termed FFA2 and FFA3, are expressed in duodenal enterochromaffin cells and L cells, respectively. Activation of LCFA receptor (FFA1) and presumed FFA3 stimulates duodenal HCO3- secretion via a glucagon-like peptide (GLP)-2 pathway, whereas FFA2 activation induces HCO3- secretion via muscarinic and 5-HT4 receptor activation. The presence of SCFA sensing in the duodenum with GLP-2 and 5-HT signals further supports the hypothesis that luminal SCFA in the foregut may contribute towards the generation of functional symptoms. Intraduodenal fatty acids (FA) and bacterial overgrowth, which generate short-chain FAs (SCFAs), have been implicated in the generation of functional dyspepsia symptoms. We studied the mechanisms by which luminal SCFA perfusion affects duodenal HCO3- secretion (DBS), a measure of mucosal neurohumoral activation. Free fatty acid receptor (FFAR) 1 (FFA1), which binds long-chain FA (LCFA), and SCFA receptors FFA2 and FFA3 were immunolocalised to duodenal enteroendocrine cells. FFA3 colocalised with glucagon-like peptide (GLP)-1, whereas FFA2 colocalised with 5-HT. Luminal perfusion of the SCFA acetate or propionate increased DBS, enhanced by dipeptidyl peptidase-IV (DPPIV) inhibition, at the same time as increasing GLP-2 portal blood concentrations. Acetate-induced DBS was partially inhibited by monocarboxylate/HCO3- exchanger inhibition without affecting GLP-2 release, implicating acetate absorption in the partial mediation of DBS. A selective FFA2 agonist dose-dependently increased DBS, unaffected by DPPIV inhibition or by cholecystokinin or 5-HT3 receptor antagonists, but was inhibited by atropine and a 5-HT4 antagonist. By contrast, a selective FFA1 agonist increased DBS accompanied by GLP-2 release, enhanced by DPPIV inhibition and inhibited by a GLP-2 receptor antagonist. Activation of FFA1 by LCFA and presumably FFA3 by SCFA increased DBS via GLP-2 release, whereas FFA2 activation stimulated DBS via muscarinic and 5-HT4 receptor activation. SCFA/HCO3- exchange also appears to be present in the duodenum. The presence of duodenal fatty acid sensing receptors that signal hormone release and possibly signal neural activation may be implicated in the pathogenesis of functional dyspepsia.	[Akiba, Yasutada; Guth, Paul H.; Kaunitz, Jonathan D.] Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA 90073 USA; [Akiba, Yasutada; Inoue, Takuya; Kaji, Izumi; Higashiyama, Masaaki; Narimatsu, Kazuyuki; Kaunitz, Jonathan D.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Akiba, Yasutada; Kaji, Izumi; Kaunitz, Jonathan D.] Brentwood Biomed Res Inst, Los Angeles, CA 90073 USA; [Kaji, Izumi; Watanabe, Masahiko] Hokkaido Univ, Dept Anat, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Iwamoto, Ken-ichi] Sch Pharmaceut Sci, Organ Chem Lab, Suruga Ku, Shizuoka 4228526, Japan; [Engel, Eli; Kaunitz, Jonathan D.] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Kuwahara, Atsukazu] Univ Shizuoka, Inst Environm Sci, Physiol Lab, Suruga Ku, Shizuoka 4228526, Japan	Kaunitz, JD (reprint author), West Los Angeles VA Med Ctr, Bldg 114,Suite 217,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	jake@ucla.edu	WATANABE, Masahiko/A-4055-2012		Department of Veterans Affairs; NIH-NIDDK [R01 DK54221, P30 DK0413];  [24-5317]	This work was supported by a Department of Veterans Affairs Merit Review Award, NIH-NIDDK R01 DK54221 (J. Kaunitz), a Grant-in-aid for Japanese Society for the Promotion of Science Fellow (I. Kaji, 24-5317) and the animal core of NIH-NIDDK P30 DK0413 (J. E. Rozengurt).	Akiba Y, 2011, DIGESTION, V83, P25, DOI 10.1159/000323401; Akiba Y, 2011, J GASTROEN HEPATOL, V26, P6, DOI 10.1111/j.1440-1746.2010.06580.x; Akiba Y, 2009, AM J PHYSIOL-GASTR L, V297, pG781, DOI 10.1152/ajpgi.90605.2008; RUPPIN H, 1980, GASTROENTEROLOGY, V78, P1500; Egerod KL, 2012, ENDOCRINOLOGY, V153, P5782, DOI 10.1210/en.2012-1595; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Akiba Y, 2008, GUT, V57, P1654, DOI 10.1136/gut.2007.144378; Wang JH, 2011, J PHARMACOL EXP THER, V339, P464, DOI 10.1124/jpet.111.184788; Akiba Y, 2007, AM J PHYSIOL-GASTR L, V293, pG1223, DOI 10.1152/ajpgi.00313.2007; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Kaji I, 2011, J MOL HISTOL, V42, P27, DOI 10.1007/s10735-010-9304-4; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Engelstoft MS, 2008, CELL METAB, V8, P447, DOI 10.1016/j.cmet.2008.11.004; Cho HJ, 2014, CELL TISSUE RES, V356, P77, DOI 10.1007/s00441-013-1780-x; Feinle C, 2001, GUT, V48, P347, DOI 10.1136/gut.48.3.347; Guan XF, 2006, GASTROENTEROLOGY, V130, P150, DOI 10.1053/j.gastro.2005.11.005; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Inoue T, 2014, DIGEST DIS SCI, V59, P1286, DOI 10.1007/s10620-013-3001-6; Karaki SI, 2008, J MOL HISTOL, V39, P135, DOI 10.1007/s10735-007-9145-y; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Fried M, 2002, GUT, V51, pI54, DOI 10.1136/gut.51.suppl_1.i54; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Barbera R, 1995, EUR J GASTROEN HEPAT, V7, P1051, DOI 10.1097/00042737-199511000-00007; Beattie DT, 2008, N-S ARCH PHARMACOL, V377, P181, DOI 10.1007/s00210-008-0276-9; BRIGHENTI F, 1995, EUR J CLIN NUTR, V49, P242; Gomes Costa Michelle Bafutto, 2012, Arquivos de Gastroenterologia, V49, P279, DOI 10.1590/S0004-28032012000400009; Dockray G J, 2003, J Physiol Pharmacol, V54 Suppl 4, P9; FISHBEIN VA, 1994, PEPTIDES, V15, P95, DOI 10.1016/0196-9781(94)90176-7; FLEMSTROM G, 1982, AM J PHYSIOL, V242, pG100; GALE JD, 1994, BRIT J PHARMACOL, V111, P332; Ghoshal UC, 2014, WORLD J GASTROENTERO, V20, P2482, DOI 10.3748/wjg.v20.i10.2482; GULLY D, 1993, EUR J PHARMACOL, V232, P13, DOI 10.1016/0014-2999(93)90722-T; HOLZER HH, 1994, AM J PHYSIOL-GASTR L, V267, pG625; HOVERSTAD T, 1984, SCAND J GASTROENTERO, V19, P1053; ILLMAN RJ, 1986, J NUTR, V116, P1694; Inoue T, 2012, AM J PHYSIOL-GASTR L, V303, pG810, DOI 10.1152/ajpgi.00195.2012; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; KONTUREK SJ, 1985, AM J PHYSIOL, V248, pG687; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Liatist S, 2010, EUR J CLIN NUTR, V64, P727, DOI 10.1038/ejcn.2010.89; Mitsuya M, 1999, BIOORGAN MED CHEM, V7, P2555, DOI 10.1016/S0968-0896(99)00177-7; Mizumori M, 2006, J PHYSIOL-LONDON, V573, P827, DOI 10.1113/jphysiol.2006.107581; Ostman E, 2005, EUR J CLIN NUTR, V59, P983, DOI 10.1038/sj.ejcn.1602197; Tappenden KA, 2003, J NUTR, V133, P3717; UMESAKI Y, 1980, PFLUG ARCH EUR J PHY, V388, P205, DOI 10.1007/BF00658482; Wang X, 1996, AM J PHYSIOL-HEART C, V270, pH476	54	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	FEB 1	2015	593	3					585	599		10.1113/jphysiol.2014.280792		15	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CB0CP	WOS:000349292900011		
J	Radziute, L; Gaigalas, G; Kato, D; Jonsson, R; Rynkun, P; Kucas, S; Jonauskas, V; Matulianec, R				Radziute, L.; Gaigalas, G.; Kato, D.; Jonsson, R.; Rynkun, P.; Kucas, S.; Jonauskas, V.; Matulianec, R.			Energy level structure of Er3+	JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER			English	Article						Energy structure; Er3+; Transition rates; Relativistic configuration interaction; Multiconfiguration Dirac-Hartree-Foc.k	ATOMIC-STRUCTURE PACKAGE; RELATIVISTIC CALCULATIONS; SPECTRA; PROGRAM; IONS; LAF3; CONFIGURATIONS; COEFFICIENTS; TRANSITIONS; EMISSION	Atomic energy levels and E2 and M1 transition rates are reported for the [Xe]4f(11) ground Configuration in Er3+ from relativistic multiconfiguration Dirac-Hartree-Fock and configuration interaction calculations. The Breit transverse interaction and leading QED effects are included as perturbations. Different strategies for describing electron correlation effects are tested and evaluated. The calculated energy levels are compared with experiment and results from semi-empirical methods. (C) 2014 Elsevier Ltd. All rights reserved.	[Radziute, L.; Gaigalas, G.; Rynkun, P.; Kucas, S.; Jonauskas, V.; Matulianec, R.] Vilnius Univ A, Inst Theoret Phys & Astron, LT-01108 Vilnius, Lithuania; [Gaigalas, G.; Kato, D.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Kato, D.] Grad Univ Adv Studies SOKENDAI, Dept Fus Sci, Toki, Gifu 5095292, Japan; [Jonsson, R.] Malmo Univ, S-20506 Malmo, Sweden	Radziute, L (reprint author), Vilnius Univ A, Inst Theoret Phys & Astron, Gastauto 12, LT-01108 Vilnius, Lithuania.	laima.radziute@tfai.vu.lt					DYALL KG, 1989, COMPUT PHYS COMMUN, V55, P425, DOI 10.1016/0010-4655(89)90136-7; OLSEN J, 1988, J CHEM PHYS, V89, P2185, DOI 10.1063/1.455063; Gaigalas G, 2004, COMPUT PHYS COMMUN, V157, P239, DOI 10.1016/S0010-4655(03)00518-6; Gaigalas G, 2001, COMPUT PHYS COMMUN, V139, P263, DOI 10.1016/S0010-4655(01)00213-2; Vilkas MJ, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062503; Jonsson P, 2013, COMPUT PHYS COMMUN, V184, P2197, DOI 10.1016/j.cpc.2013.02.016; WEBER MJ, 1967, PHYS REV, V157, P262, DOI 10.1103/PhysRev.157.262; Gaigalas G, 1997, J PHYS B-AT MOL OPT, V30, P3747, DOI 10.1088/0953-4075/30/17/006; Gaigalas G, 2003, ATOM DATA NUCL DATA, V84, P99, DOI 10.1016/S0092-640X(03)00014-7; NEWMAN DJ, 1989, REP PROG PHYS, V52, P699, DOI 10.1088/0034-4885/52/6/002; Gaigalas G, 1998, ATOM DATA NUCL DATA, V70, P1, DOI 10.1006/adnd.1998.0782; Dzuba VA, 1996, PHYS REV A, V54, P3948, DOI 10.1103/PhysRevA.54.3948; MCKENZIE BJ, 1980, COMPUT PHYS COMMUN, V21, P233, DOI 10.1016/0010-4655(80)90042-9; Sturesson L, 2007, COMPUT PHYS COMMUN, V177, P539, DOI 10.1016/j.cpc.2007.05.013; Carter W J, 1966, THESIS J HOPKINS U; Cowan R D, 1981, THEORY ATOMIC STRUCT; Faddeev LD, 2004, FOCK QUANTUM MECH QU; Fischer CF, 2007, COMPUT PHYS COMMUN, V176, P559, DOI 10.1016/j.cpc.2007.01.006; Froese Fischer C., 1997, COMPUTATIONAL ATOMIC; Grant I P, 1988, METHODS COMPUTATIONA, V2; GRANT IP, 1974, J PHYS B-AT MOL OPT, V7, P1458, DOI 10.1088/0022-3700/7/12/007; Grant IP, 2007, SPRINGER SER ATOM OP, V40, P3; Johnson W.R., 2007, ATOMIC STRUCTURE THE; Jonauskas V, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.012506; Jonauskas V, 2012, ATOM DATA NUCL DATA, V98, P19, DOI 10.1016/j.adt.2011.08.001; Jonauskas V, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/21/215005; Jonauskas V, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.053415; Karazija R, 2013, J QUANT SPECTROSC RA, V129, P131, DOI 10.1016/j.jqsrt.2013.06.003; Karazija R., 1996, INTRO THEORY XRAY EL; Kato D, 2012, PLASMA FUSION RES, V7; Kramida A., 2013, NIST ATOMIC SPECTRA; KRUPKE WF, 1963, J CHEM PHYS, V39, P1024, DOI 10.1063/1.1734352; KRUPKE WF, 1964, J CHEM PHYS, V41, P1225, DOI 10.1063/1.1726054; Kucas S, 2007, LITH J PHYS, V47, P249; Levchuk S, 2007, J NUCL MATER, V367, P1033; LINDGREN I, 1982, ATOMIC MANY BODY THE; Palaudoux J, 2010, PHYS REV A, V82; RUDZIKAS ZB, 1989, PHYS SCRIPTA, VT26, P21, DOI 10.1088/0031-8949/1989/T26/004; Vasile M, 2008, J OPTOELECTRON ADV M, V10, P2898; Wybourne B.G., 1966, SPECTROSCOPIC PROPER; WYBOURNE BG, 1960, J CHEM PHYS, V32, P639, DOI 10.1063/1.1730773	41	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4073	1879-1352		J QUANT SPECTROSC RA	J. Quant. Spectrosc. Radiat. Transf.	FEB	2015	152						94	106		10.1016/j.jqsrt.2014.11.007		13	Optics; Spectroscopy	Optics; Spectroscopy	CA5PG	WOS:000348959700008		
J	Samata, H; Wada, N; Ozawa, TC				Samata, Hiroaki; Wada, Naoki; Ozawa, Tadashi C.			Van Vleck paramagnetism of europium oxyhydroxide	JOURNAL OF RARE EARTHS			English	Article						europium oxyhydroxide; magnetic measurement; Van Vleck paramagnetism; rare earths	MAGNETIC-SUSCEPTIBILITY; EXCHANGE INTERACTIONS; IONS; CRYSTALS; EU2O3; EU	Europium oxyhydroxide crystals were synthesized by the flux method. The as-grown crystals were transparent and had a plate-like shape with natural flat surfaces. The powder XRD data were refined by assuming a monoclinic structure of the space group P2(1)/m and lattice parameters of a=0.4346 nm, b=0.3744 nm, c=0.6107 nm, and beta= 108.62 degrees. The magnetic susceptibility of the EuOOH crystals exhibited typical Van Vleck temperature-independent paramagnetism below 120 K. The calculated susceptibility, based on Van Vleck's theory, agreed with the experimental data to some extent, with the coupling constant lambda=458 +/- 10 K. The experimental results were in close agreement with the results calculated using a modified formula with lambda=505 +/- 2 K and a constant term C=4.6x10(-4) emu/(mol.Oe).	[Samata, Hiroaki; Wada, Naoki] Kobe Univ, Grad Sch Maritime Sci, Higashinada Ku, Kobe, Hyogo 6580022, Japan; [Ozawa, Tadashi C.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan	Samata, H (reprint author), Kobe Univ, Grad Sch Maritime Sci, Higashinada Ku, Kobe, Hyogo 6580022, Japan.	samata@maritime.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [21560696, 24560827]	Project supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants (21560696, 24560827)	Adachi G., 1999, SCI RARE EARTHS, P3; BOROVIKROMANOV AS, 1956, SOV PHYS JETP-USSR, V2, P657; Petrov D, 2011, J ALLOY COMPD, V509, P5038, DOI 10.1016/j.jallcom.2011.02.003; Takikawa Y, 2010, J PHYS CHEM SOLIDS, V71, P1592, DOI 10.1016/j.jpcs.2010.08.006; BUIJS M, 1987, J LUMIN, V37, P9, DOI 10.1016/0022-2313(87)90177-3; Samata H, 2007, J CRYST GROWTH, V304, P448, DOI 10.1016/j.jcrysgro.2007.03.025; ANDERSON PW, 1963, SOLID STATE PHYS, V14, P99; Samata H, 2009, J ALLOY COMPD, V468, P566, DOI 10.1016/j.jallcom.2008.01.056; Antic B, 1997, J PHYS-CONDENS MAT, V9, P365, DOI 10.1088/0953-8984/9/2/004; Barnighausen V H, 1965, ACTA CRYSTALLOGR, V19, P1047; CARO P, 1986, J MAGN MAGN MATER, V58, P61, DOI 10.1016/0304-8853(86)90123-X; Concas G, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.014427; Ebisu S, 1998, J MAGN MAGN MATER, V177, P1073, DOI 10.1016/S0304-8853(97)00509-X; HUANG NL, 1969, J APPL PHYS, V40, P1144, DOI 10.1063/1.1657569; Iida S, 1978, BUTSURITEISUUHYOU, P84; Izumi F, 2000, MATER SCI FORUM, V321-3, P198; KERN S, 1970, J PHYS CHEM SOLIDS, V31, P2639, DOI 10.1016/0022-3697(70)90259-3; Petrov D, 2012, ACTA PHYS POL A, V122, P737; Sheina LP, 1965, IAN SSSR NEORG MATER, V1, P2219; Van Vleck J.H, 1932, THEORY ELECT MAGNETI, P226	20	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1002-0721			J RARE EARTH	J. Rare Earths	FEB	2015	33	2					177	181		10.1016/S1002-0721(14)60399-9		5	Chemistry, Applied	Chemistry	CB1JP	WOS:000349383800009		
J	Mimata, Y; Nishida, J; Sato, K; Suzuki, Y; Doita, M				Mimata, Yoshikuni; Nishida, Jun; Sato, Kotaro; Suzuki, Yoshiaki; Doita, Minoru			Glenohumeral arthrodesis for malignant tumor of the shoulder girdle	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Malignant tumor; reconstruction; arthrodesis of the shoulder joint; a double-barrel vascularized fibular graft	FIBULAR BONE-GRAFT; RECONSTRUCTION; RESECTION; DEFECTS; SYSTEM	Background: Arthrodesis of the shoulder joint using a free vascularized fibular graft has been performed as a reconstruction method after resection of bone sarcoma in the shoulder girdle. Postoperative fractures occasionally occur as a complication of arthrodesis of the shoulder joint using single-bone fusion (the conventional method). We hypothesized that the clinical results of shoulder arthrodesis using a double-barrel vascularized fibula graft for the malignant tumor of the shoulder girdle would achieve superior results compared with the conventional single-bone fusion method. Methods: The clinical results of 5 patients with a malignant bone and soft tissue tumor of the shoulder girdle were retrospectively reviewed. The factors evaluated were surgical margins, reconstruction procedures, postoperative complications, local recurrences, metastasis in lymph nodes or lung, or both, survival, and functional results assessed by the Musculoskeletal Tumor Society (MSTS) score. After surgical resection, arthrodesis of the shoulder joint was performed using a free vascularized fibula graft as a reconstructive procedure for the bone defect. Arthrodesis was by single-bone fusion in 3 of 5 patients, and a double-barrel vascularized fibula graft (dual-bone fusion) was used in 2 patients. Results: The average MSTS scores were 58.3% in the group with single-bone fusion and 85.0% in the group with dual-bone fusion. Conclusion: The use of a double-barrel vascularized fibular graft may be useful in the reconstruction of large bone defects after wide excision of malignant tumors of the proximal humerus, with the advantage of avoiding postoperative fractures in shoulder arthrodesis. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Mimata, Yoshikuni; Nishida, Jun; Doita, Minoru] Iwate Med Univ, Sch Med, Dept Orthopaed Surg, Morioka, Iwate 0208505, Japan; [Sato, Kotaro; Suzuki, Yoshiaki] Iwate Prefectural Chubu Hosp, Dept Orthopaed Surg, Kitakami, Iwate, Japan	Nishida, J (reprint author), Iwate Med Univ, Sch Med, Dept Orthopaed Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	jnishida@f2.dion.ne.jp					ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; BANIC A, 1993, J RECONSTR MICROSURG, V9, P421, DOI 10.1055/s-2007-1006751; Bi ZG, 2008, CHINESE MED J-PEKING, V121, P2424; Bilgin S Sinan, 2012, J Bone Joint Surg Am, V94, pe94, DOI 10.2106/JBJS.J.01823; Chu CH, 2009, KAOHSIUNG J MED SCI, V25, P552, DOI 10.1016/S1607-551X(09)70548-0; CREIGHTON JJ, 1985, J HAND SURG-AM, V10A, P805; JONES NF, 1988, PLAST RECONSTR SURG, V81, P378, DOI 10.1097/00006534-198803000-00011; MALAWER MM, 1991, CLIN ORTHOP RELAT R, P33; Mimata Y, 2013, J SHOULDER ELB SURG, V22, pE1, DOI 10.1016/j.jse.2013.05.017; Molski M, 1997, Chir Narzadow Ruchu Ortop Pol, V62, P139; Nishida J, 2011, CURR ORTHOP PRACT, V22, P309; OConnor MI, 1996, J BONE JOINT SURG AM, V78A, P1872; ROSS AC, 1987, J BONE JOINT SURG BR, V69, P656; Safran O, 2006, J AM ACAD ORTHOP SUR, V14, P145; Wieser K, 2013, ARCH ORTHOP TRAUM SU, V133, P1219, DOI 10.1007/s00402-013-1795-5	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	FEB	2015	24	2					174	178		10.1016/j.jse.2014.05.023		5	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AY7DJ	WOS:000347721200008		
J	Omori, S; Murase, T; Oka, K; Kawanishi, Y; Oura, K; Tanaka, H; Yoshikawa, H				Omori, Shinsuke; Murase, Tsuyoshi; Oka, Kunihiro; Kawanishi, Yohei; Oura, Keiichiro; Tanaka, Hiroyuki; Yoshikawa, Hideki			Postoperative accuracy analysis of three-dimensional corrective osteotomy for cubitus varus deformity with a custom-made surgical guide based on computer simulation	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Accuracy analysis; three-dimensional; corrective osteotomy; cubitus varus; custom-made guide; computer simulation	POSTEROLATERAL ROTATORY INSTABILITY; DISPLACED SUPRACONDYLAR FRACTURES; TOTAL KNEE ARTHROPLASTY; ULNAR NERVE PALSY; DISTAL RADIUS; MALUNITED FRACTURES; UPPER EXTREMITY; HUMERUS; CHILDREN; ELBOW	Background: For correction of cubitus varus deformity resulting from supracondylar fracture of the humerus, we developed an operative method with use of a custom-made surgical guide, designed on the basis of 3-dimensional (3D) computer simulation with computed tomography data. The purpose of this study was to investigate the postoperative accuracy of this system in clinical cases. Methods: Subjects included 17 consecutive patients (13 males and 4 females) with cubitus varus deformity after supracondylar fracture. Patients underwent 3D corrective osteotomy with use of a custom-made surgical guide. Postoperative computed tomography scan was performed after bone union diagnosis on plain radiographs, and postoperative 3D bone models were compared with preoperative simulation by surface registration technique. In addition, we evaluated radiographic parameters (humerus-elbow-wrist angle and tilting angle) and range of elbow motion at the most recent follow-up. Results: Mean errors in 3D corrective osteotomy were 0.6 degrees +/- 0.7 degrees in varus-valgus rotation, 0.8 degrees +/- 1.3 degrees in flexion-extension rotation, 2.9 degrees +/- 2.8 degrees in internal-external rotation, 1.7 +/- 1.8 mm in anterior-posterior translation, 1.3 +/- 1.8 mm in lateral-medial translation, and 7.1 +/- 6.3 mm in proximal-distal translation. The mean humerus-elbow-wrist angle on plain radiographs of the affected side was 15 degrees in varus before surgery and improved to 6 degrees in valgus after surgery. The mean tilting angle of the affected side was 31 degrees before surgery and improved to 40 degrees after surgery. Conclusion: The 3D correction of cubitus varus deformity was performed accurately within the allowable error limits. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Omori, Shinsuke; Murase, Tsuyoshi; Oka, Kunihiro; Kawanishi, Yohei; Oura, Keiichiro; Tanaka, Hiroyuki; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan	Murase, T (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	tmurase-osk@umin.ac.jp					ABE M, 1995, J HAND SURG-AM, V20A, P5, DOI 10.1016/S0363-5023(05)80047-4; Audette MA, 2000, MED IMAGE ANAL, V4, P201, DOI 10.1016/S1361-8415(00)00014-1; O'Driscoll SW, 2001, J BONE JOINT SURG AM, V83A, P1358; Omori S, 2014, INT J MED ROBOT COMP, V10, P196, DOI 10.1002/rcs.1530; Raney EM, 2012, J PEDIATR ORTHOPED, V32, P232, DOI 10.1097/BPO.0b013e3182471d3f; Tibesku CO, 2013, ARCH ORTHOP TRAUM SU, V133, P405, DOI 10.1007/s00402-012-1667-4; WEILAND AJ, 1978, J BONE JOINT SURG AM, V60, P657; BELLEMORE MC, 1984, J BONE JOINT SURG BR, V66, P566; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Miyake J, 2012, J HAND SURG-EUR VOL, V37E, P506, DOI 10.1177/1753193412443644; Murase T, 2008, J BONE JOINT SURG AM, V90A, P2375, DOI 10.2106/JBJS.G.01299; von Campe A, 2006, CLIN ORTHOP RELAT R, P179, DOI 10.1097/01.blo.0000223994.79894.17; Miyake J, 2011, CLIN ORTHOP RELAT R, V469, P1766, DOI 10.1007/s11999-010-1748-z; ODRISCOLL SW, 1991, J BONE JOINT SURG AM, V73A, P440; Prommersberger KJ, 2002, J HAND SURG-BRIT EUR, V27B, P55, DOI 10.1054/jhsb.2001.0693; Chung MS, 2003, J SHOULDER ELB SURG, V12, P472, DOI 10.1016/S1058-2746(03)00090-9; Davids JR, 2011, J PEDIATR ORTHOPED, V31, P353, DOI 10.1097/BPO.0b013e31821723a6; Devnani AS, 1997, INJURY, V28, P643, DOI 10.1016/S0020-1383(97)00139-3; FRENCH PR, 1959, LANCET, V2, P439; Gong HS, 2008, CLIN ORTHOP RELAT R, V466, P899, DOI 10.1007/s11999-008-0164-0; HERNANDEZ MA, 1994, J PEDIATR ORTHOPED, V14, P487; HOVE LM, 1994, ACTA ORTHOP SCAND, V65, P434, DOI 10.3109/17453679408995488; Jeon IH, 2006, J SHOULDER ELB SURG, V15, P474, DOI 10.1016/j.jse.2005.10.009; Kapoutsis CA, 1999, IEEE T IMAGE PROCESS, V8, P1644, DOI 10.1109/83.799892; Kataoka T, 2013, J HAND SURG-AM, V38A, P909, DOI 10.1016/j.jhsa.2013.02.024; LAUPATTARAKASEM W, 1989, J BONE JOINT SURG BR, V71, P667; Lim TK, 2011, J SHOULDER ELB SURG, V20, P866, DOI 10.1016/j.jse.2011.04.003; MCCOY GF, 1988, J BONE JOINT SURG BR, V70, P283; Mitsunari A, 1995, J Shoulder Elbow Surg, V4, P23; Miyake J, 2013, J HAND SURG-EUR VOL, V38E, P133, DOI 10.1177/1753193412451383; Miyake Junichi, 2012, J Bone Joint Surg Am, V94, pe150, DOI 10.2106/JBJS.K.00829; Nam D, 2012, J KNEE SURG, V25, P213, DOI 10.1055/s-0032-1319785; O'Hara LJ, 2000, J BONE JOINT SURG BR, V82B, P204, DOI 10.1302/0301-620X.82B2 .9570; Oka K, 2012, J SHOULDER ELB SURG, V21, pE1, DOI 10.1016/j.jse.2012.05.035; Oka K, 2009, INT J MED ROBOT COMP, V5, P452, DOI 10.1002/rcs.277; Skaggs David L, 2011, J Child Orthop, V5, P305, DOI 10.1007/s11832-011-0349-z; Takeyasu Y, 2011, J SHOULDER ELB SURG, V20, P440, DOI 10.1016/j.jse.2010.11.020; Takeyasu Yukari, 2013, J Bone Joint Surg Am, V95, pe173, DOI 10.2106/JBJS.L.01622; Tricot M, 2012, ACTA ORTHOP BELG, V78, P538; Usui M, 1995, J Shoulder Elbow Surg, V4, P17; Zhang YAZ, 2011, J SHOULDER ELB SURG, V20, P51, DOI 10.1016/j.jse.2010.08.029	41	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	FEB	2015	24	2					242	249		10.1016/j.jse.2014.08.020		8	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AY7DJ	WOS:000347721200019		
J	Day, MJ; Karkare, U; Schultz, RD; Squires, R; Tsujimoto, H				Day, M. J.; Karkare, U.; Schultz, R. D.; Squires, R.; Tsujimoto, H.			Recommendations on vaccination for Asian small animal practitioners: a report of the WSAVA Vaccination Guidelines Group	JOURNAL OF SMALL ANIMAL PRACTICE			English	Article								EXECUTIVE SUMMARY In 2012 and 2013, the World Small Animal Veterinary Association (WSAVA) Vaccination Guidelines Group (VGG) undertook fact-finding visits to several Asian countries, with a view to developing advice for small companion animal practitioners in Asia related to the administration of vaccines to dogs and cats. The VGG met with numerous first opinion practitioners, small animal association leaders, academic veterinarians, government regulators and industry representatives and gathered further information from a survey of almost 700 veterinarians in India, China, Japan and Thailand. Although there were substantial differences in the nature and magnitude of the challenges faced by veterinarians in each country, and also differences in the resources available to meet those challenges, overall, the VGG identified insufficient undergraduate and postgraduate training in small companion animal microbiology, immunology and vaccinology. In most of the countries, there has been little academic research into small animal infectious diseases. This, coupled with insufficient laboratory diagnostic support, has limited the growth of knowledge concerning the prevalence and circulating strains of key infectious agents in most of the countries visited. Asian practitioners continue to recognise clinical infections that are now considered uncommon or rare in western countries. In particular, canine rabies virus infection poses a continuing threat to animal and human health in this region. Both nationally manufactured and international dog and cat vaccines are variably available in the Asian countries, but the product ranges are small and dominated by multi-component vaccines with a licensed duration of immunity (DOI) of only 1 year, or no description of DOI. Asian practitioners are largely unaware of current global trends in small animal vaccinology or of the WSAVA vaccination guidelines. Consequently, most practitioners continue to deliver annual revaccination with both core and non-core vaccines to adult animals, with little understanding that herd immunity is more important than frequent revaccination of individual animals within the population. In this paper, the VGG presents the findings of this project and makes key recommendations for the Asian countries. The VGG recommends that (1) Asian veterinary schools review and increase as needed the amount of instruction in small animal vaccinology within their undergraduate curriculum and increase the availability of pertinent postgraduate education for practitioners; (2) national small animal veterinary associations, industry veterinarians and academic experts work together to improve the scientific evidence base concerning small animal infectious diseases and vaccination in their countries; (3) national small animal veterinary associations take leadership in providing advice to practitioners based on improved local knowledge and global vaccination guidelines; (4) licensing authorities use this enhanced evidence base to inform and support the registration of improved vaccine product ranges for use in their countries, ideally with DOI for core vaccines similar or equal to those of equivalent products available in western countries (i.e. 3 or 4 years). The VGG also endorses the efforts made by Asian governments, non-governmental organisations and veterinary practitioners in working towards the goal of global elimination of canine rabies virus infection. In this paper, the VGG offers both a current pragmatic and future aspirational approach to small animal vaccination in Asia. As part of this project, the VGG delivered continuing education to over 800 Asian practitioners at seven events in four countries. Accompanying this document is a list of 80 frequently asked questions (with answers) that arose during these discussions. The VGG believes that this information will be of particular value to Asian veterinarians as they move towards implementing global trends in small companion animal vaccinology.	[Day, M. J.] Univ Bristol, Sch Vet Sci, Langford, BC BS40 5DU, Canada; [Karkare, U.] Happy Tails Vet Special, Bombay 400052, Maharashtra, India; [Schultz, R. D.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Squires, R.] James Cook Univ, Sch Vet & Biomed Sci, Townsville, Qld 4811, Australia; [Tsujimoto, H.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Internal Med, Tokyo 1138654, Japan	Day, MJ (reprint author), Univ Bristol, Sch Vet Sci, Langford, BC BS40 5DU, Canada.				MSD Animal Health	The VGG gratefully acknowledges the time given by the large number of individuals who attended our meetings and contributed valuable data and local knowledge to the project. We are particularly grateful to the small animal associations and individuals who administered the questionnaire survey in the various countries, which was a demanding and time-consuming task. In particular, we thank Dr Louis Liu (Beijing Small Animal Veterinary Association), Dr Geoffrey Chen (Shanghai Small Animal Veterinary Association) and Dr Walasinee Moonarmart (Veterinary Practitioners Association of Thailand). The work of the VGG continues to be sponsored by MSD Animal Health. We are enormously grateful for the incredible logistical support provided by the national offices of MSD Animal Health in the four countries that we visited and for the oversight given by David Sutton (MSD Global) and Dr Raphael Zwijnenberg (MSD Asia-Pacific).	Day MJ, 2010, J SMALL ANIM PRACT, V51, P338; Day MJ, 2007, J SMALL ANIM PRACT, V48, P528, DOI 10.1111/j.1748-5827.2007.00462.x	2	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4510	1748-5827		J SMALL ANIM PRACT	J. Small Anim. Pract.	FEB	2015	56	2					77	95		10.1111/jsap.12272		19	Veterinary Sciences	Veterinary Sciences	CA6LI	WOS:000349024800002		
J	Ohshita, J; Muragishi, H; Yamamoto, K; Mizumo, T; Kanezashi, M; Tsuru, T				Ohshita, Joji; Muragishi, Haruna; Yamamoto, Kazuki; Mizumo, Tomonobu; Kanezashi, Masakoto; Tsuru, Toshinori			Preparation and separation properties of porous norbornane-bridged silica membrane	JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY			English	Article						Bridged silica; Gas separation; Water separation; Sol-gel process; Porous membrane	ORGANOSILICA MEMBRANES; HYDROTHERMAL STABILITY; REVERSE-OSMOSIS; HYDROSILYLATION	Bis(trimethoxysilyl)norbornane (BTMSN) bearing a highly rigid norbornane bridge was employed as a new silica membrane precursor. The membrane prepared by subjecting BTMSN to the sol-gel process was examined for gas and water separation, and the results were compared with those of ethylene- and ethenylene-bridged silica membranes reported previously. Interestingly, the gas permeability of the BTMSN silica membrane was higher than that of the ethylene- and ethenylene-bridged silica membranes, whereas the water permeability was rather suppressed. The moderately high H-2/SF6 permeance ratio of 1,160 and the NaCl rejection of 95 % (2,000 ppm aqueous NaCl) obtained for the BTMSN silica membrane clearly indicate its potential application to gas and water separation.	[Ohshita, Joji; Muragishi, Haruna; Yamamoto, Kazuki; Mizumo, Tomonobu] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan; [Kanezashi, Masakoto; Tsuru, Toshinori] Hiroshima Univ, Grad Sch Engn, Dept Chem Engn, Higashihiroshima 7398527, Japan	Ohshita, J (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Higashihiroshima 7398527, Japan.	jo@hiroshima-u.ac.jp; tsuru@hiroshima-u.ac.jp	Kanezashi, Masakoto/G-3938-2010; Ohshita, Joji/C-7576-2011; Tsuru, Toshinori/G-6035-2010		Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency (JST)	This research was supported by Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency (JST).	Kanezashi M, 2009, J AM CHEM SOC, V131, P414, DOI 10.1021/ja806762q; Xu R, 2013, ACS APPL MATER INTER, V5, P6147, DOI 10.1021/am401056a; Xu R, 2013, AICHE J, V59, P1298, DOI 10.1002/aic.13885; Tsuru T, 2011, J MEMBRANE SCI, V384, P149, DOI 10.1016/j.memsci.2011.09.018; Zhuang TY, 2010, J MATER CHEM, V20, P6026, DOI 10.1039/c0jm01678k; UOZUMI Y, 1993, J ORG CHEM, V58, P1945, DOI 10.1021/jo00059a059; Hao TT, 2012, RSC ADV, V2, P2010, DOI 10.1039/c2ra00805j; Castricum HL, 2008, J MATER CHEM, V18, P2150, DOI 10.1039/b801972j; Qi H, 2010, CHEMSUSCHEM, V3, P1375, DOI 10.1002/cssc.201000242; Xu R, 2011, LANGMUIR, V27, P13996, DOI 10.1021/la203711u; Castricum HL, 2008, CHEM COMMUN, P1103; Frisch MJ, 2009, GAUSSIAN 09W REV A 0; HAYASHI T, 1992, PURE APPL CHEM, V64, P1911, DOI 10.1351/pac199264121911; UOZUMI Y, 1992, TETRAHEDRON LETT, V33, P7185, DOI 10.1016/S0040-4039(00)60868-7; Villaluenga JPG, 2001, J APPL POLYM SCI, V82, P3013	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0928-0707	1573-4846		J SOL-GEL SCI TECHN	J. Sol-Gel Sci. Technol.	FEB	2015	73	2					365	370		10.1007/s10971-014-3542-y		6	Materials Science, Ceramics	Materials Science	CA6JG	WOS:000349018000011		
J	Kawada, S; Hamaguchi, T; Kitayama, M; Imamura, T; Ohno, M; Kashihara, K; Iwasaki, K				Kawada, Sanami; Hamaguchi, Toshikazu; Kitayama, Michio; Imamura, Takaki; Ohno, Manabu; Kashihara, Kenichi; Iwasaki, Kouichiro			Multidetector Computed Tomography Angiography to Detect the Cause of Multiple Brain Infarctions	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Multidetector computed tomography angiography; acute multiple brain infarctions; patent foramen ovale; left atrial appendage thrombus; complicated aortic plaque	PATENT FORAMEN OVALE; ATRIAL APPENDAGE THROMBUS; CRYPTOGENIC STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CT ANGIOGRAPHY; AORTA; METAANALYSIS; DIAGNOSIS; DISEASE; ADULTS	Background: Multidetector computed tomography angiography (MDCTA) is useful to inspect cardiovascular pathologic changes with minimal invasiveness. Here we evaluated the usefulness of MDCTA to determine the cause of acute multiple brain infarction (AMBI). Methods: AMBI was defined as multiple recent infarcts demonstrated on diffusion-weighted imaging. A new infarction within 2 weeks from the last was also considered an AMBI. Results: Between January 2012 and December 2013, 967 patients were diagnosed with acute brain infarction and 138 (14.3%) with AMBI. Among them, 57 (39 men and 18 women; age, 38-93 years) were examined by MDCTA using the dual-phase method. All images were diagnostic, even if patients found it difficult to hold their breath. Fifteen patients (26.3%) were diagnosed with patent foramen ovale (PFO). Two had complications of atrial fibrillation (AF), necessitating anticoagulant therapy (ACT). Four had both PFO and severe aortic atherosclerotic plaque formation, necessitating single antiplatelet therapy (APT) and/or ACT. Fifteen patients (26.3%) developed complicated arterial plaques around the aortic arch and were administered single or dual APT and/or ACT, except 1 patient with a history of multiple cerebral bleeding. Nine patients had pre-existing AF. Furthermore, ACT was initiated for 2 other patients with thrombus or circulatory stasis in the left atrial appendage despite normal electrocardiographic findings. Two other patients were diagnosed with advanced cancer, which was considered Trousseau syndrome. The cause of AMBI was determined in 36 (63.2%) patients. Conclusions: MDCTA is a useful and less invasive method to identify the cause of embolic infarction.	[Kawada, Sanami; Hamaguchi, Toshikazu; Kitayama, Michio; Imamura, Takaki; Ohno, Manabu; Kashihara, Kenichi] Okayama Kyokuto Hosp, Dept Neurol, Okayama 7038265, Japan; [Iwasaki, Kouichiro] Okayama Kyokuto Hosp, Dept Cardiovasc Med, Okayama 7038265, Japan	Kawada, S (reprint author), Okayama Kyokuto Hosp, Naka Ku, 567-1 Kurata, Okayama 7038265, Japan.	kawada@kyokuto.or.jp					Kim YJ, 2009, RADIOLOGY, V250, P61, DOI 10.1148/radiol.2501080559; Hur J, 2009, RADIOLOGY, V251, P683, DOI 10.1148/radiol.2513090794; Mustanoja S, 2013, EUR J NEUROL, V20, P216, DOI 10.1111/j.1468-1331.2012.03872.x; Saremi F, 2008, RADIOLOGY, V249, P483, DOI 10.1148/radiol.2492080175; Meier B, 2012, EUR HEART J, V33, P705, DOI 10.1093/eurheartj/ehr443; Soliman A, 1999, J AM SOC ECHOCARDIOG, V12, P99, DOI 10.1016/S0894-7317(99)70121-5; Romero J, 2013, CIRC-CARDIOVASC IMAG, V6, P185, DOI 10.1161/CIRCIMAGING.112.000153; Harloff A, 2010, STROKE, V41, P1145, DOI 10.1161/STROKEAHA.109.577775; Serena J, 2008, STROKE, V39, P3131, DOI 10.1161/STROKEAHA.108.521427; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Horton SC, 2004, MAYO CLIN PROC, V79, P79; Kim SC, 2010, AM J CARDIOL, V106, P1174, DOI 10.1016/j.amjcard.2010.06.033; Yu TF, 2007, RADIOL CLIN N AM, V45, P461, DOI 10.1016/j.rcl.2007.04.010; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17; Altieri M, 1999, EUR NEUROL, V42, P76, DOI 10.1159/000069415; Kraywinkel K, 2005, NERVENARZT, V76, P935, DOI 10.1007/s00115-004-1874-5; Kronzon I, 2006, CIRCULATION, V114, P63, DOI 10.1161/CIRCULATIONAHA.105.593418; Roh JK, 2000, STROKE, V31, P688; Chaturvedi S, 1998, J NEUROL SCI, V160, P158, DOI 10.1016/S0022-510X(98)00243-3; Chatzikonstantinou A, 2012, CEREBROVASC DIS, V33, P322, DOI 10.1159/000335828; Finsterer J, 2010, ACTA NEUROL BELG, V110, P135; Khan AR, 2013, JACC-CARDIOVASC INTE, V6, P1316, DOI 10.1016/j.jcin.2013.08.001; Meissner I, 2006, J AM COLL CARDIOL, V47, P440, DOI 10.1016/j.jacc.2005.10.044; Revel MP, 2008, RADIOLOGY, V249, P338, DOI 10.1148/radiol.2491071874; Riaz Irbaz Bin, 2013, BMC Cardiovasc Disord, V13, P116, DOI 10.1186/1471-2261-13-116; Rodes-Cabau J, 2009, STROKE, V40, P419, DOI 10.1161/STROKEAHA.108.527507; Rundek T, 1999, STROKE, V30, P2683	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2015	24	2					348	353		10.1016/j.jstrokecerebrovasdis.2014.08.032		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CA8NJ	WOS:000349177300015		
J	Okawa, M; Ogata, T; Abe, H; Fukuda, K; Higashi, T; Inoue, T				Okawa, Masakazu; Ogata, Toshiyasu; Abe, Hiroshi; Fukuda, Kenji; Higashi, Toshio; Inoue, Tooru			Do Octogenarians Still Have a High Risk of Adverse Outcomes after Carotid Endarterectomy in the Era of a Super-aged Society? A Single-center Study in Japan	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Carotid endarterectomy; long-term follow-up; octogenarian; elderly	MORTALITY; DISEASE; MORBIDITY; STENOSIS	Background: The aim of this study was to evaluate the safety and feasibility of carotid endarterectomy (CEA) in Japanese octogenarians. Methods: This study prospectively included 157 consecutive CEA procedures in 145 patients treated at Fukuoka University Hospital between May 2008 and April 2013. Clinical and radiologic findings were obtained from the medical records and by telephone interview. Major events and outcomes were compared between patients 80 years of age or older (octogenarians) and those less than 79 years of age (nonoctogenarians). Results: The rate of major adverse events (major stroke, myocardial infarction, or death) in the perioperative period was 1.2%. Follow-up data were available for 142 patients (97.9%). Only 1 case (.7%) of ipsilateral stroke occurred during the follow-up period. Thirteen patients died of causes other than stroke. The estimated 1-, 3-, and 5-year overall survival rates were 98.5%, 96.9%, and 93.1%, respectively. Nineteen (13.4%) of the patients were octogenarians. There were no significant differences in baseline characteristics between octogenarians and nonoctogenarians, except for age. In octogenarians, there were no major adverse events during the perioperative period and no cases of stroke or stroke-related death during the follow-up period. The estimated 1-, 3-, and 5-year overall survival rates in octogenarians were 92.9%, 92.9%, and 61.9%, respectively. There was no significant difference in overall survival between octogenarians and nonoctogenarians (P = .371). Conclusions: The results of this study suggest that CEA can be safely performed in Japanese octogenarians. Midterm outcomes were relatively good, but long-term outcomes require further study.	[Okawa, Masakazu; Abe, Hiroshi; Fukuda, Kenji; Higashi, Toshio; Inoue, Tooru] Fukuoka Univ, Dept Neurosurg, Fac Med, Fukuoka 8140180, Japan; [Ogata, Toshiyasu] Fukuoka Univ, Dept Neurol, Fac Med, Fukuoka 8140180, Japan	Okawa, M (reprint author), Fukuoka Univ, Dept Neurosurg, Jounan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	okawam@fukuoka-u.ac.jp					Okawa M, 2014, J STROKE CEREBROVASC, V23, P545, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.012; Rajamani K, 2013, STROKE, V44, P1172, DOI 10.1161/STROKEAHA.111.000513; Mantese VA, 2010, STROKE, V41, pS31, DOI 10.1161/STROKEAHA.110.595330; [Anonymous], 2014, RES POP EST MONTHL R; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Young B, 1996, STROKE, V27, P2216; Brott TG, 2011, STROKE, V42, pE464, DOI 10.1161/STR.0b013e3182112cc2; Chaturvedi S, 2010, STROKE, V41, P757, DOI 10.1161/STROKEAHA.109.569426; Lichtman JH, 2009, CEREBROVASC DIS, V29, P154; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Ogata T, 2014, J STROKE CEREBROVASC, V23, P529, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.030; Shimada T, 2005, J NEUROSURG, V103, P593, DOI 10.3171/jns.2005.103.4.0593; Wennberg DE, 1998, JAMA-J AM MED ASSOC, V279, P1278, DOI 10.1001/jama.279.16.1278	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2015	24	2					370	373		10.1016/j.jstrokecerebrovasdis.2014.09.011		4	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CA8NJ	WOS:000349177300018		
J	Tanoue, S; Inamasu, J; Yamada, M; Toyama, H; Hirose, Y				Tanoue, Shunsuke; Inamasu, Joji; Yamada, Masayuki; Toyama, Hiroshi; Hirose, Yuichi			Does Dabigatran Increase the Risk of Delayed Hematoma Expansion in a Rat Model of Collagenase-induced Intracerebral Hemorrhage?	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Dabigatran; delayed hematoma expansion; intracerebral hemorrhage; magnetic resonance imaging; warfarin	THROMBIN INHIBITOR DABIGATRAN; ATRIAL-FIBRILLATION; INTRACRANIAL HEMORRHAGE; ANTITHROMBOTIC THERAPY; WARFARIN; ANTICOAGULATION; ETEXILATE; STROKE	Background: Delayed hematoma expansion is common in intracerebral hemorrhage (ICH) patients using warfarin. Dabigatran induces fewer hemorrhagic complications compared with warfarin. However, the natural history of dabigatran-related ICH remains unclear. This study aims to clarify whether dabigatran increases the risk of delayed hematoma expansion in a rat ICH model. Methods: Male Wistar rats were treated with 2 dosages of dabigatran etexilate (DE: 10 mg/kg, n = 4; 20 mg/kg, n = 3) 30 minutes before ICH induction using intraparenchymal collagenase infusion. Five rats that received saline were used as controls. Magnetic resonance imaging was performed 24 and 48 hours after ICH induction, and serial hematoma volume measurements were obtained using T2-weighted images. Expanded hematoma volumes were calculated by subtracting hematoma volumes at 48 hours from those at 24 hours; the hematoma expansion rate was defined as the ratio of the expanded hematoma volume to that at 24 hours. Results: The mean hematoma volumes (mm(3)) at 24 hours were 13.3 +/- 3.3 in the control group, 14.9 +/- 2.0 in the 10 mg/kg DE group, and 18.9 +/- 7.6 in the 20 mg/kg DE group with no significant intergroup differences (P = .26). The mean hematoma volumes at 48 hours (mm(3)) were 21.7 +/- 4.9 in the control group, 22.1 +/- 5.0 in the 10 mg/kg DE group, and 23.4 +/- 5.8 in the 20 mg/kg DE group with no significant intergroup differences (P = .90). Consequently, there were no significant intergroup differences in the hematoma expansion rates (P = .33). Conclusions: This experimental study of a rat ICH model indicates that dabigatran-related ICH may not increase the risk of delayed hematoma expansion.	[Tanoue, Shunsuke; Inamasu, Joji; Hirose, Yuichi] Fujita Hlth Univ, Sch Med, Dept Neurosurg, Toyoake, Aichi 4701192, Japan; [Tanoue, Shunsuke] Self Def Forces Cent Hosp, Dept Neurosurg, Tokyo, Japan; [Yamada, Masayuki] Fujita Hlth Univ, Sch Med Sci, Dept Radiol, Toyoake, Aichi 4701192, Japan; [Toyama, Hiroshi] Fujita Hlth Univ, Sch Med, Dept Radiol, Toyoake, Aichi 4701192, Japan	Inamasu, J (reprint author), Fujita Hlth Univ, Sch Med, Dept Neurosurg, 1-98 Kutsukake, Toyoake, Aichi 4701192, Japan.	inamasu@fujita-hu.ac.jp			Japan Brain Foundation; Fujita Research Foundation	J.I. received financial support from the Japan Brain Foundation and Fujita Research Foundation.	Lauer A, 2011, CIRCULATION, V124, P1654, DOI 10.1161/CIRCULATIONAHA.111.035972; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; ROSENBERG GA, 1990, STROKE, V21, P801; Foerch C, 2008, STROKE, V39, P3397, DOI 10.1161/STROKEAHA.108.517482; Zhou W, 2011, STROKE, V42, P3594, DOI 10.1161/STROKEAHA.111.624650; DelBigio MR, 1996, STROKE, V27, P2312; Simonsen CZ, 2014, J STROKE CEREBROVASC, V23, pE133, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.011; Pfeilschifter W, 2012, ANN NEUROL, V71, P624, DOI 10.1002/ana.23558; Wienen W, 2007, THROMB HAEMOSTASIS, V98, P333, DOI 10.1160/TH07-02-0113; Flibotte JJ, 2004, NEUROLOGY, V63, P1059; HART RG, 1995, STROKE, V26, P1471; SAKATA T, 1995, ARTERIOSCL THROM VAS, V15, P241; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Komori M, 2014, CIRC J, V78, P1335, DOI 10.1253/circj.CJ-13-1534; Baglin T, 2012, BRIT J HAEMATOL, V159, P427, DOI 10.1111/bjh.12052; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; Inamasu J, 2014, EUR J EMERG MED; Lee SB, 2006, NEUROLOGY, V67, P1272, DOI 10.1212/01.wnl.0000238104.75563.2f; Li MC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/961461; Matsushita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067691; Ogawa S, 2011, CIRC J, V75, P1539, DOI 10.1253/circj.CJ-11-0304; Tang XAN, 2010, J NEUROSCI METH, V190, P240, DOI 10.1016/j.jneumeth.2010.05.004; Toyoda K, 2014, HYPERTENS RES, V37, P463, DOI 10.1038/hr.2013.150; Uchiyama S, 2012, J STROKE CEREBROVASC, V21, P165, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.011	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2015	24	2					374	380		10.1016/j.jstrokecerebrovasdis.2014.09.010		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CA8NJ	WOS:000349177300019		
J	Watanabe, A; Fukuda, M; Suzuki, M; Kawaguchi, T; Habata, T; Akutsu, T; Kanda, T				Watanabe, Aki; Fukuda, Michinari; Suzuki, Makoto; Kawaguchi, Takayuki; Habata, Toshiya; Akutsu, Tsugio; Kanda, Tadashi			Factors Decreasing Caregiver Burden to Allow Patients with Cerebrovascular Disease to Continue in Long-term Home Care	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Caregiver burden; cerebrovascular disease; home care		Background: This study attempted to assess continued long-term home care by examining patients' independent activities of daily living (ADLs) and caregivers' free time. Methods: We surveyed the main caregivers of 52 patients with cerebrovascular disease with continuous home care from 1999 to 2010. Survey items were patients' ADLs, the frequency of use of care services, care requirements, and caregiver sense of burden. We compared the survey results between years. Results: ADLs of excretory control, verbal expression, verbal comprehension, and range of activities showed significant deterioration from 1999 to 2010. Patient need for care increased significantly but use of care services did not. Main caregivers were typically spouses who aged together with the patients. Main caregivers rarely changed; occasionally, a son or daughter-in-law became the main caregiver. Patients typically required less than 3 hours of care daily, which did not change over time. Caregivers had significantly more difficulty maintaining their own health in 2010 than 1999. However, they did not identify increases in difficulties with housework or coping with work. They felt that caregiving was a burden but did not indicate that the family relationship had deteriorated. Conclusions: Regardless of degree of independence of patients' ADLs, caregiver burden was severe. To decrease caregiver burden, it is necessary to use care services, reduce care time, and allow caregivers free time. In addition, it is possible to continue long-term home care by maintaining their relationships.	[Watanabe, Aki; Fukuda, Michinari; Suzuki, Makoto; Kawaguchi, Takayuki; Habata, Toshiya] Kitasato Univ, Sch Allied Hlth Sci, Fac Rehabil, Sagamihara, Kanagawa 2520373, Japan; [Akutsu, Tsugio] Kitasato Univ, Sch Med, Dept Neurol, Sagamihara, Kanagawa 2520373, Japan; [Kanda, Tadashi] Toyohashi Sozo Univ, Sch Hlth Sci, Dept Phys Therapy, Toyohashi, Aichi, Japan	Watanabe, A (reprint author), Kitasato Univ, Sch Allied Hlth Sci, Fac Rehabil, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	aki.wtnb@kitasato-u.ac.jp					Bugge C, 1999, STROKE, V30, P1517; ZARIT SH, 1980, GERONTOLOGIST, V20, P649; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Bureau of SocialWelfare and Public Health Tokyo Metropolitan Government, 2010, ANN TOK HOM CAR PROM; Japan Ministry of Health Labour and Welfare Health and Welfare Bureau for the Elderly Division of the Heath for the Elderly, RESEARCH; Kawashima M, 2005, JYOSEI KAIGOSYA NO K, P63; Kitahama S, 2003, B SCH HLTH SCI KOBE, V19, P15; Masaki N, 2011, J COMPR WELF SCI, V2, P125; Matsuura M, 2004, B SCH HLTH SCI KOBE, V20, P61; Miyahara S, 2011, J JAPAN RURAL MED, V60, P507; Nasu M, 2005, TYOUKI ZAITAKU RYOUY; Nishii M, 2012, J COMPR WELF SCI, V3, P155; Sawada T, 1991, ANN REP RES CARDIOVA, P485; Takeda J, 1996, J HLTH WELF STAT, V43, P17; Tsuboi A, 2002, SOGO REHABILITATION, V30, P1413; Usuda S, 1996, Nihon Koshu Eisei Zasshi, V43, P854; Watanabe A, 2001, SAGYOU RYOUHOU, V20, P116; Watanabe A, 2013, RIGAKURYOHO KAGAKU, V28, P511; Yamaoka K, 1987, NIHON KOSHU EISEI ZA, V34, P215; Miura Hiroko, 2005, Nihon Ronen Igakkai Zasshi, V42, P328; Yasuda N, 2011, W KYUSHU J REHAB SCI, V4, P59; Yokoyama Y, 1992, Nihon Koshu Eisei Zasshi, V39, P777	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2015	24	2					424	430		10.1016/j.jstrokecerebrovasdis.2014.09.013		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CA8NJ	WOS:000349177300026		
J	Yakushiji, Y; Noguchi, T; Charidimou, A; Eriguchi, M; Nishihara, M; Hara, M; Nanri, Y; Horikawa, E; Nishiyama, M; Werring, DJ; Hara, H				Yakushiji, Yusuke; Noguchi, Tomoyuki; Charidimou, Andreas; Eriguchi, Makoto; Nishihara, Masashi; Hara, Megumi; Nanri, Yusuke; Horikawa, Etsuo; Nishiyama, Masanori; Werring, David J.; Hara, Hideo			Basal Ganglia Cerebral Microbleeds and Global Cognitive Function: The Kashima Scan Study	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Cerebral microbleeds; small vessel disease; magnetic resonance imaging; cognitive dysfunction; basal ganglia	SMALL VESSEL DISEASE; BRAIN MICROBLEEDS; RISK-FACTORS; NEUROLOGICAL DISORDER; ROTTERDAM SCAN; IMPAIRMENT; DEMENTIA; ADULTS; MANIFESTATIONS; PREVALENCE	Background: We previously showed that global cognitive function was associated with deep or infratentorial (D/I) cerebral microbleeds (CMBs) in a Japanese healthy cohort. We continually recruited participates and performed further investigation to focus on the impact of different distributions of D/I CMBs on gradient-echo magnetic resonance imaging on global cognitive function. Methods: A total of 1392 subjects including subjects without CMBs (n = 1335), with D/I CMBs limited to the basal ganglia (BG; BG group, n = 33), thalamus (thalamus group, n = 14), and infratentorial area (infratentorial group, n = 10) were included in analyses. Subjects with strictly lobar CMBs (n = 43) were excluded, but subjects in the BG, thalamus, and infratentorial groups could also have lobar CMBs. The mini-mental state examination (MMSE) was administered to determine global cognitive function; scores less than 27 or more than 1.5 standard deviations (SDs) below the age-education-related mean were regarded as impaired. Results: In the multivariable logistic regression analyses, hypertension and severe white matter hyperintensities were associated with the BG group and the thalamus group. In multivariable logistic regression analysis of the association between D/I CMBs classification and impaired MMSE score, only the BG group consistently displayed associations with both MMSE score less than 27 (odds ratio [OR], 5.96; 95% confidence interval [CI], 2.08-17.09) and MMSE score more than 1.5 SDs below the age-education-related mean (OR, 3.34; 95% CI, 1.24-8.99). In the BG group, adjusted mean scores of total MMSE and "attention and calculation" were lower compared with subjects without CMBs. Conclusions: In our study of D/I CMBs, only BG CMBs have strong association with global cognitive function. This association was independent of CMBs in other location.	[Yakushiji, Yusuke; Eriguchi, Makoto; Nanri, Yusuke; Hara, Hideo] Saga Univ, Dept Internal Med, Div Neurol, Fac Med, Saga 8498501, Japan; [Yakushiji, Yusuke; Charidimou, Andreas; Werring, David J.] UCL Inst Neurol, Dept Brain Repair & Rehabil, Stroke Res Grp, London, England; [Yakushiji, Yusuke; Charidimou, Andreas; Werring, David J.] Natl Hosp Neurol & Neurosurg, London, England; [Noguchi, Tomoyuki; Nishihara, Masashi] Saga Univ, Dept Radiol, Fac Med, Saga 8498501, Japan; [Hara, Megumi] Saga Univ, Dept Prevent Med, Fac Med, Saga 8498501, Japan; [Horikawa, Etsuo] Saga Univ, Ctr Comprehens Community Med, Fac Med, Saga 8498501, Japan; [Nishiyama, Masanori] Yuai Kai Oda Hosp, Dept Internal Med, Kashima, Japan	Yakushiji, Y (reprint author), Saga Univ, Dept Internal Med, Div Neurol, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	yakushij@cc.saga-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	The Kashima Scan Study was partially supported by a Grant-in-Aid for University Reform 2006 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Apostolova LG, 2008, DEMENT GERIATR COGN, V25, P115, DOI 10.1159/000112509; Yakushiji Y, 2012, STROKE, V43, P1800, DOI 10.1161/STROKEAHA.111.647065; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Bronnick K, 2007, J NEUROL NEUROSUR PS, V78, P1064, DOI 10.1136/jnnp.2006.108076; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Viswanathan A, 2010, NEUROBIOL AGING, V31, P1629, DOI 10.1016/j.neurobiolaging.2008.09.001; Cordonnier C, 2006, NEUROLOGY, V66, P1356, DOI 10.1212/01.wnl.0000210535.20297.ae; van Norden AGW, 2011, STROKE, V42, P3382, DOI 10.1161/STROKEAHA.111.629634; van Es ACGM, 2011, NEUROLOGY, V77, P1446, DOI 10.1212/WNL.0b013e318232ab1d; Qiu C, 2010, NEUROLOGY, V75, P2221, DOI 10.1212/WNL.0b013e3182020349; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Gregoire SM, 2013, STROKE, V44, P1267, DOI 10.1161/STROKEAHA.111.000245; Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; Patel B, 2013, STROKE, V44, P356, DOI 10.1161/STROKEAHA.112.670216; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Yakushiji Y, 2008, STROKE, V39, P3323, DOI 10.1161/STROKEAHA.108.516112; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Charidimou A, 2012, J NEUROL SCI, V322, P50, DOI 10.1016/j.jns.2012.05.052; Chen YW, 2010, INT J STROKE, V5, P403, DOI 10.1111/j.1747-4949.2010.00466.x; Folstein M, 2001, MINI MENTAL STATE EX; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hara M, 2013, HYPERTENS RES, V36, P789, DOI 10.1038/hr.2013.26; Koga H, 2002, J NEUROL NEUROSUR PS, V72, P737, DOI 10.1136/jnnp.72.6.737; O'Sullivan M, 2005, J NEUROL NEUROSUR PS, V76, P1140, DOI 10.1136/jnnp.2004.045963; Takashima Y, 2011, J STROKE CEREBROVASC, V20, P105, DOI 10.1016/j.jstrokecerebrovasdis.2009.11.007; Tsushima Y, 2002, NEURORADIOLOGY, V44, P31; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356; Yakushiji Y, INTERN MED IN PRESS	33	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2015	24	2					431	439		10.1016/j.jstrokecerebrovasdis.2014.09.015		9	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CA8NJ	WOS:000349177300027		
J	Nomura, E; Suzuki, A; Inoue, I; Nakagawara, J; Takahashi, K; Takahashi, T; Manabe, Y; Yokota, C; Okada, K; Nishihara, T; Yamamoto, Y; Noda, K; Takahashi, S; Ibayashi, S; Takagi, M; Kitagawa, K; Tanahashi, N; Kuriyama, M; Hirata, K; Hosomi, N; Minematsu, K; Kobayashi, S; Matsumoto, M				Nomura, Eiichi; Suzuki, Akifumi; Inoue, Isao; Nakagawara, Jyoji; Takahashi, Kazuo; Takahashi, Tetsuya; Manabe, Yasuhiro; Yokota, Chiaki; Okada, Kazunori; Nishihara, Tetsuhiro; Yamamoto, Yasumasa; Noda, Koichi; Takahashi, Shinichi; Ibayashi, Setsuro; Takagi, Makoto; Kitagawa, Kazuo; Tanahashi, Norio; Kuriyama, Masaru; Hirata, Koichi; Hosomi, Naohisa; Minematsu, Kazuo; Kobayashi, Shotai; Matsumoto, Masayasu		J-STARS-L Investigators	Subsequent Vascular Events after Ischemic Stroke: The Japan Statin Treatment against Recurrent Stroke-Longitudinal	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Ischemic stroke; hyperlipidemia; hypertension; diabetes mellitus; statin	RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE REDUCTION; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; HEART-DISEASE; RISK-FACTORS; J-STARS; CHOLESTEROL; METAANALYSIS; OUTCOMES	Background: We undertook a multicenter cohort observational study to investigate the frequency and type of subsequent vascular events after an ischemic stroke and to compare the rates of vascular events between patients with and without hyperlipidemia. Methods: This nationwide study was conducted in 19 hospitals participating in the Japan Standard Stroke Registry Study. We enrolled ischemic stroke patients, including those with a transient ischemic attack, who had not experienced any vascular events before enrollment after their ischemic stroke events. Each subject was observed prospectively from September 1, 2003, to October 1, 2005, or until a primary end point or death. Primary end points included subsequent fatal or nonfatal vascular events: stroke, angina pectoris, acute myocardial infarction, aortic aneurysm, or arteriosclerosis obliterans. Results: A total of 449 patients (mean age, 67.6 years; 64.8% men) were enrolled in this study. Of the 41 vascular events observed during follow-up, 40 were stroke. The median observation period was 568 days. We found that patients with hyperlipidemia had a significantly higher rate of vascular events compared with those without hyperlipidemia according to the Kaplan-Meier method and the log-rank test (P = .013). Hyperlipidemia significantly increased the risk of vascular events (hazard ratio, 2.169 [1.125-4.312]; P = .021) according to the Cox proportional hazard model after adjusting for confounding factors (age, sex, days from ischemic stroke until enrollment, smoking habits, and daily drinking habits). Conclusions: This study demonstrated that stroke was the most common subsequent vascular event after ischemic stroke; the study also indicated that hyperlipidemia could be a risk factor for subsequent vascular events after ischemic stroke.	[Nomura, Eiichi; Hosomi, Naohisa; J-STARS-L Investigators] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima 7348551, Japan; [Suzuki, Akifumi] Res Inst Brain & Blood Vessels, Dept Neurol Surg, Akita, Japan; [Inoue, Isao] Brain Attack Ctr Ota Mem Hosp, Dept Neurol, Fukuyama, Hiroshima, Japan; [Nakagawara, Jyoji] Nakamura Mem Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Takahashi, Kazuo; Kobayashi, Shotai] Shimane Univ, Sch Med, Dept Neurol Hematol & Rheumatol, Izumo, Shimane, Japan; [Takahashi, Tetsuya] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan; [Manabe, Yasuhiro] Natl Hosp Org Okayama Med Ctr, Dept Neurol, Okayama, Japan; [Yokota, Chiaki; Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Okada, Kazunori] Ohda Municipal Hosp, Dept Neurol, Ohda, Japan; [Nishihara, Tetsuhiro] Kanto Med Ctr NTT EC, Dept Neurosurg, Tokyo, Japan; [Yamamoto, Yasumasa] Kyoto Second Red Cross Hosp, Dept Neurol, Kyoto, Japan; [Noda, Koichi] Natl Hosp Org Higashihiroshima, Med Ctr, Dept Neurol, Higashihiroshima, Japan; [Takahashi, Shinichi] Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Ibayashi, Setsuro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Takagi, Makoto] Tokyo Saiseikai Cent Hosp, Dept Neurol, Tokyo, Japan; [Kitagawa, Kazuo] Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka, Japan; [Tanahashi, Norio] Saitama Med Univ Int Med Ctr, Dept Neurol, Hidaka, Japan; [Kuriyama, Masaru] Univ Fukui, Dept Internal Med 2, Fukui 910, Japan; [Hirata, Koichi] Dokkyo Med Univ, Dept Neurol, Mibu, Tochigi, Japan	Hosomi, N (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	nhosomi@hiroshima-u.ac.jp	Takahashi, Shinichi/L-3454-2013		Health and Labor Sciences Research Grants for Clinical Research for Evidence-Based Medicine [H14-023, H15-020]; Comprehensive Research on Cardiovascular Diseases from the Ministry of Health, Labor and Welfare, Japan [H16-003]	This work was supported by the Health and Labor Sciences Research Grants for Clinical Research for Evidence-Based Medicine (H14-023, H15-020) and Comprehensive Research on Cardiovascular Diseases (H16-003) from the Ministry of Health, Labor and Welfare, Japan.	Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Kaplan RC, 2005, NEUROLOGY, V65, P835, DOI 10.1212/01.wnl.0000176058.09848.bb; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106; Ito E, 2003, INTERNAL MED, V42, P793, DOI 10.2169/internalmedicine.42.793; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Hillen T, 2003, STROKE, V34, P1457, DOI 10.1161/01.STR.0000072985.24967.7F; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; Uchiyama S, 2009, J NEUROL SCI, V284, P72, DOI 10.1016/j.jns.2009.04.002; Nagai Y, 2014, INT J STROKE, V9, P232, DOI 10.1111/ijs.12099; Dhamoon MS, 2006, NEUROLOGY, V66, P641, DOI 10.1212/01.wnl.0000201253.93811.f6; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Peeters A, 2002, EUR HEART J, V23, P458, DOI 10.1053/euhj.2001.2838; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Donnan GA, 2004, STROKE, V35, P1526, DOI 10.1161/01.STR.0000130461.47925.b0; Hosomi N, 2007, J NEUROL, V254, P605, DOI 10.1007/s00415-006-0365-y; Hosomi N, 2009, CEREBROVASC DIS, V27, P67, DOI 10.1159/000172636; Kaplan RC, 2006, J AM GERIATR SOC, V54, P1309, DOI 10.1111/j.1532-5415.2006.00838.x; Nomura E, 2005, INTERNAL MED, V44, P1252, DOI 10.2169/internalmedicine.44.1252; Piechowski-Jozwiak B, 2004, STROKE, V35, P1523, DOI 10.1161/01.STR.0000130460.09807.ec; MacMahon S, 2001, LANCET, V358, P1033; Ruland S, 2006, NEUROLOGY, V67, P567, DOI 10.1212/01.wnl.0000232738.02278.28; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Thrift AG, 2004, STROKE, V35, P1524, DOI 10.1161/01.STR.0000128590.48495.02; Uchiyama S, 2009, J NEUROL SCI, V287, P45, DOI 10.1016/j.jns.2009.09.011; WHISNANT J P, 1990, Stroke, V21, P637; Yokota C, 2004, CEREBROVASC DIS, V18, P111, DOI 10.1159/000079258	29	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2015	24	2					473	479		10.1016/j.jstrokecerebrovasdis.2014.09.023		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CA8NJ	WOS:000349177300032		
J	Inoue, Y; Honda, S; Watanabe, M; Ando, Y				Inoue, Yasuteru; Honda, Shoji; Watanabe, Masaki; Ando, Yukio			Educational Campaigns at Point of Purchase in Rural Supermarkets Improve Stroke Knowledge	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Stroke enlightenment; education; rural area; FAST	HIGH-SCHOOL STUDENTS; HIGH-RISK COMMUNITY; PUBLIC-EDUCATION; POPULATION; SYMPTOMS; CHILDREN; PROGRAM	Background: The number of elderly people is dramatically increasing, and this trend is especially pronounced in rural populations. The aim of the present study was to verify the effectiveness of stroke education in a rural area. Methods: The stroke educational flyers were distributed for 3 weeks at the point of purchase within supermarkets. Questionnaires were used to determine knowledge about stroke and appropriate emergent action on identifying stroke. Results: A total of 882 people responded to the questionnaires before (n = 409) and 3 months after (n = 473) the campaign. Of these, 686 (77.8%) were aged 65 years or older. The percentages of correct answers for hemiplegia and one-sided numbness (P < .05 for both) and calling emergency medical services (EMS) on identifying stroke occurrence (P < .001) were higher after the campaign compared with those before the campaign. Of the respondents aged 65 years or older, the percentages of correct answers for numbness on one side and calling for EMS on identifying stroke were higher after the campaign (P < .05 and P < .001, respectively). Conclusions: A simple point-of-purchase stroke campaign using educational flyers could meaningfully affect stroke knowledge among elderly persons in a rural community.	[Inoue, Yasuteru; Honda, Shoji; Watanabe, Masaki; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Kumamoto 8608556, Japan	Inoue, Y (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, 1-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.	yinoue@fc.kuh.kumamoto-u.ac.jp					American Stroke Association, WARN SIGNS; Amano T, 2014, J STROKE CEREBROVASC, V23, P1040, DOI 10.1016/j.jstrokecerebrovasdis.2013.08.021; Williams O, 2012, NEUROLOGY, V79, P802, DOI 10.1212/WNL.0b013e3182661f08; Williams O, 2008, STROKE, V39, P2809, DOI 10.1161/STROKEAHA.107.513143; Miyashita F, 2014, J STROKE CEREBROVASC, V23, P1385, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.016; Greenlund KJ, 2003, AM J PREV MED, V25, P315, DOI 10.1016/S0749-3797(03)00206-X; Silver FL, 2003, STROKE, V34, P1965, DOI 10.1161/01.STR.0000083175.01126.62; Miyamatsu N, 2012, STROKE, V43, P545, DOI 10.1161/STROKEAHA.111.634196; Shigehatake Y, 2014, J STROKE CEREBROVASC, V23, P1623, DOI 10.1016/j.jstrokecerebrovasdis.2014.01.001; Johnson SC, 2005, NEUROLOGY, V64, P654; Food Marketing Institute, 2004, TRENDS US CONS ATT S; Montaner J, 2001, EUR J EPIDEMIOL, V17, P581, DOI 10.1023/A:1014581003849; Worthmann H, 2013, INT J STROKE, V8, P286, DOI 10.1111/j.1747-4949.2012.00809.x	13	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2015	24	2					480	484		10.1016/j.jstrokecerebrovasdis.2014.09.022		5	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CA8NJ	WOS:000349177300033		
J	Miyazaki, M; Nagami, S; Shimizu, H; Takahashi, N				Miyazaki, Masayuki; Nagami, Shuuhei; Shimizu, Hisao; Takahashi, Nobuyuki			Acquired Hemophilia A Associated with Internal Border-zone Infarction Triggered by Major Hemorrhage of Thigh and Leg: A Case Report	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Border; zone infarction; acquired hemophilia A; hypoperfusion; major hemorrhage		It is unusual to be complicated with cerebral infarction for bleeding disorders. We describe a first case of internal border-zone infarction (I-BZI) complicated with acquired hemophilia A. A 79-year-old man was introduced from other hospital by cerebral infarction and severe anemia. His left thigh and leg were swollen with subcutaneous bleeding. Activated partial thromboplastin time was 99.4 seconds. Factor VIII activity was less than 1% and Factor VIII inhibitor concentration was 85 BU, respectively. The platelet count and prothrombin time were normal. These results were consistent with the diagnosis of acquired hemophilia A. Magnetic resonance imaging of the brain showed multiple small infarction in bilateral internal border zone. To our knowledge, this is the first case of I-BZI complicated with acquired hemophilia A. This case suggested that major hemorrhage is one of the sole causes of I-BZI. (C) 2015 by National Stroke Association	[Miyazaki, Masayuki; Nagami, Shuuhei; Shimizu, Hisao; Takahashi, Nobuyuki] Nara City Hosp, Dept Neurol, Nara 6308305, Japan	Miyazaki, M (reprint author), Nara City Hosp, Dept Neurol, 1-50-1 Higashikidera Cho, Nara 6308305, Japan.	zweatherconcrete@yahoo.co.jp					Franchini M, 2013, THROMB HAEMOSTASIS, V110, P1114, DOI 10.1160/TH13-05-0363; Mangla R, 2011, RADIOGRAPHICS, V31, P1201, DOI 10.1148/rg.315105014; Momjian-Mayor I, 2005, STROKE, V36, P567, DOI 10.1161/01.STR.0000155727.82242.e1; Yong SW, 2006, STROKE, V37, P841, DOI 10.1161/01.STR.0000202590.75972.39; Caplan LR, 2006, CEREBROVASC DIS, V21, P145, DOI 10.1159/000090791; Tsai CF, 2010, J NEUROL, V257, P2044, DOI 10.1007/s00415-010-5657-6; Lopez-Cancio E, 2014, CEREBROVASC DIS, V37, P417, DOI 10.1159/000362922	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2015	24	2					E53	E54		10.1016/j.jstrokecerebrovasdis.2014.09.019		2	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CA8NJ	WOS:000349177300001		
J	Tanaka, Y; Ueno, Y; Shimada, Y; Yamashiro, K; Tanaka, R; Urabe, T; Hattori, N				Tanaka, Yasutaka; Ueno, Yuji; Shimada, Yoshiaki; Yamashiro, Kazuo; Tanaka, Ryota; Urabe, Takao; Hattori, Nobutaka			Paradoxical Brain Embolism Associated with Kimura Disease Mimics Watershed Infarction	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Stroke; paradoxical brain embolism; Kimura disease; watershed infarction; patent foramen ovale	EOSINOPHILS; THROMBOSIS; STROKE	Kimura disease (KD) is an uncommon chronic inflammatory disease presenting as subcutaneous lymphadenopathy with eosinophilia. To date, only a single case of brain embolism caused by fibroblastic endocarditis associated with KD has been reported. Watershed infarction was seen in patients with episodes of severe hypotension or cardiac surgery. We here report a young case of KD who developed ischemic stroke and showed multiple small infarcts in the border zones between the territories of major cerebral arteries, mimicking watershed infarction. Transesophageal echocardiography revealed patent foramen ovale and atrial septal aneurysm. Concurrently, deep venous thrombus in the femoral vein was found on duplex ultrasonography. Our case supports the notion that paradoxical brain embolism associated with KD can cause multiple small embolisms and mimic watershed infarction. (C) 2015 by National Stroke Association	[Tanaka, Yasutaka; Ueno, Yuji; Shimada, Yoshiaki; Yamashiro, Kazuo; Tanaka, Ryota; Urabe, Takao; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 1138421, Japan	Ueno, Y (reprint author), Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	yuji-u@juntendo.ac.jp					Moosbauer C, 2007, BLOOD, V109, P995, DOI 10.1182/blood-2006-02-004945; TORVIK A, 1984, STROKE, V15, P221; Gottesman RF, 2006, STROKE, V37, P2306, DOI 10.1161/01.STR.0000236024.68020.3a; Chen H, 2004, AM J SURG PATHOL, V28, P505, DOI 10.1097/00000478-200404000-00010; SLUNGAARD A, 1990, J EXP MED, V171, P2025, DOI 10.1084/jem.171.6.2025; Ueno Y, 2007, J NEUROL, V254, P763, DOI 10.1007/s00415-006-0430-6; Wang JG, 2006, BLOOD, V107, P558, DOI 10.1182/blood-2005-05-2152; Barge S, 2008, AM J HEMATOL, V83, P432, DOI 10.1002/ajh.21121; Danis R, 2009, J THROMB THROMBOLYS, V27, P115, DOI 10.1007/s11239-007-0178-6; GAUCHAT JF, 1995, EUR J IMMUNOL, V25, P863, DOI 10.1002/eji.1830250335	10	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	FEB	2015	24	2					E55	E57		10.1016/j.jstrokecerebrovasdis.2014.09.018		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CA8NJ	WOS:000349177300002		
J	Iguchi, M; Hiraga, Y; Kasuya, K; Aida, TM; Watanabe, M; Sato, Y; Smith, RL				Iguchi, Masayuki; Hiraga, Yuya; Kasuya, Kazuhiro; Aida, Taku Michael; Watanabe, Masaru; Sato, Yoshiyuki; Smith, Richard Lee, Jr.			Viscosity and density of poly(ethylene glycol) and its solution with carbon dioxide at 353.2 K and 373.2 K at pressures up to 15 MPa	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Carbon dioxide; Poly(ethylene glycol); Viscosity; Density; Molecular weight; Free volume viscosity model	GLASS-TRANSITION TEMPERATURE; EQUATION-OF-STATE; FREE-VOLUME MODEL; PHASE-EQUILIBRIA; POLYETHYLENE OXIDE; SUPERCRITICAL CO2; IR SPECTROSCOPY; LIQUID POLYMERS; DISSOLVED-GAS; SYSTEMS	Few viscosity and density data have been reported for CO2-poly(ethylene glycol) solutions, even though many vapor-liquid equilibrium data exist in the literature. In this work, viscosity and density of pure poly(ethylene glycol) (PEG, M=3000, 8300, 20,000 g mol(-1)) at atmospheric pressure were measured. Viscosities of PEG 3000 and PEG 8300 solutions with CO2 were measured with a torsional vibrating viscometer at 353.2 K and 373.2 K over the range of CO2 pressures from 5 MPa to 15 MPa. The densities of CO2-PEG solutions were calculated with the perturbed-chain statistical associating fluid theory equation of state. From shear viscosity measurements, PEG 3000 and PEG 8300 were confirmed to be Newtonian and PEG 20000 was confirmed to be non-Newtonian. The viscosity reduction ratio for PEG solutions saturated with CO2 was found to be independent of the PEG molecular weight (400 <= M <= 8300 g mol(-1)). A simple equation is proposed that can correlate CO2-PEG solution viscosity reduction ratio to within 0.08 in absolute units. The CO2-PEG solution viscosities could be correlated with free volume models to within 14% using the fitted value of CO2 occupied volume. (C) 2014 Elsevier B.V. All rights reserved.	[Iguchi, Masayuki; Watanabe, Masaru; Sato, Yoshiyuki; Smith, Richard Lee, Jr.] Tohoku Univ, Res Ctr Supercrit Fluid Technol, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Hiraga, Yuya; Kasuya, Kazuhiro; Aida, Taku Michael; Watanabe, Masaru; Smith, Richard Lee, Jr.] Tohoku Univ, Res Ctr Supercrit Fluid Technol, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan	Smith, RL (reprint author), Tohoku Univ, Res Ctr Supercrit Fluid Technol, Grad Sch Environm Studies, Aoba Ku, Aramaki Aza Aoba 6-6-11, Sendai, Miyagi 9808579, Japan.	smith@scf.che.tohoku.ac.jp	Smith Jr, Richard/E-3495-2012	Smith Jr, Richard/0000-0002-9174-7681	Ministry of Education, Science, Sports and Culture	The authors would like to acknowledge partial financial support of the Ministry of Education, Science, Sports and Culture for support of this work.	Aionicesei E, 2008, J CHEM ENG DATA, V53, P185, DOI 10.1021/je700467p; Allal A, 2001, PHYS CHEM LIQ, V39, P1, DOI 10.1080/00319100108030323; TURNBULL D, 1970, J CHEM PHYS, V52, P3038, DOI 10.1063/1.1673434; Vitoux P, 2009, J PHYS CHEM B, V113, P897, DOI 10.1021/jp806709w; Pasquali I, 2008, INT J PHARMACEUT, V356, P76, DOI 10.1016/j.ijpharm.2007.12.048; Wiesmet V, 2000, J SUPERCRIT FLUID, V17, P1, DOI 10.1016/S0896-8446(99)00043-1; Obermeier B, 2011, ANGEW CHEM INT EDIT, V50, P7988, DOI 10.1002/anie.201100027; Nalawade SP, 2006, J SUPERCRIT FLUID, V36, P236, DOI 10.1016/j.supflu.2005.06.005; Guadagno T, 2004, J PHYS CHEM B, V108, P13995, DOI 10.1021/jp0481097; Gross J, 2001, IND ENG CHEM RES, V40, P1244, DOI 10.1021/ie0003887; DOOLITTLE AK, 1951, J APPL PHYS, V22, P1471, DOI 10.1063/1.1699894; Di Maio E, 2005, POLYM ENG SCI, V45, P432, DOI 10.1002/pen.20289; Nam S, 2009, MACROMOLECULES, V42, P3121, DOI 10.1021/ma802294j; Andrade END, 1934, PHILOS MAG, V17, P497; Krishnan M, 2013, J PHYS CHEM C, V117, P20592, DOI 10.1021/jp405321t; KELLEY FN, 1961, J POLYM SCI, V50, P549, DOI 10.1002/pol.1961.1205015421; Xue ZM, 2012, ANGEW CHEM INT EDIT, V51, P12325, DOI 10.1002/anie.201206197; Gourgouillon D, 1998, J SUPERCRIT FLUID, V13, P177, DOI 10.1016/S0896-8446(98)00050-3; Weidner E, 1997, J SUPERCRIT FLUID, V10, P139, DOI 10.1016/S0896-8446(97)00016-8; Areerat S, 2002, POLYM ENG SCI, V42, P2234, DOI 10.1002/pen.11113; Harrison KL, 1996, LANGMUIR, V12, P2637, DOI 10.1021/la9510137; KAWAKAMI M, 1982, J APPL POLYM SCI, V27, P2387, DOI 10.1002/app.1982.070270708; Wingert MJ, 2009, IND ENG CHEM RES, V48, P5460, DOI 10.1021/ie800896r; Pasquali I, 2008, J SUPERCRIT FLUID, V45, P384, DOI 10.1016/j.supflu.2008.01.015; Niedzwiedz K, 2008, MACROMOLECULES, V41, P4866, DOI 10.1021/ma800446n; Privat R, 2010, FLUID PHASE EQUILIBR, V295, P76, DOI 10.1016/j.fluid.2010.03.041; Iguchi M, 2013, CELLULOSE, V20, P1353, DOI 10.1007/s10570-013-9884-8; Hrncic MK, 2014, J SUPERCRIT FLUID, V87, P50, DOI 10.1016/j.supflu.2013.12.021; [Anonymous], 2011, 8803 JISZ JAP STAND, P2011; Nam S, 2008, POLYMER, V49, P5467, DOI 10.1016/j.polymer.2008.10.007; Fang YY, 2011, J RHEOL, V55, P939, DOI 10.1122/1.3596599; Gross J, 2002, IND ENG CHEM RES, V41, P1084, DOI 10.1021/ie010449g; Martin A, 2009, FLUID PHASE EQUILIBR, V286, P162, DOI 10.1016/j.fluid.2009.08.010; Allal A, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011203; Li J, 2012, J CHEM ENG DATA, V57, P610, DOI 10.1021/je201197m; COHEN MH, 1959, J CHEM PHYS, V31, P1164, DOI 10.1063/1.1730566; Liparoti S, 2012, J SUPERCRIT FLUID, V72, P46, DOI 10.1016/j.supflu.2012.08.009; Bae YC, 1996, POLYMER, V37, P3011, DOI 10.1016/0032-3861(96)89398-0; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; BOOTH C, 1971, POLYMER, V12, P309, DOI 10.1016/0032-3861(71)90053-X; CROSS MM, 1965, J COLL SCI IMP U TOK, V20, P417, DOI 10.1016/0095-8522(65)90022-X; CRUPI V, 1995, MOL PHYS, V84, P645, DOI 10.1080/00268979500100431; Crupi V, 2000, MOL PHYS, V98, P1589; Cruz MS, 2000, J CHEM ENG DATA, V45, P61, DOI 10.1021/je990157a; DANESHVAR M, 1990, J PHYS CHEM-US, V94, P2124, DOI 10.1021/j100368a071; DANESHVAR M, 1992, J SUPERCRIT FLUID, V5, P143, DOI 10.1016/0896-8446(92)90031-E; Di Maio E, 2006, J POLYM SCI POL PHYS, V44, P1863, DOI 10.1002/polb.20845; Funami E, 2007, J APPL POLYM SCI, V105, P3060, DOI 10.1002/app.26513; GALESKI A, 1982, POLYM BULL, V7, P283, DOI 10.1007/BF00256794; Gerhardt LJ, 1998, J POLYM SCI POL PHYS, V36, P1911, DOI 10.1002/(SICI)1099-0488(199808)36:11<1911::AID-POLB12>3.0.CO;2-A; Gourgouillon D, 1999, PHYS CHEM CHEM PHYS, V1, P5369, DOI 10.1039/a906927e; HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1; Hojczyk M, 2011, J APPL POLYM SCI, V119, P565, DOI 10.1002/app.32676; Hou MQ, 2007, FLUID PHASE EQUILIBR, V258, P108, DOI 10.1016/j.fluid.2007.06.002; Kouskoumvekaki IA, 2004, IND ENG CHEM RES, V43, P2830, DOI 10.1021/ie034258k; Kukova E, 2004, CHEM-ING-TECH, V76, P280, DOI 10.1002/cite.200400063; Kwag C, 2001, IND ENG CHEM RES, V40, P3048, DOI 10.1021/ie000680e; Lopes JA, 2000, J SUPERCRIT FLUID, V16, P261, DOI 10.1016/S0896-8446(99)00033-9; Matsuyama K, 2003, J APPL POLYM SCI, V89, P742, DOI 10.1002/app.12201; Matsuyama K, 2006, FLUID PHASE EQUILIBR, V249, P173, DOI 10.1016/j.fluid.2006.09.023; Pedrosa N, 2007, IND ENG CHEM RES, V46, P4678, DOI 10.1021/ie0701672; Press WH, 1992, NUMERICAL RECIPES FO; Privalko V.P., 1974, POLYM SCI U S S R, V16, P3229, DOI 10.1016/0032-3950(74)90320-7; Sarrade S, 2001, SEP PURIF TECHNOL, V25, P315, DOI 10.1016/S1383-5866(01)00058-2; Song Q. W., 2012, CAPTURE UTILIZATION; VanKrevelen DW, 2009, PROPERTIES OF POLYMERS: THEIR CORRELATION WITH CHEMICAL STRUCTURE; THEIR NUMERICAL ESTIMATION AND PREDICTION FROM ADDITIVE GROUP CONTRIBUTIONS, P1; TERAMOTO A, 1965, MAKROMOLEKUL CHEM, V85, P261; TORMALA P, 1978, RHEOL ACTA, V17, P201, DOI 10.1007/BF01517712; Viswanath D. S., 2007, VISCOSITY LIQUIDS TH; Wang JQ, 2007, GREEN CHEM, V9, P882, DOI 10.1039/b701875d; Weidner E, 1996, PROCESS TECHNOL PROC, V12, P223; Xue AL, 2003, J POLYM ENG, V23, P1; Zoller P., 1995, STANDARD PRESSURE VO	73	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	FEB	2015	97						63	73		10.1016/j.supflu.2014.10.013		11	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CA5MP	WOS:000348952800009		
J	Yamamoto, S; Furusawa, T				Yamamoto, Satoru; Furusawa, Takashi			Thermophysical flow simulations of rapid expansion of supercritical solutions (RESS)	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Numerical simulation; Thermophysical flow; RESS; Supercritical carbon dioxide; Naphthalene	HOMOGENEOUS NUCLEATION; PARTICLE FORMATION; CONDENSATION; FLUIDS; NOZZLE	Thermophysical flows of rapid expansion of supercritical solutions (RESS) were numerically simulated from the nozzle inlet to the outlet of the expansion chamber. In these studies, supercritical carbon dioxide (SCO2) was used as the solvent, and naphthalene was used as the solute. Our approach seamlessly simulated SCO2 entering the nozzle, SCO2 crossing the critical pressure in the nozzle, CO2 gas expanding into the expansion chamber, and CO2 condensation in the chamber. The simulation is based on a preconditioning method developed by Yamamoto, together with mathematical models for thermophysical properties of substances in a program package for thermophysical properties of fluids (PROPATH). A primary issue was the extent to which changing the nozzle inlet and outlet pressures impacted the solubility of the solute. We also studied the effects of changing the nozzle throat diameter and throat length. In addition, we used a simple particle-formation model to predict nucleation, condensation, and coagulation of naphthalene particles. Our results indicate that the location at which the pressure crosses the critical pressure is sensitive to the pressure at the nozzle inlet, and nucleation of naphthalene starts near that location. (C) 2014 Elsevier B.V. All rights reserved.	[Yamamoto, Satoru; Furusawa, Takashi] Tohoku Univ, Dept Comp & Math Sci, Sendai, Miyagi 9808579, Japan	Yamamoto, S (reprint author), Tohoku Univ, Dept Comp & Math Sci, Sendai, Miyagi 9808579, Japan.	yamamoto@caero.mech.tohoku.ac.jp					Angus S. B., 1976, INT THERMODYNAMIC TA; KWAUK XM, 1993, J AEROSOL SCI, V24, P445, DOI 10.1016/0021-8502(93)90031-4; PENG D, 1976, IND ENG CHEM FUND, V15, P59, DOI 10.1021/i160057a011; Helfgen B, 2003, J SUPERCRIT FLUID, V26, P225, DOI 10.1016/S0896-8446(02)00159-6; [Anonymous], PROGR PACK THERM PRO; SCHNERR GH, 1990, AIAA J, V28, P1187, DOI 10.2514/3.25190; Yamamoto S, 2005, J COMPUT PHYS, V207, P240, DOI 10.1016/j.jcp.2005.01.013; PRATSINIS SE, 1988, J COLLOID INTERF SCI, V124, P416, DOI 10.1016/0021-9797(88)90180-4; CRIST S, 1966, AIAA J, V4, P68; DEBENEDETTI PG, 1990, AICHE J, V36, P1289, DOI 10.1002/aic.690360902; Yamamoto S, 2005, ENERGY, V30, P197, DOI 10.1016/j.energy.2004.04.041; TOM JW, 1991, J AEROSOL SCI, V22, P555, DOI 10.1016/0021-8502(91)90013-8; Frenkel J., 1955, KINETIC THEORY LIQUI; Helfgen B, 2001, J AEROSOL SCI, V32, P295, DOI 10.1016/S0021-8502(00)00080-X; Liu GT, 1996, IND ENG CHEM RES, V35, P4626, DOI 10.1021/ie960142v; Matson W., 1987, IND ENG CHEM RES, V26, P2298; Turk M, 2000, J SUPERCRIT FLUID, V18, P169, DOI 10.1016/S0896-8446(00)00080-2; Yamamoto S, 2011, INT J HEAT MASS TRAN, V54, P774, DOI 10.1016/j.ijheatmasstransfer.2010.10.030; Yamamoto S, 2011, AICHE J, V57, P2629, DOI 10.1002/aic.12482	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	FEB	2015	97						192	201		10.1016/j.supflu.2014.11.016		10	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CA5MP	WOS:000348952800023		
J	Sato, T; Watanabe, R; Fukuhara, C; Itoh, N				Sato, Takafumi; Watanabe, Ryo; Fukuhara, Choji; Itoh, Naotsugu			Effect of water density on heterogeneous catalytic water gas shift reaction in the presence of Ru/C, Pd/LaCoO3 and Fe3O4 in supercritical water	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						Water gas shift reaction; Supercritical water; Heterogeneous catalyst; Reaction model with fugacity	PARTIAL OXIDATION; REACTION-KINETICS; NANOPARTICLES; REDUCTION; PRESSURE; OIL; CO	Water gas shift reaction in the presence of heterogeneous catalysts such as Ru/C, Pd/LaCoO3 and Fe3O4 was examined in supercritical water at 673 K from 0.1 to 0.5 cm(3) of water densities. These catalysts catalyzed water gas shift reaction and the main products were CO2 and H-2 center dot CH4 was formed from CO and H-2 produced by water gas shift reaction in the presence of Ru/C. CO conversion tended to decrease with increasing water density for all catalysts, which means that water essentially suppressed heterogeneous catalytic water gas shift reaction in supercritical water. The kinetics of water gas shift reaction was analyzed with an elementary-like reaction model using fugacity. The model calculation represented the trend of experimental results and revealed that the suppression of water gas shift reaction in high water density region was probably because water would cover on active sites and stabilize the adsorbed species on catalyst to decrease the ratio of vacancy of active sites on catalyst. (C) 2014 Elsevier B.V. All rights reserved.	[Sato, Takafumi; Itoh, Naotsugu] Utsunomiya Univ, Dept Mat & Environm Chem, Utsunomiya, Tochigi 321, Japan; [Watanabe, Ryo; Fukuhara, Choji] Shizuoka Univ, Grad Sch Engn, Dept Appl Chem & Biochem Engn, Shizuoka, Japan	Sato, T (reprint author), Utsunomiya Univ, Dept Mat & Environm Chem, Utsunomiya, Tochigi 321, Japan.	takafumi@cc.utsunomiya-u.ac.jp			JSPS KAKENHI Grant [26420778]; Iwatani Naoji Foundation's Research Grant	This work was partly supported by JSPS KAKENHI Grant number 26420778 and the Iwatani Naoji Foundation's Research Grant.	Akizuki M, 2011, J SUPERCRIT FLUID, V56, P14, DOI 10.1016/j.supflu.2010.11.015; Angeles-Hernandez MJ, 2009, IND ENG CHEM RES, V48, P1208, DOI 10.1021/ie8006402; Panagiotopoulou P, 2012, CATAL TODAY, V181, P138, DOI 10.1016/j.cattod.2011.05.030; Watanabe R, 2010, TOP CATAL, V53, P621, DOI 10.1007/s11244-010-9496-6; PENG D, 1976, IND ENG CHEM FUND, V15, P59, DOI 10.1021/i160057a011; Watanabe M, 2001, J SUPERCRIT FLUID, V20, P257, DOI 10.1016/S0896-8446(01)00070-5; Sato T, 2004, J SUPERCRIT FLUID, V29, P113, DOI 10.1016/S0896-8446(03)00049-4; Araki K, 2004, J CHEM ENG JPN, V37, P443, DOI 10.1252/jcej.37.443; Sato T, 2006, IND ENG CHEM RES, V45, P615, DOI 10.1021/ie0510270; Sato T, 2012, FUEL, V95, P347, DOI 10.1016/j.fuel.2011.10.016; Akgul G, 2012, J SUPERCRIT FLUID, V66, P207, DOI 10.1016/j.supflu.2011.10.009; Rice SF, 1998, J PHYS CHEM A, V102, P2673, DOI 10.1021/jp972368x; ELLIOTT DC, 1983, IND ENG CHEM PROD RD, V22, P426, DOI 10.1021/i300011a008; Mhadeshwar AB, 2004, J PHYS CHEM B, V108, P15246, DOI 10.1021/jp048698g; Cheng J, 2008, PETROL SCI TECHNOL, V26, P2088, DOI 10.1080/10916460802096162; Sato T, 2011, BIOMASS BIOENERG, V35, P1245, DOI 10.1016/j.biombioe.2010.12.015; Adschiri T, 1998, IND ENG CHEM RES, V37, P2634, DOI 10.1021/ie970751i; Osada M, 2012, ENERG FUEL, V26, P3179, DOI 10.1021/ef300460c; Mhadeshwar AB, 2005, CATAL TODAY, V105, P162, DOI 10.1016/j.cattod.2005.04.003; Arai K, 2000, IND ENG CHEM RES, V39, P4697, DOI 10.1021/ie000326g; Liu ZL, 2002, J MATER SYNTH PROCES, V10, P83, DOI 10.1023/A:1021231527095; Takahashi F, 2012, J SUPERCRIT FLUID, V61, P126, DOI 10.1016/j.supflu.2011.09.012; Basinska A, 1999, APPL CATAL A-GEN, V183, P143, DOI 10.1016/S0926-860X(99)00049-6; Femina P., 2012, RES J RECENT SCI, V1, P174; Giorgi L, 2001, J APPL ELECTROCHEM, V31, P325, DOI 10.1023/A:1017595920726; HOLGATE HR, 1992, ENERG FUEL, V6, P586, DOI 10.1021/ef00035a008; Sato M, 1998, CHEM ENG SCI, V53, P4095, DOI 10.1016/S0009-2509(98)00212-7; Twagirashema I, 2007, TOP CATAL, V42-43, P171, DOI 10.1007/s11244-007-0173-3; Wang XQJ, 2013, TOP CATAL, V56, P1899, DOI 10.1007/s11244-013-0126-y; Watanabe R, 2014, APPL CATAL A-GEN, V477, P75, DOI 10.1016/j.apcata.2014.03.005; Zaikovskii VI, 2006, J PHYS CHEM B, V110, P6881, DOI 10.1021/jp056715b	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	FEB	2015	97						211	216		10.1016/j.supflu.2014.12.003		6	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CA5MP	WOS:000348952800025		
J	Pradeep, EKC; Habu, T; Tooriyama, H; Ohtani, M; Kobiro, K				Pradeep, Ellawala K. C.; Habu, Teppei; Tooriyama, Hiroko; Ohtani, Masataka; Kobiro, Kazuya			Ultra-simple synthetic approach to the fabrication of CeO2-ZrO2 mixed nanoparticles into homogeneous, domain, and core-shell structures in mesoporous spherical morphologies using supercritical alcohols	JOURNAL OF SUPERCRITICAL FLUIDS			English	Article						CeO2-ZrO2 nanoparticles; Homogeneous, domain, core-shell structures; Rapid synthesis	OXYGEN STORAGE CAPACITY; SOLID-SOLUTION; OXIDE NANOPARTICLES; CERIUM OXIDE; ONE-POT; ZIRCONIA; CEO2; MICROSPHERES; CATALYSTS; NANOCRYSTALS	CeO2-ZrO2 composite nanoparticles with mesoporous and spherical morphologies were assembled into different homogeneously dispersed, domain, and core shell structures by changing the reaction conditions, such as the heating rate, acid, and solvent, in supercritical alcohols. CexZr1-xO2 with homogeneous structures were prepared from Ce(NO3)(3) and ZrO(NO3)(2) in the presence of formic acid in methanol by rapid heating (500 degrees C/min) to 300 degrees C, while CeO2-ZrO2 with domain structures were obtained by slow heating (5.4 degrees C/min). Treatment of mesoporous and spherical ZrO2 nanoparticles with a Ce(NO3)(3) solution in supercritical conditions yielded CeO2-ZrO2 nanocomposites with core shell morphologies, while solvents playing a key role in controlling the thickness of the outer shell; methanol produced a very thin outer shell (<1 nm) of cubic CeO2 and 2-propanol afforded a thick outer shell (100-200 nm) of cubic CeO2. (C) 2014 Elsevier B.V. All rights reserved.	[Pradeep, Ellawala K. C.; Habu, Teppei; Tooriyama, Hiroko; Ohtani, Masataka; Kobiro, Kazuya] Kochi Univ Technol, Sch Environm Sci & Engn, Tosayamada, Kochi 7828502, Japan	Ohtani, M (reprint author), Kochi Univ Technol, Sch Environm Sci & Engn, 185 Miyanokuchi, Tosayamada, Kochi 7828502, Japan.	ohtani.masataka@kochi-tech.ac.jp; kobiro.kazuya@kochi-tech.ac.jp	OHTANI, Masataka/B-5616-2013	OHTANI, Masataka/0000-0003-1016-1812	Creation of New Business and Industry program through the Kochi Prefectural Industry-Academia-Government Collaboration Research Promotion Operation	This work was partially supported by the Creation of New Business and Industry program through the Kochi Prefectural Industry-Academia-Government Collaboration Research Promotion Operation. We thank Dr. Toshiyuki Kawaharamura for his fruitful discussion.	Abe H., 2011, Q REV, V39, P21; Adamski A, 2008, MATER SCI-POLAND, V26, P373; Ahniyaz A, 2005, J PHYS CHEM B, V109, P6136, DOI 10.1021/jp050047c; Zhang CJ, 2011, PHYS CHEM CHEM PHYS, V13, P22, DOI 10.1039/c0cp01123a; Permana ADC, 2014, CHEM ENG J, V241, P216, DOI 10.1016/j.cej.2013.12.029; Nugroho A, 2014, J PHYS CHEM C, V118, P183, DOI 10.1021/jp4099182; Seo M, 2013, CARBON, V64, P207, DOI 10.1016/j.carbon.2013.07.053; Slostowski C, 2012, LANGMUIR, V28, P16656, DOI 10.1021/la303265t; Cai W, 2014, APPL CATAL B-ENVIRON, V158, P258, DOI 10.1016/j.apcatb.2014.04.022; Wang PY, 2014, PURE APPL CHEM, V86, P785, DOI 10.1515/pac-2013-1117; Wei JJ, 2011, CRYSTENGCOMM, V13, P4950, DOI 10.1039/c1ce05324h; Tyrsted C, 2010, CHEM MATER, V22, P1814, DOI 10.1021/cm903316s; Sun CW, 2012, ENERG ENVIRON SCI, V5, P8475, DOI 10.1039/c2ee22310d; Armini S, 2008, J ELECTROCHEM SOC, V155, pH653, DOI 10.1149/1.2949085; Neto RCR, 2013, APPL CATAL A-GEN, V450, P131, DOI 10.1016/j.apcata.2012.10.002; Zhou HP, 2010, J AM CHEM SOC, V132, P4998, DOI 10.1021/ja101110m; Wang PY, 2013, J SUPERCRIT FLUID, V78, P124, DOI 10.1016/j.supflu.2013.03.023; Liang X, 2010, INORG CHEM, V49, P8188, DOI 10.1021/ic100795p; Wang PY, 2012, CHEM LETT, V41, P264, DOI 10.1246/cl.2012.264; Xiao HY, 2009, J PHYS CHEM C, V113, P16625, DOI 10.1021/jp9050269; Chen Y, 2012, J POROUS MAT, V19, P289, DOI 10.1007/s10934-011-9474-9; DURAN P, 1990, J MATER SCI, V25, P5001, DOI 10.1007/BF00580121; Fuentes RO, 2008, CHEM MATER, V20, P7356, DOI 10.1021/cm801680c; HERTL W, 1989, LANGMUIR, V5, P96, DOI 10.1021/la00085a018; Hu CQ, 2009, POWDER TECHNOL, V194, P109, DOI 10.1016/j.powtec.2009.03.035; Kaspar J, 1999, CATAL TODAY, V50, P285, DOI 10.1016/S0920-5861(98)00510-0; Leitenburg C., 1995, J CHEM SOC CHEM COMM, P2181; Michel CR, 2014, SENSOR ACTUAT B-CHEM, V197, P177, DOI 10.1016/j.snb.2014.02.090; Nagai Y., 2002, R D REV TOYOTA CRDL, V37, P20; Priya NS, 2013, PROCEDIA ENGINEER, V64, P1235, DOI 10.1016/j.proeng.2013.09.203; Suda A, 2008, J MATER SCI, V43, P2258, DOI 10.1007/s10853-007-2111-y; Tsai MS, 2004, MAT SCI ENG B-SOLID, V110, P132, DOI 10.1016/j.mseb.2003.11.024; Wang YG, 2010, J SOLID STATE CHEM, V183, P277, DOI 10.1016/j.jssc.2009.11.009; YASHIMA M, 1993, J AM CERAM SOC, V76, P1745, DOI 10.1111/j.1151-2916.1993.tb06643.x; Yeste MP, 2013, J MATER CHEM A, V1, P4836, DOI 10.1039/c3ta00016h; Yi L.C., 2014, J RARE EARTH, V32, P860; YOSHIOKA T, 1992, J MATER SCI LETT, V11, P51, DOI 10.1007/BF00720779; Zeng LW, 2012, J ALLOY COMPD, V534, P64, DOI 10.1016/j.jallcom.2012.04.058	38	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0896-8446	1872-8162		J SUPERCRIT FLUID	J. Supercrit. Fluids	FEB	2015	97						217	223		10.1016/j.supflu.2014.12.004		7	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CA5MP	WOS:000348952800026		
J	Ohashi, M; Morita, S; Fukagawa, T; Kushima, R; Katai, H				Ohashi, Masaki; Morita, Shinji; Fukagawa, Takeo; Kushima, Ryoji; Katai, Hitoshi			Surgical Treatment of Non-Early Gastric Remnant Carcinoma Developing After Distal Gastrectomy For Gastric Cancer	JOURNAL OF SURGICAL ONCOLOGY			English	Article						surgical treatment; remnant gastric cancer; outcome; gastrectomy; splenectomy	PYLORUS-PRESERVING GASTRECTOMY; LYMPH-NODE DISSECTION; GASTROESOPHAGEAL JUNCTION; ANASTOMOTIC LEAKAGE; STUMP CANCER; COMPLICATIONS; RESECTION; LYMPHADENECTOMY; PROGNOSIS; SURVIVAL	Background and Objectives: The optimal surgical procedure for gastric remnant carcinoma (GRC) remains debatable. The aim of this study was to retrospectively evaluate the surgical treatments for T2-4 GRC developing after distal gastrectomy for gastric cancer. Methods: Between 1970 and 2012, a total of 50 patients underwent R0 resection for T2-4 GRC. The clinicopathologic features, therapeutic methods, and follow-up data of these patients were reviewed. Results: The tumor was located at a non-anastomotic site of the remnant stomach in 43 of the 50 patients. Total gastrectomy was performed in 48 patients and partial gastrectomy was in two patients. Lymph node metastasis was found in 19 patients. Major postoperative complications occurred in 16 patients. The overall 1-, 3-, and 5-year survival rates of the 50 patients were 90%, 66%, and 44%, respectively. Presence of small intestinal or esophageal infiltration and postoperative complications was independently associated with poorer survival. Dissection of the perigastric and splenic hilar/artery nodes was found to have potential therapeutic benefit. Conclusions: Surgical resection for T2-4 GRC developing after distal gastrectomy for gastric cancer can be invasive, but is feasible and effective. Total gastrectomy with splenectomy is one of the recommendable procedures for this disease. (C) 2014 Wiley Periodicals, Inc.	[Ohashi, Masaki; Morita, Shinji; Fukagawa, Takeo; Katai, Hitoshi] Natl Canc Ctr, Gastr Surg Div, Tokyo 1040045, Japan; [Kushima, Ryoji] Natl Canc Ctr, Div Pathol, Tokyo 1040045, Japan	Katai, H (reprint author), Natl Canc Ctr, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	hkatai@ncc.go.jp					KODAMA M, 1995, WORLD J SURG, V19, P456; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Yamashita H, 2011, ANN SURG, V254, P274, DOI 10.1097/SLA.0b013e3182263911; Sasako M, 2010, JPN J CLIN ONCOL, V40, pi28, DOI 10.1093/jjco/hyq124; Walker KG, 2004, ANN SURG, V240, P255, DOI 10.1097/01.sla.0000133186.81222.08; Ptok H, 2007, BRIT J SURG, V94, P1548, DOI 10.1002/bjs.5707; Tanigawa N, 2010, WORLD J SURG, V34, P1540, DOI 10.1007/s00268-010-0505-5; Kaminishi M, 1996, CANCER, V77, P1646, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1646::AID-CNCR34>3.3.CO;2-U; Ohashi M, 2007, BRIT J SURG, V94, P92, DOI 10.1002/bjs.5538; Sano T, 2004, J CLIN ONCOL, V22, P2767, DOI 10.1200/JCO.2004.10.184; Tokunaga M, 2009, ANN SURG ONCOL, V16, P1241, DOI 10.1245/s10434-009-0345-4; Rizk NP, 2004, J AM COLL SURGEONS, V198, P42, DOI 10.1016/j.jamcollsurg.2003.08.007; Lerut T, 2009, ANN SURG, V250, P798, DOI 10.1097/SLA.0b013e3181bdd5a8; Fujita J, 2012, GASTRIC CANCER, V15, P42, DOI 10.1007/s10120-011-0058-9; Hu X, 2009, J SURG ONCOL, V100, P472, DOI 10.1002/jso.21370; Imada T, 1998, ANTICANCER RES, V18, P231; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016]; Kawashima Y, 2008, ASCO GASTR CANC S SA; Komatsu S, 2012, J GASTROINTEST SURG, V16, P503, DOI 10.1007/s11605-011-1804-3; Morita S, 2008, BRIT J SURG, V95, P1131, DOI 10.1002/bjs.6295; Namikawa T, 2010, J GASTROINTEST SURG, V14, P1923, DOI 10.1007/s11605-010-1298-4; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sano T, 2010, J CLIN ONCOL, V28; SASAKO M, 1991, BRIT J SURG, V78, P822, DOI 10.1002/bjs.1800780718; Sobin LH, 2009, TNM CLASSIFICATION M; Suzuki Haruhisa, 2006, Gastric Cancer, V9, P315, DOI 10.1007/s10120-006-0399-y; Tokunaga M, 2013, ANN SURG ONCOL, V20, P1575, DOI 10.1245/s10434-012-2720-9; YAMAZAKI H, 1989, CANCER, V63, P613, DOI 10.1002/1097-0142(19890215)63:4<613::AID-CNCR2820630402>3.0.CO;2-0; Yoshikawa T, 2011, J CLIN ONCOL, V29	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	FEB 1	2015	111	2					208	212		10.1002/jso.23774		5	Oncology; Surgery	Oncology; Surgery	CA2CP	WOS:000348716900015		
J	Imamura, T; Komatsu, S; Ichikawa, D; Kubota, T; Okamoto, K; Konishi, H; Shiozaki, A; Fujiwara, H; Morimura, R; Murayama, Y; Kuriu, Y; Ikoma, H; Nakanishi, M; Sakakura, C; Otsuji, E				Imamura, Taisuke; Komatsu, Shuhei; Ichikawa, Daisuke; Kubota, Takeshi; Okamoto, Kazuma; Konishi, Hirotaka; Shiozaki, Atsushi; Fujiwara, Hitoshi; Morimura, Ryo; Murayama, Yasutoshi; Kuriu, Yoshiaki; Ikoma, Hisashi; Nakanishi, Masayoshi; Sakakura, Chouhei; Otsuji, Eigo			Poor Prognostic Subgroup in T3N0 Stage IIA Gastric Cancer, Suggesting an Indication for Adjuvant Chemotherapy	JOURNAL OF SURGICAL ONCOLOGY			English	Article						lymphatic invasion; peritoneal metastasis; prognostic factor	LYMPHATIC INVASION; CLINICAL-SIGNIFICANCE; MICROMETASTASIS; RECURRENCE; SURVIVAL; SURGERY; S-1	Background: Adjuvant chemotherapy following curative gastrectomy is recommended for patients with pStage II or III, except pT3 (ss), N0 gastric cancer in Japan. This study aimed to detect the poor prognostic subgroup of T3N0 gastric cancer, suggesting an indication for adjuvant chemotherapy. Methods: Between 1999 and 2011, 116 patients with pStage IIA gastric cancer underwent curative gastrectomy. We reviewed their hospital records retrospectively. Results: The 5-year overall survival (OS) rates of patients with T1N2 + T2N1 and T3N0 gastric cancer were 79% and 77%, respectively. Univariate and multivariate analyses revealed lymphatic invasion (LY) to be an independent poor prognostic factor in T3N0 gastric cancer [P = 0.004, HR 12.3 (95% CI: 2.07-112)]. The prognosis of patients with T3N0LY+ gastric cancer was significantly poorer than those with other pStage IIA gastric cancer (5-year OS; T3N0LY+ vs. other Stage IIA: 68% vs. 83%, P = 0.043). The incidence of peritoneal recurrence was higher in patients with T3N0LY+ gastric cancer than in those with other Stage IIA gastric cancer (T3N0LY+ vs. other stage IIA: 9.0% vs. 2.8%, P = 0.134). Conclusions: Lymphatic invasion was an independent poor prognostic factor in T3N0 gastric cancer. Adjuvant chemotherapy should be recommended to patients with T3N0LY+ gastric cancer. (C) 2014 Wiley Periodicals, Inc.	[Imamura, Taisuke; Komatsu, Shuhei; Ichikawa, Daisuke; Kubota, Takeshi; Okamoto, Kazuma; Konishi, Hirotaka; Shiozaki, Atsushi; Fujiwara, Hitoshi; Morimura, Ryo; Murayama, Yasutoshi; Kuriu, Yoshiaki; Ikoma, Hisashi; Nakanishi, Masayoshi; Sakakura, Chouhei; Otsuji, Eigo] Kyoto Prefectural Univ Med, Div Digest Surg, Dept Surg, Kamigyo Ku, Kyoto 6028566, Japan	Komatsu, S (reprint author), Kyoto Prefectural Univ Med, Div Digest Surg, Dept Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	skomatsu@koto.kpu-m.ac.jp					Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gunderson LL, 2002, SEMIN RADIAT ONCOL, V12, P150, DOI 10.1053/srao.2002.30817; Dicken BJ, 2006, ANN SURG, V243, P64, DOI 10.1097/01.sla.0000194087.96582.3e; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Arigami T, 2005, BRIT J CANCER, V93, P688, DOI 10.1038/sj.bjc.6602739; Gallo A, 2006, WORLD J GASTROENTERO, V12, P3237; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Ichikawa D, 2009, J SURG ONCOL, V100, P111, DOI 10.1002/jso.21311; Ishigami S, 1999, ANN SURG ONCOL, V6, P286, DOI 10.1007/s10434-999-0286-y; Iwatsuki M, 2010, ANN SURG ONCOL, V17, P2526, DOI 10.1245/s10434-010-1041-0; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; KOGA S, 1984, SURGERY, V96, P511; Komatsu S, 2005, HEPATO-GASTROENTEROL, V52, P965; Kurashige J, 2012, ANN SURG ONCOL, V19, P656; Lee CC, 2007, J GASTROEN HEPATOL, V22, P1014, DOI 10.1111/j.1440-1746.2007.04488.x; Maehara Y, 1996, SURGERY, V119, P397, DOI 10.1016/S0039-6060(96)80138-3; Maehara Y, 1997, SURGERY, V121, P633, DOI 10.1016/S0039-6060(97)90051-9; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	FEB 1	2015	111	2					221	225		10.1002/jso.23796		5	Oncology; Surgery	Oncology; Surgery	CA2CP	WOS:000348716900017		
J	Morita, K; Kim, BN; Yoshida, H; Hiraga, K; Sakka, Y				Morita, Koji; Kim, Byung-Nam; Yoshida, Hidehiro; Hiraga, Keijiro; Sakka, Yoshio			Influence of Spark Plasma Sintering (SPS) Conditions on Transmission of MgAl2O4 Spinel	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							TRANSPARENT MGAL2O4; OPTICAL-PROPERTIES; LIGHT-SCATTERING; RAMAN-SPECTRA; PRESSURE; ALUMINA; YTTRIA; DENSIFICATION; FABRICATION; CERAMICS	The effects of the spark plasma sintering (SPS) parameters, such as heating rate , temperature T and soak time t(s), and impurities on in-line transmission T-in were examined in MgAl2O4 spinel. The SPS processing at T=1300 degrees C for t(s)=20min with a low heating rate of =10 degrees C/min is a preferable condition for attaining higher T-in. For the higher T or the longer t(s), grain coarsening enhanced the coalescence of residual pores and second phase precipitation, resulting to the limited T-in even at the slow . Although the lower T and longer t(s) attained fine and dense microstructure simultaneously, the maximum T-in was limited to about 50%. The limited transmission, particularly in the visible range, can be ascribed to the discoloration caused by the carbon contamination. The carbon contamination arose from the preexisting trace CO3 impurities, irrespective of the SPS conditions. For the higher , which is the primary advantage of the SPS technique, the additional carbon contamination occurred from the paper/die and remained as glassy carbon in the matrix. To attain higher T-in by the SPS technique, the lower and T, and the shorter t(s) should be utilized after removing the impurities.	[Morita, Koji; Kim, Byung-Nam; Yoshida, Hidehiro; Hiraga, Keijiro; Sakka, Yoshio] Natl Inst Mat Sci, Adv Ceram Grp, Tsukuba, Ibaraki 3050047, Japan; [Hiraga, Keijiro] Kitami Inst Technol, Kitami, Hokkaido 0908507, Japan	Morita, K (reprint author), Natl Inst Mat Sci, Adv Ceram Grp, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	morita.koji@nims.go.jp			Amada Foundation [AF-2008016]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22560675, 21360328]	This study was financially supported by the Amada Foundation (AF-2008016) and the Grant-in-Aid for Scientific Research [(C)22560675 and (B)21360328] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	An LQ, 2012, J EUR CERAM SOC, V32, P1035, DOI 10.1016/j.jeurceramsoc.2011.11.023; Grasso S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/5/053001; Morita K, 2009, J MATER RES, V24, P2863, DOI 10.1557/JMR.2009.0335; Gunasekaran S, 2006, J RAMAN SPECTROSC, V37, P892, DOI 10.1002/jrs.1518; Wang SF, 2013, PROG SOLID STATE CH, V41, P20, DOI 10.1016/j.progsolidstchem.2012.12.002; Ganesh I, 2013, INT MATER REV, V58, P63, DOI 10.1179/1743280412Y.0000000001; Lazzeri M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.140301; Tewell CR, 2002, J PHYS CHEM B, V106, P2946, DOI 10.1021/jp012840l; Krell A, 2009, OPT MATER, V31, P1144, DOI 10.1016/j.optmat.2008.12.009; Frage N, 2010, J EUR CERAM SOC, V30, P3331, DOI 10.1016/j.jeurceramsoc.2010.08.006; Kim BN, 2010, J AM CERAM SOC, V93, P2158, DOI 10.1111/j.1551-2916.2010.03699.x; Meir S, 2009, J AM CERAM SOC, V92, P358, DOI 10.1111/j.1551-2916.2008.02893.x; Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2; Dericioglu AF, 2003, J EUR CERAM SOC, V23, P951, DOI 10.1016/S0955-2219(02)00205-4; Frost RL, 2008, J RAMAN SPECTROSC, V39, P374, DOI 10.1002/jrs.1829; Orru R, 2009, MAT SCI ENG R, V63, P127, DOI 10.1016/j.mser.2008.09.003; Zhang HB, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/5/055003; Goldstein A, 2012, J EUR CERAM SOC, V32, P2869, DOI 10.1016/j.jeurceramsoc.2012.02.051; Morita K, 2008, SCRIPTA MATER, V58, P1114, DOI 10.1016/j.scriptamat.2008.02.008; Bonnefont G, 2012, CERAM INT, V38, P131, DOI 10.1016/j.ceramint.2011.06.045; Palmer SJ, 2008, J RAMAN SPECTROSC, V39, P395, DOI 10.1002/jrs.1838; du Merac MR, 2013, J AM CERAM SOC, V96, P3341, DOI 10.1111/jace.12637; Alaniz JE, 2009, OPT MATER, V32, P62, DOI 10.1016/j.optmat.2009.06.004; HOWARD WF, 1975, INORG CHEM, V14, P767, DOI 10.1021/ic50146a013; Jiang D, 2008, J AM CERAM SOC, V91, P151, DOI 10.1111/j.1551-2916.2007.02086.x; Kim BN, 2007, SCRIPTA MATER, V57, P607, DOI 10.1016/j.scriptamat.2007.06.009; Bernard-Granger G, 2009, SCRIPTA MATER, V60, P164, DOI 10.1016/j.scriptamat.2008.09.027; Krell A, 2009, J EUR CERAM SOC, V29, P275, DOI 10.1016/j.jeurceramsoc.2008.03.024; Burrueco MI, 2013, J MOL STRUCT, V1034, P38, DOI 10.1016/j.molstruc.2012.09.006; Morita K, 2009, J AM CERAM SOC, V92, P1208, DOI 10.1111/j.1551-2916.2009.03074.x; Kim BN, 2009, J EUR CERAM SOC, V29, P323, DOI 10.1016/j.jeurceramsoc.2008.03.015; Apetz R, 2003, J AM CERAM SOC, V86, P480; Zhang HB, 2011, J AM CERAM SOC, V94, P2739, DOI 10.1111/j.1551-2916.2011.04680.x; OHORO MP, 1973, J PHYS CHEM SOLIDS, V34, P23, DOI 10.1016/0022-3697(73)90058-9; Anselmi-Tamburini U, 2007, ADV FUNCT MATER, V17, P3267, DOI 10.1002/adfm.200600959; CAPWELL RJ, 1972, CHEM PHYS LETT, V12, P443, DOI 10.1016/0009-2614(72)90002-4; Casolco S. R., 2008, SCRIPTA MATER, V58, P16; Kanzaki S., 1978, J JPN CERAM SOC, V86, P485; Kim BN, 2009, ACTA MATER, V57, P1319, DOI 10.1016/j.actamat.2008.11.010; Kim BN, 2010, ACTA MATER, V58, P4527, DOI 10.1016/j.actamat.2010.04.049; Morita K, 2012, J EUR CERAM SOC, V32, P2303, DOI 10.1016/j.jeurceramsoc.2012.02.016; Morita K., 2014, ACTA MAT IN PRESS, Vin press; Omori M, 2000, MAT SCI ENG A-STRUCT, V287, P183, DOI 10.1016/S0921-5093(00)00773-5; Osada M., 2007, TANSO, V228, P174; Sano H, 2002, SURF SCI, V502, P70, DOI 10.1016/S0039-6028(01)01900-8; Savoini B, 1998, PHYS REV B, V57, P13439, DOI 10.1103/PhysRevB.57.13439; Yoshida H, 2011, J AM CERAM SOC, V94, P3301, DOI 10.1111/j.1551-2916.2011.04583.x; Zhang HB, 2011, J AM CERAM SOC, V94, P3206, DOI 10.1111/j.1551-2916.2011.04789.x	48	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	FEB	2015	98	2					378	385		10.1111/jace.13309		8	Materials Science, Ceramics	Materials Science	CA1HC	WOS:000348662400006		
J	Yoshimoto, K; Masuno, A; Inoue, H; Watanabe, Y				Yoshimoto, Kohei; Masuno, Atsunobu; Inoue, Hiroyuki; Watanabe, Yasuhiro			Thermal Stability, Optical Transmittance, and Refractive Index Dispersion of La2O3-Nb2O5-Al2O3 Glasses	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							NIOBIUM PHOSPHATE-GLASSES; OXIDE GLASSES; BORATE GLASSES; BEHAVIOR; NB2O5; TI	La2O3-Nb2O5-Al2O3 high-refractive-index glasses were fabricated by containerless processing, and the glass-forming region was determined. The thermal stability, density, optical transmittance, and the refractive index dispersion of these glasses were investigated. All the glasses were colorless and transparent in the visible to near infrared (NIR) region and had high refractive index with low wavelength dispersion. Some of these glasses were found to have significantly high glass-forming ability. These results indicate that the ternary glasses are suitable for optical applications in the visible to NIR region. The effects of the substitution of Al2O3 for Nb2O5 on optical properties were discussed on the basis of the Drude-Voigt equation. It was suggested that the substitution of Al2O3 for Nb2O5 increased the molecular density and suppressed a decrease in the refractive index, even when both the average oscillator strength and inherent absorption wavelength decreased in La2O3-Nb2O5-Al2O3 glasses. These results are helpful for designing new optical glasses controlled to have a higher refractive index and lower wavelength dispersion.	[Yoshimoto, Kohei; Masuno, Atsunobu; Inoue, Hiroyuki; Watanabe, Yasuhiro] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Masuno, A (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan.	masuno@iis.u-tokyo.ac.jp			Nippon Sheet Glass Foundation for Materials Science and Engineering; Iketani Science and Technology Foundation; Tokuyama Science Foundation; Ministry of Education, Culture, Sports and Science and Technology of Japan [19750174, 23750236, 21550185, 25410236]	This study was supported in part by Nippon Sheet Glass Foundation for Materials Science and Engineering, Iketani Science and Technology Foundation, Tokuyama Science Foundation and Grant-in-Aid for Young Scientists (B) (19750174 and 23750236) and Grant-in-Aid for Scientific Research (C) (21550185 and 25410236) from the Ministry of Education, Culture, Sports and Science and Technology of Japan.	Abdel-Baki M, 2006, CURR OPIN SOLID ST M, V10, P217, DOI 10.1016/j.cossms.2007.08.001; Arai Y, 2008, J APPL PHYS, V103, DOI 10.1063/1.2903544; Watanabe Y, 2012, J NON-CRYST SOLIDS, V358, P3563, DOI 10.1016/j.jnoncrysol.2012.02.001; Weber JKR, 2000, J AM CERAM SOC, V83, P1868; Flambard A, 2008, J NON-CRYST SOLIDS, V354, P3540, DOI 10.1016/j.jnoncrysol.2008.03.017; Kohara S, 2011, P NATL ACAD SCI USA, V108, P14780, DOI 10.1073/pnas.1104692108; Masuno A, 2013, CHEM MATER, V25, P3056, DOI 10.1021/cm401236s; KIM SH, 1995, J AM CERAM SOC, V78, P1061, DOI 10.1111/j.1151-2916.1995.tb08437.x; Yu JD, 2006, CHEM MATER, V18, P2169, DOI 10.1021/cm0525555; Dimitrov V, 1996, J APPL PHYS, V79, P1736, DOI 10.1063/1.360962; Masuno A, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.102601; DUMBAUGH WH, 1992, J AM CERAM SOC, V75, P2315, DOI 10.1111/j.1151-2916.1992.tb05581.x; Akola J, 2013, P NATL ACAD SCI USA, V110, P10129, DOI 10.1073/pnas.1300908110; Kohara S, 2004, SCIENCE, V303, P1649, DOI 10.1126/science.1095047; FUJINO S, 1995, J AM CERAM SOC, V78, P1179, DOI 10.1111/j.1151-2916.1995.tb08466.x; Dimitrov V., 2010, J U CHEM TECHNOL MET, V45, P219; HARRISON AJ, 1947, J AM CERAM SOC, V30, P362, DOI 10.1111/j.1151-2916.1947.tb18868.x; Hirota S., 1976, Yogyo-Kyokai-Shi, V84; HIROTA S, 1978, J NON-CRYST SOLIDS, V29, P109, DOI 10.1016/0022-3093(78)90144-8; Inoue H, 2011, OPT MATER, V33, P1853, DOI 10.1016/j.optmat.2011.02.043; Masuno A, 2010, J APPL PHYS, V108, DOI 10.1063/1.3482040; Masuno A, 2014, OPT MATER EXPRESS, V4, P710, DOI 10.1364/OME.4.000710; Saddeek YB, 2010, PHYSICA B, V405, P2407, DOI 10.1016/j.physb.2010.02.055; SAMUNEVA B, 1991, J NON-CRYST SOLIDS, V129, P54, DOI 10.1016/0022-3093(91)90080-P; Sanghi S, 2010, MATER CHEM PHYS, V120, P381, DOI 10.1016/j.matchemphys.2009.11.016; Sene FF, 2004, J NON-CRYST SOLIDS, V348, P63, DOI 10.1016/j.jnoncrysol.2004.08.127; Skinner LB, 2006, J PHYS-CONDENS MAT, V18, pL407, DOI 10.1088/0953-8984/18/32/L01; Teixeira Z, 2007, J AM CERAM SOC, V90, P256, DOI 10.1111/j.1551-2916.2006.01399.x	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	FEB	2015	98	2					402	407		10.1111/jace.13310		6	Materials Science, Ceramics	Materials Science	CA1HC	WOS:000348662400010		
J	Nakanishi, T; Watanabe, K; Ueda, J; Fushimi, K; Tanabe, S; Hasegawa, Y				Nakanishi, Takayuki; Watanabe, Kazune; Ueda, Jumpei; Fushimi, Koji; Tanabe, Setsuhisa; Hasegawa, Yasuchika			Enhanced Light Storage of SrAl2O4 Glass-Ceramics Controlled by Selective Europium Reduction	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							RARE-EARTH IONS; PERSISTENT LUMINESCENCE; PHOSPHOR CRYSTALS; TRAP LEVELS; LONG; INTENSITIES; FABRICATION; MECHANISM; DY3+; EU	A luminescent Eu, Dy: SrAl2O4 glass-ceramics with high transparency in the visible region was successfully synthesized using the frozen sorbet technique with the control of O-2 partial pressure (PO2) for the oxidation of Eu2+ ions. The glass-ceramics include Eu2+, Eu3+, and Dy3+ ions, and thus exhibits three characteristic types of emission bands, 4f-5d at around 520nm (Eu2+ ions), 4f-4f at 610nm (Eu3+ ions), and 480nm (Dy3+ ions). The Eu, Dy: SrAl2O4 glass-ceramics provide remarkable long-persistent luminescence under dark condition. The glass-ceramics also exhibits color-changing luminescence in the visible region based on their remarkable light storage properties. The luminescent Eu, Dy: SrAl2O4 glass-ceramics using the frozen sorbet technique with control of PO2 are promising materials for application in novel photonic and light storage materials.	[Nakanishi, Takayuki; Watanabe, Kazune; Fushimi, Koji; Hasegawa, Yasuchika] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Ueda, Jumpei; Tanabe, Setsuhisa] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Nakanishi, T (reprint author), Hokkaido Univ, Fac Engn, Kita Ku, N13W8, Sapporo, Hokkaido 0608628, Japan.	nakanishi@eng.hokudai.ac.jp; hasegaway@eng.hokudai.ac.jp	Fushimi, Koji/E-6642-2014	Fushimi, Koji/0000-0002-8945-0969	Nippon Sheet Glass Foundation for Materials Science; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [2401, 24102012]	This work was supported by the Nippon Sheet Glass Foundation for Materials Science. This work was also supported by Grants-in-Aid for Scientific Research on Innovative Areas of "New Polymeric Materials Based on Element-Blocks (No. 2401)" (24102012) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. We thank Dr. S. Fujita for cathodeluminescence measurement at Nippon Electric Glass Co., Ltd., Japan.	BLASSE G, 1994, CHEM MATER, V6, P1465, DOI 10.1021/cm00045a002; Ueda J, 2010, J AM CERAM SOC, V93, P3084, DOI 10.1111/j.1551-2916.2010.04065.x; Bessiere A, 2014, CHEM MATER, V26, P1365, DOI 10.1021/cm403050q; Fujita S, 2010, OPT MATER, V32, P886, DOI 10.1016/j.optmat.2010.01.014; Takasaki H, 1996, J CERAM SOC JPN, V104, P322, DOI 10.2109/jcersj.104.322; Nakanishi T, 2009, IEEE J SEL TOP QUANT, V15, P1171, DOI 10.1109/JSTQE.2009.2014396; Tanabe S, 2002, OPT MATER, V19, P343, DOI 10.1016/S0925-3467(01)00236-1; Matsuzawa T, 1996, J ELECTROCHEM SOC, V143, P2670, DOI 10.1149/1.1837067; RANDALL JT, 1945, PROC R SOC LON SER-A, V184, P366; OFELT GS, 1962, J CHEM PHYS, V37, P511, DOI 10.1063/1.1701366; JUDD BR, 1962, PHYS REV, V127, P750, DOI 10.1103/PhysRev.127.750; Clabau F, 2006, CHEM MATER, V18, P3212, DOI 10.1021/cm052728q; Tanabe S, 1998, J NON-CRYST SOLIDS, V239, P170, DOI 10.1016/S0022-3093(98)00734-0; Katsumata T, 2006, J AM CERAM SOC, V89, P932, DOI 10.1111/j.1551-2916.2005.00856.x; Chen JT, 2008, CRYST GROWTH DES, V8, P3175, DOI 10.1021/cg700719h; Jung KY, 2006, CHEM MATER, V18, P2249, DOI 10.1021/cm060003w; Clabau F, 2005, CHEM MATER, V17, P3904, DOI 10.1021/cm050763r; Maldiney T, 2012, ACS SYM SER, V1113, P1; Dorenbos P, 2005, J ELECTROCHEM SOC, V152, pH107, DOI 10.1149/1.1926652; Nag A, 2003, J ALLOY COMPD, V354, P221, DOI 10.1016/S0925-8388(03)00009-4; Stevenson A, 2011, NANO LETT, V11, P3274, DOI 10.1021/nl201626q; Pan ZW, 2012, NAT MATER, V11, P58, DOI [10.1038/nmat3173, 10.1038/NMAT3173]; Nakanishi T, 2011, J CERAM SOC JPN, V119, P609, DOI 10.2109/jcersj2.119.609; Carnall W. T., 1979, HDB PHYSICS CHEM RAR, V3, P171, DOI 10.1016/S0168-1273(79)03007-5; Curie D., 1963, LUMINESCENCE CRYSTAL; Ende B. M. v. d., 2009, PHYS CHEM CHEM PHYS, V11, P11081; Grahmaier R., 1994, LUMINESCENT MAT; Holsa J, 2009, ELECTROCHEM SOC INTE, V18, P42; Katsumata T, 2002, J CRYST GROWTH, V237, P361, DOI 10.1016/S0022-0248(01)01942-X; Nakanishi T., 2006, PHYS STATUS SOLIDI A, V206, P919; Tanabe S., 2006, CERAM T, V173, P19; Tarasaki N., 2011, CHEM COMMUN, V47, P8034; Ueda J., 2012, PHYS STAT SOLIDI C, V12, P2322; Viana V., 2013, P SOC PHOTO-OPT INS, V8626; Xu N. -C., 1999, APPL PHYS LETT, V74, P2414	35	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	FEB	2015	98	2					423	429		10.1111/jace.13312		7	Materials Science, Ceramics	Materials Science	CA1HC	WOS:000348662400013		
J	Hagiwara, M; Fujihara, S				Hagiwara, Manabu; Fujihara, Shinobu			Effects of CuO Addition on Electrical Properties of 0.6BiFeO(3)-0.4(Bi0.5K0.5) TiO3 Lead-Free Piezoelectric Ceramics	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							FERROELECTRIC CERAMICS; SINTERING TEMPERATURE; DIELECTRIC-PROPERTIES; PHASE-TRANSITION; THIN-FILM; RELAXOR; ZNO	0.6BiFeO(3)-0.4(Bi0.5K0.5)TiO3 (0.6BF-0.4BKT) ceramic samples with 0.0-4.0mol% CuO were prepared by the solid-state reaction. The CuO addition aided the densification of the samples and slightly increased the lattice constant. The relaxor-like defuse dielectric peak of 0.6BF-0.4BKT became sharper with increasing the CuO content. Polarization-electric field curve of the undoped 0.6BF-0.4BKT was a pinched loop in the as-sintered state, while that was a square hysteresis with a large remanent polarization of 48C/cm(2) after the thermal quenching, demonstrating a strong domain wall pinning due to defect dipoles. We found that the CuO addition up to 2.0mol% facilitates the polarization switching in the as-sintered samples to increase the remanent polarization and the piezoelectric d(33) coefficient. The results of the structural and electrical investigations suggested that the copper ion acts as a donor in 0.6BF-0.4BKT by compensating the potassium vacancy created by the evaporation of K2O during the calcination and sintering processes.	[Hagiwara, Manabu; Fujihara, Shinobu] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Hagiwara, M (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	hagiwara@applc.keio.ac.jp			Japan Society for the Promotion of Science (JSPS) [25889049]	The authors would like to thank Dr. Takaaki Tsurumi, Dr. Hiroaki Takeda, and Dr. Takuya Hoshina in Tokyo Institute of Technology for their assistance in carrying out the experiments. This work was supported by a Grant-in-Aid for Research Activity Start-up (No. 25889049) from the Japan Society for the Promotion of Science (JSPS).	Ahn CW, 2006, J AM CERAM SOC, V89, P921, DOI 10.1111/j.1551-2916.2005.00823.x; Ahn CW, 2004, JPN J APPL PHYS 1, V43, P205, DOI 10.1143/JJAP.43.205; Lebeugle D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753390; Shvartsman VV, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2731312; Lebeugle D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024116; ROBELS U, 1993, J APPL PHYS, V73, P3454, DOI 10.1063/1.352948; Kim JM, 2010, FERROELECTRICS, V404, P88, DOI 10.1080/00150193.2010.482448; Morozov MI, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772588; Wang J, 2003, SCIENCE, V299, P1719, DOI 10.1126/science.1080615; Azough F, 2011, J EUR CERAM SOC, V31, P569, DOI 10.1016/j.jeurceramsoc.2010.10.033; Bennett J, 2013, MATER LETT, V94, P172, DOI 10.1016/j.matlet.2012.12.053; UCHINO K, 1981, J MATER SCI, V16, P569, DOI 10.1007/BF00552193; Matsuo H, 2010, J APPL PHYS, V108, DOI 10.1063/1.3506717; Cheng JR, 2003, J APPL PHYS, V94, P5153, DOI 10.1063/1.1609655; Haertling GH, 1999, J AM CERAM SOC, V82, P797; Bidault O, 1997, J APPL PHYS, V82, P5674, DOI 10.1063/1.366430; Morozov MI, 2012, FERROELECTRICS, V439, P88, DOI 10.1080/00150193.2012.741946; Li E, 2007, J AM CERAM SOC, V90, P1787, DOI 10.1111/j.1551-2916.2006.01465.x; Santos IA, 2001, J PHYS-CONDENS MAT, V13, P11733, DOI 10.1088/0953-8984/13/50/333; Leontsev SO, 2009, J AM CERAM SOC, V92, P2957, DOI 10.1111/j.1551-2916.2009.03313.x; Hiruma Y, 2007, JPN J APPL PHYS 1, V46, P1081, DOI 10.1143/JJAP.46.1081; Jo W, 2011, J EUR CERAM SOC, V31, P2107, DOI 10.1016/j.jeurceramsoc.2011.05.008; Morozov MI, 2014, J APPL PHYS, V115, DOI 10.1063/1.4863798; Nagata H, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.011502; Ozaki T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.09MC05; Pelaiz-Barranco A., 2012, ADV FERROELECTRICS, P85; Rojac T, 2010, J APPL PHYS, V108, DOI 10.1063/1.3490249; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Watanabe A, 2006, J CERAM SOC JPN, V114, P97, DOI 10.2109/jcersj.114.97; Yun KY, 2004, JPN J APPL PHYS 2, V43, pL647, DOI 10.1143/JJAP.43.L647	30	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	FEB	2015	98	2					469	475		10.1111/jace.13287		7	Materials Science, Ceramics	Materials Science	CA1HC	WOS:000348662400020		
J	Bai, S; Lu, Y; Karaki, T				Bai, Shan; Lu, Yao; Karaki, Tomoaki			Preparation of Plate-Like Sodium Niobate Particles by Hydrothermal Method	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							NANBO3 POWDERS; PIEZOELECTRIC PROPERTIES; THIN-FILMS; CERAMICS; KNBO3	Sodium niobate NaNbO3 hydrate (NN-hydrate) particles with a plate-like morphology were prepared at 140 degrees C for 2h in 12mol/L of NaOH by the hydrothermal method. Bar-like Na(8)Nb(6)O(19)13H(2)O particles were synthesized at as low as 100 degrees C for 2h. This work demonstrates that by carefully optimizing the reaction condition, we can selectively fabricate niobate structures, including the bar-like, plate-like, fibers and cube particles through a direct reaction between NaOH solution and Nb2O5. It was found that Nb6O198- formed was an important premise for formation of the NN-hydrate, and lower [OH-] was not favorable in preparing the NN-hydrate as there was an optimum [OH-]. Through researching effects of the reaction temperature, time, concentration of NaOH, and content of Nb2O5 on the NN-hydrate structure and evolution, the formation mechanism from solid reactants to the intermediate were investigated. After calcining at 800 degrees C, the synthesized NN-hydrate particles made a phase almost transform to the perovskite NaNbO3, and the morphology of these calcined particles was still plate-like.	[Bai, Shan; Lu, Yao; Karaki, Tomoaki] Toyama Prefectural Univ, Fac Engn, Dept Intelligent Syst Design Engn, Toyama 9390398, Japan	Karaki, T (reprint author), Toyama Prefectural Univ, Fac Engn, Dept Intelligent Syst Design Engn, Toyama 9390398, Japan.	chen@pu-toyama.ac.jp			CAS/SAFEA International Partnership Program for Creative Research Teams	This work was supported in part by the CAS/SAFEA International Partnership Program for Creative Research Teams.	Tyunina M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3222900; Zhang F, 2008, JPN J APPL PHYS, V47, P7685, DOI 10.1143/JJAP.47.7685; Wada T, 2001, JPN J APPL PHYS 1, V40, P5703, DOI 10.1143/JJAP.40.5703; Zhu HY, 2006, J AM CHEM SOC, V128, P2373, DOI 10.1021/ja056301w; Guo YP, 2004, JPN J APPL PHYS 1, V43, P6662, DOI 10.1143/JJAP.43.6662; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Goh GKL, 2003, J MATER RES, V18, P338, DOI 10.1557/JMR.2003.0044; Wu SY, 2010, J MATER SCI-MATER EL, V21, P450, DOI 10.1007/s10854-009-9937-9; Besserguenev A V, 2001, Inorg Chem, V40, P2582, DOI 10.1021/ic001031y; Camargo ER, 2002, CHEM MATER, V14, P2365, DOI 10.1021/cm011696d; Dias A, 2003, CHEM MATER, V15, P1344, DOI 10.1021/cm0210187; DUNGAN RH, 1964, J AM CERAM SOC, V47, P73, DOI 10.1111/j.1151-2916.1964.tb15658.x; Inagaki Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.09KC09; Kupec A, 2012, J AM CERAM SOC, V95, P515, DOI 10.1111/j.1551-2916.2011.04892.x; Lu H., 1998, MATER LETT, V34, P172; Nobre MAL, 1996, MATER LETT, V28, P215, DOI 10.1016/0167-577X(96)00062-6; Nyman M, 2002, J AM CHEM SOC, V124, P1704, DOI 10.1021/ja017081z; Nystrom MJ, 1996, APPL PHYS LETT, V68, P761, DOI 10.1063/1.116734; Prater P. L., 1981, PHYS REV B, V23, P221; Sundarakannan B, 2003, J APPL PHYS, V94, P5182, DOI 10.1063/1.1610260; Tomeno I, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104101; Wang RP, 2002, JPN J APPL PHYS 1, V41, P7119, DOI 10.1143/JJAP.41.7119; Wu MJ, 2010, MATER LETT, V64, P1157, DOI 10.1016/j.matlet.2010.02.037; Zhang F, 2011, PHYS STATUS SOLIDI A, V208, P1052, DOI 10.1002/pssa.201000097	24	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	FEB	2015	98	2					654	658		10.1111/jace.13315		5	Materials Science, Ceramics	Materials Science	CA1HC	WOS:000348662400046		
J	Morikawa, A; Yamamura, K; Suda, A; Tanabe, T; Nobukawa, T; Chiba, A; Takahashi, N				Morikawa, Akira; Yamamura, Kae; Suda, Akihiko; Tanabe, Toshitaka; Nobukawa, Takeshi; Chiba, Akiya; Takahashi, Naoki			Phase Transformation Behavior of a Pyrochlore-Type CeO2-ZrO2 Binary Compound	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							OXYGEN STORAGE CAPACITY; SOLID-SOLUTION; ORDERED ARRANGEMENT; CRYSTAL-STRUCTURE; RELEASE BEHAVIOR; 3-WAY CATALYSTS; PERFORMANCE; POWDERS; CE0.67ZR0.33O2; APPEARANCE	The phase transformation behavior of the superlattice structure of a CeO2-ZrO2 pyrochlore-type binary compound (CP) was investigated so as to better understand how to improve the thermal stability of such a system. CP was synthesized through high-temperature reduction of a conventional CeO2-ZrO2 solid solution with a 1:1 molar ratio of Ce and Zr. High-resolution transmission electron microscopy and selected-area electron diffraction clearly revealed that the pyrochlore structure of CP transformed to the standard disordered cubic fluorite or tetragonal zirconia structure after having been subjected to a high-temperature durability test; moreover, it was determined that this phase transformation moves inward from the crystallite surface. This discovery suggests a new method by which to improve upon this material for practical applications.	[Morikawa, Akira; Yamamura, Kae; Suda, Akihiko; Tanabe, Toshitaka; Takahashi, Naoki] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Nobukawa, Takeshi] Toyota Motor Co Ltd, Toyota, Aichi 4718572, Japan; [Chiba, Akiya] Cataler Corp, Shizuoka 4371492, Japan	Morikawa, A (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	a-morikawa@mosk.tytlabs.co.jp					An Y, 2007, J ALLOY COMPD, V441, P305, DOI 10.1016/j.jallcom.2006.09.110; Kaspar J, 2003, CATAL TODAY, V77, P419, DOI 10.1016/S0920-5861(02)00384-X; SUBRAMANIAN MA, 1983, PROG SOLID STATE CH, V15, P55, DOI 10.1016/0079-6786(83)90001-8; Nagai Y, 2008, TOP CATAL, V47, P137, DOI 10.1007/s11244-007-9018-3; Machida M, 2007, CHEM MATER, V19, P954, DOI 10.1021/cm062625n; Zhao MW, 2007, J CATAL, V248, P258, DOI 10.1016/j.jcat.2007.03.005; Nagai Y, 2002, CATAL TODAY, V74, P225, DOI 10.1016/S0920-5861(02)00025-1; He H, 2002, J CATAL, V206, P1, DOI 10.1006/jcat.2001.3466; Lian J, 2004, NUCL INSTRUM METH B, V218, P236, DOI 10.1016/j.nimb.2004.01.007; Morikawa A, 2008, APPL CATAL B-ENVIRON, V78, P210, DOI 10.1016/j.apcatb.2007.09.013; Cao L, 2009, CATAL COMMUN, V10, P1192, DOI 10.1016/j.catcom.2009.01.015; Granados ML, 2008, J CATAL, V256, P172, DOI 10.1016/j.jcat.2008.03.011; Guo JX, 2007, J RARE EARTH, V25, P179, DOI 10.1016/S1002-0721(07)60069-6; Guodong F., 2007, J RARE EARTH, V25, P42, DOI 10.1016/S1002-0721(07)60042-8; Izu N, 1998, J ALLOY COMPD, V270, P107, DOI 10.1016/S0925-8388(98)00464-2; Kishimoto H, 2000, J ALLOY COMPD, V312, P94, DOI 10.1016/S0925-8388(00)01168-3; Korneev V. R., 1971, INORG MATER, V7, P781; Masui T, 2000, CHEM LETT, P840, DOI 10.1246/cl.2000.840; Morikawa A, 2009, APPL CATAL B-ENVIRON, V88, P542, DOI 10.1016/j.apcatb.2008.10.019; Omata T, 2006, J ELECTROCHEM SOC, V153, pA2269, DOI 10.1149/1.2360765; Omata T, 1999, J SOLID STATE CHEM, V147, P573, DOI 10.1006/jssc.1999.8420; Otsuka-Yao-Matsuo S, 2003, HIGH TEMP MAT PR-ISR, V22, P157; OtsukaYao S, 1995, J JPN I MET, V59, P1237; Otsuka-Yao-Matsuo S, 1998, J SOLID STATE CHEM, V138, P47, DOI 10.1006/jssc.1998.7753; Sasaki T, 2003, J CERAM SOC JPN, V111, P382, DOI 10.2109/jcersj.111.382; Sasaki T, 2004, J CERAM SOC JPN, V112, P440, DOI 10.2109/jcersj.112.440; Suda A, 2004, J CERAM SOC JPN, V112, P586, DOI 10.2109/jcersj.112.586; Suda A, 2007, KEY ENG MAT, V352, P287	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	FEB	2015	98	2					659	662		10.1111/jace.13322		4	Materials Science, Ceramics	Materials Science	CA1HC	WOS:000348662400047		
J	Nishiguchi, S; Yamada, M; Fukutani, N; Adachi, D; Tashiro, Y; Hotta, T; Morino, S; Shirooka, H; Nozaki, Y; Hirata, H; Yamaguchi, M; Arai, H; Tsuboyama, T; Aoyama, T				Nishiguchi, Shu; Yamada, Minoru; Fukutani, Naoto; Adachi, Daiki; Tashiro, Yuto; Hotta, Takayuki; Morino, Saori; Shirooka, Hidehiko; Nozaki, Yuma; Hirata, Hinako; Yamaguchi, Moe; Arai, Hidenori; Tsuboyama, Tadao; Aoyama, Tomoki			Differential Association of Frailty With Cognitive Decline and Sarcopenia in Community-Dwelling Older Adults	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Article						Frailty; cognitive decline; sarcopenia; community-dwelling older adults	ALZHEIMERS-DISEASE; PHYSICAL-DISABILITY; CONSENSUS REPORT; PREVALENCE; AGE; POPULATION; IMPAIRMENT; PHENOTYPE; DIAGNOSIS; MOBILITY	Objectives: Frailty in older adults is a serious problem because of various adverse health outcomes in many countries with aging populations, such as Japan. The purpose of this study was to determine whether frailty and pre-frailty are associated with cognitive decline and sarcopenia in community-dwelling older adults. Design: This is a cross-sectional study. Setting: Japan. Participants: The participants were 273 Japanese community-dwelling older women aged 65 years and older. Measurements: We used the frailty criteria developed by the Cardiovascular Health Study to define physical frailty. We divided the cohort into nonfrail, prefrail, and frail according to frailty scores. Cognitive decline and memory decline were defined by using the Mini-Mental State Examination and Scenery Picture Memory Test, respectively. Sarcopenia was defined according to the diagnostic algorithm recommended by the Asian Working Group for Sarcopenia. Results: In the multivariate logistic regression analysis by using non-frail participants as the reference, pre-frail elderly individuals were significantly more likely to have sarcopenia than non-frail elderly individuals [odds ratio (OR): 2.77, 95% confidence interval (CI): 1.05-9.26], but not cognitive decline or memory decline. Frail elderly individuals were significantly more likely to have cognitive decline (OR: 5.76, 95% CI: 1.20-27.6), memory decline (OR: 5.53, 95% CI: 1.64-18.7) and sarcopenia (OR: 19.1, 95% CI: 3.73-98.0) than non-frail elderly individuals. Conclusions: Sarcopenia was associated with pre-frailty and frailty, whereas cognitive decline was associated only with frailty. (C) 2015 AMDA - The Society for Post-Acute and Long-Term Care Medicine.	[Nishiguchi, Shu; Fukutani, Naoto; Adachi, Daiki; Tashiro, Yuto; Hotta, Takayuki; Morino, Saori; Shirooka, Hidehiko; Nozaki, Yuma; Hirata, Hinako; Yamaguchi, Moe; Arai, Hidenori; Tsuboyama, Tadao; Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto 6068507, Japan; [Nishiguchi, Shu] Japan Soc Promot Sci, Tokyo, Japan; [Yamada, Minoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tokyo, Japan	Nishiguchi, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	nishiguchi.shu.82s@st.kyoto-u.ac.jp					Akune T, 2014, OSTEOPOROSIS INT, V25, P1081, DOI 10.1007/s00198-013-2550-z; Pel-Littel RE, 2009, J NUTR HEALTH AGING, V13, P390, DOI 10.1007/s12603-009-0051-8; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Buchman AS, 2008, NEUROLOGY, V71, P499, DOI 10.1212/01.wnl.0000324864.81179.6a; Mulero J, 2011, J NUTR HEALTH AGING, V15, P756, DOI 10.1007/s12603-011-0130-5; Gibson AL, 2008, AM J CLIN NUTR, V87, P332; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Boyle PA, 2010, J AM GERIATR SOC, V58, P248, DOI 10.1111/j.1532-5415.2009.02671.x; Speakman JR, 2010, AM J CLIN NUTR, V92, P826, DOI 10.3945/ajcn.2009.28540; Buchman AS, 2007, PSYCHOSOM MED, V69, P483, DOI 10.1097/psy.0b013e318068e1d; Kulmala J, 2014, GERONTOLOGY, V60, P16, DOI 10.1159/000353859; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Yamada M, 2013, J AM MED DIR ASSOC, V14, P911, DOI 10.1016/j.jamda.2013.08.015; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Xue QL, 2008, J GERONTOL A-BIOL, V63, P984; Janssen I, 2006, J AM GERIATR SOC, V54, P56, DOI 10.1111/j.1532-5415.2005.00540.x; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Mhaolain AMN, 2011, AGE AGEING, V40, P630, DOI 10.1093/ageing/afr066; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ikejima C, 2012, PSYCHOGERIATRICS, V12, P120, DOI 10.1111/j.1479-8301.2012.00415.x; Lezak M, 2004, NEUROPSYCHOLOGICAL A; Marcell Taylor J, 2003, J Gerontol A Biol Sci Med Sci, V58, pM911; Mitnitski Arnold B, 2004, J Gerontol A Biol Sci Med Sci, V59, pM627; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Takechi H, 2010, GERIATR GERONTOL INT, V10, P183, DOI 10.1111/j.1447-0594.2009.00576.x; Yamada M, 2014, GERIATR GERONTOL INT, V14, P8, DOI 10.1111/ggi.12209; YESAVAGE JA, 1983, J PSYCHIAT RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	34	9	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	FEB 1	2015	16	2					120	124		10.1016/j.jamda.2014.07.010		5	Geriatrics & Gerontology	Geriatrics & Gerontology	CA2KR	WOS:000348738000006		
J	Takahashi, Y; Shishido, T; Yamamoto, K; Masaoka, T; Kubo, K; Tateiwa, T; Pezzotti, G				Takahashi, Yasuhito; Shishido, Takaaki; Yamamoto, Kengo; Masaoka, Toshinori; Kubo, Kosuke; Tateiwa, Toshiyuki; Pezzotti, Giuseppe			Mechanisms of plastic deformation in highly cross-linked UHMWPE for total hip components-The molecular physics viewpoint	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Polyethylene; Cross-linking; Morphology; Deformation; Total hip arthroplasty	RANDOMIZED CONTROLLED-TRIAL; WEIGHT POLYETHYLENE; RADIOSTEREOMETRIC ANALYSIS; ACETABULAR CUPS; STERILIZATION METHODS; WEAR; RAMAN; ARTHROPLASTY; RADIATION; OXIDATION	Plastic deformation is an unavoidable event in biomedical polymeric implants for load-bearing application during long-term in-vivo service life, which involves a mass transfer process, irreversible chain motion, and molecular reorganization. Deformation-induced microstructural alterations greatly affect mechanical properties and durability of implant devices. The present research focused on evaluating, from a molecular physics viewpoint, the impact of externally applied strain (or stress) in ultra-high molecular weight polyethylene (UHMWPE) prostheses, subjected to radiation cross-linking and subsequent remelting for application in total hip arthroplasty (THA). Two different types of commercial acetabular liners, which belong to the first-generation highly cross-linked UHMWPE (HXLPE), were investigated by means of confocal/polarized Raman microprobe spectroscopy. The amount of crystalline region and the spatial distribution of molecular chain orientation were quantitatively analyzed according to a combined theory including Raman selection rules for the polyethylene orthorhombic structure and the orientation distribution function (ODF) statistical approach. The structurally important finding was that pronounced recrystallization and molecular reorientation increasingly appeared in the near-surface regions of HXLPE liners with increasing the amount of plastic (compressive) deformation stored in the microstructure. Such molecular rearrangements, occurred in response to external strains, locally increase surface cross-shear (CS) stresses, which in turn trigger microscopic wear processes in HXLPE acetabular liners. Thus, on the basis of the results obtained at the molecular scale, we emphasize here the importance of minimizing the development of irrecoverable deformation strain in order to retain the pristine and intrinsically high wear performance of HXLPE components. (C) 2014 Elsevier Ltd. All rights reserved.	[Takahashi, Yasuhito; Shishido, Takaaki; Yamamoto, Kengo; Masaoka, Toshinori; Kubo, Kosuke; Tateiwa, Toshiyuki] Tokyo Med Univ, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1600023, Japan; [Takahashi, Yasuhito] Tokyo Med Univ, Dept Bone & Joint Biomat Res, Shinjuku Ku, Tokyo 1600023, Japan; [Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Matsugasaki, Kyoto 6068585, Japan	Takahashi, Y (reprint author), Tokyo Med Univ, Dept Orthopaed Surg, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	yasuhito@tokyo-med.ac.jp					Kim JM, 2014, MACROMOLECULES, V47, P2515, DOI 10.1021/ma402297a; Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P2262, DOI 10.1007/s11999-011-1872-4; BOWDEN PB, 1974, J MATER SCI, V9, P2034, DOI 10.1007/BF00540553; Bragdon CR, 2007, J ARTHROPLASTY, V22, P125, DOI 10.1016/i.arth.2007.03.009; McKellop HA, 1999, J ORTHOP RES, V17, P329, DOI 10.1002/jor.1100170306; Kadar T, 2012, J BONE JOINT SURG BR, V94B, P302, DOI 10.1302/0301-620X.94B3.27460; McCalden RW, 2009, J BONE JOINT SURG AM, V91A, P773, DOI 10.2106/JBJS.H.00244; Bartczak Z, 2010, MACROMOL SY, V294-I, P67, DOI 10.1002/masy.201050807; Ries MD, 1996, CLIN ORTHOP RELAT R, P87; Pezzotti G, 2011, J BIOMAT SCI-POLYM E, V22, P2165, DOI 10.1163/092050610X537129; Glyn-Jones S, 2008, J BONE JOINT SURG BR, V90B, P556, DOI 10.1302/0301-620X.90B5.20545; LIN L, 1994, J MATER SCI, V29, P294, DOI 10.1007/BF01162485; Okita S, 2014, J MECH BEHAV BIOMED, V31, P55, DOI 10.1016/j.jmbbm.2013.01.022; Kumakura T, 2009, J BIOMAT SCI-POLYM E, V20, P1809, DOI 10.1163/156856208X386417; Wang A, 2001, WEAR, V248, P38, DOI 10.1016/S0043-1648(00)00522-6; Wang A, 1997, WEAR, V203, P230, DOI 10.1016/S0043-1648(96)07362-0; Wang A, 1998, TRIBOL INT, V31, P17, DOI 10.1016/S0301-679X(98)00005-X; Butler MF, 1998, POLYMER, V39, P39, DOI 10.1016/S0032-3861(97)00226-7; Thomas GER, 2011, J BONE JOINT SURG AM, V93A, P716, DOI 10.2106/JBJS.J.00287; Whittaker JP, 2010, J ARTHROPLASTY, V25, P680, DOI 10.1016/j.arth.2009.05.006; STROBL GR, 1978, J POLYM SCI POL PHYS, V16, P1181, DOI 10.1002/pol.1978.180160704; Kurtz SM, 2010, J ARTHROPLASTY, V25, P67, DOI 10.1016/j.arth.2010.04.018; Collier JP, 1996, CLIN ORTHOP RELAT R, P76; Edidin AA, 1999, J ARTHROPLASTY, V14, P616, DOI 10.1016/S0883-5403(99)90086-4; Beksac B, 2009, CLIN ORTHOP RELAT R, V467, P1765, DOI 10.1007/s11999-008-0661-1; Bellare A., 2005, TOTAL KNEE ARTHROPLA, P45, DOI 10.1007/3-540-27658-0_7; Berry DJ, 2014, CLIN ORTHOP RELAT R, V472, P3659, DOI 10.1007/s11999-014-3610-1; Charlebois SJ, 2003, BIOMATERIALS, V24, P291, DOI 10.1016/S0142-9612(02)00317-4; Goldman M, 1997, J BIOMED MATER RES, V37, P43, DOI 10.1002/(SICI)1097-4636(199710)37:1<43::AID-JBM6>3.0.CO;2-J; Gomoll A, 2002, J ORTHOPAED RES, V20, P1152, DOI 10.1016/S0736-0266(02)00073-6; Kurtz SM, 1999, BIOMATERIALS, V20, P1449, DOI 10.1016/S0142-9612(99)00038-1; Lee KY, 1997, WEAR, V203, P375, DOI 10.1016/S0043-1648(96)07370-X; Li M.G., 2006, 52 ANN M ORTH RES SO; MAXFIELD J, 1978, J POLYM SCI POL PHYS, V16, P37, DOI 10.1002/pol.1978.180160104; McKellop H, 2000, J BONE JOINT SURG AM, V82A, P1708; Mendenhall Associates Inc, 2011, ORTHOP NETW NEWS, V22, P9; Muratoglu OK, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P197, DOI 10.1016/B978-0-12-374721-1.00013-4; Peacock A.J., 2000, HDB POLYETHYLENE STR, P241; Puppulin L, 2011, ACTA BIOMATER, V7, P1150, DOI 10.1016/j.actbio.2010.10.014; Sobieraj MC, 2005, BIOMATERIALS, V26, P6430, DOI 10.1016/j.biomaterials.2005.04.008; Song J, 1999, WEAR, V225, P716, DOI 10.1016/S0043-1648(99)00066-6; Takahashi Y, 2012, J MATER SCI-MATER M, V23, P591, DOI 10.1007/s10856-011-4502-5; Takahashi Y, 2014, J MECH BEHAV BIOMED, V31, P31, DOI 10.1016/j.jmbbm.2012.12.009; Takahashi Y, 2010, ACTA BIOMATER, V6, P3583, DOI 10.1016/j.actbio.2010.02.051	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	FEB	2015	42						43	53		10.1016/j.jmbbm.2014.11.002		11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CA2PA	WOS:000348748800006		
J	Yoshida, S; Takahata, Y; Horiuchi, S; Yamamoto, M				Yoshida, Shuhei; Takahata, Yosuke; Horiuchi, Shuma; Yamamoto, Manabu			Diffraction model of peristrophic multiplexing with spherical reference wave	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND VISION			English	Article							HOLOGRAPHIC DATA-STORAGE; OPTICAL-DATA STORAGE; REFERENCE-PATTERN; EFFICIENCY; NOISE	Multiplexing recording is a primary contributor to determining the recording density in holographic data storage. Therefore, many different kinds of recording methods have been proposed. Among them, the method that utilizes spherical waves as reference waves is characterized by the ability to enable multiplexing recording only by moving (shifting or rotating) the recording medium. In our research, we propose a theoretical diffraction model of peristrophic multiplexing with a spherical reference wave and evaluate the diffraction efficiency; this multiplexing recording method has incorporated spherical reference waves in rotation of the media. Additionally, we verify the effectiveness of the model by comparing it with experimental results. (C) 2015 Optical Society of America	[Yoshida, Shuhei; Takahata, Yosuke; Horiuchi, Shuma; Yamamoto, Manabu] Tokyo Univ Sci, Dept Appl Elect, Katsushika Ku, Tokyo 1258585, Japan	Yoshida, S (reprint author), Tokyo Univ Sci, Dept Appl Elect, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	syoshida@rs.tus.ac.jp					Momose K, 2012, OPT LETT, V37, P2250, DOI 10.1364/OL.37.002250; Psaltis D, 1998, COMPUTER, V31, P52, DOI 10.1109/2.652917; Anderson K, 2004, OPT LETT, V29, P1402, DOI 10.1364/OL.29.001402; PSALTIS D, 1995, OPT LETT, V20, P782; Ushiyama Z, 2014, APPL SCI-BASEL, V4, P148, DOI 10.3390/app4020148; MOK FH, 1993, OPT LETT, V18, P915, DOI 10.1364/OL.18.000915; HEANUE JF, 1994, OPT LETT, V19, P1079, DOI 10.1364/OL.19.001079; UCHIDA N, 1973, J OPT SOC AM, V63, P280, DOI 10.1364/JOSA.63.000280; Tanaka K, 2007, OPT EXPRESS, V15, P16196, DOI 10.1364/OE.15.016196; CURTIS K, 1994, OPT LETT, V19, P993, DOI 10.1364/OL.19.000993; Kang YH, 1998, APPL OPTICS, V37, P6969, DOI 10.1364/AO.37.006969; Li JH, 2012, OPT LETT, V37, P936, DOI 10.1364/OL.37.000936; DENZ C, 1991, OPT COMMUN, V85, P171, DOI 10.1016/0030-4018(91)90389-U; RAKULJIC GA, 1992, OPT LETT, V17, P1471, DOI 10.1364/OL.17.001471; Barbastathis G, 1996, APPL OPTICS, V35, P2403, DOI 10.1364/AO.35.002403; Nobukawa T, 2014, APPL OPTICS, V53, P3773, DOI 10.1364/AO.53.003773; YIN S, 1993, OPT COMMUN, V101, P317, DOI 10.1016/0030-4018(93)90721-G; Born M., 1999, PRINCIPLES OPTICS, V7th, P695; CAMPBELL S, 1994, OPT LETT, V19, P2161, DOI 10.1364/OL.19.002161; Coufal H. J., 2000, HOLOGRAPHIC DATA STO; Curtis K., 2010, HOLOGRAPHIC DATA STO; Fukumoto A, 2008, OPT PHOTONICS NEWS, V19, P28, DOI 10.1364/OPN.19.11.000028; Liu JP, 2011, J OPT SOC AM A, V28, P229, DOI 10.1364/JOSAA.28.000229; Takabayashi M, 2014, APPL OPTICS, V53, P4375, DOI 10.1364/AO.53.004375; Yoshida S, 2013, IEICE T ELECTRON, VE96C, P1520, DOI 10.1587/transele.E96.C.1520; Yoshida S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.09LD07; Yoshida S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.03A027	27	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1084-7529	1520-8532		J OPT SOC AM A	J. Opt. Soc. Am. A-Opt. Image Sci. Vis.	FEB	2015	32	2					224	227		10.1364/JOSAA.32.000224		4	Optics	Optics	CB0AN	WOS:000349287200007		
J	Suda, K; Mitsudomi, T				Suda, Kenichi; Mitsudomi, Tetsuya			Racial Differences in Lung Cancer Genetics	JOURNAL OF THORACIC ONCOLOGY			English	Editorial Material							EGFR MUTATIONS; GEFITINIB; ADENOCARCINOMA; FREQUENCY		[Suda, Kenichi; Mitsudomi, Tetsuya] Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka 5898511, Japan	Mitsudomi, T (reprint author), Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, 377-2 Ohno Higashi, Osaka 5898511, Japan.	mitsudom@surg.med.kindai.ac.jp					Leidner RS, 2009, J CLIN ONCOL, V27, P5620, DOI 10.1200/JCO.2009.23.1431; Cote ML, 2011, J THORAC ONCOL, V6, P627, DOI 10.1097/JTO.0b013e31820a0ec0; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Bauml J, 2013, LUNG CANCER, V81, P347, DOI 10.1016/j.lungcan.2013.05.011; Tsao AS, 2006, J THORAC ONCOL, V1, P231; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Bollig-Fischer A, 2014, J THORAC ONCOL, V10, P245; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; El-Telbany Ahmed, 2012, Genes Cancer, V3, P467, DOI 10.1177/1947601912465177; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033	14	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	FEB	2015	10	2					230	231		10.1097/JTO.0000000000000439		2	Oncology; Respiratory System	Oncology; Respiratory System	CA3TM	WOS:000348829400006		
J	Okamoto, I; Miyazaki, M; Takeda, M; Terashima, M; Azuma, K; Hayashi, H; Kaneda, H; Kurata, T; Tsurutani, J; Seto, T; Hirai, F; Konishi, K; Sarashina, A; Yagi, N; Kaiser, R; Nakagawa, K				Okamoto, Isamu; Miyazaki, Masaki; Takeda, Masayuki; Terashima, Masaaki; Azuma, Koichi; Hayashi, Hidetoshi; Kaneda, Hiroyasu; Kurata, Takayasu; Tsurutani, Junji; Seto, Takashi; Hirai, Fumihiko; Konishi, Koichi; Sarashina, Akiko; Yagi, Nobutaka; Kaiser, Rolf; Nakagawa, Kazuhiko			Tolerability of Nintedanib (BIBF 1120) in Combination with Docetaxel: A Phase 1 Study in Japanese Patients with Previously Treated Non-Small-Cell Lung Cancer	JOURNAL OF THORACIC ONCOLOGY			English	Article						Clinical trials; Phase I; Docetaxel; Japanese; Nintedanib; Non-small-cell lung cancer; Pharmacokinetics	TRIPLE ANGIOKINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; ADVANCED SOLID TUMORS; 1ST-LINE TREATMENT; CONTROLLED-TRIAL; GROWTH-FACTOR; DOUBLE-BLIND; OPEN-LABEL; ANGIOGENESIS; CARBOPLATIN	Background: This phase I, open-label study evaluated the safety/tolerability and maximum tolerated dose of second-line nintedanib combined with docetaxel in Japanese patients with advanced non-small-cell lung cancer. Methods: Eligible patients received docetaxel 60 or 75 mg/m(2) (day 1) plus nintedanib 100, 150, or 200 mg twice daily (bid; days 2-21) in 21-day cycles. Standard 3 + 3 dose escalations were performed separately in patient cohorts with a body surface area (BSA) of less than 1.5 m(2) (BSA < 1.5) and BSA greater than or equal to 1.5, respectively. Results: Forty-two patients (17 BSA < 1.5, 25 BSA >= 1.5) were treated. The maximum tolerated dose of nintedanib was 150 and 200 mg bid in patients with BSA less than 1.5 and BSA greater than or equal to 1.5 (BSA >= 1.5), respectively, in combination with 75 mg/m(2) of docetaxel. Dose-limiting toxicities (all grade 3 hepatic enzyme elevations) occurred in 12 patients (six per cohort). Drug-related adverse events included neutropenia (95%), leukopenia (83%), fatigue (76%), alopecia (71%), decreased appetite (67%), and elevations in alanine aminotransferase (64%) and aspartate aminotransferase (64%). All hepatic enzyme elevations were reversible and manageable with dose reduction or discontinuation. Among 38 evaluable patients, 10 (26%) had a partial response and 18 (47%) had stable disease. Conclusion: Continuous treatment with second-line nintedanib combined with docetaxel was manageable and showed promising signs of efficacy in Japanese patients with advanced non-small-cell lung cancer.	[Okamoto, Isamu; Miyazaki, Masaki; Takeda, Masayuki; Terashima, Masaaki; Azuma, Koichi; Hayashi, Hidetoshi; Kaneda, Hiroyasu; Kurata, Takayasu; Tsurutani, Junji; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan; [Okamoto, Isamu] Kyusyu Univ Hosp, Ctr Clin & Translat Res, Fac Med, Fukuoka, Japan; [Miyazaki, Masaki] Suita Municipal Hosp, Dept Internal Med, Osaka, Japan; [Terashima, Masaaki] Kinki Univ, Fac Med, Nara Hosp, Dept Med Oncol, Nara, Japan; [Azuma, Koichi] Kurume Univ Hosp, Dept Med, Div Respirol Neurol & Rheumatol, Fukuoka, Japan; [Hayashi, Hidetoshi] Kishiwada Municipal Hosp, Dept Med Oncol, Osaka, Japan; [Kurata, Takayasu] Kansai Med Univ, Hirakata Hosp, Dept Thorac Oncol, Osaka, Japan; [Seto, Takashi; Hirai, Fumihiko; Konishi, Koichi; Yagi, Nobutaka] Kyushu Natl Canc Ctr, Dept Med Oncol, Fukuoka, Japan; [Sarashina, Akiko] Nippon Boehringer Ingelheim Co Ltd, Med Dev Div, Kawanishi, Hyogo, Japan; [Kaiser, Rolf] Boehringer Ingelheim Pharma GmbH & Co KG, Clin Pharmacokinet Pharmacodynam Dept, Biberach, Germany	Okamoto, I (reprint author), Kyushu Univ Hosp, Ctr Clin & Translat Res, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	okamotoi@kokyu.med.kyushu-u.ac.jp			Boehringer Ingelheim	The authors were fully responsible for all content and editorial decisions, were involved at all stages of manuscript development, and have approved the final version. Medical writing assistance, supported financially by Boehringer Ingelheim, was provided by Duncan Campbell of GeoMed during the preparation of this manuscript.	Huillard O, 2013, BRIT J CANCER, V108, P1034, DOI 10.1038/bjc.2013.58; Ledermann JA, 2011, J CLIN ONCOL, V29, P3798, DOI 10.1200/JCO.2010.33.5208; Okamoto I, 2010, MOL CANCER THER, V9, P2825, DOI 10.1158/1535-7163.MCT-10-0379; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Amini A, 2012, CURR CANCER DRUG TAR, V12, P23; Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185; Reck M, 2011, ANN ONCOL, V22, P1374, DOI 10.1093/annonc/mdq618; Gandara DR, 2009, J CLIN ONCOL, V27, P3540, DOI 10.1200/JCO.2008.20.8793; Mross K, 2010, CLIN CANCER RES, V16, P311, DOI 10.1158/1078-0432.CCR-09-0694; Makrilia N, 2009, EUR J INTERN MED, V20, P663, DOI 10.1016/j.ejim.2009.07.009; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; Ellis PM, 2010, CLIN CANCER RES, V16, P2881, DOI 10.1158/1078-0432.CCR-09-2944; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Doebele RC, 2012, ANN ONCOL, V23, P2094, DOI 10.1093/annonc/mdr596; Bousquet G, 2011, BRIT J CANCER, V105, P1640, DOI 10.1038/bjc.2011.440; Boehm S, 2010, GERONTOLOGY, V56, P303, DOI 10.1159/000262450; National Comprehensive Cancer Network Inc, NCCN CLIN PRACT GUID; Park SJ, 2007, ACTA HAEMATOL-BASEL, V118, P219, DOI 10.1159/000111777; Raica M, 2010, PHARMACEUTICALS, V3, P572; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Sakai M, 2009, INT J HEMATOL, V89, P319, DOI 10.1007/s12185-009-0263-z; sanofi-aventis U.S. LLC, 2013, TAXOTERE PACK INS; Saylor PJ, 2012, CLIN GENITOURIN CANC, V10, P77, DOI 10.1016/j.clgc.2012.01.010; van der Veldt AAM, 2008, BRIT J CANCER, V99, P259, DOI 10.1038/sj.bjc.6604456	26	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	FEB	2015	10	2					346	352		10.1097/JTO.0000000000000395		7	Oncology; Respiratory System	Oncology; Respiratory System	CA3TM	WOS:000348829400021		
J	Akai, A; Watanabe, Y; Hoshina, K; Obitsu, Y; Deguchi, J; Sato, O; Shigematsu, K; Miyata, T				Akai, Atsushi; Watanabe, Yoshiko; Hoshina, Katsuyuki; Obitsu, Yukio; Deguchi, Juno; Sato, Osamu; Shigematsu, Kunihiro; Miyata, Tetsuro			Family history of aortic aneurysm is an independent risk factor for more rapid growth of small abdominal aortic aneurysms in Japan	JOURNAL OF VASCULAR SURGERY			English	Article							SURVEILLANCE; EXPANSION; SIBLINGS; SMOKING	Objective: We aimed to investigate risk factors associated with more rapid growth of abdominal aortic aneurysms (AAA) < 50 mm (small AAAs) in Japan. Methods: We retrospectively investigated the clinical data of 374 patients with small AAAs (maximum diameter, <= 50 mm) who were referred to The University of Tokyo Hospital, Tokyo Medical University Hospital, or Saitama Medical Center, between 1995 and 2008. Results: A total of 374 patients (321 men and 53 women) were followed up for a median of 66 months. The median diameter on initial examination was 40 mm, and the median growth rate of the AAAs was 2.1 mm/y. The growth rate of AAAs with an initial diameter >= 45 mm was significantly greater than those with an initial diameter <45 mm (3.3 mm/y vs 2.0 mm/y, respectively; P = .007). The growth rate of AAAs was significantly greater in patients with hypertension than in those without (2.3 mm/y vs 1.7 mm/y, respectively; P = .006) and in patients with a family history of aortic aneurysm than in those without (4.2 mm/y vs 2.0 mm/y, respectively; P = .009). Logistic regression analysis revealed that a large initial diameter and family history of aortic aneurysm were independent predictors of accelerated growth rate of small AAAs in Japan. Conclusions: In the present study, a large initial diameter and family history of aortic aneurysm were independent risk factors for more rapid growth of small AAAs. Although few studies have reported similar findings thus far, family history of aortic aneurysm should be carefully considered during follow-up of patients with small AAAs.	[Akai, Atsushi] Asahi Gen Hosp, Dept Surg, Asahi, Chiba 2892511, Japan; [Watanabe, Yoshiko] Kawasaki Med Univ, Dept Physiol 1, Okayama, Japan; [Hoshina, Katsuyuki] Univ Tokyo, Grad Sch Med, Dept Surg, Div Vasc Surg, Tokyo, Japan; [Obitsu, Yukio] Int Univ Hlth & Welf, Mita Hosp, Dept Vasc Surg, Tokyo, Japan; [Deguchi, Juno; Sato, Osamu; Shigematsu, Kunihiro] Saitama Med Ctr, Dept Vasc Surg, Saitama, Japan; [Miyata, Tetsuro] Sanno Med Ctr, Dept Vasc Surg, Tokyo, Japan	Akai, A (reprint author), Asahi Gen Hosp, 1326 I, Asahi, Chiba 2892511, Japan.	atsuakai@gmail.com					ADAMSON J, 1992, BRIT J SURG, V79, P897, DOI 10.1002/bjs.1800790914; Brown LC, 1999, ANN SURG, V230, P289; Brady AR, 2002, NEW ENGL J MED, V346, P1445; Lindholt JS, 2001, EUR J VASC ENDOVASC, V21, P51, DOI 10.1053/ejvs.2000.1262; MACSWEENEY STR, 1994, LANCET, V344, P651, DOI 10.1016/S0140-6736(94)92087-7; Chang JB, 1997, SURGERY, V121, P117, DOI 10.1016/S0039-6060(97)90279-8; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; CLIFTON MA, 1977, BRIT J SURG, V64, P765, DOI 10.1002/bjs.1800641102; Frydman G, 2003, EUR J VASC ENDOVASC, V26, P396, DOI 10.1016/S1078-5884(03)00316-2; Larsson E, 2009, J VASC SURG, V49, P47, DOI 10.1016/j.jvs.2008.08.012; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Mofidi R, 2007, BRIT J SURG, V94, P310, DOI 10.1002/bjs.5573; Ogata T, 2005, J VASC SURG, V42, P891, DOI 10.1016/j.jvs.2005.08.002; Solberg S, 2005, EUR J VASC ENDOVASC, V29, P145, DOI 10.1016/j.ejvs.2004.11.015; Powell JT, 1998, LANCET, V352, P1649	15	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	FEB	2015	61	2					287	290		10.1016/j.jvs.2014.07.007		4	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	AZ8YO	WOS:000348497800001		
J	Sueyoshi, E; Nagayama, H; Sakamoto, I; Uetani, M				Sueyoshi, Eijun; Nagayama, Hiroki; Sakamoto, Ichiro; Uetani, Masataka			Carbon dioxide digital subtraction angiography as an option for detection of endoleaks in endovascular abdominal aortic aneurysm repair procedure	JOURNAL OF VASCULAR SURGERY			English	Article							CONTRAST; OUTCOMES; RISK	Objective: The purpose of this study was to evaluate carbon dioxide digital subtraction angiography (CO2-DSA) as an option for the detection of endoleaks (ELs) in the endovascular abdominal aortic aneurysm repair (EVAR) procedure. Methods: Forty patients with abdominal aortic aneurysm who were scheduled to undergo EVAR were enrolled in the study. There were 35 men and five women (mean age, 77.9 years). All patients had both iodinated contrast conventional DSA (C-DSA) and CO2-DSA immediately after EVAR. The sensitivity and specificity were calculated for the ability of CO2-DSA to detect ELs. We also correlated with computed tomography findings 6 months after EVAR. Results: C-DSA showed that 27 of the 40 patients (68%) had 28 ELs (type I, four; type II, 20; type III, three; type IV, one). CO2-DSA showed that 16 of the 40 patients (40%) had 17 ELs (type I, four; type II, 10; type III, three; type IV, none). For the prediction of direct ELs (type I and type III) with use of C-DSA as the criterion standard, CO2-DSA has a sensitivity of 1.0 and a specificity of 1.0. For the detection of persistent type II ELs (n = 11) with use of computed tomography findings 6 months from EVAR as the criterion standard, CO2-DSA has a sensitivity of 0.87 and a specificity of 0.97. C-DSA has a sensitivity of 0.82 and a specificity of 0.64. Conclusions: CO2-DSA is reliable for the detection of direct ELs and persistent type II ELs in EVAR. CO2-DSA can be an option to detect ELs in the EVAR procedure.	[Sueyoshi, Eijun; Nagayama, Hiroki; Sakamoto, Ichiro; Uetani, Masataka] Nagasaki Univ, Sch Med, Dept Radiol, Nagasaki 8528501, Japan	Sueyoshi, E (reprint author), Nagasaki Univ, Sch Med, Dept Radiol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sueyo@nagasaki-u.ac.jp					Sim J, 2005, PHYS THER, V85, P257; Jones JE, 2007, J VASC SURG, V46, P1, DOI 10.1016/j.jvs.2007.02.073; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Huang SG, 2013, ANN VASC SURG, V27, P38, DOI 10.1016/j.avsg.2012.10.001; Lee AD, 2010, VASC ENDOVASC SURG, V44, P341, DOI 10.1177/1538574410364252; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Hawkins IF, 2009, RADIOL CLIN N AM, V47, P813, DOI 10.1016/j.rcl.2009.07.002; Kessel DO, 2002, CARDIOVASC INTER RAD, V25, P476, DOI 10.1007/s00270-002-1925-x; Greenberg RK, 2004, J VASC SURG, V39, P1219, DOI 10.1016/j.jvs.2004.02.033; Chao A, 2007, J VASC SURG, V45, P451, DOI 10.1016/j.jvs.2006.11.017; Hawkins IF, 1998, EUR RADIOL, V8, P391, DOI 10.1007/s003300050400; Bush RL, 2002, ANN VASC SURG, V16, P537, DOI 10.1007/s10016-001-0273-7; Criado E, 2008, J VASC SURG, V48, P527, DOI 10.1016/j.jvs.2008.04.061; Gahlen J, 2001, J VASC SURG, V33, P646, DOI 10.1067/mva.2001.111746; Iezzi R, 2006, RADIOLOGY, V241, P915, DOI 10.1148/radiol.2413050959; Mustafa R, 2009, AM J ROENTGENOL, V192, pW178; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Patel Bhavik N, 2011, Curr Probl Diagn Radiol, V40, P208, DOI 10.1067/j.cpradiol.2011.01.002; Shaw DR, 2006, CARDIOVASC INTER RAD, V29, P323, DOI 10.1007/s00270-005-0092-2; Walker SR, 1998, J ENDOVASC SURG, V5, P318, DOI 10.1583/1074-6218(1998)005<0318:RCFERO>2.0.CO;2	20	2	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	FEB	2015	61	2					298	303		10.1016/j.jvs.2014.07.088		6	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	AZ8YO	WOS:000348497800003		
J	Takahashi, N; Shibata, R; Ouchi, N; Sugimoto, M; Murohara, T; Komori, K				Takahashi, Noriko; Shibata, Rei; Ouchi, Noriyuki; Sugimoto, Masayuki; Murohara, Toyoaki; Komori, Kimihiro			Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model	JOURNAL OF VASCULAR SURGERY			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; IN-VIVO; MYOCARDIAL-INFARCTION; TISSUE ISCHEMIA; HEART-FAILURE; ANGIOGENESIS; MORTALITY; HYPERTENSION	Objective: As first-line treatment for type 2 diabetes, metformin has gained a strong position. In addition, type 2 diabetics benefit from the fact that metformin is associated with a reduction in cardiovascular events. Nevertheless, there is a dearth of information concerning the functional role of metformin in regulating angiogenesis. Our present study explores whether metformin is involved in the modulation of the revascularization processes in vivo by employing a hindlimb mice model of ischemia-induced angiogenesis. Methods: For comparative purposes, randomly selected wild-type (WT) mice or endothelial nitric oxide synthase (eNOS) deficient mice were assigned to one of two groups. One group was orally administered a daily dose of metformin through a gastric tube whereas the other group served as a control with no metformin administered. Both groups were subjected to unilateral hindlimb ischemia. Laser Doppler analysis coupled with capillary density staining with CD31 was the method employed to determine revascularization. Adenosine monophosphate-activated protein kinase (AMPK) and eNOS phosphorylation levels were assessed using Western blot analysis. Results: Subsequent to hindlimb ischemic surgery, in comparison to the nontreated mice, metformin-treated WT mice showed accelerated limb perfusion, which was substantiated by laser Doppler blood-flow measurements and the presence of increased capillary density in the ischemic adductor muscle. Treatment with metformin significantly enhanced the increase in AMPK and eNOS phosphorylation levels of muscle tissues in WT mice induced by ischemia. In eNOS-deficient knockout mice, there was a significant increase in ischemic tissue AMPK phosphorylation induced by metformin; however, blood flow recovery in ischemic limb after surgery was unaffected. Conclusions: Metformin promoted revascularization in the presence of tissue ischemia through an AMPK/eNOS-related mechanism. Our study indicates that, in addition to its glucose-lowering effect, metformin fosters improved revascularization, which is responsible for its positive effect on patients with critical limb ischemia.	[Takahashi, Noriko; Sugimoto, Masayuki; Komori, Kimihiro] Nagoya Univ, Grad Sch Med, Dept Vasc Surg, Nagoya, Aichi 4668550, Japan; [Shibata, Rei; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan	Komori, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Vasc Surg, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	komori@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014		Japan Society for the Promotion of Science	This work was supported in part by Grant-in-Aid for Scientific Research B (K. Komori) from Japan Society for the Promotion of Science.	Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Johnson JA, 2002, DIABETES CARE, V25, P2244, DOI 10.2337/diacare.25.12.2244; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267; Sata M, 2004, HYPERTENSION, V43, P1214, DOI 10.1161/01.HYP.0000126186.29571.41; Detaille D, 2005, DIABETES, V54, P2179, DOI 10.2337/diabetes.54.7.2179; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Esfahanian N, 2012, MOL MED REP, V5, P1068, DOI 10.3892/mmr.2012.753; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Schramm TK, 2011, EUR HEART J, V32, P1900, DOI 10.1093/eurheartj/ehr077; Yilmaz MB, 2003, INT J OBESITY, V27, P1541, DOI 10.1038/sj.ijo.0802474; Maruyama S, 2012, J BIOL CHEM, V287, P408, DOI 10.1074/jbc.M111.261818; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Teng RJ, 2013, AM J PHYSIOL-LUNG C, V304, pL29, DOI 10.1152/ajplung.00200.2012; Azuma N, 2012, EUR J VASC ENDOVASC, V43, P322, DOI 10.1016/j.ejvs.2011.12.001; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; SIRTORI CR, 1984, J CARDIOVASC PHARM, V6, P914, DOI 10.1097/00005344-198409000-00027; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Eurich DT, 2005, DIABETES CARE, V28, P2345, DOI 10.2337/diacare.28.10.2345; Roussel R, 2010, ARCH INTERN MED, V170, P1892, DOI 10.1001/archinternmed.2010.409; Burla AK, 2013, INT J CARDIOL, V165, P483, DOI 10.1016/j.ijcard.2011.09.012; De Vivo Salvatore, 2005, Vasc Endovascular Surg, V39, P519, DOI 10.1177/153857440503900609; Eriksson A, 2007, DIABETES OBES METAB, V9, P483, DOI 10.1111/j.1463-1326.2006.00624.x; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; KUDO N, 1995, J BIOL CHEM, V270, P17513; Kwan HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053597; LANDIN K, 1994, THROMB HAEMOSTASIS, V71, P783; MONTANARI G, 1992, PHARMACOL RES, V25, P63, DOI 10.1016/S1043-6618(05)80065-9; Turner RC, 1998, LANCET, V352, P854; Wiernsperger NF, 2003, DIABETES METAB, V29, pS77	40	3	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	FEB	2015	61	2					489	496		10.1016/j.jvs.2013.09.061		8	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	AZ8YO	WOS:000348497800032		
J	Kato, M; Kagaya, H; Kubo, Y; Banno, H; Ohkubo, N				Kato, Masaaki; Kagaya, Hideo; Kubo, Yoji; Banno, Hiroshi; Ohkubo, Nobukazu			Real chimney technique for total debranching of supra-aortic trunks	JOURNAL OF VASCULAR SURGERY			English	Article							THORACIC ENDOVASCULAR REPAIR; ARCH; DISEASE	Side-clamping of the ascending aorta is an indispensable technique for proximal anastomosis in total debranching of supra-aortic trunks and in endovascular aneurysm repair for arch aneurysm. However, this procedure may lead to the dislodging of multiple plaques and to clamp injury of the ascending aorta. We developed a clampless technique to achieve proximal anastomosis between the ascending aorta and an artificial graft used for total debranching of supra-aortic trunks. We applied this method in six patients with arch aneurysm and a plaque-rich ascending aorta and were able to achieve total debranching of the supra-aortic trunks in all of the patients without side-clamping the ascending aorta and no procedurally related complications. This clampless anastomosis technique ("real chimney technique") in the ascending aorta is a valuable option for total debranching of supra-aortic trunks in the hybrid repair of arch aneurysms.	[Kato, Masaaki; Kagaya, Hideo; Kubo, Yoji; Banno, Hiroshi; Ohkubo, Nobukazu] Morinomiya Hosp, Dept Cardiovasc Surg, Osaka 5360025, Japan	Kato, M (reprint author), Morinomiya Hosp, Dept Cardiovasc Surg, Joutou Ku, 2-1-88 Morinomiya, Osaka 5360025, Japan.	mkat03@gmail.com			Medtronic Inc; Japan Lifeline Co, Ltd; Japan Gore Inc; Junken Medical Co, Ltd; Cook Japan Inc	M.K. has received grants from Medtronic Inc and Japan Lifeline Co, Ltd and personal fees from Japan Gore Inc, Junken Medical Co, Ltd, and Cook Japan Inc for work outside the submitted work. H.K., Y.K., H.B., and N.O. have received grants from Medtronic Inc and Japan Lifeline Co, Ltd.	Cochennec F, 2013, J VASC SURG, V57, P1560, DOI 10.1016/j.jvs.2012.11.081; De Rango P, 2014, J VASC SURG, V59, P107, DOI 10.1016/j.jvs.2013.07.010; Canaud L, 2010, J THORAC CARDIOV SUR, V140, P52, DOI 10.1016/j.jtcvs.2009.09.022; Ferrero E, 2012, EUR J CARDIO-THORAC, V41, P177, DOI 10.1016/j.ejcts.2011.05.058; Kouchoukos NT, 2010, J THORAC CARDIOV SUR, V140, pS150, DOI 10.1016/j.jtcvs.2010.07.035; Luehr M, 2013, EUR J CARDIO-THORAC, V44, P958, DOI 10.1093/ejcts/ezt180; Moulakakis Konstantinos G, 2013, Ann Cardiothorac Surg, V2, P247, DOI 10.3978/j.issn.2225-319X.2013.05.06; Okita Yutaka, 2013, Ann Cardiothorac Surg, V2, P367, DOI 10.3978/j.issn.2225-319X.2013.05.15; Shirakawa Y, 2014, EUR J CARDIO-THORAC, V45, P298, DOI 10.1093/ejcts/ezt391; Shrestha M, 2014, EUR J CARDIO-THORAC, V45, P289, DOI 10.1093/ejcts/ezt359	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	FEB	2015	61	2					542	545		10.1016/j.jvs.2014.08.066		4	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	AZ8YO	WOS:000348497800042		
J	Seto, T; Matsuda, N; Okahisa, Y; Kaji, K				Seto, Takayuki; Matsuda, Naoko; Okahisa, Yuji; Kaji, Koichi			Effects of Population Density and Snow Depth on the Winter Diet Composition of Sika Deer	JOURNAL OF WILDLIFE MANAGEMENT			English	Article						Cervus nippon; density dependent; diet composition; food availability; Japan; long-term monitoring; rumen contents; sika deer; snow depth; wintering ranges	WHITE-TAILED DEER; ODOCOILEUS-VIRGINIANUS; CHEMICAL-COMPOSITION; NORTHERN JAPAN; BODY CONDITION; CERVUS-NIPPON; FOOD-HABITS; RED DEER; MANAGEMENT; HOKKAIDO	The understanding of population density and weather effects is fundamental for evaluating the population dynamics of ungulates. However, studies focusing on temporal variations in diet composition are limited. We investigated the effects of population density and snow depth on variation in the winter diet composition of 2 contrasting sika deer (Cervus nippon) populations in Oku-Nikko and Ashio, Tochigi Prefecture, central Japan by monitoring diet composition for 15 years. The main food in Oku-Nikko was dwarf bamboo (Sasa nipponica), which has a high crude protein content. This plant sometimes had low availability because of the combination of snow accumulation and reduced culm height associated with chronic grazing. The main food in Ashio was Japanese pampas grass (Miscanthus sinensis), which has a low crude protein content, but its availability was high because of high culm height and little snow accumulation. In Oku-Nikko, snow accumulation and high deer density negatively affected the proportion of dwarf bamboo found in rumen contents, with the most significant effect found in calves. In Ashio, Japanese pampas grass composed a relatively high and constant proportion of the rumen contents when snow accumulation was 50cm; however, it was negatively affected by snow accumulation of >50cm. In addition, the utilization of Japanese pampas grass was reduced only when deer density was extremely high (>150deer/km(2)). Our results clearly demonstrate that absolute density is not the sole factor that affects variation in the winter food selection of sika deer. The combined effects of snow depth and habitat quality, such as vegetation height, are overwhelmingly important in determining the winter diet composition of sika deer populations. (c) 2015 The Wildlife Society.	[Seto, Takayuki; Okahisa, Yuji; Kaji, Koichi] Tokyo Univ Agr & Technol, Lab Wildlife Management, Fuchu, Tokyo 1838509, Japan; [Matsuda, Naoko] Tochigi Prefectural Govt, Environm & Forests Sect, Utsunomiya, Tochigi 3208501, Japan	Seto, T (reprint author), Tokyo Univ Agr & Technol, Lab Wildlife Management, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	seto.takayuki@gmail.com			JSPS KAKENHI [20310142, 25292085]; technology development project controlling forest damage by wildlife, the Forestry Agency; leader training programs of practical research, Ministry of Education Culture, Sports, Science and Technology in Japan; Environment Research and Technology Development and Fund of the Ministry of the Environment, Japan [4-1407]	We thank Y. Yano, Y. Takahashi, K. Niibe, T. Maruyama, and R. Kinomoto of the Tochigi Prefectural Government and the members of the Laboratory of Wildlife Management, Utsunomiya University for their support in long-term sika deer monitoring. We acknowledge the staff of the Ashio, Imaichi, and Nikko branches of the hunting club in Tochigi Prefecture for the capture of sika deer. We also thank the Oku-Nikko District Forest Office of the Forestry Agency and the Nikko Futarasan shrine for permission to survey forest vegetation. We are grateful to the Asian Black Bear Research Group in the Tokyo University of Agriculture and Technology for allowing us to use their accommodations during the field study. We thank Enago (www.enago.jp) for the English language review. This work was partly supported by JSPS KAKENHI (Grant Number 20310142 and 25292085); the technology development project controlling forest damage by wildlife, the Forestry Agency; leader training programs of practical research, Ministry of Education Culture, Sports, Science and Technology in Japan; the Environment Research and Technology Development and Fund (4-1407) of the Ministry of the Environment, Japan.	Aldous Shaler E., 1944, JOUR MAMMAL, V25, P130, DOI 10.2307/1375010; KOIKE H, 1985, J ARCHAEOL SCI, V12, P443, DOI 10.1016/0305-4403(85)90004-4; Kaji Koichi, 2009, P421, DOI 10.1007/978-4-431-09429-6_30; Kaji K, 2004, J WILDLIFE MANAGE, V68, P889, DOI 10.2193/0022-541X(2004)068[0889:IOACSD]2.0.CO;2; SHOJI S, 1990, SOIL SCI PLANT NUTR, V36, P105; KAJI K, 1988, ACTA THERIOL, V33, P187; Jacobson AR, 2004, ECOLOGY, V85, P1598, DOI 10.1890/02-0753; Williams CE, 2000, BIOL CONSERV, V92, P207, DOI 10.1016/S0006-3207(99)00054-3; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; ANDERSON RC, 1994, ECOL APPL, V4, P104, DOI 10.2307/1942119; Mysterud A, 2006, WILDLIFE BIOL, V12, P129, DOI 10.2981/0909-6396(2006)12[129:TCOOAI]2.0.CO;2; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; BARTMANN RM, 1984, J WILDLIFE MANAGE, V48, P262, DOI 10.2307/3808485; Burnham K. P., 2002, MODEL SELECTION MULT; CHAMRAD ALBERT D., 1964, J WILDL MAGMT, V28, P473, DOI 10.2307/3798199; Cicognani Luciano, 2000, Hystrix, V11, P121; Clary WP, 2000, J RANGE MANAGE, V53, P562, DOI 10.2307/4003148; Clutton-Brock T. H., 1989, RED DEER HIGHLANDS; Cornett MW, 2000, BIOL CONSERV, V93, P359, DOI 10.1016/S0006-3207(99)00129-9; Delgiudice GD, 2001, WILDLIFE MONOGR, P1; Forsyth DM, 2006, ECOLOGY, V87, P297, DOI 10.1890/05-0709; Garroway CJ, 2005, CAN J ZOOL, V83, P1246, DOI 10.1139/Z05-118; Heggberget Thrine Moen, 2002, Rangifer, V22, P13; HOBBS NT, 1981, J WILDLIFE MANAGE, V45, P156, DOI 10.2307/3807884; Holand Oystein, 1992, P423; Ichimura Y, 2004, ECOL RES, V19, P389, DOI 10.1111/j.1440-1703.2004.00649.x; ILLIUS AW, 1990, J ANIM ECOL, V59, P89, DOI 10.2307/5160; Japan Meteorological Agency, 2002, MESH CLIM DAT JAP 19; Japan Meteorological Agency, 2014, WEATH STAT INF; Kanzaki N., 1998, WILDLIFE CONSERVATIO, V3, P107; KLEIN DAVID R., 1960, JOUR WILDLIFE MANAGEMENT, V24, P80, DOI 10.2307/3797359; Koganezawa M, 1999, BIOSPHERE CONSERVATI, V2, P35; Kubo MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090745; Li Y., 2001, BIOSPHERE CONSERVATI, V3, P55; Li Y., 1996, WILDLIFE CONSERVATIO, V2, P23; Li Yu-Chun, 2006, Acta Zoologica Sinica, V52, P235; Maruyama N., 1985, DYNAMICS LARGER MAMM, P248; MARUYAMA N, 1983, Japanese Journal of Ecology, V33, P243; MARUYAMA N, 1983, Journal of the Mammalogical Society of Japan, V9, P274; Maruyama T., 2005, WILDLIFE RES B TOCHI, V31, P13; MCCULLOUGH DR, 1985, J MAMMAL, V66, P682, DOI 10.2307/1380794; Ministry of the Environment, 2012, REP CONTR VEG DAM SI; National Agriculture and Food Research Organization, 2001, STAND TABL FEED COMP; Parker KL, 1999, WILDLIFE MONOGR, P5; Portier C, 1998, J ZOOL, V245, P271, DOI 10.1111/j.1469-7998.1998.tb00101.x; SCOTTER GW, 1980, J RANGE MANAGE, V33, P16, DOI 10.2307/3898221; SKOGLAND T, 1985, J ANIM ECOL, V54, P359, DOI 10.2307/4484; Solberg EJ, 2001, ECOGRAPHY, V24, P441, DOI 10.1034/j.1600-0587.2001.d01-200.x; Takatsuki Seiki, 2009, P231, DOI 10.1007/978-4-431-09429-6_17; TAKATSUKI S, 1983, Japanese Journal of Ecology, V33, P17; Takatsuki Seiki, 2007, Mammal Study, V32, P115, DOI 10.3106/1348-6160(2007)32[115:MVIWFC]2.0.CO;2; Takatsuki S, 1986, MEMOIRS TOCHIGI PREF, V4, P15; TAKATSUKI S, 1994, ECOL RES, V9, P215, DOI 10.1007/BF02347497; TAKATSUKI S, 1993, ECOL RES, V8, P57, DOI 10.1007/BF02348607; Tochigi Prefectural Government, 2011, MON REP SIK DEER MAN; Tsujioka M., 1999, CAN WE PROTECT FORES; Uno H., 1998, MAMMALIAN SCI, V38, P233; Verheyden H, 2006, MAMMAL REV, V36, P217, DOI 10.1111/j.1365-2907.2006.00085.x; Yokoyama M, 2000, ECOL RES, V15, P345, DOI 10.1046/j.1440-1703.2000.00355.x	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-541X	1937-2817		J WILDLIFE MANAGE	J. Wildl. Manage.	FEB	2015	79	2					243	253		10.1002/jwmg.830		11	Ecology; Zoology	Environmental Sciences & Ecology; Zoology	CA0YO	WOS:000348639700008		
J	Sano, M; Chin, T; Takahashi, T; Ohara, H; Aso, Y				Sano, Mei; Chin, Taejun; Takahashi, Tetsuya; Ohara, Hitomi; Aso, Yuji			A Simple TLC-Densitometric Method for the Quantification of Acrylic Acid in Aqueous Solutions	JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC			English	Article						Acrylic acid; Mizoroki-Heck coupling reaction; TLC quantification	CARBOXYLIC-ACIDS; MICROBIAL-CELLS; PALLADIUM; ARYL; ARYLATION; CATALYSTS; HALIDES	Because acrylic acid is a volatile organic compound, the precise quantification of acrylic acid by thin-layer chromatography (TLC) analysis is difficult. Herein, we report a simple TLC-densitometric method for the quantification of acrylic acid in aqueous solutions following a labeling procedure using the Mizoroki-Heck coupling reaction. To make acrylic acid nonvolatile and highly sensitive for ultraviolet (UV) detection, acrylic acid in an aqueous solution was reacted with iodobenzene in a dimethyl sulfoxide solution using a base (potassium carbonate) and a catalyst (FibreCat 1001), affording trans-cinnamic acid. High-performance liquid chromatography (HPLC) analysis showed that acrylic acid could be labeled over a range of 0.01-10 mM at 60 degrees C for 30 min and the average reaction yield was 96.0%. To quantify acrylic acid by TLC analysis, the reaction mixture was extracted using ethyl acetate and then spotted on a silica gel 60 F-254 TLC plate. The spots corresponding to the labeled acrylic acid over a range of 0.1-1 mM on the TLC plate could be quantified under UV light at 254 nm. The detection limit was 0.1 nmol on the TLC plate. To evaluate the method developed, the concentrations of acrylic acid in environmental water samples after the contamination of 1 mM acrylic acid were determined by the proposed method. Compared to the results of the HPLC analysis, accuracy was estimated to be above 97.0% for all the analytes. Thus, the proposed method could be applied for the determination of acrylic acid in the environmental water samples without any interference from environmental components.	[Sano, Mei; Chin, Taejun; Ohara, Hitomi; Aso, Yuji] Kyoto Inst Technol, Dept Biobased Mat Sci, Sakyo Ku, Kyoto 6068585, Japan; [Takahashi, Tetsuya] Shimane Univ, Fac Educ, Matsue, Shimane 6908504, Japan	Aso, Y (reprint author), Kyoto Inst Technol, Dept Biobased Mat Sci, Sakyo Ku, 1 Hashigami Cho, Kyoto 6068585, Japan.	aso@kit.ac.jp			Japan Society for the Promotion of Science	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Kim SM, 2012, GREEN CHEM, V14, P2996, DOI 10.1039/c2gc36203a; MIZOROKI T, 1971, B CHEM SOC JPN, V44, P581, DOI 10.1246/bcsj.44.581; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Fukuyama T, 2004, J ORG CHEM, V69, P8105, DOI 10.1021/jo049028+; VAIRAVAMURTHY A, 1990, ANAL CHIM ACTA, V237, P215, DOI 10.1016/S0003-2670(00)83920-3; HECK RF, 1972, J ORG CHEM, V37, P2320, DOI 10.1021/jo00979a024; BROWN L, 1979, ANALYST, V104, P1165, DOI 10.1039/an9790401165; Colacot TJ, 2002, ORGANOMETALLICS, V21, P3301, DOI 10.1021/om020352+; Freidig AP, 1999, ENVIRON SCI TECHNOL, V33, P3038, DOI 10.1021/es990251b; HUIJBERTS GNM, 1994, J BACTERIOL, V176, P1661; Ignatov OV, 1998, FEMS MICROBIOL LETT, V162, P105, DOI 10.1016/S0378-1097(98)00108-6; Ignatov OV, 1997, BIOSENS BIOELECTRON, V12, P105, DOI 10.1016/S0956-5663(97)87056-X; Zaitsu K., 1999, MODERN DERIVATIZATIO, P70; Zapf A, 2005, CHEM COMMUN, P431, DOI 10.1039/b410937f	15	1	1	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	0933-4173	1789-0993		JPC-J PLANAR CHROMAT	JPC-J. Planar Chromatogr.-Mod. TLC	FEB	2015	28	1					12	16		10.1556/JPC.28.2015.1.2		5	Chemistry, Analytical	Chemistry	CA9CP	WOS:000349218300003		
J	Mack, M; Yanagita, M				Mack, Matthias; Yanagita, Motoko			Origin of myofibroblasts and cellular events triggering fibrosis	KIDNEY INTERNATIONAL			English	Review						end-stage kidney disease; erythropoietin; fibroblast; fibrosis; kidney disease	PERIPHERAL-BLOOD FIBROCYTES; RENAL INTERSTITIAL FIBROSIS; INDUCED PULMONARY-FIBROSIS; TO-MESENCHYMAL TRANSITION; MARROW-DERIVED CELLS; SERUM AMYLOID-P; ERYTHROPOIETIN-PRODUCING CELLS; GROWTH-FACTOR-BETA; BONE-MARROW; KIDNEY FIBROSIS	Renal fibrosis is a major hallmark of chronic kidney disease that is considered to be a common end point of various types of renal disease. To date, the biological meaning of fibrosis during the progression of chronic kidney diseases is unknown and possibly depends on the cell type contributing to extracellular matrix production. During the past decade, the origin of myofibroblasts in the kidney has been intensively investigated. Determining the origins of renal myofibroblasts is important because these might account for the heterogeneous characteristics and behaviors of myofibroblasts. Current data strongly suggest that collagen-producing myofibroblasts in the kidney can be derived from various cellular sources. Resident renal fibroblasts and cells of hematopoietic origin migrating into the kidney seem to be the most important ancestors of myofibroblasts. It is likely that both cell types communicate with each other and also with other cell types in the kidney. In this review, we will discuss the current knowledge on the origin of scar-producing myofibroblasts and cellular events triggering fibrosis.	[Mack, Matthias] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto 6068501, Japan	Mack, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto 6068501, Japan.	Matthias.mack@ukr.de; motoy@kuhp.kyoto-u.ac.jp					Xia YF, 2013, HYPERTENSION, V62, P1129, DOI 10.1161/HYPERTENSIONAHA.113.01837; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Ishida Y, 2007, AM J PATHOL, V170, P843, DOI 10.2353/ajpath.2007.051213; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Eddy AA, 2012, PEDIATR NEPHROL, V27, P1233, DOI 10.1007/s00467-011-1938-2; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; LI B, 1991, J EXP MED, V174, P1259, DOI 10.1084/jem.174.5.1259; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Cochrane AL, 2005, J AM SOC NEPHROL, V16, P3623, DOI 10.1681/ASN.2004090771; Sakai N, 2008, J HYPERTENS, V26, P780, DOI 10.1097/HJH.0b013e3282f3e9e6; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011; Foster K, 2008, J IMMUNOL, V180, P3183; Jang HS, 2013, BBA-MOL BASIS DIS, V1832, P817, DOI 10.1016/j.bbadis.2013.02.016; CHEEVER AW, 1994, J IMMUNOL, V153, P753; Schrimpf C, 2012, J AM SOC NEPHROL, V23, P868, DOI 10.1681/ASN.2011080851; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Pilling D, 2007, J IMMUNOL, V179, P4035; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Souma T, 2013, J AM SOC NEPHROL, V24, P1599, DOI 10.1681/ASN.2013010030; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; Schnoor M, 2008, J IMMUNOL, V180, P5707; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Scholten D, 2011, AM J PATHOL, V179, P189, DOI 10.1016/j.ajpath.2011.03.049; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Reich B, 2013, KIDNEY INT, V84, P78, DOI 10.1038/ki.2013.84; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Pallone TL, 2001, EXP NEPHROL, V9, P165; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Campanholle G, 2013, AM J PHYSIOL-CELL PH, V304, pC591, DOI 10.1152/ajpcell.00414.2012; Boor P, 2012, NEPHROL DIAL TRANSPL, V27, P3027, DOI 10.1093/ndt/gfs296; Chesney J, 1998, J IMMUNOL, V160, P419; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Inoue T, 2005, KIDNEY INT, V67, P2488, DOI 10.1111/j.1523-1755.2005.00358.x; Abe R, 2001, J IMMUNOL, V166, P7556; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Chu PY, 2010, AM J PATHOL, V176, P1735, DOI 10.2353/ajpath.2010.090574; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Nakaya Y, 2013, CANCER LETT, V341, P9, DOI 10.1016/j.canlet.2013.02.037; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Le Hir M, 2005, HISTOCHEM CELL BIOL, V123, P335, DOI 10.1007/s00418-005-0788-z; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Pilling D, 2003, J IMMUNOL, V171, P5537; Schmidt M, 2003, J IMMUNOL, V171, P380; Crawford JR, 2012, J LEUKOCYTE BIOL, V92, P699, DOI 10.1189/jlb.0112033; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Hashimoto N, 2010, AM J RESP CELL MOL, V43, P161, DOI 10.1165/rcmb.2009-0031OC; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Le Douarin NM, 2004, MECH DEVELOP, V121, P1089, DOI 10.1016/j.mod.2004.06.003; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; BUCALA R, 1994, MOL MED, V1, P71; Picard N, 2008, HISTOCHEM CELL BIOL, V130, P141, DOI 10.1007/s00418-008-0433-8; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Chen G, 2011, J AM SOC NEPHROL, V22, P1876, DOI 10.1681/ASN.2010080881; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Choi YJ, 2000, HUM PATHOL, V31, P1491, DOI 10.1053/hupa.2000.20373; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; van Deventer HW, 2008, AM J PATHOL, V173, P253, DOI 10.2353/ajpath.2008.070732; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Yang J, 2013, J AM SOC NEPHROL, V24, P1644, DOI 10.1681/ASN.2013030217; Eyden B, 2001, ULTRASTRUCT PATHOL, V25, P39; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Eyden B, 2009, J CLIN PATHOL, V62, P236, DOI 10.1136/jcp.2008.061630; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; SERON D, 1990, NEPHROL DIAL TRANSPL, V5, P889; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Yang LJ, 2002, LAB INVEST, V82, P1183, DOI 10.1097/01.LAB.0000027841.50269.61; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; KOURY ST, 1989, BLOOD, V74, P645; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Muller SM, 2008, J IMMUNOL, V180, P5344; VAAGE J, 1990, J LEUKOCYTE BIOL, V48, P274; Liptak P, 2006, NAT CLIN PRACT NEPHR, V2, P398, DOI 10.1038/ncpneph0225; BERTRAND S, 1992, INT J DEV BIOL, V36, P179; Bohle A, 1996, KIDNEY BLOOD PRESS R, V19, P191, DOI 10.1159/000174072; Castano AP, 2009, SCI TRANSL MED, V1, p5ra13, DOI DOI 10.1126/SCITRANSLMED.3000111; Crawford JR, 2010, J IMMUNOL METHODS, V363, P9, DOI 10.1016/j.jim.2010.09.025; Cullen-McEwen LA, 2005, NEPHRON EXP NEPHROL, V99, pE1, DOI 10.1159/000081792; DiRocco DP, 2013, J AM SOC NEPHROL, V24, P1399, DOI 10.1681/ASN.2012050512; Fujigaki Y, 2005, VIRCHOWS ARCH, V446, P164, DOI 10.1007/s00428-004-1155-5; Gan Y, 2011, ARTHRITIS RHEUM-US, V63, P2484, DOI 10.1002/art.30386; Gomez-Skarmeta JL, 1999, MECH DEVELOP, V80, P15, DOI 10.1016/S0925-4773(98)00190-7; Grimm PC, 2001, NEW ENGL J MED, V345, P93, DOI 10.1056/NEJM200107123450203; Heglind M, 2005, MOL CELL BIOL, V25, P5616, DOI 10.1128/MCB.25.13.5616-5625.2005; HERMAN IM, 1985, J CELL BIOL, V101, P43, DOI 10.1083/jcb.101.1.43; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Kida Y, 2011, CLIN EXP PHARMACOL P, V38, P417, DOI 10.1111/j.1440-1681.2011.05531.x; Kida Y, 2007, ARCH HISTOL CYTOL, V70, P95, DOI 10.1679/aohc.70.95; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; LEDOUARI.NM, 1974, DEV BIOL, V41, P162, DOI 10.1016/0012-1606(74)90291-7; Li JH, 2007, STEM CELLS, V25, P697, DOI 10.1634/stemcells.2006-0133; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x; NAGLE RB, 1978, LAB INVEST, V38, P270; Norman JT, 2006, CLIN EXP PHARMACOL P, V33, P989, DOI 10.1111/j.1440-1681.2006.04476.x; Okon K, 2003, AM J NEPHROL, V23, P409, DOI 10.1159/000074298; Osterreicher CH, 2010, P NATL ACAD SCI USA, V108, P308; Pilling Darrell, 2012, Methods Mol Biol, V904, P191, DOI 10.1007/978-1-61779-943-3_16; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Prunotto M, 2012, J PATHOL, V228, P131, DOI 10.1002/path.4049; Roufosse C, 2006, J AM SOC NEPHROL, V17, P775, DOI 10.1681/ASN.2005080795; Rydell-Tormanen K, 2012, LAB INVEST, V92, P917, DOI 10.1038/labinvest.2012.57; SAINIO K, 1994, INT J DEV BIOL, V38, P77; Sakai N, 2009, HUM PATHOL, V41, P672; SARIOLA H, 1988, DEVELOPMENT, V104, P589; Sato Y, 2013, AM J PHYSIOL-RENAL, V305, pF1239, DOI 10.1152/ajprenal.00233.2013; Sun DF, 2000, AM J PATHOL, V157, P1321, DOI 10.1016/S0002-9440(10)64647-0; Suzuki N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3902; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; VAAGE J, 1991, BRIT J CANCER, V63, P758, DOI 10.1038/bjc.1991.169; Xu J, 2010, AM J PHYSIOL-HEART C, V301, pH538	143	10	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	FEB	2015	87	2					297	307		10.1038/ki.2014.287		11	Urology & Nephrology	Urology & Nephrology	CA5UH	WOS:000348972800011		
J	Goto, M; Gotoh, M; Mitsui, Y; Okawa, T; Higuchi, F; Nagata, K				Goto, Masafumi; Gotoh, Masafumi; Mitsui, Yasuhiro; Okawa, Takahiro; Higuchi, Fujio; Nagata, Kensei			Rapid collapse of the humeral head after arthroscopic rotator cuff repair	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Rapid collapse of the humeral head; Arthroscopic rotator cuff repair; Metal anchor; Complication; Osteonecrosis; Humeral head replacement	OSTEONECROSIS	This report presents a case of rapidly progressive collapse of the humeral head following arthroscopic rotator cuff repair. We performed humeral head replacement 8 months after the index surgery; histological examination of the collapsed area revealed necrosis, degeneration, fibrillation, and granulation in the cartilage and trabeculae. Osteonecrosis due to the use of metal anchors was considered the primary cause of the post-operative humeral head collapse. As the demand for arthroscopic cuff repair is expected to increase in the future, we recommend that surgeons become aware of the potential for complications, as seen in the present case. IV.	[Goto, Masafumi; Gotoh, Masafumi; Mitsui, Yasuhiro; Okawa, Takahiro; Higuchi, Fujio] Kurume Univ, Med Ctr, Dept Orthoped Surg, Kurume, Fukuoka 8390863, Japan; [Nagata, Kensei] Kurume Univ, Dept Orthoped Surg, Kurume, Fukuoka 8300011, Japan	Goto, M (reprint author), Kurume Univ, Med Ctr, Dept Orthoped Surg, 155-1 Kokubu Machi, Kurume, Fukuoka 8390863, Japan.	m.goto.1037@gmail.com					GERBER C, 1990, J BONE JOINT SURG AM, V72A, P1486; Brislin KJ, 2007, ARTHROSCOPY, V23, P124, DOI 10.1016/j.arthro.2006.09.001; Beauthier V, 2010, KNEE SURG SPORT TR A, V18, P1432, DOI 10.1007/s00167-009-1016-5; Harreld KL, 2009, J AM ACAD ORTHOP SUR, V17, P345; Manabe H, 2011, KATAKANSETSU, V35, P1017; Pateder DB, 2004, J BONE JOINT SURG AM, V86A, P2290	6	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	FEB	2015	23	2					514	516		10.1007/s00167-013-2790-7		3	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CA6IY	WOS:000349016800022		
J	Mihata, T; Gates, J; McGarry, MH; Neo, M; Lee, TQ				Mihata, Teruhisa; Gates, Jeffrey; McGarry, Michelle H.; Neo, Masashi; Lee, Thay Q.			Effect of posterior shoulder tightness on internal impingement in a cadaveric model of throwing	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Posterior tightness; Rotator cuff; Internal impingement; Throwing; Shoulder	PROFESSIONAL BASEBALL PITCHERS; SUPERIOR GLENOID IMPINGEMENT; II SLAP LESIONS; GLENOHUMERAL TRANSLATION; EXTERNAL ROTATION; COCKING PHASE; PEEL-BACK; MOTION; THROWERS; LAXITY	Posterior shoulder tightness is common in throwing athletes, especially those with symptomatic shoulder internal impingement. The role of posteroinferior capsular contracture in the pathoetiologies of throwing-related injuries caused by shoulder internal impingement remains unclear. The purpose of this study was to assess effect of posterior shoulder tightness on internal impingement in a cadaveric model of throwing. Seven fresh-frozen cadaveric shoulders were tested with the shoulder abducted to 90A degrees and at maximum external rotation to simulate the late cocking phase of throwing motion. Glenohumeral joint contact pressure and area through internal impingement, humeral head shift, and the maximum humeral rotation angle were measured. Posteroinferior capsular plication was performed to simulate posteroinferior capsular tightness and induce glenohumeral internal rotation deficit. Following generation of simulated posteroinferior capsular tightness with resultant glenohumeral internal rotation deficit, glenohumeral contact pressure was significantly increased (P < 0.05), the impinged area of rotator cuff tendon was significantly decreased (P < 0.05), and the humeral head shifted posteriorly (P < 0.05) during shoulder internal impingement. Excessive posteroinferior capsular tightness can cause forceful internal impingement of the shoulder at maximum external rotation position.	[Mihata, Teruhisa; Neo, Masashi] Osaka Med Coll, Dept Orthoped Surg, Takatsuki, Osaka 5698686, Japan; [Gates, Jeffrey; McGarry, Michelle H.; Lee, Thay Q.] Long Beach VA Healthcare Syst, Orthopaed Biomech Lab, Long Beach, CA USA; [Gates, Jeffrey; McGarry, Michelle H.; Lee, Thay Q.] Univ Calif Irvine, Irvine, CA USA	Mihata, T (reprint author), Osaka Med Coll, Dept Orthoped Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	tmihata@yahoo.co.jp		Neo, Masashi/0000-0001-9208-6419			Kibler WB, 1998, AM J SPORT MED, V26, P325; Curtis AS, 2003, ARTHROSCOPY, V19, P80, DOI 10.1016/j.arthro.2003.09.030; Mihata T, 2004, AM J SPORT MED, V32, P1278, DOI 10.1177/0363546503262188; HARRYMAN DT, 1990, J BONE JOINT SURG AM, V72A, P1334; Osbahr DC, 2002, AM J SPORT MED, V30, P347; Huffman GR, 2006, AM J SPORT MED, V34, P1662, DOI 10.1177/0363546506287740; Crockett HC, 2002, AM J SPORT MED, V30, P20; Tyler TF, 2010, AM J SPORT MED, V38, P114, DOI 10.1177/0363546509346050; Lee TQ, 2001, J SHOULDER ELB SURG, V10, P68, DOI 10.1067/mse.2001.111138; Mihata T, 2012, J BONE JOINT SURG AM, V94A, P1576, DOI 10.2106/JBJS.J.01972; Jobe CM, 1997, ORTHOP CLIN N AM, V28, P137, DOI 10.1016/S0030-5898(05)70274-1; Mihata T, 2010, AM J SPORT MED, V38, P369, DOI 10.1177/0363546509346408; Donatelli R, 2000, J ORTHOP SPORT PHYS, V30, P544; Clabbers KM, 2007, J SPORT REHABIL, V16, P41; Jobe CM, 1996, CLIN ORTHOP RELAT R, P98; Reagan KM, 2002, AM J SPORT MED, V30, P354; Bigliani LU, 1997, AM J SPORT MED, V25, P609, DOI 10.1177/036354659702500504; Myers JB, 2005, AM J SPORT MED, V33, P263, DOI 10.1177/0363546504268138; McFarland EG, 1999, J SHOULDER ELB SURG, V8, P458, DOI 10.1016/S1058-2746(99)90076-9; BROWN LP, 1988, AM J SPORT MED, V16, P577, DOI 10.1177/036354658801600604; Alberta FG, 2006, J BONE JOINT SURG AM, V88A, P179, DOI 10.2106/JBJS.D.02974; Myers JB, 2006, AM J SPORT MED, V34, P385, DOI 10.1177/0363546505281804; Halbrecht JL, 1999, ARTHROSCOPY, V15, P253, DOI 10.1016/S0749-8063(99)70030-7; JOBE FW, 1993, J ORTHOP SPORT PHYS, V18, P427; Grossman MG, 2005, J BONE JOINT SURG AM, V87A, P824, DOI 10.2106/JBJS.D.01972; Burkhart SS, 2003, ARTHROSCOPY, V19, P404, DOI 10.1053/jars.2003.50128; GLOUSMAN R, 1988, J BONE JOINT SURG AM, V70A, P220; Laudner KG, 2006, J ORTHOP SPORT PHYS, V36, P485; Burkhart SS, 1998, ARTHROSCOPY, V14, P637, DOI 10.1016/S0749-8063(98)70065-9; KING JW, 1969, CLIN ORTHOP RELAT R, P116; Jobe F W, 1994, J Hand Ther, V7, P107; Mihata T, 2008, AM J SPORT MED, V36, P1604, DOI 10.1177/0363546508315198; Mihata T, 2009, AM J SPORT MED, V37, P2222, DOI 10.1177/0363546509337450; Mihata T, 2009, AM J SPORTS MED, V38, P369; Mihata T, 2005, J SHOULDER ELB SURG, V14, p19S, DOI 10.1016/j.jse.2004.10.004; Shafer BL, 2008, J BONE JOINT SURG AM, V90A, P136, DOI 10.2106/JBJS.F.00841; Walch G, 1992, J Shoulder Elbow Surg, V1, P238, DOI 10.1016/S1058-2746(09)80065-7; Yoneda M, 2006, ARTHROSCOPY, V22	38	6	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	FEB	2015	23	2					548	554		10.1007/s00167-013-2381-7		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CA6IY	WOS:000349016800027		
J	Zhang, W; Tang, XJ; Yoshida, T				Zhang, Wen; Tang, Xijin; Yoshida, Taketoshi			TESC: An approach to TExt classification using Semi-supervised Clustering	KNOWLEDGE-BASED SYSTEMS			English	Article						Text classification; Semi-supervised clustering; Unlabeled data; Support vector machines; Expectation maximization	MACHINE; EM	This paper proposes an approach called TESC (TExt classification using Semi-supervised Clustering) to improve text classification. The basic idea is to regard one category of texts from one or more than one components. Thus, we use clustering to identify the components in text collection. In clustering process, TESC makes use of labeled texts to capture silhouettes of text clusters and unlabeled texts to adapt its centroids. The category of each text cluster is labeled by the label of texts in it. When a new unlabeled text is incoming, we measure its similarity with the text clusters and give its label with that of the nearest text clusters. Experiments on Reuters-21578 and TanCorp V1.0 text collection demonstrate that, in text classification, TESC outperforms Support Vector Machines (SVMs) and back propagation neural network (BPNN), and produces comparable performance to naive Bayes with EM (Expectation Maximization) however with lower computation complexity. (C) 2014 Elsevier B.V. All rights reserved.	[Zhang, Wen] Beijing Univ Chem Technol, Sch Econ & Management, Beijing 100029, Peoples R China; [Tang, Xijin] Chinese Acad Sci, Acad Math & Syst Sci, Inst Syst Sci, Beijing 100190, Peoples R China; [Yoshida, Taketoshi] Japan Adv Inst Sci & Technol, Sch Knowledge Sci, Nomi, Ishikawa 9231292, Japan	Zhang, W (reprint author), Beijing Univ Chem Technol, Sch Econ & Management, Beijing 100029, Peoples R China.	zhangwen@mail.buct.edu.cn; xjtang@amss.ac.cn; yoshida@jaist.ac.jp			National Science Foundation of China [71101138, 61379046, 61473284, 7171187]; Beijing Natural Science Fund [4122087]; Research Fund from State Key Laboratory of Software Engineering, Wuhan University	This work is supported by the National Science Foundation of China under Grant Nos. 71101138, 61379046, 61473284 and 7171187; the Beijing Natural Science Fund under Grant No. 4122087; the Research Fund from State Key Laboratory of Software Engineering, Wuhan University. The authors of the paper would like to appreciate the anonymous reviewers for their valuable comments.	Zhang W, 2010, KNOWL-BASED SYST, V23, P379, DOI 10.1016/j.knosys.2010.01.011; Lu N, 2014, ARTIF INTELL, V209, P11, DOI 10.1016/j.artint.2014.01.001; Nigam K, 2000, MACH LEARN, V39, P103, DOI 10.1023/A:1007692713085; D'Urso P, 2013, EXPERT SYST APPL, V40, P4944, DOI 10.1016/j.eswa.2013.03.005; Zhang W, 2008, KNOWL-BASED SYST, V21, P879, DOI 10.1016/j.knosys.2008.03.044; Tan SB, 2006, EXPERT SYST APPL, V30, P290, DOI 10.1016/j.eswa.2005.07.019; Basu S., 2003, P ICML 2003 WORKSH C, P42; Bradley AP, 2014, PATTERN RECOGN LETT, V38, P93, DOI 10.1016/j.patrec.2013.11.015; Cozman F., 2003, P 20 INT C MACH LEAR; Dara R, 2002, IEEE IJCNN, P2237, DOI 10.1109/IJCNN.2002.1007489; Demirez A., 1999, P ART NEUR NETW ENG, P809; Luo XZ, 2015, KNOWL-BASED SYST, V73, P149, DOI 10.1016/j.knosys.2014.09.014; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1, P318; Tian DP, 2014, KNOWL-BASED SYST, V72, P72, DOI 10.1016/j.knosys.2014.08.023; Tsang IW, 2005, J MACH LEARN RES, V6, P363; XU L, 1993, IEEE T NEURAL NETWOR, V4, P636, DOI 10.1109/72.238318; Zhang W, 2007, J SYST SCI SYST ENG, V16, P356, DOI 10.1007/s11518-007-5050-x; Zhang W, 2015, INFORM SOFTWARE TECH, V58, P58, DOI 10.1016/j.infsof.2014.10.005; Zhu X., 2006, 1530 U WISC MAD COMP	19	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0950-7051	1872-7409		KNOWL-BASED SYST	Knowledge-Based Syst.	FEB	2015	75						152	160		10.1016/j.knosys.2014.11.028		9	Computer Science, Artificial Intelligence	Computer Science	CA8TI	WOS:000349193400012		
J	Sun, SP				Sun, Shuping			An innovative intelligent system based on automatic diagnostic feature extraction for diagnosing heart diseases	KNOWLEDGE-BASED SYSTEMS			English	Article						Heart sound; STMHT; SES1 and SES2; PCA; Boundary curve	DIASTOLIC TIME INTERVALS; VALVE DISEASES; SOUND SEGMENTATION; FEATURE-SELECTION; NEURAL-NETWORKS; ELECTROCARDIOGRAM; ALGORITHM; SUPPORT; PCA; CLASSIFICATION	An innovative intelligent diagnostic system is proposed in this study, which is primarily reflected in first heart sound (S1) and second heart sound (S2) automatic extraction, frequency feature matrix (FFM) automatic extraction, diagnostic feature y(1) and y(2) generation based on principal components analysis (PCA) and diagnostic method definition based on the classification boundary curves. Four stages corresponding to the diagnostic system implementation are summarized as follows. Stage 1 describes an envelope ET extraction from heart sound signals. In stage 2, heart sound segmentation points and peaks are first automatically located based on a novel method STMHT, and then S1 and S2 are automatically extracted according to the relationship between the systolic time interval and the diastolic time interval. In stage 3, in the frequency domain, a novel method is first proposed to generate the secondary envelopes SES1 and SES2 for S1 and 52, respectively, and then an STMHT-based FFM is automatically extracted from SES1 and SES2. Finally, the PCA-based diagnostic features y(1) and y(2) are generated from the FFM. In stage 4, support vector machine (SVM)-based classification curves for the dataset consisting of y(1) and y(2) are first generated, and then, based on the classification curves, the scatter diagram diagnostic result (SDDR) and numerical diagnostic result (NDR) are defined for diagnosis of heart diseases. The proposed intelligent diagnosis system is validated by sounds from online heart sound databases and by sounds from clinical heart diseases. As a result, the classification accuracies (CA) achieved are 91.7%, 98.8%, 98.4%, 99.8%, 98.7%, 97.8%, 98.1% and 96.5% for the detection of atrial fibrillation (AF), aortic regurgitation(AR), mitral regurgitation (MR), normal sound (NM), pulmonary stenosis (PS), small ventricular septal defect (SVSD), medium ventricular septal defect (MVSD) and large ventricular septal defect (LVSD), respectively. (C) 2014 Elsevier B.V. All rights reserved.	[Sun, Shuping] Nanyang Inst Technol, Dept Elect & Elect Engn, Nanyang 473004, Peoples R China; [Sun, Shuping] Yamaguchi Univ, Dept Mech Engn, Ube, Yamaguchi 755, Japan	Sun, SP (reprint author), Nanyang Inst Technol, Dept Elect & Elect Engn, Nanyang 473004, Peoples R China.	Shp_Sun@yeah.net					Choi S, 2011, EXPERT SYST APPL, V38, P4264, DOI 10.1016/j.eswa.2010.09.094; Maglogiannis I, 2009, COMPUT METH PROG BIO, V95, P47, DOI 10.1016/j.cmpb.2009.01.003; Safara F, 2013, COMPUT BIOL MED, V43, P1407, DOI 10.1016/j.compbiomed.2013.06.016; Akay MF, 2009, EXPERT SYST APPL, V36, P3240, DOI 10.1016/j.eswa.2008.01.009; Giri D, 2013, KNOWL-BASED SYST, V37, P274, DOI 10.1016/j.knosys.2012.08.011; Yeo TC, 1998, AM J CARDIOL, V81, P1157, DOI 10.1016/S0002-9149(98)00140-4; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Zhu BH, 2014, APPL MATH COMPUT, V227, P428, DOI 10.1016/j.amc.2013.11.028; Sepehri AA, 2008, COMPUT METH PROG BIO, V92, P186, DOI 10.1016/j.cmpb.2008.06.015; Sepehri AA, 2010, COMPUT METH PROG BIO, V99, P43, DOI 10.1016/j.cmpb.2009.10.006; Avci E, 2009, EXPERT SYST APPL, V36, P2873, DOI 10.1016/j.eswa.2008.01.030; Bioscience F., 2013, NORMAL ABNORMAL HEAR; Cesarelli M, 2012, COMPUT METH PROG BIO, V107, P513, DOI 10.1016/j.cmpb.2011.11.008; Choi S, 2010, COMPUT BIOL MED, V40, P8, DOI 10.1016/j.compbiomed.2009.10.003; Choi Z. J. Samjin, 2005, PROCEEDINGS OF THE I, P3771; Das R, 2009, COMPUT METH PROG BIO, V93, P185, DOI 10.1016/j.cmpb.2008.09.005; Dogantekin E, 2010, EXPERT SYST APPL, V37, P6368, DOI 10.1016/j.eswa.2010.02.083; HaghighiMood A, 1995, COMPUT CARDIOL, P501, DOI 10.1109/CIC.1995.482711; Huiying L., 1997, ENG MED BIOL SOC, V1630, P4; Jiang ZW, 2006, EXPERT SYST APPL, V31, P286, DOI 10.1016/j.eswa.2005.09.025; Johnson RA, 2007, APPL MULTIVARIATE ST; Joy R., 2012, EXP SYST APPL, V39, P11792; Klabunde R.E., 2014, CARDIOVASCULAR PHYSL; Kovcs F., 2011, COMPUTER METHODS AND, V104, P19; Kumar D., 2006, COMPUT CARDIOL, V33, P173; Kumar D., 2006, P IEEE C P ENG MED B, V1, P1410; Kumar D., 2006, 2006 IEEE INT C AC S, V2, pII, DOI 10.1109/ICASSP.2006.1660559; Lee J, 2013, KNOWL-BASED SYST, V37, P338, DOI 10.1016/j.knosys.2012.08.013; MacWalter D., 2013, HUMAN HEART SOUNDS M; Malarvili MB, 2003, COMPUT CARDIOL, V30, P327; MATTAR JA, 1991, CRIT CARE MED, V19, P1382; Mehta SS, 2008, IRBM, V29, P310, DOI 10.1016/j.rbmret.2008.03.006; Nilsson M, 2006, ARTIF INTELL MED, V36, P159, DOI 10.1016/j.artmed.2005.04.004; Omran S., 2004, CONTROL COMMUNICATIO, P235; Reed TR, 2004, SIMUL MODEL PRACT TH, V12, P129, DOI 10.1016/j.simpat.2003.11.005; Saracoglu R, 2012, ENG APPL ARTIF INTEL, V25, P1523, DOI 10.1016/j.engappai.2012.07.005; Shilaskar S, 2013, EXPERT SYST APPL, V40, P4146, DOI 10.1016/j.eswa.2013.01.032; Sinha RK, 2007, J MED SYST, V31, P205, DOI 10.1007/s10916-007-9056-1; Sun H. W. Shuping, 2014, COMPUT METH PROG BIO, V114, P219; Sun H. W. Shuping, COMPUT METHODS UNPUB; Sun ZJ. Y. F. Shuping, 2014, EXP SYST APPL, V41, P1769; Turkoglu I, 2003, COMPUT BIOL MED, V33, P319, DOI 10.1016/S0010-4825(03)00002-7; WHO, 2013, TOP 10 CAUS DEATH; Yan ZH, 2010, COMPUT METH PROG BIO, V98, P140, DOI 10.1016/j.cmpb.2009.09.008	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0950-7051	1872-7409		KNOWL-BASED SYST	Knowledge-Based Syst.	FEB	2015	75						224	238		10.1016/j.knosys.2014.12.001		15	Computer Science, Artificial Intelligence	Computer Science	CA8TI	WOS:000349193400017		
J	Jeon, MK; Lee, KR; Jeon, HJ; McGinn, PJ; Kang, KH; Park, GI				Jeon, Min Ku; Lee, Ki Rak; Jeon, Hyung Joon; McGinn, Paul J.; Kang, Kweon Ho; Park, Geun Il			Quaternary Pt2Ru1Fe1M1/C (M=Ni, Mo, or W) catalysts for methanol electro-oxidation reaction	KOREAN JOURNAL OF CHEMICAL ENGINEERING			English	Article						Methanol Electro-oxidation Reaction; Direct Methanol Fuel Cell; Electrocatalyst; X-ray Photoelectron Spectroscopy; CO Electro-oxidation	FUEL-CELL ANODE; PART I; BIMETALLIC ALLOYS; TERNARY CATALYSTS; ELECTROCATALYSTS; OXIDATION; RU; CO; ACID; FE	Quaternary Pt2Ru1Fe1Ni1/C (M=Ni, Mo, or W) catalysts were investigated for the methanol electro-oxidation reaction (MOR). Electrocatalytic activities of the quaternary catalysts for CO electro-oxidation were studied via CO stripping experiments, and the Pt2Ru1Fe1Ni1/C and Pt2Ru1Fe1W1/C catalysts exhibited lowered on-set potential compared to that of a commercial PtRu/C catalyst. MOR activities of the quaternary catalysts were determined by linear sweep voltammetry (LSV) experiments, and the Pt2Ru1Fe1Ni1/C catalyst outperformed the commercial PtRu/C catalyst by 170 and 150% for the mass and specific activities, respectively. X-ray photoelectron spectroscopy (XPS) was employed to analyze surface oxidation states of constituent atoms, and it was identified that the structure of the synthesized catalysts are close to a nano-composite of Pt and constituent metal hydroxides and oxides. In addition, the XPS results suggested that the bi-functional mechanism accounts for the improved performance of the Pt2Ru1Fe1Ni1/C and Pt2Ru1 Fe1W1/C catalysts.	[Jeon, Min Ku; Lee, Ki Rak; Kang, Kweon Ho; Park, Geun Il] Korea Atom Energy Res Inst, Nucl Fuel Cycle Proc Dev Div, Taejon 305353, South Korea; [Jeon, Hyung Joon] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Nishikyo Ku, Kyoto 6158510, Japan; [McGinn, Paul J.] Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA	Jeon, MK (reprint author), Korea Atom Energy Res Inst, Nucl Fuel Cycle Proc Dev Div, Daedeok Daero 989-111, Taejon 305353, South Korea.	minku@kaeri.re.kr			Nuclear R&D program of the Korean Ministry of Science, ICT & Future Planning [2012M2A8A5025802]	This work was sponsored by the Nuclear R&D program of the Korean Ministry of Science, ICT & Future Planning (No. 2012M2A8A5025802).	Ehteshami SMM, 2013, ELECTROCHIM ACTA, V93, P334, DOI 10.1016/j.electacta.2013.01.086; Goetz M, 2001, J APPL ELECTROCHEM, V31, P811, DOI 10.1023/A:1017598219719; Jeon MK, 2008, CATAL TODAY, V132, P123, DOI 10.1016/j.cattod.2007.12.011; Schmidt TJ, 1998, J ELECTROCHEM SOC, V145, P2354, DOI 10.1149/1.1838642; Micoud F, 2010, PHYS CHEM CHEM PHYS, V12, P1182, DOI 10.1039/b915244j; LEROUX C, 1988, J PHYS F MET PHYS, V18, P2033, DOI 10.1088/0305-4608/18/9/021; Wang ZB, 2009, J ALLOY COMPD, V479, P395, DOI 10.1016/j.jallcom.2008.12.061; Arico AS, 2001, FUEL CELLS, V1, P133; Antolini E, 2001, J ALLOY COMPD, V315, P118, DOI 10.1016/S0925-8388(00)01260-3; Rolison DR, 1999, LANGMUIR, V15, P774, DOI 10.1021/la9807863; Park KW, 2002, J PHYS CHEM B, V106, P1869, DOI 10.1021/jp013168v; Liu Z, 2009, J AM CHEM SOC, V131, P6924, DOI 10.1021/ja901303d; Lopes PP, 2010, ELECTROCATALYSIS, V1, P200, DOI 10.1007/s12678-010-0025-y; Lamy C, 2002, J POWER SOURCES, V105, P283, DOI 10.1016/S0378-7753(01)00954-5; WATANABE M, 1987, J ELECTROANAL CHEM, V229, P395, DOI 10.1016/0022-0728(87)85156-2; Demirci UB, 2007, J POWER SOURCES, V173, P11, DOI 10.1016/j.jpowsour.2007.04.069; Ma LA, 2010, ELECTROCHIM ACTA, V55, P9105, DOI 10.1016/j.electacta.2010.08.034; Jeon MK, 2007, ELECTROCHEM COMMUN, V9, P2163, DOI 10.1016/j.elecom.2007.06.014; He CZ, 1997, J ELECTROCHEM SOC, V144, P970, DOI 10.1149/1.1837515; MANOHARAN R, 1992, J MATER CHEM, V2, P875; Jeon MK, 2009, KOREAN J CHEM ENG, V26, P1028, DOI 10.2478/s11814-009-0171-1; Urian RC, 2003, J ELECTROANAL CHEM, V554, P307, DOI 10.1016/S0022-0728(03)00241-9; Watanabe M, 2000, J PHYS CHEM B, V104, P1762, DOI 10.1021/jp993001q; Ribeiro VA, 2010, APPL CATAL A-GEN, V372, P162, DOI 10.1016/j.apcata.2009.10.028; Roth C, 2001, J APPL ELECTROCHEM, V31, P793, DOI 10.1023/A:1017585901064; MARKOVIC NM, 1995, ELECTROCHIM ACTA, V40, P91, DOI 10.1016/0013-4686(94)00241-R; Chrzanowski W, 1998, LANGMUIR, V14, P1967, DOI 10.1021/la980184j; Long JW, 2000, J PHYS CHEM B, V104, P9772, DOI 10.1021/jp001954e; Choi JH, 2003, J ELECTROCHEM SOC, V150, pA973, DOI 10.1149/1.1581011; Lima A, 2001, J APPL ELECTROCHEM, V31, P379, DOI 10.1023/A:1017578918569; Petrii OA, 2008, J SOLID STATE ELECTR, V12, P609, DOI 10.1007/s10008-007-0334-0; Antolini E, 2007, APPL CATAL B-ENVIRON, V74, P324, DOI 10.1016/j.apcatb.2007.03.002; Camara GA, 2002, J ELECTROANAL CHEM, V537, P21, DOI 10.1016/S0022-0728(02)01223-8; Cooper JS, 2006, J POWER SOURCES, V163, P330, DOI 10.1016/j.jpowsour.2006.09.028; Ioroi T, 2003, J ELECTROCHEM SOC, V150, pA1225, DOI 10.1149/1.1598211; Jeon MK, 2009, J APPL ELECTROCHEM, V39, P1503, DOI 10.1007/s10800-009-9833-2; Jeon MK, 2007, ELECTROCHEM COMMUN, V9, P2692, DOI 10.1016/j.elecom.2007.09.001; Jeon MK, 2007, ELECTROCHEM SOLID ST, V10, pB23, DOI 10.1149/1.2382260; KENNEDY BJ, 1990, J ELECTROANAL CHEM, V293, P103, DOI 10.1016/0022-0728(90)80055-B; Kwok R., 2000, XPS PEAK FITTING PRO; Lee KR, 2009, APPL CATAL B-ENVIRON, V91, P428, DOI 10.1016/j.apcatb.2009.06.011; Liu JY, 2008, J POWER SOURCES, V175, P159, DOI 10.1016/j.jpowsour.2007.08.100; Luo H. L., 1968, J LESS-COMMON MET, V156, P299; Ralph TR, 2002, PLATIN MET REV, V46, P3; RAUB E, 1955, Z METALLKD, V46, P210; Roine A., 2002, OUTOKUMPU HSC CHEM W; Teliz E, 2012, INT J HYDROGEN ENERG, V37, P14761, DOI 10.1016/j.ijhydene.2011.12.084; Tsiouvaras N, 2010, CATAL TODAY, V158, P12, DOI 10.1016/j.cattod.2010.05.004; Umeda M, 2004, J POWER SOURCES, V136, P10, DOI 10.1016/j.jpowsour.2004.05.013; Wang ZB, 2006, ELECTROCHEM SOLID ST, V9, pA13, DOI 10.1149/1.2133722; WATANABE K, 1988, T JPN I MET, V29, P80; Watanabe M, 1999, ELECTROCHEMISTRY, V67, P1194	52	0	0	KOREAN INSTITUTE CHEMICAL  ENGINEERS	SEOUL	F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA	0256-1115	1975-7220		KOREAN J CHEM ENG	Korean J. Chem. Eng.	FEB	2015	32	2					206	215		10.1007/s11814-014-0186-0		10	Chemistry, Multidisciplinary; Engineering, Chemical	Chemistry; Engineering	CA7GS	WOS:000349086400003		
J	Yang, JCH; Wu, YL; Schuler, M; Sebastian, M; Popat, S; Yamamoto, N; Zhou, CC; Hu, CP; O'Byrne, K; Feng, JF; Lu, S; Huang, YC; Geater, SL; Lee, KY; Tsai, CM; Gorbunova, V; Hirsh, V; Bennouna, J; Orlov, S; Mok, T; Boyer, M; Su, WC; Lee, KH; Kato, T; Massey, D; Shahidi, M; Zazulina, V; Sequist, LV				Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L.; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Orlov, Sergey; Mok, Tony; Boyer, Michael; Su, Wu-Chou; Lee, Ki Hyeong; Kato, Terufumi; Massey, Dan; Shahidi, Mehdi; Zazulina, Victoria; Sequist, Lecia V.			Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials	LANCET ONCOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; OPEN-LABEL; 1ST-LINE TREATMENT; CANCER PATIENTS; CARBOPLATIN-PACLITAXEL; EXON-21 MUTATIONS; CLINICAL-TRIALS; GEFITINIB; ERLOTINIB; MULTICENTER	Background We aimed to assess the effect of afatinib on overall survival of patients with EGFR mutation-positive lung adenocarcinoma through an analysis of data from two open-label, randomised, phase 3 trials. Methods Previously untreated patients with EGFR mutation-positive stage IIIB or IV lung adenocarcinoma were enrolled in LUX-Lung 3 (n=345) and LUX-Lung 6 (n=364). These patients were randomly assigned in a 2:1 ratio to receive afatinib or chemotherapy (pemetrexed-cisplatin [LUX-Lung 3] or gemcitabine-cisplatin [LUX-Lung 6]), stratified by EGFR mutation (exon 19 deletion [del19], Leu858Arg, or other) and ethnic origin (LUX-Lung 3 only). We planned analyses of mature overall survival data in the intention-to-treat population after 209 (LUX-Lung 3) and 237 (LUX-Lung 6) deaths. These ongoing studies are registered with ClinicalTrials.gov, numbers NCT00949650 and NCT01121393. Findings Median follow-up in LUX-Lung 3 was 41 months (IQR 35-44); 213 (62%) of 345 patients had died. Median follow-up in LUX-Lung 6 was 33 months (IQR 31-37); 246 (68%) of 364 patients had died. In LUX-Lung 3, median overall survival was 28.2 months (95% CI 24.6-33.6) in the afatinib group and 28.2 months (20.7-33.2) in the pemetrexed-cisplatin group (HR 0.88, 95% CI 0.66-1.17, p=0.39). In LUX-Lung 6, median overall survival was 23.1 months (95% CI 20.4-27.3) in the afatinib group and 23.5 months (18.0-25.6) in the gemcitabine-cisplatin group (HR 0.93, 95% CI 0.72-1.22, p=0.61). However, in preplanned analyses, overall survival was significantly longer for patients with del19-positive tumours in the afatinib group than in the chemotherapy group in both trials: in LUX-Lung 3, median overall survival was 33.3 months (95% CI 26.8-41.5) in the afatinib group versus 21.1 months (16.3-30.7) in the chemotherapy group (HR 0.54, 95% CI 0.36-0.79, p=0.0015); in LUX-Lung 6, it was 31.4 months (95% CI 24.2-35.3) versus 18.4 months (14.6-25.6), respectively (HR 0.64, 95% CI 0.44-0.94, p=0.023). By contrast, there were no significant differences by treatment group for patients with EGFR Leu858Arg-positive tumours in either trial: in LUX-Lung 3, median overall survival was 27.6 months (19.8-41.7) in the afatinib group versus 40.3 months (24.3-not estimable) in the chemotherapy group (HR 1.30, 95% CI 0.80-2.11, p=0.29); in LUX-Lung 6, it was 19.6 months (95% CI 17.0-22.1) versus 24.3 months (19.0-27.0), respectively (HR 1.22, 95% CI 0.81-1.83, p=0.34). In both trials, the most common afatinib-related grade 3-4 adverse events were rash or acne (37 [16%] of 229 patients in LUX-Lung 3 and 35 [15%] of 239 patients in LUX-Lung 6), diarrhoea (33 [14%] and 13 [5%]), paronychia (26 [11%] in LUX-Lung 3 only), and stomatitis or mucositis (13 [5%] in LUX-Lung 6 only). In LUX-Lung 3, neutropenia (20 [18%] of 111 patients), fatigue (14 [13%]) and leucopenia (nine [8%]) were the most common chemotherapy-related grade 3-4 adverse events, while in LUX-Lung 6, the most common chemotherapy-related grade 3-4 adverse events were neutropenia (30 [27%] of 113 patients), vomiting (22 [19%]), and leucopenia (17 [15%]). Interpretation Although afatinib did not improve overall survival in the whole population of either trial, overall survival was improved with the drug for patients with del19 EGFR mutations. The absence of an effect in patients with Leu858Arg EGFR mutations suggests that EGFR del19-positive disease might be distinct from Leu858Arg-positive disease and that these subgroups should be analysed separately in future trials.	[Yang, James Chih-Hsin] Natl Taiwan Univ Hosp, Taipei 100, Taiwan; [Yang, James Chih-Hsin] Natl Taiwan Univ, Taipei 10764, Taiwan; [Wu, Yi-Long] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Wu, Yi-Long] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [Schuler, Martin] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Essen, Germany; [Sebastian, Martin] Goethe Univ Frankfurt, Med Ctr, D-60054 Frankfurt, Germany; [Sebastian, Martin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55122 Mainz, Germany; [Popat, Sanjay] Royal Marsden Hosp, London SW3 6JJ, England; [Yamamoto, Nobuyuki] Wakayama Med Univ, Wakayama, Japan; [Zhou, Caicun] Tongji Univ, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; [Hu, Cheng-Ping] Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China; [O'Byrne, Kenneth] Princess Alexandra Hosp, Brisbane, Qld, Australia; [O'Byrne, Kenneth] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Feng, Jifeng] Jiangsu Prov Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Lu, Shun] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Tumor Clin Med Ctr, Shanghai 200030, Peoples R China; [Huang, Yunchao] Kunming Med Univ, Affiliated Hosp 3, Yunnan Tumor Hosp, Kunming, Yunnan Province, Peoples R China; [Geater, Sarayut L.] Prince Songkla Univ, Hat Yai, Thailand; [Lee, Kye Young] Konkuk Univ, Med Ctr, Dept Internal Med, Seoul, South Korea; [Tsai, Chun-Ming] Taipei Vet Gen Hosp, Taipei, Taiwan; [Gorbunova, Vera] Russian Acad Med Sci, FSBI N N Blokhin Russian Canc Res Ctr, Moscow, Russia; [Hirsh, Vera] McGill Univ, Montreal, PQ, Canada; [Bennouna, Jaafar] Inst Cancerol Ouest, Nantes, France; [Orlov, Sergey] Pavlov State Med Univ, St Petersburg, Russia; [Mok, Tony] Chinese Univ Hong Kong, Hong Kong Canc Inst, State Key Lab South China, Hong Kong, Hong Kong, Peoples R China; [Boyer, Michael] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Su, Wu-Chou] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; [Lee, Ki Hyeong] Chungbuk Natl Univ Hosp, Cheongju, South Korea; [Kato, Terufumi] Kanagawa Cardiovasc & Resp Ctr, Yokohama, Kanagawa, Japan; [Massey, Dan; Shahidi, Mehdi; Zazulina, Victoria] Boehringer Ingelheim Ltd UK, Bracknell, Berks, England; [Sequist, Lecia V.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sequist, Lecia V.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Yang, JCH (reprint author), Natl Taiwan Univ Hosp, Taipei 100, Taiwan.	chihyang@ntu.edu.tw		Yang, James Chih-Hsin/0000-0002-5586-5138	Boehringer Ingelheim	Boehringer Ingelheim.	Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Okabe T, 2007, CANCER RES, V67, P2046, DOI 10.1158/0008-5472.CAN-06-3339; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Yang JCH, 2012, LANCET ONCOL, V13, P539, DOI 10.1016/S1470-2045(12)70086-4; SHUSTER JJ, 1991, J CLIN ONCOL, V9, P191; Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; [Anonymous], 2014, TARCEVA ERLOTINIB TA; Mok T, 2013, J CLIN ONCOL, V31, P1081, DOI 10.1200/JCO.2012.43.0652; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Zhu JQ, 2008, CANCER LETT, V265, P307, DOI 10.1016/j.canlet.2008.02.064; Wu YL, 2013, J THORAC ONCOL, V8, pS603; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Collett D., 2003, MODELLING SURVIVAL D; Ding PN, 2013, J THORAC ONCOL, V8; Mitsudomi T, 2012, P AN M AM SOC CLIN, V30, P7521; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang J, 2011, EUR J CANCER, V47, pS633; Yang JCH, 2013, J CLIN ONCOL, V31, P3342, DOI 10.1200/JCO.2012.46.1764; Yoshioka H, 2014, P AM SOC CLIN ONCO S, V32; Zhou C, 2012, P AM SOC CLIN ONCO S, V30, P7520	30	66	67	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	FEB	2015	16	2					141	151		10.1016/S1470-2045(14)71173-8		11	Oncology	Oncology	CA3YR	WOS:000348841700030		
J	Chian, KS; Leong, MF; Kono, K				Chian, Kerm Sin; Leong, Meng Fatt; Kono, Koji			Regenerative medicine for oesophageal reconstruction after cancer treatment	LANCET ONCOLOGY			English	Review							TISSUE-ENGINEERED ESOPHAGUS; SMALL-INTESTINAL SUBMUCOSA; ENDOSCOPIC MUCOSAL RESECTION; ARTIFICIAL ESOPHAGUS; BARRETTS-ESOPHAGUS; CANINE MODEL; IN-VITRO; EXPERIMENTAL REPLACEMENT; EXTRACELLULAR-MATRIX; STRICTURE PREVENTION	Removal of malignant tissue in patients with oesophageal cancer and replacement with autologous grafts from the stomach and colon can lead to problems. The need to reduce stenosis and anastomotic leakage after oesophagectomy is a high priority. Developments in tissue-engineering methods and cell-sheet technology have improved scaffold materials for oesophageal repair. Despite the many successful animal studies, few tissue-engineering approaches have progressed to clinical trials. In this Review, we discuss the status of oesophagus reconstruction after surgery. In particular, we highlight two clinical trials that used decellularised constructs and epithelial cell sheets to replace excised tissues after endoscopic submucosal dissection or mucosal resection procedures. Results from the trials showed that both decellularised grafts and epithelial-cell sheets prevented stenosis. By contrast, animal studies have shown that the use of tissue-engineered constructs after oesophagectomy remains a challenge.	[Chian, Kerm Sin] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Leong, Meng Fatt] Inst Bioengn & Nanotechnol, Dept Cell & Tissue Engn, Singapore, Singapore; [Kono, Koji] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore; [Kono, Koji] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Kono, Koji] Fukushima Med Univ, Dept Organ Regulatory Surg & Adv Canc Immunothera, Fukushima, Japan	Chian, KS (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.	askschian@ntu.edu.sg			Nanyang Technological University (Singapore); Singapore Agency for Science, Technology and Research (A*STAR; BMRC Grant ) [07/1/22/19/541]; Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore); Clinician Scientist Award (CSA); Clinician Scientist-Individual Research Grant (CS-IGR) from the National Medical Research Council of Singapore	KSC is funded by the Nanyang Technological University (Singapore) and the Singapore Agency for Science, Technology and Research (A*STAR; BMRC Grant No 07/1/22/19/541). MFL is supported by the Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore). KK is supported by a Clinician Scientist Award (CSA) and Clinician Scientist-Individual Research Grant (CS-IGR) from the National Medical Research Council of Singapore.	Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI [10.1089/ten.TEA.2010.0739, 10.1089/ten.tea.2010.0739]; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Lepage C, 2008, AM J GASTROENTEROL, V103, P2694, DOI 10.1111/j.1572-0241.2008.02191.x; Takimoto Y, 1998, J THORAC CARDIOV SUR, V116, P98, DOI 10.1016/S0022-5223(98)70247-8; Walther B, 2003, ANN SURG, V238, P803, DOI 10.1097/01.sla.0000098624.04100.b1; Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2; BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005; Hayashi K, 2004, ASAIO J, V50, P261, DOI 10.1097/01.MAT.0000123688.45717.A4; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Jansen PL, 2004, EUR SURG RES, V36, P104, DOI 10.1159/000076650; Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742; Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058; Aikawa M, 2013, J GASTROENTEROL, V48, P822, DOI 10.1007/s00535-012-0716-7; Grikscheit T, 2003, J THORAC CARDIOV SUR, V126, P537, DOI 10.1016/S0022-5223(03)00032-1; Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Zhu YB, 2007, BIOMATERIALS, V28, P861, DOI 10.1016/j.biomaterials.2006.09.051; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Anderson JM, 2001, ANN REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Lewis JJ, 2011, GASTROINTEST ENDOSC, V74, P753, DOI 10.1016/j.gie.2011.05.031; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Raeber GP, 2007, ACTA BIOMATER, V3, P615, DOI 10.1016/j.actbio.2007.03.013; Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Wei RQ, 2009, EXP BIOL MED, V234, P453, DOI 10.3181/0901-RM-5; Soller EC, 2012, BIOMATERIALS, V33, P4783, DOI 10.1016/j.biomaterials.2012.03.068; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Leong MF, 2010, J BIOMED MATER RES A, V94A, P1141, DOI 10.1002/jbm.a.32795; Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Altorki NK, 2008, ANN SURG, V247, P434, DOI 10.1097/SLA.0b013e318163a2ff; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Lopes MF, 2006, DIS ESOPHAGUS, V19, P254, DOI 10.1111/j.1442-2050.2006.00574.x; Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518; Iyer AKV, 2008, J CELL PHYSIOL, V214, P504, DOI 10.1002/jcp.21232; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Hoppo T, 2012, WORLD J SURG, V36, P2390, DOI 10.1007/s00268-012-1698-6; Wu PC, 2003, LANCET ONCOL, V4, P481, DOI 10.1016/S1470-2045(03)01167-7; Green N, 2010, TISSUE ENG PT A, V16, P1053, DOI 10.1089/ten.TEA.2009.0217; Chung A, 2011, ENDOSCOPY, V43, P1025, DOI 10.1055/s-0030-1257049; Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107; Doede T, 2009, ARTIF ORGANS, V33, P328, DOI 10.1111/j.1525-1594.2009.00727.x; Nieponice A, 2014, ANN THORAC SURG, V97, P283, DOI 10.1016/j.athoracsur.2013.08.011; Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834; Ono S, 2009, GASTROINTEST ENDOSC, V70, P860, DOI 10.1016/j.gie.2009.04.044; Nieponice A, 2009, GASTROINTEST ENDOSC, V69, P289, DOI 10.1016/j.gie.2008.04.022; Baier Leach J., 2003, BIOTECHNOL BIOENG, V82, P578; Beckstead BL, 2005, BIOMATERIALS; BELL E, 1983, J INVEST DERMATOL, V81, pS2, DOI 10.1111/1523-1747.ep12539993; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Fleckman P, 2012, J BIOMED MATER RES A, V100A, P1256, DOI 10.1002/jbm.a.34012; Kosoff RE, 2012, J CELL PHYSIOL, V227, P2654, DOI 10.1002/jcp.23007; Liang JH, 2010, ASAIO J, V56, P232, DOI 10.1097/MAT.0b013e3181d00e2c; Marzaro M, 2006, J BIOMED MATER RES A, V77A, P795, DOI 10.1002/jbm.a.30666; Nakase Y, 2008, J THORAC CARDIOV SUR, V136, P850, DOI 10.1016/j.jtcvs.2008.05.027; Oates M, 2007, BIOMATERIALS, V28, P3679, DOI 10.1016/j.biomaterials.2007.04.042; Pennathur A, 2010, ANN THORAC SURG, V89, pS2163, DOI 10.1016/j.athoracsur.2010.03.068; Poh M, 2011, ANN SURG, V253, P1122, DOI 10.1097/SLA.0b013e318217e875; Rajan E, 2005, ENDOSCOPY, V37, P1111, DOI 10.1055/s-870531; Saxena AK, 2009, J GASTROINTEST SURG, V13, P1037, DOI 10.1007/s11605-009-0836-4; Sharma B, 2013, SCI TRANSL MED, V5, P167, DOI DOI 10.1126/SCITRANSLMED.3004838; Sjoqvist S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4562; Tabira Y, 2004, AM J SURG, V187, P417, DOI 10.1016/j.amjsurg.2003.12.008; Tan B, 2013, J SURG RES, V182, P40, DOI 10.1016/j.jss.2012.07.054; URSCHEL JD, 1995, AM J SURG, V169, P634, DOI 10.1016/S0002-9610(99)80238-4; Yamamoto Y, 1999, J THORAC CARDIOV SUR, V118, P276, DOI 10.1016/S0022-5223(99)70218-7; Zhu YB, 2007, ANAL BIOCHEM, V363, P119, DOI 10.1016/j.ab.2007.01.007	76	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	FEB	2015	16	2					E84	E92				9	Oncology	Oncology	CA3YR	WOS:000348841700015		
J	Kamada, T; Tsujii, H; Blakely, EA; Debus, J; De Neve, W; Durante, M; Jakel, O; Mayer, R; Orecchia, R; Potter, R; Vatnitsky, S; Chu, WT				Kamada, Tadashi; Tsujii, Hirohiko; Blakely, Eleanor A.; Debus, Juergen; De Neve, Wilfried; Durante, Marco; Jaekel, Oliver; Mayer, Ramona; Orecchia, Roberto; Poetter, Richard; Vatnitsky, Stanislav; Chu, William T.			Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience	LANCET ONCOLOGY			English	Review							PROTON-BEAM THERAPY; PARTICLE RADIATION-THERAPY; LOCALIZED PROSTATE-CANCER; HEAVY CHARGED-PARTICLES; 2ND MALIGNANCIES; PHOTON RADIATION; CERVICAL-CANCER; PHASE-I/II; GLIOMAS; CHEMOTHERAPY	Charged particle therapy is generally regarded as cutting-edge technology in oncology. Many proton therapy centres are active in the USA, Europe, and Asia, but only a few centres use heavy ions, even though these ions are much more effective than x-rays owing to the special radiobiological properties of densely ionising radiation. The National Institute of Radiological Sciences (NIRS) Chiba, Japan, has been treating cancer with high-energy carbon ions since 1994. So far, more than 8000 patients have had this treatment at NIRS, and the centre thus has by far the greatest experience in carbon ion treatment worldwide. A panel of radiation oncologists, radiobiologists, and medical physicists from the USA and Europe recently completed peer review of the carbon ion therapy at NIRS. The review panel had access to the latest developments in treatment planning and beam delivery and to all updated clinical data produced at NIRS. A detailed comparison with the most advanced results obtained with x-rays or protons in Europe and the USA was then possible. In addition to those tumours for which carbon ions are known to produce excellent results, such as bone and soft-tissue sarcoma of the skull base, head and neck, and pelvis, promising data were obtained for other tumours, such as locally recurrent rectal cancer and pancreatic cancer. The most serious impediment to the worldwide spread of heavy ion therapy centres is the high initial capital cost. The 20 years of clinical experience at NIRS can help guide strategic decisions on the design and construction of new heavy ion therapy centres.	[Kamada, Tadashi; Tsujii, Hirohiko] Natl Inst Radiol Sci, Chiba 260, Japan; [Blakely, Eleanor A.; Chu, William T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Debus, Juergen; Jaekel, Oliver] Heidelberg Univ, Heidelberg, Germany; [Debus, Juergen; Jaekel, Oliver] Heidelberg Ion Therapy Ctr, Heidelberg, Germany; [De Neve, Wilfried] Univ Ghent, B-9000 Ghent, Belgium; [Durante, Marco] GSI Helmholtz Ctr Heavy Ion Res, Darmstadt, Germany; [Durante, Marco] Tech Univ Darmstadt, Darmstadt, Germany; [Mayer, Ramona; Vatnitsky, Stanislav] MedAustron, Wiener Neustadt, Austria; [Orecchia, Roberto] CNAO Fdn, Pavia, Italy; [Orecchia, Roberto] European Inst Oncol, Milan, Italy; [Poetter, Richard] Med Univ Vienna, Vienna, Austria	Durante, M (reprint author), GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, Planckstr 1, D-64291 Darmstadt, Germany.	m.durante@gsi.de					Tsujii H, 2012, JPN J CLIN ONCOL, V42, P670, DOI 10.1093/jjco/hys104; Okada T, 2010, J RADIAT RES, V51, P355, DOI 10.1269/jrr.10016; Allen AM, 2012, RADIOTHER ONCOL, V103, P8, DOI 10.1016/j.radonc.2012.02.001; Amaldi U, 2005, REP PROG PHYS, V68, P1861, DOI 10.1088/0034-4885/68/8/R04; Imai R, 2011, BRIT J RADIOL, V84, pS48, DOI 10.1259/bjr/13783281; Inaniwa T, 2010, PHYS MED BIOL, V55, P6721, DOI 10.1088/0031-9155/55/22/008; Potter R, 2011, RADIOTHER ONCOL, V100, P116, DOI 10.1016/j.radonc.2011.07.012; Kamada T, 2012, INT J CLIN ONCOL, V17, P85, DOI 10.1007/s10147-012-0388-6; Senan S, 2013, LANCET ONCOL, V14, pE270, DOI 10.1016/S1470-2045(12)70592-2; Schulz-Ertner D, 2004, INT J RADIAT ONCOL, V58, P631, DOI 10.1016/j.ijrobp.2003.09.041; Newhauser WD, 2011, NAT REV CANCER, V11, P438, DOI 10.1038/nrc3069; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Combs SE, 2013, RADIOTHER ONCOL, V108, P132, DOI 10.1016/j.radonc.2013.06.026; Chung CS, 2013, INT J RADIAT ONCOL, V87, P46, DOI 10.1016/j.ijrobp.2013.04.030; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Sheets NC, 2012, JAMA-J AM MED ASSOC, V307, P1611, DOI 10.1001/jama.2012.460; Loeffler JS, 2013, NAT REV CLIN ONCOL, V10, P411, DOI 10.1038/nrclinonc.2013.79; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Mizoe JE, 2007, INT J RADIAT ONCOL, V69, P390, DOI 10.1016/j.ijrobp.2007.03.003; Terasawa T, 2009, ANN INTERN MED, V151, P556, DOI 10.7326/0003-4819-151-8-200910200-00145; Chiba T, 2005, CLIN CANCER RES, V11, P3799, DOI 10.1158/1078-0432.CCR-04-1350; Durante M, 2010, NAT REV CLIN ONCOL, V7, P37, DOI 10.1038/nrclinonc.2009.183; De Ruysscher D, 2012, RADIOTHER ONCOL, V103, P5, DOI 10.1016/j.radonc.2012.01.003; Combs SE, 2013, ACTA ONCOL, V52, P1272, DOI 10.3109/0284186X.2013.818254; Peeters A, 2010, RADIOTHER ONCOL, V95, P45, DOI 10.1016/j.radonc.2009.12.002; Koh WJ, 2013, J NATL COMPR CANC NE, V11, P320; Malvezzi M, 2014, ANN ONCOL, V25, P1650, DOI 10.1093/annonc/mdu138; Durante M, 2013, TRENDS MOL MED, V19, P565, DOI 10.1016/j.molmed.2013.05.007; Bekelman JE, 2013, J NATL CANCER I, V105, P6, DOI 10.1093/jnci/djs508; Carozzo S, 2013, INT J RADIAT ONCOL, V85, P978, DOI 10.1016/j.ijrobp.2012.08.010; CASTRO JR, 1982, INT J RADIAT ONCOL, V8, P2191; Combs SE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-533; Deye JA, 2012, HEALTH PHYS, V103, P662, DOI 10.1097/HP.0b013e3182609bb7; DOE-NCI, 2013, WORKSH ION BEAM THER; Fossati P, 2012, PHYS MED BIOL, V57, P7543, DOI 10.1088/0031-9155/57/22/7543; Friedrich T, 2014, PHYS MEDICA, V30, P588, DOI 10.1016/j.ejmp.2014.04.009; Furukawa T, 2013, MED PHYS, V40, DOI 10.1118/1.4828845; Halperin EC, 2006, LANCET ONCOL, V7, P676, DOI 10.1016/S1470-2045(06)70795-1; IAEA, 2008, IAEA TECHN REP SER, V461; Iwata Y, 2013, NUCL INSTRUM METH B, V317, P793, DOI 10.1016/j.nimb.2013.03.050; Jensen AD, 2011, BRIT J RADIOL, V84, pS35, DOI 10.1259/bjr/71511359; Jermann M, 2014, INT J PARTICLE THERA, V1, P40; Pugh TJ, 2013, INT J RADIAT ONCOL, V87, P946, DOI 10.1016/j.ijrobp.2013.08.032; Rieken S, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-41; Steinstrater O, 2012, INT J RADIAT ONCOL, V84, P854, DOI 10.1016/j.ijrobp.2012.01.038; The Lancet Oncology, 2014, LANCET ONCOL, V15, P775; Tsujii H., 2014, CARBON ION RADIOTHER; Tuan J, 2013, J RADIAT RES, V54, P31, DOI 10.1093/jrr/rrt036; Valentini V, 2006, INT J RADIAT ONCOL, V64, P1129, DOI 10.1016/j.ijrobp.2005.09.017; Yonai S, 2012, MED PHYS, V39, P5028, DOI 10.1118/1.4736823; Yu JB, 2013, J NATL CANCER I, V105, P25, DOI 10.1093/jnci/djs463	51	16	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	FEB	2015	16	2					E93	E100				8	Oncology	Oncology	CA3YR	WOS:000348841700016		
J	Ogawa, R; Miwa, Y; Sumita, M; Saito, K; Kutsumizu, S				Ogawa, Ryoji; Miwa, Yohei; Sumita, Masato; Saito, Kazuya; Kutsumizu, Shoichi			Effects of the lateral substituent on the cubic phase formation of two analogous compounds, 4MODIFIER LETTER PRIME-n-hexadecyloxy-3MODIFIER LETTER PRIME-cyanobiphenyl-4-carboxylic acid (ACBC-16) and its 3MODIFIER LETTER PRIME-nitro compound (ANBC-16)	LIQUID CRYSTALS			English	Article						steric effect; cubic mesophase; hydrogen bonding; infrared spectroscopy; quantum chemical calculation	DENSITY-FUNCTIONAL THERMOCHEMISTRY; X-RAY-DIFFRACTION; BENZOIC-ACID; SMECTIC-D; 4-ALKYL-4'-ISOTHIOCYANATOBIPHENYL NTCB; OPTICAL MICROSCOPY; CARBOXYLIC-ACIDS; LIQUID-CRYSTALS; MESOPHASE; POLYMORPHISM	Two cubic (Cub) phase forming compounds, 4MODIFIER LETTER PRIME-n-hexadecyloxy-3MODIFIER LETTER PRIME-cyanobiphenyl-4-carboxylic acid (ACBC-16) and its 3 '-nitro analogue (ANBC-16) were studied by infrared (IR) spectroscopy. In the temperature region of the Cub phase, the molar fraction of hydrogen-bonded COOH groups estimated for ACBC-16 was by approximate to 0.05 at maximum larger than that for ANBC-16 and the aromatic ring CC stretching (nu(CC)(ring)) band frequency of ACBC-16 was by 3cm(-1) lower than that of ANBC-16. The quantum chemical calculation at DFT/B3LYP level, on the one hand, showed no meaningful difference in the stabilisation energy for dimerisation and the nu(CC)(ring) band frequency between the respective model compounds. These results can be ascribed to the different steric effects of the side groups; the CN group would make possible the close contact of neighbouring phenyl rings while the bulky NO2 group would not, giving slightly more stabilised dimerisation of ACBC-16 in the Cub phase than in ANBC-16.	[Ogawa, Ryoji; Miwa, Yohei; Kutsumizu, Shoichi] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 50111, Japan; [Sumita, Masato; Saito, Kazuya] Univ Tsukuba, Dept Chem, Fac Pure & Appl Sci, Tsukuba, Ibaraki 305, Japan	Kutsumizu, S (reprint author), Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 50111, Japan.	kutsu@gifu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [18550121, 25410091]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [446/19022012]; JSPS [26288031]	This work was partly supported by Grant-in-Aid for Scientific Research (C) [grant numbers 18550121 and 25410091] from Japan Society for the Promotion of Science (JSPS) and by Grant-in-Aid for Scientific Research on Priority Areas [grant number 446/19022012] from Ministry of Education, Culture, Sports, Science and Technology (MEXT) (both for S.K.) and by Grant-in-Aid for Scientific Research (B) [grant number 26288031] from JSPS (K.S.). [12,50]	Yamamura Y, 2012, J PHYS CHEM B, V116, P9255, DOI 10.1021/jp303972s; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; YAMAGUCHI T, 1995, CHEM PHYS LETT, V240, P105, DOI 10.1016/0009-2614(95)00524-8; Saito K, 2002, CHEM PHYS LETT, V366, P56, DOI 10.1016/S0009-2614(02)01535-X; Tschierske C, 2001, ANN RP CH C, V97, P191, DOI 10.1039/b101114f; BECKE AD, 1992, J CHEM PHYS, V97, P9173, DOI 10.1063/1.463343; Sorai M, 2003, CHEM REC, V3, P29, DOI 10.1002/tcr.10046; RANCON Y, 1988, J PHYS CHEM-US, V92, P2646, DOI 10.1021/j100320a049; Adachi T, 2013, B CHEM SOC JPN, V86, P1022, DOI 10.1246/bcsj.20130122; Diele S, 2002, CURR OPIN COLLOID IN, V7, P333, DOI 10.1016/S1359-0294(02)00086-9; Fujimura S, 2014, LIQ CRYST, V41, P927, DOI 10.1080/02678292.2014.892160; Saito K, 1998, LIQ CRYST, V25, P525; KATO T, 1993, B CHEM SOC JPN, V66, P3581, DOI 10.1246/bcsj.66.3581; Yamaoka Y, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3615491; ALLEN G, 1966, SPECTROCHIM ACTA, V22, P807, DOI 10.1016/0371-1951(66)80110-8; Khandpur AK, 1995, MACROMOLECULES, V28, P8796, DOI 10.1021/ma00130a012; Kutsumizu S, 2012, ISR J CHEM, V52, P844, DOI 10.1002/ijch.201200032; Horiuchi K, 2010, J PHYS CHEM B, V114, P4870, DOI 10.1021/jp100301r; MARIANI P, 1988, J MOL BIOL, V204, P165, DOI 10.1016/0022-2836(88)90607-9; LUZZATI V, 1967, NATURE, V215, P701, DOI 10.1038/215701a0; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Davies MM, 1938, J CHEM PHYS, V6, P767, DOI 10.1063/1.1750167; DEMUS D, 1968, Z NATURFORSCH PT A, VA 23, P84; DIELE S, 1972, MOL CRYST LIQ CRYST, V17, P163, DOI 10.1080/15421407208083838; Diele S., 1998, HDB LIQUID CRYSTAL B, V2B, P887; EARNEST TR, 1980, MACROMOLECULES, V13, P844, DOI 10.1021/ma60076a014; ETHERINGTON G, 1986, LIQ CRYST, V1, P209, DOI 10.1080/02678298608086509; ETHERINGTON G, 1988, LIQ CRYST, V3, P155, DOI 10.1080/02678298808086362; Even C, 2002, CHEMPHYSCHEM, V3, P1031, DOI 10.1002/cphc.200290005; Frisch M. J., 2004, GAUSSIAN 03 REVISION; GRAY GW, 1957, J CHEM SOC, P393, DOI 10.1039/jr9570000393; Gray GW, 1984, SMECTIC LIQUID CRYST, P68; Gray GW, 1986, ADV SYNTHESIS LIQUID, P22; GUILLON D, 1987, EUROPHYS LETT, V3, P79, DOI 10.1209/0295-5075/3/1/013; Imperor-Clerc M, 2005, CURR OPIN COLLOID IN, V9, P370, DOI 10.1016/j.cocis.2004.12.004; Imperor-Clerc M, 2000, LIQ CRYST, V27, P1001; Jinnai H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.010803; KUTSUMIZU S, 1994, LIQ CRYST, V16, P1109, DOI 10.1080/02678299408027881; Kutsumizu S, 1999, MOL CRYST LIQ CRYST, V330, P359, DOI [10.1080/10587259908025610, DOI 10.1080/10587259908025610]; Kutsumizu S, 1997, J PHYS CHEM B, V101, P10666, DOI 10.1021/jp9717913; Kutsumizu S, 2002, LIQ CRYST, V29, P1447, DOI 10.1080/0267829021000026069; Kutsumizu S, 2002, CURR OPIN SOLID ST M, V6, P537, DOI 10.1016/S1359-0286(03)00008-1; Kutsumizu S, 2006, LIQ CRYST, V33, P75, DOI 10.1080/02678290500445956; Kutsumizu S, 1999, CHEM COMMUN, P1181, DOI 10.1039/a902975c; Kutsumizu S, 2004, MOL CRYST LIQ CRYST, V412, P1659, DOI 10.1080/15421400490431183; Kutsumizu S, 2007, J APPL CRYSTALLOGR, V40, pS279, DOI 10.1107/S0021889807011958; Levelut AM, 1998, LIQ CRYST, V24, P105; Levelut AM, 1990, COLL PHYS COLL, V51; Nakazawa Y, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.094601; Nishikawa E, 2000, LIQ CRYST, V27, P1463; OGURA K, 1973, J POLYM SCI POL PHYS, V11, P2079, DOI 10.1002/pol.1973.180111015; Palafox MA, 2002, INT J QUANTUM CHEM, V89, P1, DOI 10.1002/qua.10202; Pelzl G, 1971, S FARADAY SOC, V5, P68, DOI 10.1039/sf9710500068; Saito K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031719; Saito K, 2000, LIQ CRYST, V27, P1555; Sato A, 1999, LIQ CRYST, V26, P1185, DOI 10.1080/026782999204219; Schoen AH, 1970, D5541 NASA, P1; Rao DSS, 1999, PHYS REV E, V59, P5572, DOI 10.1103/PhysRevE.59.5572; Silverstein R M, 1981, SPECTROSCOPIC IDENTI; Sorai M, 2003, LIQ CRYST, V30, P861, DOI 10.1080/0267829031000121206; Tansho M, 1998, LIQ CRYST, V24, P525; Tardieu A, 1976, J PHYS PARIS COLL, V37; Tschierske C, 2013, ANGEW CHEM INT EDIT, V52, P8828, DOI 10.1002/anie.201300872; UKLEJA P, 1988, PHYS REV A, V38, P4815, DOI 10.1103/PhysRevA.38.4815	65	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0267-8292	1366-5855		LIQ CRYST	Liq. Cryst.	FEB 1	2015	42	2					143	157		10.1080/02678292.2014.969342		15	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CB0DY	WOS:000349296800002		
J	Sato, O; Iwata, N; Kasai, T; Tsujii, Y; Kang, SM; Watanabe, J; Tokita, M				Sato, Osamu; Iwata, Naoto; Kasai, Takahiro; Tsujii, Yoshinobu; Kang, Sungmin; Watanabe, Junji; Tokita, Masatoshi			Nematic liquid crystal anchoring strengths of high density polymer brush surfaces	LIQUID CRYSTALS			English	Article						anchoring; nematic liquid crystal; glass transition temperature; in-plane switching; polymer brush	INPLANE SWITCHING MODE; ALIGNMENT; TEMPERATURE	The azimuthal anchoring coefficient A(2) of a nematic liquid crystal (NLC) on high-density polymer brushes was investigated using the threshold voltage for the in-plane switching of LC cells consisting of polymer-grafted substrates. A(2) was affected by the bulk glass transition temperature (T-g) of the grafted polymers and decreased with increasing temperature. The NLCs on poly(methyl methacrylate) (PMMA), poly(ethyl methacrylate) (PEMA) and poly(styrene) (PS) brushes had an A(2) of 10(-5)Jm(-2) at 25 degrees C. In contrast, the NLC on a poly(hexyl methacrylate) (PHMA) brush exhibited a small A(2) (1.1x10(-6)Jm(-2)) at 25 degrees C and was oriented along the electrodes owing to the brush surface unevenness. With increasing temperature to 90 degrees C, A(2) of the NLCs on the PEMA and PS brushes decreased to the values of 10(-7)Jm(-2), and the NLCs were oriented similar to the PHMA brush cell. Although the T(g)s of PMMA and PS are similar, at 90 degrees C the A(2) of the NLC on the PMMA brush was 4.5x10(-6)Jm(-2) and required a magnetic field for LC orientation. Such a difference in A(2) is explained by the fact that PS has better compatibility with the NLC than PMMA.	[Sato, Osamu] LG Display Co Ltd, Japan Lab, Shinagawa, Tokyo, Japan; [Iwata, Naoto; Kasai, Takahiro; Kang, Sungmin; Watanabe, Junji; Tokita, Masatoshi] Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 152, Japan; [Tsujii, Yoshinobu] Kyoto Univ, Inst Chem Res, Uji, Kyoto, Japan	Tokita, M (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 152, Japan.	mtokita@polymer.titech.ac.jp	TOKITA, Masatoshi/B-1075-2011	TOKITA, Masatoshi/0000-0002-4534-7337			Ohno K, 2005, MACROMOLECULES, V38, P2137, DOI 10.1021/ma048011q; Bryan-Brown GP, 1999, NATURE, V399, P338, DOI 10.1038/20646; Faetti S, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051708; Janossy I, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031714; Yoneya M, 1999, APPL PHYS LETT, V74, P803, DOI 10.1063/1.123373; Brandrup J., 1999, POLYM HDB; CHENG J, 1979, APPL PHYS LETT, V35, P444, DOI 10.1063/1.91166; Nemoto F, 2012, SOFT MATTER, V8, P11526, DOI 10.1039/c2sm26501j; Nespoulous M, 2007, J APPL PHYS, V102, DOI 10.1063/1.2784974; Ohe M, 1996, APPL PHYS LETT, V69, P623, DOI 10.1063/1.117927; Oswald P, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061703; Sato O, 2013, J MATER CHEM C, V1, P7992, DOI 10.1039/c3tc31700e; Sato O, 2013, LIQ CRYST, V40, P221, DOI 10.1080/02678292.2012.736546; Stoenescu DN, 2000, MOL CRYST LIQ CRYST, V351, P427, DOI 10.1080/10587250008023294; Syed IM, 2005, J APPL PHYS, V98, DOI [10.1063/1.1991972, 10.1063/1.19911972]; Tokita M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.071701; VETTER P, 1993, JPN J APPL PHYS 2, V32, pL1239; Yamaguchi R, 2001, MOL CRYST LIQ CRYST, V367, P379, DOI 10.1080/10587250108028658; Yamamoto J, 2006, Jpn Pat JP, Patent No. 84536	19	0	0	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0267-8292	1366-5855		LIQ CRYST	Liq. Cryst.	FEB 1	2015	42	2					181	188		10.1080/02678292.2014.974230		8	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CB0DY	WOS:000349296800006		
J	Heng, BT; Yeap, GY; Mahmood, WAK; Shinomiya, T; Uchida, N; Ito, MM				Heng, Boon-Teck; Yeap, Guan-Yeow; Mahmood, Wan Ahmad Kamil; Shinomiya, Teruo; Uchida, Nozomi; Ito, Masato M.			New heterocyclic metallomesogens: synthesis, mesomorphic and thermal behaviours of Cu(II) complexes with 1,2,3-triazole-based Schiff bases ligands	LIQUID CRYSTALS			English	Article						SmA; SmC; Cu(II) complexes; triazole	LIQUID-CRYSTALS SYNTHESIS; COPPER(II) COMPLEXES; NI(II) COMPLEXES; CLICK CHEMISTRY; DERIVATIVES; DIMERS; CHAINS	Two series of new Cu(II) complexes derived from the reaction of copper acetate with the non-linear 1,2,3-triazole-based Schiff bases have successfully been synthesised. The structures of the ligands and its complexes were elucidated by elemental analysis, FT-IR, H-1-NMR and UV-visible spectroscopic techniques. The differential scanning calorimetry and polarizing optical microscopy supported the anisotropic properties of uncoordinated ligands in which the focal conic fan-shaped texture and/or broken fan-shaped texture characteristics of respective SmA and SmC phases were recorded. However, not all of their corresponding Cu(II) complexes are mesogenic. Although the iodo-substituted ligands with even parity C10H29 to C14H33 are non-stable and exhibit SmA phase which is not reproducible, the ultimate Cu(II) complexes show exclusively stable SmA phase. This observation can be ascribed to the enhanced colinearity and molecular anisotropic by the presence of Cu-N and Cu-O coordination modes. On the other hand, the comparison studies show that different positions of ortho-hydroxyl group affect the mesomorphic and thermal behaviour of ligands and Cu(II) complexes.	[Heng, Boon-Teck; Yeap, Guan-Yeow; Mahmood, Wan Ahmad Kamil] Univ Sains Malaysia, Sch Chem Sci, Liquid Crystal Res Lab, Minden 11800, Penang, Malaysia; [Shinomiya, Teruo; Uchida, Nozomi; Ito, Masato M.] Soka Univ, Fac Engn, Dept Environm Engn Symbiosis, Hachioji, Tokyo 1928577, Japan	Yeap, GY (reprint author), Univ Sains Malaysia, Sch Chem Sci, Liquid Crystal Res Lab, Minden 11800, Penang, Malaysia.	gyyeap@usm.my			Universiti Sains Malaysia [1001/PKIMIA/811223]	The main author (G-Y. Yeap) would like to thank Universiti Sains Malaysia for the RU Grant No. [1001/PKIMIA/811223].	Abe Y, 2006, INORG CHIM ACTA, V359, P3934, DOI 10.1016/j.ica.2006.04.047; Yeap GY, 2009, LIQ CRYST, V36, P1431, DOI 10.1080/02678290903271504; Srividhya D, 2009, J MOL STRUCT, V927, P7, DOI 10.1016/j.molstruc.2009.01.035; Benbayer C, 2013, LIQ CRYST, V40, P1520, DOI 10.1080/02678292.2013.822111; Rezvani Z, 2006, POLYHEDRON, V25, P1915, DOI 10.1016/j.poly.2005.12.016; Gallardo H, 2008, LIQ CRYST, V35, P719, DOI 10.1080/02678290802120307; Sarkar DD, 2013, LIQ CRYST, V40, P468, DOI 10.1080/02678292.2012.757814; Frizon TE, 2014, LIQ CRYST, V41, P1162, DOI 10.1080/02678292.2014.909954; Donnio B, 2002, CURR OPIN COLLOID IN, V7, P371, DOI 10.1016/S1359-0294(02)00084-5; Jung BM, 2010, LIQ CRYST, V37, P85, DOI 10.1080/02678290903390940; Gallardo H, 2005, LIQ CRYST, V32, P667, DOI 10.1080/02678290500139732; Balamurugan S, 2014, LIQ CRYST, V41, P776, DOI 10.1080/02678292.2014.889231; Uppal BS, 2011, DALTON T, V40, P7610, DOI 10.1039/c1dt10634a; Cardinaels T, 2005, J AM CHEM SOC, V127, P17602, DOI 10.1021/ja056664w; Gray G. W., 1962, MOL STRUCTURE PROPER; Ha ST, 2009, LIQ CRYST, V36, P917, DOI 10.1080/02678290903131278; Huang KP, 2008, J CHROMATOGR A, V1215, P177, DOI 10.1016/j.chroma.2008.11.018; Liu JN, 2006, TURK J CHEM, V30, P41; Marcos M, 2004, J MATER CHEM, V14, P3321, DOI 10.1039/b409361e; Prasad D, 2012, INDIAN J CHEM B, V51, P731; Ooi YH, 2013, LIQ CRYST, V40, P516, DOI 10.1080/02678292.2012.761734; Patel DB, 2005, MOL CRYST LIQ CRYST, V432, P47, DOI 10.1080/154214090892799; Plasseraud L, 2002, J MATER CHEM, V12, P2653, DOI 10.1039/b203889g; Shanker G, 2011, J MATER CHEM, V21, P15279, DOI 10.1039/c1jm11947h; Suste A, 1996, LIQ CRYST, V20, P219, DOI 10.1080/02678299608031128; Velasco BE, 2011, SYNTHETIC COMMUN, V41, P2966, DOI 10.1080/00397911.2010.516052; Yeap GY, 2011, J MOL STRUCT, V999, P68, DOI 10.1016/j.molstruc.2011.05.036; Yeap GY, 2014, J CHEM SCI, V126, P247; Yeap GY, 2011, PHASE TRANSIT, V84, P29, DOI 10.1080/01411594.2010.513613; Yelamaggad CV, 2001, LIQ CRYST, V28, P351	30	3	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0267-8292	1366-5855		LIQ CRYST	Liq. Cryst.	FEB 1	2015	42	2					204	215		10.1080/02678292.2014.975291		12	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	CB0DY	WOS:000349296800009		
J	Yamaguchi, K; Nishimura, T; Ishiba, H; Seko, Y; Okajima, A; Fujii, H; Tochiki, N; Umemura, A; Moriguchi, M; Sumida, Y; Mitsuyoshi, H; Yasui, K; Minami, M; Okanoue, T; Itoh, Y				Yamaguchi, Kanji; Nishimura, Takeshi; Ishiba, Hiroshi; Seko, Yuya; Okajima, Akira; Fujii, Hideki; Tochiki, Nozomi; Umemura, Atsushi; Moriguchi, Michihisa; Sumida, Yoshio; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Okanoue, Takeshi; Itoh, Yoshito			Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice	LIVER INTERNATIONAL			English	Article						HFD; IL-6; insulin resistance; leptin; NAFLD; STAT3	ACTIVATED PROTEIN-KINASE; LIVER-DISEASE; IN-VITRO; NONALCOHOLIC STEATOHEPATITIS; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; RECEPTOR ANTIBODY; LIPID-METABOLISM; GENE-EXPRESSION; LINKING OBESITY	Background & AimsMice fed high-fat diet (HFD) demonstrate obesity-related systemic insulin resistance (IR). Aim of this study is to clarify the role of interleukin (IL)-6 in IR in vivo focusing on skeletal muscle, adipose tissue and liver. MethodsPlasma markers of IR and hepatic IL-6 signalling were examined in eight-week HFD feeding C57/BL6 mice. Furthermore, IR-related molecules in skeletal muscles, adipose tissues and livers were investigated following a single injection of anti- IL-6 receptor neutralizing antibody (MR16-1) in two-week HFD feeding mice. To investigate the role of IL-6 in hepatic steatosis by prolonged HFD, hepatic triglyceride accumulation was assessed in eight-week HFD feeding mice with continuous MR16-1 treatment. ResultsHigh-fat diet for both 2 and 8weeks elevated plasma IL-6, insulin and leptin, which were decreased by MR16-1 treatment. A single injection of MR16-1 ameliorated IR as assessed by glucose and insulin tolerance test, which may be attributable to upregulation of glucose transporter type 4 via phosphorylation of AMP-activated protein kinase as well as upregulation of peroxisome proliferator-activated receptor alpha in livers and, particularly, in skeletal muscles. MR16-1 also decreased mRNA expression of leptin and tumour necrosis factor-alpha and increased that of adiponectin in adipose tissue. High-fat diet for 8weeks, not 2weeks, induced hepatic steatosis and increased hepatic triglyceride content, all of which were ameliorated by MR16-1 treatment. ConclusionsBlockade of excessive IL-6 stimulus ameliorated HFD-induced IR in a skeletal muscle and modulated the production of adipokines from an early stage of NAFLD, leading to prevention of liver steatosis for a long term.	[Yamaguchi, Kanji; Nishimura, Takeshi; Ishiba, Hiroshi; Seko, Yuya; Okajima, Akira; Fujii, Hideki; Tochiki, Nozomi; Umemura, Atsushi; Moriguchi, Michihisa; Sumida, Yoshio; Mitsuyoshi, Hironori; Yasui, Kohichiroh; Minami, Masahito; Itoh, Yoshito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto 6028566, Japan; [Okanoue, Takeshi] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan	Yamaguchi, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kamigyou Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	ykanji@koto.kpu-m.ac.jp			Japan Society for the Program of Science	This study was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Program of Science (Kanji Yamaguchi and Yoshito Itoh).	Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Trujillo ME, 2004, J CLIN ENDOCR METAB, V89, P5577, DOI 10.1210/jc.2004-0603; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Glund S, 2007, DIABETES, V56, P1630, DOI 10.2337/db06-1733; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Jarrar MH, 2008, ALIMENT PHARM THERAP, V27, P412, DOI 10.1111/j.1365-2036.2007.03586.x; Ogata A, 2011, ANN RHEUM DIS, V70, P1164, DOI 10.1136/ard.2010.132845; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Uotani S, 2006, BIOCHEM BIOPH RES CO, V351, P171, DOI 10.1016/j.bbrc.2006.10.015; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Yamaguchi K, 2011, LAB INVEST, V91, P609, DOI 10.1038/labinvest.2011.2; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Okazaki M, 2002, IMMUNOL LETT, V84, P231, DOI 10.1016/S0165-2478(02)00202-X; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Serrano-Marco L, 2012, DIABETOLOGIA, V55, P743, DOI 10.1007/s00125-011-2401-4; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75; Jornayvaz FR, 2010, ANNU REV NUTR, V30, P273, DOI 10.1146/annurev.nutr.012809.104726; Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Vanni E, 2009, HEPATOLOGY, V50, P697, DOI 10.1002/hep.23031; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Lee MJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1230, DOI 10.1152/ajpendo.90927.2008; Sopasakis VR, 2004, DIABETOLOGIA, V47, P1879, DOI 10.1007/s00125-004-1544-y; Sun ZL, 2003, GASTROENTEROLOGY, V125, P202, DOI 10.1016/S0016-5085(03)00696-6	43	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	FEB	2015	35	2					550	561		10.1111/liv.12645		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA2BR	WOS:000348714500034		
J	Yamada, K; Mizukoshi, E; Sunagozaka, H; Arai, K; Yamashita, T; Takeshita, Y; Misu, H; Takamura, T; Kitamura, S; Zen, Y; Nakanuma, Y; Honda, M; Kaneko, S				Yamada, Kazutoshi; Mizukoshi, Eishiro; Sunagozaka, Hajime; Arai, Kuniaki; Yamashita, Tatsuya; Takeshita, Yumie; Misu, Hirofumi; Takamura, Toshinari; Kitamura, Seiko; Zen, Yoh; Nakanuma, Yasuni; Honda, Masao; Kaneko, Shuichi			Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis	LIVER INTERNATIONAL			English	Article						fatty acid metabolism; insulin resistance; palmitic acid; toxic lipid	LIVER-DISEASE; INSULIN-RESISTANCE; STEATOSIS; OBESITY; ASSOCIATION; PREVALENCE; PROTECTS; PLACEBO; INJURY; ELOVL6	Background & AimsNonalcoholic fatty liver disease (NAFLD) is closely related to insulin resistance and lipid metabolism. Recent studies have suggested that the quality of fat accumulated in the liver is associated with the development of nonalcoholic steatohepatitis (NASH). In this study, we investigated the fatty acid composition in liver tissue and its association with the pathology in NAFLD patients. MethodsOne hundred and three patients diagnosed with NAFLD [simple steatosis (SS): 63, NASH: 40] were examined and their hepatic fatty acids were measured using gas chromatography. In addition, relationships between the composition and composition ratios of various fatty acids and patient backgrounds, laboratory test values, histology of the liver, and expression of fat metabolism-related enzymes were investigated. ResultsThe C16:1n7 content, the C16:1n7/C16:0 and C18:1n9/C18:0 ratios were increased and the C18:0/C16:0 ratio was decreased in the NASH group. The C18:0/C16:0 and C18:1n9/C18:0 ratios were associated with the steatosis score in liver tissue, and the C16:1n7/C16:0 ratio was associated with the lobular inflammation score. The expressions levels of genes: SCD1, ELOVL6, SREBP1c, FAS and PPAR were enhanced in the NASH group. In multivariate analysis, the C18:0/C16:0 ratio was the most important factor that was correlated with the steatosis score. In contrast, the C16:1n7/C16:0 ratio was correlated with lobular inflammation. ConclusionThe fatty acid composition in liver tissue and expression of genes related to fatty acid metabolism were different between the SS and NASH groups, suggesting that the acceleration of fatty acid metabolism is deeply involved in pathogenesis of NASH.	[Yamada, Kazutoshi; Mizukoshi, Eishiro; Sunagozaka, Hajime; Arai, Kuniaki; Yamashita, Tatsuya; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 9208641, Japan; [Takeshita, Yumie; Misu, Hirofumi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan; [Kitamura, Seiko; Zen, Yoh] Kanazawa Univ Hosp, Div Pathol, Kanazawa, Ishikawa, Japan; [Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208641, Japan	Kaneko, S (reprint author), Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 9208641, Japan.	skaneko@m-kanazawa.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Honda M, 2006, HEPATOLOGY, V44, P1122, DOI 10.1002/hep.21383; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Nozaki Y, 2009, J HEPATOL, V51, P548, DOI 10.1016/j.jhep.2009.05.017; Zein CO, 2011, HEPATOLOGY, V54, P1610, DOI 10.1002/hep.24544; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI [10.1210/en.2005-0570, 10.1210/en.2006-0138]; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Pascale A, 2010, J GASTROINTEST LIVER, V19, P415; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Sanyal AJ, 2010, NEW ENGL J MED, V363, P1186; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656; Wang X, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-234	26	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	FEB	2015	35	2					582	590		10.1111/liv.12685		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA2BR	WOS:000348714500037		
J	Kasturiratne, A; Akiyama, K; Niriella, MA; Takeuchi, F; Isono, M; Dassanayake, AS; de Silva, AP; Wickremasinghe, RA; Kato, N; de Silva, HJ				Kasturiratne, Anuradhani; Akiyama, Koichi; Niriella, Madunil A.; Takeuchi, Fumihiko; Isono, Masato; Dassanayake, Anuradha S.; de Silva, Arjuna P.; Wickremasinghe, Rajitha A.; Kato, Norihiro; de Silva, Hithanadura J.			Association of genetic variants with non-alcoholic fatty liver disease in an urban Sri Lankan community	LIVER INTERNATIONAL			English	Letter									[Kasturiratne, Anuradhani; Niriella, Madunil A.; Dassanayake, Anuradha S.; de Silva, Arjuna P.; Wickremasinghe, Rajitha A.; de Silva, Hithanadura J.] Univ Kelaniya, Fac Med, Ragama, Sri Lanka; [Akiyama, Koichi; Takeuchi, Fumihiko; Isono, Masato; Kato, Norihiro] Natl Ctr Global Hlth & Med, Res Inst, Tokyo, Japan	Kasturiratne, A (reprint author), Univ Kelaniya, Fac Med, Ragama, Sri Lanka.			Niriella, Madunil/0000-0002-7213-5858			Calich AL, 2013, LIVER INT, V33, P909, DOI 10.1111/liv.12155	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1478-3223	1478-3231		LIVER INT	Liver Int.	FEB	2015	35	2					676	679		10.1111/liv.12624		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CA2BR	WOS:000348714500050		
J	Yamada, N; Sanada, Y; Hirata, Y; Okada, N; Wakiya, T; Ihara, Y; Miki, A; Kaneda, Y; Sasanuma, H; Urahashi, T; Sakuma, Y; Yasuda, Y; Mizuta, K				Yamada, Naoya; Sanada, Yukihiro; Hirata, Yuta; Okada, Noriki; Wakiya, Taiichi; Ihara, Yoshiyuki; Miki, Atsushi; Kaneda, Yuji; Sasanuma, Hideki; Urahashi, Taizen; Sakuma, Yasunaru; Yasuda, Yoshikazu; Mizuta, Koichi			Selection of Living Donor Liver Grafts for Patients Weighing 6kg or Less	LIVER TRANSPLANTATION			English	Article							LEFT-LATERAL SEGMENT; SINGLE-CENTER EXPERIENCE; SMALL INFANTS; TRANSPLANTATION; MONOSEGMENTS; REDUCTION; CHILDREN	In the field of pediatric living donor liver transplantation (LDLT), physicians sometimes must reduce the volume of left lateral segment (LLS) grafts to prevent large-for-size syndrome. There are 2 established methods for decreasing the size of an LLS graft: the use of a segment 2 (S2) monosegment graft and the use of a reduced LLS graft. However, no procedure for selecting the proper graft type has been established. In this study, we conducted a retrospective investigation of LDLT and examined the strategy of graft selection for patients weighing 6 kg. LDLT was conducted 225 times between May 2001 and December 2012, and 15 of the procedures were performed in patients weighing 6 kg. We selected S2 monosegment grafts and reduced LLS grafts if the preoperative computed tomography (CT)-volumetry value of the LLS graft was >5% and 4% to 5% of the graft/recipient weight ratio, respectively. We used LLS grafts in 7 recipients, S2 monosegment grafts in 4 recipients, reduced S2 monosegment grafts in 3 recipients, and a reduced LLS graft in 1 recipient. The reduction rate of S2 monosegment grafts for use as LLS grafts was 48.3%. The overall recipient and graft survival rates were both 93.3%, and 1 patient died of a brain hemorrhage. Major surgical complications included hepatic artery thrombosis in 2 recipients, bilioenteric anastomotic strictures in 2 recipients, and portal vein thrombosis in 1 recipient. In conclusion, our graft selection strategy based on preoperative CT-volumetry is highly useful in patients weighing 6 kg. S2 monosegment grafts are effective and safe in very small infants particularly neonates. Liver Transpl 21:233-238, 2015. (c) 2014 AASLD.	[Yamada, Naoya; Sanada, Yukihiro; Hirata, Yuta; Okada, Noriki; Wakiya, Taiichi; Ihara, Yoshiyuki; Urahashi, Taizen; Mizuta, Koichi] Jichi Med Univ, Dept Transplant Surg, Shimotsuke, Tochigi 3290498, Japan; [Miki, Atsushi; Kaneda, Yuji; Sasanuma, Hideki; Sakuma, Yasunaru; Yasuda, Yoshikazu] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi 3290498, Japan	Yamada, N (reprint author), Jichi Med Univ, Dept Transplant Surg, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	yn708@jichi.ac.jp					BROELSCH CE, 1991, ANN SURG, V214, P428, DOI 10.1097/00000658-199110000-00007; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; Jain A, 2002, TRANSPLANTATION, V73, P941, DOI 10.1097/00007890-200203270-00020; Kasahara M, 2013, LIVER TRANSPLANT, V19, P226, DOI 10.1002/lt.23572; Kasahara M, 2008, J PEDIATR SURG, V43, P1575, DOI 10.1016/j.jpedsurg.2008.02.056; desSantibanes E, 2000, LIVER TRANSPLANT, V6, P108; FERREIRA CT, 2000, J PEDIAT RIO J, V76, pS198; Kanazawa H, 2013, TRANSPLANTATION, V95, P750, DOI 10.1097/TP.0b013e31827a93b4; Kasahara M, 2003, TRANSPLANT P, V35, P1425, DOI 10.1016/S0041-1345(03)00445-7; Kasahara M, 2003, TRANSPLANTATION, V76, P694, DOI 10.1097/01.TP.0000079446.94204.F9; Magee JC, 2004, AM J TRANSPLANT, V4, P54, DOI 10.1111/j.1600-6143.2004.00398.x; McDiarmid SV, 2003, PEDIATR CLIN N AM, V50, P1335, DOI 10.1016/S0031-3955(03)00150-0; Mentha G, 1996, TRANSPLANTATION, V62, P1176, DOI 10.1097/00007890-199610270-00026; Mizuta K, 2010, AM J TRANSPLANT, V10, P2547, DOI 10.1111/j.1600-6143.2010.03274.x; Noujaim HM, 2002, J PEDIATR SURG, V37, P159, DOI 10.1053/jpsu.2002.30242; Ogawa K, 2007, TRANSPLANTATION, V83, P1337, DOI 10.1097/01.tp.0000263340.82489.18; OTTE JB, 1990, ANN SURG, V211, P146, DOI 10.1097/00000658-199002000-00006; Rogiers X, 1996, ANN SURG, V224, P331, DOI 10.1097/00000658-199609000-00009; Shehata MR, 2012, AM J TRANSPLANT, V12, P3406, DOI 10.1111/j.1600-6143.2012.04268.x; Shirouzu Y, 2010, PEDIATR TRANSPLANT, V14, P709, DOI 10.1111/j.1399-3046.2010.01332.x; Srinivasan P, 1999, SURGERY, V126, P10, DOI 10.1067/msy.1999.98686; STARZL TE, 1979, PEDIATRICS, V63, P825; STRONG R, 1995, SURGERY, V118, P904, DOI 10.1016/S0039-6060(05)80283-1; Urahashi T, 2012, PEDIATR TRANSPLANT, V16, P783, DOI 10.1111/j.1399-3046.2012.01764.x	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	FEB	2015	21	2					233	238		10.1002/lt.24048		6	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	CA0AC	WOS:000348575400012		
J	Akamatsu, N; Sugawara, Y; Nakazawa, A; Nishioka, Y; Kaneko, J; Aoki, T; Sakamoto, Y; Hasegawa, K; Kokudo, N				Akamatsu, Nobuhisa; Sugawara, Yasuhiko; Nakazawa, Akiko; Nishioka, Yujiro; Kaneko, Junichi; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kokudo, Norihiro			Hemostatic Status in Liver Transplantation: Association Between Preoperative Procoagulants/Anticoagulants and Postoperative Hemorrhaging/Thrombosis	LIVER TRANSPLANTATION			English	Article							CONVENTIONAL COAGULATION TESTS; HEPATIC-ARTERY THROMBOSIS; VENOUS RECONSTRUCTION; CIRRHOSIS; DISEASE; TRANSFUSION; HYPERCOAGULABILITY; COMPLICATIONS; MANAGEMENT; REQUIREMENTS	The delicate rebalanced hemostatic status of liver transplant recipients may lead to both hemorrhagic and thrombotic tendencies in this population. The aim of this study was to investigate the association between pretransplant procoagulants/anticoagulants and posttransplant bleeding and thrombosis among living donor liver transplant recipients. The study subjects were 403 consecutive recipients with chronic liver disease. Perioperative variables, including preoperative values for procoagulants and anticoagulants, were assessed to determine their association with posttransplant hemorrhaging and thrombosis. There were 35 hemorrhagic complications (9%) and 21 thrombotic complications (5%). In logistic regression analyses, a higher Model for End-Stage Liver Disease score (P = 0.01) and a lower fibrinogen value (P<0.001) were independently associated with hemorrhaging, whereas only a lower protein C value (P<0.001) was independently associated with thrombosis. In a receiver operating characteristic analysis, a low preoperative protein C value (with the most accurate cutoff value being 25%) was a reliable predictor of thrombotic complications after liver transplantation (area under the curve = 0.921, P<0.001, sensitivity = 0.9, specificity = 0.8). In conclusion, the decreases in both procoagulants and anticoagulants in liver transplant recipients may additively result in a delicate hemostatic balance and predispose patients to both hemorrhagic and thrombotic complications. A lower preoperative protein C value (<25%) was demonstrated to be a significant and reliable predictor of postoperative thrombotic complications in liver transplant recipients. Liver Transpl 21:258-265, 2015. (c) 2014 AASLD.	[Akamatsu, Nobuhisa; Sugawara, Yasuhiko; Nakazawa, Akiko; Nishioka, Yujiro; Kaneko, Junichi; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div, Tokyo 1138655, Japan	Sugawara, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasusuga-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	LERUT J, 1987, ANN SURG, V205, P404, DOI 10.1097/00000658-198704000-00011; Okazaki M, 2006, LIVER TRANSPLANT, V12, P46, DOI 10.1002/lt.20550; Massicotte L, 2012, TRANSPLANTATION, V93, P1276, DOI 10.1097/TP.0b013e318250fc25; Massicotte L, 2008, TRANSPLANTATION, V85, P956, DOI 10.1097/TP.0b013e318168fcd4; Tripodi A, 2011, J THROMB HAEMOST, V9, P1713, DOI 10.1111/j.1538-7836.2011.04429.x; Tripodi A, 2013, J HEPATOL, V59, P265, DOI 10.1016/j.jhep.2013.03.036; Duffy JP, 2009, J AM COLL SURGEONS, V208, P896, DOI 10.1016/j.jamcollsurg.2008.12.032; Lisman T, 2006, HEPATOLOGY, V44, P53, DOI 10.1002/hep.21231; Tripodi A, 2009, GASTROENTEROLOGY, V137, P2105, DOI 10.1053/j.gastro.2009.08.045; Lisman T, 2010, J HEPATOL, V52, P355, DOI 10.1016/j.jhep.2009.12.001; Rahbari NN, 2011, HPB, V13, P528, DOI 10.1111/j.1477-2574.2011.00319.x; Weeder PD, 2014, TRANSFUS MED REV, V28, P107, DOI 10.1016/j.tmrv.2014.03.002; Bekker J, 2009, AM J TRANSPLANT, V9, P746, DOI 10.1111/j.1600-6143.2008.02541.x; Tripodi A, 2009, THROMB RES, V124, P132, DOI 10.1016/j.thromres.2008.11.008; Caldwell SH, 2006, HEPATOLOGY, V44, P1039, DOI 10.1002/hep.21303; Arshad F, 2013, LIVER INT, V33, P820, DOI 10.1111/liv.12140; BenAri Z, 1997, J HEPATOL, V26, P554, DOI 10.1016/S0168-8278(97)80420-5; Pereboom ITA, 2009, ANESTH ANALG, V108, P1083, DOI 10.1213/ane.0b013e3181948a59; Tripodi A, 2005, HEPATOLOGY, V41, P553, DOI 10.1002/hep.20569; Warnaar N, 2008, J THROMB HAEMOST, V6, P297, DOI 10.1111/j.1538-7836.2007.02831.x; Kokudo N, 2005, AM J TRANSPLANT, V5, P1694, DOI 10.1111/j.1600-6143.2005.00917.x; Lisman T, 2010, BLOOD, V116, P878, DOI 10.1182/blood-2010-02-261891; Tripodi A, 2010, HEPATOLOGY, V52, P249, DOI 10.1002/hep.23653; Sugawara Y, 2004, LIVER TRANSPLANT, V10, P541, DOI 10.1002/lt.20129; desBoer MT, 2005, DIGEST SURG, V22, P265; desBoer MT, 2008, ANESTH ANALG, V106, P32; Ghaffaripour S, 2011, PROG TRANSPLANT, V21, P254; Hendriks H G D, 2005, Transpl Int, V17, P673, DOI 10.1007/s00147-004-0793-5; Jung JW, 2012, TRANSPL P, V44, P765, DOI 10.1016/j.transproceed.2012.01.011; Kishi Y, 2005, CLIN TRANSPLANT, V19, P769, DOI 10.1111/j.1399-0012.2005.00419.x; Laffi G, 2007, J HEPATOL, V47, P625, DOI 10.1016/j.jhep.2007.08.006; LEWIS JH, 1987, TRANSFUSION, V27, P222, DOI 10.1046/j.1537-2995.1987.27387235624.x; Lisman T, 2012, J HEPATOL, V56, P993, DOI 10.1016/j.jhep.2011.08.013; Massicotte L, 2005, CAN J ANAESTH, V52, P148; Saner FH, 2013, DIGESTION, V88, P135, DOI 10.1159/000354400; Sharara AI, 2001, NEW ENGL J MED, V345, P669, DOI 10.1056/NEJMra003007; Sugawara Y, 2002, TRANSPLANT P, V34, P3325, DOI 10.1016/S0041-1345(02)03576-5; Sugawara Yasuhiko, 2003, J Hepatobiliary Pancreat Surg, V10, P1; Tinmouth A, 2012, TRANSFUS APHER SCI, V46, P293, DOI 10.1016/j.transci.2012.03.019; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Waki K, 2011, Clin Transpl, P223; Wu SC, 2012, ANN TRANSPL, V17, P64	42	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	FEB	2015	21	2					258	265		10.1002/lt.24038		8	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	CA0AC	WOS:000348575400015		
J	Baimakhanov, Z; Soyama, A; Takatsuki, M; Hidaka, M; Hirayama, T; Kinoshita, A; Natsuda, K; Kuroki, T; Eguchi, S				Baimakhanov, Zhassulan; Soyama, Akihiko; Takatsuki, Mitsuhisa; Hidaka, Masaaki; Hirayama, Takanori; Kinoshita, Ayaka; Natsuda, Koji; Kuroki, Tamotsu; Eguchi, Susumu			Preoperative Simulation With a 3-Dimensional Printed Solid Model for One-Step Reconstruction of Multiple Hepatic Veins During Living Donor Liver Transplantation	LIVER TRANSPLANTATION			English	Letter									[Baimakhanov, Zhassulan; Soyama, Akihiko; Takatsuki, Mitsuhisa; Hidaka, Masaaki; Hirayama, Takanori; Kinoshita, Ayaka; Natsuda, Koji; Kuroki, Tamotsu; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan	Eguchi, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sueguchi@nagasaki-u.ac.jp					Ohshima S, 2014, J HEPATO-BIL-PAN SCI, V21, P235, DOI 10.1002/jhbp.81; Ikegami T, 2007, TRANSPLANTATION, V84, P836, DOI 10.1097/01.tp.0000282790.66889.a5; Lee SG, 2006, J HEPATO-BILIARY-PAN, V13, P131, DOI 10.1007/s00534-005-1019-7; Mochizuki K, 2012, ANN TRANSPL, V17, P31	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	FEB	2015	21	2					266	268		10.1002/lt.24019		3	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	CA0AC	WOS:000348575400016		
J	Yamamoto, T; Hoshina, K; Nishizawa, B; Meathrel, CE; Phillips, RA; Watanuki, Y				Yamamoto, Takashi; Hoshina, Kenji; Nishizawa, Bungo; Meathrel, Catherine E.; Phillips, Richard A.; Watanuki, Yutaka			Annual and seasonal movements of migrating short-tailed shearwaters reflect environmental variation in sub-Arctic and Arctic waters	MARINE BIOLOGY			English	Article							SOUTHEASTERN BERING-SEA; DAYTIME SURFACE SWARMS; CHUKCHI SEAS; THYSANOESSA-INERMIS; CLIMATE-CHANGE; NONBREEDING PERIOD; PRIBILOF ISLANDS; FORAGING ECOLOGY; BODY CONDITION; LIFE-HISTORY	The marine ecosystems of the Bering Sea and adjacent southern Chukchi Sea are experiencing rapid changes due to recent reductions in sea ice. Short-tailed shearwaters Puffinus tenuirostris visit this region in huge numbers between the boreal summer and autumn during non-breeding season, and represent one of the dominant top predators. To understand the implications for this species of ongoing environmental change in the Pacific sub-Arctic and Arctic seas, we tracked the migratory movements of 19 and 24 birds in 2010 and 2011, respectively, using light-level geolocators. In both years, tracked birds occupied the western (Okhotsk Sea and Kuril Islands) and eastern (southeast Bering Sea) North Pacific from May to July. In August-September of 2010, but not 2011, a substantial proportion (68 % of the tracked individuals in 2010 compared to 38 % in 2011) moved through the Bering Strait to feed in the Chukchi Sea. Based on the correlation with oceanographic variables, the probability of shearwater occurrence was highest in waters with sea surface temperatures (SSTs) of 8-10 A degrees C over shallow depths. Furthermore, shearwaters spent more time flying when SST was warmer than 9 A degrees C, suggesting increased search effort for prey. We hypothesized that the northward shift in the distribution of shearwaters may have been related to temperature-driven changes in the abundance of their dominant prey, krill (Euphausiacea), as the timing of krill spawning coincides with the seasonal increase in water temperature. Our results indicate a flexible response of foraging birds to ongoing changes in the sub-Arctic and Arctic ecosystems.	[Yamamoto, Takashi] Natl Inst Polar Res, Arctic Environm Res Ctr, Tachikawa, Tokyo 1908518, Japan; [Yamamoto, Takashi; Hoshina, Kenji; Nishizawa, Bungo; Watanuki, Yutaka] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Meathrel, Catherine E.] La Trobe Univ, Dept Environm Management & Ecol, Wodonga, Vic 3690, Australia; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Yamamoto, T (reprint author), Natl Inst Polar Res, Arctic Environm Res Ctr, 10-3 Midori Cho, Tachikawa, Tokyo 1908518, Japan.	taka.y@nipr.ac.jp			Japanese Society for Promotion of Science [20241001, 22405007]; Green Network of Excellence Program - Ministry of Education, Culture, Sports, Science, and Technology, Japan	We would like to thank Bruce Robertson and Atsuo Ito for the field assistance, and Kohei Matsuno, Mark J. Carey, George Hunt, and an anonymous reviewer for useful comments on the manuscript. The study was supported by the Japanese Society for Promotion of Science (#20241001, #22405007) and Green Network of Excellence Program funded by the Ministry of Education, Culture, Sports, Science, and Technology, Japan. Research was carried out under La Trobe University Animal Ethics Project AEC 10/32 (W) and Tasmanian Department of Primary Industries Permits to Take Wildlife for Scientific Purposes FA10161 and FA11212 held by CE Meathrel.	Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Hunt GL, 1996, MAR ECOL PROG SER, V141, P1, DOI 10.3354/meps141001; Grebmeier JM, 2012, ANNU REV MAR SCI, V4, P63, DOI 10.1146/annurev-marine-120710-100926; Iverson SJ, 2007, MAR ECOL PROG SER, V352, P235, DOI 10.3354/meps07073; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; Wong SNP, 2014, J GEOPHYS RES-OCEANS, V119, P1691, DOI 10.1002/2013JC009198; Coyle KO, 2005, FISH OCEANOGR, V14, P77, DOI 10.1111/j.1365-2419.2005.00367.x; Gall AE, 2013, CONT SHELF RES, V67, P96, DOI 10.1016/j.csr.2012.11.004; Berline L, 2008, MAR ECOL PROG SER, V360, P163, DOI 10.3354/meps07387; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Kurasawa Kouta, 2011, Japanese Journal of Ornithology, V60, P216, DOI 10.3838/jjo.60.216; Hunt GL, 1998, MAR ECOL PROG SER, V167, P241, DOI 10.3354/meps167241; SPRINGER AM, 1989, CONT SHELF RES, V9, P359, DOI 10.1016/0278-4343(89)90039-3; Weimerskirch H, 1998, MAR ECOL PROG SER, V167, P261, DOI 10.3354/meps167261; SMITH SE, 1988, B MAR SCI, V42, P76; Post E, 2013, SCIENCE, V341, P519, DOI 10.1126/science.1235225; Yamamoto T, 2010, AUK, V127, P871, DOI 10.1525/auk.2010.10029; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Serreze MC, 2007, SCIENCE, V315, P1533, DOI 10.1126/science.1139426; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; DALPADADO P, 1991, POLAR RES, V10, P443, DOI 10.1111/j.1751-8369.1991.tb00665.x; Mackley EK, 2010, MAR ECOL PROG SER, V406, P291, DOI 10.3354/meps08532; Le Corre M, 2012, BIOL CONSERV, V156, P83, DOI 10.1016/j.biocon.2011.11.015; MOORE SE, 1995, ARCTIC, V48, P155; Eisner L, 2013, POLAR BIOL, V36, P87, DOI 10.1007/s00300-012-1241-0; Ladd C, 2005, FISH OCEANOGR, V14, P178, DOI 10.1111/j.1365-2419.2005.00374.x; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Shimada K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025624; Steele M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031651; Aydin K, 2007, DEEP-SEA RES PT II, V54, P2501, DOI 10.1016/j.dsr2.2007.08.022; LINDLEY JA, 1980, MAR BIOL, V59, P225, DOI 10.1007/BF00404745; Vlietstra LS, 2005, FISH OCEANOGR, V14, P196, DOI 10.1111/j.1365-2419.2005.00369.x; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Bluhm BA, 2007, DEEP-SEA RES PT II, V54, P2919, DOI 10.1016/j.dsr2.2007.08.015; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Baduini CL, 2001, MAR ECOL PROG SER, V222, P265, DOI 10.3354/meps222265; Baduini CL, 2006, MAR ECOL PROG SER, V320, P279, DOI 10.3354/meps320279; Barton K., 2013, MUMIN MULTIMODEL INF; BirdLife International, 2004, TRACK OC WAND GLOB D; Brinton E., 1962, Bulletin Scripps Institution of Oceanography, V8, P51; Carey MJ, 2009, EMU, V109, P310, DOI 10.1071/MU09059; Carey MJ, 2014, EMU, V114, P352, DOI 10.1071/MU13115; Coyle KO, 2002, DEEP-SEA RES PT II, V49, P6009, DOI 10.1016/S0967-0645(02)00331-4; COYLE KO, 1993, CONT SHELF RES, V13, P803, DOI 10.1016/0278-4343(93)90028-V; Deibel D, 2007, ELSEV OCEANOGR SERIE, V74, P271, DOI 10.1016/S0422-9894(06)74009-0; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; HANAMURA Y, 1989, MAR BIOL, V102, P369, DOI 10.1007/BF00428489; HIGHSMITH RC, 1990, NATURE, V344, P862, DOI 10.1038/344862a0; Hill Roger D., 1994, P227; Hopcroft RR, 2010, DEEP-SEA RES PT II, V57, P27, DOI 10.1016/j.dsr2.2009.08.003; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P6147, DOI 10.1016/S0967-0645(02)00338-7; Hunt GL, 2013, J MARINE SYST, V109, P43, DOI 10.1016/j.jmarsys.2012.08.003; Iguchi N, 2004, J PLANKTON RES, V26, P1015, DOI 10.1093/plankt/fbh092; Jahncke J, 2005, MAR ECOL PROG SER, V305, P219, DOI 10.3354/meps305219; Jessopp MJ, 2013, MAR BIOL, V160, P2755, DOI 10.1007/s00227-013-2268-7; Kotori M, 1994, GEKKAN KAIYO, V26, P248; Lovvorn JR, 2001, ECOLOGY, V82, P2342, DOI 10.1890/0012-9658(2001)082[2342:MUVAFF]2.0.CO;2; Lowry Lloyd F., 2004, Journal of Cetacean Research and Management, V6, P215; Matsuno K, 2012, ICES J MAR SCI, V69, P1205, DOI 10.1093/icesjms/fss119; Moss Jamal H., 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P191; Nemoto T, 1962, J OCEANOGR SOC JPN, P615; Ogi H., 1980, Journal of the Yamashina Institute for Ornithology, V12, P157; Piatt John F., 2003, Marine Ornithology, V31, P141; Piatt JF, 1991, STUDIES HIGH LATITUD, P21; Pinet P, 2011, MAR ECOL PROG SER, V423, P291, DOI 10.3354/meps08971; Ponomareva LA, 1966, ISRAEL PROGRAM SCI T; R Development Core Team, 2008, R LANG ENV STAT COMP; Ressler PH, 2012, DEEP-SEA RES PT II, V65-70, P184, DOI 10.1016/j.dsr2.2012.02.015; Schneider DC, 1997, IBIS, V139, P175, DOI 10.1111/j.1474-919X.1997.tb04520.x; Schneider David C., 1993, Reviews in Fisheries Science, V1, P311; SCHNEIDER DC, 1986, CONT SHELF RES, V5, P241, DOI 10.1016/0278-4343(86)90017-8; Serventy DL, 1967, P 14 INT ORN C, P165; Sigler MF, 2012, DEEP-SEA RES PT II, V65-70, P292, DOI 10.1016/j.dsr2.2012.02.017; Sigler MF, 2011, OCEANOGRAPHY, V24, P250; SMITH SL, 1991, POLAR RES, V10, P461, DOI 10.1111/j.1751-8369.1991.tb00666.x; Spear LB, 1997, IBIS, V139, P234, DOI 10.1111/j.1474-919X.1997.tb04621.x; Stafford KM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL040724; Toge K, 2011, P ROY SOC B-BIOL SCI, V278, P2584, DOI 10.1098/rspb.2010.2345; VIDAL J, 1986, DEEP-SEA RES, V33, P523, DOI 10.1016/0198-0149(86)90129-9; Wassmann P, 2011, PROG OCEANOGR, V90, P1, DOI 10.1016/j.pocean.2011.02.002; Wood S. N, 2006, GEN ADDITIVE MODELS; Woodgate RA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL054092; Woodgate RA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041621; Zydelis R, 2011, P ROY SOC B-BIOL SCI, V278, P3191, DOI 10.1098/rspb.2011.0330	90	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-3162	1432-1793		MAR BIOL	Mar. Biol.	FEB	2015	162	2					413	424		10.1007/s00227-014-2589-1		12	Marine & Freshwater Biology	Marine & Freshwater Biology	AZ9WI	WOS:000348564300016		
J	Blasiak, R; Yagi, N; Kurokura, H				Blasiak, Robert; Yagi, Nobuyuki; Kurokura, Hisashi			Impacts of hegemony and shifts in dominance on marine capture fisheries	MARINE POLICY			English	Article						Sustainable fisheries management; Hegemony; Cooperation; Balloon effects; Marine capture fisheries; Game theory		Catch data indicates that the world's 25 largest marine capture fisheries have generally comprised some 40-50% of the total annual reported catch (1950-2012). From a game theory perspective, there is considerable diversity across these 25 fisheries, both in terms of the number of players and the management paradigms. Here, a dominance-oriented classification system is proposed, according to which fisheries are categorized into: (1) hegemonic systems with single-player dominance; (2) coupled systems with two-player dominance; (3) group systems with shared dominance; (4) systems with no dominant player. Among these categories, the fourth represents perhaps the greatest challenge to sustainable management, while also demonstrating the challenges of managing common pool marine ecosystem services in areas beyond national jurisdiction (ABM). The survey and analysis highlights how hegemonic conditions tend to preclude the establishment of cooperative agreements irrespective of the number of players involved in the fishery. Shifts in dominance away from hegemony, as demonstrated most recently in the case of the highly migratory Pacific Saucy, can open the door to greater cooperation. Movement of fish stocks and displacement of fishing activities, due for example to climate change, have the capacity to cause major shifts in dominance and, in some cases, destabilize existing cooperative mechanisms. (C) 2014 Elsevier Ltd. All rights reserved.	[Blasiak, Robert; Yagi, Nobuyuki; Kurokura, Hisashi] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo ku, Tokyo 1138657, Japan	Blasiak, R (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	a-rb@mail.ecc.u-tokyo.ac.jp					Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Allen R, 2010, 536 FAO; Bakun A, 2006, PROG OCEANOGR, V68, P271, DOI 10.1016/j.pocean.2006.02.004; Hannesson R, 2011, ANNU REV RESOUR ECON, V3, P181, DOI 10.1146/annurev-resource-083110-120107; Pintassilgo P, 2010, ENVIRON RESOUR ECON, V46, P377, DOI 10.1007/s10640-010-9346-9; Kwon OS, 2006, ENVIRON RESOUR ECON, V33, P463, DOI 10.1007/s10640-005-4994-x; Chouvy PA, 2013, J DRUG ISSUES, V43, P216, DOI 10.1177/0022042612467989; Arnason R, 2000, MARINE RESOURCE EC, V15, P293; Bailey KM, 2011, ECOL SOC, V16; Balton D.A, 2014, STATES BALTON SUPPOR; Bjorndal, 2007, RELEVANCE BIOECONOMI; Brasao A, 2000, MARINE RESOURCE EC, V15, P341; Carrera P, 2003, SCI MAR, V67, P245; Food and Agriculture Organization, 2012, STAT WORLD FISH AQ 2; Food and Agriculture Organization, 2014, FISHSTATJ SOFTW FISH; Hannesson R, 1997, J ENVIRON ECON MANAG, V32, P309, DOI 10.1006/jeem.1997.0971; Koehler HR, 2013, 201302 ISSF; Lindroos M, 2007, ADV FISHERIES EC FES; Lodge M.W., 2007, RECOMMENDED BEST PRA; Maihold G., 2009, RP10 SWP; Ministry of Agriculture Forestry and Fisheries (IVIAFF), 2013, LOC SECR N PAC FISH; Munro Van Houtte Willmann, 2004, 465 FAO; Pintassilgo P., 2008, INT GAME THEORY REV, V10, P303; South Pacific Regional Fishery Management Organization, 2009, INF DESCR C IN PRESS; United Nations, 1995, TECHNICAL REPORT; United Nations, 1982, UN CONV LAW SEA 1982	26	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0308-597X	1872-9460		MAR POLICY	Mar. Pol.	FEB	2015	52						52	58		10.1016/j.marpol.2014.11.001		7	Environmental Studies; International Relations	Environmental Sciences & Ecology; International Relations	CA6XM	WOS:000349060800008		
J	Kino, A; Uemura, H; Yasui, T				Kino, Ayako; Uemura, Hirokazu; Yasui, Toshiyuki			Different levels of awareness and knowledge of male climacteric in female nurses and female office workers	MATURITAS			English	Article						Nurse; Awareness; Knowledge; Male climacteric	LATE-ONSET HYPOGONADISM; TESTOSTERONE DEFICIENCY SYNDROME; AGING MEN; ANDROPAUSE	Objective: The objective of this study was to examine levels of awareness and knowledge regarding male climacteric or andropause in Japanese women. We also examined whether there are differences in these levels between nurses as a health profession group and office workers as a general population group. Methods: Two thousand and eight hundred female registered nurses and women with office-related general occupations aged 20-65 years in Japan completed health questionnaires regarding awareness and knowledge of male climacteric, including male menopausal symptoms and treatments. Results: The proportion in women who had heard of the term male climacteric in nurses was significantly higher than that in office workers. Nurses with past or current experience of menopausal symptoms were likely to recognize male climacteric. Nurses also had a higher level of knowledge than did office workers regarding male menopausal symptoms. High proportions of both nurses and office workers acknowledged depressed mood, irritability, nervousness and sleep problems as male menopausal symptoms. The proportions of women with sympathy for men with male climacteric were high in women with experience of past or current menopausal symptoms and in women who were close to men who suffered from menopausal symptoms. Conclusions: Nurses with past or current experience of menopausal symptoms had high levels of awareness and knowledge of male climacteric. To spread more information and knowledge regarding male climacteric, provision of education for these nurses may be needed. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kino, Ayako] Univ Tokushima, Grad Sch Hlth Sci, Tokushima, Japan; [Uemura, Hirokazu] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Prevent Med, Tokushima, Japan; [Yasui, Toshiyuki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Reprod Technol, Tokushima, Japan	Yasui, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Reprod Technol, Tokushima, Japan.	yasui@medsci.tokushima-u.ac.jp					Adebajo S, 2007, West Afr J Med, V26, P106; Anderson JK, 2002, J GERONTOL A-BIOL, V57, pM793; Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Senba N, 2010, CLIMACTERIC, V13, P561, DOI 10.3109/13697130903568518; Tajar A, 2012, J CLIN ENDOCR METAB, V97, P1508, DOI 10.1210/jc.2011-2513; Morales A, 2006, EUR UROL, V50, P407, DOI 10.1016/j.eururo.2006.07.001; Snyder PJ, 2004, NEW ENGL J MED, V350, P440, DOI 10.1056/NEJMp038207; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Pye SR, 2014, J CLIN ENDOCR METAB, V99, P1357, DOI 10.1210/jc.2013-2052; Wang C, 2009, J ANDROL, V30, P1, DOI 10.2164/jandrol.108.006486; Ashat Munish, 2011, Indian J Med Sci, V65, P379, DOI 10.4103/0019-5359.108952; Bahsin S, 2006, J CLIN ENDOCR METAB, V91, P1995; Fatusi A O, 2004, Aging Male, V7, P269; Heinemann Lothar A J, 2003, Health Qual Life Outcomes, V1, P15, DOI 10.1186/1477-7525-1-15; Heinemann LAJ, 1999, AGING MALE, V2, P105, DOI 10.3109/13685539909003173; Holm ACS, 2011, AGING MALE, V14, P16, DOI 10.3109/13685538.2010.518177; Horie S, 2014, AGING MALE, V17, P35, DOI 10.3109/13685538.2013.801436; Huhtaniemi I, 2014, ASIAN J ANDROL, V16, P192, DOI 10.4103/1008-682X.122336; Melby MK., 2006, CLIMACTERIC, V9, P293; Mural M, 2013, J YAMANASHI MATERN H, V12, P27; Pommerville PJ, 2006, AGING MALE, V9, P215, DOI 10.1080/13685530601040661; Reyes J A C 3rd, 2004, Aging Male, V7, P227; Taher Akmal, 2005, Acta Med Indones, V37, P82; Tsujimura A, 2011, ASIAN J ANDROL, V13, P558, DOI 10.1038/aja.2010.132; Yan YY, 2010, AM J MENS HEALTH, V4, P231, DOI 10.1177/1557988309335154	26	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-5122	1873-4111		MATURITAS	Maturitas	FEB	2015	80	2					198	204		10.1016/j.maturitas.2014.11.014		7	Geriatrics & Gerontology; Obstetrics & Gynecology	Geriatrics & Gerontology; Obstetrics & Gynecology	CA9UV	WOS:000349271200014		
J	Ito, M; Seo, E; Ogawa, R; Sanuki, M; Maeno, T; Maeno, T				Ito, Makoto; Seo, Emiko; Ogawa, Ryoko; Sanuki, Masaru; Maeno, Takami; Maeno, Tetsuhiro			Can we predict future depression in residents before the start of clinical training?	MEDICAL EDUCATION			English	Article							MENTAL-HEALTH PROBLEMS; PROSPECTIVE COHORT; WORKING-CONDITIONS; MEDICAL-SCHOOL; YOUNG DOCTORS; JOB STRESS; NATIONWIDE; REDUCTION; COHERENCE; SYMPTOMS	ContextDepression among medical residents is a very serious problem. It is, however, very difficult to detect signs of depression early, despite the severity and frequency of depression. We designed a nationwide longitudinal study to investigate whether the Sense of Coherence (SOC) Scale, an indicator of ability to cope with stress, could predict future depressive symptoms among medical residents. MethodsWe distributed self-administered questionnaires to first-year residents in 251 postgraduate education hospitals just before the start of their clinical training. The questionnaire contained the Center for Epidemiologic Studies Depression (CES-D) Scale (a screening tool for depression), the SOC Scale, and items on demographic factors. After 3months, we again distributed questionnaires to residents who had responded to the first survey. The second questionnaire contained the CES-D Scale and items on the respondents' working conditions. We categorised respondents into three groups according to their SOC scores and analysed the relationships between the three SOC groups (low, middle and high scores) and the occurrence of depressive symptoms at the follow-up survey. ResultsIn all, 1738 of 2935 residents (59.2%) responded to the first survey. Of these, 1245 residents (71.6%) also responded to the follow-up survey. A total of 189 residents were excluded because they screened positive for depressive symptoms at the first survey. Data for a further 36 were excluded because they were incomplete. At the follow-up survey, 238 of the remaining 1020 residents (23.3%) had new-onset depressive symptoms. These included 61 (41.2%) respondents in the low SOC group, 159 (22.3%) in the middle SOC group, and 18 (11.3%) in the high SOC group (p<0.01). The odds ratio of the low SOC group for new-onset depressive symptoms, adjusted for demographic factors, baseline CES-D score and mean working time, was 3.11 (95% confidence interval 1.48-6.53), using the high SOC group as the reference. ConclusionsThe SOC score was significantly related to future depressive symptoms among medical residents. The SOC Scale might be a useful and easy-to-use predictor of future depression. Discuss ideas arising from the article at discuss'	[Ito, Makoto; Seo, Emiko; Sanuki, Masaru; Maeno, Takami; Maeno, Tetsuhiro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Seo, Emiko; Ogawa, Ryoko; Sanuki, Masaru; Maeno, Tetsuhiro] Univ Tsukuba Hosp, Ctr Med Educ & Training, Tsukuba, Ibaraki, Japan	Ito, M (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	s1130422@u.tsukuba.ac.jp	Mata, Douglas/F-3513-2015	Mata, Douglas/0000-0002-8059-8668	JSPS KAKENHI [22590452]	This work was supported by JSPS KAKENHI Grant Number 22590452.	Tyssen R, 2002, HARVARD REV PSYCHIAT, V10, P154, DOI 10.1080/10673220216218; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; Levey RE, 2001, ACAD MED, V76, P142, DOI 10.1097/00001888-200102000-00010; Becker JL, 2006, AM J OBSTET GYNECOL, V195, P1444, DOI 10.1016/j.ajog.2006.06.075; Brooks SK, 2011, J MENT HEALTH, V20, P146, DOI 10.3109/09638237.2010.541300; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Jagsi R, 2008, ARCH INTERN MED, V168, P493, DOI 10.1001/archinternmed.2007.129; Michels PJ, 2003, ACAD MED, V78, P69, DOI 10.1097/00001888-200301000-00013; Murphy JM, 2000, ARCH GEN PSYCHIAT, V57, P209, DOI 10.1001/archpsyc.57.3.209; Sen S, 2010, ARCH GEN PSYCHIAT, V67, P557, DOI 10.1001/archgenpsychiatry.2010.41; Tyssen R, 2000, MED EDUC, V34, P374, DOI 10.1046/j.1365-2923.2000.00540.x; Katz ED, 2006, ACAD EMERG MED, V13, P284, DOI 10.1197/j.aem.2005.10.009; Goebert D, 2009, ACAD MED, V84, P236, DOI 10.1097/ACM.0b013e31819391bb; Baldwin PJ, 1997, SOC SCI MED, V45, P35, DOI 10.1016/S0277-9536(96)00306-1; Sakata Y, 2008, J OCCUP HEALTH, V50, P498; Tyssen R, 2001, MED EDUC, V35, P110, DOI 10.1046/j.1365-2923.2001.00770.x; Antonovsky A., 1979, HLTH STRESS COPING; Antonovsky A, 2001, UNRAVELLING MYSTERY; Brewin C R, 1997, J Occup Health Psychol, V2, P242, DOI 10.1037/1076-8998.2.3.242; Grotmol KS, 2013, J AFFECT DISORDERS, V146, P106, DOI 10.1016/j.jad.2012.08.047; Haoka T, 2010, MED EDUC, V44, P826, DOI 10.1111/j.1365-2923.2010.03725.x; Hochberg MS, 2013, AM J SURG, V205, P141, DOI 10.1016/j.amjsurg.2012.08.003; Konttinen H, 2008, SOC SCI MED, V66, P2401, DOI 10.1016/j.socscimed.2008.01.053; Maeno Te, 2008, IGAKU KYOIKU, V39, P175; HURRELL JJ, 1988, SCAND J WORK ENV HEA, V14, P27; National Institute for Occupational Safety and Health, 1999, NIOSH PUBL; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; NESBITT D, 1988, ANN INTERN MED, V109, P154; Sairenchi T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-205; Shima S, 1985, CLIN PSYCHIATR, V27, P717; Taniguchi K, 2007, TAIRYOKU EIYO MENEKI, V17, P223; Tatsukawa H, 2005, TAIRYOKU EIYO MENEKI, V15, P82; Togari T, 2005, JPN J HLTH HUM ECOL, V71, P168; Umeda T, 2010, TAIRYOKU EIYO MENEKI, V20, P183; Vetto JT, 2005, J CANCER EDUC, V20, P23, DOI 10.1207/s15430154jce2001_9; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726	36	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0308-0110	1365-2923		MED EDUC	Med. Educ.	FEB	2015	49	2					215	223		10.1111/medu.12620		9	Education, Scientific Disciplines; Health Care Sciences & Services	Education & Educational Research; Health Care Sciences & Services	CA4VC	WOS:000348902900012		
J	Bazalova-Carter, M; Ahmad, M; Matsuura, T; Takao, S; Matsuo, Y; Fahrig, R; Shirato, H; Umegaki, K; Xing, L				Bazalova-Carter, Magdalena; Ahmad, Moiz; Matsuura, Taeko; Takao, Seishin; Matsuo, Yuto; Fahrig, Rebecca; Shirato, Hiroki; Umegaki, Kikuo; Xing, Lei			Proton-induced x-ray fluorescence CT imaging	MEDICAL PHYSICS			English	Article						x-ray fluorescence; protons; CT; Monte Carlo; gold contrast; molecular imaging	NANOPARTICLE-LOADED OBJECTS; MONTE-CARLO; PIXE-TOMOGRAPHY; SIMULATION; MICE	Purpose: To demonstrate the feasibility of proton-induced x-ray fluorescence CT (pXFCT) imaging of gold in a small animal sized object by means of experiments and Monte Carlo (MC) simulations. Methods: First, proton-induced gold x-ray fluorescence (pXRF) was measured as a function of gold concentration. Vials of 2.2 cm in diameter filled with 0%-5% Au solutions were irradiated with a 220 MeV proton beam and x-ray fluorescence induced by the interaction of protons, and Au was detected with a 3x3 mm(2) CdTe detector placed at 90 degrees. with respect to the incident proton beam at a distance of 45 cm from the vials. Second, a 7-cm diameter water phantom containing three 2.2-diameter vials with 3%-5% Au solutions was imaged with a 7-mm FWHM 220 MeV proton beam in a first generation CT scanning geometry. X-rays scattered perpendicular to the incident proton beam were acquired with the CdTe detector placed at 45 cm from the phantom positioned on a translation/ rotation stage. Twenty one translational steps spaced by 3 mm at each of 36 projection angles spaced by 10. were acquired, and pXFCT images of the phantom were reconstructed with filtered back projection. A simplified geometry of the experimental data acquisition setup was modeled with the MC TOPAS code, and simulation results were compared to the experimental data. Results: A linear relationship between gold pXRF and gold concentration was observed in both experimental and MC simulation data (R-2 > 0.99). All Au vials were apparent in the experimental and simulated pXFCT images. Specifically, the 3% Au vial was detectable in the experimental [contrast-to-noise ratio (CNR) = 5.8] and simulated (CNR = 11.5) pXFCT image. Due to fluorescence x-ray attenuation in the higher concentration vials, the 4% and 5% Au contrast were underestimated by 10% and 15%, respectively, in both the experimental and simulated pXFCT images. Conclusions: Proton-induced x-ray fluorescence CT imaging of 3%-5% gold solutions in a small animal sized water phantom has been demonstrated for the first time by means of experiments and MC simulations. (C) 2015 American Association of Physicists in Medicine.	[Bazalova-Carter, Magdalena; Ahmad, Moiz; Xing, Lei] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Bazalova-Carter, Magdalena; Matsuura, Taeko; Takao, Seishin; Umegaki, Kikuo; Xing, Lei] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Quantum Med Sci & Engn, Sapporo, Hokkaido 0608648, Japan; [Matsuura, Taeko; Matsuo, Yuto; Shirato, Hiroki] Hokkaido Univ Hosp, Proton Beam Therapy Ctr, Dept Med Phys, Sapporo, Hokkaido 0608648, Japan; [Fahrig, Rebecca] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA	Bazalova-Carter, M (reprint author), Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA.	bazalova@stanford.edu			NIBIB [1K99EB016059, 1R01 EB016777]; NCI [1R01 CA176553]	The authors would like to thank Cesare Jenkins for his help with assembling the rotation/translation stage and to Joseph Perl and Jan Schuman for their help with TOPAS physics settings. The authors wish to acknowledge the support from NIBIB (1K99EB016059 and 1R01 EB016777) and NCI (1R01 CA176553).	Ahmad Moiz, 2014, IEEE Access, V2, DOI 10.1109/ACCESS.2014.2353041; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Jones BL, 2011, PHYS MED BIOL, V56, P3719, DOI 10.1088/0031-9155/56/12/017; Cheong SK, 2010, PHYS MED BIOL, V55, P647, DOI 10.1088/0031-9155/55/3/007; Perl J, 2012, MED PHYS, V39, P6818, DOI 10.1118/1.4758060; Ahmad M, 2014, IEEE T MED IMAGING, V33, P1119, DOI 10.1109/TMI.2014.2305101; RYAN CG, 1990, NUCL INSTRUM METH B, V47, P55, DOI 10.1016/0168-583X(90)90047-X; Polf JC, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3589914; Beasley D, 2008, J RADIOANAL NUCL CH, V276, P101, DOI 10.1007/s10967-008-0416-1; Beasley DG, 2013, NUCL INSTRUM METH B, V306, P109, DOI 10.1016/j.nimb.2012.12.053; Beasley DG, 2014, NUCL INSTRUM METH B, V331, P248, DOI 10.1016/j.nimb.2014.01.028; Bazalova M., 2014, 100 RSNA ANN M RSNA; Bazalova M, 2007, PHYS MED BIOL, V52, P5945, DOI 10.1088/0031-9155/52/19/015; Cong WX, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3592499; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; Johansson S., 1995, PARTICLE INDUCED XRA; Kim JK, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/24/8309; Kuang Y, 2013, MED PHYS, V40, DOI 10.1118/1.4789917; MAENHAUT W, 1980, NUCL INSTRUM METHODS, V168, P557, DOI 10.1016/0029-554X(80)91310-5; Rodt T, 2011, ACTA RADIOL, V52, P75, DOI 10.1258/ar.2010.100059; Rose A, 1973, VISION HUMAN ELECT; Vaughan D., 2001, XRAY DATA BOOKLET	22	2	2	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	FEB	2015	42	2					900	907		10.1118/1.4906169		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA9GJ	WOS:000349229600036		
J	Tominaga, H; Setoguchi, T; Tanabe, F; Kawamura, I; Tsuneyoshi, Y; Kawabata, N; Nagano, S; Abematsu, M; Yamamoto, T; Yone, K; Komiya, S				Tominaga, Hiroyuki; Setoguchi, Takao; Tanabe, Fumito; Kawamura, Ichiro; Tsuneyoshi, Yasuhiro; Kawabata, Naoya; Nagano, Satoshi; Abematsu, Masahiko; Yamamoto, Takuya; Yone, Kazunori; Komiya, Setsuro			Risk Factors for Venous Thromboembolism After Spine Surgery	MEDICINE			English	Article							PULMONARY-EMBOLISM; VEIN-THROMBOSIS; MANAGEMENT	The efficacy and safety of chemical prophylaxis to prevent the development of deep venous thrombosis (DVT) or pulmonary embolism (PE) following spine surgery are controversial because of the possibility of epidural hematoma formation. Postoperative venous thromboembolism (VTE) after spine surgery occurs at a frequency similar to that seen after joint operations, so it is important to identify the risk factors for VTE formation following spine surgery. We therefore retrospectively studied data from patients who had undergone spinal surgery and developed postoperative VTE to identify those risk factors. We conducted a retrospective clinical study with logistic regression analysis of a group of 80 patients who had undergone spine surgery at our institution from June 2012 to August 2013. All patients had been screened by ultrasonography for DVT in the lower extremities. Parameters of the patients with VTE were compared with those without VTE using the Mann-Whitney U-test and Fisher exact probability test. Logistic regression analysis was used to analyze the risk factors associated with VTE. A value of P < 0.05 was used to denote statistical significance. The prevalence of VTE was 25.0% (20/80 patients). One patient had sensed some incongruity in the chest area, but the vital signs of all patients were stable. VTEs had developed in the pulmonary artery in one patient, in the superficial femoral vein in one patient, in the popliteal vein in two patients, and in the soleal vein in 18 patients. The MannWhitney U-test and Fisher exact probability test showed that, except for preoperative walking disability, none of the parameters showed a significant difference between patients with and without VTE. Risk factors identified in the multivariate logistic regression analysis were preoperative walking disability and age. The prevalence of VTE after spine surgery was relatively high. The most important risk factor for developing postoperative VTE was preoperative walking disability. Gait training during the early postoperative period is required to prevent VTE.	[Tominaga, Hiroyuki; Tanabe, Fumito; Kawamura, Ichiro; Nagano, Satoshi; Abematsu, Masahiko; Yamamoto, Takuya; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima 8908520, Japan; [Tominaga, Hiroyuki; Setoguchi, Takao] Kagoshima Univ, Grad Sch Med & Dent Sci, Near Future Locomotor Organ Med Creat Course Kusu, Kagoshima 8908520, Japan; [Tsuneyoshi, Yasuhiro; Kawabata, Naoya] Izumi Reg Med Ctr, Dept Orthopaed Surg, Akune 8991611, Japan; [Yone, Kazunori] Kagoshima Univ Med & Dent Hosp, Div Med & Environm Safety, Kagoshima 8908520, Japan; [Yone, Kazunori] Kagoshima Univ, Fac Med, Sch Hlth Sci, Phys Therapy Dept, Kagoshima 8908544, Japan	Tominaga, H (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	hiro-tom@m2.kufm.kagoshima-u.ac.jp					Aach M, 2014, SPINE IN PRESS  0404; Alhalbouni S, 2011, VASCULAR, V19, P29, DOI 10.1258/vasc.2010.oa0252; Schoenfeld AJ, 2013, SPINE, V38, P1892, DOI 10.1097/BRS.0b013e31829fc3a0; LAWTON MT, 1995, J NEUROSURG, V83, P1, DOI 10.3171/jns.1995.83.1.0001; FOO D, 1981, SURG NEUROL, V15, P389, DOI 10.1016/0090-3019(81)90178-6; Schwarz T, 2010, J VASC SURG, V52, P1246, DOI 10.1016/j.jvs.2010.05.094; Bono CM, 2009, SPINE J, V9, P1046, DOI 10.1016/j.spinee.2009.09.005; Rokito SE, 1996, SPINE, V21, P853, DOI 10.1097/00007632-199604010-00016; Takahashi H, 2012, J ORTHOP SCI, V17, P114, DOI 10.1007/s00776-011-0188-2; Schizas C, 2008, EUR SPINE J, V17, P970, DOI 10.1007/s00586-008-0668-z; Sansone JM, 2010, J BONE JOINT SURG AM, V92A, P304, DOI 10.2106/JBJS.H.01815; Deitcher SR, 2003, MED CLIN N AM, V87, P1157, DOI 10.1016/S0025-7125(03)00104-4; Epstein Nancy E, 2013, Surg Neurol Int, V4, pS383, DOI 10.4103/2152-7806.120782; Hohl JB, 2013, J SPINAL DI IN PRESS; Nagase Yuichi, 2011, J Bone Joint Surg Am, V93, pe146, DOI 10.2106/JBJS.J.01365; Kebaish Khaled M, 2004, Neurosurg Focus, V16, pe1; Sakakima H, 2013, CASE REP ORTHOP, V2013; Strom RG, 2013, SPINE, V38, pE1498, DOI 10.1097/BRS.0b013e3182a4408d; Zhi-jian Sun, 2011, Chin Med Sci J, V26, P221	19	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2015	94	5							e466	10.1097/MD.0000000000000466		4	Medicine, General & Internal	General & Internal Medicine	CA6DZ	WOS:000349000400013		
J	Ukita, Y; Takamura, Y				Ukita, Yoshiaki; Takamura, Yuzuru			A new stroboscopic technique for the observation of microscale fluorescent objects on a spinning platform in centrifugal microfluidics	MICROFLUIDICS AND NANOFLUIDICS			English	Article						Centrifugal microfluidics; Centrifugal force; Stroboscope; Fluorescence	CELL-SEPARATION; CONTINUOUS-FLOW; SYSTEMS; DEVICE; IMMUNOASSAYS; MICROCHANNEL; NETWORKS; PARTICLE; FORCE	Fluorescence microscopy has been greatly contributed to the development of new science and technology in the field of microfluidics. In the case of centrifugal microfluidics, a microscale fluidic system is constructed on a spinning disk-shaped substrate; however, while microscopic stroboscopes have been developed, fluorescence imaging has not yet been demonstrated. This paper reports on the development of the first imaging technique that can observe small (micrometer) fluorescent objects on a spinning fluidic system. This technology is based on the combination of a Xe bulb strobe, a coaxial optics microscope, and a fluorescent optical filter. The observation of small particles on a spinning disk was demonstrated at both the bright field setting and the fluorescence setting. The system successfully demonstrates the observation of fluorescence particles on a spinning disk (at 3,000 rpm) and the sedimentation of particles in a suspension flow.	[Ukita, Yoshiaki; Takamura, Yuzuru] Japan Adv Inst Sci & Technol JAIST, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan	Ukita, Y (reprint author), Japan Adv Inst Sci & Technol JAIST, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	ukita@jaist.ac.jp	Takamura, Yuzuru/A-3450-2009		JSPS KAKENHI	This research was supported by a JSPS KAKENHI grant for young scientists. The authors greatly appreciate the comprehensive technical support from Mr. Munenori Uno of the Center for Nano Materials and Technology JAIST in developing the spinning driver and stroboscope system.	Yamada M, 2004, ANAL CHEM, V76, P5465, DOI 10.1021/ac049863r; Ukita Y, 2013, MICROFLUID NANOFLUID, V15, P829, DOI 10.1007/s10404-013-1194-9; Petersson F, 2007, ANAL CHEM, V79, P5117, DOI 10.1021/ac070444e; Pamme N, 2007, LAB CHIP, V7, P1644, DOI 10.1039/b712784g; Kang JH, 2012, LAB CHIP, V12, P2175, DOI 10.1039/c2lc40072c; Honda N, 2005, CLIN CHEM, V51, P1955, DOI 10.1373/clinchem.2005.053348; Ukita Y, 2012, SENSOR ACTUAT B-CHEM, V166, P898, DOI 10.1016/j.snb.2012.03.028; Lai S, 2004, ANAL CHEM, V76, P1832, DOI 10.1021/ac0348322; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Duffy DC, 1999, ANAL CHEM, V71, P4669, DOI 10.1021/ac990682c; Gossett DR, 2009, ANAL CHEM, V81, P8459, DOI 10.1021/ac901306y; Grumann M, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1834703; Lee BS, 2009, LAB CHIP, V9, P1548, DOI 10.1039/b820321k; Tsutsui H, 2009, MECH RES COMMUN, V36, P92, DOI 10.1016/j.mechrescom.2008.08.006; Huh D, 2007, ANAL CHEM, V79, P1369, DOI 10.1021/ac061542n; Xia N, 2006, BIOMED MICRODEVICES, V8, P299, DOI 10.1007/s10544-006-0033-0; Riegger L, 2006, SENSOR ACTUAT A-PHYS, V126, P455, DOI 10.1016/j.sna.2005.11.006; Ducree J, 2007, J MICROMECH MICROENG, V17, pS103, DOI 10.1088/0960-1317/17/7/S07; Tsukamoto M, 2009, ANALYST, V134, P1994, DOI 10.1039/b909597g; Bhagat AAS, 2008, LAB CHIP, V8, P1905; Carlo D.D., 2007, P NATL ACAD SCI USA, V104, P18892; Carlo D.D., 2009, LAB CHIP, V9, P3038; Ducree J, 2006, MICROFLUID NANOFLUID, V2, P78, DOI 10.1007/s10404-005-0056-5; Furutani S, 2010, ANAL BIOANAL CHEM, V398, P2997, DOI 10.1007/s00216-010-4205-7; Haeberle S, 2007, MICROFLUID NANOFLUID, V3, P65, DOI 10.1007/s10404-006-0106-7; Kobayashi T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.077001; Seo J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2756272	27	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1613-4982	1613-4990		MICROFLUID NANOFLUID	Microfluid. Nanofluid.	FEB	2015	18	2					245	252		10.1007/s10404-014-1426-7		8	Nanoscience & Nanotechnology; Instruments & Instrumentation; Physics, Fluids & Plasmas	Science & Technology - Other Topics; Instruments & Instrumentation; Physics	CA5WO	WOS:000348978800008		
J	Chen, B; Li, SF; Imai, H; Umeda, J; Takahashi, M; Kondoh, K				Chen, Biao; Li, Shufeng; Imai, Hisashi; Umeda, Junko; Takahashi, Makoto; Kondoh, Katsuyoshi			Inter-wall bridging induced peeling of multi-walled carbon nanotubes during tensile failure in aluminum matrix composites	MICRON			English	Article						Carbon nanotubes (CNTs); Multi-walled carbon nanotubes (MWCNTs); Fracture; Peeling; Composites	STRENGTH	In situ scanning electron microscopy (SEM) observation of a tensile test was performed to investigate the fracturing behavior of multi-walled carbon nanotubes (MWCNTs) in powder metallurgy Al matrix composites. A multiple peeling phenomenon during MWCNT fracturing was clearly observed. Its formation mechanism and resultant effect on the composite strength were examined. Through transition electron microscopy characterizations, it was observed that defective structures like inter-wall bridges cross-linked adjacent walls of MWCNTs. This structure was helpful to improve the inter-wall bonding conditions, leading to the effective load transfer between walls and resultant peeling behaviors of MWCNTs. These results might provide new understandings of the fracturing mechanisms of carbon nanotube reinforcements for designing high-performance nanocomposites. (C) 2014 Elsevier Ltd. All rights reserved.	[Chen, Biao] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Li, Shufeng; Imai, Hisashi; Umeda, Junko; Takahashi, Makoto; Kondoh, Katsuyoshi] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan	Chen, B (reprint author), Osaka Univ, Grad Sch Engn, 1 Yamadaoka, Suita, Osaka 5650871, Japan.	chen-b@jwri.osaka-u.ac.jp	Chen, Biao/A-8982-2015	Chen, Biao/0000-0002-6428-2639			Bakshi SR, 2011, CARBON, V49, P533, DOI 10.1016/j.carbon.2010.09.054; Bakshi SR, 2010, INT MATER REV, V55, P41, DOI 10.1179/095066009X12572530170543; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Boesl B, 2014, CARBON, V69, P79, DOI 10.1016/j.carbon.2013.11.061; Yamamoto G, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/31/315708; Wilson NR, 2009, NAT NANOTECHNOL, V4, P483, DOI [10.1038/nnano.2009.154, 10.1038/NNANO.2009.154]; Peng B, 2008, NAT NANOTECHNOL, V3, P626, DOI 10.1038/nnano.2008.211; Popov VN, 2004, MAT SCI ENG R, V43, P61, DOI 10.1016/j.mser.2003.10.001; Jiang L, 2012, CARBON, V50, P1993, DOI 10.1016/j.carbon.2011.12.057; Esawi AMK, 2010, COMPOS SCI TECHNOL, V70, P2237, DOI 10.1016/j.compscitech.2010.05.004; SOULE DE, 1968, J APPL PHYS, V39, P5122, DOI 10.1063/1.1655933; Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637; Byrne EM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045502; Chen B, 2014, ADV ENG MATER, V16, P972, DOI 10.1002/adem.201400232; COX HL, 1952, BRIT J APPL PHYS, V3, P72, DOI 10.1088/0508-3443/3/3/302; Cumings J, 2000, NATURE, V406, P586; Gallego J., 2012, MICRON, V44, P463; KELLY A, 1965, J MECH PHYS SOLIDS, V13, P329, DOI 10.1016/0022-5096(65)90035-9	18	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-4328			MICRON	Micron	FEB	2015	69						1	5		10.1016/j.micron.2014.10.005		5	Microscopy	Microscopy	CA5TR	WOS:000348971200001		
J	Kim, HC; Takhampunya, R; Tippayachai, B; Chong, ST; Park, JY; Kim, MS; Seo, HJ; Yeh, JY; Lee, WJ; Lee, DK; Klein, TA				Kim, Heung Chul; Takhampunya, Ratree; Tippayachai, Bousaraporn; Chong, Sung-Tae; Park, Jee-Yong; Kim, Myung-Soon; Seo, Hyun-Ji; Yeh, Jung-Yong; Lee, Won-Ja; Lee, Dong-Kyu; Klein, Terry A.			Japanese Encephalitis Virus in Culicine Mosquitoes (Diptera: Culicidae) of the Republic of Korea, 2008-2010	MILITARY MEDICINE			English	Article							SOUTH-KOREA; GENOTYPE V; INFECTION; SURVEILLANCE; TRANSMISSION; IMMUNIZATION; AMERICANS; THAILAND; ANTIBODY; FUTURE	A total of 150,805 culicine female mosquitoes were captured by Mosquito Magnet, black light, and New Jersey light traps, and at resting collections in the Republic of Korea from 2008 to 2010 as part of the U. S. Forces Korea malaria and Japanese surveillance programs. Mosquitoes were identified and culicine mosquitoes placed in pools of up to 30 mosquitoes each, by species and date of collection, and screened for flaviviruses using a reverse transcription-polymerase chain reaction assay. A total of 98/6,845 (1.4%) pools were positive by reverse transcription-polymerase chain reaction for Japanese encephalitis virus (JEV). A total of 92/2,031 (4.5%) pools of Culex tritaeniorhynchus were positive for JEV and accounted for 93.9% (92/98) of all JEV positive pools. A total of 4/804 (0.5%) and 2/175 (1.1%) pools of C. pipiens and C. bitaeniorhynchus, respectively, were positive for JEV. The JEV maximum likelihood estimations (estimated number of viral RNA positive mosquitoes per 1,000) for C. tritaeniorhynchus, C. bitaeniorhynchus, and C. pipiens were 1.71, 1.02, and 0.36 respectively. JEV is a severe health threat for local populations and of significant concern for nonimmune (unvaccinated) U.S. soldiers, civilians, and family members deployed to the Republic of Korea.	[Takhampunya, Ratree; Tippayachai, Bousaraporn] Armed Forces Res Inst Med Sci, Dept Entomol, Bangkok 10400, Thailand; [Park, Jee-Yong; Kim, Myung-Soon; Seo, Hyun-Ji] Anim & Plant Quarantine Agcy, Foreign Anim Dis Div, Anyang 430824, Gyeonggi, South Korea; [Yeh, Jung-Yong] Univ Incheon, Coll Life Sci & Bioengn, Div Life Sci, Inchon 406772, South Korea; [Lee, Won-Ja] Korea Ctr Dis Control & Prevent, NIH, Chungbuk 363951, South Korea; [Lee, Dong-Kyu] Kosin Univ, Dept Hlth & Environm, Pusan 606701, South Korea; [Klein, Terry A.] Publ Hlth Command Reg Pacific, Camp Zama, Japan; [Klein, Terry A.] Force Hlth Protect & Prevent Med, Seoul, South Korea	Kim, HC (reprint author), 5th Med Detachment, Seoul, South Korea.				Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS), Silver Spring, MD; Foreign Animal Disease Division, Animal and Plant Quarantine Agency, Anyang, Gyeonggi Province, ROK; Korea National Institute of Health; Korea Centers for Disease Control and Prevention, Osong, Chungcheongbuk Province, ROK; Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand	We thank COL Hee-Choon S. Lee, Chief, Force Health Protection and Preventive Medicine, 65th Medical Brigade, for his support. Special thanks to Mr. Dong-Chan Kim (Daeseongdong village mayor), the ROK Army Commander, and ROK Army soldiers at JSA (provide security for Daeseongdong), for their assistance in mosquito collections. This work was funded by the Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS), Silver Spring, MD, the Foreign Animal Disease Division, Animal and Plant Quarantine Agency, Anyang, Gyeonggi Province, ROK, the Korea National Institute of Health, the Korea Centers for Disease Control and Prevention, Osong, Chungcheongbuk Province, ROK, and the Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.	Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Hills SL, 2010, AM J TROP MED HYG, V82, P930, DOI 10.4269/ajtmh.2010.09-0676; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Sohn YM, 2000, EMERG INFECT DIS, V6, P17; Gu WD, 2003, J MED ENTOMOL, V40, P595, DOI 10.1603/0022-2585-40.5.595; SCHERER WF, 1959, AM J TROP MED HYG, V8, P644; Schuh AJ, 2010, J GEN VIROL, V91, P95, DOI 10.1099/vir.0.013631-0; BUESCHER EL, 1959, AM J TROP MED HYG, V8, P651; BENENSON MW, 1975, AM J TROP MED HYG, V24, P974; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.micro.40.1.395; LINCOLN AF, 1952, JAMA-J AM MED ASSOC, V150, P268; Kim HC, 2011, J MED ENTOMOL, V48, P1250, DOI 10.1603/ME11091; Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06; Gu W, 2004, MED VET ENTOMOL, V18, P200, DOI 10.1111/j.0269-283X.2004.00482.x; Kuno G, 1998, J VIROL, V72, P73; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; BANERJEE K, 1978, INDIAN J MED RES, V67, P889; Bhat H R, 1984, P NATIONAL C JAPANES, P57; BHATTACHARYA S, 1986, TROP GEOGR MED, V38, P46; Biggerstaff B, 2006, VECTOR BORNE ZOO DIS, V5, P420; Burke DS, 1988, ARBOVIRUSES EPIDEMIO, V3, P63; Baig S, 2013, MMWR-MORBID MORTAL W, V62, P658; Deuel Jr RE, 1950, AM J HYG, V51, P3; GROSSMAN RA, 1973, AM J EPIDEMIOL, V98, P133; Halstead S B, 1987, TXB PEDIAT INFECT DI, P1502; HALSTEAD SB, 1962, AM J HYG, V75, P202; HALSTEAD SB, 1962, AM J HYG, V75, P190; HULLINGHORST RL, 1951, JAMA-J AM MED ASSOC, V145, P460; In SD, 1986, REPORT NATL I HLTH K, V23, P377; In SD, 1985, REPORT NATL I HLTH K, V22, P229; Kim Heung Chul, 2007, Entomological Research, V37, P267, DOI 10.1111/j.1748-5967.2007.00124.x; Kim KH, 1965, REPORT NATL I HLTH K, V2, P35; Korea Centers for Disease Control and Prevention (K-CDC), DIS WEB STAT SYST; Lee K W, 1999, REVISION ILLUSTRATED, P40; Lee SY, 1950, B NAT I PREV INFECT, V2, P54; Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231; Long AP, 1954, MED SCI PUBLICATION, VII; Miller RH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001678; MITAMURA T., 1937, Transactiones Societatis Pathologicae Japonicae, V27, P573; Mitamura T, 1938, TOKYO IJI SHINSHI, V62, P820; Okuno T, 1978, World Health Stat Q, V31, P120; SABIN AB, 1947, AM J HYG, V46, P356; Seo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055165; SUCHARIT S, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P611; Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Tsai Theodore F., 1993, Morbidity and Mortality Weekly Report, V42, P1; Tsai T F, 1990, JAPANESE ENCEPHALITI, P1; Turell MJ, 2003, J MED ENTOMOL, V40, P580, DOI 10.1603/0022-2585-40.4.580; Turell MJ, 2006, J MED ENTOMOL, V43, P1076, DOI 10.1603/0022-2585(2006)43[1076:LTOJEW]2.0.CO;2; UMENAI T, 1985, B WORLD HEALTH ORGAN, V63, P625; VYTHILINGAM I, 1995, J AM MOSQUITO CONTR, V11, P94; Wada Y, 1972, Tropical Medicine, V14, P151; Yun SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-127	56	1	1	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	FEB	2015	180	2					158	167		10.7205/MILMED-D-14-00206		10	Medicine, General & Internal	General & Internal Medicine	CA7MR	WOS:000349101900008		
J	Nakadate, R; Arata, J; Hashizume, M				Nakadate, Ryu; Arata, Jumpei; Hashizume, Makoto			Next-generation robotic surgery - from the aspect of surgical robots developed by industry	MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES			English	Review						Robotic surgery; instrument design; laparoscopic instruments	SYSTEM; CHOLECYSTECTOMY; CATHETERS; PLATFORM	At present, much of the research conducted worldwide focuses on extending the ability of surgical robots. One approach is to extend robotic dexterity. For instance, accessibility and dexterity of the surgical instruments remains the largest issue for reduced port surgery such as single port surgery or natural orifice surgery. To solve this problem, a great deal of research is currently conducted in the field of robotics. Enhancing the surgeon's perception is an approach that uses advanced sensor technology. The real-time data acquired through the robotic system combined with the data stored in the robot (such as the robot's location) provide a major advantage. This paper aims at introducing state-of-the-art products and pre-market products in this technological advancement, namely the robotic challenge in extending dexterity and hopefully providing the path to robotic surgery in the near future.	[Nakadate, Ryu; Arata, Jumpei; Hashizume, Makoto] Kyushu Univ, Ctr Adv Med Innovat, Kyushu, Japan	Hashizume, M (reprint author), Kyushu Univ, Fac Med Sci, Dept Adv Med Initiat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	mhashi@dem.med.kyushu-u.ac.jp					Taylor RH, 2003, IEEE T ROBOTIC AUTOM, V19, P765, DOI 10.1109/TRA.2003.817058; Bergeles C, 2014, IEEE T BIO-MED ENG, V61, P1565, DOI 10.1109/TBME.2013.2293815; Phee SJ, 2012, CLIN GASTROENTEROL H, V10, P1117, DOI 10.1016/j.cgh.2012.05.019; Ott L, 2011, IEEE T ROBOT, V27, P346, DOI 10.1109/TRO.2010.2098623; Johnson PJ, 2013, LARYNGOSCOPE, V123, P1168, DOI 10.1002/lary.23512; Lindner U, 2012, CUAJ-CAN UROL ASSOC, V6, pE283, DOI 10.5489/cuaj.12218; Ernst S, 2004, CIRCULATION, V109, P1472, DOI 10.1161/01.CIR.0000125126.83579.1B; Knight B, 2008, J INVASIVE CARDIOL, V20, P250; Autorino R, 2013, EUR UROL, V63, P266, DOI 10.1016/j.eururo.2012.08.028; Weisz G, 2013, J AM COLL CARDIOL, V61, P1596, DOI 10.1016/j.jacc.2012.12.045; Thompson CC, 2009, GASTROINTEST ENDOSC, V70, P121, DOI 10.1016/j.gie.2008.11.007; Fuchs KH, 2012, SURG ENDOSC, V26, P2281, DOI 10.1007/s00464-012-2173-z; Hoogeman M, 2009, INT J RADIAT ONCOL, V74, P297, DOI 10.1016/j.ijrobp.2008.12.041; Riga CV, 2010, J VASC SURG, V51, P810, DOI 10.1016/j.jvs.2009.08.101; Kalloo AN, 2004, GASTROINTEST ENDOSC, V60, P114, DOI 10.1016/S0016-5107(04)01309-4; Beasley RA, 2012, J ROBOT; Berman D., 2011, PRACT DERMATOL, P32; Guthart G. S., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), DOI 10.1109/ROBOT.2000.844121; Kaouk JH, 2014, EUR UROL, V66, P1033, DOI 10.1016/j.eururo.2014.06.039; Larocca V, 2014, J ADV BIOTECHNOL BIO, V2, P12; Limani K, 2014, PROSTATE CANC; Patel Nisha, 2014, Endosc Int Open, V2, pE117, DOI 10.1055/s-0034-1377171; Pearle Andrew D, 2009, Am J Orthop (Belle Mead NJ), V38, P16; Perretta S, 2013, SURG ENDOSC, V27, P2630, DOI 10.1007/s00464-013-2818-6; Pryor AD, 2010, SURG ENDOSC, V24, P917, DOI 10.1007/s00464-009-0695-9; Saglam R, 2014, EUR UROL, V66, P1092, DOI 10.1016/j.eururo.2014.06.047; Striegel J, 2011, SURG ENDOSC, V25, P636, DOI 10.1007/s00464-010-1245-1; Sutherland GR, 2012, CUREUS, V4, pe40; Tanoue K, 2006, SURG ENDOSC, V20, P753, DOI 10.1007/s00464-005-0177-7; Voros S, 2010, IEEE-ASME T MECH, V15, P879, DOI 10.1109/TMECH.2010.2080683; Yamamura M, 2013, ADV ORTHOP	31	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1364-5706	1365-2931		MINIM INVASIV THER	Minim. Invasive Ther. Allied Technol.	FEB	2015	24	1					2	7		10.3109/13645706.2014.1003140		6	Surgery	Surgery	CB0BN	WOS:000349289800002		
J	Sekimoto, T; Oda, T; Kurashima, K; Hanaoka, F; Yamashita, T				Sekimoto, Takayuki; Oda, Tsukasa; Kurashima, Kiminori; Hanaoka, Fumio; Yamashita, Takayuki			Both High-Fidelity Replicative and Low-Fidelity Y-Family Polymerases Are Involved in DNA Rereplication	MOLECULAR AND CELLULAR BIOLOGY			English	Article							UBIQUITIN-BINDING DOMAINS; TRANSLESION SYNTHESIS; DAMAGE RESPONSE; ERROR-PRONE; PCNA MONOUBIQUITINATION; MUTATIONAL PROCESSES; G(2)/M CHECKPOINT; STALLING SITES; POL-ETA; CANCER	DNA rereplication is a major form of aberrant replication that causes genomic instabilities, such as gene amplification. However, little is known about which DNA polymerases are involved in the process. Here, we report that low-fidelity Y-family polymerases (Y-Pols), Pol eta, Pol iota, Pol kappa, and REV1, significantly contribute to DNA synthesis during rereplication, while the replicative polymerases, Pol delta and Pol epsilon, play an important role in rereplication, as expected. When rereplication was induced by depletion of geminin, these polymerases were recruited to rereplication sites in human cell lines. This finding was supported by RNA interference (RNAi)-mediated knockdown of the polymerases, which suppressed rereplication induced by geminin depletion. Interestingly, epistatic analysis indicated that Y-Pols collaborate in a common pathway, independently of replicative polymerases. We also provide evidence for a catalytic role for Pol eta and the involvement of Pol eta and Pol kappa in cyclin E-induced rereplication. Collectively, our findings indicate that, unlike normal S-phase replication, rereplication induced by geminin depletion and oncogene activation requires significant contributions of both Y-Pols and replicative polymerases. These findings offer important mechanistic insights into cancer genomic instability.	[Sekimoto, Takayuki; Oda, Tsukasa; Kurashima, Kiminori; Yamashita, Takayuki] Gunma Univ, Inst Mol & Cellular Regulat, Mol Genet Lab, Maebashi, Gumma 371, Japan; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Tokyo 171, Japan	Yamashita, T (reprint author), Gunma Univ, Inst Mol & Cellular Regulat, Mol Genet Lab, Maebashi, Gumma 371, Japan.	y-taka@gunma-u.ac.jp			Japan Science Technology; Global COE Program; Ministry of Education, Science, Technology, Sports and Culture of Japan; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation	This work was supported by a Grant-in-Aid for Scientific Research from Japan Science Technology; a grant from the Global COE Program; and a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Science, Technology, Sports and Culture of Japan. Financial support was also provided by the Uehara Memorial Foundation and the Kato Memorial Bioscience Foundation.	Sekimoto T, 2010, MOL CELL, V37, P79, DOI 10.1016/j.molcel.2009.12.015; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.embjol.7601178; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Jones RM, 2012, BIOCHEM J, V443, P13, DOI 10.1042/BJ20112100; Kim H, 2014, MOL CELL, V54, P107, DOI 10.1016/j.molcel.2014.02.017; Kang SH, 2010, ANALYST, V135, P1759, DOI 10.1039/c0an00145g; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Lin JJ, 2007, J BIOL CHEM, V282, P30357, DOI 10.1074/jbc.M705178200; Durando M, 2013, NUCLEIC ACIDS RES, V41, P3079, DOI 10.1093/nar/gkt016; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Shimura T, 2007, J MOL BIOL, V367, P665, DOI 10.1016/j.jmb.2007.01.018; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Liu QH, 2000, GENE DEV, V14, P1448; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Fan XL, 2013, J VIROL, V87, P1200, DOI 10.1128/JVI.02038-12; Neelsen KJ, 2013, GENE DEV, V27, P2537, DOI 10.1101/gad.226373.113; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Carvalho CMB, 2013, NAT GENET, V45, P1319, DOI 10.1038/ng.2768; Bavoux C, 2005, CANCER RES, V65, P325; Bergoglio V, 2013, J CELL BIOL, V201, P395, DOI 10.1083/jcb.201207066; Black JC, 2013, CELL, V154, P541, DOI 10.1016/j.cell.2013.06.051; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Ohmori H, 2009, ADV PROTEIN CHEM STR, V78, P99, DOI [10.1016/S1876-1623(08)78004-0, 10.1016/S1876-1623(09)78004-0]; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; Bermudez VP, 2011, J BIOL CHEM, V286, P28963, DOI 10.1074/jbc.M111.256289; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Dumstorf CA, 2009, MOL CANCER RES, V7, P247, DOI 10.1158/1541-7786.MCR-08-0399; Green BM, 2010, SCIENCE, V329, P943, DOI 10.1126/science.1190966; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yang J, 2004, CANCER RES, V64, P5597, DOI 10.1158/0008-5472.CAN-04-0603	53	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	FEB	2015	35	4					699	715		10.1128/MCB.01153-14		17	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CB0EU	WOS:000349299100006		
J	Tannous, A; Patel, N; Tamura, T; Hebert, DN				Tannous, Abla; Patel, Nishant; Tamura, Taku; Hebert, Daniel N.			Reglucosylation by UDP-glucose:glycoprotein glucosyltransferase 1 delays glycoprotein secretion but not degradation	MOLECULAR BIOLOGY OF THE CELL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; PROTEIN-QUALITY CONTROL; ALPHA-N-ACETYLGALACTOSAMINIDASE; ENDOPLASMIC-RETICULUM; MANNOSIDASE-I; MUTANT ALPHA-1-ANTITRYPSIN; SCHIZOSACCHAROMYCES-POMBE; MISFOLDED GLYCOPROTEINS; CALNEXIN CYCLE	UDP-glucose: glycoprotein glucosyltransferase 1 (UGT1) is a central quality control gatekeeper in the mammalian endoplasmic reticulum (ER). The reglucosylation of glycoproteins supports their rebinding to the carbohydrate-binding ER molecular chaperones calnexin and calreticulin. A cell-based reglucosylation assay was used to investigate the role of UGT1 in ER protein surveillance or the quality control process. UGT1 was found to modify wild-type proteins or proteins that are expected to eventually traffic out of the ER through the secretory pathway. Trapping of reglucosylated wild-type substrates in their monoglucosylated state delayed their secretion. Whereas terminally misfolded substrates or off-pathway proteins were most efficiently reglucosylated by UGT1, the trapping of these mutant substrates in their reglucosylated or monoglucosylated state did not delay their degradation by the ER-associated degradation pathway. This indicated that monoglucosylated mutant proteins were actively extracted from the calnexin/calreticulin binding-reglucosylation cycle for degradation. Therefore trapping proteins in their monoglucosylated state was sufficient to delay their exit to the Golgi but had no effect on their rate of degradation, suggesting that the degradation selection process progressed in a dominant manner that was independent of reglucosylation and the glucose-containing A-branch on the substrate glycans.	[Tannous, Abla; Hebert, Daniel N.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Tannous, Abla; Patel, Nishant; Tamura, Taku; Hebert, Daniel N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	Tamura, T (reprint author), Akita Univ, Fac Engn & Resource, Dept Life Sci, Akita 0108502, Japan.	dhebert@biochem.umass.edu			National Institutes of Health (U.S. Public Health) [GM08674]; Chemistry Biology Interface Training Program (National Research Service) [T32 GM08515]; Uehara Memorial Foundation	We are grateful to S. Krag for the generous gift of the MI8-5 Chinese hamster ovary cell line, S. Garman for the alpha-NAGAL constructs, and G. Grabowski and Y. Sun for providing the prosaposin antibody. We acknowledge the following current or former members of the Hebert laboratory for helpful discussions: B. Pearse, J. Sunryd, K. Glorda, L. Lamriben, and J. Graham. This work was supported by National Institutes of Health Grant GM08674 (U.S. Public Health; to D.N.H.), the Chemistry Biology Interface Training Program (National Research Service Award T32 GM 08515 to A.T.), and the Uehara Memorial Foundation (to T.T.).	Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Aikawa J, 2014, J BIOCHEM, V155, P375, DOI 10.1093/jb/mvu008; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; BAKSH S, 1991, J BIOL CHEM, V266, P21458; LABRIOLA C, 1995, J CELL BIOL, V130, P771, DOI 10.1083/jcb.130.4.771; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Pearse BR, 2010, J CELL BIOL, V189, P829, DOI 10.1083/jcb.200912105; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Ritter C, 2000, NAT STRUCT BIOL, V7, P278; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Caramelo JJ, 2004, J BIOL CHEM, V279, P46280, DOI 10.1074/jbc.M408404200; TROMBETTA SE, 1989, BIOCHEMISTRY-US, V28, P8108, DOI 10.1021/bi00446a022; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Clark NE, 2012, P NATL ACAD SCI USA, V109, P17400, DOI 10.1073/pnas.1203924109; Kass I, 2012, BIOPHYS J, V102, P2856, DOI 10.1016/j.bpj.2012.05.023; FERNANDEZ FS, 1994, J BIOL CHEM, V269, P30701; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; Zuber C, 2001, P NATL ACAD SCI USA, V98, P10710, DOI 10.1073/pnas.191359198; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Pan SJ, 2013, MOL BIOL CELL, V24, P1111, DOI 10.1091/mbc.E12-12-0886; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Fernandez F, 1996, EMBO J, V15, P705; Molinari M, 2005, MOL CELL, V20, P503, DOI 10.1016/j.molcel.2005.09.027; Blanco I, 2006, EUR RESPIR J, V27, P77, DOI 10.1183/09031936.06.00062305; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Labriola C, 1999, MOL BIOL CELL, V10, P1381; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; Zhang W, 2011, P NATL ACAD SCI USA, V108, P4956, DOI 10.1073/pnas.1102527108; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Taylor SC, 2004, NAT STRUCT MOL BIOL, V11, P128, DOI 10.1038/nsmb715; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Trombetta ES, 2000, J CELL BIOL, V148, P1123, DOI 10.1083/jcb.148.6.1123; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; TROMBETTA SE, 1992, J BIOL CHEM, V267, P9236; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Stigliano ID, 2011, MOL BIOL CELL, V22, P1810, DOI 10.1091/mbc.E11-01-0019; Clark NE, 2009, J MOL BIOL, V393, P435, DOI 10.1016/j.jmb.2009.08.021; Korotkov KV, 2001, J BIOL CHEM, V276, P15330, DOI 10.1074/jbc.M009861200; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Groisman B, 2011, J BIOL CHEM, V286, P1292, DOI 10.1074/jbc.M110.154849; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Spiro RG, 1996, J BIOL CHEM, V271, P11588; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Keith N, 2005, J BIOL CHEM, V280, P18138, DOI 10.1074/jbc.M501710200; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Ermonval M, 2001, GLYCOBIOLOGY, V11, P565, DOI 10.1093/glycob/11.7.565; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Ferris SP, 2013, MOL BIOL CELL, V24, P2597, DOI 10.1091/mbc.E13-02-0101; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Aridor M, 1996, TRENDS CELL BIOL, V6, P315, DOI 10.1016/0962-8924(96)10027-1; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Bottomley SP, 2011, EMBO REP, V12, P983, DOI 10.1038/embor.2011.187; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Ermonval M, 2000, GLYCOBIOLOGY, V10, P77, DOI 10.1093/glycob/10.1.77; Feigel MJ, 2013, MOL CELL, V51, P297, DOI 10.1016/j.molcel.2013.07.013; Fernandez F, 1998, EMBO J, V17, P5877, DOI 10.1093/emboj/17.20.5877; Francis E, 2003, J BIOL CHEM, V278, P25607, DOI 10.1074/jbc.M303411200; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Hebert DN, 2014, NAT CHEM BIOL, V10, P902, DOI 10.1038/nchembio.1651; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; Karaivanova VK, 1998, GLYCOBIOLOGY, V8, P725, DOI 10.1093/glycob/8.7.725; Kunte A, 2013, J BIOL CHEM, V288, P16391, DOI 10.1074/jbc.M113.474221; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; PARKER CG, 1995, EMBO J, V14, P1294; Pearse BR, 2008, J CELL BIOL, V181, P309, DOI 10.1083/jcb.200712068; Quellhorst GJ, 1999, GLYCOBIOLOGY, V9, P65, DOI 10.1093/glycob/9.1.65; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200	95	1	1	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	FEB 1	2015	26	3					390	405		10.1091/mbc.E14-08-1254		16	Cell Biology	Cell Biology	CA4EP	WOS:000348857300002		
J	Vasudevan, KK; Jiang, YY; Lechtreck, KF; Kushida, Y; Alford, LM; Sale, WS; Hennessey, T; Gaertig, J				Vasudevan, Krishna Kumar; Jiang, Yu-Yang; Lechtreck, Karl F.; Kushida, Yasuharu; Alford, Lea M.; Sale, Winfield S.; Hennessey, Todd; Gaertig, Jacek			Kinesin-13 regulates the quantity and quality of tubulin inside cilia	MOLECULAR BIOLOGY OF THE CELL			English	Article							MICROTUBULE-DEPOLYMERIZING KINESIN; TETRAHYMENA-THERMOPHILA; ALPHA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; LENGTH CONTROL; FLAGELLAR MICROTUBULES; SPINDLE ULTRASTRUCTURE; MICRONUCLEAR DIVISION; MOLECULAR-BASIS; ACETYLTRANSFERASE	Kinesin-13, an end depolymerizer of cytoplasmic and spindle microtubules, also affects the length of cilia. However, in different models, depletion of kinesin-13 either lengthens or shortens cilia, and therefore the exact function of kinesin-13 in cilia remains unclear. We generated null mutations of all kinesin-13 paralogues in the ciliate Tetrahymena. One of the paralogues, Kin13Ap, localizes to the nuclei and is essential for nuclear divisions. The remaining two paralogues, Kin13Bp and Kin13Cp, localize to the cell body and inside assembling cilia. Loss of both Kin13Bp and Kin13Cp resulted in slow cell multiplication and motility, overgrowth of cell body microtubules, shortening of cilia, and synthetic lethality with either paclitaxel or a deletion of MEC-17/ATAT1, the alpha-tubulin acetyltransferase. The mutant cilia assembled slowly and contained abnormal tubulin, characterized by altered posttranslational modifications and hypersensitivity to paclitaxel. The mutant cilia beat slowly and axonemes showed reduced velocity of microtubule sliding. Thus kinesin-13 positively regulates the axoneme length, influences the properties of ciliary tubulin, and likely indirectly, through its effects on the axonemal microtubules, affects the ciliary dynein-dependent motility.	[Vasudevan, Krishna Kumar; Jiang, Yu-Yang; Lechtreck, Karl F.; Gaertig, Jacek] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Kushida, Yasuharu] Univ Tsukuba, Dept Struct Biosci, Tsukuba, Ibaraki 3058577, Japan; [Alford, Lea M.; Sale, Winfield S.] Emory Univ, Dept Cell Biol, Atlanta, GA 30303 USA; [Hennessey, Todd] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	Gaertig, J (reprint author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	jgaertig@uga.edu			National Science Foundation [MBC-033965]; National Institutes of Health [RO1GM089912, RO1GM0571173, RO1GM110413]	This study was supported by grants from the National Science Foundation (MBC-033965) and the National Institutes of Health (RO1GM089912 to J.G., RO1GM0571173 to W.S.S., and RO1GM110413 to K.L.). We thank the following researchers for providing reagents: Martin A. Gorovsky (University of Rochester, Rochester, NY) for polyE and polyG antibodies, Joseph Frankel (University of Iowa, City, IA) for 12G10 antibodies (available from the Developmental Studies Hybridoma Bank, University of Iowa), and Marie-Helene Bre and Nicolette Levilliers (University Paris-Sud, Orsay, France) for TAP952 antibodies. We are grateful to Claire Walczak (Indiana University, Bloomington, IN) for suggestions about the domain organization of Tetrahymena kinesin-13 homologues. We acknowledge the excellent technical assistance with TEM by Mary Ard at the University of Georgia College of Veterinary Medicine (Athens, GA).	Allen RD, 2002, INT REV CYTOL, V215, P351; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Su XL, 2012, TRENDS CELL BIOL, V22, P567, DOI 10.1016/j.tcb.2012.08.003; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Asenjo AB, 2013, CELL REP, V3, P759, DOI 10.1016/j.celrep.2013.01.030; Delgehyr N, 2012, CURR BIOL, V22, P502, DOI 10.1016/j.cub.2012.01.046; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Kamiya R, 2002, INT REV CYTOL, V219, P115; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Wloga D, 2006, MOL BIOL CELL, V17, P2799, DOI 10.1091/mbc.E05-05-0450; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Wang L, 2013, J CELL SCI, V126, P1531, DOI 10.1242/jcs.124255; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Stumpff J, 2008, DEV CELL, V14, P252, DOI [10.1016/j.devcel.2007.11.014, 10.1016/j.devce1.2007.11.014]; Bre MH, 1998, MOL BIOL CELL, V9, P2655; Brown JM, 2003, MOL BIOL CELL, V14, P3192, DOI 10.1091/mbc.E03-03-0166; CALLEN AM, 1994, BIOL CELL, V81, P95, DOI 10.1016/S0248-4900(94)80002-2; Calzone FJ, 1982, EXP CELL RES, V140, P474; Chan KY, 2010, MOL BIOCHEM PARASIT, V174, P137, DOI 10.1016/j.molbiopara.2010.08.001; Chan KY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001050; Cooper JR, 2010, NAT STRUCT MOL BIOL, V17, P77, DOI 10.1038/nsmb.1728; Dave D, 2009, EUKARYOT CELL, V8, P1397, DOI 10.1128/EC.00378-08; Dave D, 2009, METHOD CELL BIOL, V93, P1, DOI 10.1016/S0091-679X(08)93001-6; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; DENTLER WL, 1977, J CELL BIOL, V74, P747, DOI 10.1083/jcb.74.3.747; DENTLER WL, 1980, J CELL SCI, V42, P207; Duan JM, 2002, CURR BIOL, V12, P313, DOI 10.1016/S0960-9822(02)00651-6; Frankel J, 2000, METHOD CELL BIOL, V62, P27; Gaertig J, 2013, METHOD ENZYMOL, V525, P265, DOI 10.1016/B978-0-12-397944-5.00013-4; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Ghosh-Roy A, 2012, DEV CELL, V23, P716, DOI 10.1016/j.devcel.2012.08.010; GOROVSKY MA, 1973, J PROTOZOOL, V20, P19, DOI 10.1111/j.1550-7408.1973.tb05995.x; HADLEY GA, 1981, MOL CELL BIOL, V1, P865; Hai B, 2000, METHOD CELL BIOL, V62, P513; HALLBERG RL, 1983, MOL CELL BIOL, V3, P503; Hennessey TM, 2012, METHOD CELL BIOL, V109, P393, DOI [10.1016/B978-0-12-385967-9.00015-3, 10.1016/B978-0-12-395967-9.00015-3]; Jerka-Dziadosz M, 2001, PROTIST, V152, P53, DOI 10.1078/1434-4610-00043; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kalebic N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2962; Kushida Y, 2011, CYTOSKELETON, V68, P89, DOI 10.1002/cm.20496; LAFOUNTAIN JR, 1979, CHROMOSOMA, V75, P293, DOI 10.1007/BF00293473; LAFOUNTAIN JR, 1980, CELL MOTIL CYTOSKEL, V1, P41; Lechtreck KF, 2013, METHOD ENZYMOL, V524, P265, DOI 10.1016/B978-0-12-397945-2.00015-9; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Moores CA, 2006, CELL CYCLE, V5, P1812; MOWAT D, 1974, EXP CELL RES, V84, P282, DOI 10.1016/0014-4827(74)90407-8; ORIAS E, 1976, EXP CELL RES, V102, P127, DOI 10.1016/0014-4827(76)90307-4; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Ross I, 2013, J CELL SCI, V126, P3441, DOI 10.1242/jcs.128694; Wang WY, 2012, J BIOL CHEM, V287, P15143, DOI 10.1074/jbc.M111.317859; Wickstead B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015020; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008	80	0	1	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	FEB 1	2015	26	3					478	494		10.1091/mbc.E14-09-1354		17	Cell Biology	Cell Biology	CA4EP	WOS:000348857300009		
J	Teng, SZ; Stegner, D; Chen, Q; Hongu, T; Hasegawa, H; Chen, L; Kanaho, Y; Nieswandt, B; Frohman, MA; Huang, P				Teng, Shuzhi; Stegner, David; Chen, Qin; Hongu, Tsunaki; Hasegawa, Hiroshi; Chen, Li; Kanaho, Yasunori; Nieswandt, Bernhard; Frohman, Michael A.; Huang, Ping			Phospholipase D1 facilitates second-phase myoblast fusion and skeletal muscle regeneration	MOLECULAR BIOLOGY OF THE CELL			English	Article							AUSTRALIAN TIGER SNAKE; PANCREATIC BETA-CELLS; MEMBRANE-FUSION; MUSCULAR-DYSTROPHY; MYOGENIC DIFFERENTIATION; PHOSPHATIDIC-ACID; GENE-EXPRESSION; ACTIVATION; MICE; LYSOPHOSPHATIDYLCHOLINE	Myoblast differentiation and fusion is a well-orchestrated multistep process that is essential for skeletal muscle development and regeneration. Phospholipase D1 (PLD1) has been implicated in the initiation of myoblast differentiation in vitro. However, whether PLD1 plays additional roles in myoblast fusion and exerts a function in myogenesis in vivo remains unknown. Here we show that PLD1 expression is up-regulated in myogenic cells during muscle regeneration after cardiotoxin injury and that genetic ablation of PLD1 results in delayed myofiber regeneration. Myoblasts derived from PLD1-null mice or treated with PLD1-specific inhibitor are unable to form mature myotubes, indicating defects in second-phase myoblast fusion. Concomitantly, the PLD1 product phosphatidic acid is transiently detected on the plasma membrane of differentiating myocytes, and its production is inhibited by PLD1 knockdown. Exogenous lysophosphatidylcholine, a key membrane lipid for fusion pore formation, partially rescues fusion defect resulting from PLD1 inhibition. Thus these studies demonstrate a role for PLD1 in myoblast fusion during myogenesis in which PLD1 facilitates the fusion of mononuclear myocytes with nascent myotubes.	[Teng, Shuzhi] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Teng, Shuzhi; Huang, Ping] Jilin Univ, Coll Basic Med Sci, Minist Educ, Key Lab Pathobiol, Changchun 130021, Peoples R China; [Stegner, David; Nieswandt, Bernhard] Univ Wurzburg, Univ Hosp, D-97080 Wurzburg, Germany; [Stegner, David; Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Chen, Qin; Frohman, Michael A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Hongu, Tsunaki; Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Dept Phys Chem, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Hongu, Tsunaki; Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Chen, Li] Jilin Univ, Coll Basic Med Sci, Dept Pharmacol, Changchun 130021, Peoples R China; [Huang, Ping] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA	Huang, P (reprint author), Jilin Univ, Coll Basic Med Sci, Minist Educ, Key Lab Pathobiol, Changchun 130021, Peoples R China.	szteng@yahoo.com; phuang@enders.tch.harvard.edu		Stegner, David/0000-0003-1059-9865	American Heart Association [SDG 0730285N]; Key Technology Project of Jilin Province [20076023]; Deutsche Forschungsgemeinschaft [Ni556/8-1]; National Institute of Child Health and Human Development	We thank Emanuela Gussoni for helpful discussion and Melissa Wu for critical reading of the manuscript. Funding for this work was generously provided by the American Heart Association (Grant SDG 0730285N to P.H.), The Key Technology Project of Jilin Province (20076023), and the Deutsche Forschungsgemeinschaft (Grant Ni556/8-1 to B.N.). The myosin heavy chain antibody (MF20, developed by Donald Fischman) was obtained from the Development Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the Department of Biology, University of Iowa, Iowa City, IA.	Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; You JS, 2014, J BIOL CHEM, V289, P1551, DOI 10.1074/jbc.M113.531392; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106; CHAPMAN VM, 1989, P NATL ACAD SCI USA, V86, P1292, DOI 10.1073/pnas.86.4.1292; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; MOHANDAS N, 1982, J BIOL CHEM, V257, P6537; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; Huang F, 2005, AM J PHYSIOL-LUNG C, V289, pL176, DOI 10.1152/ajplung.00003.2005; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Dixon RW, 1996, J NEUROPATH EXP NEUR, V55, P1230, DOI 10.1097/00005072-199612000-00006; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.E03-11-0798; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Bach AS, 2010, MOL BIOL CELL, V21, P2412, DOI 10.1091/mbc.E09-12-1063; BRAUN T, 1989, EMBO J, V8, P3617; Cazzolli Rosanna, 2009, V462, P241, DOI 10.1007/978-1-60327-115-8_16; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; HARRIS JB, 1978, CLIN EXP PHARMACOL P, V5, P587, DOI 10.1111/j.1440-1681.1978.tb00714.x; Haslett JN, 2005, MAMM GENOME, V16, P739, DOI 10.1007/s00335-005-0053-8; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Hughes WE, 2004, J BIOL CHEM, V279, P27534, DOI 10.1074/jbc.M403012200; Jaafar R, 2011, J BIOL CHEM, V286, P22609, DOI 10.1074/jbc.M110.203885; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Kozlovsky Y, 2002, BIOPHYS J, V83, P2634; Lang T, 2008, PROG LIPID RES, V47, P461, DOI 10.1016/j.plipres.2008.08.002; Lawlor MW, 2012, AM J PATHOL, V181, P961, DOI 10.1016/j.ajpath.2012.05.016; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Li D, 2003, J HUM GENET, V48, P438, DOI 10.1007/s10038-003-0045-z; MALTIN CA, 1983, CELL TISSUE RES, V232, P565, DOI 10.1007/BF00216429; Meriane M, 2000, MOL BIOL CELL, V11, P2513; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; SANTINI MT, 1990, BIOCHIM BIOPHYS ACTA, V1023, P298, DOI 10.1016/0005-2736(90)90426-O; WAKELAM MJO, 1983, BIOCHEM J, V214, P77	61	2	2	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	FEB 1	2015	26	3					506	517		10.1091/mbc.E14-03-0802		12	Cell Biology	Cell Biology	CA4EP	WOS:000348857300011		
J	Ohtsuka, H; Ishida, M; Naito, C; Murakami, H; Aiba, H				Ohtsuka, Hokuto; Ishida, Maiko; Naito, Chikako; Murakami, Hiroshi; Aiba, Hirofumi			Sexual development of Schizosaccharomyces pombe is induced by zinc or iron limitation through Ecl1 family genes	MOLECULAR GENETICS AND GENOMICS			English	Article						Schizosaccharomyces pombe; Sexual development; Metals; Stationary phase; Ecl1 family	CHRONOLOGICAL LIFE-SPAN; PRR1 RESPONSE REGULATOR; FISSION YEAST; TRANSCRIPTION FACTOR; MEIOSIS; PROTEIN; KINASE; PHOSPHORYLATION; DIFFERENTIATION; IDENTIFICATION	Ecl1 family genes (ecl1 (+), ecl2 (+), and ecl3 (+)) have been identified as extenders of the chronological lifespan in Schizosaccharomyces pombe. Here, we found that the triple-deletion mutant (a dagger ecl1/2/3) had a defect in sexual development after entry into the stationary phase, although the mutant essentially showed normal mating and sporulation under nitrogen starvation or carbon limitation. In this study, we showed that limitation of zinc or iron can be a signal for sexual development of S. pombe cells grown in Edinburgh minimal medium until the stationary phase and that Ecl1 family genes are important for this process. Because the a dagger ecl1/2/3 mutant diminishes the zinc depletion-dependent gene expression, Ecl1 family proteins may function as zinc sensors in the process of sexual development.	[Ohtsuka, Hokuto; Ishida, Maiko; Aiba, Hirofumi] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Mol Microbiol Lab,Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Naito, Chikako] Nagoya Univ, Grad Sch Bioagr Sci, Mol Microbiol Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Murakami, Hiroshi] Chuo Univ, Dept Biol Sci, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan	Aiba, H (reprint author), Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Mol Microbiol Lab,Chikusa Ku, Nagoya, Aichi 4648601, Japan.	aiba@ps.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Adaptable and Seamless Technology Transfer Program through target-driven RD, JST; Nagase Science and Technology Foundation; Asahi Glass Foundation	We thank K. Azuma and T. Shimasaki (Nagoya University, Japan) for the helpful discussion and Drs. M. Yamamoto, A. Yamashita, and Y. Watanabe (The University of Tokyo, Japan) and Dr. K. Kitamura (Hiroshima University, Japan) for materials. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Part of this work was also supported by the Adaptable and Seamless Technology Transfer Program through target-driven R&D, JST, Nagase Science and Technology Foundation, and The Asahi Glass Foundation [to HA].	Ohtsuka H, 2009, BIOSCI BIOTECH BIOCH, V73, P885, DOI 10.1271/bbb.80804; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Ohtsuka H, 2011, MOL GENET GENOMICS, V285, P67, DOI 10.1007/s00438-010-0588-6; Shimada M, 2008, EMBO J, V27, P132, DOI 10.1038/sj.emboj.7601949; Yamamoto M, 1996, CELL STRUCT FUNCT, V21, P431; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Yamamoto M, 2010, P JPN ACAD B-PHYS, V86, P788, DOI 10.2183/pjab.86.788; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Ito H, 2010, J BIOL CHEM, V285, P34616, DOI 10.1074/jbc.M110.175562; Okazaki N, 1998, MOL CELL BIOL, V18, P887; Ohtsuka H, 2013, MOL GENET GENOMICS, V288, P285, DOI 10.1007/s00438-013-0748-6; Ohtsuka H, 2012, GENES CELLS, V17, P39, DOI 10.1111/j.1365-2443.2011.01571.x; Azuma K, 2009, BIOSCI BIOTECH BIOCH, V73, P2787, DOI 10.1271/bbb.90599; Ohmiya R, 2000, MOL GEN GENET, V264, P441; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205; [Anonymous], 1991, METHOD ENZYMOL; Boch A, 2008, FEMS YEAST RES, V8, P883, DOI 10.1111/j.1567-1364.2008.00414.x; Kim L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042409; Kjaerulff S, 2005, MOL CELL BIOL, V25, P2045, DOI 10.1128/MCB.25.5.2045-2059.2005; Labbe S, 2007, BIOMETALS, V20, P523, DOI 10.1007/s10534-006-9056-5; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Ohtsuka H, 2008, FEMS YEAST RES, V8, P520, DOI 10.1111/j.1567-1364.2008.00379.x; Sukegawa Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002387; Valbuena N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011514	28	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	FEB	2015	290	1					173	185		10.1007/s00438-014-0911-8		13	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CA5BZ	WOS:000348923900014		
J	Lu, YC; Chen, YZ; Wei, YY; He, XT; Li, X; Hu, W; Yanagawa, Y; Wang, W; Wu, SX; Dong, YL				Lu, Ya-Cheng; Chen, Yan-Zhou; Wei, Yan-Yan; He, Xiao-Tao; Li, Xia; Hu, Wei; Yanagawa, Yuchio; Wang, Wen; Wu, Sheng-Xi; Dong, Yu-Lin			Neurochemical properties of the synapses between the parabrachial nucleus-derived CGRP-positive axonal terminals and the GABAergic neurons in the lateral capsular division of central nucleus of amygdala	MOLECULAR NEUROBIOLOGY			English	Article						Calcitonin gene-related peptide; GABA; Lateral capsular division of central nucleus of amygdala; Parabrachial nucleus; In situ hybridization; Synapse	GENE-RELATED PEPTIDE; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; IMMUNOREACTIVITY FORM SYNAPSES; CENTRAL EXTENDED AMYGDALA; C-FOS EXPRESSION; RAT SPINAL-CORD; SYNAPTIC PLASTICITY; STRIA TERMINALIS; PERIAQUEDUCTAL GRAY; SOLITARY TRACT	The lateral capsular division of central nucleus of amygdala (CeC) contains neurons using gamma-amino butyric acid (GABA) as the predominant neurotransmitter and expresses abundant calcitonin gene-related peptide (CGRP)-positive terminals. However, the relationship between them has not been revealed yet. Using GAD67-green fluorescent protein (GFP) knock-in mouse, we investigated the neurochemical features of synapses between CGRP-positive terminals and GABAergic neurons within CeC and the potential involvement of CGRP1 receptor by combining fluorescent in situ hybridization for CGRP1 receptor mRNA with immunofluorescent histochemistry for GFP and CGRP. The ultrastructures of these synapses were investigated with pre-embedding electron microscopy for GFP and CGRP. We found that some GABAergic neurons in the CeC received parabrachial nucleus (PBN) derived CGRP innervations and some of these GABAergic neurons can be activated by subcutaneous injection of formalin. Moreover, more than 90 % GABAergic neurons innervated by CGRP-positive terminal also express CGRP1 receptor mRNA. The CGRP-positive fibers made symmetric synapses onto the GABAergic somata, and asymmetric synapses onto the GABA-LI dendritic shafts and spines. This study provides direct ultrastructural evidences for the synaptic contacts between CGRP-positive terminals and GABAergic neurons within the CeC, which may underlie the pain-related neural pathway from PBN to CeC and be involved in the chronic pain modulation.	[Lu, Ya-Cheng; Chen, Yan-Zhou; Wei, Yan-Yan; He, Xiao-Tao; Li, Xia; Hu, Wei; Wang, Wen; Wu, Sheng-Xi; Dong, Yu-Lin] Fourth Mil Med Univ, Dept Anat Histol & Embryol, Xian 710032, Peoples R China; [Lu, Ya-Cheng; Chen, Yan-Zhou; Wei, Yan-Yan; He, Xiao-Tao; Li, Xia; Hu, Wei; Wang, Wen; Wu, Sheng-Xi; Dong, Yu-Lin] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Xian 710032, Peoples R China; [Chen, Yan-Zhou; He, Xiao-Tao; Hu, Wei] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gumma 371, Japan	Wang, W (reprint author), Fourth Mil Med Univ, Dept Anat Histol & Embryol, Xian 710032, Peoples R China.	wangwen@fmmu.edu.cn; shengxi@fmmu.edu.cn; dongtanat@fmmu.edu.cn			National Natural Science Foundation of China [81171050]; International Science & Technology Cooperation Program of China [2011DFA32560]	This work was supported by National Natural Science Foundation of China (No. 81171050 to Y.-L. Dong) and International Science & Technology Cooperation Program of China (No. 2011DFA32560 to S.-X. Wu).	Abbadie C, 1997, PAIN, V69, P101, DOI 10.1016/S0304-3959(96)03285-X; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.psych.46.1.209; Yamamoto T, 2009, ANN NY ACAD SCI, V1170, P378, DOI 10.1111/j.1749-6632.2009.03883.x; BERNARD JF, 1993, J COMP NEUROL, V329, P201, DOI 10.1002/cne.903290205; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002/cne.902930404; Saha S, 2000, NEUROSCIENCE, V99, P613, DOI 10.1016/S0306-4522(00)00240-2; Salio C, 2006, CELL TISSUE RES, V326, P583, DOI 10.1007/s00441-006-0268-3; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; McWilliams LA, 2004, PAIN, V111, P77, DOI 10.1016/j.pain.2004.06.002; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Neugebauer V, 2003, J NEUROSCI, V23, P52; Baker KB, 2004, BEHAV NEUROSCI, V118, P15, DOI 10.1037/0735-7044.118.1.15; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; MCDONALD AJ, 1982, J COMP NEUROL, V208, P401, DOI 10.1002/cne.902080409; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; Ji GC, 2009, J NEUROPHYSIOL, V102, P2253, DOI 10.1152/jn.00166.2009; Kang Y, 2004, BRAIN RES, V1028, P39, DOI 10.1016/j.brainres.2004.08.068; SCHWABER JS, 1988, J COMP NEUROL, V270, P416, DOI 10.1002/cne.902700310; Wang CC, 1999, J COMP NEUROL, V415, P341, DOI 10.1002/(SICI)1096-9861(19991220)415:3<341::AID-CNE3>3.0.CO;2-7; YAJIMA Y, 1980, BRAIN RES, V198, P446, DOI 10.1016/0006-8993(80)90759-3; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Ikeda R, 2007, PAIN, V127, P161, DOI 10.1016/j.pain.2006.09.003; Ma J, 2003, NEUROSCIENCE, V121, P991, DOI 10.1016/S0306-4522(03)00397-X; Veinante P, 1997, NEUROREPORT, V8, P2985, DOI 10.1097/00001756-199709080-00035; Rhudy JL, 2003, PAIN, V104, P617, DOI 10.1016/S0304-3959(03)00119-2; Han JS, 2005, J NEUROSCI, V25, P10717, DOI 10.1523/JNEUROSCI.4112-05.2005; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Chieng BCH, 2006, J COMP NEUROL, V497, P910, DOI 10.1002/cne.21025; Neugebauer V, 2003, J NEUROPHYSIOL, V89, P716, DOI 10.1152/jn.00799.2002; Kaneko M, 2000, J PHARMACOL EXP THER, V292, P743; Tallent Melanie K., 2008, V44, P177, DOI 10.1007/400_2007_037; Dong YL, 2010, J COMP NEUROL, V518, P4771, DOI 10.1002/cne.22487; VanderHorst VGJM, 2000, J COMP NEUROL, V424, P251, DOI 10.1002/1096-9861(20000821)424:2<251::AID-CNE5>3.0.CO;2-D; Polgar E, 2004, PAIN, V111, P144, DOI 10.1016/j.pain.2004.06.011; Jia HG, 2005, NEUROSCI LETT, V382, P153, DOI 10.1016/j.neulet.2005.03.013; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Anand KJS, 1996, PAIN, V67, P3; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Carrasquillo Y, 2007, J NEUROSCI, V27, P1543, DOI 10.1523/JNEUROSCI.3536-06.2007; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Batten TFC, 2002, AUTON NEUROSCI-BASIC, V98, P28, DOI 10.1016/S1566-0702(02)00026-7; BERNARD JF, 1990, J NEUROPHYSIOL, V63, P473; Bernard JF, 1998, J COMP NEUROL, V401, P429; Carrasquillo Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-24; COLEMANMESCHES K, 1995, BRAIN RES, V670, P75, DOI 10.1016/0006-8993(94)01272-J; D'Hanis W, 2007, J COMP NEUROL, V505, P268, DOI 10.1002/ene.21495; Finnegan TF, 2005, J PHARMACOL EXP THER, V312, P441, DOI 10.1124/jpet.104.074633; Han JS, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-10; Han JS, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-18; HARRIGAN EA, 1994, BRAIN RES BULL, V33, P529, DOI 10.1016/0361-9230(94)90079-5; Jia HG, 1997, J COMP NEUROL, V381, P262, DOI 10.1002/(SICI)1096-9861(19970512)381:3<262::AID-CNE2>3.0.CO;2-0; JU G, 1991, BRAIN RES BULL, V27, P617; Kits KS, 1997, NEUROSCIENCE, V79, P275, DOI 10.1016/S0306-4522(96)00651-3; Kozicz T, 2001, BRAIN RES, V893, P11, DOI 10.1016/S0006-8993(00)03118-8; Kozicz T, 2001, BRAIN RES, V914, P23, DOI 10.1016/S0006-8993(01)02770-6; KRUGER L, 1988, J COMP NEUROL, V273, P149, DOI 10.1002/cne.902730203; Lee Gregory P, 2004, Cogn Behav Neurol, V17, P9, DOI 10.1097/00146965-200403000-00002; Nakagawa T, 2003, NEUROSCI LETT, V344, P197, DOI 10.1016/S0304-3940(03)00465-8; Neugebauer V, 2002, J NEUROPHYSIOL, V87, P103; Oka T, 2008, NEUROSCI RES, V62, P286, DOI 10.1016/j.neures.2008.10.004; Oliver KR, 1998, MOL BRAIN RES, V57, P149, DOI 10.1016/S0169-328X(98)00052-7; PARE D, 1993, NEUROSCIENCE, V57, P1077, DOI 10.1016/0306-4522(93)90050-P; Poliacek I, 2007, BRAIN RES, V1184, P168, DOI 10.1016/j.brainres.2007.09.064; Price Donald D, 2002, Mol Interv, V2, P392, DOI 10.1124/mi.2.6.392; Puelles L, 2001, PHILOS T R SOC B, V356, P1583, DOI 10.1098/rstb.2001.0973; Sarhan M, 2005, J COMP NEUROL, V491, P418, DOI 10.1002/cne.20697; Schiess MC, 1999, J NEUROSCI RES, V58, P663, DOI 10.1002/(SICI)1097-4547(19991201)58:5<663::AID-JNR7>3.0.CO;2-A; SHIMADA S, 1985, NEUROSCIENCE, V16, P607, DOI 10.1016/0306-4522(85)90195-2; SHIMADA S, 1989, EXP BRAIN RES, V77, P217; SHIMADA S, 1992, NEUROSCI LETT, V134, P243, DOI 10.1016/0304-3940(92)90526-D; SLIWINSKAKOWALSKA M, 1989, HEARING RES, V42, P83, DOI 10.1016/0378-5955(89)90119-6; Takano K, 2003, J PHYSIOL-LONDON, V550, P973, DOI 10.1113/jphysiol.2003.042200; Takeuchi Y, 2004, BRAIN RES BULL, V64, P171, DOI 10.1016/j.brainresbull.2004.06.009; Tsubouchi K, 2007, NEUROSCI RES, V59, P390, DOI 10.1016/j.neures.2007.08.010; Tsumori T, 2006, BRAIN RES, V1070, P139, DOI 10.1016/j.brainres.2005.11.040; VanderHorst VGJM, 1996, PROG BRAIN RES, V107, P327; ZHANG RX, 1994, NEUROSCIENCE, V58, P299, DOI 10.1016/0306-4522(94)90036-1	81	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	FEB	2015	51	1					105	118		10.1007/s12035-014-8713-x		14	Neurosciences	Neurosciences & Neurology	CA6FT	WOS:000349006200009		
J	Knight, EM; Williams, HN; Stevens, AC; Kim, SH; Kottwitz, JC; Morant, AD; Steele, JW; Klein, WL; Yanagisawa, K; Boyd, RE; Lockhart, DJ; Sjoberg, ER; Ehrlich, ME; Wustman, BA; Gandy, S				Knight, E. M.; Williams, H. N.; Stevens, A. C.; Kim, S. H.; Kottwitz, J. C.; Morant, A. D.; Steele, J. W.; Klein, W. L.; Yanagisawa, K.; Boyd, R. E.; Lockhart, D. J.; Sjoberg, E. R.; Ehrlich, M. E.; Wustman, B. A.; Gandy, S.			Evidence that small molecule enhancement of beta-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound A beta	MOLECULAR PSYCHIATRY			English	Article							ALZHEIMERS-DISEASE; GM1 GANGLIOSIDE; PHARMACOLOGICAL CHAPERONE; SANDHOFF-DISEASE; TAY-SACHS; PROTEIN; BRAIN; CHOLESTEROL; GLUCOCEREBROSIDASE; MUTATIONS	Certain mutant Alzheimer's amyloid-beta (A beta) peptides (that is, Dutch mutant APP(E693Q)) form complexes with gangliosides (GA beta). These mutant A beta peptides may also undergo accelerated aggregation and accumulation upon exposure to GM2 and GM3. We hypothesized that increasing beta-hexosaminidase (beta-hex) activity would lead to a reduction in GM2 levels, which in turn, would cause a reduction in A beta aggregation and accumulation. The small molecule OT1001 is a beta-hex-targeted pharmacological chaperone with good bioavailability, blood-brain barrier penetration, high selectivity for beta-hex and low cytotoxicity. Dutch APP(E693Q) transgenic mice accumulate oligomeric A beta as they age, as well as A beta oligomer-dose-dependent anxiety and impaired novel object recognition (NOR). Treatment of Dutch APP(E693Q) mice with OT1001 caused a dose-dependent increase in brain beta-hex levels up to threefold over those observed at baseline. OT1001 treatment was associated with reduced anxiety, improved learning behavior in the NOR task and dramatically reduced GA beta accumulation in the subiculum and perirhinal cortex, both of which are brain regions required for normal NOR. Pharmacological chaperones that increase beta-hex activity may be useful in reducing accumulation of certain mutant species of A beta and in preventing the associated behavioral pathology.	[Knight, E. M.; Kim, S. H.; Kottwitz, J. C.; Morant, A. D.; Ehrlich, M. E.; Gandy, S.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Knight, E. M.; Kim, S. H.; Kottwitz, J. C.; Morant, A. D.; Ehrlich, M. E.; Gandy, S.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Knight, E. M.; Kim, S. H.; Gandy, S.] Icahn Sch Med Mt Sinai, Alzheimers Dis Res Ctr, New York, NY 10029 USA; [Williams, H. N.; Boyd, R. E.] Amicus Therapeut, Cranbury, NJ USA; [Stevens, A. C.; Steele, J. W.; Lockhart, D. J.; Sjoberg, E. R.; Wustman, B. A.] OrPhi Therapeut, Carlsbad, CA USA; [Klein, W. L.] Northwestern Univ, Dept Neurobiol, Evanston, IL USA; [Klein, W. L.] Northwestern Univ, Dept Cognit Neurol, Evanston, IL USA; [Klein, W. L.] Northwestern Univ, Alzheimers Dis Ctr, Evanston, IL USA; [Yanagisawa, K.] Natl Ctr Geriatr Gerontol, Res Inst, Obu City, Aichi, Japan; [Gandy, S.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA	Gandy, S (reprint author), Icahn Sch Med Mt Sinai, Dept Neurol, One Gustave L Levy Pl, New York, NY 10029 USA.	samuel.gandy@mssm.edu			Alzheimer's Drug Discovery Foundation [291003]; BrightFocus Foundation	This work was supported by Alzheimer's Drug Discovery Foundation grant 291003. SHK is supported by BrightFocus Foundation. The beta-hex targeted pharmacological chaperone OT1001 was supplied by Amicus Therapeutics. We thank Drs Richie Khanna, Anadina Garcia and Michelle Frascella for their assistance in animal handling and dosing, and Drs Elfrida Benjamin and Rick Hamler for their assistance in measuring OT1001 levels in the PK and PD studies conducted in C57BL/J6 mice.	Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7; Gylys KH, 2007, NEUROBIOL AGING, V28, P8, DOI 10.1016/j.neurobiolaging.2005.10.018; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; Boyd RE, 2013, J MED CHEM, V56, P2705, DOI 10.1021/jm301557k; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Yamamoto N, 2005, FEBS LETT, V579, P2185, DOI 10.1016/j.febslet.2005.03.013; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Utsumi M, 2009, GLYCOCONJUGATE J, V26, P999, DOI 10.1007/s10719-008-9216-7; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Clarke JTR, 2011, MOL GENET METAB, V102, P6, DOI 10.1016/j.ymgme.2010.09.004; Schubert U, 2000, NATURE, V404, P770; Gandy S, 2010, ANN NEUROL, V68, P220, DOI 10.1002/ana.22052; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P1935, DOI 10.1016/j.bbamem.2007.02.009; Alcalay RN, 2012, NEUROLOGY, V78, P1434, DOI 10.1212/WNL.0b013e318253d54b; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00120; Molander-Melin M, 2005, J NEUROCHEM, V92, P171, DOI 10.1111/j.1471-4159.2004.02849.x; Tamboli IY, 2011, J NEUROSCI, V31, P1837, DOI 10.1523/JNEUROSCI.2954-10.2011; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Bateman KS, 2011, J MED CHEM, V54, P1421, DOI 10.1021/jm101443u; BROOKSBANK BWL, 1989, MOL CHEM NEUROPATHOL, V11, P143; Chang EH, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00046; Daniele A, 2012, NEUROLOGY, V78, P1372, DOI 10.1212/WNL.0b013e318253d67b; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; KRACUN I, 1991, International Journal of Developmental Biology, V35, P289; Lee Hyun, 2014, Mol Cells, V37, P161, DOI 10.14348/molcells.2014.2347; Malnar M, 2014, NEUROBIOL DIS, V72, P37, DOI 10.1016/j.nbd.2014.05.033; Manna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071308; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mutoh Tatsuro, 2006, CNS & Neurological Disorders-Drug Targets, V5, P375, DOI 10.2174/187152706777950710; Osher E, 2011, MOL GENET METAB, V102, P356, DOI 10.1016/j.ymgme.2010.11.163; SELKOE DJ, 1995, NAT MED, V1, P998, DOI 10.1038/nm1095-998; Wustman BA, 2012, PEDIATR PULM, V47, P114; Yagi-Utsumi M, 2010, INT J ALZHEIMERS DIS, V2011; Yamamoto N, 2006, NEUROREPORT, V17, P1735, DOI 10.1097/01.wnr.0000239958.53072.14; Yamamoto N, 2005, BIOCHEM BIOPH RES CO, V335, P45, DOI 10.1016/j.bbrc.2005.06.028; Yanagisawa K, 1997, FEBS LETT, V420, P43, DOI 10.1016/S0014-5793(97)01484-1	48	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	FEB	2015	20	1					109	117		10.1038/mp.2014.135		9	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	CB1QR	WOS:000349403400011		
J	Ellegood, J; Anagnostou, E; Babineau, BA; Crawley, JN; Lin, L; Genestine, M; DiCicco-Bloom, E; Lai, JKY; Foster, JA; Penagarikano, O; Geschwind, DH; Pacey, LK; Hampson, DR; Laliberte, CL; Mills, AA; Tam, E; Osborne, LR; Kouser, M; Espinosa-Becerra, F; Xuan, Z; Powell, CM; Raznahan, A; Robins, DM; Nakai, N; Nakatani, J; Takumi, T; van Eede, MC; Kerr, TM; Muller, C; Blakely, RD; Veenstra-VanderWeele, J; Henkelman, RM; Lerch, JP				Ellegood, J.; Anagnostou, E.; Babineau, B. A.; Crawley, J. N.; Lin, L.; Genestine, M.; DiCicco-Bloom, E.; Lai, J. K. Y.; Foster, J. A.; Penagarikano, O.; Geschwind, D. H.; Pacey, L. K.; Hampson, D. R.; Laliberte, C. L.; Mills, A. A.; Tam, E.; Osborne, L. R.; Kouser, M.; Espinosa-Becerra, F.; Xuan, Z.; Powell, C. M.; Raznahan, A.; Robins, D. M.; Nakai, N.; Nakatani, J.; Takumi, T.; van Eede, M. C.; Kerr, T. M.; Muller, C.; Blakely, R. D.; Veenstra-VanderWeele, J.; Henkelman, R. M.; Lerch, J. P.			Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity	MOLECULAR PSYCHIATRY			English	Article							SPECTRUM DISORDERS; BEHAVIORAL PHENOTYPES; STRUCTURAL MRI; BRAIN; MICE; ABNORMALITIES; REGISTRATION; RELEVANT; SUBTYPES	Autism is a heritable disorder, with over 250 associated genes identified to date, yet no single gene accounts for > 1-2% of cases. The clinical presentation, behavioural symptoms, imaging and histopathology findings are strikingly heterogeneous. A more complete understanding of autism can be obtained by examining multiple genetic or behavioural mouse models of autism using magnetic resonance imaging (MRI)-based neuroanatomical phenotyping. Twenty-six different mouse models were examined and the consistently found abnormal brain regions across models were parieto-temporal lobe, cerebellar cortex, frontal lobe, hypothalamus and striatum. These models separated into three distinct clusters, two of which can be linked to the under and over-connectivity found in autism. These clusters also identified previously unknown connections between Nrxn1a, En2 and Fmr1; Nlgn3, BTBR and Slc6A4; and also between X monosomy and Mecp2. With no single treatment for autism found, clustering autism using neuroanatomy and identifying these strong connections may prove to be a crucial step in predicting treatment response.	[Ellegood, J.; Laliberte, C. L.; van Eede, M. C.; Henkelman, R. M.; Lerch, J. P.] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5T 3H7, Canada; [Anagnostou, E.] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Babineau, B. A.; Crawley, J. N.] NIMH, Lab Behav Neurosci, Bethesda, MD 20892 USA; [Crawley, J. N.] Univ Calif Davis, Sch Med, MIND Inst, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Lin, L.; Genestine, M.; DiCicco-Bloom, E.] UMDNJ Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ USA; [Lai, J. K. Y.; Foster, J. A.] McMaster Univ, Brain Body Inst, Hamilton, ON, Canada; [Penagarikano, O.; Geschwind, D. H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Pacey, L. K.; Hampson, D. R.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Mills, A. A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Tam, E.; Osborne, L. R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Tam, E.; Osborne, L. R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kouser, M.; Espinosa-Becerra, F.; Xuan, Z.; Powell, C. M.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Kouser, M.; Espinosa-Becerra, F.; Xuan, Z.; Powell, C. M.] Univ Texas SW Med Ctr Dallas, Dept Neurotherapeut Psychiat, Dallas, TX 75390 USA; [Raznahan, A.] NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA; [Robins, D. M.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; [Nakai, N.; Nakatani, J.; Takumi, T.] RIKEN, Brain Sci Inst, Dept Mental Biol, Wako, Saitama, Japan; [Kerr, T. M.; Muller, C.; Blakely, R. D.; Veenstra-VanderWeele, J.] Vanderbilt Brain Inst, Vanderbilt Kennedy Ctr, Dept Pharmacol, Nashville, TN USA; [Henkelman, R. M.; Lerch, J. P.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	Ellegood, J (reprint author), Hosp Sick Children, Mouse Imaging Ctr, 25 Orde St, Toronto, ON M5T 3H7, Canada.	jacob@mouseimaging.ca; jason.lerch@utoronto.ca	Henkelman, Mark/F-3662-2011; Veenstra-VanderWeele, Jeremy/K-1935-2015; 	Veenstra-VanderWeele, Jeremy/0000-0002-6349-1076; Robins, Diane M./0000-0001-6727-6309	Canadian Institute for Health Research (CIHR); Ontario Brain Institute (OBI); Ontario Mental Health Foundation (OHMF)	This work was primarily funded by the Canadian Institute for Health Research (CIHR) and the Ontario Brain Institute (OBI). JE received salary support from the Ontario Mental Health Foundation (OHMF) and RMH holds a Canada Research Chair.	van Eede MC, 2013, NEUROIMAGE, V82, P226, DOI 10.1016/j.neuroimage.2013.06.004; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Lerch JR, 2011, METHODS MOL BIOL, V711, P349, DOI 10.1007/978-1-61737-992-5_17; Ey E, 2011, AUTISM RES, V4, P5, DOI 10.1002/aur.175; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Nieman BJ, 2005, NMR BIOMED, V18, P447, DOI 10.1002/nbm.981; Lord C, 2006, ARCH GEN PSYCHIAT, V63, P694, DOI 10.1001/archpsyc.63.6.694; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Bock NA, 2003, MAGNET RESON MED, V49, P158, DOI 10.1002/mrm.10326; Kurth F, 2011, BIOL PSYCHIAT, V70, P278, DOI 10.1016/j.biopsych.2011.03.026; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Cahill LS, 2012, NEUROIMAGE, V60, P933, DOI 10.1016/j.neuroimage.2012.01.100; Brodkin ES, 2007, BEHAV BRAIN RES, V176, P53, DOI 10.1016/j.bbr.2006.06.025; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Ellegood J, 2013, NEUROIMAGE, V70, P288, DOI 10.1016/j.neuroimage.2012.12.029; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Toal F, 2010, PSYCHOL MED, V40, P1171, DOI 10.1017/S0033291709991541; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Abrahams BS, 2010, ARCH NEUROL-CHICAGO, V67, P395, DOI 10.1001/archneurol.2010.47; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Kana RK, 2011, PHYS LIFE REV, V8, P410, DOI 10.1016/j.plrev.2011.10.001; Huerta M, 2012, PEDIATR CLIN N AM, V59, P103, DOI 10.1016/j.pcl.2011.10.018; Portmann T, 2014, CELL REP, V7, P1077, DOI 10.1016/j.celrep.2014.03.036; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Hrdlicka M, 2005, EUR CHILD ADOLES PSY, V14, P138, DOI 10.1007/s00787-005-0453-z; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Ward BC, 2008, NEUROBIOL DIS, V31, P110, DOI 10.1016/j.nbd.2008.03.009; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Nieman BJ, 2007, HUM BRAIN MAPP, V28, P567, DOI 10.1002/hbm.20408; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Nieman BJ, 2006, PHYSIOL GENOMICS, V24, P154, DOI 10.1152/physiolgenomics.00217.2005; Amaral DG, 2011, BRAIN RES, V1380, P3, DOI 10.1016/j.brainres.2010.11.077; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192; Raznahan A, 2013, BIOL PSYCHIAT, V74, P563, DOI 10.1016/j.biopsych.2013.03.022; Bailey KR, 2006, ILAR J, V47, P124; Banerjee-Basu S, 2010, DIS MODEL MECH, V3, P133, DOI 10.1242/dmm.005439; Canitano R., 2012, BEHAV BRAIN RES, V251, P125; Dodero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076655; Gleave JA, 2012, PHYSIOL GENOMICS, V44, P778, DOI 10.1152/physiolgenomics.00055.2012; Lerch JP, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00006; Saywell Véronique, 2006, Biochem Biophys Res Commun, V340, P776, DOI 10.1016/j.bbrc.2005.12.080; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Veenstra-VanderWeele J, 2012, NEUROPSYCHOPHARMACOL, V37, P196, DOI 10.1038/npp.2011.185	51	10	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	FEB	2015	20	1					118	125		10.1038/mp.2014.98		8	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	CB1QR	WOS:000349403400012		
J	Wang, YQ; Yamamoto, Y; Shigemori, S; Watanabe, T; Oshiro, K; Wang, XY; Wang, PF; Sato, T; Yonekura, S; Tanaka, S; Kitazawa, H; Shimosato, T				Wang, Yeqin; Yamamoto, Yoshinari; Shigemori, Suguru; Watanabe, Takafumi; Oshiro, Kazushi; Wang, Xinyu; Wang, Pengfei; Sato, Takashi; Yonekura, Shinichi; Tanaka, Sachi; Kitazawa, Haruki; Shimosato, Takeshi			Inhibitory/Suppressive Oligodeoxynucleotide Nanocapsules as Simple Oral Delivery Devices for Preventing Atopic Dermatitis in Mice	MOLECULAR THERAPY			English	Article							CPG OLIGODEOXYNUCLEOTIDE; NC/NGA MICE; CARBONATE-APATITE; IFN-GAMMA; LISTERIA-MONOCYTOGENES; DRUG-DELIVERY; SKIN-LESIONS; DNA; ACTIVATION; EXPRESSION	Here, we report a simple and low-cost oral oligodeoxynucleotide (ODN) delivery system targeted to the gut Peyer's patches (PPs). This system requires only Dulbecco's modified eagle's medium, calcium chloride, ODNs, and basic laboratory equipment. ODN nanocapsules (ODNcaps) were directly delivered to the PPs through oral administration and were taken up by macrophages in the PPs, where they induced an immune response. Long-term continuous oral dosing with inhibitory/suppressive ODNcaps (iODNcaps, "iSG3caps" in this study) was evaluated using an atopic dermatitis mouse model to visually monitor disease course. Administration of iSG3caps improved skin lesions and decreased epidermal thickness. Underlying this effect is the ability of iSG3 to bind to and prevent phosphorylation of signal transducer and activator of transcription 6, thereby blocking the interleukin-4 signaling cascade mediated by binding of allergens to type 2 helper T cells. The results of our iSG3cap oral delivery experiments suggest that iSG3 may be useful for treating allergic diseases.	[Wang, Yeqin; Shigemori, Suguru; Shimosato, Takeshi] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Kamiina, Japan; [Yamamoto, Yoshinari; Watanabe, Takafumi; Oshiro, Kazushi; Wang, Xinyu; Wang, Pengfei; Shimosato, Takeshi] Shinshu Univ, Grad Sch Agr, Kamiina, Japan; [Sato, Takashi] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan; [Yonekura, Shinichi; Shimosato, Takeshi] Shinshu Univ, Interdisciplinary Cluster Cutting Edge Res, Inst Biomed Sci, Dept Interdisciplinary Genome Sci & Cell Metab, Kamiina, Japan; [Tanaka, Sachi] Shinshu Univ, Frontier Agrisci & Technol Ctr FAST, Kamiina, Japan; [Kitazawa, Haruki] Tohoku Univ, Grad Sch Agr Sci, Food & Feed Immunol Grp, Sendai, Miyagi 980, Japan	Shimosato, T (reprint author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, 8304 Minamiminowa, Nagano 3994598, Japan.	haruki@bios.tohoku.ac.jp; shimot@shinshu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24580388]; Mishima Kaiun Memorial Foundation (Heisei)	We thank Nao Akiba and Yuto Sakamoto (Faculty of Agriculture, Shinshu University) for excellent animal care and technical support. The study was supported by a Grant-in-Aid for Scientific Research I (No. 24580388) from the Japan Society for the Promotion of Science (JSPS) and by a grant from the Mishima Kaiun Memorial Foundation (Heisei 24, No. 8) to T.S. The authors declare no conflict of interest.	KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Shirota H, 2004, J IMMUNOL, V173, P5002; Shigemori S, 2013, APPL MICROBIOL BIOT, V97, P3603, DOI 10.1007/s00253-012-4608-9; Cengiz S, 2014, DENT MATER J, V33, P343, DOI 10.4012/dmj.2013-265; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Klaschik S, 2010, MOL IMMUNOL, V47, P1317, DOI 10.1016/j.molimm.2009.11.014; Shirota H, 2005, J IMMUNOL, V174, P4579; Yamaguchi J, 2008, J INVEST DERMATOL, V128, P2842, DOI 10.1038/jid.2008.150; Kunisawa J, 2012, ADV DRUG DELIVER REV, V64, P523, DOI 10.1016/j.addr.2011.07.003; Zhu Q, 2012, NAT MED, V18, P1291, DOI 10.1038/nm.2866; Costa LB, 2012, J INFECT DIS, V205, P1464, DOI 10.1093/infdis/jis216; Sugai T, 2005, VACCINE, V23, P5450, DOI 10.1016/j.vaccine.2004.09.041; Xiong Z, 2014, J ALZHEIMERS DIS, V40, P297, DOI 10.3233/JAD-132081; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ito Y, 2013, FEBS OPEN BIO, V3, P41, DOI 10.1016/j.fob.2012.11.002; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Inoue J, 2007, J IMMUNOL, V178, P584; Gursel M, 2002, J LEUKOCYTE BIOL, V71, P813; Wang BM, 2014, MOL THER, V22, P522, DOI 10.1038/mt.2013.190; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Hattori K, 2010, J IMMUNOL, V184, P2729, DOI 10.4049/jimmunol.0900215; Gursel I, 2003, J IMMUNOL, V171, P1393; Lautenschlager C, 2013, EUR J PHARM BIOPHARM, V85, P578, DOI 10.1016/j.ejpb.2013.09.016; Karbach J, 2012, CANCER RES, V72, P4304, DOI 10.1158/0008-5472.CAN-12-0257; Luo D, 2000, NAT BIOTECHNOL, V18, P33; Park Y, 2001, J ALLERGY CLIN IMMUN, V108, P570; Mamaeva V, 2011, MOL THER, V19, P1538, DOI 10.1038/mt.2011.105; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Asanuma H, 2012, VACCINE, V30, P803, DOI 10.1016/j.vaccine.2011.10.093; Ballarin-Gonzalez B, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.2; Cheng WK, 2014, CLIN VACCINE IMMUNOL, V21, P329, DOI 10.1128/CVI.00734-13; Choudhury BK, 2002, J IMMUNOL, V169, P5955; Chowdhury EH, 2011, BIOCHEM BIOPH RES CO, V409, P745, DOI 10.1016/j.bbrc.2011.05.079; de Coana YP, 2012, INT ARCH ALLERGY IMM, V157, P331, DOI 10.1159/000329636; Fukuda K, 2012, BIOCHEM BIOPH RES CO, V419, P482, DOI 10.1016/j.bbrc.2012.02.023; Hamasaka A, 2009, J ALLERGY CLIN IMMUN, V124, P90, DOI 10.1016/j.jaci.2009.04.025; Imal Y, 2013, P NATL ACAD SCI USA, V110, P13921; Ito S, 2005, INFECT IMMUN, V73, P3803, DOI 10.1128/IAI.73.6.3803-3805.2005; Klinman DM, 2005, ANN NY ACAD SCI, V1058, P87, DOI 10.1196/annals.1359.015; Klinman Dennis M, 2004, Nat Rev Immunol, V4, P249, DOI 10.1038/nri1329; Kutsuzawa K, 2008, BIOMATERIALS, V29, P370, DOI 10.1016/j.biomaterials.2007.09.011; Lee SY, 2006, J ALLERGY CLIN IMMUN, V117, P597, DOI 10.1016/j.jaci.2005.11.008; Maeyama J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088846; Sester DP, 2000, J IMMUNOL, V165, P4165; Shimosato T, 2010, BIOCHEM BIOPH RES CO, V394, P81, DOI 10.1016/j.bbrc.2010.02.110; Takakura M, 2005, J INVEST DERMATOL, V125, P1156, DOI 10.1111/j.0022-202X.2005.23928.x; Volpi C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2874; Youn CJ, 2004, J IMMUNOL, V173, P7556	50	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	FEB	2015	23	2					297	309		10.1038/mt.2014.239		13	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CA2PT	WOS:000348750700011		
J	Kainuma, S; Miyagawa, S; Fukushima, S; Pearson, J; Chen, YC; Saito, A; Harada, A; Shiozaki, M; Iseoka, H; Watabe, T; Watabe, H; Horitsugi, G; Ishibashi, M; Ikeda, H; Tsuchimochi, H; Sonobe, T; Fujii, Y; Naito, H; Umetani, K; Shimizu, T; Okano, T; Kobayashi, E; Daimon, T; Ueno, T; Kuratani, T; Toda, K; Takakura, N; Hatazawa, J; Shirai, M; Sawa, Y				Kainuma, Satoshi; Miyagawa, Shigeru; Fukushima, Satsuki; Pearson, James; Chen, Yi Ching; Saito, Atsuhiro; Harada, Akima; Shiozaki, Motoko; Iseoka, Hiroko; Watabe, Tadashi; Watabe, Hiroshi; Horitsugi, Genki; Ishibashi, Mana; Ikeda, Hayato; Tsuchimochi, Hirotsugu; Sonobe, Takashi; Fujii, Yutaka; Naito, Hisamichi; Umetani, Keiji; Shimizu, Tatsuya; Okano, Teruo; Kobayashi, Eiji; Daimon, Takashi; Ueno, Takayoshi; Kuratani, Toru; Toda, Koichi; Takakura, Nobuyuki; Hatazawa, Jun; Shirai, Mikiyasu; Sawa, Yoshiki			Cell-sheet Therapy With Omentopexy Promotes Arteriogenesis and Improves Coronary Circulation Physiology in Failing Heart	MOLECULAR THERAPY			English	Article							ENDOTHELIAL DYSFUNCTION; OMENTAL FLAP; FAILURE; COMBINATION; VESSELS; ARTERY; NEOVASCULARIZATION; ANGIOGENESIS; INHIBITION; DELIVERS	Cell-sheet transplantation induces angiogenesis for chronic myocardial infarction (Ml), though insufficient capillary maturation and paucity of arteriogenesis may limit its therapeutic effects. Onnentum has been used clinically to promote revascularization and healing of ischemic tissues. We hypothesized that cell-sheet transplantation covered with an omentum-flap would effectively establish mature blood vessels and improve coronary microcirculation physiology, enhancing the therapeutic effects of cell-sheet therapy. Rats were divided into four groups after coronary ligation; skeletal myoblast cell-sheet plus omentum-flap (combined), cell-sheet only, omentum-flap only, and sham operation. At 4 weeks after the treatment, the combined group showed attenuated cardiac hypertrophy and fibrosis, and a greater amount of functionally (CD31(+)/lectin(+)) and structurally (CD31(+)/alpha-SMA(+)) mature blood vessels, along with myocardial upregulation of relevant genes. Synchrotron-based microangiography revealed that the combined procedure increased vascularization in resistance arterial vessels with better dilatory responses to endothelium-dependent agents. Serial N-13-ammonia PET showed better global coronary flow reserve in the combined group, mainly attributed to improvement in the basal left ventricle. Consequently, the combined group had sustained improvements in cardiac function parameters and better functional capacity. Cell-sheet transplantation with an omentum-flap better promoted arteriogenesis and improved coronary microcirculation physiology in ischemic myocardium, leading to potent functional recovery in the failing heart.	[Kainuma, Satoshi; Miyagawa, Shigeru; Fukushima, Satsuki; Saito, Atsuhiro; Harada, Akima; Shiozaki, Motoko; Iseoka, Hiroko; Ueno, Takayoshi; Kuratani, Toru; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan; [Pearson, James; Chen, Yi Ching] Monash Univ, Monash Biomed Imaging Facil, Melbourne, Vic 3168, Australia; [Pearson, James; Chen, Yi Ching] Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; [Watabe, Tadashi; Watabe, Hiroshi] Osaka Univ, Grad Sch Med, Dept Mol Imaging Med, Suita, Osaka 5650871, Japan; [Horitsugi, Genki; Ishibashi, Mana; Ikeda, Hayato] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka 5650871, Japan; [Tsuchimochi, Hirotsugu; Sonobe, Takashi; Fujii, Yutaka] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cardiac Physiol, Osaka, Japan; [Naito, Hisamichi; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan; [Umetani, Keiji] Japan Synchrotron Radiat Res Inst, Harima, Japan; [Shimizu, Tatsuya; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Kobayashi, Eiji] Jichi Med Sch, Ctr Mol Med, Div Organ Replacement Res, Shimotsuke, Tochigi, Japan; [Daimon, Takashi] Hyogo Coll Med, Dept Biostat, Kobe, Hyogo, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2-E1 Yamadaoka, Suita, Osaka 5650871, Japan.	sawa-p@surg1.med.osaka-u.ac.jp	Tsuchimochi, Hirotsugu/D-8224-2011	Tsuchimochi, Hirotsugu/0000-0001-7591-2520	Research on Regenerative Medicine for Clinical Application from the Ministry of Health, Labour and Welfare of Japan; Australian Synchrotron International Synchrotron Access Program [ISAP AS-IA111]	We thank Tsuyoshi Ishikawa, Yuuka Fujiwara, Yuka Kataoka, Hiromi Nishinaka, Toshika Senba, and staff of the PET Molecular Imaging Center for their excellent technical assistance. This research was supported by Research on Regenerative Medicine for Clinical Application from the Ministry of Health, Labour and Welfare of Japan and the Australian Synchrotron International Synchrotron Access Program (ISAP AS-IA111). Experiments were performed at the Japan Synchrotron Radiation Research Institute (SPring-8, BL28B2, Proposal 2011A1169). T.S. is a consultant for CellSeed, Inc., and T.O. is an Advisory Board Member of CellSeed, Inc. and an inventor/developer holding a patent for temperature-responsive culture surfaces. The authors have no conflicts of interest to report.	Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Kawamura M, 2013, CIRCULATION, V128, pS87, DOI 10.1161/CIRCULATIONAHA.112.000366; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; HABIB GB, 1991, CIRCULATION, V83, P739; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Meyer B, 2005, J AM COLL CARDIOL, V46, P1011, DOI 10.1016/j.jacc.2005.04.060; Shirai M, 2013, CIRC RES, V112, P209, DOI 10.1161/CIRCRESAHA.111.300096; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; Heitzer T, 2005, ARTERIOSCL THROM VAS, V25, P1174, DOI 10.1161/01.ATV.0000166516.52477.81; Sekiya N, 2009, J THORAC CARDIOV SUR, V138, P985, DOI 10.1016/j.jtcvs.2009.02.004; Cao YH, 2005, CARDIOVASC RES, V65, P639, DOI 10.1016/j.cardiores.2004.11.020; Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Shrager JB, 2003, J THORAC CARDIOV SUR, V125, P526, DOI 10.1067/mtc.2003.12; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Gutierrez E, 2013, EUR HEART J, V34, P3175, DOI 10.1093/eurheartj/eht351; Shudo Y, 2011, J THORAC CARDIOV SUR, V142, P1188, DOI 10.1016/j.jtcvs.2011.07.002; Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje; Carmeliet P, 2001, NAT BIOTECHNOL, V19, P1019, DOI 10.1038/nbt1101-1019; Hagege AA, 2001, HYPERTENSION, V38, P1413, DOI 10.1161/hy1201.099618; Iwasaki H, 2007, ARTERIOSCL THROM VAS, V27, P1326, DOI 10.1161/ATVBAHA.106.137141; Jenkins MJ, 2012, ARTERIOSCL THROM VAS, V32, P370, DOI 10.1161/ATVBAHA.111.237172; Ludmer PL, 1986, NEW ENGL J MED, V1046, P315, DOI DOI 10.1056/NEJM198610233151702; Narita T, 2013, INT J CARDIOL, V168, P261, DOI 10.1016/j.ijcard.2012.09.081; O'Shaugnessy L, 1937, LANCET, V232, P185; Poelzl G, 2005, EUR J HEART FAIL, V7, P43, DOI 10.1016/j.ejheart.2004.04.008; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Takaba K, 2006, J THORAC CARDIOV SUR, V132, P891, DOI 10.1016/j.jtcvs.2006.06.023	30	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	FEB	2015	23	2					374	386		10.1038/mt.2014.225		13	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CA2PT	WOS:000348750700018		
J	Sydnes, MO; Isobe, M				Sydnes, Magne O.; Isobe, Minoru			Exclusive formation of azo-compounds upon hydrogenolysis of nitrobenzeneseleninic acid derivatives over Pd/C	MONATSHEFTE FUR CHEMIE			English	Article						Azo-compounds; Benzeneseleninic acid; Nitrobenzeneseleninic acid; Nitration	ORGANOSELENIUM COMPOUNDS; PHARMACOLOGY; CYCLIZATION; REDUCTION; CHEMISTRY; PHOSPHATE	Hydrogenolysis of 3-nitrobenzeneseleninic acid and 3-bromo-4-nitrobenzeneseleninic acid under standard conditions (Pd/C, H-2 1 atm in MeOH) gave exclusively the corresponding azo-compounds. Nitration of the azo-compounds with HNO3 in H2SO4 at 0 A degrees C yielded solely 3-nitrobenzeneseleninic acid and 3-bromo-4-nitrobenzeneseleninic acid in return.	[Sydnes, Magne O.] Univ Stavanger, Dept Math & Nat Sci, Fac Sci & Technol, Stavanger, Norway; [Sydnes, Magne O.] Nagoya Univ, Grad Sch Bioagr Sci, Organ Chem Lab, Nagoya, Aichi 4648601, Japan; [Isobe, Minoru] Natl Sun Yat Sen Univ, Dept Chem, Kaohsiung 80424, Taiwan; [Isobe, Minoru] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan	Sydnes, MO (reprint author), Univ Stavanger, Dept Math & Nat Sci, Fac Sci & Technol, Stavanger, Norway.	magne.o.sydnes@uis.no			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [16002007]; JSPS; University of Stavanger; Research program, Green Production Chemistry	Financial support from a Grant-in-Aid for Specially Promoted Research (16002007) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) is gratefully acknowledged. M.O.S. is grateful for the provision of a JSPS Post-doctoral Fellowship for foreign researchers. Financial support from the University of Stavanger and the Research program, Green Production Chemistry is also gratefully acknowledged. We thank Mr. A. Miyazaki and Dr. M. Kuse for MS analysis, Mr. Y. Sawayama for excellent technical assistance, and Dr. A. Garavelas for help with literature.	Abdo M, 2008, J AM CHEM SOC, V130, P13196, DOI 10.1021/ja804489m; Mugesh G, 2001, CHEM REV, V101, P2125, DOI 10.1021/cr000426w; Besse D, 1997, ANGEW CHEM INT EDIT, V36, P883, DOI 10.1002/anie.199708831; Lunde SA, 2013, SYNLETT, V24, P2340, DOI 10.1055/s-0033-1339860; Xiao X, 2014, TETRAHEDRON LETT, V55, P2056, DOI 10.1016/j.tetlet.2013.10.048; Rye CS, 2005, CURR MED CHEM, V12, P3127, DOI 10.2174/092986705774933452; Bayse CA, 2010, J INORG BIOCHEM, V104, P1, DOI 10.1016/j.jinorgbio.2009.09.007; Kucharski S, 1999, NEW J CHEM, V23, P765, DOI 10.1039/a901306g; Nogueira CW, 2004, CHEM REV, V104, P6255, DOI 10.1021/cr0406559; Behaghel O, 1932, BER DTSCH CHEM GES, V65, P812, DOI 10.1002/cber.19320650525; Behaghel O, 1935, CHEM BER, V68, P1540; BENEDETTI A, 1982, AUST J CHEM, V35, P1365; Cheng H, 2013, ANILINE; Duan J, 1999, SYNLETT, V1245; Freidlin LK, 1951, DOKLADY ADAD NAUK SS, V76, P551; Funahashi K, 1977, Ger Offen, Patent No. [DE 2649748, 2649748]; Gelder EA, 2005, CHEM COMMUN, V522; Glaser R, 1996, J ORG CHEM, V61, P1047, DOI 10.1021/jo950783k; Haber F, 1898, Z ELEKTROCHEM, V22, P506; Jagadeesh RV, 2011, J MOL CATAL A-CHEM, V338, P92, DOI 10.1016/j.molcata.2011.02.002; Janovsky JV, 1886, MONATSH CHEM, V7, P124, DOI 10.1007/BF01516565; Janovsky JV, 1885, MONATSH CHEM, V6, P157, DOI 10.1007/BF01554624; Karame I, 2004, TETRAHEDRON-ASYMMETR, V15, P1569, DOI 10.1016/j.tetasy.2004.03.023; KICE JL, 1978, J AM CHEM SOC, V100, P5094, DOI 10.1021/ja00484a031; MCCULLOUGH JD, 1949, J AM CHEM SOC, V71, P674, DOI 10.1021/ja01170a083; Parnham M, 1996, J EXP OPIN INVEST DR, V5, P861; Prediger I, 2008, SYNTHESIS-STUTTGART, P2191, DOI 10.1055/s-2008-1067154; SINGH J, 1962, CAN J CHEM, V40, P1921, DOI 10.1139/v62-295; Smith MB, 1994, ORG SYNTH, P197; Stuhr-Hansen N, 2000, ORG LETT, V2, P7, DOI 10.1021/ol991093w; SYDNES MO, 2008, ISOBE M CHEM ASIAN J, V3, P102; Werner A, 1899, CHEM BER, V32, P3256	32	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0026-9247	1434-4475		MONATSH CHEM	Mon. Chem.	FEB	2015	146	2					351	356		10.1007/s00706-014-1373-8		6	Chemistry, Multidisciplinary	Chemistry	CA5YW	WOS:000348985900016		
J	Chen, CC; Huang, TC; Park, JJ; Yen, NY				Chen, Chia-Chen; Huang, Tien-Chi; Park, James J.; Yen, Neil Y.			Real-time smartphone sensing and recommendations towards context-awareness shopping	MULTIMEDIA SYSTEMS			English	Article						Smartphone sensing; Recommendation system; Context-awareness; Association rules	SYSTEMS; DESIGN	This study investigates a smart environment, namely "Intelligent Shopping-aid Sensing System (iS(3))" for online shopping support in the next era by developing a context-aware automated service system. Sensors, radio frequency identification (RFID), are applied for the recognition, collection, and delivery of user contexts. Following the collected contexts from sensors, integrated mining and analysis techniques (i.e., customized clustering analysis and association rules) were implemented for the provision of instant and personal information to users. Information of products, such as locations, specifications, and characteristics can be collected quickly through the deployed RFID reader and display. Moreover, local applications on mobile devices offer real-time interactions between central system and end users. The system is expected to prompt the product promotion, inquiry and online marketing to shopping malls (and related companies as well). In the empirical results, the quality of recommendations with the proposed approach reaches 70 % accuracy rate. The traditional and non-clustering approaches are 56 and 46 %, respectively. This study reduces long-term operation costs of retailers, stimulates service innovation and experience economy and enhances corporate operational performance.	[Chen, Chia-Chen] Natl Chung Hsing Univ, Dept Management Informat Syst, Taichung 40227, Taiwan; [Huang, Tien-Chi] Natl Taichung Univ Sci & Technol, Dept Informat Management, Taichung, Taiwan; [Park, James J.] Seoul Natl Univ Sci & Technol, Dept Comp Sci & Engn, Seoul, South Korea; [Yen, Neil Y.] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan	Huang, TC (reprint author), Natl Taichung Univ Sci & Technol, Dept Informat Management, Taichung, Taiwan.	tchuang@nutc.edu.tw; parkjonghyuk1@hotmail.com			National Scientific Council (NSC) of the Republic of China (ROC) [NSC 101-2622-E-005-016-CC3, NSC 102-2410-H-005-064, NSC 102-2622-E-005-014-CC3, NSC 102-2511-S-025-003]	The authors are grateful for the support of the National Scientific Council (NSC) of the Republic of China (ROC) under Grant No. NSC 101-2622-E-005-016-CC3, NSC 102-2410-H-005-064, NSC 102-2622-E-005-014-CC3, and the partially support under Grant No. NSC 102-2511-S-025-003.	ABI Research, 2010, RFID MARK REACH 5 35; ABI Research, RET APP RFID IT LEV; Abowd D., 1998, Virtual Reality, V3, DOI 10.1007/BF01408562; Adams F.G., 2003, E BUSINESS REVOLUTIO; Huang YM, 2011, COMPUT EDUC, V57, P2291, DOI 10.1016/j.compedu.2011.05.023; [Anonymous], 1998, J INTERACT MARK, DOI 10.1002/(SICI)1520-6653(199824)12:1<17::AID-DIR3>3.0.CO;2-K; Chen CC, 2012, COMPUT EDUC, V59, P873, DOI 10.1016/j.compedu.2012.04.003; Chu HC, 2010, COMPUT EDUC, V55, P1618, DOI 10.1016/j.compedu.2010.07.004; Huang YM, 2012, COMPUT EDUC, V58, P273, DOI 10.1016/j.compedu.2011.08.008; Gupta S, 2003, J INTERACT MARK, V17, P9, DOI 10.1002/dir.10045; Asthana A., 1994, P IEEE WORKSH MOB CO, P69; Bauer H.H., 2003, YB MARKETING CONSUME, V1, P47; Bohnenberger T., 2005, PERVASIVE 05 GERM; Brown J., 2002, BUSINESS WEEK; Chen CC, 2012, INT J MOB COMMUN, V10, P231, DOI 10.1504/IJMC.2012.048110; De Sanctis M., 2012, 2012 IEEE 1 AESS EUR, P1; Huang WH, 2006, MULTIMEDIA SYST, V11, P203, DOI 10.1007/s00530-005-0009-6; Huang YM, 2012, EDUC TECHNOL SOC, V15, P150; Hughes A.M., 1994, STRATEGIC DATABASE M; Hwang GJ, 2010, COMPUT EDUC, V54, P404, DOI 10.1016/j.compedu.2009.08.024; Kim JH, 2010, MULTIMEDIA SYST, V16, P275, DOI 10.1007/s00530-010-0194-9; McGill M., 1983, INTRO MODERN INFORM; Pine II B.J., 1999, EXPERIENCE EC WORK I; Rashvand H.F., 2013, MULTIMEDIA SYST; Saliba MT, 2000, QUAL PROG, V33, P63; Such JM, 2012, LECT NOTES ARTIF INT, V7068, P411; Swedberg C., MICROSD CARD BRINGS; van Rijsbergen C.J., 1979, INFORM RETRIEVAL; Want R., 1999, CHI, V99, P370; Wickramasuriya J., 2004, P 12 ANN ACM INT C M, P48, DOI 10.1145/1027527.1027537; Zhang W, 2010, MULTIMEDIA SYST, V16, P293, DOI 10.1007/s00530-010-0192-y	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-4962	1432-1882		MULTIMEDIA SYST	Multimedia Syst.	FEB	2015	21	1			SI		61	72		10.1007/s00530-013-0348-7		12	Computer Science, Information Systems; Computer Science, Theory & Methods	Computer Science	AZ8DN	WOS:000348445100006		
J	Wei, YM; Wang, K; Wang, ZH; Tatano, H				Wei, Yi-Ming; Wang, Ke; Wang, Zhao-Hua; Tatano, Hirokazu			Vulnerability of infrastructure to natural hazards and climate change in China	NATURAL HAZARDS			English	Editorial Material									[Wei, Yi-Ming; Wang, Ke; Wang, Zhao-Hua] Beijing Inst Technol, Ctr Energy & Environm Policy Res, Beijing 100081, Peoples R China; [Wei, Yi-Ming; Wang, Ke; Wang, Zhao-Hua] Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China; [Tatano, Hirokazu] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan	Wei, YM (reprint author), Beijing Inst Technol, Ctr Energy & Environm Policy Res, Beijing 100081, Peoples R China.	wei@bit.edu.cn		Tatano, Hirokazu/0000-0001-7209-4358				0	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	FEB	2015	75			2			S107	S110		10.1007/s11069-014-1432-9		4	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	CA5BI	WOS:000348921900001		
J	Takeda, H; Wei, ZB; Koso, H; Rust, AG; Yew, CCK; Mann, MB; Ward, JM; Adams, DJ; Copeland, NG; Jenkins, NA				Takeda, Haruna; Wei, Zhubo; Koso, Hideto; Rust, Alistair G.; Yew, Christopher Chin Kuan; Mann, Michael B.; Ward, Jerrold M.; Adams, David J.; Copeland, Neal G.; Jenkins, Nancy A.			Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression	NATURE GENETICS			English	Article							COLORECTAL-CANCER; INTESTINAL TUMORIGENESIS; NEGATIVE REGULATOR; SOMATIC MUTATIONS; WNT RECEPTORS; LIVER-CANCER; STEM-CELLS; SUPPRESSOR; P53; ADENOCARCINOMA	To provide a more comprehensive understanding of the genes and evolutionary forces driving colorectal cancer (CRC) progression, we performed Sleeping Beauty (SB) transposon mutagenesis screens in mice carrying sensitizing mutations in genes that act at different stages of tumor progression. This approach allowed us to identify a set of genes that appear to be highly relevant for CRC and to provide a better understanding of the evolutionary forces and systems properties of CRC. We also identified six genes driving malignant tumor progression and a new human CRC tumor-suppressor gene, ZNF292, that might also function in other types of cancer. Our comprehensive CRC data set provides a resource with which to develop new therapies for treating CRC.	[Takeda, Haruna; Koso, Hideto; Yew, Christopher Chin Kuan; Mann, Michael B.; Ward, Jerrold M.; Copeland, Neal G.; Jenkins, Nancy A.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Div Genom & Genet, Singapore, Singapore; [Takeda, Haruna] Kanazawa Med Univ, Sch Med, Dept Oncol Pathol, Kanazawa, Ishikawa, Japan; [Wei, Zhubo; Mann, Michael B.; Jenkins, Nancy A.] Houston Methodist Res Inst, Canc Res Program, Houston, TX USA; [Koso, Hideto] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan; [Rust, Alistair G.; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Hinxton, Cambs, England	Jenkins, NA (reprint author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Div Genom & Genet, Singapore, Singapore.	njenkins2@houstonmethodist.org	ASTAR, IMCB/E-2320-2012; 	Mann, Michael/0000-0002-7515-6515	Biomedical Research Council; Agency for Science, Technology and Research (A-STAR), Singapore; Cancer Prevention Research Institute of Texas (CPRIT); Cancer Research UK; Wellcome Trust	We thank K. Rogers, S. Rogers and the Institute of Molecular and Cell Biology histopathology core for performing the histopathological analysis; M.M. Taketo (Kyoto University) for supplying Smad4<SUP>KO</SUP> mice and S. Robin (Institute Curie) for supplying Vil1-creER<SUP>T2</SUP> mice; Y. Ito for helpful discussions and encouragement; and, P. Goh, P. Cheok, N. Lim,.D. Chen and C. Wee for monitoring mice and animal technical assistance. The Biomedical Research Council, Agency for Science, Technology and Research (A-STAR), Singapore, and the Cancer Prevention Research Institute of Texas (CPRIT) supported this research. N.G.C. and N.A.J. are both CPRIT Scholars in Cancer Research. D.J.A. and A.G.R. are supported by Cancer Research UK and the Wellcome Trust.	Ahn J, 2011, ONCOGENE, V30, P445, DOI 10.1038/onc.2010.424; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; BOS JL, 1989, CANCER RES, V49, P4682; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Yoshio T, 2010, CARCINOGENESIS, V31, P1185, DOI 10.1093/carcin/bgq065; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Pinto D, 2005, BIOL CELL, V97, P185; Starr TK, 2011, P NATL ACAD SCI USA, V108, P5765, DOI 10.1073/pnas.1018012108; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Bard-Chapeau EA, 2014, NAT GENET, V46, P24, DOI 10.1038/ng.2847; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Cowin PA, 2012, CANCER RES, V72, P4060, DOI 10.1158/0008-5472.CAN-12-0203; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Das TK, 2013, ONCOGENE, V32, P3184, DOI 10.1038/onc.2012.326; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang W., 2008, BIOINFORMATION, V2, P428; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Li J, 2012, DEVELOPMENT, V139, P3531, DOI 10.1242/dev.082222; LIPKIN SM, 1993, GENE DEV, V7, P1674, DOI 10.1101/gad.7.9.1674; Meek DW, 2011, MOL CELL BIOCHEM, V356, P133, DOI 10.1007/s11010-011-0966-3; Noll JE, 2012, ONCOGENE, V31, P2836, DOI 10.1038/onc.2011.456; Rotili Dante, 2011, Genes Cancer, V2, P663, DOI 10.1177/1947601911417976; Scharenberg MA, 2010, INT J BIOCHEM CELL B, V42, P1911, DOI 10.1016/j.biocel.2010.08.014; Singh H, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.16; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040	55	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					142	150		10.1038/ng.3175		9	Genetics & Heredity	Genetics & Heredity	CA1TQ	WOS:000348694700009		
J	Kuchenbaecker, KB; Ramus, SJ; Tyrer, J; Lee, A; Shen, HC; Beesley, J; Lawrenson, K; McGuffog, L; Healey, S; Lee, JM; Spindler, TJ; Lin, YG; Pejovic, T; Bean, Y; Li, Q; Coetzee, S; Hazelett, D; Miron, A; Southey, M; Terry, MB; Goldgar, DE; Buys, SS; Janavicius, R; Dorfling, CM; van Rensburg, EJ; Neuhausen, SL; Ding, YC; Hansen, TVO; Jonson, L; Gerdes, AM; Ejlertsen, B; Barrowdale, D; Dennis, J; Benitez, J; Osorio, A; Garcia, MJ; Komenaka, I; Weitzel, JN; Ganschow, P; Peterlongo, P; Bernard, L; Viel, A; Bonanni, B; Peissel, B; Manoukian, S; Radice, P; Papi, L; Ottini, L; Fostira, F; Konstantopoulou, I; Garber, J; Frost, D; Perkins, J; Platte, R; Ellis, S; Godwin, AK; Schmutzler, RK; Meindl, A; Engel, C; Sutter, C; Sinilnikova, OM; Damiola, F; Mazoyer, S; Stoppa-Lyonnet, D; Claes, K; De Leeneer, K; Kirk, J; Rodriguez, GC; Piedmonte, M; O'Malley, DM; de la Hoya, M; Caldes, T; Aittomaki, K; Nevanlinna, H; Collee, JM; Rookus, MA; Oosterwijk, JC; Tihomirova, L; Tung, N; Hamann, U; Isaccs, C; Tischkowitz, M; Imyanitov, EN; Caligo, MA; Campbe, IG; Hogervorst, FBL; Olah, E; Diez, O; Blanco, I; Brunet, J; Lazaroso, C; Pujana, MA; Jakubowska, A; Gronwald, J; Lubinski, J; Sukiennicki, G; Barkardottir, RB; Plante, M; Simard, J; Soucy, P; Montagna, M; Tognazzo, S; Teixeira, MR; Pankratz, VS; Wang, XS; Lindor, N; Szabo, CI; Kauff, N; Vijai, J; Aghajanian, CA; Pfeiler, G; Berger, A; Singer, CF; Tea, MK; Phelan, CM; Greene, MH; Mai, PL; Rennert, G; Mulligan, AM; Tchatchou, S; Andrulis, IL; Glendon, G; Toland, AE; Jensen, UB; Kruse, TA; Thomassen, M; Bojesen, A; Zidan, J; Friedman, E; Laitman, Y; Soller, M; Liljegren, A; Arver, B; Einbeigi, Z; Stenmark-Askmalm, M; Olopade, OI; Nussbaum, RL; Rebbeck, TR; Nathanson, KL; Domchek, SM; Lu, KH; Karlan, BY; Walsh, C; Lester, J; Hein, A; Ekici, AB; Beckmann, MW; Fasching, PA; Lambrechts, D; Van Nieuwenhuysen, E; Vergote, I; Lambrechts, S; Dicks, E; Doherty, JA; Wicklund, KG; Rossing, MA; Rudolph, A; Chang-Claude, J; Wang-Gohrke, S; Eilber, U; Moysich, KB; Odunsi, K; Sucheston, L; Lele, S; Wilkens, LR; Goodman, MT; Thompson, PJ; Shvetsov, YB; Runnebaum, IB; Durst, M; Hillemanns, P; Dork, T; Antonenkova, N; Bogdanova, N; Leminen, A; Pelttari, LM; Butzow, R; Modugno, F; Kelley, JL; Edwards, RP; Ness, RB; du Bois, A; Heitz, F; Schwaab, I; Harter, P; Matsuo, K; Hosono, S; Orsulic, S; Jensen, A; Kjaer, SK; Hogdall, E; Hasmad, HN; Azmi, MAN; Teo, SH; Woo, YL; Fridley, BL; Goode, EL; Cunningham, JM; Vierkant, RA; Bruinsma, F; Giles, GG; Liang, D; Hildebrandt, MAT; Wu, XF; Levine, DA; Bisogna, M; Berchuck, A; Iversen, ES; Schildkraut, JM; Concannon, P; Weber, RP; Cramer, DW; Terry, KL; Poole, EM; Tworoger, SS; Bandera, EV; Orlow, I; Olson, SH; Krakstad, C; Salvesen, HB; Tangen, IL; Bjorge, L; van Altena, AM; Aben, KKH; Kiemeney, LA; Massuger, LFAG; Kellar, M; Brooks-Wilson, A; Kelemen, LE; Cook, LS; Le, ND; Cybulski, C; Yang, H; Lissowska, J; Brinton, LA; Wentzensen, N; Hogdall, C; Lundvall, L; Nedergaard, L; Baker, H; Song, HL; Eccles, D; McNeish, I; Paul, J; Carty, K; Siddiqui, N; Glasspool, R; Whittemore, AS; Rothstein, JH; McGuire, V; Sieh, W; Ji, BT; Zheng, W; Shu, XO; Gao, YT; Rosen, B; Risch, HA; McLaughlin, JR; Narod, SA; Monteiro, AN; Chen, A; Lin, HY; Permuth-Wey, J; Sellers, TA; Tsai, YY; Chen, Z; Ziogas, A; Anton-Culver, H; Gentry-Maharaj, A; Menon, U; Harrington, P; Lee, AW; Wu, AH; Pearce, CL; Coetzee, G; Pike, MC; Dansonka-Mieszkowska, A; Timorek, A; Rzepecka, IK; Kupryjanczyk, J; Freedman, M; Noushmehr, H; Easton, DF; Offit, K; Couch, FJ; Gayther, S; Pharoah, PP; Antoniou, AC; Chenevix-Trench, G				Kuchenbaecker, Karoline B.; Ramus, Susan J.; Tyrer, Jonathan; Lee, Andrew; Shen, Howard C.; Beesley, Jonathan; Lawrenson, Kate; McGuffog, Lesley; Healey, Sue; Lee, Janet M.; Spindler, Tassja J.; Lin, Yvonne G.; Pejovic, Tanja; Bean, Yukie; Li, Qiyuan; Coetzee, Simon; Hazelett, Dennis; Miron, Alexander; Southey, Melissa; Terry, Mary Beth; Goldgar, David E.; Buys, Saundra S.; Janavicius, Ramunas; Dorfling, Cecilia M.; van Rensburg, Elizabeth J.; Neuhausen, Susan L.; Ding, Yuan Chun; Hansen, Thomas V. O.; Jonson, Lars; Gerdes, Anne-Marie; Ejlertsen, Bent; Barrowdale, Daniel; Dennis, Joe; Benitez, Javier; Osorio, Ana; Garcia, Maria Jose; Komenaka, Ian; Weitzel, Jeffrey N.; Ganschow, Pamela; Peterlongo, Paolo; Bernard, Loris; Viel, Alessandra; Bonanni, Bernardo; Peissel, Bernard; Manoukian, Siranoush; Radice, Paolo; Papi, Laura; Ottini, Laura; Fostira, Florentia; Konstantopoulou, Irene; Garber, Judy; Frost, Debra; Perkins, Jo; Platte, Radka; Ellis, Steve; Godwin, Andrew K.; Schmutzler, Rita Katharina; Meindl, Alfons; Engel, Christoph; Sutter, Christian; Sinilnikova, Olga M.; Damiola, Francesca; Mazoyer, Sylvie; Stoppa-Lyonnet, Dominique; Claes, Kathleen; De Leeneer, Kim; Kirk, Judy; Rodriguez, Gustavo C.; Piedmonte, Marion; O'Malley, David M.; de la Hoya, Miguel; Caldes, Trinidad; Aittomaeki, Kristiina; Nevanlinna, Heli; Collee, J. Margriet; Rookus, Matti A.; Oosterwijk, Jan C.; Tihomirova, Laima; Tung, Nadine; Hamann, Ute; Isaccs, Claudine; Tischkowitz, Marc; Imyanitov, Evgeny N.; Caligo, Maria A.; Campbell, Ian G.; Hogervorst, Frans B. L.; Olah, Edith; Diez, Orland; Blanco, Ignacio; Brunet, Joan; Lazaroso, Conxi; Angel Pujana, Miguel; Jakubowska, Anna; Gronwald, Jacek; Lubinski, Jan; Sukiennicki, Grzegorz; Barkardottir, Rosa B.; Plante, Marie; Simard, Jacques; Soucy, Penny; Montagna, Marco; Tognazzo, Silvia; Teixeira, Manuel R.; Pankratz, Vernon S.; Wang, Xianshu; Lindor, Noralane; Szabo, Csilla I.; Kauff, Noah; Vijai, Joseph; Aghajanian, Carol A.; Pfeiler, Georg; Berger, Andreas; Singer, Christian F.; Tea, Muy-Kheng; Phelan, Catherine M.; Greene, Mark H.; Mai, Phuong L.; Rennert, Gad; Mulligan, Anna Marie; Tchatchou, Sandrine; Andrulis, Irene L.; Glendon, Gord; Toland, Amanda Ewart; Jensen, Uffe Birk; Kruse, Torben A.; Thomassen, Mads; Bojesen, Anders; Zidan, Jamal; Friedman, Eitan; Laitman, Yael; Soller, Maria; Liljegren, Annelie; Arver, Brita; Einbeigi, Zakaria; Stenmark-Askmalm, Marie; Olopade, Olufunmilayo I.; Nussbaum, Robert L.; Rebbeck, Timothy R.; Nathanson, Katherine L.; Domchek, Susan M.; Lu, Karen H.; Karlan, Beth Y.; Walsh, Christine; Lester, Jenny; Hein, Alexander; Ekici, Arif B.; Beckmann, Matthias W.; Fasching, Peter A.; Lambrechts, Diether; Van Nieuwenhuysen, Els; Vergote, Ignace; Lambrechts, Sandrina; Dicks, Ed; Doherty, Jennifer A.; Wicklund, Kristine G.; Rossing, Mary Anne; Rudolph, Anja; Chang-Claude, Jenny; Wang-Gohrke, Shan; Eilber, Ursula; Moysich, Kirsten B.; Odunsi, Kunle; Sucheston, Lara; Lele, Shashi; Wilkens, Lynne R.; Goodman, Marc T.; Thompson, Pamela J.; Shvetsov, Yurii B.; Runnebaum, Ingo B.; Duerst, Matthias; Hillemanns, Peter; Doerk, Thilo; Antonenkova, Natalia; Bogdanova, Natalia; Leminen, Arto; Pelttari, Liisa M.; Butzow, Ralf; Modugno, Francesmary; Kelley, Joseph L.; Edwards, Robert P.; Ness, Roberta B.; du Bois, Andreas; Heitz, Florian; Schwaab, Ira; Harter, Philipp; Matsuo, Keitaro; Hosono, Satoyo; Orsulic, Sandra; Jensen, Allan; Kjaer, Susanne Kruger; Hogdall, Estrid; Hasmad, Hanis Nazihah; Azmi, Mat Adenan Noor; Teo, Soo-Hwang; Woo, Yin-Ling; Fridley, Brooke L.; Goode, Ellen L.; Cunningham, Julie M.; Vierkant, Robert A.; Bruinsma, Fiona; Giles, Graham G.; Liang, Dong; Hildebrandt, Michelle A. T.; Wu, Xifeng; Levine, Douglas A.; Bisogna, Maria; Berchuck, Andrew; Iversen, Edwin S.; Schildkraut, Joellen M.; Concannon, Patrick; Weber, Rachel Palmieri; Cramer, Daniel W.; Terry, Kathryn L.; Poole, Elizabeth M.; Tworoger, Shelley S.; Bandera, Elisa V.; Orlow, Irene; Olson, Sara H.; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.; Bjorge, Line; van Altena, Anne M.; Aben, Katja K. H.; Kiemeney, Lambertus A.; Massuger, Leon F. A. G.; Kellar, Melissa; Brooks-Wilson, Angela; Kelemen, Linda E.; Cook, Linda S.; Le, Nhu D.; Cybulski, Cezary; Yang, Hannah; Lissowska, Jolanta; Brinton, Louise A.; Wentzensen, Nicolas; Hogdall, Claus; Lundvall, Lene; Nedergaard, Lotte; Baker, Helen; Song, Honglin; Eccles, Diana; McNeish, Ian; Paul, James; Carty, Karen; Siddiqui, Nadeem; Glasspool, Rosalind; Whittemore, Alice S.; Rothstein, Joseph H.; McGuire, Valerie; Sieh, Weiva; Ji, Bu-Tian; Zheng, Wei; Shu, Xiao-Ou; Gao, Yu-Tang; Rosen, Barry; Risch, Harvey A.; McLaughlin, John R.; Narod, Steven A.; Monteiro, Alvaro N.; Chen, Ann; Lin, Hui-Yi; Permuth-Wey, Jenny; Sellers, Thomas A.; Tsai, Ya-Yu; Chen, Zhihua; Ziogas, Argyrios; Anton-Culver, Hoda; Gentry-Maharaj, Aleksandra; Menon, Usha; Harrington, Patricia; Lee, Alice W.; Wu, Anna H.; Pearce, Celeste L.; Coetzee, Gerry; Pike, Malcolm C.; Dansonka-Mieszkowska, Agnieszka; Timorek, Agnieszka; Rzepecka, Iwona K.; Kupryjanczyk, Jolanta; Freedman, Matt; Noushmehr, Houtan; Easton, Douglas F.; Offit, Kenneth; Couch, Fergus J.; Gayther, Simon; Pharoah, Paul P.; Antoniou, Antonis C.; Chenevix-Trench, Georgia		EMBRACE; GEMO Study Collaborators; Breast Cancer Family Registry; HEBON; KConFab Investigators; Australian Canc Study Ovarian Canc; Australian Ovarian Canc Study Grp; Consortium Invest Modifiers BRCA1	Identification of six new susceptibility loci for invasive epithelial ovarian cancer	NATURE GENETICS			English	Article							BRCA2 MUTATION CARRIERS; GENOME-WIDE ASSOCIATION; ABO BLOOD-GROUP; BREAST-CANCER; GENETIC-VARIATION; COMMON VARIANTS; HUMAN ELG1; RISK; MYOPODIN; METAANALYSIS	Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibility alleles. The pattern of association at these loci is consistent in BRCA1 and BRCA2 mutation carriers who are at high risk of EOC. After imputation to 1000 Genomes Project data, we assessed associations of 11 million genetic variants with EOC risk from 15,437 cases unselected for family history and 30,845 controls and from 15,252 BRCA1 mutation carriers and 8,211 BRCA2 mutation carriers (3,096 with ovarian cancer), and we combined the results in a meta-analysis. This new study design yielded increased statistical power, leading to the discovery of six new EOC susceptibility loci. Variants at 1p36 (nearest gene, WNT4), 4q26 (SYNPO2), 9q34.2 (ABO) and 17q11.2 (ATAD5) were associated with EOC risk, and at 1p34.3 (RSPO1) and 6p22.1 (GPX6) variants were specifically associated with the serous EOC subtype, all with P < 5 x 10(-8). Incorporating these variants into risk assessment tools will improve clinical risk predictions for BRCA1 and BRCA2 mutation carriers.	[Kuchenbaecker, Karoline B.; Lee, Andrew; McGuffog, Lesley; Barrowdale, Daniel; Dennis, Joe; Frost, Debra; Perkins, Jo; Platte, Radka; Ellis, Steve; Easton, Douglas F.; Antoniou, Antonis C.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Ramus, Susan J.; Shen, Howard C.; Lawrenson, Kate; Lee, Janet M.; Spindler, Tassja J.; Hazelett, Dennis; Lee, Alice W.; Wu, Anna H.; Pearce, Celeste L.; Coetzee, Gerry; Pike, Malcolm C.; Gayther, Simon] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Tyrer, Jonathan; Dennis, Joe; Dicks, Ed; Baker, Helen; Song, Honglin; Harrington, Patricia; Pharoah, Paul P.] Univ Cambridge, Dept Oncol, Strangeways Res Lab, Cambridge, England; [Beesley, Jonathan; Healey, Sue; Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Cancer Div, Brisbane, Qld, Australia; [Lin, Yvonne G.] Univ So Calif, Dept Obstet & Gynaecol, Los Angeles, CA USA; [Pejovic, Tanja; Bean, Yukie; Kellar, Melissa] Oregon Hlth & Sci Univ, Dept Obstet & Gynaecol, Portland, OR 97201 USA; [Pejovic, Tanja; Bean, Yukie; Kellar, Melissa] Knight Canc Inst, Portland, OR USA; [Li, Qiyuan; Freedman, Matt] Ctr Funct Canc Epigenet, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Coetzee, Simon; Noushmehr, Houtan] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, BR-14049 Ribeirao Preto, Brazil; Ctr Cell Based Therapy, Ribeirao Preto, Brazil; [Coetzee, Simon] Ctr Integrat Syst Biol, Ribeirao Preto, Brazil; [Hazelett, Dennis; Coetzee, Gerry] Univ So Calif, Dept Urol, Los Angeles, CA USA; [Miron, Alexander] Case Western Reserve Univ, Sch Med, Dept Genom & Genome Sci, Cleveland, OH 44106 USA; [Southey, Melissa] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Terry, Mary Beth] Columbia Univ, Dept Epidemiol, New York, NY USA; [Goldgar, David E.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Buys, Saundra S.] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT USA; [Janavicius, Ramunas] Vilnius Univ Hosp Santariskiu Clin, Hematol Oncol & Transfus Med Ctr, Dept Mol & Regenerat Med, Vilnius, Lithuania; [Janavicius, Ramunas] State Res Inst Ctr Innovat Med, Vilnius, Lithuania; [Dorfling, Cecilia M.; van Rensburg, Elizabeth J.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Neuhausen, Susan L.; Ding, Yuan Chun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Hansen, Thomas V. O.; Jonson, Lars] Univ Copenhagen Hosp, Ctr Genet Med, DK-2100 Copenhagen, Denmark; [Gerdes, Anne-Marie] Univ Copenhagen Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Ejlertsen, Bent] Univ Copenhagen Hosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Benitez, Javier; Osorio, Ana; Garcia, Maria Jose] Spanish Natl Canc Ctr CNIO, Human Canc Genet Program, Human Genet Grp, Madrid, Spain; Spanish Natl Canc Ctr CNIO, Human Canc Genet Program, Human Genotyping Unit CEGEN, Madrid, Spain; [Benitez, Javier; Osorio, Ana; Garcia, Maria Jose] CIBERER, Biomed Network Rare Dis, Madrid, Spain; [Komenaka, Ian] Maricopa Cty Gen Hosp, Clin Canc Genet Community Res Network, Duarte, CA USA; [Weitzel, Jeffrey N.] Clin Canc Genet, Clin Canc Genet Community Res Network, Duarte, CA USA; [Ganschow, Pamela] Cook Cty Hlth & Hosp Syst, Clin Canc Genet Community Res Network, Duarte, CA USA; [Peterlongo, Paolo] Italian Fdn Canc Research, Fdn Ist FIRC Oncol Molecolare IFOM, Milan, Italy; [Bernard, Loris] Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Bernard, Loris] Cogentech Canc Genet Test Lab, Milan, Italy; [Viel, Alessandra] CRO, Aviano Natl Canc Inst, Aviano, Italy; [Bonanni, Bernardo] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy; [Peissel, Bernard; Manoukian, Siranoush] Italian Res Hospital, Fdn IRCCS, INT, Dept Prevent & Predict Med,Unit Med Genet, Milan, Italy; [Radice, Paolo] Fdn IRCCS, INT, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy; [Papi, Laura] Univ Florence, Dept Biomed Expt & Clin Sci, Unit Med Genet, Florence, Italy; [Ottini, Laura] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Fostira, Florentia; Konstantopoulou, Irene] Natl Ctr Sci Res Demokritos, INRASTES Inst Nucl & Radiol Sci & Technology, Mol Diag Lab, Athens, Greece; [Garber, Judy] Childrens Hosp, Dana Farber Canc Inst, Canc Risk & Prevent Clin, Boston, MA 02115 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Schmutzler, Rita Katharina] Univ Hosp Cologne, Fac Med, Center Hereditary Breast & Ovarian Canc, Cologne, Germany; Univ Hosp Cologne, Fac Med, CIO, Cologne, Germany; Univ Hosp Cologne, CMMC, Cologne, Germany; [Meindl, Alfons] Tech Univ Munich, Klinikum Rechts Isar, Dept Gynecol & Obstet, Div Tumor Genet, D-80290 Munich, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Sutter, Christian] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Sinilnikova, Olga M.; Damiola, Francesca; Mazoyer, Sylvie] Univ Lyon, Ctr Rech Cancerol Lyon, CNRS UMR 5286, INSERM U1052, Lyon, France; [Sinilnikova, Olga M.] Hosp Civils Lyon, Ctr Leon Berard, Unite Mixte Genet Constitutionnelle Canc Frequent, Lyon, France; [Stoppa-Lyonnet, Dominique] Inst Curie, Dept Tumor Biol, Paris, France; Inst Curie, INSERM, U830, Paris, France; [Stoppa-Lyonnet, Dominique] Univ Paris 05, Paris, France; [Claes, Kathleen; De Leeneer, Kim] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Kirk, Judy] Westmead Hosp, ANZGOG, Sydney, NSW, Australia; [Kirk, Judy] Westmead Hosp, Familial Canc Serv, Sydney, NSW, Australia; [Rodriguez, Gustavo C.] NorthShore Univ HealthSystem, Div Gynecol Oncol, Evanston, IL USA; [Piedmonte, Marion] Roswell Pk Canc Inst, Stat & Data Ctr, Gynecol Oncol Grp, Buffalo, NY 14263 USA; [O'Malley, David M.] Ohio State Univ, James Canc Ctr, Columbus, OH 43210 USA; [de la Hoya, Miguel; Caldes, Trinidad] Hosp Clin San Carlos, IdISSC Inst Invest Sanit Hosp Clin San Carlos, Mol Oncol Lab, Madrid, Spain; [Aittomaeki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Nevanlinna, Heli; Leminen, Arto; Pelttari, Liisa M.; Butzow, Ralf] Univ Helsinki, Dept Obstet & Gynaecol, Helsinki, Finland; [Nevanlinna, Heli; Leminen, Arto; Pelttari, Liisa M.; Butzow, Ralf] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Collee, J. Margriet] Erasmus Univ, Med Ctr, Family Canc Clin, Dept Clin Genet, Rotterdam, Netherlands; [Rookus, Matti A.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Oosterwijk, Jan C.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Tihomirova, Laima] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Tung, Nadine] Beth Israel Deaconess Med Ctr, Dept Med Oncol, Boston, MA 02215 USA; [Hamann, Ute] DKFZ, Mol Genet Breast Canc, Heidelberg, Germany; [Isaccs, Claudine] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA; [Tischkowitz, Marc] McGill Univ, Program Canc Genet, Montreal, PQ, Canada; [Imyanitov, Evgeny N.] NN Petrov Inst Oncol, St Petersburg, Russia; [Caligo, Maria A.] Univ Pisa, Dept Lab Med, Sect Genet Oncol, Pisa, Italy; [Caligo, Maria A.] Univ Hosp Pisa, Pisa, Italy; [Campbell, Ian G.] Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic, Australia; [Hogervorst, Frans B. L.] Netherlands Canc Inst, Family Canc Clin, Amsterdam, Netherlands; [Olah, Edith] Natl Inst Oncol, Dept Mol Genet, Budapest, Hungary; [Diez, Orland] Univ Hosp Vall Hebron, VHIO, Oncogenet Grp, Barcelona, Spain; [Diez, Orland] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Blanco, Ignacio] Catalan Inst Oncol, IDIBELL Bellvitge Biomed Res Inst, Hereditary Canc Program, Genet Counseling Unit, Barcelona, Spain; [Brunet, Joan] Catalan Inst Oncol, IDIBGI Institut dInvestigacie Biomed Girona, Hereditary Canc Program, Genet Counseling Unit, Girona, Spain; [Lazaroso, Conxi; Angel Pujana, Miguel] Catalan Inst Oncol, IDIBELL, Hereditary Canc Program, Molecular Diagnost Unit, Barcelona, Spain; [Jakubowska, Anna; Gronwald, Jacek; Lubinski, Jan; Sukiennicki, Grzegorz] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Barkardottir, Rosa B.] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Barkardottir, Rosa B.] Univ Iceland, Fac Med, Biomed Ctr, Reykjavik, Iceland; [Plante, Marie] CHUQ, Gynaecol Oncol Serv, Quebec City, PQ, Canada; [Simard, Jacques; Soucy, Penny] Univ Laval, CHUQ, Res Ctr, Quebec City, PQ, Canada; [Montagna, Marco; Tognazzo, Silvia] IRCCS, IOV, Immunol & Mol Oncol Unit, Padua, Italy; [Teixeira, Manuel R.; McNeish, Ian] Univ Porto, Inst Biomed Sci ICBAS, P-4100 Oporto, Portugal; [Teixeira, Manuel R.] Portuguese Oncol Inst, Dept Genet, Oporto, Portugal; [Pankratz, Vernon S.; Lindor, Noralane; Goode, Ellen L.; Couch, Fergus J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Wang, Xianshu; Cunningham, Julie M.; Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Szabo, Csilla I.] NHGRI, NIH, Bethesda, MD 20892 USA; [Kauff, Noah; Vijai, Joseph; Aghajanian, Carol A.; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Pfeiler, Georg; Berger, Andreas; Singer, Christian F.; Tea, Muy-Kheng] Med Univ Vienna, Ctr Comprehens Canc, Dept Obstet & Ginecol, Vienna, Austria; [Phelan, Catherine M.; Monteiro, Alvaro N.; Permuth-Wey, Jenny; Sellers, Thomas A.; Tsai, Ya-Yu] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Greene, Mark H.; Mai, Phuong L.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Rennert, Gad] Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel; [Mulligan, Anna Marie; Andrulis, Irene L.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Tchatchou, Sandrine; Glendon, Gord] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Toland, Amanda Ewart] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Jensen, Uffe Birk] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Kruse, Torben A.; Thomassen, Mads] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Bojesen, Anders] Vejle Hosp, Dept Clin Genet, Vejle, Denmark; [Zidan, Jamal] Rivka Ziv Med Ctr, Inst Oncol, Safed, Israel; [Friedman, Eitan; Laitman, Yael] Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, Tel Aviv, Israel; [Soller, Maria] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Liljegren, Annelie; Arver, Brita] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Einbeigi, Zakaria] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden; [Stenmark-Askmalm, Marie] Linkoping Univ, Dept Clin & Expt Med, Div Clin Genet, Linkoping, Sweden; [Olopade, Olufunmilayo I.] Univ Chicago, Med Ctr, Ctr Clin Canc Genet & Global Hlth, Chicago, IL 60637 USA; [Nussbaum, Robert L.] Univ Calif San Francisco, Dept Med Genet, San Francisco, CA 94143 USA; [Rebbeck, Timothy R.; Nathanson, Katherine L.; Domchek, Susan M.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Lu, Karen H.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Karlan, Beth Y.; Walsh, Christine; Lester, Jenny; Orsulic, Sandra] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [Hein, Alexander; Beckmann, Matthias W.; Fasching, Peter A.] Univ Erlangen Nurnberg, Erlangen Univ Hosp, Dept Obstet & Gynecol, D-91054 Erlangen, Germany; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Lambrechts, Diether] Vesalius Res Ctr, VIB, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Van Nieuwenhuysen, Els; Vergote, Ignace; Lambrechts, Sandrina] Univ Leuven, Dept Oncol, Div Gynecol Oncol, Leuven, Belgium; [Doherty, Jennifer A.] Geisel Sch Med, Dept Community & Family Med, Epidemiol & Biostat Sect, Lebanon, NH USA; [Wicklund, Kristine G.; Rossing, Mary Anne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Rossing, Mary Anne] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rudolph, Anja; Chang-Claude, Jenny; Eilber, Ursula] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynaecol, D-89069 Ulm, Germany; [Moysich, Kirsten B.; Sucheston, Lara; Lele, Shashi] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Wilkens, Lynne R.; Shvetsov, Yurii B.] Univ Hawaii Canc Ctr, Canc Epidemiol Program, Honolulu, HI USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Commun & Populat Hlth Res Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Runnebaum, Ingo B.; Duerst, Matthias] Univ Jena, Jena Univ Hosp, Dept Gynecol, Jena, Germany; [Hillemanns, Peter] Hannover Med Sch, Clin Obstet & Gynaecol, Hannover, Germany; [Doerk, Thilo; Bogdanova, Natalia] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Antonenkova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandrov, Minsk, Byelarus; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Modugno, Francesmary] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Kelley, Joseph L.; Edwards, Robert P.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Edwards, Robert P.] Univ Pittsburgh, Ovarian Canc Ctr Excellence, Pittsburgh, PA USA; [Modugno, Francesmary] Magee Womens Res Inst, Womens Canc Res ProgramInst Canc, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [du Bois, Andreas; Heitz, Florian; Harter, Philipp] Dr Horst Schmidt Klin Wiesbaden, Dept Gynecol & Gynecol Oncol, Wiesbaden, Germany; [du Bois, Andreas; Heitz, Florian; Harter, Philipp] Klin Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany; [Schwaab, Ira] Inst Humangenetik Wiesbaden, Wiesbaden, Germany; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Hosono, Satoyo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Jensen, Allan; Kjaer, Susanne Kruger; Hogdall, Estrid] Danish Canc Soc, Res Ctr, Dept Virus Lifestyle & Genes, Copenhagen, Denmark; [Kjaer, Susanne Kruger; Hogdall, Claus; Lundvall, Lene] Univ Copenhagen, Dept Gynaecol, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Mol Unit, Copenhagen, Denmark; [Hasmad, Hanis Nazihah; Teo, Soo-Hwang] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya, Malaysia; [Azmi, Mat Adenan Noor; Woo, Yin-Ling] Univ Malaya, Med Ctr, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia; [Teo, Soo-Hwang; Woo, Yin-Ling] Univ Malaya, Fac Med, Med Ctr, Canc Res Inst, Kuala Lumpur, Malaysia; [Fridley, Brooke L.] Univ Kansas, Med Ctr, Biostat & Informat Shared Resource, Kansas City, KS 66103 USA; [Vierkant, Robert A.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Bruinsma, Fiona; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Liang, Dong] Texas So Univ, Coll Pharm & Hlth Sci, Houston, TX 77004 USA; [Hildebrandt, Michelle A. T.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Levine, Douglas A.; Bisogna, Maria] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Schildkraut, Joellen M.] Duke Canc Inst, Canc Control & Populat Sci, Durham, NC USA; [Schildkraut, Joellen M.; Weber, Rachel Palmieri] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Concannon, Patrick] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Concannon, Patrick] Univ Florida, Genet Inst, Gainesville, FL USA; [Cramer, Daniel W.; Terry, Kathryn L.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Cramer, Daniel W.; Terry, Kathryn L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Obstetr & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Bandera, Elisa V.] Rutgers Canc Inst New Jersey, Cancer Prevent & Control, New Brunswick, NJ USA; [Orlow, Irene; Olson, Sara H.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Epidemiol Serv, New York, NY 10021 USA; [Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.; Bjorge, Line] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers, Bergen, Norway; [Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.; Bjorge, Line] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [van Altena, Anne M.; Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Gynaecol, Nijmegen, Netherlands; [Aben, Katja K. H.] Ctr Comprehens Canc, Utrecht, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, Nijmegen, Netherlands; [Brooks-Wilson, Angela] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Kelemen, Linda E.] Med Univ S Carolina, Coll Med, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Cook, Linda S.] Univ New Mexico, Dept Internal Med, Div Epidemiol & Biostat, Albuquerque, NM 87131 USA; [Le, Nhu D.] British Columbia Canc Agcy, Canc Control Res, Vancouver, BC V5Z 4E6, Canada; [Cybulski, Cezary] Pomeranian Med Univ, Internat Hereditary Canc Ctr, Dept Genet & Pathol, Clin Opthalmol, Szczecin, Poland; [Yang, Hannah; Brinton, Louise A.; Wentzensen, Nicolas; Ji, Bu-Tian] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Inst Oncol, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Nedergaard, Lotte; Paul, James; Carty, Karen] Univ Copenhagen, Dept Pathol, Copenhagen, Denmark; [Eccles, Diana] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [McNeish, Ian] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Beatson Inst Canc Res, Inst Canc Sci, Glasgow, Lanark, Scotland; [Glasspool, Rosalind] Beatson West Scotland, Ctr Canc, Canc Res UK Clin, Trials Unit, Glasgow, Lanark, Scotland; [Siddiqui, Nadeem] Glasgow Royal Infirm, Dept Gynecol Oncol, Glasgow G4 0SF, Lanark, Scotland; [Whittemore, Alice S.; Rothstein, Joseph H.; McGuire, Valerie; Sieh, Weiva] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Shanghai, Peoples R China; [Rosen, Barry] Univ Toronto, Fac Med, Dept Obstet & Gynaecol, Toronto, ON, Canada; [Rosen, Barry] Princess Margaret Hosp, Dept Gynecol Oncol, Toronto, ON M4X 1K9, Canada; [Risch, Harvey A.] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [McLaughlin, John R.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Chen, Ann; Lin, Hui-Yi; Chen, Zhihua] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL USA; [Ziogas, Argyrios; Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, Elizabeth Garrett Anderson EGA Inst Womens Hlth, London, England; [Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Dansonka-Mieszkowska, Agnieszka; Rzepecka, Iwona K.; Kupryjanczyk, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Inst Oncol, Dept Pathol, Warsaw, Poland; [Timorek, Agnieszka] Med Univ Warsaw, Fac Med 2, Dept Obstet Gynecol & Oncol, Warsaw, Poland; [Timorek, Agnieszka] Brodnowski Hosp, Warsaw, Poland	Chenevix-Trench, G (reprint author), QIMR Berghofer Med Res Inst, Cancer Div, Brisbane, Qld, Australia.	georgia.trench@qimrberghofer.edu.au	Woo, Yin Ling/B-5198-2010; Teixeira, Manuel/E-4885-2011; Massuger, Leon/H-8072-2014; Osorio, Ana/I-4324-2014; Dork, Thilo/J-8620-2012; Ligtenberg, Marjolijn/N-9666-2013; Blanco, Ignacio/D-2565-2013; Hein, Alexander/F-6999-2010; Jansen van Rensburg, Elizabeth (Lizette)/B-9104-2011; Kiemeney, Lambertus/D-3357-2009; Teo,  Soo-hwang/H-2353-2014; Brooks-Wilson, Angela/E-9399-2012; Bandera, Elisa/M-4169-2014; Menkiszak, Janusz/I-4036-2014; montagna, marco/E-2225-2012; Coetzee, Simon/C-1218-2014; Fridley, Brooke/D-8315-2015; BYRSKI, Tomasz/I-2844-2014; Ehrencrona, Hans/M-5619-2014; Brinton, Louise/G-7486-2015	Woo, Yin Ling/0000-0003-1742-1066; Teixeira, Manuel/0000-0002-4896-5982; Osorio, Ana/0000-0001-8124-3984; Ligtenberg, Marjolijn/0000-0003-1290-1474; Blanco, Ignacio/0000-0002-7414-7481; Evans, Gareth/0000-0002-8482-5784; McNeish, Iain/0000-0002-9387-7586; Peixoto, Ana/0000-0002-1404-5897; Kjaer, Susanne/0000-0002-8347-1398; Hein, Alexander/0000-0003-2601-3398; Kiemeney, Lambertus/0000-0002-2368-1326; Brooks-Wilson, Angela/0000-0003-1009-6408; Bandera, Elisa/0000-0002-8789-2755; Coetzee, Simon/0000-0003-4267-5930; Fridley, Brooke/0000-0001-7739-7956; Ehrencrona, Hans/0000-0002-5589-3622; Brinton, Louise/0000-0003-3853-8562	European Commission Seventh Framework Programme [223175-HEALTH-F2-2009-223175]; Cancer Research UK [C12292/A11174, C1287/A10118]; Ovarian Cancer Research Fund; US National Cancer Institute GAME-ON Post-GWAS Initiative [U19-CA148112]; Wellcome Trust [076113]; National Health and Medical Research Council of Australia Program Grant	We thank all the individuals who took part in this study and all the researchers, clinicians, and technical and administrative staff who made possible the many studies contributing to this work (a full list is provided in the Supplementary Note), including X.Q. Chen for iPLEX genotyping. The COGS project is funded through a European Commission Seventh Framework Programme grant (agreement number 223175-HEALTH-F2-2009-223175). CIMBA data management and data analysis were supported by Cancer Research UK grants C12292/A11174 and C1287/A10118. The Ovarian Cancer Association Consortium (OCAC) is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). Scientific development and funding for this project were in part supported by the US National Cancer Institute GAME-ON Post-GWAS Initiative (U19-CA148112). This study made use of data generated by the Wellcome Trust Case Control Consortium. Funding for the project was provided by the Wellcome Trust under award 076113. The results published here are in part based on data generated by The Cancer Genome Atlas (TCGA) Pilot Project established by the US National Cancer Institute and US National Human Genome Research Institute (database of Genotypes and Phenotypes (dbGaP) accession phs000178.v8.p7). The cBio Portal is developed and maintained by the Computational Biology Center at the Memorial Sloan-Kettering Cancer Center. S. Healey is supported by a National Health and Medical Research Council of Australia Program Grant to G.C.-T. Details of the funding of individual investigators and studies are provided in the Supplementary Note. A full list of the investigators who contributed to the generation of the data is available on the CIMBA website (see URLs).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Sikdar N, 2009, CELL CYCLE, V8, P3199, DOI 10.4161/cc.8.19.9752; Couch FJ, 2012, CANCER EPIDEM BIOMAR, V21, P645, DOI 10.1158/1055-9965.EPI-11-0888; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Ramus SJ, 2012, HUM MUTAT, V33, P690, DOI 10.1002/humu.22025; Zuo YF, 2012, J CELL PHYSIOL, V227, P1399, DOI 10.1002/jcp.22853; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Poole EM, 2012, CANCER CAUSE CONTROL, V23, P1805, DOI 10.1007/s10552-012-0059-y; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Sanchez-Carbayo M, 2003, ONCOGENE, V22, P5298, DOI 10.1038/sj.onc.1206616; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227; Auranen A, 1996, BRIT J CANCER, V74, P280, DOI 10.1038/bjc.1996.352; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Bolton KL, 2012, J INTERN MED, V271, P366, DOI 10.1111/j.1365-2796.2011.02509.x; Jervis S, 2014, J MED GENET, V51, P108, DOI 10.1136/jmedgenet-2013-102015; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Bell DW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002245; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Pagliardini L, 2013, J MED GENET, V50, P43, DOI 10.1136/jmedgenet-2012-101257; Barnes DR, 2012, GENET EPIDEMIOL, V36, P274, DOI 10.1002/gepi.21620; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Chenevix-Trench G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1670; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; De Ganck A, 2008, BIOCHEM BIOPH RES CO, V370, P269, DOI 10.1016/j.bbrc.2008.03.086; Gaudet MM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003173; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Jing L, 2004, AM J PATHOL, V164, P1799, DOI 10.1016/S0002-9440(10)63738-8; Lin F, 2001, AM J PATHOL, V159, P1603, DOI 10.1016/S0002-9440(10)63006-4; Permuth-Wey J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2613; Ramus SJ, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq494; Rummel S, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-41; Tomaselli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016366; Wacholder Sholom, 2011, J Natl Cancer Inst, V103, P82, DOI 10.1093/jnci/djq510	38	20	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2015	47	2					164	171		10.1038/ng.3185		8	Genetics & Heredity	Genetics & Heredity	CA1TQ	WOS:000348694700012		
J	Tormann, T; Enescu, B; Woessner, J; Wiemer, S				Tormann, Thessa; Enescu, Bogdan; Woessner, Jochen; Wiemer, Stefan			Randomness of megathrust earthquakes implied by rapid stress recovery after the Japan earthquake	NATURE GEOSCIENCE			English	Article							TOHOKU EARTHQUAKE; PACIFIC COAST; NORTHEASTERN JAPAN; SIZE DISTRIBUTION; SUBDUCTION ZONE; OKI EARTHQUAKE; MAGNITUDE; MODEL; COMPLETENESS; HYPOTHESIS	Constraints on the recurrence times of subduction zone earthquakes are important for seismic hazard assessment and mitigation. Models of such megathrust earthquakes often assume that subduction zones are segmented and earthquakes occur quasi-periodically owing to constant tectonic loading. Here we analyse the occurrence of small earthquakes compared to larger ones-the b-values-on a 1,000-km-long section of the subducting Pacific Plate beneath central and northern Japan since 1998. We find that the b-values vary spatially and mirror the tectonic regime. For example, high b-values, indicative of low stress, occur in locations characterized by deep magma chambers and low b-values, or high stress, occur where the subducting and overriding plates are strongly coupled. There is no significant variation in the low b-values to suggest the plate interface is segmented in a way that might limit potential ruptures. Parts of the plate interface that ruptured during the 2011 Tohoku-oki earthquake were highly stressed in the years leading up to the earthquake. Although the stress was largely released during the 2011 rupture, we find that the stress levels quickly recovered to pre-quake levels within just a few years. We conclude that large earthquakes may not have a characteristic location, size or recurrence interval, and might therefore occur more randomly distributed in time.	[Tormann, Thessa; Wiemer, Stefan] ETH, Swiss Seismol Serv, CH-8092 Zurich, Switzerland; [Enescu, Bogdan] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Woessner, Jochen] Risk Management Solut Inc, CH-8006 Zurich, Switzerland	Tormann, T (reprint author), ETH, Swiss Seismol Serv, Sonneggstr 5, CH-8092 Zurich, Switzerland.	thessa.tormann@sed.ethz.ch	Wiemer, Stefan/E-5033-2015; Enescu, Bogdan/J-6980-2012	Enescu, Bogdan/0000-0003-2153-0097	SNF [PMPDP2 134174]; 'Mega-Earthquake Risk Management' project at the University of Tsukuba	We thank J. Hardebeck, S. Jonsson and M. Wyss for feedback on the manuscript. We thank JMA for sharing the earthquake catalogue. Figures were produced with The Generic Mapping Tools http://gmt.soest.hawaii.edu. Part of this study was funded through SNF grant PMPDP2 134174. B.E. acknowledges support from the 'Mega-Earthquake Risk Management' project at the University of Tsukuba.	Aki K., 1965, B EARTHQ RES I TOKYO, V43, P237; Uchida N, 2011, EARTH PLANETS SPACE, V63, P675, DOI 10.5047/eps.2011.07.006; Tormann T, 2010, B SEISMOL SOC AM, V100, P3325, DOI 10.1785/0120100151; BAK P, 1989, J GEOPHYS RES-SOLID, V94, P15635, DOI 10.1029/JB094iB11p15635; Hayes GP, 2011, EARTH PLANETS SPACE, V63, P529, DOI 10.5047/eps.2011.05.012; Stein S, 2012, TECTONOPHYSICS, V562, P1, DOI 10.1016/j.tecto.2012.06.047; Nanjo KZ, 2010, B SEISMOL SOC AM, V100, P3261, DOI 10.1785/0120100077; Wei SJ, 2012, EARTH PLANET SC LETT, V333, P91, DOI 10.1016/j.epsl.2012.04.006; Wiemer S, 2002, ADV GEOPHYS, V45, P259; Ghosh A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031617; Schorlemmer D, 2005, NATURE, V437, P539, DOI 10.1038/nature04094; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; Woessner J, 2005, B SEISMOL SOC AM, V95, P684, DOI 10.1785/0120040007; Toda S, 2011, EARTH PLANETS SPACE, V63, P725, DOI 10.5047/eps.2011.05.010; Pollitz FF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048632; Geller RJ, 2011, NATURE, V472, P407, DOI 10.1038/nature10105; Kagan YY, 2012, SEISMOL RES LETT, V83, P951, DOI 10.1785/0220120107; Kagan YY, 2013, B SEISMOL SOC AM, V103, P1181, DOI 10.1785/0120120110; SAMMONDS PR, 1992, NATURE, V359, P228, DOI 10.1038/359228a0; Asano Y, 2011, EARTH PLANETS SPACE, V63, P669, DOI 10.5047/eps.2011.06.016; Hashimoto C, 2009, NAT GEOSCI, V2, P141, DOI 10.1038/NGEO421; Suzuki W, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049136; Bachmann CE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051480; Tormann T, 2013, GEOPHYS J INT, V193, P1474, DOI 10.1093/gji/ggt093; Schorlemmer D, 2005, NATURE, V434, P1086, DOI 10.1038/4341086a; Yagi Y, 2004, EARTH PLANETS SPACE, V56, P311; Goebel T. H. W., 2013, GEOPHYS RES LETT, V40, P1; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185; Hardebeck JL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053438; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Ikeda Y., 2011, P INT S ENG LESS LEA, P238; KAGAN YY, 1991, J GEOPHYS RES-SOL EA, V96, P21419, DOI 10.1029/91JB02210; Kanda RVS, 2013, GEOPHYS J INT, V192, P38, DOI 10.1093/gji/ggs028; Kulkarni R, 2013, B SEISMOL SOC AM, V103, P3205, DOI 10.1785/0120120105; Kun F, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062207; Mogi K., 1962, B EARTHQ RES I TOKYO, V40, P831; Nakaya S., 2003, J GEOPHYS RES, V111; Nanjo K. Z., 2011, GEOPHYS RES LETT, V39; Nishimura T., 2011, J DISASTER RES, V9, P294; Reid HF, 1910, MECH EARTHQUAKE CALI, V2; Rosenau M, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2009JB006359; Scholz C. H., 1968, Bulletin of the Seismological Society of America, V58; SHI Y, 1982, B SEISMOL SOC AM, V72, P1677; Stein RS, 2013, SCIENCE, V341, P850, DOI 10.1126/science.1238944; Toda S, 2011, EARTH PLANETS SPACE, V63, P171, DOI 10.5047/eps.2011.01.004; Tormann T., 2014, J GEOPHYS RES, V119, P1; van Stiphout T, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005958; Wyss M, 2001, GEOPHYS RES LETT, V28, P1819, DOI 10.1029/2000GL012558; Yagi Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048701	49	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	FEB	2015	8	2					152	158		10.1038/NGEO2343		7	Geosciences, Multidisciplinary	Geology	CB0YS	WOS:000349354200021		
J	Christle, DJ; Falk, AL; Andrich, P; Klimov, PV; Ul Hassan, J; Son, NT; Janzen, E; Ohshima, T; Awschalom, DD				Christle, David J.; Falk, Abram L.; Andrich, Paolo; Klimov, Paul V.; Ul Hassan, Jawad; Son, Nguyen T.; Janzen, Erik; Ohshima, Takeshi; Awschalom, David D.			Isolated electron spins in silicon carbide with millisecond coherence times	NATURE MATERIALS			English	Article							NUCLEAR-MAGNETIC-RESONANCE; QUBITS; THERMOMETRY; DEFECTS; STATE	The elimination of defects from SiC has facilitated its move to the forefront of the optoelectronics and power-electronics industries(1). Nonetheless, because certain SiC defects have electronic states with sharp optical and spin transitions, they are increasingly recognized as a platform for quantum information and nanoscale sensing(2-16). Here, we show that individual electron spins in high-purity monocrystalline 4H-SiC can be isolated and coherently controlled. Bound to neutral divacancy defects(2,3), these states exhibit exceptionally long ensemble Hahn-echo spin coherence times, exceeding 1 ms. Coherent control of single spins in a material amenable to advanced growth and microfabrication techniques is an exciting route towards wafer-scale quantum technologies.	[Christle, David J.; Falk, Abram L.; Andrich, Paolo; Klimov, Paul V.; Awschalom, David D.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA; [Christle, David J.; Andrich, Paolo; Klimov, Paul V.; Awschalom, David D.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Ul Hassan, Jawad; Son, Nguyen T.; Janzen, Erik] Linkoping Univ, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden; [Ohshima, Takeshi] Japan Atom Energy Agcy, Takasaki, Gumma 3701292, Japan	Awschalom, DD (reprint author), Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.	awsch@uchicago.edu	Janzen, Erik/I-5373-2013; Ul Hassan, Jawad/C-7415-2013; Son, Nguyen/C-5551-2013	Janzen, Erik/0000-0001-7721-5091; Ul Hassan, Jawad/0000-0001-9537-2226; Son, Nguyen/0000-0002-6810-4282	NSF; Center for Nanoscale Materials [CNM 39211]; Knut & Alice Wallenberg Foundation; Linkoping Linnaeus Initiative for Novel Functionalized Materials; Swedish Government Strategic Research Area Grant in Materials Science (Advanced Functional Materials); Ministry of Education, Science, Sports and Culture of Japan [26286047]; AFOSR MURI	The authors thank A. Gali, B. B. Buckley, W. F. Koehl, F. J. Heremans and G. Calusine for helpful discussions. The authors also thank S. Chemerisov and A. B. Norstel for assistance preparing preliminary samples and gratefully acknowledge support from the NSF, AFOSR MURI, the Center for Nanoscale Materials (CNM 39211), the Knut & Alice Wallenberg Foundation, the Linkoping Linnaeus Initiative for Novel Functionalized Materials, the Swedish Government Strategic Research Area Grant in Materials Science (Advanced Functional Materials), and the Ministry of Education, Science, Sports and Culture of Japan, Grant-in-Aid (B) 26286047.	Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Weber JR, 2010, P NATL ACAD SCI USA, V107, P8513, DOI 10.1073/pnas.1003052107; Koehl WF, 2011, NATURE, V479, P84, DOI 10.1038/nature10562; Castelletto S, 2014, NAT MATER, V13, P151, DOI [10.1038/nmat3806, 10.1038/NMAT3806]; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Stanwix PL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.201201; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Hassan J, 2008, J CRYST GROWTH, V310, P4424, DOI 10.1016/j.jcrysgro.2008.06.081; Carlos WE, 2003, PHYSICA B, V340, P151, DOI 10.1016/j.physb.2003.09.048; Falk AL, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.187601; Carlos WE, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235201; Baranov PG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.125203; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; Toyli DM, 2013, P NATL ACAD SCI USA, V110, P8417, DOI 10.1073/pnas.1306825110; Klimov PV, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.087601; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Gali A, 2011, PHYS STATUS SOLIDI B, V248, P1337, DOI 10.1002/pssb.201046254; Baranov PG, 2005, JETP LETT+, V82, P441, DOI 10.1134/1.2142873; Magnusson B, 2005, MATER SCI FORUM, V483, P341; Soltamov VA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.226402; Calusine G, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890083; Falk AL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2854; Kraus H., 2013, NATURE PHYS, V10, P157; Oort E. V., 1990, CHEM PHYS, V143, P131; Riedel R., 2012, PHYS REV LETT, V109; Saddow S., 2004, ADV SILICON CARBIDE; Son NT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.055501; Tol J. v., 2009, APPL MAGN RESON, V36, P259; Widmann M., 2014, NATURE MAT; WRACHTRUP J, 1993, NATURE, V363, P244, DOI 10.1038/363244a0	30	16	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	FEB	2015	14	2					160	163		10.1038/NMAT4144		4	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CA0IE	WOS:000348600200011		
J	Widmann, M; Lee, SY; Rendler, T; Son, NT; Fedder, H; Paik, S; Yang, LP; Zhao, N; Yang, S; Booker, I; Denisenko, A; Jamali, M; Momenzadeh, SA; Gerhardt, I; Ohshima, T; Gali, A; Janzen, E; Wrachtrup, J				Widmann, Matthias; Lee, Sang-Yun; Rendler, Torsten; Son, Nguyen Tien; Fedder, Helmut; Paik, Seoyoung; Yang, Li-Ping; Zhao, Nan; Yang, Sen; Booker, Ian; Denisenko, Andrej; Jamali, Mohammad; Momenzadeh, S. Ali; Gerhardt, Ilja; Ohshima, Takeshi; Gali, Adam; Janzen, Erik; Wrachtrup, Joerg			Coherent control of single spins in silicon carbide at room temperature	NATURE MATERIALS			English	Article							QUBITS; ELECTRON; DIAMOND; DEPOSITION; DYNAMICS; DEVICES; BATH	Spins in solids are cornerstone elements of quantum spintronics(1). Leading contenders such as defects in diamond(2-5) or individual phosphorus dopants in silicon(6) have shown spectacular progress, but either lack established nanotechnology or an efficient spin/photon interface. Silicon carbide (SiC) combines the strength of both systems(5):it has a large bandgap with deep defects(7-9) and benefits from mature fabrication techniques(10-12). Here, we report the characterization of photoluminescence and optical spin polarization from single silicon vacancies in SiC, and demonstrate that single spins can be addressed at room temperature. We show coherent control of a single defect spin and find long spin coherence times under ambient conditions. Our study provides evidence that SiC is a promising system for atomic-scale spintronics and quantum technology.	[Widmann, Matthias; Lee, Sang-Yun; Rendler, Torsten; Fedder, Helmut; Paik, Seoyoung; Denisenko, Andrej; Jamali, Mohammad; Momenzadeh, S. Ali; Gerhardt, Ilja; Wrachtrup, Joerg] Univ Stuttgart, Inst Phys 3, D-70569 Stuttgart, Germany; [Widmann, Matthias; Lee, Sang-Yun; Rendler, Torsten; Fedder, Helmut; Paik, Seoyoung; Yang, Sen; Denisenko, Andrej; Jamali, Mohammad; Momenzadeh, S. Ali; Gerhardt, Ilja; Wrachtrup, Joerg] Univ Stuttgart, Res Ctr SCOPE, D-70569 Stuttgart, Germany; [Son, Nguyen Tien; Booker, Ian; Janzen, Erik] Linkoping Univ, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden; [Yang, Li-Ping; Zhao, Nan] Beijing Computat Sci Res Ctr, Beijing 100084, Peoples R China; [Ohshima, Takeshi] Japan Atom Energy Agcy, Takasaki, Gumma 3701292, Japan; [Gali, Adam] Hungarian Acad Sci, Wigner Res Ctr Phys, H-1525 Budapest, Hungary; [Gali, Adam] Budapest Univ Technol & Econ, Dept Atom Phys, H-1111 Budapest, Hungary	Lee, SY (reprint author), Univ Stuttgart, Inst Phys 3, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.	s.lee@physik.uni-stuttgart.de	Janzen, Erik/I-5373-2013; Lee, Sang-Yun/J-9747-2013; Son, Nguyen/C-5551-2013; Zhao, Nan/G-9063-2011; 	Janzen, Erik/0000-0001-7721-5091; Lee, Sang-Yun/0000-0003-1777-980X; Son, Nguyen/0000-0002-6810-4282; Zhao, Nan/0000-0002-4521-709X; Gali, Adam/0000-0002-3339-5470	EU via SQUTEC; EU via SIQS; EU via QINVC; DARPA via QuASAR; Max Planck Society; DFG via SPP [1601]; DFG via Forschergruppe [FOR1493]; Lendulet programme of the Hungarian Academy of Sciences; Hungarian OTKA grant [K101819, K106114]; Knut & Alice Wallenberg Foundation; Linkoping Linnaeus Initiative for Novel Functionalized Materials; Ministry of Education, Science, Sports and Culture in Japan [26286047]; NKBRP (973 Program) [2014CB848700]; NSFC [11121403]	We acknowledge support by the EU via SQUTEC, SIQS and QINVC; DARPA via QuASAR; DFG via SPP 1601 and Forschergruppe FOR1493 and the Max Planck Society. A. G. acknowledges support from the Lendulet programme of the Hungarian Academy of Sciences, and Hungarian OTKA grant nos K101819 and K106114. Support from the Knut & Alice Wallenberg Foundation (N.T.S., A.G. and E.J.), Linkoping Linnaeus Initiative for Novel Functionalized Materials (N. T. S.), and the Ministry of Education, Science, Sports and Culture in Japan, Grant-in-Aid for Scientific Research (B) 26286047 (T.O.) is acknowledged. N.Z. acknowledges NKBRP (973 Program) 2014CB848700 and NSFC No. 11121403. We thank R. Kolesov, R. Stohr, P. Hemmer, N. Mizuochi and A. Guth for fruitful discussions and experimental aid.	Aichinger T, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3695330; Janzen E, 2009, PHYSICA B, V404, P4354, DOI 10.1016/j.physb.2009.09.023; Song BS, 2011, OPT EXPRESS, V19, P11084, DOI 10.1364/OE.19.011084; Matsunami H, 2006, MICROELECTRON ENG, V83, P2, DOI 10.1016/j.mee.2005.10.012; Weber JR, 2010, P NATL ACAD SCI USA, V107, P8513, DOI 10.1073/pnas.1003052107; Koehl WF, 2011, NATURE, V479, P84, DOI 10.1038/nature10562; Jenny JR, 2004, MATER SCI FORUM, V457-460, P35; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Castelletto S, 2014, NAT MATER, V13, P151, DOI [10.1038/nmat3806, 10.1038/NMAT3806]; Kimoto T, 2001, APPL PHYS LETT, V79, P2761, DOI 10.1063/1.1413724; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Son NT, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155204; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; Mizuochi N, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.235202; Falk AL, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.187601; Baranov PG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.125203; Riedel D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.226402; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Morton JJL, 2011, ANNU REV CONDEN MA P, V2, P189, DOI 10.1146/annurev-conmatphys-062910-140514; Klimov PV, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.087601; Yang YT, 2001, APPL PHYS LETT, V78, P162, DOI 10.1063/1.1338959; de Lange G, 2010, SCIENCE, V330, P60, DOI 10.1126/science.1192739; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Awschalom DD, 2013, SCIENCE, V339, P1174, DOI 10.1126/science.1231364; de Sousa R, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.115322; Soltamov VA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.226402; Christle D. J., NATURE MAT; Falk AL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2854; Hain TC, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870456; Ivanov IG, 2014, MATER SCI FORUM, V778-780, P471, DOI 10.4028/www.scientific.net/MSF.778-780.471; Janzen E., 2008, DEFECTS MICROELECTRO, P615; Kraus H, 2014, NAT PHYS, V10, P157, DOI [10.1038/nphys2826, 10.1038/NPHYS2826]; LEE SY, 2013, NAT NANOTECHNOL, V8, P487; Maboudian R, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4807902; Tsuchida H, 2001, MATER SCI FORUM, V353-356, P131; Witzel WM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.187602; Yang L-P., ELECT SPIN DECOHEREN	37	17	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	FEB	2015	14	2					164	168		10.1038/NMAT4145		5	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CA0IE	WOS:000348600200012		
J	Weinert, T; Olieric, V; Waltersperger, S; Panepucci, E; Chen, LR; Zhang, H; Zhou, DY; Rose, J; Ebihara, A; Kuramitsu, S; Li, D; Howe, N; Schnapp, G; Pautsch, A; Bargsten, K; Prota, AE; Surana, P; Kottur, J; Nair, DT; Basilico, F; Cecatiello, V; Pasqualato, S; Boland, A; Weichenrieder, O; Wang, BC; Steinmetz, MO; Caffrey, M; Wang, MT				Weinert, Tobias; Olieric, Vincent; Waltersperger, Sandro; Panepucci, Ezequiel; Chen, Lirong; Zhang, Hua; Zhou, Dayong; Rose, John; Ebihara, Akio; Kuramitsu, Seiki; Li, Dianfan; Howe, Nicole; Schnapp, Gisela; Pautsch, Alexander; Bargsten, Katja; Prota, Andrea E.; Surana, Parag; Kottur, Jithesh; Nair, Deepak T.; Basilico, Federica; Cecatiello, Valentina; Pasqualato, Sebastiano; Boland, Andreas; Weichenrieder, Oliver; Wang, Bi-Cheng; Steinmetz, Michel O.; Caffrey, Martin; Wang, Meitian			Fast native-SAD phasing for routine macromolecular structure determination	NATURE METHODS			English	Article							ANOMALOUS DIFFRACTION; BIOLOGICAL MACROMOLECULES; CRYSTAL-STRUCTURES; CRYSTALLOGRAPHY; REFINEMENT; SOFTWARE; GENOMICS; STRATEGY; SULFUR	We describe a data collection method that uses a single crystal to solve X-ray structures by native SAD (single-wavelength anomalous diffraction). We solved the structures of 11 real-life examples, including a human membrane protein, a protein-DNA complex and a 266-kDa multiprotein-ligand complex, using this method. The data collection strategy is suitable for routine structure determination and can be implemented at most macromolecular crystallography synchrotron beamlines.	[Weinert, Tobias; Olieric, Vincent; Waltersperger, Sandro; Panepucci, Ezequiel; Wang, Meitian] Swiss Light Source Paul Scherrer Inst, Villigen, Switzerland; [Chen, Lirong; Zhang, Hua; Zhou, Dayong; Rose, John; Wang, Bi-Cheng] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Ebihara, Akio] Gifu Univ, Fac Appl Biol Sci, Biol Chem Lab, Gifu, Japan; [Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan; [Li, Dianfan; Howe, Nicole; Caffrey, Martin] Trinity Coll Dublin, Sch Med, Membrane Struct & Funct Biol Grp, Dublin, Ireland; [Li, Dianfan; Howe, Nicole; Caffrey, Martin] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Schnapp, Gisela; Pautsch, Alexander; Steinmetz, Michel O.] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Bargsten, Katja; Prota, Andrea E.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, Villigen, Switzerland; [Surana, Parag; Kottur, Jithesh; Nair, Deepak T.] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Basilico, Federica; Cecatiello, Valentina; Pasqualato, Sebastiano] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Boland, Andreas; Weichenrieder, Oliver] Max Planck Inst Dev Biol, Tubingen, Germany	Wang, MT (reprint author), Swiss Light Source Paul Scherrer Inst, Villigen, Switzerland.	meitian.wang@psi.ch	Olieric, Vincent/D-1078-2011; Weinert, Tobias/I-4813-2013	Weinert, Tobias/0000-0002-0339-3722			Adams MWW, 2003, ACCOUNTS CHEM RES, V36, P191, DOI 10.1021/ar0101382; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Diederichs K, 2010, ACTA CRYSTALLOGR D, V66, P733, DOI 10.1107/S0907444910014836; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Mueller M, 2012, ACTA CRYSTALLOGR D, V68, P42, DOI 10.1107/S0907444911049833; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Hendrickson WA, 2014, Q REV BIOPHYS, V47, P49, DOI 10.1017/S0033583514000018; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Liu Q, 2013, ACTA CRYSTALLOGR D, V69, P1314, DOI 10.1107/S0907444913001479; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Sharma A, 2013, NUCLEIC ACIDS RES, V41, P5104, DOI 10.1093/nar/gkt146; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Zeldin OB, 2013, J APPL CRYSTALLOGR, V46, P1225, DOI 10.1107/S0021889813011461; Dauter Z, 1999, J MOL BIOL, V289, P83, DOI 10.1006/jmbi.1999.2743; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Li DF, 2014, CRYST GROWTH DES, V14, P2034, DOI 10.1021/cg500157x; Liu ZJ, 2011, ACTA CRYSTALLOGR A, V67, P544, DOI 10.1107/S0108767311037469; HENDRICKSON WA, 1981, NATURE, V290, P107, DOI 10.1038/290107a0; [Anonymous], PYMOL MOL GRAPH SYST; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nr1317; Basilico F., 2014, ELIFE, V3, P1; Cowtan K., 2012, INT TABLES CRYSTALLO, P385; Cowtan K., 2012, CCP4 NEWSL, V48; Dinapoli R., 2013, DETECT ASS EQUIP, V731, P68; Henrich B., 2009, DETECT ASS EQUIP, V607, P247; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Weiss MS, 2001, ACTA CRYSTALLOGR D, V57, P689, DOI 10.1107/S0907444901003572	34	6	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	FEB	2015	12	2					131	U163		10.1038/nmeth.3211		6	Biochemical Research Methods	Biochemistry & Molecular Biology	CA4GL	WOS:000348862500014		
J	Takayanagi, H				Takayanagi, Hiroshi			OSTEOIMMUNOLOGY IN 2014 Two-faced immunology-from osteogenesis to bone resorption	NATURE REVIEWS RHEUMATOLOGY			English	Editorial Material							IMMUNE	Even though activation of immunity is associated with bone destruction, new mechanisms have been described in 2014 through which immunology-associated pathways can cooperate to support osteogenesis. These advances support the view of the immune system as a central mechanism which can regulate bone homeostasis, regeneration and destruction.	[Takayanagi, Hiroshi] Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan	Takayanagi, H (reprint author), Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	takayana@m.u-tokyo.ac.jp					Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Bozec A., 2014, SCI TRANSL MED, V6; Kim SJ, 2014, J IMMUNOL, V193, P3902, DOI 10.4049/jimmunol.1302998; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Negishi-Koga T., 2012, BONEKEY REP, V1, P1; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Yoshitaka T, 2014, CELL REP, V8, P1752, DOI 10.1016/j.celrep.2014.08.023	10	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4790	1759-4804		NAT REV RHEUMATOL	Nat. Rev. Rheumatol.	FEB	2015	11	2					74	75		10.1038/nrrheum.2014.219		2	Rheumatology	Rheumatology	CA9SQ	WOS:000349265500006		
J	Tanji, H; Ohto, U; Shibata, T; Taoka, M; Yamauchi, Y; Isobe, T; Miyake, K; Shimizu, T				Tanji, Hiromi; Ohto, Umeharu; Shibata, Takuma; Taoka, Masato; Yamauchi, Yoshio; Isobe, Toshiaki; Miyake, Kensuke; Shimizu, Toshiyuki			Toll-like receptor 8 senses degradation products of single-stranded RNA	NATURE STRUCTURAL & MOLECULAR BIOLOGY			English	Article							IMMUNE-RESPONSES; INTERFERING RNA; RECOGNITION; INDUCTION; TOLL-LIKE-RECEPTOR-7; RESPONSIVENESS; ACTIVATION; AGONISTS; LIGANDS; VIRUSES	Toll-like receptor 8 (TLR8) recognizes viral or bacterial single-stranded RNA (ssRNA) and activates innate immune systems. TLR8 is activated by uridine- and guanosine-rich ssRNA as well as by certain synthetic chemicals; however, the molecular basis for ssRNA recognition has remained unknown. In this study, to elucidate the recognition mechanism of ssRNA, we determined the crystal structures of human TLR8 in complex with ssRNA. TLR8 recognized two degradation products of ssRNA uridine and a short oligonucleotide at two distinct sites: uridine bound the site on the dimerization interface where small chemical ligands are recognized, whereas short oligonucleotides bound a newly identified site on the concave surface of the TLR8 horseshoe structure. Site-directed mutagenesis revealed that both binding sites were essential for activation of TLR8 by ssRNA. These results demonstrate that TLR8 is a sensor for both uridine and a short oligonucleotide derived from RNA.	[Tanji, Hiromi; Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Shibata, Takuma; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan; [Shibata, Takuma; Isobe, Toshiaki; Shimizu, Toshiyuki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Taoka, Masato; Yamauchi, Yoshio; Isobe, Toshiaki] Tokyo Metropolitan Univ, Grad Sch Sci & Technol, Dept Chem, Tokyo 158, Japan	Shimizu, T (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan.	shimizu@mol.f.u-tokyo.ac.jp			Japan Society for the Promotion of Science KAKENHI [25121709, 25115504, 26711002, 25860354, 25253032, 23116007, 25291010]; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	We thank the beamline staff members at Photon Factory and SPring-8 for their assistance with data collection. We also thank M. Osawa and I. Shimada for their help with the ITC data acquisition. This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science KAKENHI, grant nos. 25121709, 25115504, 26711002 (U.O.), 25860354 (T. Shibata), 25253032 (K.M.), 23116007 and 25291010 (T. Shimizu); by the Takeda Science Foundation (U.O. and T. Shimizu); and by the Mochida Memorial Foundation for Medical and Pharmaceutical Research (U.O.).	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; Cervantes JL, 2013, J LEUKOCYTE BIOL, V94, P1231, DOI 10.1189/jlb.0413206; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-500; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Forsbach A, 2008, J IMMUNOL, V180, P3729; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kokatla HP, 2014, CHEMMEDCHEM, V9, P719, DOI 10.1002/cmdc.201300573; Wang JP, 2008, BLOOD, V112, P2028, DOI 10.1182/blood-2008-01-132860; Song DH, 2012, IMMUNOL REV, V250, P216, DOI 10.1111/j.1600-065X.2012.01167.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Diebold SS, 2006, EUR J IMMUNOL, V36, P3256, DOI 10.1002/eji.2006366171; Sioud M, 2006, EUR J IMMUNOL, V36, P1222, DOI 10.1002/eji.200535708; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Takeuchi O, 2002, J IMMUNOL, V169, P10; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Gantier MP, 2010, HUM MUTAT, V31, P1069, DOI 10.1002/humu.21321; Li Y, 2013, MICROBES INFECT, V15, P88, DOI 10.1016/j.micinf.2012.10.008; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Triantafilou K, 2005, CELL MICROBIOL, V7, P1117, DOI 10.1111/j.1462-5822.2005.00537.x	33	12	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1545-9993	1545-9985		NAT STRUCT MOL BIOL	Nat. Struct. Mol. Biol.	FEB	2015	22	2					109	115		10.1038/nsmb.2943		7	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CA5SF	WOS:000348967400005		
J	Kuribayashi, S; Iwakiri, K; Kawada, A; Kawami, N; Hoshino, S; Takenouchi, N; Hosaka, H; Shimoyama, Y; Kawamura, O; Yamada, M; Kusano, M				Kuribayashi, S.; Iwakiri, K.; Kawada, A.; Kawami, N.; Hoshino, S.; Takenouchi, N.; Hosaka, H.; Shimoyama, Y.; Kawamura, O.; Yamada, M.; Kusano, M.			Variant parameter values-as defined by the Chicago Criteria-produced by ManoScan and a new system with Unisensor catheter	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						Chicago criteria; esophageal manometry; high-resolution manometry; ManoScan; Starlet; Unisensor catheter	HIGH-RESOLUTION MANOMETRY; ESOPHAGEAL MOTILITY; PRESSURE TOPOGRAPHY	BackgroundRecently reported normal values for esophageal motility obtained by high-resolution manometry (HRM) using a system with a Unisensor catheter were significantly different from those obtained by the ManoScan((R)), which could result in a wrong diagnosis. To clarify whether these differences were due to system or subject differences, we compared the manometric parameter values between ManoScan and a new system with a Unisensor catheter (Starlet) in the same subjects. MethodsA total of 103 volunteers without any symptoms related to esophageal motility disorders were recruited. Esophageal HRM was performed using both the ManoScan and the Starlet in all subjects. Data from the ManoScan were analyzed using ManoView, and data from the Starlet were analyzed by a program with e-sleeve function. Integrated relaxation pressure, distal contractile integral, contractile front velocity (CFV), intrabolus pressure, and distal latency were calculated by both analyzing programs, and the values of these parameters were compared between the two systems by a signed rank test. Key ResultsData from a total of 97 participants were analyzed. The values of all parameters, except CFV, measured by the Starlet were significantly higher than those obtained by the ManoScan (p<0.01). Conclusions & InferencesBoth systems can measure esophageal motility appropriately; nevertheless, we confirmed that the two systems showed different values of the parameters defined by the Chicago criteria. These differences should be recognized to evaluate esophageal motility precisely.	[Kuribayashi, S.; Kawada, A.; Hosaka, H.; Shimoyama, Y.; Yamada, M.] Gunma Univ Hosp, Dept Gastroenterol, Maebashi, Gunma 3718511, Japan; [Kuribayashi, S.] Numata Natl Hosp, Natl Hosp Org, Dept Gastroenterol & Hepatol, Numata, Gunma, Japan; [Iwakiri, K.; Hoshino, S.] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Gastroenterol, Chiba, Japan; [Kawami, N.; Takenouchi, N.] Nippon Med Coll Hosp, Dept Gastroenterol, Tokyo, Japan; [Kawamura, O.; Kusano, M.] Gunma Univ Hosp, Dept Endoscopy & Endoscop Surg, Maebashi, Gunma, Japan	Kuribayashi, S (reprint author), Gunma Univ Hosp, Dept Gastroenterol, 3-39-15 Showa Machi, Maebashi, Gunma 3718511, Japan.	shikokuri@yahoo.co.jp			Star Medical, Inc.	This study was supported by the research grant funded by Star Medical, Inc.	Ghosh SK, 2007, AM J PHYSIOL-GASTR L, V293, pG878, DOI 10.1152/ajpgi.00252.2007; Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; Ghosh SK, 2006, AM J PHYSIOL-GASTR L, V290, pG988, DOI 10.1152/ajpgi.00510.2005; Pandolfino JE, 2009, NEUROGASTROENT MOTIL, V21, P796, DOI 10.1111/j.1365-2982.2009.01311.x; Pandolfino JE, 2008, AM J GASTROENTEROL, V103, P27, DOI 10.1111/j.1572-0241.2007.01532.x; Bogte A, 2013, NEUROGASTROENT MOTIL, V25, P762, DOI 10.1111/nmo.12167; Pandolfino John E, 2006, Am J Physiol Gastrointest Liver Physiol, V290, pG1033; Pandolifino JE, 2006, GASTROENTEROLOGY, V131, P1725, DOI 10.1053/j.gastro.2006.09.009; Wang K, 2012, BMC GASTROENTEROL, V12, P157	9	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	FEB	2015	27	2			SI		188	194		10.1111/nmo.12446		7	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Gastroenterology & Hepatology; Neurosciences & Neurology	CA1LA	WOS:000348672900004		
J	Saito, T; Katayama, T; Sawada, J; Kano, K; Asanome, A; Takahashi, K; Sato, N; Hasebe, N				Saito, Tsukasa; Katayama, Takayuki; Sawada, Jun; Kano, Kohei; Asanome, Asuka; Takahashi, Kae; Sato, Nobuyuki; Hasebe, Naoyuki			Combination therapy for segmental craniocervical dystonia (Meige syndrome) with aripiprazole, trihexyphenidyl, and botulinum toxin: three cases reports	NEUROLOGICAL SCIENCES			English	Article						Meige syndrome; Craniocervical dystonia; Dystonia; Botulinum toxin; Aripiprazole	DISORDERS	Segmental craniocervical dystonia is characterized by blephalospasm and oromandibular dystonia and is also called Meige syndrome. The current treatment strategy including botulinum toxin (BTX) injections has not yet attained an acceptable level. We describe a long-term favorable response of a novel combination therapy with aripiprazole (ARP), trihexyphenidyl (THP), and BTX in three patients with segmental craniocervical dystonia. The symptoms of three patients responded promptly to the combination therapy with ARP 3-6 mg daily, THP 2-8 mg daily, and BTX. Although the patients were required to receive a BTX 50-100 IU injection every 3-6 months, their symptoms were kept in a satisfactory condition for up to 2 years without any adverse effects. ARP possesses the potential for dramatically improving dystonia. THP has the possibility to enhance the efficacy of ARP and prolong the effective period of BTX. It may be an important requisite to give all three agents together for a successful treatment. The combination therapy with ARP, THP, and BTX was well-tolerated and useful in controlling the symptoms of segmental craniocervical dystonia, however, the reason why this combination therapy succeeded is unknown. A further long-term follow-up is required to monitor the delayed neurological adverse effects.	[Saito, Tsukasa; Katayama, Takayuki; Sawada, Jun; Kano, Kohei; Asanome, Asuka; Takahashi, Kae; Sato, Nobuyuki; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Internal Med, Div Cardiovasc Resp & Neurol, Asahikawa, Hokkaido 0788510, Japan	Saito, T (reprint author), Asahikawa Med Univ, Dept Internal Med, Div Cardiovasc Resp & Neurol, Midorigaoka Higashi 2-1-1, Asahikawa, Hokkaido 0788510, Japan.	tsukasa@asahikawa-med.ac.jp; katataka@asahikawa-med.ac.jp; sawajun@asahikawa-med.ac.jp; kano-k@asahikawa-med.ac.jp; ask.asnm@gmail.com; kae.t-452@live.jp; nsato@asahikawa-med.ac.jp; haselove@asahikawa-med.ac.jp					Balash Y, 2004, EUR J NEUROL, V11, P361, DOI 10.1111/j.1468-1331.2004.00845.x; Potkin SG, 2003, ARCH GEN PSYCHIAT, V60, P681, DOI 10.1001/archpsyc.60.7.681; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; LeDoux MS, 2009, PARKINSONISM RELAT D, V15, P483, DOI 10.1016/j.parkreldis.2009.04.006; Sanghadia M, 2007, J NEUROPSYCH CLIN N, V19, P89, DOI 10.1176/appi.neuropsych.19.1.89; VANDENBERGH P, 1995, MUSCLE NERVE, V18, P720, DOI 10.1002/mus.880180708	6	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	FEB	2015	36	2					243	245		10.1007/s10072-014-1927-x		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AZ9WO	WOS:000348565100010		
J	Kitagawa, M; Paultre, D; Rademaker, H				Kitagawa, Munenori; Paultre, Danae; Rademaker, Hanna			Intercellular communication via plasmodesmata	NEW PHYTOLOGIST			English	Editorial Material						cell-to-cell communication; lipid raft; phloem transport; plant defence; plant development; plasmodesmata; small RNA	MOVEMENT		[Kitagawa, Munenori] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Paultre, Danae] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [Rademaker, Hanna] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark	Kitagawa, M (reprint author), RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan.	munenori.kitagawa@riken.jp					Lee JY, 2001, TRENDS MICROBIOL, V9, P5, DOI 10.1016/S0966-842X(00)01901-6; Raffaele S, 2009, PLANT CELL, V21, P1541, DOI 10.1105/tpc.108.064279; Maule A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00030	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	FEB	2015	205	3					970	972		10.1111/nph.13254		3	Plant Sciences	Plant Sciences	CA2HX	WOS:000348730600007		
J	Mazzitelli, G; Hirooka, Y; Hu, JS; Mirnov, SV; Nygren, R; Shimada, M; Ono, M; Tabares, FL				Mazzitelli, G.; Hirooka, Y.; Hu, J. S.; Mirnov, S. V.; Nygren, R.; Shimada, M.; Ono, M.; Tabares, F. L.			Conference Report on the 3rd International Symposium on Lithium Application for Fusion Devices	NUCLEAR FUSION			English	Article						conference report; lithium; liquid metal		The third International Symposium on Lithium Application for Fusion Device (ISLA-2013) was held on 9-11 October 2013 at ENEA Frascati Centre with growing participation and interest from the community working on more general aspect of liquid metal research for fusion energy development. ISLA-2013 has been confirmed to be the largest and the most important meeting dedicated to liquid metal application for the magnetic fusion research. Overall, 45 presentation plus 5 posters were given, representing 28 institutions from 11 countries. The latest experimental results from nine magnetic fusion devices were presented in 16 presentations from NSTX (PPPL, USA), FTU (ENEA, Italy), T-11M (Trinity, RF), T-10 (Kurchatov Institute, RF), TJ-II (CIEMAT, Spain), EAST(ASIPP, China), HT-7 (ASIPP, China), RFX (Padova, Italy), KTM (NNC RK, Kazakhstan). Sessions were devoted to the following: (I) lithium in magnetic confinement experiments (facility overviews), (II) lithium in magnetic confinement experiments (topical issues), (III) special session on liquid lithium technology, (IV) lithium laboratory test stands, (V) Lithium theory/modelling/comments, (VI) innovative lithium applications and (VII) special Session on lithium-safety and lithium handling. There was a wide participation from the fusion technology communities, including IFMIF and TBM communities providing productive exchange with the physics oriented magnetic confinement liquid metal research groups. This international workshop will continue on a biennial basis (alternating with the Plasma-Surface Interactions (PSI) Conference) and the next workshop will be held at CIEMAT, Madrid, Spain, in 2015.	[Mazzitelli, G.] Assoc EURATOM ENEA Fus, Ctr Ric Frascati, I-00044 Frascati, Italy; [Hirooka, Y.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Hirooka, Y.] Grad Univ Adv Studies, Toki, Gifu 5095292, Japan; [Hu, J. S.] Chinese Acad Sci, Inst Plasma Phys, Hefei 230031, Anhui, Peoples R China; [Mirnov, S. V.] TRINITI, Troitsk 142190, Moscow Reg, Russia; [Mirnov, S. V.] NRNU MEPhI, Moscow 115409, Russia; [Nygren, R.] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Shimada, M.] IFERC Obuchi, JAEA Int Fus Res Ctr, Rokkasho, Aomori, Japan; [Ono, M.] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Tabares, F. L.] As EURATOM CIEMAT, Natl Inst Fus, Madrid 28040, Spain	Mazzitelli, G (reprint author), Assoc EURATOM ENEA Fus, Ctr Ric Frascati, CP 65, I-00044 Frascati, Italy.	guiseppe.mazzitelli@enea.it					Hirooka Y., 2010, NUCL FUSION, V50; Ono M., 2012, NUCL FUSION, V52; Zohm H., 2013, NUCL FUSION, V53	3	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	FEB	2015	55	2							027001	10.1088/0029-5515/55/2/027001		9	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CA3ZE	WOS:000348843100020		
J	Harada, A; Suzuki, K; Miura, S; Hasui, T; Kamiguchi, N; Ishii, T; Taniguchi, T; Kuroita, T; Takano, A; Stepanov, V; Halldin, C; Kimura, H				Harada, Akina; Suzuki, Kazunori; Miura, Shotaro; Hasui, Tomoaki; Kamiguchi, Naomi; Ishii, Tsuyoshi; Taniguchi, Takahiko; Kuroita, Takanobu; Takano, Akihiro; Stepanov, Vladimir; Halldin, Christer; Kimura, Haruhide			Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A	NUCLEAR MEDICINE AND BIOLOGY			English	Article						PDE10A; Autoradiography; PET; T-773; C-11	POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO EVALUATION; IMMUNOHISTOCHEMICAL LOCALIZATION; PRECLINICAL EVALUATION; HUNTINGTONS-DISEASE; SIGNALING PATHWAYS; PDE10A INHIBITORS; DRUG DEVELOPMENT; BASAL GANGLIA; RAT-BRAIN	Introduction: Phosphodiesterase 10A (PDE10A) is a dual-substrate PDE that hydrolyzes both CAMP and cGMP and is selectively expressed in striatal medium spiny neurons. Recent studies have suggested that PDE10A inhibition is a novel approach for the treatment of disorders such as schizophrenia and Huntington's disease. A positron emission tomography (PET) occupancy study can provide useful information for the development of PDE10A inhibitors. We discovered T-773 as a candidate PET radioligand for PDE10A and investigated its properties by in vitro autoradiography and a PET study in a monkey. Methods: Profiling of T-773 as a PET radioligand for PDE10A was conducted by in vitro enzyme inhibitory assay, in vitro autoradiography, and PET study in a monkey. Results: T-773 showed a high binding affinity and selectivity for human recombinant PDE10A2 in vitro; the IC50 value in an enzyme inhibitory assay was 0.77 nmol/L, and selectivity over other PDEs was more than 2500-fold. In autoradiography studies using mouse, rat, monkey, or human brain sections, radiolabeled T-773 selectively accumulated in the striatum. This selective accumulation was not observed in the brain sections of Pde10a-KO mice. The binding of[H-3]T-773 to PDE10A in rat brain sections was competitively inhibited by MP-10, a selective PDE10A inhibitor. In rat brain sections, [H-3]T-773 bound to a single high affinity site of PDE10A with K-d values of 12.2 +/- 22 and 4.7 +/- 12 nmol/L in the caudate-putamen and nucleus accumbens, respectively. In a monkey PET study, [C-11]T-773 showed good brain penetration and striatum-selective accumulation. Conclusion: These results suggest that [C-11]T-773 is a potential PET radioligand for PDE10A. (C) 2014 Elsevier Inc. All rights reserved.	[Harada, Akina; Suzuki, Kazunori; Miura, Shotaro; Hasui, Tomoaki; Taniguchi, Takahiko; Kuroita, Takanobu; Kimura, Haruhide] Takeda Pharmaceut Co Ltd, CNS Drug Discovery Unit, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan; [Kamiguchi, Naomi] Takeda Pharmaceut Co Ltd, Drug Metab & Pharmacokinet Res Labs, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan; [Ishii, Tsuyoshi] Takeda Pharmaceut Co Ltd, Biomol Res Labs, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan; [Takano, Akihiro; Stepanov, Vladimir; Halldin, Christer] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden	Kimura, H (reprint author), Takeda Pharmaceut Co Ltd, CNS Drug Discovery Unit, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	haruhide.kimura@takeda.com			Takeda Pharmaceutical Company Limited	This work was sponsored by Takeda Pharmaceutical Company Limited. We wish to express our sincere thanks to Nicholas Hird, Teruaki Okuda, and Keisuke Hirai for their support and helpful discussions.	Andres JI, 2011, J MED CHEM, V54, P5820, DOI 10.1021/jm200536d; Raub TJ, 2006, MOL PHARMACEUT, V3, P3, DOI 10.1021/mp0500871; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Giampa C, 2009, NEUROBIOL DIS, V34, P450, DOI 10.1016/j.nbd.2009.02.014; Verhoest PR, 2009, J MED CHEM, V52, P5188, DOI [10.1021/jm900521k, 10.1021/jm9015334]; Menniti FS, 2007, CURR OPIN INVESTIG D, V8, P54; Plisson C, 2014, J NUCL MED, V55, P595, DOI 10.2967/jnumed.113.131409; Van Laere K, 2013, J NUCL MED, V54, P1285, DOI 10.2967/jnumed.112.118679; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; Barret O, 2014, J NUCL MED, V55, P1297, DOI 10.2967/jnumed.113.122895; Nord M, 2011, CNS NEUROSCI THER, V17, P97, DOI 10.1111/j.1755-5949.2010.00222.x; Karam CS, 2010, TRENDS PHARMACOL SCI, V31, P381, DOI 10.1016/j.tips.2010.05.004; Fan JD, 2014, BIOORGAN MED CHEM, V22, P2648, DOI 10.1016/j.bmc.2014.03.028; Halldin C, 2001, CURR PHARM DESIGN, V7, P1907, DOI 10.2174/1381612013396871; Tu Z, 2011, BIOORGAN MED CHEM, V19, P1666, DOI 10.1016/j.bmc.2011.01.032; Celen S, 2010, J NUCL MED, V51, P1584, DOI 10.2967/jnumed.110.077040; KARLSSON P, 1993, PSYCHOPHARMACOLOGY, V113, P149, DOI 10.1007/BF02245691; Andersson J, 2009, APPL RADIAT ISOTOPES, V67, P106, DOI 10.1016/j.apradiso.2008.09.010; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Plisson C, 2011, NUCL MED BIOL, V38, P875, DOI 10.1016/j.nucmedbio.2011.02.005; Celen S, 2013, NEUROIMAGE, V82, P13, DOI 10.1016/j.neuroimage.2013.04.123; Kehler J, 2011, CURR PHARM DESIGN, V17, P137; Pike VW, 2009, TRENDS PHARMACOL SCI, V30, P431, DOI 10.1016/j.tips.2009.05.005; Frank R, 2003, NAT REV DRUG DISCOV, V2, P566, DOI 10.1038/nrd1130; Kleiman RJ, 2011, J PHARMACOL EXP THER, V336, P64, DOI 10.1124/jpet.110.173294; Van Laere K, 2013, EUR J NUCL MED MOL I, V40, P254, DOI 10.1007/s00259-012-2270-1; Lee CM, 2006, TRENDS PHARMACOL SCI, V27, P310, DOI 10.1016/j.tips.2006.04.004; Arakawa R, 2010, PSYCHOPHARMACOLOGY, V209, P285, DOI 10.1007/s00213-010-1783-1; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Hwang DR, 2014, NUCL MED BIOL, V41, P343, DOI 10.1016/j.nucmedbio.2014.01.007; Krebs M, 2006, EXPERT OPIN PHARMACO, V7, P1005, DOI 10.1517/14656566.7.8.1005; Minuzzi L, 2010, NEUROCHEM INT, V56, P747, DOI 10.1016/j.neuint.2010.01.010; Paxinos G, 2001, MOUSE BRAIN STEREOTA; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Rourke C, 2006, PSYCHOPHARMACOLOGY, V184, P107, DOI 10.1007/s00213-005-0230-1; Stepanov V, 2013, J LABELLED COMPD RAD, V56, pS312; Takano A, 2010, CURR PHARM DESIGN, V16, P371; Waarde A v, 2000, Curr Pharm Des, V6, P1593, DOI 10.2174/1381612003398951; Waterhouse Rikki N, 2003, Mol Imaging Biol, V5, P376, DOI 10.1016/j.mibio.2003.09.014	44	11	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	FEB	2015	42	2					146	154		10.1016/j.nucmedbio.2014.09.005		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ7QE	WOS:000348412200011		
J	Nishi, K; Mizutani, A; Shikano, N; Fujita, K; Kobayashi, M; Ono, M; Nishii, R; Sasaki, Y; Kinuya, S; Kawai, K				Nishi, Kodai; Mizutani, Asuka; Shikano, Naoto; Fujita, Ken-ichi; Kobayashi, Masato; Ono, Masahiro; Nishii, Ryuichi; Sasaki, Yasutuna; Kinuya, Seigo; Kawai, Keiichi			In vivo radioactive metabolite analysis for individualized medicine: A basic study of a new method of CYP activity assay using I-123-IMP	NUCLEAR MEDICINE AND BIOLOGY			English	Article						CYP activity; I-123-Imp; Individualized medicine; Metabolite analysis; Mouse	CYP2C19; PHARMACOKINETICS; HYDROCHLORIDE; POLYMORPHISMS; DRUG	Introduction: I-123-N-isopropyl-p-iodoamphetamine (I-123-IMP) is metabolized and converted to I-123-p-iodoamphetamine (I-123-PIA) by CYP2C19 in humans. Since variations in 123I-PIA levels reflect variations in CYP2C19 activity, CYP2C19 activity can be estimated by quantitative analysis of I-123-PIA levels. Thus, I-123-IMP administration can provide diagnostic information not only regarding cerebral blood flow (rCBF) but also regarding metabolic function. The aim of the present study was to detect variations in CYP activity in mice using metabolite analysis. Methods: Metabolism of I-125-IMP in pooled homogenates of mouse liver (MLH) was analyzed by high-performance liquid chromatography (HPLC) in the presence or absence of NADPH. The amount of I-125-PIA generated was calculated as the normalized peak area of the chromatogram. Inhibition of I-125-IMP metabolism was evaluated using the inhibitor SKF-525A. A biodistribution study of I-125-IMP was performed to determine the organ distribution of I-125-IMP/I-125-IMP metabolites and the effect of SKF-525A. Variations in CYP activity in vivo were detected by administration of I-123-IMP and/or SKF-525A to mice. The liver and the kidney were then excised, homogenized and analyzed using HPLC. Results: I-125-IMP was metabolized by MLH in the presence of NADPH, and the production of I-125-PIA was inhibited by SKF-525A. SKF-525A did not greatly affect the biodistribution of I-125-IMP/I-125-IMP metabolites in vivo. Both I-123-IMP and I-123-PIA were detected in organs of control mice. However, I-123-PIA was not detected in the livers or kidneys of mice treated with SKF-525A. Conclusions: CYP activity in vivo was inhibited by SKF-525A treatment. Variations in CYP activity could be detected in the blood, liver and kidney as changes in the peak area of 123I-PIA. Advances in knowledge and implications for patient care: I-123-IMP metabolite analysis has the potential to provide beneficial information for prediction of the effect of medicines, in addition to its contribution to more accurate rCBF diagnosis that reflects individual CYP activity. (C) 2014 Elsevier Inc. All rights reserved.	[Nishi, Kodai] Nagasaki Univ, Dept Radioisotope Med, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Nishi, Kodai; Mizutani, Asuka; Kobayashi, Masato; Ono, Masahiro; Kawai, Keiichi] Kanazawa Univ, Sch Hlth Sci, Coll Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Shikano, Naoto] Ibaraki Prefectural Univ Hlth Sci, Dept Radiol Sci, Ibaraki, Japan; [Fujita, Ken-ichi; Sasaki, Yasutuna] Showa Univ, Inst Mol Oncol, Tokyo, Japan; [Ono, Masahiro] Nihon Medi Phys Co Ltd, Res Ctr, Chiba, Japan; [Nishii, Ryuichi] Univ Miyazaki Hosp, Miyazaki, Japan; [Kinuya, Seigo] Kanazawa Univ, Sch Med Sci, Coll Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Kawai, Keiichi] Univ Fukui, Biomed Imaging Res Ctr, Fukui 910, Japan	Kawai, K (reprint author), Kanazawa Univ, Sch Hlth Sci, Coll Med Pharmaceut & Hlth Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	kei@mhs.mp.kanazawa-u.ac.jp					Alonso-Navarro H, 2006, MED CLIN-BARCELONA, V126, P697, DOI 10.1157/13088772; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Reed JR, 2012, PHARMACOL THERAPEUT, V133, P299, DOI 10.1016/j.pharmthera.2011.11.009; Singh D, 2011, DRUG DISCOV TODAY, V16, P793, DOI 10.1016/j.drudis.2011.08.003; Wijnen PAHM, 2007, ALIMENT PHARM THERAP, V26, P211, DOI 10.1111/j.1365-2036.2007.03490.x; Daly AK, 2003, FUND CLIN PHARMACOL, V17, P27, DOI 10.1046/j.1472-8206.2003.00119.x; Tozuka Z, 2010, CLIN PHARMACOL THER, V88, P824, DOI 10.1038/clpt.2010.206; BALDWIN RM, 1988, J NUCL MED, V29, P122; COHEN MB, 1986, APPL RADIAT ISOTOPES, V37, P749; Cumming P, 1999, SYNAPSE, V34, P124, DOI 10.1002/(SICI)1098-2396(199911)34:2<124::AID-SYN5>3.0.CO;2-O; Fujita K, 2012, DRUG METAB DISPOS, V40, P843, DOI 10.1124/dmd.111.043893; KAUSER K, 1991, CIRC RES, V68, P1154; Mimura H, 2006, ANN NUCL MED, V20, P589, DOI 10.1007/BF02984656; Nunoya KI, 1996, J PHARMACOL EXP THER, V277, P768; Saeed LH, 2013, INT J MED SCI, V10, P1497, DOI 10.7150/ijms.6795; van der Weide J, 1999, ANN CLIN BIOCHEM, V36, P722	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	FEB	2015	42	2					171	176		10.1016/j.nucmedbio.2014.08.015		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ7QE	WOS:000348412200014		
J	Temma, T; Nishigori, K; Onoe, S; Sampei, S; Kimura, I; Ono, M; Saji, H				Temma, Takashi; Nishigori, Kantaro; Onoe, Satoru; Sampei, Sotaro; Kimura, Ikuo; Ono, Masahiro; Saji, Hideo			Radiofluorinated probe for PET imaging of fatty acid binding protein 4 in cancer	NUCLEAR MEDICINE AND BIOLOGY			English	Article						Fatty acid binding protein 4; Radiolabeled probe; Positron emission tomography; PET; Nuclear imaging	CELL CARCINOMA; TUMOR-GROWTH; BLADDER; FABP	Introduction: Cancer-associated adipocytes metabolically interact with adjacent cancer cells to promote tumor proliferation and metastasis. Fatty acid binding protein 4 (FABP4) participates in this interaction, and is gathering attention as a therapeutic and diagnostic target. Positron emission tomography (PET) is a useful diagnostic method that enables noninvasive in vivo quantitative imaging of biofunctional molecules with probes labeled with positron-emitting radioisotopes. Here a novel F-18 labeled probe for PET FABP4 imaging developed through dedicated drug design from a radioiodinated probe we recently reported is evaluated in vitro and in vivo. Methods: We designed the [F-18]-labeled FTAP1 and FTAP3 probe, composed of a single or triple oxyethylene linker and a triazolopyrimidine scaffold derived from an FABP4 inhibitor. FABP4 binding affinities for chemically synthesized FTAP1 and FTAP3 were measured using FABP4 and 8-anilino-1-naphthalene sulfonic acid. Cell membrane permeability was measured using a commercially available plate assay system. After radiosynthesis, [F-18]FTAP1 affinity and selectivity were evaluated using immobilized FABP3, FABP4, and FABP5. Cell uptake was investigated using differentiated adipocytes expressing FABP4 with inhibitor treatment. Following biodistribution studies in C6 glioblastoma-bearing mice, ex vivo autoradiography and immunohistochemistty were performed using thin sliced tumor sections. PET/CT imaging was then performed on C6 tumor beating mice. Results: FTAP1 showed high FABP4 affinity (K-i = 68 +/- 8.9 nM) and adequate cell permeability. [F-18]FTAP1 with >= 98% radiochemical purity was shown to selectively bind to FABP4 (16.3- and 9.3-fold higher than for FABP3 and FABP5, respectively). [F-18]FTAP1 was taken up by FABP4 expressing cells, and this uptake could be blocked by an inhibitor, indicating very low non-specific cell binding. [F-18]FTAP1 showed high tumor accumulation, which demonstrates its potential use for in vivo tumor PET imaging, and the intratumoral radioactivity distribution corresponded to the FABP4 expression profile. Conclusion: [F-18]FTAP1 is a promising PET probe to target FABP4. (C) 2014 Elsevier Inc. All rights reserved.	[Temma, Takashi; Nishigori, Kantaro; Onoe, Satoru; Sampei, Sotaro; Ono, Masahiro; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, Kyoto 6068501, Japan; [Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Kimura, Ikuo] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacogen, Sakyo Ku, Kyoto 6068501, Japan	Saji, H (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Sakyo Ku, 46-29 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan.	hsaji@pharm.kyoto-u.ac.jp			Ministry of Health, Labour and Welfare of Japan; JSPS KAKENHI [24591813]	The authors have no competing interest to declare. This work was supported in part by a Health and Labour Science Research Grant "Research on Noninvasive and Minimally Invasive Medical Devices" from the Ministry of Health, Labour and Welfare of Japan and by JSPS KAKENHI Grant Number 24591813. The funders had no role in study design, data collection and analysis, derision to publish, or preparation of the manuscript.	Hefetz-Sela S, 2013, PHARMACOL THERAPEUT, V138, P197, DOI 10.1016/j.pharmthera.2013.01.008; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Kakwani MD, 2011, BIOORG MED CHEM LETT, V21, P6523, DOI 10.1016/j.bmcl.2011.08.076; Agardh HE, 2011, J INTERN MED, V269, P200, DOI 10.1111/j.1365-2796.2010.02304.x; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Avdeef Alex, 2001, Current Topics in Medicinal Chemistry, V1, P277, DOI 10.2174/1568026013395100; Boiteux G, 2009, INT J CANCER, V124, P1820, DOI 10.1002/ijc.24112; Camenisch G, 1998, Eur J Pharm Sci, V6, P317; Cataltepe O, 2012, NEUROPATH APPL NEURO, V38, P400, DOI 10.1111/j.1365-2990.2011.01237.x; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Makowski L, 2004, J NUTR, V134, p2464S; Nishigori K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094668; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Tolle A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-302	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	FEB	2015	42	2					184	191		10.1016/j.nucmedbio.2014.10.006		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AZ7QE	WOS:000348412200016		
J	Akter, S; Eguchi, M; Kurotani, K; Kochi, T; Pham, NM; Ito, R; Kuwahara, K; Tsuruoka, H; Mizoue, T; Kabe, I; Nanri, A				Akter, Shamima; Eguchi, Masafumi; Kurotani, Kayo; Kochi, Takeshi; Pham, Ngoc Minh; Ito, Rie; Kuwahara, Keisuke; Tsuruoka, Hiroko; Mizoue, Tetsuya; Kabe, Isamu; Nanri, Akiko			High dietary acid load is associated with increased prevalence of hypertension: The Furukawa Nutrition and Health Study	NUTRITION			English	Article						Acid-base balance; Potential renal acid load; Net endogenous acid production; Estimated glomerular filtration rate; Hypertension	CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR-I; BLOOD-PRESSURE; BASE-BALANCE; HISTORY QUESTIONNAIRES; INCIDENT HYPERTENSION; MAGNESIUM EXCRETION; JAPANESE ADULTS; URINARY CALCIUM; RISK-FACTORS	Objective: Acid-base status has been suggested to influence blood pressure, but there is a paucity of epidemiologic evidence linking dietary acid load to hypertension. We examined cross-sectionally the association between dietary acid load and hypertension in a Japanese working population. Methods: Data were derived from health surveys from 2028 employees, ages 18 to 70 y, in two workplaces in Japan. A validated brief diet history questionnaire was used to assess diet. Two measures were used to characterize dietary acid load: potential renal acid load and estimated net endogenous acid production, which were derived from nutrient intakes. Multilevel logistic regression was used to examine the association between dietary acid load and hypertension with adjustment of potential confounding variables. Results: High dietary acid load was suggestively associated with increased prevalence of hypertension. The multivariable adjusted odds ratios (95% confidence interval) of hypertension for the lowest through highest tertiles of net endogenous acid production were 1.00 (reference), 1.07 (0.80-1.42), and 1.33 (0.998-1.78), respectively (P for trend = 0.053). This positive association was statistically significant among normal-weight (body mass index <23 kg/m(2); P for trend = 0.03) and non-shift workers (P for trend = 0.04). Similar positive associations were observed between potential renal acid load and hypertension. Conclusions: The present findings suggest that high dietary acid load may be associated with increased prevalence of hypertension among those who were normal weight and non-shift workers. (C) 2015 Elsevier Inc. All rights reserved.	[Akter, Shamima; Kurotani, Kayo; Kuwahara, Keisuke; Mizoue, Tetsuya; Nanri, Akiko] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Eguchi, Masafumi; Kochi, Takeshi; Ito, Rie; Tsuruoka, Hiroko; Kabe, Isamu] Furukawa Elect Corp Ltd, Dept Hlth Adm, Tokyo, Japan; [Pham, Ngoc Minh] Thai Nguyen Univ Med & Pharm, Fac Publ Hlth, Dept Epidemiol, Thai Nguyen, Thai Nguyen Pro, Vietnam	Akter, S (reprint author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.	samimarub@yahoo.com					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Murakami K, 2008, BRIT J NUTR, V100, P642, DOI 10.1017/S0007114508901288; Maurer M, 2003, AM J PHYSIOL-RENAL, V284, pF32, DOI 10.1152/ajprenal.00212.2002; Remer T, 2003, AM J CLIN NUTR, V77, P1255; Souto G, 2011, METAB SYNDR RELAT D, V9, P247, DOI 10.1089/met.2010.0108; Engberink MF, 2012, AM J CLIN NUTR, V95, P1438, DOI 10.3945/ajcn.111.022343; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)17741-1; Taylor EN, 2006, AM J KIDNEY DIS, V48, P905, DOI 10.1053/j.ajkd.2006.09.004; Remer T, 2000, SEMIN DIALYSIS, V13, P221, DOI 10.1046/j.1525-139x.2000.00062.x; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Zhang LX, 2009, HYPERTENSION, V54, P751, DOI 10.1161/HYPERTENSIONAHA.109.135582; Buclin T, 2001, OSTEOPOROSIS INT, V12, P493, DOI 10.1007/s001980170095; WHITWORTH JA, 1995, STEROIDS, V60, P76, DOI 10.1016/0039-128X(94)00033-9; Frassetto LA, 1998, AM J CLIN NUTR, V68, P576; Kelly JJ, 1998, CLIN EXP PHARMACOL P, V25, pS51, DOI 10.1111/j.1440-1681.1998.tb02301.x; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI [10.2188/jeaJE20110075, 10.2188/jea.JE20110075]; REMER T, 1995, J AM DIET ASSOC, V95, P791, DOI 10.1016/S0002-8223(95)00219-7; Brungger M, 1997, KIDNEY INT, V51, P216, DOI 10.1038/ki.1997.26; Coffman TM, 2008, HYPERTENSION, V51, P811, DOI 10.1161/HYPERTENSIONAHA.105.063636; Fagherazzi G, 2014, DIABETOLOGIA, V57, P313, DOI 10.1007/s00125-013-3100-0; Forman J, 2007, J HUM HYPERTENS, V22, P122; GONICK HC, 1968, AM J CLIN NUTR, V21, P898; Goraya N, 2012, CURR OPIN NEPHROL HY, V21, P552, DOI 10.1097/MNH.0b013e328356233b; He J, 1999, Am Heart J, V138, P211; Kestelooty H, 2011, AM J EPIDEMIOL, V174, P44, DOI 10.1093/aje/kwr049; Lawes CM, 2001, LANCET, V2008, P1513; Lucas P A, 1988, Kidney Int Suppl, V25, pS19; LUCAS PA, 1987, CLIN SCI, V73, P211; Luno J, 2006, J AM SOC NEPHROL, V17, pS157, DOI 10.1681/ASN.2006111191; Mardon J, 2008, J NUTR, V138, P718; Morikawa Y, 1999, SCAND J WORK ENV HEA, V25, P100; Nielsen TF, 2011, ARCH GYNECOL OBSTET, V283, P443, DOI 10.1007/s00404-010-1371-y; Oishi M, 2005, J HYPERTENS, V23, P2173, DOI 10.1097/01.hjh.0000189870.55914.b3; Ordonez FA, 2000, PEDIATR NEPHROL, V14, P720; Remer T, 2001, EUR J NUTR, V40, P214, DOI 10.1007/s394-001-8348-1; REMER T, 1994, AM J CLIN NUTR, V59, P1356; Rylander R, 2009, MAGNESIUM RES, V22, P262, DOI 10.1684/mrh.2009.0182; Science and Technology Agency, 2005, STAND TABL FOOD COMP; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; SWISLOCKI ALM, 1989, AM J HYPERTENS, V2, P419; Taylor EN, 2007, HYPERTENSION, V50, P320, DOI 10.1161/HYPERTENSIONAHA.107.092643; Taylor EN, 2006, AM J KIDNEY DIS, V47, P780, DOI 10.1053/j.ajkd.2006.01.024; Zhang LX, 2011, J HYPERTENS, V29, P229, DOI 10.1097/HJH.0b013e32834103bf	46	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	FEB	2015	31	2					298	303		10.1016/j.nut.2014.07.007		6	Nutrition & Dietetics	Nutrition & Dietetics	CA0WD	WOS:000348633400005		
J	Inoue, S; Honma, K; Mochizuki, K; Goda, T				Inoue, Seiya; Honma, Kazue; Mochizuki, Kazuki; Goda, Toshinao			Induction of histone H3K4 methylation at the promoter, enhancer, and transcribed regions of the Si and Sglt1 genes in rat jejunum in response to a high-starch/low-fat diet	NUTRITION			English	Article						Histone H3K4 methylation; Jejunum; Sucrase-isomaltase; Sodium-dependent glucose cotransporter; Dietary carbohydrate	SUCRASE-ISOMALTASE GENE; RESISTANT STARCH; EXPRESSION; ACETYLATION; METHYLTRANSFERASE; CHROMATIN; INTESTINE; LYSINE-4; MICE; MARK	Objective: Histone methylation patterns are associated with various aspects of biology, including transcriptional regulation. Methylation of histone H3 at lysine 4 (H3K4) leads to transcriptional activation through recruitment of transcription activation complexes onto target genes; in contrast, methylation of histone H3K9, or histone H4K20, leads to transcriptional inactivation attracting heterochromatin protein 1 (HP1). It is not yet known whether jejunal induction of sucrase-isomaltase (Si) and sodium-dependent glucose cotransporter (Sglt1) genes by intake of a high-starch/low-fat diet in rats is regulated by coordinated changes of these histone methylation events. In the present study, we investigated whether these histone modifications at the promoter, enhancer, and transcribed regions of Si and Sglt1 genes in rat jejunum are affected by consumption of a high-starch/low-fat diet. Methods: Chromatin immunoprecipitation assays using antibodies against methylated-histone H3K4, H3K9, H4K20, and HP1 were performed at various regions associated with the Si and Sglt1 genes in jejunum of rats fed a high-starch/low-fat diet or a low-starch/high-fat diet for 7 d. Results: Feeding rats the high-starch/low-fat diet induced mono-, di-, and trimethylation of histone H3K4 on the promoter and transcribed regions of the Si and Sglt1 genes. In contrast, methylation of histones H3K9 and H4K20, and binding of HP1 at these gene regions, were not affected by the high-starch/low-fat diet. Conclusion: These observations suggest that induction of Si and Sglt1 gene expression in rat jejunum by a high-starch/low-fat diet intake is positively associated with histone H3K4 methylation, but not with histone H3K9/H4K20 methylation, or with binding of HP1. (C) 2015 Elsevier Inc. All rights reserved.	[Inoue, Seiya; Honma, Kazue; Mochizuki, Kazuki; Goda, Toshinao] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Dept Nutr & Life Sci, Lab Nutr Physiol, Shizuoka 4228526, Japan; [Mochizuki, Kazuki] Univ Yamanashi, Fac Life & Environm Sci, Dept Local Produce & Food Sci, Kofu, Yamanashi, Japan	Goda, T (reprint author), Univ Shizuoka, Grad Sch Nutr & Environm Sci, Dept Nutr & Life Sci, Lab Nutr Physiol, Shizuoka 4228526, Japan.	gouda@u-shizouka-ken-ac.jp			Ministry of Education, Culture, Sports Science and Technology of Japan (MEXT) [20590233, 22680054]; Global COE program; Center of Excellence for Evolutionary Human Health Sciences of MEXT; Takeda Science Foundation	This work was supported by Grants-in-Aid for Scientific Research (20590233) and for Young Scientists (22680054) from the Ministry of Education, Culture, Sports Science and Technology of Japan (MEXT), the Global COE program, the Center of Excellence for Evolutionary Human Health Sciences of MEXT, and a grant from the Takeda Science Foundation. SI conducted the experiments and analysis, and wrote the manuscript. KH assisted in writing the manuscript. KM assisted with the experiments, data analysis, and writing the manuscript. TG organized the study. The authors have no conflicts of interest to declare.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Takizawa F, 2013, BIOCHEM BIOPH RES CO, V433, P66, DOI 10.1016/j.bbrc.2013.02.064; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Dyer J, 2002, AM J PHYSIOL-GASTR L, V282, pG241; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cb.02.110186.001351; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Fujimoto S, 2011, BIOCHEM BIOPH RES CO, V404, P223, DOI 10.1016/j.bbrc.2010.11.097; Honma K, 2007, BIOCHEM BIOPH RES CO, V357, P1124, DOI 10.1016/j.bbrc.2007.04.070; Inoue S, 2011, J NUTR SCI VITAMINOL, V57, P162, DOI 10.3177/jnsv.57.162; Kishi K, 1999, J NUTR, V129, P953; Miller RS, 2008, J NUTR, V138, P1033; Musri MM, 2006, J BIOL CHEM, V281, P17180, DOI 10.1074/jbc.M601295200; Nichols BL, 2009, J NUTR, V139, P684, DOI 10.3945/jn.108.098434; Quezada-Calvillo R, 2007, J NUTR, V137, P1725; SEMENZA G, 1985, ANN NY ACAD SCI, V456, P83, DOI 10.1111/j.1749-6632.1985.tb14848.x; Shimada M, 2009, J AGR FOOD CHEM, V57, P8049, DOI 10.1021/jf900594z; Shimada M, 2013, J NUTR BIOCHEM, V24, P606, DOI 10.1016/j.jnutbio.2012.03.006; Tanaka T, 1998, BIOCHEM J, V331, P225; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; Van de Laar FA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003639.pub2; Wang H, 1996, J NUTR, V126, P1455; YASUTAKE H, 1995, BBA-GEN SUBJECTS, V1243, P270, DOI 10.1016/0304-4165(94)00143-L	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	FEB	2015	31	2					366	372		10.1016/j.nut.2014.07.017		7	Nutrition & Dietetics	Nutrition & Dietetics	CA0WD	WOS:000348633400015		
J	Tokuda, Y; Miura, N; Kobayashi, M; Hoshinaga, Y; Murai, A; Aoyama, H; Ito, H; Morita, T; Horio, F				Tokuda, Yuki; Miura, Natsuko; Kobayashi, Misato; Hoshinaga, Yukiko; Murai, Atsushi; Aoyama, Hiroaki; Ito, Hiroyuki; Morita, Tatsuya; Horio, Fumihiko			Ascorbic acid deficiency increases endotoxin influx to portal blood and liver inflammatory gene expressions in ODS rats	NUTRITION			English	Article						Ascorbic acid; Ascorbic acid deficiency; Endotoxin; Hepatic inflammation; Inflammatory cytokines; Acute-phase proteins; ODS rat	HIGH-FAT DIET; METABOLIC ENDOTOXEMIA; GUT MICROBIOTA; PROTEIN; INTERLEUKIN-18; BILIRUBIN; OBESITY; INJURY	Objective: The aim of this study was to determine whether ascorbic acid (AsA) deficiency-induced endotoxin influx into portal blood from the gastrointestinal tract contributes to the inflammatory changes in the liver. Method: The mechanisms by which AsA deficiency provokes inflammatory changes in the liver were investigated in Osteogenic Disorder Shionogi (ODS) rats (which are unable to synthesize AsA). Male ODS rats (6-wk-old) were fed a diet containing sufficient (300 mg/kg) AsA (control group) or a diet without AsA (AsA-deficient group) for 14 or 18 d. Results: On day 14, the hepatic mRNA levels of acute-phase proteins and inflammation-related genes were significantly higher in the AsA-deficient group than the control group, and these elevations by AsA deficiency were exacerbated on day 18. The serum concentrations of interleukin (IL)-1 beta and IL-6, which induce acute-phase proteins in the liver, were also significantly elevated on day 14 in the AsA-deficient group compared with the respective values in the control group. IL-1 beta mRNA levels in the liver, spleen, and lung were increased by AsA deficiency. Moreover, on both days 14 and 18, the portal blood endotoxin concentration was significantly higher in the AsA-deficient group than in the control group, and a significant correlation between serum IL-1 beta concentrations and portal endotoxin concentrations was found in AsA-deficient rats. In the histologic analysis of the ileum tissues, the number of goblet cells per villi was increased by AsA deficiency. Conclusion: These results suggest that AsA deficiency-induced endotoxin influx into portal blood from the gastrointestinal tract contributes to the inflammatory changes in the liver. (C) 2015 Elsevier Inc. All rights reserved.	[Tokuda, Yuki; Miura, Natsuko; Kobayashi, Misato; Hoshinaga, Yukiko; Murai, Atsushi; Horio, Fumihiko] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; [Aoyama, Hiroaki] Inst Environm Toxicol, Div Toxicol, Ibaraki, Japan; [Ito, Hiroyuki; Morita, Tatsuya] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan	Horio, F (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan.	horiof@agr.nagoya-u.ac.jp			KAKENHI [22658042]	This work was supported by KAKENHI (No. 22658042) to FH. FH YT, and NM participated in the conception and design of the study. YT, NM, MK, YH, HI, and FH conducted the research. YT, NM, MK, AM, HA, TM, and FH analyzed and interpreted the data. YT, AM, MK, and FH wrote the paper. FH had primary responsibility for the final content. All authors read and approved the final version of the manuscript.	Roe JH, 1943, J BIOL CHEM, V147, P399; Erridge C, 2007, AM J CLIN NUTR, V86, P1286; KAWAI T, 1992, J BIOL CHEM, V267, P21973; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Volin MV, 2011, J INTERF CYTOK RES, V31, P745, DOI 10.1089/jir.2011.0050; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Fukui H, 2011, J GASTROEN HEPATOL, V26, P423, DOI 10.1111/j.1440-1746.2011.06668.x; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; MIZUSHIMA Y, 1984, EXPERIENTIA, V40, P359, DOI 10.1007/BF01952551; Ito H, 2009, J NUTR, V139, P1640, DOI 10.3945/jn.109.110171; Amar J, 2008, AM J CLIN NUTR, V87, P1219; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Horio F, 2006, J NUTR SCI VITAMINOL, V52, P28, DOI 10.3177/jnsv.52.28; HORIO F, 1985, J NUTR, V115, P1630; Ikeda S, 1997, J NUTR, V127, P2173; Ikeda S, 1996, J NUTR, V126, P2505; Ikeda S, 1998, J NUTR, V128, P832; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	FEB	2015	31	2					373	379		10.1016/j.nut.2014.07.009		7	Nutrition & Dietetics	Nutrition & Dietetics	CA0WD	WOS:000348633400016		
J	Yoneme, H; Hatakeyama, J; Danjo, A; Oida, H; Yoshinari, M; Aijima, R; Murata, N; Watanabe, T; Oki, Y; Kido, MA				Yoneme, Hiroshi; Hatakeyama, Junko; Danjo, Atsushi; Oida, Hanako; Yoshinari, Masao; Aijima, Reona; Murata, Naohisa; Watanabe, Toshiyuki; Oki, Yuji; Kido, Mizuho A.			Milk basic protein supplementation enhances fracture healing in mice	NUTRITION			English	Article						Bone; Dairy proteins; Osteogenesis; Bone repair; mu CT; Bone strength	BONE-MINERAL DENSITY; HEALTHY ADULT WOMEN; MBP SUPPLEMENTATION; CONTROLLED-TRIAL; WHEY-PROTEIN; CYSTATIN-C; METABOLISM; RESORPTION; DIFFERENTIATION; IDENTIFICATION	Objectives: There is an unmet need for agents that can stimulate bone healing. The goal of this study was to evaluate the effects of basic proteins from milk whey (milk basic protein [MBP]) on fracture healing in mice. Methods: Closed tibial transverse fractures were generated in 6-wk-old male C3 H/HeJ mice given either tap water or MBP-supplemented water for 3, 7, 14, 28, and 56 d after fracture generation. The tibial tissues were analyzed by radiography, iCT, and a three-point bending test. The expression levels of genes associated with bone metabolism were analyzed by real-time reverse transcription-polymerase chain reaction. Results: Quantitative mu CT analysis showed that MBP-treated fractured tibiae had a larger hard callus in the sectional area and a larger volume compared with fractured tibiae without MBP treatment. The expression levels of genes associated with chondrogenesis and osteogenesis showed greater increases in fractured tibiae with MBP treatment. Significant increases in the callus mechanical properties were found in MBP-treated tibiae. Conclusions: MBP supplementation has the potential to improve fracture healing and bone strength in mouse tibiae. MBP could be a potential safe, low-cost, and easily administered nutritional element to prevent secondary fractures in patients with bone fractures. (C) 2015 Elsevier Inc. All rights reserved.	[Yoneme, Hiroshi; Hatakeyama, Junko; Danjo, Atsushi; Oida, Hanako; Aijima, Reona; Murata, Naohisa; Watanabe, Toshiyuki; Oki, Yuji; Kido, Mizuho A.] Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka 812, Japan; [Danjo, Atsushi; Aijima, Reona] Saga Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Saga 840, Japan; [Yoshinari, Masao] Tokyo Dent Coll, Oral Hlth Sci Ctr, Div Oral Implant Res, Chiba, Japan	Kido, MA (reprint author), Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Fukuoka 812, Japan.	kido@dent.kyushu-u.ac.jp			Fukuoka College of Medicine and Health; Milk Science Research Institute (Megmilk Snow Brand Co. Ltd.)	We appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University. H.Y. is supported by the Fukuoka College of Medicine and Health. This study was partly supported by the Milk Science Research Institute (Megmilk Snow Brand Co. Ltd.). The members of the Milk Science Research Institute had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cranney A, 2007, CAN MED ASSOC J, V177, P575, DOI 10.1503/cmaj.070234; Toba Y, 2000, BONE, V27, P403, DOI 10.1016/S8756-3282(00)00332-X; Aoe S, 2005, OSTEOPOROSIS INT, V16, P2123, DOI 10.1007/s00198-005-2012-3; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Takada Y, 1997, INT DAIRY J, V7, P821, DOI 10.1016/S0958-6946(97)00073-3; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Aoe S, 2001, BIOSCI BIOTECH BIOCH, V65, P913, DOI 10.1271/bbb.65.913; Goldhahn J, 2012, CALCIFIED TISSUE INT, V90, P343, DOI 10.1007/s00223-012-9587-4; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Danjo A, 2007, BIOCHEM BIOPH RES CO, V360, P199, DOI 10.1016/j.bbrc.2007.06.028; Fried A, 2012, NUTRITION, V28, P331, DOI 10.1016/j.nut.2011.07.022; Itabashi Akira, 2006, Clin Calcium, V16, P1632; Jobara K, 2014, NUTRITION, V20, P1195; Jørgensen Niklas R, 2011, Curr Osteoporos Rep, V9, P149, DOI 10.1007/s11914-011-0065-0; Lawton DM, 1997, J CLIN PATHOL-MOL PA, V50, P194; Matsuoka Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2531, DOI 10.1271/bbb.66.2531; Morita Y, 2011, J DAIRY SCI, V94, P2270, DOI 10.3168/jds.2010-4039; Morita Y, 2008, BONE, V42, P380, DOI 10.1016/j.bone.2007.10.012; Pereira PC, 2014, NUTRITION, V30, P619, DOI 10.1016/j.nut.2013.10.011; Ronga M, 2013, INJURY, V44, pS34, DOI 10.1016/S0020-1383(13)70008-1; Takada Y, 1997, J NUTR SCI VITAMINOL, V43, P199; Uenishi Kazuhiro, 2006, Clin Calcium, V16, P1606; Uenishi K, 2007, OSTEOPOROSIS INT, V18, P385, DOI 10.1007/s00198-006-0228-5; Yamamura J, 2002, BIOSCI BIOTECH BIOCH, V66, P702, DOI 10.1271/bbb.66.702	25	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	FEB	2015	31	2					399	405		10.1016/j.nut.2014.08.008		7	Nutrition & Dietetics	Nutrition & Dietetics	CA0WD	WOS:000348633400019		
J	Ide, K; Yamada, H; Umegaki, K; Mizuno, K; Kawakami, N; Hagiwara, Y; Matsumoto, M; Yoshida, H; Kim, K; Shiosaki, E; Yokochi, T; Harada, K				Ide, Kazuki; Yamada, Hiroshi; Umegaki, Keizo; Mizuno, Katsuki; Kawakami, Nobuko; Hagiwara, Yuka; Matsumoto, Mizuki; Yoshida, Hidefumi; Kim, Kang; Shiosaki, Emi; Yokochi, Tsunehiro; Harada, Kiyoshi			Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson's disease	NUTRITION			English	Article						Parkinson's disease; Clinical assessment; Biomarkers; Oxidative stress; Vitamin C	ASCORBIC-ACID; IN-VITRO; PLASMA; BRAIN; NEURONS; BLOOD	Objectives: Vitamin C is a major antioxidant and also is known as a neuromodulator in dopaminergic neurons. The aim of this study was to investigate the association between lymphocyte and plasma vitamin C levels in various stages of Parkinson's disease (PD). Methods: Sixty-two individuals with PD (age 71 +/- 8.8 y [mean +/- SD]) being treated at Shizuoka General Hospital from December 2007 to August 2013 were consecutively recruited. PD severity was classified using the Hoehn-Yahr scale for staging PD. Fasting blood samples were collected, and plasma and lymphocyte vitamin C levels were measured. The association between PD severity and vitamin C levels was estimated by ordinal logistic regression with confounding variables. Results: The distribution of Hoehn-Yahr stages in patients was as follows: stage I, 7; II, 28; III, 16; and IV, 11. Lymphocyte vitamin C levels in patients with severe PD were significantly lower (odds ratio [OR], 0.87; 95% confidence interval [Cl], 0.80-0.97; P < 0.01) compared with those at less severe stages. Plasma vitamin C levels also tended to be lower in patients with severe PD; however, this was not significant (OR, 0.98; 95% CI, 0.96-1.00; P = 0.09). Conclusions: Our findings suggest that lymphocyte vitamin C levels in the peripheral blood may be a potentially useful biomarker for the progression of PD. (C) 2015 Elsevier Inc. All rights reserved.	[Ide, Kazuki; Yamada, Hiroshi; Mizuno, Katsuki] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka 4228526, Japan; [Yamada, Hiroshi; Kawakami, Nobuko; Hagiwara, Yuka; Matsumoto, Mizuki; Yoshida, Hidefumi; Kim, Kang; Harada, Kiyoshi] Shizuoka Prefectural Gen Hosp, Dept Neurol, Shizuoka, Japan; [Umegaki, Keizo] Natl Inst Hlth & Nutr, Tokyo 162, Japan; [Shiosaki, Emi; Yokochi, Tsunehiro] Shizuoka Prefectural Gen Hosp, Dept Clin Lab Med, Shizuoka, Japan	Yamada, H (reprint author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Drug Evaluat & Informat, Shizuoka 4228526, Japan.	hyamada@u-shizuoka-ken.ac.jp	Ide, Kazuki/D-7289-2015	Ide, Kazuki/0000-0001-6377-1361	Japanese Ministry of Health, Labor, and Welfare [242 20 501]	H. Yamada received a grant from the Japanese Ministry of Health, Labor, and Welfare (No. 242 20 501). KU received a grant from the Japanese Ministry of Health, Labor, and Welfare (No. 242 20 501). H. Yamada, KI, KU, and KH conceived of and designed the study. KM, NK, YH, MM, H. Yoshida, KK, ES, TY, and KH acquired the data. KI, H. Yamada, KU, and KM analyzed and interpreted the data. KI, H. Yamada drafted the manuscript.	Sharma S, 2013, NEUROCHEM INT, V63, P201, DOI 10.1016/j.neuint.2013.06.005; Chen CM, 2009, NEUROBIOL DIS, V33, P429, DOI 10.1016/j.nbd.2008.11.011; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Bagga V, 2008, CELL TRANSPLANT, V17, P763, DOI 10.3727/096368908786516774; Halliday GM, 2010, ANN NY ACAD SCI, V1184, P188, DOI 10.1111/j.1749-6632.2009.05118.x; Yurekli VA, 2013, CELL MOL NEUROBIOL, V33, P205, DOI 10.1007/s10571-012-9886-3; Ballaz S, 2013, J NEUROSCI RES, V91, P1609, DOI 10.1002/jnr.23276; Bowman GL, 2009, J ALZHEIMERS DIS, V16, P93, DOI 10.3233/JAD-2009-0923; EVANS RM, 1982, BRIT J NUTR, V47, P473, DOI 10.1079/BJN19820059; GRUNEWALD RA, 1993, BRAIN RES REV, V18, P123, DOI 10.1016/0165-0173(93)90010-W; Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11; Kenae PC, 2011, PARKINSONS DIS; KING D, 1992, POSTGRAD MED J, V68, P634; Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.0.CO;2-I; Sato S, 2005, NEUROLOGY, V64, P1081; Shinde S, 2006, NEUROL INDIA, V54, P390; UMEGAKI K, 1994, J NUTR SCI VITAMINOL, V40, P73; WILSON CWM, 1975, ANN NY ACAD SCI, V258, P355, DOI 10.1111/j.1749-6632.1975.tb29295.x; Yamada H, 2004, DIABETES CARE, V27, P2491, DOI 10.2337/diacare.27.10.2491	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	FEB	2015	31	2					406	408		10.1016/j.nut.2014.08.001		3	Nutrition & Dietetics	Nutrition & Dietetics	CA0WD	WOS:000348633400020		
J	Nakao, J; Ohba, T; Takaishi, K; Katabuchi, H				Nakao, Junko; Ohba, Takashi; Takaishi, Kiyomi; Katabuchi, Hidetaka			Omega-3 fatty acids for the treatment of hypertriglyceridemia during the second trimester	NUTRITION			English	Article						Pregnancy; Hypertriacylglycerolemia; Pancreatitis; EPA; Second trimester	PREGNANCY; PANCREATITIS; ACID	Objective: Serum triacylglycerol (TG) levels increase during pregnancy. High serum TG levels may elicit acute pancreatitis; therefore, it is important that pregnant women are managed well to abrogate the rapid rise of TG levels in pregnancy. The aim of this study was to report on the effect of eicosapentaenoic acid administration on pregnant women with hypertriacylglycerolemia in the second trimester. Method: We report on four patients who presented to Kumamoto University Hospital from January 2005 to March 2013. Findings: All four patients delivered neonates at term without complicating acute pancreatitis. Additionally, in three cases of multipara, the maximum serum TG levels were decreased to 10% to 49% of their preceding pregnancy. Conclusion: Oral eicosapentaenoic acid administration might be a safe and useful treatment for hypertriacylglycerolemia during pregnancy and may prevent the development of acute pancreatitis. (C) 2015 Elsevier Inc. All rights reserved.	[Nakao, Junko; Ohba, Takashi; Takaishi, Kiyomi; Katabuchi, Hidetaka] Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Kumamoto, Japan	Nakao, J (reprint author), Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Kumamoto, Japan.	amethyst_j_0229@yahoo.co.jp					Papadakis EP, 2011, EUR J OBSTET GYN R B, V159, P261, DOI 10.1016/j.ejogrb.2011.07.037; Takaishi K, 2009, NUTRITION, V25, P1094, DOI 10.1016/j.nut.2009.04.009; Sivakumaran P, 2009, J CLIN APHERESIS, V24, P42, DOI 10.1002/jca.20192; Eddy JJ, 2008, OBSTET GYNECOL, V112, P1075, DOI 10.1097/AOG.0b013e318185a032; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Briggs GG, 2011, FENOFIBRATE DRUGS PR; Crisan LS, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.003; DYERBERG J, 1978, LANCET, V2, P117; FAHRAEUS L, 1985, OBSTET GYNECOL, V66, P468; Ido Yumi, 2012, Nihon Shokakibyo Gakkai Zasshi, V109, P1236; KAPLAN NM, 1989, ARCH INTERN MED, V149, P1514, DOI 10.1001/archinte.149.7.1514; Lloret L.C., 2008, PANCREAS, V37, P13; Sato S, 2013, J OBSTET GYNAECOL RE, V39, P1541, DOI 10.1111/jog.12095	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	FEB	2015	31	2					409	412		10.1016/j.nut.2014.09.006		4	Nutrition & Dietetics	Nutrition & Dietetics	CA0WD	WOS:000348633400021		
J	Mita, T; Furuhashi, M; Hiramitsu, S; Ishii, J; Hoshina, K; Ishimura, S; Fuseya, T; Watanabe, Y; Tanaka, M; Ohno, K; Akasaka, H; Ohnishi, H; Yoshida, H; Saitoh, S; Shimamoto, K; Miura, T				Mita, Tomohiro; Furuhashi, Masato; Hiramitsu, Shinya; Ishii, Junnichi; Hoshina, Kyoko; Ishimura, Shutaro; Fuseya, Takahiro; Watanabe, Yuki; Tanaka, Marenao; Ohno, Kohei; Akasaka, Hiroshi; Ohnishi, Hirofumi; Yoshida, Hideaki; Saitoh, Shigeyuki; Shimamoto, Kazuaki; Miura, Tetsuji			FABP4 is Secreted from Adipocytes by Adenyl Cyclase-PKA- and Guanylyl Cyclase-PKG-Dependent Lipolytic Mechanisms	OBESITY			English	Article							ACID-BINDING PROTEIN; METABOLIC SYNDROME; APOLIPOPROTEIN-E; AP2; MICE; ATHEROSCLEROSIS; OBESITY; DEFICIENT; ELEVATION; BIOMARKER	ObjectiveFatty acid-binding protein 4 (FABP4) is expressed in adipocytes, and elevated plasma FABP4 level is associated with obesity-mediated metabolic phenotype. Postprandial regulation and secretory signaling of FABP4 has been investigated. MethodsTime courses of FABP4 levels were examined during an oral glucose tolerance test (OGTT; n=53) or a high-fat test meal eating (n=35). Effects of activators and inhibitors of adenyl cyclase (AC)-protein kinase A (PKA) signaling and guanylyl cyclase (GC)-protein kinase G (PKG) signaling on FABP4 secretion from mouse 3T3-L1 adipocytes were investigated. ResultsFABP4 level significantly declined after the OGTT or a high-fat meal eating, while insulin level was increased. Treatment with low and high glucose concentration or palmitate for 2 h did not affect FABP4 secretion from 3T3-L1 adipocytes. FABP4 secretion was increased by stimulation of lipolysis using isoproterenol, a (3)-adrenoceptor agonist (CL316243), forskolin, dibutyryl-cAMP and atrial natriuretic peptide, and the induced FABP4 secretion was suppressed by insulin or an inhibitor of PKA (H-89), PKG (KT5823) or hormone sensitive lipase (CAY10499). ConclusionsFABP4 is secreted from adipocytes in association with lipolysis regulated by AC-PKA- and GC-PKG-mediated signal pathways. Plasma FABP4 level declines postprandially, and suppression of FABP4 secretion by insulin-induced anti-lipolytic signaling may be involved in this decline in FABP4 level.	[Mita, Tomohiro; Furuhashi, Masato; Hoshina, Kyoko; Ishimura, Shutaro; Fuseya, Takahiro; Watanabe, Yuki; Tanaka, Marenao; Ohno, Kohei; Akasaka, Hiroshi; Ohnishi, Hirofumi; Yoshida, Hideaki; Saitoh, Shigeyuki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Hiramitsu, Shinya] Hiramitsu Heart Clin, Nagoya, Aichi, Japan; [Ishii, Junnichi] Fujita Hlth Univ, Sch Med, Dept Joint Res Lab Clin Med, Toyoake, Aichi 47011, Japan; [Ohnishi, Hirofumi] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Saitoh, Shigeyuki] Sapporo Med Univ, Sch Hlth Sci, Dept Nursing, Div Med & Behav Subjects, Sapporo, Hokkaido, Japan; [Shimamoto, Kazuaki] Sapporo Med Univ, Sapporo, Hokkaido, Japan	Furuhashi, M (reprint author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan.	furuhasi@sapmed.ac.jp			JSPS KAKENHI; Uehara Memorial Foundation; SENSHIN Medical Research Foundation; Japan Diabetes Foundation; Takeda Medical Research Foundation; Ono Medical Research Foundation; Takeda Science Foundation; Akiyama Life Science Foundation; Yamaguchi Endocrine Research Foundation	M.F. has been supported by grants from JSPS KAKENHI, Uehara Memorial Foundation, SENSHIN Medical Research Foundation, Japan Diabetes Foundation, Takeda Medical Research Foundation, Ono Medical Research Foundation, Takeda Science Foundation, Akiyama Life Science Foundation, and Yamaguchi Endocrine Research Foundation.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hiramitsu S, 2012, J CARDIOL, V60, P395, DOI 10.1016/j.jjcc.2012.07.010; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Coe NR, 1999, J LIPID RES, V40, P967; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Karpisek M, 2007, EUR J CLIN INVEST, V37, P637, DOI 10.1111/j.1365-2362.2007.001835.x; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Miyoshi T, 2011, HEART VESSELS, V26, P408, DOI 10.1007/s00380-010-0060-x; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Furuhashi M., 2011, INT J INFLAM, V2011, DOI DOI 10.4061/2011/642612; Furuhashi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027356; Fuseya T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0126-7; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Kralisch S, 2014, INT J OBESITY, V38, P1251, DOI 10.1038/ijo.2013.232; Moro C, 2013, AM J PHYSIOL-HEART C, V304, pH358, DOI 10.1152/ajpheart.00704.2012; Scheja L, 1999, DIABETES, V48, P1987, DOI 10.2337/diabetes.48.10.1987; Schlottmann I, 2014, INT J OBESITY, V38, P1221, DOI 10.1038/ijo.2013.241; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Stich V, 2004, P NUTR SOC, V63, P369, DOI 10.1079/PNS2004350; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; vonsEynatten M, 2012, ARTERIOSCLER THROMB, V32, P2327	30	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	FEB	2015	23	2					359	367		10.1002/oby.20954		9	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CA6QN	WOS:000349040400018		
J	Hasegawa, A; Igarashi, H; Ohta, T; Kurachi, H; Takahashi, K				Hasegawa, Ayumi; Igarashi, Hideki; Ohta, Tsuyoshi; Kurachi, Hirohisa; Takahashi, Kazuhiro			Three-Dimensional Computed Tomography of Pelvic Masses in Mayer-Rokitansky-Kuster-Hauser Syndrome	OBSTETRICS AND GYNECOLOGY			English	Article							MULLERIAN REMNANT; LEIOMYOMA UTERI; WOMAN; WOMEN	BACKGROUND: Mayer-Rokitansky-Kuster-Hauser syndrome is a rare congenital anomaly characterized by congenital aplasia or hypoplasia of the uterus and vagina. We report a case of Mayer-Rokitansky-Kuster-Hauser syndrome with multiple large pelvic masses diagnosed by three-dimensional computed tomography (CT) angiography. CASE: A 40-year-old woman with Mayer-Rokitansky-Kuster-Hauser syndrome presented with an abdominal mass that had grown for 3 months. Magnetic resonance imaging (MRI) confirmed several solid masses, and normal bilateral ovaries were detected; three-dimensional CT revealed that these tumors were supplied from the right ovarian and uterine arteries, suggesting that they arose from the uterus. Accordingly, leiomyoma was suspected. Laparoscopic surgery was contraindicated, and the patient therefore underwent laparotomy. The masses were resected with the bilateral rudimentary uteri and fallopian tubes, and pathologic evaluation confirmed leiomyoma. CONCLUSIONS: Combined MRI and three-dimensional CT angiography can accurately evaluate the origin and anatomic properties of leiomyomas in patients with Mayer-Rokitansky-Kuster-Hauser syndrome.	[Igarashi, Hideki] Yamagata Univ, Fac Med, Dept Obstet & Gynecol, Yamagata 9909585, Japan; Osaka Med Ctr, Osaka, Japan; Res Inst Maternal & Child Hlth, Osaka, Japan	Igarashi, H (reprint author), Yamagata Univ, Fac Med, Dept Obstet & Gynecol, Iida Nishi 2-2-2, Yamagata 9909585, Japan.	igarashi@med.id.yamagata-u.ac.jp					Razavi MK, 2002, RADIOLOGY, V224, P707, DOI 10.1148/radiol.2243011513; Beecham CT, 1977, AM J OBSTET GYNECOL, V29, P346; Dandu S., 2000, Journal of Obstetrics and Gynaecology (Abingdon), V20, P98; Deka D, 2011, EUR J OBSTET GYN R B, V154, P115, DOI 10.1016/j.ejogrb.2010.07.042; Deligeoroglou E, 2004, FERTIL STERIL, V81, P1385, DOI 10.1016/j.fertmstert.2003.09.067; Edmonds D Keith, 2003, J Pediatr Adolesc Gynecol, V16, P65, DOI 10.1016/S1083-3188(03)00013-5; FARBER M, 1978, OBSTET GYNECOL, V51, pS70; Fletcher HM, 2012, OBSTET GYNECOL, V119, P483, DOI 10.1097/AOG.0b013e318242a9b5; Forsnes EV, 1999, OBSTET GYNECOL, V94, P862, DOI 10.1016/S0029-7844(99)00290-2; Fukuda J, 2010, J OBSTET GYNECOL RES, V36, P91; Galajdova L, 2003, J OBSTET GYNAECOL, V23, P228; Ito Yoshihiro, 2006, Archives of Gynecology and Obstetrics, V274, P252, DOI 10.1007/s00404-006-0156-9; Jadoul P, 2004, FERTIL STERIL, V81, P203, DOI 10.1016/j.fertnstert.2003.07.007; Kundu K, 2014, FERTIL STERIL, V102, P607, DOI 10.1016/j.fertnstert.2014.04.034; Lamarca M, 2009, FERTIL STERIL, V91, pe13; Lanowska M, 2009, FERTIL STERIL, V91, pe17; METZGER DA, 1988, J REPROD MED, V33, P246; Papa G, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2008.04.061; Pati Shyamapada, 2009, J Indian Med Assoc, V107, P460; POWELL B, 1988, J REPROD MED, V33, P493; Purwar M B, 1983, Asia Oceania J Obstet Gynaecol, V9, P55; Rawat Kishan S, 2013, J Radiol Case Rep, V7, P39, DOI 10.3941/jrcr.v7i3.1267; Rhee CS, 1999, ABDOM IMAGING, V24, P202, DOI 10.1007/s002619900478; Sato K, 2014, AM J OBSTET GYNECOL, V210; Tsin DA, 2000, J AM ASSOC GYN LAP, V7, P411, DOI 10.1016/S1074-3804(05)60488-4	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7844			OBSTET GYNECOL	Obstet. Gynecol.	FEB	2015	125	2					393	396		10.1097/AOG.0000000000000646		4	Obstetrics & Gynecology	Obstetrics & Gynecology	CA0GR	WOS:000348595500018		
J	Matsuo, K; Opper, NR; Ciccone, MA; Garcia, J; Tierney, KE; Baba, T; Muderspach, LI; Roman, LD				Matsuo, Koji; Opper, Neisha R.; Ciccone, Marcia A.; Garcia, Jocelyn; Tierney, Katherine E.; Baba, Tsukasa; Muderspach, Laila I.; Roman, Lynda D.			Time Interval Between Endometrial Biopsy and Surgical Staging for Type I Endometrial Cancer Association Between Tumor Characteristics and Survival Outcome	OBSTETRICS AND GYNECOLOGY			English	Article							TREATMENT DELAY; CARCINOMA; DIAGNOSIS; WOMEN	OBJECTIVE: To examine whether wait time between endometrial biopsy and surgical staging correlates with tumor characteristics and affects survival outcomes in patients with type I endometrial cancer. METHODS: A retrospective study was conducted to examine patients with grade 1 and 2 endometrioid adenocarcinoma diagnosed by preoperative endometrial biopsy who subsequently underwent hysterectomy-based surgical staging between 2000 and 2013. Patients who received neoadjuvant chemotherapy or hormonal treatment were excluded. Time interval and grade change between endometrial biopsy and hysterectomy were correlated to demographics and survival outcomes. RESULTS: Median wait time was 57 days (range 1-177 days) among 435 patients. Upgrading of the tumor to grade 3 in the hysterectomy specimen was seen in 4.7% of 321 tumors classified as grade 1 and 18.4% of 114 tumors classified as grade 2 on the endometrial biopsy, respectively. Wait time was not associated with grade change (P>.05). Controlling for age, ethnicity, body habitus, medical comorbidities, CA 125 level, and stage, multivariable analysis revealed that wait time was not associated with survival outcomes (5-year overall survival rates, wait time 1-14, 15-42, 43-84, and 85 days or more; 62.5%, 93.6%, 95.2%, and 100%, respectively, P>.05); however, grade 1 to 3 on the hysterectomy specimen remained as an independent prognosticator associated with decreased survival (5-year overall survival rates, grade 1 to 3 compared with grade change 1 to 1, 82.1% compared with 98.5%, P=.01). Among grade 1 preoperative biopsies, grade 1 to 3 was significantly associated with nonobesity (P=.039) and advanced stage (P=.019). CONCLUSION: Wait time for surgical staging was not associated with decreased survival outcome in patients with type I endometrial cancer.	[Matsuo, Koji] Univ So Calif, Dept Obstet & Gynecol, Div Gynecol Oncol, Los Angeles Cty Med Ctr, Los Angeles, CA 90033 USA; Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto, Japan	Matsuo, K (reprint author), Univ So Calif, Dept Obstet & Gynecol, Div Gynecol Oncol, Los Angeles Cty Med Ctr, 2020 Zonal Ave,IRD520, Los Angeles, CA 90033 USA.	koji.matsuo@gmail.com					Matsuo K, 2013, GYNECOL ONCOL, V128, P544, DOI 10.1016/j.ygyno.2012.12.014; Nagle CM, 2011, J CLIN ONCOL, V29, P2253, DOI 10.1200/JCO.2010.32.2164; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; Voss MA, 2012, GYNECOL ONCOL, V124, P15, DOI 10.1016/j.ygyno.2011.07.030; Helpman L, 2014, BRIT J CANCER, V110, P609, DOI 10.1038/bjc.2013.766; Ward KK, 2012, GYNECOL ONCOL, V126, P176, DOI 10.1016/j.ygyno.2012.04.013; Wright JD, 2012, LANCET, V379, P1352, DOI 10.1016/S0140-6736(12)60442-5; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Elit LM, 2014, J CLIN ONCOL, V32, P27, DOI 10.1200/JCO.2013.51.3671; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Levy T, 2006, AM J OBSTET GYNECOL, V195, P454, DOI 10.1016/j.ajog.2006.01.092; Matsuo K, 2014, EUR J OBSTET GYN R B, V179, P216, DOI 10.1016/j.ejogrb.2014.04.017; MENCZER J, 1995, AM J OBSTET GYNECOL, V173, P774, DOI 10.1016/0002-9378(95)90340-2; Menczer J, 2014, J CLIN ONCOL, V32, P2113, DOI 10.1200/JCO.2014.55.6746; Pirog EC, 1997, GYNECOL ONCOL, V67, P303, DOI 10.1006/gyno.1997.4874; Rose PG, 1996, NEW ENGL J MED, V335, P640, DOI 10.1056/NEJM199608293350907; Santin Alessandro D, 2004, Expert Rev Anticancer Ther, V4, P679, DOI 10.1586/14737140.4.4.679; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208	18	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7844			OBSTET GYNECOL	Obstet. Gynecol.	FEB	2015	125	2					424	433		10.1097/AOG.0000000000000636		10	Obstetrics & Gynecology	Obstetrics & Gynecology	CA0GR	WOS:000348595500022		
J	Mori, AS; Ota, AT; Fujii, S; Seino, T; Kabeya, D; Okamoto, T; Ito, MT; Kaneko, N; Hasegawa, M				Mori, Akira S.; Ota, Aino T.; Fujii, Saori; Seino, Tatsuyuki; Kabeya, Daisuke; Okamoto, Toru; Ito, Masamichi T.; Kaneko, Nobuhiro; Hasegawa, Motohiro			Biotic homogenization and differentiation of soil faunal communities in the production forest landscape: taxonomic and functional perspectives	OECOLOGIA			English	Article						Forest restoration; Null model; Oribatid mites; Soil arthropods; Soil mesofauna	ORIBATID MITES; BETA-DIVERSITY; ENVIRONMENTAL-CHANGE; PHYLOGENETIC STRUCTURE; RETENTION FORESTRY; ECOSYSTEM SERVICES; ASSEMBLY PROCESSES; LAND-USE; BIODIVERSITY; SIMILARITY	Biotic homogenization has been reported worldwide. Although simplification of communities across space is often significant at larger scales, it could also occur at the local scale by changing biotic interactions. This study aimed to elucidate local community processes driving biotic homogenization of soil faunal communities, and the possibility of biotic re-differentiation. We recorded species of oribatid mites in litter and soil layers along a gradient of forest conversion from monoculture larch plantation to primary forests in central Japan. We collected data for functional traits of the recorded species to quantify functional diversity. Then we quantified their taxonomic/functional turnover. Litter diversity was reduced in the larch-dominated stands, leading to habitat homogenization. Consequently, litter communities were biologically homogenized and differentiated in the plantations and in the natural forest, respectively. Turnover of functional traits for litter communities was lower and higher than expected by chance in the plantations and in the natural stand, respectively. This result suggests that the dominant assembly process shifts from limiting similarity to habitat filtering along the forest restoration gradient. However, support for such niche-based explanations was not observed for communities in the soil layer. In the monocultures, functional diversity expected from a given regional species pool significantly decreased for litter communities but not for those in the soil layer. Such discrepancy between communities in different layers suggests that communities more exposed to anthropogenic stresses are more vulnerable to the loss of their functional roles. Our study explains possible community processes behind the observed patterns of biological organization, which can be potentially useful in guiding approaches for restoring biodiversity.	[Mori, Akira S.; Ota, Aino T.; Fujii, Saori; Ito, Masamichi T.; Kaneko, Nobuhiro] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Seino, Tatsuyuki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Kabeya, Daisuke; Okamoto, Toru; Hasegawa, Motohiro] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Mori, AS (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, 79-7 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	akira.s.mori@gmail.com	Mori, Akira/A-6570-2013	Mori, Akira/0000-0002-8422-1198	Ministry of Education, Culture, Sports, Science and Technology in Japan; Asahi Glass Foundation	The authors thank the staff of the Insect Ecology Laboratory and the Kiso Experimental Station at the Forestry and Forest Products Research Institute, and those at the Soil Ecology Laboratory of Yokohama National University, for their help and guidance in the research. Budgetary support was provided by a Grant-in-aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology in Japan (to M. H.) and from the Asahi Glass Foundation (to A. S. M.). We appreciate L. Ruess and the two reviewers for their constructive comments.	Anderson M.J., 2010, ECOL LETT, V14, P19, DOI DOI 10.1111/J.1461-0248.2010.01552.X; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Mori AS, 2013, GLOBAL ECOL BIOGEOGR, V22, P878, DOI 10.1111/geb.12058; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Thompson ID, 2011, BIOSCIENCE, V61, P972, DOI 10.1525/bio.2011.61.12.7; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Heino J, 2013, OECOLOGIA, V171, P971, DOI 10.1007/s00442-012-2451-4; Kaneko N, 1999, ECOL RES, V14, P131, DOI 10.1046/j.1440-1703.1999.00292.x; Yamamoto N, 2007, P NATL ACAD SCI USA, V104, P10524, DOI 10.1073/pnas.0701583104; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Gosselin F, 2012, J ECOL, V100, P1289, DOI 10.1111/1365-2745.12002; Caruso T, 2012, J ANIM ECOL, V81, P214, DOI 10.1111/j.1365-2656.2011.01886.x; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Norkko A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02646; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P659, DOI 10.1111/geb.12020; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Lindo Z, 2012, GLOBAL CHANGE BIOL, V18, P2448, DOI 10.1111/j.1365-2486.2012.02725.x; Vellend M, 2007, J ECOL, V95, P565, DOI 10.1111/j.1365-2745.2007.01233.x; Luck GW, 2011, J BIOGEOGR, V38, P894, DOI 10.1111/j.1365-2699.2010.02449.x; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; Ingimarsdottir M, 2012, OECOLOGIA, V170, P745, DOI 10.1007/s00442-012-2334-8; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; TAKEDA H, 1987, RES POPUL ECOL, V29, P291, DOI 10.1007/BF02538892; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Purschke O, 2013, J ECOL, V101, P857, DOI 10.1111/1365-2745.12098; Mori AS, 2014, BIOL CONSERV, V175, P65, DOI 10.1016/j.biocon.2014.04.016; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Smart SM, 2006, P R SOC B, V273, P2659, DOI 10.1098/rspb.2006.3630; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Lindo Z, 2009, OECOLOGIA, V160, P817, DOI 10.1007/s00442-009-1348-3; LUXTON M, 1972, PEDOBIOLOGIA, V12, P434; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Gustafsson L, 2012, BIOSCIENCE, V62, P633, DOI 10.1525/bio.2012.62.7.6; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Zaitsev AS, 2014, APPL SOIL ECOL, V76, P60, DOI 10.1016/j.apsoil.2013.12.009; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; TUKEY JW, 1958, ANN MATH STAT, V29, P614; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Watkins AJ, 2003, OIKOS, V102, P525, DOI 10.1034/j.1600-0706.2003.11630.x; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Staelens J, 2011, ANN FOREST SCI, V68, P89, DOI 10.1007/s13595-011-0010-5; Aoki J., 1983, Bulletin of the Institute of Environmental Science and Technology Yokohama National University, V10, P171; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; CPF, 2012, SFM MULT FUNC FOR SU; Donoso DA, 2010, OECOLOGIA, V164, P201, DOI 10.1007/s00442-010-1607-3; Fujii S, 2012, SOIL BIOL BIOCHEM, V54, P77, DOI 10.1016/j.soilbio.2012.04.021; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Gutierrez-Canovas C, 2013, GLOBAL ECOL BIOGEOGR, V22, P796, DOI 10.1111/geb.12060; Hansen RA, 2000, ECOLOGY, V81, P1120; Hasegawa M, 2013, APPL SOIL ECOL; KANEKO N, 1988, REV ECOL BIOL SOL, V25, P353; Knoke T, 2007, EUROPEAN J FOREST RE, V127, P89, DOI DOI 10.1007/S10342-007-0186-2; Lindenmayer D.B., 2002, CONSERVING FOREST BI; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maraun M, 2007, ECOGRAPHY, V30, P209, DOI 10.1111/j.2007.0906-7590.04994.x; Pool TK, 2012, DIVERS DISTRIB, V18, P366, DOI 10.1111/j.1472-4642.2011.00836.x; Quinn GP, 2002, EXPT DESIGN DATA ANA, P537; SIEPEL H, 1993, SOIL BIOL BIOCHEM, V25, P1491, DOI 10.1016/0038-0717(93)90004-U; Simova I, 2011, GLOBAL ECOL BIOGEOGR, V20, P842, DOI 10.1111/j.1466-8238.2011.00650.x; Trentanovi G, 2013, DIVERS DISTRIB, V19, P738, DOI 10.1111/ddi.12028; Wall DH, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P1; Wallwork J. A., 1976, DISTRIBUTION DIVERSI	77	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0029-8549	1432-1939		OECOLOGIA	Oecologia	FEB	2015	177	2					533	544		10.1007/s00442-014-3111-7		12	Ecology	Environmental Sciences & Ecology	CA5XK	WOS:000348981500021		
J	Kato, S; Kurimura, S; Lim, HH; Mio, N				Kato, Susumu; Kurimura, Sunao; Lim, Hwan Hong; Mio, Norikatsu			Induced heating by nonlinear absorption in LiNbO3-type crystals under continuous-wave laser irradiation	OPTICAL MATERIALS			English	Article						Catastrophic breakdown; LiNbO3-type crystal; Continuous-wave laser; Polaron; Accumulation effect	LITHIUM-NIOBATE CRYSTALS; PERIODICALLY POLED LINBO3; 2ND-HARMONIC GENERATION; SMALL POLARONS; ENERGY; TIME	We investigate light-induced heating by nonlinear absorption in LiNbO3-type crystals under continuous-wave (CW) laser irradiation. The heat source is one-photon absorption by long-lived excited states created by two-photon absorption. The accumulated effect of excited states, which act as light absorbers, is significant for a CW laser. Light-induced heating causes catastrophic CW laser breakdown in LiNbO3-type crystals in which the band-gap energy is less than twice the photon energy and in which long-lived excited states, like polarons, can exist. For LiNbO3, the threshold intensity for catastrophic breakdown is estimated to be in the order of MW/cm(2). (C) 2014 Elsevier B.V. All rights reserved.	[Kato, Susumu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Kurimura, Sunao; Lim, Hwan Hong] Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan; [Mio, Norikatsu] Univ Tokyo, Photon Sci Ctr, Bunkyo Ku, Tokyo 1138656, Japan	Kato, S (reprint author), Natl Inst Adv Ind Sci & Technol, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.				JSPS KAKENHI [22540512, 25610173]	The authors acknowledge useful discussions with Dr. S. Todoroki. This work was supported by JSPS KAKENHI (22540512, 25610173).	Ishizuki H, 2010, OPT EXPRESS, V18, P253, DOI 10.1364/OE.18.000253; Merschjann C, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/1/015906; Lim HH, 2011, OPT EXPRESS, V19, P22588, DOI 10.1364/OE.19.022588; JERMANN F, 1993, J OPT SOC AM B, V10, P2085, DOI 10.1364/JOSAB.10.002085; EMIN D, 1993, PHYS REV B, V48, P13691, DOI 10.1103/PhysRevB.48.13691; Louchev OA, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2056593; Schirmer OF, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/12/123201; Herth P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067404; Enomoto S, 2011, J APPL PHYS, V110, DOI 10.1063/1.3642959; Tovstonog SV, 2008, OPT EXPRESS, V16, P11294, DOI 10.1364/OE.16.011294; Beyer O, 2006, APPL PHYS B-LASERS O, V83, P527, DOI 10.1007/s00340-006-2227-9; Qiu Y, 2005, PHYS STATUS SOLIDI C, V2, P232, DOI 10.1002/pssc.200460153; Berben D, 2000, J APPL PHYS, V87, P1034, DOI 10.1063/1.371976; Conradi D, 2008, PHYS STATUS SOLIDI-R, V2, P284, DOI 10.1002/pssr.200802176; Emin D, 2013, POLARONS, P1; HAND DP, 1988, OPT LETT, V13, P767, DOI 10.1364/OL.13.000767; Herth P, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.125128; Kostritskii SM, 2012, J APPL PHYS, V111, DOI 10.1063/1.4716470; Kurimura S., 2013, ADV SOL STAT LAS C; Louchev OA, 2005, J APPL PHYS, V98, DOI 10.1063/1.2138786; Maxein D, 2008, APPL PHYS B-LASERS O, V92, P543, DOI 10.1007/s00340-008-3103-6; Merschjann C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.052302; Merschjann C, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085114; Nikogosyan D. N., 2005, NONLINEAR OPTICAL CR; Sasamoto S, 2009, J APPL PHYS, V105, DOI 10.1063/1.3095763; Todoroki S., 2012, SELECTED TOPICS OPTI, P551; Torbruegge S, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.125112; Tovstonog SV, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2450648	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	FEB	2015	40						10	13		10.1016/j.optmat.2014.11.029		4	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CA4RH	WOS:000348891700002		
J	Nomura, Y; Wang, YT; Yabushita, A; Luo, CW; Fuji, T				Nomura, Yutaka; Wang, Yu-Ting; Yabushita, Atsushi; Luo, Chih-Wei; Fuji, Takao			Controlling the carrier-envelope phase of single-cycle mid-infrared pulses with two-color filamentation	OPTICS LETTERS			English	Article							TERAHERTZ PULSES; LASER-PULSES; GENERATION; AIR; EMISSION; AMPLITUDES; FIELDS	Carrier-envelope phase (CEP) of single-cycle pulses generated through two-color filamentation has been investigated. We have observed a particular behavior of the phase: the phase of high-frequency components of the generated pulses changes continuously and linearly with the relative phase between the two-color input pulses, whereas the phase of the low-frequency components takes only two discrete values. The transition of the phase behavior has been clearly observed by using frequency-resolved optical gating capable of CEP determination. We have found out that such a phase behavior is a unique feature of single-cycle pulses generated with a passive CEP stabilization scheme. (C) 2015 Optical Society of America	[Nomura, Yutaka; Fuji, Takao] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Wang, Yu-Ting; Yabushita, Atsushi; Luo, Chih-Wei] Natl Chiao Tung Univ, Dept Electrophys, Hsinchu 300, Taiwan	Fuji, T (reprint author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	fuji@ims.ac.jp	Fuji, Takao/D-8627-2011; Nomura, Yutaka/C-9850-2011	Fuji, Takao/0000-0002-1428-0889; Nomura, Yutaka/0000-0003-2081-8240	MEXT/JSPS KAKENHI [24360030, 26600120]; SENTAN JST (Japan Science and Technology Agency); RIKEN-IMS joint programme on "Extreme Photonics"; Consortium for Photon Science and Technology	This work was supported by MEXT/JSPS KAKENHI (24360030, 26600120), SENTAN JST (Japan Science and Technology Agency), the RIKEN-IMS joint programme on "Extreme Photonics," and Consortium for Photon Science and Technology. Y. W. acknowledges the post-JENESYS program named EXODASS for expenses during his work in Japan.	Blanchard F, 2009, OPT EXPRESS, V17, P6044, DOI 10.1364/OE.17.006044; Manzoni C, 2010, OPT LETT, V35, P757, DOI 10.1364/OL.35.000757; Fuji T, 2004, OPT LETT, V29, P632, DOI 10.1364/OL.29.000632; Cook DJ, 2000, OPT LETT, V25, P1210, DOI 10.1364/OL.25.001210; Babushkin I, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123029; Bartel T, 2005, OPT LETT, V30, P2805, DOI 10.1364/OL.30.002805; Thomson MD, 2010, OPT EXPRESS, V18, P23173, DOI 10.1364/OE.18.023173; Dai JM, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3068501; Kim KY, 2007, OPT EXPRESS, V15, P4577, DOI 10.1364/OE.15.004577; Thomson MD, 2007, LASER PHOTONICS REV, V1, P349, DOI 10.1002/lpor.200710025; Fuji T, 2013, APPL SCI-BASEL, V3, P122, DOI 10.3390/app3010122; Nomura Y, 2012, OPT EXPRESS, V20, P24741, DOI 10.1364/OE.20.024741; Sell A, 2008, OPT LETT, V33, P2767, DOI 10.1364/OL.33.002767; Karpowicz N, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2828709; Cerullo G, 2011, LASER PHOTONICS REV, V5, P323, DOI 10.1002/lpor.201000013; Kress M, 2004, OPT LETT, V29, P1120, DOI 10.1364/OL.29.001120; Babushkin I, 2010, OPT EXPRESS, V18, P9658, DOI 10.1364/OE.18.009658; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Baltuska A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.133901; Li M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4759268; Nomura Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3820; Shirai H, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2319091; Xie X, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.075005	23	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	FEB 1	2015	40	3					423	426		10.1364/OL.40.000423		4	Optics	Optics	CA8IN	WOS:000349162000033		
J	Noguchi, Y; Kim, HJ; Ishino, R; Goushi, K; Adachi, C; Nakayama, Y; Ishii, H				Noguchi, Yutaka; Kim, Hyung-Jun; Ishino, Ryuta; Goushi, Kenichi; Adachi, Chihaya; Nakayama, Yasuo; Ishii, Hisao			Charge carrier dynamics and degradation phenomena in organic light-emitting diodes doped by a thermally activated delayed fluorescence emitter	ORGANIC ELECTRONICS			English	Article						Organic light-emitting diodes; TADF; Interface; Degradation; Charge accumulation; Orientation polarization	EFFICIENCY; DEVICE	We report on the charge carrier dynamics and their degradation phenomena in an organic light-emitting diode (OLED) doped by a thermally activated delayed fluorescence emitter; (4s, 6s)-2,4,5,6-tetra(9H-carbazol-9-yl) isophthalonitrile (4CzIPN). Displacement current measurement (DCM) data revealed the presence of negative interface charge originating from the spontaneous orientation polarization of the electron transport layer (ETL), 1,3,5-tris(1-phenyl-1H-benzimidazol-2-yl) benzene. The negative interface charge acts as a hole reservoir and thus confines the recombination zone near the emission layer (EML); 4,4'-bis(N-carbazolyl)-1,1'-biphenyl (CBP):4CzIPN (5 wt%)/ETL interface. By keeping the recombination zone far from the hole transport layer, 4,40-bis[N-(1-naphthyl)-N-phenylamino]- biphenyl (alpha-NPD), a better electroluminescence efficiency is expected because the Dexter energy transfer from the triplet state of 4CzIPN to that of alpha-NPD is suppressed. Moreover, we found an excellent linear relation between the accumulated hole amount and luminance losses owing to device aging. The results are consistent with hole traps originating at the degradation products of CBP as the main factor of device degradation. We suggest device architectures based on the charge carrier dynamics for better efficiency and lifetime. (C) 2014 Elsevier B.V. All rights reserved.	[Noguchi, Yutaka] Meiji Univ, Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan; [Kim, Hyung-Jun; Ishino, Ryuta; Nakayama, Yasuo; Ishii, Hisao] Chiba Univ, Grad Sch Adv Integrat Sci, Chiba 2638522, Japan; [Goushi, Kenichi; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res, Fukuoka 8190395, Japan; [Goushi, Kenichi; Adachi, Chihaya] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan; [Ishii, Hisao] Chiba Univ, Ctr Frontier Sci, Chiba 2638522, Japan	Noguchi, Y (reprint author), Meiji Univ, Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan.	noguchi@meiji.ac.jp; ishii130@faculty.chiba-u.jp	Ishii, Hisao/E-7955-2015		JSPS; Council for Science and Technology Policy; Global-COE Project of Chiba University (Advanced School for Organic Electronics); KAKENHI [21245042, 22750167, 25288114]	Yutaka Noguchi would like to thank Professor Wolfgang Brutting and the members of his group (Universitat Augsburg) for their helpful discussions and kind cooperation in the experiments. We would also like to thank Nippon Steel & Sumikin Chemical Co., Ltd. for providing alpha-NPD. This research was supported by JSPS through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)'' initiated by the Council for Science and Technology Policy, the Global-COE Project of Chiba University (Advanced School for Organic Electronics), and KAKENHI (Grant Nos. 21245042, 22750167, and 25288114).	Noguchi Y, 2012, J APPL PHYS, V111, DOI 10.1063/1.4724349; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; Adachi C, 2001, J APPL PHYS, V90, P5048, DOI 10.1063/1.1409582; Yokoyama D, 2009, ORG ELECTRON, V10, P127, DOI 10.1016/j.orgel.2008.10.010; Kondakov DY, 2003, J APPL PHYS, V93, P1108, DOI 10.1063/1.1531231; Adachi C, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.060101; Brutting W, 2013, PHYS STATUS SOLIDI A, V210, P44, DOI 10.1002/pssa.201228320; Brutting W, 2001, ORG ELECTRON, V2, P1, DOI 10.1016/S1566-1199(01)00009-X; Kroger M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.235321; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Murawski C, 2013, ADV MATER, V25, P6801, DOI 10.1002/adma.201301603; Kondakov DY, 2007, J APPL PHYS, V101, DOI 10.1063/1.2430922; Franky S., 2010, ADV MATER, V22, P3762; Ito E, 2002, J APPL PHYS, V92, P7306, DOI 10.1063/1.1518759; Jarikov VV, 2009, J APPL PHYS, V105, DOI 10.1063/1.3072622; Nakamitsu S., 2014, COMMUNICATION; Nakanotani H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02127; Nakayama Y, 2012, ORG ELECTRON, V13, P2850, DOI 10.1016/j.orgel.2012.08.033; Noguchi Y, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807797; Noguchi Y., 2012, PHYS ORGANIC SEMICON; Ozawa Y., 2014, COMMUNICATION; Shibata M., 2014, COMMUNICATION	22	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	FEB	2015	17						184	191		10.1016/j.orgel.2014.12.009		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AZ8XP	WOS:000348495400025		
J	Jeon, I; Kutsuzawa, D; Hashimoto, Y; Yanase, T; Nagahama, T; Shimada, T; Matsuo, Y				Jeon, Il; Kutsuzawa, Dai; Hashimoto, Yu; Yanase, Takashi; Nagahama, Taro; Shimada, Toshihiro; Matsuo, Yutaka			Multilayered MoS2 nanoflakes bound to carbon nanotubes as electron acceptors in bulk heterojunction inverted organic solar cells	ORGANIC ELECTRONICS			English	Article						Carbon nanotubes; Molybdenum disulfides; Chemical vapor deposition; Electron acceptors; Photovoltaics	HYDROGEN EVOLUTION REACTION; METAL DICHALCOGENIDES; MOLYBDENUM-DISULFIDE; CONJUGATED POLYMERS; MONOLAYER MOS2; LAYER MOS2; LARGE-AREA; TRANSISTORS; NANOPARTICLES; PERFORMANCE	We demonstrate the deposition of multilayered MoS2 on a low-cost metallic-semiconducting carbon nanotube via chemical vapor deposition, and the use of this material as electron acceptor species forming a bulk heterojunction with P3HT in inverted-type organic photovoltaics (OPVs). This is an uplifting discovery, in which MoS2 has been used as an electron acceptor in spite of its innate immiscibility with organic compounds. This is possible because we utilize carbon nanotube's nature to intercalate with P3HT through pi-pi interaction. The successful binding of MoS2 onto carbon nanotube bundles and its optoelectronic effect as a photovoltaic device has been lucidly analyzed through various techniques in this paper. The effect has been ultimately evidenced by a power conversion efficiency of 0.46%, which proves MoS2 with many advantages can also be used as a photoactive layer. (C) 2014 Elsevier B.V. All rights reserved.	[Jeon, Il; Matsuo, Yutaka] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Kutsuzawa, Dai; Hashimoto, Yu; Yanase, Takashi; Nagahama, Taro; Shimada, Toshihiro] Hokkaido Univ, Fac Engn, Div Mat Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Shimada, Toshihiro; Matsuo, Yutaka] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan	Shimada, T (reprint author), Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan.	shimadat@eng.hokudai.ac.jp; matsuo@chem.s.u-tokyo.ac.jp	Matsuo, Yutaka/C-9897-2011	Matsuo, Yutaka/0000-0001-9084-9670	CREST project	Authors would like to thank Prof. Tetsuya Hasegawa (The University of Tokyo) for fruitful discussions during the project. Also we would like to thank Mr. Takashi Endo and Dr. Youngmin Wang for the TEM measurement, and Mr. Keita Suzuki for the AES measurement. This work was supported by the CREST project.	Bahr JL, 2002, J MATER CHEM, V12, P1952, DOI 10.1039/b201013p; Takanezawa K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2972113; Ren SQ, 2011, NANO LETT, V11, P5316, DOI 10.1021/nl202796u; FIVAZ R, 1967, PHYS REV, V163, P743, DOI 10.1103/PhysRev.163.743; Peiro AM, 2006, J MATER CHEM, V16, P2088, DOI 10.1039/b602084d; Li YG, 2011, J AM CHEM SOC, V133, P7296, DOI 10.1021/ja201269b; SHIMADA T, 1994, JPN J APPL PHYS 1, V33, P2696, DOI 10.1143/JJAP.33.2696; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Liu KK, 2012, NANO LETT, V12, P1538, DOI 10.1021/nl2043612; Lee YH, 2012, ADV MATER, V24, P2320, DOI 10.1002/adma.201104798; Arnold MS, 2009, NANO LETT, V9, P3354, DOI 10.1021/nl901637u; Yoon Y, 2011, NANO LETT, V11, P3768, DOI 10.1021/nl2018178; Coakley KM, 2003, APPL PHYS LETT, V83, P3380, DOI 10.1063/1.1616197; Li TS, 2007, J PHYS CHEM C, V111, P16192, DOI 10.1021/jp075424v; Kyaw AKK, 2013, ADV MATER, V25, P2397, DOI 10.1002/adma.201300295; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Zhang YJ, 2012, NANO LETT, V12, P1136, DOI 10.1021/nl2021575; Li DJ, 2014, NANO LETT, V14, P1228, DOI 10.1021/nl404108a; Li H, 2012, SMALL, V8, P63, DOI 10.1002/smll.201101016; Perkins FK, 2013, NANO LETT, V13, P668, DOI 10.1021/nl3043079; Arkhipov VI, 2003, APPL PHYS LETT, V82, P3245, DOI 10.1063/1.1572965; He ZC, 2012, NAT PHOTONICS, V6, P591, DOI 10.1038/NPHOTON.2012.190; Qiu H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3696045; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/nmat3633, 10.1038/NMAT3633]; Gu X, 2013, ADV ENERGY MATER, V3, P1262, DOI 10.1002/aenm201300549; Hwang H, 2011, NANO LETT, V11, P4826, DOI 10.1021/nl202675f; ROXLO CB, 1987, J VAC SCI TECHNOL A, V5, P555, DOI 10.1116/1.574671; Olson DC, 2007, J PHYS CHEM C, V111, P16670, DOI 10.1021/jp0734225; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Brown PJ, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.064203; Fujimori T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3162; Najmaei S., 2010, APPL PHYS LETT, V100; Shanmugam M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3703602; Streetman B. G., 1995, SOLID STATE ELECT DE; Zhang X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3983	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	FEB	2015	17						275	280		10.1016/j.orgel.2014.12.025		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AZ8XP	WOS:000348495400036		
J	Sugiyama, T; Kim, YT; Oda, H				Sugiyama, T.; Kim, Y. T.; Oda, H.			Osteoporosis therapy: a novel insight from natural homeostatic system in the skeleton	OSTEOPOROSIS INTERNATIONAL			English	Review						Bone modeling; Cathepsin K inhibitor; Mechanical loading; Parathyroid hormone Sclerostin antibody	BONE-MINERAL DENSITY; POSTMENOPAUSAL OSTEOPOROSIS; SCLEROSTIN ANTIBODY; ADAPTIVE RESPONSE; RANDOMIZED-TRIAL; TERIPARATIDE; INCREASES; TURNOVER; WOMEN; MASS	The skeleton normally responds to mechanical environment to maintain the resulting elastic deformation (strain) of bone, while increased bone strength by an osteoporosis drug results in decreased bone strain. Thus, it can be hypothesized that the effect of osteoporosis therapy is limited by natural homeostatic system in the skeleton. This logic is consistent with the fact that there exists a powerful effect that returns bone mass to its pre-treatment level after the withdrawal of treatment with osteoporosis agents. The present hypothesis provides a new significant insight into the mechanisms by which osteoporosis drugs improve bone fragility. Here we briefly discuss the effects of teriparatide, romosozumab, and odanacatib on bones in animals and humans.	[Sugiyama, T.; Kim, Y. T.; Oda, H.] Saitama Med Univ, Dept Orthopaed Surg, Moroyama, Saitama 3500495, Japan	Sugiyama, T (reprint author), Saitama Med Univ, Dept Orthopaed Surg, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	tsugiym@saitama-med.ac.jp					Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P1871, DOI 10.1210/jc.2011-3060; Bone HG, 2011, J CLIN ENDOCR METAB, V96, P972, DOI [10.1210/jc.2010-1502, 10.1210/jc.2010]; Engelke K, 2015, J BONE MINER RES, V30, P30, DOI 10.1002/jbmr.2292; Tsai JN, 2013, LANCET, V382, P50, DOI 10.1016/S0140-6736(13)60856-9; Srinivasan S, 2012, AGEING RES REV, V11, P353, DOI 10.1016/j.arr.2011.12.007; Lindsay R, 2009, OSTEOPOROSIS INT, V20, P943, DOI 10.1007/s00198-008-0766-0; Eisman JA, 2011, J BONE MINER RES, V26, P242, DOI 10.1002/jbmr.212; Sugiyama T, 2011, BONE, V49, P133, DOI 10.1016/j.bone.2011.03.775; Brown JP, 2014, J BONE MINER RES, V29, P2051, DOI 10.1002/jbmr.2236; Cusick T, 2012, J BONE MINER RES, V27, P524, DOI 10.1002/jbmr.1477; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Pennypacker BL, 2014, J BONE MINER RES, V29, P1847, DOI 10.1002/jbmr.2211; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; Pierroz DD, 2010, J BIOL CHEM, V285, P28164, DOI 10.1074/jbc.M110.101964; Ma YFL, 2006, J BONE MINER RES, V21, P855, DOI 10.1359/JBMR.060314; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Morse A, 2014, J BONE MINER RES, V29, P2456, DOI 10.1002/jbmr.2278; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319; Ellman R, 2013, J BONE MINER RES, V28, P875, DOI 10.1002/jbmr.1814; Ominsky MS, 2014, J BONE MINER RES, V29, P1424, DOI 10.1002/jbmr.2152; Milovanovic P, 2013, ACS NANO, V7, P7542, DOI 10.1021/nn401360u; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Cosman F, 2011, J BONE MINER RES, V26, P503, DOI 10.1002/jbmr.238; Jamal SA, 2011, JAMA-J AM MED ASSOC, V305, P800, DOI 10.1001/jama.2011.176; Masarachia PJ, 2012, J BONE MINER RES, V27, P509, DOI 10.1002/jbmr.1475; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Boonen S, 2012, J BONE MINER RES, V27, P963, DOI 10.1002/jbmr.1570; Delgado-Calle J, 2014, CALCIFIED TISSUE INT, V94, P414, DOI 10.1007/s00223-013-9821-8; Fratzl-Zelman N, 2004, J CLIN ENDOCR METAB, V89, P1538, DOI 10.1210/jc.2003-031055; Gajic-Veljanoski O, 2014, J CLIN ENDOCR METAB, V99, P3070, DOI 10.1210/jc.2014-1162; Gardner JC, 2005, J CLIN ENDOCR METAB, V90, P6392, DOI 10.1210/jc.2005-1235; Luchavova M, 2011, EUR J ENDOCRINOL, V164, P643, DOI 10.1530/EJE-10-1108; Ma YL, 2014, BONE, V59, P139, DOI 10.1016/j.bone.2013.11.011; Matsumoto Toshio, 2014, Bonekey Rep, V3, P513, DOI 10.1038/bonekey.2014.8; Michalska D, 2012, OSTEOPOROSIS INT, V23, P2885, DOI 10.1007/s00198-012-1955-4; Poole KES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016190; Rizzoli R, 2014, MANAGEMENT OF OSTEOP, DOI [10.1007/ s00198- 014- 2755- 9, DOI 10.1007/S00198-014-2755-9]; Sakai S, 2015, J BONE MINER RES, V30, P128, DOI 10.1002/jbmr.2317; Schulte FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062172; Shanbhogue W, 2014, J BONE MINER RES, DOI [10.1002/jbmr.2310, DOI 10.1002/JBMR.2310]; Sugiyama T, 2013, ANN INTERN MED, V159, P856, DOI 10.7326/0003-4819-159-12-201312170-00014; Sugiyama T, 2013, LANCET, V382, P767, DOI 10.1016/S0140-6736(13)61829-2; Sugiyama T, 2014, OSTEOPOROSIS INT, V25, P2497, DOI 10.1007/s00198-014-2798-y; Sugiyama T, 2004, LANCET, V364, P28, DOI 10.1016/S0140-6736(04)16585-9; Sugiyama T, 2002, LANCET, V359, P1160, DOI 10.1016/S0140-6736(02)08147-3; Tsai JN, 2015, J BONE MINER RES, V30, P39, DOI 10.1002/jbmr.2315	50	1	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	FEB	2015	26	2					443	447		10.1007/s00198-014-2923-y		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CA6JM	WOS:000349018700003		
J	Bone, HG; Dempster, DW; Eisman, JA; Greenspan, SL; McClung, MR; Nakamura, T; Papapoulos, S; Shih, WJ; Rybak-Feiglin, A; Santora, AC; Verbruggen, N; Leung, AT; Lombardi, A				Bone, H. G.; Dempster, D. W.; Eisman, J. A.; Greenspan, S. L.; Mcclung, M. R.; Nakamura, T.; Papapoulos, S.; Shih, W. J.; Rybak-Feiglin, A.; Santora, A. C.; Verbruggen, N.; Leung, A. T.; Lombardi, A.			Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial	OSTEOPOROSIS INTERNATIONAL			English	Article						Cathepsin K; Fracture; Odanacatib; Osteoporosis; Postmenopausal	CATHEPSIN-K INHIBITOR; BONE-MINERAL DENSITY; TRABECULAR BONE; WOMEN; ALENDRONATE; RESORPTION; DENOSUMAB; HISTOMORPHOMETRY; PREVENTION; DISCOVERY	Odanacatib is a cathepsin K inhibitor investigated for the treatment of postmenopausal osteoporosis. Phase 2 data indicate that 50 mg once weekly inhibits bone resorption and increases bone mineral density, with only a transient decrease in bone formation. We describe the background, design and participant characteristics for the phase 3 registration trial. Odanacatib (ODN) is a selective cathepsin K inhibitor being evaluated for the treatment of osteoporosis. In a phase 2 trial, ODN 50 mg once weekly reduced bone resorption while preserving bone formation and progressively increased BMD over 5 years. We describe the phase III Long-Term ODN Fracture Trial (LOFT), an event-driven, randomized, blinded placebo-controlled trial, with preplanned interim analyses to permit early termination if significant fracture risk reduction was demonstrated. An extension was planned, with participants remaining on their randomized treatment for up to 5 years, then transitioning to open-label ODN. The three primary outcomes were radiologically determined vertebral, hip, and clinical non-vertebral fractures. Secondary end points included clinical vertebral fractures, BMD, bone turnover markers, and safety and tolerability, including bone histology. Participants were women, 65 years or older, with a BMD T-score a parts per thousand currency signa'2.5 at the total hip (TH) or femoral neck (FN) or with a prior radiographic vertebral fracture and a T-score a parts per thousand currency signa'1.5 at the TH or FN. They were randomized to ODN or placebo tablets. All received weekly vitamin D-3 (5600 international units (IU)) and daily calcium supplements as needed to ensure a daily intake of approximately 1200 mg. Altogether, 16,713 participants were randomized at 387 centers. After a planned interim analysis, an independent data monitoring committee recommended that the study be stopped early due to robust efficacy and a favorable benefit/risk profile. Following the base study closeout, 8256 participants entered the study extension. This report details the background and study design of this fracture end point trial and describes the baseline characteristics of its participants.	[Dempster, D. W.] Columbia Univ, New York, NY USA; [Eisman, J. A.] Notre Dame Univ, St Vincent Hosp, Garvan Inst Med Res, Sydney, NSW, Australia; [Eisman, J. A.] UNSW Australia, Sydney, NSW, Australia; [Greenspan, S. L.] Univ Pittsburgh, Pittsburgh, PA USA; [Mcclung, M. R.] Oregon Osteoporosis Ctr, Portland, OR USA; [Nakamura, T.] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan; [Papapoulos, S.] Leiden Univ Med Ctr, Leiden, Netherlands; [Shih, W. J.] Robert Wood Johnson Med Sch, Piscataway, NJ USA; [Rybak-Feiglin, A.; Santora, A. C.; Verbruggen, N.; Leung, A. T.; Lombardi, A.] Merck Sharp & Dohme Corp, Piscataway, NJ USA; [Bone, H. G.] St Lukes Hosp, Osteoporosis Ctr, Kansas City, MO 64111 USA	Bone, HG (reprint author), Michigan Bone & Mineral Clin, Detroit, MI 48236 USA.	hgbone.md@att.net			Merck & Co., Inc., Whitehouse Station, NJ	This study was funded by Merck & Co., Inc., Whitehouse Station, NJ.	Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Zebaze RM, 2014, BONE, V59, P173, DOI 10.1016/j.bone.2013.11.016; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Stoch SA, 2013, BRIT J CLIN PHARMACO, V75, P1240, DOI 10.1111/j.1365-2125.2012.04471.x; Lewiecki EM, 2011, NAT REV RHEUMATOL, V7, P631, DOI 10.1038/nrrheum.2011.130; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Eisman JA, 2011, J BONE MINER RES, V26, P242, DOI 10.1002/jbmr.212; Kiviranta R, 2001, J BONE MINER RES, V16, P1444, DOI 10.1359/jbmr.2001.16.8.1444; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Bone HG, 2013, J CLIN ENDOCR METAB, V98, P4483, DOI 10.1210/jc.2013-1597; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Stoch SA, 2009, CLIN PHARMACOL THER, V86, P175, DOI 10.1038/clpt.2009.60; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Langdahl B, 2012, J BONE MINER RES, V27, P2251, DOI 10.1002/jbmr.1695; Falgueyret JP, 2005, J MED CHEM, V48, P7535, DOI 10.1021/jm0504961; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; GENANT HK, 1993, J BONE MINER RES, V8, P1137; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Gauthier JY, 2008, BIOORG MED CHEM LETT, V18, P923, DOI 10.1016/j.bmcl.2007.12.047; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Black DM, 2012, NEW ENGL J MED, V366, P2051, DOI 10.1056/NEJMp1202623; Bone HG, 2010, J BONE MINER RES, V25, P937, DOI 10.1359/jbmr.091035; Roschger P, 2001, BONE, V29, P185, DOI 10.1016/S8756-3282(01)00485-9; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Duong L, 2012, BONEKEY REP, V1, P1; Heaney RP, 1997, J BONE MINER RES, V12, P1143, DOI 10.1359/jbmr.1997.12.8.1143; Hernandez CJ, 2001, BONE, V29, P511, DOI 10.1016/S8756-3282(01)00613-5; Kanis J, 2003, J BONE MINER RES, V18, P1133, DOI 10.1359/jbmr.2003.18.6.1133; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Recker RR, 2011, BONE, V49, P955, DOI 10.1016/j.bone.2011.07.017; Vittinghoff E, 2010, STAT MED, V29, P1127, DOI 10.1002/sim.3870	39	11	11	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	FEB	2015	26	2					699	712		10.1007/s00198-014-2944-6		14	Endocrinology & Metabolism	Endocrinology & Metabolism	CA6JM	WOS:000349018700031		
J	Sugimoto, T; Matsumoto, T; Hosoi, T; Miki, T; Gorai, I; Yoshikawa, H; Tanaka, Y; Tanaka, S; Fukunaga, M; Sone, T; Nakano, T; Ito, M; Matsui, S; Yoneda, T; Takami, H; Watanabe, K; Osakabe, T; Okubo, N; Shiraki, M; Nakamura, T				Sugimoto, T.; Matsumoto, T.; Hosoi, T.; Miki, T.; Gorai, I.; Yoshikawa, H.; Tanaka, Y.; Tanaka, S.; Fukunaga, M.; Sone, T.; Nakano, T.; Ito, M.; Matsui, S.; Yoneda, T.; Takami, H.; Watanabe, K.; Osakabe, T.; Okubo, N.; Shiraki, M.; Nakamura, T.			Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)	OSTEOPOROSIS INTERNATIONAL			English	Article						Bone mineral density; Bone turnover marker; Denosumab; Fracture; Japanese; Long-term; Osteoporosis	OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; NONVERTEBRAL FRACTURES; FREEDOM EXTENSION; RISK REDUCTION; PREVENTION; ACTIVATION; EXPOSURE; DENSITY	A 12-month extension phase of DIRECT in Japanese subjects with osteoporosis showed that total 3 years of denosumab treatment in Japanese postmenopausal women and men with osteoporosis was associated with low fracture rates, persistent bone turnover marker (BTM) reductions, continuous bone mineral density (BMD) increases, and a favorable overall benefit/risk profile. The DIRECT trial demonstrated that 2 years of treatment with denosumab 60 mg subcutaneously every 6 months significantly reduced the incidence of vertebral fracture compared to placebo in Japanese postmenopausal women and men with osteoporosis. The purpose of this study is to evaluate the efficacy and safety of denosumab treatment for up to 3 years. This study includes a 2-year randomized, double-blind, placebo-controlled phase and a 1-year open-label extension phase in which all subjects received denosumab. The data correspond to 3 years of denosumab treatment in subjects who received denosumab (long-term group) and 1 year of denosumab treatment in subjects who received placebo (cross-over group) in the double-blind phase. Eight hundred and ten subjects who completed the double-blind phase enrolled into the extension phase, and 775 subjects completed the study. All subjects received denosumab with daily supplements of calcium and vitamin D. The cumulative 36-month incidences of new or worsening vertebral fractures and new vertebral fractures were 3.8 and 2.5 %, respectively, in the long-term group. In this group, the BMD continued to increase, and the reduction in BTMs was maintained. In the cross-over group, comparable BMD increases and BTMs reductions to those of in their first year of the long-term group were confirmed. Adverse events did not show a notable increase with long-term denosumab administration. One event of osteonecrosis of the jaw occurred in the cross-over group. Three-year denosumab treatment in Japanese subjects with osteoporosis showed a favorable benefit/risk profile.	[Sugimoto, T.] Shimane Univ Fac Med, Izumo, Shimane, Japan; [Matsumoto, T.] Univ Tokushima, Sch Med, Tokushima 770, Japan; [Hosoi, T.] Kenkoin Clin, Tokyo, Japan; [Miki, T.] Osaka City Univ, Sch Med, Osaka 545, Japan; [Gorai, I.] Hori Hosp, Yokohama, Kanagawa, Japan; [Yoshikawa, H.] Osaka Univ, Sch Med, Osaka, Japan; [Tanaka, Y.] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan; [Tanaka, S.] Univ Tokyo, Tokyo, Japan; [Fukunaga, M.; Sone, T.] Kawasaki Med Univ, Kurashiki, Okayama, Japan; [Nakano, T.] Tamana Cent Hosp, Tamana, Japan; [Ito, M.] Nagasaki Univ Hosp, Nagasaki, Japan; [Matsui, S.] Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan; [Yoneda, T.] Osaka Univ, Sch Dent, Osaka, Japan; [Takami, H.; Watanabe, K.; Osakabe, T.; Okubo, N.] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Shiraki, M.] Res Inst, Practice Involut Dis, Nagano, Japan; [Nakamura, T.] Natl Ctr Global Hlth & Med, Tokyo, Japan	Takami, H (reprint author), Daiichi Sankyo Co Ltd, Tokyo, Japan.	watanabe.ko.bh@daiichisankyo.co.jp			Daiichi-Sankyo., Tokyo, Japan	The study was sponsored by Daiichi-Sankyo., Tokyo, Japan. The authors acknowledge Amgen for editorial assistance on the manuscript.	Ivaska KK, 2010, J BONE MINER RES, V25, P393, DOI 10.1359/jbmr.091006; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Papapoulos S, 2012, J BONE MINER RES, V27, P694, DOI 10.1002/jbmr.1479; Bone HG, 2013, J CLIN ENDOCR METAB, V98, P4483, DOI 10.1210/jc.2013-1597; Hochberg MC, 2002, J CLIN ENDOCR METAB, V87, P1586, DOI 10.1210/jc.87.4.1586; Orimo H, 1998, J BONE MINER METAB, V16, P139, DOI 10.1007/s007740050038; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Genant HK, 1996, J BONE MINER RES, V11, P984; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Austin M, 2012, J BONE MINER RES, V27, P687, DOI 10.1002/jbmr.1472; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Kumagai Y, 2011, BONE, V49, P1101, DOI 10.1016/j.bone.2011.08.007; Nakamura T, 2014, J CLIN ENDOCR METAB, V99, P2599, DOI 10.1210/jc.2013-4175; Papapoulos S, 2013, AM SOC BON MIN RES 2	16	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	FEB	2015	26	2					765	774		10.1007/s00198-014-2964-2		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CA6JM	WOS:000349018700037		
J	Nagao, T; Inden, Y; Shimano, M; Fujita, M; Yanagisawa, S; Kato, H; Ishikawa, S; Miyoshi, A; Okumura, S; Ohguchi, S; Yamamoto, T; Yoshida, N; Hirai, M; Murohara, T				Nagao, Tomoyuki; Inden, Yasuya; Shimano, Masayuki; Fujita, Masaya; Yanagisawa, Satoshi; Kato, Hiroyuki; Ishikawa, Shinji; Miyoshi, Aya; Okumura, Satoshi; Ohguchi, Shiou; Yamamoto, Toshihiko; Yoshida, Naoki; Hirai, Makoto; Murohara, Toyoaki			Efficacy and Safety of Apixaban in the Patients Undergoing the Ablation of Atrial Fibrillation	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						apixaban; atrial fibrillation; catheter ablation	RADIOFREQUENCY CATHETER ABLATION; FACTOR XA INHIBITOR; PERIPROCEDURAL ANTICOAGULATION; THROMBIN GENERATION; BLEEDING COMPLICATIONS; IN-VITRO; DABIGATRAN; WARFARIN; RIVAROXABAN; STROKE	IntroductionApixaban, a factor Xa (FXa) inhibitor, is a new oral anticoagulant for stroke prevention in atrial fibrillation (AF). However, little is known about its efficacy and safety as a periprocedural anticoagulant therapy for patients who had undergone catheter ablation (CA) for AF. Methods and ResultsWe evaluated 342 consecutive patients who underwent CA for AF between April 2013 and March 2014 and received apixaban (n = 105) and warfarin (n = 237) for uninterrupted periprocedural anticoagulation. We retrospectively investigated the occurrence of bleeding and thromboembolic complications during the procedural period and compared them between the apixaban group (AG) and warfarin group (WG). Thromboembolic complications occurred in one (0.4%) patient in the WG. Major and minor bleeding complications occurred in one (1%) and four (4%) patients in the AG, and three (1%) and 12 (5%) patients in the WG. No significant difference in complications was observed between the AG and WG. Of importance, adverse event rates did not differ between the two groups after adjusting by a propensity score analysis. In preoperative tests of blood coagulation, there were significant differences in the prothrombin time, activated partial thromboplastin time, FXa activity, and prothrombin fragment 1 + 2 (F1+2) levels between the AG and WG. ConclusionThe use of apixaban during the periprocedural period of AF ablation seemed as efficacious and safe as warfarin.	[Nagao, Tomoyuki; Inden, Yasuya; Shimano, Masayuki; Fujita, Masaya; Yanagisawa, Satoshi; Kato, Hiroyuki; Ishikawa, Shinji; Miyoshi, Aya; Okumura, Satoshi; Ohguchi, Shiou; Yamamoto, Toshihiko; Yoshida, Naoki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Yoshida, Naoki] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Hirai, Makoto] Nagoya Univ, Grad Sch Hlth Sci, Nagoya, Aichi 4668550, Japan	Inden, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	inden@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; Yanagisawa, Satoshi/Q-1723-2015				Hermans C, 2006, CURR MED RES OPIN, V22, P471, DOI 10.1185/030079906X89801; Walenga JM, 2010, INT J CLIN PRACT, V64, P956, DOI 10.1111/j.1742-1241.2009.02286.x; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Wong PC, 2008, J THROMB HAEMOST, V6, P820, DOI 10.1111/j.1538-7836.2008.02939.x; Haissaguerre M, 2005, J CARDIOVASC ELECTR, V16, P1125, DOI 10.1111/j.1540-8167.2005.00307.x; Hart RG, 2007, ANN INTERN MED, V146, P857; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Di Biase L, 2014, CIRCULATION, V129, P2638, DOI 10.1161/CIRCULATIONAHA.113.006426; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Tada H, 2001, J AM COLL CARDIOL, V38, P750, DOI 10.1016/S0735-1097(01)01425-5; Konduru SV, 2012, J INTERV CARD ELECTR, V35, P277, DOI 10.1007/s10840-012-9719-9; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Gerotziafas GT, 2007, J THROMB HAEMOST, V5, P886, DOI 10.1111/j.1538-7836.2007.02429.x; Khadzhynov D, 2013, THROMB HAEMOSTASIS, V109, P596, DOI 10.1160/TH12-08-0573; Frost C, 2014, BRIT J CLIN PHARMACO, V78, P877, DOI 10.1111/bcp.12393; Gouin-Thibault I, 2014, THROMB HAEMOSTASIS, V111, P240, DOI 10.1160/TH13-06-0470; Sardar P, 2014, AM J CARDIOL, V113, P1173, DOI 10.1016/j.amjcard.2013.12.027; Barrett YC, 2010, THROMB HAEMOSTASIS, V104, P1263, DOI 10.1160/TH10-05-0328; Hussein AA, 2009, HEART RHYTHM, V6, P1425, DOI 10.1016/j.hrthm.2009.07.007; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Kim JS, 2013, HEART RHYTHM, V10, P483, DOI 10.1016/j.hrthm.2012.12.011; Di Biase L, 2010, CIRCULATION, V121, P2550, DOI 10.1161/CIRCULATIONAHA.109.921320; Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE; Maddox W, 2013, J CARDIOVASC ELECTR, V24, P861, DOI 10.1111/jce.12143; Oral H, 2007, CIRCULATION, V115, P2606, DOI 10.1161/CIRCULATIONAHA.107.691386; Di Biase L, 2014, HEART RHYTHM, V11, P791, DOI 10.1016/j.hrthm.2014.03.003; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; Lakkireddy D, 2012, J AM COLL CARDIOL, V59, P1168, DOI 10.1016/j.jacc.2011.12.014; Kaseno K, 2012, CIRC J, V76, P2337, DOI 10.1253/circj.CJ-12-0498; Lakkireddy D, 2014, J AM COLL CARDIOL, V63, P982, DOI 10.1016/j.jacc.2013.11.039; Cui Yimin, 2013, Clin Pharmacol, V5, P177, DOI 10.2147/CPAA.S51981; Ellis Christopher R, 2013, Vasc Health Risk Manag, V9, P341, DOI 10.2147/VHRM.S28271; Escolar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078696; GRANGER CB, 1995, CIRCULATION, V91, P1929; Lee DSY, 2001, EUROPACE, V3, P195, DOI 10.1053/eupc.2001.0167	36	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	FEB	2015	38	2					155	163		10.1111/pace.12553		9	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	CA4VD	WOS:000348903100002		
J	Masuda, R; Miyazaki, S; Kusa, S; Komatsu, Y; Hachiya, H; Iesaka, Y				Masuda, Ryo; Miyazaki, Shinsuke; Kusa, Shigeki; Komatsu, Yuki; Hachiya, Hitoshi; Iesaka, Yoshito			Discrimination of Thoracic Vein Potentials Facilitated by Atrial Pacing during the Isolation	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						thoracic vein; far-field potential; isolation; atrial fibrillation	SUPERIOR VENA-CAVA; CATHETER ABLATION; PULMONARY VEIN; END-POINT; FIBRILLATION; MULTICENTER; FOCI	BackgroundAlthough electrical thoracic vein (TV) isolation is an established strategy during atrial fibrillation (AF) ablation, discriminating TV potentials from far-field signals is critical for the achievement. Methods and ResultsOne hundred consecutive drug-refractory symptomatic paroxysmal AF patients who underwent AF catheter ablation were included. All patients underwent circumferential pulmonary vein (PV) isolation during distal coronary sinus (CS) pacing with a cycle length of 600 ms. A superior vena cava (SVC) isolation was added during high right atrial (HRA) pacing with the same cycle length in 79 patients in whom SVC potentials were identified. The interval between the near-field PV potentials and far-field atrial signals significantly prolonged more during distal CS pacing than sinus rhythm (SR) in the left superior (26.0 [18.5-32.8] ms to 36.0 [24.3-55.5] ms, P < 0.01) and left inferior PVs (21.0 [14.0-30.0] ms to 40.0 [23.0-56.0] ms, P < 0.01), but not in the right superior (34.0 [20.0-40.0] ms to 23.0 [18.0-36.0] ms, P = 0.13) and right inferior PVs (22.0 [16.0-28.0] ms to 25.0 [18.0-38.0] ms, P = 0.05). The interval between the SVC potentials and far-field atrial signals significantly prolonged more during HRA pacing than SR (20.0 [0-32.0] ms to 34.0 [24.0-46.0] ms, P < 0.01). Electrical isolation was successfully achieved in all TVs without any complications except for transient right phrenic nerve palsy in two patients. ConclusionsDiscrimination of ipsilateral left PVs and SVC potentials is facilitated by pacing from the distal CS and HRA, respectively. Better recognition of TV potentials would help to achieve electrical isolation.	[Masuda, Ryo; Miyazaki, Shinsuke; Kusa, Shigeki; Komatsu, Yuki; Hachiya, Hitoshi; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Div Cardiol, Ctr Cardiovasc, Tsuchiura, Ibaraki 3000053, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Div Cardiol, Ctr Cardiovasc, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp					Miller MA, 2012, EUROPACE, V14, P653, DOI 10.1093/europace/eus048; Tsai CF, 2000, CIRCULATION, V102, P67; Shah D, 2003, PACE, V26, P1631, DOI 10.1046/j.1460-9592.2003.t01-1-00243.x; Haissaguerre M, 2000, CIRCULATION, V101, P1409; Liu XP, 2006, J CARDIOVASC ELECTR, V17, P1263, DOI 10.1111/j.1540-8167.2006.00621.x; Nault I, 2010, EUR HEART J, V31, P1046, DOI 10.1093/eurheartj/ehq079; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Miyazaki S, 2011, HEART, V97, P668, DOI 10.1136/hrt.2009.186874; Sacher F, 2006, J AM COLL CARDIOL, V47, P2498, DOI 10.1016/j.jacc.2006.02.050; Fukumoto K, 2014, J CARDIOVASC ELECTR, V25, P16, DOI 10.1111/jce.12271; Goya M, 2002, CIRCULATION, V106, P1317, DOI 10.1161/01.CIR.0000033115.92612.F4; Hachiya H, 2007, J CARDIOVASC ELECTR, V18, P1; Higuchi K, 2010, HEART RHYTHM, V7, P1186, DOI 10.1016/j.hrthm.2010.05.017; Shah D, 2006, HEART RHYTHM, V3, P898, DOI 10.1016//j.hrthm.2006.04.022; Shah D, 2002, CIRCULATION, V105, P2821, DOI 10.1161/01.CIR.0000021596.01916.35; Takahashi A, 2002, CIRCULATION, V105, P2998, DOI 10.1161/01.CIR.0000019585.91146.AB	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	FEB	2015	38	2					225	230		10.1111/pace.12502		6	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	CA4VD	WOS:000348903100011		
J	Shimakawa, Y; Takao, Y; Anderson, ST; Taal, M; Yamaguchi, T; Giana, L; Ndow, G; Sarr, L; Kambi, A; Njai, HF; Bottomley, C; Nyan, O; Sabally, S; D'Alessandro, U; Taylor-Robinson, SD; Thursz, M; Lemoine, M; Njie, R				Shimakawa, Yusuke; Takao, Yuki; Anderson, Suzanne T.; Taal, Makie; Yamaguchi, Takashi; Giana, Lamin; Ndow, Gibril; Sarr, Louise; Kambi, Abubacarr; Njai, Harr Freeya; Bottomley, Christian; Nyan, Ousman; Sabally, Saihou; D'Alessandro, Umberto; Taylor-Robinson, Simon D.; Thursz, Mark; Lemoine, Maud; Njie, Ramou			The prevalence and burden of symptoms in patients with chronic liver diseases in The Gambia, West Africa	PALLIATIVE MEDICINE			English	Letter									[Shimakawa, Yusuke; Anderson, Suzanne T.; Ndow, Gibril; Sarr, Louise; Kambi, Abubacarr; Njai, Harr Freeya; D'Alessandro, Umberto; Lemoine, Maud; Njie, Ramou] Med Res Council MRC Unit, Banjul, Gambia; [Shimakawa, Yusuke; Bottomley, Christian; D'Alessandro, Umberto] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Takao, Yuki; Taylor-Robinson, Simon D.; Thursz, Mark; Lemoine, Maud] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W2 1NY, England; [Taal, Makie] Amer Int Univ, Banjul, Gambia; [Yamaguchi, Takashi] Kobe Univ, Dept Palliat Med, Grad Sch Med, Kobe, Hyogo 657, Japan; [Giana, Lamin; Ndow, Gibril; Njie, Ramou] MRC Unit, Gambia Hepatitis Intervent Study, IARC, Banjul, Gambia; [Sarr, Louise; Kambi, Abubacarr; Nyan, Ousman] Edward Francis Small Teaching Hosp, Banjul, Gambia; [Sabally, Saihou] Brikama Hlth Ctr, Hands Care, Brikama, Gambia	Lemoine, M (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Norfolk Pl, London W2 1NY, England.	m.lemoine@imperial.ac.uk	D'Alessandro, Umberto/D-3457-2015	D'Alessandro, Umberto/0000-0001-6341-5009			Powell RA, 2007, J PAIN SYMPTOM MANAG, V33, P229, DOI 10.1016/j.jpainsymman.2006.10.008; Harding R, 2013, LANCET ONCOL, V14, pE183, DOI 10.1016/S1470-2045(12)70396-0; Ladep NG, 2014, HEPATOLOGY, V60, P1291, DOI 10.1002/hep.27264	3	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2163	1477-030X		PALLIATIVE MED	Palliat. Med.	FEB	2015	29	2					184	185		10.1177/0269216314547103		2	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medicine, General & Internal	Health Care Sciences & Services; Public, Environmental & Occupational Health; General & Internal Medicine	CA7NJ	WOS:000349103800012		
J	Shin, SP; Zenke, K; Yokoyama, H; Yoshinaga, T				Shin, Sang Phil; Zenke, Kosuke; Yokoyama, Hiroshi; Yoshinaga, Tomoyoshi			Factors affecting sporoplasm release in Kudoa septempunctata	PARASITOLOGY RESEARCH			English	Article						Kudoa septempunctata; Sporoplasm release; Food-borne illness; Glucose	FLOUNDER PARALICHTHYS-OLIVACEUS; IN-VITRO; CELLS; MULTIVALVULIDA; ANTIGENS; MYXOZOA; FISH	The myxosporean parasite Kudoa septempunctata has been isolated from cultured olive flounder (Paralichthys olivaceus) and was recently identified as a cause of food poisoning in humans. Since the sporoplasm plays an important role in causing diarrhea by invading intestinal cells, the specific factors affecting the release of sporoplasm from spores should be determined. Thus, we investigated the effect of digestive and serum enzymes, fetal bovine serum (FBS), temperature, and the role of glucose in cell culture media on the release of sporoplasm. Sporoplasm release was observed in the groups treated with FBS and media containing glucose. In addition, 1,10-phenanthroline inhibited the release of sporoplasm in the FBS medium. These results indicate that K. septempunctata uses glucose for releasing its sporoplasm and that zinc or metalloprotease is related to the release mechanism. The present study provides important information for the development of agents to prevent sporoplasm release and the consequent food poisoning caused by K. septempunctata.	[Shin, Sang Phil; Zenke, Kosuke; Yokoyama, Hiroshi; Yoshinaga, Tomoyoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan; [Shin, Sang Phil] Kinki Univ, Fisheries Lab, Wakayama 6492211, Japan	Shin, SP (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan.	charisma-shin@daum.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A6A3A03063215]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A6A3A03063215).	ADAMS JB, 1991, INT J FOOD SCI TECH, V26, P1; Alama-Bermejo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032679; AlKurashi M, 2011, VET PARASITOL, V177, P267, DOI 10.1016/j.vetpar.2010.11.053; Lom J, 2006, FOLIA PARASIT, V53, P1; Casas SM, 2002, DIS AQUAT ORGAN, V52, P217, DOI 10.3354/dao052217; Harada T, 2012, INT J FOOD MICROBIOL, V156, P161, DOI 10.1016/j.ijfoodmicro.2012.03.018; Kawai T, 2012, CLIN INFECT DIS, V54, P1046, DOI 10.1093/cid/cir1040; Daniel RM, 1996, BIOCHEM J, V317, P1; Lin RS, 1998, J BIOL CHEM, V273, P32878, DOI 10.1074/jbc.273.49.32878; Matsukane Y, 2010, PARASITOL RES, V107, P865, DOI 10.1007/s00436-010-1941-8; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; Moran JDW, 1999, AQUACULTURE, V172, P163, DOI 10.1016/S0044-8486(98)00437-2; Chase JC, 2001, DIS AQUAT ORGAN, V45, P121, DOI 10.3354/dao045121; de Velasco GM, 2008, PARASITOL RES, V103, P713, DOI 10.1007/s00436-008-1017-1; Faff L, 2000, BRAIN RES, V853, P22, DOI 10.1016/S0006-8993(99)02221-0; Hall A, 1998, RHO GTPASES ACTIN CY, V279, P509, DOI [10.1126/science.279.5350.509, DOI 10.1126/SCIENCE.279.5350.509]; Jeon CH, 2014, PARASITOL RES, V113, P1759, DOI 10.1007/s00436-014-3821-0; Kalwat MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.73; KRISHNAMURTI C, 1980, CANCER RES, V40, P4092; Ohnishi T, 2013, FOODBORNE PATHOG DIS, V10, P137, DOI 10.1089/fpd.2012.1294; Okano S, 2006, AM J VET RES, V67, P1020, DOI 10.2460/ajvr.67.6.1020; Song Jun-Young, 2013, Journal of Fish Pathology, V26, P129, DOI 10.7847/jfp.2013.26.3.129; WILBER CG, 1948, J BIOL CHEM, V173, P141	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	FEB	2015	114	2					795	799		10.1007/s00436-014-4305-y		5	Parasitology	Parasitology	AZ9WX	WOS:000348566000052		
J	Itoh, K; Fushiki, S				Itoh, Kyoko; Fushiki, Shinji			The role of L1cam in murine corticogenesis, and the pathogenesis of hydrocephalus	PATHOLOGY INTERNATIONAL			English	Review						corticogenesis; hydrocephalus; knock-in mouse; L1cam; migration; RNA interference	ADHESION MOLECULE L1; X-LINKED HYDROCEPHALUS; NEURONAL MIGRATION; HOMOPHILIC BINDING; NEURITE OUTGROWTH; NERVOUS-SYSTEM; GROWTH CONE; CELL-MIGRATION; KNOCKOUT MICE; AXON GUIDANCE	L1cam (L1), one of the cell adhesion molecules belonging to the immunoglobulin superfamily, plays critical roles in neuronal migration, axon growth, guidance, fasciculation, and synaptic plasticity in the central as well as the peripheral nervous system. A number of X-linked forms of mental retardation have been associated with mutations in the L1 gene, including X-linked hydrocephalus in humans. Although model mice with different sites of L1 mutation have been studied, the pathogenetic mechanisms of hydrocephalus and mental retardation still remain unsolved. We herein present an overview of the function of L1 in the central nervous system and describe a human case of L1 mutation and knock-in mice that showed deleted sixth immunoglobulin of L1. Finally, we present experimental evidence showing that L1 is involved in murine neocortical histogenesis and propose a hypothetical mechanism of L1-linked hydrocephalus, with reference to corticogenesis.	[Itoh, Kyoko; Fushiki, Shinji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto 6028566, Japan	Itoh, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	kxi14@koto.kpu-m.ac.jp			KAKENHI-Japanese Society of Promotion of Sciences; Ministry of Sports, Culture and Science, Japanese Government [15591160, 18390308, 22390214]	The authors are grateful for the financial support received for the research herein described from KAKENHI-Japanese Society of Promotion of Sciences and the Ministry of Sports, Culture and Science, Japanese Government (KI: No. 15591160, 18390308, 22390214).	Kamiguchi H, 2001, J NEUROSCI, V21, P9194; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Adle-Biassette H, 2013, ACTA NEUROPATHOL, V126, P427, DOI 10.1007/s00401-013-1146-1; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Yamasaki M, 1997, NEUROPEDIATRICS, V28, P175, DOI 10.1055/s-2007-973696; Jacob J, 2002, J NEUROBIOL, V51, P177, DOI 10.1002/neu.10052; Weller S, 2001, HUM MUTAT, V18, P1, DOI 10.1002/humu.1144; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schmid RS, 2000, J NEUROSCI, V20, P4177; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Yip PM, 1998, MOL BIOL CELL, V9, P277; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Kiefel H, 2011, TRENDS MOL MED, V17, P178, DOI 10.1016/j.molmed.2010.11.005; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Vos YJ, 2010, HUM MUTAT, V31, pE1102, DOI 10.1002/humu.21172; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Kamiguchi H, 2000, J NEUROSCI, V20, P3676; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; De Angelis E, 2001, J BIOL CHEM, V276, P32738, DOI 10.1074/jbc.M105156200; Demyanenko GP, 2001, DEV BRAIN RES, V126, P21, DOI 10.1016/S0165-3806(00)00129-2; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Itoh K, 2004, J CELL BIOL, V165, P145, DOI 10.1083/jcb.200312107; Itoh K, 2014, CLIN NEUROEMBRYOLOGY, P299; Kamiguchi H, 1998, J NEUROSCI, V18, P3749; Kamiguchi H, 1998, J NEUROSCI, V18, P5311; Kamiguchi H, 1998, ANNU REV NEUROSCI, V21, P97, DOI 10.1146/annurev.neuro.21.1.97; Kishimoto T, 2013, J NEUROSCI RES, V91, P42, DOI 10.1002/jnr.23141; Letourneau PC, 1996, PERSPECT DEV NEUROBI, V4, P111; LINDNER J, 1986, BRAIN RES, V377, P298, DOI 10.1016/0006-8993(86)90872-3; Montgomery AMP, 1996, J CELL BIOL, V132, P475, DOI 10.1083/jcb.132.3.475; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Oleszewski M, 2000, J BIOL CHEM, V275, P34478, DOI 10.1074/jbc.M004147200; Ruppert M, 1995, J CELL BIOL, V131, P1881, DOI 10.1083/jcb.131.6.1881; Schmid RS, 2004, NEUROREPORT, V15, P2791; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Tapanes-Castillo A, 2010, NEUROGENETICS, V11, P53, DOI 10.1007/s10048-009-0203-3; Thelen K, 2002, J NEUROSCI, V22, P4918; Tonosaki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086186; Wang SS, 2007, DEV DYNAM, V236, P853, DOI 10.1002/dvdy.21070; Zhao XN, 1998, J NEUROCHEM, V71, P960	49	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	FEB	2015	65	2					58	66		10.1111/pin.12245		9	Pathology	Pathology	CA8ES	WOS:000349150200002		
J	Yamada, S; Wang, KY; Tanimoto, A; Sasaguri, Y				Yamada, Sohsuke; Wang, Ke-Yong; Tanimoto, Akihide; Sasaguri, Yasuyuki			Novel function of histamine signaling in hyperlipidemia-induced atherosclerosis: Histamine H1 receptors protect and H2 receptors accelerate atherosclerosis	PATHOLOGY INTERNATIONAL			English	Article						histamine; histamine H1 receptor (HH1R); histamine H2 receptor (HH2R); hyperlipidemia-induced atherosclerosis; inflammatory factors; scavenger receptor (SR)	SMOOTH-MUSCLE-CELLS; CORONARY-ARTERY-DISEASE; NONALCOHOLIC-STEATOHEPATITIS; KNOCKOUT MICE; LIPID UPTAKE; MAST-CELLS; EXPRESSION; APOPTOSIS; MONOCYTES/MACROPHAGES; ARTERIOSCLEROSIS	Histamine is not only essential for acute inflammatory reactions, but it also participates in a chronic inflammatory disorder. We generated apolipoprotein E (apoE) and histamine receptors (HHRs), including the major H1 and H2 receptors (HH1R, HH2R) double knockout mice (DKO) to clarify the role of HHRs in hyperlipidemia-induced atherosclerosis, in which apoE-KO and DKO mice were fed a high cholesterol diet. We found that pronounced hyperlipidemia-induced atherosclerotic progression occurred in HH1R/apoE-DKO mice, but in HH2R/apoE-DKO mice less atherosclerosis, despite pro-atherogenic serum cholesterol levels compared with apoE-KO mice. Furthermore, the increased expressions of scavenger receptors (SRs), such as SR-A, CD36 and lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1), nuclear factor-kappa B (NFB), monocyte chemoattractant protein (MCP-1), matrix metalloproteinases (MMPs) or liver X receptor (LXR)-related inflammatory signaling factors, were consistent with the pro-atherogenic phenotype of HH2R/apoE-DKO mice. We hypothesize that histamine/HH1R and HH2R signaling has conflicting innate functions, inflammatory/atherogenic and anti-inflammatory/anti-atherogenic actions, and that there are innate links between histamine signaling and hyperlipidemia-induced atherosclerosis, independently of serum cholesterol metabolism. Specific histamine signaling blockers, in particular, HH2R blockers, are a possible novel therapeutic target for hyperlipidemia-induced atherosclerosis.	[Yamada, Sohsuke; Wang, Ke-Yong; Tanimoto, Akihide; Sasaguri, Yasuyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 8078555, Japan; [Wang, Ke-Yong] Univ Occupat & Environm Hlth, Sch Med, Shared Use Res Ctr, Kitakyushu, Fukuoka 8078555, Japan; [Tanimoto, Akihide] Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oncol, Dept Tumor Pathol, Kagoshima 890, Japan; [Sasaguri, Yasuyuki] Fukuoka Wajiro Hosp, Pathol Lab, Fukuoka, Japan	Sasaguri, Y (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	yasu3219@med.uoeh-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [19590413, 20590416, 24790394]; Fukuoka Foundation for Sound Health Cancer Research Fund, Fukuoka, Japan	This manuscript is based upon Pathology Award Lecture in 2009 at 99th annual meeting of The Japanese Society of Pathology. This work was supported in part by Grants-in-Aid for Scientific Research (19590413, 20590416, and 24790394) from the Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan (to S.Y., A.T., and Y.S.) and by Fukuoka Foundation for Sound Health Cancer Research Fund, Fukuoka, Japan (to S.Y.). S.Y and K-Y.W. contributed equally to this study. We would like to thank Hiroko Isagai, Hana Nishimura, and Naoko Une for their expert technical assistance.	Yamada S, 2008, AM J PATHOL, V172, P1419, DOI 10.2353/ajpath.2008.070604; Clejan S, 2002, J CELL MOL MED, V6, P583, DOI 10.1111/j.1582-4934.2002.tb00456.x; Steffel J, 2005, CIRCULATION, V112, P341, DOI 10.1161/CIRCULATIONAHA.105.553735; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; Sasaguri Y, 2005, CIRC RES, V96, P974, DOI 10.1161/01.RES.0000166325.00383.ed; Laine P, 1999, CIRCULATION, V99, P361; Cercek B, 1997, ATHEROSCLEROSIS, V131, P59, DOI 10.1016/S0021-9150(96)06767-6; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Noguchi H, 2014, AM J PATHOL, V184, P644, DOI 10.1016/j.ajpath.2013.11.030; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Iribarren C, 2004, INT J EPIDEMIOL, V33, P743, DOI 10.1093/ije/dyh081; Rozenberg I, 2010, ARTERIOSCL THROM VAS, V30, P923, DOI 10.1161/ATVBAHA.109.201079; Hu CP, 2008, CARDIOVASC RES, V79, P287, DOI 10.1093/cvr/cvn110; Knoflach M, 2005, ARCH INTERN MED, V165, P2521, DOI 10.1001/archinte.165.21.2521; Brzozowski T, 2001, J PHYSIOLOGY-PARIS, V95, P89, DOI 10.1016/S0928-4257(01)00013-4; FORMAN MB, 1985, NEW ENGL J MED, V313, P1138, DOI 10.1056/NEJM198510313131807; Guo X, 2012, ANTIOXID REDOX SIGN, V17, P1362, DOI 10.1089/ars.2012.4549; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Higuchi S, 2001, FEBS LETT, V505, P217, DOI 10.1016/S0014-5793(01)02823-X; Kobayashi T, 2000, J CLIN INVEST, V105, P1741, DOI 10.1172/JCI9441; Murata Y, 2005, ARTERIOSCL THROM VAS, V25, P430, DOI 10.1161/01.ATV.0000148705.13411.65; Nabeshima A, 2013, ANTIOXID REDOX SIGN, V19, P1983, DOI 10.1089/ars.2012.4946; SASAGURI Y, 1994, LAB INVEST, V71, P261; Sasaguri Y, 2002, CONNECT TISSUE, V34, P327; SASAGURI Y, 1991, VIRCHOWS ARCH B, V60, P91, DOI 10.1007/BF02899532; TAKAGISHI T, 1995, AM J PATHOL, V146, P981; Tanimoto A, 2007, ARTERIOSCL THROM VAS, V27, P1556, DOI 10.1161/ATVBAHA.106.139089; Tanimoto A, 2001, FEBS LETT, V508, P345, DOI 10.1016/S0014-5793(01)03073-3; Tanimoto A, 2006, TRENDS CARDIOVAS MED, V16, P280, DOI 10.1016/j.tcm.2006.06.001; Tasaki T, 2013, AM J PATHOL, V182, P597, DOI 10.1016/j.ajpath.2012.10.008; Wang KY, 2010, AM J PATHOL, V177, P713, DOI 10.2353/ajpath.2010.091198; Wang KY, 2000, FEBS LETT, V473, P345, DOI 10.1016/S0014-5793(00)01560-X; Wang KY, 2011, ARTERIOSCL THROM VAS, V31, P800, DOI 10.1161/ATVBAHA.110.215228; WHITE MV, 1990, J ALLERGY CLIN IMMUN, V86, P599, DOI 10.1016/S0091-6749(05)80223-4; Yamada S, 2013, PATHOL INT, V63, P435, DOI 10.1111/pin.12091; Yamada S, 2011, ARTERIOSCL THROM VAS, V31, P1555, DOI 10.1161/ATVBAHA.111.227140	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	FEB	2015	65	2					67	80		10.1111/pin.12246		14	Pathology	Pathology	CA8ES	WOS:000349150200003		
J	Yang, Y; Suzuki, K; Abe, E; Li, CP; Uno, M; Akiyama, F; Yamauchi, H; Kikuchi, M; Ohde, S; Deshpande, G; Shibahara, Y; Nakamura, Y; Sasano, H				Yang, Yang; Suzuki, Koyu; Abe, Eriko; Li, Chihping; Uno, Mieko; Akiyama, Futoshi; Yamauchi, Hideko; Kikuchi, Mari; Ohde, Sachiko; Deshpande, Gautam; Shibahara, Yukiko; Nakamura, Yasuhiro; Sasano, Hironobu			The significance of combined CK5/6 and p63 immunohistochemistry in predicting the risks of subsequent carcinoma development in intraductal papilloma of the breast	PATHOLOGY INTERNATIONAL			English	Article						atypical papilloma; intraductal papilloma; p63; predictor; subsequent carcinoma; CK5; 6	CORE-NEEDLE-BIOPSY; DIFFERENTIAL-DIAGNOSIS; MYOEPITHELIAL CELL; ESTROGEN-RECEPTOR; BENIGN PAPILLOMA; LESIONS; CANCER; EXCISION; RECOMMENDATIONS; PROLIFERATION	Prediction of subsequent risks of breast carcinoma (BC) development in intraductal papilloma (IDP) has remained controversial with the exception of atypical papilloma (AP). The potential value of immunohistochemistry (IHC) of cytokeratin 5/6 [CK5/6] and p63 have been proposed but its standardization has also remained controversial. We studied 17 patients initially diagnosed as IDP or AP who subsequently developed BC with 34 age-matched controls. We compared histological features, results of IHC (estrogen receptor [ER], progesterone receptor [PR], human epidermal growth factor receptor 2 [HER2], p63, CK5/6, Ki67), and ultrasound findings. Univariate conditional logistic regression analysis revealed that the status of both CK5/6 and p63/CK5/6 were significantly associated with subsequent BC development (P < 0.05). BC development in CK5/6 positive patients was 17.9% and p63/CK5/6 double positive patients 8.6%, respectively. Ultrasound evaluation was not significantly associated with any of the parameters examined and subsequent carcinoma development. Despite CK5/6 positivity, the subsequent incidence of BC development was nearly 20%. However p63/CK5/6 double positive status could predict a significantly lower subsequent carcinoma incidence, indicating a more accurate prognostic utility. Combining p63/CK5/6 with histological findings could be easily applied and could predict the subsequent BC development of the patients diagnosed as IDP at biopsy.	[Yang, Yang; Suzuki, Koyu; Abe, Eriko; Li, Chihping; Uno, Mieko; Sasano, Hironobu] St Lukes Int Hosp, Dept Pathol, Tokyo 1048560, Japan; [Yamauchi, Hideko] St Lukes Int Hosp, Dept Breast Surg, Tokyo 1048560, Japan; [Kikuchi, Mari] St Lukes Int Hosp, Dept Radiol, Tokyo 1048560, Japan; [Ohde, Sachiko; Deshpande, Gautam] St Lukes Int Hosp, St Lukes Life Sci Inst, Tokyo 1048560, Japan; [Akiyama, Futoshi] Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Tokyo 170, Japan; [Yang, Yang; Abe, Eriko; Shibahara, Yukiko; Nakamura, Yasuhiro; Sasano, Hironobu] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan	Yang, Y (reprint author), St Lukes Int Hosp, Dept Pathol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	yangyang@luke.ac.jp					Sydnor MK, 2007, RADIOLOGY, V242, P58, DOI 10.1148/radiol.2421031988; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Sakr R, 2008, EJSO-EUR J SURG ONC, V34, P1304, DOI 10.1016/j.ejso.2008.03.013; Kil WH, 2008, BREAST, V17, P258, DOI 10.1016/j.breast.2007.10.008; BUDWITNOVOTNY DA, 1986, CANCER RES, V46, P5419; Ueng SH, 2009, ARCH PATHOL LAB MED, V133, P893, DOI 10.1043/1543-2165-133.6.893; Allred DC, 1998, MODERN PATHOL, V11, P155; Deugnier MA, 2002, BREAST CANCER RES, V4, P224, DOI 10.1186/bcr459; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Mahooti S, 2010, ONCOTARGET, V1, P131; Pathmanathan N, 2013, J CLIN PATHOL, V66, P512, DOI 10.1136/jclinpath-2012-201085; Otterbach F, 2000, HISTOPATHOLOGY, V37, P232, DOI 10.1046/j.1365-2559.2000.00882.x; Youk JH, 2011, RADIOLOGY, V258, P81, DOI 10.1148/radiol.10100728; Masood S, 2011, ADV ANAT PATHOL, V18, P190, DOI 10.1097/PAP.0b013e31821698cc; Bernik SF, 2009, AM J SURG, V197, P473, DOI 10.1016/j.amjsurg.2008.04.007; Chang JM, 2010, EUR RADIOL, V20, P1093, DOI 10.1007/s00330-009-1649-2; Cheng TY, 2009, ANN SURG ONCOL, V16, P3375, DOI 10.1245/s10434-009-0637-8; Clarke RB, 2003, STEROIDS, V68, P789, DOI 10.1016/S0039-128X(03)00122-3; Collins LC, 2006, AM J SURG PATHOL, V30, P1002, DOI 10.1097/00000478-200608000-00011; Furuya C, 2012, PATHOL INT, V62, P381, DOI 10.1111/j.1440-1827.2012.02811.x; Grin A, 2009, AM J SURG PATHOL, V33, P1615, DOI 10.1097/PAS.0b013e3181aec446; Jung SY, 2010, WORLD J SURG, V34, P261, DOI 10.1007/s00268-009-0313-y; Lakhani SR, 2012, WHO CLASSIFICATION T, P100; PAGE DL, 1994, WORLD J SURG, V18, P32; Page DL, 1996, CANCER, V78, P258, DOI 10.1002/(SICI)1097-0142(19960715)78:2<258::AID-CNCR11>3.0.CO;2-V; PAGE DL, 1992, HUM PATHOL, V23, P1095, DOI 10.1016/0046-8177(92)90026-Y; Renshaw AA, 2004, AM J CLIN PATHOL, V122, P217, DOI 10.1309/K1BNJXETEY3H06UL; Schiff R, 2010, DIS BREAST, P408; Tse GM, 2009, J CLIN PATHOL, V62, P407, DOI 10.1136/jcp.2008.063016; Tse GMK, 2007, J CLIN PATHOL, V60, P315, DOI 10.1136/jcp.2006.036830; Tseng HS, 2009, EJSO-EUR J SURG ONC, V35, P21, DOI 10.1016/j.ejso.2008.06.004; Wiratkapun C, 2013, DIAGN INTERV RADIOL, V19, P371, DOI 10.5152/dir.2013.017	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	FEB	2015	65	2					81	88		10.1111/pin.12248		8	Pathology	Pathology	CA8ES	WOS:000349150200004		
J	Tajima, S; Waki, M; Doi, W; Hayashi, K; Takenaka, S; Fukaya, Y; Kimura, R				Tajima, Shogo; Waki, Michihiko; Doi, Wataru; Hayashi, Kazumasa; Takenaka, Syunsuke; Fukaya, Yoshie; Kimura, Ryosuke			Acquired cystic disease-associated renal cell carcinoma with a focal sarcomatoid component: Report of a case showing more pronounced polysomy of chromosomes 3 and 16 in the sarcomatoid component	PATHOLOGY INTERNATIONAL			English	Article						acquired cystic disease-associated renal cell carcinoma; chromosome 16; chromosome 3; E-cadherin; N-cadherin; polysomy; sarcomatoid	KIDNEY-DISEASE; PATHOBIOLOGICAL ASPECTS; NEOPLASMS; SPECTRUM; FOCUS	Acquired cystic disease (ACD)-associated renal cell carcinoma (RCC) has recently been established. Herein we report the sixth case of ACD-associated RCC with a sarcomatoid change. The patient was a 77-year-old man who regularly underwent hemodialysis for 14 years due to chronic renal failure resulting from IgA nephropathy. On computed tomography, a large right RCC was observed with contrast enhancement in the arterial phase. A nodular protrusion into the perirenal fat was detected. Right nephrectomy was performed under laparoscopy. Surgically resected specimens revealed a tan-to-yellow tumor (95 x 75 x 55mm) with a whitish nodule (20 x 15 x 15mm) invading into the perirenal fat. Histopathologically, the large carcinoma component of the tumor displayed a cribriform or microcystic growth pattern with deposition of oxalate crystals. The whitish nodule corresponded to the sarcomatoid component, and the spindled and pleomorphic tumor cells showed diffuse positivity of p53 on immunohistochemistry. Fluorescence in situ hybridization revealed trisomy of chromosomes 3 and 16 in the carcinoma component, as was expected from the literature. In addition, increased polysomy of these chromosomes was also observed in the sarcomatoid component. This finding may be related to the development of the sarcomatoid component along with the TP53 mutation.	[Tajima, Shogo] Shizuoka Saiseikai Gen Hosp, Dept Pathol, Shizuoka 4228021, Japan; [Doi, Wataru; Hayashi, Kazumasa; Takenaka, Syunsuke; Fukaya, Yoshie; Kimura, Ryosuke] Shizuoka Saiseikai Gen Hosp, Dept Urol, Shizuoka 4228021, Japan; [Waki, Michihiko] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Shizuoka, Japan	Tajima, S (reprint author), Shizuoka Saiseikai Gen Hosp, Dept Pathol, Suruga Ku, 1-1-1 Oshika, Shizuoka 4228021, Japan.	stajima-tky@umin.ac.jp					Ricke RM, 2013, J CELL BIOL, V201, P11, DOI 10.1083/jcb.201301061; Pan CC, 2009, HISTOPATHOLOGY, V55, P145, DOI 10.1111/j.1365-2559.2009.03361.x; Hughson MD, 1996, J AM SOC NEPHROL, V7, P2461; TRUONG LD, 1995, AM J KIDNEY DIS, V26, P1, DOI 10.1016/0272-6386(95)90146-9; ODA H, 1995, CANCER RES, V55, P658; Kuroda N, 2011, MED MOL MORPHOL, V44, P228, DOI 10.1007/s00795-010-0496-1; Sule N, 2005, AM J SURG PATHOL, V29, P443, DOI 10.1097/01.pas.0000152131.58492.97; Truong LD, 2003, ADV ANAT PATHOL, V10, P135, DOI 10.1097/00125480-200305000-00003; Kuroda N, 2011, ANN DIAGN PATHOL, V15, P462, DOI 10.1016/j.anndiagpath.2010.07.008; Kuroda N, 2003, HISTOL HISTOPATHOL, V18, P551; Tickoo SK, 2006, AM J SURG PATHOL, V30, P141, DOI 10.1097/01.pas.0000185382.80844.b1; Kuroda N, 2011, HISTOL HISTOPATHOL, V26, P1215; Behnes Carl Ludwig, 2012, Diagn Pathol, V7, P95, DOI 10.1186/1746-1596-7-95; Hosseini M, 2014, HUM PATHOL, V45, P1406, DOI 10.1016/j.humpath.2014.02.014; Kuroda N, 2008, HISTOL HISTOPATHOL, V23, P1327; Kuroda N, 2010, MED MOL MORPHOL, V43, P231, DOI 10.1007/s00795-009-0465-8; Petrolla AA, 2006, J UROLOGY, V176, P345, DOI 10.1016/j.juro.2006.04.007; Prozialeck Walter C, 2004, BMC Physiol, V4, P10, DOI 10.1186/1472-6793-4-10; Rioux-Leclercq Nathalie C, 2003, Arch Pathol Lab Med, V127, pE89; SUVARNA SK, 1994, AM J KIDNEY DIS, V24, P581	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	FEB	2015	65	2					89	94		10.1111/pin.12232		6	Pathology	Pathology	CA8ES	WOS:000349150200005		
J	Sugiyama, T; Tajiri, T; Hiraiwa, S; Inomoto, C; Kajiwara, H; Kojima, S; Tobita, K; Nakamura, N				Sugiyama, Tomoko; Tajiri, Takuma; Hiraiwa, Shinichiro; Inomoto, Chie; Kajiwara, Hiroshi; Kojima, Seiichiro; Tobita, Kouske; Nakamura, Naoya			Hepatic adrenal rest tumor: Diagnostic pitfall and proposed algorithms to prevent misdiagnosis as lipid-rich hepatocellular carcinoma	PATHOLOGY INTERNATIONAL			English	Article						adrenal rest tumor of the liver; arginase-1; CD56; hepatocellular carcinoma	HEPATOCYTE PARAFFIN-1; LIVER; TISSUE; ANGIOMYOLIPOMA; MARKERS; KIDNEY	We present a case of adrenal rest tumor of the liver in which differential diagnosis from lipid rich-hepatocellular carcinoma (HCC) was challenging. The patient was a 50-year-old woman in whom a 3-cm tumorous mass was discovered in segment 7 of the liver during computed tomography evaluation of a uterine leiomyoma. The preoperative diagnosis was HCC, and subsegmental liver resection was performed. The tumor appeared as a well-demarcated golden yellow nodule consisting of clear or partially eosinophilic cells arranged in a trabecular pattern. The initial impression of this lesion was that of clear cell type or lipid-rich type HCC because it stained positive for Hep Par1, but negative for arginase-1 and positive for CD56 which is one of the neuroendocrine markers. The lesion also stained positive for SF-1 and 3-HSD, both of which are markers of adrenocortical tissue. The final diagnosis was hepatic adrenal rest tumor. Hepatic adrenal rest tumor should be considered in the differential diagnosis of segment 7 tumor. A diagnostic algorithm that includes immunohistochemical staining for CD56 and arginase-1 is to rule out the possibility of lipid-rich HCC.	[Sugiyama, Tomoko; Tajiri, Takuma; Hiraiwa, Shinichiro] Tokai Univ, Hachioji Hosp, Dept Diagnost Pathol, Hachioji, Tokyo 1920032, Japan; [Kojima, Seiichiro] Tokai Univ, Hachioji Hosp, Dept Internal Med, Hachioji, Tokyo 1920032, Japan; [Tobita, Kouske] Tokai Univ, Hachioji Hosp, Dept Surg, Hachioji, Tokyo 1920032, Japan; [Inomoto, Chie; Kajiwara, Hiroshi; Nakamura, Naoya] Tokai Univ, Sch Med, Dept Pathol, Hiratsuka, Kanagawa 25912, Japan	Sugiyama, T (reprint author), Tokai Univ, Hachioji Hosp, Dept Diagnost Pathol, 1838 Ishikawa Machi, Hachioji, Tokyo 1920032, Japan.	sugitomo@tokai-u.jp					Alessandro L, 2004, AM J CLIN PATHOL, V122, P721; WENNERBERG AE, 1993, AM J PATHOL, V143, P1050; Tsui WMS, 1999, AM J SURG PATHOL, V23, P34, DOI 10.1097/00000478-199901000-00004; Yan BC, 2010, AM J SURG PATHOL, V34, P1147, DOI 10.1097/PAS.0b013e3181e5dffa; Ye HH, 2009, MODERN PATHOL, V22, P175, DOI 10.1038/modpathol.2008.162; Arai K, 2000, PATHOL INT, V50, P244, DOI 10.1046/j.1440-1827.2000.01029.x; Baba Y, 2008, HEPATOL RES, V38, P1154, DOI 10.1111/j.1872-034X.2008.00360.x; GOREN E, 1991, UROLOGY, V38, P187, DOI 10.1016/S0090-4295(05)80085-8; Honjo K, 2004, SHINDAN BYOURI, V21, P325; HYAMS VJ, 1960, AM J SURG, V99, P960, DOI 10.1016/0002-9610(60)90498-0; Ishak KG, 1999, ATLAS TUMOR PATHOL, V31, P152; Lugli A, 2004, AM J CLIN PATHOL, V122, P721, DOI 10.1309/KC09YTF2M4DLUY06; Makhlouf HR, 2002, ARCH PATHOL LAB MED, V126, P49; Moore KL, 2003, DEV HUMAN CLIN ORIEN, P288; Sangoi AR, 2010, AM J SURG PATHOL, V34, P423, DOI 10.1097/PAS.0b013e3181cfb506; Sasano H, 1990, ENDOCR PATHOL, V1, P94, DOI 10.1007/BF02915624; Tajima T, 2001, J COMPUT ASSIST TOMO, V25, P98, DOI 10.1097/00004728-200101000-00018; TANAKA S, 1983, AM J ROENTGENOL, V140, P701; Yokoyama H, 2013, TOHOKU J EXP MED, V229, P267, DOI 10.1620/tjem.229.267; Yong MS, 2010, KOREAN J HEPATOL, V16, P338	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	FEB	2015	65	2					95	99		10.1111/pin.12234		5	Pathology	Pathology	CA8ES	WOS:000349150200006		
J	Matsumura, M; Okudela, K; Tateishi, Y; Umeda, S; Mitsui, H; Suzuki, T; Nakayama, T; Inayama, Y; Ohashi, K				Matsumura, Mai; Okudela, Koji; Tateishi, Yoko; Umeda, Shigeaki; Mitsui, Hideaki; Suzuki, Takehisa; Nakayama, Takashi; Inayama, Yoshiaki; Ohashi, Kenichi			Leptomeningeal melanomatosis associated with neurocutaneous melanosis: An autopsy case report	PATHOLOGY INTERNATIONAL			English	Article						melanoma; melanomatosis; neurocutaneous melanosis; p16; p53; proliferation	FEATURES; NEVI	An autopsy case of leptomeningeal melanomatosis associated with neurocutaneous melanosis (NCM) involving a 44-year-old male is reported. The autopsy showed that the leptomeningeal surface of the brain and the spinal cord were covered with a diffuse black lesion. A histological examination detected diffusely distributed, proliferating, melanin-containing cells and demonstrated that the lesion consisted of three different components; i.e. regions of melanomatosis, melanocytosis, and melanocyte hyperplasia. In the leptomeningeal melanomatosis component, tumor cells with pleomorphic nuclei and prominent nucleoli had infiltrated into the cerebral parenchyma via Virchow-Robin spaces. The Ki-67 labeling index and the nuclear accumulation of p53 and p16 protein were immunohistochemically examined in each component. The Ki-67 labeling indices of the melanomatosis, melanocytosis, and melanocyte hyperplasia components were 8.7%, 0.8%, and 0%, respectively. Immunostaining of nuclear p16 produced a negative result in the melanomatosis component, but positive results in the melanocytosis and melanocyte hyperplasia components, whereas nuclear p53 expression was not detected in any of the components. This case suggests that p16(INK4)/CDKN2 may play a significant role in progression of leptomeningeal melanocytic neoplasms. We also reviewed previously reported cases of leptomeningeal neoplasms associated with NCM and discussed the relationship between the biological behavior and proliferative activity of such lesions.	[Matsumura, Mai; Okudela, Koji; Tateishi, Yoko; Umeda, Shigeaki; Mitsui, Hideaki; Suzuki, Takehisa; Ohashi, Kenichi] Yokohama City Univ, Dept Pathol, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Nakayama, Takashi] Saiseikai Yokohamashi Nanbu Hosp, Dept Pathol, Yokohama, Kanagawa, Japan; [Inayama, Yoshiaki] Yokohama City Univ, Med Ctr, Dept Pathol, Yokohama, Kanagawa 2360004, Japan	Matsumura, M (reprint author), Yokohama City Univ, Dept Pathol, Grad Sch Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	t126065c@yokohama-cu.ac.jp					Fu YJ, 2010, J NEUROSURG-PEDIATR, V6, P82, DOI 10.3171/2010.3.PEDS1025; Livingstone E, 2009, J CLIN ONCOL, V27, P2290, DOI 10.1200/JCO.2008.20.4388; KADONAGA JN, 1991, J AM ACAD DERMATOL, V24, P747, DOI 10.1016/0190-9622(91)70115-I; Liubinas SV, 2010, J CLIN NEUROSCI, V17, P1227, DOI 10.1016/j.jocn.2010.01.017; Brat DJ, 2007, WHO CLASSIFICATION T, V4th, P181; Burger PC, 2007, TUMORS CENTRAL NERVO, P453; Elder DE, 2010, MELANOCYTIC TUMORS S, P26; Fox H, 1972, HDB CLIN NEUROLOGY, P414; Gerami P, 2013, J INVEST DERMATOL, V133, P2127, DOI 10.1038/jid.2013.146; Inoue T, 2005, JPN J CLIN ONCOL, V42, P94; Kurokawa R, 2013, NEUROL MED-CHIR, V53, P730, DOI 10.2176/nmc.cr2012-0241; Küsters-Vandevelde Heidi Vn, 2014, Acta Neuropathol Commun, V2, P41, DOI 10.1186/2051-5960-2-41; Mcclelland S, 2007, J NEUROSURG, V107, P500, DOI 10.3171/PED-07/12/500; Oka H, 1999, J NEURO-ONCOL, V44, P41, DOI 10.1023/A:1006127619926; Pavey SJ, 2002, MELANOMA RES, V12, P539, DOI 10.1097/01.cmr.0000043154.28051.9f; Piccinin S, 1997, INT J CANCER, V74, P26, DOI 10.1002/(SICI)1097-0215(19970220)74:1<26::AID-IJC5>3.0.CO;2-2; Rokitansky J, 1861, ALLG WIEN MED ZTG, V26, P113; Shinno K, 2003, NEUROL MED-CHIR, V43, P619, DOI 10.2176/nmc.43.619; Striano P, 2012, BRAIN PATHOL, V22, P725, DOI 10.1111/j.1750-3639.2012.00619.x; Yamazaki Y, 2013, PEDIATR INT, V55, P240, DOI 10.1111/j.1442-200X.2012.03653.x	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	FEB	2015	65	2					100	105		10.1111/pin.12238		6	Pathology	Pathology	CA8ES	WOS:000349150200007		
J	Komori, Y; Nishida, H; Daa, T; Arakane, M; Kashima, K; Inomata, M; Kitano, S; Yokoyama, S				Komori, Yoko; Nishida, Haruto; Daa, Tsutomu; Arakane, Motoki; Kashima, Kenji; Inomata, Masafumi; Kitano, Seigo; Yokoyama, Shigeo			Peutz-Jeghers-type polyp with malignant transformation arising in the ileal conduit	PATHOLOGY INTERNATIONAL			English	Letter							HAMARTOMATOUS POLYP; ILEUM		[Komori, Yoko; Nishida, Haruto; Daa, Tsutomu; Arakane, Motoki; Kashima, Kenji; Yokoyama, Shigeo] Oita Univ, Fac Med, Dept Diagnost Pathol, Oita 87011, Japan; [Komori, Yoko; Inomata, Masafumi; Kitano, Seigo] Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, Oita 87011, Japan	Komori, Y (reprint author), Oita Univ, Fac Med, Dept Diagnost Pathol, Oita 87011, Japan.						Zbuk KM, 2007, NAT CLIN PRACT GASTR, V4, P492, DOI 10.1038/ncpgasthep0902; Moyer GC, 2012, ONCOL REP, V27, P371, DOI 10.3892/or.2011.1534; Ali-El-Dein B, 2002, J UROLOGY, V167, P84, DOI 10.1016/S0022-5347(05)65388-8; Jamaludin AZF, 2009, SURG TODAY, V39, P527, DOI 10.1007/s00595-008-3873-9; MOORCRAFT J, 1983, BRIT J UROL, V55, P185, DOI 10.1111/j.1464-410X.1983.tb06552.x; Nozoe T, 2013, SURG TODAY, V43, P191, DOI 10.1007/s00595-012-0190-0; Okada H, 2013, PATHOL INT, V63, P188, DOI 10.1111/pin.12037; Sekino Yusuke, 2011, J Med Case Rep, V5, P240, DOI 10.1186/1752-1947-5-240; Suzuki S, 2008, WORLD J GASTROENTERO, V14, P944, DOI 10.3748/wjg.14.944	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	FEB	2015	65	2					106	107		10.1111/pin.12233		2	Pathology	Pathology	CA8ES	WOS:000349150200008		
J	Chu, SW; Tanaka, J				Chu, Shaowei; Tanaka, Jiro			Design of a motion-based gestural menu-selection interface for a self-portrait camera	PERSONAL AND UBIQUITOUS COMPUTING			English	Article						Digital camera; Gesture user interface; Motion gestures; Image processing; Human computer interaction		Self-portraits allow users to capture memories, create art, and advance their photography skills. However, most existing camera interfaces are limited in that they do not support life-size previews, deviceless remote control, and real-time control over important camera functions. In this paper, we describe a new self-portrait camera system and develop a gesture interface for self-portraits. This self-portrait camera system supports life-size projection of a preview as well as a motion-based gesture system to select menu options to control camera functions including the shutter trigger, aperture size, shutter speed, and color balance. We experimentally evaluated the gesture-recognition accuracy and examined the effectiveness of the system compared with a hand-held remote control. The results suggest that the gesture-based interface is effective for controlling self-portrait camera options and improves the user experience when taking self-portraits. The gesture interface is expected to be useful in developing next-generation self-portrait cameras.	[Chu, Shaowei; Tanaka, Jiro] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki 3058573, Japan	Chu, SW (reprint author), Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki 3058573, Japan.	chushaowei2010@gmail.com; jiro@cs.tsukuba.ac.jp					Baker S, 2004, INT J COMPUT VISION, V56, P221, DOI 10.1023/B:VISI.0000011205.11775.fd; Molnar J, 2010, COMPUT VIS IMAGE UND, V114, P1104, DOI 10.1016/j.cviu.2010.07.006; Bayazit M, 2009, IAPR C MACH VIS APPL, P9; Chen M, 2010, MIR 2010, P405; Chu S, 2012, ACHI 2012, P112; Chu S, 2013, T HUM INTERFACE SOC, V15, P247; Chu S, 2013, P 11 AS PAC C COMP H, P93; Chu SW, 2011, LECT NOTES COMPUT SC, V6762, P238; Eisenstein J, 2006, P CHI 2006, P1111, DOI 10.1145/1124772.1124938; Graham-Rowe D, 2011, NEW SCI, P25; Guimbretiere F., 2012, P 2012 ACM ANN C HUM, P825, DOI 10.1145/2207676.2208521; Ni T, 2011, INT J HUM-COMPUT ST, V69, P551, DOI 10.1016/j.ijhcs.2011.05.001; Okabe D, 2006, PERV IM CAPT SHAR WO, P2; Zivkovic Z, 2004, LECT NOTES COMPUT SC, V3166, P90	14	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1617-4909	1617-4917		PERS UBIQUIT COMPUT	Pers. Ubiquitous Comput.	FEB	2015	19	2			SI		415	424		10.1007/s00779-014-0776-1		10	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	AZ8DW	WOS:000348445900013		
J	Sawamura, R; Kazui, M; Kurihara, A; Izumi, T				Sawamura, R.; Kazui, M.; Kurihara, A.; Izumi, T.			Pharmacokinetics of loxoprofen and its active metabolite after dermal application of loxoprofen gel to rats	PHARMAZIE			English	Article							DRUG	This study was conducted to evaluate the pharmacokinetics of loxoprofen (LX) and its active metabolite (trans-OH form) after a single dermal application of LX gel (LX-G) to rats. In the skin at the treated site, generation of the trans-OH form was detected and both LX and the trans-OH form remained at high concentrations for 24 h after dermal application. Furthermore, both LX and the trans-OH form also remained in the skeletal muscle over 24 h after the single dermal application, while they eliminated rapidly after the single oral administration. The area under the curve up to the last measurable point (AUC(0-t)) for plasma concentrations of LX or the trans-OH form after dermal application of LX-G was less than 11% of that after oral administration of LX. In addition, C-max and AUC(0-t) increased in a saturable manner while increasing the dose. Overall, these results demonstrated that the trans-OH form was generated at the treated site with the process of dermal absorption of LX and it remained at the target site for a long period with low systemic exposure compared to oral administration.	[Sawamura, R.; Kazui, M.; Kurihara, A.; Izumi, T.] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Tokyo 1408710, Japan	Sawamura, R (reprint author), Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	sawamura.ryoko.yi@daiichisankyo.co.jp					Heyneman CA, 2000, DRUGS, V60, P555, DOI 10.2165/00003495-200060030-00004; Sanchez-Borges M, 2010, MED CLIN N AM, V94, P853, DOI 10.1016/j.mcna.2010.03.005; VanDerKlauw MM, 1996, CLIN EXP ALLERGY, V26, P1355, DOI 10.1046/j.1365-2222.1996.d01-300.x; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; Trommer H, 2006, SKIN PHARMACOL PHYS, V19, P106, DOI 10.1159/000091978; SATO K, 1991, J PHARM SCI, V80, P104, DOI 10.1002/jps.2600800203; Daiichi Sankyo Co. Ltd, 2015, INV BROCH 2015; Honma M., 1994, J CLIN THER MED, V10, P2107; Kajita Y, 2012, J NEW REM CLIN, V61, P2039; Koo TS, 2005, J PHARM SCI-US, V94, P2187, DOI 10.1002/jps.20451; Lacroix I, 2004, FUND CLIN PHARMACOL, V18, P201, DOI 10.1111/j.1472-8206.2004.00224.x; Matsubara T, 2011, PAIN CLINIC, V32, P715; MATSUDA K, 1984, BIOCHEM PHARMACOL, V33, P2473, DOI 10.1016/0006-2952(84)90720-2	13	0	0	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	FEB	2015	70	2					74	80		10.1691/ph.2015.4077		7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CA6VP	WOS:000349054200002		
J	Mironov, S; Inagaki, K; Sato, YS; Kokawa, H				Mironov, S.; Inagaki, K.; Sato, Y. S.; Kokawa, H.			Microstructural evolution of pure copper during friction-stir welding	PHILOSOPHICAL MAGAZINE			English	Article						microstructure; copper; friction-stir welding; texture; electron backscatter diffraction (EBSD)	RECRYSTALLIZATION; TEXTURE; TORSION; JOINT	The microstructural evolution of pure copper during friction-stir welding was found to be principally influenced by welding temperature. At temperatures below ~0.5 T-m (where T-m is melting point), the microstructure was shown to be essentially determined by continuous recrystallization, leading to significant grain refinement and related material strengthening in the stir zone. In contrast, grain structure development at temperatures above ~0.5 T-m was dominated by discontinuous recrystallization producing a relatively coarse grain structure in the stir zone and giving rise to material softening.	[Mironov, S.; Inagaki, K.; Sato, Y. S.; Kokawa, H.] Tohoku Univ, Dept Mat Proc, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Mironov, S (reprint author), Tohoku Univ, Dept Mat Proc, Grad Sch Engn, Aoba Ku, 6-6-02 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	smironov@material.tohoku.ac.jp	Kokawa, Hiroyuki/B-2655-2014	Kokawa, Hiroyuki/0000-0003-3255-7180	Tohoku University	The authors are grateful to Mr A. Honda for technical assistance and Dr K. Kobayashi for help with EBSD measurements. One of the authors (S. Mironov) would like to express his hearty thanks to Tohoku University for providing a scientific fellowship.	MONTHEILLET F, 1985, ACTA METALL MATER, V33, P705, DOI 10.1016/0001-6160(85)90035-5; Gourdet S, 2003, ACTA MATER, V51, P2685, DOI 10.1016/S1359-6454(03)00078-8; Xue P, 2010, METALL MATER TRANS A, V41A, P2010, DOI 10.1007/s11661-010-0254-y; Reynolds AP, 2005, SCRIPTA MATER, V52, P491, DOI 10.1016/j.scriptamat.2004.11.009; Prangnell PB, 2005, ACTA MATER, V53, P3179, DOI 10.1016/j.actamat.2005.03.044; Mironov S, 2011, ACTA MATER, V59, P5472, DOI 10.1016/j.actamat.2011.05.021; Lee WB, 2004, MATER LETT, V58, P1041, DOI 10.1016/j.matlet.2003.08.014; Xue P, 2011, SCRIPTA MATER, V64, P1051, DOI 10.1016/j.scriptamat.2011.02.019; BAILEY JE, 1962, PROC R SOC LON SER-A, V267, P11, DOI 10.1098/rspa.1962.0080; Pettersen T, 2003, METALL MATER TRANS A, V34A, P2727, DOI 10.1007/s11661-003-0174-1; Sun YF, 2010, MAT SCI ENG A-STRUCT, V527, P6879, DOI 10.1016/j.msea.2010.07.030; Xu N, 2014, MATER DESIGN, V56, P20, DOI 10.1016/j.matdes.2013.10.076	12	2	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-6435	1478-6443		PHILOS MAG	Philos. Mag.	FEB 1	2015	95	4					367	381		10.1080/14786435.2015.1006293		15	Materials Science, Multidisciplinary; Mechanics; Metallurgy & Metallurgical Engineering; Physics, Applied; Physics, Condensed Matter	Materials Science; Mechanics; Metallurgy & Metallurgical Engineering; Physics	CB1NA	WOS:000349393400003		
J	Li, L; Nagai, T; Seto, Y; Fujino, K; Kawano, J; Itoh, S				Li, Lin; Nagai, Takaya; Seto, Yusuke; Fujino, Kiyoshi; Kawano, Jun; Itoh, Shoich			Superior solid solubility of MnSiO3 in CaSiO3 perovskite	PHYSICS AND CHEMISTRY OF MINERALS			English	Article						Solid solution; MnSiO3 perovskite; CaSiO3 perovskite; High pressure; High temperature	DIAMOND-ANVIL CELL; PHASE-TRANSITION; LOWER MANTLE; STABILITY; GARNET; SYSTEM; GPA	The silicate perovskite phase relation between CaSiO3 and MnSiO3 was investigated at 35-52 GPa and at 1,800 K using laser-heated diamond anvil cells combined with angle-dispersive synchrotron X-ray diffraction and energy-dispersive X-ray spectroscopic chemical analyses with scanning or transmission electron microscopy. We found that MnSiO3 can be incorporated into CaSiO3 perovskite up to 55, and 20 mol % of CaSiO3 is soluble in MnSiO3 perovskite. The range of 55-80 mol % of MnSiO3 in the CaSiO3-MnSiO3 perovskite system could be immiscible. We also observed that the two perovskite structured phases of the Mn-bearing CaSiO3 and the Ca-bearing MnSiO3 coexisted at these conditions. The Mn-bearing CaSiO3 perovskite has non-cubic symmetry and the Ca-bearing MnSiO3 perovskite has an orthorhombic structure with space group Pbnm. All the perovskite structured phases in the CaSiO3-MnSiO3 system convert to the amorphous phase during pressure release. MnSiO3 is the first chemical component confirmed to show such a superior solid solubility in CaSiO3 perovskite.	[Li, Lin] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Nagai, Takaya; Kawano, Jun; Itoh, Shoich] Hokkaido Univ, Dept Nat Hist Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Seto, Yusuke] Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan; [Fujino, Kiyoshi] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan	Nagai, T (reprint author), Hokkaido Univ, Dept Nat Hist Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan.	nagai@mail.sci.hokudai.ac.jp	SETO, YUSUKE/D-5735-2015; Seto, Yusuke/D-5751-2015; Kawano, Jun/A-5487-2012	SETO, YUSUKE/0000-0002-5423-2136; Seto, Yusuke/0000-0002-5423-2136; 	JSPS KAKENHI [18340167]; MEXT KAKENHI [20103002, 20002002, 22224010]	We thank T. Kikegawa and D. Hamane for their technical support with the X-ray diffraction experiments. We also thank Prof. M. Akaogi and an anonymous reviewer for helpful comments and constructive criticism. Synchrotron X-ray diffraction experiments were performed at the Photon Factory (proposal no. 2008G012, 2010G060, 2012G050). T. Nagai is partly supported by JSPS KAKENHI Grant Number 18340167 and MEXT KAKENHI Grant Number 20103002. S. Itoh is partly supported by MEXT KAKENHI Grant Number 20002002 and 22224010.	Akber-Knutson S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013523; IRIFUNE T, 1994, EARTH PLANET SC LETT, V126, P351, DOI 10.1016/0012-821X(94)90117-1; Fritsch S, 1996, J AM CERAM SOC, V79, P1761, DOI 10.1111/j.1151-2916.1996.tb07993.x; BROWN PE, 1980, CONTRIB MINERAL PETR, V74, P417; Fujino K, 2008, AM MINERAL, V93, P653, DOI 10.2138/am.2008.2645; Fujino K, 2009, PHYS EARTH PLANET IN, V177, P147, DOI 10.1016/j.pepi.2009.08.009; Fujino K, 1998, GEOPH MONOG SERIES, V101, P409; Jung DY, 2011, PHYS CHEM MINER, V38, P311, DOI 10.1007/s00269-010-0405-0; KESSON SE, 1995, EARTH PLANET SC LETT, V134, P187, DOI 10.1016/0012-821X(95)00112-P; Kurashina T, 2004, PHYS EARTH PLANET IN, V145, P67, DOI 10.1016/j.pepi.2004.02.005; Li L, 2014, PHYS CHEM MINER, V41, P431, DOI 10.1007/s00269-013-0618-0; MAO HK, 1989, J GEOPHYS RES-SOLID, V94, P17889, DOI 10.1029/JB094iB12p17889; Sata N, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.104114; Seto Yusuke, 2010, Review of High Pressure Science and Technology, V20, DOI 10.4131/jshpreview.20.269; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Shim SH, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016148; Stixrude L, 1996, AM MINERAL, V81, P1293; Uchida T, 2009, EARTH PLANET SC LETT, V282, P268, DOI 10.1016/j.epsl.2009.03.027; Vitos L, 2006, PHYS EARTH PLANET IN, V156, P108, DOI 10.1016/j.pepi.2006.02.004; Watanuki T, 2001, REV SCI INSTRUM, V72, P1289, DOI 10.1063/1.1343869; YAGI T, 1989, P JPN ACAD B-PHYS, V65, P129, DOI 10.2183/pjab.65.129	21	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-1791	1432-2021		PHYS CHEM MINER	Phys. Chem. Miner.	FEB	2015	42	2					123	129		10.1007/s00269-014-0703-z		7	Materials Science, Multidisciplinary; Mineralogy	Materials Science; Mineralogy	CA6JQ	WOS:000349019300002		
J	Ikemura, T; Kashima, H; Yamaguchi, Y; Miyaji, A; Hayashi, N				Ikemura, Tsukasa; Kashima, Hideaki; Yamaguchi, Yuji; Miyaji, Akane; Hayashi, Naoyuki			Inner ocular blood flow responses to an acute decrease in blood pressure in resting humans	PHYSIOLOGICAL MEASUREMENT			English	Article						autoregulation; ocular blood flow; retinal circulation; choroidal circulation	DYNAMIC CEREBRAL AUTOREGULATION; THIGH CUFF DEFLATION; PERFUSION-PRESSURE; HEALTHY-SUBJECTS; EXERCISE; MECHANISMS; CIRCULATION; ARTERY; BRAIN	Whether inner ocular vessels have an autoregulatory response to acute fluctuations in blood pressure is unclear. We tried to examine the validity of acute hypotension elicited by thigh-cuff release as to assess the dynamic autoregulation in the ocular circulation. Blood flow velocity in the superior nasal and inferior temporal retinal arterioles, and in the retinal and choroidal vasculature were measured with the aid of laser speckle flowgraphy before and immediately after an acute decrease in blood pressure in 20 healthy subjects. Acute hypotension was induced by a rapid release of bilateral thigh occlusion cuffs that had been inflated to 220 mmHg for 2 min. The ratio of the relative change in retinal and choroidal blood flow velocity to the relative change in mean arterial blood pressure (MAP) was calculated. Immediately after cuff release, the MAP and blood flows in the all ocular target vessels decreased significantly from the baseline values obtained before thigh-cuff release. The ratio of the relative change in inner ocular blood flow velocity to that in the MAP exceeded 1% / %mmHg. An explicit dynamic autoregulation in inner ocular vessels cannot be demonstrated in response to an acute hypotension induced by the thigh-cuff release technique.	[Ikemura, Tsukasa] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan; [Kashima, Hideaki; Yamaguchi, Yuji] Kyushu Univ, Grad Sch Human Environm Studies, Kasuga, Fukuoka 8168580, Japan; [Ikemura, Tsukasa; Yamaguchi, Yuji; Miyaji, Akane; Hayashi, Naoyuki] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Ookayama, Meguro 1528552, Japan	Ikemura, T (reprint author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan.	naohayashi@hum.titech.ac.jp			 [247022]	This study was partly supported by a grant-in-aid for a JSPS Research Fellowship for Young Researchers (no. 247022, to TI).	Aizawa Naoko, 2011, Clin Ophthalmol, V5, P1171, DOI 10.2147/OPTH.S22093; BILL A, 1975, PHYSIOL REV, V55, P383; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Iester M, 2007, OPHTHALMOLOGICA, V221, P180, DOI 10.1159/000099298; TIECKS FP, 1995, STROKE, V26, P1014; JOHNSON PC, 1986, CIRC RES, V59, P483; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; AASLID R, 1989, STROKE, V20, P45; Kaya S, 2011, MICROVASC RES, V82, P269, DOI 10.1016/j.mvr.2011.07.005; LASSEN NA, 1959, PHYSIOL REV, V39, P183; ALM A, 1973, EXP EYE RES, V15, P15, DOI 10.1016/0014-4835(73)90185-1; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; KROEKER EJ, 1955, CIRC RES, V3, P623; Fadel PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1383; Garhofer G, 2010, ACTA OPHTHALMOL, V88, P717, DOI 10.1111/j.1755-3768.2009.01587.x; Riva CE, 1997, GRAEF ARCH CLIN EXP, V235, P618, DOI 10.1007/BF00946937; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; Riva CE, 2010, ACTA OPHTHALMOL, V88, P622, DOI 10.1111/j.1755-3768.2009.01621.x; Kolodjaschna J, 2005, INVEST OPHTH VIS SCI, V46, P636, DOI 10.1167/iovs.04-0717; Davis MJ, 1999, PHYSIOL REV, V79, P387; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; Guan K, 2006, DIABETES, V55, P813, DOI 10.2337/diabetes.55.03.06.db05-0937; Guelen I, 2003, BLOOD PRESS MONIT, V8, P27, DOI 10.1097/01.mbp.0000057013.67622.97; Hayashi N, 2011, EUR J APPL PHYSIOL, V111, P2601, DOI 10.1007/s00421-011-1880-9; Ikemura T, 2011, EUROPEAN J APPL PHYS, V112, P641; Ikemura T, 2012, EUR J APPL PHYSIOL, V112, P3313, DOI 10.1007/s00421-012-2313-0; Ogoh S, 2010, J APPL PHYSIOL, V108, P1701, DOI 10.1152/japplphysiol.01031.2009; Okuno T, 2006, EYE, V20, P796, DOI 10.1038/sj.eye.6702004; Panerai RB, 1996, IEEE T BIO-MED ENG, V43, P779, DOI 10.1109/10.508541; URSINO M, 1995, IEEE T BIO-MED ENG, V42, P529, DOI 10.1109/10.387192	30	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	FEB	2015	36	2					219	230		10.1088/0967-3334/36/2/219		12	Biophysics; Engineering, Biomedical; Physiology	Biophysics; Engineering; Physiology	CA1ZS	WOS:000348709100005		
J	Sugimoto, H; Watanabe, K; Toyama, T; Takahashi, S; Sugiyama, S; Lee, MC; Hamada, N				Sugimoto, Hideki; Watanabe, Kiyoko; Toyama, Toshizo; Takahashi, Shun-suke; Sugiyama, Shuta; Lee, Masaichi-Chang-il; Hamada, Nobushiro			Inhibitory Effects of French Pine Bark Extract, Pycnogenol (R), on Alveolar Bone Resorption and on the Osteoclast Differentiation	PHYTOTHERAPY RESEARCH			English	Article						Pycnogenol((R)); alveolar bone resorption; Porphyromonas gingivalis; osteoclastogenesis	PERIODONTAL TISSUE DESTRUCTION; GINGIVAL OXIDATIVE STRESS; TUMOR-NECROSIS-FACTOR; PORPHYROMONAS-GINGIVALIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ANTIOXIDANT ACTIVITY; ACTIVATION; INFLAMMATION; POLYPHENOLS; ADHERENCE	Pycnogenol((R)) (PYC) is a standardized bark extract from French maritime pine (Pinus pinaster Aiton). We examined the inhibitory effects of PYC on alveolar bone resorption, which is a characteristic feature of periodontitis, induced by Porphyromonas gingivalis (P.gingivalis) and osteoclast differentiation. In rat periodontitis model, rats were divided into four groups: group A served as the non-infected control, group B was infected orally with P.gingivalis ATCC 33277, group C was administered PYC in the diet (0.025%: w/w), and group D was infected with P.gingivalis and administered PYC. Administration of PYC along with P.gingivalis infection significantly reduced alveolar bone resorption. Treatment of P.gingivalis with 1 mu g/ml PYC reduced the number of viable bacterial cells. Addition of PYC to epithelial cells inhibited adhesion and invasion by P.gingivalis. The effect of PYC on osteoclast formation was confirmed by tartrate-resistant acid phosphatase staining. PYC treatment significantly inhibited osteoclast formation. Addition of PYC (1-100 mu g/ml) to purified osteoclasts culture induced cell apoptosis. These results suggest that PYC may prevent alveolar bone resorption through its antibacterial activity against P.gingivalis and by suppressing osteoclastogenesis. Therefore, PYC may be useful as a therapeutic and preventative agent for bone diseases such as periodontitis. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Sugimoto, Hideki] Kanagawa Dent Univ, Dept Infect Control, Yokosuka, Kanagawa 2388580, Japan; [Watanabe, Kiyoko; Toyama, Toshizo; Hamada, Nobushiro] Kanagawa Dent Univ, Dept Microbiol, Yokosuka, Kanagawa 2388580, Japan; [Takahashi, Shun-suke] Kanagawa Dent Univ, Dept Oral Sci, Yokosuka, Kanagawa 2388580, Japan; [Sugiyama, Shuta] Kanagawa Dent Univ, Yokohama Clin, Yokohama, Kanagawa 2210835, Japan; [Lee, Masaichi-Chang-il] Kanagawa Dent Univ, Inst Res Disaster Dent Med Yokosuka & Shonan, Yokosuka, Kanagawa 2388580, Japan	Watanabe, K (reprint author), Kanagawa Dent Univ, Dept Microbiol, 82 Inaoka Cho, Yokosuka, Kanagawa 2388580, Japan.	watanabe@kdu.ac.jp					Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Grimm T, 2004, FREE RADICAL BIO MED, V36, P811, DOI 10.1016/j.freeradbiomed.2003.12.017; Garlet GP, 2006, ORAL MICROBIOL IMMUN, V21, P12; BAKER PJ, 1994, ARCH ORAL BIOL, V39, P1035, DOI 10.1016/0003-9969(94)90055-8; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; El Gharras H, 2009, INT J FOOD SCI TECH, V44, P2512, DOI 10.1111/j.1365-2621.2009.02077.x; Peng Q, 2000, CELL MOL LIFE SCI, V57, P834, DOI 10.1007/s000180050045; Tomofuji T, 2009, FREE RADICAL BIO MED, V46, P163, DOI 10.1016/j.freeradbiomed.2008.09.040; Zhao L, 2013, J MED FOOD, V16, P428, DOI 10.1089/jmf.2012.0207; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805; Tomofuji T, 2009, J PERIODONTOL, V80, P1799, DOI 10.1902/jop.2009.090270; Torras MAC, 2005, PHYTOTHER RES, V19, P647, DOI 10.1002/ptr.1662; Sharma A, 2005, J DENT RES, V84, P462; Sakanaka S, 1996, BIOSCI BIOTECH BIOCH, V60, P745; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; EVANS RT, 1992, ARCH ORAL BIOL, V37, P813, DOI 10.1016/0003-9969(92)90115-O; D'Aiuto F, 2010, J DENT RES, V89, P1241, DOI 10.1177/0022034510375830; Arcangeli P, 2000, FITOTERAPIA, V71, P236, DOI 10.1016/S0367-326X(99)00164-1; Chos KJ, 2006, ANN NY ACAD SCI, V928, P141; Dales BA, 2000, PERIODONTOL, V30, P70; Feng Z, 2006, PERIODONTOL, V40, P50, DOI DOI 10.1111/J.1600-0757.2005.00148.X; Grimm Tanja, 2006, J Inflamm (Lond), V3, P1, DOI 10.1186/1476-9255-3-1; Haffajee AD, 2000, PERIODONTOL, V5, P78; Hamada N, 2007, J PERIODONTOL, V78, P933, DOI 10.1902/jop.2007.060245; Highfields J, 2009, AUST DENT J S1, V54, P511; Holt SC, 2000, PERIODONTOL, V38, P72; Hosseini S, 2001, J MED FOOD, V4, P201, DOI 10.1089/10966200152744472; Kimbrough C, 2002, PHYTOMEDICINE, V9, P410, DOI 10.1078/09447110260571643; Laus BH, 2004, J ASTHMA, V41, P825; Lees ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211; Lins RW, 2009, BIOCHEM BIOPH RES CO, V379, P1033; Pandeys KB, 2009, OXID MED CELL LONGEV, V2, P2155; Scalbert A, 2005, AM J CLIN NUTR, V81, P2155; Yuns JH, 2007, J PERIODONTAL RES, V42, P212	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	FEB	2015	29	2					251	259		10.1002/ptr.5245		9	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA7DB	WOS:000349076500009		
J	Yang, SH; Ahn, EK; Lee, JA; Shin, TS; Tsukamoto, C; Suh, JW; Mei, I; Chung, G				Yang, Seung Hwan; Ahn, Eun-Kyung; Lee, Jung A.; Shin, Tai-Sun; Tsukamoto, Chigen; Suh, Joo-won; Mei, Itabashi; Chung, Gyuhwa			Soyasaponins Aa and Ab Exert an Anti-Obesity Effect in 3T3-L1 Adipocytes Through Downregulation of PPAR gamma	PHYTOTHERAPY RESEARCH			English	Article						soyasaponins; adipogenesis; peroxisome proliferator-activated receptor gamma (PPAR); adipogenic marker genes; 3T3-L1 cells	COLON-CANCER CELLS; SOYBEAN SEED; GENE-EXPRESSION; ADIPOGENESIS; SAPONINS; DIFFERENTIATION; MACROAUTOPHAGY; SOYASAPOGENOL; RECEPTORS; INDUCTION	Saponins are a diverse group of biologically functional products in plants. Soyasaponins are usually glycosylated, which give rise to a wide diversity of structures and functions. In this study, we investigated the effects and molecular mechanism of soyasaponins Aa and Ab in regulating adipocyte differentiation and expression of adipogenic marker genes in 3T3-L1 adipocytes. Soyasaponins Aa and Ab dose-dependently inhibited the accumulation of lipids and the expression of adiponectin, adipocyte determination and differentiation factor 1/sterol regulatory element binding protein 1c, adipocyte fatty acid-binding protein 2, fatty acid synthase, and resistin in 3T3-L1 adipocytes. In addition, soyasaponins Aa and Ab suppressed the transcriptional activity of peroxisome proliferator-activated receptor (PPAR) in HEK 293T cells. Furthermore, we confirmed that the expression of PPAR and of CCAAT-enhancer-binding protein (C/EBP) was suppressed at both the mRNA and protein levels in 3T3-L1 adipocytes by treatment with soyasaponins Aa and Ab. Taken together, these findings indicate that soyasaponin Aa and Ab markedly inhibit adipocyte differentiation and expression of various adipogenic marker genes through the downregulation of the adipogenesis-related transcription factors PPAR and C/EBP in 3T3-L1 adipocytes. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Yang, Seung Hwan] Myongji Univ, Ctr Nutraceut & Pharmaceut Mat, Yongin 449728, Gyeonggi, South Korea; [Ahn, Eun-Kyung; Lee, Jung A.] Gyeonggi Inst Sci & Technol Promot, Inst Nat Prod Res, Suwon 443270, Gyeonggi, South Korea; [Shin, Tai-Sun] Chonnam Natl Univ, Dept Nutr, Yeosu 550749, Chonnam, South Korea; [Tsukamoto, Chigen] Iwate Univ, Dept Appl Biol Chem, Morioka, Iwate 0208550, Japan; [Suh, Joo-won] Myongji Univ, Div Biosci & Bioinformat, Seoul 449728, Gyeonggi, South Korea; [Mei, Itabashi; Chung, Gyuhwa] Chonnam Natl Univ, Dept Biotechnol, Yeosu 550749, Chonnam, South Korea	Suh, JW (reprint author), Myongji Univ, Div Biosci & Bioinformat, Seoul 449728, Gyeonggi, South Korea.	jwsuh@mju.ac.kr; chung@chonnam.ac.kr			Next-Generation BioGreen 21 Program [PJ009643]; Rural Development Administration, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0013600]	This work was supported by a grant from the Next-Generation BioGreen 21 Program (no. PJ009643) to S. H. Y. and J. W. S., Rural Development Administration, Republic of Korea and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0013600).	Ahns EK, 2013, PHYTOTHER RES, V27, P761; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351; Ellington AA, 2006, CARCINOGENESIS, V27, P298, DOI 10.1093/carcin/bgi214; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; KUDOU S, 1993, BIOSCI BIOTECH BIOCH, V57, P546; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; TSUKAMOTO C, 1993, PHYTOCHEMISTRY, V34, P1351, DOI 10.1016/0031-9422(91)80028-Y; Rosen ED, 2000, GENE DEV, V14, P1293; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Burns RP, 1996, CURR OPIN CELL BIOL, V8, P826; Ellington AA, 2005, CARCINOGENESIS, V26, P159, DOI 10.1093/carcin/bgh297; Fenwicks GR, 1991, TOXIC SUBSTANCES CRO, P285, DOI 10.1533/9781845698454.285; Glatzs JF, 1995, LEUKOT ESSENT FAT AC, V52, P121; Ishii Y, 2006, BIOL PHARM BULL, V29, P1759, DOI 10.1248/bpb.29.1759; Jeon T, 2004, LIFE SCI, V75, P3195, DOI 10.1016/j.lfs.2004.06.012; Kims JB, 1996, GENE DEV, V10, P1096; Kuzuhara H, 2000, EUR J PHARMACOL, V391, P175, DOI 10.1016/S0014-2999(99)00931-0; Morrison R. F., 2000, J NUTR, V130, p3116S; Muratas M, 2006, SOY PROTEIN RES, V9, P82; Murata M., 2005, Soy Protein Research, Japan, V8, P81; SHIRAIWA M, 1991, AGR BIOL CHEM TOKYO, V55, P315; SHIRAIWA M, 1991, AGR BIOL CHEM TOKYO, V55, P911; Suls HS, 1998, ANNU REV NUTR, V18, P331; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tsukamoto C., 2006, Soy in health and disease prevention, P155; Zhang W, 2008, J AGR FOOD CHEM, V56, P2603, DOI 10.1021/jf0731550	30	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	FEB	2015	29	2					281	287		10.1002/ptr.5252		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA7DB	WOS:000349076500012		
J	Ohara, T; Muroyama, K; Yamamoto, Y; Murosaki, S				Ohara, Tatsuya; Muroyama, Koutarou; Yamamoto, Yoshihiro; Murosaki, Shinji			A Combination of Glucosyl Hesperidin and Caffeine Exhibits an Anti-obesity Effect by Inhibition of Hepatic Lipogenesis in Mice	PHYTOTHERAPY RESEARCH			English	Article						glucosyl hesperidin; caffeine; anti-obesity effect; lipogenesis; liver	SERUM TRIGLYCERIDE LEVEL; METABOLIC SYNDROME; HEPG2 CELLS; CARDIOVASCULAR-DISEASE; LIPID-ACCUMULATION; CITRIC-ACID; KK MICE; ARGININE; MIXTURE; ADIPOSITY	To develop an anti-obesity agent, we examined the combination effect of glucosyl hesperidin (G-hesperidin) and caffeine on obesity in mice. High-fat diet-induced obese KK mice were fed a low-fat diet with or without G-hesperidin, caffeine, or their combination for 2weeks. Decreases in body weight and significantly lower adipose tissue weight were observed in the combination-fed mice but not in the G-hesperidin-fed or caffeine-fed mice. DNA microarray analysis of mouse liver suggested that the feeding of G-hesperidin+caffeine was associated with lower lipogenesis. Therefore, we examined the anti-lipogenic effect of G-hesperidin+caffeine in fasted-refed KK mice. Hepatic triglyceride levels were significantly lower in the mice fed G-hesperidin+caffeine during the refeeding period but not in the mice fed each alone. In addition, hepatic expressions of genes related to lipogenesis, such as sterol regulatory element-binding protein-1c or fatty acid synthase, were significantly lower in the mice fed G-hesperidin+caffeine compared with that in the control mice. These results suggested that G-hesperidin+caffeine is effective for controlling obesity partly by the inhibition of hepatic lipogenesis. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ohara, Tatsuya; Muroyama, Koutarou; Yamamoto, Yoshihiro; Murosaki, Shinji] House Wellness Foods Corp, Inst Res & Dev, Itami, Hyogo 6640011, Japan	Ohara, T (reprint author), House Wellness Foods Corp, Inst Res & Dev, 3-20 Imoji, Itami, Hyogo 6640011, Japan.	Ohara_Tatsuya@house-wf.co.jp					Jung UJ, 2006, INT J BIOCHEM CELL B, V38, P1134, DOI 10.1016/j.biocel.2005.12.002; Castellani LW, 2008, J BIOL CHEM, V283, P11633, DOI 10.1074/jbc.M708995200; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Garg A, 2001, PHYTOTHER RES, V15, P655, DOI 10.1002/ptr.1074; Akiyama S, 2009, BIOSCI BIOTECH BIOCH, V73, P2779, DOI 10.1271/bbb.90576; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; Plump AS, 1997, J LIPID RES, V38, P1033; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Quan HY, 2013, BMB REP, V46, P207, DOI 10.5483/BMBRep.2013.46.4.153; Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123; Ninomiya T, 2007, STROKE, V38, P2063, DOI 10.1161/STROKEAHA.106.479642; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Koutsari C, 2006, J LIPID RES, V47, P1643, DOI 10.1194/jlr.R600011-JLR200; Parks EJ, 1999, J CLIN INVEST, V104, P1087, DOI 10.1172/JCI6572; Chiba H, 2003, J NUTR, V133, P1892; ASTRUP A, 1992, METABOLISM, V41, P686, DOI 10.1016/0026-0495(92)90304-S; COSTILL DL, 1978, MED SCI SPORT EXER, V10, P155; Hijiyas H, 1991, European Patent, Patent No. [0402049 A2, 0402049]; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; LEIJTEN PAA, 1984, J PHYSIOL-LONDON, V357, P327; McCarthy MF, 2004, MED HYPOTHESES, V63, P1065, DOI 10.1016/j.mehy.2002.11.002; Mitsuzumis H, 2011, JPN PHARMACOL THER, V39, P727; Miwa Y, 2004, J NUTR SCI VITAMINOL, V50, P211; Miwa Y, 2005, J NUTR SCI VITAMINOL, V51, P460; Miwa Y, 2006, J NUTR SCI VITAMINOL, V52, P223, DOI 10.3177/jnsv.52.223; Murosaki S, 2007, J NUTR, V137, P2252; Muroyama K, 2003, J NUTR SCI VITAMINOL, V49, P56; Muroyama K, 2003, BIOSCI BIOTECH BIOCH, V67, P2325, DOI 10.1271/bbb.67.2325; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Yamada M, 2006, BIOSCI BIOTECH BIOCH, V70, P1386, DOI 10.1271/bbb.50657	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	FEB	2015	29	2					310	316		10.1002/ptr.5258		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CA7DB	WOS:000349076500016		
J	da Silva, JAT; Kim, H; Engelmann, F				da Silva, Jaime A. Teixeira; Kim, Haenghoon; Engelmann, Florent			Chrysanthemum low-temperature storage and cryopreservation: a review	PLANT CELL TISSUE AND ORGAN CULTURE			English	Review						Cold storage; Cryostorage; Encapsulation; In vitro storage; Liquid nitrogen; Plant growth regulators	DROPLET-VITRIFICATION PROCEDURES; CINERARIAEFOLIUM SHOOT TIPS; GRANDIFLORUM RAMAT KITAM; ENCAPSULATION-DEHYDRATION; IN-VITRO; PLANT-REGENERATION; IMPROVES CRYOPRESERVATION; FREEZING TOLERANCE; GENETIC STABILITY; APICAL MERISTEMS	Chrysanthemum (Dendranthema x grandiflora (Ramat.) Kitamura) is an ornamental plant that responds well to in vitro growth conditions. This receptivity makes it a particularly attractive target for low-temperature storage and cryopreservation studies. This review examines in detail the protocols thus far used to achieve the short- to long-term low-temperature and cryostorage of important chrysanthemum germplasm. Occasionally, medicinal chrysanthemum species have also been cryostored, and these studies are also examined in detail. Since chrysanthemum is sensitive to both osmotic stress and chemical toxicity of vitrification solutions, a generalized protocol for the cryopreservation of chrysanthemum apical or axillary shoot tips is proposed: excision of apical or axillary shoot tips after 4 or 7 weeks, respectively, from final subculture; progressive preculture with 10 % sucrose for 31 h, 17.5 % sucrose for 17 h, then 25 % sucrose for 7 h; osmoprotection with 17.5 % glycerol + 17.5 % sucrose for 40 min; cryoprotection with PVS3 (50 % glycerol + 50 % sucrose) vitrification solution for 60 min (axillary) or 90 min (apical); cooling and warming using aluminium foil strips; unloading with 30 % sucrose for 40 min. When smaller axillary shoot tips are used, cryoprotection of samples with 37.5 % glycerol + 15 % DMSO + 15 % ethylene glycol + 22.5 % sucrose at 0 A degrees C for about 60 min can be applied.	[Kim, Haenghoon] Sunchon Natl Univ, Dept Well Being Resources, Sunchon 540742, South Korea; [Engelmann, Florent] IRD, UMR DIADE, F-34394 Montpellier 5, France	da Silva, JAT (reprint author), POB 7,Miki Cho PO,Ikenobe 3011-2, Kagawa Ken 7610799, Japan.	jaimetex@yahoo.com; cryohkim@sunchon.ac.kr; florent.engelmann@ird.fr					Osorio-Saenz A, 2011, CRYOLETTERS, V32, P477; Sharma S, 2013, BIOTECHNOL ADV, V31, P186, DOI 10.1016/j.biotechadv.2012.09.007; Yamamoto S, 2011, CRYOLETTERS, V32, P256; Kim HH, 2009, CRYOLETTERS, V30, P320; Sakai A, 2007, CRYOLETTERS, V28, P151; Martin C, 2005, CRYOBIOLOGY, V51, P281, DOI 10.1016/j.cryobiol.2005.08.001; Gusta LV, 2005, J PLANT GROWTH REGUL, V24, P308, DOI 10.1007/s00344-005-0079-x; Wang RR, 2014, SCI HORTIC-AMSTERDAM, V176, P330, DOI 10.1016/j.scienta.2014.07.031; Panis B, 2005, PLANT SCI, V168, P45, DOI 10.1016/j.plantsci.2004.07.022; Lee YG, 2011, CRYOLETTERS, V32, P487; Kim HH, 2012, CRYOLETTERS, V33, P271; Engelmann F, 2011, IN VITRO CELL DEV-PL, V47, P5, DOI 10.1007/s11627-010-9327-2; Hitmi A, 2000, J PLANT PHYSIOL, V156, P408; Kim HH, 2009, CRYOLETTERS, V30, P291; Engelmann F, 2004, IN VITRO CELL DEV-PL, V40, P427, DOI 10.1079/IVP2004541; Martin C, 2011, J PLANT PHYSIOL, V168, P158, DOI 10.1016/j.jplph.2010.06.025; Sakai A, 2000, CRYO-LETT, V21, P53; da Silva JAT, 2004, PLANT CELL TISS ORG, V79, P1, DOI 10.1023/B:TICU.0000049444.67329.b9; Halmagyi A, 2004, PLANT CELL REP, V22, P371, DOI 10.1007/s00299-003-0703-9; FUKAI S, 1991, EUPHYTICA, V54, P201; Niino T, 2013, CRYOLETTERS, V34, P549; MATSUMOTO T, 1994, PLANT CELL REP, V13, P442, DOI 10.1007/BF00231963; Ashmore S. E., 1997, STATUS REPORT DEV AP; BANNIER L J, 1972, Hortscience, V7, P194; Budiarto K, 2009, JURNAL BUMI LESTARI, V9, P48; Engelmann F, 2012, CONSERVATION TROPICA, P107; Fukai S., 1992, MEM FAC AGR KAGAWA U, V56, P1; FUKAI S, 1990, SCI HORTIC-AMSTERDAM, V45, P167, DOI 10.1016/0304-4238(90)90079-T; Fukai S, 1988, PLANT TISSUE CULTURE, V5, P20; FUKAI S, 1994, SCI HORTIC-AMSTERDAM, V57, P347, DOI 10.1016/0304-4238(94)90117-1; FUKAI S, 1990, J JPN SOC HORTIC SCI, V59, P383; Gonzalez-Arnao MT, 2006, CRYOLETTERS, V27, P155; Hayat Shamsul, 2012, Plant Signal Behav, V7, P1456, DOI 10.4161/psb.21949; Hitmi A, 1997, PLANT CELL REP, V17, P60, DOI 10.1007/s002990050352; Hitmi A, 1999, CRYO-LETT, V20, P45; Hitmi A, 2000, J PLANT PHYSIOL, V157, P47; Hitmi A, 1999, CRYO-LETT, V20, P113; Lambardi M, 2006, FLORICULTURE ORNAMEN, V2, P347; Lee YG, 2011, CNU J AGR SCI, V38, P227; [刘艳霞 LIU Yan-xia], 2009, [植物遗传资源学报, Journal of Plant Genetic Resources], V10, P249; [刘蓁 Liu Zhen], 2010, [药物生物技术, Pharmaceutical Biotechnology], V17, P237; Mallon R, 2008, CRYOLETTERS, V29, P363; MAZUR P, 1984, AM J PHYSIOL, V247, pC125; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NISHIZAWA S, 1993, PLANT SCI, V91, P67, DOI 10.1016/0168-9452(93)90189-7; Normah MN, 2012, CONSERVATION TROPICA; Ozudogru EA, 2010, METHODS MOL BIOL, V589, P303, DOI 10.1007/978-1-60327-114-1_28; Pinker I, 2005, PROPAG ORNAM PLANTS, V5, P186; Reed B.M., 2008, PLANT CRYOPRESERVATI; ROXAS NJL, 1995, J JPN SOC HORTIC SCI, V63, P863; SAKAI A, 1990, PLANT CELL REP, V9, P30, DOI 10.1007/BF00232130; Shinoyama H., 2006, FLORICULTURE ORNAMEN, VI, P140; Silva J. A. T. da, 2003, African Journal of Biotechnology, V2, P547; Teixeira da Silva JA, 2005, J HERBS SPICES MED P, V11, P1; da Silva JAT, 2003, BIOTECHNOL ADV, V21, P715, DOI 10.1016/S0734-9750(03)00117-4; TEIXEIRA DA SILVA J.A., 2012, ASIAN AUSTRALASIAN J, V6, P121; da Silva JAT, 2013, CRIT REV PLANT SCI, V32, P21, DOI 10.1080/07352689.2012.696461; Silva J. A. T. da, 2004, African Journal of Biotechnology, V3, P706; Trifunovic M, 2007, ACTA HORTIC, P319; Withers L, 1998, BIOTECHNOLOGY AGR, P57; Yoon JW, 2006, CRYOLETTERS, V27, P211; Zalewska Malgorzata, 2013, Folia Horticulturae, V25, P133, DOI 10.2478/fhort-2013-0015	62	2	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6857	1573-5044		PLANT CELL TISS ORG	Plant Cell Tissue Organ Cult.	FEB	2015	120	2					423	440		10.1007/s11240-014-0641-y		18	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CA3LE	WOS:000348807200002		
J	Salak, F; Uemura, S; Sugimoto, K				Salak, Feridoun; Uemura, Satoshi; Sugimoto, Kiyotoshi			Thermal Pretreatment of Kudzu Biomass (Pueraria lobata) as Filler in Cost-Effective PLA Biocomposite Fabrication Process	POLYMER ENGINEERING AND SCIENCE			English	Article							COMPOSITES; ACID; FIBERS; BIODEGRADABILITY; POLY(L-LACTIDE); NANOCOMPOSITES; POLYLACTIDE; GLYCOL)	This article aims on the fabrication of cost-effective polylactic acid (PLA) biocomposites using kudzu biomass derivatives as new filler. In this way, it has been realized that pretreatment of the filler was an essential requirement. We demonstrated thermal pyrolysis process that targeted to extraction and isolation of all extractable and unnecessary compounds such as intracellular water and bio-oil from the biomass. Also, to further improve the compatibility of the filler with PLA, noncatalytic thermal esterification reactions of kudzu after thermal pyrolysis (called char) were carried out as second pretreatment stage in the presence of phthalic anhydride. Kudzu derivatives obtained from either first or second pretreatment reactions were melt-blended with PLA in various rates. The blends were then compression molded into dumbbell specimens. Physicomechanical properties of the prepared biocomposites were evaluated using several analytical techniques. It was found that biocomposites containing treated biomass had higher values of physicomechanical properties than untreated ones. The final rate of filler to PLA with acceptable properties was set up to 50%. Obviously, the cost of PLA can be reduced using higher rates of low-cost filler on a finished-product basis. Extracted valuable compounds from biomass via thermal pyrolysis could be another benefit of the process. POLYM. ENG. SCI., 55:340-348, 2015. (c) 2014 Society of Plastics Engineers	[Salak, Feridoun; Uemura, Satoshi; Sugimoto, Kiyotoshi] Nara Prefectural Govt, Nara Prefecture Inst Ind Dev, Life Mat Grp, Nara 6308031, Japan	Salak, F (reprint author), Nara Prefectural Govt, Nara Prefecture Inst Ind Dev, Life Mat Grp, Nara 6308031, Japan.	salak_feridoun@yahoo.co.jp					Harris AM, 2008, J APPL POLYM SCI, V107, P2246, DOI 10.1002/app.27261; Becidan M, 2007, J ANAL APPL PYROL, V78, P207, DOI 10.1016/j.jaap.2006.07.002; Bodirlau R, 2008, BIORESOURCES, V3, P789; Kulinski Z, 2006, BIOMACROMOLECULES, V7, P2128, DOI 10.1021/bm060089m; Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.0.CO;2-E; Ishida S, 2009, J APPL POLYM SCI, V113, P558, DOI 10.1002/app.30134; Pluta M, 2006, J POLYM SCI POL PHYS, V44, P299, DOI 10.1002/polb.20694; Chun KS, 2013, POLYM-PLAST TECHNOL, V52, P287, DOI 10.1080/03602559.2012.749282; WOODHAMS RT, 1984, POLYM ENG SCI, V24, P1166, DOI 10.1002/pen.760241504; Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5; Bessadok A, 2008, COMPOS PART A-APPL S, V39, P29, DOI 10.1016/j.compositesa.2007.09.007; Wu CS, 2005, MACROMOL BIOSCI, V5, P352, DOI 10.1002/mabi.200400159; Salmah H, 2012, POLYM-PLAST TECHNOL, V51, P86, DOI 10.1080/03602559.2011.618156; Salmah H, 2013, J THERMOPLAST COMPOS, V26, P809, DOI 10.1177/0892705711429981; Raquez JM, 2008, MACROMOL MATER ENG, V293, P447, DOI 10.1002/mame.200700395; Ross AB, 2008, BIORESOURCE TECHNOL, V99, P6494, DOI 10.1016/j.biortech.2007.11.036; Chun KS, 2013, POLYM ENG SCI, V53, P1109, DOI 10.1002/pen.23359; Siyamak S, 2012, MOLECULES, V17, P1969, DOI 10.3390/molecules17021969; Qu P, 2010, BIORESOURCES, V5, P1811; Chun KS, 2013, BIORESOURCES, V8, P3260; Wu CS, 2003, POLYM DEGRAD STABIL, V80, P127, DOI 10.1016/S0141-3910(02)00393-2; Boonfaung P., 2011, P PUR APPL CHEM INT, V621; Daneshvar S., 2012, INT J CHEM ENG APPL, V3, P256; Drzal L. T., 2005, NATURAL FIBERS BIOPO, P113; Farsi M., 2012, J REINF PLAST COMP, V24, P3587; GUO WY, 1993, J APPL POLYM SCI, V50, P1435, DOI 10.1002/app.1993.070500815; Jia ZY, 2009, J APPL POLYM SCI, V114, P1105, DOI 10.1002/app.30638; Müller-Hagedorn M., 2007, Journal of Analytical and Applied Pyrolysis, V79, P136, DOI 10.1016/j.jaap.2006.12.008; Noorunisa K., 2007, J REINFORCED PLASTIC, V26, P1065; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Rosseinsky MJ, 2004, MICROPOR MESOPOR MAT, V73, P15, DOI 10.1016/j.micromeso.2003.05.001; Thomas S., 2001, HDB ENG SPECIALTY TH, V3, P349; Venkatesha Prasanna G., 2013, SCH J ENG RES, V2, P21	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0032-3888	1548-2634		POLYM ENG SCI	Polym. Eng. Sci.	FEB	2015	55	2					340	348		10.1002/pen.23909		9	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	AZ7XE	WOS:000348427600012		
J	Gong, PJ; Ohshima, M				Gong, Pengjian; Ohshima, Masahiro			Open-Cell Foams of Polyethylene Terephthalate/Bisphenol A Polycarbonate Blend	POLYMER ENGINEERING AND SCIENCE			English	Article							POLYMER BLENDS; POLY(ETHYLENE-TEREPHTHALATE); CRYSTALLIZATION; MISCIBILITY; MORPHOLOGY; TRANSESTERIFICATION; COMPATIBILITY; COALESCENCE; EXTRUSION; BEHAVIOR	Open microcellular foams of polyethylene terephthalate (PET)/polycarbonate (PC) blends were prepared by controlling their foaming behavior at the interface between these two polymers. Interface modification was a crucial factor in governing the foaming behavior and cell morphology of the blend foams: annealing at 280 degrees C, i.e., conducting the transesterification reaction, generates a PET-b-PC copolymer, which lowers the interfacial tension, increases the affinity between PET and PC, and decreases the crystallinity of the PET domains. When CO2 foaming was performed at the interface modified with the copolymer, an interesting fibril-like structure was formed. The cell density of the PET/PC blend then increased, and its cell size reduced to the microscale while maintaining a high open-cell ratio. The effect of heat annealing (transesterification reaction) on CO2-foaming was studied to reveal the relationship among the interface affinity, crystallinity, and degree of fibrillation. The optimal heat-annealing procedure generated a fibril-like structure in the PET/PC blend foams with a high cell density (7 x 10(11) cm(-3)), small cell size (less than 2 m), and 100% open-cell ratio. POLYM. ENG. SCI., 55:375-385, 2015. (c) 2014 Society of Plastics Engineers	[Gong, Pengjian; Ohshima, Masahiro] Kyoto Univ, Dept Chem Engn, Kyoto 606, Japan	Ohshima, M (reprint author), Kyoto Univ, Dept Chem Engn, Kyoto 606, Japan.	m.ohshima@kyoto-u.ac.jp					KIM WN, 1987, MACROMOLECULES, V20, P1876, DOI 10.1021/ma00174a030; Zhai WT, 2008, J POLYM SCI POL PHYS, V46, P1641, DOI 10.1002/polb.21498; Zhai WT, 2008, POLYM ENG SCI, V48, P1312, DOI 10.1002/pen.21095; Lee PC, 2005, POLYM ENG SCI, V45, P1445, DOI 10.1002/pen.20422; Marin N, 2002, POLYMER, V43, P4723, DOI 10.1016/S0032-3861(02)00280-X; Krause B, 2001, MACROMOLECULES, V34, P8792, DOI 10.1021/ma010854j; Krause B, 2002, MACROMOLECULES, V35, P1738, DOI 10.1021/ma011672s; Wang ZG, 1999, POLYMER, V40, P4615, DOI 10.1016/S0032-3861(99)00067-1; Park CB, 2005, J POLYM ENG, V25, P239; Asthana H, 1999, MACROMOLECULES, V32, P3412, DOI 10.1021/ma980181d; Ma DZ, 1999, J POLYM SCI POL PHYS, V37, P2960, DOI 10.1002/(SICI)1099-0488(19991101)37:21<2960::AID-POLB6>3.0.CO;2-V; Wong DT, 2012, J MEMBRANE SCI, V394, P175, DOI 10.1016/j.memsci.2011.12.037; GRAEBLING D, 1993, MACROMOLECULES, V26, P320, DOI 10.1021/ma00054a011; Spitael P, 2004, POLYM ENG SCI, V44, P2090, DOI 10.1002/pen.20214; Spitael P, 2004, MACROMOLECULES, V37, P6874, DOI 10.1021/ma049712q; Kohlhoff D, 2011, MACROMOL MATER ENG, V296, P770, DOI 10.1002/mame.201000371; PORTER RS, 1992, POLYMER, V33, P2019, DOI 10.1016/0032-3861(92)90866-U; Fiorini M, 1997, POLYMER, V38, P413, DOI 10.1016/S0032-3861(96)00520-4; Gong PJ, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39228; Gong PJ, 2011, J MACROMOL SCI B, V50, P329, DOI 10.1080/00222341003652302; Gong PJ, 2012, J POLYM SCI POL PHYS, V50, P1173, DOI 10.1002/polb.23099; Klempner D., 1991, HDB POLYM FOAMS FOAM; Krause B, 2001, J MEMBRANE SCI, V187, P181, DOI 10.1016/S0376-7388(01)00329-5; Kumar C. A., 2011, POLYM ENG SCI, V51, P1749; Lee PC, 2006, IND ENG CHEM RES, V45, P175, DOI 10.1021/ie050498j; Lee PC, 2007, J CELL PLAST, V43, P431, DOI 10.1177/0021955X07079150; Li Y, 2011, CHEM ENG SCI, V66, P3656, DOI 10.1016/j.ces.2011.04.035; Liao Q, 2012, POLYM ENG SCI, V52, P1495, DOI 10.1002/pen.23087; Liao X., 2012, J NANOMATER, V1, P2012; Mantovani M., 2005, Japan Patent, Patent No. [4279,624, 4279624]; Miyamoto R., 2012, P POL PROC SOC 28 AN; NASSAR TR, 1979, J APPL POLYM SCI, V23, P85, DOI 10.1002/app.1979.070230108; Park CB, 2006, CELL POLYM, V25, P1; Ruckdaschel H, 2010, ADV POLYM SCI, V227, P199, DOI 10.1007/12_2009_32; Sharudin R. W., 2010, J APPL POLYM SCI, V119, P1042; Siripurapu S, 2005, MACROMOLECULES, V38, P2271, DOI 10.1021/ma047991b; SUZUKI T, 1989, POLYMER, V30, P1287, DOI 10.1016/0032-3861(89)90050-5; The Society of Polymer Science, 2006, KIS; Tol RT, 2005, POLYMER, V46, P2955, DOI 10.1016/j.polymer.2005.02.020; Zhai WT, 2012, POLYM ENG SCI, V52, P2078, DOI 10.1002/pen.23157; Zhang ZP, 2001, EUR POLYM J, V37, P1961, DOI 10.1016/S0014-3057(01)00089-1	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0032-3888	1548-2634		POLYM ENG SCI	Polym. Eng. Sci.	FEB	2015	55	2					375	385		10.1002/pen.23894		11	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	AZ7XE	WOS:000348427600016		
J	Nakahara, H				Nakahara, Hisashi			Auto Correlation Analysis of Coda Waves from Local Earthquakes for Detecting Temporal Changes in Shallow Subsurface Structures: the 2011 Tohoku-Oki, Japan Earthquake	PURE AND APPLIED GEOPHYSICS			English	Article						Temporal changes; coda waves; auto correlation; Tohoku-Oki earthquake	PASSIVE IMAGE INTERFEROMETRY; TIME-LAPSE CHANGES; M-W 9.0; SEISMIC VELOCITY; PACIFIC COAST; SITE RESPONSE; KIK-NET; K-NET; FAULT; CRUST	For monitoring temporal changes in subsurface structures I propose to use auto correlation functions of coda waves from local earthquakes recorded at surface receivers, which probably contain more body waves than surface waves. Use of coda waves requires earthquakes resulting in decreased time resolution for monitoring. Nonetheless, it may be possible to monitor subsurface structures in sufficient time resolutions in regions with high seismicity. In studying the 2011 Tohoku-Oki, Japan earthquake (Mw 9.0), for which velocity changes have been previously reported, I try to validate the method. KiK-net stations in northern Honshu are used in this analysis. For each moderate earthquake normalized auto correlation functions of surface records are stacked with respect to time windows in the S-wave coda. Aligning the stacked, normalized auto correlation functions with time, I search for changes in phases arrival times. The phases at lag times of < 1 s are studied because changes at shallow depths are focused. Temporal variations in the arrival times are measured at the stations based on the stretching method. Clear phase delays are found to be associated with the mainshock and to gradually recover with time. The amounts of the phase delays are 10 % on average with the maximum of about 50 % at some stations. The deconvolution analysis using surface and subsurface records at the same stations is conducted for validation. The results show the phase delays from the deconvolution analysis are slightly smaller than those from the auto correlation analysis, which implies that the phases on the auto correlations are caused by larger velocity changes at shallower depths. The auto correlation analysis seems to have an accuracy of about several percent, which is much larger than methods using earthquake doublets and borehole array data. So this analysis might be applicable in detecting larger changes. In spite of these disadvantages, this analysis is still attractive because it can be applied to many records on the surface in regions where no boreholes are available.	Tohoku Univ, Grad Sch Sci, Dept Geophys, Aoba Ku, Sendai, Miyagi 9808578, Japan	Nakahara, H (reprint author), Tohoku Univ, Grad Sch Sci, Dept Geophys, Aoba Ku, 6-3 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.	naka@zisin.gp.tohoku.ac.jp			JST J-RAPID program; JSPS KAKENHI [24540449, 23540449]	Seismograms recorded by KiK-net and managed by the National Research Institute for Earth Science and Disaster Prevention (NIED) were used in this study. I am grateful to Takeshi Nishimura, Florent Brenguier, Mare Yamamoto and the other members of our Japan-France "Namazu" project for enlightening discussions. The idea for the method used in this study came from long collaboration with Kazuo Yoshimoto. Comments from the editor, Dr. Koji Uenishi, and two anonymous reviewers were really helpful to improve the quality of this manuscript. Some of the figures were made using the Generic Mapping Tool (WESSEL and SMITH 1998). This study was partially supported by the JST J-RAPID program and JSPS KAKENHI Grant Numbers 24540449 and 23540449.	Wegler U, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005869; Bonilla LF, 2011, EARTH PLANETS SPACE, V63, P785, DOI 10.5047/eps.2011.06.012; Snieder R, 2002, SCIENCE, V295, P2253, DOI 10.1126/science.1070015; Sawazaki K, 2009, B SEISMOL SOC AM, V99, P352, DOI 10.1785/0120080058; GARDNER GHF, 1974, GEOPHYSICS, V39, P770, DOI 10.1190/1.1440465; Nakata N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048800; Shapiro NM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019491; Vidale JE, 2003, NATURE, V421, P524, DOI 10.1038/nature01354; Wegler U, 2007, GEOPHYS J INT, V168, P1029, DOI 10.1111/j.1365-246X.2006.03284.x; Minato S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051405; Brenguier F, 2008, NAT GEOSCI, V1, P126, DOI 10.1038/ngeo104; POUPINET G, 1984, J GEOPHYS RES, V89, P5719, DOI 10.1029/JB089iB07p05719; Hadziioannou C, 2009, J ACOUST SOC AM, V125, P3688, DOI 10.1121/1.3125345; RATDOMOPURBO A, 1995, GEOPHYS RES LETT, V22, P775, DOI 10.1029/95GL00302; Campillo M, 2003, SCIENCE, V299, P547, DOI 10.1126/science.1078551; Wegler U., 2006, Geophysical Research Letters, V33, DOI 10.1029/2006GL025928; CLAERBOU.JF, 1968, GEOPHYSICS, V33, P264, DOI 10.1190/1.1439927; DANESHVAR MR, 1995, GEOPHYSICS, V60, P1178, DOI 10.1190/1.1443846; Furumoto M, 2001, GEOPHYS RES LETT, V28, P3737, DOI 10.1029/2001GL013172; Ikuta R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013974; Li YG, 1998, SCIENCE, V279, P217, DOI 10.1126/science.279.5348.217; Nakahara H, 2006, GEOPHYS J INT, V165, P719, DOI 10.1111/J.1365-246X.2006.02916.X; Nakahara H, 2013, B SEISMOL SOC AM, V103, P1348, DOI 10.1785/0120120155; Nakata N, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008595; Nishimura T, 2005, EARTH PLANETS SPACE, V57, P491; NISHIMURA T., 2013, GEOPHYS J INT UNPUB; Ohmi S, 2008, EARTH PLANETS SPACE, V60, P1069; Okada Y, 2004, EARTH PLANETS SPACE, V56, pXV; Sato H, 2012, SEISMIC WAVE PROPAGA; Sawazaki K, 2013, GEOPHYS J INT, V193, P238, DOI 10.1093/gji/ggs080; SCHERBAUM F, 1987, B SEISMOL SOC AM, V77, P1905; Sens-Schonfelder C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027797; Takagi R, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051342; TSUTSUI T, 1992, GEOPHYS PROSPECT, V40, P15, DOI 10.1111/j.1365-2478.1992.tb00362.x; Uchida N, 2004, TECTONOPHYSICS, V385, P1, DOI 10.1016/j.tecto.2004.04.015; WEAVER R., 2002, ULTRASONICS, V20, P436; WESSEL P, 1998, EOS T AGU, V0079; Wu CQ, 2011, EARTH PLANETS SPACE, V63, P791, DOI 10.5047/eps.2011.06.011; YOSHIMOTO K., 2008, 7 GEN ASS AS SEISM C	39	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0033-4553	1420-9136		PURE APPL GEOPHYS	Pure Appl. Geophys.	FEB	2015	172	2					213	224		10.1007/s00024-014-0849-0		12	Geochemistry & Geophysics	Geochemistry & Geophysics	CA3DT	WOS:000348787100002		
J	Zhang, P; Matsumoto, R				Zhang, Paul; Matsumoto, Ryutaroh			Quantum strongly secure ramp secret sharing	QUANTUM INFORMATION PROCESSING			English	Article						Quantum secret sharing; Non-perfect secret sharing; Ramp secret sharing; Strong security		Quantum secret sharing is a scheme for encoding a quantum state (the secret) into multiple shares and distributing them among several participants. If a sufficient number of shares are put together, then the secret can be fully reconstructed. If an insufficient number of shares are put together however, no information about the secret can be revealed. In quantum ramp secret sharing, partial information about the secret is allowed to leak to a set of participants, called an unqualified set, that cannot fully reconstruct the secret. By allowing this, the size of a share can be drastically reduced. This paper introduces a quantum analog of classical strong security in ramp secret sharing schemes. While the ramp secret sharing scheme still leaks partial information about the secret to unqualified sets of participants, the strong security condition ensures that qudits with critical information can no longer be leaked.	[Zhang, Paul] CALTECH, Pasadena, CA 91125 USA; [Matsumoto, Ryutaroh] Tokyo Inst Technol, Dept Commun & Comp Engn, Tokyo 152, Japan; [Matsumoto, Ryutaroh] Aalborg Univ, Dept Math Sci, Aalborg, Denmark	Matsumoto, R (reprint author), CALTECH, Pasadena, CA 91125 USA.	pzpzpzp1@gmail.com; ryutaroh@rmatsumoto.org		Matsumoto, Ryutaroh/0000-0002-5085-8879	Ministry of Education, Culture, Sports, Science and Technology; National Institute of Information and Communications Technology, Japan; Japan Society for the Promotion of Science [23246071, 26289116]; Villum Foundation	The authors would like to thank the reviewers for their careful reading that improved the presentation. This research was conducted as part of Tokyo Institute of Technology International Research Opportunities Program under Re-Inventing Japan Project funded by Ministry of Education, Culture, Sports, Science and Technology. This research is partly supported by the National Institute of Information and Communications Technology, Japan, and by the Japan Society for the Promotion of Science Grant Nos. 23246071 and 26289116, and the Villum Foundation through their VELUX Visiting Professor Programme 2013-2014.	SHAMIR A, 1979, COMMUN ACM, V22, P612, DOI 10.1145/359168.359176; Ogawa T, 2005, PHYS REV A, V72, DOI [10.1103/PhysRevA.72.032318, 10.1103/PhysRevA.032318]; Cleve R, 1999, PHYS REV LETT, V83, P648, DOI 10.1103/PhysRevLett.83.648; Gottesman D, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.042311; Blakley G.R., 1985, LNCS, V196, P242; Capocelli R. M., 1993, Journal of Cryptology, V6; Iwamoto M, 2006, INFORM PROCESS LETT, V97, P52, DOI 10.1016/j.ipl.2005.09.012; MCELIECE RJ, 1981, COMMUN ACM, V24, P583, DOI 10.1145/358746.358762; Nielsen M, 2000, QUANTUM COMPUTATION; Nishiara Mikihiko, 2009, IEICE Transactions on Fundamentals of Electronics, Communications and Computer Sciences, VJ92-A; Ogata W., 1993, LECT NOTES COMPUTER, V718, P56, DOI [10.1007/3-540-57220-1_52, DOI 10.1007/3-540-57220-1_52]; Smith A.D., 2000, ARXIVQUANTPH0001087; Stinson D. S., 2006, CRYPTOGRAPHY THEORY; Yamamoto H., 1986, Electronics and Communications in Japan, Part 1 (Communications), V69, DOI 10.1002/ecja.4410690906	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1570-0755	1573-1332		QUANTUM INF PROCESS	Quantum Inf. Process.	FEB	2015	14	2					715	729		10.1007/s11128-014-0863-2		15	Physics, Multidisciplinary; Physics, Mathematical	Physics	CA6KS	WOS:000349022800020		
J	Ohno, Y; Nishio, M; Koyama, H; Seki, S; Tsubakimoto, M; Fujisawa, Y; Yoshikawa, T; Matsumoto, S; Sugimura, K				Ohno, Yoshiharu; Nishio, Mizuho; Koyama, Hisanobu; Seki, Shinichiro; Tsubakimoto, Maho; Fujisawa, Yasuko; Yoshikawa, Takeshi; Matsumoto, Sumiaki; Sugimura, Kazuro			Solitary Pulmonary Nodules: Comparison of Dynamic First-Pass Contrast-enhanced Perfusion Area-Detector CT, Dynamic First-Pass Contrast-enhanced MR Imaging, and FDG PET/CT	RADIOLOGY			English	Article							MULTIDETECTOR ROW CT; BLOOD-FLOW; FLEISCHNER-SOCIETY; INTEGRATED PET/CT; BENIGN LESIONS; WASH-IN; MANAGEMENT; MALIGNANCY; STATEMENT; DIAGNOSIS	Purpose: To prospectively compare the capabilities of dynamic perfusion area-detector computed tomography (CT), dynamic magnetic resonance (MR) imaging, and positron emission tomography (PET) combined with CT (PET/CT) with use of fluorine 18 fluorodeoxyglucose (FDG) for the diagnosis of solitary pulmonary nodules. Materials and Methods: The institutional review board approved this study, and written informed consent was obtained from each subject. A total of 198 consecutive patients with 218 nodules prospectively underwent dynamic perfusion area-detector CT, dynamic MR imaging, FDG PET/CT, and microbacterial and/or pathologic examinations. Nodules were classified into three groups: malignant nodules (n = 133) and benign nodules with low (n = 53) or high (n = 32) biologic activity. Total perfusion was determined with dual-input maximum slope models at area-detector CT, maximum and slope of enhancement ratio at MR imaging, and maximum standardized uptake value (SUVmax) at PET/CT. Next, all indexes for malignant and benign nodules were compared with the Tukey honest significant difference test. Then, receiver operating characteristic analysis was performed for each index. Finally, sensitivity, specificity, and accuracy were compared with the McNemar test. Results: All indexes showed significant differences between malignant nodules and benign nodules with low biologic activity (P < .0001). The area under the receiver operating characteristic curve for total perfusion was significantly larger than that for other indexes (. 0006 <= P <= .04). The specificity and accuracy of total perfusion were significantly higher than those of maximum relative enhancement ratio (specificity, P < .0001; accuracy, P < .0001), slope of enhancement ratio (specificity, P < .0001; accuracy, P < .0001), and SUVmax (specificity, P < .0001; accuracy, P < .0001). Conclusion: Dynamic perfusion area-detector CT is more specific and accurate than dynamic MR imaging and FDG PET/CT in the diagnosis of solitary pulmonary nodules in routine clinical practice. (C) RSNA, 2014	[Ohno, Yoshiharu; Nishio, Mizuho; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, Kobe, Hyogo 6500017, Japan; [Ohno, Yoshiharu; Nishio, Mizuho; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch Med, Div Funct & Diagnost Imaging Res, Dept Radiol, Kobe, Hyogo 6500017, Japan; [Koyama, Hisanobu; Seki, Shinichiro; Tsubakimoto, Maho; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Div Radiol, Dept Radiol, Kobe, Hyogo 6500017, Japan; [Fujisawa, Yasuko] Toshiba Med Syst, Otawara, Japan	Ohno, Y (reprint author), Kobe Univ, Grad Sch Med, Adv Biomed Imaging Res Ctr, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yosirad@kobe-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (JSTS.KAKEN) [24591762]; Toshiba Medical Systems; Bayer Pharma	Supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (JSTS. KAKEN; No. 24591762); Toshiba Medical Systems; and Bayer Pharma.	Ohno Y, 2008, J MAGN RESON IMAGING, V27, P1284, DOI 10.1002/jmri.21348; Zhang MM, 1997, RADIOLOGY, V205, P471; Matthies A, 2002, J NUCL MED, V43, P871; Schaefer JF, 2004, RADIOLOGY, V232, P544, DOI 10.1148/radiol.2322030515; Ohno Y, 2011, RADIOLOGY, V258, P599, DOI 10.1148/radiol.10100245; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Swensen SJ, 2000, RADIOLOGY, V214, P73; Li Y, 2010, BRIT J RADIOL, V83, P785, DOI 10.1259/bjr/58020866; Sitartchouk I, 2008, INVEST RADIOL, V43, P349, DOI 10.1097/RLI.0b013e3181690148; Cronin P, 2008, RADIOLOGY, V246, P772, DOI 10.1148/radiol.2463062148; Ng QS, 2006, RADIOLOGY, V239, P547, DOI 10.1148/radiol.2392050568; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Bury T, 1996, EUR RESPIR J, V9, P410, DOI 10.1183/09031936.96.09030410; Ohno Y, 2002, RADIOLOGY, V224, P503, DOI 10.1148/radiol.2242010992; Aquino SL, 2006, EUR J NUCL MED MOL I, V33, P692, DOI 10.1007/s00259-005-0018-x; Swensen SJ, 1996, RADIOLOGY, V201, P447; Yi CA, 2006, J NUCL MED, V47, P443; BLAND JM, 1986, LANCET, V1, P307; Cotran RS, 1999, PATHOLOGIC BASIS DIS, P50; Gupta NC, 1996, J NUCL MED, V37, P943; Jeong YJ, 2005, RADIOLOGY, V237, P675, DOI 10.1148/radiol.2372041549; Lee KS, 2007, CHEST, V131, P1516, DOI 10.1378/chest.06-2526; LITTLETON JT, 1990, RADIOLOGY, V177, P861; MILNE ENC, 1977, INVEST RADIOL, V12, P479; MILNE ENC, 1967, AMER J ROENTGENOL RA, V100, P603; Milne E N, 1987, J Thorac Imaging, V2, P15, DOI 10.1097/00005382-198710000-00005; MILNE ENC, 1976, INT J RADIAT ONCOL, V1, P739; Ohno Y, 2013, AM J ROENTGENOL, V200, pW593, DOI 10.2214/AJR.12.9197; Ohno Y, 2007, J MAGN RESON IMAGING, V25, P55, DOI 10.1002/jmri.20790; OIKAWA M, 1975, CANCER, V35, P385, DOI 10.1002/1097-0142(197502)35:2<385::AID-CNCR2820350214>3.0.CO;2-A	30	1	2	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	FEB	2015	274	2					563	575		10.1148/radiol.14132289		13	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA1WS	WOS:000348700300029		
J	Hirooka, M; Koizumi, Y; Miyake, T; Ochi, H; Tokumoto, Y; Tada, F; Matsuura, B; Abe, M; Hiasa, Y				Hirooka, Masashi; Koizumi, Yohei; Miyake, Teruki; Ochi, Hironori; Tokumoto, Yoshio; Tada, Fujimasa; Matsuura, Bunzo; Abe, Masanori; Hiasa, Yoichi			Nonalcoholic Fatty Liver Disease: Portal Hypertension Due to Outflow Block in Patients without Cirrhosis	RADIOLOGY			English	Article							TIME TISSUE ELASTOGRAPHY; METABOLIC SYNDROME; NONINVASIVE DIAGNOSIS; ESOPHAGEAL-VARICES; DOPPLER FLOWMETRY; SPLEEN STIFFNESS; HEPATIC-FIBROSIS; FLOW; STEATOHEPATITIS; SEVERITY	Purpose: To prospectively evaluate whether the characteristics of hepatic blood flow change during the early stages of fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Materials and Methods: All participants provided written informed consent, and the study protocols were approved by the institutional ethics committee. A total of 121 patients with NAFLD that was diagnosed at histologic examination were enrolled. Hepatic blood flow was measured by means of Doppler ultrasonography (US), and the ratio of arterial to portal blood flow (arterioportal ratio) was calculated. Elasticity of the spleen was measured by means of real-time tissue elastography. The elastic ratio was measured as the value in the small splenic vessel divided by the value of the splenic parenchyma. The arterioportal ratio and splenic elasticity were compared in patients with all stages of fibrosis (F0-F4) and with all levels of platelet counts. Correlations among the resistive index of the hepatic artery and that of the splenic artery, the fibrosis 4 index, hepatic elasticity, arterioportal ratio, splenic elasticity, and platelet counts were analyzed. Univariate and multivariate logistic regression analyses were performed. Correlations in patients with platelet counts greater than 200000/mu L also were analyzed. Results: The mean 6 standard deviation arterioportal ratio was significantly higher at fibrosis stage 2 (2.4 +/- 0.6) than at fibrosis stage 0 (1.8 +/- 0.4) in patients with NAFLD (P < .01). Increased splenic stiffness at earlier stages of fibrosis also was observed in patients with NAFLD (fibrosis stage 2, 4.4 +/- 2.3; fibrosis stage 0, 3.2 +/- 1.9; P < .05). In patients with NAFLD with platelet counts higher than 200000/mu L, pericellular fibrosis was the only significant predictor of hepatic hemodynamic change at multivariate analysis (odds ratio, 7.17; 95% confidence interval: 1.33, 57.13; P = .021). Conclusion: Change in hepatic blood flow occurred during the earliest stage of hepatic fibrosis in patients with NAFLD because of outflow block in the sinusoidal area. (C) RSNA, 2014	[Hirooka, Masashi; Koizumi, Yohei; Miyake, Teruki; Ochi, Hironori; Tokumoto, Yoshio; Tada, Fujimasa; Matsuura, Bunzo; Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan	Hiasa, Y (reprint author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime 7910295, Japan.	hiasa@m.ehime-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [25860541, 24590980]; Japanese Ministry of Health, Labor, and Welfare	Supported in part by Grants-in-Aid for Scientific Research (JSPS KAKENHI 25860541 to Y.K., 24590980 to Y.H.) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. Y.H. supported in part by a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor, and Welfare.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Koda M, 1996, HEPATO-GASTROENTEROL, V43, P199; ZOLI M, 1995, J HEPATOL, V23, P129, DOI 10.1016/0168-8278(95)80326-2; Lim AKP, 2005, AM J ROENTGENOL, V184, P1848; Colecchia A, 2012, GASTROENTEROLOGY, V143, P646, DOI 10.1053/j.gastro.2012.05.035; Mohammadi A, 2011, MED ULTRASON, V13, P200; Balci A, 2008, J CLIN ULTRASOUND, V36, P134, DOI 10.1002/jcu.20440; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; ZIRONI G, 1992, J HEPATOL, V16, P298, DOI 10.1016/S0168-8278(05)80660-9; Takuma Y, 2013, GASTROENTEROLOGY, V144, P92, DOI 10.1053/j.gastro.2012.09.049; OHNISHI K, 1985, RADIOLOGY, V155, P757; Koizumi Y, 2011, RADIOLOGY, V258, P610, DOI 10.1148/radiol.10100319; Ochi H, 2012, HEPATOLOGY, V56, P1271, DOI 10.1002/hep.25756; Yoneda M, 2011, J GASTROENTEROL, V46, P1300, DOI 10.1007/s00535-011-0436-4; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Hano H, 2013, VIRCHOWS ARCH, V462, P533, DOI 10.1007/s00428-013-1402-8; Hirata M, 2001, EUR J CLIN INVEST, V31, P528, DOI 10.1046/j.1365-2362.2001.00840.x; Hirooka M, 2011, RADIOLOGY, V261, P960, DOI 10.1148/radiol.11110156; MENDES FD, 2012, CLIN GASTROENTEROL H, V10, pE2; MENDES FD, 2012, RADIOLOGY, V10, P1028; OHNISHI K, 1987, AM J GASTROENTEROL, V82, P507; Shimada M, 2002, J HEPATOL, V37, P154, DOI 10.1016/S0168-8278(02)00099-5	25	0	0	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	FEB	2015	274	2					597	604		10.1148/radiol.14132952		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA1WS	WOS:000348700300032		
J	Hamada, T; Yasunaga, H; Nakai, Y; Isayama, H; Horiguchi, H; Fushimi, K; Koike, K				Hamada, Tsuyoshi; Yasunaga, Hideo; Nakai, Yousuke; Isayama, Hiroyuki; Horiguchi, Hiromasa; Fushimi, Kiyohide; Koike, Kazuhiko			Severe Bleeding after Percutaneous Transhepatic Drainage of the Biliary System: Effect of Antithrombotic Agents-Analysis of 34 606 Cases from a Japanese Nationwide Administrative Database	RADIOLOGY			English	Article							DOSE ASPIRIN THERAPY; HIGH-RISK PATIENTS; ACUTE CHOLECYSTITIS; PEPTIC-ULCER; HEMORRHAGIC CHOLECYSTITIS; ACETYLSALICYLIC-ACID; SECONDARY PREVENTION; PRIMARY HEMOSTASIS; LIVER-BIOPSY; CHOLECYSTOSTOMY	Purpose: To investigate the relationship between antithrombotic agents (antiplatelet agents and anticoagulants) and severe bleeding after percutaneous transhepatic biliary drainage (PTBD) for biliary obstruction, or cholecystostomy for acute cholecystitis. Materials and Methods: This retrospective study was institutional review board-approved, and patient consent was waived. Between July 2007 and March 2012, 34 606 patients who underwent PTBD (23 375 patients) or cholecystostomy (11 231 patients) were identified in the Diagnosis Procedure Combination database covering 1119 Japanese hospitals. The association between oral administration of antithrombotic agents prior to the procedure and severe bleeding was evaluated, with adjustment for other potential risk factors, such as age, chronic renal failure, liver cirrhosis, and procedure type. Users of antithrombotic agents were categorized as the continuation group, when they took these agents on the procedure day, or as the discontinuation group, when none were taken. Severe bleeding was defined as bleeding which required red blood cell transfusion or transcatheter arterial embolization within 3 days of the procedure. Univariate and multivariate logistic regression models fitted with generalized estimating equations were performed to evaluate the effect of antithrombotic agents on the bleeding complication. Results: Overall, 780 of 34 606 patients (2.3%) experienced severe bleeding. In the multivariate model, continuation of antiplatelet agents was significantly associated with severe bleeding versus nonuse (odds ratio [OR], 1.87; 95% confidence interval [CI]: 1.14, 3.05; P = .013), whereas discontinuation of antiplatelet agents showed no association (OR, 0.92; 95% CI: 0.70, 1.20; P = .517). The effect of neither continuation nor discontinuation of anticoagulants on severe bleeding was significant. Other significant risk factors for bleeding included older age, chronic renal failure, liver cirrhosis, academic hospital, and PTBD. Conclusion: The continuation of antiplatelet agents can increase severe bleeding after percutaneous transhepatic drainage, whereas the effect of continuation of anticoagulants was inconclusive. (C) RSNA, 2014	[Hamada, Tsuyoshi; Nakai, Yousuke; Isayama, Hiroyuki; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan; [Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1138655, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Care Informat, Tokyo, Japan	Isayama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	isayama-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan [H22-Policy-031]; Ministry of Education, Culture, Sports, Science and Technology [22390131]; World-Leading Innovative R&D on Science and Technology (FIRST program) from the Council for Science and Technology Policy, Japan [0301002001001]	Supported by a Grant-in-Aid for Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan (grant H22-Policy-031), a Grant-in-Aid for Scientific Research B from the Ministry of Education, Culture, Sports, Science and Technology (grant 22390131), and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from the Council for Science and Technology Policy, Japan (grant 0301002001001).	HAMLIN JA, 1986, RADIOLOGY, V158, P199; NAGINO M, 1992, HEPATO-GASTROENTEROL, V39, P296; Wallace MJ, 2003, J VASC INTERV RADIOL, V14, P323, DOI 10.1097/01.RVI.0000058413.01661.b9; Derogar M, 2013, CLIN GASTROENTEROL H, V11, P38, DOI 10.1016/j.cgh.2012.08.034; Sonksen JR, 1999, BRIT J ANAESTH, V82, P360; Patel IJ, 2012, J VASC INTERV RADIOL, V23, P727, DOI 10.1016/j.jvir.2012.02.012; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Borzellino G, 1999, BRIT J SURG, V86, P1521, DOI 10.1046/j.1365-2168.1999.01284.x; Weber A, 2009, EUR J RADIOL, V72, P412, DOI 10.1016/j.ejrad.2008.08.012; Hatzidakis AA, 2002, EUR RADIOL, V12, P1778, DOI 10.1007/s00330-001-1247-4; Dewhurst C, 2012, AM J ROENTGENOL, V199, pW753, DOI 10.2214/AJR.11.8445; Winbladh A, 2009, HPB, V11, P183, DOI 10.1111/j.1477-2574.2009.00052.x; Byrne MF, 2003, J AM COLL SURGEONS, V197, P206, DOI 10.1016/S1072-7515(03)00143-1; EKNOYAN G, 1969, NEW ENGL J MED, V280, P677, DOI 10.1056/NEJM196903272801301; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Amitrano L, 2002, SEMIN LIVER DIS, V22, P83, DOI 10.1055/s-2002-23205; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; MUELLER PR, 1982, AM J ROENTGENOL, V138, P17; Higham J, 2002, GUT, V50, P460, DOI 10.1136/gut.50.4.460; Choi SH, 2011, RADIOLOGY, V261, P969, DOI 10.1148/radiol.11110254; Collins R, 2009, LANCET, V373, P1849; Chen YY, 2010, AM J MED SCI, V340, P338, DOI 10.1097/MAJ.0b013e3181e9563e; Ihama Yoko, 2012, World J Hepatol, V4, P288, DOI 10.4254/wjh.v4.i10.288; LO LD, 1995, J VASC INTERV RADIOL, V6, P629, DOI 10.1016/S1051-0443(95)71150-2; MAKUUCHI M, 1980, RADIOLOGY, V136, P165; MCVAY PA, 1990, AM J CLIN PATHOL, V94, P747; MELIN MM, 1995, BRIT J SURG, V82, P1274, DOI 10.1002/bjs.1800820939; Mohr TS, 2012, ORTHOPEDICS, V35, P687, DOI 10.3928/01477447-20120725-06; Ono S, 2012, J GASTROENTEROL, V47, P770, DOI 10.1007/s00535-012-0538-7; Pandya R, 2008, ABDOM IMAGING, V33, P652, DOI 10.1007/s00261-007-9358-2; Saad Wael E A, 2008, Tech Vasc Interv Radiol, V11, P60, DOI 10.1053/j.tvir.2008.05.007; TAKADA T, 1976, Journal of Surgical Oncology, V8, P83, DOI 10.1002/jso.2930080113; Tamai Y, 1999, HAEMOSTASIS, V29, P269; Welschbillig-Meunier K, 2005, Surg Endosc, V19, P1256, DOI 10.1007/s00464-004-2248-6; Winick A B, 2001, Tech Vasc Interv Radiol, V4, P200, DOI 10.1053/tvir.2001.28465; Yasunaga H, 2012, HEPATOL RES, V42, P1073, DOI 10.1111/j.1872-034X.2012.01022.x; Yasunaga H, 2012, BMC HEALTH SERV RES, V28, P129	37	0	0	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	FEB	2015	274	2					605	613		10.1148/radiol.14140293		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CA1WS	WOS:000348700300033		
J	Hibino, Y				Hibino, Yuri			Implications of the legalization of non-commercial surrogacy for local kinship and motherhood in Vietnamese society	REPRODUCTIVE BIOMEDICINE ONLINE			English	Editorial Material						kinship; motherhood; regulation; surrogacy; Vietnam		Until recently, surrogacy was banned in Vietnam for all cases. The government, however, has altered its position on reproductive technology and will soon legalize non-commercial surrogacy among relatives. Motherhood is highly venerated in Vietnamese society and, under this local kinship conception, gestational process is of paramount importance in establishing a connection between the fetus and the woman. The implications of this new government decision for local kinship, motherhood and the individuals concerned will be discussed. (C) 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.	Kanazawa Univ, Kanazawa, Ishikawa, Japan	Hibino, Y (reprint author), Kanazawa Univ, Kanazawa, Ishikawa, Japan.	hibino@staff.kanazawa-u.ac.jp					[Anonymous], 2013, VIETNAM DELIBERATING; Hibino Y., 2014, OBSTET GYNECOL, V81, P1521; Pashigian M.J., 2009, J VIETNAMESE STUDIES, V4, P34; Viet Nam News, 2012, VIET NAM NEWS	4	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1472-6483	1472-6491		REPROD BIOMED ONLINE	Reprod. Biomed. Online	FEB	2015	30	2					113	114		10.1016/j.rbmo.2014.10.015		2	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CA7GY	WOS:000349087000002		
J	Takita, K; Morimoto, Y				Takita, Koichi; Morimoto, Yuji			Nociceptin/orphanin FQ slows inspiratory rhythm via its direct effects on the pre-Botzinger complex	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Nociceptin/orphanin FQ; Respiratory rhythm generation; Retrotrapezoid nucleus/parafacial respiratory group; Pre-Botzinger complex; Brainstem	SPINAL-CORD PREPARATION; RESPIRATORY RHYTHM; NEWBORN RATS; PREBOTZINGER COMPLEX; MEDULLA-OBLONGATA; NEONATAL-RAT; IN-VITRO; NEURONS; GENERATION; SLICES	In a previous study, we showed that in an in vitro en bloc preparation of newborn rats perfused with standard [K+] (6.2 mM) and high [K+] (11.2 mM) artificial cerebrospinal fluid (aCSF), nociceptin/orphanin FQ (N/OFQ) suppresses bursting of pre-inspiratory neurons with 1:1 coupling to the fictive inspiration. However, it is unclear whether the pre-Botzinger complex (preBotC) is involved in the N/OFQ-induced slowing. Using in vitro en bloc preparations with and without the retrotrapezoid nucleus/parafacial respiratory group (RTN/pFRG) perfused with high [K+] aCSF, we found the following: (1) there were no differences in the effects of N/OFQ on the inspiratory rhythm between the preparations with and without the RTN/pFRG, (2) N/OFQ decreased the input resistance of inspiratory neurons (Insps) in the preparations without the RTN/pFRG and suppressed their ectopic firing activities, and (3) N/OFQ suppressed the spontaneous firing of Insps under a chemical synaptic transmission blockade. In conclusion, it is possible that the preBotC is involved in N/OFQ-induced inspiratory rhythm slowing. (C) 2014 Elsevier B.V. All rights reserved.	[Takita, Koichi; Morimoto, Yuji] Hokkaido Univ, Grad Sch Med, Dept Anesthesiol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Takita, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Anesthesiol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	ktakita@med.hokudai.ac.jp			Department of Anesthesiology, Hokkaido University Graduate School of Medicine [PK420041]	The financial source of this study is the research funds (No. PK420041) of the Department of Anesthesiology, Hokkaido University Graduate School of Medicine.	Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Onimaru H, 2003, J NEUROSCI, V23, P1478; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; Takeda S, 2001, ANESTHESIOLOGY, V95, P740, DOI 10.1097/00000542-200109000-00029; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; JOHNSON SM, 1994, J NEUROPHYSIOL, V72, P2598; Mellen NM, 2012, CURR OPIN NEUROBIOL, V22, P676, DOI 10.1016/j.conb.2012.01.001; Mellen NM, 2010, J NEUROSCI, V30, P8383, DOI 10.1523/JNEUROSCI.5510-09.2010; ONIMARU H, 1988, BRAIN RES, V445, P314, DOI 10.1016/0006-8993(88)91194-8; ONIMARU H, 1992, PFLUG ARCH EUR J PHY, V420, P399, DOI 10.1007/BF00374476; ONIMARU H, 1989, EXP BRAIN RES, V76, P530, DOI 10.1007/BF00248909; Onimaru H, 2006, J NEUROPHYSIOL, V96, P55, DOI 10.1152/jn.01175.2005; Pace RW, 2007, J PHYSIOL-LONDON, V580, P485, DOI 10.1113/jphysiol.2006.124602; Panaitescu B, 2013, NEUROSCIENCE, V255, P158, DOI 10.1016/j.neuroscience.2013.09.058; Ruangkittisakul A, 2007, J PHYSIOL-LONDON, V584, P489, DOI 10.1113/jphysiol.2007.142760; Ruangkittisakul A, 2006, J NEUROSCI, V26, P11870, DOI 10.1523/JNEUROSCI.3357-06.2006; Ruangkittisakul A, 2006, NEUROSCI LETT, V401, P194, DOI 10.1016/j.neulet.2006.03.015; Ruangkittisakul A, 2010, RESP PHYSIOL NEUROBI, V172, P94, DOI 10.1016/j.resp.2010.04.025; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173; Takita K, 2003, BRIT J ANAESTH, V91, P385, DOI 10.1093/bja/aeg191; Takita K, 2008, NEUROSCI LETT, V443, P129, DOI 10.1016/j.neulet.2008.08.002; Takita K, 2010, RESP PHYSIOL NEUROBI, V173, P86, DOI 10.1016/j.resp.2010.06.016	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	FEB 1	2015	207						14	21		10.1016/j.resp.2014.12.005		8	Physiology; Respiratory System	Physiology; Respiratory System	CA4NY	WOS:000348882700003		
J	Fujii, M; Shirai, T; Mori, K; Mikamo, M; Shishido, Y; Akita, T; Morita, S; Asada, K; Suda, T				Fujii, Masato; Shirai, Toshihiro; Mori, Kazutaka; Mikamo, Masashi; Shishido, Yuichiro; Akita, Takefumi; Morita, Satoru; Asada, Kazuhiro; Suda, Takafumi			Inspiratory resonant frequency of forced oscillation technique as a predictor of the composite physiologic index in interstitial lung disease	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Composite physiologic index; Fibrosis; Forced oscillation technique; Interstitial lung disease; Resonant frequency	COMBINED PULMONARY-FIBROSIS; RESPIRATORY RESISTANCE; COMPUTED-TOMOGRAPHY; REACTANCE; COPD; MECHANICS; EMPHYSEMA; ASTHMA	The composite physiologic index (CPI), which is derived from FEV1, PVC, and diffusing capacity, has been developed to predict the extent of fibrosis on high-resolution computed tomography (HRCT). However, the relevance to the forced oscillation technique (FOT) is not fully understood. We hypothesized that FOT would independently predict the CPI in interstitial lung disease (ILD). In this cross-sectional study we assessed the relationship between pulmonary function tests, forced oscillatory parameters, and the degree of fibrosis in ILD. Spirometry, evaluation of diffusing capacity for carbon monoxide, and the broad-band frequency FOT were performed in 93 patients with a clinical/HRCT diagnosis of ILD. The CPI was calculated and fibrosis extent was measured by HRCT and scored. Univariate analyses revealed that, of the forced oscillatory parameters, inspiratory resonant frequency best correlated with PVC, FEV1, diffusing capacity, CPI, and fibrosis score. In multiple regression analyses, CPI was independently predicted by inspiratory resonant frequency and fibrosis score (model R-2 = 0.405, p < 0.0001). (C) 2014 Elsevier B.V. All rights reserved.	[Fujii, Masato; Shirai, Toshihiro; Shishido, Yuichiro; Akita, Takefumi; Morita, Satoru; Asada, Kazuhiro] Shizuoka Prefectural Gen Hosp, Dept Resp Med, Shizuoka 4208527, Japan; [Mori, Kazutaka; Mikamo, Masashi; Suda, Takafumi] Hamamatsu Univ, Sch Med, Dept Internal Med 2, Hamamatsu, Shizuoka, Japan	Shirai, T (reprint author), Shizuoka Prefectural Gen Hosp, Dept Resp Med, 4-27-1 Kita Ando, Shizuoka 4208527, Japan.	mfujii74@gmail.com; toshihiro-shirai@i.shizuoka-pho.jp; mori.kazutaka@gmail.com; masa.mikam@gmail.com; sisidiba@gmail.com; takefumi-akita@i.shizuoka-pho.jp; cqn00563@nifty.com; kazuhiro-asada@i.shizuoka-pho.jp; suda@hama-med.ac.jp					American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P1107; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Sugiyama A, 2013, RESP MED, V107, P875, DOI 10.1016/j.rmed.2013.03.005; Di Mango AMGT, 2006, RESP MED, V100, P399, DOI 10.1016/j.rmed.2005.07.005; Mori K, 2011, COPD, V8, P456, DOI 10.3109/15412555.2011.626818; Mori K, 2013, RESP PHYSIOL NEUROBI, V185, P235, DOI 10.1016/j.resp.2012.10.009; VANNOORD JA, 1989, EUR RESPIR J, V2, P846; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Schmidt SL, 2011, EUR RESPIR J, V38, P176, DOI 10.1183/09031936.00114010; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Paredi P, 2010, THORAX, V65, P263, DOI 10.1136/thx.2009.120790; Dellaca RL, 2009, EUR RESPIR J, V33, P1329, DOI 10.1183/09031936.00139608; Hansell DM, 2008, RADIOLOGY, V3, P697, DOI DOI 10.1148/RADI0L.2462070712; Hozumi H, 2011, J COMPUT ASSIST TOMO, V35, P583, DOI 10.1097/RCT.0b013e31822a5883; Japanese Respiratory Society, 2004, GUID RESP FUNCT TEST; Mikamo M, 2013, RESP PHYSIOL NEUROBI, V189, P42, DOI 10.1016/j.resp.2013.06.018; Tanimura K., 2014, J PHYSL SCI	18	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	FEB 1	2015	207						22	27		10.1016/j.resp.2014.12.009		6	Physiology; Respiratory System	Physiology; Respiratory System	CA4NY	WOS:000348882700004		
J	Nakanishi, Y				Nakanishi, Yoichi			Implementation of modern therapy approaches and research for non-small cell lung cancer in Japan	RESPIROLOGY			English	Review						biomarker; echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene; epidermal growth factor receptor; ethnic difference; individualized medicine	RECEPTOR TYROSINE KINASE; PREVIOUSLY TREATED PATIENTS; PHASE-III TRIAL; ADJUVANT CHEMOTHERAPY; EGFR MUTATIONS; SMOKING STATUS; CONCURRENT RADIOTHERAPY; INTERSTITIAL PNEUMONIA; GEFITINIB RESISTANCE; ACTIVATING MUTATIONS	The genetic backgrounds of the Japanese (or Asians) are, at least in part, different from those of Caucasians. It is necessary to recognize this difference to develop medicine that is both optimized and individualized. In particular, the consideration of ethnic differences is becoming increasingly important for lung cancer medicine. Japanese clinical practice guidelines indicate that some clinical biomarkers, such as epidermal growth factor receptor gene mutations, echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene and uridine diphosphate glucuronosyltransferase genotypes should be determined in appropriate lung cancer patients. At the present time, tests for these biomarkers are covered by the Japanese national health-care programme, as is treatment with certain targeted drugs and cytotoxic agents. Therefore, most patients with lung cancer in Japan receive these tests as part of daily practice if their performance status and organ function are judged to be eligible. In addition, ethnic differences in bone marrow toxicity caused by cytotoxic drugs are reflected in treatment choice, and the requirements for the development of treatment modalities suitable for rare targeted populations are also increasing. To meet these requirements, many collaborative groups in Japan that have improved their infrastructure for investigator-initiated trials and conducted important activities need to provide further optimal treatment modalities for Japanese and Asian patients with lung cancer. Here, the characteristics of lung cancer in Japanese patients, general aspects of medical treatment and the care system in Japan, and representative studies on lung cancer in Japan are reviewed.	Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Fukuoka 8128582, Japan	Nakanishi, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yoichi@kokyu.med.kyushu-u.ac.jp			Chugai Pharmaceutical; Pfizer Japan; Boehringer Ingelheim Japan; Daiichi-Sankyo	The author has received funding for research independent of this work from Chugai Pharmaceutical, Pfizer Japan, Boehringer Ingelheim Japan and Daiichi-Sankyo and has received honoraria for lecture independent of this work from Chugai Pharmaceutica, Pfizer Japan and Boehringer Ingelheim Japan.	Alexandrov K, 2010, TOXICOL LETT, V198, P63, DOI 10.1016/j.toxlet.2010.04.009; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Nakagawa T, 2013, CANCER RES, V73, P2428, DOI 10.1158/0008-5472.CAN-12-3479; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; ISHIDA Y, 1992, EMBO J, V11, P3887; RODENHUIS S, 1988, CANCER RES, V48, P5738; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; KAWATO Y, 1991, CANCER RES, V51, P4187; Couraud S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/j.ejca.2012.03.007; Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Okamoto I, 2010, J CLIN ONCOL, V28, P5240, DOI 10.1200/JCO.2010.31.0326; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Hasegawa Y, 2011, J THORAC ONCOL, V6, P1881, DOI 10.1097/JTO.0b013e31822722b6; Sawabata N, 2010, J THORAC ONCOL, V5, P1369, DOI 10.1097/JTO.0b013e3181e452b9; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Sawabata N, 2011, J THORAC ONCOL, V6, P1229, DOI 10.1097/JTO.0b013e318219aae2; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Wada H, 1996, J CLIN ONCOL, V14, P1048; Toffoli G, 2006, J CLIN ONCOL, V24, P3061, DOI 10.1200/JCO.2005.05.5400; Xie M, 2012, J CELL BIOCHEM, V113, P1501, DOI 10.1002/jcb.24019; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Pei XH, 1999, J BIOL CHEM, V274, P35240, DOI 10.1074/jbc.274.49.35240; Kohno T, 2013, CANCER SCI, V104, P1396, DOI 10.1111/cas.12275; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; Ishiguro Y, 2013, ONCOTARGET, V4, P550; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Kawaguchi T, 2010, J THORAC ONCOL, V5, P1001, DOI 10.1097/JTO.0b013e3181e2f607; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Wang S, 2013, J THORAC ONCOL, V8, P719, DOI 10.1097/JTO.0b013e31828b51d4; Nakagawa K, 2012, J THORAC ONCOL, V7, P1296, DOI 10.1097/JTO.0b013e3182598abb; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Uramoto H, 2010, ANTICANCER RES, V30, P2513; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Ho YS, 2010, INTERNAL MED, V49, P2219, DOI 10.2169/internalmedicine.49.3687; Kaira K, 2013, LUNG CANCER, V82, P449, DOI 10.1016/j.lungcan.2013.09.004; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Lara PN, 2009, J CLIN ONCOL, V27, P2530, DOI 10.1200/JCO.2008.20.1061; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Zakowski MF, 2006, NEW ENGL J MED, V355, P213, DOI 10.1056/NEJMc053610; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Ando Y, 2000, CANCER RES, V60, P6921; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Biomarker Committee the Japan Lung Cancer Society, 2011, GUID ALK GEN TEST LU; BLACKLOCK J, 1961, BRIT J CANCER, V15, P745, DOI 10.1038/bjc.1961.85; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Fukui Takayuki, 2008, Gen Thorac Cardiovasc Surg, V56, P97, DOI 10.1007/s11748-007-0193-8; GELB AF, 1984, CHEST, V86, P662, DOI 10.1378/chest.86.5.662; Goya T, 2005, LUNG CANCER-J IASLC, V50, P227, DOI 10.1016/j.luncan.2005.05.021; Hamada C, 2009, J THORAC ONCOL, V12, P1511; Harada C, 2011, AM J RESP CRIT CARE, V183, P743, DOI 10.1164/rccm.201002-0188OC; Henschen F, 1968, GANN, V6, P447; Ho C, 2005, LUNG CANCER-J IASLC, V49, P225, DOI 10.1016/j.lungcan.2005.02.011; Hotta K, 2005, CANCER J, V11, P417, DOI 10.1097/00130404-200509000-00010; Ichinose Y, 2011, J THORAC ONCOL, V6, P2069, DOI 10.1097/JTO.0b013e3182307e5a; Ikeda N, 2011, LASER SURG MED, V43, P749, DOI 10.1002/lsm.21091; Inoue A, 2008, CANCER SCI, V99, P1679, DOI 10.1111/j.1349-7006.2008.00857.x; Katayama R, 2012, SCI TRANSL MED, V5, P1472; Kiyohara C, 2010, J NUCL ACIDS, V2010; Kogure Y, 2013, J THORAC ONCOL, V8, P753, DOI 10.1097/JTO.0b013e31828b51f5; Loke J, 1982, CLIN CHEST MED, V2, P321; Lu J, 2014, J ONCOL PHARM PRACT, DOI [10.1177/1078155214538087, DOI 10.1177/1078155214538087]; Marugame T, 2005, CANCER SCI, V96, P120, DOI 10.1111/j.1349-7006.2005.00013.x; Mok TS, 2009, NEW ENGL J MED, V10, P947; Nakajima Takahiro, 2013, Gen Thorac Cardiovasc Surg, V61, P390, DOI 10.1007/s11748-013-0224-6; Nakanishi Y, 2000, AM J RESP CELL MOL, V22, P747; Noda Kazumasa, 2002, New England Journal of Medicine, V346, P85, DOI 10.1056/NEJMoa003034; Ohyanagi F, 2009, BRIT J CANCER, V101, P225, DOI 10.1038/sj.bjc.6605152; Raimondi S, 2006, AM J EPIDEMIOL, V164, P1027, DOI 10.1093/aje/kwj321; Katakami N, 2012, J CLIN ONCOL, V30; Schulz C, 2009, ANTI-CANCER DRUG, V20, P867, DOI 10.1097/CAD.0b013e328330c7d2; Shi Y, 2014, J THORAC ONCOL, V2, P154; SHIBUYA M, 1982, J VIROL, V42, P143; Spinelli P, 1993, ENDOSC SURG ALLIED T, V2, P82; Sugimura T, 1986, Dev Toxicol Environ Sci, V12, P3; Toyokawa G, 2014, CLIN LUNG CANCER, V14, P108; WEINBERGER SE, 1978, ANN INTERN MED, V89, P459; Wu YL, 2014, LANCET ONCOL, V2, P213; Yamagiwa K., 1918, J CANCER RES, V3, P1; Yasufuku Kazuhiro, 2008, Gen Thorac Cardiovasc Surg, V56, P268, DOI 10.1007/s11748-008-0249-4; Yoshioka H, 2014, P AM SOC CLIN ONCOL; Zhang A, 2007, PHARMACOGENOMICS J, V7, P333, DOI 10.1038/sj.tpj.6500424	107	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	FEB	2015	20	2					199	208		10.1111/resp.12460		10	Respiratory System	Respiratory System	AZ3EK	WOS:000348110300007		
J	Horita, N; Miyazawa, N; Tomaru, K; Inoue, M; Ishigatsubo, Y; Kaneko, T				Horita, Nobuyuki; Miyazawa, Naoki; Tomaru, Koji; Inoue, Miyo; Ishigatsubo, Yoshiaki; Kaneko, Takeshi			Vitamin D binding protein genotype variants and risk of chronic obstructive pulmonary disease: A meta-analysis	RESPIROLOGY			English	Review						allele; group-specific component; inheritance; Mendelian model; single nucleotide polymorphism	GROUP-SPECIFIC COMPONENT; COPD; GC; SUSCEPTIBILITY; ASSOCIATION; ALLELE; POPULATION; GENE; LUNG	Background and objective: Genetic susceptibility for development of chronic obstructive pulmonary disease (COPD) is under intensive investigation. Among the three alleles of vitamin D binding protein, or group-specific (GC) components, some have suggested that having GC-1F and GC-2 alleles was associated with a risk of COPD. Although previous studies have shown considerable variance, no meta-analysis has been conducted. Methods: Through four databases, two independent investigators searched for case-control studies providing sufficient data to calculate odds ratios by the vitamin D binding protein allele variant and genotype variant for a case of COPD. Studies whose control did not satisfy the Hardy-Weinberg equilibrium (Chi-square P0.05) were excluded. We used a fixed-model to estimate the pooled odds ratio at both allele and genotype level. Results: Of 141 candidate studies, six were included. We analysed 1712 subjects, consisting of 466 Asians, 1246 Caucasians, 531 COPD cases and 1181 non-COPD controls. The prevalence of each allele among the 1181 controls was as follows: GC-1F 14.0%, GC-1S 53.8% and GC-2 31.9%. When compared to GC-1S, the GC-1F allele and GC-2 allele were associated with COPD risk with pooled odds ratios of 1.44 (95% CI 1.14-1.83, P=0.002) and 0.83 (95% CI 0.69-0.996, P=0.045), respectively. When compared to the 1S-1S genotype, the 1F-1F genotype was a risk factor of COPD with pooled odds ratio of 2.64 (95% CI 1.29-5.39, P=0.008). Conclusion: The GC-1F allele of the vitaminD binding protein was a risk for COPD in recessive mode.	[Horita, Nobuyuki; Miyazawa, Naoki; Tomaru, Koji; Inoue, Miyo] Saiseikai Yokohamashi Nanbu Hosp, Dept Resp Med, Yokohama, Kanagawa 2348503, Japan; [Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan; [Kaneko, Takeshi] Yokohama City Univ, Grad Sch Med, Dept Pulmonol, Yokohama, Kanagawa 232, Japan	Horita, N (reprint author), Saiseikai Yokohamashi Nanbu Hosp, Dept Resp Med, Kounan Ku, 3-2-10 Kounandai, Yokohama, Kanagawa 2348503, Japan.	nobuyuki_horita@yahoo.co.jp					Altman DG, 2003, BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, pS77; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Shen LH, 2010, J INT MED RES, V38, P1093; Abbas S, 2008, CANCER EPIDEM BIOMAR, V17, P1339, DOI 10.1158/1055-9965.EPI-08-0162; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Nagasawa H, 2005, ANTICANCER RES, V25, P3689; Korytina GF, 2006, MOL BIOL+, V40, P231; Kasuga I, 2003, THORAX, V58, P790, DOI 10.1136/thorax.58.9.790; Bosse Y, 2012, INT J CHRONIC OBSTR, V7, P607, DOI 10.2147/COPD.S35294; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Sandford AJ, 2002, THORAX, V57, P736, DOI 10.1136/thorax.57.8.736; Wood AM, 2011, THORAX, V66, P205, DOI 10.1136/thx.2010.140921; Ishii T, 2001, EUR RESPIR J, V18, P753, DOI 10.1183/09031936.01.00094401; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Ito I, 2004, CHEST, V125, P63, DOI 10.1378/chest.125.1.63; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Schellenberg D, 1998, AM J RESP CRIT CARE, V157, P957; Ohkura K, 2006, ANTICANCER RES, V26, P4073; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; HORNE SL, 1990, HUM HERED, V40, P173; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Global Initiative for Chronic Obstructive Lung Disease, 2014, GLOB STRAT DIAGN MAN; KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950; Laufs Jürgen, 2004, Am J Pharmacogenomics, V4, P63, DOI 10.2165/00129785-200404010-00007; Lu Ming, 2004, Zhonghua Nei Ke Za Zhi, V43, P117; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Smolonska J, 2009, AM J RESP CRIT CARE, V180, P618, DOI 10.1164/rccm.200905-0722OC; Wilk JB, 2007, BMC MED GENET S1, V8, pS8, DOI DOI 10.1186/1471-2350-8-S1-S8	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	FEB	2015	20	2					219	225		10.1111/resp.12448		7	Respiratory System	Respiratory System	AZ3EK	WOS:000348110300009		
J	Chubachi, S; Nakamura, H; Sasaki, M; Haraguchi, M; Miyazaki, M; Takahashi, S; Tanaka, K; Funatsu, Y; Asano, K; Betsuyaku, T				Chubachi, Shotaro; Nakamura, Hidetoshi; Sasaki, Mamoru; Haraguchi, Mizuha; Miyazaki, Masaki; Takahashi, Saeko; Tanaka, Kyuto; Funatsu, Yohei; Asano, Koichiro; Betsuyaku, Tomoko		Keio COPD Comorbidity Res K-CCR	Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD	RESPIROLOGY			English	Article						bone mineral density; chronic obstructive pulmonary disease; genetic polymorphism; low-density lipoprotein receptor-related protein 5; osteoporosis	OBSTRUCTIVE PULMONARY-DISEASE; BONE-MINERAL DENSITY; VERTEBRAL FRACTURES; LUNG-DISEASE; MEN; PHENOTYPES; DENSITOMETRY; INFLAMMATION; DISORDERS; DECLINE	Background and objectiveOsteoporosis is an important systemic comorbidity of chronic obstructive pulmonary disease (COPD). However, neither its mechanisms nor its risk factors have been fully elucidated. With regard to genetic factors, low-density lipoprotein receptor-related protein 5 (LRP5) A1330V is known to be associated with osteoporosis in the general population, but the influence of this polymorphism in COPD is unknown. The aim of this study was to investigate the potential risk factors of COPD-related bone loss and fracture. MethodsKeio University and affiliated hospitals have enrolled an observational cohort to investigate the management of COPD comorbidities. To assess risk factors for osteopenia and osteoporosis, bone mineral density (BMD) of the hip and lumbar spine, presence of vertebral fracture, quantitative data on emphysema and airway wall on computed tomography, as well as LRP5 genotype were analysed in patients with or at risk for COPD (n=270). ResultsThe percentage of subjects with osteoporosis (T-score-2.5), osteopenia (T-score between -1 and -2.5) and a normal BMD (T-score-1) was 15.2%, 35.9% and 48.9%, respectively. T-score was significantly decreased in subjects with LRP5TT genotype (n=15) compared with that in those with CC/CT genotype (n=255) (-1.83 vs. -0.98, P=0.0167). On multivariate logistic regression analysis, female gender (odds ratio (OR) 10.4; P<0.0001), severe emphysema (OR 2.3; P=0.013) and LRP5TT genotype (OR 3.7; P=0.031) independently increased the risk of osteopenia/osteoporosis. ConclusionsThis study confirmed the complex pathophysiology of COPD-related osteoporosis, including the influence of gender, clinical phenotype and genetic factors. Risk factors for COPD-associated osteoporosis are not fully elucidated. This observational COPD cohort study demonstrates that a polymorphism in low-density lipoprotein receptor-related protein 5 gene, female gender and the presence of severe emphysema are independent risk factors for low bone mineral density in patients with or at risk for COPD.	[Chubachi, Shotaro; Nakamura, Hidetoshi; Sasaki, Mamoru; Haraguchi, Mizuha; Miyazaki, Masaki; Takahashi, Saeko; Tanaka, Kyuto; Funatsu, Yohei; Betsuyaku, Tomoko] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo 160, Japan; [Nakamura, Hidetoshi] Saitama Med Univ, Dept Resp Med, Moroyama, Saitama, Japan; [Asano, Koichiro] Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Hiratsuka, Kanagawa 25912, Japan	Nakamura, H (reprint author), Saitama Med Univ, Dept Resp Med, 38 Morohongo, Moroyama, Saitama, Japan.	hnakamur@saitama-med.ac.jp			GlaxoSmithKline	This study was funded by GlaxoSmithKline. TB discloses having received honoraria/paid expert testimony and her university having received research grants from GlaxoSmithKline.	Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Fujiwara S, 2003, J BONE MINER RES, V18, P1547, DOI 10.1359/jbmr.2003.18.8.1547; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Makita H, 2007, THORAX, V62, P932, DOI 10.1136/thx.2006.072777; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102; Knudsen ST, 2003, EUR J ENDOCRINOL, V149, P39, DOI 10.1530/eje.0.1490039; Ezura Y, 2007, BONE, V40, P997, DOI 10.1016/j.bone.2005.06.025; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Koay MA, 2005, TRENDS MOL MED, V11, P129, DOI 10.1016/j.molmed.2005.01.004; Lehouck A, 2011, CHEST, V139, P648, DOI 10.1378/chest.10-1427; GENANT HK, 1993, J BONE MINER RES, V8, P1137; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Park KJ, 1999, RADIOLOGY, V211, P541; Biskobing DM, 2002, CHEST, V121, P609, DOI 10.1378/chest.121.2.609; Nishimura M, 2012, AM J RESP CRIT CARE, V185, P44, DOI 10.1164/rccm.201106-0992OC; Ferguson GT, 2009, CHEST, V136, P1456, DOI 10.1378/chest.08-3016; Bai P, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-157; Barrett-Connor E, 2003, WHO TECH REP SER, V921, P1; Betsuyaku T, 2000, RESPIRATION, V67, P261, DOI 10.1159/000029508; Bon J, 2011, AM J RESP CRIT CARE, V183, P885, DOI 10.1164/rccm.201004-0666OC; Brito-Mutunayagam R, 2010, CHEST, V138, P605, DOI 10.1378/chest.09-2607; Duckers JM, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-101; Gallagher JC, 2008, MATURITAS, V60, P65, DOI 10.1016/j.maturitas.2008.04.005; Graat-Verboom L, 2011, J BONE MINER RES, V26, P561, DOI 10.1002/jbmr.257; Graat-Verboom L, 2010, J OSTEOPOROS, V2010; Grundberg E, 2008, OSTEOPOROSIS INT, V19, P829, DOI 10.1007/s00198-007-0512-z; JERGAS M, 1995, J BONE MINER RES, V10, P1101; JOHNSTON CC, 1991, NEW ENGL J MED, V324, P1105; Kjensli A, 2007, BONE, V40, P493, DOI 10.1016/j.bone.2006.09.005; Mishima Michiaki, 1997, Frontiers of Medical and Biological Engineering, V8, P79; Miyazaki M, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-13; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Newell JD, 2013, J THORAC IMAG, V28, P266, DOI 10.1097/RTI.0b013e31829f6796; Nishimura M, 2004, COMMITTEE PULMONARY; Ogura-Tomomatsu H, 2012, COPD, V9, P332, DOI 10.3109/15412555.2012.667850; Ohara T, 2008, CHEST, V134, P1244, DOI 10.1378/chest.07-3054; SLEMENDA CW, 1992, ANN INTERN MED, V117, P286; vansMeurs JB, 2006, J BONE MINER RES, V21, P141	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	FEB	2015	20	2					286	295		10.1111/resp.12429		10	Respiratory System	Respiratory System	AZ3EK	WOS:000348110300018		
J	Horii, T; Murakami, T; Akagi, T; Uji, A; Ueda-Arakawa, N; Nishijima, K; Yoshimura, N				Horii, Takahiro; Murakami, Tomoaki; Akagi, Tadamichi; Uji, Akihito; Ueda-Arakawa, Naoko; Nishijima, Kazuaki; Yoshimura, Nagahisa			OPTICAL COHERENCE TOMOGRAPHIC REFLECTIVITY OF CYSTOID SPACES IS RELATED TO RECURRENT DIABETIC MACULAR EDEMA AFTER TRIAMCINOLONE	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						cystoid spaces; diabetic macular edema; optical coherence tomography; reflectivity; triamcinolone acetonide	INTRAVITREAL TRIAMCINOLONE; RETINOPATHY; ACETONIDE; PHOTOCOAGULATION; INJECTION; PATHOLOGY; OCCLUDIN; PATTERN; TRIAL	Purpose: To determine the association between reflectivity levels in foveal cystoid spaces on optical coherence tomography images and the course of the logarithm of the minimum angle of resolution (logMAR) after triamcinolone acetonide treatment for diabetic macular edema. Methods: We retrospectively reviewed 58 consecutive eyes treated with an intravitreal or sub-Tenon's injection of triamcinolone acetonide for diabetic macular edema. The foveal cystoid spaces within central 1 mm were circumscribed, followed by measurement of optical coherence tomography reflectivity. The correlation between the reflectivity and visual outcome was investigated. Results: The optical coherence tomography reflectivity levels in foveal cystoid spaces increased at 1 month after treatment, but not at 3 months or 6 months. The preoperative reflectivity levels were correlated negatively with logMAR changes from 1 month to 6 months and from 3 months to 6 months but not with logMAR at individual time points compared with the preoperative logMAR. The changes in foveal thickness from 1 month to 6 months were correlated negatively with the baseline reflectivity and positively with logMAR changes from 1 month to 6 months and from 3 months to 6 months. Conclusion: Lower optical coherence tomography reflectivity in foveal cystoid spaces was associated with the rebound in macular thickening and visual deterioration after triamcinolone acetonide treatment for diabetic macular edema.	[Horii, Takahiro; Murakami, Tomoaki; Akagi, Tadamichi; Uji, Akihito; Ueda-Arakawa, Naoko; Nishijima, Kazuaki; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan	Murakami, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, 54 Shogoin Kawaracho, Kyoto 6068507, Japan.	mutomo@kuhp.kyoto-u.ac.jp					Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Ip MS, 2004, DIABETES CARE, V27, P1794, DOI 10.2337/diacare.27.7.1794; Otani T, 1999, AM J OPHTHALMOL, V127, P688, DOI 10.1016/S0002-9394(99)00033-1; Horii T, 2010, AM J OPHTHALMOL, V150, P840, DOI 10.1016/j.ajo.2010.06.015; LEWIS H, 1992, OPHTHALMOLOGY, V99, P753; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Jermak CM, 2007, SURV OPHTHALMOL, V52, P503, DOI 10.1016/j.survophthal.2007.06.004; Browning DJ, 2007, OPHTHALMOLOGY, V114, P525, DOI 10.1016/j.ophtha.2006.06.052; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Jonas JB, 2001, AM J OPHTHALMOL, V132, P425, DOI 10.1016/S0002-9394(01)01010-8; Murakami T, 2012, INVEST OPHTH VIS SCI, V53, P1506, DOI 10.1167/iovs.11-9231; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; YANOFF M, 1984, SURV OPHTHALMOL, V28, P505, DOI 10.1016/0039-6257(84)90233-9; Gibran SK, 2007, OPHTHALMOLOGY, V114, P890, DOI 10.1016/j.ophtha.2006.11.026; Bolz M, 2009, OPHTHALMOLOGY, V116, P914, DOI 10.1016/j.ophtha.2008.12.039; Murakami T, 2011, AM J OPHTHALMOL, V151, P310, DOI 10.1016/j.ajo.2010.08.022; Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P3529, DOI 10.1167/iovs.07-1320; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Ip MS, 2008, OPHTHALMOLOGY, V115, P1447, DOI 10.1016/j.ophtha.2008.06.015; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Felinski EA, 2008, EXP EYE RES, V86, P867, DOI 10.1016/j.exer.2008.01.002; Gregori NZ, 2009, BRIT J OPHTHALMOL, V93, P373, DOI 10.1136/bjo.2007.136127; Guthoff R, 2011, KLIN MONATSBL AUGENH, V228, P468, DOI 10.1055/s-0029-1245487; Horii Takahiro, 2012, Ophthalmology, V119, P1047, DOI 10.1016/j.ophtha.2011.10.030; Jonas JB, 2002, GRAEF ARCH CLIN EXP, V240, P782, DOI 10.1007/s00417-002-0529-0; Joussen Antonia M, 2007, Dev Ophthalmol, V39, P1; Kameda T, 2011, GRAEF ARCH CLIN EXP, V249, P3, DOI 10.1007/s00417-010-1447-1; Murakami T, 2011, OPHTHALMOLOGY, V118, P359, DOI 10.1016/j.ophtha.2010.03.035; Shin HJ, 2012, GRAEF ARCH CLIN EXP, V250, P61, DOI 10.1007/s00417-011-1774-x; TSO MOM, 1982, OPHTHALMOLOGY, V89, P902; WOLTER JR, 1981, A GRAEF ARCH KLIN EX, V216, P85, DOI 10.1007/BF00414576	33	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	FEB	2015	35	2					264	271				8	Ophthalmology	Ophthalmology	CA2UU	WOS:000348764200015		
J	Hisatomi, T; Notomi, S; Tachibana, T; Oishi, S; Asato, R; Yamashita, T; Murakami, Y; Ikeda, Y; Enaida, H; Sakamoto, T; Ishibashi, T				Hisatomi, Toshio; Notomi, Shoji; Tachibana, Takashi; Oishi, Seiichiro; Asato, Ryo; Yamashita, Takehiro; Murakami, Yusuke; Ikeda, Yasuhiro; Enaida, Hiroshi; Sakamoto, Taiji; Ishibashi, Tatsuro			BRILLIANT BLUE G DOUBLE STAINING ENHANCES SUCCESSFUL INTERNAL LIMITING MEMBRANE PEELING WITH MINIMAL ADVERSE EFFECT BY LOW CELLULAR PERMEABILITY INTO LIVE CELLS	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						brilliant blue G; vitrectomy; chromovitrectomy; internal limiting membrane; epiretinal membrane; cell death; apoptosis; cellular permeability	MACULAR HOLE SURGERY; PLANA VITRECTOMY IMPROVES; APOPTOSIS-INDUCING FACTOR; BIRDS-EYE ANALYSIS; INDOCYANINE GREEN; PHOTORECEPTOR APOPTOSIS; TRIAMCINOLONE ACETONIDE; PURINERGIC RECEPTORS; SUBRETINAL INJECTION; P2X(7) RECEPTORS	Purpose: Brilliant Blue G is used as a surgical adjuvant for retinal surgery. Although BBG double or multiple staining was reported, the effectiveness and safety of repeated staining is still elusive. To further examine the effectiveness and safety, we examined BBG in clinical cases in vivo, primary cell culture in vitro, and surgically resected specimen ex vivo. Methods: A retrospective interventional case series with in vitro and ex vivo studies were performed. Vitrectomy was performed in 28 cases of epiretinal membrane with BBG single to multiple staining. The surgically resected membranes were stained by BBG with or without cellular fixation. Primary cell cultures were examined with BBG and live/death cell markers, such as Calcein AM and TUNEL. Results: Single staining provided satisfactory staining in seven cases. Double or multiple staining substantially visualized internal limiting membrane (21 cases), especially the edges of remaining internal limiting membrane (11 cases). Adverse retinal staining was not noted and the final visual acuity showed no difference with multiple staining. The live cells barely stained with BBG, while some dead cells were stained. Conclusion: Brilliant Blue G multiple staining substantially enhanced the visualization of internal limiting membrane. The absence of abnormal staining supports the safety of repeated BBG staining.	[Hisatomi, Toshio; Notomi, Shoji; Tachibana, Takashi; Oishi, Seiichiro; Asato, Ryo; Murakami, Yusuke; Ikeda, Yasuhiro; Enaida, Hiroshi; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan; [Hisatomi, Toshio; Notomi, Shoji] Kyushu Med Ctr, Clin Res Inst, Fukuoka, Japan; [Yamashita, Takehiro; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan	Hisatomi, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hisatomi@med.kyushu-u.ac.jp			Ministry of Education, Science, and Culture of the Japanese Government	Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of the Japanese Government.	Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Lee JE, 2003, RETINA-J RET VIT DIS, V23, P675, DOI 10.1097/00006982-200310000-00012; Hisatomi T, 2001, AM J PATHOL, V158, P1271, DOI 10.1016/S0002-9440(10)64078-3; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Sonoda KH, 2004, OPHTHALMOLOGY, V111, P226, DOI 10.1016/j.ophtha.2003.05.034; Puthussery T, 2004, J COMP NEUROL, V472, P13, DOI 10.1002/cne.20045; Shimada H, 2009, OPHTHALMOLOGY, V116, P1370, DOI 10.1016/j.ophtha.2009.01.024; Hisatomi T, 2008, J CLIN INVEST, V118, P2025, DOI 10.1172/JCI34267; Jiang LH, 2000, MOL PHARMACOL, V58, P82; Ueno A, 2007, RETINA-J RET VIT DIS, V27, P499, DOI 10.1097/IAE.0b013e318030a129; Kadonosono K, 2000, ARCH OPHTHALMOL-CHIC, V118, P1116; Rodrigues EB, 2009, SURV OPHTHALMOL, V54, P576, DOI 10.1016/j.survophthal.2009.04.011; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Hisatomi T, 2003, AM J PATHOL, V162, P1869, DOI 10.1016/S0002-9440(10)64321-0; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Burk SE, 2000, OPHTHALMOLOGY, V107, P2010, DOI 10.1016/S0161-6420(00)00375-4; Eckardt C, 1997, OPHTHALMOLOGE, V94, P545, DOI 10.1007/s003470050156; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P623, DOI 10.1097/00006982-200607000-00006; Enaida H, 2002, GRAEF ARCH CLIN EXP, V240, P209, DOI 10.1007/s00417-002-0433-7; Enaida H, 2013, RETINA-J RET VIT DIS, V33, P2170, DOI 10.1097/IAE.0b013e31828e69d6; Enaida Hiroshi, 2008, Dev Ophthalmol, V42, P115, DOI 10.1159/000138989; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007; Farah ME, 2009, AM J OPHTHALMOL, V148, P332, DOI 10.1016/j.ajo.2009.04.003; Hisatomi T, 2009, EXP NEUROL, V218, P347, DOI 10.1016/j.expneurol.2009.03.007; Hisatomi T, 2012, AM J PATHOL, V181, P53, DOI 10.1016/j.ajpath.2012.03.022; Hisatomi T, 2006, ARCH OPHTHALMOL-CHIC, V124, P514, DOI 10.1001/archopht.124.4.514; Hisatomi T, 2005, AM J OPHTHALMOL, V139, P1121, DOI 10.1016/j.ajo.2004.11.051; Hisatomi T, 2006, ARCH OPHTHALMOL-CHIC, V124, P1005, DOI 10.1001/archopht.124.7.1005; Hisatomi T, 2007, BRIT J OPHTHALMOL, V91, P520, DOI 10.1136/bjo.2006.102046; Ho JD, 2004, BRIT J OPHTHALMOL, V88, P556, DOI 10.1136/bjo.2003.018523; Kadonosono K, 2013, RETINA-J RET VIT DIS, V33, P812, DOI 10.1097/IAE.0b013e3182807629; Kawahara S, 2007, INVEST OPHTH VIS SCI, V48, P4426, DOI 10.1167/iovs.07-0358; Kawaji T, 2004, GRAEF ARCH CLIN EXP, V242, P158, DOI 10.1007/s00417-003-0798-2; Maia M, 2004, RETINA-J RET VIT DIS, V24, P69, DOI 10.1097/00006982-200402000-00011; Matsumoto H, 2007, RETINA-J RET VIT DIS, V27, P174, DOI 10.1097/01.iae.0000237954.35359.fd; Nakamura H, 2005, OPHTHAL SURG LAS IM, V36, P37; Nakamura T, 2003, CURR EYE RES, V27, P395; Notomi S, 2011, AM J PATHOL, V179, P2798, DOI 10.1016/j.ajpath.2011.08.035; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; Sakamoto T, 2002, GRAEF ARCH CLIN EXP, V240, P423, DOI 10.1007/s00417-002-0454-2; Sakamoto T, 2009, GRAEF ARCH CLIN EXP, V247, P1153, DOI 10.1007/s00417-009-1118-2; Tadayoni R, 2003, OPHTHALMOLOGY, V110, P604, DOI 10.1016/S0161-6420(02)01761-X; Ward MM, 2010, ADV EXP MED BIOL, V664, P385, DOI 10.1007/978-1-4419-1399-9_44	44	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	FEB	2015	35	2					310	318				9	Ophthalmology	Ophthalmology	CA2UU	WOS:000348764200021		
J	Yamamoto, Y; Miyazaki, D; Sasaki, SI; Miyake, KI; Kaneda, S; Ikeda, Y; Baba, T; Yamasaki, A; Noguchi, Y; Inoue, Y				Yamamoto, Yukimi; Miyazaki, Dai; Sasaki, Shin-Ichi; Miyake, Ken-Ichiro; Kaneda, Shuzo; Ikeda, Yoshifumi; Baba, Takashi; Yamasaki, Atsushi; Noguchi, Yumiko; Inoue, Yoshitsugu			ASSOCIATIONS OF INFLAMMATORY CYTOKINES WITH CHOROIDAL NEOVASCULARIZATION IN HIGHLY MYOPIC EYES	RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES			English	Article						cytokines; high myopia; myopic choroidal neovascularization	ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; PATHOLOGICAL MYOPIA; INTRAVITREAL BEVACIZUMAB; GENE POLYMORPHISMS; REFRACTIVE ERROR; METALLOPROTEINASE; MACROPHAGES; ACTIVATION; CELLS	Purpose: To determine the relationships between the levels of intraocular inflammatory cytokines and the clinical characteristics of myopic choroidal neovascularization (mCNV) in eyes with myopic maculopathy. Methods: One hundred eyes of 100 cases, including 51 mCNV eyes, 14 highly myopic eyes without choroidal neovascularization, and 35 normal subjects, were studied. The intraocular levels of choroidal neovascularization-related cytokines, like vascular endothelial growth factor, MCP-1, IL-8, IL-10, and IL-23, were determined. Results: The levels of vascular endothelial growth factor and IL-8 were significantly higher in eyes with mCNV than in high myopia eyes without mCNV with significant odds ratio of 2.00 and 2.25 per quartile, respectively (P < 0.05). When myopic lesions of patients with mCNV were classified into 3 categories based on the severity, IL-8 and MCP-1 were significantly elevated depending on the presence of maculopathy (P < 0.05). Vascular endothelial growth factor was significantly elevated in eyes of Category 2. An advancement of the maculopathy category was significantly associated with the need for multiple treatment of intravitreal bevacizumab (P < 0.05). In 12 eyes that required multiple intravitreal bevacizumab, the MCP-1 level was significantly elevated. Conclusion: The significant associations of mCNV in highly myopic eyes with elevated levels of vascular endothelial growth factor or inflammatory cytokines and maculopathy lesions strongly suggest an involvement of inflammation in the etiology of mCNVs.	[Yamamoto, Yukimi; Miyazaki, Dai; Sasaki, Shin-Ichi; Miyake, Ken-Ichiro; Kaneda, Shuzo; Ikeda, Yoshifumi; Baba, Takashi; Yamasaki, Atsushi; Noguchi, Yumiko; Inoue, Yoshitsugu] Tottori Univ, Fac Med, Div Ophthalmol & Visual Sci, Yonago, Tottori 6838504, Japan	Miyazaki, D (reprint author), Tottori Univ, Fac Med, Div Ophthalmol & Visual Sci, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	dm@grape.med.tottori-u.ac.jp			Japanese Ministry of Education, Science, and Culture [23791984, 25670733]	Supported by Grand-in-Aid 23791984 and 25670733 for Scientific Research from the Japanese Ministry of Education, Science, and Culture.	Akagi-Kurashige Y, 2012, INVEST OPHTH VIS SCI, V53, P2349, DOI 10.1167/iovs.11-9405; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Sasaki S, 2012, INVEST OPHTH VIS SCI, V53, P3424, DOI 10.1167/iovs.11-7913; Ikuno Y, 2009, AM J OPHTHALMOL, V147, P94, DOI 10.1016/j.ajo.2008.07.017; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Cohen SY, 1996, OPHTHALMOLOGY, V103, P1241; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Ohno-Matsui K, 2003, BRIT J OPHTHALMOL, V87, P570, DOI 10.1136/bjo.87.5.570; Chan WM, 2007, OPHTHALMOLOGY, V114, P2190, DOI 10.1016/j.ophtha.2007.03.043; Hysi PG, 2010, NAT GENET, V42, P902, DOI 10.1038/ng.664; Hayashi K, 2011, AM J OPHTHALMOL, V151, P137, DOI 10.1016/j.ajo.2010.06.046; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; GROSSNIKLAUS HE, 1992, RETINA-J RET VIT DIS, V12, P127; Hall NF, 2009, INVEST OPHTH VIS SCI, V50, P2632, DOI 10.1167/iovs.08-2427; Hayashi K, 2010, OPHTHALMOLOGY, V117; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/gm315, 10.1186/PREACCEPT-1418491035586234]; Ricci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066978; Riise R, 1988, Acta Ophthalmol Suppl, V185, P109; Sawada O, 2011, ACTA OPHTHALMOL, V89, P459, DOI 10.1111/j.1755-3768.2009.01717.x; Secrétan M, 1997, Eur J Ophthalmol, V7, P307; Tominaga T, 2009, INVEST OPHTH VIS SCI, V50, P5181, DOI 10.1167/iovs.09-3637; Wakabayashi T, 2013, J OPHTHALMOL, V2013, DOI [10.1155/2013/257381, DOI 10.1155/2013/257381]; Wojciechowski R, 2010, INVEST OPHTH VIS SCI, V51, P4989, DOI 10.1167/iovs.10-5474	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0275-004X	1539-2864		RETINA-J RET VIT DIS	Retin.-J. Retin. Vitr. Dis.	FEB	2015	35	2					344	350				7	Ophthalmology	Ophthalmology	CA2UU	WOS:000348764200025		
J	Asaeda, T; Rashid, MH				Asaeda, T.; Rashid, M. H.			NUTRIENT RETENTION ASSOCIATED WITH PHENOLOGICAL FEATURES IN SPARGANIUM ERECTUM STANDS IN A LOWLAND STREAM	RIVER RESEARCH AND APPLICATIONS			English	Article						cohort; sedimentation; ecosystem engineer; emergent macrophyte	SUBMERGED MACROPHYTES; PHRAGMITES-AUSTRALIS; FINE SEDIMENT; RIVER SPREE; WATER-FLOW; SOIL REDOX; BIOGEOCHEMISTRY; PHOSPHORUS; REDUCTION; GERMANY	In a previous study, we found that Sparganium erectum, an emergent macrophyte, accumulates sediment inside the stand because of its phenological features. Because this species usually grows in a nutrient-rich environment, we hypothesize that a high trophic level is maintained in the accumulated sediment. To test this hypothesis, we intensively studied flow velocity, nutrient budget and nutrient flux in and outside of S. erectum stands along the Moto-Arakawa River, Saitama, Japan and found that the growth stages of S. erectum substantially affected the flow conditions inside the stand. The growth stages of this plant also controlled the depositional rate of sediment and organic particles. After the collapse of each cohort, a substantial amount of organic matter accumulated on the stand bed. Because the accumulated organic matter mineralized very fast, the concentration of total carbon (TC), total nitrogen (TN) and total phosphorus (TP) increased substantially after the collapse of the shoots. While the concentrations of TC, TN and TP within the stand's sediment varied seasonally, the concentrations of these elements were always higher inside than outside of the stand. More than five times the amount of carbon and twice the amount of nitrogen and phosphorus were physically retained in the stand for 1 year compared with the amounts assimilated by the plants. The ratio of carbon to nitrogen in the stand's sediment also remained constant throughout the growing period. Conversely, the nitrogen to phosphorus ratio of the accumulated sediment was much lower than that of other plant tissues. The main flow contains suspended organic solids that constantly supply the stand and partially occupy the channel where they eventually settle. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Asaeda, T.] Saitama Univ, Inst Environm Sci & Technol, Sakura, Saitama 3388570, Japan; [Asaeda, T.; Rashid, M. H.] Saitama Univ, Dept Environm Sci & Technol, Sakura, Saitama 3388570, Japan; [Rashid, M. H.] Bangladesh Agr Univ, Mymensingh, Bangladesh	Asaeda, T (reprint author), Saitama Univ, Dept Environm Sci & Technol, 255 Shimo Okubo, Sakura, Saitama 3388570, Japan.	asaeda@mail.saitama-u.ac.jp	Asaeda, Takashi/C-5278-2008		Ministry of Education, Culture, Sports, Science and Technology, Japan; Japanese Society for the Promotion of Science (JSPS); River Basin Environmental Foundation; Foundation of River and Watershed Management, Japan	This research was supported financially by grants from the Ministry of Education, Culture, Sports, Science and Technology (Research Grant-in-Aid), Japan; the Japanese Society for the Promotion of Science (JSPS); and the River Basin Environmental Foundation and Foundation of River and Watershed Management, Japan.	Jones JB, 1996, TRENDS ECOL EVOL, V11, P239, DOI 10.1016/0169-5347(96)10013-6; Sand-Jensen K, 1998, FRESHWATER BIOL, V39, P663; Asaeda T, 2005, FRESHWATER BIOL, V50, P1991, DOI 10.1111/j.1365-2427.2005.01445.x; SVENDSEN LM, 1993, HYDROBIOLOGIA, V251, P123, DOI 10.1007/BF00007172; WANG ZP, 1993, SOIL SCI SOC AM J, V57, P382; Schulz M, 2003, WATER RES, V37, P569, DOI 10.1016/S0043-1354(02)00276-2; Walling DE, 2003, APPL GEOCHEM, V18, P195, DOI 10.1016/S0883-2927(02)00121-X; Koetsier P, 2000, J N AM BENTHOL SOC, V19, P633, DOI 10.2307/1468122; Fisher SG, 2004, ECOLOGY, V85, P2369, DOI 10.1890/03-0244; Horppila J, 2003, WATER RES, V37, P4468, DOI 10.1016/S0043-1354(03)00405-6; Wigand C, 1997, AQUAT BOT, V56, P233, DOI 10.1016/S0304-3770(96)01108-4; Jones JI, 2012, RIVER RES APPL, V28, P1006, DOI 10.1002/rra.1486; APHA, 1998, STANDARD METHODS EXA; Asaeda T, 2010, RIVER RES APPL, V26, P1153, DOI 10.1002/rra.1322; Asaeda T, 2001, ECOL MODEL, V137, P61, DOI 10.1016/S0304-3800(00)00432-4; Asaeda T, 2002, HYDROBIOLOGIA, V485, P205, DOI 10.1023/A:1021314203532; Britton NL, 1913, ILLUSTRATED FLORA NO, V1; COOK CDK, 1962, J ECOL, V50, P247, DOI 10.2307/2257208; Ennabili A, 1998, AQUAT BOT, V62, P45, DOI 10.1016/S0304-3770(98)00075-8; Gibbs H, 2012, EGU GEN ASS 22 27 AP, P490; Green JC, 2005, AQUAT ECOL, V39, P1, DOI 10.1007/s10452-004-1913-0; Kozerski HP, 2003, HYDROBIOLOGIA, V494, P51, DOI 10.1023/A:1025477223638; Maazouzi C, 2013, J SOIL SEDIMENT, V13, P207, DOI 10.1007/s11368-012-0622-x; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI DOI 10.1016/S0003-2670(00)88444-5; PETTICREW EL, 1992, CAN J FISH AQUAT SCI, V49, P2483, DOI 10.1139/f92-274; Sand-Jensen K, 1997, FRESHWATER BIOL PRIO, P74; Schulz M, 2003, AQUAT BOT, V76, P17, DOI 10.1016/S0304-3770(03)00015-9; Smilauer P., 2002, CANOCO REFERENCE MAN; SMITH CJ, 1983, J ENVIRON QUAL, V12, P186; TAKAI Y, 1966, FOLIA MICROBIOL, V11, P304, DOI 10.1007/BF02878902; Wlodarczyk T, 2000, ACTA AGROPHYSICA, V28, P39	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1535-1459	1535-1467		RIVER RES APPL	River Res. Appl.	FEB	2015	31	2					207	215		10.1002/rra.2733		9	Environmental Sciences; Water Resources	Environmental Sciences & Ecology; Water Resources	AZ8YK	WOS:000348497400008		
J	Li, MX; Guo, SX; Hirata, H; Ishihara, H				Li, Maoxun; Guo, Shuxiang; Hirata, Hideyuki; Ishihara, Hidenori			Design and performance evaluation of an amphibious spherical robot	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Article						Amphibious spherical robot; Quadruped walking; Walking gait; Water-jet propeller	UNDERWATER VEHICLE; MANIPULATION; MODULATION; NAVIGATION	This paper presents an amphibious spherical robot that consists of a sealed upper hemispheroid, two quarter spherical shells, and a plastic circular plate. It has a plastic shelf for carrying the micro-robots, and four actuating units for movement. Each unit is composed of a water-jet propeller and two servomotors, each of which can rotate 90 in the horizontal and vertical directions. The robot is capable of motion on land, as well as underwater. The robot is capable of three walking gaits; therefore, we describe experiments on various terrains to evaluate the walking motion performance, including stability and velocity. Additionally, plenty of underwater experiments are conducted to evaluate the underwater performance, containing horizontal and vertical motions, and to verify the fixture and deployment mechanism for the micro-robot. (C) 2014 Elsevier B.V. All rights reserved.	[Li, Maoxun] Kagawa Univ, Grad Sch Engn, Hayashichou, Kagawa 221720, Japan; [Guo, Shuxiang; Hirata, Hideyuki; Ishihara, Hidenori] Kagawa Univ, Fac Engn, Hayashichou, Kagawa 221720, Japan; [Guo, Shuxiang] Beijing Inst Technol, Beijing, Peoples R China	Li, MX (reprint author), Kagawa Univ, Grad Sch Engn, Hayashichou, Kagawa 221720, Japan.	s14d505@stmail.eng.kagawa-u.ac.jp			Kagawa University Characteristic Prior Research Fund	This research was supported by the Kagawa University Characteristic Prior Research Fund 2012.	Guo SX, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (ICMA), P1173; Guo SX, 2013, 2013 ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING (CME), P602; Santos CP, 2012, ROBOT AUTON SYST, V60, P912, DOI 10.1016/j.robot.2012.01.004; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; Santos CP, 2011, ROBOT AUTON SYST, V59, P620, DOI 10.1016/j.robot.2011.05.003; Korde UA, 2004, OCEAN ENG, V31, P1205, DOI 10.1016/j.oceaneng.2004.01.001; Kim J, 2006, OCEAN ENG, V33, P566, DOI 10.1016/j.oceaneng.2005.07.008; [Anonymous], 2012, TOSHIBA 4 LEGGED NUC; YOERGER DR, 1990, IEEE J OCEANIC ENG, V15, P167, DOI 10.1109/48.107145; Shi LW, 2012, SENSORS-BASEL, V12, P16732, DOI 10.3390/s121216732; Yu SC, 2013, OCEAN ENG, V70, P149, DOI 10.1016/j.oceaneng.2013.06.006; Lin XC, 2010, INFORMATION-TOKYO, V13, P1985; Boxerbaum A.S., 2005, P IEEE ASME INT C AD, P1459, DOI 10.1109/AIM.2005.1511216; Brunetto P., 2008, SMART MATER STRUCT, V17, P025; Chase R., 2012, ROBOTICS, P1; Dudek G, 2007, COMPUTER, V40, P46, DOI 10.1109/MC.2007.6; Guo Shuxiang, 2013, P 2013 IEEE INT C IN, P1038; Hirose S., 2009, ROBOTICS AUTOMATION, V16, P88; Kim SJ, 2007, SMART MATER STRUCT, V16, pN6, DOI 10.1088/0964-1726/16/1/N02; Lee D, 2012, OCEAN ENG, V48, P59, DOI 10.1016/j.oceaneng.2012.04.006; Tadakuma K., 2011, P 2011 IEEE INT C RO, P5056; Yu J., 2013, J FIELD ROBOT, P1; Yu S., 2011, 2011 IEEE INT C ROB, P2960; Zhang SW, 2013, J BIONIC ENG, V10, P434, DOI 10.1016/S1672-6529(13)60247-4; Zhou C., 2010, J BIONIC ENG S, V7, P137; Zhou WL, 2004, SENSOR ACTUAT A-PHYS, V114, P406, DOI 10.1016/j.sna.2003.11.001	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	FEB	2015	64						21	34		10.1016/j.robot.2014.11.007		14	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	CA4NO	WOS:000348881600002		
J	Huang, YJ; Chiba, R; Arai, T; Ueyama, T; Ota, J				Huang, Yanjiang; Chiba, Ryosuke; Arai, Tamio; Ueyama, Tsuyoshi; Ota, Jun			Robust multi-robot coordination in pick-and-place tasks based on part-dispatching rules	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Article						Part-dispatching rule; Multi-robot system; Pattern variation; Pick-and-place task; Greedy randomized adaptive search procedure; Monte Carlo strategy	OPTIMIZATION PROBLEMS; GENETIC ALGORITHM; MOVING CONVEYOR; MONTE-CARLO; CYCLE TIME; SYSTEMS; ARCHITECTURE; COOPERATION; ROBOTS; ENVIRONMENT	This paper addresses the problem of realizing multi-robot coordination that is robust against pattern variation in a pick-and-place task. To improve productivity and reduce the number of parts remaining on the conveyor, a robust and appropriate part flow and multi-robot coordinate strategy are needed. We therefore propose combining part-dispatching rules to coordinate robots, by integrating a greedy randomized adaptive search procedure (GRASP) and a Monte Carlo strategy (MCS). GRASP is used to search for the appropriate combination of part-dispatching rules, and MCS is used to estimate the minimum-maximal part flow for one combination of part-dispatching rules. The part-dispatching rule of first-in first-out is used to control the final robot lathe multi-robot system to pick up parts left by other robots, and the part-dispatching rule of shortest processing time is used to make the other robots pick up as many parts as possible. By comparing it with non-cooperative game theory, we verify that the appropriate combination of part-dispatching rules is effective in improving the productivity of a multi-robot system. By comparing it with a genetic algorithm, we also verify that MCS is effective in estimating minimum-maximal part flow. The task-completion success rate derived via the proposed method reached 99.4% for 10,000 patterns. (C) 2014 Elsevier B.V. All rights reserved.	[Huang, Yanjiang] S China Univ Technol, Sch Mech & Automot Engn, Guangzhou 510640, Guangdong, Peoples R China; [Huang, Yanjiang; Ota, Jun] Univ Tokyo, Ctr Engn RACE, Kashiwa, Chiba 2778568, Japan; [Chiba, Ryosuke] Tokyo Metropolitan Univ, Fac Syst Design, Hino, Tokyo 1910065, Japan; [Arai, Tamio] Shibaura Inst Technol, Coll Engn, Dept Mech Engn, Koto Ku, Tokyo 1358548, Japan; [Ueyama, Tsuyoshi] DENSO WAVE Inc, Agui, Aichi 4702297, Japan	Huang, YJ (reprint author), Univ Tokyo, Ctr Engn RACE, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778568, Japan.	mehuangyj@scut.edu.cn			Global COE Program "Global Center of Excellence for Mechanical Systems Innovation", MEXT, Japan	This work was partially supported by the Global COE Program "Global Center of Excellence for Mechanical Systems Innovation", MEXT, Japan.	Fierro R, 2002, INT J ROBOT RES, V21, P977, DOI 10.1177/0278364902021010981; Aissi H, 2009, EUR J OPER RES, V197, P427, DOI 10.1016/j.ejor.2008.09.012; PANWALKAR SS, 1977, OPER RES, V25, P45, DOI 10.1287/opre.25.1.45; Sexton RS, 1999, EUR J OPER RES, V114, P589, DOI 10.1016/S0377-2217(98)00114-3; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; [Anonymous], 2007, SPEC ROB; Yokoo M, 1998, IEEE T KNOWL DATA EN, V10, P673, DOI 10.1109/69.729707; Parker LE, 1998, IEEE T ROBOTIC AUTOM, V14, P220, DOI 10.1109/70.681242; Steiger JH, 2000, STRUCT EQU MODELING, V7, P149, DOI 10.1207/S15328007SEM0702_1; Beyer HG, 2007, COMPUT METHOD APPL M, V196, P3190, DOI 10.1016/j.cma.2007.03.003; Muthen LK, 2002, STRUCT EQU MODELING, V9, P599, DOI 10.1207/S15328007SEM0904_8; Bonert M, 2000, INT J COMP INTEG M, V13, P301, DOI 10.1080/095119200407660; Janak SL, 2007, COMPUT CHEM ENG, V31, P171, DOI 10.1016/j.compchemeng.2006.05.035; Mattone R, 2000, ROBOT CIM-INT MANUF, V16, P81, DOI 10.1016/S0736-5845(99)00041-1; PUKELSHEIM F, 1994, AM STAT, V48, P88, DOI 10.2307/2684253; Beirlant J., 2004, STAT EXTREMES THEORY; Bozma HI, 2012, ROBOT CIM-INT MANUF, V28, P530, DOI 10.1016/j.rcim.2011.12.001; Causey G. C., 1999, Proceedings 1999 IEEE International Conference on Robotics and Automation (Cat. No.99CH36288C), DOI 10.1109/ROBOT.1999.773983; Chapman AC, 2011, KNOWL ENG REV, V26, P411, DOI 10.1017/S0269888911000178; Cheng M.G., 2009, SICE T IND APPL, V8, P54; Chiba R., 2010, J ROBOT MECHATRONICS, V22, P475; Delmaire H., 1999, INVEST OPER, V8, P217; FEO TA, 1995, J GLOBAL OPTIM, V6, P109, DOI 10.1007/BF01096763; Fox D., 1999, Proceedings Sixteenth National Conference on Artificial Intelligence (AAI-99). Eleventh Innovative Applications of Artificial Intelligence Conference (IAAI-99); Galante G, 2006, INT J PROD RES, V44, P639, DOI 10.1080/00207540500337544; Hasan M, 2000, COMPUT IND ENG, V38, P323, DOI 10.1016/S0360-8352(00)00043-7; Huang Y.J., 2012, P IEEE INT C ROB BIO, P1887; Bozma HI, 2002, ROBOT CIM-INT MANUF, V18, P125, DOI 10.1016/S0736-5845(01)00035-7; Jin Y., 2003, J STRUCT MULTIDICIP, V25, P99; Kakamu K., 2005, 5 JAP KOR CAD CAM WO, P185; Kosuge K., 1994, Robotics and Autonomous Systems, V12, DOI 10.1016/0921-8890(94)90048-5; Laskari EC, 2002, IEEE C EVOL COMPUTAT, P1576; Latombe J. C., 1991, ROBOT MOTION PLANNIN; Li J., 2008, INT J ACHIEV MAT MAN, V31, P526; Li TY, 1997, INT J ROBOT RES, V16, P144, DOI 10.1177/027836499701600202; Liu J. S., 2001, MONTE CARLO STRATEGI; MAY FB, 1989, ROBOT CIM-INT MANUF, V6, P37, DOI 10.1016/0736-5845(89)90083-5; NOF SY, 1989, INT J PROD RES, V27, P477, DOI 10.1080/00207548908942561; NOREILS FR, 1993, INT J ROBOT RES, V12, P79, DOI 10.1177/027836499301200106; Pagello E, 1999, ROBOT AUTON SYST, V29, P65, DOI 10.1016/S0921-8890(99)00039-1; Rasiel E., 1999, THE MCKINSEY WAY; Resende M.G.C., 1999, STATE ART HDB METAHE; Scheffe H, 1999, ANAL VARIANCE; SONG YY, 1993, INT J PROD RES, V31, P1541, DOI 10.1080/00207549308956808	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	FEB	2015	64						70	83		10.1016/j.robot.2014.10.018		14	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	CA4NO	WOS:000348881600006		
J	Taniguchi, K; Shinohara, M; Nozaki, S; Katayose, M				Taniguchi, K.; Shinohara, M.; Nozaki, S.; Katayose, M.			Acute decrease in the stiffness of resting muscle belly due to static stretching	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						muscle elasticity; shear modulus; joint flexibility; ultrasound elastography; strain injuries	SHEAR ELASTIC-MODULUS; IN-VIVO; TENDON UNIT; MUSCULOTENDINOUS STIFFNESS; PASSIVE STIFFNESS; SKELETAL-MUSCLE; RISK-FACTORS; ELASTOGRAPHY; MOTION; RANGE	The purpose of the study was to examine the acute effect of static stretching exercise on the resting stiffness of gastrocnemius muscle belly. Ten healthy young adults performed standing wall stretching in dorsiflexion for 1min at a time and repeated five times. Before and after stretching, the shear modulus was measured in medial and lateral heads of the resting gastrocnemius muscle with ultrasound shear-wave elastography. After the stretching, dorsiflexion range of motion (ROM) of the ankle joint increased (P<0.01) by 3.9 degrees and returned in 20min. Immediately after stretching, shear modulus decreased (P<0.01) by 14%, compared with before stretching across muscle heads. The decrease in shear modulus returned in 20min after stretching. In the comparison group of 10 additional subjects, the standing intervention without stretching had no influence on these measures. There was a negative correlation between dorsiflexion ROM and shear modulus in either head before and after stretching. The results demonstrate the transient decreases in the stiffness of the resting gastrocnemius muscle belly and indicate that joint flexibility is greater in individuals with lower resting stiffness of the muscle belly.	[Taniguchi, K.; Nozaki, S.; Katayose, M.] Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido 0608556, Japan; [Shinohara, M.] Georgia Inst Technol, Sch Appl Physiol, Atlanta, GA 30332 USA; [Shinohara, M.] Atlanta VA Med Ctr, Rehabil R&D Ctr Excellence, Decatur, GA USA	Taniguchi, K (reprint author), Sapporo Med Univ, Sch Hlth Sci, Chu Ou Ku, South 3,West 17, Sapporo, Hokkaido 0608556, Japan.	ktani@sapmed.ac.jp		Shinohara, Minoru/0000-0002-9260-0366	Ministry of Education, Culture, Sports, Science and Technology [23700612]	This study was supported, in part, by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology Grant (#23700612). We thank Canon Marketing Japan for lending the device for ultrasound shear-wave elastography. Thanks to Dr Vasiliy Buharin (Georgia Institute of Technology) for proofreading the manuscript.	Riddle D, 2003, J BONE JOINT SURG AM, V85A, P872; Cipriani DJ, 2012, J STRENGTH COND RES, V26, P2119, DOI 10.1519/JSC.0b013e31823b862a; Arda K, 2011, AM J ROENTGENOL, V197, P532, DOI 10.2214/AJR.10.5449; Bressel E, 2002, PHYS THER, V82, P880; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Weppler CH, 2010, PHYS THER, V90, P438, DOI 10.2522/ptj.20090012; Zhao H, 2011, J APPL PHYSIOL, V111, P435, DOI 10.1152/japplphysiol.01361.2010; Herbert RD, 2011, J PHYSIOL-LONDON, V589, P5257, DOI 10.1113/jphysiol.2011.212175; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Hoyt K, 2008, PHYS MED BIOL, V53, P4063, DOI 10.1088/0031-9155/53/15/004; Marusiak J, 2011, MOVEMENT DISORD, V26, P2119, DOI 10.1002/mds.23841; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Kaufman KR, 1999, AM J SPORT MED, V27, P585; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Basford JR, 2002, ARCH PHYS MED REHAB, V83, P1530, DOI 10.1053/apmr.2002.35472; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Bouillard K, 2012, J APPL PHYSIOL, V113, P1353, DOI 10.1152/japplphysiol.00858.2012; Ryan ED, 2008, J ORTHOP SPORT PHYS, V38, P632, DOI 10.2519/jospt.2008.2843; Hoge KM, 2010, J STRENGTH COND RES, V24, P2618, DOI 10.1519/JSC.0b013e3181e73974; Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445; Lun V, 2004, BRIT J SPORT MED, V38, P576, DOI 10.1136/bjsm.2003.005488; Chuang LL, 2012, STROKE RES TREAT, DOI [10.1155/2012/617694, DOI 10.1155/2012/617694]; Harvey L, 2003, SPINAL CORD, V41, P559, DOI 10.1038/sj.sc.3101486; Jung DY, 2009, J ORTHOP SPORT PHYS, V39, P867, DOI 10.2519/jospt.2009.3158; KANEHISA H, 1994, INT J SPORTS MED, V15, P420, DOI 10.1055/s-2007-1021081; Koulouris G, 2007, SKELETAL RADIOL, V36, P921, DOI 10.1007/s00256-007-0306-6; Kubo K, 2009, INT J SPORTS MED, V30, P139, DOI 10.1055/s-0028-1104573; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Magnusson SP, 2000, MED SCI SPORT EXER, V32, P1160, DOI 10.1097/00005768-200006000-00020; Miller W A, 1977, Am J Sports Med, V5, P191, DOI 10.1177/036354657700500505; Mizuno T, 2013, SCAND J MED SCI SPOR, V23, P23, DOI 10.1111/j.1600-0838.2011.01329.x; Page Phil, 2012, Int J Sports Phys Ther, V7, P109; Portney LG, 2009, FDN CLIN RES APPL PR, P585; Radford JA, 2006, BRIT J SPORT MED, V40, P870, DOI 10.1136/bjsm.2006.029348; Ryan ED, 2008, MED SCI SPORT EXER, V40, P1529, DOI 10.1249/MSS.0b013e31817242eb; Taniguchi K, 2012, 19 BIENN C INT SOC E, P526; Tweed JL, 2008, J AM PODIAT MED ASSN, V98, P436; Uffmann K, 2004, NMR BIOMED, V17, P181, DOI 10.1002/nbm.887	40	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	FEB	2015	25	1					32	40		10.1111/sms.12146		9	Sport Sciences	Sport Sciences	CA3XT	WOS:000348839100021		
J	Ozawa, J; Kaneguchi, A; Tanaka, R; Kawamata, S; Kurose, T; Moriyama, H; Kito, N; Kawaguchi, N; Matsuura, N				Ozawa, J.; Kaneguchi, A.; Tanaka, R.; Kawamata, S.; Kurose, T.; Moriyama, H.; Kito, N.; Kawaguchi, N.; Matsuura, N.			Interaction between gastrocnemius muscle weakness and moderate exercise deteriorates joint integrity in rat knee	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						Articular cartilage; type II collagen; botulinum toxin type A; the gastrocnemius muscle; treadmill running	HUMAN ARTICULAR-CARTILAGE; SYNOVIAL-FLUID; QUADRICEPS STRENGTH; OSTEOARTHRITIS; DEGENERATION; GAIT; GLYCOSAMINOGLYCAN; DEGRADATION; INJECTION; EPITOPES	The aim of this study was to determine the effect on the knee joint of the interaction between ankle muscle weakness and moderate exercise. Gastrocnemius muscle weakness was induced by intramuscular injection of botulinum toxin type A (BTX) in rats. Low-speed treadmill running (12m/min for 60min) was applied for 6 weeks in rats with and without BTX. Untreated animals were used as controls. After BTX injection, the gastrocnemius muscle weakness was confirmed by 3-D motion analysis in kinematic features of the hindlimb during locomotion as an increased maximal dorsiflexion angle during the stance phase. Serum biomarker analysis by enzyme-linked immunosorbent assay revealed that low-speed running decreased the catabolic effect on type II collagen. However, the inhibition of catabolism induced by running exercise was significantly counteracted by BTX injection. In addition, thinning of the cartilage layer and a reduction in the chondrocyte density was also found in the tibial plateau of the knee in the BTX-injected rats after running for 6 weeks. These data suggest that moderate exercise have a positive effect on joint homeostasis. However, ankle muscle weakness may alter the mechanical environment of the knee and impair the integrity of joint cartilage with moderate exercise.	[Ozawa, J.; Tanaka, R.; Kito, N.] Hiroshima Int Univ, Fac Rehabil, Dept Rehabil, Hiroshima 7392695, Japan; [Kaneguchi, A.] Hiroshima Int Univ, Grad Sch Med Technol & Hlth Welf Sci, Hiroshima 7392695, Japan; [Kawamata, S.; Kurose, T.] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Moriyama, H.] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo, Japan; [Kawaguchi, N.; Matsuura, N.] Osaka Univ, Grad Sch Med, Osaka, Japan	Ozawa, J (reprint author), Hiroshima Int Univ, Fac Rehabil, Dept Rehabil, Kurose Gakuendai 555-36, Hiroshima 7392695, Japan.	j-ozawa@hs.hirokoku-u.ac.jp			Ministry of Education, Culture, Sport, Science, and Technology of Japan	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sport, Science, and Technology of Japan. We thank Mr Tomoaki Nishino for his technical assistance.	Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; Hunt MA, 2010, KNEE, V17, P296, DOI 10.1016/j.knee.2010.02.010; Leong DJ, 2011, FASEB J, V25, P182, DOI 10.1096/fj.10-164277; Liphardt AM, 2009, OSTEOARTHR CARTILAGE, V17, P1598, DOI 10.1016/j.joca.2009.07.007; Pickett A, 2008, TOXICON, V52, P455, DOI 10.1016/j.toxicon.2008.06.021; Herzog W, 2007, J BIOMECH, V40, pS54, DOI 10.1016/j.jbiomech.2007.03.001; Frisbie DD, 2008, OSTEOARTHR CARTILAGE, V16, P1196, DOI 10.1016/j.joca.2008.03.008; Eckstein F, 2006, J ANAT, V208, P491, DOI 10.1111/j.1469-7580.2006.00546.x; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI [10.1016/j.joca.2007.12.013, 10.1016/j.joca.2010.01.013]; Yuan GH, 2003, ARTHRITIS RHEUM, V48, P602, DOI 10.1002/art.10768; Heijink A, 2012, KNEE SURG SPORT TR A, V20, P423, DOI 10.1007/s00167-011-1818-0; Moriyama H, 2012, BIOGERONTOLOGY, V13, P369, DOI 10.1007/s10522-012-9381-8; Fransen M, 2009, J RHEUMATOL, V36, P1109, DOI 10.3899/jrheum.090058; Bautch JC, 2000, ANN RHEUM DIS, V59, P887, DOI 10.1136/ard.59.11.887; Roos EM, 2005, ARTHRITIS RHEUM, V52, P3507, DOI 10.1002/art.21415; Brin M F, 1997, Muscle Nerve Suppl, V6, pS146; Otterness IG, 1998, ARTHRITIS RHEUM, V41, P2068, DOI 10.1002/1529-0131(199811)41:11<2068::AID-ART23>3.0.CO;2-L; Chen WM, 2012, J BIOMECH, V45, P1783, DOI 10.1016/j.jbiomech.2012.04.024; Beckett J, 2012, J ORTHOP RES, V30, P1604, DOI 10.1002/jor.22124; Bennell K, 2005, CURR OPIN RHEUMATOL, V17, P634, DOI 10.1097/01.bor.0000171214.49876.38; Chu Q, 2002, OSTEOARTHR CARTILAGE, V10, P662, DOI 10.1053/joca.2002.0812; Dugan Sheila A, 2005, Phys Med Rehabil Clin N Am, V16, P603, DOI 10.1016/j.pmr.2005.02.007; HARMAND MF, 1982, BIOCHIM BIOPHYS ACTA, V717, P190, DOI 10.1016/0304-4165(82)90169-6; Helmark IC, 2011, RHEUMATOL INT, V32, P1009; Horisberger M, 2012, CLIN BIOMECH, V27, P292, DOI 10.1016/j.clinbiomech.2011.09.012; HUGHES PCR, 1970, J ANAT, V106, P371; Longino D, 2005, J ORTHOP RES, V23, P1411, DOI 10.1016/j.orthres.2005.02.016; Mikesky AE, 2000, J ORTHOPAED RES, V18, P171, DOI 10.1002/jor.1100180202; Misiaszek JE, 2002, J NEUROPHYSIOL, V87, P229; Moriyama H, 2008, OSTEOARTHR CARTILAGE, V16, P392, DOI 10.1016/j.joca.2007.07.002; Ni GX, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3521; Youssef AR, 2009, OSTEOARTHR CARTILAGE, V17, P1228, DOI 10.1016/j.joca.2009.03.017; Sekiya I, 2009, J ORTHOP RES, V27, P1088, DOI 10.1002/jor.20840; Tang T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2363; Vincent KR, 2012, PM&R, V4, pS3, DOI 10.1016/j.pmrj.2012.01.020; Vos P, 2009, J ORTHOP RES, V27, P1332, DOI 10.1002/jor.20897	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	FEB	2015	25	1					E11	E19		10.1111/sms.12195		9	Sport Sciences	Sport Sciences	CA3XT	WOS:000348839100002		
J	Ishigooka, J; Nakamura, J; Fujii, Y; Iwata, N; Kishimoto, T; Iyo, M; Uchimura, N; Nishimura, R; Shimizu, N				Ishigooka, Jun; Nakamura, Jun; Fujii, Yasuo; Iwata, Nakao; Kishimoto, Toshifumi; Iyo, Masaomi; Uchimura, Naohisa; Nishimura, Ryoji; Shimizu, Naoaki		ALPHA Study Grp	Efficacy and safety of aripiprazole once-monthly in Asian patients with schizophrenia: A multicenter, randomized, double-blind, non-inferiority study versus oral aripiprazole	SCHIZOPHRENIA RESEARCH			English	Article						Aripiprazole; Long-acting injection; Schizophrenia; Asian; Efficacy; Safety	MAINTENANCE TREATMENT; SCHIZOAFFECTIVE DISORDER; PLACEBO; RELAPSE; ANTIPSYCHOTICS; SCALE; DEPOT; TERM	Objective: This study was designed to evaluate efficacy and safety of aripiprazole once-monthly (AOM) by verifying non-inferiority of AOM to oral aripiprazole in Asian patients with schizophrenia. Method: The study consisted of a screening phase and three phases: an oral conversion phase (<= 12 weeks), an oral stabilization phase (<= 12 weeks) and a 52-week double-blind phase. Patients meeting stabilization criteria for 4 weeks during the oral stabilization phase were randomly assigned (1: 1) to AOM (400 mg) or oral aripiprazole (6-24 mg/day). The primary endpoint was Kaplan-Meier estimated rate of non-exacerbation of psychotic symptoms/non-relapse at Week 26. Results: A total of 724 patients were screened, and 502 patients entered the oral stabilization phase. Of 455 patients randomized in the double-blind phase, 228 received AOM and 227 received oral aripiprazole. The non-exacerbation of psychotic symptoms/non-relapse rates at Week 26 were 95.0% (AOM) and 94.7% (oral aripiprazole) and the difference was 0.3% (95% CI: -3.9,4.5), thus non-inferiority of AOM compared to oral aripiprazole with respect to non-exacerbation of psychotic symptoms/non-relapse rate was shown with a margin of -3.9% which is well above the pre-defined non-inferiority limit (-15%). The proportions of patients meeting exacerbation of psychotic symptoms/relapse criteria and stabilization of psychotic symptoms/maintenance criteria were 6.6% and 92.5% in both groups. Discontinuation rates due to all reasons were 25.9% (AOM) and 33.5% (oral aripiprazole). AOM was well tolerated as well as oral aripiprazole. Conclusions: Non-inferiority of AOM to oral aripiprazole was established. AOM is efficacious in maintenance treatment of stabilized schizophrenia, with comparable efficacy and tolerability to oral aripiprazole. Clinical Trials Registration: JapicCTI-101175 (C) 2014 Elsevier B.V. All rights reserved.	[Ishigooka, Jun] Tokyo Womens Med Univ, Dept Psychiat, Shinjuku Ku, Tokyo 1628666, Japan; [Nakamura, Jun] Univ Occupat & Environm Hlth, Sch Med, Dept Psychiat, Yahata Nishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Fujii, Yasuo] Yamanashi Prefectural Kita Hosp, Dept Neuropsychiat, Nirasakishi, Yamanashi 4070046, Japan; [Iwata, Nakao] Fujita Hlth Univ, Dept Psychiat, Sch Med, Toyoake, Aichi 4701192, Japan; [Kishimoto, Toshifumi] Nara Med Univ, Dept Psychiat, Sch Med, Kashihara, Nara 6348521, Japan; [Iyo, Masaomi] Chiba Univ, Dept Psychiat, Sch Med, Chuou Ku, Chiba 2608670, Japan; [Uchimura, Naohisa] Kurume Univ, Dept Neuropsychiat, Sch Med, Kurume, Fukuoka 8300011, Japan; [Nishimura, Ryoji] Fukuoka Univ, Dept Psychiat, Fac Med, Jonan Ku, Fukuoka 8140180, Japan; [Shimizu, Naoaki] Otsuka Pharmaceut Co Ltd, Minato Ku, Tokyo 1088242, Japan	Ishigooka, J (reprint author), Tokyo Womens Med Univ, Dept Psychiat, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ishigooka.jun@twmu.ac.jp			Otsuka Pharmaceutical Co., Ltd. (Tokyo) [Japiccti-101175]	This study was funded by Otsuka Pharmaceutical Co., Ltd. (Tokyo), clinical trial registration: Japiccti-101175.	Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Kane JM, 2012, J CLIN PSYCHIAT, V73, P617, DOI 10.4088/JCP.11m07530; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Marder SR, 2003, SCHIZOPHR RES, V61, P123, DOI 10.1016/S0920-9964(03)00050-1; Kishimoto T, 2013, J CLIN PSYCHIAT, V74, P957, DOI 10.4088/JCP.13r08440; Hough D, 2010, SCHIZOPHR RES, V116, P107, DOI 10.1016/j.schres.2009.10.026; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Kirson NY, 2013, J CLIN PSYCHIAT, V74, P568, DOI 10.4088/JCP.12r08167; Potkin SG, 2003, ARCH GEN PSYCHIAT, V60, P681, DOI 10.1001/archpsyc.60.7.681; Pigott TA, 2003, J CLIN PSYCHIAT, V64, P1048; Fleischhacker WW, 2014, BRIT J PSYCHIAT, V205, P135, DOI 10.1192/bjp.bp.113.134213; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; Fukahara S., 1998, J CLIN EPIDEMIOL, V51, P1045; Guy W, 1976, PUBLICATION ADM, P218; Higashi Kyoko, 2013, Ther Adv Psychopharmacol, V3, P200, DOI 10.1177/2045125312474019; Inada T, 2009, DIEPSS 2 GENERATION; Kasper S, 2003, INT J NEUROPSYCHOPH, V6, P325, DOI 10.1017/S1461145703003651; Kishimoto T, 2014, SCHIZOPHRENIA BULL, V40, P192, DOI 10.1093/schbul/sbs150	19	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	FEB	2015	161	2-3					421	428		10.1016/j.schres.2014.12.013		8	Psychiatry	Psychiatry	AZ8GB	WOS:000348452100041		
J	Nakajima, S; Takeuchi, H; Fervaha, G; Plitman, E; Chung, JK; Caravaggio, F; Iwata, Y; Mihashi, Y; Gerretsen, P; Remington, G; Mulsant, B; Graff-Guerrero, A				Nakajima, Shinichiro; Takeuchi, Hiroyoshi; Fervaha, Gagan; Plitman, Eric; Chung, Jun Ku; Caravaggio, Fernando; Iwata, Yusuke; Mihashi, Yukiko; Gerretsen, Philip; Remington, Gary; Mulsant, Benoit; Graff-Guerrero, Ariel			Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: Analysis of the CATIE phase 2E data	SCHIZOPHRENIA RESEARCH			English	Article						Schizophrenia; Depression; Clozapine; Quetiapine; CATIE	TREATMENT-RESISTANT SCHIZOPHRENIA; DOUBLE-BLIND; 2ND-GENERATION ANTIPSYCHOTICS; RATING-SCALE; RISPERIDONE; TRIAL; OLANZAPINE; SUICIDE; DRUGS; METAANALYSIS	Background: The comparative antidepressant effects of clozapine and other atypical antipsychotics for schizophrenia remain elusive, leading us to examine this question using the data from the Clinical Antipsychotic Trials of Intervention Effectiveness phase 2E. Methods: Ninety-nine patients who discontinued treatment with olanzapine, quetiapine, risperidone, or ziprasidone because of inadequate efficacy were randomly assigned to open-label treatment with clozapine (n = 49) or double-blind treatment with another atypical antipsychotic not previously received in the trial (olanzapine [n = 19], quetiapine [n = 15], or risperidone [n = 16]). The primary outcome was the Calgary Depression Scale for Schizophrenia (CDSS) total score. Antidepressant effects of clozapine and the other atypical antipsychotics were compared in patients with chronic schizophrenia and those with amajor depressive episode (MDE) at baseline (i.e. = 6 on the CDSS), using mixed models. Results: No differences in the baseline CDSS total scores were found between the treatment groups regardless of presence of an MDE. Clozapine was more effective than quetiapine in antidepressant effects for chronic schizophrenia (p < .01 for the whole sample and p = .01 for those with an MDE), and comparable to olanzapine and risperidone. Conclusion: The present findings suggest that clozapine demonstrates superior antidepressant effects to quetiapine and comparable effects to olanzapine and risperidone in chronic schizophrenia regardless of presence of MDE. Given the indication of clozapine for treatment-resistant schizophrenia (TRS) and the negative impacts of depressive symptoms on clinical outcomes in schizophrenia, further research is warranted to investigate antidepressant effects of clozapine in TRS with an MDE. (C) 2014 Elsevier B.V. All rights reserved.	[Nakajima, Shinichiro; Plitman, Eric; Chung, Jun Ku; Caravaggio, Fernando; Iwata, Yusuke; Mihashi, Yukiko; Gerretsen, Philip; Graff-Guerrero, Ariel] Ctr Addict & Mental Hlth, Res Imaging Ctr, Multimodal Imaging Grp, Toronto, ON M5T 1R8, Canada; [Nakajima, Shinichiro; Gerretsen, Philip; Mulsant, Benoit; Graff-Guerrero, Ariel] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Div, Toronto, ON M5T 1R8, Canada; [Nakajima, Shinichiro; Takeuchi, Hiroyoshi; Fervaha, Gagan; Plitman, Eric; Chung, Jun Ku; Caravaggio, Fernando; Iwata, Yusuke; Gerretsen, Philip; Remington, Gary; Mulsant, Benoit; Graff-Guerrero, Ariel] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Nakajima, Shinichiro; Takeuchi, Hiroyoshi; Iwata, Yusuke; Remington, Gary] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Takeuchi, Hiroyoshi; Fervaha, Gagan; Remington, Gary] Ctr Addict & Mental Hlth, Complex Mental Illness Program, Schizophrenia Div, Toronto, ON M5T 1R8, Canada; [Fervaha, Gagan; Plitman, Eric; Chung, Jun Ku; Caravaggio, Fernando; Gerretsen, Philip] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Remington, Gary; Mulsant, Benoit; Graff-Guerrero, Ariel] Ctr Addict & Mental Hlth, Campbell Res Inst, Toronto, ON M5T 1R8, Canada	Graff-Guerrero, A (reprint author), Ctr Addict & Mental Hlth, Res Imaging Ctr, Multimodal Imaging Grp, 250 Coll St, Toronto, ON M5T 1R8, Canada.	shinichiro_nakajima@hotmail.com; hirotak@dk9.so-net.ne.jp; gagan.fervaha@camh.ca; plitmaneric@gmail.com; junku.chung@mail.utoronto.ca; fernando.caravaggio@gmail.com; yusuke.iwata2010@gmail.com; yukiko.mihashi@mail.utoronto.ca; philgerretsen@yahoo.com; gary.remington@camh.ca; benoit.mulsant@camh.ca; ariel_graff@yahoo.com.mx		Gerretsen, Philip/0000-0003-4053-6814			ADDINGTON D, 1994, SCHIZOPHR RES, V11, P239, DOI 10.1016/0920-9964(94)90017-5; ADDINGTON D, 1993, BRIT J PSYCHIAT, V163, P39; Addington D. E., 2010, J CLIN PSYCHIAT, V72, P75; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Fervaha G, 2013, SCHIZOPHR RES, V151, P203, DOI 10.1016/j.schres.2013.10.021; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Sands JR, 1999, SCHIZOPHRENIA BULL, V25, P157; Leucht S, 2009, AM J PSYCHIAT, V166, P152, DOI 10.1176/appi.ajp.2008.08030368; Stroup TS, 2003, SCHIZOPHRENIA BULL, V29, P15; Rosenheck RA, 2006, AM J PSYCHIAT, V163, P2080, DOI 10.1176/appi.ajp.163.12.2080; ADDINGTON D, 1990, SCHIZOPHR RES, V3, P247, DOI 10.1016/0920-9964(90)90005-R; Siris SG, 2001, J PSYCHOPHARMACOL, V15, P127; Lewis SW, 2006, SCHIZOPHRENIA BULL, V32, P715, DOI 10.1093/schbul/sbj067; Lindenmayer JP, 2004, J CLIN PSYCHIAT, V65, P551; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82; BECH P, 1975, ACTA PSYCHIAT SCAND, V51, P161, DOI 10.1111/j.1600-0447.1975.tb00002.x; Seeman P, 2002, CAN J PSYCHIAT, V47, P27; McEvoy JP, 2006, AM J PSYCHIAT, V163, P600, DOI 10.1176/appi.ajp.163.4.600; Kasckow J, 2011, CNS DRUGS, V25, P129, DOI 10.2165/11586450-000000000-00000; Azorin JM, 2001, AM J PSYCHIAT, V158, P1305, DOI 10.1176/appi.ajp.158.8.1305; Breier AF, 1999, AM J PSYCHIAT, V156, P294; Collins AA, 1996, SCHIZOPHR RES, V20, P205, DOI 10.1016/0920-9964(95)00107-7; Dollfus S, 2005, SCHIZOPHR RES, V78, P157, DOI 10.1016/j.schres.2005.06.001; GIBBONS RD, 1993, J PSYCHIAT RES, V27, P259, DOI 10.1016/0022-3956(93)90037-3; Inagaki A., 2012, DOSE EQUIVALENTS PSY; Kim JH, 2014, COMPR PSYCHIAT, V55, P708, DOI 10.1016/j.comppsych.2013.11.002; Kontaxakis VP, 2000, EUR PSYCHIAT, V15, P274, DOI 10.1016/S0924-9338(00)00232-7; MAIER W, 1985, EUR ARCH PSY CLIN N, V234, P417, DOI 10.1007/BF00386061; MELTZER HY, 1995, AM J PSYCHIAT, V152, P183; Reine G, 2003, ACTA PSYCHIAT SCAND, V108, P297, DOI 10.1034/j.1600-0447.2003.00132.x; Resnick SG, 2004, PSYCHIAT SERV, V55, P540, DOI 10.1176/appi.ps.55.5.540; Tollefson GD, 1998, ARCH GEN PSYCHIAT, V55, P250, DOI 10.1001/archpsyc.55.3.250; Tollefson GD, 1999, BIOL PSYCHIAT, V46, P365, DOI 10.1016/S0006-3223(99)00049-9	36	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	FEB	2015	161	2-3					429	433		10.1016/j.schres.2014.12.024		5	Psychiatry	Psychiatry	AZ8GB	WOS:000348452100042		
J	Gando, S				Gando, Satoshi			Hemostasis and Thrombosis in Trauma Patients	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						trauma; traumatic brain injury; coagulopathy; fibrinolysis; disseminated intravascular coagulation; acute coagulopathy trauma shock; fat embolism syndrome	DISSEMINATED INTRAVASCULAR COAGULATION; MULTIPLE ORGAN DYSFUNCTION; SEVERE HEAD-INJURY; SERIAL LABORATORY EXAMINATION; CENTRAL-NERVOUS-SYSTEM; PROTEIN-C PATHWAY; BRAIN-INJURY; FAT-EMBOLISM; ACUTE COAGULOPATHY; TISSUE FACTOR	Hemostasis and thrombosis in trauma patients consist of physiological hemostasis for wound healing and the pathological reaction of disseminated intravascular coagulation (DIC). Whole body trauma, isolated brain injury, and fat embolism syndrome, if extremely severe, can cause DIC and affect a patient's prognosis. Shock-induced hyperfibrinolysis causes DIC with the fibrinolytic phenotype, contributing to oozing-type severe bleeding. If uncontrolled, this phenotype progresses to thrombotic phenotype at the late stage of trauma, followed by microvascular thrombosis, leading to organ dysfunction. Another type of pathological hemostatic change is acute coagulopathy of trauma shock (ACOTS), which gives rise to activated protein C-mediated systemic hypocoagulation, resulting in bleeding. ACOTS occurs only in trauma associated with shock-induced hypoperfusion and there is nothing to suggest DIC in this phenomenon. This review will provide information about the recent advances in hemostasis and thrombosis in trauma and will clarify the pathogeneses of the pathological processes observed in trauma patients.	[Gando, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Div Acute & Crit Care Med, Sapporo, Hokkaido 0608638, Japan	Gando, S (reprint author), Hokkaido Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Div Acute & Crit Care Med,Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	gando@med.hokudai.ac.jp					Ito T, 2007, J THROMB HAEMOST, V5, P109, DOI 10.1111/j.1538-7836.2006.02255.x; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Hess JR, 2008, J TRAUMA, V65, P748, DOI [10.1097/TA.0b013e3181877a9c, 10.1097/TA.0b013e181877a9c]; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958; Gando S, 2009, J TRAUMA, V67, P381, DOI 10.1097/TA.0b013e3181a84f63; Esmon CT, 1999, BEST PRACT RES CL HA, V12, P343, DOI 10.1053/beha.1999.0029; LEVI M, 1993, JAMA-J AM MED ASSOC, V270, P975, DOI 10.1001/jama.270.8.975; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Gando S, 2013, J THROMB HAEMOST, V11, P826, DOI 10.1111/jth.12190; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; SUFFREDINI AF, 1989, NEW ENGL J MED, V320, P1165, DOI 10.1056/NEJM198905043201802; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; CLARK JA, 1980, J NEUROSURG, V52, P266, DOI 10.3171/jns.1980.52.2.0266; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; OKAJIMA K, 1994, AM J HEMATOL, V45, P16, DOI 10.1002/ajh.2830450104; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Yanagida Y, 2013, SURGERY, V154, P48, DOI 10.1016/j.surg.2013.02.004; Miller P, 2011, AM J FOREN MED PATH, V32, P291, DOI 10.1097/PAF.0b013e31822a6428; Owings JT, 1997, SEMIN THROMB HEMOST, V23, P17; Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; ISHII H, 1985, J CLIN INVEST, V76, P2178, DOI 10.1172/JCI112225; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; GANDO S, 1995, CRIT CARE MED, V23, P1835, DOI 10.1097/00003246-199511000-00009; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68663.78; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Levi M, 2007, CRIT CARE MED, V35, P2191, DOI 10.1097/01.CCM.0000281468.94108.4B; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Gando S, 1997, THROMB HAEMOSTASIS, V77, P278; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; Mellor A, 2001, ANAESTHESIA, V56, P145, DOI 10.1046/j.1365-2044.2001.01724.x; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Gando S, 2010, CRIT CARE MED, V38, pS35, DOI 10.1097/CCM.0b013e3181c9e31d; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327; Lemarchant S, 2012, NEUROPHARMACOLOGY, V62, P749, DOI 10.1016/j.neuropharm.2011.10.020; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; ISHII H, 1991, THROMB HAEMOSTASIS, V65, P618; Arai F, 2007, ANESTHESIOLOGY, V107, P509, DOI 10.1097/01.anes.0000278898.62036.5f; Armstead VE, 1999, ANESTHESIOLOGY, V91, P1844, DOI 10.1097/00000542-199912000-00039; BERGENTZ SVEN-ERIK, 1961, ACTA CHIR SCAND, V122, P21; Bouillon B, 2010, J TRAUMA, V68, P225, DOI 10.1097/TA.0b013e3181c42815; Wiles CE, 2005, J TRAUMA, V58, P729; Chandler WL, 2010, AM J CLIN PATHOL, V134, P90, DOI 10.1309/AJCP3WPOYSKK6BFE; Cohen Mitchell Jay, 2007, J Trauma, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Schrieber M, 2007, J TRAUMA, V63, P1261; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Engelman DT, 1996, WORLD J SURG, V20, P5; Gando S, 2001, CRIT CARE MED, V29, P262, DOI 10.1097/00003246-200102000-00006; GANDO S, 1995, J TRAUMA, V39, P660, DOI 10.1097/00005373-199510000-00007; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943; Gando S, 1999, J TRAUMA, V46, P1076; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; Gando S, 1990, Nihon Geka Gakkai Zasshi, V91, P17; Hayakawa M, 2011, SURGERY, V149, P221, DOI 10.1016/j.surg.2010.06.010; Kao SJ, 2007, CLIN SCI, V113, P279, DOI 10.1042/CS20070011; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34; KEIMOWIT.RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Kushimoto S, 2001, NEUROSURGERY, V49, P1089; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Marder VJ, 2006, HEMOSTASIS THROMBOSI, P1571; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Murshid WR, 2002, BRIT J NEUROSURG, V16, P362, DOI 10.1080/0268869021000007597; Noel P, 2013, SEMIN HEMATOL, V50, P259, DOI 10.1053/j.seminhematol.2013.06.009; Oshiro A, 2014, CRIT CARE, V18, DOI 10.1186/cc13816; RISEBOROUGH EJ, 1976, CLIN ORTHOP RELAT R, P248; SALDEEN T, 1970, J TRAUM, V10, P287, DOI 10.1097/00005373-197004000-00002; SALDEEN T, 1970, J TRAUM, V10, P273, DOI 10.1097/00005373-197004000-00001; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; SERCKHAN.A, 1965, ACTA PATHOL MIC SC, V65, P31; Shier M R, 1980, Surg Annu, V12, P139; STUMP DC, 1990, SEMIN THROMB HEMOST, V16, P260, DOI 10.1055/s-2007-1002678; TAYLOR F, 1991, BLOOD, V78, P357; Gando S, 2012, J Thromb Haemost, V10, P2593; TOUHO H, 1986, NEUROSURGERY, V19, P523; TOVI D, 1973, ACTA NEUROL SCAND, V49, P152; Wu Xue-Hai, 2003, Chin J Traumatol, V6, P114	102	2	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	FEB	2015	41	1					26	34		10.1055/s-0034-1398378		9	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CA9HZ	WOS:000349234700005		
J	Hayakawa, M; Gando, S; Ono, Y; Wada, T; Yanagida, Y; Sawamura, A				Hayakawa, Mineji; Gando, Satoshi; Ono, Yuichi; Wada, Takeshi; Yanagida, Yuichiro; Sawamura, Atsushi			Fibrinogen Level Deteriorates before Other Routine Coagulation Parameters and Massive Transfusion in the Early Phase of Severe Trauma: A Retrospective Observational Study	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						disseminated intravascular coagulation; fibrinolysis; fibrinogenolysis; coagulopathy; bleeding	DISSEMINATED INTRAVASCULAR COAGULATION; UPDATED EUROPEAN GUIDELINE; MAJOR TRAUMA; BLOOD-LOSS; HEAD-INJURY; MANAGEMENT; COAGULOPATHY; CONCENTRATE; PLASMA; CRYOPRECIPITATE	In trauma, hemostatic functions should bemaintained appropriately to prevent massive bleeding. This study elucidated the time-dependent changes in platelet count and coagulation variables, and the effects of disseminated intravascular coagulation (DIC) on these changes during the early phase of trauma. Trauma patients with an injury severity score >= 16 were enrolled. The critical levels of platelet count and coagulation variables were defined according to recent trauma guidelines. Massive transfusion was defined as >10 units red cell concentrate. The time from arrival at the emergency department to reaching the critical levels and meeting the criteria for massive transfusion were evaluated. Eighty trauma patients were enrolled; 35 were diagnosed with DIC on arrival. Among all patients, fibrinogen levels reached the critical level earliest among routine coagulation parameters; other routine coagulation parameters deteriorated after the patients met the criteria for massive transfusion. Routine coagulation parameters reached their critical levels earlier in DIC patients than patients without DIC. Massive transfusion was performed more frequently in DIC patients, who met the criteria earlier. During the early phase of trauma, fibrinogen levels deteriorate earlier than other routine coagulation parameters, especially in DIC patients.	[Hayakawa, Mineji; Gando, Satoshi; Ono, Yuichi; Wada, Takeshi; Yanagida, Yuichiro; Sawamura, Atsushi] Hokkaido Univ Hosp, Emergency & Crit Care Ctr, Sapporo, Hokkaido 0608648, Japan	Hayakawa, M (reprint author), Hokkaido Univ Hosp, Emergency & Crit Care Ctr, N14W5, Sapporo, Hokkaido 0608648, Japan.	mineji@dream.com					Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Gando S, 2001, SEMIN THROMB HEMOST, V27, P585, DOI 10.1055/s-2001-18864; Nienaber U, 2011, INJURY, V42, P697, DOI 10.1016/j.injury.2010.12.015; Gando S, 2009, J TRAUMA, V67, P381, DOI 10.1097/TA.0b013e3181a84f63; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Wafaisade A, 2013, J TRAUMA ACUTE CARE, V74, P387, DOI 10.1097/TA.0b013e31827e2410; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; Stainsby D, 2006, BRIT J HAEMATOL, V135, P634; Lier H, 2011, INTENS CARE MED, V37, P572, DOI 10.1007/s00134-011-2139-y; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Hiippala S, 1998, VOX SANG, V74, P399; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Hoyt DB, 2008, J TRAUMA, V65, P755, DOI [10.1097/TA.0b013e318185fa9f, 10.1097/TA.0b013e1815a9f]; White NJ, 2010, RESUSCITATION, V81, P111, DOI 10.1016/j.resuscitation.2009.09.017; Inaba K, 2013, J AM COLL SURGEONS, V216, P290, DOI 10.1016/j.jamcollsurg.2012.10.017; Levy JH, 2012, ANESTH ANALG, V114, P261, DOI 10.1213/ANE.0b013e31822e1853; Bolliger D, 2010, ANESTHESIOLOGY, V113, P1205, DOI 10.1097/ALN.0b013e3181f22b5a; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; Chambers LA, 2011, AM J CLIN PATHOL, V136, P364, DOI 10.1309/AJCPH16YXJEFSHEO; Dickneite G, 2009, BLOOD COAGUL FIBRIN, V20, P535, DOI 10.1097/MBC.0b013e32832da1c5; Gaarder C, 2008, SCAND J SURG, V97, P15; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943; GOODNIGH.SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Hayakawa M, 2011, SURGERY, V149, P221, DOI 10.1016/j.surg.2010.06.010; Holcomb JB, 2013, J TRAUMA ACUTE CARE, V75, pS31, DOI 10.1097/TA.0b013e31828fa3ed; Hoyt DB, 2008, J TRAUMA, V65, P764; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; McLoughlin TM, 1996, ANESTH ANALG, V83, P459, DOI 10.1097/00000539-199609000-00003; Meyer MAS, 2011, VOX SANG, V101, P185, DOI 10.1111/j.1423-0410.2011.01478.x; Ozier Y, 2011, J THROMB HAEMOST, V9, P6, DOI 10.1111/j.1538-7836.2010.04083.x; Ranucci M, 2012, BRIT J ANAESTH, V109, P135, DOI 10.1093/bja/aes227; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Schlimp CJ, 2014, HAMOSTASEOLOGIE, V34, P29, DOI 10.5482/HAMO-13-07-0038; Schochl H, 2011, CRIT CARE, V15, DOI 10.1186/cc10539; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686	38	3	3	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	FEB	2015	41	1					35	42		10.1055/s-0034-1398379		8	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CA9HZ	WOS:000349234700006		
J	Tsuruta, D				Tsuruta, Daisuke			Leverage and firm performance of small businesses: evidence from Japan	SMALL BUSINESS ECONOMICS			English	Article						Leverage; Trade credit; Bank credit; Firm performance; Small business	TRADE CREDIT; CORPORATE PERFORMANCE; FINANCIAL DISTRESS; INVESTMENT; MARKETS; GROWTH	Highly leveraged small businesses cannot obtain enough credit because of the debt overhang problem. Therefore, highly leveraged firms may lose potential profits from profitable investment opportunities in which they are unable to invest. On the other hand, highly leveraged small businesses can enhance their performance because banks and trade creditors monitor their activity and prevent inefficient management. Using small-business data for Japan, we empirically investigate the relationship between firm performance and leverage. We find, first, that highly leveraged small businesses increase their trade payables less even if they have investment opportunities. Second, highly leveraged small businesses convert more bills receivables into cash by selling them to finance companies to finance their growth opportunities. Third, highly leveraged firms enjoy stronger performance (measured as firm sales growth or profitability) compared with low-leveraged firms. These results highlight the benefits of high leverage for small businesses.	Nihon Univ, Coll Econ, Chiyoda Ku, Tokyo 1028360, Japan	Tsuruta, D (reprint author), Nihon Univ, Coll Econ, Chiyoda Ku, 1-3-2 Misaki Cho, Tokyo 1028360, Japan.	tsuruta.daisuke@nihon-u.ac.jp					Agostino M, 2010, SMALL BUS ECON, V35, P335, DOI 10.1007/s11187-008-9154-6; ALTMAN EI, 1984, J FINANC, V39, P1067, DOI 10.2307/2327613; OPLER TC, 1994, J FINANC, V49, P1015, DOI 10.2307/2329214; Kang JK, 2000, J BUS, V73, P1, DOI 10.1086/209630; Bottazzi G, 2014, SMALL BUS ECON, V42, P99, DOI 10.1007/s11187-012-9465-5; Ahn S, 2006, J FINANC ECON, V79, P317, DOI 10.1016/j.jfineco.2005.03.002; Berger AN, 1998, J BANK FINANC, V22, P613, DOI 10.1016/S0378-4266(98)00038-7; Ongena S, 2001, J FINANC ECON, V61, P449, DOI 10.1016/S0304-405X(01)00069-1; Berger AN, 2006, J BANK FINANC, V30, P2945, DOI 10.1016/j.jbankfin.2006.05.008; Aivazian VA, 2005, J CORP FINANC, V11, P277, DOI 10.1016/S0929-1199(03)00062-2; Lang L, 1996, J FINANC ECON, V40, P3, DOI 10.1016/0304-405X(95)00842-3; Canton E, 2013, SMALL BUS ECON, V41, P701, DOI 10.1007/s11187-012-9451-y; MYERS SC, 1977, J FINANC ECON, V5, P147, DOI 10.1016/0304-405X(77)90015-0; BERGER AN, 1995, J BUS, V68, P351, DOI 10.1086/296668; Molina CA, 2012, FINANC MANAGE, V41, P187, DOI 10.1111/j.1755-053X.2012.01182.x; Cai J, 2011, J CORP FINANC, V17, P391, DOI 10.1016/j.jcorpfin.2010.12.003; Campello M, 2006, J FINANC ECON, V82, P135, DOI 10.1016/j.jfineco.2005.04.001; Caneghem T. V., 2012, BUSINESS FINANCE, V39, P341; Cole RA, 2004, J FINANC QUANT ANAL, V39, P227; Demirguc-Kunt A., 1999, POLICY RES WORKING P, V2143, DOI [10.1596/1813-9450-2143, DOI 10.1596/1813-9450-2143]; JENSEN MC, 1986, AM ECON REV, V76, P323; Joeveer K, 2013, SMALL BUS ECON, V41, P479, DOI 10.1007/s11187-012-9440-1; Klapper L, 2006, J BANK FINANC, V30, P3111, DOI 10.1016/j.jbankfin.2006.05.001; MATSUMURA T, 1995, J LEGAL STUD, V24, P165, DOI 10.1086/467956; PETERSEN MA, 1994, J FINANC, V49, P3, DOI 10.2307/2329133; Petersen MA, 1997, REV FINANC STUD, V10, P661, DOI 10.1093/rfs/10.3.661; Sakai K, 2010, J BANK FINANC, V34, P1970, DOI 10.1016/j.jbankfin.2010.01.001; Storey D.J., 1994, UNDERSTANDING SMALL; Weill L, 2008, SMALL BUS ECON, V30, P251, DOI 10.1007/s11187-006-9045-7; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-898X	1573-0913		SMALL BUS ECON	Small Bus. Econ. Group	FEB	2015	44	2					385	410		10.1007/s11187-014-9601-5		26	Business; Economics; Management	Business & Economics	CA5DV	WOS:000348929300009		
J	Higuchi, T; Owaku, T; Lida, Y; Sakai, E; Kobayashi, M; Kumigashira, H				Higuchi, Tohru; Owaku, Tomohiro; Lida, Yasutaka; Sakai, Enju; Kobayashi, Masaki; Kumigashira, Hiroshi			Proton conduction of BaCe0.90Y0.10O3-delta thin film with lattice distortion	SOLID STATE IONICS			English	Article						BaCe0.9Y0.103-d; Thin film; Proron conduction; Lattice distortion; Activaion energy; Electronic structure	PULSED-LASER DEPOSITION; X-RAY SPECTROSCOPY; Y-DOPED SRCEO3; IONIC-CONDUCTION; BACEO3; OXIDES; SUPERLATTICE; CERAMICS; GROWTH; CEO2	The proton conduction of BaCe0.90Y0.10O3-delta (BCY) film on Al2O3 (0001) substrate grown by RF magnetron sputtering has been studied as a function of film thickness (20-600 nm) in the temperature region of 300-700 degrees C. The lattice constants and grain size of the as-deposited film increase with increasing flim thickness. The film thickness above similar to 200 nm, which close to the lattice constants of the bulk, shows high proton conductivity with small activation energy (E-A) of similar to 0.3 eV below 500 degrees C. The BCY thin film has the mixed valent states of Ce4+ and Ce3+ created by the charge transfer from 0 2p to Ce 4f states. The E-A corresponds to the energy difference between the top of valence band and the Fermi level. These results originate to the changes of O-O bond length and oxygen vacancies in the a-c plane of the BCY thin film. (C) 2014 Elsevier B.V. All rights reserved.	[Higuchi, Tohru; Owaku, Tomohiro; Lida, Yasutaka] Tokyo Univ Sci, Dept Appl Phys, Katsushika, Tokyo 1258585, Japan; [Sakai, Enju; Kobayashi, Masaki; Kumigashira, Hiroshi] High Energy Accelerator Org KEK, Photon Factory, Tsukuba, Ibaraki 3050801, Japan	Higuchi, T (reprint author), Tokyo Univ Sci, Dept Appl Phys, 6-3-1 Niijuku, Katsushika, Tokyo 1258585, Japan.	higuchi@rs.kagu.tus.ac.jp	Higuchi, Tohru/C-6544-2012		Program Advisory Committee at the Institute of Materials Structure Science, KEK [201352-002]	The authors would like to thank Mr. Teppei Okumura and Ms. Chizuko Kudo for their technical and analysis supports. This work at KEK-PF was done under the approval of the Program Advisory Committee (proposal No. 201352-002) at the Institute of Materials Structure Science, KEK.	Kuwata N, 2005, JPN J APPL PHYS 1, V44, P8613, DOI 10.1143/JJAP.44.8613; Hosono H, 2008, J APPL PHYS, V104, DOI 10.1063/1.3035845; Ogawa H, 2008, J ALLOY COMPD, V449, P375, DOI 10.1016/j.jallcom.2006.02.103; Pergolesi D, 2010, NAT MATER, V9, P846, DOI [10.1038/nmat2837, 10.1038/NMAT2837]; Sata N, 2000, NATURE, V408, P946, DOI 10.1038/35050047; Kreuer KD, 1999, SOLID STATE IONICS, V125, P285, DOI 10.1016/S0167-2738(99)00188-5; Iwahara H, 1996, SOLID STATE IONICS, V86-8, P9, DOI 10.1016/0167-2738(96)00087-2; Shimojo F, 1998, J PHYS SOC JPN, V67, P2008, DOI 10.1143/JPSJ.67.2008; Horiba K, 2003, REV SCI INSTRUM, V74, P3406, DOI 10.1063/1.1584093; Glockner R, 1999, SOLID STATE IONICS, V122, P145, DOI 10.1016/S0167-2738(99)00070-3; IWAHARA H, 1981, SOLID STATE IONICS, V3-4, P359, DOI 10.1016/0167-2738(81)90113-2; Iguchi F, 2006, SOLID STATE IONICS, V177, P2381, DOI 10.1016/j.ssi.2006.07.008; Ma GL, 1998, SOLID STATE IONICS, V110, P103, DOI 10.1016/S0167-2738(98)00130-1; Beche E, 2008, SURF INTERFACE ANAL, V40, P264, DOI 10.1002/sia.2686; MATSUMOTO M, 1994, PHYS REV B, V50, P11340, DOI 10.1103/PhysRevB.50.11340; YAJIMA T, 1991, SOLID STATE IONICS, V47, P117, DOI 10.1016/0167-2738(91)90189-I; Higuchi T, 2004, JPN J APPL PHYS 2, V43, pL731, DOI 10.1143/JJAP.43.L731; Hibino T, 2001, J PHYS CHEM B, V105, P11399, DOI 10.1021/jp0124342; Higuchi T, 2003, JPN J APPL PHYS 2, V42, pL1265, DOI 10.1143/JJAP.42.L1265; Iguchi F, 2011, SOLID STATE IONICS, V192, P97, DOI 10.1016/j.ssi.2010.05.046; Kannan R., 1988, SCI REP, V3, P2138; Knight KS, 2000, SOLID STATE IONICS, V127, P43, DOI 10.1016/S0167-2738(99)00269-6; Kreuer KD, 1996, SOLID STATE IONICS, V86-8, P613, DOI 10.1016/0167-2738(96)00221-4; Matsumoto H, 2005, J ELECTROCHEM SOC, V152, pA488, DOI 10.1149/1.1852442; Matsumoto M, 1996, J ELECTRON SPECTROSC, V78, P179, DOI 10.1016/S0368-2048(96)80056-9; Sata N, 1999, SOLID STATE IONICS, V121, P321, DOI 10.1016/S0167-2738(99)00065-X; Shimazu Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JG01	27	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738	1872-7689		SOLID STATE IONICS	Solid State Ion.	FEB	2015	270						1	5		10.1016/j.ssi.2014.11.016		5	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CA9XG	WOS:000349277500001		
J	Hibi, Y; Tanibata, N; Hayashi, A; Tatsumisago, M				Hibi, Yoshiaki; Tanibata, Naoto; Hayashi, Akitoshi; Tatsumisago, Masahiro			Preparation of sodium ion conducting Na3PS4-NaI glasses by a mechanochemical technique	SOLID STATE IONICS			English	Article						Solid electrolyte; Glass; Glass-ceramic; Sodium ion conductor; Sodium iodide; Sulfide	CERAMIC ELECTROLYTES; BATTERIES; CHALLENGES; LI2S-P2S5	Structures and ionic conductivities of the (100 - x)Na3PS4 center dot xNaI(0 <= x (mol%) <= 33) glasses and glass-ceramics were investigated. In the XRD patterns, halo patterns were observed in the composition range of 0 <= x <= 29. The glass-ceramics were prepared by a heat treatment of the glasses. In the glass-ceramics with NaI, an unknown phase which has not been reported was mainly precipitated. The Raman spectra of the glasses and glass-ceramics indicated that all samples included the PS43- units. The conductivities of glasses increased with increasing the NaI content, and the 71Na(3)PS4 center dot 29NaI glass showed the highest conductivity of 1.4 x 10(-5) S cm(-1). The conductivities of the glass-ceramics at all composition were over 10(-4) S cm(-1). (C) 2014 Elsevier B.V. All rights reserved.	[Hibi, Yoshiaki; Tanibata, Naoto; Hayashi, Akitoshi; Tatsumisago, Masahiro] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Sakai, Osaka 5998531, Japan	Hayashi, A (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	hayashi@chem.osakafu-u.ac.jp			JST, "Advanced Low Carbon Technology Research and Development Program (ALCA)"	This research was supported by JST, "Advanced Low Carbon Technology Research and Development Program (ALCA)".	MERCIER R, 1981, SOLID STATE IONICS, V5, P663, DOI 10.1016/0167-2738(81)90341-6; Kitaura H, 2011, J MATER CHEM, V21, P118, DOI 10.1039/c0jm01090a; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/nmat3066, 10.1038/NMAT3066]; Ujiie S, 2012, SOLID STATE IONICS, V211, P42, DOI 10.1016/j.ssi.2012.01.017; Mizuno F, 2006, SOLID STATE IONICS, V177, P2721, DOI 10.1016/j.ssi.2006.04.017; Hayashi A, 2003, ELECTROCHEM COMMUN, V5, P111, DOI 10.1016/S1388-2481(02)00555-6; Hayashi A, 2014, J POWER SOURCES, V258, P420, DOI 10.1016/j.jpowsour.2014.02.054; Komaba S, 2011, ADV FUNCT MATER, V21, P3859, DOI 10.1002/adfm.201100854; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Bischoff C, 2012, J NON-CRYST SOLIDS, V358, P3216, DOI 10.1016/j.jnoncrysol.2012.09.023; Hayashi A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1843; Hueso KB, 2013, ENERG ENVIRON SCI, V6, P734, DOI 10.1039/c3ee24086j; Ujiie S., 2012, J SOLID STATE ELECTR, V17, P675	14	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738	1872-7689		SOLID STATE IONICS	Solid State Ion.	FEB	2015	270						6	9		10.1016/j.ssi.2014.11.024		4	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CA9XG	WOS:000349277500002		
J	Nemani, VM; Kim, HJ; Bjerke-Kroll, BT; Yagi, M; Sacramento-Dominguez, C; Akoto, H; Papadopoulos, EC; Sanchez-Perez-Grueso, F; Pellise, F; Nguyen, JT; Wulff, I; Ayamga, J; Mahmud, R; Hodes, RM; Boachie-Adjei, O				Nemani, Venu M.; Kim, Han Jo; Bjerke-Kroll, Benjamin T.; Yagi, Mitsuru; Sacramento-Dominguez, Cristina; Akoto, Harry; Papadopoulos, Elias C.; Sanchez-Perez-Grueso, Francisco; Pellise, Ferran; Nguyen, Joseph T.; Wulff, Irene; Ayamga, Jennifer; Mahmud, Rufai; Hodes, Richard M.; Boachie-Adjei, Oheneba		FOCOS Spine Study Grp	Preoperative Halo-Gravity Traction for Severe Spinal Deformities at an SRS-GOP Site in West Africa	SPINE			English	Article						halo-gravity traction; scoliosis; kyphosis; pediatric deformity; vertebral column resection; 3-column osteotomy; global outreach	VERTEBRAL COLUMN RESECTION; SEVERE SCOLIOSIS; SKELETAL TRACTION; FEMORAL TRACTION; BRAIN-ABSCESS; NERVE INJURY; EFFICACY; CHILDREN	Study Design. Retrospective analysis of a prospectively collected single-center database. Objective. We describe a modified halo-gravity traction (HGT) protocol for patients with severe spinal deformities in West Africa, and assess the clinical and radiographic outcomes. Summary of Background Data. Three-column osteotomies are frequently used in the correction of severe spinal deformities; however, these can be associated with high complication rates and significant risk for neurological injury. Preoperative traction is one modality used to obtain a partial correction prior to definitive fusion. Low numbers and variability of traction protocols, however, have limited previous reports of sustained HGT. Methods. All patients who underwent HGT in Ghana from April 2012 to August 2013 were reviewed. HGT was started at 20% body weight and increased by 10% per week until 50% body weight was reached by 4 weeks or thereafter as tolerated. Demographic variables, operative data, radiographic parameters, and health-related quality of life scores were collected. A deformity reduction index was calculated at each time point by summing the scoliosis and abnormal kyphosis for each patient and reported as a percentage of the preoperative deformity. Results. Twenty-nine patients underwent HGT for an average 107 days prior to definitive posterior spinal fusion (24 patients) or placement of growing rods (5 patients). The major curve improved from an average 131 degrees to 90 degrees (31%) after HGT, and to an average 57 degrees (56%) postoperatively. Pure kyphotic curves were rigid (flexibility 22% after traction), with a correction index of 3.88, which is similar to historical controls. Deformity correction with HGT plateaued at 63 days. Overall Scoliosis Research Society-22 questionnaire scores improved significantly pretraction versus postoperatively, but there was no change after traction versus before traction. There were 11 pin tract infections, with no neurological complications. Conclusion. HGT is a safe method to partially correct severe spinal deformities prior to a definitive procedure, and may reduce the need for higher risk 3-column osteotomies. Importantly, kyphosis secondary to infection with spontaneous apical ankylosis is relatively resistant to HGT.	[Nemani, Venu M.; Kim, Han Jo; Bjerke-Kroll, Benjamin T.; Nguyen, Joseph T.; Boachie-Adjei, Oheneba] Hosp Special Surg, New York, NY 10021 USA; [Yagi, Mitsuru] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Sacramento-Dominguez, Cristina] Hosp Ruber Int, Spine Unit, Madrid, Spain; [Akoto, Harry; Wulff, Irene] Korle Bu Teaching Hosp, Dept Neurosurg, Accra, Ghana; [Papadopoulos, Elias C.] Univ Athens, Sch Med, Dept Orthopaed 2, GR-11527 Athens, Greece; [Sanchez-Perez-Grueso, Francisco] Hosp La Paz, Spine Unit, Dept Orthoped Surg, Madrid, Spain; [Pellise, Ferran] Hosp Gen Valle Hebron, Serv COT, Spine Unit, Barcelona, Spain; [Ayamga, Jennifer; Mahmud, Rufai] FOCOS Hosp, Res Dept, Accra, Ghana; [Hodes, Richard M.] AJJDC, Addis Ababa, Ethiopia	Nemani, VM (reprint author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.	vnemani@gmail.com					Suk SI, 2005, SPINE, V30, P1682, DOI 10.1097/01.brs.0000170590.21071.c1; Lenke LG, 2009, SPINE, V34, P2213, DOI 10.1097/BRS.0b013e3181b53cba; Bogunovic L, 2013, SPINE DEFORM, V1, P33; Buchowski JM, 2006, J BONE JOINT SURG AM, V88A, P2035, DOI 10.2106/JBJS.E.00823; Bumpass DB, 2014, SPINE, V39, P587; DEWALD RL, 1970, J BONE JOINT SURG AM, VA 52, P233; Garabekyan T, 2014, J PEDIATR ORTHOP B, V23, P1, DOI 10.1097/BPB.0b013e32836486b6; Ginsburg GM, 1998, SPINE, V23, P1490, DOI 10.1097/00007632-199807010-00011; HUMBYRD DE, 1981, SPINE, V6, P365, DOI 10.1097/00007632-198107000-00006; Jhaveri S, 2009, EUR SPINE J, V18, P352, DOI 10.1007/s00586-008-0852-1; Lenke LG, 2013, SPINE, V38, P119; LETTS RM, 1975, J BONE JOINT SURG AM, V57, P616; Lewis SJ, 2011, SPINE, V36, P1627, DOI 10.1097/BRS.0b013e318216124e; Luhmann SJ, 2005, SPINE, V30, P2061, DOI 10.1097/01.brs.0000179299.78791.96; MACEWEN GD, 1975, J BONE JOINT SURG AM, VA 57, P404; Park DK, 2013, J SPINAL DISORD TECH, V26, P146, DOI 10.1097/BSD.0b013e318237828c; Rinella A, 2005, SPINE, V30, P475, DOI 10.1097/01.brs.0000153707.80497.a2; Ruf M, 2013, SPINE, V38, pE1662; Sink EL, 2001, J PEDIATR ORTHOPED, V21, P519, DOI 10.1097/00004694-200107000-00020; Skaggs DL, 2014, SPINE DEFORM, V2, P61; SWANK SM, 1982, SPINE, V7, P343, DOI 10.1097/00007632-198207000-00004; Takeshita K, 2006, SPINE, V31, P2381, DOI 10.1097/01.brs.0000238964.73390.b6; TINDALL GT, 1959, ARCH SURG-CHICAGO, V79, P638; Vitale MG, 2008, SPINE, V33, P1242; Watanabe K, 2010, J ORTHOP SCI, V15, P720, DOI 10.1007/s00776-010-1523-8; WILKINS C, 1977, CLIN ORTHOP RELAT R, P106	26	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	FEB 1	2015	40	3					153	161		10.1097/BRS.0000000000000675		9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CA3TI	WOS:000348828600014		
J	Yang, HO; Haldeman, S; Nakata, A; Choi, B; Delp, L; Baker, D				Yang, Haiou; Haldeman, Scott; Nakata, Akinori; Choi, BongKyoo; Delp, Linda; Baker, Dean			Work-Related Risk Factors for Neck Pain in the US Working Population	SPINE			English	Article						neck pain; sex; occupation; hours of work; stress; population-based study	2000-2010 TASK-FORCE; MUSCULOSKELETAL DISORDERS; LONG WORKHOURS; OFFICE WORKERS; SHOULDER PAIN; UNITED-STATES; FOLLOW-UP; SYMPTOMS; NURSES; PREVALENCE	Study Design. This study uses the Taylor linearized variance estimation method to compute weighted unadjusted and adjusted prevalence of neck pain by occupation, with a cross-section data set from the 2009 to 2012 National Health Interview Survey. Objective. The goal of this study was to explore occupational patterns of neck pain and the relationship between long work hours and neck pain in the working population in the United States. Summary of Background Data. The past research has demonstrated that specific occupations have a high prevalence of neck pain. However, occupational patterns of neck pain in the United States have been understudied. Methods. Risk of neck pain was estimated using univariate and multivariate logistic regression with odds ratios (ORs) with 95% confidence interval (CI) as measures of association. Results. After controlling for demographic, socioeconomic status, and behavior-related factors and compared with workers in architecture and engineering occupation group, the top 5 occupational groups with significantly higher relative prevalence of neck pain included: military specific (OR, 2.50; 95% CI, 1.17-5.35); arts, design, entertainment, sports, and media (OR, 1.70; 95% CI, 1.34-2.17); life, physical, and social science (OR, 1.67; 95% CI, 1.33-2.11); health care support (OR, 1.55; 95% CI, 1.23-1.97); and installation, maintenance, and repair (OR, 1.54; 95% CI, 1.21-1.96). Compared with those who worked 40 hours, people who worked 46 to 59 hours (OR, 1.20; 95% CI, 1.10-1.30) and 60 or more hours of work per week (OR, 1.35; 95% CI-1.21, 1.51) were more likely to report neck pain. Conclusion. This study adds to the evidence that an individual's occupation and work hours affect workers' risk for neck pain. This study indicates a need for new research efforts and public policies targeted to workers who are susceptible to neck pain in the United States.	[Yang, Haiou; Choi, BongKyoo; Baker, Dean] Univ Calif Irvine, Ctr Occupat & Environm Hlth, Irvine, CA 92617 USA; [Haldeman, Scott] Univ Calif Irvine, Dept Neurol, Irvine, CA 92617 USA; [Haldeman, Scott] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Nakata, Akinori] Univ Occupat & Environm Hlth, Sch Hlth Sci, Fukuoka, Japan; [Delp, Linda] Univ Calif Los Angeles, Labor Occupat Safety & Hlth Program, Los Angeles, CA USA	Yang, HO (reprint author), Univ Calif Irvine, Ctr Occupat & Environm Hlth, 100 Theory,Ste 100, Irvine, CA 92617 USA.	hyang@uci.edu					Alperovitch-Najenson D, 2010, ARCH ENVIRON OCCUP H, V65, P218, DOI 10.1080/19338244.2010.486422; Korhonen T, 2003, OCCUP ENVIRON MED, V60, P475, DOI 10.1136/oem.60.7.475; Cho CY, 2012, J MANIP PHYSIOL THER, V35, P534, DOI 10.1016/j.jmpt.2012.07.004; Hoy DG, 2010, BEST PRACT RES CL RH, V24, P783, DOI 10.1016/j.berh.2011.01.019; Trinkoff AM, 2006, AM J IND MED, V49, P964, DOI 10.1002/ajim.20330; Eltayeb S, 2009, J OCCUP REHABIL, V19, P315, DOI 10.1007/s10926-009-9196-x; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Kierklo A, 2011, ANN AGR ENV MED, V18, P79; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171; Dembe AE, 2005, OCCUP ENVIRON MED, V62, P588, DOI 10.1136/oem.2004.016667; Magnusson ML, 1996, SPINE, V21, P710, DOI 10.1097/00007632-199603150-00010; Andersen LL, 2010, MANUAL THER, V15, P100, DOI 10.1016/j.math.2009.08.004; Larsson B, 2007, BEST PRACT RES CL RH, V21, P447, DOI 10.1016/j.berh.2007.02.015; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Brandt LPA, 2004, SCAND J WORK ENV HEA, V30, P399; Viikari-Juntura E, 2000, J CLIN EPIDEMIOL, V53, P800, DOI 10.1016/S0895-4356(00)00197-9; Guzman J, 2008, SPINE, V33, pS14, DOI 10.1097/BRS.0b013e3181643efb; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Alipour A, 2008, AM J IND MED, V51, P372, DOI 10.1002/ajim.20562; Andersen JH, 2002, SPINE, V27, P660; Lipscomb JA, 2002, SCAND J WORK ENV HEA, V28, P394; Palmer KT, 2001, SCAND J WORK ENV HEA, V27, P49; Bureau of Labor Statistics, 2014, LAB FORC STAT CURR P; Caruso C, 2004, OVERTIME EXTENDED WO, P1; Cassidy JD, 2008, J MANIP PHYSIOL THER, V31, P442, DOI 10.1016/j.jmpt.2008.06.008; Center for Disease Control and Prevention, 2012, NAT HLTH INT SURV; Christensen JO, 2010, PAIN, V151, P162, DOI 10.1016/j.pain.2010.07.001; Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4; De Loose V, 2008, MIL MED, V173, P474; Division of Health Interview Statistics, 2012, 2011 NAT HLTH INT SU; Division of Health Interview Statistics, 2013, 2012 NAT HLTH INT SU; Division of Health Interview Statistics, 2010, 2009 NAT HLTH INT SU; Division of Health Interview Statistics, 2013, VAR EST OTH AN ISS; Division of Health Interview Statistics, 2011, 2010 NAT HLTH INT SU; Dong XW, 2005, SCAND J WORK ENV HEA, V31, P329; Eriksen W, 1999, J OCCUP ENVIRON MED, V41, P893, DOI 10.1097/00043764-199910000-00010; Fredriksson K, 1999, OCCUP ENVIRON MED, V56, P59; Haldeman S, 2008, SPINE, V33, pS5, DOI 10.1097/BRS.0b013e3181643f40; Hecker DE, 2012, MON LABOR REV, P85; Heiden B, 2013, APPL ERGON, V44, P652, DOI 10.1016/j.apergo.2013.01.001; Ostergren PO, 2005, J EPIDEMIOL COMMUN H, V59, P721, DOI 10.1136/jech.2005.034801; Parsons Van L, 2014, Vital Health Stat 2, P1; Pratt LA, 2007, ADV DATA, V30, P1; Punnett L, 2004, OCCUP ENVIRON MED, V61, P954, DOI 10.1136/oem.2004.014399; Ranasinghe P, 2011, ENV HLTH, V10, P9; Serranheira F, 2012, WORK, V41, P2449, DOI 10.3233/WOR-2012-0479-2449; Shrestha BP, 2008, J NEPAL MED ASSOC, V47, P77; U.S. Bureau of Labor Statistics, STAND OCC CLASS COD; US Department of Health and Human Services, 2010, HLTH PEOPL 2010 UND; Ward B, 2012, EARLY RELEASE SELECT; Waters TR, 2004, J ELECTROMYOGR KINES, V14, P7, DOI 10.1016/j.jelekin.2003.09.004	51	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	FEB 1	2015	40	3					184	192		10.1097/BRS.0000000000000700		9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CA3TI	WOS:000348828600018		
J	Fujibayashi, S; Hynes, RA; Otsuki, B; Kimura, H; Takemoto, M; Matsuda, S				Fujibayashi, Shunsuke; Hynes, Richard A.; Otsuki, Bungo; Kimura, Hiroaki; Takemoto, Mitsuru; Matsuda, Shuichi			Effect of Indirect Neural Decompression Through Oblique Lateral Interbody Fusion for Degenerative Lumbar Disease	SPINE			English	Article						LLIF; OLIF; MRI; indirect neural decompression; minimally invasive; spinal stenosis; interbody fusion; lumbar spine; surgery; retroperitoneal approach	TRANSPSOAS APPROACH; CLINICAL ARTICLE; SURGERY; ANATOMY; PLEXUS; INJURY	Study Design. Prospective consecutive clinical study to assess the decompressive benefit and outcome of oblique lateral interbody fusion for lumbar degenerative diseases. Objective. To evaluate radiologically the effect of interbody distraction upon neural patency via an anterolateral retroperitoneal approach for the treatment of lumbar degenerative diseases. Summary of Background Data. Traditional treatment for symptomatic lumbar stenosis uses direct posterior decompression with or without fusion. Symptoms of radiculopathy and neurological claudication may also be alleviated indirectly through restoration of intervertebral and foraminal heights and correction of spinal alignment. Methods. Twenty-eight consecutive patients presenting with degenerative conditions that included concomitant lumbar stenosis underwent oblique lateral interbody fusion combined with percutaneous pedicle screw fixation at 52 lumbar levels without neuromonitoring. Magnetic resonance images were obtained successfully for 48 of 52 levels. The cross-sectional area of the thecal sac (CSA) was measured preoperatively and postoperatively on T2-weighted axial magnetic resonance images. Differences in CSA were compared, and the relationship between the ratio of CSA extension and that of the preoperative CSA was assessed. The change in disc height and segmental disc angle were measured. The relationships between CSA, disc height, segmental disc angle, and clinical results were assessed by correlational analysis. Results. Twenty-eight oblique lateral interbody fusions were performed successfully without neural complications. There was clinical improvement in all cases. The mean CSA increased from 99.6 mm(2) preoperatively to 134.3 mm(2) postoperatively (P < 0.001). The median CSA extension ratio was 30.2% and this correlated inversely with preoperative CSA. Disc height, segmental disc angle, and clinical results improved significantly. Multivariate regression analysis demonstrated that the preoperative CSA was the only independent factor that correlated inversely with the CSA extension ratio (corrected R-2 = 0.361; P < 0.001). Conclusion. Spinal stenosis was resolved successfully by indirect decompression through a miniopen anterolateral retroperitoneal approach without the need for neuromonitoring.	[Fujibayashi, Shunsuke; Otsuki, Bungo; Kimura, Hiroaki; Takemoto, Mitsuru; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan; [Hynes, Richard A.] Florida Inst Technol, Melbourne, FL 32901 USA	Fujibayashi, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	shfuji@kuhp.kyoto-u.ac.jp					Aichmair A, 2013, SPINE, V38, pE1483, DOI 10.1097/BRS.0b013e3182a3d1b4; Anand N, 2013, J NEUROSURG-SPINE, V18, P18, DOI 10.3171/2012.9.SPINE12659; Oliveira L, 2010, SPINE, V35, pS331, DOI 10.1097/BRS.0b013e3182022db0; Barrey C, 2013, WORLD NEUROSURG, V79, P784, DOI 10.1016/j.wneu.2012.03.019; Kepler CK, 2012, J NEUROSURG-SPINE, V16, P329, DOI 10.3171/2012.1.SPINE11528; Marchi L, 2013, J NEUROSURG-SPINE, V19, P110, DOI 10.3171/2013.4.SPINE12319; Moro T, 2003, SPINE, V28, P423, DOI 10.1097/00007632-200303010-00002; Fujiwara A, 2003, SPINE, V28, P1601, DOI 10.1097/00007632-200307150-00023; Ahmadian A, 2013, J NEUROSURG-SPINE, V18, P289, DOI 10.3171/2012.11.SPINE12755; Davis TT, 2011, J BONE JOINT SURG AM, V93A, P1482, DOI 10.2106/JBJS.J.00962; Fontes RBV, 2013, J NEUROSURG-SPINE, V18, P13, DOI 10.3171/2012.10.SPINE12311; Hussain NS, 2012, J NEUROSURG-SPINE, V17, P415, DOI 10.3171/2012.8.SPINE12243; Morr S, 2013, J NEUROSURG-SPINE, V19, P502, DOI 10.3171/2013.7.SPINE12352; Ozgur Burak M, 2006, Spine J, V6, P435, DOI 10.1016/j.spinee.2005.08.012; Smith WD, 2012, J SPINAL DISORD TECH, V25, P285, DOI 10.1097/BSD.0b013e31821e262f	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	FEB 1	2015	40	3					E175	E182		10.1097/BRS.0000000000000703		8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CA3TI	WOS:000348828600007		
J	Funaba, M; Kanchiku, T; Imajo, Y; Suzuki, H; Yoshida, Y; Nishida, N; Taguchi, T				Funaba, Masahiro; Kanchiku, Tsukasa; Imajo, Yasuaki; Suzuki, Hidenori; Yoshida, Yuichiro; Nishida, Norihiro; Taguchi, Toshihiko			Transcranial Magnetic Stimulation in the Diagnosis of Cervical Compressive Myelopathy	SPINE			English	Article						central motor conduction time; cervical compressive myelopathy; spinal cord evoked potentials; transcranial magnetic stimulation; responsible level	MOTOR CONDUCTION TIME; SPINAL-CORD POTENTIALS; SPONDYLOTIC MYELOPATHY; EVOKED-POTENTIALS; LEVEL DIAGNOSIS; BLOCK; PROLONGATION; MECHANISM; NERVE; C3-4	Study Design. Single-center retrospective study. Objective. To reveal the characteristic changes in central motor conduction time (CMCT) produced by transcranial magnetic stimulation among the responsible levels of cervical compressive myelopathy (CCM). Summary of Background Data. CMCT is a useful and noninvasive measure for evaluating the central motor pathway. However, a systematic correlation between CMCT findings and the responsible level of CCM has so far not been addressed in a large patient cohort. Method. We measured CMCT in 75 patients with CCM who were determined by intraoperative spinal cord evoked potentials to have a single site of conduction abnormality at the intervertebral level. Twenty-one healthy controls were also evaluated. Motor evoked potentials, compound muscle action potentials, and F wave were recorded from bilateral abductor digiti minimi (ADM) and abductor hallucis (AH) muscles. CMCT was calculated as follows: motor evoked potentials latency - (CMAPs latency + F latency - 1)/2 (ms). Result. The mean values of ADM-CMCT and AH-CMCT at each responsible level were significantly longer than those of normal values (P < 0.01). However, the mean value of ADM-CMCT at the C6-C7 level was markedly shorter than those at the other levels, whereas the mean values of AH-CMCT were not significantly different between each responsible level. We determined that an ADM-CMCT longer than 7.9 ms (mean + 2.5 standard deviation) was abnormal. Using this definition, the sensitivity of ADM-CMCT for CCM was 92% for C3-C4 myelopathy, 95% for C4-C5, 58% for C5-C6, and 9% for C6-C7. Conclusion. ADM-CMCT is useful for the screening of CCM rostral to the C5-C6 level. Diagnosis of patients with C6-C7 myelopathy should include assessment of the AH-CMCT.	[Funaba, Masahiro; Kanchiku, Tsukasa; Imajo, Yasuaki; Suzuki, Hidenori; Yoshida, Yuichiro; Nishida, Norihiro; Taguchi, Toshihiko] Yamaguchi Univ, Grad Sch Med, Dept Orthoped Surg, Yamaguchi, Japan	Funaba, M (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Orthoped Surg, Yamaguchi, Japan.	funa51.mf@gmail.com					Ofuji A, 1998, J NEUROL SCI, V160, P26, DOI 10.1016/S0022-510X(98)00160-9; TAVY DLJ, 1994, MUSCLE NERVE, V17, P235, DOI 10.1002/mus.880170215; Kaneko K, 2001, CLIN NEUROPHYSIOL, V112, P1035, DOI 10.1016/S1388-2457(01)00533-8; DENOORDHOUT AM, 1991, NEUROLOGY, V41, P75; Kaneko K, 1997, SPINE, V22, P636, DOI 10.1097/00007632-199703150-00012; Lo YL, 2004, SPINE, V29, P1137, DOI 10.1097/00007632-200405150-00017; Nakanishi K, 2006, CLIN NEUROPHYSIOL, V117, P623, DOI 10.1016/j.clinph.2005.11.010; Nakanishi K, 2007, J NEUROL SCI, V256, P71, DOI 10.1016/j.jns.2007.02.009; Baker AT, 1985, LANCET, V1, P1106; Funaba M, 2014, SPINAL CORD, V52, P191, DOI 10.1038/sc.2013.149; Ichihara K, 2003, J NEUROSURG, V99, P278, DOI 10.3171/spi.2003.99.3.0278; Imajo Y, 2011, SPINAL CORD, V49, P1128, DOI 10.1038/sc.2011.68; Jaskolski DJ, 1989, BRIT J NEUROSURG, V4, P354; Kanchiku T, 2001, SPINE, V26, P269; Kaneko K, 2003, RINSYO SEIKEI GEKA, P383; Kokubun S, 1993, ORTHOP SURG, V28, P881; Lazzaro VD, 1992, ELECTROENCEPHALOGR C, V85, P311; Lyu RK, 2004, J NEUROL NEUROSUR PS, V75, P256; Matsumoto H, 2012, MUSCLE NERVE, V46, P932, DOI 10.1002/mus.23430; Nakamae T, 2010, EUR SPINE J, V19, P685, DOI 10.1007/s00586-009-1246-8; SATOMI K, 1988, SPINE, V13, P1217, DOI 10.1097/00007632-198811000-00003; Seichi A, 2006, SPINE, V31, P1338, DOI 10.1097/01.brs.0000219475.21126.6b; SHINOMIYA K, 1988, SPINE, V13, P1225, DOI 10.1097/00007632-198811000-00004; Takahashi J, 2008, SPINE, V33, pE15, DOI 10.1097/BRS.0b013e31815e5dae; Tani T, 1999, J NEUROL NEUROSUR PS, V66, P456, DOI 10.1136/jnnp.66.4.456; Tsuzuki N, 1983, ORTHOP SURG, V34, P329; Uematsu Y, 2002, SPINE SPINAL CORD, V15, P502; Yonemura H, 2004, J ORTHOP SCI, V9, P540, DOI 10.1007/s00776-004-0832-1	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	FEB 1	2015	40	3					E161	E167		10.1097/BRS.0000000000000698		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CA3TI	WOS:000348828600005		
J	Takeshima, Y; Matsuda, R; Hironaka, Y; Motoyama, Y; Nakase, H				Takeshima, Yasuhiro; Matsuda, Ryosuke; Hironaka, Yasuo; Motoyama, Yasushi; Nakase, Hiroyuki			Rheumatoid Arthritis-Induced Lateral Atlantoaxial Subluxation With Multiple Vertebrobasilar Infarctions	SPINE			English	Article						rheumatoid arthritis; multiple cerebral infarction; vertebral artery; atlantoaxial subluxation; positional vertebral artery occlusion; 3-dimensional computed tomography angiography; lateral subluxation; posterior fusion	VERTEBRAL ARTERY-OCCLUSION; CERVICAL-SPINE; FEATURES	Study Design. Case report. Objective. To highlight the probability that lateral atlantoaxial subluxation (AAS) exists in patients with rheumatoid arthritis (RA) and induces vertebrobasilar infarctions that are more foregrounded than compressive myelopathy. Summary of Background Data. Although lateral subluxation is a well-known subtype of AAS, a case of cerebral ischemia associated with lateral AAS has not been reported before. Methods. A 52-year-old male with a 6-year history of RA had a sudden onset of visual field defect and mild right cerebellar ataxia. Head magnetic resonance imaging revealed acute multiple infarctions in the vertebrobasilar area, and magnetic resonance angiography revealed stenosis of the left vertebral artery (VA). Lateral radiograph of the cervical spine in the neutral position revealed atlanto-occipital assimilation and anterior AAS. T2-weighted sagittal images on cervical magnetic resonance imaging revealed high signal intensity in the spinal cord at C1-C2. Cerebral angiography revealed right VA occlusion and severe stenosis of the left V3 segment of VA. Three-dimensional computed tomography angiography of the craniovertebral junction revealed lateral AAS, which was due to severe erosive changes of the facet joints, and the left V3 portion was stenosed by a bony component. During conservative therapy, the patient experienced left occulomotor nerve palsy due to a second stroke. Results. Two months later, the patient underwent occipitocervical posterior fusion with an iliac bone graft. His postoperative course was uneventful, and the left VA stenosis disappeared. At the 45-month follow-up, he had no further infarctions. Bony fusion was radiologically confirmed, and 3-dimensional computed tomography angiography revealed good patency of the affected left VA. Conclusion. In patients with RA, the potential risk of AAS should be recognized. Lateral AAS in particular may induce cerebral ischemia by positional VA occlusion in advanced stages of the disease.	[Takeshima, Yasuhiro; Matsuda, Ryosuke; Hironaka, Yasuo; Motoyama, Yasushi; Nakase, Hiroyuki] Nara Med Univ, Sch Med, Dept Neurosurg, Kashihara, Nara 6348521, Japan	Takeshima, Y (reprint author), Nara Med Univ, Sch Med, Dept Neurosurg, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	takeshim@naramed-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24791516]	Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 24791516) funds were received in support of this work.	WEBB FWS, 1968, BRIT MED J, V2, P537; Takeshima Y, 2014, SPINE, V39, pE860, DOI 10.1097/BRS.0000000000000341; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659; Fujiwara H, 2012, MOD RHEUMATOL, V22, P605, DOI 10.1007/s10165-011-0547-z; Gaikwad SB, 2004, SPINE, V29, pE321, DOI 10.1097/01.BRS.0000132518.18374.19; HALLA JT, 1982, ARTHRITIS RHEUM, V25, P1316, DOI 10.1002/art.1780251107; Kuether TA, 1997, NEUROSURGERY, V41, P432; Kuether TA, 1997, NEUROSURGERY, V41, P427, DOI 10.1097/00006123-199708000-00019; Neo M, 2008, MOD RHEUMATOL, V18, P327, DOI 10.1007/s10165-008-0059-7; Saito Kozue, 2010, Clin Med Insights Case Rep, V3, P1; Saito K, 2010, J NEUROIMAGING, V20, P284, DOI 10.1111/j.1552-6569.2008.00309.x; Sakamoto Y, 2011, NEUROLOGY, V77, P1403, DOI 10.1212/WNL.0b013e31823152f9; WEISSMAN BNW, 1982, RADIOLOGY, V144, P745; Yoshitomi H, 2011, SPINE, V36, pE1493, DOI 10.1097/BRS.0b013e31820053a3	14	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	FEB 1	2015	40	3					E186	E189		10.1097/BRS.0000000000000701		4	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CA3TI	WOS:000348828600009		
